PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baranovskiy, AG; Gu, JY; Babayeva, ND; Kurinov, I; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Gu, Jianyou; Babayeva, Nigar D.; Kurinov, Igor; Pavlov, Youri I.; Tahirov, Tahir H.			Crystal structure of the human Pol is an element of B-subunit in complex with the C-terminal domain of the catalytic subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-EPSILON; CYCLE-DEPENDENT PHOSPHORYLATION; IRON-SULFUR CLUSTER; NONCATALYTIC SUBUNIT; ALPHA; REPLICATION; PRIMASE; DPB2; ARCHITECTURE; ORIGIN	The eukaryotic B-family DNA polymerases include four members: Pol alpha, Pol delta, Pol epsilon, and Pol zeta, which share common architectural features, such as the exonuclease/polymerase and C-terminal domains (CTDs) of catalytic subunitsboundto indispensable B-subunits, which serve as scaffolds that mediate interactions with other components of the replication machinery. Crystal structures for the B-subunits of Pol alpha and Pol delta / Pol zeta have been reported: the former within the primosome and separately with CTD and the latter with the N-terminal domain of the C-subunit. Here we present the crystal structure of the human Pol epsilon B-subunit (p59) in complex with CTD of the catalytic subunit (p261C). The structure revealed a well defined electron density for p261C and the phosphodiesterase and oligonucleotide/ oligosaccharide-binding domains of p59. However, electron density was missing for the p59 N-terminal domain and for the linker connecting it to the phosphodiesterase domain. Similar to Pol alpha, p261(C) of Pol epsilon contains a three-helix bundle in the middle and zinc-binding modules on each side. Intersubunit interactions involving 11 hydrogen bonds and numerous hydrophobic contacts account for stable complex formation with a buried surface area of 3094 A(2). Comparative structural analysis of p59-p261C with the corresponding Pol alpha complex revealed significant differences between the B-subunits and CTDs, as well as their interaction interfaces. The B-subunit of Pol delta / Pol zeta also substantially differs from B-subunits of either Pol alpha or Pol epsilon. This work provides a structural basis to explain biochemical and genetic data on the importance of B-subunit integrity in replisome function in vivo.	[Baranovskiy, Andrey G.; Gu, Jianyou; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Genet & Anat, Omaha, NE 68198 USA; [Kurinov, Igor] Cornell Univ, Northeastern Collaborat Access Team, Adv Photon Source, Dept Chem & Chem Biol, Argonne, IL 60439 USA; [Gu, Jianyou] Zhejiang Prov Hosp Tradit Chinese Med, Hangzhou 310006, Zhejiang, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Zhejiang Chinese Medical University	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796	NCI NIH HHS [P30 CA036727] Funding Source: Medline; NCRR NIH HHS [S10 RR029205] Funding Source: Medline; NIGMS NIH HHS [P41 GM103403, R01 GM101167] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P41GM103403] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aksenova A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001209; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Asturias FJ, 2006, NAT STRUCT MOL BIOL, V13, P35, DOI 10.1038/nsmb1040; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020062; Baranovskiy AG, 2016, J BIOL CHEM, V291, P10006, DOI 10.1074/jbc.M116.717405; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bermudez VP, 2011, J BIOL CHEM, V286, P28963, DOI 10.1074/jbc.M111.256289; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dmowski M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006572; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Dua R, 2002, J BIOL CHEM, V277, P7889, DOI 10.1074/jbc.M108546200; FOIANI M, 1995, MOL CELL BIOL, V15, P883; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garbacz M, 2015, DNA REPAIR, V29, P23, DOI 10.1016/j.dnarep.2015.02.007; Garcia JS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-82; Georgescu R, 2017, P NATL ACAD SCI USA, V114, pE697, DOI 10.1073/pnas.1620500114; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hogg M, 2014, NAT STRUCT MOL BIOL, V21, P49, DOI 10.1038/nsmb.2712; Isoz I, 2012, NUCLEIC ACIDS RES, V40, P11545, DOI 10.1093/nar/gks880; Jain R, 2014, J MOL BIOL, V426, P301, DOI 10.1016/j.jmb.2013.10.015; Jaszczur M, 2008, GENETICS, V178, P633, DOI 10.1534/genetics.107.082818; Jaszczur M, 2009, MUTAT RES-FUND MOL M, V669, P27, DOI 10.1016/j.mrfmmm.2009.04.012; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kesti T, 2004, J BIOL CHEM, V279, P14245, DOI 10.1074/jbc.M313289200; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kraszewska J, 2012, MUTAT RES-FUND MOL M, V737, P34, DOI 10.1016/j.mrfmmm.2012.06.002; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Li Y, 2000, J BIOL CHEM, V275, P31554; Makarova AV, 2015, DNA REPAIR, V29, P47, DOI 10.1016/j.dnarep.2015.02.012; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nuutinen T, 2008, NUCLEIC ACIDS RES, V36, P5102, DOI 10.1093/nar/gkn497; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Sun JC, 2015, NAT STRUCT MOL BIOL, V22, P976, DOI 10.1038/nsmb.3113; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Tsubotao T, 2006, J BIOL CHEM, V281, P32898, DOI 10.1074/jbc.M606637200; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Zahurancik WJ, 2015, DNA REPAIR, V29, P16, DOI 10.1016/j.dnarep.2015.01.008; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655; Zhou JC, 2017, P NATL ACAD SCI USA, V114, P4141, DOI 10.1073/pnas.1700530114; Zhou JQ, 1997, NUCLEIC ACIDS RES, V25, P1094, DOI 10.1093/nar/25.6.1094	57	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15717	15730		10.1074/jbc.M117.792705	http://dx.doi.org/10.1074/jbc.M117.792705			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28747437	Green Published, hybrid			2022-12-26	WOS:000411512200012
J	Zhao, ZY; Tang, KW; Muylaert, I; Sarnuelsson, T; Elias, P				Zhao, Zhiyuan; Tang, Ka-Wei; Muylaert, Isabella; Sarnuelsson, Tore; Elias, Per			CDK9 and SPT5 proteins are specifically required for expression of herpes simplex virus 1 replication-dependent late genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; P-TEFB; TERMINAL DOMAIN; MACROMOLECULAR-SYNTHESIS; GAMMA-2 GENES; TRANSCRIPTION; TYPE-1; ELONGATION; PROMOTER; ICP27	DNA replication greatly enhances expression of the herpes simplex virus 1 (HSV-1) gamma 2 late genes by still unknown mechanisms. Here, we demonstrate that 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), an inhibitor of CDK9, suppresses expression of gamma 2 late genes with an IC50 of 5 mu M, which is at least 10 times lower than the IC50 value required for inhibition of expression of early genes. The effect of DRB could not be explained by inhibition of DNA replication per se or loading of RNA polymerase II to late promoters and subsequent reduction of transcription. Instead, DRB reduces accumulation of gamma 2 late mRNA in the cytoplasm. In addition, we show that siRNA-mediated knockdown of the transcription factor SPT5, but not NELF-E, also gives rise to a specific inhibition of HSV-1 late gene expression. Finally, addition of DRB reduces co-immunoprecipitation of ICP27 using an anti-SPT5 antibody. Our results suggest that efficient expression of replication-dependent gamma 2 late genes is, at least in part, regulated by CDK9 dependent co-and/or post-transcriptional events involving SPT5 and ICP27.	[Zhao, Zhiyuan; Tang, Ka-Wei; Muylaert, Isabella; Sarnuelsson, Tore; Elias, Per] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Inst Biomed, Box 440, SE-40530 Gothenburg, Sweden	University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Inst Biomed, Box 440, SE-40530 Gothenburg, Sweden.	per.elias@medkem.gu.se	Zhao, Zhiyuan/Q-9330-2018	Zhao, Zhiyuan/0000-0002-6962-1791; Tang, Ka-Wei/0000-0003-1189-5092	Swedish Cancer Society [16 0400]	Swedish Cancer Society(Swedish Cancer Society)	This work was supported by Grant 16 0400 from the Swedish Cancer Society (to P.E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abrisch RG, 2016, J VIROL, V90, P2503, DOI 10.1128/JVI.02665-15; Albert TK, 2014, BRIT J PHARMACOL, V171, P55, DOI 10.1111/bph.12408; Alfonso-Dunn R, 2017, CELL HOST MICROBE, V21, P507, DOI 10.1016/j.chom.2017.03.007; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Biglione S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-47; BLUMEL J, 1995, J GEN VIROL, V76, P3119, DOI 10.1099/0022-1317-76-12-3119; COEN DM, 1986, SCIENCE, V234, P53, DOI 10.1126/science.3018926; COOK WJ, 1995, J VIROL, V69, P7291, DOI 10.1128/JVI.69.11.7291-7294.1995; Dai-Ju JQ, 2006, J VIROL, V80, P3567, DOI 10.1128/JVI.80.7.3567-3581.2006; DAVISON MJ, 1984, J GEN VIROL, V65, P859, DOI 10.1099/0022-1317-65-5-859; Dembowski JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006166; Dembowski JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004939; Durand LO, 2008, J VIROL, V82, P10591, DOI 10.1128/JVI.01242-08; Fujinaga K, 2004, MOL CELL BIOL, V24, P787, DOI 10.1128/MCB.24.2.787-795.2004; GUZOWSKI JF, 1994, J VIROL, V68, P7774, DOI 10.1128/JVI.68.12.7774-7789.1994; GUZOWSKI JF, 1993, J VIROL, V67, P5098, DOI 10.1128/JVI.67.9.5098-5108.1993; HOMA FL, 1986, MOL CELL BIOL, V6, P3652, DOI 10.1128/MCB.6.11.3652; HOMA FL, 1988, GENE DEV, V2, P40, DOI 10.1101/gad.2.1.40; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Jean S, 2001, VIROLOGY, V283, P273, DOI 10.1006/viro.2001.0902; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; KIBLER PK, 1991, J VIROL, V65, P6749, DOI 10.1128/JVI.65.12.6749-6760.1991; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Laitem C, 2015, NAT STRUCT MOL BIOL, V22, P396, DOI 10.1038/nsmb.3000; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu Y, 2009, MOL CELL BIOL, V29, P4852, DOI 10.1128/MCB.00609-09; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; MAVROMARANAZOS P, 1987, VIROLOGY, V161, P593, DOI 10.1016/0042-6822(87)90156-5; Mayer A, 2012, MOL CELL BIOL, V32, P1321, DOI 10.1128/MCB.06310-11; MCKNIGHT SL, 1984, CELL, V37, P253, DOI 10.1016/0092-8674(84)90321-0; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; Muylaert I, 2012, J BIOL CHEM, V287, P33142, DOI 10.1074/jbc.M112.356782; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pande NT, 1998, VIROLOGY, V246, P145, DOI 10.1006/viro.1998.9189; PEDERSON NE, 1992, J VIROL, V66, P6226, DOI 10.1128/JVI.66.10.6226-6232.1992; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Ping Yueh-Hsin, 2004, Retrovirology, V1, P46, DOI 10.1186/1742-4690-1-46; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sampath P, 2008, J VIROL, V82, P2339, DOI 10.1128/JVI.02459-07; Sandri-Goldin RM, 2011, FUTURE MICROBIOL, V6, P1261, DOI [10.2217/FMB.11.119, 10.2217/fmb.11.119]; Schneider S, 2010, MOL CELL BIOL, V30, P2353, DOI 10.1128/MCB.00116-10; Sedlackova L, 2010, J VIROL, V84, P2707, DOI 10.1128/JVI.02005-09; Smith RWP, 2017, P NATL ACAD SCI USA, V114, P6310, DOI 10.1073/pnas.1610417114; Smith RWP, 2005, BIOCHEM SOC T, V33, P499, DOI 10.1042/BST0330499; Sonawane YA, 2016, J MED CHEM, V59, P8667, DOI 10.1021/acs.jmedchem.6b00150; Weir JP, 2001, GENE, V271, P117, DOI 10.1016/S0378-1119(01)00512-1; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	57	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15489	15500		10.1074/jbc.M117.806000	http://dx.doi.org/10.1074/jbc.M117.806000			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28743741	Green Published, hybrid			2022-12-26	WOS:000410809800028
J	Nomura, W; Maeta, K; Inoue, Y				Nomura, Wataru; Maeta, Kazuhiro; Inoue, Yoshiharu			Phosphatidylinositol 3,5-bisphosphate is involved in methylglyoxal-induced activation of the Mpk1 mitogen-activated protein kinase cascade in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR PROTEIN; GLYOXALASE-I; YEAST; STRESS; MEMBRANE; CELL; COMPLEX; MORPHOLOGY; PATHWAY; ENDOCYTOSIS	Methylglyoxal (MG) is a natural metabolite derived from glycolysis, and this 2-oxoaldehyde has been implicated in some diseases including diabetes. However, the physiological significance of MG for cellular functions is yet to be fully elucidated. We previously reported that MG activates the Mpk1 (MAPK) cascade in the yeast Saccharomyces cerevisiae. To gain further insights into the cellular functions and responses to MG, we herein screened yeast-deletion mutant collections for susceptibility to MG. We found that mutants defective in the synthesis of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) are more susceptible to MG. PtdIns(3,5)P-2 levels increased following MG treatment, and vacuolar morphology concomitantly changed to a single swollen shape. MG activated the Pkc1-Mpk1 MAPK cascade in which a small GTPase Rho1 plays a crucial role, and the MG-induced phosphorylation of Mpk1 was impaired in mutants defective in the PtdIns(3,5)P-2 biosynthetic pathway. Of note, heat shock-induced stress also provoked Mpk1 phosphorylation in a Rho1-dependent manner; however, PtdIns(3,5)P-2 was dispensable for the heat shock-stimulated activation of this signaling pathway. Our results suggest that PtdIns(3,5)P-2 is specifically involved in the MG-induced activation of the Mpk1 MAPK cascade and in the cellular adaptation to MG-induced stress.	[Nomura, Wataru; Maeta, Kazuhiro; Inoue, Yoshiharu] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Mol Microbiol, Uji, Kyoto 6110011, Japan; [Nomura, Wataru] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Lab Mol Funct Food, Uji, Kyoto 6110011, Japan; [Maeta, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Neurotherapeut, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Inoue, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Lab Mol Microbiol, Uji, Kyoto 6110011, Japan.	y_inoue@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26560397]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Challenging Exploratory Research (to W.N.) from Japan Society for the Promotion of Science (JSPS) Grant 26560397. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed N, 2005, J NEUROCHEM, V92, P255, DOI 10.1111/j.1471-4159.2004.02864.x; Angeloni Cristina, 2014, Biomed Res Int, V2014, P238485, DOI 10.1155/2014/238485; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Bonangelino CJ, 1997, MOL CELL BIOL, V17, P6847, DOI 10.1128/MCB.17.12.6847; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Chen F, 2004, P NATL ACAD SCI USA, V101, P7687, DOI 10.1073/pnas.0402338101; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Desfougeres Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29045; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Dove SK, 2007, BIOCHEM SOC SYMP, V74, P129, DOI 10.1042/BSS2007c12; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Duex JE, 2006, EUKARYOT CELL, V5, P723, DOI 10.1128/EC.5.4.723-731.2006; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Gaubitz C, 2016, TRENDS BIOCHEM SCI, V41, P532, DOI 10.1016/j.tibs.2016.04.001; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hama H, 2000, METHODS, V20, P465, DOI 10.1006/meth.2000.0959; Hatakeyama R, 2017, J CELL SCI, V130, P1169, DOI 10.1242/jcs.198382; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Inoue Y, 2011, SEMIN CELL DEV BIOL, V22, P278, DOI 10.1016/j.semcdb.2011.02.002; Jin N, 2016, BIOCHEM SOC T, V44, P177, DOI 10.1042/BST20150174; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Junaid MA, 2004, AM J MED GENET A, V131A, P11, DOI 10.1002/ajmg.a.30349; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maeta K, 2004, MOL CELL BIOL, V24, P8753, DOI 10.1128/MCB.24.19.8753-8764.2004; Matafome P, 2013, ENDOCRINE, V43, P472, DOI 10.1007/s12020-012-9795-8; McCartney AJ, 2014, BIOESSAYS, V36, P52, DOI 10.1002/bies.201300012; Meaden PG, 1999, YEAST, V15, P1211, DOI 10.1002/(SICI)1097-0061(19990915)15:12<1211::AID-YEA448>3.0.CO;2-H; Nomura W, 2017, CELL SIGNAL, V31, P146, DOI 10.1016/j.cellsig.2017.01.002; Nomura W, 2015, MOL CELL BIOL, V35, P1269, DOI 10.1128/MCB.01118-14; PAYNE GS, 1985, SCIENCE, V230, P1009, DOI 10.1126/science.2865811; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; RANGANATHAN S, 1993, J BIOL CHEM, V268, P5661; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P238, DOI 10.1021/bi00829a034; SILVEIRA LA, 1990, J CELL BIOL, V111, P1437, DOI 10.1083/jcb.111.4.1437; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Takatsume Y, 2006, J BIOL CHEM, V281, P9086, DOI 10.1074/jbc.M511037200; THORNALLEY PJ, 1989, DIABETES RES CLIN PR, V7, P115, DOI 10.1016/0168-8227(89)90101-0; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yoshida A, 2012, J BIOL CHEM, V287, P701, DOI 10.1074/jbc.M111.322222; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209	64	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15039	15048		10.1074/jbc.M117.791590	http://dx.doi.org/10.1074/jbc.M117.791590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28743744	Green Published, hybrid			2022-12-26	WOS:000409902100026
J	Hertting, O; Luthje, P; Sullivan, D; Aspenstrom, P; Brauner, A				Hertting, Olof; Luthje, Petra; Sullivan, Devin; Aspenstrom, Pontus; Brauner, Annelie			Vitamin D-deficient mice have more invasive urinary tract infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; HUMAN UROTHELIAL CELLS; CATHELICIDIN; EXPRESSION; IMMUNITY	Vitamin D deficiency is a common health problem with consequences not limited to bone and calcium hemostasis. Low levels have also been linked to tuberculosis and other respiratory infections as well as autoimmune diseases. We have previously shown that supplementation with vitamin D can induce the antimicrobial peptide cathelicidin during ex vivo infection of human urinary bladder. In rodents, however, cathelicidin expression is not linked to vitamin D and therefore this vitamin D-related effect fighting bacterial invasion is not relevant. To determine if vitamin D had further protective mechanisms during urinary tract infections, we therefore used a mouse model. In vitamin D-deficient mice, we detected more intracellular bacterial communities in the urinary bladder, higher degree of bacterial spread to the upper urinary tract and a skewed cytokine response. Furthermore, we show that the vitamin D receptor was upregulated in the urinary bladder and translocated into the cell nucleus after E. coli infection. This study supports a more general role for vitamin D as a local immune response mediator in the urinary tract.	[Hertting, Olof; Luthje, Petra; Brauner, Annelie] Karolinska Univ Hosp, Div Clin Mircrobiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hertting, Olof; Luthje, Petra; Brauner, Annelie] Karolinska Inst, Stockholm, Sweden; [Hertting, Olof] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Pediat Infect Dis Unit, Stockholm, Sweden; [Sullivan, Devin] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Stockholm, Sweden; [Aspenstrom, Pontus] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; Karolinska Institutet	Brauner, A (corresponding author), Karolinska Univ Hosp, Div Clin Mircrobiol, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.; Brauner, A (corresponding author), Karolinska Inst, Stockholm, Sweden.	Annelie.Brauner@ki.se	Hertting, Olof/ABB-9574-2020	Hertting, Olof/0000-0002-0813-7998; Sullivan, Devin/0000-0001-6176-108X	Swedish Research Council [56X-20356]; ALF project funds; KI funds; Swedish Cancer Society [2014/0644]	Swedish Research Council(Swedish Research CouncilEuropean Commission); ALF project funds; KI funds; Swedish Cancer Society(Swedish Cancer Society)	This work was funded by the Swedish Research Council, 56X-20356 (AB), ALF project funds (AB); KI funds (AB), Swedish Cancer Society, 2014/0644 (PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chapman EJ, 2008, MOL CANCER RES, V6, P1154, DOI 10.1158/1541-7786.MCR-07-2168; Chromek M, 2008, J MOL MED, V86, P37, DOI 10.1007/s00109-007-0256-4; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; FOXMAN B, 1990, AM J PUBLIC HEALTH, V80, P331, DOI 10.2105/AJPH.80.3.331; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hertting O, 2003, CLIN EXP IMMUNOL, V131, P225, DOI 10.1046/j.1365-2249.2003.02076.x; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz DJ, 2011, INFECT IMMUN, V79, P4250, DOI 10.1128/IAI.05339-11; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Stamm WE, 2002, AM J MED, V113, p1S; White JH, 2008, INFECT IMMUN, V76, P3837, DOI 10.1128/IAI.00353-08; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998	26	11	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180810	10.1371/journal.pone.0180810	http://dx.doi.org/10.1371/journal.pone.0180810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749951	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700018
J	Armiento, A; Moireau, P; Martin, D; Lepejova, N; Doumic, M; Rezaei, H				Armiento, Aurora; Moireau, Philippe; Martin, Davy; Lepejova, Nad'a; Doumic, Marie; Rezaei, Human			The mechanism of monomer transfer between two structurally distinct PrP oligomers	PLOS ONE			English	Article							PROTEIN; PRIONS	In mammals, Prion pathology refers to a class of infectious neuropathologies whose mechanism is based on the self-perpetuation of structural information stored in the pathological conformer. The characterisation of the PrP folding landscape has revealed the existence of a plethora of pathways conducing to the formation of structurally different assemblies with different biological properties. However, the biochemical interconnection between these diverse assemblies remains unclear. The PrP oligomerisation process leads to the formation of neurotoxic and soluble assemblies called O1 oligomers with a high size heterodispersity. By combining the measurements in time of size distribution and average size with kinetic models and data assimilation, we revealed the existence of at least two structurally distinct sets of assemblies, termed O-a and O-b, forming O1 assemblies. We propose a kinetic model representing the main processes in prion aggregation pathway: polymerisation, depolymerisation, and disintegration. The two groups interact by exchanging monomers through a disintegration process that increases the size of O-a. Our observations suggest that PrP oligomers constitute a highly dynamic population.	[Armiento, Aurora] Univ Paris Diderot, Sorbonne Paris Cite, Lab JL Lions, UMR CNRS 7598,Inria, Paris, France; [Doumic, Marie] Sorbonne Univ, INRIA, UPMC Univ Paris 06, Lab JL Lions,UMR CNRS 7598, Paris, France; [Moireau, Philippe] INRIA, Campus Ecole Polytech, F-91128 Palaiseau, France; [Moireau, Philippe] Univ Paris Saclay, Campus Ecole Polytech, F-91128 Palaiseau, France; [Martin, Davy; Lepejova, Nad'a; Rezaei, Human] INRA, UR892, Virol Immunol Mol, F-78350 Jouy En Josas, France; [Doumic, Marie] Univ Vienna, Wolfgang Pauli Inst, Oskar Morgenstern Pl 1, A-1090 Vienna, Austria	Inria; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Inria; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Inria; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Vienna	Doumic, M (corresponding author), Sorbonne Univ, INRIA, UPMC Univ Paris 06, Lab JL Lions,UMR CNRS 7598, Paris, France.; Moireau, P (corresponding author), INRIA, Campus Ecole Polytech, F-91128 Palaiseau, France.; Moireau, P (corresponding author), Univ Paris Saclay, Campus Ecole Polytech, F-91128 Palaiseau, France.; Rezaei, H (corresponding author), INRA, UR892, Virol Immunol Mol, F-78350 Jouy En Josas, France.; Doumic, M (corresponding author), Univ Vienna, Wolfgang Pauli Inst, Oskar Morgenstern Pl 1, A-1090 Vienna, Austria.	philippe.moireau@inria.fr; marie.doumic@inria.fr; human.rezaei@jouy.inra.fr	Moireau, Philippe/D-1282-2010; Doumic, Marie/AAC-5766-2020	Moireau, Philippe/0000-0001-9996-5213; Doumic, Marie/0000-0002-3183-8215; Martin, Davy/0000-0003-2421-716X	ERC Starting Grant SKIPPERAD [306321]	ERC Starting Grant SKIPPERAD	ERC Starting Grant SKIPPERAD, number 306321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.A., M.D. and H.R. have been supported by the ERC Starting Grant SKIPPER<SUP>AD</SUP> (number 306321).	Annamalai K, 2016, ANGEW CHEM INT EDIT, V55, P4822, DOI 10.1002/anie.201511524; Armiento A, 2016, J THEOR BIOL, V397, P68, DOI 10.1016/j.jtbi.2016.02.037; Becker R, 1935, ANN PHYS-BERLIN, V24, P719; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Collet JF, 2002, SIAM J APPL MATH, V62, P1488, DOI 10.1137/S0036139900378852; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Hariz S, 1999, APPL MATH LETT, V12, P81, DOI 10.1016/S0893-9659(98)00138-4; Jazwinski A.H., 2007, STOCHASTIC PROCESSES, P93; Kaiser-Schulz G, 2007, PLOS PATHOG, V3; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; LIFSHITZ IM, 1961, J PHYS CHEM SOLIDS, V19, P35, DOI 10.1016/0022-3697(61)90054-3; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Prigent S, 2011, PRION, V5, P69, DOI 10.4161/pri.5.2.16383; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Zhang JN, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050295	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180538	10.1371/journal.pone.0180538	http://dx.doi.org/10.1371/journal.pone.0180538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746342	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800014
J	Lee, AR; Kim, S; Ko, KW; Park, CS				Lee, A-Ram; Kim, Sulgi; Ko, Kwang Woo; Park, Chul-Seung			Differential effects of N-linked glycosylation of Vstm5 at multiple sites on surface expression and filopodia formation	PLOS ONE			English	Article							RECEPTOR SUBUNITS; PROTEIN GLYCOSYLATION; DENDRITIC FILOPODIA; CELL-SURFACE; MEMBRANE; SCHIZOPHRENIA; TRANSPORTER; TRAFFICKING; SYNAPTOGENESIS; MORPHOLOGY	V-set and transmembrane domain-containing protein 5 (Vstm5), a newly characterized small membrane glycoprotein, can induce membrane protrusions in various cells. Vstm5 can modulate both the position and complexity of central neurons by altering their membrane morphology and dynamics. In this study, we investigated the significance of glycosylation in the expression and function of Vstm5. Four N-linked glycosylation sites (Asn(43), Asn(87), Asn(101), and Asn(108)) are predicted to be located in the extracellular N-terminus of mouse Vstm5. Although all four sites were glycosylated, their functional roles may not be identical. N-glycosylation at multiple sites affects differentially the function of Vstm5. Glycosylation at individual sites not only played essential roles in surface expression of Vstm5 but also in the formation of neuronal dendritic filopodia. These results indicate that N-linked glycosylation at multiple sites plays important roles by differentially influencing the expression, targeting, and biological activity of Vstm5.	[Lee, A-Ram; Kim, Sulgi; Ko, Kwang Woo; Park, Chul-Seung] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Lee, A-Ram; Park, Chul-Seung] Gwangju Inst Sci & Technol, Bioimaging Res Ctr Gwangju, Gwangju, South Korea; [Ko, Kwang Woo] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Washington University (WUSTL)	Park, CS (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea.; Park, CS (corresponding author), Gwangju Inst Sci & Technol, Bioimaging Res Ctr Gwangju, Gwangju, South Korea.	cspark@gist.ac.kr		Park, Chul-Seung/0000-0003-0209-1412	National Leading Research Laboratory from the National Research Foundation of Korea [20110028665]; GIST	National Leading Research Laboratory from the National Research Foundation of Korea(National Research Foundation of Korea); GIST	This work was supported by the grant for National Leading Research Laboratory (20110028665) from the National Research Foundation of Korea (study design, and data collection and analysis) and by the grant for Bio-imaging Research Center by GIST in 2016 and 2017 (data collection and analysis, decision to publish, and preparation of the manuscript).	Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Biernacka JM, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.47; Bungert S, 2001, J BIOL CHEM, V276, P23539, DOI 10.1074/jbc.M101902200; Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489; Chevet E, 2001, CURR OPIN STRUC BIOL, V11, P120, DOI 10.1016/S0959-440X(00)00168-8; Console L, 2015, BBA-MOL CELL RES, V1853, P1636, DOI 10.1016/j.bbamcr.2015.03.017; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; Fiala JC, 1998, J NEUROSCI, V18, P8900; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hidaka C, 2015, BIOCHEM BIOPH RES CO, V462, P346, DOI 10.1016/j.bbrc.2015.04.139; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Jing L, 2012, J NEUROSCI, V32, P4080, DOI 10.1523/JNEUROSCI.5021-11.2012; Khanna R, 2001, J BIOL CHEM, V276, P34028, DOI 10.1074/jbc.M105248200; Kim DS, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0468-5; Lee AR, 2016, J NEUROSCI, V36, P10181, DOI 10.1523/JNEUROSCI.0541-16.2016; Luk WKW, 2012, FEBS J, V279, P3229, DOI 10.1111/j.1742-4658.2012.08708.x; Matsuda K, 2004, J NEUROCHEM, V89, P928, DOI 10.1111/j.1471-4159.2004.02377.x; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mueller TM, 2014, NEUROPSYCHOPHARMACOL, V39, P528, DOI 10.1038/npp.2013.190; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Scott Hilary, 2014, Adv Neurobiol, V9, P367, DOI 10.1007/978-1-4939-1154-7_17; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Tucholski J, 2013, NEUROREPORT, V24, P688, DOI 10.1097/WNR.0b013e328363bd8a; Tucholski J, 2013, SCHIZOPHR RES, V146, P177, DOI 10.1016/j.schres.2013.01.031; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583; Zhou TT, 2012, INT J BIOL SCI, V8, P630, DOI 10.7150/ijbs.3684; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181257	10.1371/journal.pone.0181257	http://dx.doi.org/10.1371/journal.pone.0181257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746350	gold, Green Submitted, Green Published			2022-12-26	WOS:000406371800032
J	Sabet, S; George, MA; EI-Shorbagy, HM; Bassiony, H; Farroh, KY; Youssef, T; Salaheldin, TA				Sabet, Salwa; George, Marina A.; EI-Shorbagy, Haidan M.; Bassiony, Heba; Farroh, Khaled Y.; Youssef, Tareq; Salaheldin, Taher A.			Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; UNITED-STATES; IN-VITRO; INFECTION; EXPRESSION; THERAPY; DRUG; EPIDEMIOLOGY; OPTIMIZATION; FABRICATION	Background Development of an effective non-viral vaccine against hepatitis C virus infection is of a great importance. Gelatin nanoparticles (Gel. NPs) have an attention and promising approach as a viable carrier for delivery of vaccine, gene, drug and other biomolecules in the body. Aim of work The present study aimed to develop stable Gel. NPs conjugated with nonstructural protein 2 (NS2) gene of Hepatitis C Virus genotype 4a (HCV4a) as a safe and an efficient vaccine delivery system. Methods and results Gel.NPs were synthesized and characterized (size: 150 +/- 2 nm and zeta potential + 17.6 mv). NS2 gene was successfully cloned and expressed into E. coli M15 using pQE-30 vector. Antigenicity of the recombinant NS2 protein was confirmed by Western blotting to verify the efficiency of NS2 as a possible vaccine. Then NS2 gene was conjugated to gelatin nanoparticles and a successful conjugation was confirmed by labeling and imaging using Confocal Laser Scanning Microscope (CLSM). Interestingly, the transformation of the conjugated NS2/Gel. NPs complex into E. coli DH5-a was 50% more efficient than transformation with the gene alone. In addition, conjugated NS2/Gel. NPs with ratio 1: 100 (w/w) showed higher transformation efficiency into E. coli DH5-a than the other ratios (1: 50 and 2: 50). Conclusion Gel. NPs effectively enhanced the gene delivery in bacterial cells without affecting the structure of NS2 gene and could be used as a safe, easy, rapid, cost-effective and non-viral vaccine delivery system for HCV.	[Sabet, Salwa; EI-Shorbagy, Haidan M.; Bassiony, Heba] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [George, Marina A.; Youssef, Tareq] Cairo Univ, Natl Inst Laser Enhanced Sci, Dept Photochem & Photobiol, Giza, Egypt; [Farroh, Khaled Y.; Salaheldin, Taher A.] Agr Res Ctr, Nanotechnol & Adv Mat Cent Lab, Giza, Egypt; [Salaheldin, Taher A.] British Univ Egypt, Mostafa El Sayed Nanotechnol Res Ctr, El Sherouk, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); British University in Egypt	Sabet, S (corresponding author), Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt.; Salaheldin, TA (corresponding author), Agr Res Ctr, Nanotechnol & Adv Mat Cent Lab, Giza, Egypt.; Salaheldin, TA (corresponding author), British Univ Egypt, Mostafa El Sayed Nanotechnol Res Ctr, El Sherouk, Egypt.	salwa@sci.cs.edu.eg; t1salah@hotmail.com		, Ahmed/0000-0003-1262-6820; El-Shorbagy, Haidan/0000-0001-5440-3057; Sabet, Salwa/0000-0002-4097-7866				Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Bhatti Z, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-8; Brzoska M, 2004, BIOCHEM BIOPH RES CO, V318, P562, DOI 10.1016/j.bbrc.2004.04.067; Choi YS, 2014, MOL CELL TOXICOL, V10, P1, DOI 10.1007/s13273-014-0001-3; Coester CJ, 2000, J MICROENCAPSUL, V17, P187; D'Ambrosio R, 2016, LIVER INT, V36, P783, DOI 10.1111/liv.13106; Doss W, 2015, J HEPATOL, V63, P581, DOI 10.1016/j.jhep.2015.04.023; Dumoulin FL, 2003, VIROLOGY, V305, P260, DOI 10.1006/viro.2002.1701; Elkady A, 2009, J MED VIROL, V81, P1015, DOI 10.1002/jmv.21492; Esmat G, 2013, E MEDITERR HEALTH J, V19, P587; Foox M, 2015, EXPERT OPIN DRUG DEL, V12, P1547, DOI 10.1517/17425247.2015.1037272; Gad RR, 2008, LIVER INT, V28, P1112, DOI 10.1111/j.1478-3231.2008.01750.x; Gorzin AA, 2012, J VIRAL HEPATITIS, V19, P189, DOI 10.1111/j.1365-2893.2011.01504.x; Gorzin Zahra, 2014, Iranian Biomedical Journal, V18, P1, DOI 10.6091/ibj.1231.2013; Harris HE, 2007, J VIRAL HEPATITIS, V14, P213, DOI 10.1111/j.1365-2893.2006.00795.x; Hosseinkhani H, 2015, POLYM ADVAN TECHNOL, V26, P198, DOI 10.1002/pat.3432; Jadhav NR, 2013, INT J PHARM INVESTIG, V3, P126, DOI 10.4103/2230-973X.119213; Jahanshahi M, 2008, J APPL STAT, V35, P1345, DOI 10.1080/02664760802382426; Jahanshahi M, 2008, PHYS STATUS SOLIDI A, V205, P2898, DOI 10.1002/pssa.200824329; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kamal SM, 2005, GUT, V54, P858, DOI 10.1136/gut.2004.057182; Kramer MF, 2001, CURR PROTOC MOL BIOL; Lehrman S, 1999, NATURE, V401, P517, DOI 10.1038/43977; Lorenz IC, 2010, VIRUSES-BASEL, V2, P1635, DOI 10.3390/v2081635; Ofokansi K, 2010, EUR J PHARM BIOPHARM, V76, P1, DOI 10.1016/j.ejpb.2010.04.008; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; Shiehzadeh F, 2016, CURR PHARM DES; Su K, 2015, BIOTECHNOL LETT, V37, P2139, DOI 10.1007/s10529-015-1907-0; Sun JY, 2003, GENE THER, V10, P964, DOI 10.1038/sj.gt.3302039; Truong-Le VL, 1998, HUM GENE THER, V9, P1709, DOI 10.1089/hum.1998.9.12-1709; Tseng CL, 2013, J NANOMATER, V2013, DOI 10.1155/2013/238351; VILE RG, 1993, CANCER RES, V53, P962; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023; Zwiorek K, 2008, PHARM RES-DORDR, V25, P551, DOI 10.1007/s11095-007-9410-5	38	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181723	10.1371/journal.pone.0181723	http://dx.doi.org/10.1371/journal.pone.0181723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746382	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800054
J	Iwase, K; Tanaka, M; Hirose, K; Uyeda, TQP; Hondal, H				Iwase, Kohei; Tanaka, Masateru; Hirose, Keiko; Uyeda, Taro Q. P.; Hondal, Hajime			Acceleration of the sliding movement of actin filaments with the use of a non-motile mutant myosin in in vitro motility assays driven by skeletal muscle heavy meromyosin	PLOS ONE			English	Article							REACTIVE THIOL REGION; FIXED H-MEROMYOSIN; F-ACTIN; FORCE GENERATION; MOTOR DOMAIN; ACTOMYOSIN; SURFACE; G680V; ATP; INHIBITION	We examined the movement of an actin filament sliding on a mixture of normal and genetically modified myosin molecules that were attached to a glass surface. For this purpose, we used a Dictyostelium G680V mutant myosin II whose release rates of Pi and ADP were highly suppressed relative to normal myosin, leading to a significantly extended life-time of the strongly bound state with actin and virtually no motility. When the mixing ratio of G680V mutant myosin II to skeletal muscle HMM (heavy myosin) was 0.01%, the actin filaments moved intermittently. When they moved, their sliding velocities were about two-fold faster than the velocity of skeletal HMM alone. Furthermore, sliding movements were also faster when the actin filaments were allowed to slide on skeletal muscle HMM-coated glass surfaces in the motility buffer solution containing G680V HMM. In this case no intermittent movement was observed. When the actin filaments used were copolymerized with a fusion protein consisting of Dictyostelium actin and Dictyostelium G680V myosin II motor domain, similar faster sliding movements were observed on skeletal muscle HMM-coated surfaces. The filament sliding velocities were about two-fold greater than the velocities of normal actin filaments. We found that the velocity of actin filaments sliding on skeletal muscle myosin molecules increased in the presence of a non-motile G680V mutant myosin motor.	[Iwase, Kohei; Tanaka, Masateru; Hondal, Hajime] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata, Japan; [Hirose, Keiko; Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Uyeda, Taro Q. P.] Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan	Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST); Waseda University	Hondal, H (corresponding author), Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata, Japan.	hhonda@vos.nagaokaut.ac.jp	Hirose, Keiko/M-5429-2018	Hirose, Keiko/0000-0003-4587-8346; Honda, Hajime/0000-0002-4959-5880				Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Bengtsson E, 2016, BIOPHYS J, V111, P1465, DOI 10.1016/j.bpj.2016.08.025; EGELMAN EH, 1995, CURR OPIN STRUC BIOL, V5, P172, DOI 10.1016/0959-440X(95)80072-7; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; HONDA H, 1986, J MOL BIOL, V191, P131, DOI 10.1016/0022-2836(86)90428-6; Honda H, 1999, BIOPHYS CHEM, V80, P139, DOI 10.1016/S0301-4622(99)00076-9; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; Ji Sakamaki, 2003, BIOPHYSICAL CHEM, V105, P59; Kim E, 1998, BIOCHEMISTRY-US, V37, P17801, DOI 10.1021/bi981286b; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; Oda T, 1996, BIOPHYS CHEM, V61, P63, DOI 10.1016/S0301-4622(96)00023-3; OOSAWA F, 1973, COLD SPRING HARB SYM, V37, P277, DOI 10.1101/SQB.1973.037.01.038; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Preller M, 2011, J BIOL CHEM, V286, P35051, DOI 10.1074/jbc.M111.265298; PROCHNIEWICZ E, 1990, J MOL BIOL, V216, P761, DOI 10.1016/0022-2836(90)90397-5; PROCHNIEWICZ E, 1993, BIOPHYS J, V65, P113, DOI 10.1016/S0006-3495(93)81057-9; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; SEKINE T, 1966, J BIOCHEM, V59, P195, DOI 10.1093/oxfordjournals.jbchem.a128284; SELLERS JR, 1990, SCIENCE, V249, P406, DOI 10.1126/science.2377894; Shimo R, 2001, BIOPHYS CHEM, V93, P23, DOI 10.1016/S0301-4622(01)00203-4; Siddique MSP, 2005, BIOCHEM BIOPH RES CO, V337, P1185, DOI 10.1016/j.bbrc.2005.09.159; Takagi Y, 2004, PHILOS T R SOC B, V359, P1913, DOI 10.1098/rstb.2004.1561; Tokuraku K, 2009, J MOL BIOL, V386, P149, DOI 10.1016/j.jmb.2008.12.008; Uyeda TQP, 2002, BIOCHEMISTRY-US, V41, P9525, DOI 10.1021/bi026177i; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Yokoyama K, 2002, BIOCHEM BIOPH RES CO, V299, P825, DOI 10.1016/S0006-291X(02)02758-4	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181171	10.1371/journal.pone.0181171	http://dx.doi.org/10.1371/journal.pone.0181171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742155	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700031
J	Liu, Y; Watson, SC; Gettings, JR; Lund, RB; Nordone, SK; Yabsley, MJ; McMahan, CS				Liu, Yan; Watson, Stella C.; Gettings, Jenna R.; Lund, Robert B.; Nordone, Shila K.; Yabsley, Michael J.; McMahan, Christopher S.			A Bayesian spatio-temporal model for forecasting Anaplasma species seroprevalence in domestic dogs within the contiguous United States	PLOS ONE			English	Article							DIROFILARIA-IMMITIS PREVALENCE; BURGDORFERI SENSU-LATO; BORRELIA-BURGDORFERI; LYME-DISEASE; GRANULOCYTIC ANAPLASMOSIS; EHRLICHIA-CANIS; PHAGOCYTOPHILUM; SURVEILLANCE; TICKS; COINFECTIONS	This paper forecasts the 2016 canine Anaplasma spp. seroprevalence in the United States from eight climate, geographic and societal factors. The forecast's construction and an assessment of its performance are described. The forecast is based on a spatial-temporal conditional autoregressive model fitted to over 11 million Anaplasma spp. seroprevalence test results for dogs conducted in the 48 contiguous United States during 2011-2015. The forecast uses county-level data on eight predictive factors, including annual temperature, precipitation, relative humidity, county elevation, forestation coverage, surface water coverage, population density and median household income. Non-static factors are extrapolated into the forthcoming year with various statistical methods. The fitted model and factor extrapolations are used to estimate next year's regional prevalence. The correlation between the observed and model-estimated county-by-county Anaplasma spp. seroprevalence for the five-year period 2011-2015 is 0.902, demonstrating reasonable model accuracy. The weighted correlation (accounting for different sample sizes) between 2015 observed and forecasted county-by-county Anaplasma spp. seroprevalence is 0.987, exhibiting that the proposed approach can be used to accurately forecast Anaplasma spp. seroprevalence. The forecast presented herein can a priori alert veterinarians to areas expected to see Anaplasma spp. seroprevalence beyond the accepted endemic range. The proposed methods may prove useful for forecasting other diseases.	[Liu, Yan; Watson, Stella C.; Gettings, Jenna R.; Lund, Robert B.; McMahan, Christopher S.] Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA; [Nordone, Shila K.] North Carolina State Univ, Coll Vet Med, Comparat Med Inst, Dept Mol & Biomed Sci, Raleigh, NC USA; [Yabsley, Michael J.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA 30602 USA; [Yabsley, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	Clemson University; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	McMahan, CS (corresponding author), Clemson Univ, Dept Math Sci, Clemson, SC 29634 USA.; Yabsley, MJ (corresponding author), Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA 30602 USA.; Yabsley, MJ (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	myabsley@uga.edu; mcmaha2@clemson.edu		Yabsley, Michael/0000-0003-2452-5015; Liu, Yan/0000-0002-3787-5906; mcmahan, christopher/0000-0001-5056-9615	Companion Animal Parasite Council; National Science Foundation [DMS 1407480]; National Institutes of Health [R01 AI121351]; Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121351] Funding Source: NIH RePORTER	Companion Animal Parasite Council; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship(Boehringer Ingelheim); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	IDEXX Laboratories, Inc. is thanked for their data contribution. The Companion Animal Parasite Council financially supported this work. YL and RBL also thank National Science Foundation Grant DMS 1407480. CSM was partially supported by Grant R01 AI121351 from the National Institutes of Health. JRG is supported by The Boehringer Ingelheim Vetmedica-CAPC Infectious Disease Postdoctoral Fellowship.	Adams Deborah, 2015, MMWR Morb Mortal Wkly Rep, V62, P1, DOI 10.15585/mmwr.mm6253a1; Banerjee S., 2014, HIERARCHICAL MODELIN; Beall MJ, 2008, VECTOR-BORNE ZOONOT, V8, P455, DOI 10.1089/vbz.2007.0236; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Bowman D, 2009, VET PARASITOL, V160, P138, DOI 10.1016/j.vetpar.2008.10.093; Bowman DD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1804-y; Brockwell P., 2006, INTRO TIME SERIES FO; Caulfield AJ, 2015, CLIN LAB MED, V35, P827, DOI 10.1016/j.cll.2015.07.006; Cressie N., 2015, STAT SPATIO TEMPORAL; Dahlgren FS, 2016, AM J TROP MED HYG, V94, P299, DOI 10.4269/ajtmh.15-0691; Dahlgren FS, 2015, AM J TROP MED HYG, V93, P66, DOI 10.4269/ajtmh.15-0122; Drouin EE, 2004, J AUTOIMMUN, V23, P281, DOI 10.1016/j.jaut.2004.06.005; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Eberts MD, 2011, J AM ANIM HOSP ASSOC, V47, pE86, DOI 10.5326/JAAHA-MS-5578; Eisen RJ, 2016, J MED ENTOMOL; Gelman A., 2021, BAYESIAN DATA ANAL; Greig B, 1996, J CLIN MICROBIOL, V34, P44, DOI 10.1128/JCM.34.1.44-48.1996; Kohn B, 2008, J VET INTERN MED, V22, P1289, DOI 10.1111/j.1939-1676.2008.0180.x; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Lathers CM, 2001, J CLIN PHARMACOL, V41, P595, DOI 10.1177/00912700122010474; Lilliehook I, 1998, VET CLIN PATH, V27, P116, DOI 10.1111/j.1939-165X.1998.tb01030.x; Little SE, 2010, VET CLIN N AM-SMALL, V40, P1121, DOI 10.1016/j.cvsm.2010.07.004; Lopez-Quilez A, 2009, REV SPATIO TEMPORAL; Martinez-Beneito MA, 2008, STAT MED, V27, P2874, DOI 10.1002/sim.3103; McMahan CS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1431-7; Mead P, 2011, EMERG INFECT DIS, V17, P1710, DOI 10.3201/eid1709.110210; Millen K, 2013, VECTOR-BORNE ZOONOT, V13, P340, DOI 10.1089/vbz.2012.1025; Movilla R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1686-z; Nair ADS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148239; Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704; O'Connor TP, 2006, AM J VET RES, V67, P206, DOI 10.2460/ajvr.67.2.206; Poitout FM, 2005, J CLIN MICROBIOL, V43, P796, DOI 10.1128/JCM.43.2.796-801.2005; Qurollo Barbara A., 2014, Infection Ecology & Epidemiology, V4, P24699, DOI 10.3402/iee.v4.24699; Spencer JA, 2003, PARASITOL RES, V90, pS106, DOI 10.1007/s00436-003-0904-8; Steere AC, 2003, CLIN INFECT DIS, V36, P1078, DOI 10.1086/368187; Stern HS, 1999, INFERENCE EXTREMES D; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Wang DM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-264; Wengenmayer C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0525-3; Xia H, 1998, STAT MED, V17, P2025, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2025::AID-SIM865>3.0.CO;2-M; Yabsley MJ, 2006, VECTOR-BORNE ZOONOT, V6, P7, DOI 10.1089/vbz.2006.6.7	42	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0182028	10.1371/journal.pone.0182028	http://dx.doi.org/10.1371/journal.pone.0182028			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738085	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700092
J	Mehrdana, F; Kania, PW; Nazemi, S; Buchmann, K				Mehrdana, Foojan; Kania, Per Walter; Nazemi, Sasan; Buchmann, Kurt			Immunomodulatory effects of excretory/secretory compounds from Contracaecum osculatum larvae in a zebrafish inflammation model	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTOR; COD GADUS-MORHUA; ANISAKIS ALLERGY; BALTIC SEA; INFECTION; EXPRESSION; COMPONENTS; ENDOTOXIN; FAMILIES	Excretory/secretory (ES) compounds isolated from third-stage larvae of the anisakid nematode Contracaecum osculatum parasitizing liver of Baltic cod were investigated for effects on immune gene expression in a zebrafish LPS-induced inflammation model. ES products containing a series of proteins, of which some had enzymatic activity, were injected solely or with LPS. ES proteins alone induced up-regulation of a number of immune-related genes, but generally to a lower degree compared to LPS. When co-injected with LPS, the worm products exacerbated merely expression of five genes affecting Th1, Th2, Th17 and innate responses compared to the LPS-injected group. However, the level of overexpression decreased in an inverse dose-dependent manner. The immune regulating action of C. osculatum ES products is interpreted as an important evolutionary ability of larval parasites in the transport host which makes it less susceptible to host immune responses whereby the probability of reaching the final host is increased.	[Mehrdana, Foojan; Kania, Per Walter; Buchmann, Kurt] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Lab Aquat Pathobiol, Frederiksberg C, Denmark; [Nazemi, Sasan] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet & Anim Sci, Frederiksberg C, Denmark	University of Copenhagen; University of Copenhagen	Mehrdana, F (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Lab Aquat Pathobiol, Frederiksberg C, Denmark.	foojan@sund.ku.dk		Buchmann, Kurt/0000-0002-2747-237X	European Union's Horizon research and innovation programme through the grant [634429]; Villum Fonden [00007220] Funding Source: researchfish	European Union's Horizon research and innovation programme through the grant; Villum Fonden(Villum Fonden)	This work was supported by the European Union's Horizon 2020 research and innovation programme through the grant agreement No.634429 (ParaFishControl) received by KB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahumada V, 2015, CLIN EXP ALLERGY, V45, P1189, DOI 10.1111/cea.12513; Bahlool QZM, 2013, FISH SHELLFISH IMMUN, V35, P734, DOI 10.1016/j.fsi.2013.06.007; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Bhattacharya C, 1997, TROP MED INT HEALTH, V2, P686, DOI 10.1046/j.1365-3156.1997.d01-353.x; Christoffersen TB, 2016, J FISH DIS, P1; Feng W, 2016, J IMMUNOL, V197, P151, DOI 10.4049/jimmunol.1502334; Haarder S, 2016, OJI, V6, P154, DOI DOI 10.4236/0JI.2016.64016; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Itami DM, 2005, CLIN EXP ALLERGY, V35, P873, DOI 10.1111/j.1365-2222.2005.02268.x; Lee DL, 1996, INT J PARASITOL, V26, P499, DOI 10.1016/0020-7519(96)00040-9; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Caballero ML, 2013, INT ARCH ALLERGY IMM, V162, P39, DOI 10.1159/000351056; Mattiucci S, 2013, EMERG INFECT DIS, V19, P496, DOI 10.3201/eid1903.121017; Mehrdana F, 2014, VET PARASITOL, V205, P581, DOI 10.1016/j.vetpar.2014.08.027; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Morales Fenero Camila Ideli, 2016, World J Exp Med, V6, P9, DOI 10.5493/wjem.v6.i1.9; Nagasawa K., 2012, Biosphere Science, V51, P61; Neves LR, 2013, J PARASITOL, V99, P718, DOI 10.1645/12-84.1; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; PRITCHARD DI, 1995, PARASITOL TODAY, V11, P255, DOI 10.1016/0169-4758(95)80206-1; Qualizza R, 2009, IRAN J ALLERGY ASTHM, V8, P161, DOI 08.03/ijaai.161164; Rusinek O, 2015, OCEANOL HYDROBIOL ST, V44, P68, DOI 10.1515/ohs-2015-0007; SCHAUM E, 1967, DEUT MED WOCHENSCHR, V92, P2230, DOI 10.1055/s-0028-1106122; Schaum E, 1967, DEUT MED WOCHENSCHR, V92, P47; Scholmerich J, 2013, DIGEST DIS, V31, P391, DOI 10.1159/000354708; Shamsi S, 2011, MED J AUSTRALIA, V194, P199, DOI 10.5694/j.1326-5377.2011.tb03772.x; Skov J, 2009, AQUACULTURE, V298, P24, DOI 10.1016/j.aquaculture.2009.09.024; Skrzypczak M, 2014, ACTA PARASITOL, V59, P165, DOI 10.2478/s11686-014-0226-2; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Strom SB, 2015, PARASITOL RES, V114, P1217, DOI 10.1007/s00436-014-4306-x; Tobin DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002349; Valls A, 2005, REV FR ALLERGOL, V45, P108, DOI 10.1016/j.allerg.2005.01.005; Zuo S, 2018, J HELMINTHOL, V92, P81, DOI 10.1017/S0022149X17000025	35	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181277	10.1371/journal.pone.0181277	http://dx.doi.org/10.1371/journal.pone.0181277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742146	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700033
J	Neto, E; Alves, CJ; Leitao, L; Sousa, DM; Alencastre, IS; Conceicao, F; Lamghari, M				Neto, Estrela; Alves, Cecilia J.; Leitao, Luis; Sousa, Daniela M.; Alencastre, Ines S.; Conceicao, Francisco; Lamghari, Meriem			Axonal outgrowth, neuropeptides expression and receptors tyrosine kinase phosphorylation in 3D organotypic cultures of adult dorsal root ganglia	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; SUBSTANCE-P; PERIPHERAL PROCESSES; SPINAL-CORD; RAT; REGENERATION; NEUROTROPHINS; ACTIVATION; MECHANISMS	Limited knowledge from mechanistic studies on adult sensory neuronal activity was generated, to some extent, in recapitulated adult in vivo 3D microenvironment. To fill this gap there is a real need to better characterize the adult dorsal root ganglia (aDRG) organotypic cultures to make these in vitro systems exploitable for different approaches, ranging from basic neurobiology to regenerative therapies, to address the sensory nervous system in adult stage. We conducted a direct head-to-head comparison of aDRG and embryonic DRG (eDRG) organotypic culture focusing on axonal growth, neuropeptides expression and receptors tyrosine kinase (RTK) activation associated with neuronal survival, proliferation and differentiation. To identify alterations related to culture conditions, these parameters were also addressed in retrieved aDRG and eDRG and compared with organotypic cultures. Under similar neurotrophic stimulation, aDRG organotypic cultures displayed lower axonal outgrowth rate supported by reduced expression of growth associated protein-43 and high levels of RhoA and glycogen synthase kinase 3 beta mRNA transcripts. In addition, differential alteration in sensory neuropeptides expression, namely calcitonin gene-related peptide and substance P, was detected and was mainly pronounced at gene expression levels. Among 39 different RTK, five receptors from three RTK families were emphasized: tropomyosin receptor kinase A (TrkA), epidermal growth factor receptors (EGFR, ErbB2 and ErbB3) and platelet-derived growth factor receptor (PDGFR). Of note, except for EGFR, the phosphorylation of these receptors was dependent on DRG developmental stage and/or culture condition. In addition, EGFR and PDGFR displayed alterations in their cellular expression pattern in cultured DRG. Overall we provided valuable information particularly important when addressing in vitro the molecular mechanisms associated with development, maturation and regeneration of the sensory nervous system.	[Neto, Estrela; Alves, Cecilia J.; Leitao, Luis; Sousa, Daniela M.; Alencastre, Ines S.; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, i3S, Oporto, Portugal; [Neto, Estrela; Alves, Cecilia J.; Leitao, Luis; Sousa, Daniela M.; Alencastre, Ines S.; Conceicao, Francisco; Lamghari, Meriem] Univ Porto, INEB Inst Engn Biomed, Oporto, Portugal; [Neto, Estrela] Univ Porto, FMUP Fac Med, Oporto, Portugal; [Leitao, Luis; Lamghari, Meriem] Univ Porto, ICBAS, Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Lamghari, M (corresponding author), Univ Porto, i3S, Oporto, Portugal.; Lamghari, M (corresponding author), Univ Porto, INEB Inst Engn Biomed, Oporto, Portugal.; Lamghari, M (corresponding author), Univ Porto, ICBAS, Oporto, Portugal.	lamghari@ineb.up.pt	Neto, Estrela C/M-2561-2013; Sousa, Daniela/C-1485-2014; Conceição, Francisco/HCI-8740-2022; Lamghari, Meriem/K-2159-2013	Neto, Estrela C/0000-0003-2334-2292; Sousa, Daniela/0000-0001-8498-0664; Conceicao, Francisco/0000-0003-4587-2470; Alencastre, Ines/0000-0002-5591-5596; Lamghari, Meriem/0000-0002-2500-4548; Alves, Cecilia Juliana/0000-0002-0719-574X	Fundo Europeu de Desenvolvimento Regional (FEDER) through the COMPETE - Operational Programme for Competitiveness and Internationalisation (POCI), Portugal; Fundacao para a Ciencia e a Tecnologia (FCT) / Ministerio da Ciencia, Tecnologia e Inovacao [POCI-01-0145-FEDER-007274]; Ph.D. fellowships [SFRH/BD/81152/2011, SFRH/BD/109686/2015]; Post-Doc fellowships [SFRH/BPD/ 63618/2009, SFRH/BPD/75285/2010];  [PTDC/ BIMMED/4041/2014]	Fundo Europeu de Desenvolvimento Regional (FEDER) through the COMPETE - Operational Programme for Competitiveness and Internationalisation (POCI), Portugal; Fundacao para a Ciencia e a Tecnologia (FCT) / Ministerio da Ciencia, Tecnologia e Inovacao; Ph.D. fellowships; Post-Doc fellowships; 	This work was financed by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through Fundacao para a Ciencia e a Tecnologia (FCT) / Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274) and in the framework of the financed project PTDC/ BIMMED/4041/2014. EN and LL are recipients of Ph.D. fellowships (SFRH/BD/81152/2011 and SFRH/BD/109686/2015, respectively). CJA and ISA are recipients of Post-Doc fellowships (SFRH/BPD/ 63618/2009 and SFRH/BPD/75285/2010, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165465; An LH, 2016, NEUROCHEM RES, V41, P1000, DOI 10.1007/s11064-015-1782-z; [Anonymous], 2021, LANG ENV STAT COMP; Aoki Y, 2007, SPINE, V32, P857, DOI 10.1097/01.brs.0000259810.48681.90; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Bessa S, 2013, LECT NOTES COMPUT SC, V7887, P141; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; CHONG MS, 1994, J NEUROSCI, V14, P4375; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; FITZGERALD M, 1985, BRAIN RES, V332, P131, DOI 10.1016/0006-8993(85)90396-8; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Hausott B, 2009, ANAT REC, V292, P1976, DOI 10.1002/ar.20964; Horie H, 1997, NEUROREPORT, V8, P1955, DOI 10.1097/00001756-199705260-00032; INAISHI Y, 1992, J NEUROSCI, V12, P518; JESSELL T, 1979, BRAIN RES, V168, P247, DOI 10.1016/0006-8993(79)90167-7; Kim H, 2015, SPINE J, V15, P1823, DOI 10.1016/j.spinee.2015.03.017; Kimpinski K, 1997, J NEUROBIOL, V33, P395, DOI 10.1002/(SICI)1097-4695(199710)33:4<395::AID-NEU5>3.0.CO;2-5; Koprivica V, 2005, SCIENCE, V310, P106, DOI 10.1126/science.1115462; Le Gall-Ianotto C, 2012, NEUROSCIENCE, V210, P47, DOI 10.1016/j.neuroscience.2012.02.043; Leslie JR, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00067; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Matsuda S, 1996, ANAT EMBRYOL, V193, P475; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Neto E, 2014, INTEGR BIOL-UK, V6, P586, DOI 10.1039/c4ib00035h; Paivalainen S, 2008, MOL CELL NEUROSCI, V37, P568, DOI 10.1016/j.mcn.2007.12.005; Passmore Gayle M., 2005, Journal of Pharmacological and Toxicological Methods, V51, P201, DOI 10.1016/j.vascn.2004.08.007; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Skoff AM, 2006, EXP NEUROL, V197, P430, DOI 10.1016/j.expneurol.2005.10.006; TOMA JG, 1992, J NEUROSCI, V12, P2504; Vellani Vittorio, 2011, J Pain Res, V4, P177, DOI 10.2147/JPR.S21931; VERGE VMK, 1995, J NEUROSCI, V15, P2081, DOI 10.1523/JNEUROSCI.15-03-02081.1995; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Vigneswara V., 2012, J SIGNAL TRANSDUCT, V2012; VILLAR MJ, 1991, EXP NEUROL, V112, P29, DOI 10.1016/0014-4886(91)90111-O; Wan L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163566; WONG J, 1991, J NEUROSCI, V11, P543; Xian CJ, 2001, EXP NEUROL, V172, P182, DOI 10.1006/exnr.2001.7771; Xian CJ, 1999, EXP NEUROL, V157, P317, DOI 10.1006/exnr.1999.7063; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	44	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181612	10.1371/journal.pone.0181612	http://dx.doi.org/10.1371/journal.pone.0181612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742111	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700057
J	Sarma, H; Islam, MA; Khan, JR; Chowdhury, KIA; Gazi, R				Sarma, Haribondhu; Islam, Mohammad Ashraful; Khan, Jahidur Rahman; Chowdhury, Kamal Ibne Amin; Gazi, Rukhsana			Impact of teachers training on HIV/AIDS education program among secondary school students in Bangladesh: A cross-sectional survey	PLOS ONE			English	Article							HIV PREVENTION; SEX WORKERS	Background In 2007, the Government of Bangladesh incorporated a chapter on HIV/AIDS into the national curriculum for an HIV-prevention program for school students. For the efficient dissemination of knowledge, an intervention was designed to train the teachers and equip them to educate on the topic of HIV/AIDS. The present study intended to understand the impact of this intervention by assessing the knowledge, attitudes and behaviours related to HIV/AIDS, among the targeted students. Methods A cross-sectional survey was conducted with the students at randomly selected schools from two adjacent districts. Considering exposure to intervention, one district was assigned for intervention and the other as a control. In total, 1,381 students, aged 13-18 years (or above) were interviewed, 675 from the control areas and 706 from the intervention areas. Univariate and bivariate analyses were performed on the collected data. Results A significantly higher proportion (p < 0.001) of students in the intervention areas attended HIV/AIDS classes, demonstrated better knowledge and fewer misconceptions regarding the transmission and prevention of HIV. The same was derived regarding their attitude towards people living with HIV, as a higher proportion (p < 0.001) responded positively, compared to the control groups of the study. Additionally, multinomial logistic regression analysis showed that students in intervention area were more likely to have good knowledge on HIV transmission (OR 2.71, 95% CI 1.74-4.22) and prevention (OR 2.15, 95% CI 1.41-3.26) compared to the students in the control areas. Conclusions The training programme needs to be scaled up, since it is likely to have an impact among students; we have witnessed that the interventions particularly helped increase HIV/AIDS knowledge among students and positively change the students' attitudes towards HIV/ AIDS.	[Sarma, Haribondhu; Islam, Mohammad Ashraful; Chowdhury, Kamal Ibne Amin] Icddr b, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Sarma, Haribondhu] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT, Australia; [Khan, Jahidur Rahman] Univ Dhaka, cBLAST, Dhaka, Bangladesh; [Gazi, Rukhsana] Icddr b, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); Australian National University; University of Dhaka; International Centre for Diarrhoeal Disease Research (ICDDR)	Sarma, H (corresponding author), Icddr b, Nutr & Clin Serv Div, Dhaka, Bangladesh.; Sarma, H (corresponding author), Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Acton, ACT, Australia.	hsarma@icddrb.org	Sarma, Haribondhu/AAG-4817-2020; Chowdhury, Kamal Ibne Amin/F-1175-2011; Khan, Jahidur/E-3286-2019; Chowdhury, Kamal Ibne Amin/ABC-2515-2020	Chowdhury, Kamal Ibne Amin/0000-0001-7125-7071; Khan, Jahidur/0000-0002-3029-6303; Sarma, Haribondhu/0000-0003-1553-8498	Save the Children-USA [BAN-202-G01-H00]	Save the Children-USA(United States Agency for International Development (USAID))	The study was funded by Save the Children-USA (grant no.BAN-202-G01-H00).; The study was funded by Save the Children-USA (Grant No. BAN-202-G01-H00). icddr,b acknowledges with gratitude the commitment of Save the Children-USA to its research efforts. icddr,b is grateful to the government of Bangladesh, Canada, Sweden, Japan and the UK for providing core/unrestricted support. The authors acknowledge Ms. Antara Kabir for her support in English editing of the manuscript. The authors thank all the study subjects for their valuable participation. The authors also thank Mr. Fakhar Uddin and Md. Mazharul Islam for their support during revision of the manuscript. The authors acknowledge contribution of the Field Research Officers, Senior Field Research Assistants, and Field Research Assistants who helped during data-collection.	Abdeyazdan Z, 2008, ARCH CLIN INFECT DIS, P3; Bangladesh Bureau of Statistics UNICEF, 2009, TECHNICAL REPORT, VI; Breuner CC, 2016, PEDIATRICS, P138; Carr-Hill R, 2002, IMPACT HIV AIDS ED I, P95; Centers for Disease Control and Prevention, 2005, HDB EV HIV ED ASS IN; Fonner VA, 2014, PLOS ONE, P9; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; Gao XX, 2012, PROCEEDINGS OF 2012 INTERNATIONAL SYMPOSIUM - WOMEN'S HUMAN RESOURCES DEVELOPMENT & MANAGEMENT, FEMALE SURVIVAL & DEVELOPMENT, P7; Gazi R, 2009, INT J SEX HEALTH, V21, P167, DOI 10.1080/19317610903178675; Gupta Pratibha, 2013, N Am J Med Sci, V5, P119, DOI 10.4103/1947-2714.107531; Haignere CS, 1996, J SCHOOL HEALTH, V66, P140; Huda MN., 2013, ADV INFECT DIS, V03, P274, DOI [10.4236/aid.2013.34042, DOI 10.4236/AID.2013.34042]; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2004, MED HIV AIDS MAK DIF; Kirby D., 2007, RES FINDINGS PROGRAM; Kirby D. B., 2008, Sexuality Research and Social Policy, V5, P18, DOI 10.1525/srsp.2008.5.3.18; Kirby DB, 2007, J ADOLESCENT HEALTH, V40, P206, DOI 10.1016/j.jadohealth.2006.11.143; Koksal Selcuk, 2005, INFECT DIS J PAKISTA, P118; Mathews C, 2006, AIDS CARE, V18, P388, DOI 10.1080/09540120500498203; National AIDS and STD Program (NASP), 2008, SAV CHILDR US ICDDR; National AIDS and STD Programme, 2009, IMP HIV AIDS PREV EN; National AIDS and STD Programme, 2009, CREAT COND ACC LIF S; National AIDS/ STD Programme, 2006, BAS HIV AIDS SURV ST; National AIDS/ STD Programme (NASP), 2011, ENDL HIV AIDS SURV S; Nessa K, 2004, J CLIN MICROBIOL, V42, P618, DOI 10.1128/JCM.42.2.618-621.2004; Oljira L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17349; Othman SM, 2015, GLOBAL J HLTH SCI, V7, P16, DOI DOI 10.5539/GJHS.V7N1P16.RETRIEVED; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Rashid SF, 1999, SOCIAL INTERACTION D; Rondini S, 2009, GHANA AFR J REPROD H, V13, P51; Ross DA, 2006, WHO TECH REP SER, V938, P1; Rutagumirwa SK, 2006, SECONDARY SCH STUDEN; Sarma H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-990; Sarma H, 2013, J HEALTH POPUL NUTR, V31, P20; Susan P, 2007, AIDS EDUCPREVEN, V19, P408; Thanavanh B, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17387; Uddin MA, 2010, 2 INT C HUM SOC SCI; UNAIDS, 2006, SYST REV EV DEV COUN; UNAIDS, 2008, REP GLOB AIDS EP; UNICEF, 2009, MULT IND CLUST SURV	39	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181627	10.1371/journal.pone.0181627	http://dx.doi.org/10.1371/journal.pone.0181627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28742103	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700058
J	Martin-Sanz, RC; Callejas-Diaz, M; Tonnabel, J; Climent, JM				Martin-Sanz, Ruth C.; Callejas-Diaz, Marta; Tonnabel, Jeanne; Climent, Jose M.			Maintenance costs of serotiny in a variably serotinous pine: The role of water supply	PLOS ONE			English	Article							CANOPY SEED STORAGE; REPRODUCTIVE ALLOCATION; FIRE; HALEPENSIS; RELEASE; TRAITS; HERITABILITY; CONES	Serotiny is an important adaptation for plants in fire-prone environments. However, different mechanisms also induce the opening of serotinous cones in the absence of fire in variably serotinous species. Xeriscence-cone opening driven by dry and hot conditions- is considered to be mediated only by the external environment, but endogenous factors could also play a significant role. Using the variably serotinous Pinus halepensis as our model species, we determined the effects of cone age and scales density in cone opening, and using in-situ and ex-situ manipulative experiments we investigated the role of water availability in the opening of serotinous cones. We hypothesized that loss of connection between the cones and the branch through the peduncles or the absence of water supply could induce a faster cone opening. Results showed that older cones lost more water and opened at lower temperatures, with no influence of scales density. Both field and chamber manipulative experiments ( using paired cones of the same whorl) confirmed that water intake through the peduncles affected significantly the pace of cone opening, such that lack of water supply speeded up cone dehiscence. However, this was true for weakly serotinous provenances - more common in this species -, while highly serotinous provenances were indifferent to this effect in the field test. All our results support that cone serotiny in P. halepensis involves the allocation of water to the cones, which is highly consistent with the previously observed environmental effects. Importantly, the existence of maintenance costs of serotinous cones has strong implications on the effects of climate change in the resilience of natural populations, via modifications of the canopy seed banks and recruitment after stand-replacing fires. Moreover, evolutionary models for serotiny in P. halepensis must take into account the significant contribution of maintenance costs to the complex interaction between genotype and the environment.	[Martin-Sanz, Ruth C.; Callejas-Diaz, Marta; Climent, Jose M.] Natl Inst Agr & Food Res & Technol, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain; [Martin-Sanz, Ruth C.; Climent, Jose M.] Univ Valladolid, Natl Inst Agr & Food Res & Technol, Sustainable Forest Management Res Inst, Palencia, Spain; [Tonnabel, Jeanne] Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, Lausanne, Switzerland	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Valladolid; University of Lausanne	Martin-Sanz, RC (corresponding author), Natl Inst Agr & Food Res & Technol, Forest Res Ctr, Dept Forest Ecol & Genet, Madrid, Spain.; Martin-Sanz, RC (corresponding author), Univ Valladolid, Natl Inst Agr & Food Res & Technol, Sustainable Forest Management Res Inst, Palencia, Spain.	ruth.martin.sanz@gmail.com	Climent, José/B-9090-2009; Callejas-Díaz, Marta/I-1411-2019; Martín-Sanz, Ruth C./AAA-6205-2020; Tonnabel, Jeanne/AAF-7561-2019	Climent, José/0000-0002-0815-2645; Callejas-Díaz, Marta/0000-0001-9687-1529; Martín-Sanz, Ruth C./0000-0002-0980-2283; 	Spanish "Ministerio de Economia, lndustria y Competitividad [AGL2012-40151-0O3-02, AGL2015-68274-C3-01, FPI BES-2013-064210]	Spanish "Ministerio de Economia, lndustria y Competitividad	This research was funded by the Spanish "Ministerio de Economia, lndustria y Competitividad (http://www.mineco.gob.es/), grant numbers AGL2012-40151-0O3-02 and AGL2015-68274-C3-01, both to JC, and grant number FPI BES-2013-064210 to RMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Sanchez R, 2015, INT J WILDLAND FIRE, V24, P507, DOI 10.1071/WF14045; Altman D.G., 1991, PRACTICAL STATISTIC; Benkman CW, 2003, AM NAT, V162, P182, DOI 10.1086/376580; Blondel J, 2010, MEDITERRANEAN REGION; Borchert M, 2003, PLANT ECOL, V168, P207, DOI 10.1023/A:1024447811238; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bradshaw SD, 2011, TRENDS PLANT SCI, V16, P69, DOI 10.1016/j.tplants.2010.10.007; Briand CH, 2015, PLANT ECOL, V216, P157, DOI 10.1007/s11258-014-0424-x; Castellanos MC, 2015, MOL ECOL, V24, P5633, DOI 10.1111/mec.13421; Causley CL, 2016, PLANT ECOL, V217, P773, DOI 10.1007/s11258-015-0552-y; Chambel M.R., 2013, FOREST TREE BREEDING, VVolume 25, P229, DOI DOI 10.1007/978-94-007-6146-9_5; Climent J, 2008, AM J BOT, V95, P833, DOI 10.3732/ajb.2007354; COWLING RM, 1985, AUST J ECOL, V10, P345, DOI 10.1111/j.1442-9993.1985.tb00895.x; Cramer MD, 2009, AUSTRAL ECOL, V34, P653, DOI 10.1111/j.1442-9993.2009.01971.x; Elliott PE, 1988, 1 U COL MOUNT RES ST; Enright NJ, 1996, J ECOL, V84, P9, DOI 10.2307/2261695; GAUTHIER S, 1993, CAN J FOREST RES, V23, P394, DOI 10.1139/x93-057; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gil L, REGIONES PROCEDENCIA; Gonzalo-Jimenez J, 2010, DIAGNOSIS FITOCLIMAT; Harris MS, 2010, J ECOL, V98, P509, DOI 10.1111/j.1365-2745.2009.01623.x; He TH, 2012, NEW PHYTOL, V194, P751, DOI 10.1111/j.1469-8137.2012.04079.x; Hernandez-Serrano A, 2014, ANN BOT-LONDON, V114, P571, DOI 10.1093/aob/mcu142; Hernandez-Serrano A, 2013, AM J BOT, V100, P2349, DOI 10.3732/ajb.1300182; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keeley Jon E., 1998, P219; LAMONT BB, 1991, BOT REV, V57, P277, DOI 10.1007/BF02858770; LAMONT BB, 1991, OIKOS, V60, P266, DOI 10.2307/3544876; LEVYADUN S, 1995, INT J PLANT SCI, V156, P50, DOI 10.1086/297228; Espelta JM, 2011, OIKOS, V120, P1752, DOI 10.1111/j.1600-0706.2011.19570.x; Martin-Sanz RC, 2016, AM J BOT, V103, P1582, DOI 10.3732/ajb.1600199; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moya D, 2008, TREES-STRUCT FUNCT, V22, P511, DOI 10.1007/s00468-008-0211-1; Nathan R, 1999, J ECOL, V87, P659, DOI 10.1046/j.1365-2745.1999.00382.x; Ne'eman G, 2004, PLANT ECOL, V171, P69, DOI 10.1023/B:VEGE.0000029380.04821.99; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Pinol J, 1998, CLIMATIC CHANGE, V38, P345, DOI 10.1023/A:1005316632105; Poorter H., 1994, WHOLE PLANT PERSPECT, P111; R Core Team, 2016, R FDN STAT COMP; Salvatore R, 2010, NEW FOREST, V39, P329, DOI 10.1007/s11056-009-9174-3; Santos-del-Blanco L, 2010, FOREST SYST, V19, P381; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Tapias R, 2004, PLANT ECOL, V171, P53, DOI 10.1023/B:VEGE.0000029383.72609.f0; Tapias R, 2001, J ECOL, V89, P629, DOI 10.1046/j.1365-2745.2001.00575.x; Thanos CA, 2000, ECOLOGY, BIOGEOGRAPHY AND MANAGEMENT OF PINUS HALEPENSIS AND P BRUTIA FOREST ECOSYSTEMS IN THE MEDITERRANEAN BASIN, P79; Tonnabel J, 2012, J ECOL, V100, P1464, DOI 10.1111/j.1365-2745.2012.02023.x; Westerling AL, 2008, CLIMATIC CHANGE, V87, pS231, DOI 10.1007/s10584-007-9363-z	49	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181648	10.1371/journal.pone.0181648	http://dx.doi.org/10.1371/journal.pone.0181648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732015	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100052
J	Andorsen, OF; Ahmed, LA; Emaus, N; Klouman, E				Andorsen, Ole Fredrik; Ahmed, Luai Awad; Emaus, Nina; Klouman, Elise			A prospective cohort study on risk factors of musculoskeletal complaints (pain and/or stiffness) in a general population. The Tromso study	PLOS ONE			English	Article							CHRONIC WIDESPREAD PAIN; NORD-TRONDELAG HEALTH; 11-YEAR FOLLOW-UP; WORKING POPULATION; CIGARETTE-SMOKING; BACK-PAIN; PREVALENCE; ADULTS; HUNT; EPIDEMIOLOGY	Background Female gender has been associated with musculoskeletal complaints (MSCs), but there are limited studies on how other factors may influence women and men differently. The aim of this prospective cohort study was to explore possible predictors of MSCs in women and men free of MSCs at baseline. Methods The present study included participants from the population-based Tromso study, with baseline data from 1994-1995 and follow-up data from 2007-2008. MSCs were defined as having pain and/or stiffness in muscles and joints for 3 consecutive months during the past year. Predictors of MSCs were examined through binary logistic regression analyses and presented as odds ratios with 95% confidence intervals. Results At baseline 4,496 participants reported no MSCs and among these 2,015 (44.8%) and 441 (9.8%) participants reported mild or severe MSCs, respectively, at follow-up. Female gender predicted MSCs in multivariable logistic regression analyses (odds ratio [OR] 1.46, 95% confidence interval [CI]: 1.29-1.66). Educational level of primary/secondary school (OR 1.73, 95% CI: 1.46-2.05) was the strongest predictor of MSCs, followed by poor self-perceived health (OR 1.62, 95% CI: 1.30-2.02). Other predictors were BMI >= 30 kg/m(2) (OR 1.39, 95% CI: 1.10-1.77) and smoking (OR 1.33, 95% CI: 1.16-1.52). Age and physical activity level were not significantly associated with MSCs. Gender-stratified analyses revealed that mental health complaints (i.e., depression and/or anxiety) predicted MSCs in men (OR 2.03, 95% CI: 1.18-3.50), but not in women. Current smoking (OR 1.43, 95% CI: 1.16-1.76) and poor self-perceived health ( OR 1.90, 95% CI: 1.34-2.71) showed slightly higher odds ratios among women than men, but the gender differences were not significant. Conclusion The present study demonstrates that several negative health determinants are predicting subsequent MSCs. However, the examined risk factors could not explain the higher prevalence of MSCs in women.	[Andorsen, Ole Fredrik; Klouman, Elise] Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Ahmed, Luai Awad; Emaus, Nina] Univ Tromso, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Ahmed, Luai Awad] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; United Arab Emirates University	Andorsen, OF (corresponding author), Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway.	ole.f.andorsen@uit.no	Ahmed, Luai A./J-7225-2013	Ahmed, Luai A./0000-0001-5292-8212	University of Tromso - The Arctic University of Norway	University of Tromso - The Arctic University of Norway	This study was supported by an internal grant from the University of Tromso - The Arctic University of Norway. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorsen Ole Fredrik, 2014, BMC Res Notes, V7, P506, DOI 10.1186/1756-0500-7-506; [Anonymous], 2013, TAL TOB 1973 2012; [Anonymous], 2015, STAT SICK LEAV NORW; [Anonymous], 2016, ANB TYS AKT; Bassols A, 1999, PAIN, V83, P9, DOI 10.1016/S0304-3959(99)00069-X; Bergman S, 2001, J RHEUMATOL, V28, P1369; Blyth FM, 2001, PAIN, V89, P127, DOI 10.1016/S0304-3959(00)00355-9; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Bruce B, 2005, ARTHRITIS RES THER, V7, pR1263, DOI 10.1186/ar1825; Buskila D, 2000, J RHEUMATOL, V27, P1521; Cimmino MA, 2001, CLIN EXP RHEUMATOL, V19, P35; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Erdogan-Ciftci E, 2010, SOC SCI MED, V71, P1981, DOI 10.1016/j.socscimed.2010.09.003; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Hagen K, 2005, SCAND J PUBLIC HEALT, V33, P268, DOI 10.1080/14034940510005699; Hagen K, 2011, PAIN MED, V12, P1657, DOI 10.1111/j.1526-4637.2011.01240.x; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holley AL, 2013, J PAIN, V14, P1131, DOI 10.1016/j.jpain.2013.04.012; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Ihlebaek C LE, 2004, PLAGER FLEST KOSTERR; Jimenez-Sanchez S, 2010, J PAIN, V11, P612, DOI 10.1016/j.jpain.2009.09.015; Jinks C, 2008, RHEUMATOLOGY, V47, P368, DOI 10.1093/rheumatology/kem374; Kjeldsberg M, 2013, SCAND J PRIM HEALTH, V31, P36, DOI 10.3109/02813432.2012.751697; Kvalheim S, 2016, EUR J PAIN, V20, P458, DOI 10.1002/ejp.747; Kvalheim S, 2013, PAIN, V154, P1073, DOI 10.1016/j.pain.2013.03.015; Lake JK, 2000, J CLIN EPIDEMIOL, V53, P245, DOI 10.1016/S0895-4356(99)00155-9; Loevinger BL, 2007, METABOLISM, V56, P87, DOI 10.1016/j.metabol.2006.09.001; McBeth J, 2007, BEST PRACT RES CL RH, V21, P403, DOI 10.1016/j.berh.2007.03.003; Miyakawa M, 2012, EUR J PUBLIC HEALTH, V22, P593, DOI 10.1093/eurpub/ckr064; Morseth B, 2012, EUR J EPIDEMIOL, V27, P463, DOI 10.1007/s10654-012-9665-y; Mundal I, 2014, PAIN, V155, P1555, DOI 10.1016/j.pain.2014.04.033; Mundal I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-213; Ng KFJ, 2002, CLIN J PAIN, V18, P275, DOI 10.1097/00002508-200209000-00001; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Palmer KT, 2003, ANN RHEUM DIS, V62, P33, DOI 10.1136/ard.62.1.33; Parajuli R, 2013, CANCER EPIDEM BIOMAR, V22, P862, DOI 10.1158/1055-9965.EPI-12-1351; Parot-Schinkel E, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-122; Paulis WD, 2014, OBES REV, V15, P52, DOI 10.1111/obr.12067; Rustoen T, 2004, EUR J PAIN, V8, P555, DOI 10.1016/j.ejpain.2004.02.002; Schou Morten Brix, 2006, Tidsskr Nor Laegeforen, V126, P2644; Sogaard AJ, 2003, NOR EPIDEMIOL, V13, P279, DOI DOI 10.5324/NJE.V13I2.296; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; Steinsbekk A, 2007, SCAND J PRIM HEALTH, V25, P86, DOI 10.1080/02813430701267439; Tukker A, 2009, PUBLIC HEALTH NUTR, V12, P359, DOI 10.1017/S1368980008002103; van den Heuvel SG, 2005, PREV MED, V41, P260, DOI 10.1016/j.ypmed.2004.11.006; Verbunt JA, 2003, EUR J PAIN, V7, P9, DOI 10.1016/S1090-3801(02)00071-X; Wijnhoven HAH, 2006, CLIN J PAIN, V22, P717, DOI 10.1097/01.ajp.0000210912.95664.53; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zvolensky MJ, 2010, ADDICT BEHAV, V35, P1008, DOI 10.1016/j.addbeh.2010.06.019	50	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181417	10.1371/journal.pone.0181417	http://dx.doi.org/10.1371/journal.pone.0181417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727753	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500068
J	Rosenzweig, B; Rubinstein, ND; Reznik, E; Shingarev, R; Juluru, K; Akin, O; Hsieh, JJ; Jaimes, EA; Russo, P; Susztak, K; Coleman, JA; Hakimi, AA				Rosenzweig, Barak; Rubinstein, Nimrod D.; Reznik, Ed; Shingarev, Roman; Juluru, Krishna; Akin, Oguz; Hsieh, James J.; Jaimes, Edgar A.; Russo, Paul; Susztak, Katalin; Coleman, Jonathan A.; Hakimi, A. Ari			Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ENDOTHELIAL PROGENITOR CELLS; RADICAL NEPHRECTOMY; VOLUME; MASS; HYPERTROPHY; REDUCTION; INJURY; AGE	Background and objectives Pre-operative kidney volume is an independent predictor of glomerular filtration rate in renal cell carcinoma patients. Compensatory renal growth (CRG) can ensue prior to nephrectomy in parallel to tumor growth and benign parenchyma loss. We aimed to test whether renal metabolite abundances significantly associate with CRG, suggesting a causative relationship. Design, setting, participants, and measurements Tissue metabolomics data from 49 patients, with a median age of 60 years, were previously collected and the pre-operative fold-change of their contra to ipsi-lateral benign kidney volume served as a surrogate for their CRG. Contra-lateral kidney volume fold-change within a 3.3+/-2.1 years follow-up interval was used as a surrogate for long-term CRG. Using a multivariable statistical model, we identified metabolites whose abundances significantly associate with CRG. Results Our analysis found 13 metabolites in the benign (e.g. L-urobilin, Variable Influence in Projection, VIP, score = 3.02, adjusted p = 0.017) and 163 metabolites in the malignant (e.g. 3-indoxyl-sulfate, VIP score = 1.3, adjusted p = 0.044) tissues that significantly associate with CRG. Benign/tumor fold change in metabolite abundances revealed three additional metabolites with that significantly positively associate with CRG (e.g. p-cresol sulfate, VIP score = 2.945, adjusted p = 0.033). At the pathway level, we show that fatty-acid oxidation is highly enriched with metabolites whose benign tissue abundances strongly positively associate with CRG, both pre-operatively and long term, whereas in the tumor tissue significant enrichment of dipeptides and benzoate (positive association), glycolysis/gluconeogenesis, lysolipid and nucleotide sugar pentose (negative associations) sub-pathways, were observed. Conclusion These data suggest that specific biological processes in the benign as well as in the tumor parenchyma strongly influence compensatory renal growth.	[Rosenzweig, Barak; Russo, Paul; Coleman, Jonathan A.; Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Rubinstein, Nimrod D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Reznik, Ed] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Shingarev, Roman; Jaimes, Edgar A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Juluru, Krishna; Akin, Oguz] Mem Sloan Kettering Canc Ctr, Dept Radiol, Body Imaging Serv, 1275 York Ave, New York, NY 10021 USA; [Hsieh, James J.; Hakimi, A. Ari] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Susztak, Katalin] Univ Penn, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA	Memorial Sloan Kettering Cancer Center; Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania	Coleman, JA; Hakimi, AA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA.; Hakimi, AA (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	colemanj@mskcc.org; hakimia@mskcc.org	Susztak, Katalin/ABE-7474-2021	Susztak, Katalin/0000-0002-1005-3726; Coleman, Jonathan/0000-0002-6428-7835	Sidney Kimmel Center for Prostate and Urologic Cancers; NIH/NCI Cancer Center Support Grant [P30 CA008748, P30]; NATIONAL CANCER INSTITUTE [T32CA082088, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087635] Funding Source: NIH RePORTER	Sidney Kimmel Center for Prostate and Urologic Cancers; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Sidney Kimmel Center for Prostate and Urologic Cancers and an NIH/NCI Cancer Center Support Grant (P30 CA008748), P30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benipal B, 2011, BIOCHEM PHARMACOL, V81, P295, DOI 10.1016/j.bcp.2010.10.010; Boon AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15482; Deguchi T, 2004, KIDNEY INT, V65, P162, DOI 10.1111/j.1523-1755.2004.00354.x; Funahashi Y, 2011, UROLOGY, V77, P1404, DOI 10.1016/j.urology.2010.03.063; Gong IH, 2012, J UROLOGY, V187, P344, DOI 10.1016/j.juro.2011.09.005; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Hauser P, 2005, KIDNEY INT, V68, P2497, DOI 10.1111/j.1523-1755.2005.00725.x; Jeon HG, 2014, EUR J CANCER, V50, P64, DOI 10.1016/j.ejca.2013.08.018; Jeon HG, 2012, BJU INT, V109, P1468, DOI 10.1111/j.1464-410X.2011.10531.x; Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762; Lekawanvijit S, 2014, J PHYSIOL-LONDON, V592, P3969, DOI 10.1113/jphysiol.2014.273078; MOLLER JC, 1988, APMIS, V96, P82; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Papamandjaris AA, 1998, LIFE SCI, V62, P1203, DOI 10.1016/S0024-3205(97)01143-0; Park BH, 2016, WORLD J UROL, V34, P63, DOI 10.1007/s00345-015-1551-2; Sejima T, 2015, INT J UROL, V22, P14, DOI 10.1111/iju.12612; SHAPIRO JI, 1994, KIDNEY INT, V45, pS100; Song TR, 2014, INT UROL NEPHROL, V46, P743, DOI 10.1007/s11255-013-0592-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka M, 2014, ATHEROSCLEROSIS, V234, P421, DOI 10.1016/j.atherosclerosis.2014.03.015; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; TOBACK FG, 1974, J CLIN INVEST, V54, P91, DOI 10.1172/JCI107754; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Wei QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106647; Weiss RH, 2012, NAT REV NEPHROL, V8, P22, DOI 10.1038/nrneph.2011.152; Wu VC, 2013, ANGIOGENESIS, V16, P609, DOI 10.1007/s10456-013-9339-8; Ying Y, 2011, CIRC J, V75, P2252, DOI 10.1253/circj.CJ-11-0046; ZALUPS RK, 1990, J PHARMACOL EXP THER, V254, P962; Ziboh VA, 2000, PROSTAG OTH LIPID M, V63, P3, DOI 10.1016/S0090-6980(00)00093-9	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180350	10.1371/journal.pone.0180350	http://dx.doi.org/10.1371/journal.pone.0180350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727768	Green Published, gold			2022-12-26	WOS:000406634500019
J	Teo, Z; Sng, MK; Chan, JSK; Lim, MMK; Li, Y; Li, L; Phua, T; Lee, JYH; Tan, ZW; Zhu, P; Tan, NS				Teo, Z.; Sng, M. K.; Chan, J. S. K.; Lim, M. M. K.; Li, Y.; Li, L.; Phua, T.; Lee, J. Y. H.; Tan, Z. W.; Zhu, P.; Tan, N. S.			Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3 gamma expression	ONCOGENE			English	Article							TUMOR MICROENVIRONMENT; CANCER; HYPOXIA; METASTASIS; METABOLISM; CADHERIN; ANGPTL4; PROTEIN; GLYCOLYSIS; INTERACTS	Metastatic cancer cells acquire energy-intensive processes including increased invasiveness and chemoresistance. However, how the energy demand is met and the molecular drivers that coordinate an increase in cellular metabolic activity to drive epithelial-mesenchymal transition (EMT), the first step of metastasis, remain unclear. Using different in vitro and in vivo EMT models with clinical patient's samples, we showed that EMT is an energy-demanding process fueled by glucose metabolism-derived adenosine triphosphate (ATP). We identified angiopoietin-like 4 (ANGPTL4) as a key player that coordinates an increase in cellular energy flux crucial for EMT via an ANGPTL4/14-3-3. signaling axis. This augmented cellular metabolic activity enhanced metastasis. ANGPTL4 knockdown suppresses an adenylate energy charge elevation, delaying EMT. Using an in vivo dualinducible EMT model, we found that ANGPTL4 deficiency reduces cancer metastasis to the lung and liver. Unbiased kinase inhibitor screens and Ingenuity Pathway Analysis revealed that ANGPTL4 regulates the expression of 14-3-3. adaptor protein via the phosphatidylinositol-3-kinase/AKT and mitogen-activated protein kinase signaling pathways that culminate to activation of transcription factors, CREB, cFOS and STAT3. Using a different mode of action, as compared with protein kinases, the ANGPTL4/14-3-3. signaling axis consolidated cellular bioenergetics and stabilized critical EMT proteins to coordinate energy demand and enhanced EMT competency and metastasis, through interaction with specific phosphorylation signals on target proteins.	[Teo, Z.; Sng, M. K.; Chan, J. S. K.; Lim, M. M. K.; Li, Y.; Li, L.; Phua, T.; Lee, J. Y. H.; Tan, Z. W.; Zhu, P.; Tan, N. S.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Phua, T.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Tan, N. S.] Nanyang Technol, Lee Kong Chian Sch Med, Singapore, Singapore; [Tan, N. S.] Inst Mol & Cell Biol, Singapore, Singapore; [Tan, N. S.] KK Womens & Childrens Hosp, KK Res Ctr, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); KK Women's & Children's Hospital	Teo, Z; Zhu, P; Tan, NS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	zqteo@ntu.edu.sg; PCZhu@ntu.edu.sg; nstan@ntu.edu.sg	Tan, Nguan Soon/A-2220-2011; Sng, Ming Keat/J-7266-2013	Tan, Nguan Soon/0000-0003-0136-7341; Sng, Ming Keat/0000-0002-5529-4371	Ministry of Education, Singapore [MOE2014-T2-1-012, 2012-T1-001-036]	Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported by grants from Ministry of Education, Singapore (MOE2014-T2-1-012 and 2012-T1-001-036).	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; Bridges Dave, 2004, Sci STKE, V2004, pre10, DOI 10.1126/stke.2422004re10; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chu K, 2013, ONCOTARGET, V4, P446, DOI 10.18632/oncotarget.872; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Dang CV, 1997, J BIOENERG BIOMEMBR, V29, P345, DOI 10.1023/A:1022446730452; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; Hu K, 2016, ONCOTARGET, V7, P7816, DOI 10.18632/oncotarget.6868; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Khong TL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-518; Klymkowsky MW, 2009, AM J PATHOL, V174, P1588, DOI 10.2353/ajpath.2009.080545; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; LIVE TR, 1975, J BIOL CHEM, V250, P1786; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Mak BC, 2004, CANCER INVEST, V22, P588, DOI 10.1081/CNV-200027144; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Montagner A, 2014, EMBO MOL MED, V6, P80, DOI 10.1002/emmm.201302666; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; RIDGE JW, 1972, BIOCHEM J, V127, P351, DOI 10.1042/bj1270351; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schito L, 2017, BBA-REV CANCER, V1868, P239, DOI 10.1016/j.bbcan.2017.05.004; Shiraishi T, 2015, ONCOTARGET, V6, P130, DOI 10.18632/oncotarget.2766; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sousa B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-734; Steeg PS, 2008, NAT CLIN PRACT ONCOL, V5, P206, DOI 10.1038/ncponc1066; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tinti M, 2014, DATABASE-OXFORD, DOI 10.1093/database/bat085; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Zadra G, 2015, MOL CANCER RES, V13, P1059, DOI 10.1158/1541-7786.MCR-15-0068; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Zhu XM, 2016, LUNG, V194, P637, DOI 10.1007/s00408-016-9895-y	48	23	24	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6408	6419		10.1038/onc.2017.244	http://dx.doi.org/10.1038/onc.2017.244			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28745316	Green Published, hybrid			2022-12-26	WOS:000415622900005
J	Kumar, R; Ozorowski, G; Kumar, V; Holden, LG; Shrivastava, T; Patil, S; Deshpande, S; Ward, AB; Bhattacharya, J				Kumar, Rajesh; Ozorowski, Gabriel; Kumar, Vivek; Holden, Lauren G.; Shrivastava, Tripti; Patil, Shilpa; Deshpande, Suprit; Ward, Andrew B.; Bhattacharya, Jayanta			Characterization of a stable HIV-1B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HIV; CD4; MUTATIONS; VACCINE; RESPONSES; ESCAPE; DESIGN; PLASMA; GENES	The HIV-1 envelope (Env) is a glycoprotein consisting of a trimer of heterodimers containing gp 120 and gp41 subunits that mediates virus entry and is a major target of broadly neutralizing antibodies (bnAbs) developed during infection in some individuals. The engagement of the HIV-1 gp120 glycoprotein to the host CD4 protein triggers conformational changes in gp120 that allow its binding to co-receptors and is necessary for virus entry to establish infection. Native-like HIV-1 Env immunogens representing distinct clades have been proposed to improve immunogenicity. In the present study, we examined the basis of resistance of an HIV-1 B/C recombinant Env (LT5. J4b12C) to non-neutralizing antibodies targeting CD4-induced Env epitopes in the presence of soluble CD4 (sCD4). Using native polyacrylamide gel shift assay and negative-stain EM, we found that the prefusion conformational state of LT5. J4b12C trimeric Env was largely unaffected in the presence of excess sCD4 with most Env trimers appearing to be in a ligand-free state. This resistance to CD4-induced conformational changes was associated with a lower affinity for CD4. Moreover, the LT5. J4b12C trimeric Env preferentially bound to the neutralizing antibodies compared with non-neutralizing antibodies. Taken together, we report on an HIV-1 B/C recombinant, native-like trimeric Env protein that is highly resistant to CD4-induced conformational changes but displays epitopes recognized by a diverse array of bnAbs. Such features make this B/C recombinant trimeric Env a useful addition to the pool of other recently identified native-like HIV-1 Env trimers suitable for use as antigenic bait for bnAb isolation, structural studies, and use as potential immunogens.	[Kumar, Rajesh; Kumar, Vivek; Shrivastava, Tripti; Patil, Shilpa; Deshpande, Suprit; Bhattacharya, Jayanta] Natl Capital Reg Biotech Sci Cluster, HIV Vaccine Translat Res Lab, Translat Hlth Sci & Technol Inst, Faridabad 121001, Haryana, India; [Ozorowski, Gabriel; Holden, Lauren G.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Holden, Lauren G.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Bhattacharya, Jayanta] Int AIDS Vaccine Initiat, New York, NY 10004 USA	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative	Bhattacharya, J (corresponding author), Natl Capital Reg Biotech Sci Cluster, HIV Vaccine Translat Res Lab, Translat Hlth Sci & Technol Inst, Faridabad 121001, Haryana, India.; Bhattacharya, J (corresponding author), Int AIDS Vaccine Initiat, New York, NY 10004 USA.	JBhattacharya@iavi.org	Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Ozorowski, Gabriel/HCH-0634-2022	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Holden, Lauren/0000-0001-8014-4503; Deshpande, Suprit/0000-0002-6170-3661	Bill and Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark, Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; United States Agency for International Development	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Foreign Affairs of Denmark, Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation; United Kingdom Department for International Development; United States Agency for International Development(United States Agency for International Development (USAID))	We thank Prof. John P. Moore and the members of the SOSIP trimer HIV Vaccine Research and Design team, Weill Cornell Medical College, New York, for the generous gift of the BG505 SOSIP. 664 plasmid DNA. We thank Dr. Shubbir Ahmed for helpful discussions. The work of the International AIDS Vaccine Initiative (IAVI) is made possible by generous support from many donors, including the Bill and Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation, the United Kingdom Department for International Development, and the United States Agency for International Development.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BACK NKT, 1993, J VIROL, V67, P6897, DOI 10.1128/JVI.67.11.6897-6902.1993; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Chen J, 2015, SCIENCE, V349, P191, DOI 10.1126/science.aaa9804; Chuang GY, 2017, J VIROL, V91, DOI 10.1128/JVI.02268-16; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guenaga J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004570; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Hu JK, 2015, J VIROL, V89, P10383, DOI 10.1128/JVI.01653-15; Julien JP, 2015, P NATL ACAD SCI USA, V112, P11947, DOI 10.1073/pnas.1507793112; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lee B, 1999, P NATL ACAD SCI USA, V96, P5215, DOI 10.1073/pnas.96.9.5215; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Mukhopadhyay S, 2012, AIDS RES HUM RETROV, V28, P739, DOI [10.1089/AID.2011.0238, 10.1089/aid.2011.0238]; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Patil S, 2016, J VIROL, V90, P3446, DOI 10.1128/JVI.03090-15; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046713; Ringe R, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-76; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2014, NATURE, V514, P437, DOI 10.1038/nature13926; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Winkler C, 2004, HUM MOL GENET, V13, pR9, DOI 10.1093/hmg/ddh075; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yasmeen A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-41; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	44	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15849	15858		10.1074/jbc.M117.803056	http://dx.doi.org/10.1074/jbc.M117.803056			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28743743	Green Published, hybrid			2022-12-26	WOS:000411512200022
J	Wu, HC; Wang, XY; Xue, M; Xue, M; Wu, C; Lu, QB; Ding, ZY; Xv, XP; Lin, JF				Wu, Haocheng; Wang, Xinyi; Xue, Ming; Xue, Melanie; Wu, Chen; Lu, Qinbao; Ding, Zheyuan; Xv, Xiaoping; Lin, Junfen			Spatial characteristics and the epidemiology of human infections with avian influenza A (H7N9) virus in five waves from 2013 to 2017 in Zhejiang Province, China	PLOS ONE			English	Article							A(H7N9) VIRUS; PATTERNS; RISK	Background The five-wave epidemic of H7N9 in China emerged in the second half of 2016. This study aimed to compare the epidemiological characteristics among the five waves, estimating the possible infected cases and inferring the extent of the possible epidemic in the areas that have not reported cases before. Methods The data for the H7N9 cases from Zhejiang Province between 2013 and 2017 was obtained from the China Information Network System of Disease Prevention and Control. The start date of each wave was 16 March 2013, 1 July 2013, 1 July 2014, 1 July 2015 and 1 July 2016. The F test or Pearson's chi-square test were used to compare the characteristics of the five waves. Global and local autocorrelation analysis was carried out to identify spatial autocorrelations. Ordinary kriging interpolation was analyzed to estimate the number of human infections with H7N9 virus and to infer the extent of infections in the areas with no cases reported before. Result There were 45, 94, 45, 34 and 80 cases identified from the first wave to the fifth, respectively. The death rate was significantly different among the five waves of epidemics (chi(2) = 10.784, P = 0.029). The age distribution (F = 0.903, P = 0.462), gender (chi(2) = 2.674, P = 0.614) and occupation (chi(2) = 19.764, P = 0.407) were similar in each period. Most of the cases were males and farmers. A significant trend (chi(2) = 70.328, P<0.001) was identified that showed a growing proportion of rural cases. There were 31 high-high clusters and 3 high-low clusters at the county level among the five waves and 12, 8, 2, 9 and 3 clusters in each wave, respectively. The total cases infected with the H7N9 virus were far more than those that have been reported now, and the affected areas continue to expand. The epidemic in the north of Zhejiang Province persisted in all five waves. Since the second wave, the virus spread to the south areas and central areas. There was an obvious decline in the infected cases in the urban areas, and the epidemics mostly occurred in the rural areas after the fourth wave. The epidemic was relatively dispersed since the third wave had fewer than two cases in most of the areas and showed a reinforcing trend again in the fifth wave. Conclusions The study revealed that there were few differences in the epidemiologic characteristics among the five waves of the epidemic. However, the areas where the possible epidemic circulated was larger than reported. The epidemic cross- regional expansion continued and mostly occurred in rural areas. Continuous closure of the live poultry market (LPM) is strongly recommended in both rural and urban areas. Illegal and scattered live poultry trading, especially in rural areas, must be forbidden. It is suggested too that a more rigorous management be performed on live poultry trade and wholesale across the area. Health education, surveillance of cases and pathogenicity should also be strengthened.	[Wu, Haocheng; Wang, Xinyi; Wu, Chen; Lu, Qinbao; Ding, Zheyuan; Xv, Xiaoping; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wu, Haocheng; Lin, Junfen] Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China; [Xue, Ming] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Xue, Melanie] Kingston Univ UK, London, England	Zhejiang Provincial Center for Disease Control & Prevention	Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Lin, JF (corresponding author), Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China.	hchwu@cdc.zj.cn	Wang, Xin/GYU-1129-2022; Wang, Xinyi/AAE-4342-2019		Provincial Medical Research Fund of Zhejiang, China [2015RCB008, 2017KY131]	Provincial Medical Research Fund of Zhejiang, China	This work was supported by grants from Provincial Medical Research Fund of Zhejiang, China (grant number were 2015RCB008 and 2017KY131). The document in website were http://www.zjmed.org.cn/previewerlet.do?id=8DD1BAEA38B99297 and http://www.zjmed.org.cn/previewerlet.do?id=00B32CCF219B843D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf M Dewan 1, 2013, PLOS NEGLECT TROP D, V7, pe1998; Barbosa GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002873; CARRAT F, 1992, AM J EPIDEMIOL, V135, P1293, DOI 10.1093/oxfordjournals.aje.a116236; Carrel M, 2016, HEALTH PLACE, V39, P79, DOI 10.1016/j.healthplace.2016.02.009; Chen GW, 2016, PLOS ONE, V11; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Feng L., 2014, Eurosurveillance, V19, P20984, DOI 10.2807/1560-7917.ES2014.19.49.20984; Fu CC, 2016, ENV SCI POLLUT RES; He F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2278-0; Hu Y, 2014, AM J TROP MED HYG, V91, P547, DOI 10.4269/ajtmh.14-0251; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lin YP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1983-3; Ling F, 2015, ZOONOSES PUBLIC HLTH, V62, P29, DOI 10.1111/zph.12110; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu J, 2014, CURR OPIN VIROL, V5, P91, DOI 10.1016/j.coviro.2014.03.001; Liu X.N., 2008, SPATIAL ANAL THEORIE, P189; National Health and Family Planning Commission of the People's Republic of China, 2014, VIR; National Health and Family Planning Commission of the People's Republic of China, 2014, CHIN GUID EP PREV CO; National Health and Family Planning Commission of the People's Republic of China, 2013, VIR; Nielsen CF, 2008, AM J TROP MED HYG, V78, P53, DOI 10.4269/ajtmh.2008.78.53; Qu LL, 2016, ENV SCI POLLUT RES; Sha JP, 2016, ARCH VIROL, V161, P1239, DOI 10.1007/s00705-016-2781-3; Sun Y, 2015, J CLIN VIROL, V70, P16, DOI 10.1016/j.jcv.2015.06.092; Tang FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083487; Wang DY, 2016, J VIROL, V90, P5561, DOI 10.1128/JVI.03173-15; Wang XY, 2015, EPIDEMIOL INFECT, V143, P1839, DOI 10.1017/S095026881400257X; Wang XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135718; Wu P, 2014, EMERGING INFECT DIS, V20; Xiang NJ, 2016, MMWR-MORBID MORTAL W, V65, P1390, DOI 10.15585/mmwr.mm6549a2; Xiang NJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2049-2; Xiang NJ, 2016, INFLUENZA OTHER RESP; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zhou L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw182	34	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180763	10.1371/journal.pone.0180763	http://dx.doi.org/10.1371/journal.pone.0180763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750032	gold, Green Submitted, Green Published			2022-12-26	WOS:000406575700017
J	Hamada, N				Hamada, Nobuyuki			Ionizing radiation response of primary normal human lens epithelial cells	PLOS ONE			English	Article							MOUSE LENS; CATALYTIC SUBUNIT; INDUCED CATARACTS; INHIBITOR NU7441; TUMOR-SUPPRESSOR; GENE-EXPRESSION; IN-VIVO; IDENTIFICATION; TELOMERASE; PROTEIN	Whilst the cataractogenic potential of ionizing radiation has been known for over the past 120 years, little is known about radiation responses of lens cells. Our previous work was the first to evaluate the radiosensitivity of lens cells with the clonogenic assay, documenting that the survival of HLEC1 human lens epithelial cells is comparable to that of WI-38 human lung fibroblasts. Moreover, HLEC1 cells were found to contain subsets where irradiation stimulates proliferation or facilitates formation of abortive colonies with fewer cells than human fibroblasts. This study aims to gain insights into these mechanisms. Irradiation of HLEC1 cells with 10% survival dose caused a growth delay but did not reduce viability. HLEC1 cells at high cumulative population doubling level were more susceptible to radiogenic premature senescence than WI-38 cells. Concerning p53 binding protein 1 (53BP1) foci, HLEC1 cells harbored less spontaneous foci but more radiogenic foci than in WI-38 cells, and the focus number returned to spontaneous levels within 48 h postirradiation both in HLEC1 and WI-38. The chemical inhibition of DNA repair kinases ataxia telangiectasia mutated, DNA-dependent protein kinase or both delayed and attenuated the appearance and disappearance of radiogenic 53BP1 foci, increased radiogenic premature senescence and enhanced clonogenic inactivation. The DNA microarray analysis suggested both radiogenic stimulation and inhibition of cell proliferation. Treatment with conditioned medium from irradiated cells did not change growth and the plating efficiency of nonirradiated cells. These results partially explain mechanisms of our previous observations, such that unrepaired or incompletely repaired DNA damage causes a growth delay in a subset of HLEC1 cells without changing viability through induction of premature senescence, thereby leading to clonogenic inactivation, but that growth is stimulated in another subset via as yet unidentified mechanisms, warranting further studies.	[Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Komae, Tokyo, Japan	Central Research Institute of Electric Power Industry - Japan	Hamada, N (corresponding author), Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Komae, Tokyo, Japan.	hamada-n@criepi.denken.or.jp		Hamada, Nobuyuki/0000-0003-2518-6131				Abend M, 2016, RADIAT RES, V185, P109, DOI 10.1667/RR14221.1; Ainsbury EA, 2016, MUTAT RES-REV MUTAT, V770, P238, DOI 10.1016/j.mrrev.2016.07.010; Bannik K, 2013, RADIAT ENVIRON BIOPH, V52, P279, DOI 10.1007/s00411-012-0451-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brzoska K, 2015, RADIAT ENVIRON BIOPH, V54, P353, DOI 10.1007/s00411-015-0603-8; Chalupecky H, 1897, ZENTRALBL PRAKT AUGE, V21, P234; Chang PY, 2007, RADIAT ENVIRON BIOPH, V46, P187, DOI 10.1007/s00411-006-0087-7; Chang PY, 2000, RADIAT RES, V154, P477, DOI 10.1667/0033-7587(2000)154[0477:PIIFEI]2.0.CO;2; Chang PY, 2005, RADIAT RES, V164, P531, DOI 10.1667/RR3368.1; Cuella-Martin R, 2016, MOL CELL, V64, P51, DOI 10.1016/j.molcel.2016.08.002; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; Fritz A, 2002, CANCER RES, V62, P3048; Fujimichi Y., 2015, THESIS; Fujimichi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098154; Gupta A, 2014, RADIAT RES, V181, P1, DOI 10.1667/RR13572.1; Hamada N., 2017, INT J RAD B IN PRESS, V93; Hamada N, 2007, J RADIAT RES, V48, P87, DOI 10.1269/jrr.06084; Hamada N, 2016, MUTAT RES-REV MUTAT, V770, P262, DOI 10.1016/j.mrrev.2016.08.005; Hamada N, 2015, CANCER LETT, V368, P262, DOI 10.1016/j.canlet.2015.02.017; Hamada N, 2014, J RADIAT RES, V55, P831, DOI 10.1093/jrr/rru036; Hamada N, 2014, J RADIAT RES, V55, P629, DOI 10.1093/jrr/rru019; Hamada N, 2014, RADIAT RES, V181, P9, DOI 10.1667/RR13505.1; Hamada Nobuyuki, 2011, Curr Mol Pharmacol, V4, P79; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huang XQ, 2005, INVEST OPHTH VIS SCI, V46, P2503, DOI 10.1167/iovs.05-0154; ICRP, 2007, ICRP PUBL, V103, DOI 10.1016/j.icrp.2007.10.003; ICRP, 2017, ICRP INT COMM RAD PR, V118; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kim JT, 2004, YONSEI MED J, V45, P380, DOI 10.3349/ymj.2004.45.3.380; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lyu L, 2016, FASEB J, V30, P1087, DOI 10.1096/fj.15-278036; Maddala R, 2011, DEV BIOL, V360, P30, DOI 10.1016/j.ydbio.2011.09.004; Markiewicz E, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150011; Moffatt-Jauregui CE, 2013, J PERIODONTAL RES, V48, P713, DOI 10.1111/jre.12059; Nagai N, 2016, INVEST OPHTH VIS SCI, V57, P1408, DOI 10.1167/iovs.15-19026; Nakamura H, 2002, J RADIAT RES, V43, P167, DOI 10.1269/jrr.43.167; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; NCRP, 2016, GUID RAD DOS LIM LEN; Neriishi K, 2009, RAD CAT WORKSH 2009; Ohki R, 2014, P NATL ACAD SCI USA, V111, pE2404, DOI 10.1073/pnas.1319962111; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rollins W, 1903, BOSTON MED SURG J, V148, P0364, DOI 10.1056/NEJM190304021481404; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Saberi Alihossein, 2015, Asian Pac J Cancer Prev, V16, P8553; Shan WW, 2012, CELL CYCLE, V11, P2107, DOI 10.4161/cc.20544; SUZUKI K, 2001, RAD RES, V155; Tilton SC, 2016, RADIAT RES, V186, P531, DOI 10.1667/RR14471.1; Wang CX, 2013, EXP EYE RES, V111, P79, DOI 10.1016/j.exer.2013.03.006; Wiley LA, 2011, DIS MODEL MECH, V4, P484, DOI 10.1242/dmm.006593; Wolf N, 2008, MOL VIS, V14, P274; Worgul BV, 2002, P NATL ACAD SCI USA, V99, P9836, DOI 10.1073/pnas.162349699; Yamauchi M, 2004, BIOCHEM BIOPH RES CO, V323, P906, DOI 10.1016/j.bbrc.2004.08.175; Yang G, 2007, ONCOGENE, V26, P1492, DOI 10.1038/sj.onc.1209905; Yang G, 2007, CARCINOGENESIS, V28, P174, DOI 10.1093/carcin/bgl115; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	58	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181530	10.1371/journal.pone.0181530	http://dx.doi.org/10.1371/journal.pone.0181530			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746371	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800041
J	Aweke, YH; Ayanto, SY; Ersado, TL				Aweke, Yitagesu Habtu; Ayanto, Samuel Yohannes; Ersado, Tariku Laelago			Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: Community-based cross-sectional study	PLOS ONE			English	Article								Background Cervical cancer is the second most common female cancer which Ethiopia put a strategic goal to reduce its incidence and mortality by 2020. Lack of knowledge and poor attitude towards the disease and risk factors can affect screening practice and development of preventive behavior for cervical cancer. The aim of this study was to assess knowledge, attitude, practices and factors for each domain for cervical cancer among women of child bearing age in Hossana town, Southern, Ethiopia. Methods Community based cross sectional study was carried out in June 2015. A total of 583 participants were selected using systematic random sampling technique. Pretested structured interviewer administered questionnaire was used to gather the data. Data were entered in to Epi Info software version 3.5.4 and exported to SPSS version 16 for descriptive and logistic regression analysis. Results Two hundred seventy (46.3%) of the respondents had poor comprehensive knowledge. Only 58 (9.9%) of participants had been screed for the cervical cancer before the survey. Two hundred three (34.8%) of participants had negative attitude towards selected proxy variables. Not having health seeking behavior for cervical cancer [AOR: 5.45, 95% CI: (1.18, 30.58), P < 0.031], had not ever received information about cervical cancer and its prevention [AOR: 2.63, 95% CI: (1.78,8.84), P < 0.018] and not actively seeking health information about cervical cancer [AOR: 6.25, (95% CI: (1.26, 31.06) P < 0.025] were significantly associated factors with poor knowledge. Poor knowledge score was associated with poor attitude [AOR: 56.51, 95% CI: (23.76, 134.37), P < 0.001]. Had not ever received information about the disease from any source [AOR: 45.24, (95% CI: (11.47, 178.54), P < 0.001] was significantly associated factor with not to be screened for the disease. Conclusion This study highlighted the importance of awareness creation, increasing knowledge, promoting active searching for health information and experiences of receiving information from any information sources regarding cervical cancer. Therefore, it will be essential to integrate cervical cancer prevention strategies with other reproductive health services at all level of health care delivery system.	[Aweke, Yitagesu Habtu] Hossana Coll Hlth Sci, Dept Hlth Informat, Hossana, Ethiopia; [Ayanto, Samuel Yohannes] Hossana Coll Hlth Sci, Dept Midwifery, Hossana, Ethiopia; [Ersado, Tariku Laelago] Hossana Coll Hlth Sci, Dept Clin Nursing, Hossana, Ethiopia		Aweke, YH (corresponding author), Hossana Coll Hlth Sci, Dept Hlth Informat, Hossana, Ethiopia.	yitagesuh@yahoo.com	Ersado, Tariku/GYI-8514-2022; Ayanto, Samuel/GWV-8159-2022		Hossana College of Health Sciences [6223]	Hossana College of Health Sciences	YHA and SYA received fund from Hossana College of Health Sciences for the research project under the grant number 6223. We acknowledge the college for its close follow up and deciding to publish/disseminate the research. The college had no role in study design, data collection and analysis, or preparation of the manuscript. And the College would not consider the publication cost as the primary objective just for implementation in solving the community problem.; We would like to thank Hossana College of Health Sciences Research and community service for funding of the research activity under budget code of 6223, following up and deciding for dissemination of findings. We are also grateful for Hossana town residents for participating in the study, data collectors and Hossana town health office for their cooperation during the entire process of data collection.	Abdullah NN, 2013, PROCD SOC BEHV, V85, P110, DOI 10.1016/j.sbspro.2013.08.343; Agurto I, 2005, INT J GYNECOL OBSTET, V89, pS38, DOI 10.1016/j.ijgo.2005.01.015; Ahmed Saad Aliyu, 2013, Niger Med J, V54, P316, DOI 10.4103/0300-1652.122337; Amosu AM., 2011, ANN BIOL RES, V2, P206; Assoumou SZ, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0193-2; Bansal Agam B, 2015, J Nat Sci Biol Med, V6, P324, DOI 10.4103/0976-9668.159993; Basu Partha, 2013, South Asian J Cancer, V2, P187, DOI 10.4103/2278-330X.119877; Bayu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149908; Belete Netsanet, 2015, Gynecol Oncol Res Pract, V2, P6, DOI 10.1186/s40661-015-0012-3; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; Broutet N., INTERVENTIONS ENCOUR; Chadza E., 2012, Health, V4, P1015, DOI 10.4236/health.2012.411155; de Sanjose Serrano B, 2012, HUMAN PAPILLOMAVIRUS; Ekechi C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1096; Federal Ministry of Health Ethiopia (FMoH), 2015, HLTH SECT TRANSF PLA; Ferlay J. S. I., 2013, IARC CANC BASE; FMOH, NAT STRAT ACT PLAN N; FMOH Federal Ministry of Health Ethiopia, 2015, NAT CANC CONTR PLAN; Gedefaw A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084519; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Hailu A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-69; Hoque M, 2008, E AFRICAN J PUBLIC H, V5; Jaglarz K, 2014, J GYNECOL ONCOL, V25, P81, DOI 10.3802/jgo.2014.25.2.81; Kolahdooz F., KNOWLEDGE ATTITUDES; Moscicki AB, 2005, J ADOLESCENT HEALTH, V37, pS3, DOI 10.1016/j.jadohealth.2005.09.011; Mwaka AD, 2016, HEALTH EXPECT, V19, P854, DOI 10.1111/hex.12382; Pathfinder international, 2014, AIDS SUPP ETH WOM AC; Tefera F., 2016, J CANC ED; Torres E, 2013, HEALTH EDUC RES, V28, P772, DOI 10.1093/her/cys106; Varughese N., 2016, CHRISMED J HLTH RES, V3, P51, DOI [10.4103/2348-3334.172401, DOI 10.4103/2348-3334.172401]; WHO, 2014, ATT 9 GLOB NONC DIS; Woldeamanuel YW, 2013, LANCET ONCOL, V14, P289, DOI 10.1016/S1470-2045(12)70399-6; World Health Organization, 2013, COMPR CERV CANC PREV; Wright KO., 2014, COMMUNITY PERCEPTION, P9; Yu Foo Qing, 2015, Asian Pac J Cancer Prev, V16, P145	35	77	77	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181415	10.1371/journal.pone.0181415	http://dx.doi.org/10.1371/journal.pone.0181415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742851	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000030
J	Chiesi, F; Bonacchi, A; Primi, C; Miccinesi, G				Chiesi, Francesca; Bonacchi, Andrea; Primi, Caterina; Miccinesi, Guido			Assessing unmet needs in patients with cancer: An investigation of differential item functioning of the Needs Evaluation Questionnaire across gender, age and phase of the disease	PLOS ONE			English	Article							SUPPORTIVE CARE NEEDS; RESPONSE THEORY MODELS; BREAST-CANCER; INFORMATION; WOMEN	The Needs Evaluation Questionnaire (NEQ) is a self-administered instrument used in oncology clinical practice and research. Objective The main aim of this study was to provide evidence of the broad employability of the NEQ with patients of different gender and age with cancer in different phases of the disease and care process, using an Item Response Theory (IRT) approach and investigating Differential Item Functioning (DIF). Methods The NEQ was completed by 762 patients visiting, consecutively, outpatient clinics or admitted to oncology wards. Patients included in the study had different primary tumor sites and were in different phases of the disease and care process. The properties of the questionnaire were analyzed by applying IRT to test how well each item of the scale concurs in measuring unmet needs, how reliable the whole scale is, and whether the scale was metrically invariant across gender, age, and phase of the disease. Results Results showed that the NEQ performed well in measuring unmet needs and measurement equivalence of the scale across gender, age, and phase of the disease was verified. Conclusions The current study supports the utility and broad employability of the NEQ, thus providing empirical evidence that it is psychometrically sound and metrically equivalent across different groups of cancer patients. As such, the scale could be an effective tool when planning psychosocial interventions to improve the care process and patients' quality of life.	[Chiesi, Francesca; Primi, Caterina] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Sect Psychol, Florence, Italy; [Bonacchi, Andrea] Ctr Studi & Ric Synth, Florence, Italy; [Miccinesi, Guido] Canc Res & Prevent ISPO, Clin & Descript Epidemiol Unit, Florence, Italy	University of Florence	Chiesi, F (corresponding author), Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth NEURO, Sect Psychol, Florence, Italy.	francesca.chiesi@unifi.it	Chiesi, Francesca/AAB-5819-2022; miccinesi, guido/AAB-5476-2022	Chiesi, Francesca/0000-0002-6861-9219; miccinesi, guido/0000-0002-7452-9594	Lega Italiana per la Lotta contro i Tumori - LILT	Lega Italiana per la Lotta contro i Tumori - LILT	This work was funded by Lega Italiana per la Lotta contro i Tumori - LILT.	Annunziata MA, 2009, PSYCHO-ONCOLOGY, V18, P549, DOI 10.1002/pon.1445; Baker F., 2001, BASICS ITEM RESPONSE; Baum M, 2004, PSYCHO-ONCOLOGY, V13, P850, DOI 10.1002/pon.880; Bonacchi A, 2010, PSYCHO-ONCOLOGY, V19, P1294, DOI 10.1002/pon.1693; Bonacchi A, 2014, J PAIN SYMPTOM MANAG, V47, P26, DOI 10.1016/j.jpainsymman.2013.03.014; Cai L., 2011, IRTPRO 2 1 WINDOWS; Cai L, 2006, BRIT J MATH STAT PSY, V59, P173, DOI 10.1348/000711005X66419; Carey M, 2012, SUPPORT CARE CANCER, V20, P207, DOI 10.1007/s00520-011-1327-1; Carlson LE, 2012, J CLIN ONC; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; Clavarino Alexandra M, 2002, Aust J Rural Health, V10, P188, DOI 10.1046/j.1440-1584.2002.00436.x; Davis C, 2003, SOC WORK HEALTH CARE, V36, P25, DOI 10.1300/J010v36n03_02; DRASGOW F, 1983, APPL PSYCH MEAS, V7, P189, DOI 10.1177/014662168300700207; Embretson S, 2000, MULTIVARIATE APPL BO; Fitch M, 2000, Hosp Q, V3, P39; Girgis A, 2000, AUST NZ J PUBL HEAL, V24, P166, DOI 10.1111/j.1467-842X.2000.tb00137.x; Hambleton R. K., 1991, FUNDAMENTALS ITEM RE; HARRISON J, 1995, SOC SCI MED, V41, P1255, DOI 10.1016/0277-9536(94)00411-L; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Lintz K, 2003, PSYCHO-ONCOLOGY, V12, P769, DOI 10.1002/pon.702; Lupton D., 1996, HLTH SOCIOLOGY EMOTI, P57; Muthen L., 2016, MPLUS COMPREHENSIVE; Nixon A, 2010, J CLIN NURS, V19, DOI 10.1111/j.1365-2702.2009.03112.x; Osse BHP, 2000, CANCER-AM CANCER SOC, V88, P900, DOI 10.1002/(SICI)1097-0142(20000215)88:4<900::AID-CNCR22>3.0.CO;2-2; Reckases MD., 1979, J EDUC STATIST, V4, P207, DOI DOI 10.3102/10769986004003207; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Reise SP, 2009, ANNU REV CLIN PSYCHO, V5, P27, DOI 10.1146/annurev.clinpsy.032408.153553; Richardson A, 2007, SUPPORT CARE CANCER, V15, P1125, DOI 10.1007/s00520-006-0205-8; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Soothill K, 2001, SUPPORT CARE CANCER, V9, P597, DOI 10.1007/s005200100278; Steginga SK, 2001, PSYCHO-ONCOL, V10, P66, DOI 10.1002/1099-1611(200101/02)10:1<66::AID-PON493>3.0.CO;2-Z; Sutherland G, 2009, EUR J CANCER CARE, V18, P577, DOI 10.1111/j.1365-2354.2008.00932.x; Tamburini M, 2000, ANN ONCOL, V11, P31, DOI 10.1023/A:1008396930832; Tamburini M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-12; Wen Kuang-Yi, 2004, Health Qual Life Outcomes, V2, P11; Willems RA, 2016, PSYCHO-ONCOLOGY, V25, P51, DOI 10.1002/pon.3870	36	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0179765	10.1371/journal.pone.0179765	http://dx.doi.org/10.1371/journal.pone.0179765			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8DV	28742867	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000005
J	Stelzl, E; Haas, B; Bauer, B; Zhang, S; Fiss, EH; Hillman, G; Hamilton, AT; Mehta, R; Heil, ML; Marins, EG; Santner, BI; Kessler, HH				Stelzl, Evelyn; Haas, Bernhard; Bauer, Bernd; Zhang, Sherry; Fiss, Ellen H.; Hillman, Grantland; Hamilton, Aaron T.; Mehta, Rochak; Heil, Marintha L.; Marins, Ed G.; Santner, Brigitte I.; Kessler, Harald H.			First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencing	PLOS ONE			English	Article							INTERGENOTYPIC RECOMBINANT; GENETIC DIVERSITY; GENOTYPES; EVOLUTION; SUBTYPE	Hepatitis C virus (HCV) intergenotypic recombinant forms have been reported for various HCV genotypes/subtypes in several countries worldwide. In a recent study, four patients living in Austria had been identified to be possibly infected with a recombinant HCV strain. To clarify results and determine the point of recombination, full-genome next-generation sequencing using the Illumina MiSeq v2 300 cycle kit (Illumina, San Diego, CA, USA) was performed in the present study. Samples of all of the patients contained the recombinant HCV strain 2k/1b. The point of recombination was found to be within the HCV NS2 gene between nucleotide positions 3189-3200 based on H77 numbering. While three of four patients were male and had migration background from Chechnya (n = 2) and Azerbaijan (n = 1), the forth patient was a female born in Austria. Three of the four patients including the female had intravenous drug abuse as a risk factor for HCV transmission. While sequencing techniques are limited to a few specialized laboratories, a genotyping assay that uses both ends of the HCV genome should be employed to identify patients infected with a recombinant HCV strain. The correct identification of recombinant strains also has an impact considering the tailored choice of anti-HCV treatment.	[Stelzl, Evelyn; Santner, Brigitte I.; Kessler, Harald H.] Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria; [Haas, Bernhard] Gen Hosp Graz West, Dept Internal Med, Graz, Austria; [Bauer, Bernd] Gen Hosp Horgas Enzenbach, Gratwein, Austria; [Zhang, Sherry; Fiss, Ellen H.; Hillman, Grantland; Hamilton, Aaron T.; Mehta, Rochak; Heil, Marintha L.; Marins, Ed G.] Roche Mol Diagnost, Pleasanton, CA USA	Medical University of Graz; Roche Holding	Stelzl, E (corresponding author), Med Univ Graz, Inst Hyg Microbiol & Environm Med, Graz, Austria.	evelyn.stelzl@medunigraz.at		Marins, Ed/0000-0002-1326-5177; Stelzl, Evelyn/0000-0003-0860-7221	Roche Molecular Systems	Roche Molecular Systems	This work was supported by Roche Molecular Systems. The funder provided support in the form of reagents and manpower but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder did not provide support in the form of salaries for authors ES, BH, BB, BIS, HHK.	Cuypers L, 2015, VIRUSES-BASEL, V7, P5018, DOI 10.3390/v7092857; Demetriou VL, 2011, ADV VIROL, V2011, DOI 10.1155/2011/710438; Echeverria N, 2015, WORLD J HEPATOL, V7, P831, DOI 10.4254/wjh.v7.i6.831; European Association for the Study of the Liver, 2016, EASL REC TREATM HEP; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hedskog C, 2015, HEPATOLOGY, V61, P471, DOI 10.1002/hep.27361; Kalinina O, 2002, J VIROL, V76, P4034, DOI 10.1128/JVI.76.8.4034-4043.2002; Legrand-Abravanel F, 2007, J VIROL, V81, P4357, DOI 10.1128/JVI.02639-06; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Moreau I, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-95; Morel V, 2010, J CLIN VIROL, V47, P382, DOI 10.1016/j.jcv.2010.01.011; Paolucci S, 2017, ANTIVIR THER; Raghwani J, 2012, J VIROL, V86, P2212, DOI 10.1128/JVI.06184-11; Ramiere C, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.43.20944; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stelzl E, 2017, CLIN CHEM LAB MED, V55, P517, DOI 10.1515/cclm-2016-0620; Tallo T, 2007, J MED VIROL, V79, P374, DOI 10.1002/jmv.20828; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Todt D, 2017, J ANTIMICROB CHEMOTH, V72, P1541, DOI 10.1093/jac/dkw572	21	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181273	10.1371/journal.pone.0181273	http://dx.doi.org/10.1371/journal.pone.0181273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742818	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000025
J	Yong, ASC; Javadzadegan, A; Fearon, WF; Moshfegh, A; Lau, JK; Nicholls, S; Ng, MKC; Kritharides, L				Yong, Andy S. C.; Javadzadegan, Ashkan; Fearon, William F.; Moshfegh, Abouzar; Lau, Jerrett K.; Nicholls, Stephen; Ng, Martin K. C.; Kritharides, Leonard			The relationship between coronary artery distensibility and fractional flow reserve	PLOS ONE			English	Article							CT ANGIOGRAPHY; BLOOD-FLOW; DIAGNOSTIC PERFORMANCE; COMPUTED-TOMOGRAPHY; VULNERABLE PLAQUE; CLINICAL-OUTCOMES; LUMINAL AREA; WALL MODEL; DISEASE; PRESSURE	Discordance between angiography-based anatomical assessment of coronary stenosis severity and fractional flow reserve (FFR) has been attributed to several factors including lesion length and irregularity, and the myocardial territory supplied by the target vessel. We sought to examine if coronary arterial distensibility is an independent contributor to this discordance. There were two parts to this study. The first consisted of "in silico" models of 26 human coronary arteries. Computational fluid dynamics-derived FFR was calculated for fully rigid, partially distensible and fully distensible models of the 26 arteries. The second part of the study consisted of 104 patients who underwent coronary angiography and FFR measurement. Distensibility at the lesion site (Distensibility(MLA)) and for the reference vessel (Distensibility(Ref)) was determined by analysing three-dimensional angiography images during end-systole and end-diastole. Computational fluid dynamics-derived FFR was 0.67 +/- 0.19, 0.70 +/- 0.18 and 0.75 +/- 0.17 (P<0.001) in the fully rigid, partially distensible and fully distensible models respectively. FFR correlated with both Distensibility(MLA) (r = 0.36, P<0.001) and Distensibility(Ref) (r = 0.44, P<0.001). Two-way ANCOVA analysis revealed that Distensibility(MLA) (F(1, 100) = 4.17, p = 0.031) and percentage diameter stenosis (F (1, 100) = 60.30, p < 0.01) were both independent predictors of FFR. Coronary arterial distensibility is a novel, independent determinant of FFR, and an important factor contributing to the discordance between anatomical and functional assessment of stenosis severity.	[Yong, Andy S. C.; Javadzadegan, Ashkan; Moshfegh, Abouzar] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Yong, Andy S. C.; Javadzadegan, Ashkan; Moshfegh, Abouzar; Lau, Jerrett K.; Kritharides, Leonard] Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia; [Yong, Andy S. C.; Kritharides, Leonard] Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia; [Fearon, William F.] Stanford Univ, Med Ctr, Div Cardiovasc Med, Stanford, CA 94305 USA; [Nicholls, Stephen] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Ng, Martin K. C.] Univ Sydney, Royal Prince Alfred Hosp, Sydney, NSW, Australia	Macquarie University; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; Stanford University; South Australian Health & Medical Research Institute (SAHMRI); University of Sydney	Yong, ASC (corresponding author), Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia.; Yong, ASC (corresponding author), Univ Sydney, ANZAC Res Inst, Sydney, NSW, Australia.; Yong, ASC (corresponding author), Univ Sydney, Concord Hosp, Dept Cardiol, Sydney, NSW, Australia.	andy.yong@sydney.edu.au	Ekanayake, Kanchana/P-8817-2016; Kritharides, Leonard/AAQ-2720-2020; Stefanadis, Christodoulos/ABH-2232-2020; Yong, Andy S C/B-2196-2008; Research Institute, ANZAC/CAE-9030-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Nicholls, Stephen/0000-0002-9668-4368; Javadzadegan, Ashkan/0000-0002-9896-2261; Moshfegh, Abouzar/0000-0002-7488-7041; Yong, Andy/0000-0002-6268-4300	National Heart Foundation of Australia Future Leader Fellowship [100448]; RACP; National Health and Medical Research Council program [1037903]	National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); RACP; National Health and Medical Research Council program(National Health and Medical Research Council (NHMRC) of Australia)	Associate Professor Yong was supported by a National Heart Foundation of Australia Future Leader Fellowship (ID 100448) and a Sir Roy McCaughey Research Establishment Grant from the RACP. Professor Kritharides was supported by a National Health and Medical Research Council program grant (ID 1037903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2016, CLIN PHYSIOL FUNCT I, V36, P261, DOI 10.1111/cpf.12220; Ahmadi N, 2012, J AM COLL CARDIOL, V59, pE2101, DOI 10.1016/S0735-1097(12)62102-0; Briasoulis A, 2015, INT J CARDIOL, V187, P334, DOI 10.1016/j.ijcard.2015.03.325; Coenen A, 2015, RADIOLOGY, V274, P674, DOI 10.1148/radiol.14140992; Ferrari Markus, 2006, Cardiovasc Ultrasound, V4, P14, DOI 10.1186/1476-7120-4-14; Hadamitzky M, 2013, J AM COLL CARDIOL, V62, P468, DOI 10.1016/j.jacc.2013.04.064; Javadzadegan A, 2013, AM J PHYSIOL-HEART C, V304, pH559, DOI 10.1152/ajpheart.00428.2012; Jeremias A, 2000, HEART, V84, P314, DOI 10.1136/heart.84.3.314; Johnson NP, 2014, J AM COLL CARDIOL, V64, P1641, DOI 10.1016/j.jacc.2014.07.973; Kelle S, 2011, AM J CARDIOL, V108, P491, DOI 10.1016/j.amjcard.2011.03.078; Konala BC, 2011, J BIOMECH, V44, P842, DOI 10.1016/j.jbiomech.2010.12.011; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Koshiba N, 2007, J BIOMECH ENG-T ASME, V129, P374, DOI 10.1115/1.2720914; Lansky AJ, 2014, JACC-CARDIOVASC INTE, V7, P778, DOI 10.1016/j.jcin.2014.05.002; Lee JMS, 2008, ATHEROSCLEROSIS, V197, P951, DOI 10.1016/j.atherosclerosis.2007.09.001; Lin K, 2011, RADIOLOGY, V261, P771, DOI 10.1148/radiol.11110573; Menter FR, 2006, FLOW TURBUL COMBUST, V77, P277, DOI 10.1007/s10494-006-9047-1; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; NAKATANI S, 1995, CIRCULATION, V91, P2904, DOI 10.1161/01.CIR.91.12.2904; Norgaard BL, 2014, J AM COLL CARDIOL, V63, P1145, DOI 10.1016/j.jacc.2013.11.043; Papafaklis MI, 2014, EUROINTERVENTION, V10, P574, DOI 10.4244/EIJY14M07_01; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Sadat U, 2013, J ATHEROSCLER THROMB, V20, P46, DOI 10.5551/jat.12633; Sasaki O, 2012, CLIN RES CARDIOL, V101, P545, DOI 10.1007/s00392-012-0424-6; Tang DL, 2001, J BIOMECH ENG-T ASME, V123, P548, DOI 10.1115/1.1406036; Taylor CA, 2013, J AM COLL CARDIOL, V61, P2233, DOI 10.1016/j.jacc.2012.11.083; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tu SX, 2014, JACC-CARDIOVASC INTE, V7, P768, DOI 10.1016/j.jcin.2014.03.004; van de Hoef TP, 2014, CIRC-CARDIOVASC INTE, V7, P301, DOI 10.1161/CIRCINTERVENTIONS.113.001049; Vavuranakis M, 1999, J AM COLL CARDIOL, V34, P1075, DOI 10.1016/S0735-1097(99)00331-9; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Yong ASC, 2011, EUR HEART J, V32, P345, DOI 10.1093/eurheartj/ehq259; Zarins CK, 2013, J CARDIOVASC TRANSL, V6, P708, DOI 10.1007/s12265-013-9498-4	34	15	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181824	10.1371/journal.pone.0181824	http://dx.doi.org/10.1371/journal.pone.0181824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742827	Green Published, gold			2022-12-26	WOS:000406370000057
J	Cho, HR; Kim, HS; Park, JS; Park, SC; Kim, KP; Wood, TD; Choi, YS				Cho, Ha Ra; Kim, Han Sol; Park, Jun Seo; Park, Seung Cheol; Kim, Kwang Pyo; Wood, Troy D.; Choi, Yong Seok			Construction and characterization of the Korean whole saliva proteome to determine ethnic differences in human saliva proteome	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; ELECTROSPRAY-IONIZATION; BIOMARKERS; SEPARATION; DISEASE	As the first step to discover protein disease biomarkers from saliva, global analyses of the saliva proteome have been carried out since the early 2000s, and more than 3,000 proteins have been identified in human saliva. Recently, ethnic differences in the human plasma proteome have been reported, but such corresponding studies on human saliva in this aspect have not been previously reported. Thus, here, in order to determine ethnic differences in the human saliva proteome, a Korean whole saliva (WS) proteome catalogue indexing 480 proteins was built and characterized through nLC-Q-IMS-TOF analyses of WS samples collected from eleven healthy South Korean male adult volunteers for the first time. Identification of 226 distinct Korean WS proteins, not observed in the integrated human saliva protein dataset, and significant gene ontology distribution differences in the Korean WS proteome compared to the integrated human saliva proteome strongly support ethnic differences in the human saliva proteome. Additionally, the potential value of ethnicity-specific human saliva proteins as biomarkers for diseases highly prevalent in that ethnic group was confirmed by finding 35 distinct Korean WS proteins likely to be associated with the top 10 deadliest diseases in South Korea. Finally, the present Korean WS protein list can serve as the first level reference for future proteomic studies including disease biomarker studies on Korean saliva.	[Cho, Ha Ra; Kim, Han Sol; Park, Jun Seo; Choi, Yong Seok] Dankook Univ, Coll Pharm, Cheonan, Chungnam, South Korea; [Park, Seung Cheol; Kim, Kwang Pyo] Kyung Hee Univ, Inst Nat Sci, Dept Appl Chem, Coll Appl Sci, Yongin, Kyoungki, South Korea; [Wood, Troy D.] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA	Dankook University; Kyung Hee University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Choi, YS (corresponding author), Dankook Univ, Coll Pharm, Cheonan, Chungnam, South Korea.; Wood, TD (corresponding author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.	twood@buffalo.edu; analysc@dankook.ac.kr	Wood, Troy/X-5832-2019; Kim, Kwang Pyo/AAG-1815-2020	Wood, Troy/0000-0002-2556-8511; Kim, Kwang Pyo/0000-0003-0095-3787	National Research Foundation of Korea - Korean Government [2014R1A1A1004674]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by a grant (2014R1A1A1004674 to YSC) of the National Research Foundation of Korea funded by the Korean Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel TE, 2012, CHEM SOC REV, V41, P3912, DOI 10.1039/c2cs15331a; Bandhakavi S, 2009, J PROTEOME RES, V8, P5590, DOI 10.1021/pr900675w; Camisasca DR, 2017, J PROTEOMICS, V151, P43, DOI 10.1016/j.jprot.2016.07.029; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; Choi YS, 2016, ARCH PHARM RES, V39, P390, DOI 10.1007/s12272-015-0663-y; Choi YS, 2013, J CHROMATOGR B, V930, P129, DOI 10.1016/j.jchromb.2013.05.003; Choi YS, 2012, ARCH PHARM RES, V35, P1861, DOI 10.1007/s12272-012-1102-y; Corstjens PLAM, 2012, J AM DENT ASSOC, V143, P12, DOI DOI 10.14219/JADA.ARCHIVE.2012.0338; Csosz E, 2017, J PROTEOMICS, V153, P30, DOI 10.1016/j.jprot.2016.08.009; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Fang X, 2007, ANAL CHEM, V79, P5785, DOI 10.1021/ac070611a; Fearon JD, 2003, J ECON GROWTH, V8, P195, DOI 10.1023/A:1024419522867; Gonzalez-Begne M, 2011, J PROTEOME RES, V10, P5031, DOI 10.1021/pr200505t; GraphPad Software, 2017, QUICKCALCS; IMIM-UPF, 2016, DAT DIS REL BIOM; Jacobs R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160546; Jeong SK, 2010, PROTEOMICS, V10, P1250, DOI 10.1002/pmic.200900371; Kim CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009065; Korean Statistical Information Service, 2016, STAT DAT CAUS DEATH; Kuehl MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125320; Loo JA, 2010, J DENT RES, V89, P1016, DOI 10.1177/0022034510380414; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Princeton University, 2017, GEN GEN ONT GO TERM; Righetti PG, 2005, ELECTROPHORESIS, V26, P297, DOI 10.1002/elps.200406189; Shanghai Institutes for Biological Sciences, 2008, SYS BOD FLUID DAT; Shliaha PV, 2013, J PROTEOME RES, V12, P2323, DOI 10.1021/pr300775k; Sivadasan P, 2015, J PROTEOMICS, V127, P89, DOI 10.1016/j.jprot.2015.05.039; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; UCLA Dental Research Institute, 2005, HUM SAL PROT CENTR R; University of Southern California, 2017, PANTHER CLASS SYST; Wang QH, 2015, CLIN CHIM ACTA, V438, P214, DOI 10.1016/j.cca.2014.08.037; Xie HW, 2005, MOL CELL PROTEOMICS, V4, P1826, DOI 10.1074/mcp.D500008-MCP200; Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181765	10.1371/journal.pone.0181765	http://dx.doi.org/10.1371/journal.pone.0181765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742128	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700066
J	Kovarik, JJ; Kernbauer, E; Holzl, MA; Hofer, J; Gualdoni, GA; Schmetterer, KG; Miftaril, F; Sobanov, Y; Meshcheryakova, A; Mechtcheriakova, D; Witzeneder, N; Greiner, G; Ohradanova-Repic, A; Waidhofer-Sollner, P; Saemann, MD; Decker, T; Zlabinger, GJ				Kovarik, Johannes J.; Kernbauer, Elisabeth; Hoelzl, Markus A.; Hofer, Johannes; Gualdoni, Guido A.; Schmetterer, Klaus G.; Miftaril, Fitore; Sobanov, Yury; Meshcheryakova, Anastasia; Mechtcheriakova, Diana; Witzeneder, Nadine; Greiner, Georg; Ohradanova-Repic, Anna; Waidhofer-Soellner, Petra; Saeemann, Marcus D.; Decker, Thomas; Zlabinger, Gerhard J.			Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES INFECTION; DENDRITIC CELL-FUNCTION; A/J MOUSE MACROPHAGES; HUMAN MONOCYTES; INTRACELLULAR MULTIPLICATION; LEGIONELLA-PNEUMOPHILA; SIGNALING PATHWAY; MAMMALIAN TARGET; PROTEIN-KINASE; MICE	A crucial role of cell metabolism in immune cell differentiation and function has been recently established. Growing evidence indicates that metabolic processes impact both, innate and adaptive immunity. Since a down-stream integrator of metabolic alterations, mammalian target of rapamycin (mTOR), is responsible for controlling the balance between pro-inflammatory interleukin (IL)-12 and anti-inflammatory IL-10, we investigated the effect of upstream interference using metabolic modulators on the production of pro-and anti-inflammatory cytokines. Cytokine release and protein expression in human and murine myeloid cells was assessed after toll-like receptor (TLR)-activation and glucose-deprivation or co-treatment with 50-adenosine monophosphate (AMP)-activated protein kinase (AMPK) activators. Additionally, the impact of metabolic interference was analysed in an in-vivo mouse model. Glucose-deprivation by 2-deoxy-D-glucose (2-DG) increased the production of IL-12p40 and IL-23p19 in monocytes, but dose-dependently inhibited the release of anti-inflammatory IL-10. Similar effects have been observed using pharmacological AMPK activation. Consistently, an inhibition of the tuberous sclerosis complex-mTOR pathway was observed. In line with our in vitro observations, glycolysis inhibition with 2-DG showed significantly reduced bacterial burden in a Th2-prone Listeria monocytogenes mouse infection model. In conclusion, we showed that fasting metabolism modulates the IL-12/IL-10 cytokine balance, establishing novel targets for metabolism-based immune-modulation.	[Kovarik, Johannes J.; Hoelzl, Markus A.; Hofer, Johannes; Gualdoni, Guido A.; Miftaril, Fitore; Waidhofer-Soellner, Petra; Zlabinger, Gerhard J.] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Kovarik, Johannes J.; Hofer, Johannes; Saeemann, Marcus D.] Med Univ Vienna, Dept Internal Med 3, Clin Div Nephrol & Dialysis, Vienna, Austria; [Kernbauer, Elisabeth; Decker, Thomas] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Vienna, Austria; [Schmetterer, Klaus G.; Witzeneder, Nadine; Greiner, Georg] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Sobanov, Yury; Meshcheryakova, Anastasia; Mechtcheriakova, Diana] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Ohradanova-Repic, Anna] Med Univ Vienna, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Zlabinger, GJ (corresponding author), Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	gerhard.zlabinger@meduniwien.ac.at	Ohradanova-Repic, Anna/ABG-3709-2020	Ohradanova-Repic, Anna/0000-0002-8005-8522; Greiner, Georg/0000-0002-0917-4117; Waidhofer-Sollner, Petra/0000-0002-9481-3584; Meshcheryakova, Anastasia/0000-0003-4359-9546; Zlabinger, Gerhard/0000-0002-7478-4173; Gualdoni, Guido/0000-0001-9490-0197; Kovarik, Johannes/0000-0002-0206-082X; Mechtcheriakova, Diana/0000-0002-8737-3592	Austrian Science Fund (FWF) projects [P22441-B13, P23228-B19]; European Union's Horizon 2020 Research and Innovation Program [683356]	Austrian Science Fund (FWF) projects(Austrian Science Fund (FWF)); European Union's Horizon 2020 Research and Innovation Program	The work was supported in part by the Austrian Science Fund (FWF) projects P22441-B13 and P23228-B19 to DM. A.O.R. was supported from the European Union's Horizon 2020 Research and Innovation Program under grant agreement No 683356.; We thank Erika Bajna for assistance in TissueFAXS and Margarethe Merio for assistance in cell culture experiments. The work was supported in part by the Austrian Science Fund (FWF) projects P22441-B13 and P23228-B19 to DM. A.O.R. was supported from the European Union's Horizon 2020 Research and Innovation Program under grant agreement No 683356	Abdi K, 2015, CYTOKINE, V76, P53, DOI 10.1016/j.cyto.2015.07.026; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; BROWN J, 1962, METABOLISM, V11, P1098; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Carrero JA, 2012, ADV IMMUNOL, V113, P157, DOI 10.1016/B978-0-12-394590-7.00001-4; Dai WJ, 1997, J IMMUNOL, V158, P5297; Dai WJ, 1997, J IMMUNOL, V158, P2259; Dong H, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00024; Dreau D, 2000, J INTERF CYTOK RES, V20, P247, DOI 10.1089/107999000312667; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gualdoni GA, 2016, FASEB J, V30, P3800, DOI 10.1096/fj.201600522R; Gualdoni GA, 2014, BBA-GEN SUBJECTS, V1840, P95, DOI 10.1016/j.bbagen.2013.09.009; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Indramohan M, 2012, INFECT IMMUN, V80, P4099, DOI 10.1128/IAI.00589-12; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Jana M, 2009, MOL IMMUNOL, V46, P773, DOI 10.1016/j.molimm.2008.10.033; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kovarik JJ, 2013, IMMUNOLOGY, V139, P395, DOI 10.1111/imm.12089; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Ma X., 2015, F1000RES, V4, DOI 10.12688/f1000research.7010.1; Matsuda F, 2009, AUTOPHAGY, V5, P484, DOI 10.4161/auto.5.4.7760; MCCOMB RB, 1964, CANCER RES, V24, P198; Mechtcheriakova D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025611; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Meshcheryakova A, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7947; MILLER ES, 1993, BRAIN BEHAV IMMUN, V7, P317, DOI 10.1006/brbi.1993.1031; Miller ES, 1998, PHYSIOL BEHAV, V65, P535, DOI 10.1016/S0031-9384(98)00199-1; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; OGAWA M, 1994, INFECT IMMUN, V62, P266, DOI 10.1128/IAI.62.1.266-270.1994; Ohradanova-Repic A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2015.39; Ohtani M, 2008, BLOOD, V112, P635, DOI 10.1182/blood-2008-02-137430; Risitano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107431; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Sieve AN, 2010, EUR J IMMUNOL, V40, P2236, DOI 10.1002/eji.200939759; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Suzuki H, 2016, IMMUNOL LETT, V176, P18, DOI 10.1016/j.imlet.2016.05.009; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Torres-Castro I, 2016, IMMUNOL LETT, V176, P81, DOI 10.1016/j.imlet.2016.06.001; Trinchieri Alberto, 2003, Arch Ital Urol Androl, V75, P49; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Witter AR, 2016, J IMMUNOL, V197, P1557, DOI 10.4049/jimmunol.1600599; Yang K, 2015, IMMUNITY, V42, P4, DOI 10.1016/j.immuni.2014.12.029; Zhu YP, 2015, J IMMUNOL, V194, P584, DOI 10.4049/jimmunol.1401024	54	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180900	10.1371/journal.pone.0180900	http://dx.doi.org/10.1371/journal.pone.0180900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742108	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700019
J	Li, N; Xu, H; Wang, ZH; Sun, LN; Chen, GD				Li, Na; Xu, Hui; Wang, Zhenhua; Sun, Lining; Chen, Guodong			A salient region detection model combining background distribution measure for indoor robots	PLOS ONE			English	Article							VISUAL-ATTENTION	Vision system plays an important role in the field of indoor robot. Saliency detection methods, capturing regions that are perceived as important, are used to improve the performance of visual perception system. Most of state-of-the-art methods for saliency detection, performing outstandingly in natural images, cannot work in complicated indoor environment. Therefore, we propose a new method comprised of graph-based RGB-D segmentation, primary saliency measure, background distribution measure, and combination. Besides, region roundness is proposed to describe the compactness of a region to measure background distribution more robustly. To validate the proposed approach, eleven influential methods are compared on the DSD and ECSSD dataset. Moreover, we build a mobile robot platform for application in an actual environment, and design three different kinds of experimental constructions that are different viewpoints, illumination variations and partial occlusions. Experimental results demonstrate that our model outperforms existing methods and is useful for indoor mobile robots.	[Li, Na; Xu, Hui; Wang, Zhenhua; Sun, Lining; Chen, Guodong] Soochow Univ, Robot & Microsyst Ctr, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Chen, GD (corresponding author), Soochow Univ, Robot & Microsyst Ctr, Suzhou, Jiangsu, Peoples R China.	guodongxyz@163.com			National Natural Science Foundation of China (NSFC) [61305118, U1509202]; National Natural Science Foundation of Jiangsu (JSNSF) [BK20130329]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Jiangsu (JSNSF)	This project was funded by the National Natural Science Foundation of China (Grant No. 61305118 and No. U1509202) and the National Natural Science Foundation of Jiangsu (Grant No. BK20130329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of the National Natural Science Foundation of China (NSFC, Grant No. 61305118 and U1509202) and the National Natural Science Foundation of Jiangsu (JSNSF, Grant No. BK20130329).	Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Achanta R, 2009, PROC CVPR IEEE, P1597, DOI 10.1109/CVPRW.2009.5206596; Begum M, 2011, IEEE T AUTON MENT DE, V3, P92, DOI 10.1109/TAMD.2010.2096505; Borji A., 2012, P IEEE C COMP VIS PA, P23, DOI DOI 10.1109/CVPRW.2012.6239191; Borji A, 2012, LECT NOTES COMPUT SC, V7573, P414, DOI 10.1007/978-3-642-33709-3_30; Breazeal C, 2001, IEEE T SYST MAN CY A, V31, P443, DOI 10.1109/3468.952718; Butko NJ, 2008, IEEE INT CONF ROBOT, P2398, DOI 10.1109/ROBOT.2008.4543572; Ciptadi A, 2013, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2013, DOI 10.5244/C.27.112; Domhof J, 2015, IEEE INT C INT ROBOT, P2406, DOI 10.1109/IROS.2015.7353703; Donoser M, 2009, IEEE I CONF COMP VIS, P817, DOI 10.1109/ICCV.2009.5459296; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Feng SH, 2010, SIGNAL PROCESS, V90, P1, DOI 10.1016/j.sigpro.2009.05.017; Ferreira JF, 2014, IEEE T AUTON MENT DE, V6, P110, DOI 10.1109/TAMD.2014.2303072; Frintrop S., 2006, VOCUS VISUAL ATTENTI; Frintrop S, 2009, IEEE INT CONF ROBOT, P758; Goferman S, 2012, IEEE T PATTERN ANAL, V34, P1915, DOI 10.1109/TPAMI.2011.272; Hong Li, 2015, Image and Graphics. 8th International Conference, ICIG 2015. Proceedings: LNCS 9219, P271, DOI 10.1007/978-3-319-21969-1_24; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jiang LX, 2015, IEEE INT CONF ROBOT, P1323, DOI 10.1109/ICRA.2015.7139362; Jianqiang Ren, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P25, DOI 10.1109/CVPRW.2015.7301391; Kuhn B, 2012, IEEE INT C INT ROBOT, P807, DOI 10.1109/IROS.2012.6385515; Liu Tie, 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.383047; Lukic L, 2015, IEEE T AUTON MENT DE, V7, P76, DOI 10.1109/TAMD.2015.2417353; Madokoro H, 2015, COMPUTER SCI INFORM, V5, P188; Meger D, 2008, ROBOT AUTON SYST, V56, P503, DOI 10.1016/j.robot.2008.03.008; Min Chen, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P409, DOI 10.1109/INFCOMW.2011.5928847; Perazzi F, 2012, PROC CVPR IEEE, P733, DOI 10.1109/CVPR.2012.6247743; Ren ZX, 2014, IEEE T CIRC SYST VID, V24, P769, DOI 10.1109/TCSVT.2013.2280096; Rutishauser U, 2004, PROC CVPR IEEE, P37; Saleiro M, 2015, LECT NOTES COMPUT SC, V9176, P505, DOI 10.1007/978-3-319-20681-3_48; Scharfenberger C, 2013, 2013 INTERNATIONAL CONFERENCE ON COMPUTER AND ROBOT VISION (CRV), P75, DOI 10.1109/CRV.2013.25; Shirai K, 2014, INT C CONTR AUTOMAT, P1046, DOI 10.1109/ICCAS.2014.6987945; Tu WC, 2016, PROC CVPR IEEE, P2334, DOI 10.1109/CVPR.2016.256; Walther D, 2005, COMPUT VIS IMAGE UND, V100, P41, DOI 10.1016/j.cviu.2004.09.004; Wang P, 2014, IEEE INT CONF ROBOT, P1546, DOI 10.1109/ICRA.2014.6907057; Wang X. M., 2015, THESIS; Yan Q, 2013, PROC CVPR IEEE, P1155, DOI 10.1109/CVPR.2013.153; Yang C, 2013, PROC CVPR IEEE, P3166, DOI 10.1109/CVPR.2013.407; Zhai Y., 2006, PROC14TH ACM INT C M, DOI DOI 10.1145/1180639.1180824; Zhang G, 2010, LECT NOTES COMPUT SC, V5995, P193; Zhang JM, 2015, IEEE I CONF COMP VIS, P1404, DOI 10.1109/ICCV.2015.165; Zhou L, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2438546; Zhu WJ, 2014, PROC CVPR IEEE, P2814, DOI 10.1109/CVPR.2014.360	43	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180519	10.1371/journal.pone.0180519	http://dx.doi.org/10.1371/journal.pone.0180519			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742089	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700013
J	Seo, H; Pare, Y; Min, BJ; Seo, ME; Kim, JH				Seo, Heewon; Pare, Yoomi; Min, Byung Joo; Seo, Myung Eui; Kim, Ju Han			Evaluation of exome variants using the Ion Proton Platform to sequence error-prone regions	PLOS ONE			English	Article							TORRENT	The Ion Proton sequencer from Thermo Fisher accurately determines sequence variants from target regions with a rapid turnaround time at a low cost. However, misleading variantcalling errors can occur. We performed a systematic evaluation and manual curation of read-level alignments for the 675 ultrarare variants reported by the Ion Proton sequencer from 27 whole-exome sequencing data but that are not present in either the 1000 Genomes Project and the Exome Aggregation Consortium. We classified positive variant calls into 393 highly likely false positives, 126 likely false positives, and 156 likely true positives, which comprised 58.2%, 18.7%, and 23.1% of the variants, respectively. We identified four distinct error patterns of variant calling that may be bioinformatically corrected when using different strategies: simplicity region, SNV cluster, peripheral sequence read, and base inversion. Local de novo assembly successfully corrected 201 (38.7%) of the 519 highly likely or likely false positives. We also demonstrate that the two sequencing kits from Thermo Fisher (the Ion PI Sequencing 200 kit V3 and the Ion PI Hi-Q kit) exhibit different error profiles across different error types. A refined calling algorithm with better polymerase may improve the performance of the Ion Proton sequencing platform.	[Seo, Heewon; Pare, Yoomi; Min, Byung Joo; Seo, Myung Eui; Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, SNUBI, Seoul, South Korea	Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Div Biomed Informat, SNUBI, Seoul, South Korea.	juhan@snu.ac.kr		Seo, Heewon/0000-0001-6218-8609	Ministry of Food and Drug Safety [16183MFDS541]; Korean Health Technology R&D Project, Ministry of Health and Welfare [HI16C11280000]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korean Health Technology R&D Project, Ministry of Health and Welfare	This research was supported by a grant (no.16183MFDS541) from the Ministry of Food and Drug Safety in 2016and by a grant(no. HI16C11280000) from the Korean Health Technology R&D Project, Ministry of Health and Welfare.	AAV Pablo HCG de Sa, 2014, J PROTEOM BIOINFORM, P7; Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Damiati E, 2016, HUM GENET, V135, P499, DOI 10.1007/s00439-016-1656-8; Frith MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028819; Fuller CW, 2009, NAT BIOTECHNOL, V27, P1013, DOI 10.1038/nbt.1585; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Jighly Abdulqader, 2011, BMC Res Notes, V4, P239, DOI 10.1186/1756-0500-4-239; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Ravenscroft G, 2015, AM J HUM GENET, V96, P955, DOI 10.1016/j.ajhg.2015.04.014; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Zhang BZ, 2015, APPL ENVIRON MICROB, V81, P4536, DOI 10.1128/AEM.00111-15	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181304	10.1371/journal.pone.0181304	http://dx.doi.org/10.1371/journal.pone.0181304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742110	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700035
J	Warton, DI; Thibaut, L; Wang, YA				Wartonl, David I.; Thibaut, Loic; Wang, Yi Alice			The PIT-trap-A "model-free" bootstrap procedure for inference about regression models with discrete, multivariate responses	PLOS ONE			English	Article							CLUSTERED DATA	Bootstrap methods are widely used in statistics, and bootstrapping of residuals can be especially useful in the regression context. However, difficulties are encountered extending residual resampling to regression settings where residuals are not identically distributed (thus not amenable to bootstrapping)-common examples including logistic or Poisson regression and generalizations to handle clustered or multivariate data, such as generalised estimating equations. We propose a bootstrap method based on probability integral transform (PIT-) residuals, which we call the PIT-trap, which assumes data come from some marginal distribution F of known parametric form. This method can be understood as a type of "model-free bootstrap", adapted to the problem of discrete and highly multivariate data. PIT-residuals have the key property that they are (asymptotically) pivotal. The PIT-trap thus inherits the key property, not afforded by any other residual resampling approach, that the marginal distribution of data can be preserved under PIT-trapping. This in turn enables the derivation of some standard bootstrap properties, including second-order correctness of pivotal PIT-trap test statistics. In multivariate data, bootstrapping rows of PIT-residuals affords the property that it preserves correlation in data without the need for it to be modelled, a key point of difference as compared to a parametric bootstrap. The proposed method is illustrated on an example involving multivariate abundance data in ecology, and demonstrated via simulation to have improved properties as compared to competing resampling methods.	[Wartonl, David I.; Thibaut, Loic] UNSW, Sch Math & Stat, Sydney, NSW, Australia; [Wartonl, David I.] UNSW, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Wang, Yi Alice] Hong Kong Baptist Univ, Dept Comp Sci, Inst Computat & Theoret Studies, Hong Kong, Hong Kong, Peoples R China	University of New South Wales Sydney; University of New South Wales Sydney; Hong Kong Baptist University	Warton, DI (corresponding author), UNSW, Sch Math & Stat, Sydney, NSW, Australia.; Warton, DI (corresponding author), UNSW, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	David.Warton@unsw.edu.au	Wang, Yi Alice/L-8254-2016; Warton, David/B-5791-2009; Thibaut, Loic/G-4284-2011	Wang, Yi Alice/0000-0002-8448-8570; Warton, David/0000-0001-9441-6645; Thibaut, Loic/0000-0003-3813-682X	Australian Research Council [FT120100501, DP0987729]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Future Fellowship (FT120100501) Discovery Scheme (DP0987729). For comments on the manuscript thanks to Gery Geenens and Francis Hui.; This work was supported by the Australian Research Council (FT120100501, DP0987729) to David Warton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockwell AE, 2007, STAT PROBABIL LETT, V77, P1473, DOI 10.1016/j.spl.2007.02.008; Chambers R, 2013, J COMPUT GRAPH STAT, V22, P452, DOI 10.1080/10618600.2012.681216; Cherubini U., 2004, COPULA METHODS FINAN; Davison AC, 1997, BOOTSTRAP METHODS TH; Dunn PK., 1996, J COMPUTATIONAL GRAP, V5, P236, DOI DOI 10.2307/1390802; Edgington E. S., 1995, RANDOMIZATION TESTS; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; HALL P., 1992, SPRINGER SERIES STAT; He XM, 2002, J AM STAT ASSOC, V97, P783, DOI 10.1198/016214502388618591; Hu F, 2000, CANADIAN J STAT, V28; HU FF, 1995, BIOMETRIKA, V82, P263; LAWLESS JF, 1987, CAN J STAT, V15, P209, DOI 10.2307/3314912; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Loughin T M, 1997, Lifetime Data Anal, V3, P157, DOI 10.1023/A:1009609218622; LOUGHIN TM, 1995, J STAT COMPUT SIM, V52, P367, DOI 10.1080/00949659508811686; McCullagh P, 1989, GEN LINEAR MODELS; Politis DN, 2013, TEST-SPAIN, V22, P183, DOI 10.1007/s11749-013-0317-7; Politis DN, 2015, FRONT PROBAB STAT SC, P1, DOI 10.1007/978-3-319-21347-7; Ruschendorf L, 2009, J STAT PLAN INFER, V139, P3921, DOI 10.1016/j.jspi.2009.05.030; SMITH JQ, 1985, J FORECASTING, V4, P283, DOI 10.1002/for.3980040305; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2008, J AM STAT ASSOC, V103, P340, DOI 10.1198/016214508000000021; Warton DI, 2011, BIOMETRICS, V67, P116, DOI 10.1111/j.1541-0420.2010.01438.x; WARWICK RM, 1990, J EXP MAR BIOL ECOL, V135, P19, DOI 10.1016/0022-0981(90)90196-J; WU CFJ, 1986, ANN STAT, V14, P1261, DOI 10.1214/aos/1176350142	25	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181790	10.1371/journal.pone.0181790	http://dx.doi.org/10.1371/journal.pone.0181790			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738071	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700071
J	Barzegaran, E; Knyazeva, MG				Barzegaran, Elham; Knyazeva, Maria G.			Functional connectivity analysis in EEG source space: The choice of method	PLOS ONE			English	Article							SOURCE LOCALIZATION; BRAIN; SYNCHRONIZATION; CHALLENGES; DENSITY; EEG/MEG; MEG; OSCILLATIONS; RESPONSES; ELECTRODE	Functional connectivity (FC) is among the most informative features derived from EEG. However, the most straightforward sensor-space analysis of FC is unreliable owing to volume conductance effects. An alternative-source-space analysis of FC-is optimal for high-and mid-density EEG (hdEEG, mdEEG); however, it is questionable for widely used low-density EEG (ldEEG) because of inadequate surface sampling. Here, using simulations, we investigate the performance of the two source FC methods, the inverse-based source FC (ISFC) and the cortical partial coherence (CPC). To examine the effects of localization errors of the inverse method on the FC estimation, we simulated an oscillatory source with varying locations and SNRs. To compare the FC estimations by the two methods, we simulated two synchronized sources with varying between-source distance and SNR. The simulations were implemented for hdEEG, mdEEG, and ldEEG. We showed that the performance of both methods deteriorates for deep sources owing to their inaccurate localization and smoothing. The accuracy of both methods improves with the increasing between-source distance. The best ISFC performance was achieved using hd/mdEEG, while the best CPC performance was observed with ldEEG. In conclusion, with hdEEG, ISFC outperforms CPC and therefore should be the preferred method. In the studies based on ldEEG, the CPC is a method of choice.	[Barzegaran, Elham] CHU Vaudois, Dept Clin Neurosci, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland; Univ Lausanne, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Barzegaran, E (corresponding author), CHU Vaudois, Dept Clin Neurosci, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland.	e.barzegaran@gmail.com		Barzegaran, Elham/0000-0001-9337-2134	Swiss National Science Foundation; Swiss Research Program Nano-Tera grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Research Program Nano-Tera grant	This work was supported by Swiss National Science Foundation and Swiss Research Program Nano-Tera (www.nano-tera.ch) grant to Maria G. Knyazeva (BodyPoweredSenSE project).	Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Attal Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059856; Barzegaran E, 2015, J NEUROLOGY NEUROSUR; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cottereau BR, 2012, HUM BRAIN MAPP, V33, P2694, DOI 10.1002/hbm.21394; Daunizeau J, 2007, NEUROIMAGE, V38, P67, DOI 10.1016/j.neuroimage.2007.06.034; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Fuchs M, 1999, J CLIN NEUROPHYSIOL, V16, P267, DOI 10.1097/00004691-199905000-00006; GEVINS A, 1990, Brain Topography, V3, P53, DOI 10.1007/BF01128862; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grieve PG, 2003, CLIN NEUROPHYSIOL, V114, P1594, DOI 10.1016/S1388-2457(03)00122-6; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Jalili M, 2014, IEEE T NEUR SYS REH, V22, P212, DOI 10.1109/TNSRE.2013.2289899; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kaiboriboon K, 2012, NAT REV NEUROL, V8, P498, DOI 10.1038/nrneurol.2012.150; Kiebel SJ, 2006, NEUROIMAGE, V30, P1273, DOI 10.1016/j.neuroimage.2005.12.055; Knyazeva MG, 2013, NEUROBIOL AGING, V34, P694, DOI 10.1016/j.neurobiolaging.2012.07.012; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V107, P343, DOI 10.1016/S0013-4694(98)00084-4; Laarne PH, 2000, BRAIN TOPOGR, V12, P249, DOI 10.1023/A:1023422504025; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; NUNEZ PL, 1991, J CLIN NEUROPHYSIOL, V8, P397, DOI 10.1097/00004691-199110000-00005; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Pascual-Marqui R.D., 1999, INT J BIOELECTROMAGN, V1, P75; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD., ARXIV07111455; Pascual-Marqui RD, 2011, ARXIV11080251; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Sohrabpour A, 2016, IEEE T BIO-MED ENG, V63, P2474, DOI 10.1109/TBME.2016.2616474; Sohrabpour A, 2016, NEUROIMAGE, V142, P27, DOI 10.1016/j.neuroimage.2016.05.064; Srinivasan R, 1998, BEHAV RES METH INS C, V30, P8, DOI 10.3758/BF03209412; Tikhonov A., 1977, SOLUTION ILL POSED P; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; van Diessen E, 2015, CLIN NEUROPHYSIOL, V126, P1468, DOI 10.1016/j.clinph.2014.11.018; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vinck M, 2015, NEUROIMAGE, V108, P301, DOI 10.1016/j.neuroimage.2014.12.017; Yang L, 2011, NEUROIMAGE, V56, P1908, DOI 10.1016/j.neuroimage.2011.03.043; Zalesky A, 2012, NEUROIMAGE, V60, P1055, DOI 10.1016/j.neuroimage.2012.01.068	52	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181105	10.1371/journal.pone.0181105	http://dx.doi.org/10.1371/journal.pone.0181105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727750	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500040
J	Fatehchand, K; Santhanam, R; Shen, B; Erickson, EL; Gautam, S; Elavazhagan, S; Mo, XK; Belay, T; Tridandapani, S; Butchar, JP				Fatehchand, Kavin; Santhanam, Ramasamy; Shen, Brenda; Erickson, Ericka L.; Gautam, Shalini; Elavazhagan, Saranya; Mo, Xiaokui; Belay, Tesfaye; Tridandapani, Susheela; Butchar, Jonathan P.			Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells	PLOS ONE			English	Article							NUTRITIONAL SUPPLEMENT; IMMUNE FUNCTION; CANCER; AHCC; EXPRESSION; CHEMOTHERAPY; THERAPY; SAFETY; TRANSCRIPTION; REVEALS	Active Hexose Correlated Compound (AHCC) has been shown to have many immunostimulatory and anti-cancer activities in mice and in humans. As a natural product, AHCC has potential to create safer adjuvant therapies in cancer patients. Acute Myeloid Leukemia (AML) is the least curable and second-most common leukemia in adults. AML is especially terminal to those over 60 years old, where median survival is only 5 to 10 months, due to inability to receive intensive chemotherapy. Hence, the purpose of this study was to investigate the effects of AHCC on AML cells both in vitro and in vivo. Results showed that AHCC induced Caspase-3-dependent apoptosis in AML cell lines as well as in primary AML leukopheresis samples. Additionally, AHCC induced Caspase-8 cleavage as well as Fas and TRAIL upregulation, suggesting involvement of the extrinsic apoptotic pathway. In contrast, monocytes from healthy donors showed suppressed Caspase-3 cleavage and lower cell death. When tested in a murine engraftment model of AML, AHCC led to significantly increased survival time and decreased blast counts. These results uncover a mechanism by which AHCC leads to AML-cell specific death, and also lend support for the further investigation of AHCC as a potential adjuvant for the treatment of AML.	[Fatehchand, Kavin; Tridandapani, Susheela] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Fatehchand, Kavin; Santhanam, Ramasamy; Shen, Brenda; Erickson, Ericka L.; Gautam, Shalini; Elavazhagan, Saranya; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Belay, Tesfaye] Bluefield State Univ, Sch Arts & Sci, Bluefield, WV USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Bluefield State College	Tridandapani, S (corresponding author), Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA.; Tridandapani, S; Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu			NIH [P01 CA095426, R01 CA162411, F30 CA217006, P30 CA016058, P20 GM103434, R15 A1124156]; NATIONAL CANCER INSTITUTE [R01CA203584, P30CA016058, F30CA217006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI124156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH P01 CA095426 (S.T., J.P.B.); NIH R01 CA162411 (S.T., J.P.B.); F30 CA217006 (K.F.) P30 CA016058 (The Ohio State University Comprehensive Cancer Center); P20 GM103434 (T.B.); R15 A1124156 (T. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoedo N. D., 2013, BIOSCI REP, V33; Andersson A, 2005, LEUKEMIA, V19, P1042, DOI 10.1038/sj.leu.2403749; Aviles H, 2008, AM J SURG, V195, P537, DOI 10.1016/j.amjsurg.2007.05.045; Basmadjian C, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00020; Belay T, 2015, J NUTR MED DIET CARE, V1; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Cao ZY, 2015, NUTR RES PRACT, V9, P129, DOI 10.4162/nrp.2015.9.2.129; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cowawintaweewat S, 2006, ASIAN PAC J ALLERGY, V24, P33; Cruijsen M, 2015, J CLIN MED, V4, P1, DOI 10.3390/jcm4010001; Daddaoua A, 2007, J NUTR, V137, P1222, DOI 10.1093/jn/137.5.1222; Daddaoua A, 2013, FOOD CHEM, V136, P1288, DOI 10.1016/j.foodchem.2012.09.039; Davis TA, 2000, J CLIN ONCOL, V18, P3135, DOI 10.1200/JCO.2000.18.17.3135; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dombret H, 2016, BLOOD, V127, P53, DOI 10.1182/blood-2015-08-604520; Estey E, 2015, BLOOD, V125, P2461, DOI 10.1182/blood-2015-01-561373; Fatehchand K, 2016, J BIOL CHEM; Ferrara F, 2013, LANCET, V381, P484, DOI 10.1016/S0140-6736(12)61727-9; Gao YF, 2006, CANCER IMMUNOL IMMUN, V55, P1258, DOI 10.1007/s00262-005-0111-9; Hangai S, 2013, J ALTERN COMPLEM MED, V19, P905, DOI 10.1089/acm.2012.0914; Hughes MA, 2009, MOL CELL, V35, P265, DOI 10.1016/j.molcel.2009.06.012; Ichim G, 2016, NAT REV CANCER, V16, P539, DOI 10.1038/nrc.2016.58; Ignacio RM, 2015, CYTOKINE, V76, P131, DOI 10.1016/j.cyto.2015.06.002; Ishizuka R., 2012, PERS MED U, V1, P39, DOI [DOI 10.1016/J.PMU.2012.05.006, 10.1016/j.pmu.2012.05.006]; Ito T, 2014, NUTR CANCER, V66, P377, DOI 10.1080/01635581.2014.884232; Kojima K, 2010, LEUKEMIA, V24, P33, DOI 10.1038/leu.2009.212; Lee WW, 2012, CELL IMMUNOL, V275, P19, DOI 10.1016/j.cellimm.2012.04.001; Lowenberg B, 2016, BLOOD, V127, P1, DOI 10.1182/blood-2015-10-662684; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Mallet JF, 2016, EUR J NUTR, V55, P139, DOI 10.1007/s00394-015-0832-2; Matsui Y, 2002, J HEPATOL, V37, P78, DOI 10.1016/S0168-8278(02)00091-0; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Matsushita K, 1998, ANTI-CANCER DRUG, V9, P343, DOI 10.1097/00001813-199804000-00008; McDonnell MA, 2003, CELL DEATH DIFFER, V10, P1005, DOI 10.1038/sj.cdd.4401271; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Nakao M, 1996, LEUKEMIA, V10, P1911; Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.3.CO;2-Q; PARIDA DK, 2011, INT J CLIN MED, V2, P588, DOI DOI 10.4236/IJCM.2011.25097; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Porter AG, 2006, NAT CHEM BIOL, V2, P509, DOI 10.1038/nchembio1006-509; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Ritz BW, 2006, J NUTR, V136, P2868, DOI 10.1093/jn/136.11.2868; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; Shigama Kota, 2009, J Exp Ther Oncol, V8, P43; Spierings ELH, 2007, J NUTR SCI VITAMINOL, V53, P536, DOI 10.3177/jnsv.53.536; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Tokunaga M, 2015, ANTICANCER RES, V35, P6063; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Vetvicka V, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.01.05; Wouters BJ, 2016, BLOOD, V127, P42, DOI 10.1182/blood-2015-07-604512; Yanagimoto H, 2016, NUTR CANCER, V68, P234, DOI 10.1080/01635581.2016.1134597	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181729	10.1371/journal.pone.0181729	http://dx.doi.org/10.1371/journal.pone.0181729			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727820	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500109
J	Weir, MC; Hellwig, S; Tan, L; Liu, Y; Gray, NS; Smithgall, TE				Weir, Mark C.; Hellwig, Sabine; Tan, Li; Liu, Yao; Gray, Nathanael S.; Smithgall, Thomas E.			Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; SMALL-MOLECULE INHIBITORS; THERAPEUTIC TARGET; DIFFERENTIATION; IDENTIFICATION; ANTAGONIST; EXPRESSION; MUTATIONS; FAMILY	Acute myelogenous leukemia (AML) is often associated with activating mutations in the receptor tyrosine kinase, Flt3, including internal tandem duplications (ITDs) within the regulatory juxtamembrane region. Previous studies have linked Flt3-ITD to the activation of the Fes protein tyrosine kinase in AML, and RNAi-knockdown studies suggest that Fes may be required for Flt3 function. In this study, we tested Fes inhibitors from three different chemical classes for their growth-suppressive activity against Flt3-ITD+ myeloid leukemia cell lines (MV4-11, MOLM-13 and MOLM-14) vs. myeloid cells with wild-type Flt3 (THP-1). All Fes inhibitors selectively inhibited the growth of Flt3-ITD+ AML cells, with IC50 values for diaminopyrimidine and pyrrolopyridine inhibitors ranging from 19 to 166 nM. In contrast, a pyrazolopyrimidine inhibitor was less potent in Flt3-ITD+ AML cells, with IC50 values in the 1.0 mu M range. In vitro kinase assays showed that the most potent inhibitors of Flt3-ITD+ AML cell proliferation blocked both Fes and Flt3-ITD kinase activity, while the pyrazolopyrimidine was more selective for Fes vs. Flt3-ITD. All three inhibitors induced significant apoptosis in Flt3ITD(+) AML cells, with potency equivalent to or greater than the established Flt3-ITD inhibitor, tandutinib. Transformation of TF-1 cells with Flt3-ITD resulted in constitutive activation of endogenous Fes, and rendered the cells highly sensitive to all three Fes inhibitors with IC50 values in the 30-500 nM range. The pyrrolopyridine compound also induced apoptotic responses in patient-derived Flt3-ITD+ AML bone marrow cells but not in normal bone marrow mononuclear cells. These results demonstrate that Fes kinase activity contributes to Flt3-ITD signaling in AML, and suggests that dual inhibition of both Flt3 and Fes may provide a therapeutic advantage for the treatment of Flt3-ITD+ AML.	[Weir, Mark C.; Hellwig, Sabine; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA; [Tan, Li; Liu, Yao; Gray, Nathanael S.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Tan, Li; Liu, Yao; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hellwig, Sabine] ARUP Labs, Salt Lake City, UT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Utah System of Higher Education; University of Utah; ARUP Laboratories	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	tsmithga@pitt.edu		Tan, Li/0000-0002-1199-9046; Hellwig, Sabine/0000-0002-9809-947X	National Cancer Institute of the National Institutes of Health [CA185702]; NATIONAL CANCER INSTITUTE [R21CA185702] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by the National Cancer Institute of the National Institutes of Health (grant number CA185702 to T.E.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey E, 2013, P NATL ACAD SCI USA, V110, P21113, DOI 10.1073/pnas.1310559110; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DeAngelo DJ, 2006, BLOOD, V108, P3674, DOI 10.1182/blood-2006-02-005702; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dos SC, 2013, BLOOD, V122, P1900; Dos SC, 2008, BLOOD, V111, P2269, DOI DOI 10.1182/BLOOD-2007-04-082099; Drexler HG, 2004, LEUKEMIA, V18, P227, DOI 10.1038/sj.leu.2403236; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Greer Peter A, 2012, Front Biosci (Schol Ed), V4, P489; Gu TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015640; Hellwig S, 2012, CHEM BIOL, V19, P529, DOI 10.1016/j.chembiol.2012.01.020; Hellwig S, 2011, FRONT BIOSCI-LANDMRK, V16, P3146, DOI 10.2741/3902; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; Kadia TM, 2016, ANN ONCOL, V27, P770, DOI 10.1093/annonc/mdw015; Kantarjian H, 2016, AM J HEMATOL, V91, P131, DOI 10.1002/ajh.24246; Kayser S, 2014, LEUKEMIA LYMPHOMA, V55, P243, DOI 10.3109/10428194.2013.800198; Kelly LM, 2002, CANCER CELL, V1, P421, DOI 10.1016/S1535-6108(02)00070-3; Khwaja A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.10; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Klco JM, 2013, BLOOD, V121, P1633, DOI 10.1182/blood-2012-09-459313; Konig H, 2015, EXPERT OPIN THER TAR, V19, P37, DOI 10.1517/14728222.2014.960843; Leischner H, 2012, BLOOD, V119, P4026, DOI 10.1182/blood-2011-07-365726; Okamoto M, 2007, LEUKEMIA, V21, P403, DOI 10.1038/sj.leu.2404547; Panjarian S, 2013, J BIOL CHEM, V288, P6116, DOI 10.1074/jbc.M112.431312; Pene-Dumitrescu T, 2008, ONCOGENE, V27, P7055, DOI 10.1038/onc.2008.330; Puissant A, 2014, CANCER CELL, V25, P226, DOI 10.1016/j.ccr.2014.01.022; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; Smithgall TE, 1998, CRIT REV ONCOGENESIS, V9, P43, DOI 10.1615/CritRevOncog.v9.i1.40; Takashima Y, 2003, BIOCHEMISTRY-US, V42, P3567, DOI 10.1021/bi0272499; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Voisset E, 2010, LEUKEMIA, V24, P721, DOI 10.1038/leu.2009.301; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181178	10.1371/journal.pone.0181178	http://dx.doi.org/10.1371/journal.pone.0181178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727840	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500043
J	Sallon, C; Callebaut, I; Boulay, I; Fontaine, J; Logeart-Avrannoglou, D; Henriquet, C; Pugniere, M; Cayla, X; Monget, P; Harichaux, G; Labas, V; Canepa, S; Taragnat, C				Sallon, Celine; Callebaut, Isabelle; Boulay, Ida; Fontaine, Joel; Logeart-Avrannoglou, Delphine; Henriquet, Corinne; Pugniere, Martine; Cayla, Xavier; Monget, Philippe; Harichaux, Gregoire; Labas, Valerie; Canepa, Syvie; Taragnat, Catherine			Thrombospondin-1 (TSP-1), a new bone morphogenetic protein-2 and-4 ( BMP-2/4) antagonist identified in pituitary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; DYNAMIC REGULATION; STATISTICAL-MODEL; ACTIVIN; HORMONE; GROWTH; INVOLVEMENT; SECRETION; FSH; ACTIVATION	Bone morphogenetic proteins (BMPs) regulate diverse cellular responses during embryogenesis and in adulthood including cell differentiation, proliferation, and death in various tissues. In the adult pituitary, BMPs participate in the control of hormone secretion and cell proliferation, suggesting a potential endocrine/paracrine role for BMPs, but some of the mechanisms are unclear. Here, using a bioactivity test based on embryonic cells (C3H10T1/2) transfected with a BMP-responsive element, we sought to determine whether pituitary cells secrete BMPs or BMP antagonists. Interestingly, we found that pituitary-conditioned medium contains a factor that inhibits action of BMP-2 and -4. Combining surface plasmon resonance and high-resolution mass spectrometry helped pinpoint this factor as thrombospondin-1 (TSP-1). Surface plasmon resonance and co-immunoprecipitation confirmed that recombinant human TSP-1 can bind BMP-2 and -4 and antagonize their effects on C3H10T1/2 cells. Moreover, TSP-1 inhibited the action of serum BMPs. We also report that the von Willebrand type C domain of TSP-1 is likely responsible for this BMP-2/4-binding activity, an assertion based on sequence similarity that TSP-1 shares with the von Willebrand type C domain of Crossveinless 2 (CV-2), a BMP antagonist and member of the chordin family. In summary, we identified for the first time TSP-1 as a BMP-2/-4 antagonist and presented a structural basis for the physical interaction between TSP-1 and BMP-4. We propose that TSP-1 could regulate bioavailability of BMPs, either produced locally or reaching the pituitary via blood circulation. In conclusion, our findings provide new insights into the involvement of TSP-1 in the BMP-2/-4 mechanisms of action.	[Sallon, Celine; Boulay, Ida; Fontaine, Joel; Cayla, Xavier; Monget, Philippe; Harichaux, Gregoire; Labas, Valerie; Canepa, Syvie; Taragnat, Catherine] Univ Tours, CNRS,Inst Natl Rech Agr, Inst Francais Cheval & Equitat,UMR85, Unite Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Callebaut, Isabelle] Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, CNRS, MNHN,IRD,IUC,UMR 7590, F-75005 Paris, France; [Logeart-Avrannoglou, Delphine] Univ Paris Diderot, CNRS, UMR 7052, Sorbonne Paris Cite,B2OA, F-75010 Paris, France; [Henriquet, Corinne; Pugniere, Martine] Univ Montpellier, Inst Rech Cancerol Montpellier, INSERM, ICM Inst Reg Canc,IRCM,U1194, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Taragnat, C (corresponding author), INRA, UMR Physiol Reprod & Comportements, F-37380 Nouzilly, France.	catherine.taragnat@inra.fr	PUGNIERE, Martine/AAD-4315-2020; Logeart-Avramoglou, Delphine/N-7390-2017; Pugniere, Martine/T-1355-2017	PUGNIERE, Martine/0000-0002-2049-2909; Logeart-Avramoglou, Delphine/0000-0002-2052-9425; Pugniere, Martine/0000-0002-2049-2909	Institut National de Recherche Agronomique; French "Region Centre"; Ministere de la Recherche et de la Technologie	Institut National de Recherche Agronomique; French "Region Centre"(Region Centre-Val de Loire); Ministere de la Recherche et de la Technologie	This work was supported by Institut National de Recherche Agronomique and the French "Region Centre." The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ph.D. fellowship from the Ministere de la Recherche et de la Technologie.	Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; CARROLL RS, 1991, ENDOCRINOLOGY, V129, P3299, DOI 10.1210/endo-129-6-3299; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; Faure MO, 2005, J ENDOCRINOL, V186, P109, DOI 10.1677/joe.1.05988; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Giacomini D, 2006, ENDOCRINOLOGY, V147, P247, DOI 10.1210/en.2005-0958; Giacomini D, 2009, MOL ENDOCRINOL, V23, P1102, DOI 10.1210/me.2008-0425; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Huang HJ, 2001, ENDOCRINOLOGY, V142, P2275, DOI 10.1210/en.142.6.2275; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lee KB, 2007, J MOL ENDOCRINOL, V38, P315, DOI 10.1677/jme.1.02196; Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicol L, 2008, J ENDOCRINOL, V196, P497, DOI 10.1677/jOE-07-0542; Nudi M, 2005, MOL ENDOCRINOL, V19, P1329, DOI 10.1210/me.2004-0425; Otsuka F, 2002, ENDOCRINOLOGY, V143, P4938, DOI 10.1210/en.2002-220929; Otsuka F, 2013, ACTA MED OKAYAMA, V67, P75; Otsuka F, 2010, ENDOCR J, V57, P3, DOI 10.1507/endocrj.K09E-310; Paez-Pereda M, 2003, P NATL ACAD SCI USA, V100, P1034, DOI 10.1073/pnas.0237312100; Pardali E, 2012, INT J BIOL SCI, V8, P195, DOI [10.7150/ijbs.8.195, 10.7150/ijbs.3805]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012; Sallon C, 2010, J ENDOCRINOL, V207, P55, DOI 10.1677/JOE-10-0035; Sarkar AJ, 2007, J ENDOCRINOL, V192, P395, DOI 10.1677/joe.1.06925; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Song KN, 2010, J BIOL CHEM, V285, P12169, DOI 10.1074/jbc.M109.087197; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Tsukamoto N, 2011, MOL CELL ENDOCRINOL, V332, P163, DOI 10.1016/j.mce.2010.10.008; Vailhe B, 2003, CURR PHARM DESIGN, V9, P583, DOI 10.2174/1381612033391342; Recouvreux MV, 2012, ENDOCRINOLOGY, V153, P3861, DOI 10.1210/en.2012-1007; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6; WEISS J, 1992, ENDOCRINOLOGY, V131, P1403, DOI 10.1210/en.131.3.1403; WEISS J, 1995, ENDOCRINOLOGY, V136, P1885, DOI 10.1210/en.136.5.1885; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Ye L, 2016, CANCER LETT, V380, P586, DOI 10.1016/j.canlet.2015.10.036; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young JM, 2008, J ENDOCRINOL, V196, P251, DOI 10.1677/JOE-07-0148; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017; Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	56	5	5	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15352	15368		10.1074/jbc.M116.736207	http://dx.doi.org/10.1074/jbc.M116.736207			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747434	Green Published, hybrid			2022-12-26	WOS:000410809800017
J	Lobo, GP; Fulmer, D; Guo, LL; Zuo, XF; Dang, YJ; Kim, SH; Su, YH; George, K; Obert, E; Ben Fogelgren; Nihalani, D; Norris, RA; Rohrer, B; Lipschutz, JH				Lobo, Glenn P.; Fulmer, Diana; Guo, Lilong; Zuo, Xiaofeng; Dang, Yujing; Kim, Seok-Hyung; Su, Yanhui; George, Kola; Obert, Elisabeth; Ben Fogelgren; Nihalani, Deepak; Norris, Russell A.; Rohrer, Barbel; Lipschutz, Joshua H.			The exocyst is required for photoreceptor ciliogenesis and retinal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY CILIA; ZEBRAFISH; RHODOPSIN; TRANSPORT; PROTEINS; GOLGI; CDC42; RAB8; DEGENERATION; CILIOPATHY	We previously have shown that the highly conserved eightprotein exocyst trafficking complex is required for ciliogenesis in kidney tubule cells. We hypothesized here that ciliogenic programs are conserved across organs and species. To determine whether renal primary ciliogenic programs are conserved in the eye, and to characterize the function and mechanisms by which the exocyst regulates eye development in zebrafish, we focused on exoc5, a central component of the exocyst complex, by analyzing both exoc5 zebrafish mutants, and photoreceptorspecific Exoc5 knock-out mice. Two separate exoc5 mutant zebrafish lines phenocopied exoc5 morphants and, strikingly, exhibited a virtual absence of photoreceptors, along with abnormal retinal development and cell death. Because the zebrafish mutant was a global knockout, we also observed defects in several ciliated organs, including the brain (hydrocephalus), heart (cardiac edema), and kidney (disordered and shorter cilia). exoc5 knockout increased phosphorylation of the regulatory protein Mob1, consistent with Hippo pathway activation. exoc5 mutant zebrafish rescue with human EXOC5 mRNA completely reversed the mutant phenotype. We accomplished photoreceptor-specific knockout of Exoc5 with our Exoc5 fl/fl mouse line crossed with a rhodopsin-Cre driver line. In Exoc5 photoreceptor-specific knock-out mice, the photoreceptor outer segment structure was severely impaired at 4 weeks of age, although a full-field electroretinogram indicated a visual response was still present. However, by 6 weeks, visual responses were eliminated. In summary, we show that ciliogenesis programs are conserved in the kidneys and eyes of zebrafish and mice and that the exocyst is necessary for photoreceptor ciliogenesis and retinal development, most likely by trafficking cilia and outer-segment proteins.	[Lobo, Glenn P.; Fulmer, Diana; Guo, Lilong; Zuo, Xiaofeng; Dang, Yujing; Kim, Seok-Hyung; Su, Yanhui; George, Kola; Nihalani, Deepak; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Lobo, Glenn P.; Obert, Elisabeth; Rohrer, Barbel] Med Univ South Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Fulmer, Diana; Guo, Lilong; Norris, Russell A.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Ben Fogelgren] Univ Hawaii Manoa, Dept Anat Biochem & Physiol, Honolulu, HI 96813 USA; [Rohrer, Barbel] Ralph H Johnson Vet Affairs Med Ctr, Div Res, Charleston, SC 29401 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Hawaii System; University of Hawaii Manoa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Lipschutz, JH (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,CSB 829, Charleston, SC 29425 USA.	lipschut@musc.edu	nihalani, deepak/AAK-9453-2020; Guo, Lilong/AAJ-8492-2021; GUO, LILONG/AAH-7104-2019; Lobo, Glenn P./AAI-9736-2020	Guo, Lilong/0000-0001-9376-3274; Fulmer, Diana/0000-0001-7675-9951	National Institutes of Health [P30DK074038]; NATIONAL EYE INSTITUTE [R21EY025034, R01EY024581] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131546, R01HL127692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444, P20GM103457] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444, I01BX000820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The UAB P30 Hepatorenal Fibrocystic Disease Core Center (supported by National Institutes of Health Grant P30DK074038) is gratefully acknowledged for generating the second exoc5 zebrafish mutant line using CRISPR gene editing, as well as for previously generating the Exoc5fl/fl mouse line.	Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Bachmann-Gagescu R, 2011, HUM MOL GENET, V20, P4041, DOI 10.1093/hmg/ddr332; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Baye LM, 2011, HUM MOL GENET, V20, P1467, DOI 10.1093/hmg/ddr025; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Choi SY, 2015, INVEST OPHTH VIS SCI, V56, P3361, DOI 10.1167/iovs.14-15692; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; DERETIC D, 1993, J CELL SCI, V106, P803; DERETIC D, 1995, J CELL SCI, V108, P215; Dixon-Salazar TJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003544; Fogelgren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129346; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Fruhmesser A, 2013, EUR J HUM GENET, V21, P1177, DOI 10.1038/ejhg.2013.18; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; Happe H, 2011, J PATHOL, V224, P133, DOI 10.1002/path.2856; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Luna G, 2016, INVEST OPHTH VIS SCI, V57, P4641, DOI 10.1167/iovs.15-19044; Luo N, 2012, VISION RES, V75, P98, DOI 10.1016/j.visres.2012.09.011; Meire F, 2011, MOL VIS, V17, P2072; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novick P, 2002, TRENDS CELL BIOL, V12, P247, DOI 10.1016/S0962-8924(02)02293-6; Rogers KK, 2004, BIOCHEM BIOPH RES CO, V319, P138, DOI 10.1016/j.bbrc.2004.04.165; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Smyth BJ, 2003, INT REV CYTOL, V231, P51, DOI 10.1016/S0074-7696(03)31002-2; Stoetzel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13586; Sukumaran S, 2009, VISION RES, V49, P479, DOI 10.1016/j.visres.2008.12.009; Tsujikawa M, 2004, INT J DEV BIOL, V48, P925, DOI 10.1387/ijdb.041890mt; Wen J, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-100; Woodell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067894; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	45	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14814	14826		10.1074/jbc.M117.795674	http://dx.doi.org/10.1074/jbc.M117.795674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729419	Green Published, hybrid			2022-12-26	WOS:000409902100010
J	Omoyinmi, E; Standing, A; Keylock, A; Price-Kuehne, F; Gomes, SM; Rowczenio, D; Nanthapisal, S; Cullup, T; Nyanhete, R; Ashton, E; Murphy, C; Clarke, M; Ahlfors, H; Jenkins, L; Gilmour, K; Eleftheriou, D; Lachmann, HJ; Hawkins, PN; Klein, N; Brogan, PA				Omoyinmi, Ebun; Standing, Ariane; Keylock, Annette; Price-Kuehne, Fiona; Gomes, Sonia Melo; Rowczenio, Dorota; Nanthapisal, Sira; Cullup, Thomas; Nyanhete, Rodney; Ashton, Emma; Murphy, Claire; Clarke, Megan; Ahlfors, Helena; Jenkins, Lucy; Gilmour, Kimberly; Eleftheriou, Despina; Lachmann, Helen J.; Hawkins, Philip N.; Klein, Nigel; Brogan, Paul A.			Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis	PLOS ONE			English	Article							WISKOTT-ALDRICH-SYNDROME; ARTICULAR SYNDROME; SOMATIC MOSAICISM; DISEASE; MUTATIONS; VARIANTS; AUTOIMMUNITY; DEFECTS; IMMUNODEFICIENCY; THROMBOCYTOPENIA	Background Monogenic autoinflammatory diseases (AID) are a rapidly expanding group of genetically diverse but phenotypically overlapping systemic inflammatory disorders associated with dysregulated innate immunity. They cause significant morbidity, mortality and economic burden. Here, we aimed to develop and evaluate the clinical impact of a NGS targeted gene panel, the "Vasculitis and Inflammation Panel" (VIP) for AID and vasculitis. Methods The Agilent Sure Design tool was used to design 2 versions of VIP; VIP1 targeting 113 genes, and a later version, VIP2, targeting 166 genes. Captured and indexed libraries (QXT Target Enrichment System) prepared for 72 patients were sequenced as a multiplex of 16 samples on an Illumina MiSeq sequencer in 150bp paired-end mode. The cohort comprised 22 positive control DNA samples from patients with previously validated mutations in a variety of the genes; and 50 prospective samples from patients with suspected AID in whom previous Sanger based genetic screening had been non-diagnostic. Results VIP was sensitive and specific at detecting all the different types of known mutations in 22 positive controls, including gene deletion, small INDELS, and somatic mosaicism with allele fraction as low as 3%. Six/50 patients (12%) with unclassified AID had at least one class 5 (clearly pathogenic) variant; and 11/50 (22%) had at least one likely pathogenic variant (class 4). Overall, testing with VIP resulted in a firm or strongly suspected molecular diagnosis in 16/50 patients (32%). Conclusions The high diagnostic yield and accuracy of this comprehensive targeted gene panel validate the use of broad NGS-based testing for patients with suspected AID.	[Omoyinmi, Ebun; Standing, Ariane; Keylock, Annette; Price-Kuehne, Fiona; Gomes, Sonia Melo; Nanthapisal, Sira; Murphy, Claire; Clarke, Megan; Eleftheriou, Despina; Klein, Nigel; Brogan, Paul A.] UCL Great Ormond St Inst Child Hlth ICH, London, England; [Rowczenio, Dorota; Lachmann, Helen J.; Hawkins, Philip N.] UCL, NAC, Royal Free Campus, London, England; [Cullup, Thomas; Nyanhete, Rodney; Ashton, Emma; Ahlfors, Helena; Jenkins, Lucy] GOSH NHS Fdn Trust, NE Thames Reg Genet Lab, London, England; [Gilmour, Kimberly] Great Ormond St Hosp NHS Fdn Trust, Immunol, London, England; [Eleftheriou, Despina] UCL, UCLH, Arthrit Res UK Ctr Adolescent Rheumatol, London, England; [Eleftheriou, Despina] GOSH, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Omoyinmi, E (corresponding author), UCL Great Ormond St Inst Child Hlth ICH, London, England.	e.omoyinmi@ucl.ac.uk	Nanthapisal, Sira/ABD-7818-2021	Nanthapisal, Sira/0000-0003-3196-4657; Omoyinmi, Ebun/0000-0002-3042-3827; Lachmann, Helen/0000-0001-8378-2498; Brogan, Paul/0000-0001-6178-6893; Ahlfors, Helena/0000-0002-8183-0895; Klein, Nigel/0000-0003-3925-9258; Standing, Ariane/0000-0002-7178-4274	Rosetrees Trust; Swedish Orphan Biovitrum (SOBI); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; National Institute for Health Research (NIHR); Rosetrees Trust [M465, M8-F2-CD1, M8-F1-CD1] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [W1122] Funding Source: researchfish	Rosetrees Trust(Rosetrees Trust); Swedish Orphan Biovitrum (SOBI); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); Great Ormond Street Hospital Childrens Charity	This work was funded in part from institutional grants from Rosetrees Trust and Swedish Orphan Biovitrum (SOBI) and supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	[Anonymous], 2015, J ALLERGY CLIN IMMUN, V136, P484, DOI 10.1016/j.jaci.2014.12.1941; Arostegui JI, 2010, ARTHRITIS RHEUM-US, V62, P1158, DOI 10.1002/art.27342; Baudhuin LM, 2015, J MOL DIAGN, V17, P456, DOI 10.1016/j.jmoldx.2015.03.004; Browning MJ, 2015, J MED GENET, V52, P856, DOI 10.1136/jmedgenet-2015-103266; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Chin ELH, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-6; De Jesus AA, 2014, PEDIAT RHEUMATOL ONL, V12, pO25; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; Dupuis-Girod S, 2003, PEDIATRICS, V111, pE622, DOI 10.1542/peds.111.5.e622; Heindl M, 2012, GASTROENTEROLOGY, V142, P1093, DOI 10.1053/j.gastro.2012.01.011; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; House IG, 2015, IMMUNOL CELL BIOL, V93, P575, DOI 10.1038/icb.2015.1; Izawa K, 2012, DNA RES, V19, P143, DOI 10.1093/dnares/dsr047; Kammermeier J, 2014, J MED GENET, V51, P748, DOI 10.1136/jmedgenet-2014-102624; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kim DK, 2005, DIS COLON RECTUM, V48, P1714, DOI 10.1007/s10350-005-0130-9; Kroese M, 2007, EUR J HUM GENET, V15, P917, DOI 10.1038/sj.ejhg.5201867; Kroese M, 2010, PUBLIC HEALTH GENOM, V13, P538, DOI 10.1159/000294278; Lachmann HJ, 2014, ANN RHEUM DIS, V73, P2160, DOI 10.1136/annrheumdis-2013-204184; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li P, 2016, CLIN REV ALLERG IMMU, V50, P55, DOI 10.1007/s12016-015-8466-y; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Meeths M, 2014, EXP CELL RES, V325, P10, DOI 10.1016/j.yexcr.2014.03.014; Mensa-Vilaro A, 2016, ARTHRITIS RHEUMATOL, V68, P1039, DOI 10.1002/art.39519; Moat Stuart J, 2004, Hum Mutat, V23, P206, DOI 10.1002/humu.9214; Nakagawa K, 2015, ANN RHEUM DIS, V74, P603, DOI 10.1136/annrheumdis-2013-204361; Nanthapisal S, 2016, ARTHRITIS RHEUMATOL, V68, P2314, DOI 10.1002/art.39699; Omoyinmi E, 2014, ARTHRITIS RHEUMATOL, V66, P197, DOI 10.1002/art.38217; Pathak S, 2016, J CLIN PATHOL; Ravet N, 2006, ANN RHEUM DIS, V65, P1158, DOI 10.1136/ard.2005.048611; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rowczenio DM, 2016, ARTHRITIS RHEUMATOL, V68, P2044, DOI 10.1002/art.39683; Rowczenio DM, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4171; Rusmini M, 2016, ANN RHEUM DIS, V75, P1550, DOI 10.1136/annrheumdis-2015-207701; Russo RAG, 2014, RHEUMATOLOGY, V53, P1927, DOI 10.1093/rheumatology/keu170; Slavova-Azmanova NS, 2013, BLOOD, V122, P262, DOI 10.1182/blood-2012-10-463158; Standing A, 2014, PEDIATR RHEUMATOL, V12, P1; Standing ASI, 2017, J EXP MED, V214, P59, DOI 10.1084/jem.20161228; Stoffels M, 2016, ANNU REV GENOM HUM G, V17, P245, DOI 10.1146/annurev-genom-090413-025334; Tanaka N, 2011, ARTHRITIS RHEUM-US, V63, P3625, DOI 10.1002/art.30512; van El CG, 2013, EUR J HUM GENET, V21, P580, DOI 10.1038/ejhg.2013.46; Wallis Y., 2013, PRACTICE GUIDELINES; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang KJ, 2014, BLOOD, V124, P1331, DOI 10.1182/blood-2014-05-573105; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	47	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181874	10.1371/journal.pone.0181874	http://dx.doi.org/10.1371/journal.pone.0181874			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750028	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700095
J	Yi, BN; Jahangir, A; Evans, AK; Briggs, D; Ravina, K; Ernest, J; Farimani, AB; Sun, WC; Rajadas, J; Green, M; Feinberg, EN; Pande, VS; Shamloo, M				Yi, Bitna; Jahangir, Alam; Evans, Andrew K.; Briggs, Denise; Ravina, Kristine; Ernest, Jacqueline; Farimani, Amir B.; Sun, Wenchao; Rajadas, Jayakumar; Green, Michael; Feinberg, Evan N.; Pande, Vijay S.; Shamloo, Mehrdad			Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; B-MEDIATED TRANSCRIPTION; ALZHEIMERS-DISEASE; MOUSE MODEL; 7-TRANSMEMBRANE RECEPTORS; FUNCTIONAL SELECTIVITY; INTERFERON-GAMMA; MICE; ACTIVATION; INHIBITION	The beta-1 adrenergic receptor (ADRB1) is a promising therapeutic target intrinsically involved in the cognitive deficits and pathological features associated with Alzheimer's disease (AD). Evidence indicates that ADRB1 plays an important role in regulating neuroinflammatory processes, and activation of ADRB1 may produce neuroprotective effects in neuroinflammatory diseases. Novel small molecule modulators of ADRB1, engineered to be highly brain permeable and functionally selective for the G protein with partial agonistic activity, could have tremendous value both as pharmacological tools and potential lead molecules for further preclinical development. The present study describes our ongoing efforts toward the discovery of functionally selective partial agonists of ADRB1 that have potential therapeutic value for AD and neuroinflammatory disorders, which has led to the identification of the molecule STD-101-D1. As a functionally selective agonist of ADRB1, STD-101-D1 produces partial agonistic activity on G protein signaling with an EC50 value in the low nanomolar range, but engages very little beta-arrestin recruitment compared to the unbiased agonist isoproterenol. STD-101-D1 also inhibits the tumor necrosis factor alpha (TNF alpha) response induced by lipopolysaccharide (LPS) both in vitro and in vivo, and shows high brain penetration. Other than the therapeutic role, this newly identified, functionally selective, partial agonist of ADRB1 is an invaluable research tool to study mechanisms of G protein-coupled receptor signal transduction.	[Yi, Bitna; Jahangir, Alam; Evans, Andrew K.; Briggs, Denise; Ravina, Kristine; Ernest, Jacqueline; Green, Michael; Shamloo, Mehrdad] Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; [Farimani, Amir B.; Feinberg, Evan N.; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Sun, Wenchao; Rajadas, Jayakumar] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University	Shamloo, M (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA.	mshamloo@stanford.edu	evans, andrew k/A-7143-2012; Pande, Vijay/ABE-8145-2020; Rajadas, Jayakumar/AHC-0630-2022; Farimani, Amir Barati/K-4601-2019; Sun, Wenchao/H-7738-2017	Sun, Wenchao/0000-0003-4306-2896; Rajadas, Jayakumar/0000-0001-6520-3923; Ravina, Kristine/0000-0002-0927-5719; Evans, Andrew/0000-0003-2986-6476; Briggs, Denise/0000-0002-4824-3947	National Institute of Neurological Disorders and Stroke [NS069375, NS097945]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present study was supported by the National Institute of Neurological Disorders and Stroke (NS069375 and NS097945; MS) (https:// www.ninds.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2011, P NATL ACAD SCI USA, V108, P18488, DOI 10.1073/pnas.1104807108; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; ANG EL, 1990, BRIT HEART J, V64, P256; Ardestani PM, 2017, NEUROPHARMACOLOGY, V116, P371, DOI 10.1016/j.neuropharm.2017.01.010; BASTAIN W, 1988, EUR J CLIN PHARMACOL, V34, P469, DOI 10.1007/BF01046704; Berg KA, 1998, ANN NY ACAD SCI, V861, P104, DOI 10.1111/j.1749-6632.1998.tb10180.x; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Blasko I, 1997, NEUROSCI LETT, V238, P17, DOI 10.1016/S0304-3940(97)00845-8; Breivogel CS, 2008, BEHAV PHARMACOL, V19, P298, DOI 10.1097/FBP.0b013e328308f1e6; BYLUND DB, 1994, PHARMACOL REV, V46, P121; Coutellier L, 2014, ANN CLIN TRANSL NEUR, V1, P348, DOI 10.1002/acn3.57; Cruickshank John M, 2010, Indian Heart J, V62, P101; De Luca A, 1997, RIV BIOL-BIOL FORUM, V90, P371; Faizi M, 2011, NEUROBIOL DIS, V43, P397, DOI 10.1016/j.nbd.2011.04.011; Feinstein DL, 2002, NEUROCHEM INT, V41, P357, DOI 10.1016/S0197-0186(02)00049-9; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; Frishman WH, 2013, J CARDIOVASC PHARM T, V18, P310, DOI 10.1177/1074248413484986; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; GORMAN AL, 1993, PHARMACOL BIOCHEM BE, V45, P1; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Guirao X, 1997, AM J PHYSIOL-ENDOC M, V273, pE1203, DOI 10.1152/ajpendo.1997.273.6.E1203; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HETIER E, 1991, EXP BRAIN RES, V86, P407; Janelsins MC, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-23; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kuo LH, 2008, MOL BIOL CELL, V19, P4201, DOI 10.1091/mbc.E07-09-0987; KUSIAK JW, 1987, BIOCHEM PHARMACOL, V36, P269, DOI 10.1016/0006-2952(87)90700-3; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Ma SL, 2004, NEUROLOGY, V62, P307, DOI 10.1212/01.WNL.0000103288.49441.E4; Madrigal JLM, 2005, J NEUROSCI RES, V81, P390, DOI 10.1002/jnr.20481; Madrigal JLM, 2009, J NEUROSCI, V29, P263, DOI 10.1523/JNEUROSCI.4926-08.2009; Markus T, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-94; McAlpine FE, 2009, NEUROBIOL DIS, V34, P163, DOI 10.1016/j.nbd.2009.01.006; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Moller D, 2014, J MED CHEM, V57, P4861, DOI 10.1021/jm5004039; Murakami Tsuyoshi, 2003, Drug Metab Pharmacokinet, V18, P252, DOI 10.2133/dmpk.18.252; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Ogawa S, 2016, BIOORG MED CHEM LETT, V26, P2446, DOI 10.1016/j.bmcl.2016.03.110; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Parry GCN, 1997, J IMMUNOL, V159, P5450; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Strubbe JH, 1999, PHYSIOL BEHAV, V65, P885; Suzuki A, 2011, J NEUROSCI, V31, P8786, DOI 10.1523/JNEUROSCI.3257-10.2011; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wall EA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000202; WALLER DG, 1989, EUR HEART J, V10, P1003, DOI 10.1093/oxfordjournals.eurheartj.a059412; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378; Yoshimura T, 1997, PHARMACOLOGY, V54, P144, DOI 10.1159/000139481; Zhou L, 2013, J BIOL CHEM, V288, P36703, DOI 10.1074/jbc.M113.504381	64	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180319	10.1371/journal.pone.0180319	http://dx.doi.org/10.1371/journal.pone.0180319			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746336	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800010
J	Lin, GR; Sun, FL; Wang, CZ; Zhang, L; Zhang, XZ				Lin, Guorong; Sun, Fulin; Wang, Chunzhong; Zhang, Li; Zhang, Xinzhong			Assessment of the effect of Enteromorpha prolifera on bacterial community structures in aquaculture environment	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; MACROALGAL BLOOMS; PROBIOTIC BACTERIA; ROSEOBACTER CLADE; GENOME SEQUENCE; ULVA-LACTUCA; SP NOV.; ACTINOBACTERIA; MICROORGANISMS; DECOMPOSITION	In recent years, Enteromorpha prolifera blooms had serious impacts on costal environments and fisheries in China. Nevertheless, the effects of E. prolifera on microbial ecology remain unknown. In this study, for the first time, an Illumina sequencing analysis was used to investigate bacterial communities in source water, aquaculture ponds with E. prolifera, and an aquaculture pond in which E. prolifera -free. Principal coordinate and phylogenic analyses revealed obvious differences among the bacterial communities in the pond water with and without E. prolifera. Abundant bacterial taxa in the E. prolifera-containing pond were generally absent from the pond without E. prolifera. Interestingly, pond water with E. prolifera was dominated by Actinomycetales (> 50%), as well as by anaerobic bacteria in the underlying sediment (Desulfobacterales and Desulfuromonadales (> 20%). Pond water in which E. prolifera-free was dominated by Rhodobacterales (58.19%), as well as aerobic and facultative anaerobic bacteria in the sediment. In addition, the ecological functions of other dominant bacteria, such as Candidatus Aquiluna, Microcella spp., and Marivita spp., should be studied in depth. Overall, massive growth of E. prolifera will have serious effects on bacterial communities, and, thus, it will have an important impact on the environment. The novel findings in this study will be valuable for understanding green tides.	[Lin, Guorong] Putian Univ, Fujian Prov Key Lab Ecol Toxicol Effects & Contro, Coll Environm & Biol Engn, Putian, Peoples R China; [Sun, Fulin] Chinese Acad Sci, South China Sea Inst Oceanol, Daya Bay Marine Biol Res Stn, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Wang, Chunzhong] Putian Inst Aquaculture Sci Fujian Prov, Putian, Peoples R China; [Zhang, Li] Putian Ocean & Fishery Enviormental Monitoring St, Putian, Peoples R China; [Zhang, Xinzhong] Nantong Univ, Sch Life Sci, Nantong, Peoples R China	Putian University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Nantong University	Sun, FL (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, Daya Bay Marine Biol Res Stn, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China.	flsun@scsio.ac.cn			Project of Guangdong Science and Technology Department [2016A020221024, 2017A020216008]; Project of Fujian Science and Technology Department [2015N0013, 201611002]; National Natural Science Foundation of China [41406130]; national Spark Program project [2015GA720002]; Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration [201507]; Chinese Academy of Sciences [SQ201220]; Science and Technology plan project of Nantong city [MS12016058]	Project of Guangdong Science and Technology Department; Project of Fujian Science and Technology Department; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national Spark Program project; Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration; Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology plan project of Nantong city	This research was supported by the Project of Guangdong Science and Technology Department (2016A020221024 and 2017A020216008), the Project of Fujian Science and Technology Department (2015N0013 and 201611002), the National Natural Science Foundation of China (41406130), the national Spark Program project (2015GA720002), the Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration (201507), the Knowledge Innovation Program of the Chinese Academy of Sciences (SQ201220), and Science and Technology plan project of Nantong city (MS12016058).	Asami H, 2005, APPL ENVIRON MICROB, V71, P2925, DOI 10.1128/AEM.71.6.2925-2933.2005; BALKWILL DL, 1989, GEOMICROBIOL J, V7, P33, DOI 10.1080/01490458909377848; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Cardona E, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0770-z; China, 2008, OCEAN NEWS; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Corzo A, 2009, MAR ECOL PROG SER, V380, P81, DOI 10.3354/meps07923; Crab R, 2007, AQUACULTURE, V270, P1, DOI 10.1016/j.aquaculture.2007.05.006; DENHARTOG C, 1994, AQUAT BOT, V47, P21, DOI 10.1016/0304-3770(94)90045-0; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Garrity GM, 2006, BERGEYS MANUAL SYSTE, P575; Gatesoupe FJ, 1999, AQUACULTURE, V180, P147, DOI 10.1016/S0044-8486(99)00187-8; Gomez-Consarnau L, 2012, ENVIRON MICROBIOL, V14, P2361, DOI 10.1111/j.1462-2920.2012.02804.x; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P112, DOI 10.1099/ijs.0.001743-0; Hjelm M, 2004, SYST APPL MICROBIOL, V27, P360, DOI 10.1078/0723-2020-00256; Hu C. M, 2010, J GEOPHYS RES OCEANS, V115; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kang I, 2012, J BACTERIOL, V194, P3550, DOI 10.1128/JB.00586-12; Kondo R, 2012, MICROBES ENVIRON, V27, P193, DOI 10.1264/jsme2.ME11278; Lachnit T, 2009, AQUAT BIOL, V5, P181, DOI 10.3354/ab00149; Lenk S, 2012, ISME J, V6, P2178, DOI 10.1038/ismej.2012.66; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu Y, 2016, BIORESOURCE TECHNOL, V206, P9, DOI 10.1016/j.biortech.2016.01.066; Lomstein BA, 2006, AQUAT BOT, V85, P271, DOI 10.1016/j.aquabot.2006.05.006; Ludwig W, 2010, TAXONOMIC OUTLINES P, P21; Microcella Verissimo A., 2015, BERGEYS MANUAL SYSTE; Morand P, 2005, J COASTAL RES, V21, P1009, DOI 10.2112/04-700A.1; Moriarty DJW, 1997, AQUACULTURE, V151, P333, DOI 10.1016/S0044-8486(96)01487-1; Nedergaard RI, 2002, J EXP MAR BIOL ECOL, V275, P15, DOI 10.1016/S0022-0981(02)00211-3; Nelson TA, 2008, ECOLOGY, V89, P1287, DOI 10.1890/07-0494.1; Norkko A, 1996, MAR ECOL PROG SER, V131, P143, DOI 10.3354/meps131143; Osterholz H, 2016, ISME J, V10, P1717, DOI 10.1038/ismej.2015.231; PREGNALL AM, 1983, MAR BIOL, V73, P37, DOI 10.1007/BF00396283; Romero M, 2010, FEMS MICROBIOL LETT, V304, P131, DOI 10.1111/j.1574-6968.2009.01889.x; Seyedsayamdost MR, 2011, NAT CHEM, V3, P331, DOI [10.1038/nchem.1002, 10.1038/NCHEM.1002]; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; SUNDBACK K, 1990, MAR ECOL PROG SER, V58, P261; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Voget S, 2015, ISME J, V9, P371, DOI 10.1038/ismej.2014.134; Wang CZ, 2014, FISHERIES SCI, V80, P1001, DOI 10.1007/s12562-014-0765-3; Wang YX, 2013, INT J SYST EVOL MICR, V63, P2907, DOI 10.1099/ijs.0.043869-0; WEISSE T, 1990, LIMNOL OCEANOGR, V35, P781, DOI 10.4319/lo.1990.35.4.0781; Yoon JH, 2013, INT J SYST EVOL MICR, V63, P423, DOI 10.1099/ijs.0.039065-0; Zhang XZ, 2011, J FISH BIOL, V79, P178, DOI 10.1111/j.1095-8649.2011.03012.x	47	22	22	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0179792	10.1371/journal.pone.0179792	http://dx.doi.org/10.1371/journal.pone.0179792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742878	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000006
J	Shoji, T; Kuroda, H; Suzuki, M; Ibuki, H; Araie, M; Yoneya, S				Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Ibuki, Hisashi; Araie, Makoto; Yoneya, Shin			Glaucomatous changes in lamina pores shape within the lamina cribrosa using wide bandwidth, femtosecond mode-locked laser OCT	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; NERVE DAMAGE; VISUAL-FIELD; SD-OCT; THICKNESS; EYES; DISPLACEMENT; MORPHOMETRY	Purpose The lamina cribrosa (LC) is known to play a critical role in the pathogenesis of glaucoma. Although it has been reported that striae-shaped or slit-shaped lamina pores are more frequent in eyes with primary open angle glaucoma (POAG), this observation is based only on fundus photography. The primary object of this study is to perform layer-by-layer comparisons of the shape of lamina pores within the LC in vivo. Design Cross-sectional study. Methods Optic nerve head B-scans were obtained using custom-made broad-wavelength optical coherence tomography with a mode-locked laser. A total of 300 single B-scans per eye were obtained and three-dimensional images were rendered from these image sequences to obtain 2-mu m thin-slice en face images of the LC. Elongation indices (EIs) of the lamina pores were measured from the anterior surface (AS) of the LC to the deeper layers in 40-mu m increments. Results Thirteen eyes from 10 primary open angle glaucoma (POAG) patients of mean deviation - 15.2 (- 16.5, -12.9) (median [25,75 percentile]) dB and 10 eyes from 7 normal controls were studied. Although the EI value was not significantly different between the superior, temporal and inferior regions of the LC at any depth level in either group, it was greater at the AS than at the 40 mu m and 80 mu m depth levels (P <.001) in both groups, and was greater in the POAG group only at the AS and 40 mu m depth level ( P <=.05). After adjustment for age and refraction, the effects of depth and presence of POAG on the EI value remained significant. Also, the severity of glaucoma and depth were significant factors associated with EI in multivariate analysis. Conclusions Elongation of lamina pores was significantly more evident at the anterior surface and the 40mdepth level of the LC in POAG eyes than in normal eyes, suggesting that nerve fiber bundles passing through the LC were under greater stress in the anterior layers of the LC.	[Shoji, Takuhei; Ibuki, Hisashi; Araie, Makoto; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Saitama, Japan; [Shoji, Takuhei; Kuroda, Hiroto; Suzuki, Masayuki; Yoneya, Shin] Saitama Med Univ, Dept Ophthalmol, Adv Laser Med Ctr, Saitama, Japan; [Araie, Makoto] Kanto Cent Hosp, Dept Ophthalmol, Tokyo, Japan; [Kuroda, Hiroto; Suzuki, Masayuki] Aichi Med Univ, Fac Med, Tokyo, Japan	Saitama Medical University; Saitama Medical University; Aichi Medical University	Shoji, T (corresponding author), Saitama Med Univ, Dept Ophthalmol, Saitama, Japan.; Shoji, T (corresponding author), Saitama Med Univ, Dept Ophthalmol, Adv Laser Med Ctr, Saitama, Japan.	shoojii@gmail.com	Shoji, Takuhei/W-1856-2017	Shoji, Takuhei/0000-0002-5464-2573	Takeda Science Foundation, Tokyo, Japan; Saitama Medical University Hospital; Japan Society for the Promotion of Science (JSPS); KAKENHI [25870678, 15K04699, 15K21335, 16KK0208]; Grants-in-Aid for Scientific Research [15K21335] Funding Source: KAKEN	Takeda Science Foundation, Tokyo, Japan(Takeda Science Foundation (TSF)); Saitama Medical University Hospital; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Takeda Science Foundation, Tokyo, Japan, Grant-in-Aid for Young researchers from Saitama Medical University Hospital, and the Japan Society for the Promotion of Science (JSPS; KAKENHI grant numbers 25870678, 15K04699, 15K21335 and 16KK0208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2012, INVEST OPHTH VIS SCI, V53, P4111, DOI 10.1167/iovs.11-7536; Akashi A, 2015, INVEST OPHTH VIS SCI, V56, P6573, DOI 10.1167/iovs.15-17635; Anderson DR, 2000, AM J OPHTHALMOL, V130, P827, DOI 10.1016/S0002-9394(00)00665-6; Fontana L, 1998, CURR EYE RES, V17, P363, DOI 10.1080/02713689808951216; Furlanetto RL, 2013, INVEST OPHTH VIS SCI, V54, P4836, DOI 10.1167/iovs.12-11530; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; GLYNN RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P381, DOI 10.1001/archopht.1992.01080150079033; Inoue R, 2009, OPHTHALMOLOGY, V116, P214, DOI 10.1016/j.ophtha.2008.09.008; Ivers KM, 2011, INVEST OPHTH VIS SCI, V52, P5473, DOI 10.1167/iovs.11-7347; JONAS JB, 1991, INVEST OPHTH VIS SCI, V32, P401; Jonas JB, 2003, INVEST OPHTH VIS SCI, V44, P5189, DOI 10.1167/iovs.03-0174; Kuroda H, HIGH SPEED 3 DIMENSI; Kuroda H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824493; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2013, GRAEF ARCH CLIN EXP, V251, P847, DOI 10.1007/s00417-012-2145-y; Lee EJ, 2012, INVEST OPHTH VIS SCI, V53, P7576, DOI 10.1167/iovs.12-10305; Lee EJ, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.034; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Maeda H, 1999, JPN J OPHTHALMOL, V43, P415, DOI 10.1016/S0021-5155(99)00090-8; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; MILLER KM, 1988, OPHTHALMOLOGY, V95, P135; OGDEN TE, 1988, EXP EYE RES, V46, P559, DOI 10.1016/S0014-4835(88)80012-5; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Omodaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122347; Park HYL, 2013, OPHTHALMOLOGY, V120, P745, DOI 10.1016/j.ophtha.2012.09.051; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P505; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2159; Roberts MD, 2010, INVEST OPHTH VIS SCI, V51, P5675, DOI 10.1167/iovs.10-5411; Shoji T, 2016, GRAEFEARCH CLIN EX; Shoji T, 2015, GRAEF ARCH CLIN EXP, V253, P313, DOI 10.1007/s00417-014-2870-5; Shoji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116305; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; WILCZEK M, 1947, BRIT J OPHTHALMOL, V31, P551, DOI 10.1136/bjo.31.9.551; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	41	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181675	10.1371/journal.pone.0181675	http://dx.doi.org/10.1371/journal.pone.0181675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742840	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000046
J	Charnaud, SC; Dixon, MWA; Nie, CQ; Chappell, L; Sanders, PR; Nebl, T; Hanssen, E; Berriman, M; Chan, JA; Blanch, AJ; Beeson, JG; Rayner, JC; Przyborski, JM; Tilley, L; Crabb, BS; Gilson, PR				Charnaud, Sarah C.; Dixon, Matthew W. A.; Nie, Catherine Q.; Chappell, Lia; Sanders, Paul R.; Nebl, Thomas; Hanssen, Eric; Berriman, Matthew; Chan, Jo-Anne; Blanch, Adam J.; Beeson, James G.; Rayner, Julian C.; Przyborski, Jude M.; Tilley, Leann; Crabb, Brendan S.; Gilson, Paul R.			The exported chaperone Hsp70-x supports virulence functions for Plasmodium falciparum blood stage parasites	PLOS ONE			English	Article							SEQUENCING-LIBRARY PREPARATION; INFECTED ERYTHROCYTES; MALARIA PARASITES; PROTEIN EXPORT; PROTEOMIC ANALYSIS; PTEX COMPONENT; GENE DELETION; REVEALS; CELL; MEMBRANE	Malaria is caused by five different Plasmodium spp. in humans each of which modifies the host erythrocyte to survive and replicate. The two main causes of malaria, P. falciparum and P. vivax, differ in their ability to cause severe disease, mainly due to differences in the cytoadhesion of infected erythrocytes (IE) in the microvasculature. Cytoadhesion of P. falciparum in the brain leads to a large number of deaths each year and is a consequence of exported parasite proteins, some of which modify the erythrocyte cytoskeleton while others such as PfEMP1 project onto the erythrocyte surface where they bind to endothelial cells. Here we investigate the effects of knocking out an exported Hsp70-type chaperone termed Hsp70-x that is present in P. falciparum but not P. vivax. Although the growth of Delta hsp70-x parasites was unaffected, the export of PfEMP1 cytoadherence proteins was delayed and Delta hsp70-x IE had reduced adhesion. The Delta hsp70-x IE were also more rigid than wild-type controls indicating changes in the way the parasites modified their host erythrocyte. To investigate the cause of this, transcriptional and translational changes in exported and chaperone proteins were monitored and some changes were observed. We propose that PfHsp70-x is not essential for survival in vitro, but may be required for the efficient export and functioning of some P. falciparum exported proteins.	[Charnaud, Sarah C.; Nie, Catherine Q.; Sanders, Paul R.; Chan, Jo-Anne; Beeson, James G.; Crabb, Brendan S.; Gilson, Paul R.] Burnet Inst, Melbourne, Vic, Australia; [Dixon, Matthew W. A.; Blanch, Adam J.; Tilley, Leann; Crabb, Brendan S.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Dixon, Matthew W. A.; Hanssen, Eric; Blanch, Adam J.; Tilley, Leann] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic, Australia; [Chappell, Lia; Berriman, Matthew; Rayner, Julian C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England; [Nebl, Thomas] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Przyborski, Jude M.] Philips Univ Marburg, FB Biol, Parasitol, Marburg, Germany; [Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Melbourne, Vic, Australia	Burnet Institute; University of Melbourne; University of Melbourne; Wellcome Trust Sanger Institute; Walter & Eliza Hall Institute; Monash University	Gilson, PR (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Gilson, PR (corresponding author), Monash Univ, Melbourne, Vic, Australia.	gilson@burnet.edu.au	Berriman, Matthew/A-7618-2011; Dixon, Matthew/N-4503-2019; Przyborski, Jude/ABC-9498-2021; Hanssen, Eric/A-7217-2013; Nebl, Thomas/N-1620-2017	Berriman, Matthew/0000-0002-9581-0377; Dixon, Matthew/0000-0001-9732-9686; Przyborski, Jude/0000-0002-3494-7767; Blanch, Adam/0000-0001-6565-2438; Charnaud, Sarah/0000-0002-9029-9696; Hanssen, Eric/0000-0002-4064-1844; Rayner, Julian/0000-0002-9835-1014; Chappell, Lia/0000-0002-2317-3524; Nebl, Thomas/0000-0003-4003-9340	National Health and Medical Research Council [1092789, 1078065]; OzEMalaR Researcher Exchange funding; Victorian Operational Infrastructure Support Program	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); OzEMalaR Researcher Exchange funding; Victorian Operational Infrastructure Support Program	The authors would like to thank National Health and Medical Research Council (grant numbers 1092789 & 1078065), OzEMalaR Researcher Exchange funding and Victorian Operational Infrastructure Support Program received by the Burnet Institute.	Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2016, WORLD MALARIA REPORT; Antinori S, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.013; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; BERMAN PA, 1991, J CLIN INVEST, V88, P1848, DOI 10.1172/JCI115506; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Chan JA, 2016, CELL MOL LIFE SCI, V73, P4141, DOI 10.1007/s00018-016-2267-1; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chappell LVL, 2014, NOVEL APPROACHES TRA; Cooke BM, 2002, BRIT J HAEMATOL, V117, P203, DOI 10.1046/j.1365-2141.2002.03404.x; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Crabb BS, 2010, INT J PARASITOL, V40, P509, DOI 10.1016/j.ijpara.2010.02.002; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deplaine G, 2011, BLOOD, V117, pE88, DOI 10.1182/blood-2010-10-312801; Desai SA, 2014, TRENDS PARASITOL, V30, P151, DOI 10.1016/j.pt.2014.01.003; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Elsworth B, 2016, CELL MICROBIOL, V18, P1551, DOI 10.1111/cmi.12596; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hatherley R, 2014, J BIOMOL STRUCT DYN, V32, P1766, DOI 10.1080/07391102.2013.834849; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Jha P, 2017, MOL BIOCHEM PARASIT, V214, P10, DOI 10.1016/j.molbiopara.2017.03.003; Kats LM, 2014, INT J PARASITOL, V44, P319, DOI 10.1016/j.ijpara.2014.01.003; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Larremore DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9368; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; McQueen PG, 2004, P NATL ACAD SCI USA, V101, P9161, DOI 10.1073/pnas.0308256101; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Nunes MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011747; Oberli A, 2014, FASEB J, V28, P4420, DOI 10.1096/fj.14-256057; Otto TD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5754; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Pachlatko E, 2010, MOL MICROBIOL, V77, P1136, DOI 10.1111/j.1365-2958.2010.07278.x; Prieto JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004098; Proellocks NI, 2014, FASEB J, V28, P3103, DOI 10.1096/fj.14-250399; Quashie NB, 2008, BIOCHEM J, V411, P287, DOI 10.1042/BJ20071460; Rhiel M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36174; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SA D, 2013, SCI WORLD J; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Schneider AG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-30; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Simpson JA, 1999, T ROY SOC TROP MED H, V93, P165, DOI 10.1016/S0035-9203(99)90295-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Zhang Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep42188; Zhang Y, 2015, P NATL ACAD SCI USA, V112, P6068, DOI 10.1073/pnas.1505584112	74	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181656	10.1371/journal.pone.0181656	http://dx.doi.org/10.1371/journal.pone.0181656			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732045	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100053
J	Whitworth, KW; Marshall, AK; Symanski, E				Whitworth, Kristina W.; Marshall, Amanda K.; Symanski, Elaine			Maternal residential proximity to unconventional gas development and perinatal outcomes among a diverse urban population in Texas	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; LOW-BIRTH-WEIGHT; PRETERM BIRTH; GESTATIONAL-AGE; WATER-QUALITY; WASTE-WATER; RISK; EXPOSURE; OIL; HEALTH	Objective To assess associations between unconventional natural gas development (UGD) and perinatal outcomes. Methods We conducted a retrospective birth cohort study among 158,894 women with a birth or fetal death from November 30, 2010-November 29, 2012 in the Barnett Shale, in North Texas. We constructed three UGD-activity metrics by calculating the inverse distance-weighted sum of active wells within three separate geographic buffers surrounding the maternal residence: <=(1/2), 2, or 10-miles. We excluded women if the nearest well to her residence was >20 miles. Metrics were categorized by tertiles among women with >= 1 well within the respective buffer; women with zero wells <= 10 miles (the largest buffer) served as a common referent group. We used logistic or linear regression with generalized estimating equations to assess associations between UGD-activity and preterm birth, small-for-gestational age (SGA), fetal death, or birthweight. Adjusted models of fetal death and birthweight included: maternal age, race/ethnicity, education, pre-pregnancy body mass index, parity, smoking, adequacy of prenatal care, previous poor pregnancy outcome, and infant sex. Preterm birth models included all of the above except parity; SGA models included all of the above except previous poor pregnancy outcome. Results We found increased adjusted odds of preterm birth associated with UGD-activity in the highest tertiles of the (1/2)-(odds ratio (OR) = 1.14; 95% confidence interval 1.03, 1.25), 2-(1.14; 1.07, 1.22), and 10-mile (1.15; 1.08, 1.22) metrics. Increased adjusted odds of fetal death were found in the second tertile of the 2- mile metric (1.56; 1.16, 2.11) and the highest tertile of the 10- mile metric (1.34; 1.04-1.72). We found little indication of an association with SGA or term birthweight. Conclusions Our results are suggestive of an association between maternal residential proximity to UGD-activity and preterm birth and fetal death. Quantifying chemical and non-chemical stressors among residents near UGD should be prioritized.	[Whitworth, Kristina W.; Marshall, Amanda K.] UTHlth Sch Publ Hlth San Antonio, Dept Epidemiol Human Genet & Environm Sci, San Antonio, TX 78229 USA; [Whitworth, Kristina W.; Marshall, Amanda K.; Symanski, Elaine] UTHlth Sch Publ Hlth, Southwest Ctr Occupat & Environm Hlth, Houston, TX 77030 USA; [Symanski, Elaine] UTHlth Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA		Whitworth, KW (corresponding author), UTHlth Sch Publ Hlth San Antonio, Dept Epidemiol Human Genet & Environm Sci, San Antonio, TX 78229 USA.; Whitworth, KW (corresponding author), UTHlth Sch Publ Hlth, Southwest Ctr Occupat & Environm Hlth, Houston, TX 77030 USA.	Kristina.W.Whitworth@uth.tmc.edu		whitworth, kristina/0000-0003-2334-6066	National Institute of Environmental Health Sciences (NIEHS) [1 R03 ES023954-01]; Occupational Epidemiology Traineeship - National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) [T420H008421]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008421] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Occupational Epidemiology Traineeship - National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was funded by the National Institute of Environmental Health Sciences (NIEHS), Grant number 1 R03 ES023954-01. AKM was supported by an Occupational Epidemiology Traineeship funded by Grant No. T420H008421 from the National Institute for Occupational Safety and Health (NIOSH)/Centers for Disease Control and Prevention (CDC) to the Southwest Center for Occupational and Environmental Health, a NIOSH-funded Education and Research Center.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Armendariz A., 2009, EMISSIONS NATURAL GA; ATSDR, 2007, TOX PROF BENZ; Basso O, 2010, EPIDEMIOLOGY, V21, P521, DOI 10.1097/EDE.0b013e3181debe5e; Brou L, 2012, BJOG-INT J OBSTET GY, V119, P458, DOI 10.1111/j.1471-0528.2011.03266.x; Burton TG, 2016, SCI TOTAL ENVIRON, V545, P114, DOI 10.1016/j.scitotenv.2015.12.084; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; Casey JA, 2016, EPIDEMIOLOGY, V27, pE37, DOI 10.1097/EDE.0000000000000537; Catalano R, 2014, SOC SCI MED, V108, P237, DOI 10.1016/j.socscimed.2014.01.050; Christopherson S., 2012, J TOWN CITY MANAGE, V2, P1; Colborn T, 2014, HUM ECOL RISK ASSESS, V20, P86, DOI 10.1080/10807039.2012.749447; Coons T., 2008, COMMUNITY HLTH RISK; Cox LA, 2013, CRIT REV TOXICOL, V43, P26, DOI 10.3109/10408444.2013.777689; Eastern Research Group, 2011, FORT WORTH NAT GAS A; Elliott EG, 2017, J EXPO SCI ENV EPID, V27, P90, DOI 10.1038/jes.2015.81; Faiz AS, 2012, AM J EPIDEMIOL, V176, P308, DOI 10.1093/aje/kws029; Ferrar KJ, 2013, ENVIRON SCI TECHNOL, V47, P3472, DOI 10.1021/es301411q; Fontenot BE, 2013, ENVIRON SCI TECHNOL, V47, P10032, DOI 10.1021/es4011724; Ingraffea AR, 2014, P NATL ACAD SCI USA, V111, P10955, DOI 10.1073/pnas.1323422111; Jacquet JB, 2014, ENVIRON SCI TECHNOL, V48, P8321, DOI 10.1021/es404647x; Kassotis CD, 2016, ENVIRON HEALTH PERSP, V124, P256, DOI 10.1289/ehp.1409535; Kassotis CD, 2016, SCI TOTAL ENVIRON, V557, P901, DOI 10.1016/j.scitotenv.2016.03.113; Korfmacher KS, 2013, NEW SOLUT, V23, P13, DOI 10.2190/NS.23.1.c; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Li XY, 2017, ENVIRON POLLUT, V227, P596, DOI 10.1016/j.envpol.2017.03.055; Lupo PJ, 2010, PAEDIATR PERINAT EP, V24, P200, DOI 10.1111/j.1365-3016.2010.01096.x; Macey GP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-82; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McKenzie LM, 2014, ENVIRON HEALTH PERSP, V122, P412, DOI 10.1289/ehp.1306722; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; New York State Department of Environmental Conservation, 2011, REV DRAFT SUPPL GEN; Olaguer EP, 2012, J AIR WASTE MANAGE, V62, P966, DOI 10.1080/10962247.2012.688923; Saxton KB, 2017, J EVOLUTION BIOL, V30, P889, DOI 10.1111/jeb.13061; Siddika N, 2016, OCCUP ENVIRON MED, V73, P573, DOI 10.1136/oemed-2015-103086; Slama R, 2008, ENVIRON HEALTH PERSP, V116, P791, DOI 10.1289/ehp.11074; Stacy SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126425; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Talge NM, 2014, PEDIATRICS, V133, P844, DOI 10.1542/peds.2013-3285; Texas Department of State Health Services Center for Health Statistics, GUID GEOC; Texas Department of State Health Services Center for Health Statistics, 2015, TEX POP 2015 PROJ; U. S. Environmental Protection Agency, 2013, PROC HYDR FRACT 2013; US House of Representatives Committee on Energy and Commerce, 2011, CHEM US HYDR FRACT; Vengosh A, 2014, ENVIRON SCI TECHNOL, V48, P8334, DOI 10.1021/es405118y; Wallace ME, 2013, MATERN CHILD HLTH J, V17, P1025, DOI 10.1007/s10995-012-1083-y; Webb Ellen, 2014, Reviews on Environmental Health, V29, P307, DOI 10.1515/reveh-2014-0057; WHO, 2006, INDIAN J MED RES; Wilcox AJ, 2011, AM J EPIDEMIOL, V174, P1062, DOI 10.1093/aje/kwr230; Wood R, 2011, SHALE GAS PROVISIONA; Wu J, 2011, ENVIRON RES, V111, P685, DOI 10.1016/j.envres.2011.03.008; Zielinska B, 2011, MONITORING EMISSIONS, P71	54	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180966	10.1371/journal.pone.0180966	http://dx.doi.org/10.1371/journal.pone.0180966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732016	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100018
J	Jung, YS; Lee, BH; Yoo, SH				Jung, Yi-seul; Lee, Byung-Hoo; Yoo, Sang-Ho			Physical structure and absorption properties of tailor-made porous starch granules produced by selected amylolytic enzymes	PLOS ONE			English	Article							ALPHA-AMYLASE; CORN; HYDROLYSIS; DEGRADATION; IMPACT	Porous starch granules (PSGs) with various pores and cavity sizes were prepared by amylolysis enzymes. The greatest hydrolysis rate on corn starch granule was observed with alpha-amylase, followed by gluco- and beta-amylases. Temperature increase enhanced glucoamylase reaction rate more drastically than other enzyme treatments. Final hydrolysis level with glucoamylase reached to 66.9%, close to 67.5% of alpha-amylolysis. The alpha-amylase-treated PSGs displayed the greatest pore size and ratio of cavity-to-granule diameters. Gelatinization onset temperatures of PSGs increased to 72.1 (alpha-), 68.7 (beta-), and 68.1 degrees C (gluco-amylolysis) after 8 h; enthalpy changes of beta- and gluco-amylase-treated PSGs increased to 13.4, and 13.1 J/g but alpha-amylase-treated one showed slightly reduced value of 8.5 J/g. Water holding capacities of PSGs were 209.7 (alpha-), 94.6 (beta-), and 133.8% (gluco-amylolysis), and the untreated control had 89.1%; oil holding capacities of them showed 304.5, 182.7, and 211.5%, respectively, while the untreated control had 161.8%. Thus, enzyme types and their reaction conditions can be applied to generate desirable cavity and pore sizes in starch granules. This biocatalytic approach could contribute to develop tailor-made PSGs with distinct internal structure for specific uses in wide range of food, pharmaceutical and other industrial applications.	[Jung, Yi-seul; Yoo, Sang-Ho] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea; [Jung, Yi-seul; Yoo, Sang-Ho] Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea; [Lee, Byung-Hoo] Gachon Univ, Coll BioNano Technol, Dept Food Sci & Biotechnol, Sungnam, South Korea	Sejong University; Sejong University; Gachon University	Yoo, SH (corresponding author), Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea.; Yoo, SH (corresponding author), Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul, South Korea.	shyoo@sejong.ac.kr	Yoo, Sang-Ho/AAI-4446-2020	Yoo, Sang-Ho/0000-0002-7258-5090	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014M3A7B4051898]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014M3A7B4051898). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2014M3A7B4051898).	Amylolysis of native potato and corn starches D SEM AFM nitrogen and iodine sorption investigations, 2009, LWT-FOOD SCI TECHNOL, V42, P1219; Benavent-Gil Y, 2017, CARBOHYD POLYM, V157, P533, DOI 10.1016/j.carbpol.2016.10.047; Bertofta E, 2016, CARBOHYD POLYM, V140, P113, DOI 10.1016/j.carbpol.2015.12.025; Chang PR, 2011, CARBOHYD POLYM, V83, P1016, DOI 10.1016/j.carbpol.2010.08.076; Chen G, 2012, J CEREAL SCI, V56, P316, DOI 10.1016/j.jcs.2012.01.011; Chen YS, 2011, CARBOHYD POLYM, V85, P272, DOI 10.1016/j.carbpol.2011.01.047; Chung YL, 2006, CARBOHYD POLYM, V63, P527, DOI 10.1016/j.carbpol.2005.10.031; Donald A. M., 2004, Starch in food: structure, function and applications, P156, DOI 10.1533/9781855739093.1.156; Dura A, 2014, CARBOHYD POLYM, V101, P837, DOI 10.1016/j.carbpol.2013.10.013; Genkina NK, 2007, BIOMACROMOLECULES, V8, P2329, DOI 10.1021/bm070349f; Glenn GM, 2010, J AGR FOOD CHEM, V58, P4180, DOI 10.1021/jf9037826; Helbert W, 1996, INT J BIOL MACROMOL, V19, P165, DOI 10.1016/0141-8130(96)01123-3; Huber KC, 1997, CEREAL CHEM, V74, P537, DOI 10.1094/CCHEM.1997.74.5.537; Kim JY, 2013, CARBOHYD POLYM, V91, P39, DOI 10.1016/j.carbpol.2012.07.049; Lauro M, 1999, CEREAL CHEM, V76, P925, DOI 10.1094/CCHEM.1999.76.6.925; Lazou A, 2010, FOOD RES INT, V43, P609, DOI 10.1016/j.foodres.2009.09.017; Li HY, 2013, INT J BIOL MACROMOL, V61, P156, DOI 10.1016/j.ijbiomac.2013.07.004; Li HY, 2013, INT J BIOL MACROMOL, V55, P276, DOI 10.1016/j.ijbiomac.2013.01.021; Luo ZG, 2008, STARCH-STARKE, V60, P646, DOI 10.1002/star.200800014; Miao M, 2015, FOOD CHEM, V177, P1, DOI 10.1016/j.foodchem.2014.12.101; Qian JQ, 2011, INT J FOOD SCI TECH, V46, P179, DOI 10.1111/j.1365-2621.2010.02469.x; Sarikaya E, 2000, PROCESS BIOCHEM, V35, P711, DOI 10.1016/S0032-9592(99)00133-8; Sengupta S, 2000, APPL MICROBIOL BIOT, V53, P732, DOI 10.1007/s002530000327; Shariffa YN, 2009, FOOD HYDROCOLLOID, V23, P434, DOI 10.1016/j.foodhyd.2008.03.009; Sujka M, 2007, INT AGROPHYS, V21, P107; Sumner JB, 1935, J BIOL CHEM, V108, P51; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Te Wierik G. H. P., 1996, International Journal of Pharmaceutics (Amsterdam), V134, P27, DOI 10.1016/0378-5173(95)04383-7; Tester RF, 2006, ANIM FEED SCI TECH, V130, P39, DOI 10.1016/j.anifeedsci.2006.01.016; Uthumporn U, 2013, IND CROP PROD, V43, P441, DOI 10.1016/j.indcrop.2012.07.060; Wu Y, 2011, STARCH-STARKE, V63, P217, DOI 10.1002/star.201000036; Yan H, 2010, FOOD RES INT, V43, P767, DOI 10.1016/j.foodres.2009.11.013; Yao WR, 2002, STARCH-STARKE, V54, P260, DOI [10.1002/1521-379X(200206)54:6&lt;260::AID-STAR260&gt;3.0.CO;2-Z, 10.1002/1521-379X(200206)54:6<260::AID-STAR260>3.0.CO;2-Z]; Yuryev V, 2006, STARCH ACHIEVEMENTS; Zhang B, 2012, INT J BIOL MACROMOL, V50, P250, DOI 10.1016/j.ijbiomac.2011.11.002; Zhou X, 2010, J CEREAL SCI, V51, P57, DOI 10.1016/j.jcs.2009.09.005	36	23	24	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181372	10.1371/journal.pone.0181372	http://dx.doi.org/10.1371/journal.pone.0181372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727742	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500065
J	Saunders, WB; Greenfest-Allen, E; Ward, PD				Saunders, W. Bruce; Greenfest-Allen, Emily; Ward, Peter D.			Demographic disequilibrium in living nautiloids (Nautilus and Allonautilus): Canary in the coal mines?	PLOS ONE			English	Article							PEARLY NAUTILUS; CEPHALOPOD; BUOYANCY	Averaged demographic data from previously unfished populations of Nautilus and Allonautilus (Cephalopoda) provide a baseline to determine if a population is undisturbed and in "equilibrium" or is in "disequilibrium" as a result of fishery pressure. Data are available for previously undisturbed local nautiloid populations in Papua New Guinea, Australia, Indonesia, Fiji, Palau, American Samoa, New Caledonia and Vanuatu (total n = 2,669 live-caught, tagged and released animals). The data show that unfished populations average similar to 75% males and similar to 74% mature animals. By contrast, unpublished, anecdotal and historical records since 1900 from the heavily fished central Philippines have shown a persistent decline in trap yields and a change in demographics of N. pompilius. By 1979, a sample of fished live-caught animals (n = 353) comprised only similar to 28% males and similar to 27% mature animals. Continued uncontrolled trapping caused collapse of the fishery and the shell industry has moved elsewhere, including Indonesia. In addition, we show that estimated rates of population decline are offered by unpublished tag-release records in unfished Palau. These data show that patterns of trap yields and demographic differences between fished and unfished populations in relative age class and sex ratios can indicate disequilibria wrought by fisheries pressure that can render local populations inviable. Given adequate samples (n >= 100 live-caught animals), a threshold of < 50% males and mature animals in fished populations should signal the need to initiate curative conservation initiatives. The current trajectory of uncontrolled nautiloid fisheries can only mean trouble and possibly extinction of local populations of this ancient, iconic molluscan lineage.	[Saunders, W. Bruce] Bryn Mawr Coll, Dept Geol, Bryn Mawr, PA 19010 USA; [Greenfest-Allen, Emily] Univ Penn, Perelman Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	Bryn Mawr College; University of Pennsylvania; Pennsylvania Medicine; University of Washington; University of Washington Seattle	Saunders, WB (corresponding author), Bryn Mawr Coll, Dept Geol, Bryn Mawr, PA 19010 USA.	wsaunder@brynmawr.edu						[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barord GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100799; BIDDER AM, 1962, NATURE, V196, P451, DOI 10.1038/196451a0; Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; Carlson BA, 1992, P 17 INT COR REEF S, V1, P587; Carlson BC, 2015, NAUTILUS RES PALAU 2; CITES, 1973, TEXT CONV TEXT CONV; CITES, 2016, 17 M C PART JOH S AF; COLLINS D, 1987, NAUTILUS BIOL PALEOB, P421; DAVIS RA, 1987, NAUTILUS BIOL PALEOB, P3; De Angelis P, 2012, GEOBIOS-LYON, V45, P5, DOI 10.1016/j.geobios.2011.11.005; Dean B, 1901, AM NAT, V35, P819, DOI 10.1086/278007; Del Norte-Campos A.G.C., 2005, PHUKET MAR BIO CEN R, V66, P299; DENTON EJ, 1966, J MAR BIOL ASSOC UK, V46, P723, DOI 10.1017/S0025315400033440; Dugdale H, 1976, NATL GEOGR MAG, V149, P38; Dunstan A, 2010, FISH RES, V106, P239, DOI 10.1016/j.fishres.2010.06.015; Dunstan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016716; Grandperrin R, REPORT NAUTILU UNPUB; Griffin L. E., 1900, MEMOIR NAT ACAD SCI, V8, P101; Groth JG, 2015, AM MUS NOVIT, P1; Hamada T, 1980, NAUTILUS MACROMPHALU; HAVEN N, 1972, Veliger, V15, P75; Hayasaka S, 1983, 1 KAG U RES CTR S PA; LANDMAN NH, 1987, NAUTILUS BIOL PALEOB, P401; Nijman V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140593; Owen R., 1832, OIR PEARLY NAUTILUS; Rumpf Georg Eberhard, 1705, AMBOINSCHE RARITEITK; Saunders W. B., 2009, NAUTILUS BIOL PALEOB; Saunders WB, 2017, AM MALACOL BULL, V35, P1; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; SAUNDERS WB, 1978, PALEOBIOLOGY, V4, P349, DOI 10.1017/S0094837300006047; Saunders WB, 2017, ZOOLOGICAL MORPHOM 2; Saunders WB, 2017, ZOOLOGICAL MORPHOM 1; SAUNDERS WB, 1987, NAUTILUS BIOL PALEOB, P137; SWAN ARH, 1987, NAUTILUS BIOL PALEOB, P85; Vandepas LE, 2016, ECOL EVOL, V6, P4924, DOI 10.1002/ece3.2248; Ward P. D., 1987, NATURAL HIST NAUTILU; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Willey A., 1902, CONTRIBUTION NATUR 6, P691; Williams RC, 2015, MOL ECOL, V24, P3316, DOI 10.1111/mec.13255; WOODRUFF DS, 1983, P ACAD NAT SCI PHILA, V135, P147; WOODRUFF DS, 1987, NAUTILUS BIOL PALEOB, P65; WRAY CG, 1995, PALEOBIOLOGY, V21, P220, DOI 10.1017/S009483730001321X	44	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179811	10.1371/journal.pone.0179811	http://dx.doi.org/10.1371/journal.pone.0179811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727800	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500009
J	Yadav, A; Kumar, B; Lang, JC; Teknos, TN; Kumar, P				Yadav, A.; Kumar, B.; Lang, J. C.; Teknos, T. N.; Kumar, P.			A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus	ONCOGENE			English	Article							GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; PHOSPHOLIPID-BINDING; TUMOR-METASTASIS; EXPRESSION; GENE; INTERLEUKIN-6; HEAD; EHD2; IDENTIFICATION	Myoferlin, a member of ferlin family of proteins, was first discovered as a candidate gene for muscular dystrophy and cardiomyopathy. Recently, myoferlin was shown to be also expressed in endothelial and cancer cells where it was shown to modulate vascular endothelial growth factor (VEGFR)-2 and epidermal growth factor receptor (EGFR) signaling by enhancing their stability and recycling. Based on these reports, we hypothesized that myoferlin might be regulating IL-6 signaling by modulating IL-6R stabilization and recycling. However, in our immunoprecipitation (IP) experiments, we did not observe myoferlin binding with IL-6R. Instead, we made a novel discovery that in resting cells myoferlin was bound to EHD2 protein and when cells were treated with IL-6, myoferlin dissociated from EHD2 and binds to activated STAT3. Interestingly, myoferlin depletion did not affect STAT3 phosphorylation, but completely blocked STAT3 translocation to nucleus. In addition, inhibition of STAT3 phosphorylation by phosphorylation-defective STAT3 mutants or JAK inhibitor blocked STAT3 binding to myoferlin and nuclear translocation. Myoferlin knockdown significantly decreased IL-6-mediated tumor cell migration, tumorsphere formation and ALDH-positive cancer stem cell population, in vitro. Furthermore, myoferlin knockdown significantly decreased IL-6-meditated tumor growth and tumor metastasis. Based on these results, we have proposed a novel model for the role of myoferlin in chaperoning phosphorylated STAT3 to the nucleus.	[Yadav, A.; Kumar, B.; Lang, J. C.; Teknos, T. N.; Kumar, P.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Kumar, B.; Lang, J. C.; Teknos, T. N.; Kumar, P.] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, 420W 12th Ave,Room 464, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kumar, P (corresponding author), Ohio State Univ, Dept Otolaryngol Head & Neck Surg, 420W 12th Ave,Room 464, Columbus, OH 43210 USA.	Pawan.Kumar@osumc.edu			NIH/NCI [CA178649]; Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R21CA178649] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ohio State University Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by funding from NIH/NCI (CA178649 to PK) and The Ohio State University Comprehensive Cancer Center (PK and TNT). NIH/NCI-CA178649 (P Kumar) and The Ohio State University Comprehensive Cancer Center.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Adam PJ, 2003, J BIOL CHEM, V278, P6482, DOI 10.1074/jbc.M210184200; Al Moustafa AE, 2004, ONCOGENE, V23, P350, DOI 10.1038/sj.onc.1207148; Amatschek S, 2004, CANCER RES, V64, P844, DOI 10.1158/0008-5472.CAN-03-2361; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; DeFranco DB, 2000, KIDNEY INT, V57, P1241, DOI 10.1046/j.1523-1755.2000.00957.x; Demonbreun AR, 2010, J CELL SCI, V123, P2413, DOI 10.1242/jcs.065375; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Difilippantonio S, 2003, EUR J CANCER, V39, P1936, DOI 10.1016/S0959-8049(03)00419-2; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eisenberg MC, 2011, P NATL ACAD SCI USA, V108, P20078, DOI 10.1073/pnas.1116327108; Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Jimenez JL, 2007, J NEUROL SCI, V260, P114, DOI 10.1016/j.jns.2007.04.016; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kumar B, 2016, ONCOTARGET, V7, P18665, DOI 10.18632/oncotarget.7625; Kumar Bhavna, 2015, Genes Cancer, V6, P169; Kumar P, 2005, LAB INVEST, V85, P756, DOI 10.1038/labinvest.3700272; Kumar P, 2008, LAB INVEST, V88, P740, DOI 10.1038/labinvest.2008.46; Lederle W, 2011, INT J CANCER, V128, P2803, DOI 10.1002/ijc.25621; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0396-4; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Liu YP, 2008, INT J MOL MED, V21, P153; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv JJ, 2015, CANCER INVEST, V33, P420, DOI 10.3109/07357907.2015.1055757; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Riedel F, 2005, ANTICANCER RES, V25, P2761; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Schreiner SJ, 2002, J BIOL CHEM, V277, P45680, DOI 10.1074/jbc.M204255200; Shi YH, 2015, J MOL HISTOL, V46, P221, DOI 10.1007/s10735-015-9614-7; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TIAN SS, 1994, BLOOD, V84, P1760; Turtoi A, 2013, CANCER RES, V73, P5438, DOI 10.1158/0008-5472.CAN-13-1142; Turtoi A, 2011, J PROTEOME RES, V10, P4302, DOI 10.1021/pr200527z; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villalva C, 2011, INT J CANCER, V128, P826, DOI 10.1002/ijc.25416; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Yang XJ, 2015, TUMOR BIOL, V36, P3717, DOI 10.1007/s13277-014-3011-9; Yu C, 2011, VASC PHARMACOL, V55, P26, DOI 10.1016/j.vph.2011.04.001; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	57	14	14	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6374	6382		10.1038/onc.2017.245	http://dx.doi.org/10.1038/onc.2017.245			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28745314	Green Accepted			2022-12-26	WOS:000415622900002
J	Mi, YS; Qi, GY; Fan, R; Qiao, QL; Sun, YL; Gao, YQ; Liu, XB				Mi, Yashi; Qi, Guoyuan; Fan, Rong; Qiao, Qinglian; Sun, Yali; Gao, Yuqi; Liu, Xuebo			EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS	FASEB JOURNAL			English	Article						insulin resistance; cognitive disorder; appetite; circadian clock	HIPPOCAMPAL SYNAPTIC PLASTICITY; INDUCED INSULIN-RESISTANCE; CIRCADIAN-RHYTHMS; NEUROTROPHIC FACTOR; ADULT NEUROGENESIS; TEA POLYPHENOL; DIET; OBESITY; BDNF; EXPRESSION	Obesity, which is caused by an energy imbalance between calorie intake and consumption, has become a major international health burden. Obesity increases the risk of insulin resistance and age-related cognitive decline, accompanied by peripheral inflammation. (-)-Epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea, possesses antioxidant, anti-inflammatory, and cardioprotective activities; however, few reports have focused on its potential effect on cognitive disorders. In this study, our goal was to investigate the protective effects of EGCG treatment on insulin resistance and memory impairment induced by a high-fat and high-fructose diet (HFFD). We randomly assigned 3-mo-old C57BL/6Jmice to 3 groups with different diets: control group, HFFD group, and HFFD plus EGCG group. Memory loss was assessed by using the Morris water maze test, during which EGCG was observed to prevent HFFD-elicited memory impairment and neuronal loss. Consistent with these results, EGCG attenuated HFFD-induced neuronal damage. Of note, EGCG significantly ameliorated insulin resistance and cognitive disorder by up-regulating the insulin receptor substrate-1 (IRS-1)/AKT and ERK/cAMP response element binding protein (CREB)/brain-derived neurotrophic factor (BDNF) signaling pathways. Long-term HFFD-triggered neuroinflammation was restored by EGCG supplementation by inhibiting the MAPK and NF-kB pathways, as well as the expression of inflammatory mediators, such as TNF-alpha. EGCG also reversed high glucose and glucosamine-induced insulin resistance in SH-SY5Y neuronal cells by improving the oxidized cellular status and mitochondrial function. To our knowledge, this study is the first to provide compelling evidence that the nutritional compound EGCG has the potential to ameliorate HFFD-triggered learning and memory loss.-Mi, Y., Qi, G., Fan, R., Qiao, Q., Sun, Y., Gao, Y., Liu, X. EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS.	[Mi, Yashi; Qi, Guoyuan; Fan, Rong; Qiao, Qinglian; Sun, Yali; Gao, Yuqi; Liu, Xuebo] Northwest A&F Univ, Coll Food Sci & Engn, Lab Funct Chem & Nutr Food, Yangling, Peoples R China	Northwest A&F University - China	Liu, XB (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, 28 Xi Nong Rd, Yangling 712100, Peoples R China.	xueboliu@aliyun.com	Qi, Guoyuan/ABN-1711-2022; Qi, Guoyuan/AAZ-9695-2020		National Natural Science Foundation of China [31571842]; National Key Research and Development Program of China [2016YFD0400601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Elsevier Language Editing Services for its linguistic assistance during the preparation of this manuscript. This work was supported by the National Natural Science Foundation of China (Grant 31571842) and the National Key Research and Development Program of China (Grant 2016YFD0400601). The authors declare no conflicts of interest.	Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200; Bake T, 2014, APPETITE, V77, P60, DOI 10.1016/j.appet.2014.02.020; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; Bhagwat S., 2014, USDA DATABASE FLAVON; Blesa J., 2016, PARKINSONS DIS CELL; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Branecky KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137970; Catuara-Solarz S, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0103-16.2016; Chakrabarti SK, 2009, OBESITY, V17, P1657, DOI 10.1038/oby.2009.192; Cisternas P, 2015, BBA-MOL BASIS DIS, V1852, P2379, DOI 10.1016/j.bbadis.2015.08.016; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Franco-Robles E, 2016, MOLECULES, V21, DOI 10.3390/molecules21080998; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; Genzer Y, 2016, MOL CELL ENDOCRINOL, V430, P49, DOI 10.1016/j.mce.2016.04.015; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; He BK, 2016, CELL METAB, V23, P610, DOI 10.1016/j.cmet.2016.03.007; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kanoski SE, 2007, BEHAV BRAIN RES, V182, P57, DOI 10.1016/j.bbr.2007.05.004; Kao Y, 2000, AM J CLIN NUTR, V72, P1232; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Li HY, 2016, MOL NUTR FOOD RES, V60, P2565, DOI 10.1002/mnfr.201600162; Li Q, 2009, NEUROSCIENCE, V163, P741, DOI 10.1016/j.neuroscience.2009.07.014; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Liu ZG, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600734; Liu ZG, 2017, FOOD FUNCT, V8, P710, DOI 10.1039/c6fo01562j; Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0140839, 10.1371/journal.pone.0128274]; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Pinto NB, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/161092; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Qiu YY, 2017, BBA-MOL BASIS DIS, V1863, P978, DOI 10.1016/j.bbadis.2017.01.026; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; Roopchand DE, 2015, DIABETES, V64, P2847, DOI 10.2337/db14-1916; Ropelle ER, 2006, J PHYSIOL-LONDON, V577, P997, DOI 10.1113/jphysiol.2006.120006; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981; Westerterp-Plantenga MS, 2005, OBES RES, V13, P1195, DOI 10.1038/oby.2005.142; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533; Zhu SM, 2011, MOL CELL BIOCHEM, V353, P305, DOI 10.1007/s11010-011-0799-0; Ziegler AN, 2015, NAT REV ENDOCRINOL, V11, P161, DOI 10.1038/nrendo.2014.208	67	81	82	4	72	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4998	5011		10.1096/fj.201700400RR	http://dx.doi.org/10.1096/fj.201700400RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739640				2022-12-26	WOS:000413398500029
J	Seno, K; Hayashi, F				Seno, Keiji; Hayashi, Fumio			Palmitoylation is a prerequisite for dimerization-dependent raftophilicity of rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENT; PROTEIN-COUPLED RECEPTOR; RESISTANT MEMBRANE RAFTS; DISK MEMBRANES; CRYSTAL-STRUCTURE; NATIVE MEMBRANES; BOVINE RHODOPSIN; PHOTOTRANSDUCTION; TRANSDUCIN; PHOTORECEPTORS	The visual photopigment rhodopsin (Rh) is a prototypical G protein-coupled receptor (GPCR) responsible for initiation of the phototransduction cascade in rod photoreceptors. Similar to other GPCRs, Rh can form dimers or even higher oligomers and tends to have a supramolecular organization that is likely important in the dim light response. Rh also exhibits high affinity for lipid rafts (i.e. raftophilicity) upon light-dependent binding with the cognate G protein transducin (G(t)), suggesting the presence of lipid raft-like domains in the retinal disk membrane and their importance in phototransduction. However, the relationship between Rh oligomerization and lipid rafts in the disk membrane remains to be explored. Given previous findings that G(t) binds to dimeric Rh and that Rh is posttranslationally modified with two highly raftophilic palmitoyl moieties, we hypothesized that Rh becomes raftophilic upon dimerization. Here, using biochemical assays, we found that Rh*-G(t) complexes in the detergent-resistant membrane are partially resistant to cholesterol depletion by methyl-beta-cyclodextrin and that the Rh-to-G(t) stoichiometry in this methyl-beta-cyclodextrinresistant complex is 2:1. Next, we found that IgG-mediated Rh-Rh cross-linking renders Rh highly raftophilic, supporting the premise that Rh becomes raftophilic upon dimerization. Rh depalmitoylation via reduction of thioester linkages blocked the translocation of IgG-cross-linked Rh to the detergent-resistant membrane, highlighting that the two palmitoyl moieties are important for the dimerization-dependent raftophilicity of Rh. These results indicate that palmitoylated GPCRs such as Rh can acquire raftophilicity upon G protein-stabilized dimerization and thereby organize receptor-cluster rafts by recruiting raftophilic lipids.	[Seno, Keiji] Hamamatsu Univ Sch Med, Fac Med, Dept Biol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Seno, Keiji] Hamamatsu Univ Sch Med, Int Mass Imaging Ctr, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Hayashi, Fumio] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kobe University	Hayashi, F (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	fhayashi@port.kobe-u.ac.jp		Hayashi, Fumio/0000-0002-9253-5488	Japan Society for the Promotion of Science [26291031]; Grants-in-Aid for Scientific Research [17H03666, 17KT0024] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research 26291031 from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Ablonczy Z, 2006, VISION RES, V46, P4493, DOI 10.1016/j.visres.2006.08.003; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P18867; Buzhynskyy N, 2011, J MOL RECOGNIT, V24, P483, DOI 10.1002/jmr.1086; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CORLESS JM, 1982, P NATL ACAD SCI-BIOL, V79, P1116, DOI 10.1073/pnas.79.4.1116; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; DRATZ EA, 1985, BIOCHIM BIOPHYS ACTA, V832, P337, DOI 10.1016/0167-4838(85)90268-7; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; Jastrzebska B., 2015, MOTHODS MOL BIOL, V1271, P221; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2011, PROG LIPID RES, V50, P267, DOI 10.1016/j.plipres.2011.03.002; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Kawamura S, 2002, ADV EXP MED BIOL, V514, P61; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kobe F, 2008, BBA-MOL CELL RES, V1783, P1503, DOI 10.1016/j.bbamcr.2008.02.021; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Martin RE, 2005, INVEST OPHTH VIS SCI, V46, P1147, DOI 10.1167/iovs.04-1207; Mazzolini M, 2015, P NATL ACAD SCI USA, V112, pE2715, DOI 10.1073/pnas.1423162112; MORRISON DF, 1991, J BIOL CHEM, V266, P20118; Nair KS, 2002, CURR BIOL, V12, P421, DOI 10.1016/S0960-9822(02)00691-7; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Polozova A, 2000, BIOPHYS J, V79, P2632, DOI 10.1016/S0006-3495(00)76502-7; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Senin II, 2004, J BIOL CHEM, V279, P48647, DOI 10.1074/jbc.M402516200; Seno K, 2001, J BIOL CHEM, V276, P20813, DOI 10.1074/jbc.C100032200; Tanimoto Y, 2015, BIOPHYS J, V109, P2307, DOI 10.1016/j.bpj.2015.10.015; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; YAMAZAKI A, 1987, J BIOL CHEM, V262, P9316; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	51	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15321	15328		10.1074/jbc.M117.804880	http://dx.doi.org/10.1074/jbc.M117.804880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747438	Green Published, hybrid			2022-12-26	WOS:000410809800014
J	Santos, MCD; Silveira, LCD; Moura-Tonello, SCG; Porta, A; Catai, AM; Souza, GD				de Souza Santos, Marcio Clementino; de Lima Silveira, Luiz Carlos; Garcia Moura-Tonello, Silvia Cristina; Porta, Alberto; Catai, Aparecida Maria; Souza, Givago da Silva			Heart rate variability in multibacillar leprosy: Linear and nonlinear analysis	PLOS ONE			English	Article							CARDIAC AUTONOMIC MODULATION; LOW-FREQUENCY POWER; CONDITIONAL ENTROPY; SYMBOLIC ANALYSIS; SYMPATHETIC TONE; SCHWANN-CELLS; COMPLEXITY; SPECTRUM; DYSFUNCTION; IMPAIRMENT	Objective To evaluate the heart rate variability (HRV) in patients with multibacillary leprosy using dynamic linear and nonlinear analysis. Material and methods Twenty-one leprosy patients (mean age: 39.14 +/- 10.58 years) and 21 healthy subjects (mean age: 36.24 +/- 12.64 years) completed the sample. Heart rate variability recording was performed by a Polar RS800 CX heart monitor during a period of 15 min in the supine position and 15 min in a sitting position. Analysis of HRV was performed by frequency domain from high frequency (HF) and low frequency (LF) spectral indexes in absolute and normalized units. The nonlinear analysis of HRV was calculated using symbolic analysis (0V%, 1V %, 2LV% and 2UV% indexes), Shannon entropy (SE) and normalized complexity index (NCI). Results Linear analysis: both groups showed higher HF values (p < 0.05) and smaller LF values (p < 0.05) in supine than in sitting position. The leprosy patients showed higher LF values (p < 0.05) and smaller HF values (p < 0.05) compared to the controls on supine position. Symbolic analysis: leprosy patients had higher 0V% values (p < 0.05), smaller 2LV% values (p < 0.05) and 2UV % values compared to healthy subjects on both positions. The 1V% had higher values (p < 0.05) for leprosy patients than for controls in the sitting position. The control subjects had smaller 0V% values (p < 0.05), and higher 2UV % values (p < 0.05) in the supine position compared to the sitting position. Leprosy patients had higher 2UV index values (p < 0.05) in the supine position compared to the sitting position. In the complexity analysis, leprosy patients had smaller SE and NCI values (p < 0.05) than the control in the supine position. There was no difference between the SE and NCI values of leprosy and the control subjects in the sitting position. The control subjects had higher SE and NCI values (p < 0.05) in the supine position than in the sitting position. Conclusion Leprosy patients had higher sympathetic modulation and smaller vagal modulation than controls, indicating less HRV and cardiac modulation with lower complexity. The control group displayed significant HRV differences in response to position changes while leprosy patients had fewer HRV differences after the same postural change. An analysis of HRV with linear and non-linear dynamics proved to be a reliable method and promising for the investigation of autonomic dysfunction in patients with multibacillary leprosy.	[de Souza Santos, Marcio Clementino] Para State Univ, Ctr Biol Sci & Hlth, Belem, Para, Brazil; [de Souza Santos, Marcio Clementino; de Lima Silveira, Luiz Carlos; Souza, Givago da Silva] Fed Univ Para, Trop Med Nucleus, Belem, Para, Brazil; [de Lima Silveira, Luiz Carlos; Souza, Givago da Silva] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil; [de Lima Silveira, Luiz Carlos] Ceuma Univ, Sao Luis, Maranhao, Brazil; [Garcia Moura-Tonello, Silvia Cristina; Catai, Aparecida Maria] Univ Fed Sao Carlos, Physiotherapy Dept, Sao Carlos, SP, Brazil; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy	Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Ceuma; Universidade Federal de Sao Carlos; University of Milan; IRCCS Policlinico San Donato	Santos, MCD (corresponding author), Para State Univ, Ctr Biol Sci & Hlth, Belem, Para, Brazil.; Santos, MCD (corresponding author), Fed Univ Para, Trop Med Nucleus, Belem, Para, Brazil.	marcio.clementino@gmail.com	Catai, Aparecida Maria/G-4612-2012; Santos, Marcio/GON-6051-2022; Souza, Givago/W-6393-2019	Souza, Givago/0000-0002-4525-3971	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [311938/2013-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (researcher scholarship grant number 311938/2013-2 to AMC). The CNPq had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot NC, 1996, NEUROSCI LETT, V206, P57, DOI 10.1016/0304-3940(96)12425-3; Abd-Elkawi FA, 2014, EGYPT J DERMATOL VEN, V34, P41; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P317; [Anonymous], PRACT NEUROL; Ayres M., 2007, BIOESTAT 5 0; BECK JS, 1991, J NEUROL NEUROSUR PS, V54, P965, DOI 10.1136/jnnp.54.11.965; Billman G. E., 2007, HEART RATE VARIABILI, P54; Burggren WW, 2005, J EXP BIOL, V208, P3221, DOI 10.1242/jeb.01762; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Camm AJ, 1996, EUR HEART J, V17, P354; Catai AM, 2014, ENTROPY-SWITZ, V16, P6686, DOI 10.3390/e16126686; Croft RP, 2000, LANCET, V355, P1603, DOI 10.1016/S0140-6736(00)02216-9; Santos MCD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180677; Ermakova N., 1936, INT J LEPROSY, V4; Freeman R, 2005, LANCET, V365, P1259, DOI 10.1016/S0140-6736(05)74815-7; Giles D, 2016, EUR J APPL PHYSIOL, V116, P563, DOI 10.1007/s00421-015-3303-9; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Gonçalves Aguinaldo, 2013, Rev. bras. epidemiol., V16, P611, DOI 10.1590/S1415-790X2013000300006; Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449; Javorka M, 2005, CLIN PHYSIOL FUNCT I, V25, P119, DOI 10.1111/j.1475-097X.2004.00601.x; Katoch K, 1983, Nihon Rai Gakkai Zasshi, V52, P73; Khandoker AH, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-3; Khanolkar V., 1955, INDIAN J MED SCI S1, V9; KHATTRI HN, 1978, INT J LEPROSY, V46, P172; Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450; Magagnin V, 2011, PHYSIOL MEAS, V32, P1775, DOI 10.1088/0967-3334/32/11/S05; Makikallio Timo H, 2002, Card Electrophysiol Rev, V6, P250, DOI 10.1023/A:1016381025759; MALIK M, 1994, BRIT HEART J, V71, P3; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Maraes VRFS, 2001, BRAS J MED BIOL RES, V34, P871; Martelli D, 2014, AM J PHYSIOL-HEART C, V307, pH1005, DOI 10.1152/ajpheart.00361.2014; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Moura-Tonello SCG, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-13; Neves VR, 2012, CLIN AUTON RES, V22, P175, DOI 10.1007/s10286-012-0160-z; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Perseguini NM, 2011, BRAZ J MED BIOL RES, V44, P29, DOI 10.1590/S0100-879X2011000100005; Piccirillo G, 2009, HEART RHYTHM, V6, P546, DOI 10.1016/j.hrthm.2009.01.006; Porta A, 2007, CHAOS, V17, DOI 10.1063/1.2404630; Porta A, 2006, P IEEE, V94, P805, DOI 10.1109/JPROC.2006.871774; Porta A, 1998, BIOL CYBERN, V78, P71, DOI 10.1007/s004220050414; Porta A, 2001, IEEE T BIO-MED ENG, V48, P1282, DOI 10.1109/10.959324; Porta A, 2007, AM J PHYSIOL-HEART C, V293, pH702, DOI 10.1152/ajpheart.00006.2007; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Rahman F, 2011, CLIN AUTON RES, V21, P133, DOI 10.1007/s10286-010-0098-y; Caruso FCR, 2016, BRAZ J CARDIOVA SURG, V31, P38, DOI 10.5935/1678-9741.20160007; Ryan AD, 2003, ANAESTHESIA, V58, P432, DOI 10.1046/j.1365-2044.2003.03145.x; Scollard DM, 1999, AM J PATHOL, V154, P1611, DOI 10.1016/S0002-9440(10)65414-4; Shah P K, 1990, Indian J Lepr, V62, P91; Siebert J, 2004, MED SCI MONITOR, V10, pMT31; Singh D, 2004, PHYSIOL MEAS, V25, P721, DOI 10.1088/0967-3334/25/3/012; Solanki I, 2016, NEUROCHEM INT, V95, P100, DOI 10.1016/j.neuint.2015.11.001; Soysal A, 2004, CAN J NEUROL SCI, V31, P357, DOI 10.1017/S0317167100003449; Spierings E, 2000, IMMUNOL CELL BIOL, V78, P349, DOI 10.1046/j.1440-1711.2000.00939.x; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Takahashi ACM, 2012, INTERN EMERG MED, V7, P229, DOI 10.1007/s11739-011-0512-z; Ulvi H, 2003, ACTA NEUROL SCAND, V107, P42, DOI 10.1034/j.1600-0404.2003.01307.x; Van Brakel WH, 2005, LEPROSY REV, V76, P277; Watanabe Nobuhiro, 2007, Chiropr Osteopat, V15, P19; WilderSmith A, 1997, INT J LEPROSY, V65, P20	61	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180677	10.1371/journal.pone.0180677	http://dx.doi.org/10.1371/journal.pone.0180677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750014	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700014
J	Tsunoda, SP; Prigge, M; Abe-Yoshizumi, R; Inoue, K; Kozaki, Y; Ishizuka, T; Yawo, H; Yizhar, O; Kandori, H				Tsunoda, Satoshi P.; Prigge, Matthias; Abe-Yoshizumi, Rei; Inoue, Keiichi; Kozaki, Yuko; Ishizuka, Toru; Yawo, Hiromu; Yizhar, Ofer; Kandori, Hideki			Functional characterization of sodium-pumping rhodopsins with different pumping properties	PLOS ONE			English	Article							DRIVEN NA+ PUMP; ANGSTROM RESOLUTION; WILD-TYPE; LIGHT; BACTERIORHODOPSIN; PH; CHANNELRHODOPSINS; TRANSPORT; NEURONS; CELLS	Sodium pumping rhodopsins (NaRs) are a unique member of the microbial-type I rhodopsin family which actively transport Na+ and H+ depending on ionic condition. In this study, we surveyed 12 different NaRs from various sources of eubacteria for their electrophysiological as well as spectroscopic properties. In mammalian cells several of these NaRs exhibited a Na+ based pump photocurrent and four interesting candidates were chosen for further characterization. Voltage dependent photocurrent amplitudes revealed a membrane potential-sensitive turnover rate, indicating the presence of an electrically-charged intermediate(s) in the photocycle reaction. The NaR from Salinarimonas rosea DSM21201 exhibited a red-shifted absorption spectrum, and slower kinetics compared to the first described sodium pump, KR2. Although the ratio of Na+ to H+ ion transport varied among the NaRs we tested, the NaRs from Flagellimonas sp_DIK and Nonlabens sp_YIK_SED-11 showed significantly higher Na+ selectivity when compared to KR2. All four further investigated NaRs showed a functional expression in dissociated hippocampal neuron culture and hyperpolarizing activity upon light-stimulation. Additionally, all four NaRs allowed optical inhibition of electrically-evoked neuronal spiking. Although efficiency of silencing was 3-5 times lower than silencing with the enhanced version of the proton pump AR3 from Halorubrum sodomense, our data outlines a new approach for hyperpolarization of excitable cells without affecting the intracellular and extracellular proton environment.	[Tsunoda, Satoshi P.; Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Tsunoda, Satoshi P.; Abe-Yoshizumi, Rei; Inoue, Keiichi; Kozaki, Yuko; Kandori, Hideki] Nagoya Inst Technol, Grad Sch Engn, Life Sci & Appl Chem, Nagoya, Aichi, Japan; [Tsunoda, Satoshi P.; Abe-Yoshizumi, Rei; Inoue, Keiichi; Kozaki, Yuko; Kandori, Hideki] Nagoya Inst Technol, OptoBioTechnol Res Ctr, Nagoya, Aichi, Japan; [Prigge, Matthias; Yizhar, Ofer] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Inoue, Keiichi] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi, Japan; [Ishizuka, Toru; Yawo, Hiromu] Tohoku Univ, Dept Dev Biol & Neurosci, Grad Sch Life Sci, Sendai, Miyagi, Japan	Japan Science & Technology Agency (JST); Nagoya Institute of Technology; Nagoya Institute of Technology; Weizmann Institute of Science; Nagoya Institute of Technology; Tohoku University	Kandori, H (corresponding author), Nagoya Inst Technol, Grad Sch Engn, Life Sci & Appl Chem, Nagoya, Aichi, Japan.; Kandori, H (corresponding author), Nagoya Inst Technol, OptoBioTechnol Res Ctr, Nagoya, Aichi, Japan.	kandori@nitech.ac.jp	YIZHAR, OFER/AAV-8497-2021; Ishizuka, Toru/L-8191-2017; Inoue, Keiichi/AEO-3337-2022; Tsunoda, Satoshi/AAN-7023-2021	Ishizuka, Toru/0000-0003-4405-8792; Inoue, Keiichi/0000-0002-6898-4347; Tsunoda, Satoshi/0000-0003-3636-1521	PRESTO, Japan Science and Technology Agency [JPMJPR1688, JPMJPR15P2]; Japanese Ministry of Education, Culture, Sports, Science and Technology [26708001, 26620005, 17H03007, 25104009, 15H02391]; ERC (StG OptoNEUROMOD) [337637]; Human Frontier Science Program; Israel Science Foundation (ISF) [1351-12]; Miverva Foundation	PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERC (StG OptoNEUROMOD); Human Frontier Science Program(Human Frontier Science Program); Israel Science Foundation (ISF)(Israel Science Foundation); Miverva Foundation	This work was financially supported by grants from PRESTO, Japan Science and Technology Agency to SPT (JPMJPR1688) and KI (JPMJPR15P2), by the Japanese Ministry of Education, Culture, Sports, Science and Technology to KI (26708001, 26620005, 17H03007) and HK (25104009, 15H02391), by the ERC (StG OptoNEUROMOD #337637) to OY, by the Human Frontier Science Program and the Israel Science Foundation (ISF #1351-12) to OY, and by a Miverva Foundation postdoctoral fellowship to MP.	Balashov SP, 2014, BIOCHEMISTRY-US, V53, P7549, DOI 10.1021/bi501064n; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Gaby M, 2016, CELL REP, V16, P2259, DOI 10.1016/j.celrep.2016.07.057; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Ferenczi EA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23947; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; Geibel S, 2013, PLOS ONE, V8; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Gushchin I, 2011, J MOL BIOL, V412, P591, DOI 10.1016/j.jmb.2011.07.022; Hoque MR, 2016, PLOS ONE, V11, P1; Hososhima S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119558; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kato Y, 2015, J PHYS CHEM LETT, V6, P5111, DOI 10.1021/acs.jpclett.5b02371; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kwon YM, 2015, DIVERSITY FUNCTIONAL; Li H, 2015, BIOPHYS J, V109, P1446, DOI 10.1016/j.bpj.2015.08.018; Lorinczi E, 2009, J MOL BIOL, V393, P320, DOI 10.1016/j.jmb.2009.07.055; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Prigge M, 2012, J BIOL CHEM, V287, P31804, DOI 10.1074/jbc.M112.391185; Raimondo JV, 2016, J NEUROSCI, V36, P7002, DOI 10.1523/JNEUROSCI.0664-16.2016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Vogt A, 2013, BIOPHYS J, V105, P2055, DOI 10.1016/j.bpj.2013.08.031; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084	38	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0179232	10.1371/journal.pone.0179232	http://dx.doi.org/10.1371/journal.pone.0179232			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749956	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700002
J	Rafiq, M; Hayat, M; Anesio, AM; Jamil, SUU; Hassan, N; Shah, AA; Hasan, F				Rafiq, Muhammad; Hayat, Muhammad; Anesio, Alexandre M.; Jamil, Syed Umair Ullah; Hassan, Noor; Shah, Aamer Ali; Hasan, Fariha			Recovery of metallo-tolerant and antibiotic resistant psychrophilic bacteria from Siachen glacier, Pakistan	PLOS ONE			English	Article							HIMALAYAN MOUNTAIN-RANGES; SP-NOV.; HAMTA GLACIER; SP. NOV.; ICE; MICROORGANISMS; GENES; COMMUNITIES; ENDOSPORES; DIVERSITY	Cultureable bacterial diversity of previously unexplored Siachen glacier, Pakistan, was studied. Out of 50 isolates 33 (66%) were Gram negative and 17 (34%) Gram positive. About half of the isolates were pigment producers and were able to grow at 4-37 degrees C. 16S rRNA gene sequences revealed Gram negative bacteria dominated by Proteobacteria (especially gamma-proteobacteria and beta-proteobacteria) and Flavobacteria. The genus Pseudomonas (51.51%, 17) was dominant among gamma-proteobacteria. beta-proteobacteria constituted 4 (12.12%) Alcaligenes and 4 (12.12%) Janthinobacterium strains. Among Gram positive bacteria, phylum Actinobacteria, Rhodococcus (23.52%, 4) and Arthrobacter (23.52%, 4) were the dominating genra. Other bacteria belonged to Phylum Firmicutes with representative genus Carnobacterium (11.76%, 2) and 4 isolates represented 4 genera Bacillus, Lysinibacillus, Staphylococcus and Planomicrobium. Most of the Gram negative bacteria were moderate halophiles, while most of the Gram positives were extreme halophiles and were able to grow up to 6.12 M of NaCl. More than 2/3 of the isolates showed antimicrobial activity against multidrug resistant S. aureus, E. coli, Klebsiella pneumonia, Enterococcus faecium, Candida albicans, Aspergillus flavus and Aspergillus fumigatus and ATCC strains. Gram positive bacteria (94.11%) were more resistant to heavy metals as compared to Gram negative (78.79%) and showed maximum tolerance against iron and least tolerance against mercury.	[Rafiq, Muhammad; Hayat, Muhammad; Jamil, Syed Umair Ullah; Hassan, Noor; Shah, Aamer Ali; Hasan, Fariha] Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan; [Rafiq, Muhammad] Abdul Wali Khan Univ, Dept Microbiol, Mardan, Pakistan; [Rafiq, Muhammad; Anesio, Alexandre M.] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol, Avon, England; [Jamil, Syed Umair Ullah] Bahria Univ, Dept Earth & Environm Sci, Islamabad, Pakistan	Quaid I Azam University; Abdul Wali Khan University; University of Bristol	Hasan, F (corresponding author), Quaid I Azam Univ, Dept Microbiol, Islamabad, Pakistan.	farihahasan@yahoo.com	Hayat, Muhammad/HDN-8672-2022; Anesio, Alexandre/A-7597-2008	Anesio, Alexandre/0000-0003-2990-4014; Hassan, Noor/0000-0002-6619-6806; Shah, Aamer/0000-0001-7454-4105	Higher Education Commission, Pakistan, fellowship	Higher Education Commission, Pakistan, fellowship	The funds were provided for the research, but no funds for the publication charges. The research grant was from, Higher Education Commission, Pakistan, fellowship for Muhammad Rafiq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ActionAid, 2010, PEARSON ED, P58; Anesio AM, 2012, TRENDS ECOL EVOL, V27, P219, DOI 10.1016/j.tree.2011.09.012; Baghel VS, 2005, ENZYME MICROB TECH, V36, P654, DOI 10.1016/j.enzmictec.2004.09.005; Berge JP, 2005, ADV BIOCHEM ENG BIOT, V96, P49, DOI 10.1007/b135782; Bhatia M, 2006, APPL ENVIRON MICROB, V72, P5838, DOI 10.1128/AEM.00595-06; Biondi N, 2008, J APPL MICROBIOL, V105, P105, DOI 10.1111/j.1365-2672.2007.03716.x; Boetius A., 2015, NAT REV MICROBIOL; Boyd ES, 2010, ENV MICROBIOL REP, V2, P685, DOI 10.1111/j.1758-2229.2010.00162.x; Branda E, 2010, FEMS MICROBIOL ECOL, V72, P354, DOI 10.1111/j.1574-6941.2010.00864.x; Butinar L, 2007, ANTON LEEUW INT J G, V91, P277, DOI 10.1007/s10482-006-9117-3; Carpenter EJ, 2000, APPL ENVIRON MICROB, V66, P4514, DOI 10.1128/AEM.66.10.4514-4517.2000; Chaturvedi P, 2005, INT J SYST EVOL MICR, V55, P2113, DOI 10.1099/ijs.0.63806-0; Chaturvedi P, 2006, INT J SYST EVOL MICR, V56, P2765, DOI 10.1099/ijs.0.64508-0; Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207; Collins RE, 2010, ENVIRON MICROBIOL, V12, P1828, DOI 10.1111/j.1462-2920.2010.02179.x; Dancer SJ, 1997, J APPL MICROBIOL, V82, P597, DOI 10.1111/j.1365-2672.1997.tb03590.x; Dimitrova S, 2013, APPL BIOCHEM BIOTECH, V169, P301, DOI 10.1007/s12010-012-9983-2; Fedarko K, 2003, THE COLDEST WAR; Gupta P, 2015, ARCH MICROBIOL, V197, P851, DOI 10.1007/s00203-015-1121-4; Hemala L, 2014, RES MICROBIOL, V165, P447, DOI 10.1016/j.resmic.2014.05.035; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Kemkar NA, 2006, STANFORD ENV LAW J, V25, P67; Kim HJ, 2008, INT J SYST EVOL MICR, V58, P817, DOI 10.1099/ijs.0.65501-0; Kishore KH, 2010, INT J SYST EVOL MICR, V60, P1909, DOI 10.1099/ijs.0.015271-0; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; La-Farge C, 2013, P NAT ACAD SCI; Liu YQ, 2009, EXTREMOPHILES, V13, P411, DOI 10.1007/s00792-009-0227-5; Mangano S, 2014, POLAR BIOL, V37, P227, DOI 10.1007/s00300-013-1426-1; Mannisto MK, 2006, SYST APPL MICROBIOL, V29, P229, DOI 10.1016/j.syapm.2005.09.001; Mikucki JA, 2007, APPL ENVIRON MICROB, V73, P4029, DOI 10.1128/AEM.01396-06; Miteva Vanya, 2008, P31, DOI 10.1007/978-3-540-74335-4_3; Miteva VI, 2005, APPL ENVIRON MICROB, V71, P7806, DOI 10.1128/AEM.71.12.7806-7818.2005; Montross SN, 2013, GEOLOGY, V41, P215, DOI 10.1130/G33572.1; MORITA RY, 1975, BACTERIOL REV, V39, P144, DOI 10.1128/MMBR.39.2.144-167.1975; Mueller DR, 2004, POLAR BIOL, V27, P66, DOI 10.1007/s00300-003-0580-2; Musilova M, 2015, FRONT MICROBIOL, P6; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; O'Brien A, 2004, FEMS MICROBIOL ECOL, V11; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Onyenwoke RU, 2004, ARCH MICROBIOL, V182, P182, DOI 10.1007/s00203-004-0696-y; Parnell J, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2014.0293; Reddy GSN, 2008, INT J SYST EVOL MICR, V58, P2229, DOI 10.1099/ijs.0.65715-0; Reddy GSN, 2010, INT J SYST EVOL MICR, V60, P866, DOI 10.1099/ijs.0.011775-0; Sanchez LA, 2009, EXTREMOPHILES, V13, P111, DOI 10.1007/s00792-008-0203-5; Segawa T, 2013, ENV MICROBIOL REP, V5, P127, DOI 10.1111/1758-2229.12011; Seiler C, 2007, ROLE PREVALENCE ANTI, P101; Sheridan PP, 2003, APPL ENVIRON MICROB, V69, P2153, DOI 10.1128/AEM.69.4.2153-2160.2003; Shivaji S, 2005, INT J SYST EVOL MICR, V55, P1083, DOI 10.1099/ijs.0.63532-0; Shivaji S, 2004, CELL MOL BIOL, V50, P525; Takeuchi N, 2004, ARCT ANTARCT ALP RES, V36, P92, DOI 10.1657/1523-0430(2004)036[0092:ASACOT]2.0.CO;2; Takeuchi N, 2006, ANN GLACIOL-SER, V43, P378, DOI 10.3189/172756406781812113; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomova I, 2014, POL POLAR RES, V35, P593, DOI 10.2478/popore-2014-0028; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; Wadham JL, 2012, NATURE, V488, P633, DOI 10.1038/nature11374; Yung PT, 2007, FEMS MICROBIOL ECOL, V59, P300, DOI 10.1111/j.1574-6941.2006.00218.x; Zhang De-Chao, 2013, Biology (Basel), V2, P85, DOI 10.3390/biology2010085; Zhang DC, 2011, INT J SYST EVOL MICR, V61, P587, DOI 10.1099/ijs.0.023135-0; Zhang DC, 2010, INT J SYST EVOL MICR, V60, P2149, DOI 10.1099/ijs.0.017178-0; Zhang S, 2007, BIOGEOSCIENCES, V4, P1, DOI 10.5194/bg-4-1-2007; Zhang XJ, 2009, FEMS MICROBIOL ECOL, V67, P21, DOI 10.1111/j.1574-6941.2008.00604.x	63	28	29	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0178180	10.1371/journal.pone.0178180	http://dx.doi.org/10.1371/journal.pone.0178180			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746396	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800001
J	Beck, SV; Carvalho, GR; Barlow, A; Ruber, L; Tan, HH; Nugroho, E; Wowor, D; Nor, SAM; Herder, F; Muchlisin, ZA; de Bruyn, M				Beck, Samantha V.; Carvalho, Gary R.; Barlow, Axel; Ruber, Lukas; Tan, Heok Hui; Nugroho, Estu; Wowor, Daisy; Nor, Siti Azizah Mohd; Herder, Fabian; Muchlisin, Zainal A.; de Bruyn, Mark			Plio-Pleistocene phylogeography of the Southeast Asian Blue Panchax killifish, Aplocheilus panchax	PLOS ONE			English	Article							GONDWANA LIFE RAFTS; FRESH-WATER FISHES; ALLOPATRIC SPECIATION; STATISTICAL-METHOD; POPULATION-GROWTH; DIVERSIFICATION; BIOGEOGRAPHY; HISTORY; DNA; CYPRINODONTIFORMES	The complex climatic and geological history of Southeast Asia has shaped this region's high biodiversity. In particular, sea level fluctuations associated with repeated glacial cycles during the Pleistocene both facilitated, and limited, connectivity between populations. In this study, we used data from two mitochondrial and three anonymous nuclear markers to determine whether a fresh/brackish water killifish, Aplocheilus panchax, Hamilton, 1822, could be used to further understand how climatic oscillations and associated sea level fluctuations have shaped the distribution of biota within this region, and whether such patterns show evidence of isolation within palaeodrainage basins. Our analyses revealed three major mitochondrial clades within A. panchax. The basal divergence of A. panchax mitochondrial lineages was approximately 3.5 Ma, whilst the subsequent divergence timings of these clades occurred early Pleistocene (similar to 2.6 Ma), proceeding through the Pleistocene. Continuous phylogeographic analysis showed a clear west-east dispersal followed by rapid radiation across Southeast Asia. Individuals from Krabi, just north of the Isthmus of Kra, were more closely related to the Indian lineages, providing further evidence for a freshwater faunal disjunction at the Isthmus of Kra biogeographic barrier. Our results suggest that Sulawesi, across the Wallace Line, was colonised relatively recently (similar to 30 ka). Nuclear DNA is less geographically structured, although Mantel tests indicated that nuclear genetic distances were correlated with geographic proximity. Overall, these results imply that recent gene flow, as opposed to historical isolation, has been the key factor determining patterns of nuclear genetic variation in A. panchax, however, some evidence of historical isolation is retained within the mitochondrial genome. Our study further validates the existence of a major biogeographic boundary at the Kra Isthmus, and also demonstrates the use of widely distributed fresh/brackishwater species in phylogeographic studies, and their ability to disperse across major marine barriers in relatively recent time periods.	[Beck, Samantha V.] Holar Univ Coll, Dept Aquaculture & Fish Biol, Haskolinn A Holum, Sauoarkrokur, Iceland; [Beck, Samantha V.] Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland; [Carvalho, Gary R.; de Bruyn, Mark] Bangor Univ, Environm Ctr Wales, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Barlow, Axel] Univ Potsdam, Inst Biochem & Biol, Karl Liebknecht Str, Golm, Germany; [Ruber, Lukas] Nat Hist Museum Burgergemeinde Bern, Bernastr, Bern, Switzerland; [Ruber, Lukas] Univ Bern, Inst Ecol & Evolut, Baltzerstr, Bern, Switzerland; [Tan, Heok Hui] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore; [Nugroho, Estu] Indonesian Res Inst Freshwater Aquaculture, Bogor, Java, Indonesia; [Wowor, Daisy] Indonesian Inst Sci LIPI, Res Ctr Biol Puslit Biol, Cibinong, Indonesia; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Herder, Fabian] Zool Forsch Museum Alexander Koenig, Sekt Ichthyol, Adenauerallee, Bonn, Germany; [Muchlisin, Zainal A.] Syiah Kuala Univ, Dept Aquaculture Marine & Fishery Sci, Banda Aceh, Indonesia; [de Bruyn, Mark] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia	University of Iceland; Bangor University; University of Potsdam; University of Bern; National University of Singapore; Indonesian Institute of Sciences; Universiti Sains Malaysia; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Universitas Syiah Kuala; University of Sydney	Beck, SV (corresponding author), Holar Univ Coll, Dept Aquaculture & Fish Biol, Haskolinn A Holum, Sauoarkrokur, Iceland.; Beck, SV (corresponding author), Univ Iceland, Inst Life & Environm Sci, Reykjavik, Iceland.; de Bruyn, M (corresponding author), Bangor Univ, Environm Ctr Wales, Sch Biol Sci, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.; de Bruyn, M (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	beck@mail.holar.is; markus.debruyn@gmail.com	Muchlisin, Zainal Abidin/E-2317-2015; de Bruyn, Mark/C-5568-2008; Beck, Samantha/GQZ-2693-2022; Rüber, Lukas/D-5436-2013; Nor, Siti Azizah Mohd/A-8275-2011	Muchlisin, Zainal Abidin/0000-0002-0858-1853; de Bruyn, Mark/0000-0003-1528-9604; Rüber, Lukas/0000-0003-0125-008X; nugroho, estu/0000-0002-3755-757X; Barlow, Axel/0000-0002-5532-9458; Beck, Samantha V./0000-0002-8614-6478	Global Innovation Initiative	Global Innovation Initiative	Global Innovation Initiative Grant to MdB, "Environmental DNA for rapid assessment of biodiversity and conservation priorities in Indonesia", will be used for data submission in Dryad upon acceptance of publication.	Adamson EAS, 2012, FRESHWATER BIOL, V57, P2211, DOI 10.1111/j.1365-2427.2012.02864.x; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; [Anonymous], 2007, FRESHWATER FISH DIST; [Anonymous], TRACER V1 6; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bartakova V, 2015, J BIOGEOGR, V42, P1832, DOI 10.1111/jbi.12567; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bohlen J, 2011, MOL PHYLOGENET EVOL, V61, P854, DOI 10.1016/j.ympev.2011.08.003; Briggs JC, 2003, SYST BIOL, V52, P548, DOI 10.1080/10635150390218385; Brown RM, 2013, ANNU REV ECOL EVOL S, V44, P411, DOI 10.1146/annurev-ecolsys-110411-160323; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Costa WJEM, 2013, VERTEBR ZOOL, V63, P139; Croft DP, 2003, OECOLOGIA, V137, P62, DOI 10.1007/s00442-003-1268-6; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; de Bruyn M, 2012, BIOTIC EVOLUTION ENV, P317; de Bruyn M, 2014, SYST BIOL, V63, P879, DOI 10.1093/sysbio/syu047; de Bruyn M, 2013, SYST BIOL, V62, P398, DOI 10.1093/sysbio/syt007; de Bruyn M, 2011, CONSERV GENET RESOUR, V3, P53, DOI 10.1007/s12686-010-9286-2; DeBoer TS, 2014, B MAR SCI, V90, P277, DOI 10.5343/bms.2013.1003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERSTS PJ, GEOGRAPHIC DISTANCE; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Fu YX, 1997, GENETICS, V147, P915; Garcia G, 2006, J ZOOL SYST EVOL RES, V44, P75, DOI 10.1111/j.1439-0469.2005.00346.x; Hall R, 2011, GEOL SOC SPEC PUBL, V355, P1, DOI 10.1144/SP355.1; Herder F, 2012, AQUAT INVASIONS, V7, P521, DOI 10.3391/ai.2012.7.4.009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huxley T., 1868, P ZOOLOGICAL SOC LON, P294; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Joly S, 2006, SYST BIOL, V55, P623, DOI 10.1080/10635150600863109; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klaus S, 2013, J BIOGEOGR, V40, P63, DOI 10.1111/j.1365-2699.2012.02771.x; Kottelat M, 2013, FISHES INLAND WATERS; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Li JT, 2013, P NATL ACAD SCI USA, V110, P3441, DOI 10.1073/pnas.1300881110; Lim P, 1999, AQUAT LIVING RESOUR, V12, P379, DOI 10.1016/S0990-7440(99)00107-2; Lindsey C.C., 1986, P639; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; MANTEL N, 1967, CANCER RES, V27, P209; Martin AP, 1998, MOL PHYLOGENET EVOL, V9, P192, DOI 10.1006/mpev.1997.0461; Mittermeier Russell A., 2004, P1; Muchlisin Z. A., 2009, International Journal of Zoological Research, V5, P62; Murphy WJ, 1997, MOL BIOL EVOL, V14, P790, DOI 10.1093/oxfordjournals.molbev.a025819; Myers G. S., 1938, Smithsonian Report Washington, V1937, P339; Myers GS, 1938, ANNU REP BOARD REGEN, V92; Parenti LR, 1998, RAFFLES B ZOOL, V46, P139; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; de Leon JLP, 2014, MOL PHYLOGENET EVOL, V79, P404, DOI 10.1016/j.ympev.2014.07.007; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Snorrason SS, ADAPTIVE SPECIATION, P210; So N, 2006, HEREDITY, V96, P166, DOI 10.1038/sj.hdy.6800781; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sparks JS, 2005, SYST BIOL, V54, P158, DOI 10.1080/10635150590906019; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Vrtilek M, 2016, J ZOOL SYST EVOL RES, V54, P289, DOI 10.1111/jzs.12134; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; ZAKARIAISMAIL M, 1994, HYDROBIOLOGIA, V285, P41, DOI 10.1007/BF00005652	73	17	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0179557	10.1371/journal.pone.0179557	http://dx.doi.org/10.1371/journal.pone.0179557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742862	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000406370000004
J	Patnaik, SK; Kannisto, ED; Mallick, R; Vachani, A; Yendamuri, S				Patnaik, Santosh K.; Kannisto, Eric D.; Mallick, Reema; Vachani, Anil; Yendamuri, Sai			Whole blood microRNA expression may not be useful for screening non-small cell lung cancer	PLOS ONE			English	Article							PERIPHERAL-BLOOD; GENE-EXPRESSION; MICROARRAY DATA; MANAGEMENT; DISEASE; ARRAY; MIRNA; CLASSIFICATION; BIOMARKERS; SIGNATURES	At least seven studies have suggested that microRNA levels in whole blood can be diagnostic for lung cancer. We conducted a large bi-institutional study to validate this. Qiagen (R) PAX-gene (TM) Blood miRNA System was used to collect blood and extract RNA from it for 85 pathologic stage I-IV non-small cell lung cancer (NSCLC) cases and 76 clinically-relevant controls who had a benign pulmonary mass, or a high risk of developing lung cancer because of a history of cigarette smoking or age >60 years. Cases and controls were similar for age, gender, race, and blood hemoglobin and leukocyte but not platelet levels (0.23 and 0.26 million/mu l, respectively; t test P = 0.01). Exiqon (R) MiRCURY (TM) microarrays were used to quantify microRNAs in RNA isolates. Quantification was also performed using Taqman (TM) microRNA reverse transcription (RT)-PCR assays for five microRNAs whose lung cancer-diagnostic potential had been suggested in seven published studies. Of the 1,941 human mature microRNAs detectable with the microarray platform, 598 (31%) were identified as expressed and reliably quantified among the study's subjects. However, none of the microRNAs was differentially expressed between cases and controls (P >0.05 at false discovery rate <5% in test using empirical Bayes-moderated t statistics). In classification analyses with leave-one-out internal cross-validation, cases and controls could be identified by microRNA expression with 47% and 50% accuracy with support vector machines and top-scoring pair methods, respectively. Cases and controls did not differ for RT-PCR-based measurements of any of the five microRNAs whose biomarker potential had been suggested by seven previous studies. Additionally, no difference for microRNA expression was noticed in microarray-based microRNA profiles of whole blood of 12 stage IA-IIIB NSCLC cases before and three-four weeks after tumor resection. These findings show that whole blood microRNA expression profiles lack diagnostic value for high-risk screening of NSCLC, though such value may exist for selective sub-groups of NSCLC and control populations.	[Patnaik, Santosh K.; Kannisto, Eric D.; Yendamuri, Sai] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Patnaik, Santosh K.; Yendamuri, Sai] SUNY Buffalo, Dept Surg, Buffalo, NY USA; [Mallick, Reema] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Vachani, Anil] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Patnaik, SK; Yendamuri, S (corresponding author), Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA.; Patnaik, SK; Yendamuri, S (corresponding author), SUNY Buffalo, Dept Surg, Buffalo, NY USA.	santosh.patnaik@roswellpark.arg; sai.yendamuri@roswellpark.org			OneBreath Clinical Research Award from Chest Foundation [1R21CA156087-01A1]; career development grant from National Cancer Institute [K07CA111952]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	OneBreath Clinical Research Award from Chest Foundation; career development grant from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by OneBreath Clinical Research Award to SY from Chest Foundation (URL: www.chestnet.org/Foundation),and by research grant 1R21CA156087-01A1 and career development grant K07CA111952 to AV from National Cancer Institute (URL: www.cancer.gov). The funders had no role in study design, data	Berger JA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-194; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cronin KA, 2006, JNCI-J NATL CANCER I, V98, P637, DOI 10.1093/jnci/djj163; Dudoit S, 2003, INTERDISC STAT, P93; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferreira JA, 2006, STAT APPL GENET MOL, V5; Fukushima Y, 2011, CIRC J, V75, P336, DOI 10.1253/circj.CJ-10-0457; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hausler SFM, 2010, BRIT J CANCER, V103, P693, DOI 10.1038/sj.bjc.6605833; Jeong HC, 2011, MOL MED REP, V4, P383, DOI 10.3892/mmr.2011.430; Katsuura S, 2012, NEUROSCI LETT, V516, P79, DOI 10.1016/j.neulet.2012.03.062; Keller A, 2011, MOL BIOSYST, V7, P3187, DOI 10.1039/c1mb05353a; Keller A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-353; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Leek JT, 2009, BIOINFORMATICS, V25, P1203, DOI 10.1093/bioinformatics/btp126; Leidinger P, 2014, ONCOTARGET, V5, P9484, DOI 10.18632/oncotarget.2419; Leidinger P, 2011, LUNG CANCER, V74, P41, DOI 10.1016/j.lungcan.2011.02.003; Leshkowitz D, 2013, RNA, V19, P527, DOI 10.1261/rna.036475.112; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Muller MC, 2002, LEUKEMIA, V16, P2395, DOI 10.1038/sj.leu.2402734; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; O'Connell RM, 2011, BLOOD, V118, P2960, DOI 10.1182/blood-2011-03-291971; Orlova IA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-195; Ost D, 2000, AM J RESP CRIT CARE, V162, P782, DOI 10.1164/ajrccm.162.3.9812152; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Patnaik Santosh Kumar, 2012, BMC Res Notes, V5, P40, DOI 10.1186/1756-0500-5-40; Perng DW, 1996, JPN J CLIN ONCOL, V26, P229, DOI 10.1093/oxfordjournals.jjco.a023219; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Qin LX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098879; Radom-Aizik S, 2010, J APPL PHYSIOL, V109, P252, DOI 10.1152/japplphysiol.01291.2009; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slawski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-439; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stewart Sherri L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Ulivi P, 2013, INT J MOL SCI, V14, P10332, DOI 10.3390/ijms140510332; van Iterson M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-439; Wang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017167; Widera C, 2011, J MOL CELL CARDIOL, V51, P872, DOI 10.1016/j.yjmcc.2011.07.011; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647	49	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181926	10.1371/journal.pone.0181926	http://dx.doi.org/10.1371/journal.pone.0181926			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742859	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000060
J	Sena, A; Ebi, KL; Freitas, C; Corvalan, C; Barcellos, C				Sena, Aderita; Ebi, Kristie L.; Freitas, Carlos; Corvalan, Carlos; Barcellos, Christovam			Indicators to measure risk of disaster associated with drought: Implications for the health sector	PLOS ONE			English	Article							CLIMATE-CHANGE; SOCIAL VULNERABILITY; CHANGING CLIMATE; PUBLIC-HEALTH; RESILIENCE; MANAGEMENT; FRAMEWORK; EVENTS	Introduction Brazil has a large semiarid region, which covers part of 9 states, over 20% of the 5565 municipalities in the country and at 22.5 million persons, 12% of the country's population. This region experiences recurrent and extended droughts and is characterized by low economic development, scarcity of natural resources including water, and difficult agricultural and livestock production. Local governments and communities need easily obtainable tools to aid their decision making process in managing risks associated with drought. Methods To inform decision-making at the level of municipalities, we investigated factors contributing to the health risks of drought. We used education and poverty indicators to measure vulnerability, number of drought damage evaluations and historical drought occurrences as indicators of hazard, and access to water as an indicator of exposure, to derive a drought disaster risk index. Results Indicators such as access to piped water, illiteracy and poverty show marked differences in most states and, in nearly all states, the living conditions of communities in the semiarid region are worse than in the rest of each state. There are municipalities at high drought disaster risk in every state and there are a larger number of municipalities at higher risks from the center to the north of the semiarid region. Conclusions Understanding local hazards, exposures and vulnerabilities provides the means to understand local communities' risks and develop interventions to reduce them. In addition, communities in these regions need to be empowered to add their traditional knowledge to scientific tools, and to identify the actions most relevant to their needs and realities.	[Sena, Aderita; Barcellos, Christovam] Oswaldo Cruz Fdn Fiocruz, Inst Sci & Technol Commun & Informat Hlth ICICT, Rio De Janeiro, Brazil; [Ebi, Kristie L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Freitas, Carlos] Oswaldo Cruz Fdn Fiocruz, Natl Sch Publ Hlth ENSP, Rio De Janeiro, Brazil; [Corvalan, Carlos] Univ Canberra, Fac Hlth, Canberra, ACT, Australia	Fundacao Oswaldo Cruz; University of Washington; University of Washington Seattle; Fundacao Oswaldo Cruz; University of Canberra	Sena, A (corresponding author), Oswaldo Cruz Fdn Fiocruz, Inst Sci & Technol Commun & Informat Hlth ICICT, Rio De Janeiro, Brazil.	aderitasena@gmail.com	Barcellos, Christovam/G-6856-2012; Barcellos, Christovam/GQA-5106-2022	Barcellos, Christovam/0000-0002-1161-2753; Barcellos, Christovam/0000-0002-1161-2753				Almeida L, 2016, P ISCRAM 2016 C RIO; Alpino TA, 2016, CIENC SAUDE COLETIVA, V21, P809, DOI 10.1590/1413-81232015213.21392015; [Anonymous], 2015, ATLAS VULNERABILIDAD; Balbus JM, 2009, J OCCUP ENVIRON MED, V51, P33, DOI 10.1097/JOM.0b013e318193e12e; Barata M, 2015, ESTUDO VULNERABILIDA; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Brasil. Ministerio da Integracao Nacional-MIN. Secretaria de Desenvolvimento Regional, 2005, NOV DEL SEM BRAS; Cardona OD, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P65; Costa D, 2016, MODELAGEM CLIMATICA; Noronha MGRDES, 2009, CIENC SAUDE COLETIVA, V14, P497, DOI 10.1590/S1413-81232009000200018; de Freitas CM, 2012, CIENC SAUDE COLETIVA, V17, P1577, DOI 10.1590/S1413-81232012000600021; De Loyola Hummell BM, 2013, SOCIAL VULNERABILITY; de Mello Rezende G.B., 2016, OPEN J SOC SCI, V4, P32, DOI [10.4236/jss.2016.412004, DOI 10.4236/JSS.2016.412004]; Debortoli N, 2016, MODELAGEM CLIMATICA; Dekker S., 2008, LUND U SCH AVIATION, V1, P1; der Vorm JV, 2011, P 4 RES ENG S, P263; Ebi KL, 2016, WEATHER CLIM EXTREME, V11, P95, DOI 10.1016/j.wace.2015.10.001; Ebi KL, 2011, INT J ENV RES PUB HE, V8, P4582, DOI 10.3390/ijerph8124582; Field C.B., 2012, MANAGING RISKS EXTRE; Fischer AP, 2013, J FOREST, V111, P357, DOI 10.5849/jof.12-091; Freitas CM, 2015, DESASTRES NATURAIS S; Grigoletto JC, 2016, CIENC SAUDE COLETIVA, V21, P709, DOI 10.1590/1413-81232015213.26212015; Guimarães Sullyandro Oliveira, 2016, Rev. bras. meteorol., V31, P337, DOI 10.1590/0102-778631320150150; Hales S., 2003, CLIMATE CHANGE HUMAN; Handmer J, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P231; Hess JJ, 2012, ENVIRON HEALTH PERSP, V120, P171, DOI 10.1289/ehp.1103515; Hollnagel E., 2009, RESILIENCE ENG PERSP, V2, P117; Hollnagel E., 2011, RESILIENCE ENG PRACT, pxxix; Hollnagel E, 2011, P 4 RES ENG S JUN 8; Hummell BMD, 2016, INT J DISAST RISK SC, V7, P111, DOI 10.1007/s13753-016-0090-9; IBGE-Instituto Brasileiro de Geografia e Estatistica, 2010, ATL CENS DEM 2010; INSA I.B.G.E., 2014, SIST GEST INF CONH S; IPCC, 2007, CONTRIBUTION WORKING; Junior B, 2016, SHAPEFILES DO BRASIL; Kasperson RE, 2005, MILLENIUM ECOSYSTEM, P143; Kjellstrom T, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20816; Lavell A, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P25; Lima R. C. C., 2011, DESERTIFICACAO MUDAN; Machado MSM, 2013, PRODUCAO FOCO, V3, P120; Oviedo RAM, 2015, INTERFACE-BOTUCATU, V19, P237, DOI 10.1590/1807-57622014.0436; Marengo JA, 2008, MUDANCA CLIMA BRASIL, P149; Marengo JA, 2015, CLIMATIC CHANGE, V129, P103, DOI 10.1007/s10584-014-1310-1; Milioli G, 2007, DESENVOLV MEIO AMBIE, P75; MIN, 2016, SIST INT INF DES S2I; Minayo GC, 2006, REV GEST INTEGRADA S, V1; Munoz Sanchez AI, 2007, CIENC SAUDE COLETIVA, V12, P319, DOI 10.1590/S1413-81232007000200007; NDMC, 2016, TYP OF DROUGHT; Obermaier Martin, 2013, Estud. av., V27, P155, DOI 10.1590/S0103-40142013000200011; Oppenheimer M, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1039; Oviatt K., 2010, SOCIAL VULNERABILITY; PAHO, 2008, CLIM CHANG HUM HLTH; Patz J., 2012, OUR PLANET OUR HLTH; Paz AA, 2006, ACTA PAUL ENFERM; PBMC. Surnario Executivo, 2013, SUM EX CONTR GRUP TR; Pecillo M, 2016, INT J OCCUP SAF ERGO, V22, P291, DOI 10.1080/10803548.2015.1126142; Penna NA, 2014, DESIGUALDADES SOCIOE; Phillips B, 2010, SOCIAL VULNERABILITY; Rodrigues L, 2011, INDICADORES VULNERAB; Santana MO, 2007, ATLAS AREAS SUSCEPTI; Scandlyn J., 2010, SOCIAL VULNERABILITY, P27; Sena A, 2015, ATUACAO SETOR SAUDE; Sena A, 2016, CIENC SAUDE COLETIVA, V21, P671, DOI 10.1590/1413-81232015213.21642015; Sena A, 2014, INT J ENV RES PUB HE, V11, P10737, DOI 10.3390/ijerph111010737; Seneviratne S. I., 2012, MANAGING RISKS EXTRE, V109, P230, DOI DOI 10.1017/CB09781139177245.006; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Stanke C, 2013, PLOS CURR DISASTERS; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; UN-United Nations, 2015, SEND FRAM DIS RISK R; UNISDR, 2009, DROUGHT RISK RED FRA, P198; UNISDR, 2015, GLOB ASS REP DIS RIS; UNISDR (United Nations Office for Disaster Risk Reduction), 2009, TERM DIS RISK RED; Wilhite DA, 2014, WEATHER CLIM EXTREME, V3, P4, DOI 10.1016/j.wace.2014.01.002; World Health Organization, 2015, OP FRAM BUILD CLIM R; Yusa A, 2015, INT J ENV RES PUB HE, V12, P8359, DOI 10.3390/ijerph120708359	75	15	15	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181394	10.1371/journal.pone.0181394	http://dx.doi.org/10.1371/journal.pone.0181394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742848	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000028
J	Seo, K; Kim, JK; Oh, DH; Ryu, H; Choi, H				Seo, Kyoungwon; Kim, Jae-kwan; Oh, Dong Hoon; Ryu, Hokyoung; Choi, Hojin			Virtual daily living test to screen for mild cognitive impairment using kinematic movement analysis	PLOS ONE			English	Article							INSTRUMENTAL ACTIVITIES; ALZHEIMERS-DISEASE; OLDER-ADULTS; DAILY-LIFE; REALITY; DEMENTIA; OUTCOMES; TOOL	Questionnaires or computer-based tests for assessing activities of daily living are well-known approaches to screen for mild cognitive impairment (MCI). However, questionnaires are subjective and computerized tests only collect simple performance data with conventional input devices such as a mouse and keyboard. This study explored the validity and discriminative power of a virtual daily living test as a new diagnostic approach to assess MCI. Twenty-two healthy controls and 20 patients with MCI were recruited. The virtual daily living test presents two complex daily living tasks in an immersive virtual reality environment. The tasks were conducted based on subject body movements and detailed behavioral data (i.e., kinematic measures) were collected. Performance in both the proposed virtual daily living test and conventional neuropsychological tests for patients with MCI was compared to healthy controls. Kinematic measures considered in this study, such as body movement trajectory, time to completion, and speed, classified patients with MCI from healthy controls, F(8, 33) = 5.648, p < 0.001, eta(2) = 0.578. When both hand and head speed were employed in conjunction with the immediate free-recall test, a conventional neuropsychological test, the discrimination power for screening MCI was significantly improved to 90% sensitivity and 95.5% specificity (cf. the immediate free-recall test alone has 80% sensitivity and 77.3% specificity). Inclusion of the kinematic measures in screening for MCI significantly improved the classification of patients with MCI compared to the healthy control group, Wilks' Lambda = 0.451, p < 0.001.	[Seo, Kyoungwon] Hanyang Univ, Dept Ind Engn, Seoul, South Korea; [Kim, Jae-kwan; Ryu, Hokyoung] Hanyang Univ, Dept Arts & Technol, Seoul, South Korea; [Oh, Dong Hoon] Hanyang Univ, Inst Hlth & Soc, Seoul, South Korea; [Oh, Dong Hoon] Seulha Mental Hlth Clin, Jeju, South Korea; [Choi, Hojin] Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University	Ryu, H (corresponding author), Hanyang Univ, Dept Arts & Technol, Seoul, South Korea.; Choi, H (corresponding author), Hanyang Univ, Coll Med, Dept Neurol, Seoul, South Korea.	hryu@hanyang.ac.kr; chj@hanyang.ac.kr	Seo, Kyoungwon/GLN-5886-2022	Seo, Kyoungwon/0000-0003-3435-0685	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1D1A1B03931389]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1D1A1B03931389). Hokyoung Ryu (corresponding author) obtained this funding, supervised the study, and completed conclusion/discussions. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Allain P, 2014, J INT NEUROPSYCH SOC, V20, P468, DOI 10.1017/S1355617714000344; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; Frasson P, 2011, NEUROL SCI, V32, P1057, DOI 10.1007/s10072-011-0607-3; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Graf Carla, 2009, Medsurg Nurs, V18, P315; Han Ji Won, 2010, [Journal of Korean Geriatric Psychiatry, 노인정신의학], V14, P27; Hesseberg K, 2013, DEMENT GERIATR COGN, V36, P146, DOI 10.1159/000351010; Jekel K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0099-0; Kee BS, 1996, J KOREAN NEUROPSYCHI, V35, P298; Klinger E, 2013, IRBM, V34, P113, DOI 10.1016/j.irbm.2013.01.005; Kubicki A, 2016, FRONT AGING NEUROSCI, P8; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; Montero-Odasso M, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-35; Muller S, 2017, J MOTOR BEHAV, P1; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peres K, 2006, NEUROLOGY, V67, P461, DOI 10.1212/01.wnl.0000228228.70065.f1; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Price M, 2011, J ANXIETY DISORD, V25, P763, DOI 10.1016/j.janxdis.2011.03.004; Pusswald G, 2015, J ALZHEIMERS DIS, V47, P479, DOI 10.3233/JAD-150284; Reppermund S, 2013, PSYCHOL MED, V43, P2437, DOI 10.1017/S003329171200308X; Riener R, 2012, VIRTUAL REALITY MED, P161; Roberts RO, 2014, NEUROLOGY, V82, P317, DOI 10.1212/WNL.0000000000000055; Scherder E, 2008, GERONTOLOGY, V54, P333, DOI 10.1159/000168203; Schrader C, 2012, COMPUT HUM BEHAV, V28, P648, DOI 10.1016/j.chb.2011.11.011; Schroter A, 2003, DEMENT GERIATR COGN, V15, P132, DOI 10.1159/000068484; Shulman LM, 2006, MOVEMENT DISORD, V21, P794, DOI 10.1002/mds.20803; Suchy Y, 2011, J CLIN EXP NEUROPSYC, V33, P92, DOI 10.1080/13803395.2010.493148; Tsang MMY, 2013, SCHIZOPHR RES, V144, P51, DOI 10.1016/j.schres.2012.12.024; Won CW, 2002, J KOREAN GERIATR SOC, V6, P107, DOI DOI 10.1037/T06803-000]	33	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181883	10.1371/journal.pone.0181883	http://dx.doi.org/10.1371/journal.pone.0181883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28738088	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700085
J	Shim, EJ; Lee, KM; Kim, EJ; Kim, HG; Jang, JH				Shim, Eun Jung; Lee, Kyung Mi; Kim, Eui Jong; Kim, Hyug-Gi; Jang, Ji Hye			CT pattern analysis of necrotizing and nonnecrotizing lymph nodes in Kikuchi disease	PLOS ONE			English	Article							TUBERCULOUS LYMPHADENITIS; CERVICAL LYMPHADENOPATHY; FUJIMOTO-DISEASE	Objective The purpose of this study was to determine whether a CT interpretation with imaging pattern analysis differentiates Kikuchi disease (KD) from the two more frequently encountered differential lymph nodes diagnoses of tuberculous lymphadenopathy (TL) and reactive hyperplasia (RH). Materials and methods Between January 2012 and July 2015, 20 patients with KD (6 men, 14 women; mean age, 27.80 years), 36 patients with RH (10 men, 26 women; mean age, 33.08 years) and 34 patients with TL (17 men, 17 women; mean age, 39.82 years) were pathologically diagnosed using US-guided fine needle aspiration biopsy, core needle biopsy, or surgical excisional biopsy. We recorded the total number, location, and size of the affected cervical lymph nodes, and two radiologists reviewed the characteristic imaging findings, including the presence of necrosis, cortical enhancement pattern, perinodal infiltration, conglomeration and nodal calcification, to form a consensus. In addition, we compared two attenuation indices on the nonnecrotic portion of the affected lymph nodes, nodal cortical attenuation (NCA) and the ratio of NCA to the adjacent muscle (NCA/M). Results Conglomeration, enhancement pattern and NCA/M values were independent predictive CT features to distinguish KD from RH. Age and enhancement pattern discriminated KD from TL. Only the mean NCA/M value was a statistically significant CT feature (p = .008) in differentiating KD from both RH+TL. The mean NCA/M of KD (1.67 +/- 0.20) was significantly higher than that of RH (1.49 +/- 0.20) or TL (1.47 +/- 0.21). Conclusion Our results indicate that in case of nonnecrotic lymphadenopathy, a higher NCA/M index can differentiate KD from RH and TL. In addition, the enhancement pattern according to the degree of necrosis discriminated between KD and TL in the case of necrotic lymphadenopathy.	[Shim, Eun Jung; Lee, Kyung Mi; Kim, Eui Jong; Kim, Hyug-Gi] Kyung Hee Univ, Coll Med, Dept Radiol, Kyung Hee Univ Hosp, 26 Kyunghee Daero, Seoul, South Korea; [Jang, Ji Hye] Korea Canc Ctr Hosp, Dept Radiol, 75 Nowon Ro, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital; National Cancer Center - Korea (NCC)	Lee, KM (corresponding author), Kyung Hee Univ, Coll Med, Dept Radiol, Kyung Hee Univ Hosp, 26 Kyunghee Daero, Seoul, South Korea.	lolabunny0111@hanmail.net		Lee, Kyung Mi/0000-0003-3424-0208	Ministry of Education of the Republic of Korea [NRF-2016R1D1A1B03933173]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea)	This work was supported by Basic Science Research Program through the Ministry of Education of the Republic of Korea (NRF-2016R1D1A1B03933173).	Baek HJ, 2014, JPN J RADIOL, V32, P637, DOI 10.1007/s11604-014-0357-2; Bosch X, 2004, AM J CLIN PATHOL, V122, P141, DOI 10.1309/YF081L4TKYWVYVPQ; De Backer AI, 2007, EUR RADIOL, V17, P1111, DOI 10.1007/s00330-006-0412-1; Han KM, 2011, KOREAN J PATHOL, V45, P626, DOI 10.4132/KoreanJPathol.2011.45.6.626; Kato H, 2011, EUR J RADIOL, V80, pE576, DOI 10.1016/j.ejrad.2011.09.009; Kim HA, 2011, INDIAN J PEDIATR, V78, P616, DOI 10.1007/s12098-010-0289-5; KIM TA, 1995, CLIN IMAG, V19, P1, DOI 10.1016/0899-7071(94)00032-8; Kwon SY, 2004, AM J NEURORADIOL, V25, P1099; Lee KH, 2014, J ULTRAS MED, V33, P2201, DOI 10.7863/ultra.33.12.2201; Lee S, 2012, AM J NEURORADIOL, V33, P135, DOI 10.3174/ajnr.A2724; LEE Y, 1994, J COMPUT ASSIST TOMO, V18, P370, DOI 10.1097/00004728-199405000-00006; Moon WK, 1997, RADIOGRAPHICS, V17, P391, DOI 10.1148/radiographics.17.2.9084080; Na DG, 1997, AM J NEURORADIOL, V18, P1729; Ryoo I, 2015, KOREAN J RADIOL, V16, P767, DOI 10.3348/kjr.2015.16.4.767; Yoon YS, 2014, J KOREAN SOC RADIOLO, V71, P6	15	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181169	10.1371/journal.pone.0181169	http://dx.doi.org/10.1371/journal.pone.0181169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742156	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700030
J	Bhangu, J; King-Kallimanis, BL; Donoghue, OA; Carroll, L; Kenny, RA				Bhangu, Jaspreet; King-Kallimanis, Bellinda L.; Donoghue, Orna A.; Carroll, Laura; Kenny, Rose Anne			Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; DEPRESSIVE SYMPTOMS; RISK-FACTORS; PREVALENCE; MANAGEMENT; DIAGNOSIS; ACCIDENT	Objectives To calculate the prevalence of all falls, non-accidental falls and syncope in an older population and characterize cardiovascular risk profiles. Design Prospective, longitudinal cohort study. Setting The first two waves of data from the Irish Longitudinal Study on Ageing (TILDA). Participants 8172 community-dwelling adults aged 50 years and older resident in the Republic of Ireland Measurements Self-reported history of all falls, non-accidental falls and syncope in the year preceding the first two waves of data collection. Demographic factors and self-reported cardiovascular conditions were used to characterize cardiovascular risk profiles. Results The prevalence of all falls in the past year was 19.2% or 192 per thousand persons and increased with age (50 - 64 years 17.5%; 65 - 74 years 19.4%; 75+ years 24.4%). Non-accidental falls had an estimated prevalence of 5.1% or 51 falls per thousand persons and accounted for 26.5% of all falls reported and also increased with age (50 - 64 years 4.0%; 65 - 74 years 5.5%; 75+ years 8.0%). The prevalence for syncope was estimated to be 4.4% or 44per thousand persons but did not show a similar age gradient. Participants with at least 5 cardiovascular conditions were more likely to report all falls (OR = 2.07, 95% CI 1.18 - 3.64, p< 0.05) and NAF (OR = 2.89, 95% CI 1.28 - 6.52, p< 0.05). Conclusions The prevalence of all falls and non-accidental falls increases with age but the same pattern was not consistently observed for syncope. There is an increased odds of reporting all three outcomes with increasing number of self-reported cardiovascular conditions. Further work is needed to uncover the interplay between cardiovascular disease and subsequent falls.	[Bhangu, Jaspreet; King-Kallimanis, Bellinda L.; Donoghue, Orna A.; Carroll, Laura; Kenny, Rose Anne] Trinity Coll Dublin, Irish Longitudinal Study Ageing, Dublin, Ireland	Trinity College Dublin	Bhangu, J (corresponding author), Trinity Coll Dublin, Irish Longitudinal Study Ageing, Dublin, Ireland.	jbhangu@tcd.ie	Bhangu, Jaspreet/GRF-1191-2022	Donoghue, Orna/0000-0002-2091-3478; Kenny, Rose Anne/0000-0002-9336-8124	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health; Irish Life	Atlantic Philanthropies; Irish Government; Health Research Board; Department of Health; Irish Life	Funding for TILDA was gratefully received from the Atlantic Philanthropies (www.atlantiphilanthropes.org), the Irish Government, and the Health Research Board (www.hrb.ie). TILDA was funded by the Department of Health and Atlantic Philanthropies, along with support from Irish Life in the form of a charitable gift. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboni P, 2015, J CARDIOVASC MED, V16, P82, DOI 10.2459/JCM.0000000000000076; [Anonymous], 2014, OLD AD FALLS FALLS O; Anpalahan M, 2012, EUR J INTERN MED, V23, pE48, DOI 10.1016/j.ejim.2011.10.010; Bhangu J, 2016, HEART; Bhangu JS, 2014, AGE AGEING; CAMPBELL A J, 1981, Age and Ageing, V10, P264, DOI 10.1093/ageing/10.4.264; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Chen Lin Y, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2006.01.029; Clark DO, 2005, J AM GERIATR SOC, V53, P1582, DOI 10.1111/j.1532-5415.2005.53485.x; Cronin H, 2010, CLIN GERIATR MED, V26, P539, DOI 10.1016/j.cger.2010.07.006; Davies AJ, 1996, AGE AGEING, V25, P362, DOI 10.1093/ageing/25.5.362; Downton J H, 1991, Aging (Milano), V3, P219; Finucane C, 2017, J AM GERIATR SOC, V65, P474, DOI 10.1111/jgs.14563; Health NIoP, 2016, METH WCCFDS; Jansen S, 2015, J AM MED DIR ASS; Jansen S, 2014, AGE AGEING; Jansen S, 2015, AGE AGEING, V44, P598, DOI 10.1093/ageing/afv017; Kearney PM, 2011, INT J EPIDEMIOL, V40, P877, DOI 10.1093/ije/dyr116; Kenny RAM, 2001, J AM COLL CARDIOL, V38, P1491, DOI 10.1016/S0735-1097(01)01537-6; Kenny RA, 2015, EUROPACE, V17, P1325, DOI 10.1093/europace/euv115; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Menant JC, 2016, J AM GERIATR SOC, V64, P1073, DOI 10.1111/jgs.14104; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Parry SW, 2008, CLIN MED, V8, P157, DOI 10.7861/clinmedicine.8-2-157; Probst MA, 2015, AM J EMERG MED, V33, P998, DOI 10.1016/j.ajem.2015.04.030; Prudham D, 1981, Age Ageing, V10, P141; Rafanelli M, 2014, AGING CLIN EXP RES, V26, P33, DOI 10.1007/s40520-013-0124-8; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Richardson DA, 1997, PACE, V20, P820, DOI 10.1111/j.1540-8159.1997.tb03912.x; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Shaw FE, 1997, POSTGRAD MED J, V73, P635, DOI 10.1136/pgmj.73.864.635; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Whelan BJ, 2013, J AM GERIATR SOC, V61, pS265, DOI 10.1111/jgs.12199	35	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180997	10.1371/journal.pone.0180997	http://dx.doi.org/10.1371/journal.pone.0180997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732008	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100020
J	Chang, JH; Hsu, SC; Bai, KJ; Huang, SK; Hsu, CW				Chang, Jer-Hwa; Hsu, Shih-Chang; Bai, Kuan-Jen; Huang, Shau-Ku; Hsu, Chin-Wang			Association of time-serial changes in ambient particulate matters (PMs) with respiratory emergency cases in Taipei's Wenshan District	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OUTDOOR AIR-POLLUTION; HOSPITAL ADMISSIONS; DAILY MORTALITY; CASE-CROSSOVER; PM2.5; EXPOSURE; PARTICLES; ASTHMA; PHAGOCYTOSIS	Ambient air pollution poses a significant risk for a group of common and often debilitating respiratory diseases, but its direct impact on cause-specific respiratory diseases using emergency room visit (ERV) as an indicator remains to be fully explored. In this study, we conducted a time-series study of ambient PM2.5, NO2, SO2 and their association with ERV for asthma, COPD and pneumonia in a four-year time span. Relative risks for ERV as per log increase in the level of ambient pollutants with time lags of up to 10 days were calculated, using a generalized additive model of Poisson regression. Daily 24-h average concentrations of PM2.5 and pollutant gases were obtained from a local Gutting air quality monitoring station. Results showed that the ERVs for pneumonia and asthma were associated with the level of PM2.5. The effects of PM2.5 on the risk of ERV for asthma were found to be significant at lag days 1 and 2 with increasing risk of 4.34% [RR: 1.091; CI: 1.020-1.166 (95%)] and 3.58% [RR: 1.074; CI: 1.007-1.146 (95%)], respectively. The ERV for pneumonia was associated with the level of PM2.5 at lag days 5, 6 and 7, with increasing risk of 1.92% [RR: 1.039; CI: 1.009-1.070 (95%)], 2.03% [RR: 1.041; CI: 1.009-1.075 (95%)], and 1.82% [RR: 1.037; CI: 1.001-1.075 (95%)], respectively. Further, PM2.5, but not NO2 and SO2, posed a significant risk of ERV for asthma during spring at lag days 0, 1 and 2 (17.12%, RR: 1.408, CI: 1.075-1.238; 15.30%, RR: 1.358 CI: 1.158-1.166; 11.94%, RR: 1.165, CI: 1.004-1.121), which was particularly evident for those who were younger than 75 years of age. In contrast, only PM2.5 was a significant risk of ERV for COPD, which was primarily for those who were younger than 75 years of age during summer season at lag days 3, 4 and 5. (26.66%, RR: 1.704, CI: 1.104-2.632; 26.99%; RR: 1.716, CI: 1.151-2.557; 24.09%; RR: 1.619, CI: 1.111-2.360). Collectively, these results suggested significant seasonal variation and differential time lag effects of PM2.5 on ERV for asthma, COPD and pneumonia.	[Chang, Jer-Hwa; Bai, Kuan-Jen] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Chang, Jer-Hwa; Bai, Kuan-Jen] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei, Taiwan; [Hsu, Shih-Chang; Hsu, Chin-Wang] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Dept Emergency & Crit Med, Taipei, Taiwan; [Huang, Shau-Ku] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Zhunan, Miaoli County, Taiwan; [Huang, Shau-Ku] Shen Zhen Univ, Lou Hu Hosp, Shenzhen, Peoples R China; [Huang, Shau-Ku] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan; [Huang, Shau-Ku] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Hsu, Chin-Wang] Taipei Med Univ, Sch Med, Dept Emergency Med, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Health Research Institutes - Taiwan; Shenzhen University; Kaohsiung Medical University; Johns Hopkins University; Johns Hopkins Medicine; Taipei Medical University	Hsu, CW (corresponding author), Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Dept Emergency & Crit Med, Taipei, Taiwan.; Hsu, CW (corresponding author), Taipei Med Univ, Sch Med, Dept Emergency Med, Coll Med, Taipei, Taiwan.	wan11119@gmail.com	Hsu, Shih-Chang/I-4277-2012	Hsu, Shih-Chang/0000-0003-1010-1182	Taipei Medical University, Taiwan [105-wf-eva-13]; Kaohsiung Medical University The Talent Plan [KMU-SH000184]; National Health Research Institutes, Taiwan [EOPP10-014, EOSP07-014]	Taipei Medical University, Taiwan; Kaohsiung Medical University The Talent Plan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the Taipei Medical University [grant number: 105-wf-eva-13 to CWH], Taiwan and, in part, by Kaohsiung Medical University The Talent Plan (KMU-SH000184 to SKH), and by grants from National Health Research Institutes (EOPP10-014 and EOSP07-014 to SKH), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Taipei Medical University [grant number: 105-wf-eva-13 to CWH], Taiwan and, in part, by Kaohsiung Medical University The Talent Plan (KMU-SH000184 to SKH), and by grants from National Health Research Institutes (EOPP10-014 and EOSP07-014 to SKH), Taiwan.	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; [Anonymous], 2006, Lancet, V368, P1302; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Bates JT, 2015, ENVIRON SCI TECHNOL, V49, P13605, DOI 10.1021/acs.est.5b02967; Cheng MH, 2014, J TOXICOL ENV HEAL A, V77, P1075, DOI 10.1080/15287394.2014.922387; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Devos S, 2016, ENVIRON INT, V94, P525, DOI 10.1016/j.envint.2016.06.012; Falcon-Rodriguez CI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00003; Gasparrini A., 2014, DISTRIBUTED LAG LINE, P1; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Heo J, 2014, EPIDEMIOLOGY, V25, P379, DOI 10.1097/EDE.0000000000000044; Huang SK, 2015, J THORAC DIS, V7, P23, DOI 10.3978/j.issn.2072-1439.2014.12.13; Hwang SL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040366; Janssen NAH, 2013, SCI TOTAL ENVIRON, V463, P20, DOI 10.1016/j.scitotenv.2013.05.062; Lee CL, 2016, J HAZARD MATER, V314, P286, DOI 10.1016/j.jhazmat.2016.04.047; Li P, 2015, ENVIRON SCI POLLUT R, V22, P358, DOI 10.1007/s11356-014-3301-1; Lundborg M, 2006, ENVIRON RES, V100, P197, DOI 10.1016/j.envres.2005.08.007; Meng ZQ, 2006, ENVIRON TOXICOL PHAR, V22, P277, DOI 10.1016/j.etap.2006.04.005; Meszaros D, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2014-000063; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Nakhle MM, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4409-6; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Riva DR, 2011, INHAL TOXICOL, V23, P257, DOI 10.3109/08958378.2011.566290; Roy AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085011; Song QK, 2014, INT J ENV RES PUB HE, V11, P11822, DOI 10.3390/ijerph111111822; Tsai SS, 2014, J TOXICOL ENV HEAL A, V77, P192, DOI 10.1080/15287394.2013.853337; Tsai SS, 2013, INT J ENV RES PUB HE, V10, P6015, DOI 10.3390/ijerph10116015; Tunno BJ, 2016, SCI TOTAL ENVIRON, V573, P27, DOI 10.1016/j.scitotenv.2016.08.011; Vrijens K, 2015, ENVIRON HEALTH PERSP, V123, P399, DOI 10.1289/ehp.1408459; Winquist A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-68; World Health Organization, 2013, REV EV HLTH ASP AIR, P309; Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zhang SQ, 2016, ENVIRON RES, V148, P15, DOI 10.1016/j.envres.2016.03.008; Zhou HW, 2007, AM J RESP CELL MOL, V36, P460, DOI 10.1165/rcmb.2006-0293OC	35	14	15	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181106	10.1371/journal.pone.0181106	http://dx.doi.org/10.1371/journal.pone.0181106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732014	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100022
J	Gillinder, KR; Tuckey, H; Bell, CC; Magor, GW; Huang, S; Ilsley, MD; Perkins, AC				Gillinder, Kevin R.; Tuckey, Hugh; Bell, Charles C.; Magor, Graham W.; Huang, Stephen; Ilsley, Melissa D.; Perkins, Andrew C.			Direct targets of pSTAT5 signalling in erythropoiesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; BCL-X GENE; CHIP-SEQ; ERYTHROID-CELLS; MYELOPROLIFERATIVE DISORDERS; DNA-BINDING; STAT5; RECEPTOR; ACTIVATION; JAK2	Erythropoietin (EPO) acts through the dimeric erythropoietin receptor to stimulate proliferation, survival, differentiation and enucleation of erythroid progenitor cells. We undertook two complimentary approaches to find EPO-dependent pSTAT5 target genes in murine erythroid cells: RNA-seq of newly transcribed (4sU-labelled) RNA, and ChIP-seq for pSTAT5 30 minutes after EPO stimulation. We found 302 pSTAT5-occupied sites: similar to 15% of these reside in promoters while the rest reside within intronic enhancers or intergenic regions, some >100kb from the nearest TSS. The majority of pSTAT5 peaks contain a central palindromic GAS element, TTCYXRGAA. There was significant enrichment for GATA motifs and CACCC-box motifs within the neighbourhood of pSTAT5-bound peaks, and GATA1 and/or KLF1 co-occupancy at many sites. Using 4sU-RNA-seq we determined the EPO-induced transcriptome and validated differentially expressed genes using dynamic CAGE data and qRT-PCR. We identified known direct pSTAT5 target genes such as Bcl2l1, Pim1 and Cish, and many new targets likely to be involved in driving erythroid cell differentiation including those involved in mRNA splicing (Rbm25), epigenetic regulation (Suv420h2), and EpoR turnover (Clint1/EpsinR). Some of these new EpoR-JAK2-pSTAT5 target genes could be used as biomarkers for monitoring disease activity in polycythaemia vera, and for monitoring responses to JAK inhibitors.	[Gillinder, Kevin R.; Tuckey, Hugh; Bell, Charles C.; Magor, Graham W.; Huang, Stephen; Ilsley, Melissa D.; Perkins, Andrew C.] Univ Queensland, Translat Res Inst, Mater Res Inst, Canc Genom Grp, Brisbane, Qld, Australia; [Tuckey, Hugh; Huang, Stephen; Ilsley, Melissa D.; Perkins, Andrew C.] Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld, Australia; [Perkins, Andrew C.] Princess Alexandra Hosp, Brisbane, Qld, Australia	Mater Research; University of Queensland; University of Queensland	Perkins, AC (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Canc Genom Grp, Brisbane, Qld, Australia.; Perkins, AC (corresponding author), Univ Queensland, Fac Med & Biomed Sci, Brisbane, Qld, Australia.; Perkins, AC (corresponding author), Princess Alexandra Hosp, Brisbane, Qld, Australia.	andrew.perkins@mater.uq.edu.au	Huang, Stephen/M-6356-2016; Perkins, Andrew/X-4180-2019; Perkins, Andrew/AAJ-9696-2020; Ilsley, Melissa D/M-6370-2016; Gillinder, Kevin/I-6224-2013	Huang, Stephen/0000-0002-1127-8898; Perkins, Andrew/0000-0003-3644-7093; Ilsley, Melissa D/0000-0001-9751-2309; Bell, Charles/0000-0003-2194-8311; Gillinder, Kevin/0000-0002-1221-9718	Mater Research	Mater Research	The work was supported by core grant funding to A.C.P. from Mater Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brooks AJ, 2015, CELL CYCLE, V14, P285, DOI 10.1080/15384101.2015.1006533; Coghill E, 2001, BLOOD, V97, P1861, DOI 10.1182/blood.V97.6.1861; DeVilbiss AW, 2015, MOL CELL BIOL, V35, P2073, DOI 10.1128/MCB.01422-14; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Fujio Y, 1997, J CLIN INVEST, V99, P2898, DOI 10.1172/JCI119484; Gillinder KR, 2017, NUCLEIC ACIDS RES, V45, P1130, DOI 10.1093/nar/gkw1014; Hay D, 2016, NAT GENET; Hirst J, 2015, MOL BIOL CELL, V26, P3085, DOI 10.1091/mbc.E15-04-0245; Huddleston H, 2003, BLOOD, V102, P142, DOI 10.1182/blood-2002-10-3245; Ingley E, 2012, IUBMB LIFE, V64, P402, DOI 10.1002/iub.1024; Jain D, 2015, GENOM DATA, V4, P1, DOI 10.1016/j.gdata.2015.01.008; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kazi JU, 2014, SOCS PROTEINS REGULA; Kershaw NJ, 2013, BIOCHEM SOC T, V41, P1042, DOI 10.1042/BST20130077; Ketteler R, 2003, J BIOL CHEM, V278, P2654, DOI 10.1074/jbc.M211236200; Kieran MW, 1996, P NATL ACAD SCI USA, V93, P9126, DOI 10.1073/pnas.93.17.9126; Kim AR, 2017, CELL, V168, P1053, DOI 10.1016/j.cell.2017.02.026; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lerdrup M, 2016, NAT STRUCT MOL BIOL, V23, P349, DOI 10.1038/nsmb.3180; Liang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005526; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Magor GW, 2015, BLOOD, V125, P2405, DOI 10.1182/blood-2014-08-590968; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McMullin MF, 2016, INT J LAB HEMATOL, V38, P59, DOI 10.1111/ijlh.12506; Menon MP, 2006, J CLIN INVEST, V116, P683, DOI 10.1172/JCI25227; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Park HJ, 2016, EMBO J, V35, P580, DOI 10.15252/embj.201592383; Sarna MK, 2003, ONCOGENE, V22, P3221, DOI 10.1038/sj.onc.1206381; Sathyanarayana BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160339; Sathyanarayana P, 2008, BLOOD, V111, P5390, DOI 10.1182/blood-2007-10-119743; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Singh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038530; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Tallack MR, 2012, GENOME RES, V22, P2385, DOI 10.1101/gr.135707.111; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Wei YJ, 2016, NUCLEIC ACIDS RES, V44, pD172, DOI 10.1093/nar/gkv1243; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wierenga ATJ, 2010, BLOOD, V115, P4367, DOI 10.1182/blood-2009-10-250894; Wu AML, 2014, AM J PHYSIOL-ENDOC M, V307, pE596, DOI 10.1152/ajpendo.00323.2014; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu WS, 2011, GENOME RES, V21, P1659, DOI 10.1101/gr.125088.111; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	62	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180922	10.1371/journal.pone.0180922	http://dx.doi.org/10.1371/journal.pone.0180922			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732065	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100015
J	Ouertatani-Sakouhi, H; Kicka, S; Chiriano, G; Harrison, CF; Hilbi, H; Scapozza, L; Soldati, T; Cosson, P				Ouertatani-Sakouhi, Hajer; Kicka, Sebastien; Chiriano, Gianpaolo; Harrison, Christopher F.; Hilbi, Hubert; Scapozza, Leonardo; Soldati, Thierry; Cosson, Pierre			Inhibitors of Mycobacterium marinum virulence identified in a Dictyostelium discoideum host model	PLOS ONE			English	Article							TUBERCULOSIS; INFECTION; SECRETION; PROTEIN; BIOSYNTHESIS; LEGIONELLA; RESISTANCE; BACTERIA; SYSTEM	Tuberculosis remains one of the major threats to public health worldwide. Given the prevalence of multi drug resistance (MDR) in Mycobacterium tuberculosis strains, there is a strong need to develop new anti-mycobacterial drugs with modes of action distinct from classical antibiotics. Inhibitors of mycobacterial virulence might target new molecular processes and may represent a potential new therapeutic alternative. In this study, we used a Dictyostelium discoideum host model to assess virulence of Mycobacterium marinum and to identify compounds inhibiting mycobacterial virulence. Among 9995 chemical compounds, we selected 12 inhibitors of mycobacterial virulence that do not inhibit mycobacterial growth in synthetic medium. Further analyses revealed that 8 of them perturbed functions requiring an intact mycobacterial cell wall such as sliding motility, bacterial aggregation or cell wall permeability. Chemical analogs of two compounds were analyzed. Chemical modifications altered concomitantly their effect on sliding motility and on mycobacterial virulence, suggesting that the alteration of the mycobacterial cell wall caused the loss of virulence. We characterized further one of the selected compounds and found that it inhibited the ability of mycobacteria to replicate in infected cells. Together these results identify new antimycobacterial compounds that represent new tools to unravel the molecular mechanisms controlling mycobacterial pathogenicity. The isolation of compounds with anti-virulence activity is the first step towards developing new antibacterial treatments.	[Ouertatani-Sakouhi, Hajer; Cosson, Pierre] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland; [Kicka, Sebastien; Soldati, Thierry] Univ Geneva, Dept Biochem, Geneva, Switzerland; [Chiriano, Gianpaolo; Scapozza, Leonardo] Univ Lausanne, Pharmaceut Biochem, Sch Pharmaceut Sci, Univ Geneva, 30 Quai Ernst Ansermet, Geneva, Switzerland; [Harrison, Christopher F.; Hilbi, Hubert] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Dept Med, Munich, Germany; [Hilbi, Hubert] Univ Zurich, Inst Med Microbiol, Dept Med, Gloriastr 30-32, Zurich, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Lausanne; University of Munich; University of Zurich	Cosson, P (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.	Pierre.Cosson@unige.ch	SOLDATI, Thierry/U-6494-2019; SOLDATI, Thierry/A-2902-2009; Hilbi, Hubert/AAU-5815-2020; Hill, Andrew/B-4527-2009	SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931; Hilbi, Hubert/0000-0002-5462-9301; Hill, Andrew/0000-0001-5581-2354; Scapozza, Leonardo/0000-0003-1079-648X; Cosson, Pierre/0000-0002-4881-0358	Swiss National Science Foundation Grant [CRSI33_130016]; Novartis Consumer Health Foundation; Swiss National Science Foundation Grant (SystemsX HostpathX grant)	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); Novartis Consumer Health Foundation; Swiss National Science Foundation Grant (SystemsX HostpathX grant)	This work was supported by the Swiss National Science Foundation Grant (Sinergia grant CRSI33_130016 to to PC, TS, LS, HH; SystemsX HostpathX grant to PC, TS, HH) and a grant from Novartis Consumer Health Foundation (to HOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2004, J BIOL CHEM, V279, P18824, DOI 10.1074/jbc.M400791200; Alibaud L, 2008, CELL MICROBIOL, V10, P729, DOI 10.1111/j.1462-5822.2007.01080.x; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Arafah Sonia, 2013, Methods Mol Biol, V983, P403, DOI 10.1007/978-1-62703-302-2_22; Benghezal M, 2006, CELL MICROBIOL, V8, P139, DOI 10.1111/j.1462-5822.2005.00607.x; Burguiere A, 2005, MICROBIOL-SGM, V151, P2087, DOI 10.1099/mic.0.27938-0; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; CLARK HF, 1963, J BACTERIOL, V86, P1057, DOI 10.1128/JB.86.5.1057-1069.1963; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Frasinyuk MS, 2014, BIOORG MED CHEM LETT, V24, P3546, DOI 10.1016/j.bmcl.2014.05.056; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Green KD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00208; Hagedorn M, 2007, CELL MICROBIOL, V9, P2716, DOI 10.1111/j.1462-5822.2007.00993.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hagele S, 2000, CELL MICROBIOL, V2, P165, DOI 10.1046/j.1462-5822.2000.00044.x; Harrison CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074813; Hoffmann C, 2014, CELL MICROBIOL, V16, P15, DOI 10.1111/cmi.12235; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Johnson BK, 2015, ANTIMICROB AGENTS CH, V59, P4436, DOI 10.1128/AAC.00719-15; Kicka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087834; Lienhardt C, 2012, J INFECT DIS, V205, pS241, DOI 10.1093/infdis/jis034; Lima WC, 2011, SEMIN CELL DEV BIOL, V22, P77, DOI 10.1016/j.semcdb.2010.11.006; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Martinez A, 1999, J BACTERIOL, V181, P7331; Mascarello A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077081; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Mori M, 2014, BIOORG MED CHEM LETT, V24, P2508, DOI 10.1016/j.bmcl.2014.04.004; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Rybniker J, 2014, CELL HOST MICROBE, V16, P538, DOI 10.1016/j.chom.2014.09.008; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wang QL, 2015, INFECT IMMUN, V83, P2844, DOI 10.1128/IAI.03081-14; Yu J, 2012, INFECT IMMUN, V80, P1381, DOI 10.1128/IAI.06370-11	37	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181121	10.1371/journal.pone.0181121	http://dx.doi.org/10.1371/journal.pone.0181121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727774	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500042
J	Lim, H; Yu, CY; Jou, TS				Lim, HooiCheng; Yu, Chun-Ying; Jou, Tzuu-Shuh			Galectin-8 regulates targeting of Gp135/podocalyxin and lumen formation at the apical surface of renal epithelial cells	FASEB JOURNAL			English	Article						apical sorting; cell polarity; lateral lumens	MAJOR SIALOPROTEIN; BASAL POLARITY; MDCK CELLS; PODOCALYXIN; TRAFFICKING; MEMBRANE; DOMAIN; IDENTIFICATION; POLARIZATION; ORIENTATION	Establishment of apical-basal polarity, through correct targeting of polarity determinants to distinct domains of the plasma membrane, is a fundamental process for the development of functioning epithelial tubules. Here we report that galectin (Gal)-8 regulates apical-basal polarity of Madin-Darby canine kidney (MDCK) cells via apical targeting of 135-kDa glycoprotein (Gp135). Gal-8 interacts with newly synthesized Gp135 in a glycandependent manner. Gal-8 knockdown induces aberrant lumens at the lateral domain and mistargeting of Gp135 to this structure, thus disrupting the kidney epithelial polarity of MDCK cells, which organize lumens at the apical surface. The O-glycosylation deletionmutant of Gp135 phenocopies the effect of Gal-8 knockdown, which suggests that Gal-8 is the decoding machinery for the apical sorting signals of Gp135 residing at its O-glycosylation-rich region. Collectively, our results reveal a new role of Gal-8 in the development of luminal organs by regulating targeting of apical polarity protein Gp135.-Lim, H., Yu, C.-Y., Jou, T.-S. Galectin-8 regulates targeting of Gp135/podocalyxin and lumen formation at the apical surface of renal epithelial cells.	[Lim, HooiCheng; Yu, Chun-Ying] Natl Taiwan Univ, Grad Inst Mol Med, Taipei, Taiwan; [Jou, Tzuu-Shuh] Natl Taiwan Univ, Grad Inst Clin Med, 7 Chung Shan S Rd, Taipei 10002, Taiwan; [Yu, Chun-Ying] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Jou, TS (corresponding author), Natl Taiwan Univ, Grad Inst Clin Med, 7 Chung Shan S Rd, Taipei 10002, Taiwan.	jouts@ntu.edu.tw	Yu, Chun-ying/AAE-8368-2020; yu, chun ying/ABB-3212-2020	Yu, Chun-ying/0000-0002-7320-7876; yu, chun ying/0000-0002-7320-7876; JOU, TZUU-SHUH/0000-0003-4341-5137	Taiwan Ministry of Science and Technology (MOST) [103-2320-B-002-049-MY3]; Taiwan MOST Postdoctoral Fellowship [104-2811-B-002-092, 105-2811-B-002-028]	Taiwan Ministry of Science and Technology (MOST); Taiwan MOST Postdoctoral Fellowship	The authors thank the staff of the imaging core at the First Core Laboratories (National Taiwan University College of Medicine) for technical assistance. This work was supported by the Taiwan Ministry of Science and Technology (MOST; to T-S.J.). H.L. was supported by the Taiwan MOST Postdoctoral Fellowship (104-2811-B-002-092 and 105-2811-B-002-028). The authors declare no conflicts of interest.	Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Cheng HY, 2005, J AM SOC NEPHROL, V16, P1612, DOI 10.1681/ASN.2004121145; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; DEKAN G, 1991, P NATL ACAD SCI USA, V88, P5398, DOI 10.1073/pnas.88.12.5398; Delacour D, 2006, CURR BIOL, V16, P408, DOI 10.1016/j.cub.2005.12.046; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delacour D, 2009, TRAFFIC, V10, P1405, DOI 10.1111/j.1600-0854.2009.00960.x; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Earl LA, 2011, GLYCOBIOLOGY, V21, P6, DOI 10.1093/glycob/cwq144; KERJASCHKI D, 1985, AM J PATHOL, V118, P343; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Lin WL, 2007, HISTOCHEM CELL BIOL, V127, P399, DOI 10.1007/s00418-006-0252-8; Lu RF, 2014, MOL BIOL CELL, V25, P1744, DOI 10.1091/mbc.E13-12-0724; Meder D, 2005, J CELL BIOL, V168, P303, DOI 10.1083/jcb.200407072; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Mrozowska PS, 2016, J CELL BIOL, V213, P355, DOI 10.1083/jcb.201512024; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Overeem AW, 2015, TRENDS CELL BIOL, V25, P476, DOI 10.1016/j.tcb.2015.04.002; Poland PA, 2011, J BIOL CHEM, V286, P6780, DOI 10.1074/jbc.M110.179002; Richards M, 2015, CURR BIOL, V25, P2325, DOI 10.1016/j.cub.2015.07.045; Roman-Fernandez A, 2016, TRAFFIC, V17, P1244, DOI 10.1111/tra.12417; Stechly L, 2009, TRAFFIC, V10, P438, DOI 10.1111/j.1600-0854.2009.00882.x; Stowell SR, 2008, J BIOL CHEM, V283, P20547, DOI 10.1074/jbc.M802495200; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yu CY, 2007, MOL BIOL CELL, V18, P1710, DOI 10.1091/mbc.E06-07-0629	31	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4917	4927		10.1096/fj.201601386R	http://dx.doi.org/10.1096/fj.201601386R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28747404				2022-12-26	WOS:000413398500022
J	Lewis, J; Roberson, D; Foulsham, T				Lewis, Jennifer; Roberson, Debi; Foulsham, Tom			The impact of facial abnormalities and their spatial position on perception of cuteness and attractiveness of infant faces	PLOS ONE			English	Article							LINE-BISECTION; BABY SCHEMA; AGE; ASYMMETRIES; APPEARANCE; BEAUTIFUL; RESPONSES; GENDER; BABIES; BIASES	Research has demonstrated that how "cute" an infant is perceived to be has consequences for caregiving. Infants with facial abnormalities receive lower ratings of cuteness, but relatively little is known about how different abnormalities and their location affect these aesthetic judgements. The objective of the current study was to compare the impact of different abnormalities on the perception of infant faces, while controlling for infant identity. In two experiments, adult participants gave ratings of cuteness and attractiveness in response to face images that had been edited to introduce common facial abnormalities. Stimulus faces displayed either a haemangioma (a small, benign birth mark), strabismus (an abnormal alignment of the eyes) or a cleft lip (an abnormal opening in the upper lip). In Experiment 1, haemangioma had less of a detrimental effect on ratings than the more severe abnormalities. In Experiment 2, we manipulated the position of a haemangioma on the face. We found small but robust effects of this position, with abnormalities in the top and on the left of the face receiving lower cuteness ratings. This is consistent with previous research showing that people attend more to the top of the face (particularly the eyes) and to the left hemifield.	[Lewis, Jennifer; Roberson, Debi; Foulsham, Tom] Univ Essex, Dept Psychol, Colchester, Essex, England	University of Essex	Foulsham, T (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.	foulsham@essex.ac.uk	Lewis, Jennifer/HCH-4635-2022; Roberson, Debi/C-1612-2009	Roberson, Debi/0000-0002-6778-8547; Foulsham, Tom/0000-0002-8444-7269				Astle AT, 2016, OPTOM PRACT, V17, P121; Badr LK, 2001, INFANT BEHAV DEV, V24, P129; Bates D, 2014, ARXIV14065823; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; Butler S, 2005, NEUROPSYCHOLOGIA, V43, P52, DOI 10.1016/j.neuropsychologia.2004.06.005; Casey RJ, 1996, J APPL DEV PSYCHOL, V17, P495, DOI 10.1016/S0193-3973(96)90013-1; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Failla CV, 2003, BRAIN COGNITION, V52, P353, DOI 10.1016/S0278-2626(03)00181-7; Foulsham T, 2013, VISION RES, V78, P14, DOI 10.1016/j.visres.2012.12.001; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2128, DOI 10.1016/j.ophtha.2009.04.034; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Golle J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121554; Guo K, 2012, PSYCHOL RES-PSYCH FO, V76, P263, DOI 10.1007/s00426-011-0340-9; Guo K, 2009, ANIM COGN, V12, P409, DOI 10.1007/s10071-008-0199-3; Harrison MA, 2011, INFANT BEHAV DEV, V34, P610, DOI 10.1016/j.infbeh.2011.06.003; HILDEBRANDT KA, 1979, INFANT BEHAV DEV, V2, P329, DOI 10.1016/S0163-6383(79)80043-0; Hunnius S, 2011, COGNITION EMOTION, V25, P193, DOI 10.1080/15298861003771189; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KARRAKER KH, 1990, BASIC APPL SOC PSYCH, V11, P371, DOI 10.1207/s15324834basp1104_2; Keating CF, 2003, J NONVERBAL BEHAV, V27, P89, DOI 10.1023/A:1023962425692; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Kwart DG, 2012, PERCEPTION, V41, P925, DOI 10.1068/p7136; Laidlaw KE, 2012, J EXP PSYCHOL HUM PE; LANGLOIS JH, 1995, DEV PSYCHOL, V31, P464, DOI 10.1037/0012-1649.31.3.464; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; MERTENS I, 1993, NEUROPSYCHOLOGIA, V31, P989, DOI 10.1016/0028-3932(93)90154-R; Mojon-Azzi SM, 2011, BRIT J OPHTHALMOL, V95, P473, DOI 10.1136/bjo.2010.185793; Nattyen HT, 2009, OPHTHALMOLOGY, V116, P355, DOI 10.1016/j.ophtha.2008.10.007; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Ossandon JP, 2014, J VISION, V14, DOI 10.1167/14.2.20; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Reyes JA, 2015, PLOS ONE, V10; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; RITTER JM, 1991, CHILD DEV, V62, P68, DOI 10.2307/1130705; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Saether L, 2009, VISION RES, V49, P2870, DOI 10.1016/j.visres.2009.09.001; Sherman GD, 2013, EMOTION, V13, P151, DOI 10.1037/a0029259; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; Smolinski KN, 2005, CLIN PEDIATR, V44, P747, DOI 10.1177/000992280504400902; Sprengelmeyer R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065844; STEPHAN CW, 1984, CHILD DEV, V55, P576, DOI 10.2307/1129969; van Belle G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00020; Volk A, 2002, HUM NATURE-INT BIOS, V13, P437, DOI 10.1007/s12110-002-1002-9; Volk AA, 2007, EVOL PSYCHOL, V5, DOI DOI 10.1177/147470490700500101; Yamamoto R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006042; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180499	10.1371/journal.pone.0180499	http://dx.doi.org/10.1371/journal.pone.0180499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1CT	28749958	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000406575700010
J	Martin-Torrijos, L; Llach, MC; Pou-Rovira, Q; Dieguez-Uribeondo, J				Martin-Torrijos, Laura; Campos Llach, Miquel; Pou-Rovira, Quim; Dieguez-Uribeondo, Javier			Resistance to the crayfish plague, Aphanomyces astaci (Oomycota) in the endangered freshwater crayfish species, Austropotamobius pallipes	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; NOBLE CRAYFISH; PERSISTENT INFECTION; IMMUNE DEFENSE; FUNGUS; POPULATION; ECOLOGY; CARRY; DNA	The pathogen Aphanomyces astaci Schikora 1906 is responsible for the decline of the native crayfish species of Europe, and their current endangered status. This pathogenic species is native to North America and only colonizes aquatic decapods. The North American crayfish species have a high resistance to this pathogen, while species from other regions are highly susceptible. However, recent field and laboratory observations indicate that there might exist some populations with resistance against this disease. The objective of this study was to test the susceptibility of 8 selected native European crayfish populations of Austropotamobius pallipes Lereboullet 1858 from the Pyrenees. We challenged them against the genome sequenced strain AP03 of A. astaci isolated from a North American red swamp crayfish, Procambarus clarkii Girard 1852, in the Garrotxa Natural Park, Girona. The results showed that there are significant differences (P<0,001) among populations, although most of them show high mortality rates after the zoospore challenge with A. astaci. However, one population from Girona exhibited a 100% survival during a four-month monitoring period under the experimental conditions tested. Histological analyses revealed a high immune reaction in tissues examined, i.e., encapsulation and melanization of hyphae, similar to that found in North American resistant crayfish species. These results represent the first observation of a native European crayfish population showing high resistance towards the most virulent genotype of this pathogen, i.e., genotype Pc. The identification of this population is of key importance for the management of these endangered species, and represents a crucial step forward towards the elucidation of the factors involved in the immune reaction against this devastating pathogen.	[Martin-Torrijos, Laura; Dieguez-Uribeondo, Javier] CSIC, RJB, Dept Mycol, Plaza Murillo 2, Madrid, Spain; [Campos Llach, Miquel; Pou-Rovira, Quim] Consorci Estany, Placa Estudis 2, Banyoles, Girona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Dieguez-Uribeondo, J (corresponding author), CSIC, RJB, Dept Mycol, Plaza Murillo 2, Madrid, Spain.	dieguez@rjb.csic.es	MARTIN-TORRIJOS, LAURA/AAH-8654-2019; dieguez-uribeondo, javier/I-2178-2015; Diéguez-Uribeondo, Javier/ABF-1130-2021	MARTIN-TORRIJOS, LAURA/0000-0002-2850-2737; dieguez-uribeondo, javier/0000-0002-4488-0658; Diéguez-Uribeondo, Javier/0000-0002-4488-0658	European Commission in the framework of the LIFE Potamo Fauna project as a part of the group of actions for the conservation of the species A. pallipes [LIFE12 NAT / ES / 001091]; Ministerio de Economia y Competitividad, Spain [CGL2016-80526-R]; Gobierno de Navarra	European Commission in the framework of the LIFE Potamo Fauna project as a part of the group of actions for the conservation of the species A. pallipes; Ministerio de Economia y Competitividad, Spain; Gobierno de Navarra	This study has been funded by the European Commission in the framework of the LIFE Potamo Fauna project [LIFE12 NAT / ES / 001091] (http://www.lifepotamofauna.org/es) as a part of the group of actions for the conservation of the species A. pallipes. Additional funding was provided by Ministerio de Economia y Competitividad, Spain (CGL2016-80526-R) (http:// www.mineco.gob.es/portal/site/mineco/), and Gobierno de Navarra (https://www.navarra.es/home_es/Gebierno+de+Navarra/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been funded by the European Commission in the framework of the LIFE Potamo Fauna project [LIFE12 NAT / ES / 001091] as a part of the group of actions for the conservation of the species A. pallipes. Additional funding was provided by Ministerio de Economia y Competitividad, Spain (CGL2016-80526-R), and Gobierno de Navarra. We would like to thank Joan Montserrat (Parc Natural de la Zona Volcanica de la Garrotxa, Generalitat de Catalunya), Miguel Macias and Fina Torres (Catalan forestry agent) for their involvement and collaboration, and The Servicio de Biodiversidad of the Government of Navarra for providing crayfish samples and detailed information of native crayfish populations. We also like to thank Dr. Mario Garcia Paris, MNCN-CSIC, for critically reading the manuscript, Dr. Vladimir Sandoval-Sierra, RJB-CSIC, for the image formatting assistance, Emilio Cano and Alberto Herrero, RJB-CSIC, for the technical assistance, and Ashleigh Bandimere for revising the English.	Alderman DJ, 1996, REV SCI TECH OIE, V15, P603, DOI 10.20506/rst.15.2.943; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2003, HOST PROPHENOLOXIDAS, P1462; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dieguez-Uribeondo J, 2003, PHYTOPATHOLOGY, V93, P923, DOI 10.1094/PHYTO.2003.93.8.923; Dieguez-Uribeondo J., 2005, B FR PECHE PISCIC, P380; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; Elsworth PG, 2012, EPIDEMIOL INFECT, V140, P1972, DOI 10.1017/S0950268811002743; Fureder L, 2010, IUCN RED LIST THREAT; Gruber C, 2014, ANN ZOOL FENN, V51, P371, DOI 10.5735/086.051.0403; HUANG TS, 1994, AQUACULTURE, V126, P1, DOI 10.1016/0044-8486(94)90243-7; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jussila J, 2011, AQUACULTURE, V321, P17, DOI 10.1016/j.aquaculture.2011.08.026; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kokko H, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012006; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Kusar D, 2013, DIS AQUAT ORGAN, V103, P157, DOI 10.3354/dao02567; Lowe S, 2000, 100 WORLDS WORST INV, P12; Makkonen J, 2012, DIS AQUAT ORGAN, V102, P129, DOI 10.3354/dao02547; Makkonen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36089; Makkonen J, 2014, J INVERTEBR PATHOL, V115, P86, DOI 10.1016/j.jip.2013.10.009; Muzquiz JL, 1997, B FR PECHE PISCIC, P753; NYHLEN L, 1980, J INVERTEBR PATHOL, V36, P187, DOI 10.1016/0022-2011(80)90023-3; Oidtmann B, 2004, VET MICROBIOL, V100, P269, DOI 10.1016/j.vetmic.2004.01.019; Oidtmann B, 2006, DIS AQUAT ORGAN, V72, P53, DOI 10.3354/dao072053; Pedraza-Lara C, 2010, MOL PHYLOGENET EVOL, V57, P327, DOI 10.1016/j.ympev.2010.06.007; Racaniello VR, 2004, J CLIN INVEST, V113, P796, DOI [10.1172/JCI200421370, 10.1172/JCI21370]; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Rezinciuc S., 2015, Freshwater crayfish: a global overview, P182; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P612, DOI 10.1016/j.funbio.2013.10.007; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; SODERHALL K, 1979, J INVERTEBR PATHOL, V34, P285, DOI 10.1016/0022-2011(79)90075-2; UNESTAM T, 1975, AUST J EXP BIOL MED, V53, P349, DOI 10.1038/icb.1975.40; Unestam T., 1969, RESISTANCE CRAYFISH; Viljamaa-Dirks S, 2011, B EUR ASSOC FISH PAT, V31, P182; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	36	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181226	10.1371/journal.pone.0181226	http://dx.doi.org/10.1371/journal.pone.0181226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750039	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700032
J	Potriquet, J; Laohaviroj, M; Bethony, JM; Mulvenna, J				Potriquet, Jeremy; Laohaviroj, Marut; Bethony, Jeffrey M.; Mulvenna, Jason			A modified FASP protocol for high-throughput preparation of protein samples for mass spectrometry	PLOS ONE			English	Article								To facilitate high-throughput proteomic analyses we have developed a modified FASP protocol which improves the rate at which protein samples can be processed prior to mass spectrometry. Adapting the original FASP protocol to a 96-well format necessitates extended spin times for buffer exchange due to the low centrifugation speeds tolerated by these devices. However, by using 96-well plates with a more robust polyethersulfone molecular weight cutoff membrane, instead of the cellulose membranes typically used in these devices, we could use isopropanol as a wetting agent, decreasing spin times required for buffer exchange from an hour to 30 minutes. In a typical work flow used in our laboratory this equates to a reduction of 3 hours per plate, providing processing times similar to FASP for the processing of up to 96 samples per plate. To test whether our modified protocol produced similar results to FASP and other FASP-like protocols we compared the performance of our modified protocol to the original FASP and the more recently described eFASP and MStern-blot. We show that all FASP-like methods, including our modified protocol, display similar performance in terms of proteins identified and reproducibility. Our results show that our modified FASP protocol is an efficient method for the high-throughput processing of protein samples for mass spectral analysis.	[Potriquet, Jeremy; Mulvenna, Jason] QIMR Berghofer Med Res Inst, Genet & Computat Biol Dept, Brisbane, Qld 4060, Australia; [Laohaviroj, Marut] Khon Kaen Univ, Dept Pathol, Fac Med, Khon Kaen, Thailand; [Bethony, Jeffrey M.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Bethony, Jeffrey M.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA; [Mulvenna, Jason] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; Khon Kaen University; George Washington University; George Washington University; University of Queensland	Mulvenna, J (corresponding author), QIMR Berghofer Med Res Inst, Genet & Computat Biol Dept, Brisbane, Qld 4060, Australia.; Mulvenna, J (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.	jason.mulvenna@qimrberghofer.edu.au		Bethony, Jeffrey/0000-0002-7901-2113	National Cancer Institute [R01CA155297]; National Institute of Allergy and Infectious Disease [P50AI098639]; National Health and Medical Research Council of Australia [1051627]; National Health and Medical Research Council, Australia (NHMRC); NATIONAL CANCER INSTITUTE [R01CA155297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI098639] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by award R01CA155297 from the National Cancer Institute, award P50AI098639 from the National Institute of Allergy and Infectious Disease and fellowship support (JPM) and research support (grant number 1051627) from the National Health and Medical Research Council of Australia. JM is supported by a Career Development Fellowship from the National Health and Medical Research Council, Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by award R01CA155297 from the National Cancer Institute, award P50AI098639 from the National Institute of Allergy and Infectious Disease and fellowship support (JPM) and research support (grant number 1051627) from the National Health and Medical Research Council of Australia. JM is supported by a Career Development Fellowship from the National Health and Medical Research Council, Australia (NHMRC). The data reported in this paper were obtained at the Central Analytical Research Facility operated by the Institute for Future Environments (QUT).	Arul AB, 2015, B KOREAN CHEM SOC, V36, P1791, DOI 10.1002/bkcs.10338; Berger ST, 2015, MOL CELL PROTEOMICS, V14, P2814, DOI 10.1074/mcp.O115.049650; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; Ghahremani H., 2011, CHEM SIN, V2, P212; Kachuk C, 2015, J CHROMATOGR A, V1418, P158, DOI 10.1016/j.chroma.2015.09.042; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Nagaraj N, 2008, J PROTEOME RES, V7, P5028, DOI 10.1021/pr800412j; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nel AJM, 2015, J PROTEOME RES, V14, P1637, DOI 10.1021/pr501266c; RUIZ CC, 1995, COLLOID POLYM SCI, V273, P1033, DOI 10.1007/BF00657670; Sidim T, 2013, J SURFACTANTS DETERG, V16, P601, DOI 10.1007/s11743-012-1429-x; Smith MPW, 2013, KIDNEY INT, V84, P1214, DOI 10.1038/ki.2013.200; Switzar L, 2013, PROTEOMICS, V13, P2980, DOI 10.1002/pmic.201300080; Wisniewski JR, 2011, ANAL BIOCHEM, V410, P307, DOI 10.1016/j.ab.2010.12.004; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yu YB, 2014, ANAL CHEM, V86, P5470, DOI 10.1021/ac5008317	18	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0175967	10.1371/journal.pone.0175967	http://dx.doi.org/10.1371/journal.pone.0175967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750034	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700001
J	Sarin, N; Engel, F; Kalayda, GV; Mannewitz, M; Cinatl, J; Rothweiler, F; Michaelis, M; Saafan, H; Ritter, CA; Jaehde, U; Frotschl, R				Sarin, Navin; Engel, Florian; Kalayda, Ganna V.; Mannewitz, Mareike; Cinatl, Jindrich, Jr.; Rothweiler, Florian; Michaelis, Martin; Saafan, Hisham; Ritter, Christoph A.; Jaehde, Ulrich; Froetschl, Roland			Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G(2)/M cell cycle arrest	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; HUMAN FIBROBLASTS; DNA-REPLICATION; TUMOR-CELLS; PROTEIN; GENE; SENSITIVITY; EXPRESSION; DEATH; LINES	The efficacy of cisplatin-based chemotherapy in cancer is limited by the occurrence of innate and acquired drug resistance. In order to better understand the mechanisms underlying acquired cisplatin resistance, we have compared the adenocarcinoma-derived non-small cell lung cancer (NSCLC) cell line A549 and its cisplatin-resistant sub-line A549(r)CDDP(2000) with regard to cisplatin resistance mechanisms including cellular platinum accumulation, DNA-adduct formation, cell cycle alterations, apoptosis induction and activation of key players of DNA damage response. In A549(r)CDDP(2000) cells, a cisplatin-induced G(2)/M cell cycle arrest was lacking and apoptosis was reduced compared to A549 cells, although equitoxic cisplatin concentrations resulted in comparable platinum-DNA adduct levels. These differences were accompanied by changes in the expression of proteins involved in DNA damage response. In A549 cells, cisplatin exposure led to a significantly higher expression of genes coding for proteins mediating G(2)/M arrest and apoptosis (mouse double minute 2 homolog (MDM2), xeroderma pigmentosum complementation group C (XPC), stress inducible protein (SIP) and p21) compared to resistant cells. This was underlined by significantly higher protein levels of phosphorylated Ataxia telangiectasia mutated (pAtm) and p53 in A549 cells compared to their respective untreated control. The results were compiled in a preliminary model of resistance-associated signaling alterations. In conclusion, these findings suggest that acquired resistance of NSCLC cells against cisplatin is the consequence of altered signaling leading to reduced G(2)/M cell cycle arrest and apoptosis.	[Sarin, Navin; Kalayda, Ganna V.; Mannewitz, Mareike; Jaehde, Ulrich] Univ Bonn, Clin Pharm, Inst Pharm, Bonn, Germany; [Engel, Florian; Froetschl, Roland] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany; [Cinatl, Jindrich, Jr.; Rothweiler, Florian] Goethe Univ Hosp Frankfurt, Inst Med Virol, Frankfurt, Germany; [Michaelis, Martin] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; [Michaelis, Martin] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Saafan, Hisham; Ritter, Christoph A.] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, Clin Pharm, Greifswald, Germany	University of Bonn; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Kent; University of Kent; Ernst Moritz Arndt Universitat Greifswald	Frotschl, R (corresponding author), Fed Inst Drugs & Med Devices BfArM, Bonn, Germany.	roland.froetschl@bfarm.de		Mannewitz, Mareike/0000-0003-0676-547X	Bundesinstitut fur Arzneimittel and Medizinprodukte [9/00042]	Bundesinstitut fur Arzneimittel and Medizinprodukte	The project was partially funded by grant 9/00042 of Bundesinstitut fur Arzneimittel and Medizinprodukte to RF. FE was funded by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barr MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054193; Chen SF, 2010, LUNG CANCER, V70, P63, DOI 10.1016/j.lungcan.2010.05.010; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Friedberg EC, 2000, MUTAT RES-DNA REPAIR, V459, P99, DOI 10.1016/S0921-8777(99)00068-3; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657, DOI 10.1124/mol.59.4.657; HAO XY, 1994, CARCINOGENESIS, V15, P1167, DOI 10.1093/carcin/15.6.1167; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; Horibe S, 2015, LIFE SCI, V124, P31, DOI 10.1016/j.lfs.2015.01.011; Ishiguro H, 2016, ONCOL LETT, V11, P277, DOI 10.3892/ol.2015.3882; Jiang PH, 2006, WORLD J GASTROENTERO, V12, P1597, DOI 10.3748/wjg.v12.i10.1597; KASAHARA K, 1991, CANCER RES, V51, P3237; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lundholm L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.211; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Meek DW, 2015, BIOCHEM J, V469, P325, DOI 10.1042/BJ20150517; MEIJER C, 1990, CANCER TREAT REV, V17, P389, DOI 10.1016/0305-7372(90)90081-P; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Millward MJ, 1997, J CLIN ONCOL, V15, P750, DOI 10.1200/JCO.1997.15.2.750; Moskot M, 2015, MOL CELL BIOCHEM, V407, P97, DOI 10.1007/s11010-015-2458-3; Mountzios G, 2008, BIOMARK INSIGHTS, V3, P219; NIE ZR, 1995, CANCER RES, V55, P4760; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Rose Maimon C., 2014, Genomics Proteomics & Bioinformatics, V12, P198, DOI 10.1016/j.gpb.2014.10.003; Rosell R, 2003, LUNG CANCER-J IASLC, V41, pS97, DOI 10.1016/S0169-5002(03)00151-X; Saviozzi S, 2009, CANCER RES, V69, P3390, DOI 10.1158/0008-5472.CAN-08-2981; Schilder RJ, 2009, CANC INVESTIGATION, V10, P307; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shackelford RE, 2001, J BIOL CHEM, V276, P21951, DOI 10.1074/jbc.M011303200; Shahbazi Jeyran, 2013, Frontiers in Genetics, V4, P80, DOI 10.3389/fgene.2013.00080; Shtivelman E, 2014, ONCOTARGET, V5, P1392, DOI 10.18632/oncotarget.1891; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Tegeder I, 2003, CLIN PHARMACOL THER, V73, P417, DOI 10.1016/S0009-9236(03)00008-0; Tomasin R, 2001, J BIOL CHEM, V276, P44185, DOI 10.1074/jbc.M105647200; Tomasini R, 2005, ONCOGENE, V24, P8093, DOI 10.1038/sj.onc.1208951; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; Wang M, 2013, J CHEMOTHERAPY, V25, P162, DOI 10.1179/1973947812Y.0000000056; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Weaver DA, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-18; Wu YH, 2007, CANCER-AM CANCER SOC, V110, P215, DOI 10.1002/cncr.22743; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065309; Zheng NN, 2016, SCI REP-UK, V6, DOI 10.1038/srep25892; Zisowsky J, 2007, BIOCHEM PHARMACOL, V73, P298, DOI 10.1016/j.bcp.2006.10.003	50	86	89	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181081	10.1371/journal.pone.0181081	http://dx.doi.org/10.1371/journal.pone.0181081			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746345	Green Accepted, Green Published, gold			2022-12-26	WOS:000406371800026
J	Gustafson, MP; Staff, NP; Bornschlegl, S; Butler, GW; Maas, ML; Kazamel, M; Zubair, A; Gastineau, DA; Windebank, AJ; Dietz, AB				Gustafson, Michael P.; Staff, Nathan P.; Bornschlegl, Svetlana; Butler, Greg W.; Maas, Mary L.; Kazamel, Mohamed; Zubair, Adeel; Gastineau, Dennis A.; Windebank, Anthony J.; Dietz, Allan B.			Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis	PLOS ONE			English	Article							DISEASE PROGRESSION; T-CELLS; CYTOKINE SECRETION; INHERITED ALS; MONOCYTES; ACTIVATION; NEUROINFLAMMATION; LYMPHOCYTES; TRIAL; CYTOTOXICITY	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a median lifespan of 2-3 years after diagnosis. There are few meaningful treatments that alter progression in this disease. Preclinical and clinical studies have demonstrated that neuroinflammation may play a key role in the progression rate of ALS. Despite this, there are no validated biomarkers of neuroinflammation for use in clinical practice or clinical trials. Biomarkers of neuroinflammation could improve patient management, provide new therapeutic targets, and possibly help stratify clinical trial selection and monitoring. However, attempts to identify a singular cause of neuroinflammation have not been successful. Here, we performed multiparameter flow cytometry to comprehensively assess 116 leukocyte populations and phenotypes from lymphocytes, monocytes, and granulocytes in a cohort of 80 ALS patients. We identified 32 leukocyte phenotypes that were altered in ALS patients compared to age and gender matched healthy volunteers (HV) that included phenotypes of both inflammation and immune suppression. Unsupervised hierarchical clustering and principle component analysis of ALS and HV immunophenotypes revealed two distinct immune profiles of ALS patients. ALS patients were clustered into a profile distinct from HVs primarily due to differences in a multiple T cell phenotypes, CD3(+) CD56(+) T cells and HLA- DR on monocytes. Patients clustered into an abnormal immune profile were younger, more likely to have a familial form of the disease, and survived longer than those patients who clustered similarly with healthy volunteers (344 weeks versus 184 weeks; p = 0.012). The data set generated from this study establishes an extensive accounting of immunophenotypic changes readily suitable for biomarker validation studies. The extensive immune system changes measured in this study indicate that normal immune homeostatic mechanisms are disrupted in ALS patients, and that multiple immune states likely exist within a population of patients with ALS.	[Gustafson, Michael P.; Bornschlegl, Svetlana; Butler, Greg W.; Maas, Mary L.; Gastineau, Dennis A.; Dietz, Allan B.] Mayo Clin, Dept Lab Med & Pathol, Human Cellular Therapy Lab, Div Transfus Med, Rochester, MN 55905 USA; [Staff, Nathan P.; Zubair, Adeel; Windebank, Anthony J.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Kazamel, Mohamed] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Gastineau, Dennis A.] Mayo Clin, Dept Hematol, Rochester, MN USA; [Dietz, Allan B.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Alabama System; University of Alabama Birmingham; Mayo Clinic; Mayo Clinic	Dietz, AB (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Human Cellular Therapy Lab, Div Transfus Med, Rochester, MN 55905 USA.; Dietz, AB (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	dietz.allan@mayo.edu	Dietz, Allan/AAI-6976-2021; Gustafson, Michael P./H-4056-2011; Staff, Nathan/M-2583-2019; Dietz, Allan B/H-7414-2015	Dietz, Allan/0000-0003-3410-9621; Gustafson, Michael P./0000-0002-5514-7072; Staff, Nathan/0000-0001-6760-3859; Dietz, Allan B/0000-0003-3410-9621	Mayo Clinic Department of Laboratory Medicine and Pathology; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Center for Clinical and Translational Sciences [UL1TR000135]; NIH [CA169443]	Mayo Clinic Department of Laboratory Medicine and Pathology; Mayo Clinic Center for Regenerative Medicine; Mayo Clinic Center for Clinical and Translational Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Mayo Clinic Department of Laboratory Medicine and Pathology, the Mayo Clinic Center for Regenerative Medicine, the Mayo Clinic Center for Clinical and Translational Sciences (UL1TR000135) and an NIH grant awarded to NPS (CA169443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Beers DR, 2011, BRAIN BEHAV IMMUN, V25, P1025, DOI 10.1016/j.bbi.2010.12.008; Beers DR, 2011, BRAIN, V134, P1293, DOI 10.1093/brain/awr074; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Correia MP, 2011, IMMUNOBIOLOGY, V216, P604, DOI 10.1016/j.imbio.2010.09.012; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; ENGELHARDT JI, 1993, ARCH NEUROL-CHICAGO, V50, P30, DOI 10.1001/archneur.1993.00540010026013; Franceschetti M, 2009, EXP HEMATOL, V37, P616, DOI 10.1016/j.exphem.2009.01.010; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Gustafson MP, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0231-8; Gustafson MP, 2015, CLIN CANCER RES, V21, P4224, DOI 10.1158/1078-0432.CCR-15-0260; Gustafson MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121546; Gustafson MP, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-7; Gustafson' MP, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-18; Gustafson MP, 2010, NEURO-ONCOLOGY, V12, P631, DOI 10.1093/neuonc/noq001; Henkel JS, 2013, EMBO MOL MED, V5, P64, DOI 10.1002/emmm.201201544; Holmoy T, 2008, EUR J NEUROL, V15, P360, DOI 10.1111/j.1468-1331.2008.02065.x; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Laborde RR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00147; Lemster BH, 2008, J IMMUNOL, V180, P1979, DOI 10.4049/jimmunol.180.3.1979; Lin Y, 2011, BLOOD, V117, P872, DOI 10.1182/blood-2010-05-283820; Malaspina A, 2015, INT IMMUNOL, V27, P117, DOI 10.1093/intimm/dxu099; Mantovani S, 2009, J NEUROIMMUNOL, V210, P73, DOI 10.1016/j.jneuroim.2009.02.012; Meininger V, 2009, AMYOTROPH LATERAL SC, V10, P378, DOI 10.3109/17482960902803432; Murdock BJ, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000242; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pievani A, 2011, BLOOD, V118, P3301, DOI 10.1182/blood-2011-02-336321; Rentzos M, 2012, ACTA NEUROL SCAND, V125, P260, DOI 10.1111/j.1600-0404.2011.01528.x; Schwartz M, 2014, J AUTOIMMUN, V54, P8, DOI 10.1016/j.jaut.2014.08.002; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhao WH, 2013, J NEUROIMMUNE PHARM, V8, P888, DOI 10.1007/s11481-013-9489-x; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	37	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0182002	10.1371/journal.pone.0182002	http://dx.doi.org/10.1371/journal.pone.0182002			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742871	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000065
J	Inui-Yamamoto, C; Yamamoto, T; Ueda, K; Nakatsuka, M; Kumabe, S; Inui, T; Iwai, Y				Inui-Yamamoto, Chizuko; Yamamoto, Takashi; Ueda, Katsura; Nakatsuka, Michiko; Kumabe, Shunji; Inui, Tadashi; Iwai, Yasutomo			Taste preference changes throughout different life stages in male rats	PLOS ONE			English	Article							CHORDA TYMPANI NERVE; OLD FISCHER RATS; AGED RATS; AGING RATS; RESPONSES; METABOLISM; NEUROBIOLOGY; SENSITIVITY; PERCEPTION; EXPRESSION	Taste preference, a key component of food choice, changes with aging. However, it remains unclear how this occurs. To determine differences in taste preference between rats in different life stages, we examined the consumption of taste solutions and water using a two-bottle test. Male Sprague-Dawley rats of different ages were used: juvenile (3 - 6 weeks), young adult (8 - 11 weeks), adult (17 - 20 weeks), middle-aged (34 - 37 weeks), and old-aged (69 - 72 weeks). The intakes of the high and low concentration solutions presented simultaneously were measured. We observed that the old-aged group had lower preference ratios for 0.3 M sucrose and 0.1 M MSG in comparison with other groups. The preference ratio for 0.03 mM QHCl was higher in the middle-aged group than in the three younger groups and higher in the old-aged group than the juvenile group. The taste preferences for HCl and NaCl did not significantly differ among the age groups. The old-aged group tended to prefer high concentrations of sucrose, QHCl, NaCl, and MSG to low concentrations, indicating age-related decline in taste sensitivity. We also aimed to investigate differences between life stages in the electrophysiological responses of the chorda tympani nerve, one of the peripheral gustatory nerves, to taste stimuli. The electrophysiological recordings showed that aging did not alter the function of the chorda tympani nerve. This study showed that aging induced alterations in taste preference. It is likely that these alterations are a result of functional changes in other peripheral taste nerves, the gastrointestinal system, or the central nervous system.	[Inui-Yamamoto, Chizuko; Ueda, Katsura; Nakatsuka, Michiko; Kumabe, Shunji; Iwai, Yasutomo] Osaka Dent Univ, Dept Oral Anat, Hirakata, Osaka, Japan; [Yamamoto, Takashi] Kio Univ, Fac Hlth Sci, Dept Hlth & Nutr, Nara, Japan; [Inui, Tadashi] Osaka Univ, Grad Sch Human Sci, Dept Behav Sci, Div Behav Physiol, Suita, Osaka, Japan; [Inui-Yamamoto, Chizuko] Osaka Univ, Grad Sch Dent, Dept Oral Anat & Dev Biol, Suita, Osaka, Japan	Osaka University; Osaka University	Inui-Yamamoto, C (corresponding author), Osaka Dent Univ, Dept Oral Anat, Hirakata, Osaka, Japan.; Inui-Yamamoto, C (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral Anat & Dev Biol, Suita, Osaka, Japan.	inui@dent.osaka-u.ac.jp		Yamamoto, Takashi/0000-0003-0132-2936; Inui, Chizuko/0000-0002-9963-0410; Inui, Tadashi/0000-0002-1708-164X	Mishima Kaiun Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [23792136]; Grants-in-Aid for Scientific Research [17K00835] Funding Source: KAKEN	Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Mishima Kaiun Memorial Foundation and Grants-in-Aid for Young Scientists (B) (No. 23792136) to CIY from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ackroff K, 2012, PHYSIOL BEHAV, V107, P207, DOI 10.1016/j.physbeh.2012.06.022; AIZAWA T, 1994, PANCREAS, V9, P454, DOI 10.1097/00006676-199407000-00007; BARTOSHUK LM, 1986, J GERONTOL, V41, P51, DOI 10.1093/geronj/41.1.51; BEIDLER LM, 1955, AM J PHYSIOL, V181, P235, DOI 10.1152/ajplegacy.1955.181.2.235; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; COOPER RM, 1959, J GERONTOL, V14, P56, DOI 10.1093/geronj/14.1.56; DRAZNIN B, 1985, DIABETES, V34, P1168, DOI 10.2337/diabetes.34.11.1168; Drewnowski A, 2000, P NUTR SOC, V59, P239, DOI 10.1017/S0029665100000264; FERRELL MF, 1981, J COMP NEUROL, V198, P37, DOI 10.1002/cne.901980105; Fukunaga A, 2005, J GERONTOL A-BIOL, V60, P109, DOI 10.1093/gerona/60.1.109; Frutos MGS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.006; Grill H, 1987, EVALUATING TASTE EFF, P151; Harada S, 2004, CHEM SENSES, V29, P209, DOI 10.1093/chemse/bjh024; Heyer BR, 2004, CHEM SENSES, V29, P721, DOI 10.1093/chemse/bjh081; HILL DL, 1988, SCIENCE, V241, P1826, DOI 10.1126/science.3175625; HILL DL, 1990, TRENDS NEUROSCI, V13, P188, DOI 10.1016/0166-2236(90)90046-D; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Inui-Yamamoto C, 2009, PHYSIOL BEHAV, V96, P717, DOI 10.1016/j.physbeh.2009.01.013; JAKUBCZAK LF, 1977, J GERONTOL, V32, P49, DOI 10.1093/geronj/32.1.49; Jiang Zheng-Er, 2013, Lab Anim Res, V29, P19, DOI 10.5625/lar.2013.29.1.19; KEYS A, 1973, METABOLISM, V22, P579, DOI 10.1016/0026-0495(73)90071-1; MCBRIDE MR, 1986, J GERONTOL, V41, P306, DOI 10.1093/geronj/41.3.306; MISTRETTA CM, 1986, J GERONTOL, V41, P315, DOI 10.1093/geronj/41.3.315; Miura H, 2014, NEUROSCI LETT, V577, P56, DOI 10.1016/j.neulet.2014.06.018; Mojet J, 2001, CHEM SENSES, V26, P845, DOI 10.1093/chemse/26.7.845; MOORE LM, 1982, J GERONTOL, V37, P64, DOI 10.1093/geronj/37.1.64; Murphy C, 1986, Psychol Aging, V1, P312, DOI 10.1037/0882-7974.1.4.312; MURPHY C, 1989, ANN NY ACAD SCI, V561, P251; Murphy Claire, 2008, Journal of Nutrition for the Elderly, V27, P247, DOI 10.1080/01639360802261862; Navarro-Mora G, 2011, PHYSIOL BEHAV, V103, P134, DOI 10.1016/j.physbeh.2011.02.026; Nesic DM, 2013, EUR J PHARMACOL, V710, P85, DOI 10.1016/j.ejphar.2013.03.052; NIIJIMA A, 1991, PHYSIOL BEHAV, V49, P1025, DOI 10.1016/0031-9384(91)90218-D; Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431; Shin YK, 2012, J GERONTOL A-BIOL, V67, P336, DOI 10.1093/gerona/glr192; Shock NW, 1955, J GERONTOL, V10, P31, DOI 10.1093/geronj/10.1.31; SMITH JC, 1989, ANN NY ACAD SCI, V561, P291; Spector AC, 2000, NEUROSCI BIOBEHAV R, V24, P391, DOI 10.1016/S0149-7634(00)00013-0; Thaw AK, 1996, CHEM SENSES, V21, P189, DOI 10.1093/chemse/21.2.189; Ueji K, 2012, PHYSIOL BEHAV, V106, P417, DOI 10.1016/j.physbeh.2012.02.021; Vernet D, 1998, ENDOCRINOLOGY, V139, P3254, DOI 10.1210/en.139.7.3254; Yoshida R, 2012, J ORAL BIOSCI, V54, P67, DOI 10.1016/j.job.2012.02.002	42	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181650	10.1371/journal.pone.0181650	http://dx.doi.org/10.1371/journal.pone.0181650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742813	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000044
J	McDonnell, SL; Baggerly, KA; Baggerly, CA; Aliano, JL; French, CB; Baggerly, LL; Ebeling, MD; Rittenberg, CS; Goodier, CG; Nino, JFM; Wineland, RJ; Newman, RB; Hollis, BW; Wagner, CL				McDonnell, Sharon L.; Baggerly, Keith A.; Baggerly, Carole A.; Aliano, Jennifer L.; French, Christine B.; Baggerly, Leo L.; Ebeling, Myla D.; Rittenberg, Charles S.; Goodier, Christopher G.; Nino, Julio F. Mateus; Wineland, Rebecca J.; Newman, Roger B.; Hollis, Bruce W.; Wagner, Carol L.			Maternal 25(OH)D concentrations >= 40 ng/mL associated with 60% lower preterm birth risk among general obstetrical patients at an urban medical center	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; VITAMIN-D SUPPLEMENTATION; D DEFICIENCY; PREGNANCY; OUTCOMES; PREVENTION; TRIALS	Background Given the high rate of preterm birth (PTB) nationwide and data from RCTs demonstrating risk reduction with vitamin D supplementation, the Medical University of South Carolina (MUSC) implemented a new standard of care for pregnant women to receive vitamin D testing and supplementation. Objectives To determine if the reported inverse relationship between maternal 25(OH) D and PTB risk could be replicated at MUSC, an urban medical center treating a large, diverse population. Methods Medical record data were obtained for pregnant patients aged 18-45 years between September 2015 and December 2016. During this time, a protocol that included 25(OH) D testing at first prenatal visit with recommended follow-up testing was initiated. Free vitamin D supplements were offered and the treatment goal was >= 40 ng/mL. PTB rates (<37 weeks) were calculated, and logistic regression and locally weighted regression (LOESS) were used to explore the association between 25(OH) D and PTB. Subgroup analyses were also conducted. Results Among women with a live, singleton birth and at least one 25(OH) D test during pregnancy (N = 1,064), the overall PTB rate was 13%. The LOESS curve showed gestational age rising with increasing 25(OH) D. Women with 25(OH) D >= 40 ng/mL had a 62% lower risk of PTB compared to those <20 ng/mL (p<0.0001). After adjusting for socioeconomic variables, this lower risk remained (OR = 0.41, p = 0.002). Similar decreases in PTB risk were observed for PTB subtypes (spontaneous: 58%, p = 0.02; indicated: 61%, p = 0.006), by race/ethnicity (white: 65%, p = 0.03; non-white: 68%, p = 0.008), and among women with a prior PTB (80%, p = 0.02). Among women with initial 25(OH) D <40 ng/mL, PTB rates were 60% lower for those with >= 40 vs. <40 ng/mL on a follow-up test (p = 0.006); 38% for whites (p = 0.33) and 78% for non-whites (p = 0.01). Conclusions Maternal 25(OH) D concentrations >= 40 ng/mL were associated with substantial reduction in PTB risk in a large, diverse population of women.	[McDonnell, Sharon L.; Baggerly, Carole A.; Aliano, Jennifer L.; French, Christine B.; Baggerly, Leo L.] GrassrootsHealth, Encinitas, CA 92024 USA; [Baggerly, Keith A.] Univ Texas MD Anderson Canc Ctr, Deptartment Bioinformat & Computat Biol, Houston, TX 77030 USA; [Ebeling, Myla D.; Rittenberg, Charles S.; Goodier, Christopher G.; Nino, Julio F. Mateus; Wineland, Rebecca J.; Newman, Roger B.; Hollis, Bruce W.; Wagner, Carol L.] Med Univ South Carolina, Childrens Hosp, Charleston, SC USA	University of Texas System; UTMD Anderson Cancer Center; Medical University of South Carolina	French, CB (corresponding author), GrassrootsHealth, Encinitas, CA 92024 USA.	christine@grassrootshealth.org		French, Christine/0000-0001-5859-7231	W. K. Kellogg Foundation; Select Health of South Carolina (Charleston, SC); National Institutes of Health, National Center for Advancing Translational Sciences [UL1 RR029882, UL1 TR000062]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	W. K. Kellogg Foundation; Select Health of South Carolina (Charleston, SC); National Institutes of Health, National Center for Advancing Translational Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this project was provided by the W. K. Kellogg Foundation, www.wkkf.org, Select Health of South Carolina (Charleston, SC), www.selecthealthofsc.com, and the National Institutes of Health, National Center for Advancing Translational Sciences grant #UL1 RR029882 and UL1 TR000062, ncats.nih.gov. Free vitamin D supplements were made available for all pregnant women at MUSC through Bio-Tech Pharmacal (Fayetteville, AR), www.biotechpharmacal.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar LM, 2015, OBSTET GYNECOL, V125, P439, DOI 10.1097/AOG.0000000000000621; Bodnar LM, 2013, OBSTET GYNECOL, V122, P91, DOI 10.1097/AOG.0b013e3182941d9a; Garland CF, 2011, ANTICANCER RES, V31, P607; Gernand AD, 2016, BJOG; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Martin JA, 2011, NATL VITAL STAT REP, V60, P1; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P1216, DOI 10.1016/S0002-9378(99)70111-0; Miliku K, 2016, AM J CLIN NUTR, V103, P1514, DOI 10.3945/ajcn.115.123752; Perez-Ferre N, 2012, ENDOCR PRACT, V18, P676, DOI 10.4158/EP12025.OR; Qin LL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050301; Wagner CL, 2016, J STEROID BIOCHEM, V155, P245, DOI 10.1016/j.jsbmb.2015.10.022; Wagner CL, 2013, J STEROID BIOCHEM, V136, P313, DOI 10.1016/j.jsbmb.2013.01.002; Wagner CL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.888; Zhou SS, 2017, J OBSTET GYNAECOL RE, V43, P247, DOI 10.1111/jog.13239	16	82	86	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180483	10.1371/journal.pone.0180483	http://dx.doi.org/10.1371/journal.pone.0180483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738090	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700012
J	Murphy, SM; Augustine, B; Ulrey, WA; Guthrie, JM; Scheick, BK; McCown, JW; Cox, JJ				Murphy, Sean M.; Augustine, Ben C.; Ulrey, Wade A.; Guthrie, Joseph M.; Scheick, Brian K.; McCown, J. Walter; Cox, John J.			Consequences of severe habitat fragmentation on density, genetics, and spatial capture-recapture analysis of a small bear population	PLOS ONE			English	Article							AMERICAN BLACK BEAR; URSUS-AMERICANUS; OVERLAPPING GENERATIONS; MODEL SELECTION; TENSAS RIVER; LIFE-HISTORY; ONE-MIGRANT; SIZE; DIVERSITY; EXTINCTION	Loss and fragmentation of natural habitats caused by human land uses have subdivided several formerly contiguous large carnivore populations into multiple small and often isolated subpopulations, which can reduce genetic variation and lead to precipitous population declines. Substantial habitat loss and fragmentation from urban development and agriculture expansion relegated the Highlands-Glades subpopulation (HGS) of Florida, USA, black bears (Ursus americanus floridanus) to prolonged isolation; increasing human land development is projected to cause >= 50% loss of remaining natural habitats occupied by the HGS in coming decades. We conducted a noninvasive genetic spatial capture-recapture study to quantitatively describe the degree of contemporary habitat fragmentation and investigate the consequences of habitat fragmentation on population density and genetics of the HGS. Remaining natural habitats sustaining the HGS were significantly more fragmented and patchier than those supporting Florida's largest black bear subpopulation. Genetic diversity was low (A(R) = 3.57; H-E = 0.49) and effective population size was small (N-E = 25 bears), both of which remained unchanged over a period spanning one bear generation despite evidence of some immigration. Subpopulation density (0.054 bear/km(2)) was among the lowest reported for black bears, was significantly female-biased, and corresponded to a subpopulation size of 98 bears in available habitat. Conserving remaining natural habitats in the area occupied by the small, genetically depauperate HGS, possibly through conservation easements and government land acquisition, is likely the most important immediate step to ensuring continued persistence of bears in this area. Our study also provides evidence that preferentially placing detectors (e.g., hair traps or cameras) primarily in quality habitat across fragmented landscapes poses a challenge to estimating density-habitat covariate relationships using spatial capture-recapture models. Because habitat fragmentation and loss are likely to increase in severity globally, further investigation of the influence of habitat fragmentation and detector placement on estimation of this relationship is warranted.	[Murphy, Sean M.; Ulrey, Wade A.; Guthrie, Joseph M.; Cox, John J.] Univ Kentucky, Dept Forestry, Lexington, KY 40506 USA; [Augustine, Ben C.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Scheick, Brian K.; McCown, J. Walter] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Gainesville, FL USA; [Murphy, Sean M.] New Mexico Dept Game & Fish, Santa Fe, NM 87507 USA; [Ulrey, Wade A.] Nature Conservancy, Swanton, OH USA; [Guthrie, Joseph M.] Nelson Byrd Woltz Landscape Architects, Charlottesville, VA USA	University of Kentucky; Virginia Polytechnic Institute & State University; Florida Fish & Wildlife Conservation Commission; New Mexico Department of Game and Fish	Murphy, SM (corresponding author), Univ Kentucky, Dept Forestry, Lexington, KY 40506 USA.; Murphy, SM (corresponding author), New Mexico Dept Game & Fish, Santa Fe, NM 87507 USA.	smmurp2@uky.edu	Murphy, Sean/AAM-4692-2021	Murphy, Sean/0000-0002-9404-8878	Disney Wordwide Conservation Fund [5-37629]; Florida Fish and Wildlife Conservation Commission; Fish and Wildlife Foundation of Florida [CWT 1011-02, CWT 1112-02, CWT 1213-01]; University of Kentucky, Department of Forestry; Archbold Biological Station; Disney Worldwide Conservation Fund	Disney Wordwide Conservation Fund; Florida Fish and Wildlife Conservation Commission; Fish and Wildlife Foundation of Florida; University of Kentucky, Department of Forestry; Archbold Biological Station; Disney Worldwide Conservation Fund	Disney Wordwide Conservation Fund provided funding for this study to JJC (grant #5-37629; URL: https://thewaltdisneycompany.com/environment/#disney-conservation-fund), but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Florida Fish and Wildlife Conservation Commission provided support for this study, but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Fish and Wildlife Foundation of Florida provided funding for this study to JJC (grant #CWT 1011-02, CWT 1112-02, CWT 1213-01; URL: http://www.fishwildlifeflorida.org/), but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. University of Kentucky, Department of Forestry provided funding for this study to JJC (internal funds, no grant; URL: http://forestry.ca.uky.edu/), but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Archbold Biological Station provided support for this study, but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Disney Worldwide Conservation Fund, Fish and Wildlife Foundation of Florida, Department of Forestry at University of Kentucky, and Archbold Biological Station for support of our research. We thank M. Gandolfi, J. Styga, S. Kennedy, and J. Gehring for their assistance with constructing and monitoring hair traps. We are grateful for the expedient laboratory analyses by staff at Wildlife Genetics International. We very much appreciate the support from the numerous private landowners in Highlands and Glades counties, Florida; access to their lands ensured the success of this study. We thank the Academic Editor and 2 anonymous referees for providing helpful reviews of manuscript drafts. Any opinions, findings, conclusions, or recommendations expressed herein are those of the authors and do not necessarily reflect the views of our respective institutions. Use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by University of Kentucky, Virginia Polytechnic Institute and State University, or Florida Fish and Wildlife Conservation Commission.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Archbold Biological Station, 2010, STAT FACT SHEET; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Augustine BC, 2014, METHODS ECOL EVOL, V5, P1154, DOI 10.1111/2041-210X.12289; Belant JL, 2005, URSUS, V16, P85, DOI 10.2192/1537-6176(2005)016[0085:ABBPSA]2.0.CO;2; Belkhir K, 2004, GENETIX 4 0 SOFTWARE; Benson JF, 2007, J WILDLIFE MANAGE, V71, P117, DOI 10.2193/2005-580; Beston JA, 2011, J WILDLIFE MANAGE, V75, P1588, DOI 10.1002/jwmg.195; Boersen MR, 2003, WILDLIFE SOC B, V31, P197; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers DL, 2017, ASTA-ADV STAT ANAL, P1; Brown SK, 2009, J MAMMAL, V90, P1066, DOI 10.1644/08-MAMM-A-193.1; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caliskan M., 2012, ANAL GENETIC VARIATI; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Carr M.H., 2016, FLORIDA 2070 TECHNIC; Casella G, 2008, STAT INFERENCE; Chandler RB, 2014, METHODS ECOL EVOL, V5, P1351, DOI 10.1111/2041-210X.12153; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Clark JD, 2015, J WILDLIFE MANAGE, V79, P1347, DOI 10.1002/jwmg.955; Clark JD, 2010, J WILDLIFE MANAGE, V74, P1448, DOI 10.2193/2009-529; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Dixon JD, 2007, CONSERV GENET, V8, P455, DOI 10.1007/s10592-006-9184-z; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dobey S, 2005, WILDLIFE MONOGR, P1; Drewry JM, 2013, J WILDLIFE MANAGE, V77, P153, DOI 10.1002/jwmg.443; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Efford MG, 2014, ECOLOGY, V95, P1341, DOI 10.1890/13-1497.1; Efford M. G., 2009, MODELING DEMOGRAPHIC; Efford MG, 2017, SECR SPATIALLY EXPLI; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Evans J.S., 2014, ARCGIS TOOLBOX SURFA; Evans MJ, 2017, LANDSCAPE URBAN PLAN, V162, P13, DOI 10.1016/j.landurbplan.2017.01.009; Ewel JJ, 1990, ECOSYSTEMS FLORIDA; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Florida Fish and Wildlife Conservation Commission, 2012, FLOR BLACK BEAR MAN; Florida Fish and Wildlife Conservation Commission, 2017, WHAT IS A BMU; Francois O, 2015, LANDSCAPE GENETICS C, P114, DOI DOI 10.1002/9781118525258.CH07; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Garrison EP, 2007, J WILDLIFE MANAGE, V71, P720, DOI 10.2193/2005-689; Guthrie J.M., 2012, THESIS; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hall E. R., 1981, MAMMALS N AM; Hedrick P, 2005, TRENDS ECOL EVOL, V20, P109, DOI 10.1016/j.tree.2005.01.006; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Hooker MJ, 2015, URSUS, V26, P107, DOI 10.2192/URSUS-D-14-00025; Hostetler JA, 2009, BIOL CONSERV, V142, P2456, DOI 10.1016/j.biocon.2009.05.029; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Humm J, 2017, J WILDLIFE MANAGEMEN; Jerina K, 2008, J MAMMAL, V89, P1491, DOI 10.1644/07-MAMM-A-357.1; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jones Mark D., 2003, Ursus (Knoxville), V14, P188; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Keyghobadi N, 2007, CAN J ZOOL, V85, P1049, DOI 10.1139/Z07-095; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Laufenberg JS, 2016, WILDLIFE MONOGR, V194, P1, DOI 10.1002/wmon.1018; Laufenberg JS, 2013, J WILDLIFE MANAGE, V77, P1010, DOI 10.1002/jwmg.534; Liley SG, 2015, URSUS, V26, P1, DOI 10.2192/URSUS-D-15-00006.1; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Maehr David S., 2004, Florida Field Naturalist, V32, P85; MAEHR DS, 2001, BLACK BEAR HABITAT M; Martinez AM, 2006, LIVEST SCI, V102, P140, DOI 10.1016/j.livsci.2005.12.002; McGarigal K., 2012, TECH REP; Merkle Jerod A., 2011, Human-Wildlife Interactions, V5, P159; Miller TEX, 2013, ECOL LETT, V16, P354, DOI 10.1111/ele.12049; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Murphy SM, 2016, J WILDLIFE MANAGE, V80, P1390, DOI 10.1002/jwmg.21144; Murphy SM, 2015, J WILDLIFE MANAGE, V79, P807, DOI 10.1002/jwmg.886; Murphy SM, 2017, URSUS IN PRESS; Noss RF, 2015, DIVERS DISTRIB, V21, P236, DOI 10.1111/ddi.12278; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; Onorato DP, 2004, J MAMMAL, V85, P140, DOI 10.1644/1545-1542(2004)085<0140:PPWAMO>2.0.CO;2; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Pelletier A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172319; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Pruett CL, 2008, J AVIAN BIOL, V39, P252, DOI 10.1111/j.2008.0908-8857.04094.x; Puckett EE, 2015, MOL BIOL EVOL, V32, P2338, DOI 10.1093/molbev/msv114; Puckett EE, 2014, MOL ECOL, V23, P2414, DOI 10.1111/mec.12748; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ripa J, 2000, OIKOS, V90, P89, DOI 10.1034/j.1600-0706.2000.900109.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robinson SJ, 2007, J MAMMAL, V88, P1288, DOI 10.1644/06-MAMM-A-284R.1; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Royle JA, 2017, BIORXIV; Scheick BK, 2014, URSUS, V25, P24, DOI 10.2192/URSUS-D-12-00020.1; Seal US., 1994, PLAN GENETIC RESTORA; Seddon J, 2003, P ROY SOC LOND B BIO, V270, P91; Shannon G, 2014, PEERJ, V2, DOI 10.7717/peerj.532; Sollmann R, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1406; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Sun CC, 2017, J WILDLIFE MANAGEMEN; Sutherland C, 2015, METHODS ECOL EVOL, V6, P169, DOI 10.1111/2041-210X.12316; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Triant DA, 2004, CONSERV GENET, V5, P647, DOI 10.1007/s10592-003-1861-6; Ulrey W. A, 2008, THESIS; US Fish and Wildlife Service, 1999, S FLOR MULT REC PLAN; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vucetich JA, 2000, ANIM CONSERV, V3, P261, DOI 10.1017/S1367943000000986; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang XL, 2014, METHODS ECOL EVOL, V5, P634, DOI 10.1111/2041-210X.12198; Waples RS, 2016, HEREDITY, V117, P241, DOI 10.1038/hdy.2016.29; Waples RS, 2016, MOL ECOL, V25, P4689, DOI 10.1111/mec.13814; Waples RS, 2014, GENETICS, V197, P769, DOI 10.1534/genetics.114.164822; Weekley Carl W., 2008, Florida Scientist, V71, P45; Whittle A.J., 2009, THESIS; Wooding JB, 1994, PROCEEDINGS OF THE FORTY-EIGHTH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P270; Woods JG, 1999, WILDLIFE SOC B, V27, P616	120	16	16	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181849	10.1371/journal.pone.0181849	http://dx.doi.org/10.1371/journal.pone.0181849			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738077	Green Published, gold			2022-12-26	WOS:000406362700078
J	Luo, M; Yang, SY; Li, X; Liu, P; Xue, J; Zhou, XP; Su, KW; Xu, X; Qing, Y; Qiu, JF; Li, YL				Luo, Mei; Yang, Shiya; Li, Xuan; Liu, Pin; Xue, Jian; Zhou, Xipeng; Su, Kewen; Xu, Xuan; Qing, Ying; Qiu, Jingfu; Li, Yingli			The KP1_4563 gene is regulated by the cAMP receptor protein and controls type 3 fimbrial function in Klebsiella pneumoniae NTUH-K2044	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; PYOGENIC LIVER-ABSCESS; CAPSULAR POLYSACCHARIDE SYNTHESIS; PESTIS BIOVAR MICROTUS; ESCHERICHIA-COLI; BIOFILM FORMATION; CYCLIC-AMP; CATABOLITE REPRESSION; ACTIVATOR PROTEIN; SERRATIA-MARCESCENS	Klebsiella pneumoniae (K. pneumoniae) is an opportunistic pathogen that can adhere to host cells or extracellular matrix via type 1 and type 3 fimbriae. KP1_4563 is a gene encoding a hypothetical protein in K. pneumoniae NTUH-K2044. KP1_4563 is located between the type 1 and type 3 fimbrial gene clusters and is likely associated with fimbrial function given its putative conserved domains of unknown function (DUF1471). Cyclic AMP receptor protein (CRP) regulates virulence-related gene expression and is a crucial transcriptional regulator in many bacteria. The predicted DNA recognition motif of CRP is present in the KP1_4563 promoter region. This study aimed to investigate the function of KP1_4563 in fimbriae and its transcriptional regulation mechanism by CRP. We generated Kp1_4563 mutant and complementation strains. We utilized phenotype and adhesion assays to evaluate the role of KP1_4563 in fimbriae. We conducted quantitative RT-PCR (qRT-PCR), LacZ fusion, electrophoretic mobility shift, and DNase I footprinting assays to study the transcriptional regulation of KP1_4563 gene by CRP. We found that KP1_4563 negatively regulates the function of type 3 fimbriae. Compared with NTUH-K2044, the absence of KP1_4563 enhanced the ability of Kp_4563 to adhere to A549 cells. CRP negatively regulates KP1_4563 by directly binding to its promoter region. KP1_4563 plays an important role in type 3 fimbrial function. This novel insight will assist in the development of strategies for preventing K. pneumoniae infection.	[Luo, Mei; Li, Xuan; Liu, Pin; Zhou, Xipeng; Su, Kewen; Xu, Xuan; Qing, Ying; Qiu, Jingfu; Li, Yingli] Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China; [Yang, Shiya] Dianjiang Ctr Dis Control & Prevent, Chongqing, Peoples R China; [Xue, Jian] Zunyi Med & Pharmaceut Coll, Zunyi City, Peoples R China	Chongqing Medical University	Qiu, JF; Li, YL (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Chongqing, Peoples R China.	jfqiu@126.com; liylyl@126.com		jian, xue/0000-0001-6575-2295	National Natural Science Foundation of China [31200064, 31071093, 31170129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research leading to this manuscript has received funding from the National Natural Science Foundation of China (31200064, 31071093 and 31170129).	ADEGBOLA RA, 1982, INFECT IMMUN, V38, P306, DOI 10.1128/IAI.38.1.306-315.1982; ADEGBOLA RA, 1983, J GEN MICROBIOL, V129, P2175; ALLEN BL, 1991, J BACTERIOL, V173, P916, DOI 10.1128/jb.173.2.916-920.1991; Barbadoro P, 2015, AM J INFECT CONTROL, V43, P707, DOI 10.1016/j.ajic.2015.02.011; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Chang Chia-Chen, 2006, Acta Neurol Taiwan, V15, P84; Deng KP, 2011, APPL ENVIRON MICROB, V77, P3952, DOI 10.1128/AEM.02420-10; DONNENBERG MS, 1992, INFECT IMMUN, V60, P3953, DOI 10.1128/IAI.60.10.3953-3961.1992; DUGUID JP, 1959, J GEN MICROBIOL, V21, P271, DOI 10.1099/00221287-21-1-271; EBRIGHT RH, 1989, NUCLEIC ACIDS RES, V17, P10295, DOI 10.1093/nar/17.24.10295; Eletsky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101787; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; FAVREBONTE S, 1995, INFECT IMMUN, V63, P1318, DOI 10.1128/IAI.63.4.1318-1328.1995; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GUNASEKERA A, 1992, J BIOL CHEM, V267, P14713; [何礼洋 HE Liyang], 2007, [微生物学杂志, Journal of Mirobiology], V27, P15; HORNICK DB, 1991, J CLIN MICROBIOL, V29, P1795, DOI 10.1128/JCM.29.9.1795-1800.1991; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hsu CR, 2011, MICROBIOL-SGM, V157, P3446, DOI 10.1099/mic.0.050336-0; Jagnow J, 2003, MICROBIOL-SGM, V149, P2397, DOI 10.1099/mic.0.26434-0; Johnson JG, 2010, J BACTERIOL, V192, P3944, DOI 10.1128/JB.00304-10; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kabbani MS, 2016, J INFECT PUBLIC HEAL, V9, P600, DOI 10.1016/j.jiph.2015.12.017; Kalivoda EJ, 2008, APPL ENVIRON MICROB, V74, P3461, DOI 10.1128/AEM.02733-07; Khater F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116215; Kil KS, 1997, J CLIN MICROBIOL, V35, P2370, DOI 10.1128/JCM.35.9.2370-2374.1997; Klemm P, 2000, INT J MED MICROBIOL, V290, P27; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Langstraat J, 2001, INFECT IMMUN, V69, P5805, DOI 10.1128/IAI.69.9.5805-5812.2001; Li YL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-143; Lin CT, 2006, J BIOCHEM, V140, P429, DOI 10.1093/jb/mvj168; Lin CT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162884; Livrelli V, 1996, J CLIN MICROBIOL, V34, P1963, DOI 10.1128/JCM.34.8.1963-1969.1996; Luo M, 2016, EUR J CLIN MICROBIOL, V35, P1557, DOI 10.1007/s10096-016-2712-y; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Meyer M, 2001, J BACTERIOL, V183, P5248, DOI 10.1128/JB.183.18.5248-5256.2001; MOBLEY HLT, 1990, J INFECT DIS, V161, P525, DOI 10.1093/infdis/161.3.525; Mukhopadhyay J, 1999, FEBS LETT, V453, P215, DOI 10.1016/S0014-5793(99)00719-X; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Murphy CN, 2013, INFECT IMMUN, V81, P3009, DOI 10.1128/IAI.00348-13; OLD DC, 1982, J MED MICROBIOL, V15, P551, DOI 10.1099/00222615-15-4-551; Ou Q, 2017, J MED MICROBIOL, V66, P1, DOI 10.1099/jmm.0.000391; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; PODSCHUN R, 1993, J INFECT DIS, V168, P1415, DOI 10.1093/infdis/168.6.1415; Romling U, 2009, CONTRIB MICROBIOL, V16, P161, DOI 10.1159/000219379; Rudd KE, 1998, ELECTROPHORESIS, V19, P536, DOI 10.1002/elps.1150190413; Salazar JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057272; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Skorupski K, 1997, P NATL ACAD SCI USA, V94, P265, DOI 10.1073/pnas.94.1.265; Stahlhut SG, 2013, J BACTERIOL, V195, P5602, DOI 10.1128/JB.00753-13; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; Stahlhut SG, 2012, J MED MICROBIOL, V61, P317, DOI 10.1099/jmm.0.036350-0; Stella NA, 2008, RES MICROBIOL, V159, P562, DOI 10.1016/j.resmic.2008.07.003; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Struve C, 2009, INFECT IMMUN, V77, P5016, DOI 10.1128/IAI.00585-09; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tarkkanen AM, 1997, INFECT IMMUN, V65, P1546, DOI 10.1128/IAI.65.4.1546-1549.1997; TARKKANEN AM, 1992, INFECT IMMUN, V60, P1187, DOI 10.1128/IAI.60.3.1187-1192.1992; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073363; Wang ZC, 2015, MICROBIOL-SGM, V161, P2395, DOI 10.1099/mic.0.000185; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Wu CC, 2010, MICROBIOL-SGM, V156, P1983, DOI 10.1099/mic.0.038158-0; Xue J, 2016, GENE, V593, P28, DOI 10.1016/j.gene.2016.08.006; Yadav KK, 2016, THER ADV INFECT DIS, V3, P83, DOI 10.1177/2049936116652326; Zhan LJ, 2008, INFECT IMMUN, V76, P5028, DOI 10.1128/IAI.00370-08; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908	68	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180666	10.1371/journal.pone.0180666	http://dx.doi.org/10.1371/journal.pone.0180666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732013	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100008
J	Medrano, G; Guan, PH; Barlow-Anacker, AJ; Gosain, A				Medrano, Giuliana; Guan, Peihong; Barlow-Anacker, Amanda J.; Gosain, Ankush			Comprehensive selection of reference genes for quantitative RT-PCR analysis of murine extramedullary hematopoiesis during development	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; POLYADENYLATED RNA; MOUSE OOCYTES; EXPRESSION; EMBRYOS; CELLS; THYMUS; LIVER; YOLK	The purpose of this study was to perform a comprehensive evaluation and selection of reference genes for the study of extramedullary hematopoiesis during development and the early post-natal period. A total of six candidate reference genes (ACTB, GAPDH, HPRT1, PPID, TBP, TUBB3) in four organs (heart, liver, spleen, and thymus) over five perinatal time points (Embryonic days 14.5, 16.5, 18.5, Post-natal days 0, 21) were evaluated by quantitative real-time PCR. The expression stability of the candidate reference genes were analyzed using geNorm, NormFinder, Bestkeeper, Delta CT method, and RefFinder software packages. Detailed methodology for isolation of high quality/purity RNA and analysis is presented. Detailed analysis demonstrated that TBP is the best single reference gene for embryonic samples and HPRT1 is the best single reference gene for post-natal and pooled embryonic and post-natal samples. Organ-level analysis demonstrated that HPRT1 was the most suitable reference gene for heart, liver and thymus samples, while TBP was the best candidate for spleen samples. In general, TUBB3 was consistently the least stable gene for normalization. This is the first study to describe a systematic comprehensive selection of reference genes for murine extramedullary hematopoietic tissues over a developmental time course. We provide suggested reference genes for individual tissues and developmental stages and propose that a combination of reference genes affords flexibility in experimental design and analysis.	[Medrano, Giuliana; Guan, Peihong; Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Div Pediat Surg, Memphis, TN 38163 USA; [Barlow-Anacker, Amanda J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI USA; [Gosain, Ankush] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN 38103 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Wisconsin System; University of Wisconsin Madison	Gosain, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Surg, Div Pediat Surg, Memphis, TN 38163 USA.; Gosain, A (corresponding author), Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN 38103 USA.	agosain@uthsc.edu		Gosain, Ankush/0000-0002-0428-1503	National Institutes of Health, USA [DK098271]; American College of Surgeons, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK098271] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health, USA (DK098271, www.nih.gov) to AG and the American College of Surgeons, USA (George H.A. Clowes Career Development Award, www.facs.org) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; BARCENA A, 1993, BLOOD, V82, P3401; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Golfier F, 2000, BRIT J HAEMATOL, V109, P173, DOI 10.1046/j.1365-2141.2000.02009.x; Golfier F, 1999, BONE MARROW TRANSPL, V24, P451, DOI 10.1038/sj.bmt.1701940; HUYHN A, 1995, BLOOD, V86, P4474, DOI 10.1182/blood.V86.12.4474.bloodjournal86124474; Jordan S, 2013, CELL HOST MICROBE, V13, P535, DOI 10.1016/j.chom.2013.04.007; Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; LOBACH DF, 1987, J CLIN IMMUNOL, V7, P81, DOI 10.1007/BF00916002; MacNamara KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028669; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Mannhalter C, 2000, CLIN CHEM LAB MED, V38, P171, DOI 10.1515/CCLM.2000.026; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; MIGLIACCIO G, 1986, J CLIN INVEST, V78, P51, DOI 10.1172/JCI112572; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; Pinkert C., 2014, TRANSGENIC ANIMAL TE, V3rd; PUNNONEN J, 1993, J IMMUNOL, V151, P100; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rossi MID, 1999, INT IMMUNOL, V11, P509, DOI 10.1093/intimm/11.4.509; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sohawon D, 2012, J MED IMAG RADIAT ON, V56, P538, DOI 10.1111/j.1754-9485.2012.02397.x; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yamamoto K, 2016, MOL MED REP, V13, P587, DOI 10.3892/mmr.2015.4621; Zaretsky AG, 2012, INFECT IMMUN, V80, P3602, DOI 10.1128/IAI.00333-12; Zhang QJ, 2003, BIRTH DEFECTS RES A, V67, P533, DOI 10.1002/bdra.10075	35	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181881	10.1371/journal.pone.0181881	http://dx.doi.org/10.1371/journal.pone.0181881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732075	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100067
J	Coquoz, S; Marchand, PJ; Bouwens, A; Mouchiroud, L; Sorrentino, V; Szlag, D; Auwerx, J; Lasser, T				Coquoz, Severine; Marchand, Paul J.; Bouwens, Arno; Mouchiroud, Laurent; Sorrentino, Vincenzo; Szlag, Daniel; Auwerx, Johan; Lasser, Theo			Label-free three-dimensional imaging of Caenorhabditis elegans with visible optical coherence microscopy	PLOS ONE			English	Article							PROJECTION TOMOGRAPHY; QUANTIFICATION; TOOL	Fast, label-free, high-resolution, three-dimensional imaging platforms are crucial for high-throughput in vivo time-lapse studies of the anatomy of Caenorhabditis elegans, one of the most commonly used model organisms in biomedical research. Despite the needs, methods combining all these characteristics have been lacking. Here, we present label-free imaging of live Caenorhabditis elegans with three-dimensional sub-micrometer resolution using visible optical coherence microscopy (visOCM). visOCM is a versatile optical imaging method which we introduced recently for tomography of cell cultures and tissue samples. Our method is based on Fourier domain optical coherence tomography, an interferometric technique that provides three-dimensional images with high sensitivity, high acquisition rate and micrometer-scale resolution. By operating in the visible wavelength range and using a high NA objective, visOCM attains lateral and axial resolutions below 1 mu m. Additionally, we use a Bessel illumination offering an extended depth of field of approximately 40 mu m. We demonstrate that visOCM's imaging properties allow rapid imaging of full sized living Caenorhabditis elegans down to the sub-cellular level. Our system opens the door to many applications such as the study of phenotypic changes related to developmental or ageing processes.	[Coquoz, Severine; Marchand, Paul J.; Bouwens, Arno; Szlag, Daniel; Lasser, Theo] Ecole Polytech Fed Lausanne, Lab Opt Biomed, Lausanne, Switzerland; [Mouchiroud, Laurent; Sorrentino, Vincenzo; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Coquoz, S (corresponding author), Ecole Polytech Fed Lausanne, Lab Opt Biomed, Lausanne, Switzerland.	severine.coquoz@alumni.epfl.ch	Auwerx, Johan/ABE-9307-2021; Sorrentino, Vincenzo/R-4403-2018; Bouwens, Arno/D-5754-2013	Sorrentino, Vincenzo/0000-0002-7212-370X; Marchand, Paul James/0000-0003-2528-3193; Auwerx, Johan/0000-0002-5065-5393; Bouwens, Arno/0000-0003-4004-3518	Horizon Framework Programme for Research and Innovation [SEFRI 16.0047, 686271]; EPFL [R01AG043930]; NIH [R01AG043930]; Systems X [SySX.ch 2013/153]; Velux Stiftung [1019]; Swiss National Science Foundation [31003A-140780]	Horizon Framework Programme for Research and Innovation; EPFL; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Systems X; Velux Stiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work in the T.L. laboratory is partially supported by Horizon 2020 Framework Programme for Research and Innovation (SEFRI 16.0047, 686271). The work in the J.A. laboratory is supported by the EPFL, NIH (R01AG043930), Systems X (SySX.ch 2013/153), Velux Stiftung (1019), and the Swiss National Science Foundation (31003A-140780).	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Bassi A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3640808; Berclaz C, 2016, BIOMED OPT EXPRESS, V7, P4569, DOI 10.1364/BOE.7.004569; Berclaz C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10385; Berclaz C, 2012, BIOMED OPT EXPRESS, V3, P1365, DOI 10.1364/BOE.3.001365; Bolmont T, 2012, J NEUROSCI, V32, P14548, DOI 10.1523/JNEUROSCI.0925-12.2012; Boot MJ, 2008, NAT METHODS, V5, P609, DOI 10.1038/nmeth.1219; BRENNER S, 1974, GENETICS, V77, P71; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Colas JF, 2009, ORGANOGENESIS, V5, P211, DOI 10.4161/org.5.4.10426; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Isikman SO, 2011, P NATL ACAD SCI USA, V108, P7296, DOI 10.1073/pnas.1015638108; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Leitgeb RA, 2006, OPT LETT, V31, P2450, DOI 10.1364/OL.31.002450; Marchand PJ, 2017, BIOMED OPT EXPRESS, V8, P3343, DOI 10.1364/BOE.8.003343; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rieckher M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018963; Santi PA, 2011, J HISTOCHEM CYTOCHEM, V59, P129, DOI 10.1369/0022155410394857; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Villiger M, 2009, DIABETOLOGIA, V52, P1599, DOI 10.1007/s00125-009-1383-y; Villiger M, 2010, OPT LETT, V35, P3489, DOI 10.1364/OL.35.003489; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068056	33	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181676	10.1371/journal.pone.0181676	http://dx.doi.org/10.1371/journal.pone.0181676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727813	Green Submitted, gold, Green Published			2022-12-26	WOS:000406634500101
J	Liu, PY; Xu, YY; Tang, YH; Du, M; Yu, X; Sun, J; Xiao, L; He, MA; Wei, S; Yuan, J; Wang, YJ; Liang, Y; Wu, TC; Miao, X; Yao, P				Liu, Peiyi; Xu, Yanyan; Tang, Yuhan; Du, Min; Yu, Xiao; Sun, Jian; Xiao, Lin; He, Meian; Wei, Sheng; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun; Miao, Xiaoping; Yao, Ping			Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men	PLOS ONE			English	Article							ASIA-PACIFIC REGION; CIGARETTE-SMOKING; DECREASED PREVALENCE; METABOLIC SYNDROME; DIABETES-MELLITUS; POPULATION; STEATOHEPATITIS; ASSOCIATIONS; MANAGEMENT; FIBROSIS	Background Whether cigarette smoking and moderate drinking are associated with non-alcoholic fatty liver disease (NAFLD) has not been fully described. This study investigated the separate and joint effects of smoking and moderate drinking on Chinese men with NAFLD. Methods Across-sectional assay from DFTJ Cohort study was performed with a size of 9432 elderly Chinese men excluding excessive alcohol consumption (<210g/week). Fatty liver was diagnosed by standardized ultrasonographic inspection. The odds ratio (OR) of alcohol consumption and smoking for the prevalence of NAFLD were analyzed using multiple logistic regression with multiple adjustments. Results The prevalence of NAFLD in current smokers (pack-year >= 40) and drinkers (80 similar to 210g/week or drinking duration >= 35years) was significantly higher than that in non-smokers and nondrinkers, respectively. The combination of current smoking (pack-year >= 40) and drinking (80 similar to 210g/week) was associated with the highest risk of NAFLD (OR 1.85; 95% confidence interval [CI] 1.28-2.68; P<0.01). The similar combined effect was found in participants with pack-year >= 40 and drinking duration >= 35 years (OR 1.72; 95% CI 1.26 -2.34; P<0.01). Moreover, an interaction was observed between current smoking and moderate drinking in NAFLD. Conclusions In elderly Chinese men, cigarette smoking and moderate alcohol consumption exerts an evident joint effect and interaction on the prevalence of NAFLD, although both are significantly and independently associated with NAFLD prevalence. Such findings highlight particular significance of avoidance of cigarette and alcohol on NAFLD prevention.	[Liu, Peiyi; Xu, Yanyan; Tang, Yuhan; Du, Min; Yu, Xiao; Sun, Jian; Xiao, Lin; Yao, Ping] Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan, Hubei, Peoples R China; [Liu, Peiyi; Xu, Yanyan; Tang, Yuhan; Du, Min; Yu, Xiao; Sun, Jian; Xiao, Lin; Yao, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [He, Meian; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun] Huazhong Univ Sci & Technol, Inst Occupat Med, Wuhan, Hubei, Peoples R China; [He, Meian; Yuan, Jing; Wang, Youjie; Liang, Yuan; Wu, Tangchun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China; [Wei, Sheng; Miao, Xiaoping] Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China; [Wei, Sheng; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yao, P (corresponding author), Huazhong Univ Sci & Technol, Dept Nutr & Food Hyg, Hubei Key Lab Food Nutr & Safety, Wuhan, Hubei, Peoples R China.; Yao, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China.; Miao, X (corresponding author), Huazhong Univ Sci & Technol, Dept Epidemiol & Biostat, Wuhan, Hubei, Peoples R China.; Miao, X (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE,Key Lab Environm & Hlth, Wuhan, Hubei, Peoples R China.	yaoping@mails.tjmu.edu.cn; miaoxp@hust.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation of China [81472979, 81402673]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is financially supported by National Natural Science Foundation of China (No. 81472979 and 81402673). Yuhan Tang was participated in analysis and interpretation of data, and in critical revision of the manuscript. Ping Yao was involved in study concept and design, as well as critical revision of the manuscript.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455; Bataller R, 2006, HEPATOLOGY, V44, P1394, DOI 10.1002/hep.21484; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hannah WN, 2016, DIGEST DIS SCI, V61, P1365, DOI 10.1007/s10620-016-4153-y; Hashimoto Y, 2015, J GASTROEN HEPATOL, V30, P546, DOI 10.1111/jgh.12786; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Jia WP, 2013, BIOMED ENVIRON SCI, V26, P947, DOI 10.3967/bes2013.029; Kwon HK, 2014, LIVER INT, V34, P129, DOI 10.1111/liv.12230; Liu B, 2009, AM J EPIDEMIOL, V169, P153, DOI 10.1093/aje/kwn280; Moriya A, 2011, ALIMENT PHARM THER, V33, P378, DOI 10.1111/j.1365-2036.2010.04520.x; Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; Nakashita Y, 2010, J EPIDEMIOL, V20, P391, DOI 10.2188/jea.JE20100043; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; POZZATO G, 1995, J GERONTOL A-BIOL, V50, pB135, DOI 10.1093/gerona/50A.3.B135; Schooling CM, 2009, J EPIDEMIOL COMMUN H, V63, P121, DOI 10.1136/jech.2008.077602; Wadd Sarah, 2014, BMC Res Notes, V7, P741, DOI 10.1186/1756-0500-7-741; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Wang XF, 2011, HEPATOB PANCREAT DIS, V10, P276, DOI 10.1016/S1499-3872(11)60046-5; Will JC, 2001, INT J EPIDEMIOL, V30, P540, DOI 10.1093/ije/30.3.540; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Yalcinkaya E, 2014, EUR REV MED PHARMACO, V18, P760; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Yeung SLA, 2015, AM J EPIDEMIOL, V182, P320, DOI 10.1093/aje/kwv069; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; Yu M, 2014, J EPIDEMIOL, V24, P361, DOI 10.2188/jea.JE20130112; Zein CO, 2010, HEPATOLOGY, V51, P1487, DOI 10.1002/hep.23694; Zhang CF, 2016, J SENSORS, V2016, DOI 10.1155/2016/9307560	39	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181497	10.1371/journal.pone.0181497	http://dx.doi.org/10.1371/journal.pone.0181497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727853	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500080
J	Wada, H; Masumoto-Kubo, C; Tsutsumi, K; Nonami, H; Tanaka, F; Okada, H; Erra-Balsells, R; Hiraoka, K; Nakashima, T; Hakata, M; Morita, S				Wada, Hiroshi; Masumoto-Kubo, Chisato; Tsutsumi, Koichi; Nonami, Hiroshi; Tanaka, Fukuyo; Okada, Haruka; Erra-Balsells, Rosa; Hiraoka, Kenzo; Nakashima, Taiken; Hakata, Makoto; Morita, Satoshi			Turgor-responsive starch phosphorylation in Oryza sativa stems: A primary event of starch degradation associated with grain-filling ability	PLOS ONE			English	Article							APOPLASTIC SOLUTE ACCUMULATION; NONSTRUCTURAL CARBOHYDRATE; VITIS-VINIFERA; RICE; WATER; CELL; EXPRESSION; PROTEIN; METABOLISM; GROWTH	Grain filling ability is mainly affected by the translocation of carbohydrates generated from temporarily stored stem starch in most field crops including rice (Oryza sativa L.). The partitioning of non-structural stem carbohydrates has been recognized as an important trait for raising the yield ceiling, yet we still do not fully understand how carbohydrate partitioning occurs in the stems. In this study, two rice subspecies that exhibit different patterns of nonstructural stem carbohydrates partitioning, a japonica-dominant cultivar, Momiroman, and an indica-dominant cultivar, Hokuriku 193, were used as the model system to study the relationship between turgor pressure and metabolic regulation of non-structural stem carbohydrates, by combining the water status measurement with gene expression analysis and a dynamic prefixed C-13 tracer analysis using a mass spectrometer. Here, we report a clear varietal difference in turgor-associated starch phosphorylation occurred at the initiation of non-structural carbohydrate partitioning. The data indicated that starch degradation in Hokuriku 193 stems occurred at full-heading, 5 days earlier than in Momiroman, contributing to greater sink filling. Gene expression analysis revealed that expression pattern of the gene encoding alpha-glucan, water dikinase (GWD1) was similar between two varieties, and the maximum expression level in Hokuriku 193, reached at full heading (4 DAH), was greater than in Momiroman, leading to an earlier increase in a series of amylase-related gene expression in Hokuriku 193. In both varieties, peaks in turgor pressure preceded the increases in GWD1 expression, and changes in GWD1 expression was correlated with turgor pressure. Additionally, a threshold is likely to exist for GWD1 expression to facilitate starch degradation. Taken together, these results raise the possibility that turgor-associated starch phosphorylation in cells is responsible for the metabolism that leads to starch degradation. Because the two cultivars exhibited remarkable varietal differences in the pattern of non-structural carbohydrate partitioning, our findings propose that the observed difference in grain-filling ability originated from turgor-associated regulation of starch phosphorylation in stem parenchyma cells. Further understanding of the molecular mechanism of turgor-regulation may provide a new selection criterion for breaking the yield barriers in crop production.	[Wada, Hiroshi; Masumoto-Kubo, Chisato; Tsutsumi, Koichi; Hakata, Makoto; Morita, Satoshi] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan; [Nonami, Hiroshi; Okada, Haruka; Nakashima, Taiken] Ehime Univ, Fac Agr, Dept Biomech Syst, Matsuyama, Ehime, Japan; [Tanaka, Fukuyo] Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan; [Erra-Balsells, Rosa] Univ Buenos Aires, Fac Exact & Nat Sci, Dept Organ Chem CIHIDECAR, Buenos Aires, DF, Argentina; [Hiraoka, Kenzo] Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi, Japan	National Agriculture & Food Research Organization - Japan; Ehime University; National Agriculture & Food Research Organization - Japan; University of Buenos Aires; University of Yamanashi	Wada, H (corresponding author), Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Chikugo, Fukuoka, Japan.	hwada@affrc.go.jp	TANAKA, Fukuyo/L-3978-2019	TANAKA, Fukuyo/0000-0002-0904-3248; Wada, Hiroshi/0000-0003-0510-5744	JSPS KAKENHI Grant [24248005, 24228004, 16H02533]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 24248005 (SM) and JSPS KAKENHI Grant Number 16H02533 (HW) and in part by JSPS KAKENHI Grant Number 24228004 (HN). RE-B is a research member of National Council of Scientific and Technological Research (CONICET), Argentina.; The authors gratefully acknowledge Dr. Mark Matthews for kindly supplying the thermocouple sensors for the isopiestic psychrometry, and Dr. Hiroshi Nakano for helpful comments on the manuscript. The authors also thank Mr. Akitoshi Honbu, Mr. Keiji Miike, Ms. Fujiko Komiya, Ms. Fumie Tsuru, and Ms. Kumika Kakiuchi for their help in growing the rice plants and assistance with the experiments. This work was supported by JSPS KAKENHI Grant Number 24248005 and JSPS KAKENHI Grant Number 16H02533 and in part by JSPS KAKENHI Grant Number 24228004. RE-B is a research member of National Council of Scientific and Technological Research (CONICET), Argentina.	BOYER JS, 1995, MEASURING WATER STAT, P178; Castellarin SD, 2016, J EXP BOT, V67, P709, DOI 10.1093/jxb/erv483; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Finan JD, 2009, ANN BIOMED ENG, V37, P477, DOI 10.1007/s10439-008-9618-5; Gambetta GA, 2013, PHYSIOL PLANTARUM, V148, P334, DOI 10.1111/ppl.12014; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; GUERRERO FD, 1990, PLANT MOL BIOL, V15, P11, DOI 10.1007/BF00017720; Hirabayashi H., 2010, B NATL I CROP SCI, V11, P31; Hirano T, 2011, PLANT PROD SCI, V14, P318, DOI 10.1626/pps.14.318; Hirose T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00147; Hoshikawa K., 1989, GROWING RICE PLANT A, Vxvi; Jayaram B, 2004, ANNU REV BIOPH BIOM, V33, P343, DOI 10.1146/annurev.biophys.33.110502.140414; JONES JT, 1995, PLANT MOL BIOL, V28, P983, DOI 10.1007/BF00032661; Khush GS, 2011, P NARO S FUK JAP, P1; Kotting O, 2010, CURR OPIN PLANT BIOL, V13, P321, DOI 10.1016/j.pbi.2010.01.003; Kramer P.J., 1995, WATER RELATIONS PLAN; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Matsuba K., 1991, Bulletin of the Chugoku National Agricultural Experiment Station, P11; MCCAIN DC, 1995, BIOPHYS J, V69, P1105, DOI 10.1016/S0006-3495(95)79984-2; Mohapatra PK, 2004, FUNCT PLANT BIOL, V31, P131, DOI 10.1071/FP03177; MOORE PH, 1991, PLANT PHYSIOL, V96, P794, DOI 10.1104/pp.96.3.794; Morita S, 2011, CROP SCI, V51, P818, DOI 10.2135/cropsci2010.06.0373; Ohnishi M, 1999, JPN J CROP SCI, V68, P126, DOI 10.1626/jcs.68.126; OPARKA KJ, 1992, PLANT J, V2, P741, DOI 10.1111/j.1365-313X.1992.tb00143.x; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Proseus TE, 1999, PLANT PHYSIOL, V119, P775, DOI 10.1104/pp.119.2.775; Proseus TE, 2005, ANN BOT-LONDON, V95, P967, DOI 10.1093/aob/mci113; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Sacks E. J., 2014, PERENNIAL CROPS FOOD, P16; SAITOH K, 1991, JPN J CROP SCI, V60, P255, DOI 10.1626/jcs.60.255; Schwabe JWR, 1997, CURR OPIN STRUC BIOL, V7, P126, DOI 10.1016/S0959-440X(97)80016-4; Scofield GN, 2007, J EXP BOT, V58, P3155, DOI 10.1093/jxb/erm153; Silver DM, 2014, TRENDS PLANT SCI, V19, P471, DOI 10.1016/j.tplants.2014.01.008; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Sugimura Y, 2015, PLANT PROD SCI, V18, P277, DOI 10.1626/pps.18.277; Taiz L, 2010, PLANT PHYSIOL, Vxxxiv, P782; Toyota K, 2006, PLANTA, V223, P248, DOI 10.1007/s00425-005-0128-5; Tsukaguchi T, 1996, JPN J CROP SCI, V65, P445, DOI 10.1626/jcs.65.445; Uehlein N, 2008, PLANT CELL, V20, P648, DOI 10.1105/tpc.107.054023; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wada H, 2008, PLANTA, V227, P1351, DOI 10.1007/s00425-008-0707-3; Wada Hiroshi, 2004, Environment Control in Biology, V42, P193; Wada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110374; Wada H, 2014, PLANT PHYSIOL, V164, P1800, DOI 10.1104/pp.113.231688; Wada H, 2009, J EXP BOT, V60, P1773, DOI 10.1093/jxb/erp050; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Working Group I, 2014, CLIMATE CHANGE 2013, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324]; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Yoshinaga S, 2013, FIELD CROP RES, V150, P74, DOI 10.1016/j.fcr.2013.06.004; ZHU GL, 1992, PLANT PHYSIOL, V100, P2071, DOI 10.1104/pp.100.4.2071	54	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181272	10.1371/journal.pone.0181272	http://dx.doi.org/10.1371/journal.pone.0181272			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727805	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500052
J	Ding, D; Huang, H; Jiang, W; Yu, W; Zhu, H; Liu, J; Saiyin, H; Wu, J; Huang, H; Jiang, S; Yu, L				Ding, D.; Huang, H.; Jiang, W.; Yu, W.; Zhu, H.; Liu, J.; Saiyin, H.; Wu, J.; Huang, H.; Jiang, S.; Yu, L.			Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway	ONCOGENE			English	Article							CELL LUNG-CANCER; IDENTIFICATION; GENES	Hepatocellular carcinoma (HCC) is a major health threat worldwide. Although the involvement of reticulocalbin-2 (RCN2) in cell differentiation has been reported, its function in oncogenesis is poorly understood. Here, we showed that RCN2 was upregulated in tumors compared with adjacent non-tumorous tissues in HCC patients and RCN2 expression clinically correlated with tumor size, disease recurrence and survival rate. Both knockdown and knockout of RCN2 significantly inhibited HCC cell proliferation by inducing G1/S transition arrest and downregulating cyclin D1 expression, while the proliferative ability was restored in knockout HCC cells with exogenously expressed RCN2. Mechanistically, we demonstrated that RCN2 interacted with the epidermal growth factor receptor (EGFR). Knockout of RCN2 in HCC cells not only inhibited activation of the EGFR-ERK pathway by blocking EGF-mediated EGFR dimerization and internalization but also suppressed cell proliferation and EGFR phosphorylation under long exposure to EGF. We further showed that knockout of RCN2 inhibited EGFR phosphorylation, Ki-67 expression and tumor growth in nude mice. Moreover, we demonstrated that RCN2 knockout sensitized HCC cells to tyrosine kinase inhibitors, including erlotinib, lapatinib and sunitinib. Taken together, our results indicate that RCN2 plays a pivotal role in HCC cell proliferation and tumor growth presumably through regulating activation of the EGFR-ERK pathway. Our work also suggests that RCN2 is a potential therapeutic target of HCC.	[Ding, D.; Huang, H.; Yu, W.; Zhu, H.; Saiyin, H.; Wu, J.; Jiang, S.; Yu, L.] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Jiang, W.] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai, Peoples R China; [Zhu, H.] Fudan Univ, Sch Life Sci, Key Lab Med Mol Virol, Minist Educ Hlth, Shanghai, Peoples R China; [Liu, J.] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med,Shanghai Key Lab Assisted Reprod &, Shanghai, Peoples R China; [Huang, H.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN USA	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Mayo Clinic	Jiang, S; Yu, L (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	smjiang@fudan.edu.cn; longyu@fudan.edu.cn		Saiyin, Hexige/0000-0003-2993-6817; Ding, Donglin/0000-0003-2339-7349	National Key Science and Technology Project of China [2013ZX10002010]; National Basic Research Program of China (973 Program) [2013CB910504]	National Key Science and Technology Project of China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	We are thankful to Professor Jiahuai Han at Xiamen University for providing RCN2 cDNA. We thank Dr Suqin Shen, Longjiang Liu and Huazheng Yu at Fudan University for their technical support. This study was supported by National Key Science and Technology Project of China (2013ZX10002010), National Basic Research Program of China (973 Program, 2013CB910504).	Cavallo F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S7; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Foerster S, 2013, PROTEOMICS, V13, P3131, DOI 10.1002/pmic.201300154; Giribaldi G, 2013, J PROTEOMICS, V91, P385, DOI 10.1016/j.jprot.2013.07.018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirano T, 2005, INT J CANCER, V117, P460, DOI 10.1002/ijc.21172; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang W., 2015, CELL CYCLE HEPATOCEL, V34, P4460, DOI DOI 10.1038/onc.2014.373; Kharbanda A, 2014, CLIN CANCER RES, V20, P5423, DOI 10.1158/1078-0432.CCR-13-3168; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Llovet JM, 2014, CLIN CANCER RES, V20, P2072, DOI 10.1158/1078-0432.CCR-13-0547; Ludvigsen M, 2009, PROTEOMICS, V9, P5267, DOI 10.1002/pmic.200900321; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Manichaikul A, 2011, AM J PHYSIOL-HEART C, V301, pH1056, DOI 10.1152/ajpheart.00366.2011; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang RY, 2013, GASTROENTEROLOGY, V145, P1436, DOI 10.1053/j.gastro.2013.08.009; Wang ZC, 2015, HEPATOLOGY, V62, P1201, DOI 10.1002/hep.27911; Wu YM, 2011, CANCER RES, V71, P7270, DOI 10.1158/0008-5472.CAN-11-1161; Yu LR, 2000, ELECTROPHORESIS, V21, P3058, DOI 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U	32	21	24	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 30	2017	36	48					6691	6700		10.1038/onc.2017.230	http://dx.doi.org/10.1038/onc.2017.230			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FO4AJ	28745317				2022-12-26	WOS:000416780800004
J	Monteiro, S; Santos, R				Monteiro, Silvia; Santos, Ricardo			Nanofluidic digital PCR for the quantification of Norovirus for water quality assessment	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; REVERSE-TRANSCRIPTION-PCR; DNA COPY NUMBER; QUANTITATIVE PCR; RT-PCR; VIRUS; ENTEROCOCCUS; INHIBITION; PLATFORM	Sensitive detection of water- and foodborne enteric viruses is extremely relevant, especially due to the low concentrations in which they are found. Accurate and sensitive detection of Norovirus, the primary responsible for water-and foodborne outbreaks, is of particular importance. Quantification of Norovirus is commonly performed by quantitative RT-PCR (RT-qPCR). In recent years a new platform was developed, digital PCR, that quantifies without the need for a standard curve thus decreasing the errors associated with its utilization. The platform developed by LifeTechnologies, QuantStudio 3D Digital PCR is amongst the least studied digital platform and although it allows the direct detection of DNA targets it requires a two-step RT-PCR for the detection of RNA targets. In this work we developed a new protocol able to detect Norovirus using a one-step digital PCR reaction (RT-dPCR). The performance of the newly developed one-step digital PCR was compared to RT-qPCR for the detection of Norovirus genogroup I and genogroup II. The sensitivity of RT-dPCR was identical to that of RT-qPCR, and the quantitative data determined by both methods were not significantly different for most samples. This one-step absolute quantification approach is a useful tool to minimize the time spent currently using this particular platform to amplify viral RNA and to standardize quantification of enteric viruses in food and environmental samples. This study proved the usefulness of the newly developed RT-dPCR protocol for a sensitive and accurate detection of low-copy targets.	[Monteiro, Silvia; Santos, Ricardo] Univ Lisbon, Inst Super Tecn, Lab Anal, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Monteiro, S (corresponding author), Univ Lisbon, Inst Super Tecn, Lab Anal, Lisbon, Portugal.	silvia.monteiro@tecnico.ulisboa.pt	Monteiro, Silvia/AAD-4997-2022; Monteiro, Silvia/S-2932-2019; Santos, Ricardo/AAD-2993-2022	Monteiro, Silvia/0000-0002-9943-0742; Santos, Ricardo/0000-0003-1944-4261	FP7 KBBE EU project AQUAVALENS from the European Union [311846]	FP7 KBBE EU project AQUAVALENS from the European Union	This work was supported by the FP7 KBBE EU project AQUAVALENS, grant agreement 311846 from the European Union. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 1521612013 ISOTS; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; Boizeau L, 2014, J CLIN MICROBIOL, V52, P3497, DOI 10.1128/JCM.01306-14; Bosch A, 2008, CURR OPIN BIOTECH, V19, P295, DOI 10.1016/j.copbio.2008.04.006; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Buzard GS, 2012, FORENSIC SCI INT, V223, P292, DOI 10.1016/j.forsciint.2012.10.003; Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012; California Department of Public Health, 2014, CCR IND POT REUS GRO; Cao Y, 2012, J APPL MICROBIOL, V113, P66, DOI 10.1111/j.1365-2672.2012.05305.x; Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008; Cao YP, 2013, WATER RES, V47, P233, DOI 10.1016/j.watres.2012.09.056; Coudray-Meunier C, 2015, INT J FOOD MICROBIOL, V201, P17, DOI 10.1016/j.ijfoodmicro.2015.02.006; da Silva AK, 2007, APPL ENVIRON MICROB, V73, P7891, DOI 10.1128/AEM.01428-07; Dhoubhadel BG, 2014, J MED MICROBIOL, V63, P528, DOI 10.1099/jmm.0.071464-0; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Dong LH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13174; Dube S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002876; EPA U. S., 2012, 1611 US EPA OFF WAT; Flannery J, 2012, APPL ENVIRON MICROB, V78, P3400, DOI 10.1128/AEM.07569-11; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Martin-Latil S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01183; Nicot F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080233; Nixon G, 2014, ANAL CHEM, V86, P4387, DOI 10.1021/ac500208w; Paranychianakis NV, 2015, CRIT REV ENV SCI TEC, V45, P1409, DOI 10.1080/10643389.2014.955629; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; PUIG M, 1994, APPL ENVIRON MICROB, V60, P2963, DOI 10.1128/AEM.60.8.2963-2970.1994; Racki N, 2014, ANAL BIOANAL CHEM, V406, P661, DOI 10.1007/s00216-013-7476-y; Sanders R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075296; Sanders R, 2011, ANAL CHEM, V83, P6474, DOI 10.1021/ac103230c; Sedlak RH, 2017, J CLIN MICROBIOL, V55, P442, DOI 10.1128/JCM.01970-16; Stewart JR, 2013, WATER RES, V47, P6829, DOI 10.1016/j.watres.2013.04.063; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Zhang YH, 2016, ANAL CHIM ACTA, V914, P7, DOI 10.1016/j.aca.2016.02.006	36	25	26	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0179985	10.1371/journal.pone.0179985	http://dx.doi.org/10.1371/journal.pone.0179985			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749991	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700007
J	Abu Baker, MA; Reeve, N; Conkey, AAT; Macdonald, DW; Yamaguchi, N				Abu Baker, Mohammad A.; Reeve, Nigel; Conkey, April A. T.; Macdonald, David W.; Yamaguchi, Nobuyuki			Hedgehogs on the move: Testing the effects of land use change on home range size and movement patterns of free-ranging Ethiopian hedgehogs	PLOS ONE			English	Article							NART NATURE-RESERVE; ERINACEUS-EUROPAEUS; HABITAT USE; EUROPEAN HEDGEHOG; DAURIAN HEDGEHOGS; MATING SYSTEMS; RICHNESS; MONGOLIA; ECOLOGY; MAMMALS	Degradation and alteration of natural environments because of agriculture and other land uses have major consequences on vertebrate populations, particularly on spatial organization and movement patterns. We used GPS tracking to study the effect of land use and sex on the home range size and movement of a typical model species, the Ethiopian hedgehogs. We used free-ranging hedgehogs from two areas with different land use practices: 24 from an area dominated by irrigated farms (12 male male, 12 female female) and 22 from a natural desert environment within a biosphere reserve (12 male male, 10 female female). Animals were significantly heavier in the resource-rich irrigated farms area (417.71 +/- 12.77SE g) in comparison to the natural desert area (376.37 +/- 12.71SE g). Both habitat and sex significantly influenced the home range size of hedgehogs. Home ranges were larger in the reserve than in the farms area. Total home ranges averaged 103 ha (+/- 17 SE) for males and 42 ha (+/- 11SE) for females in the farms area, but were much larger in the reserve averaging 230 ha (+/- 33 SE) for males and 150 ha (+/- 29 SE) for females. The home ranges of individuals of both sexes overlapped. Although females were heavier than males, body weight had no effect on home range size. The results suggest that resources provided in the farms (e.g. food, water, and shelters) influenced animal density and space use. Females aggregated around high-resource areas (either farms or rawdhats), whereas males roamed over greater distances, likely in search of mating opportunities to maximize reproductive success. Most individual home ranges overlapped with many other individuals of either sex, suggesting a non-territorial, promiscuous mating. Patterns of space use and habitat utilization are key factors in shaping aspects of reproductive biology and mating system. To minimize the impacts of agriculture on local wildlife, we recommend that biodiversity-friendly agro-environmental schemes be introduced in the Middle East where the transformation from dry lands to `islands of fertility' is often extreme.	[Abu Baker, Mohammad A.; Yamaguchi, Nobuyuki] Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar; [Reeve, Nigel] 2 Paxton Gardens, Woking, Surrey, England; [Conkey, April A. T.] Texas A&M Univ Kingsville, Caesar Kleberg Wildlife Res Inst, Kingsville, TX USA; [Conkey, April A. T.] Texas A&M Univ Kingsville, Dept Anim Rangeland & Wildlife Sci, Kingsville, TX USA; [Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Tubney House, Oxford, England	Qatar University; Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University Kingsville; University of Oxford	Abu Baker, MA; Yamaguchi, N (corresponding author), Qatar Univ, Dept Biol & Environm Sci, Doha, Qatar.	abubakerma@gmail.com; yamaguchi@qu.edu.qa	Yamaguchi, Nobuyuki/AAN-4884-2020; Abu Baker, Mohammad/T-7967-2019	Yamaguchi, Nobuyuki/0000-0002-6492-6588; Abu Baker, Mohammad/0000-0003-1905-0879	NPRP award [NPRP 5-083-1-019]; Qatar National Research Fund (a member of The Qatar Foundation)	NPRP award; Qatar National Research Fund (a member of The Qatar Foundation)	This project was made possible by a NPRP award (NPRP 5-083-1-019) to Nobuyuki Yamaguchi from the Qatar National Research Fund (a member of The Qatar Foundation).	Abu Baker MA, 2016, MAMMALIA, V80, P515, DOI 10.1515/mammalia-2015-0018; Abu Baker MA, 2016, J ARID ENVIRON, V125, P52, DOI 10.1016/j.jaridenv.2015.10.002; ALSOLIMAN TM, 1993, J ARCHIT PLAN RES, V10, P219; Balba, 1995, MANAGEMENT PROBLEM S; BATES P. J. J., 1991, MAMMALS ARABIA; Blondel DV, 2009, J MAMMAL, V90, P715, DOI 10.1644/08-MAMM-A-009R2.1; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BOITANI L, 1984, Z SAUGETIERKD, V49, P193; Brown J. L., 1964, Wilson Bulletin, V76, P160; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Calder WA., 1984, SIZE FUNCTION LIFE H; CASSINI MH, 1994, ECOGRAPHY, V17, P289, DOI 10.1111/j.1600-0587.1994.tb00105.x; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CLUTTONBROCK TH, 1978, NATURE, V273, P191, DOI 10.1038/273191a0; CORBET GB, 1988, MAMMAL REV, V18, P117, DOI 10.1111/j.1365-2907.1988.tb00082.x; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Doncaster CP, 2001, J ANIM ECOL, V70, P33; Dowding CV, 2010, ANIM BEHAV, V80, P13, DOI 10.1016/j.anbehav.2010.04.007; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fischer J, 2008, FRONT ECOL ENVIRON, V6, P382, DOI 10.1890/070019; Fisher DO, 1999, ANIM BEHAV, V58, P121, DOI 10.1006/anbe.1999.1119; Fisher DO, 2000, J ANIM ECOL, V69, P1083, DOI 10.1046/j.1365-2656.2000.00450.x; Garcia-Rodriguez Sergi, 2014, Galemys, V26, P49; GAULIN SJC, 1988, J MAMMAL, V69, P311, DOI 10.2307/1381381; Gehrt SD, 1998, ANIM BEHAV, V55, P1211, DOI 10.1006/anbe.1997.0657; Glasby L, 2013, EUR J WILDLIFE RES, V59, P915, DOI 10.1007/s10344-013-0770-3; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Haigh A, 2013, MAMMALIA, V77, P163, DOI 10.1515/mammalia-2012-0094; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hof AR, 2010, ANIM CONSERV, V13, P467, DOI 10.1111/j.1469-1795.2010.00359.x; Kenward R. E., 2008, RANGES 8 ANAL TRACKI; Kenward RE., 2000, MANUAL WILDLIFE RADI; Khorozyan I, 2014, BIODIVERS CONSERV, V23, P1995, DOI 10.1007/s10531-014-0700-z; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Kristiansson H, 1984, THESIS; Krupp F, 2009, ZOOKEYS, P3, DOI 10.3897/zookeys.31.371; Levesque DL, 2012, J ZOOL, V287, P161, DOI 10.1111/j.1469-7998.2012.00899.x; Lovari S, 2013, BEHAV PROCESS, V99, P42, DOI 10.1016/j.beproc.2013.06.005; Lucherini M, 1996, BEHAV PROCESS, V36, P103, DOI 10.1016/0376-6357(95)00018-6; Macdonald DW, 2015, WILDLIFE CONSERVATION ON FARMLAND, VOL 1: MANAGING FOR NATURE ON LOWLAND FARMS, P1; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Manly B.F.J., 2002, RESOURCE SELECTION A; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; MICOL T, 1994, J ANIM ECOL, V63, P851, DOI 10.2307/5262; Moorhouse TP, 2014, BIOL CONSERV, V176, P109, DOI 10.1016/j.biocon.2014.05.015; Moran S, 2009, J ZOOL, V278, P349, DOI 10.1111/j.1469-7998.2009.00583.x; MORRIS PA, 1988, J ZOOL, V214, P433, DOI 10.1111/j.1469-7998.1988.tb03751.x; Msuha MJ, 2012, BIODIVERS CONSERV, V21, P2747, DOI 10.1007/s10531-012-0331-1; Murdoch James D., 2006, Mongolian Journal of Biological Sciences, V4, P25; Newsome TM, 2013, ECOGRAPHY, V36, P914, DOI 10.1111/j.1600-0587.2013.00056.x; Rautio A, 2013, ANN ZOOL FENN, V50, P107, DOI 10.5735/086.050.0110; Reeve N., 1994, HEDGEHOGS T AD POYSE; Reeve N.J., 1982, Symposia of the Zoological Society of London, V49, P207; Riber AB, 2006, ACTA THERIOL, V51, P363, DOI 10.1007/BF03195183; Richer R, 2009, 2 GEORG U CTR INT RE, V2; Rooney SM, 1998, MAMMAL REV, V28, P89, DOI 10.1046/j.1365-2907.1998.00028.x; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Sandell M., 1989, P164; SCHOENFELD M, 1985, MAMMALIA, V49, P339, DOI 10.1515/mamm.1985.49.3.339; Shapira I, 2008, ANIM CONSERV, V11, P1, DOI 10.1111/j.1469-1795.2007.00145.x; Sillitoe P, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-28; Sprent J, 2012, AUST J ZOOL, V60, P46, DOI 10.1071/ZO11098; Steinmann AR, 2005, ACTA THERIOL, V50, P197, DOI 10.1007/BF03194483; Stirrat SC, 2003, WILDLIFE RES, V30, P593, DOI 10.1071/WR02066; Sweitzer RA, 2003, WEST N AM NATURALIST, V63, P1; Viggers KL, 2005, J APPL ECOL, V42, P99, DOI 10.1111/j.1365-2664.2005.01001.x; Warwick Hugh, 2006, Lutra, V49, P89; White G. C., 1990, ANAL RADIO TRACKING; Yamaguchi N, 2003, J MAMMAL, V84, P1341, DOI 10.1644/1545-1542(2003)084<1341:TBOCIR>2.0.CO;2; Yamaguchi N, 2013, J ARID ENVIRON, V99, P1, DOI 10.1016/j.jaridenv.2013.09.001; Zapletal M, 2015, J ARID ENVIRON, V114, P100, DOI 10.1016/j.jaridenv.2014.11.010; Zapletal Mirka, 2012, Mongolian Journal of Biological Sciences, V10, P41	74	14	15	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180826	10.1371/journal.pone.0180826	http://dx.doi.org/10.1371/journal.pone.0180826			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746381	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800020
J	Han, ZL; Wang, DQ; Liu, F; Zhao, ZY				Han, Zengliang; Wang, Dongqing; Liu, Feng; Zhao, Zhiyong			Multi-AGV path planning with double-path constraints by using an improved genetic algorithm	PLOS ONE			English	Article							AUTOMATED GUIDED VEHICLE; HYBRID ELECTRIC VEHICLES; MEMETIC ALGORITHM; OPTIMIZATION; TRANSPORTATION; NETWORK; DESIGN; SYSTEM; NUMBER	This paper investigates an improved genetic algorithm on multiple automated guided vehicle (multi-AGV) path planning. The innovations embody in two aspects. First, three-exchange crossover heuristic operators are used to produce more optimal offsprings for getting more information than with the traditional two-exchange crossover heuristic operators in the improved genetic algorithm. Second, double-path constraints of both minimizing the total path distance of all AGVs and minimizing single path distances of each AGV are exerted, gaining the optimal shortest total path distance. The simulation results show that the total path distance of all AGVs and the longest single AGV path distance are shortened by using the improved genetic algorithm.	[Han, Zengliang; Wang, Dongqing; Zhao, Zhiyong] Qingdao Univ, Coll Automat & Elect Engn, Qingdao 266071, Peoples R China; [Liu, Feng] Univ Texas Arlington, Dept Ind Engn, Arlington, TX 76019 USA	Qingdao University; University of Texas System; University of Texas Arlington	Wang, DQ (corresponding author), Qingdao Univ, Coll Automat & Elect Engn, Qingdao 266071, Peoples R China.	dqwang64@163.com	Liu, Feng/AAK-1113-2021	Liu, Feng/0000-0002-5225-8199; Wang, Dongqing/0000-0001-8856-4289	National Natural Science Foundation of China [61573205]; Shandong Provincial Natural Science Foundation of China [ZR2015FM017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This research was supported by the National Natural Science Foundation of China (No. 61573205) and the Shandong Provincial Natural Science Foundation of China (No. ZR2015FM017).	Alcaide D, 2007, EUR J OPER RES, V177, P147, DOI 10.1016/j.ejor.2005.11.019; Anvari B, 2016, AUTOMAT CONSTR, V71, P226, DOI 10.1016/j.autcon.2016.08.007; Bai SF, 2012, NANJING U AERONAUTIC, V31, P10; Bocewicz G, 2015, IFAC PAPERSONLINE, V48, P2103, DOI 10.1016/j.ifacol.2015.06.399; Bocewicz G, 2014, ENG APPL ARTIF INTEL, V30, P49, DOI 10.1016/j.engappai.2014.02.003; Bogdan G, 2016, IEEE T AUTOM SCI ENG, V13, P1433; Chodrow PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161738; Contreras-Bolton C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137724; Egbelu PJ, 2009, INT J PROD RES, V44, P543; Endo S., 2000, Transactions of the Institute of Systems, Control and Information Engineers, V13, P115, DOI 10.5687/iscie.13.3_115; Falsafi H, 2014, ENERGY, V64, P853, DOI 10.1016/j.energy.2013.10.034; Hadas Y, 2016, TRANSPORT POLICY, V52, P186, DOI 10.1016/j.tranpol.2016.08.006; Hsueh CF, 2010, COMPUT IND ENG, V58, P594, DOI 10.1016/j.cie.2009.12.008; Hu XS, 2017, MECH SYST SIGNAL PR, V87, P4, DOI 10.1016/j.ymssp.2016.03.004; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; Hu XS, 2012, IEEE T CONTR SYST T, V24, P1036; INGBER L, 1989, MATH COMPUT MODEL, V12, P967, DOI 10.1016/0895-7177(89)90202-1; Jaiganesh V, 2014, PROCEDIA ENGINEER, V97, P2011, DOI 10.1016/j.proeng.2014.12.444; Ji M, 2010, COMPUT IND ENG, V59, P544, DOI 10.1016/j.cie.2010.06.013; Jiang ZB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165804; Jin F, 2004, CHINESE J SCI INSTRU, P844; Kok KY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150558; Koo PH, 2005, INT J FLEX MANUF SYS, V17, P23, DOI 10.1007/s10696-005-5992-6; Li B, 2017, ADV ENG SOFTW, V106, P33, DOI 10.1016/j.advengsoft.2017.01.002; Liu Q, 2014, COMPUT OPER RES, V44, P42, DOI 10.1016/j.cor.2013.10.010; Long Q, 2015, SWARM EVOL COMPUT, V22, P1, DOI 10.1016/j.swevo.2015.01.002; Lu L, 2012, APPL STOCH MODELS BU, V3, P85; Martinez-Barbera H, 2010, ROBOT CIM-INT MANUF, V26, P296, DOI 10.1016/j.rcim.2009.10.003; Miyamoto T, 2016, COMPUT IND ENG, V91, P1, DOI 10.1016/j.cie.2015.10.017; Neri F, 2012, SWARM EVOL COMPUT, V2, P1, DOI 10.1016/j.swevo.2011.11.003; Ojalehto V, 2014, COMPUT OPTIM APPL, V58, P757, DOI 10.1007/s10589-014-9639-y; Peer ES, 2003, PROCEEDINGS OF THE 2003 IEEE SWARM INTELLIGENCE SYMPOSIUM (SIS 03), P235, DOI 10.1109/SIS.2003.1202274; Prakash A, 2011, EXPERT SYST APPL, V38, P3161, DOI 10.1016/j.eswa.2010.09.002; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Qu SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147341; Ramezani M, 2013, APPL MATH MODEL, V37, P328, DOI 10.1016/j.apm.2012.02.032; Sabar NR, 2017, ENG APPL ARTIF INTEL, V63, P45, DOI 10.1016/j.engappai.2017.04.021; Said H, 2014, AUTOMAT CONSTR, V43, P110, DOI 10.1016/j.autcon.2014.03.017; Smolic-Rocak N, 2010, IEEE T AUTOM SCI ENG, V7, P151, DOI 10.1109/TASE.2009.2016350; Vis IFA, 2001, J OPER RES SOC, V52, P409, DOI 10.1057/palgrave.jors.2601094; Vivaldini K, 2016, INT J ADV MANUF TECH, V82, P719, DOI 10.1007/s00170-015-7343-4; Wang F, 2011, DECIS SUPPORT SYST, V51, P262, DOI 10.1016/j.dss.2010.11.020; Wang JQ, 2016, APPL SOFT COMPUT, V43, P415, DOI 10.1016/j.asoc.2016.02.021; Wang YZ, 2017, COMPUT IND ENG, V106, P105, DOI 10.1016/j.cie.2016.12.017; Xia GM, 2007, COMPUTER ENG SCI, V29, P6; Xidias EK, 2011, ROBOT AUTON SYST, V59, P34, DOI 10.1016/j.robot.2010.10.003; Xin J., 2014, PROC 19 IFAC WORLD C, P9828, DOI DOI 10.3182/20140824-6-ZA-1003.01306; Xu G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170803; Yang SQ, 2014, COMPUTER ENG APPL, V169, P8; Zhang L, 2013, 39 ANN C IEEE IND EL; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043; Zhang Z, 2017, IEEE T CYBERNETICS, V47, P1367, DOI 10.1109/TCYB.2016.2544866	54	33	35	17	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181747	10.1371/journal.pone.0181747	http://dx.doi.org/10.1371/journal.pone.0181747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746355	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800058
J	Algarte, VM; Siqueira, T; Landeiro, VL; Rodrigues, L; Bonecker, CC; Rodrigues, LC; Santana, NF; Thomaz, SM; Bini, LM				Algarte, Vanessa Majewski; Siqueira, Tadeu; Landeiro, Victor Lemes; Rodrigues, Liliana; Bonecker, Claudia Costa; Rodrigues, Luzia Cleide; Santana, Natalia Fernanda; Thomaz, Sidinei Magela; Bini, Luis Mauricio			Main predictors of periphyton species richness depend on adherence strategy and cell size	PLOS ONE			English	Article							SHALLOW LAKE; PHYTOPLANKTON; COMMUNITY; PRODUCTIVITY; DISTURBANCE; DIVERSITY; DYNAMICS; PATTERNS; NUTRIENT; BIOMASS	Periphytic algae are important components of aquatic ecosystems. However, the factors driving periphyton species richness variation remain largely unexplored. Here, we used data from a subtropical floodplain (Upper Parana A River floodplain, Brazil) to quantify the influence of environmental variables (total suspended matter, temperature, conductivity, nutrient concentrations, hydrology, phytoplankton biomass, phytoplankton species richness, aquatic macrophyte species richness and zooplankton density) on overall periphytic algal species richness and on the richness of different algal groups defined by morphological traits (cell size and adherence strategy). We expected that the coefficients of determination of the models estimated for different trait-based groups would be higher than the model coefficient of determination of the entire algal community. We also expected that the relative importance of explanatory variables in predicting species richness would differ among algal groups. The coefficient of determination for the model used to predict overall periphytic algal species richness was higher than the ones obtained for models used to predict the species richness of the different groups. Thus, our first prediction was not supported. Species richness of aquatic macrophytes was the main predictor of periphyton species richness of the entire community and a significant predictor of the species richness of small mobile, large mobile and small-loosely attached algae. Abiotic variables, phytoplankton species richness, chlorophyll-a concentration, and hydrology were also significant predictors, depending on the group. These results suggest that habitat heterogeneity (as proxied by aquatic macrophytes richness) is important for maintaining periphyton species richness in floodplain environments. However, other factors played a role, suggesting that the analysis of species richness of different trait-based groups unveils relationships that were not detectable when the entire community was analysed together.	[Algarte, Vanessa Majewski; Rodrigues, Liliana; Bonecker, Claudia Costa; Rodrigues, Luzia Cleide; Santana, Natalia Fernanda; Thomaz, Sidinei Magela] Univ Estadual Maringa, Dept Ciencias Biol, Programa Posgrad Ecol Ambientes Aquat Continentai, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Maringa, Parana, Brazil; [Siqueira, Tadeu] Univ Estadual Paulista, UNESP, Inst Biociencias, Dept Ecol, Rio Claro, SP, Brazil; [Landeiro, Victor Lemes] Univ Fed Mato Grosso, Inst Biociencias, Dept Bot & Ecol, Cuiaba, MG, Brazil; [Bini, Luis Mauricio] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade Estadual de Maringa; Universidade Estadual Paulista; Universidade Federal de Mato Grosso; Universidade Federal de Goias	Algarte, VM (corresponding author), Univ Estadual Maringa, Dept Ciencias Biol, Programa Posgrad Ecol Ambientes Aquat Continentai, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Maringa, Parana, Brazil.	vanialgarte@hotmail.com	Siqueira, Tadeu/A-6978-2009; Rodrigues, Luzia C/B-7856-2017; Bini, Luis Mauricio/D-5865-2013; Rodrigues, Luzia/AAB-2194-2021; Thomaz, Sidinei Magela/A-7331-2013; Landeiro, Victor/H-2195-2012; Bonecker, Claudia C/D-5946-2013	Siqueira, Tadeu/0000-0001-5069-2904; Rodrigues, Luzia C/0000-0002-0593-0931; Bini, Luis Mauricio/0000-0003-3398-9399; Rodrigues, Luzia/0000-0002-0593-0931; Landeiro, Victor/0000-0002-9341-6050; Bonecker, Claudia C/0000-0003-4338-9012; Rodrigues, Liliana/0000-0001-5902-6203	Brazilian Federal Agency; Evaluation of Graduate Education (CAPES); National Counsel of Technological and Scientific Development (CNPq); CNPq; Sao Paulo Research Foundation (FAPESP) [2013/50424-1]	Brazilian Federal Agency; Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The Brazilian Federal Agency for Support and Evaluation of Graduate Education (CAPES) granted a scholarship to the first author. This study was funded by the "Long -Term Ecological Research" program of the National Counsel of Technological and Scientific Development (CNPq) and received logistical support from the Research Centre in Limnology, Ichthyology and Aquaculture Nupelia. LR, SMT, LMB and CCB received financial support from CNPq productivity scholarships. Additional funding was provided to TS through grant #2013/50424-1, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Agostinho AA, 2000, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 1, P89; Albay M, 2003, HYDROBIOLOGIA, V506, P531, DOI 10.1023/B:HYDR.0000008606.69572.f6; Algarte VM, 2014, HYDROBIOLOGIA, V722, P279, DOI 10.1007/s10750-013-1711-6; ALLAN JD, 1976, AM NAT, V110, P165, DOI 10.1086/283056; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; BIGGS BJF, 1989, FRESHWATER BIOL, V22, P209, DOI 10.1111/j.1365-2427.1989.tb01096.x; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; Bini LM, 2004, J BIOGEOGR, V31, P1819, DOI 10.1111/j.1365-2699.2004.01126.x; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Brown R. C., 2007, Endosperm: developmental and molecular biology, P1; BROWN SD, 1973, HYDROBIOLOGIA, V43, P333, DOI 10.1007/BF00015355; Cardinale BJ, 2006, J ECOL, V94, P609, DOI 10.1111/j.1365-2745.2006.01107.x; Chaparro G, 2015, RIVER RES APPL, V31, P85, DOI 10.1002/rra.2711; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Cottingham KL, 1998, ECOL APPL, V8, P508, DOI 10.2307/2641090; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; GINE MF, 1980, ANAL CHIM ACTA, V114, P191, DOI 10.1016/S0003-2670(01)84290-2; Golterman HL, 1978, METHODS PHYS CHEM AN; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; Hillebrand H, 2002, J N AM BENTHOL SOC, V21, P349, DOI 10.2307/1468475; Hillebrand H, 2007, P NATL ACAD SCI USA, V104, P10904, DOI 10.1073/pnas.0701918104; Hinojosa-Garro D, 2010, FUND APPL LIMNOL, V177, P19, DOI 10.1127/1863-9135/2010/0177-0019; Jackson G, 2006, ESTUAR COAST, V29, P1212, DOI 10.1007/BF02781821; Koroleff K.J.H., 1976, METHODS SEAWATER ANA, P117; Laugaste R, 2005, HYDROBIOLOGIA, V547, P137, DOI 10.1007/s10750-005-4155-9; Legendre P., 2012, NUMERICAL ECOLOGY; Liess A, 2009, J ECOL, V97, P326, DOI 10.1111/j.1365-2745.2008.01463.x; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Low-Decarie E, 2014, FRONT ECOL ENVIRON, V12, P412, DOI 10.1890/130230; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Mackereth F.J.H., 1978, WATER ANAL SOME REVI; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marquet PA, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P191; Nabout JC, 2009, ACTA OECOL, V35, P720, DOI 10.1016/j.actao.2009.07.002; Padial AA, 2012, ECOL INDIC, V13, P55, DOI 10.1016/j.ecolind.2011.05.007; Passy SI, 2007, AQUAT BOT, V86, P171, DOI 10.1016/j.aquabot.2006.09.018; Passy SI, 2009, GLOBAL ECOL BIOGEOGR, V18, P383, DOI 10.1111/j.1466-8238.2009.00453.x; Pfeiffer TZ, 2015, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2014038; Pinheiro J., 2013, PACKAGE NLME; R Core Team, 2021, R LANGUAGE ENV STAT; Rakocevic J, 2012, ARCH BIOL SCI, V64, P585, DOI 10.2298/ABS1202585R; Rautio M, 2006, FRESHWATER BIOL, V51, P1038, DOI 10.1111/j.1365-2427.2006.01550.x; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Roberto MC, 2009, BRAZ J BIOL, V69, P717, DOI 10.1590/S1519-69842009000300025; Rodrigues L, 2004, BIO INL WAT, P125; Rodrigues Liliana, 2001, Revista Brasileira de Botanica, V24, P235; Romo S, 2007, FUND APPL LIMNOL, V170, P197, DOI 10.1127/1863-9135/2007/0170-0197; Sekar R, 2002, FRESHWATER BIOL, V47, P1893, DOI 10.1046/j.1365-2427.2002.00936.x; Siqueira T, 2015, HYDROBIOLOGIA, V750, P5, DOI 10.1007/s10750-014-2071-6; Soininen J, 2009, J BIOGEOGR, V36, P720, DOI 10.1111/j.1365-2699.2008.02034.x; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Steinman Alan D., 1996, P341, DOI 10.1016/B978-012668450-6/50041-2; Symonds M. R. E., 2014, MODERN PHYLOGENETIC, P105, DOI DOI 10.1007/978-3-662-43550-2_5; Tang T, 2013, AQUAT ECOL, V47, P453, DOI 10.1007/s10452-013-9458-8; Thomaz Sidinei Magela, 2010, Acta Limnol. Bras., V22, P218, DOI 10.4322/actalb.02202011; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Wetzel CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045071; Wetzel R. G., 1991, LIMNOLOGICAL ANAL; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Zuur Alain F., 2009, P1	64	16	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181720	10.1371/journal.pone.0181720	http://dx.doi.org/10.1371/journal.pone.0181720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742122	gold, Green Submitted, Green Published			2022-12-26	WOS:000406362700062
J	Chowdhary, J; Loffler, FE; Smith, JC				Chowdhary, Janamejaya; Loffler, Frank E.; Smith, Jeremy C.			Community detection in sequence similarity networks based on attribute clustering	PLOS ONE			English	Article							LARGE-SCALE; PROTEIN; ALIGNMENT; DATABASE; TOOL	Networks are powerful tools for the presentation and analysis of interactions in multi-component systems. A commonly studied mesoscopic feature of networks is their community structure, which arises from grouping together similar nodes into one community and dissimilar nodes into separate communities. Here, the community structure of protein sequence similarity networks is determined with a new method: Attribute Clustering Dependent Communities (ACDC). Sequence similarity has hitherto typically been quantified by the alignment score or its expectation value. However, pair alignments with the same score or expectation value cannot thus be differentiated. To overcome this deficiency, the method constructs, for pair alignments, an extended alignment metric, the link attribute vector, which includes the score and other alignment characteristics. Rescaling components of the attribute vectors qualitatively identifies a systematic variation of sequence similarity within protein superfamilies. The problem of community detection is then mapped to clustering the link attribute vectors, selection of an optimal subset of links and community structure refinement based on the partition density of the network. ACDC-predicted communities are found to be in good agreement with gold standard sequence databases for which the "ground truth" community structures (or families) are known. ACDC is therefore a community detection method for sequence similarity networks based entirely on pair similarity information. A serial implementation of ACDC is available from https://cmb.ornl.gov/resources/developments	[Chowdhary, Janamejaya; Smith, Jeremy C.] Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37830 USA; [Chowdhary, Janamejaya; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Joint Inst Biol Sci, Oak Ridge, TN 37830 USA; [Chowdhary, Janamejaya; Smith, Jeremy C.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA; [Loffler, Frank E.] Univ Tennessee, Dept Microbiol, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Loffler, Frank E.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA; [Loffler, Frank E.; Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Chowdhary, J; Smith, JC (corresponding author), Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN 37830 USA.; Chowdhary, J; Smith, JC (corresponding author), Univ Tennessee, Oak Ridge Natl Lab, Joint Inst Biol Sci, Oak Ridge, TN 37830 USA.; Chowdhary, J; Smith, JC (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA.; Loffler, FE (corresponding author), Univ Tennessee, Dept Microbiol, Dept Civil & Environm Engn, Knoxville, TN 37996 USA.; Loffler, FE (corresponding author), Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA.; Loffler, FE; Smith, JC (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	janamejaya.chowdhary@gmail.com; frank.loeffler@utk.edu; smithjc@ornl.gov	smith, jeremy c/B-7287-2012	smith, jeremy c/0000-0002-2978-3227	University of Tennessee	University of Tennessee	This work was funded by the University of Tennessee.	Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P1; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alva V, 2015, ELIFE, V4, DOI 10.7554/eLife.09410; [Anonymous], NETWORKS AN INTRODUC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Barthelemy M, 2011, PHYS REP, V499, P1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernardes JS, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-014-0445-4; Borgatti S.P., 2018, ANAL SOCIAL NETWORKS; Bothorel C, 2015, NETW SCI, V3, P408, DOI 10.1017/nws.2015.9; Brown SD, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r8; Brown SD, 2014, J BIOL CHEM, V289, P30221, DOI 10.1074/jbc.R114.569350; Brys G, 2004, J COMPUT GRAPH STAT, V13, P996, DOI 10.1198/106186004X12632; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cerina F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037507; Cormen Thomas H., 2009, INTRO ALGORITHMS; Creusefond Jean, 2016, Advances in Network Science. 12th International Conference and School, NetSci-X 2016. Proceedings: LNCS 9564, P111, DOI 10.1007/978-3-319-28361-6_9; David F, 1996, FLUCTUATING GEOMETRI; Dovoedo YH., 2011, CONTRIBUTIONS OUTLIE; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Evans TS, 2010, EUR PHYS J B, V77, P265, DOI 10.1140/epjb/e2010-00261-8; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Haggerty LS, 2014, MOL BIOL EVOL, V31, P501, DOI 10.1093/molbev/mst228; Halary S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-146; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Junker BHaS F., 2007, ANAL BIOL NETWORKS; Lee KM, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-50742-1; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nepusz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-120; Newman MEJ., 2006, STRUCTURE DYNAMICS N; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pearson WR., 2002, CURRENT PROTOCOLS BI; Powers David MW., 2015, ARXIV PREPRINT ARXIV; Rodriguez-Esteban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000597; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Schlessinger A, 2010, PROTEIN SCI, V19, P412, DOI 10.1002/pro.320; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tan P. -N., 2005, INTRO DATA MINING, V1st; Tukey JW, 1977, EXPLORATORY DATA ANA; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; VINGRON M, 1994, J MOL BIOL, V235, P1, DOI 10.1016/S0022-2836(05)80006-3; Weston J, 2004, P NATL ACAD SCI USA, V101, P6559, DOI 10.1073/pnas.0308067101; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wolfsheimer S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061913; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z; Yang J, 2014, P IEEE, V102, P1892, DOI 10.1109/JPROC.2014.2364018	56	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0178650	10.1371/journal.pone.0178650	http://dx.doi.org/10.1371/journal.pone.0178650			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738060	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700002
J	Erez, O; Romero, R; Maymon, E; Chaemsaithong, P; Done, B; Pacora, P; Panaitescu, B; Chaiworapongsa, T; Hassan, SS; Tarca, AL				Erez, Offer; Romero, Roberto; Maymon, Eli; Chaemsaithong, Piya; Done, Bogdan; Pacora, Percy; Panaitescu, Bogdan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Tarca, Adi L.			The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study	PLOS ONE			English	Article							UTERINE ARTERY DOPPLER; PLACENTAL GROWTH-FACTOR; FOR-GESTATIONAL-AGE; ANTI-ANGIOGENIC FACTORS; MATERNAL PLASMA-CONCENTRATIONS; NECROSIS-FACTOR-ALPHA; HYPERTENSIVE DISORDERS; FACTOR RECEPTOR-1; SOLUBLE ENDOGLIN; NORMAL-PREGNANCY	Background Late-onset preeclampsia is the most prevalent phenotype of this syndrome; nevertheless, only a few biomarkers for its early diagnosis have been reported. We sought to correct this deficiency using a high through-put proteomic platform. Methods A case-control longitudinal study was conducted, including 90 patients with normal pregnancies and 76 patients with late-onset preeclampsia (diagnosed at >= 34 weeks of gestation). Maternal plasma samples were collected throughout gestation (normal pregnancy: 2-6 samples per patient, median of 2; late-onset preeclampsia: 2-6, median of 5). The abundance of 1,125 proteins was measured using an aptamers-based proteomics technique. Protein abundance in normal pregnancies was modeled using linear mixed-effects models to estimate mean abundance as a function of gestational age. Data was then expressed as multiples of-the-mean (MoM) values in normal pregnancies. Multi-marker prediction models were built using data from one of five gestational age intervals (8-16, 16.1-22, 22.1-28, 28.1-32, 32.1-36 weeks of gestation). The predictive performance of the best combination of proteins was compared to placental growth factor (PIGF) using bootstrap. Results 1) At 8-16 weeks of gestation, the best prediction model included only one protein, matrix metalloproteinase 7 (MMP-7), that had a sensitivity of 69% at a false positive rate (FPR) of 20% (AUC = 0.76); 2) at 16.1-22 weeks of gestation, MMP-7 was the single best predictor of late-onset preeclampsia with a sensitivity of 70% at a FPR of 20% (AUC = 0.82); 3) after 22 weeks of gestation, PlGF was the best predictor of late-onset preeclampsia, identifying 1/3 to 1/2 of the patients destined to develop this syndrome (FPR = 20%); 4) 36 proteins were associated with late-onset preeclampsia in at least one interval of gestation (after adjustment for covariates); 5) several biological processes, such as positive regulation of vascular endothelial growth factor receptor signaling pathway, were perturbed; and 6) from 22.1 weeks of gestation onward, the set of proteins most predictive of severe preeclampsia was different from the set most predictive of the mild form of this syndrome. Conclusions Elevated MMP-7 early in gestation (8-22 weeks) and low PlGF later in gestation (after 22 weeks) are the strongest predictors for the subsequent development of late-onset preeclampsia, suggesting that the optimal identification of patients at risk may involve a two-step diagnostic process.	[Erez, Offer; Romero, Roberto; Maymon, Eli; Chaemsaithong, Piya; Done, Bogdan; Pacora, Percy; Panaitescu, Bogdan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Tarca, Adi L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,US Dept Hlth & Human Serv,NIH, Bethesda, MD 20892 USA; [Erez, Offer; Romero, Roberto; Maymon, Eli; Chaemsaithong, Piya; Done, Bogdan; Pacora, Percy; Panaitescu, Bogdan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Tarca, Adi L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,US Dept Hlth & Human Serv,NIH, Detroit, MI USA; [Erez, Offer; Maymon, Eli; Pacora, Percy; Panaitescu, Bogdan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Tarca, Adi L.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Erez, Offer] Ben Gurion Univ Negev, Soroka Univ, Sch Med, Fac Hlth Sci,Div Obstet & Gynecol,Matern Dept D, Beer Sheva, Israel; [Erez, Offer] Ben Gurion Univ Negev, Soroka Univ, Fac Hlth Sci, Sch Med,Div Obstet & Gynecol,Obstet Day Care Ctr, Beer Sheva, Israel; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Coll Engn, Detroit, MI 48202 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; University of Michigan System; University of Michigan; Michigan State University; Wayne State University; Wayne State University	Romero, R; Tarca, AL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,US Dept Hlth & Human Serv,NIH, Bethesda, MD 20892 USA.; Romero, R; Tarca, AL (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,US Dept Hlth & Human Serv,NIH, Detroit, MI USA.; Romero, R (corresponding author), Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.; Romero, R (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.; Romero, R (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA.; Tarca, AL (corresponding author), Wayne State Univ, Dept Comp Sci, Coll Engn, Detroit, MI 48202 USA.	prbchiefstaff@med.wayne.edu; atarca@med.wayne.edu	; Romero, Roberto/A-5268-2019	Chaemsaithong, piya/0000-0002-5398-6868; chaemsaithong, piya/0000-0003-1750-9834; Romero, Roberto/0000-0002-4448-5121; Tarca, Adi Laurentiu/0000-0003-1712-7588	Perinatology Research Branch; Program for Perinatal Research and Obstetrics, Division of Intramural Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; U.S. Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS [HHSN275201300006C]; Perinatal Initiative of the Wayne State University School of Medicine	Perinatology Research Branch; Program for Perinatal Research and Obstetrics, Division of Intramural Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U.S. Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Perinatal Initiative of the Wayne State University School of Medicine	This research was supported, in part, by the Perinatology Research Branch, Program for Perinatal Research and Obstetrics, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with Federal funds from NICHD/NIH/DHHS under Contract No. HHSN275201300006C. ALT was also supported by the Perinatal Initiative of the Wayne State University School of Medicine.	Aardema MW, 2001, PLACENTA, V22, P405, DOI 10.1053/plac.2001.0676; Abbas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084935; Abdelaziz A, 2012, ULTRASOUND OBST GYN, V40, P398, DOI 10.1002/uog.11205; Adams T, 2014, SEMIN PERINATOL, V38, P146, DOI 10.1053/j.semperi.2014.03.003; Aggarwal PK, 2006, KIDNEY INT, V69, P621, DOI 10.1038/sj.ki.5000075; Akolekar R, 2008, ULTRASOUND OBST GYN, V32, P732, DOI 10.1002/uog.6244; Akolekar R, 2013, FETAL DIAGN THER, V33, P8, DOI 10.1159/000341264; Akolekar R, 2011, PRENATAL DIAG, V31, P66, DOI 10.1002/pd.2660; Akolekar R, 2009, PRENATAL DIAG, V29, P753, DOI 10.1002/pd.2279; Allen RE, 2014, EUR J OBSTET GYN R B, V182, P194, DOI 10.1016/j.ejogrb.2014.09.027; [Anonymous], 2016, Obstet Gynecol, V127, pe123, DOI 10.1097/AOG.0000000000001406; [Anonymous], 2002, OBSTET GYNECOL, V99, P159; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baer RJ, 2015, OBSTET GYNECOL, V126, P753, DOI 10.1097/AOG.0000000000001040; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bdolah Y, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.783; Beckmann I, 2004, HYPERTENS PREGNANCY, V23, P319, DOI 10.1081/PRG-200030334; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Berg CJ, 2009, OBSTET GYNECOL, V113, P1075, DOI 10.1097/AOG.0b013e3181a09fc0; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Burke B, 2004, IMMUNOBIOLOGY, V209, P51, DOI 10.1016/j.imbio.2004.04.005; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chaiworapongsa T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.016; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Cheng YW, 2011, BJOG-INT J OBSTET GY, V118, P1446, DOI 10.1111/j.1471-0528.2011.03045.x; Cohen A, 2007, DIABETES CARE, V30, P375, DOI 10.2337/dc06-1514; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Crispi F, 2006, AM J OBSTET GYNECOL, V195, P201, DOI 10.1016/j.ajog.2006.01.014; Crovetto F, 2015, PRENATAL DIAG, V35, P183, DOI 10.1002/pd.4519; Dashe JS, 2016, OBSTET GYNECOL, V128, P181, DOI 10.1097/AOG.0000000000001385; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Dayarian A, 2014, BIOINFORMATICS; Dekker GA, 1996, J PERINAT MED, V24, P99; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Drolet DW, 2016, NUCL ACID THER; Durst JK, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.024; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Erez-Weiss I, 2005, HYPERTENS PREGNANCY, V24, P125, DOI 10.1081/PRG-200059853; Eskild A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.003; Espinoza J, 2014, ULTRASOUND OBST GYN, V43, P165, DOI 10.1002/uog.12518; Espinoza J, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.002; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gilbert JS, 2008, AM J PHYSIOL-HEART C, V294, pH541, DOI 10.1152/ajpheart.01113.2007; Gilbert JS, 2007, HYPERTENSION, V50, P1142, DOI 10.1161/HYPERTENSIONAHA.107.096594; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Goncalves I, 2015, ARTERIOSCL THROM VAS, V35, P1723, DOI 10.1161/ATVBAHA.115.305631; Granger JP, 2002, MICROCIRCULATION, V9, P147, DOI 10.1038/sj.mn.7800137; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112; Hnat MD, 2002, AM J OBSTET GYNECOL, V186, P422, DOI 10.1067/mob.2002.120280; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Jelin AC, 2010, J MATERN-FETAL NEO M, V23, P389, DOI [10.1080/14767050903168416, 10.3109/14767050903168416]; Jeyabalan A, 2015, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 4TH EDITION, P133, DOI 10.1016/B978-0-12-407866-6.00007-9; Junus K, 2012, MOL HUM REPROD, V18, P146, DOI 10.1093/molehr/gar067; Katabuchi Hidetaka, 2003, Medical Electron Microscopy, V36, P253, DOI 10.1007/s00795-003-0223-2; Kenneth L, 2010, HYPERTENS PREGNANCY, V29, P262, DOI 10.3109/10641950902777697; Kim YM, 2015, J MATERN-FETAL NEO M, V28, P2001, DOI 10.3109/14767058.2014.976198; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lamarca B, 2010, Minerva Ginecol, V62, P105; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lindheimer MD, 2007, HYPERTENSION, V50, P35, DOI 10.1161/HYPERTENSIONAHA.107.089045; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472; Llurba E, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/275613; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Madazli R, 2014, ARCH GYNECOL OBSTET, V290, P53, DOI 10.1007/s00404-014-3176-x; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Makris A, 2016, HYPERTENSION, V67, P1263, DOI 10.1161/HYPERTENSIONAHA.116.07286; Martinez-Fierro ML, 2017, BIOMARKERS, P1; Mastrogiannis DS, 2009, CURR DIABETES REP, V9, P296, DOI 10.1007/s11892-009-0046-1; Maymon E, 2000, AM J OBSTET GYNECOL, V182, P1545, DOI 10.1067/mob.2000.107652; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.017; Mbah AK, 2010, BJOG-INT J OBSTET GY, V117, P997, DOI 10.1111/j.1471-0528.2010.02593.x; Mehan MR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-32; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Melchiorre K, 2008, ULTRASOUND OBST GYN, V32, P133, DOI 10.1002/uog.5400; Mifsud W, 2014, FETAL DIAGN THER, V36, P117, DOI 10.1159/000359969; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Muresan D, 2016, MED ULTRASON, V18, P103, DOI 10.11152/mu.2013.2066.181.dop; Myatt L, 2013, BJOG-INT J OBSTET GY, V120, P1183, DOI 10.1111/1471-0528.12128; Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4; Myers JE, 2013, BJOG-INT J OBSTET GY, V120, P1215, DOI 10.1111/1471-0528.12195; Ngo D, 2016, CIRCULATION, V134, P270, DOI 10.1161/CIRCULATIONAHA.116.021803; Norton ME, 2016, OBSTET GYNECOL, V127, pE108, DOI 10.1097/AOG.0000000000001405; O'Gorman N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011801; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Ornaghi S, 2013, J MATERN-FETAL NEO M, V26, P1299, DOI 10.3109/14767058.2013.783807; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Ozimek JA, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.022; Parra-Cordero M, 2013, ULTRASOUND OBST GYN, V41, P538, DOI 10.1002/uog.12264; Parretti E, 2006, HYPERTENSION, V47, P449, DOI 10.1161/01.HYP.0000205122.47333.7f; Paruk F, 2000, Semin Neonatol, V5, P197, DOI 10.1053/siny.2000.0023; Pelisek J, 2009, CEREBROVASC DIS, V28, P601, DOI 10.1159/000247605; Perales A, 2017, ULTRASOUND OBST GYN, V50, P373, DOI 10.1002/uog.17373; PIJNENBORG R, 1991, BRIT J OBSTET GYNAEC, V98, P648, DOI 10.1111/j.1471-0528.1991.tb13450.x; Poon LCY, 2009, ULTRASOUND OBST GYN, V34, P142, DOI 10.1002/uog.6452; Poon LCY, 2013, FETAL DIAGN THER, V33, P16, DOI 10.1159/000341712; Poon LCY, 2009, HYPERTENSION, V53, P812, DOI 10.1161/HYPERTENSIONAHA.108.127977; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Rajakumar A, 2009, PLACENTA, V30, P25, DOI 10.1016/j.placenta.2008.10.006; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Rasmussen S, 2014, BJOG-INT J OBSTET GY, V121, P1351, DOI 10.1111/1471-0528.12677; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Reister F, 2006, J PERINAT MED, V34, P272, DOI 10.1515/JPM.2006.052; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROBERTS JM, 1991, AM J HYPERTENS, V4, P700, DOI 10.1093/ajh/4.8.700; ROBERTS JM, 1991, SEMIN PERINATOL, V15, P86; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; Robertson W B, 1976, Perspect Nephrol Hypertens, V5, P115; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Romero R, 2015, 12 WORLD C PER MED M; Romero R, 2017, AM J OBSTET GYNECOL; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2013, J CLIN INVEST, V123, P2775, DOI 10.1172/JCI70431; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; SALAFIA CM, 1995, AM J OBSTET GYNECOL, V173, P1097, DOI 10.1016/0002-9378(95)91333-5; Sarno L, 2015, HYPERTENS PREGNANCY, V34, P284, DOI 10.3109/10641955.2015.1015731; SCHIFF E, 1994, AM J OBSTET GYNECOL, V170, P1224, DOI 10.1016/S0002-9378(13)90438-5; Schlembach D, 2007, ULTRASOUND OBST GYN, V29, P407, DOI 10.1002/uog.3930; Schutte JM, 2010, BJOG-INT J OBSTET GY, V117, P399, DOI 10.1111/j.1471-0528.2009.02382.x; Scioscia M, 2009, J REPROD IMMUNOL, V82, P100, DOI 10.1016/j.jri.2009.04.009; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SomaLogic, SOMAMER TECHN NOT; Soto E, 2012, J MATERN-FETAL NEO M, V25, P498, DOI 10.3109/14767058.2011.591461; Stekkinger E, 2009, OBSTET GYNECOL, V114, P1076, DOI 10.1097/AOG.0b013e3181b7b242; Tarca AL, 2013, BIOINFORMATICS, V29, P2892, DOI 10.1093/bioinformatics/btt492; Tarca AL, 2013, SYSTEMS BIOMEDICINE, V1; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Tobinaga CM, 2014, ACTA OBSTET GYN SCAN, V93, P469, DOI 10.1111/aogs.12366; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Vatten LJ, 2004, BJOG-INT J OBSTET GY, V111, P298, DOI 10.1111/j.1471-0528.2004.00071.x; Verlohren S, 2014, ULTRASOUND OBST GYN, V44, P293, DOI 10.1002/uog.13310; Vettraino IM, 1996, PLACENTA, V17, P557, DOI 10.1016/S0143-4004(96)80072-5; Villa PM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-110; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; von Versen-Hoeynck FM, 2007, FRONT BIOSCI-LANDMRK, V12, P2457, DOI 10.2741/2247; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Webber J, 2014, MOL CELL PROTEOMICS, V13, P1050, DOI 10.1074/mcp.M113.032136; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c; Wikstom AK, 2007, OBSTET GYNECOL, V109, P1368, DOI 10.1097/01.AOG.0000264552.85436.a1; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563; Yu CKH, 2008, ULTRASOUND OBST GYN, V31, P310, DOI 10.1002/uog.5252	175	58	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181468	10.1371/journal.pone.0181468	http://dx.doi.org/10.1371/journal.pone.0181468			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738067	gold, Green Submitted, Green Published			2022-12-26	WOS:000406362700044
J	Hofhuis, A; van de Kassteele, J; Sprong, H; van den Wijngaard, CC; Harms, MG; Fonville, M; van Leeuwen, AD; Simoes, M; van Pelt, W				Hofhuis, Agnetha; van de Kassteele, Jan; Sprong, Hein; van den Wijngaard, Cees C.; Harms, Margriet G.; Fonville, Manoj; van Leeuwen, Arieke Docters; Simoes, Mariana; van Pelt, Wilfrid			Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model	PLOS ONE			English	Article							BURGDORFERI-SENSU-LATO; REAL-TIME PCR; IXODES-RICINUS; TRANSMISSION; INFECTION; SCAPULARIS; DYNAMICS; DISEASE; EPIDEMIOLOGY; PREVENTION	Background Understanding and quantification of the risk of Lyme borreliosis after a tick bite can aid development of prevention strategies against Lyme borreliosis. Methods We used 3,525 single tick bite reports from three large prospective studies on the transmission risk of tick-borne pathogens to humans, with 50 reports of Lyme borreliosis during the follow-up period, among 1,973 reports with known outcome. A structural equation model was applied to estimate the risk of Lyme borreliosis after a tick bite, and quantify the influence of: developmental stage of the tick, detection of Borrelia burgdorferi s.l. DNA in the tick by PCR, tick engorgement, patient-estimated duration of tick attachment, and patient age. Results The overall risk of developing Lyme borreliosis after a tick bite was 2.6% (95% CI 1.4-5.1). The risk increased with: Tick engorgement: 1.4% (95% CI 0.7%-2.3%) for low engorgement to 5.5% (95% CI 2.8%-9.2%) for substantially engorged ticks; Rising patient-estimated tick attachment duration: 2.0% (95% CI 1.3%-2.8%) after <12 hours, to 5.2% (95% CI 3.0%-8.9%) after >= 4 days; Detection of Borrelia burgdorferi s.l. DNA in ticks: 6.7% (95% CI 3.6%-13.5%), versus 1.4% (95% CI 0.7%-2.9%) when ticks tested negative. The highest observed risk of Lyme borreliosis was 14.4% (95% CI 6.8%-24.6%) after one tick bite of a substantially engorged tick that tested positive for Borrelia burgdorferi s.l. DNA, which corresponds to one new case of Lyme borreliosis per 7 (95% CI 4-15) of such tick bites. Conclusions An individual's risk of Lyme borreliosis after a tick bite can be predicted with tick engorgement, patient-estimated duration of tick attachment, and detection of Borrelia burgdorferi s.l. DNA in the tick.	[Hofhuis, Agnetha; Sprong, Hein; van den Wijngaard, Cees C.; Harms, Margriet G.; Fonville, Manoj; van Leeuwen, Arieke Docters; Simoes, Mariana; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [van de Kassteele, Jan] Natl Inst Publ Hlth & Environm, Dept Stat Informat & Math Modeling, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Hofhuis, A (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	Agnetha.Hothuis@rivm.nl	Harms, Margriet/AAN-5811-2020	Simoes, Mariana/0000-0002-2555-5366; Sprong, Hein/0000-0002-0218-4320; van de Kassteele, Jan/0000-0001-5926-6709	Ministry of Health, Welfare and Sport of the Netherlands	Ministry of Health, Welfare and Sport of the Netherlands	This study was financed by, and conducted on behalf of, the Ministry of Health, Welfare and Sport of the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Joke W.B. van der Giessen, Dr. Tineke Herremans, Dr. Daan W. Notermans, Dr. Sita C. Bennema, Dr. Arnold J.H. van Vliet, and Christa Drenth contributed to the data collection of the three nationwide prospective studies on the transmission risk of tick-borne pathogens to humans in the Netherlands. Professor Dr. Roel A. Coutinho provided helpful comments on this manuscript. This study was financed by, and conducted on behalf of, the ministry of Health, Welfare and Sport of the Netherlands.	[Anonymous], 2004, TICKS DOMESTIC ANIMA; BINGHAM PM, 1995, PEDIATRICS, V96, P1053; CHRISTEN HJ, 1990, ACTA PAEDIATR SCAND, V79, P1219; Cook MJ, 2015, INT J GEN MED, V8, P1, DOI 10.2147/IJGM.S73791; Crippa M, 2002, VECTOR-BORNE ZOONOT, V2, P3, DOI 10.1089/153036602760260724; des Vignes F, 2001, J INFECT DIS, V183, P773, DOI 10.1086/318818; Falco RC, 1996, AM J EPIDEMIOL, V143, P187, DOI 10.1093/oxfordjournals.aje.a008728; Fonville M, 2014, EMERG INFECT DIS, V20, P1244, DOI 10.3201/eid2007.131525; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Gooskens J, 2006, CLIN MICROBIOL INFEC, V12, P894, DOI 10.1111/j.1469-0691.2006.01509.x; Gray J, 2005, INT J MED MICROBIOL, V295, P567, DOI 10.1016/j.ijmm.2005.05.008; Gray JS, 1998, ZBL BAKT-INT J MED M, V287, P175; Gray JS, 1998, ZBL BAKT-INT J MED M, V287, P211, DOI 10.1016/S0934-8840(98)80123-0; HANSEN K, 1992, BRAIN, V115, P399, DOI 10.1093/brain/115.2.399; Heylen D, 2013, ENVIRON MICROBIOL, V15, P663, DOI 10.1111/1462-2920.12059; Hofhuis A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0777-6; Hofhuis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064361; Hubalek Zdenek, 2009, V37, P31, DOI 10.1159/000213069; Huegli D, 2011, TICKS TICK-BORNE DIS, V2, P129, DOI 10.1016/j.ttbdis.2011.05.002; JAENSON TGT, 1991, PARASITOL TODAY, V7, P39, DOI 10.1016/0169-4758(91)90187-S; Kahl O, 1998, ZBL BAKT-INT J MED M, V287, P41; Nahimana I, 2004, EUR J CLIN MICROBIOL, V23, P603, DOI 10.1007/s10096-004-1162-0; Peltomaa M, 1998, SCAND J INFECT DIS, V30, P269, DOI 10.1080/00365549850160927; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; PIESMAN J, 1993, J INFECT DIS, V167, P1082, DOI 10.1093/infdis/167.5.1082; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; RIVM, 2013, LCI GUID LYM BORR; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Sprong H, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-338; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Strle F, 2002, WIEN KLIN WOCHENSCHR, V114, P493; Strle F, 1996, CLIN INFECT DIS, V23, P61, DOI 10.1093/clinids/23.1.61; Takken W, 2016, VECTOR BORNE ZOONOTI; Tijsse-Klasen E, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-42; van Duijvendijk G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1389-5; Wang GQ, 2003, APPL ENVIRON MICROB, V69, P4561, DOI 10.1128/AEM.69.8.4561-4565.2003; Warshafsky S, 2010, J ANTIMICROB CHEMOTH, V65, P1137, DOI 10.1093/jac/dkq097; Wielinga PR, 2006, APPL ENVIRON MICROB, V72, P7594, DOI 10.1128/AEM.01851-06; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667	41	32	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181807	10.1371/journal.pone.0181807	http://dx.doi.org/10.1371/journal.pone.0181807			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742149	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700074
J	Donnelly, TT; Al-Khater, AH; Al-Bader, SB; Al-Kuwari, MG; Malik, MAA; Al-Meer, N; Singh, R				Donnelly, Tam Truong; Al-Khater, Al-Hareth; Al-Bader, Salha Bujassoum; Al-Kuwari, Mohamed Ghaith; Malik, Mariam Ali Abdul; Al-Meer, Nabila; Singh, Rajvir			Perceptions of Arab men regarding female breast cancer screening examinations-Findings from a Middle East study	PLOS ONE			English	Article							WOMEN	Objectives In the Middle East, Qatar in particular, the incidence of breast cancer has substantially increased in recent years, and is expected to double by 2030. This diagnosis also occurs at a later stage in the disease. Early detection along with proper treatment reduces radical mastectomy and mortality rates, yet only one-third of Arab women in Qatar participate in breast cancer screening (BCS) activities of any sort. Many women in the conservative Qatari society rely on male family members for support and protection. This study investigates the attitudes and perceptions of Arab men in regards to breast cancer screening and what they see as both incentives and barriers to women's participation in BCS activities. Design A qualitative methodology using purposive sampling technique was chosen in order to explore participant's attitudes, beliefs and health-related actions. Individual in-depth interviews with open-ended questions were conducted with 50 Arab men during October 2011 to May 2012. Data collection, analysis, and interpretation occurred simultaneously. NVivo 9, a qualitative data analysis software program was used to organize themes and subthemes. Results It was found that most men understood the importance of regular BCS in early detection of breast cancer. They felt they had an important role in encouraging the women in their lives to participate in BCS activities, but were adamant that any examination must be done by a female health care professional. Few knew details about screening guidelines in Qatar, but most had a basic knowledge of some screening activities. Most indicated an interest in learning more about BC and screening activities in order to better help and inform their female family members. Conclusion Because Arab men perceive that their opinions and support are a major factor influencing female family members' participation in breast cancer screening, it is important that any program instituted to increase such screening participation be aimed at both men and women. More information is needed by both sexes as to the need for and benefits of regular screening activities, the techniques used, and the newly revised guidelines in Qatar. Such a program needs to be introduced in the near future in order to avert, at least partially, the expected doubling in breast cancer cases by 2030 in the Middle East.	[Donnelly, Tam Truong] Univ Calgary, Fac Nursing & Med, Calgary, AB, Canada; [Al-Khater, Al-Hareth; Al-Bader, Salha Bujassoum] Hamad Med Corp, Dept Hematol & Oncol, Doha, Qatar; [Al-Kuwari, Mohamed Ghaith] Aspetar, Hlth Lifestyle Program, Doha, Qatar; [Malik, Mariam Ali Abdul] Qatar Minist Publ Hlth, Primary Hlth Care, Doha, Qatar; [Al-Meer, Nabila] Qatar Minist Publ Hlth, Nursing, Doha, Qatar; [Singh, Rajvir] Hamad Med Corp, Res Dept, Doha, Qatar	University of Calgary; Hamad Medical Corporation; Aspetar Orthopaedic & Sports Medicine Hospital; Hamad Medical Corporation	Donnelly, TT (corresponding author), Univ Calgary, Fac Nursing & Med, Calgary, AB, Canada.	tdonnell@ucalgary.ca		Al-Kuwari, Mohamed Ghaith/0000-0002-9158-5395	Qatar National Research Fund under its National Priorities Research Program [NPRP 09-261-3-059]; Qatar National Research Fund	Qatar National Research Fund under its National Priorities Research Program(Qatar National Research Fund (QNRF)); Qatar National Research Fund(Qatar National Research Fund (QNRF))	This publication was made possible by a grant from Qatar National Research Fund under its National Priorities Research Program (NPRP 09-261-3-059). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Qatar National Research Fund. We are grateful to all the men who participated in this research, as well as to the Qatar National Research Fund which provided us with funding to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhannadi HS, 2011, THESIS; Al-Saad S, 2007, BAHRAIN MED B, V31, P1; Al-Saad S, 2009, BAHRAIN MED B, V31; Almalki A., 2010, WOMAN TODAY, P60; Almalki A., 2010, WOMAN TODAY, P66; American Cancer Society, 2013, SURV RAT BREAST CANC; ANDERSON JM, 1986, SOC SCI MED, V22, P1277, DOI 10.1016/0277-9536(86)90195-4; Bener A, 2001, J CANCER EDUC, V16, P215; Bener Abdulbari, 2002, Oncol Nurs Forum, V29, pE91, DOI 10.1188/02.ONF.E91-E98; Brown R, 2012, LANCET ONCOL, V13, pE501, DOI 10.1016/S1470-2045(12)70461-8; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Cryder CE, 2010, SOC SCI MED, V70, P455, DOI 10.1016/j.socscimed.2009.10.047; Donnelly T.T., 2013, J IMMIGR MINOR HEALT, V17, P925; Donnelly TT, 2006, CAN J NURS RES, V38, P83; Donnelly TT, 2015, AVICENNA, DOI 10.5339/avi.2015.3; Donnelly TT, 2012, AVICENNA, DOI 10.5339/avi.2012.2; Donnelly TT, 2004, THESIS; El Saghir Nagi S, 2007, Int J Surg, V5, P225; GANSTER DC, 1983, ACAD MANAGE J, V26, P321, DOI 10.2307/255979; Gnerlich JL, 2009, J AM COLL SURGEONS, V208, P341, DOI 10.1016/j.jamcollsurg.2008.12.001; Green L.W., 1991, HLTH PROMOTION PLANN; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Hamilton N., 1996, POPULATION HLTH PROM; Hwang J. J., 2015, QUAL HEALTH RES, V27, P714; Kaufman SR, 1994, QUALITATIVE METHODS, P123; Kheirelseid EAH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-383; KLEINMAN A, 1978, SOC SCI MED-MED ANTH, V12, P85, DOI 10.1016/0160-7987(78)90014-5; Kleinman A., 1980, PATIENTS HEALERS CON; Mai V, 2009, SALUD PUBLICA MEXICO, V51, pS228, DOI 10.1590/S0036-36342009000800013; Miller A B, 2010, East Mediterr Health J, V16, P1022; Morse JM, 2015, QUAL HEALTH RES, V25, P587, DOI 10.1177/1049732315576699; National Cancer Program, 2016, BREAST CANC SCREEN; Poland BD, 2000, SETTINGS HLTH PROMOT; Qatar Supreme Council of Health, 2011, NAT CANC STRAT 2011; Sallis J.F., 2002, HLTH BEHAV HLTH ED T, V3rd ed., P462; Speziale H., 2010, QUALITATIVE RES NURS; Swanson G M, 1994, J Natl Cancer Inst Monogr, P69; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tarabeia J, 2007, EUR J CANCER PREV, V16, P36, DOI 10.1097/01.cej.0000228407.91223.85; Vollman AR, 2012, CANADIAN COMMUNITY P; World Health Organization, 2012, GLOBOCAN 2012 EST CA; World Health Organization, 2008, WORLD CANC REPORT 20	42	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180696	10.1371/journal.pone.0180696	http://dx.doi.org/10.1371/journal.pone.0180696			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732040	Green Submitted, gold, Green Published			2022-12-26	WOS:000406643100010
J	Glover, J; Man, TK; Barkauskas, DA; Hall, D; Tello, T; Sullivan, MB; Gorlick, R; Janeway, K; Grier, H; Lau, C; Toretsky, JA; Borinstein, SC; Khanna, C; Fan, TM				Glover, Jason; Man, Tsz-Kwong; Barkauskas, Donald A.; Hall, David; Tello, Tanya; Sullivan, Mary Beth; Gorlick, Richard; Janeway, Katherine; Grier, Holcombe; Lau, Ching; Toretsky, Jeffrey A.; Borinstein, Scott C.; Khanna, Chand; Fan, Timothy M.		COG Osteosarcoma Biol Grp	Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation	PLOS ONE			English	Article							GROWTH-FACTOR; EXPRESSION; CANCER	The prospective banking of osteosarcoma tissue samples to promote research endeavors has been realized through the establishment of a nationally centralized biospecimen repository, the Children's Oncology Group (COG) biospecimen bank located at the Biopathology Center (BPC)/Nationwide Children's Hospital in Columbus, Ohio. Although the physical inventory of osteosarcoma biospecimens is substantive (>15,000 sample specimens), the nature of these resources remains exhaustible. Despite judicious allocation of these high-value biospecimens for conducting sarcoma-related research, a deeper understanding of osteosarcoma biology, in particular metastases, remains unrealized. In addition the identification and development of novel diagnostics and effective therapeutics remain elusive. The QuadW-COG Childhood Sarcoma Biostatistics and Annotation Office (CSBAO) has developed the High Dimensional Data (HDD) platform to complement the existing physical inventory and to promote in silico hypothesis testing in sarcoma biology. The HDD is a relational biologic database derived from matched osteosarcoma biospecimens in which diverse experimental readouts have been generated and digitally deposited. As proof-of-concept, we demonstrate that the HDD platform can be utilized to address previously unrealized biologic questions though the systematic juxtaposition of diverse datasets derived from shared biospecimens. The continued population of the HDD platform with high-value, high-throughput and mineable datasets allows a shared and reusable resource for researchers, both experimentalists and bioinformatics investigators, to propose and answer questions in silico that advance our understanding of osteosarcoma biology.	[Glover, Jason] Randall Childrens Hosp, Childrens Canc & Blood Disorders Program, Portland, OR USA; [Man, Tsz-Kwong] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Man, Tsz-Kwong] Texas Childrens Canc Ctr, Houston, TX USA; [Barkauskas, Donald A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Hall, David; Tello, Tanya; Sullivan, Mary Beth] Childrens Oncol Grp, QuadW COG Childhood Sarcoma Biostat & Annotat Off, Monrovia, CA USA; [Gorlick, Richard] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Janeway, Katherine; Grier, Holcombe] Harvard Med Sch, Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat, Boston, MA USA; [Lau, Ching] Connecticut Childrens Med Ctr, Ctr Canc & Blood Disorders, Hartford, CT USA; [Toretsky, Jeffrey A.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Borinstein, Scott C.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Khanna, Chand] Ethos Discovery Washington DC & Ethos Vet Hlth, Woburn, MA USA; [Fan, Timothy M.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	Baylor College of Medicine; Texas Children's Cancer Center; University of Southern California; Children's Oncology Group (COG); University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Connecticut Children's Medical Center; Georgetown University; Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Fan, TM (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.	t-fan@illinois.edu		Fan, Timothy/0000-0003-2510-7050; Man, Tsz-Kwong/0000-0001-5920-5746; GORLICK, RICHARD/0000-0001-8995-2929	High Dimensional Database is through the WWWW (QuadW) Foundation; NATIONAL CANCER INSTITUTE [U10CA180899, U10CA180886] Funding Source: NIH RePORTER	High Dimensional Database is through the WWWW (QuadW) Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the development of the High Dimensional Database is through the WWWW (QuadW) Foundation, a philanthropic organization which provides financial support for personal operating under the QuadW-COG Childhood Sarcoma Biostatistics and Annotation Office. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett-Connor E, 1998, J BONE MINER RES, V13, P1343, DOI 10.1359/jbmr.1998.13.8.1343; Borinstein SC, 2014, PEDIATR BLOOD CANCER, V61, P749, DOI 10.1002/pbc.24778; Borinstein SC, 2011, CANCER-AM CANCER SOC, V117, P4966, DOI 10.1002/cncr.26112; Ebb D, 2012, J CLIN ONCOL, V30, P2545, DOI 10.1200/JCO.2011.37.4546; Glover J, 2015, PEDIATR BLOOD CANCER, V62, P450, DOI 10.1002/pbc.25346; Gorlick S, 2014, PEDIATR BLOOD CANCER, V61, P1558, DOI 10.1002/pbc.25074; Gueler B, 2012, HUM REPROD, V27, P1547, DOI 10.1093/humrep/des047; Hong Y, 2016, TUBERC RESPIR DIS, V79, P85, DOI 10.4046/trd.2016.79.2.85; Koshkina NV, 2007, J PEDIAT HEMATOL ONC, V29, P815, DOI 10.1097/MPH.0b013e3181581506; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Russo VC, 2015, CYTOKINE GROWTH F R, V26, P329, DOI 10.1016/j.cytogfr.2014.12.001; Yau SW, 2015, J CELL COMMUN SIGNAL, V9, P125, DOI 10.1007/s12079-015-0261-2; Zhao YD, 2008, CANCER INFORM, V6, P9; Zhu Y., 2015, UROLOGIC ONCOLOGY, V33	14	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181204	10.1371/journal.pone.0181204	http://dx.doi.org/10.1371/journal.pone.0181204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732082	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100027
J	Nagy, G; Oostenbrink, C; Hritz, J				Nagy, Gabor; Oostenbrink, Chris; Hritz, Jozef			Exploring the binding pathways of the 14-3-3 zeta : protein Structural and free-energy profiles revealed by Hamiltonian replica exchange molecular dynamics with distancefield distance restraints	PLOS ONE			English	Article							SIMULATIONS; SITES; PHOSPHOSERINE; RECOGNITION; FORCE; NMR	The 14-3-3 zeta protein family performs regulatory functions in eukaryotic organisms by binding to a large number of phosphorylated protein partners. Whilst the binding mode of the phosphopeptides within the primary 14-3-3 zeta binding site is well established based on the crystal structures of their complexes, little is known about the binding process itself. We present a computational study of the process by which phosphopeptides bind to the 14-3-3 zeta protein. Applying a novel scheme combining Hamiltonian replica exchange molecular dynamics and distancefield restraints allowed us to map and compare the most likely phosphopeptidebinding pathways to the 14-3-3 zeta protein. The most important structural changes to the protein and peptides involved in the binding process were identified. In order to bind phosphopeptides to the primary interaction site, the 14-3-3 zeta adopted a newly found wide-opened conformation. Based on our findings we additionally propose a secondary interaction site on the inner surface of the 14-3-3 zeta dimer, and a direct interference on the binding process by the flexible C-terminal tail. A minimalistic model was designed to allow for the efficient calculation of absolute binding affinities. Binding affinities calculated from the potential of mean force along the binding pathway are in line with the available experimental estimates for two of the studied systems.	[Nagy, Gabor; Hritz, Jozef] Masaryk Univ, CEITEC MU, Brno, Czech Republic; [Oostenbrink, Chris] Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, Vienna, Austria; [Nagy, Gabor] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Gottingen, Germany	Masaryk University Brno; University of Natural Resources & Life Sciences, Vienna; Max Planck Society	Hritz, J (corresponding author), Masaryk Univ, CEITEC MU, Brno, Czech Republic.	jozef.hritz@ceitec.muni.cz	Oostenbrink, Chris/S-8002-2019; Hritz, Jozef/J-6887-2015	Oostenbrink, Chris/0000-0002-4232-2556; Hritz, Jozef/0000-0002-4512-9241	Czech Science Foundation [GF15-34684L]; SoMoPro II Programme; European Union; South Moravian Region (Czech Republic); Austrian Science Fund (FWF) [W1224]; Austrian Science Foundation (FWF) [I 1999-N28]; European Research Council (ERC) [240608]; Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project [LM2015070]	Czech Science Foundation(Grant Agency of the Czech Republic); SoMoPro II Programme; European Union(European Commission); South Moravian Region (Czech Republic); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)European Commission); Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project	This work was supported by Czech Science Foundation, no. GF15-34684L (J.H., G.N.). J.H. was also supported from the SoMoPro II Programme, co-financed by the European Union and the South Moravian Region (Czech Republic). The paper reflects only the author's views and the Union is not liable for any use that may be made of the information contained therein. G.N. also acknowledges the BioTop doctoral exchange program, funded by the Austrian Science Fund (FWF; grant no. W1224). C.O. gratefully acknowledges the financial support of the Austrian Science Foundation (FWF; grant no. I 1999-N28) and the European Research Council (ERC; grant no. 240608). The computational simulations were realised in the National Supercomputing Center IT4Innovations, which was supported by The Ministry of Education, Youth and Sports from the Large Infrastructures for Research, Experimental Development and Innovations project LM2015070. Further computational resources were provided by the CESNET LM2015042 and the CERIT Scientific Cloud LM2015085, provided under the programme "Projects of Large Research, Development, and Innovations Infrastructures." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadei A, 2000, J CHEM PHYS, V112, P9, DOI 10.1063/1.480557; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; de Ruiter A, 2013, J CHEM THEORY COMPUT, V9, P883, DOI 10.1021/ct300967a; Doudou S, 2009, J CHEM THEORY COMPUT, V5, P909, DOI 10.1021/ct8002354; Eichenberger AP, 2011, J CHEM THEORY COMPUT, V7, P3379, DOI 10.1021/ct2003622; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Heinz TN, 2001, J CHEM PHYS, V115, P1125, DOI 10.1063/1.1379764; Hritz J, 2014, BIOPHYS J, V107, P2185, DOI 10.1016/j.bpj.2014.08.039; Hu GD, 2014, INT J MOL SCI, V15, P2794, DOI 10.3390/ijms15022794; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2012, J MOL BIOL, V423, P486, DOI 10.1016/j.jmb.2012.08.009; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nagy G, 2014, J CHEM INF MODEL, V54, P266, DOI 10.1021/ci400541d; Oostenbrink C, 2012, CURR DRUG METAB, V13, P190, DOI 10.2174/138920012798918453; Petrov D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003154; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmid N, 2012, COMPUT PHYS COMMUN, V183, P890, DOI 10.1016/j.cpc.2011.12.014; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sugita Y, 2000, J CHEM PHYS, V113, P6042, DOI 10.1063/1.1308516; TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273; Truong AB, 2002, PROTEINS, V49, P321, DOI 10.1002/prot.10210; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180633	10.1371/journal.pone.0180633	http://dx.doi.org/10.1371/journal.pone.0180633			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727767	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500026
J	Roussel, P; Porcherie, A; Reperant-Ferter, M; Cunha, P; Gitton, C; Rainard, P; Germon, P				Roussel, Perrine; Porcherie, Adeline; Reperant-Ferter, Maryline; Cunha, Patricia; Gitton, Christophe; Rainard, Pascal; Germon, Pierre			Escherichia coli mastitis strains: In vitro phenotypes and severity of infection in vivo	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; PERSISTENT BOVINE MASTITIS; IMMUNE-RESPONSE; ALVEOLAR MACROPHAGES; DAIRY-COWS; MILK; NEUTROPHILS; GLAND; INFLAMMATION; MODELS	Mastitis remains a major infection of dairy cows and an important issue for dairy farmers and the dairy industry, in particular infections due to Escherichia coli strains. So far, properties specific to E. coli causing mastitis remain ill defined. In an attempt to better understand the properties required for E. coli to trigger mastitis, we used a range of in vitro assays to phenotypically characterize four E. coli strains, including the prototypical E. coli mastitis strain P4, possessing different relative abilities to cause mastitis in a mouse model. Our results indicate that a certain level of serum resistance might be required for colonization of the mammary gland. Resistance to neutrophil killing is also likely to contribute to a slower clearance of bacteria and higher chances to colonize the udder. In addition, we show that the four different strains do induce a pro-inflammatory response by mammary epithelial cells but with different intensities. Interestingly, the prototypical mastitis strain P4 actually induces the less intense response while it is responsible for the most severe infections in vivo. Altogether, our results suggest that different strategies can be used by E. coli strains to colonize the mammary gland and cause mastitis.	[Roussel, Perrine; Porcherie, Adeline; Reperant-Ferter, Maryline; Cunha, Patricia; Gitton, Christophe; Rainard, Pascal; Germon, Pierre] Univ Francois Rabelais Tours, INRA, ISP, UMR 1282, Nouzilly, France	INRAE	Germon, P (corresponding author), Univ Francois Rabelais Tours, INRA, ISP, UMR 1282, Nouzilly, France.	pierre.germon@inra.fr	GERMON, Pierre/M-5264-2019; GERMON, Pierre/AAC-9111-2019	GERMON, Pierre/0000-0003-3078-876X; Porcherie, Adeline/0000-0002-8177-2461; Rainard, Pascal/0000-0002-5477-2626	"Microbiology and Food Chain"; "Animal Health" divisions of INRA; IFR136 "Agents Transmissibles et Infectiologie"; GISA metaprogram (RUMINFLAME project)	"Microbiology and Food Chain"; "Animal Health" divisions of INRA; IFR136 "Agents Transmissibles et Infectiologie"; GISA metaprogram (RUMINFLAME project)	Dr P. Roussel was recipient of a grant from the "Microbiology and Food Chain" and "Animal Health" divisions of INRA. This work was supported by grants from the IFR136 "Agents Transmissibles et Infectiologie" and from the GISA metaprogram (RUMINFLAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr P. Roussel was recipient of a grant from the "Microbiology and Food Chain" and "Animal Health" divisions of INRA. We thank Ghizlane Dahbi for typing of strains. We wish to thank Vanaique Guillory, Corinne Beauge, Remi Delaunay, Arnaud Faurie, Guillaume Martin and Anne Pinard for their technical assistance in mice experiments. We are also grateful to Eric Briant, Mickael Delanoue, Mickael Dupont, Ludovic Metayer for their help in selecting and milking cows. This work was supported by grants from the IFR136 "Agents Transmissibles et Infectiologie" and from the GISA metaprogram (RUMINFLAME project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ANDERSON JC, 1977, VET PATHOL, V14, P618, DOI 10.1177/030098587701400608; Blum S, 2008, VET MICROBIOL, V132, P135, DOI 10.1016/j.vetmic.2008.05.012; Blum SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136387; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Bougarn S, 2011, J DAIRY SCI, V94, P2425, DOI 10.3168/jds.2010-3859; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; BROOKER BE, 1981, EXPERIENTIA, V37, P290, DOI 10.1007/BF01991661; Burvenich C, 2003, VET RES, V34, P521, DOI 10.1051/vetres:2003023; CARROLL EJ, 1973, AM J VET RES, V34, P1143; CHANDLER RL, 1970, J MED MICROBIOL, V3, P273, DOI 10.1099/00222615-3-2-273; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Dopfer D, 2001, VET MICROBIOL, V80, P285, DOI 10.1016/S0378-1135(01)00307-8; Elazar S, 2010, VET RES, V41, DOI 10.1051/vetres/2010025; Elazar S, 2010, VET RES, V41, DOI 10.1051/vetres/2009058; Goldstone RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30115; Gunther J, 2016, VET RES, V47, DOI 10.1186/s13567-016-0307-3; Gunther J, 2009, VET RES, V40, DOI 10.1051/vetres/2009014; HEYNEMAN R, 1990, J DAIRY SCI, V73, P985, DOI 10.3168/jds.S0022-0302(90)78756-5; HILL AW, 1981, RES VET SCI, V31, P107, DOI 10.1016/S0034-5288(18)32532-3; HILL AW, 1983, VET MICROBIOL, V8, P293, DOI 10.1016/0378-1135(83)90081-0; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Kempf F, 2015, GENOME ANNOUNCEMENTS, V3; Kempf F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147954; Kornalijnslijper JE, 2003, VET MICROBIOL, V91, P125, DOI 10.1016/S0378-1135(02)00266-3; Mehrzad J, 2004, J DAIRY SCI, V87, P4150, DOI 10.3168/jds.S0022-0302(04)73558-4; NEMETH J, 1994, VET MICROBIOL, V40, P231, DOI 10.1016/0378-1135(94)90112-0; Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Porcherie A, 2016, J IMMUNOL, V196, P803, DOI 10.4049/jimmunol.1500705; Porcherie A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-14; Pupo E, 2013, FEBS J, V280, P1095, DOI 10.1111/febs.12104; Rainard P, 2003, VET RES, V34, P647, DOI 10.1051/vetres:2003025; Rainard P, 2008, MOL IMMUNOL, V45, P4020, DOI 10.1016/j.molimm.2008.06.010; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Riollet C, 2000, INFLAMM RES, V49, P486, DOI 10.1007/s000110050621; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schukken YH, 2011, VET IMMUNOL IMMUNOP, V144, P270, DOI 10.1016/j.vetimm.2011.08.022; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; VANDEPUTTEVANMESSOM G, 1993, J DAIRY RES, V60, P19, DOI 10.1017/S002202990002731X; Vangroenweghe F, 2004, J DAIRY SCI, V87, P4132, DOI 10.3168/jds.S0022-0302(04)73556-0	45	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e178285	10.1371/journal.pone.0178285	http://dx.doi.org/10.1371/journal.pone.0178285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727781	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500002
J	Chen, X; Zhi, X; Pan, PP; Cui, J; Cao, LH; Weng, WZ; Zhou, QR; Wang, L; Zhai, X; Zhao, Q; Hu, HG; Huang, BT; Su, JC				Chen, Xiao; Zhi, Xin; Pan, Panpan; Cui, Jin; Cao, Liehu; Weng, Weizong; Zhou, Qirong; Wang, Lin; Zhai, Xiao; Zhao, Qingiie; Hu, Honggang; Huang, Biaotong; Su, Jiacan			Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis	FASEB JOURNAL			English	Article						postmenopausal osteoporosis; NFATc1; osteoclasts	NF-KAPPA-B; DEFICIENCY-INDUCED OSTEOPOROSIS; RECEPTOR ACTIVATOR; ESTROGEN DEFICIENCY; SIGNALING PATHWAYS; POSTMENOPAUSAL OSTEOPOROSIS; PROINFLAMMATORY CYTOKINES; DIFFERENTIATION; INFLAMMATION; LIGAND	Osteoporosis is a metabolic bone disease characterized by decreased bone density and strength due to excessive loss of bone protein and mineral content. The imbalance between osteogenesis by osteoblasts and osteoclastogenesis by osteoclasts contributes to the pathogenesis of postmenopausal osteoporosis. Estrogen withdrawal leads to increased levels of proinflammatory cytokines. Overactivated osteoclasts by inflammation play a vital role in the imbalance. Matrine is an alkaloid found in plants from the Sophora genus with various pharmacological effects, including anti-inflammatory activity. Here we demonstrate that matrine significantly prevented ovariectomy-induced bone loss and inhibited osteoclastogenesis in vivo with decreased serum levels of TRAcp5b, TNF-alpha, and IL-6. In vitro matrine significantly inhibited osteoclast differentiation induced by receptor activator for NF-kappa B ligand (RANKL) and M-CSF in bone marrow monocytes and RAW264.7 cells as demonstrated by tartrate-resistant acid phosphatase (TRAP) staining and actin-ring formation as well as bone resorption through pit formation assays. For molecular mechanisms, matrine abrogated RANKL-induced activation of NF-kappa B, AKT, and MAPK pathways and suppressed osteoclastogenesis-related marker expression, including matrix metalloproteinase 9, NFATc1, TRAP, C-Src, and cathepsin K. Our study demonstrates that matrine inhibits osteoclastogenesis through modulation of multiple pathways and that matrine is a promising agent in the treatment of osteoclast-related diseases such as osteoporosis.	[Chen, Xiao; Pan, Panpan; Cao, Liehu; Weng, Weizong; Zhou, Qirong; Wang, Lin; Zhai, Xiao; Su, Jiacan] Second Mil Med Univ, Dept Orthoped Trauma, Shanghai Changhai Hosp, Shanghai, Peoples R China; [Zhi, Xin; Cui, Jin] Second Mil Med Univ, Shanghai Changhai Hosp, Grad Management Unit, Shanghai, Peoples R China; [Zhao, Qingiie; Hu, Honggang] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Chen, Xiao; Pan, Panpan; Cao, Liehu; Weng, Weizong; Zhou, Qirong; Wang, Lin; Zhao, Qingiie; Hu, Honggang; Huang, Biaotong; Su, Jiacan] China South Korea Bioengn Ctr, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Su, JC (corresponding author), Second Mil Med Univ, Dept Orthoped, Changhai Hosp, Changhai Rd, Shanghai 200433, Peoples R China.	drsujiacan@163.com	Jiacan, Su/N-7068-2019	Jiacan, Su/0000-0001-7080-263X	Shanghai Municipal Science and Technology Commission [15411950600]	Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank the Clear-Med-Trans Studio (Shanghai, China) for language polishing, Shanghai GeekBiotech (Shanghai, China) for technical support, Dr. J. Wang (Fudan University, Shanghai, China) for technical guidance, and Sir C. Liu for providing matrine. This work was supported by Shanghai Municipal Science and Technology Commission Key Program (15411950600). The authors declare no conflicts of interest.	Abu-Amer Y, 2013, OSTEOPOROSIS INT, V24, P2377, DOI 10.1007/s00198-013-2313-x; Andreopoulou P, 2015, ANNU REV MED, V66, P329, DOI 10.1146/annurev-med-070313-022841; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Barlow DH, 2010, HUM REPROD UPDATE, V16, P761, DOI 10.1093/humupd/dmq008; Bharti AC, 2004, J BIOL CHEM, V279, P6065, DOI 10.1074/jbc.M308062200; Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Del Fattore A, 2008, ARCH BIOCHEM BIOPHYS, V473, P147, DOI 10.1016/j.abb.2008.01.011; Del Puente A, 2015, J BIOL REG HOMEOS AG, V29, P527; Dou C, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.69; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Guan HF, 2015, FASEB J, V29, P1092, DOI 10.1096/fj.14-262055; Jakob F, 2015, UNFALLCHIRURG, V118, P925, DOI 10.1007/s00113-015-0085-9; Janas A, 2017, N-S ARCH PHARMACOL, V390, P175, DOI 10.1007/s00210-016-1295-6; Jia M, 2015, BEST PRACT RES CL EN, V29, P557, DOI 10.1016/j.beem.2015.04.008; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Koide M, 2009, J BONE MINER RES, V24, P1469, DOI [10.1359/JBMR.090302, 10.1359/jbmr.090302]; Lee EJ, 2014, PHYTOMEDICINE, V21, P1208, DOI 10.1016/j.phymed.2014.04.002; Lewiecki EM, 2011, NAT REV RHEUMATOL, V7, P631, DOI 10.1038/nrrheum.2011.130; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Li MJ, 2015, INT J MOL MED, V36, P1335, DOI 10.3892/ijmm.2015.2330; Ma J, 2015, J AM COLL CARDIOL, V66, pC23, DOI 10.1016/j.jacc.2015.06.1115; Pino AM, 2010, J BONE MINER RES, V25, P492, DOI 10.1359/jbmr.090802; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Moriwaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097177; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Novella S, 2012, ARTERIOSCL THROM VAS, V32, P2035, DOI 10.1161/ATVBAHA.112.250308; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Quach JM, 2015, J BONE MINER RES, V30, P886, DOI 10.1002/jbmr.2415; Shao HM, 2013, ONCOL LETT, V6, P517, DOI 10.3892/ol.2013.1399; Shukla P, 2017, J BIOL CHEM, V292, P4686, DOI 10.1074/jbc.M116.764779; Sun DQ, 2016, BIOCHEM BIOPH RES CO, V477, P83, DOI 10.1016/j.bbrc.2016.06.024; Tyagi AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044552; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Walsh MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00511; Warren JT, 2015, J CELL BIOCHEM, V116, P2476, DOI 10.1002/jcb.25191; Wu X, 2012, J BONE MINER RES, V27, P1298, DOI 10.1002/jbmr.1576; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; Xu WH, 2014, HEPATOLOGY, V60, P648, DOI 10.1002/hep.27138; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yu B, 2014, NAT MED, V20, P1009, DOI 10.1038/nm.3586; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zeng XZ, 2017, BIOCHEM PHARMACOL, V124, P57, DOI 10.1016/j.bcp.2016.10.007; Zeng XY, 2015, BRIT J PHARMACOL, V172, P4303, DOI 10.1111/bph.13209; Zhang B, 2011, EUR J PHARM SCI, V44, P573, DOI 10.1016/j.ejps.2011.09.020; Zhang PP, 2016, CANCER LETT, V376, P95, DOI 10.1016/j.canlet.2016.01.011; Zhou Y, 2009, MED HYPOTHESES, V73, P83, DOI 10.1016/j.mehy.2009.01.029	49	62	67	4	44	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4855	4865		10.1096/fj.201700316R	http://dx.doi.org/10.1096/fj.201700316R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739641	Green Published			2022-12-26	WOS:000413398500017
J	Zhao, ZY; Liang, YJ; Liu, Y; Xu, P; Flamme-Wiese, MJ; Sun, DM; Sun, JE; Mullins, RF; Chen, Y; Cai, JY				Zhao, Zhenyang; Liang, Yuejin; Liu, Yin; Xu, Pei; Flamme-Wiese, Miles J.; Sun, Deming; Sun, Jiaren; Mullins, Robert F.; Chen, Yan; Cai, Jiyang			Choroidal gamma delta T cells in protection against retinal pigment epithelium and retinal injury	FASEB JOURNAL			English	Article						inflammation; choriocapillaris drop out; immune modulation; AhR	ARYL-HYDROCARBON RECEPTOR; MACULAR DEGENERATION; IMMUNE PRIVILEGE; SODIUM IODATE; RPE; ACTIVATION; INNATE; NLRP3; NEOVASCULARIZATION; INFLAMMATION	gamma delta T cells located near the epithelial barrier are integral components of local inflammatory and innate immune responses. We have previously reported the presence of choroidal gd T cells in a model of chronic degeneration of the retinal pigment epithelium (RPE). The goals of the current study were to further define the functions of choroidal gd T cells and to explore the underlying mechanisms of their action. Our data demonstrate that choroidal gamma delta Tcells are activated by RPE injury in response to NaIO3 treatment, and that they express genes that encode immunosuppressive cytokines, such as IL-4 and IL-10. gd-T-cell-deficient mice developed profound RPE and retinal damage at doses that caused minimal effects in wild-type mice, and adoptive transfer of gd T cells prevented sensitization. Intravitreal injection of IL-4 and IL-10 ameliorated RPE toxicity that was inducedbyNaIO(3). Ex vivo coculture of gamma delta Tcells with RPE explants activated the production of anti-inflammatory cytokines via an aryl hydrocarbon receptor (AhR)-dependent mechanism. AhR deficiency abolished the protective effects of gd T cells after adoptive transfer. Collectively, these findings define important roles for choroid gd T cells in maintaining tissue homeostasis in the outer retina.-Zhao, Z., Liang, Y., Liu, Y., Xu, P., Flamme-Wiese, M. J., Sun, D., Sun, J., Mullins, R. F., Chen, Y., Cai, J. Choroidal gd T cells in protection against retinal pigment epithelium and retinal injury.	[Zhao, Zhenyang; Xu, Pei; Chen, Yan; Cai, Jiyang] Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, 301 Univ Blvd, Galveston, TX 77555 USA; [Liang, Yuejin; Sun, Jiaren] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Liu, Yin] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Flamme-Wiese, Miles J.; Mullins, Robert F.] Univ Iowa, Stephen A Wynn Inst Vis Res, Iowa City, IA USA; [Sun, Deming] Univ Calif Los Angeles, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Iowa; Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cai, JY (corresponding author), Univ Texas Med Branch, Dept Ophthalmol & Visual Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	jicai@utmb.edu	Mullins, Robert F/I-6717-2013; Liang, Yuejin/X-5250-2019; Xu, Pei/B-1680-2016	Liang, Yuejin/0000-0002-9557-1847; Mullins, Robert/0000-0002-5006-0891; Xu, Pei/0000-0002-9480-8021	U.S. National Institutes of Health, National Eye Institute [EY021937, EY026999, EY022403, EY024605]; Ted Nash Long Life Foundation; Carl Marshall Reeves and Mildred Almen Reeves Foundation; BrightFocus Foundation; International Retina Research Foundation; NATIONAL EYE INSTITUTE [R01EY021937, R01EY024605, R01EY018827, R01EY022403, R01EY026999] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Ted Nash Long Life Foundation; Carl Marshall Reeves and Mildred Almen Reeves Foundation; BrightFocus Foundation(BrightFocus Foundation); International Retina Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health, National Eye Institute Grants EY021937, EY026999, EY022403, and EY024605; the Ted Nash Long Life Foundation; Carl Marshall Reeves and Mildred Almen Reeves Foundation; BrightFocus Foundation; and International Retina Research Foundation. The authors declare no conflicts of interest.	Akitsu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8464; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; Ashour HM, 2006, J IMMUNOL, V177, P8331, DOI 10.4049/jimmunol.177.12.8331; Balmer J, 2015, INT J MOL SCI, V16, P15086, DOI 10.3390/ijms160715086; Born W K, 2000, Respir Res, V1, P151, DOI 10.1186/rr26; Camelo S, 2016, OPHTHALMOLOGICA, V236, P53, DOI 10.1159/000446587; Carido M, 2014, INVEST OPHTH VIS SCI, V55, P5431, DOI 10.1167/iovs.14-14325; Chen SD, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/369312; Chen Y, 2002, J BIOL CHEM, V277, P33242, DOI 10.1074/jbc.M202026200; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Cheruvu NPS, 2006, INVEST OPHTH VIS SCI, V47, P4513, DOI 10.1167/iovs.06-0404; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chirco KR, 2016, EXP EYE RES, V146, P393, DOI 10.1016/j.exer.2015.09.003; Choudhary M, 2015, J PATHOL, V235, P101, DOI 10.1002/path.4433; Clemson CM, 2017, OCUL IMMUNOL INFLAMM, V25, P179, DOI 10.3109/09273948.2015.1092560; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coughlin B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23794; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Detrick B, 2010, IMMUNOL RES, V47, P153, DOI 10.1007/s12026-009-8146-1; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Green DR, 2001, NAT REV MOL CELL BIO, V2, P917, DOI 10.1038/35103104; Gregerson DS, 2007, INVEST OPHTH VIS SCI, V48, P4654, DOI 10.1167/iovs.07-0286; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Han H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11432; Hasegawa E, 2013, J IMMUNOL, V190, P1778, DOI 10.4049/jimmunol.1202495; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hu P, 2013, P NATL ACAD SCI USA, V110, pE4069, DOI 10.1073/pnas.1307574110; Imai A, 2012, INVEST OPHTH VIS SCI, V53, P7299, DOI 10.1167/iovs.12-10182; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kaestel CG, 2005, CURR EYE RES, V30, P375, DOI 10.1080/02713680590934120; Kannan R, 2014, NEURAL REGEN RES, V9, P2044, DOI 10.4103/1673-5374.147927; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kawazoe Y, 2012, EXP EYE RES, V94, P32, DOI 10.1016/j.exer.2011.11.002; Kelly J, 2007, J CLIN INVEST, V117, P3421, DOI 10.1172/JCI32430; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091; Kuhl AA, 2007, J LEUKOCYTE BIOL, V81, P168, DOI 10.1189/jlb.1105696; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liang DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150078; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Misiak A, 2017, J IMMUNOL, V198, P363, DOI 10.4049/jimmunol.1601024; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; O'Brien RL, 2010, SEMIN IMMUNOL, V22, P193, DOI 10.1016/j.smim.2010.03.006; Park CY, 2010, OCUL IMMUNOL INFLAMM, V18, P24, DOI 10.3109/09273940903326203; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; ROSENBAUM JT, 1995, J IMMUNOL, V155, P4090; SIM GK, 1994, INT IMMUNOL, V6, P1287, DOI 10.1093/intimm/6.9.1287; Skelsey ME, 2001, J IMMUNOL, V166, P4327, DOI 10.4049/jimmunol.166.7.4327; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Stange J, 2013, SEMIN IMMUNOPATHOL, V35, P645, DOI 10.1007/s00281-013-0389-1; Sumaria N, 2011, J EXP MED, V208, P505, DOI 10.1084/jem.20101824; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tseng WA, 2013, INVEST OPHTH VIS SCI, V54, P110, DOI 10.1167/iovs.12-10655; Wallace CA, 2013, INVEST OPHTH VIS SCI, V54, P722, DOI 10.1167/iovs.12-10602; Wang W, 2011, OPHTHALMOL EYE DIS, V3, DOI 10.4137/OED.S7797; Wenkel H, 2000, INVEST OPHTH VIS SCI, V41, P3467; Wohl SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022408; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Zhang SJ, 2016, INVEST OPHTH VIS SCI, V57, P312, DOI 10.1167/iovs.15-17578; ZHAO ZY, 2014, INVEST OPHTH VIS SCI, V55; Zhou R, 2012, J IMMUNOL, V188, P1742, DOI 10.4049/jimmunol.1102415; Zhu YJ, 2016, IMMUNOLOGY, V147, P414, DOI 10.1111/imm.12571	80	13	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4903	4916		10.1096/fj.201700533R	http://dx.doi.org/10.1096/fj.201700533R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28729290	Green Published, Green Submitted			2022-12-26	WOS:000413398500021
J	Zhang, CY; Chang, CF; Zhao, WM; Gao, H; Wang, QW; Li, DM; Zhang, FC; Zhang, SF; Xu, CS				Zhang, Chunyan; Chang, Cuifang; Zhao, Weiming; Gao, Hang; Wang, Qiwen; Li, Deming; Zhang, Fuchun; Zhang, Shifu; Xu, Cunshuan			The novel protein C9orf116 promotes rat liver cell line BRL-3A proliferation	PLOS ONE			English	Article							IN-VIVO; HEPATOCYTE PROLIFERATION; DIFFERENTIAL REGULATION; LENTIVIRAL VECTORS; GENE-EXPRESSION; GROWTH-HORMONE; CYCLIN B1; C-JUN; REGENERATION; PHASE	Our previous study has proved that the chromosome 9 open reading frame 116 (C9orf116) (NM_001106564.1) was significantly up-regulated in the proliferation phase of liver regeneration. To study its possible physiological function, we analyzed the effect of C9orf116 on BRL-3A cells via over-expression and interference technique. MTT results showed that the cell viability of the interference group was significantly lower than the control group at 48h after transfection (P<0.05), whereas it was significantly higher in the over-expression group (P<0.05). The flow cytometry results showed that C9orf116 knockdown or over-expression had little effect on BRL-3A cell apoptosis. However, the number of cells in division phase (G2/M) was significantly reduced in the interference group (P<0.05), but significantly increased in the over-expression group (P<0.01). Furthermore, the expressions of cell proliferation-related genes CCNA2, CCND1 and MYC both at mRNA and protein levels were down-regulated in the interference group and up-regulated in the over-expression group. Therefore, we concluded that C9orf116 may promote cell proliferation by modulating cell cycle transition and the expression of key genes CCNA2, CCND1 and MYC in BRL-3A cells.	[Zhang, Chunyan; Zhang, Fuchun] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China; [Zhang, Chunyan; Chang, Cuifang; Zhao, Weiming; Gao, Hang; Wang, Qiwen; Li, Deming; Zhang, Shifu; Xu, Cunshuan] Henan Normal Univ, Coll Life Sci, State Key Lab Cultivat Base Cell Differentiat Reg, Xinxiang, Henan, Peoples R China; [Zhang, Chunyan; Chang, Cuifang; Zhao, Weiming; Gao, Hang; Wang, Qiwen; Li, Deming; Zhang, Shifu; Xu, Cunshuan] Henan Normal Univ, Coll Life Sci, Henan Engn Lab Bioengn & Drug Dev, Xinxiang, Henan, Peoples R China	Xinjiang University; Henan Normal University; Henan Normal University	Xu, CS (corresponding author), Henan Normal Univ, Coll Life Sci, State Key Lab Cultivat Base Cell Differentiat Reg, Xinxiang, Henan, Peoples R China.; Xu, CS (corresponding author), Henan Normal Univ, Coll Life Sci, Henan Engn Lab Bioengn & Drug Dev, Xinxiang, Henan, Peoples R China.	cellkeylab@126.com			National Nature Science Foundation of China [31572270]; Natural Science Foundation of Henan [142300413227]; Key Scientific Research Projects of Henan Province [15A180007]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan; Key Scientific Research Projects of Henan Province	Funded by National Nature Science Foundation of China (No. 31572270), Natural Science Foundation of Henan (No. 142300413227), Key Scientific Research Projects of Henan Province (Grant No. 15A180007) -Qiwen Wang.	ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; ALCORN JA, 1990, HEPATOLOGY, V11, P909, DOI 10.1002/hep.1840110602; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Berasain C, 2005, GASTROENTEROLOGY, V128, P424, DOI 10.1053/j.gastro.2004.11.006; Bohm F, 2010, EMBO MOL MED, V2, P294, DOI 10.1002/emmm.201000085; Conway-Campbell BL, 2007, P NATL ACAD SCI USA, V104, P13331, DOI 10.1073/pnas.0600181104; Dai KQ, 2014, CELLS TISSUES ORGANS, V200, P132, DOI 10.1159/000380762; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ding Y, 2016, INDUCED RAT BONE MES; Dissen GA, 2009, METHODS, V49, P70, DOI 10.1016/j.ymeth.2009.06.004; Duregon E, 2015, NEURO-ONCOLOGY, V17, P663, DOI 10.1093/neuonc/nov002; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Garnier D, 2009, HEPATOLOGY, V50, P1946, DOI 10.1002/hep.23225; Geng XF, 2016, GENE, V575, P224, DOI 10.1016/j.gene.2015.08.066; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027; Heger S, 2007, J CLIN INVEST, V117, P2145, DOI 10.1172/JCI31752; Hendzel MJ, 1998, J BIOL CHEM, V273, P24470, DOI 10.1074/jbc.273.38.24470; Jiang Y, 2011, J CELL BIOCHEM, V112, P3194, DOI 10.1002/jcb.23246; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Kalimuthu S, 2013, INT J MOL SCI, V14, P2334, DOI 10.3390/ijms14022334; Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074; Kinney EL, 2008, J CELL PHYSIOL, V216, P621, DOI 10.1002/jcp.21437; Kountouras J, 2001, HEPATO-GASTROENTEROL, V48, P556; Liu CY, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-56; Liu L, 2012, AM J PHYSIOL-CELL PH, V302, pC277, DOI 10.1152/ajpcell.00341.2011; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miquet JG, 2013, CELL CYCLE, V12, P1042, DOI 10.4161/cc.24026; MORELLO D, 1990, ONCOGENE, V5, P1511; Nanou A, 2013, MOL THER, V21, P1486, DOI 10.1038/mt.2013.115; Nanou A, 2009, PROG BRAIN RES, V175, P187, DOI 10.1016/S0079-6123(09)17513-1; Nelsen CJ, 2001, CANCER RES, V61, P8564; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Rickheim DG, 2002, HEPATOLOGY, V36, P30, DOI 10.1053/jhep.2002.33996; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rohan JNP, 2009, ENDOCRINOLOGY, V150, P2046, DOI 10.1210/en.2008-1395; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Stan SD, 2008, NUTR CANCER, V60, P51, DOI 10.1080/01635580802381477; Sun LH, 2015, TOXICON, V95, P6, DOI 10.1016/j.toxicon.2014.12.010; Sung YH, 2010, CANCER RES, V70, P10454, DOI 10.1158/0008-5472.CAN-10-0031; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; Zhang JH, 2015, GENE, V563, P45, DOI 10.1016/j.gene.2015.03.010; ZINDY F, 1992, BIOCHEM BIOPH RES CO, V182, P1144, DOI 10.1016/0006-291X(92)91851-G; Zou H, 2015, BIOL TRACE ELEM RES, V164, P90, DOI 10.1007/s12011-014-0201-7	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180607	10.1371/journal.pone.0180607	http://dx.doi.org/10.1371/journal.pone.0180607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749992	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700012
J	Friedman, O; Carmel, N; Sela, M; Abu Jabal, A; Inbal, A; Ben Hamou, M; Krelin, Y; Gur, E; Shani, N				Friedman, Or; Carmel, Narin; Sela, Meirav; Abu Jabal, Ameen; Inbal, Amir; Ben Hamou, Moshe; Krelin, Yakov; Gur, Eyal; Shani, Nir			Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model	PLOS ONE			English	Article							DELAYED GRAFT FUNCTION; HUMAN HAND ALLOGRAFT; KIDNEY-TRANSPLANTATION; TISSUE ALLOTRANSPLANTATION; INTERFERON-GAMMA; WOUND REPAIR; T-CELLS; FRACTALKINE; CYTOKINES; FACE	Background Hand and face vascularized composite allotransplantation (VCA) is an evolving and challenging field with great opportunities. During VCA, massive surgical damage is inflicted on both donor and recipient tissues, which may contribute to the high VCA rejection rates. To segregate between the damage-induced and rejection phase of post-VCA responses, we compared responses occurring up to 5 days following syngeneic versus allogeneic vascularized groin flap transplantations, culminating in transplant acceptance or rejection, respectively. Methods The immune response elicited upon transplantation of a syngeneic versus allogeneic vascularized groin flap was compared at Post-operative days 2 or 5 by histology, immunohistochemistry and by broad-scope gene and protein analyses using quantitative real-time PCR and Multiplex respectively. Results Immune cell infiltration began at the donor-recipient interface and paralleled expression of a large group of wound healing-associated genes in both allografts and syngrafts. By day 5 post-transplantation, cell infiltration spread over the entire allograft but remained confined to the wound site in the syngraft. This shift correlated with upregulation of IL-18, INFg, CXCL9, 10 and 11, CCL2, CCL5, CX3CL1 and IL-10 in the allograft only, suggesting their role in the induction of the anti-alloantigen adaptive immune response. Conclusions High resemblance between the cues governing VCA and solid organ rejection was observed. Despite this high resemblance we describe also, for the first time, a damage induced inflammatory component in VCA rejection as immune cell infiltration into the graft initiated at the surgical damage site spreading to the entire allograft only at late stage rejection. We speculate that the highly inflammatory setting created by the unique surgical damage during VCA may enhance acute allograft rejection.	[Friedman, Or; Carmel, Narin; Sela, Meirav; Abu Jabal, Ameen; Inbal, Amir; Ben Hamou, Moshe; Krelin, Yakov; Gur, Eyal; Shani, Nir] Tel Aviv Univ, Plast Reconstruct Surg Dept, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Shani, N (corresponding author), Tel Aviv Univ, Plast Reconstruct Surg Dept, Tel Aviv Sourasky Med Ctr, Sackler Fac Med, Tel Aviv, Israel.	nirs@tlvmc.gov.il	Friedman, Or/I-1578-2019	Friedman, Or/0000-0002-4362-7909				Alegre ML, 2008, CURR OPIN ORGAN TRAN, V13, P358, DOI 10.1097/MOT.0b013e3283061149; Bergfeld W, 2013, AM J TRANSPLANT, V13, P2750, DOI 10.1111/ajt.12379; Caterson EJ, 2013, J CRANIOFAC SURG, V24, P51, DOI 10.1097/SCS.0b013e31827104e1; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; DiPrieto L, 1998, J CLIN INVEST, V101, P1693; Dubernard JM, 2007, NEW ENGL J MED, V357, P2451, DOI 10.1056/NEJMoa072828; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Fischer S, 2014, CURR OPIN ORGAN TRAN, V19, P531, DOI 10.1097/MOT.0000000000000140; Foroohar A, 2011, HAND CLIN, V27, P405, DOI 10.1016/j.hcl.2011.07.005; Goldberg A, 2007, FASEB J, V21, P2840, DOI 10.1096/fj.06-7910com; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Grellner W, 2002, FORENSIC SCI INT, V130, P90, DOI 10.1016/S0379-0738(02)00342-0; Grose R, 2002, EMBO REP, V3, P575, DOI 10.1093/embo-reports/kvf119; Halloran P, 1997, INJURY RESPONSE CONC; Hancock WW, 2003, IMMUNOL REV, V196, P37, DOI 10.1046/j.1600-065X.2003.00084.x; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; Kanitakis J, 2003, TRANSPLANTATION, V76, P688, DOI 10.1097/01.TP.0000079458.81970.9A; Kapoor A, 2000, TRANSPLANTATION, V69, P1147, DOI 10.1097/00007890-200003270-00020; Khalifian S, 2014, LANCET, V384, P2153, DOI 10.1016/S0140-6736(13)62632-X; Kim SC, 2014, TRANSPLANT REV-ORLAN, V28, P15, DOI 10.1016/j.trre.2013.10.004; Lantieri L, 2008, LANCET, V372, P639, DOI 10.1016/S0140-6736(08)61277-5; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; McKay DB, 2011, SEMINARS IMMUNOPATHO; Lopez MM, 2006, TRANSPL IMMUNOL, V17, P31, DOI 10.1016/j.trim.2006.09.018; Mori DN, 2014, IMMUNOL REV, V258, P132, DOI 10.1111/imr.12146; Mulligan MS, 2000, EXP MOL PATHOL, V69, P167, DOI 10.1006/exmp.2000.2327; Nagano H, 1997, TRANSPLANTATION, V63, P1101, DOI 10.1097/00007890-199704270-00009; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Peng WH, 2008, KIDNEY INT, V74, P1454, DOI 10.1038/ki.2008.459; Pomahac B, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015651; Robinson LA, 2000, J IMMUNOLOGY, V165; Schneeberger S, 2011, TRANSPL INT, V24, P760, DOI 10.1111/j.1432-2277.2011.01261.x; Sekine Y, 2000, AM J RESP CELL MOL, V23, P719, DOI 10.1165/ajrcmb.23.6.3825; Shores JT, 2015, PLAST RECONSTR SURG, V135, p351E, DOI 10.1097/PRS.0000000000000892; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Siemionow M, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5873-z; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695; Striz I, 2005, IMMUNOL LETT, V99, P30, DOI 10.1016/j.imlet.2005.01.010; Thaunat O, 2015, CURR OPIN ORGAN TRAN, V20, P596, DOI 10.1097/MOT.0000000000000242; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Wang WZ, 2011, PLAST RECONSTR SURG, V128, p685E, DOI 10.1097/PRS.0b013e318230c57b; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wolfram D, 2014, INSIGHTS COMPUTATION; Wu WK, 2015, KIDNEY INT, V88, P851, DOI 10.1038/ki.2015.190; Wyburn K, 2005, NEPHROL DIAL TRANSPL, V20, P699, DOI 10.1093/ndt/gfh712; Zhang F, 2001, J RECONSTR MICROSURG, V17, P211, DOI 10.1055/s-2001-14353	56	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181507	10.1371/journal.pone.0181507	http://dx.doi.org/10.1371/journal.pone.0181507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746417	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800038
J	Hirut, B; Shimelis, H; Fentahun, M; Bonierbale, M; Gastelo, M; Asfaw, A				Hirut, Betaw; Shimelis, Hussein; Fentahun, Mengistu; Bonierbale, Merideth; Gastelo, Manuel; Asfaw, Asrat			Combining ability of highland tropic adapted potato for tuber yield and yield components under drought	PLOS ONE			English	Article							CHLOROPHYLL CONCENTRATION; GROWTH-PARAMETERS; WATER-STRESS; GRAIN-YIELD; LEAF-AREA; TOLERANCE; FIELD; RESISTANCE; CULTIVARS; LEAVES	Recurrent drought and late blight disease are the major factors limiting potato productivity in the northwest Ethiopian highlands. Incorporating drought tolerance and late blight resistance in the same genotypes will enable the development of cultivars with high and stable yield potential under erratic rainfall conditions. The objectives of this study were to assess combining ability effects and gene action for tuber yield and traits related to drought tolerance in the International Potato Centre's (CIP's) advanced clones from the late blight resistant breeding population B group 'B3C2' and to identify promising parents and families for cultivar development. Sixteen advanced clones from the late blight resistant breeding population were crossed in two sets using the North Carolina Design II. The resulting 32 families were evaluated together with five checks and 12 parental clones in a 7 x 7 lattice design with two water regimes and two replications. The experiment was carried out at Adet, in northwest Ethiopia under well-watered and water stressed conditions with terminal drought imposed from the tuber bulking stage. The results showed highly significant differences between families, checks, and parents for growth, physiological, and tuber yield related traits. Traits including marketable tuber yield, marketable tuber number, average tuber weight and groundcover were positively correlated with total tuber yield under both drought stressed and well-watered conditions. Plant height was correlated with yield only under drought stressed condition. GCA was more important than SCA for total tuber yield, marketable tuber yield, average tuber weight, plant height, groundcover, and chlorophyll content under stress. This study identified the parents with best GCA and the combinations with best SCA effects, for both tuber yield and drought tolerance related traits. The new population is shown to be a valuable genetic resource for variety selection and improvement of potato's adaptation to the drought prone areas in northwest Ethiopia and similar environments.	[Hirut, Betaw; Asfaw, Asrat] Int Potato Ctr CIP, Subsaharan Africa Reg Program, Addis Ababa, Ethiopia; [Hirut, Betaw; Shimelis, Hussein] Univ KwaZulu Natal, ACCI, Pietermaritzburg, Kwazulu Natal, South Africa; [Fentahun, Mengistu] EIAR, Addis Ababa, Ethiopia; [Bonierbale, Merideth; Gastelo, Manuel] Int Potato Ctr CIP, Disciplinary Ctr Excellency Genet Genom & Crop Im, Lima, Peru; [Asfaw, Asrat] IITA, Abuja, Nigeria	CGIAR; International Potato Center (CIP); University of Kwazulu Natal; Ethiopian Institute of Agricultural Research (EIAR); CGIAR; International Potato Center (CIP); CGIAR; International Institute of Tropical Agriculture (IITA)	Hirut, B (corresponding author), Int Potato Ctr CIP, Subsaharan Africa Reg Program, Addis Ababa, Ethiopia.; Hirut, B (corresponding author), Univ KwaZulu Natal, ACCI, Pietermaritzburg, Kwazulu Natal, South Africa.	H.Getinet@cgiar.org	Shimelis, Hussein/N-5073-2013; Hirut, Betaw/R-1587-2019	Shimelis, Hussein/0000-0003-2793-8392; Betaw, Hirut/0000-0002-1205-3711; GASTELO BENAVIDES, MANUEL ANTONIO/0000-0001-5329-555X	Alliance for a Green Revolution in Africa through African Centre for Crop Improvement [PASS 030]	Alliance for a Green Revolution in Africa through African Centre for Crop Improvement	This research was funded by the Alliance for a Green Revolution in Africa through African Centre for Crop Improvement with Grant number PASS 030; https://agra.org/. The grant was provided to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari U, 2015, FOOD ENERGY SECUR, V4, P110, DOI 10.1002/fes3.61; Anithakumari AM, 2012, MOL BREEDING, V30, P1413, DOI 10.1007/s11032-012-9728-5; Asfaw A, 2015, Potato and Sweetpotato in Africa: Transforming the Value Chains for Food and Nutrition Security, P134, DOI 10.1079/9781780644202.0134; BAKER RJ, 1978, CROP SCI, V18, P533, DOI 10.2135/cropsci1978.0011183X001800040001x; BEIL GM, 1967, CROP SCI, V7, P225, DOI 10.2135/cropsci1967.0011183X000700030016x; Berhan G., 2011, J STRATEGIC INNOVATI, V7, P135; Betaw H., 2016, GENETIC ANAL DROUGHT; BIDINGER FR, 1987, AUST J AGR RES, V38, P49, DOI 10.1071/AR9870049; Blonquist JM, 2009, AGR FOREST METEOROL, V149, P1931, DOI [10.1016/j.agrformet.2009.10.003, 10.1016/j.agrformet.2009.06.021]; BLUM A, 1982, FIELD CROP RES, V5, P137, DOI 10.1016/0378-4290(82)90014-4; Blum A, 2011, PLANT BREEDING FOR WATER-LIMITED ENVIRONMENTS, P1, DOI 10.1007/978-1-4419-7491-4; Blum A., 1988, Plant breeding for stress environments.; Boyd NS, 2002, POTATO RES, V45, P117, DOI 10.1007/BF02736107; BROWN J, 1989, THEOR APPL GENET, V77, P246, DOI 10.1007/BF00266194; Cabello R, 2014, AM J POTATO RES, V91, P492, DOI 10.1007/s12230-014-9379-7; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Comstock R. E., 1952, Heterosis., P494; COX DJ, 1984, CROP SCI, V24, P963, DOI 10.2135/cropsci1984.0011183X002400050033x; Daryanto S, 2016, AGR WATER MANAGE, V176, P122, DOI 10.1016/j.agwat.2016.05.019; de Galarreta JIR, 2006, PLANT BREEDING, V125, P183, DOI 10.1111/j.1439-0523.2006.01181.x; Deblonde P, 2000, AGRONOMIE, V20, P595; Deblonde PMK, 2001, EUR J AGRON, V14, P31, DOI 10.1016/S1161-0301(00)00081-2; Devaux A, 2014, POTATO RES, V57, P185, DOI 10.1007/s11540-014-9265-1; Engida M, 1999, ETHIOPIAN J NATURAL, V1, P137; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Gebrehiwot T, 2011, INT J APPL EARTH OBS, V13, P309, DOI 10.1016/j.jag.2010.12.002; Hallauer A.R., 1988, QUANTITATIVE GENETIC; HAVERKORT AJ, 1990, POTATO RES, V33, P89, DOI 10.1007/BF02358133; Hirut BG, 2017, J PHYTOPATHOL, V165, P1, DOI 10.1111/jph.12514; Holland JB, 2006, CROP SCI, V46, P642, DOI 10.2135/cropsci2005.0191; Kolech SA, 2015, AM J POTATO RES, V92, P551, DOI 10.1007/s12230-015-9467-3; Lahlou O, 2003, AGRONOMIE, V23, P257, DOI 10.1051/agro:2002089; Landeo JA, 1995, PHYTOPHTHORA INFESTANS 150, P268; MACKERRON DKL, 1988, POTATO RES, V31, P269, DOI 10.1007/BF02365535; MARIS B, 1989, EUPHYTICA, V41, P163, DOI 10.1007/BF00022425; Mersha E, 2005, MONITORING PREDICTIN, P227; Mienie A, 2008, S AFR J SCI, V104, P156; Monneveux P, 2013, PLANT SCI, V205, P76, DOI 10.1016/j.plantsci.2013.01.011; Obidiegwu JE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00542; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Ramirez DA, 2014, SCI HORTIC-AMSTERDAM, V168, P202, DOI 10.1016/j.scienta.2014.01.036; REYNOLDS MP, 1994, AUST J PLANT PHYSIOL, V21, P717, DOI 10.1071/PP9940717; Rolando JL, 2015, ENVIRON EXP BOT, V110, P27, DOI 10.1016/j.envexpbot.2014.09.006; Schafleitner R., 2007, Potato Research, V50, P71, DOI 10.1007/s11540-007-9030-9; Shock CC, 2013, IRRIGATION MONITORIN; Simane B., 1999, African Crop Science Journal, V7, P9; Simon MR, 1999, THEOR APPL GENET, V98, P310, DOI 10.1007/s001220051074; Snedecor G.W., 1989, AMES IOWA STATE U PR; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPITTERS CJT, 1990, PLANT SOIL, V123, P193, DOI 10.1007/BF00011268; Teixeira J, 2007, ENVIRON EXP BOT, V60, P121, DOI 10.1016/j.envexpbot.2006.09.003; Uddling J, 2007, PHOTOSYNTH RES, V91, P37, DOI 10.1007/s11120-006-9077-5; van der Mescht A, 1999, S AFR J SCI, V95, P407; Van Loon CD, 1986, DROUGHT MAJOR CONSTR; Vayda M. E., 1994, P239; Woldegiorgis G, 2012, POTATO VARIETY DEV S; Yactayo W, 2013, AGR WATER MANAGE, V123, P65, DOI 10.1016/j.agwat.2013.03.009	57	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181541	10.1371/journal.pone.0181541	http://dx.doi.org/10.1371/journal.pone.0181541			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742868	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000036
J	Roecker, K; Mahler, H; Heyde, C; Roll, M; Gollhofer, A				Roecker, Kai; Mahler, Hubert; Heyde, Christian; Roell, Mareike; Gollhofer, Albert			The relationship between movement speed and duration during soccer matches	PLOS ONE			English	Article							CRITICAL POWER; PHYSICAL-ACTIVITY; METABOLIC POWER; MOTION ANALYSIS; PERFORMANCE; WORK; STRENGTH; PROFILE; SPORTS; MODEL	The relationship between the time duration of movement (t(dur)) and related maximum possible power output has been studied and modeled under many conditions. Inspired by the so-called power profiles known for discontinuous endurance sports like cycling, and the critical power concept of Monod and Scherrer, the aim of this study was to evaluate the numerical characteristics of the function between maximum horizontal movement velocity (HSpeed) and t(dur) in soccer. To evaluate this relationship, GPS data from 38 healthy soccer players and 82 game participations (>= 30 min active playtime) were used to select maximum HSpeed for 21 distinct t(dur) values (between 0.3 s and 2,700 s) based on moving medians with an incremental t(dur) window-size. As a result, the relationship between HSpeed and Log(t(dur)) appeared reproducibly as a sigmoidal decay function, and could be fitted to a five-parameter equation with upper and lower asymptotes, and an inflection point, power and decrease rate. Thus, the first three parameters described individual characteristics if evaluated using mixed-model analysis. This study shows for the first time the general numerical relationship between t(dur) and HSpeed in soccer games. In contrast to former descriptions that have evaluated speed against power, HSpeed against t(dur) always yields a sigmoidal shape with a new upper asymptote. The evaluated curve fit potentially describes the maximum moving speed of individual players during the game, and allows for concise interpretations of the functional state of team sports athletes.	[Roecker, Kai; Mahler, Hubert; Heyde, Christian; Roell, Mareike] Furtwangen Univ, Appl Publ Hlth AGW, Furtwangen, Germany; [Roecker, Kai; Mahler, Hubert; Heyde, Christian; Gollhofer, Albert] Albert Ludwigs Univ Freiburg, Inst Sports & Sports Sci IfSS, Freiburg, Germany; [Heyde, Christian] Adidas AG, Future Team, Herzogenaurach, Germany	University of Freiburg; Adidas Group	Roecker, K (corresponding author), Furtwangen Univ, Appl Publ Hlth AGW, Furtwangen, Germany.; Roecker, K (corresponding author), Albert Ludwigs Univ Freiburg, Inst Sports & Sports Sci IfSS, Freiburg, Germany.	kai.roecker@hs-furtwangen.de	Albert, Gollhofer/V-3291-2019; Roecker, Kai/GOP-3245-2022; Gollhofer, Albert/ABF-5766-2020	Roecker, Kai/0000-0003-1133-2548; 	adidas	adidas	The funder (adidas) provided support in the form of salaries for authors HM, CH and MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Armitage R, 2016, VALIDATION TEAM ELIT, P1; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P295, DOI 10.1123/ijspp.6.3.295; Bangsbo J, 1994, Acta Physiol Scand Suppl, V619, P1; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Barris S, 2008, SPORTS MED, V38, P1025, DOI 10.2165/00007256-200838120-00006; Billat LV, 1999, SPORTS MED, V27, P359, DOI 10.2165/00007256-199927060-00002; Boyd LJ, 2011, INT J SPORT PHYSIOL, V6, P311, DOI 10.1123/ijspp.6.3.311; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Broxterman RM, 2013, RESP PHYSIOL NEUROBI, V185, P380, DOI 10.1016/j.resp.2012.08.024; Buchheit M, 2015, INT J SPORTS MED, V36, P1149, DOI 10.1055/s-0035-1555927; Bundle MW, 2012, EXERC SPORT SCI REV, V40, P174, DOI 10.1097/JES.0b013e318258e1c1; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Carling C, 2016, J SPORT SCI, V34, P2215, DOI 10.1080/02640414.2016.1176228; Carling C, 2013, SPORTS MED, V43, P655, DOI 10.1007/s40279-013-0055-8; Carter H, 2014, SCI SPORT, V29, P51, DOI 10.1016/j.scispo.2013.07.014; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; Chambers R, 2015, SPORTS MED, V45, P1065, DOI 10.1007/s40279-015-0332-9; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; de Lucas RD, 2013, SCI SPORT, V28, pE9, DOI 10.1016/j.scispo.2012.04.004; Dekerle J, 2008, SCI SPORT, V23, P231, DOI 10.1016/j.scispo.2007.06.015; Di Salvo V, 2009, INT J SPORTS MED, V30, P205, DOI 10.1055/s-0028-1105950; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Edgeworth F. Y., 1888, MAG J SCI, V25, P184, DOI [DOI 10.1080/14786448808628170, 10.1080/14786448808628170]; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Gabbett TJ, 2013, INT J SPORT PHYSIOL, V8, P130, DOI 10.1123/ijspp.8.2.130; Gabbett TJ, 2012, J SCI MED SPORT, V15, P80, DOI 10.1016/j.jsams.2011.07.004; Gertjan E, 2016, J STRENGTH COND RES, V30, P351; Gilgien M, 2014, SENSORS-BASEL, V14, P18433, DOI 10.3390/s141018433; HARDLE W, 1995, J R STAT SOC C-APPL, V44, P258; Haugen T, 2016, SPORTS MED, V46, P641, DOI 10.1007/s40279-015-0446-0; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Hausler J, 2016, SPORTS MED, V46, P559, DOI 10.1007/s40279-015-0440-6; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hoppe MW, 2015, INT J SPORTS MED, V36, P563, DOI 10.1055/s-0034-1398578; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Mohr M, 2011, J SPORTS SCI, V21, P519; MONOD H, 1965, ERGONOMICS, V8, P329, DOI 10.1080/00140136508930810; Morton RH, 1996, EUR J APPL PHYSIOL O, V73, P491, DOI 10.1007/BF00357670; Morton RH, 1996, ERGONOMICS, V39, P611, DOI 10.1080/00140139608964484; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Paul DJ, 2016, SPORTS MED, V46, P421, DOI 10.1007/s40279-015-0428-2; Pinot J, 2011, INT J SPORTS MED, V32, P839, DOI 10.1055/s-0031-1279773; Quod MJ, 2010, INT J SPORTS MED, V31, P397, DOI 10.1055/s-0030-1247528; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Richards FJ, 1959, ARCH ZOOTEC, V10, P290; Schimpchen J, 2016, J SPORT SCI, V34, P519, DOI 10.1080/02640414.2015.1112023; Smith CGM, 2001, EUR J APPL PHYSIOL, V85, P19, DOI 10.1007/s004210100384; Varley MC, 2012, INT J SPORTS MED; VAUTIER JF, 1995, APPL ERGON, V26, P117, DOI 10.1016/0003-6870(95)00009-2; Vescovi JD, 2012, J SCI MED SPORT, V15, P474, DOI 10.1016/j.jsams.2012.03.006; Wilkinson M, 2013, INT J SPORTS MED, V34, P281, DOI 10.1055/s-0032-1331775; Wisloff U, 2004, BRIT J SPORT MED, V38, P285, DOI 10.1136/bjsm.2002.002071; Wundersitz DWT, 2015, INT J SPORTS MED, V36, P742, DOI 10.1055/s-0035-1547265; Wundersitz DWT, 2015, J BIOMECH, V48, P3975, DOI 10.1016/j.jbiomech.2015.09.015; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Ypma TJ, 2012, SOC IND APPL MATH, V37, P531	59	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181781	10.1371/journal.pone.0181781	http://dx.doi.org/10.1371/journal.pone.0181781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742832	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000054
J	Hayakawa, K; Mezaki, K; Kobayakawa, M; Yamamoto, K; Mutoh, Y; Tsuboi, M; Hasimoto, T; Nagamatsu, M; Kutsuna, S; Takeshita, N; Katanami, Y; Ishikane, M; Ohmagaril, N				Hayakawa, Kayoko; Mezaki, Kazuhisa; Kobayakawa, Masao; Yamamoto, Kei; Mutoh, Yoshikazu; Tsuboi, Motoyuki; Hasimotol, Takehiro; Nagamatsu, Maki; Kutsuna, Satoshi; Takeshita, Nozomi; Katanami, Yuichi; Ishikane, Masahiro; Ohmagaril, Norio			Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan	PLOS ONE			English	Article							MICROARRAY-BASED ASSAY; IN-SITU HYBRIDIZATION; NUCLEIC-ACID TEST; ANTIMICROBIAL STEWARDSHIP; EPIDEMIOLOGY; COMBINATION	Background Rapid identification of positive blood cultures is important for initiation of optimal treatment in septic patients. Effects of automated, microarray-based rapid identification systems on antibiotic prescription against community-onset bacteremia (COB) remain unclear. Methods We prospectively enrolled 177 patients with 185 COB episodes (occurring within 72 h of admission) over 17 months. Bacteremia episodes due to gram-positive bacteria (GP) and gram-negative bacteria (GN) in the same patient were counted separately. For GP bacteremia, patients with >= 2 sets of positive blood cultures were included. The primary study objective was evaluating the rates of antibiotic prescription changes within 2 days of rapid identification using the Verigene system. Results Bacteremia due to GN and GP included 144/185 (77.8%) and 41/185 (22.2%) episodes, respectively. Antibiotic prescription changes occurred in 51/185 cases (27.6% [95% CI:21.3-34.6%]) after Verigene analysis and 70/185 cases (37.8% [30.8-45.2%]) after conventional identification and susceptibility testing. Prescription changes after Verigene identification were more frequent in GP (17/41[41.5%]) than in GN (34/144[23.5%]). Among bacteremia due to single pathogen targeted by Verigene test, bacterial identification agreement between the two tests was high (GP: 38/39[97.4%], GN: 116/116[100%]). The Verigene test correctly predicted targeted antimicrobial resistance. The durations between the initiation of incubation and reporting of the results for the Verigene system and conventional test was 28.3 h (IQR: 25.8-43.4 h) and 90.6 h (68.3-118.4 h), respectively. In only four of the seven episodes of COB in which two isolates were identified by conventional tests, the Verigene test correctly identified both organisms. Conclusion We observed a high rate of antibiotic prescription changes after the Verigene test in a population with COB especially in GP. The Verigene test would be a useful tool in antimicrobial stewardship programs among patients with COB.	[Hayakawa, Kayoko; Yamamoto, Kei; Mutoh, Yoshikazu; Tsuboi, Motoyuki; Hasimotol, Takehiro; Nagamatsu, Maki; Kutsuna, Satoshi; Takeshita, Nozomi; Katanami, Yuichi; Ishikane, Masahiro; Ohmagaril, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Mezaki, Kazuhisa] Natl Ctr Global Hlth & Med, Dept Clin Lab, Tokyo, Japan; [Kobayakawa, Masao] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Ishikane, Masahiro] Tohoku Univ, Grad Sch Med, Div Global Infect Dis, Dept Infect & Epidemiol, Sendai, Miyagi, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tohoku University	Hayakawa, K (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan.	khayakawa@hosp.ncgm.go.jp	Ishikane, Masahiro/ABA-9878-2020; 小早川, 雅男/HII-5007-2022; Hayakawa, Kayoko/GNW-2394-2022	Ishikane, Masahirio/0000-0002-4719-651X	Hitachi High-Technologies Corporation & Grants for International Health Research from the MHLW of Japan [28S-1106]	Hitachi High-Technologies Corporation & Grants for International Health Research from the MHLW of Japan	This study is supported in part by Hitachi High-Technologies Corporation & Grants for International Health Research (28S-1106) from the MHLW of Japan. Luminex Corporation manufactures/markets the Verigene (R) System (Verigene (R) Reader & Verigene (R) Processor), Verigene (R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP), and Verigene (R) Gram-Negative Blood Culture Nucleic Acid Test (BC-GN). Hitachi High-Technologies Corporation is a Marketing Authorization Holder of Verigene (R) System, Verigene (R) BC-GP, and Verigene (R) BC-GN in Japan. Verigene (R) BC-GP and Verigene (R) BC-GN used in the current study were provided by Hitachi High-Technologies Corporation. The authors were responsible for the cost of Verigene (R) System used in this study. Hitachi High-Technologies Corporation or Luminex Corporation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; BARTLETT RC, 1991, DIAGN MICR INFEC DIS, V14, P195, DOI 10.1016/0732-8893(91)90032-B; Bork JT, 2015, ANTIMICROB AGENTS CH, V59, P1593, DOI 10.1128/AAC.04259-14; Box MJ, 2015, PHARMACOTHERAPY, V35, P269, DOI 10.1002/phar.1557; CLSI, 2012, M100S22 CLSI; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Forrest GN, 2008, ANTIMICROB AGENTS CH, V52, P3558, DOI 10.1128/AAC.00283-08; Forrest GN, 2006, J ANTIMICROB CHEMOTH, V58, P154, DOI 10.1093/jac/dkl146; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayakawa K, 2016, J INFECT CHEMOTHER; Neuner EA, 2016, INFECT CONT HOSP EP, V37, P1361, DOI 10.1017/ice.2016.175; Rodriguez-Bano J, 2010, CLIN INFECT DIS, V50, P40, DOI 10.1086/649537; Samuel LP, 2013, J CLIN MICROBIOL, V51, P1188, DOI 10.1128/JCM.02982-12; Showier A, 2015, JACC-CARDIOVASC IMAG, V8, P924, DOI 10.1016/j.jcmg.2015.02.027; Suzuki Hiromichi, 2015, J Infect Chemother, V21, P849, DOI 10.1016/j.jiac.2015.08.019; Timbrook TT, 2016, CLIN INFECT DIS; Uno N, 2015, DIAGN MICR INFEC DIS, V83, P344, DOI 10.1016/j.diagmicrobio.2015.08.004; Walker T, 2016, J CLIN MICROBIOL, V54, P1789, DOI 10.1128/JCM.00376-16; Weiss E, 2015, CLIN MICROBIOL INFEC, V21, pE81, DOI [10.1016/j.cmi.2015.03.013, 10.1016/j.cmi.2015.07.010]	19	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181548	10.1371/journal.pone.0181548	http://dx.doi.org/10.1371/journal.pone.0181548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742143	gold, Green Submitted, Green Published			2022-12-26	WOS:000406362700053
J	Trivedi, MS; Holger, D; Bui, AT; Craddock, TJA; Tartar, JL				Trivedi, Malay S.; Holger, Dana; Bui, Anh Tuyet; Craddock, Travis J. A.; Tartar, Jaime L.			Short-term sleep deprivation leads to decreased systemic redox metabolites and altered epigenetic status	PLOS ONE			English	Article							NEUROCOGNITIVE CONSEQUENCES; OXIDATIVE STRESS; DNA METHYLATION; CYSTEINE UPTAKE; RESTRICTION; GLUTATHIONE; CORTISOL; TRANSCRIPTION; TRANSPORTER; MODULATION	Sleep is critical for repair as well as the rejuvenation processes in the body and many of these functions are regulated via underlying cellular metabolic homeostasis. Changes in sleep pattern are reported to alter such metabolic function resulting in altered disease susceptibility or behavior. Here, we measured the extent to which overnight total sleep deprivation (SD) in young adult humans can influence systemic (plasma-derived) redox-metabolism including the major antioxidant, glutathione as well as DNA methylation levels. Nineteen participants (n = 19, mu age = 21, SD = 3.09) underwent morning testing before and after overnight total SD. Biochemical measures before and after SD revealed that glutathione, ATP, cysteine, and homocysteine levels were significantly reduced following one night of sleep deprivation (all p's < 0.01). Parallel to the well-recognized fact that sleep deprivation (maintaining wakefulness) uses up metabolic reserves, we observed that morning cortisol levels were blunted after sleep deprivation. There were no significant correlations between self-reported or actigraphy-measured sleep and the biochemical measurements, strongly indicating that prior sleep behavior did not have any direct influence on the biochemical measures taken at baseline or after sleep deprivation. Results from the current investigation supports the previous literature implicating the induction of oxidative stress and ATP depletion with sleep deprivation. Furthermore, such altered antioxidant status can also induce downstream epigenetic changes. Although we did not measure the specific genes that were altered under the influence of such sleep deprivation, such epigenetic changes could potentially contribute towards disease predisposition.	[Trivedi, Malay S.; Holger, Dana; Bui, Anh Tuyet] Nova Southeastern Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA; [Craddock, Travis J. A.] Nova Southeastern Univ, Dept Psychol & Neurosci, Comp Sci & Clin Immunol, Ft Lauderdale, FL USA; [Craddock, Travis J. A.] Nova Southeastern Univ, Clin Syst Biol Grp, Inst Neuroimmune Med, Ft Lauderdale, FL USA; [Tartar, Jaime L.] Nova Southeastern Univ, Dept Psychol & Neurosci, Ft Lauderdale, FL USA	Nova Southeastern University; Nova Southeastern University; Nova Southeastern University; Nova Southeastern University	Trivedi, MS (corresponding author), Nova Southeastern Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33314 USA.	mtrivedi@nova.edu	Holger, Dana/GYD-9682-2022	Holger, Dana/0000-0001-7171-7015; Craddock, Travis/0000-0001-7244-6317	Nova Southeastern University [PFRDG R000]	Nova Southeastern University	This work was supported by the Nova Southeastern University under grant PFRDG R000. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SM, 2016, NAT SCI SLEEP, V8, P55, DOI 10.2147/NSS.S78947; AKERSTEDT T, 1980, SLEEP, V3, P23, DOI 10.1093/sleep/3.1.23; Al-Farsi YM, 2012, NUTRITION; Alfarra R, 2015, BIOL PSYCHOL, V104, P1, DOI 10.1016/j.biopsycho.2014.11.001; Andersen ML, 2004, EXP GERONTOL, V39, P817, DOI 10.1016/j.exger.2004.02.007; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Beck MJ, 2001, TOXICOL SCI, V62, P92, DOI 10.1093/toxsci/62.1.92; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; BONNET MH, 1995, SLEEP, V18, P581, DOI 10.1093/sleep/18.7.581; Broussard JL, 2015, DIABETOLOGIA, V58, P791, DOI 10.1007/s00125-015-3500-4; Buckley TM, 2005, J CLIN ENDOCR METAB, V90, P3106, DOI 10.1210/jc.2004-1056; Cedernaes J, 2015, J CLIN ENDOCR METAB, V100, pE1255, DOI [10.1210/jc.2015-2284, 10.1210/JC.2015-2284]; Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001; Deth R, 2008, NEUROTOXICOLOGY, V29, P190, DOI 10.1016/j.neuro.2007.09.010; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Elder GJ, 2014, SLEEP MED REV, V18, P215, DOI 10.1016/j.smrv.2013.05.001; Everson CA, 2005, AM J PHYSIOL-REG I, V288, pR374, DOI 10.1152/ajpregu.00565.2004; Everson CA, 2014, SLEEP, V37, P1929, DOI 10.5665/sleep.4244; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Gopalakrishnan A, 2004, SLEEP, V27, P27, DOI 10.1093/sleep/27.1.27; Himi T, 2003, J NEURAL TRANSM, V110, P1337, DOI 10.1007/s00702-003-0049-z; Hodgson N, 2013, J ALZHEIMERS DIS, V36, P197, DOI 10.3233/JAD-130101; KANT GJ, 1984, SLEEP, V7, P142, DOI 10.1093/sleep/7.2.142; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Muratore CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056927; Pena JL, 1999, BRAIN RES, V816, P463, DOI 10.1016/S0006-8993(98)01194-9; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ramanathan L, 2002, NEUROREPORT, V13, P1387, DOI 10.1097/00001756-200208070-00007; Redwine L, 2000, J CLIN ENDOCR METAB, V85, P3597, DOI 10.1210/jc.85.10.3597; REIMUND E, 1994, MED HYPOTHESES, V43, P231, DOI 10.1016/0306-9877(94)90071-X; Rupp TL, 2009, SLEEP, V32, P311, DOI 10.1093/sleep/32.3.311; Singh R, 2008, BIOGERONTOLOGY, V9, P153, DOI 10.1007/s10522-008-9124-z; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Trivedi MS, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00092; Trivedi MS, 2014, J NUTR BIOCHEM, V25, P1011, DOI 10.1016/j.jnutbio.2014.05.004; Villafuerte G, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/234952; Zhang YT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146797	38	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181978	10.1371/journal.pone.0181978	http://dx.doi.org/10.1371/journal.pone.0181978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738082	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700090
J	Wang, MX; Kanako, N; Zhang, YQ; Xiao, XL; Gao, QP; Tetsuya, K				Wang, Mingxing; Kanako, Nakajima; Zhang, Yanqiu; Xiao, Xulang; Gao, Qipin; Tetsuya, Konishi			A unique polysaccharide purified from Hericium erinaceus mycelium prevents oxidative stress induced by H2O2 in human gastric mucosa epithelium cell	PLOS ONE			English	Article							APOPTOSIS; CULTURE; MUSHROOM; PEPTIDE; GROWTH; ULCER; RATS	Hericium erinaceus (HE) has been used both as a traditional Chinese medicine and home remedy for treatment of gastric and duodenal ulcers and gastritis. EP-1, a purified polysaccharide isolated from HE mycelium, has recently been identified as the active component responsible for HE anti-gastritis activity. Because oxidative stress has been implicated as a pathogenic cause of gastritis and gastric ulcers, EP-1 antioxidant properties were systematically examined in vitro using the human gastric mucosal epithelial cell line, GES-1. Results showed that EP-1 possessed higher oxygen radical absorbance capacity (ORAC) and 2-3 times higher ability to scavenge 2,2-diphenyl-1-picrylhydrazyl (DPPH), superoxide and hydroxyl radicals than a hot water extract of commercially available HE fruiting body. A crude mycelial polysaccharide (CMPS) extract of HE, from which EP-1 was purified, showed slightly stronger radical scavenging activity and ORAC than EP-1, with the exception of DPPH-scavenging activity. Antioxidant activities of these extracts were further studied using hydrogen peroxide (H2O2)-abused GES-1 cells; EP-1 dose-dependently preserved cell viability of abused cells as assessed via MTT assay. Moreover, FACS analysis revealed that EP-1 prevented H2O2-induced apoptotic cell death by inhibiting activation of apoptotic cellular signals within mitochondria-dependent apoptotic pathways. CMPS also prevented H2O2-induced oxidative stress, but to a lesser degree than did EP-1, even though CMPS exhibited comparable or stronger in vitro antioxidant activity than did EP-1.	[Wang, Mingxing; Zhang, Yanqiu] Changchun Univ Chinese Med, Affiliated Hosp, Changchun, Jilin, Peoples R China; [Kanako, Nakajima; Tetsuya, Konishi] Niigata Univ Pharm & Appl Life Sci, Liaison RD Ctr, Niigata, Japan; [Xiao, Xulang; Gao, Qipin] Changchun Univ Chinese Med, Res & Dev Ctr, Changchun, Jilin, Peoples R China	Changchun University of Chinese Medicine; Niigata University; Changchun University of Chinese Medicine	Wang, MX (corresponding author), Changchun Univ Chinese Med, Affiliated Hosp, Changchun, Jilin, Peoples R China.; Gao, QP (corresponding author), Changchun Univ Chinese Med, Res & Dev Ctr, Changchun, Jilin, Peoples R China.	cc_wmx@163.com; gaogipin@sina.com			National Natural Science Foundation of China [NSFC 81603276]; Foundation of Health and Family Planning Commission of Jilin Province [20152F2C01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Health and Family Planning Commission of Jilin Province	This work was financial supported by research grants from the National Natural Science Foundation of China(NSFC 81603276) and supported by the Foundation of Health and Family Planning Commission of Jilin Province (Grant No. 20152F2C01)s work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2008, INT J MED MUSHROOMS, V10, P325, DOI 10.1615/IntJMedMushr.v10.i4.40; Al-Sayed E, 2015, PHYTOMEDICINE, V22, P5, DOI 10.1016/j.phymed.2014.10.002; Ali MA, 1998, BIOCHEM MOL BIOL INT, V46, P137; Choi D, 2011, KOREAN J CHEM ENG, V28, P1427, DOI 10.1007/s11814-011-0109-2; CINI M, 1994, NEUROCHEM RES, V19, P283, DOI 10.1007/BF00971576; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Kimura S, 2016, METABOLISM, V65, P138, DOI 10.1016/j.metabol.2015.10.030; Klamt F, 2005, J BIOL CHEM, V280, P21346, DOI 10.1074/jbc.M501170200; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Ling W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001111; Luo T, 2006, ANESTH ANALG, V103, P110, DOI 10.1213/01.ane.0000221183.02244.80; Malinowska E, 2009, ENZYME MICROB TECH, V44, P334, DOI 10.1016/j.enzmictec.2008.12.003; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Oz HS, 2007, TRANSL RES, V150, P122, DOI 10.1016/j.trsl.2006.12.010; Park SC, 2016, J CONTROL RELEASE, V221, P37, DOI 10.1016/j.jconrel.2015.11.027; Rahman MM, 2006, FREE RADICAL RES, V40, P993, DOI 10.1080/10715760600815322; Sakurai K, 2004, FREE RADICAL RES, V38, P487, DOI 10.1080/1071576042000209808; Takahashi A, 2004, BRAIN RES BULL, V62, P497, DOI 10.1016/j.brainresbull.2003.07.009; Vargas FSD, 2016, BMC COMPLEM ALTERN M, V16, P1; Wang MX, 2015, INT J MED MUSHROOMS, V17, P1055, DOI 10.1615/IntJMedMushrooms.v17.i11.50; Wang MX, 2015, INT J BIOL MACROMOL, V81, P656, DOI 10.1016/j.ijbiomac.2015.08.043; Wang ZJ, 2004, CARBOHYD POLYM, V57, P241, DOI 10.1016/j.carbpol.2004.04.018; Yang LF, 2008, J NEUROIMMUNOL, V199, P10, DOI 10.1016/j.jneuroim.2008.04.028	23	18	20	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181546	10.1371/journal.pone.0181546	http://dx.doi.org/10.1371/journal.pone.0181546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742114	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700052
J	Peng, Y; Wang, SN; Li, KM; Liu, JT; Zheng, Y; Shan, S; Yang, YQ; Li, RJ; Zhang, YJ; Guo, YY				Peng, Yong; Wang, Shan-Ning; Li, Ke-Ming; Liu, Jing-Tao; Zheng, Yao; Shan, Shuang; Yang, Ye-Qing; Li, Rui-Jun; Zhang, Yong-Jun; Guo, Yu-Yuan			Identification of odorant binding proteins and chemosensory proteins in Microplitis mediator as well as functional characterization of chemosensory protein 3	PLOS ONE			English	Article							CHEMICAL COMMUNICATION; ANTENNAL TRANSCRIPTOME; PHEROMONE-BINDING; INDUCED VOLATILES; SOLUBLE-PROTEINS; PARASITOID WASP; GENE FAMILY; HYMENOPTERA; INSECT; IMMUNOLOCALIZATION	Odorant binding proteins (OBPs) and chemosensory proteins (CSPs) play important roles in transporting semiochemicals through the sensillar lymph to olfactory receptors in insect antennae. In the present study, twenty OBPs and three CSPs were identified from the antennal transcriptome of Microplitis mediator. Ten OBPs (MmedOBP11 - 20) and two CSPs (MmedCSP2-3) were newly identified. The expression patterns of these new genes in olfactory and non-olfactory tissues were investigated by real-time quantitative PCR (qPCR) measurement. The results indicated that MmedOBP14, MmedOBP18, MmedCSP2 and MmedCSP3 were primarily expressed in antennae suggesting potential olfactory roles in M. mediator. However, other genes including MmedOBP11-13, 15-17, 19 - 20 appeared to be expressed at higher levels in body parts than in antennae. Focusing on the functional characterization of MmedCSP3, immunocytochemistry and fluorescent competitive binding assays were conducted indoors. It was found that MmedCSP3 was specifically located in the sensillum lymph of olfactory sensilla basiconca type 2. The recombinant MmedCSP3 could bind several types of host insects odors and plant volatiles. Interestingly, three sex pheromone components of Noctuidae insects, cis-11-hexadecenyl aldehyde (Z11-16: Ald), cis-11-hexadecanol (Z11-16: OH), and trans-11-tetradecenyl acetate (E11-14: Ac), showed high binding affinities (Ki = 17.24 - 18.77 mu M). The MmedCSP3 may be involved in locating host insects. Our data provide a base for further investigating the physiological roles of OBPs and CSPs in M. mediator, and extend the function of MmedCSP3 in chemoreception of M. mediator.	[Peng, Yong; Yang, Ye-Qing; Li, Rui-Jun] Agr Univ Hebei, Coll Plant Protect, Baoding, Peoples R China; [Peng, Yong; Wang, Shan-Ning; Li, Ke-Ming; Liu, Jing-Tao; Zheng, Yao; Shan, Shuang; Yang, Ye-Qing; Zhang, Yong-Jun; Guo, Yu-Yuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Li, Ke-Ming] Chinese Acad Trop Agr Sci, Inst Banana & Plantain, Haikou, Hainan, Peoples R China; [Shan, Shuang] China Agr Univ, Coll Plant Protect, Beijing, Peoples R China	Hebei Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Tropical Agricultural Sciences; China Agricultural University	Li, RJ (corresponding author), Agr Univ Hebei, Coll Plant Protect, Baoding, Peoples R China.; Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	liruijun99@sina.com; yjzhang@ippcaas.cn			National Natural Science Foundation of China [31272048, 31471778, 31672038]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31621064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31272048, 31471778 and 31672038) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 31621064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR AP, 1986, CAN ENTOMOL, V118, P487, DOI 10.4039/Ent118487-5; Belz E, 2013, BIOCONTROL, V58, P163, DOI 10.1007/s10526-012-9472-0; BREER H, 1994, BBA-MOL CELL RES, V1224, P277, DOI 10.1016/0167-4889(94)90201-1; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; CARDE RT, 1977, J CHEM ECOL, V3, P143, DOI 10.1007/BF00994141; Dong Wen-Xia, 2006, Acta Entomologica Sinica, V49, P1054; Field LM, 2000, INSECT MOL BIOL, V9, P545, DOI 10.1046/j.1365-2583.2000.00221.x; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Herde M, 2008, PLANT CELL, V20, P1152, DOI 10.1105/tpc.106.049478; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Horikoshi M, 1997, J CHEM ECOL, V23, P1505, DOI 10.1023/B:JOEC.0000006418.49537.5d; Hua JF, 2012, J CHEM ECOL, V38, P1163, DOI 10.1007/s10886-012-0178-7; Huang Yongping, 1996, Entomologia Sinica, V3, P172; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; Li Ke-ming, 2012, Scientia Agricultura Sinica, V45, P3522; Li KM, 2014, J CHEM ECOL, V40, P541, DOI 10.1007/s10886-014-0458-5; Li WX, 2008, ANN ENTOMOL SOC AM, V101, P613, DOI 10.1603/0013-8746(2008)101[613:ROPATI]2.0.CO;2; Li XR, 2011, INT J BIOL SCI, V7, P848, DOI 10.7150/ijbs.7.848; Liu NY, 2013, COMP BIOCHEM PHYS A, V165, P254, DOI 10.1016/j.cbpa.2013.03.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Reddy GVP, 2002, J CHEM ECOL, V28, P131, DOI 10.1023/A:1013519003944; Snoeren TAL, 2010, J EXP BOT, V61, P3041, DOI 10.1093/jxb/erq127; Sun L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08073; Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178; Swanson JAI, 2009, J CHEM ECOL, V35, P1108, DOI 10.1007/s10886-009-9683-8; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiery D, 1995, J CHEM ECOL, V21, P2015, DOI 10.1007/BF02033859; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; Wang SN, 2016, J INSECT PHYSIOL, V90, P27, DOI 10.1016/j.jinsphys.2016.05.002; Wang SN, 2015, INT J BIOL SCI, V11, P737, DOI 10.7150/ijbs.11786; Wanner KW, 2005, INSECT MOL BIOL, V14, P289, DOI 10.1111/j.1365-2583.2005.00559.x; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yu HL, 2010, ENVIRON ENTOMOL, V39, P600, DOI 10.1603/EN09162; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; Zhao YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148159; Zhou CX, 2015, COMP BIOCHEM PHYS D, V16, P10, DOI 10.1016/j.cbd.2015.06.003; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08	45	24	27	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180775	10.1371/journal.pone.0180775	http://dx.doi.org/10.1371/journal.pone.0180775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732030	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100012
J	Noguera, PA; Grunow, B; Klinger, M; Lester, K; Collet, B; del-Pozo, J				Noguera, Patricia A.; Grunow, Bianka; Klinger, Matthias; Lester, Katherine; Collet, Bertrand; del-Pozo, Jorge			Atlantic salmon cardiac primary cultures: An in vitro model to study viral host pathogen interactions and pathogenesis	PLOS ONE			English	Article							MUSCLE INFLAMMATION HSMI; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; PANCREAS DISEASE; ANEMIA-VIRUS; SALAR L.; CARDIOMYOPATHY SYNDROME; PATHOLOGICAL-CHANGES; HEART RESEARCH; ANIMAL-MODELS	Development of Salmon Cardiac Primary Cultures (SCPCs) from Atlantic salmon pre-hatch embryos and their application as in vitro model for cardiotropic viral infection research are described. Producing SCPCs requires plating of trypsin dissociated embryos with subsequent targeted harvest from 24h up to 3 weeks, of relevant tissues after visual identification. SCPCs are then transferred individually to chambered wells for culture in isolation, with incubation at 15-22 degrees. SCPCs production efficiency was not influenced by embryo's origin (0.75/farmed or wild embryo), but mildly influenced by embryonic developmental stage (0.3 decline between 380 and 445 accumulated thermal units), and strongly influenced by time of harvest post-plating (0.6 decline if harvested after 72 hours). Beating rate was not significantly influenced by temperature (15-22 degrees) or age (2-4 weeks), but was significantly lower on SCPCs originated from farmed embryos with a disease resistant genotype (F = 5.3, p<0.05). Two distinct morphologies suggestive of an ex vivo embryonic heart and a de novo formation were observed sub-grossly, histologically, ultra-structurally and with confocal microscopy. Both types contained cells consistent with cardiomyocytes, endothelium, and fibroblasts. Ageing of SCPCs in culture was observed with increased auto fluorescence in live imaging, and as myelin figures and cellular degeneration ultra-structurally. The SCPCs model was challenged with cardiotropic viruses and both the viral load and the mx gene expression were measurable along time by qPCR. In summary, SCPCs represent a step forward in salmon cardiac disease research as an in vitro model that partially incorporates the functional complexity of the fish heart.	[Noguera, Patricia A.; Lester, Katherine; Collet, Bertrand] Marine Scotland Sci, Aquaculture & Marine Environm, Aberdeen, Scotland; [Grunow, Bianka] Fraunhofer Res Inst Marine Biotechnol, Lubeck, Germany; [Klinger, Matthias] Univ Lubeck, Inst Anat, Lubeck, Germany; [del-Pozo, Jorge] Univ Edinburgh, Royal Dick Sch Vet Sci, Edinburgh, Midlothian, Scotland; [Grunow, Bianka] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, Greifswald, Germany	Marine Scotland Science (MSS); University of Lubeck; University of Edinburgh; Ernst Moritz Arndt Universitat Greifswald	Noguera, PA (corresponding author), Marine Scotland Sci, Aquaculture & Marine Environm, Aberdeen, Scotland.	Patricia.Noguera@gov.scot		Noguera, Patricia/0000-0003-2247-6926; Grunow, Bianka/0000-0001-8503-2754	Scottish Government [AQ0030]	Scottish Government	This work was funded by the Scottish Government under project AQ0030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Atkins GJ., 2013, ISRN VIROL, V2013, P1, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; BBSRC, 2014, MULT APPR FISH HLTH; Biacchesi S, 2016, VET RES, V47, DOI 10.1186/s13567-015-0301-1; Carvan MJ, 2005, ENV TOXICOLOGY; Chaput G, 2012, ICES J MAR SCI, V69, P1538, DOI 10.1093/icesjms/fss013; Chen ZQ, 2015, J EXP BIOL, V218, P803, DOI 10.1242/jeb.113993; Collet B, 2015, PLOS ONE, P10; Collet B, 2013, J VIROL METHODS, V191, P113, DOI 10.1016/j.jviromet.2013.04.009; Collet B, 2009, VET IMMUNOL IMMUNOP, V130, P92, DOI 10.1016/j.vetimm.2008.12.022; Crane M, 2011, VIRUSES-BASEL, V3, P2025, DOI 10.3390/v3112025; Croce AC, 2014, EUR J HISTOCHEM, V58, P320, DOI 10.4081/ejh.2014.2461; Di Guardo G, 2015, EUR J HISTOCHEM, V59, P72, DOI 10.4081/ejh.2015.2485; Drennan JD, 2007, J FISH DIS, V30, P367, DOI 10.1111/j.1365-2761.2007.00817.x; European Parliamentary Research, 2014, AQ EU EUR PARL RES S; FAO Fisheries & Aquaculture-Species Fact Sheets-Salmo salar, 1758, FAO FISHERIES AQUACU; FERGUSON HW, 1986, J FISH DIS, V9, P95, DOI 10.1111/j.1365-2761.1986.tb00987.x; Fields S, 2005, SCIENCE, V307, P1885, DOI 10.1126/science.1108872; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; FLEMING P, 1977, J GEN VIROL, V37, P93, DOI 10.1099/0022-1317-37-1-93; Fryer J. L., 1994, Journal of Tissue Culture Methods, V16, P87, DOI 10.1007/BF01404816; Fryer JL, 1964, METHODS IN VITRO CUL; Gahlawat SK, 2009, FISH SHELLFISH IMMUN, V26, P672, DOI 10.1016/j.fsi.2009.02.021; Gibson RJ, 1993, NATURAL WATERS; Grunow B, 2010, J FISH BIOL, V76, P427, DOI 10.1111/j.1095-8649.2009.02535.x; Grunow B, 2012, OJ CELL SCI THER OMI, P3; Grunow B, 2015, J EXP BIOL, V218, P1116, DOI 10.1242/jeb.118224; Grunow B, 2011, CELL PHYSIOL BIOCHEM, V27, P1, DOI 10.1159/000325212; Haugland O, 2011, J VIROL, V85, P5275, DOI 10.1128/JVI.02154-10; Katz ML, 2002, ARCH GERONTOL GERIAT, V34, P169, DOI 10.1016/S0167-4943(02)00005-5; Kibenge FSB, 2016, AQUACULTURE VIROLOGY, P1; Lewis J, 1996, J VIROL, V70, P1828, DOI 10.1128/JVI.70.3.1828-1835.1996; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lohr JL, 2000, AM J MED GENET, V97, P248, DOI 10.1002/1096-8628(200024)97:4<248::AID-AJMG1275>3.0.CO;2-C; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Martin SAM, 2007, PHYSIOL GENOMICS, V32, P33, DOI 10.1152/physiolgenomics.00064.2007; Matejusova I, 2013, ARCH VIROL, V158, P2143, DOI 10.1007/s00705-013-1689-4; McBeath AJA, 2007, FISH SHELLFISH IMMUN, V22, P230, DOI 10.1016/j.fsi.2006.05.004; McLoughlin MF, 2007, J FISH DIS, V30, P511, DOI 10.1111/j.1365-2761.2007.00848.x; Mehnert JM, 2013, CELL PHYSIOL BIOCHEM, V32, P1374, DOI 10.1159/000356576; Moretti A, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014027; MURPHY TM, 1992, J FISH DIS, V15, P401, DOI 10.1111/j.1365-2761.1992.tb01239.x; Nemtsas P, 2010, J MOL CELL CARDIOL, V48, P161, DOI 10.1016/j.yjmcc.2009.08.034; Pennell W., 1996, PRINCIPLES SALMONID; Perry SF, 2010, FISH PHYSIOL, V29, P1; Saltveit SJ, 2013, LIMNOLOGICA, V43, P325, DOI 10.1016/j.limno.2013.05.009; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Schier AF, 2013, NATURE, V496, P443, DOI 10.1038/nature12094; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; SSPO, 2015, SUST SCOTT SALM SCOT; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Verkerk AO, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00255; Vernon PS, 2005, J VIROL, V79, P3438, DOI 10.1128/JVI.79.6.3438-3447.2005; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5; Yousaf MN, 2013, VET IMMUNOL IMMUNOP, V151, P49, DOI 10.1016/j.vetimm.2012.10.004; Yousaf MN, 2012, FISH SHELLFISH IMMUN, V33, P305, DOI 10.1016/j.fsi.2012.05.008; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	57	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181058	10.1371/journal.pone.0181058	http://dx.doi.org/10.1371/journal.pone.0181058			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727799	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500038
J	Yin, R; Zhao, MZ; Wang, KY; Lin, YP; Wang, YF; Sun, CY; Wang, Y; Zhang, MP				Yin, Rui; Zhao, Mingzhu; Wang, Kangyu; Lin, Yanping; Wang, Yanfang; Sun, Chunyu; Wang, Yi; Zhang, Meiping			Functional differentiation and spatial-temporal co-expression networks of the NBS-encoding gene family in Jilin ginseng, Panax ginseng CA Meyer	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DISEASE RESISTANCE GENES; IDENTIFICATION; EXPRESSION; VISUALIZATION; REVEALS; TIR	Ginseng, Panax ginseng C.A. Meyer, is one of the most important medicinal plants for human health and medicine. It has been documented that over 80% of genes conferring resistance to bacteria, viruses, fungi and nematodes are contributed by the nucleotide binding site (NBS)-encoding gene family. Therefore, identification and characterization of NBS genes expressed in ginseng are paramount to its genetic improvement and breeding. However, little is known about the NBS-encoding genes in ginseng. Here we report genome-wide identification and systems analysis of the NBS genes actively expressed in ginseng (PgNBS genes). Four hundred twelve PgNBS gene transcripts, derived from 284 gene models, were identified from the transcriptomes of 14 ginseng tissues. These genes were classified into eight types, including TNL, TN, CNL, CN, NL, N, RPW8-NL and RPW8-N. Seven conserved motifs were identified in both the Toll/interleukine-1 receptor (TIR) and coiled-coil (CC) typed genes whereas six were identified in the RPW8 typed genes. Phylogenetic analysis showed that the PgNBS gene family is an ancient family, with a vast majority of its genes originated before ginseng originated. In spite of their belonging to a family, the PgNBS genes have functionally dramatically differentiated and been categorized into numerous functional categories. The expressions of the across tissues, different aged roots and the roots of different genotypes. However, they are coordinating in expression, forming a single co-expression network. These results provide a deeper understanding of the origin, evolution and functional differentiation and expression dynamics of the NBS-encoding gene family in plants in general and in ginseng particularly, and a NBS gene toolkit useful for isolation and characterization of disease resistance genes and for enhanced disease resistance breeding in ginseng and related species.	[Yin, Rui; Zhao, Mingzhu; Wang, Kangyu; Lin, Yanping; Sun, Chunyu; Wang, Yi; Zhang, Meiping] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Wang, Kangyu; Sun, Chunyu; Wang, Yi; Zhang, Meiping] Ctr Ginseng Germplasm Res Dev & Utilizat, Changchun, Jilin, Peoples R China; [Wang, Yanfang] Jilin Agr Univ, Coll Chinese Med Mat, Changchun, Jilin, Peoples R China	Jilin Agricultural University; Jilin Agricultural University	Wang, Y; Zhang, MP (corresponding author), Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China.; Wang, Y; Zhang, MP (corresponding author), Ctr Ginseng Germplasm Res Dev & Utilizat, Changchun, Jilin, Peoples R China.	wanglaoshi0606@163.com; meiping.zhang@jlau.edu.cn			China 863 Project [2013AA102604-3]; Development and Reform Commission of Jilin Province [2016C064]; Bureau of Science and Technology of Jilin Province [20170101010JC]	China 863 Project(National High Technology Research and Development Program of China); Development and Reform Commission of Jilin Province; Bureau of Science and Technology of Jilin Province	This work was funded by the China 863 Project (2013AA102604-3) to MPZ, and the Development and Reform Commission of Jilin Province (2016C064) and the Bureau of Science and Technology of Jilin Province (20170101010JC) to YW.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Lee ST, 2008, ALZ DIS ASSOC DIS, V22, P222, DOI 10.1097/WAD.0b013e31816c92e6; Li XY, 2010, PLANT SYST EVOL, V289, P101, DOI 10.1007/s00606-010-0331-0; Lozano R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034775; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Nair RA, 2007, THEOR APPL GENET, V116, P123, DOI 10.1007/s00122-007-0652-8; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Wan HJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-109; Wan HJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-502; Wang KY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18283; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Xie X, 2010, MOL MED REP, V3, P635, DOI 10.3892/mmr_00000308; Zhang MP, 2010, NUCLEIC ACIDS RES, V38, P6513, DOI 10.1093/nar/gkq524; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	30	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181596	10.1371/journal.pone.0181596	http://dx.doi.org/10.1371/journal.pone.0181596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727829	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500090
J	Yang, Q; Zhang, RS; Cai, H; Wang, LX				Yang, Qiang; Zhang, Roushu; Cai, Hui; Wang, Lai-Xi			Revisiting the substrate specificity of mammalian alpha 1,6-fucosyltransferase reveals that it catalyzes core fucosylation of N-glycans lacking alpha 1,3-arm GlcNAc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-TYPE OLIGOSACCHARIDES; CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEIN-SYNTHESIS; L-FUCOSE; CELLS; IDENTIFICATION; GLYCOSYLATION; TRANSFERASES; PURIFICATION; RECOGNITION	The mammalian alpha 1,6-fucosyltransferase (FUT8) catalyzes the core fucosylation of N-glycans in the biosynthesis of glycoproteins. Previously, intensive in vitro studies with crude extract or purified enzyme concluded that the attachment of a GlcNAc on the alpha 1,3 mannose arm of N-glycan is essential for FUT8-catalyzed core fucosylation. In contrast, we have recently shown that expression of erythropoietin in a GnTI knock-out, FUT8-overexpressing cell line results in the production of fully core-fucosylated glycoforms of the oligomannose substrate Man(5)GlcNAc(2), suggesting that FUT8 can catalyze core fucosylation of N-glycans lacking an alpha 1,3-arm GlcNAc in cells. Here, we revisited the substrate specificity of FUT8 by examining its in vitro activity toward an array of selected N-glycans, glycopeptides, and glycoproteins. Consistent with previous studies, we found that free N-glycans lacking an unmasked alpha 1,3-arm GlcNAc moiety are not FUT8 substrates. However, Man(5)GlcNAc(2) glycan could be efficiently core-fucosylated by FUT8 in an appropriate protein/peptide context, such as with the erythropoietin protein, a V3 polypeptide derived from HIV-1 gp120, or a simple 9-fluorenylmethyl chloroformate-protected Asn moiety. Interestingly, when placed in the V3 polypeptide context, a mature bi-antennary complex-type N-glycan also could be core-fucosylated by FUT8, albeit at much lower efficiency than the Man(5)GlcNAc(2) peptide. This study represents the first report of in vitro FUT8-catalyzed core fucosylation of N-glycans lacking the alpha 1,3-arm GlcNAc moiety. Our results suggest that an appropriate polypeptide context or other adequate structural elements in the acceptor substrate could facilitate the core fucosylation by FUT8.	[Yang, Qiang; Zhang, Roushu; Cai, Hui; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr, College Pk, MD 20742 USA.	wang518@umd.edu	Wang, Lai-Xi/E-8755-2019; ZHANG, ROUSHU/GYR-1974-2022; Wang, Lai-Xi/E-8790-2019; wang, xl/Y-8251-2019; Wang, Xin/AAN-8435-2021; wang, xiao/HGB-7081-2022; Wang, Xin/GYU-1129-2022	Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; wang, xiao/0000-0002-4088-3341; 	National Institutes of Health [R01 GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01 GM080374. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; BOSMANN HB, 1968, ARCH BIOCHEM BIOPHYS, V128, P470, DOI 10.1016/0003-9861(68)90053-2; Calderon AD, 2016, ORG BIOMOL CHEM, V14, P4027, DOI 10.1039/c6ob00586a; Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Kaminska J, 1998, GLYCOCONJUGATE J, V15, P783, DOI 10.1023/A:1006959915435; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Mimura Y, 2018, PROTEIN CELL, V9, P47, DOI 10.1007/s13238-017-0433-3; Miyoshi E, 1999, BBA-GEN SUBJECTS, V1473, P9, DOI 10.1016/S0304-4165(99)00166-X; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Saribas AS, 2007, BIOCHEM BIOPH RES CO, V362, P381, DOI 10.1016/j.bbrc.2007.07.199; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Serna S, 2011, J AM CHEM SOC, V133, P16495, DOI 10.1021/ja205392z; SHAO MC, 1994, CARBOHYD RES, V251, P163, DOI 10.1016/0008-6215(94)84283-3; Snovida SI, 2008, J AM SOC MASS SPECTR, V19, P1138, DOI 10.1016/j.jasms.2008.04.033; VOYNOW JA, 1991, J BIOL CHEM, V266, P21572; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; Yang Q, 2016, J BIOL CHEM, V291, P11064, DOI 10.1074/jbc.M116.720789; Yang Q, 2010, BIOCONJUGATE CHEM, V21, P875, DOI 10.1021/bc9004238; Zhu YP, 2010, NAT CHEM BIOL, V6, P125, DOI [10.1038/NCHEMBIO.278, 10.1038/nchembio.278]	28	30	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14796	14803		10.1074/jbc.M117.804070	http://dx.doi.org/10.1074/jbc.M117.804070			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729420	Green Published, hybrid			2022-12-26	WOS:000409902100008
J	Zhu, XZ; Yang, YJ; Chen, GL; Medo, M; Tian, H; Cai, SM				Zhu, Xuzhen; Yang, Yujie; Chen, Guilin; Medo, Matus; Tian, Hui; Cai, Shi-Min			Information filtering based on corrected redundancy-eliminating mass diffusion	PLOS ONE			English	Article							AWARE RECOMMENDER SYSTEMS; OF-THE-ART; ACCURACY; MODEL	Methods used in information filtering and recommendation often rely on quantifying the similarity between objects or users. The used similarity metrics often suffer from similarity redundancies arising from correlations between objects' attributes. Based on an unweighted undirected object-user bipartite network, we propose a Corrected Redundancy-Eliminating similarity index (CRE) which is based on a spreading process on the network. Extensive experiments on three benchmark data sets-Movilens, Netflix and Amazon-show that when used in recommendation, the CRE yields significant improvements in terms of recommendation accuracy and diversity. A detailed analysis is presented to unveil the origins of the observed differences between the CRE and mainstream similarity indices.	[Zhu, Xuzhen; Yang, Yujie; Chen, Guilin; Tian, Hui] Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Beijing 100876, Peoples R China; [Medo, Matus] Univ Fribourg, Dept Phys, Chemin Musee 3, CH-1700 Fribourg, Switzerland; [Cai, Shi-Min] Univ Elect Sci & Technol China, Web Sci Ctr, Sch Engn & Comp Sci, Chengdu 611731, Sichuan, Peoples R China; [Cai, Shi-Min] Univ Elect Sci & Technol China, Big Data Res Ctr, Chengdu 611731, Sichuan, Peoples R China	Beijing University of Posts & Telecommunications; University of Fribourg; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Cai, SM (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Sch Engn & Comp Sci, Chengdu 611731, Sichuan, Peoples R China.; Cai, SM (corresponding author), Univ Elect Sci & Technol China, Big Data Res Ctr, Chengdu 611731, Sichuan, Peoples R China.	shimin.cai81@gmail.com	Medo, Matus/J-6660-2019; cai, shimin/L-7841-2014	Medo, Matus/0000-0001-8865-9085; Zhu, Xuzhen/0000-0002-9159-6844; Cai, Shimin/0000-0002-2089-5150	National Natural Science Foundation of China [61602048, 61673086, 61471060]; support project of Sichuan Provincial Science and Technology Department [2015GZ0143]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); support project of Sichuan Provincial Science and Technology Department; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (Nos. 61602048, 61673086, and 61471060), the support project of Sichuan Provincial Science and Technology Department (No.2015GZ0143), and the Fundamental Research Funds for the Central Universities.	Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; [Anonymous], 1948, BIOL SKR, V5, P1; [Anonymous], 2004, P 10 ACM SIGKDD INT, DOI DOI 10.1145/1014052.1014097; Billsus D., 2007, The Adaptive Web. Methods and Strategies of Web Personalization, P550; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Burke R, 2002, USER MODEL USER-ADAP, V12, P331, DOI 10.1023/A:1021240730564; Campos PG, 2014, USER MODEL USER-ADAP, V24, P67, DOI 10.1007/s11257-012-9136-x; Doan A, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1924421.1924442; Felfernig A., 2008, ACM INT C EL COMM IC, P17; Goggin G., 2012, CELL PHONE CULTURE M; Goldberg K, 2001, INFORM RETRIEVAL, V4, P133, DOI 10.1023/A:1011419012209; Guan Y, 2014, FRONT COMPUT SCI-CHI, V8, P289, DOI 10.1007/s11704-013-3012-7; Hannon J., 2010, P 4 ACM C REC SYST R, P199, DOI DOI 10.1145/1864708.1864746; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Liu HF, 2014, KNOWL-BASED SYST, V56, P156, DOI 10.1016/j.knosys.2013.11.006; Liu JG, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037101; Lu E L, 2011, PHYS REV E, V83; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Maslov S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.248701; Pastor-Satorras R., 2007, EVOLUTION STRUCTURE; Ren J, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/58007; Ricci F, 2011, RECOMMENDER SYSTEMS HANDBOOK, P1, DOI 10.1007/978-0-387-85820-3_1; Unger Moshe, 2015, P 9 ACM C RECOMMENDE, P383, DOI DOI 10.1145/2792838.2796546; Yao LN, 2015, IEEE T SERV COMPUT, V8, P453, DOI 10.1109/TSC.2014.2355842; Zeng W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06140; Zhang GQ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123027; Zhang YC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154301; Zhang ZK, 2011, J COMPUT SCI TECH-CH, V26, P767, DOI 10.1007/s11390-011-0176-1; Zheng P., 2010, SMART PHONE NEXT GEN; Zhou T, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/58004; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123008; Zhu XZ, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/48007; Zhu XZ, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/07/P07004	39	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181402	10.1371/journal.pone.0181402	http://dx.doi.org/10.1371/journal.pone.0181402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749976	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700042
J	Banjara, M; Ghosh, C; Dadas, A; Mazzone, P; Janigro, D				Banjara, Manoj; Ghosh, Chaitali; Dadas, Aaron; Mazzone, Peter; Janigro, Damir			Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients	PLOS ONE			English	Article							PARANEOPLASTIC CEREBELLAR DEGENERATION; NEUROLOGICAL SYNDROMES; NMDA RECEPTOR; ANTIBODIES; ENCEPHALOMYELITIS; REPERTOIRE; DIAGNOSIS; PROTEIN; NR1	Antibodies against brain proteins were identified in the plasma of cancer patients and are defined to cause paraneoplastic neurological syndromes. The profiles of brain-directed antibodies in non-small cell lung cancer (NSCLC) are largely unknown. Here, for the first time, we compared autoantibodies against brain proteins in NSCLC (n = 18) against those present in age-matched non-cancer control subjects (n = 18) with a similar life-style, habit, and medical history. Self-recognizing immunoglobulin (IgG) are primarily directed against cells in the cortex (P = 0.008), hippocampus (P = 0.003-0.05), and cerebellum (P = 0.02). More specifically, IgG targets were prominent in the pyramidal, Purkinje, and granule cell layers. Furthermore, autoimmune IgG signals were localized to neurons (81%), astrocytes (48%), and endothelial (29%) cells. While cancer sera yielded overall higher intensity signals, autoantigens of 100, 65, 45, 37, and 30 kDa molecular weights were the most represented. Additionally, a group of 100 kDa proteins seem more prevalent in female adenocarcinoma patients (4/5, 80%). In conclusion, our results revealed autoantigen specificity in NSCLC, which implicitly depends on patient's demographics and disease history. Patients at risk for lung cancer but with no active disease revealed that the immune profile in NSCLC is disease-dependent.	[Banjara, Manoj; Ghosh, Chaitali] Cleveland Clin, Lerner Res Inst, Cerebrovasc Res, Cleveland, OH 44106 USA; [Banjara, Manoj; Ghosh, Chaitali] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA; [Ghosh, Chaitali] Cleveland Clin, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44106 USA; [Dadas, Aaron] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Mazzone, Peter] Cleveland Clin, Resp Ctr, Cleveland, OH 44106 USA; [Janigro, Damir] Flocel Inc, Cleveland, OH 44103 USA; [Janigro, Damir] Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; Case Western Reserve University	Ghosh, C (corresponding author), Cleveland Clin, Lerner Res Inst, Cerebrovasc Res, Cleveland, OH 44106 USA.; Ghosh, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44106 USA.; Ghosh, C (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44106 USA.; Janigro, D (corresponding author), Flocel Inc, Cleveland, OH 44103 USA.; Janigro, D (corresponding author), Case Western Reserve Univ, Dept Physiol, Cleveland, OH 44106 USA.	ghoshc@ccf.org; djangro@flocel.com	Mazzone, Peter/AAW-5401-2021; Janigro, Damir/P-1750-2018	Mazzone, Peter/0000-0003-2121-0595; Janigro, Damir/0000-0002-9645-0318	NIH [R01NS078307, UH4TR000491, R01NS43284, R41MH093302, R21NS077236, R42M H093302, R21HD057256, R01NS095825]; Brain and Behavior Foundation (NARSAD); American Heart Association [13SDG13950015]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078307, R01NS095825] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Foundation (NARSAD); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work is supported by NIH R01NS078307 (awarded to DJ and CG), UH4TR000491 awarded to DJ and CG, NIH R01NS43284, R41MH093302, R21NS077236, R42M H093302, and R21HD057256, awarded to DJ. This work is also supported by NIH R01NS095825, Brain and Behavior Foundation (NARSAD) and American Heart Association (13SDG13950015) awarded to CG. The funder provided support in the form of salaries for authors MB and CG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Furthermore, affiliation of DJ with Flocel Inc. has no financial relationship to the study and Flocel has no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	American Cancer Society (ACS), 2016, CANC FACTS FIG 2016; Bei R, 2009, CANCER LETT, V281, P8, DOI 10.1016/j.canlet.2008.11.009; Bourcier KD, 2001, J VIROL, V75, P9836, DOI 10.1128/JVI.75.20.9836-9843.2001; Caron E, 2015, ELIFE, V4, DOI 10.7554/eLife.07661; Conti F, 1999, CEREB CORTEX, V9, P110, DOI 10.1093/cercor/9.2.110; DALMAU J, 1992, MEDICINE, V71, P59, DOI 10.1097/00005792-199203000-00001; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Dalmau J, 2007, ANN NEUROL, V61, P25, DOI 10.1002/ana.21050; Darnell RB, 2003, NEW ENGL J MED, V349, P1543, DOI 10.1056/NEJMra023009; DeBiasi RL, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0450-9; Diamond B, 2013, ANNU REV IMMUNOL, V31, P345, DOI 10.1146/annurev-immunol-020711-075041; Fernandez Madrid Felix, 2005, Cancer Detect Prev, V29, P59, DOI 10.1016/j.cdp.2004.10.002; Flink MT, 2002, J PHYSIOL-LONDON, V543, P567, DOI 10.1113/jphysiol.2002.021048; Graus F, 2001, BRAIN, V124, P1138, DOI 10.1093/brain/124.6.1138; GRAUS F, 1991, J NEUROL SCI, V106, P82, DOI 10.1016/0022-510X(91)90198-G; Graus F, 2014, BLOOD, V123, P3230, DOI 10.1182/blood-2014-03-537506; Heffer-Lauc M, 2007, J HISTOCHEM CYTOCHEM, V55, P805, DOI 10.1369/jhc.7A7195.2007; Hiasa Y, 2003, CLIN NEUROL NEUROSUR, V106, P47, DOI 10.1016/S0303-8467(03)00059-3; Honnorat J, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-22; Huerta PT, 2006, P NATL ACAD SCI USA, V103, P678, DOI 10.1073/pnas.0510055103; Hurley K, 2015, RESP CARE, V60, pE144, DOI 10.4187/respcare.03879; Iffland PH, 2013, NEUROBIOL DIS, V59, P206, DOI 10.1016/j.nbd.2013.07.006; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kanaji N, 2014, WORLD J CLIN ONCOL, V5, P197, DOI 10.5306/wjco.v5.i3.197; Kazarian M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-33; Kennedy RC, 2003, INT REV IMMUNOL, V22, P141, DOI 10.1080/08830180305222; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Musunuru K, 2008, J NEURO-ONCOL, V90, P213, DOI 10.1007/s11060-008-9650-1; Reijerkerk A, 2010, J NEUROCHEM, V113, P447, DOI 10.1111/j.1471-4159.2010.06598.x; Roberts WK, 2004, CURR OPIN IMMUNOL, V16, P616, DOI 10.1016/j.coi.2004.07.009; Sabater L, 2006, J NEUROL NEUROSUR PS, V77, P1359, DOI 10.1136/jnnp.2006.097188; Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183; Sakai K, 2004, NEUROBIOL DIS, V15, P529, DOI 10.1016/j.nbd.2003.11.003; Schittenhelm RB, 2015, ARTHRITIS RHEUMATOL, V67, P702, DOI 10.1002/art.38963; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soussi T, 2000, CANCER RES, V60, P1777; Spiro SG, 2007, CHEST, V132, p149S, DOI 10.1378/chest.07-1358; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Tanaka K, 2004, J NEUROL SCI, V217, P25, DOI 10.1016/j.jns.2003.08.006; Torchilin VP, 2001, TRENDS IMMUNOL, V22, P424; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Voutsas Vasileios, 2008, J Med Case Rep, V2, P270, DOI 10.1186/1752-1947-2-270; Wang H, 2008, NEUROLOGY, V71, P1142, DOI 10.1212/01.wnl.0000316195.52001.e1; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Woodard Kelly M, 2008, Expert Opin Med Diagn, V2, P911, DOI 10.1517/17530059.2.8.911; Zaborowski MP, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/630602	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181409	10.1371/journal.pone.0181409	http://dx.doi.org/10.1371/journal.pone.0181409			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746384	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800035
J	Derose, KP; Payan, DD; Fulcar, MA; Terrero, S; Acevedo, R; Farias, H; Palar, K				Derose, Kathryn P.; Payan, Denise D.; Fulcar, Maria Altagracia; Terrero, Sergio; Acevedo, Ramon; Farias, Hugo; Palar, Kartika			Factors contributing to food insecurity among women living with HIV in the Dominican Republic: A qualitative study	PLOS ONE			English	Article							AIDS-RELATED STIGMA; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; LATIN-AMERICA; HIV/AIDS; HEALTH; ADHERENCE; SECURITY; GENDER; DISCRIMINATION	Background Food insecurity contributes to poor health outcomes among people living with HIV. In Latin America and the Caribbean, structural factors such as poverty, stigma, and inequality disproportionately affect women and may fuel both the HIV epidemic and food insecurity. Methods We examined factors contributing to food insecurity among women living with HIV (WLHIV) in the Dominican Republic (DR). Data collection included in-depth, semi-structured interviews in 2013 with 30 WLHIV with indications of food insecurity who resided in urban or peri-urban areas and were recruited from local HIV clinics. In-person interviews were conducted in Spanish. Transcripts were coded using content analysis methods and an inductive approach to identify principal and emergent themes. Results Respondents identified economic instability as the primary driver of food insecurity, precipitated by enacted stigma in the labor and social domains. Women described experiences of HIV-related labor discrimination in formal and informal sectors. Women commonly reported illegal HIV testing by employers, and subsequent dismissal if HIV-positive, especially in tourism and free trade zones. Enacted stigma in the social domain manifested as gossip and rejection by family, friends, and neighbors and physical, verbal, and sexual abuse by intimate partners, distancing women from sources of economic and food support. These experiences with discrimination and abuse contributed to internalized stigma among respondents who, as a result, were fearful and hesitant to disclose their HIV status; some participants reported leaving spouses and/or families, resulting in further isolation from economic resources, food and other support. A minority of participants described social support by friends, spouses, families and support groups, which helped to ameliorate food insecurity and emotional distress. Conclusions Addressing food insecurity among WLHIV requires policy and programmatic interventions to enforce existing laws designed to protect the rights of people living with HIV, reduce HIV-related stigma, and improve gender equality.	[Derose, Kathryn P.; Payan, Denise D.] RAND Corp, Dept Behav & Policy Sci, Santa Monica, CA 90401 USA; [Payan, Denise D.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Fulcar, Maria Altagracia; Terrero, Sergio] Dominican Republ Country Off, United Nations World Food Programme, Santo Domingo, Dominican Rep; [Acevedo, Ramon] Consejo Nacl VIH SIDA CONAVIHSIDA, Santo Domingo, Dominican Rep; [Farias, Hugo] Reg Bur Latin Amer & Caribbean, United Nations World Food Programme, Panama City, Panama; [Palar, Kartika] Univ Calif San Francisco, Sch Med, Div HIV ID & Global Med, San Francisco, CA USA	RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Derose, KP (corresponding author), RAND Corp, Dept Behav & Policy Sci, Santa Monica, CA 90401 USA.	derose@rand.org		Derose, Kathryn/0000-0001-7742-6024; Payan, Denise/0000-0003-3236-862X	World Food Programme (WFP); National Institute of Mental Health; NIMH [R34MH110325]; Agency for Healthcare Research and Quality; AHRQ [T32HS00046]; National Institute of Diabetes and Digestive and Kidney Diseases; NIDDK [K01 DK107335]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK107335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH110325] Funding Source: NIH RePORTER; AHRQ [5T32HS000046-26] Funding Source: Federal RePORTER	World Food Programme (WFP); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	We acknowledge financial support from the World Food Programme (WFP) for local data collection. For analysis and manuscript preparation, we acknowledge the following institutions for partial or full salary support of various co-authors: the National Institute of Mental Health or NIMH (grant number R34MH110325, Dr. Derose); the Agency for Healthcare Research and Quality or AHRQ (grant number T32HS00046, Dr. Palar, Dr. Payan); the National Institute of Diabetes and Digestive and Kidney Diseases or NIDDK (grant number K01 DK107335, Dr. Palar). The contents of the manuscript are solely the responsibility of the authors and do not represent the official views of WFP, NIMH, AHRQ, or NIDDK. The funders provided support in the form of salaries for authors [NIMH: KPD; AHRQ: DDP, KP; NIDDK: KP; WFP: MAF, ST, HF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aberman NL, 2014, AIDS BEHAV, V18, pS554, DOI 10.1007/s10461-014-0822-z; Aibibula W, 2016, AIDS BEHAV, P1; Alexy E, 2013, LANCET, V382, P15; Allen C., 2012, ADDRESSING LINKS GEN, P1; ANDERSON SA, 1990, J NUTR, V120, P1559, DOI 10.1093/jn/120.suppl_11.1555; Anema A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061277; [Anonymous], 2012, ELCSA MANUAL USO APL; [Anonymous], 2012, GLOB REP UNAIDS REP; Arregui M., 2007, INTERAM J PSYCHOL, V41, P31; Baez LEF, 2014, ESTADO EPIDEMICO VIH; Barrington C, 2016, GLOB PUBLIC HEALTH, P1; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Boyer S, 2011, SOC SCI MED, V72, P1383, DOI 10.1016/j.socscimed.2011.02.030; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Carneiro F Galrao, 2015, RESILIENT GROWTH PER; Cohen J, 2006, SCIENCE, V313, P468, DOI 10.1126/science.313.5786.468; Derose K., 2010, ROLE FAITH BASED ORG; Earnshaw V., 2013, STIGMA DISCRIMINATIO, P23, DOI [10.1007/978-94-007-6324-1_2, DOI 10.1007/978-94-007-6324-1_2]; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Espino A, 2013, FEM ECON, V19, P267, DOI 10.1080/13545701.2013.801558; Fielding-Miller R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-79; Forsythe S, 1998, HEALTH POLICY PLANN, V13, P277, DOI 10.1093/heapol/13.3.277; Franke MF, 2011, AIDS BEHAV, V15, P1483, DOI 10.1007/s10461-010-9789-6; Garcia PJ, 2014, CURR HIV-AIDS REP, V11, P146, DOI 10.1007/s11904-014-0204-1; Himmelgreen DA, 2009, AJAR-AFR J AIDS RES, V8, P401, DOI 10.2989/AJAR.2009.8.4.4.1041; Hosegood V, 2007, SOC SCI MED, V65, P1249, DOI 10.1016/j.socscimed.2007.05.002; Ivers LC, 2011, AM J CLIN NUTR, V94, p1740S, DOI 10.3945/ajcn.111.012617; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, DOM REP HIV AIDS EST; Kalichman SC, 2014, J COMMUN HEALTH, V39, P1133, DOI 10.1007/s10900-014-9868-0; Lekas HM, 2011, QUAL HEALTH RES, V21, P1205, DOI 10.1177/1049732311405684; Loevinsohn M, 2003, HIV AIDS FOOD SECURI; Martin A, 2011, J HIV-AIDS SOC SERV, V10, P194, DOI 10.1080/15381501.2011.572746; Martin MA, 2012, SOC SCI MED, V74, P1754, DOI 10.1016/j.socscimed.2011.11.013; McMahon JH, 2011, JAIDS-J ACQ IMM DEF, V58, P60, DOI 10.1097/QAI.0b013e318227f8dd; Melgar-Quinonez H., 2010, Seguranca Alimentar e Nutricional, V17, P48; Miles M.B., 1994, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; Mollmann M., 2004, TEST INEQUALITY DISC; Morrison A, 2007, WORLD BANK RES OBSER, V22, P25, DOI 10.1093/wbro/lkm003; Musumari PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085327; OECD, 2010, ATL GEND DEV SOC NOR; Padilla M, 2008, CARIBBEAN PLEASURE I; Padilla MS, 2010, AM J PUBLIC HEALTH, V100, P70, DOI 10.2105/AJPH.2009.161968; Palar K, 2015, 10 INT C HIV TREATM, P1; Palar K, 2016, AIDS, V30, P1457, DOI 10.1097/QAD.0000000000001095; Palar K, 2015, AIDS BEHAV, V19, P1527, DOI 10.1007/s10461-014-0922-9; Palar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061935; Palermo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062353; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Paudel V, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0032-9; Rael CT, 2016, AIDS CARE, V28, P319, DOI 10.1080/09540121.2015.1095277; Renzaho AMN, 2010, NUTRITION, V26, P1, DOI 10.1016/j.nut.2009.05.001; Rodrigo C, 2010, INT HEALTH, V2, P9, DOI 10.1016/j.inhe.2009.12.003; Rojas Patria, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P306, DOI 10.1177/1545109710397770; Sasaki Y, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-34; Saumure K., 2008, SAGE ENCY QUALITATIV, P195; Semba RD, 1999, BRIT J NUTR, V81, P181, DOI 10.1017/S0007114599000379; Singer AW, 2015, AIDS BEHAV, V19, P1510, DOI 10.1007/s10461-014-0873-1; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Strauss A., 1990, BASICS QUALITATIVE R; Sutherland ME, 2014, J HIV AIDS INFECT DI, V2, P1, DOI DOI 10.17303/JAID.2014.301; Tsai AC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001203; Tsai AC, 2012, SOC SCI MED, V74, P2012, DOI 10.1016/j.socscimed.2012.02.033; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; Varas-Diaz N, 2005, QUAL HEALTH RES, V15, P169, DOI 10.1177/1049732304272059; Vogenthaler NS, 2010, PUBLIC HEALTH NUTR, V13, P1478, DOI 10.1017/S1368980009993181; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2014, AIDS, V28, P115, DOI 10.1097/01.aids.0000433238.93986.35; Weiser SD, 2012, AIDS, V26, P67, DOI 10.1097/QAD.0b013e32834cad37; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Whittle HJ, 2015, SOC SCI MED, V143, P154, DOI 10.1016/j.socscimed.2015.08.027; Wolfe WR, 2006, AIDS CARE, V18, P931, DOI 10.1080/09540120500333558; World Bank, 2014, PROSP NOT SHAR WEAK; World Bank, 2016, DAT URB POP TOT; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4	80	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181568	10.1371/journal.pone.0181568	http://dx.doi.org/10.1371/journal.pone.0181568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8DV	28742870	Green Published, gold			2022-12-26	WOS:000406370000037
J	Greenwood, S; Deane, C; Rees, OL; Freedman, B; Kumar, S; Ben Ramadan, N; Wilkinson, S; Marais, G; Lord, J; Chakravorty, S; Height, SE; Gardner, K; Rees, DC				Greenwood, Simon; Deane, Colin; Rees, Oliver L.; Freedman, Ben; Kumar, Suresh; Ben Ramadan, Naser; Wilkinson, Sarah; Marais, Grant; Lord, Julie; Chakravorty, Subarna; Height, Susan E.; Gardner, Kate; Rees, David C.			The significance of inadequate transcranial Doppler studies in children with sickle cell disease	PLOS ONE			English	Article							FLOW VELOCITIES; STROKE; ANEMIA; TCD; ULTRASONOGRAPHY; TRANSFUSIONS; MANAGEMENT; RATES; RISK	Sickle cell disease (SCD) is a common cause of cerebrovascular disease in childhood. Primary stroke prevention is effective using transcranial Doppler (TCD) scans to measure intracranial blood velocities, and regular blood transfusions or hydroxycarbamide when these are abnormal. Inadequate TCD scans occur when it is not possible to measure velocities in all the main arteries. We have investigated the prevalence and significance of this in a retrospective audit of 3915 TCD scans in 1191 children, performed between 2008 and 2015. 79% scans were normal, 6.4% conditional, 2.8% abnormal and 12% inadequate. 21.6% of 1191 patients had an inadequate scan at least once. The median age of first inadequate scan was 3.3 years (0.7 - 19.4), with a U-shaped frequency distribution with age: 28% aged 2 - 3 years, 3.5% age 10 years, 25% age 16 years. In young children reduced compliance was the main reason for inadequate TCDs, whereas in older children it was due to a poor temporal ultrasound window. The prevalence of inadequate TCD was 8% in the main Vascular Laboratory at King's College Hospital and significantly higher at 16% in the outreach clinics (P<0.0001), probably due to the use of a portable ultrasound machine. Inadequate TCD scans were not associated with underlying cerebrovascular disease.	[Greenwood, Simon; Deane, Colin; Freedman, Ben] Kings Coll Hosp London, Vasc Lab, London, England; [Rees, Oliver L.] Imperial Coll, Med Sch, London, England; [Kumar, Suresh] Darent Valley Hosp, Dept Paediat, Dartford, Kent, England; [Ben Ramadan, Naser] Medway Maritime Hosp, Dept Paediat, Gillingham, Kent, England; [Wilkinson, Sarah; Lord, Julie] Lewisham & Greenwich NHS Trust, Dept Paediat, London, England; [Marais, Grant] Croydon Univ Hosp, Dept Paediat, London, England; [Chakravorty, Subarna; Height, Susan E.; Gardner, Kate; Rees, David C.] Kings Coll Hosp London, Dept Paediat Haematol, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; Imperial College London; Medway Maritime Hospital; Croydon University Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital	Rees, DC (corresponding author), Kings Coll Hosp London, Dept Paediat Haematol, London, England.	david.rees@kcl.ac.uk	Rees, David/B-6789-2011	Rees, David/0000-0003-3647-1050	Stroke Association (TSA)	Stroke Association (TSA)	This work was partly supported by grant from Stroke Association (TSA 2012/06) (www.stroke.org.uk). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, PEDIATR RADIOL, V35, P229, DOI 10.1007/s00247-005-1409-7; ADAMS RJ, 1998, NEW ENGL J MED, V339, P5, DOI [DOI 10.1056/NEJM199807023390102, 10.1056/NEJM199807023390102]; Adams RJ, 2013, STROKE, V44, P2930, DOI 10.1161/STROKEAHA.113.001312; Arkuszewski M, 2011, AM J NEURORADIOL, V32, P1444, DOI 10.3174/ajnr.A2529; Bazan R, 2015, ULTRASOUND MED BIOL, V41, P2131, DOI 10.1016/j.ultrasmedbio.2015.04.008; Bernaudin F, 2011, BLOOD, V117, P1130, DOI 10.1182/blood-2010-06-293514; Brousse V, 2015, BRIT J HAEMATOL, V170, P615, DOI 10.1111/bjh.13477; Brousse V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1765; Deane CR, 2008, ARCH DIS CHILD, V93, P138, DOI 10.1136/adc.2007.125799; Deane CR, 2010, HAEMATOL-HEMATOL J, V95, P1287, DOI 10.3324/haematol.2010.022624; DeBaun MR, 2016, BLOOD, V127, P829, DOI 10.1182/blood-2015-09-618579; Disorders NHSaUFoH, 2016, TRANSCRANIAL DOPPLER; Fullerton HJ, 2004, BLOOD, V104, P336, DOI 10.1182/blood-2004-02-0636; Hankins JS, 2008, BRIT J HAEMATOL, V142, P94, DOI 10.1111/j.1365-2141.2008.07167.x; Hebbel RP, 2011, AM J HEMATOL, V86, P123, DOI 10.1002/ajh.21952; Hokazono M, 2011, SAO PAULO MED J, V129, P134, DOI 10.1590/S1516-31802011000300003; Jones AM, 2001, PEDIATR RADIOL, V31, P461, DOI 10.1007/s002470100427; Lagunju I, 2012, AM J HEMATOL, V87, P544, DOI 10.1002/ajh.23152; Lowe LH, 2005, PEDIATR RADIOL, V35, P54, DOI 10.1007/s00247-004-1257-x; Naqvi J, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/629378; Neish AS, 2002, RADIOLOGY, V222, P709, DOI 10.1148/radiol.2223010524; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pavlakis SG, 2010, PEDIATR BLOOD CANCER, V54, P256, DOI 10.1002/pbc.22282; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; Roberts L, 2009, ANN HEMATOL, V88, P943, DOI 10.1007/s00277-009-0757-z; Telfer P, 2016, J PEDIAT HEMATOL ONC, V38, P517, DOI 10.1097/MPH.0000000000000633; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7	28	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181681	10.1371/journal.pone.0181681	http://dx.doi.org/10.1371/journal.pone.0181681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742875	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000048
J	Myllymaki, H; Niskanen, M; Oksanen, KE; Sherwood, E; Ahava, M; Parikka, M; Ramet, M				Myllymaki, Henna; Niskanen, Mirja; Oksanen, Kaisa Ester; Sherwood, Eleanor; Ahava, Maarit; Parikka, Mataleena; Ramet, Mika			Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio)	PLOS ONE			English	Article							RESUSCITATION-PROMOTING FACTORS; CALMETTE-GUERIN VACCINATION; RPF-LIKE GENES; MYCOBACTERIUM-TUBERCULOSIS; MEDIATES RESISTANCE; BACTERIAL-GROWTH; T-CELLS; IN-VIVO; INFECTION; PROTEINS	Tuberculosis (TB) remains a major global health challenge and the development of a better vaccine takes center stage in fighting the disease. For this purpose, animal models that are capable of replicating the course of the disease and are suitable for the early-stage screening of vaccine candidates are needed. A Mycobacterium marinum infection in adult zebrafish resembles human TB. Here, we present a pre-clinical screen for a DNA-based tuberculosis vaccine in the adult zebrafish using an M. marinum infection model. We tested 15 antigens representing different types of mycobacterial proteins, including the Resuscitation Promoting factors (Rpf), PE/PPE protein family members, other membrane proteins and metabolic enzymes. The antigens were expressed as GFP fusion proteins, facilitating the validation of their expression in vivo. The efficiency of the antigens was tested against a low-dose intraperitoneal M. marinum infection (approximate to 40 colony forming units), which mimics a primary M. tuberculosis infection. While none of the antigens was able to completely prevent a mycobacterial infection, four of them, namely RpfE, PE5_1, PE31 and cdh, led to significantly reduced bacterial burdens at four weeks post infection. Immunization with RpfE also improved the survival of the fish against a high-dose intraperitoneal injection with M. marinum (approximate to 10.000 colony forming units), resembling the disseminated form of the disease. This study shows that the M. marinum infection model in adult zebrafish is suitable for the pre-clinical screening of tuberculosis vaccines and presents RpfE as a potential antigen candidate for further studies.	[Myllymaki, Henna; Niskanen, Mirja; Oksanen, Kaisa Ester; Sherwood, Eleanor; Ahava, Maarit; Parikka, Mataleena; Ramet, Mika] Univ Tampere, BioMediTech Inst, Tampere, Finland; [Myllymaki, Henna; Niskanen, Mirja; Oksanen, Kaisa Ester; Sherwood, Eleanor; Ahava, Maarit; Parikka, Mataleena; Ramet, Mika] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Parikka, Mataleena] Tampere Univ Hosp, Oral & Maxillofacial Unit, Tampere, Finland; [Ramet, Mika] Univ Oulu, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland; [Ramet, Mika] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Oksanen, Kaisa Ester] MedEngine Oy, Helsinki, Finland; [Sherwood, Eleanor] Univ Glasgow, Sch Life Sci, Glasgow, Lanark, Scotland; [Sherwood, Eleanor] Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester, Lancs, England	Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Oulu; University of Oulu; University of Glasgow; University of Manchester	Myllymaki, H (corresponding author), Univ Tampere, BioMediTech Inst, Tampere, Finland.; Myllymaki, H (corresponding author), Univ Tampere, Fac Med & Life Sci, Tampere, Finland.	henna.myllymaki@uta.fi		Myllymaki, Henna/0000-0002-6936-4879; Parikka, Mataleena/0000-0001-5555-3815	Tampere Tuberculosis Foundation; Finnish Academy (MR) [277495]; Sigrid Juselius foundation; Janeand Aatos Erkko Foundation; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Competitive State Research Financing of the Expert Responsibility area of Oulu University Hospital; Finnish Anti-tuberculosis Foundation; Finnish Cultural Foundation Pirkanmaa Regional Fund	Tampere Tuberculosis Foundation; Finnish Academy (MR); Sigrid Juselius foundation(Sigrid Juselius Foundation); Janeand Aatos Erkko Foundation; Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Competitive State Research Financing of the Expert Responsibility area of Oulu University Hospital; Finnish Anti-tuberculosis Foundation; Finnish Cultural Foundation Pirkanmaa Regional Fund	This work was supported by: the Tampere Tuberculosis Foundation, http://www.tuberkuloosisaatio.fi/,(HM,KEO,MPandMR); the Finnish Academy (MR) (grant number277495), http://www.aka.fi/en/; the Sigrid Juselius foundation,http://sigridjuselius.fi/en/main-page/, MR, MP); the Janeand Aatos Erkko Foundation, http://jaes.fi/en/, (MR); the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, http://www. pshp.fi/en-US,(MR); -Competitive State Research Financing of the Expert Responsibility area of Oulu University Hospital, https://www.ppshp.fi/,(MR); the Finnish Anti-tuberculosis Foundation, https:// www.tb-foundation.org/, (HM, KEO, MP); the Finnish Cultural Foundation Pirkanmaa Regional Fund, https://skr.fi/en,(KEO).	Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Ahmed A, 2015, IUBMB LIFE, V67, P414, DOI 10.1002/iub.1387; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; [Anonymous], 2013, NAT GENET, V45, P1176; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Berg RD, 2016, CELL, V165, P139, DOI 10.1016/j.cell.2016.02.034; Brennan MJ, 2017, INFECT IMMUN; Brunner K, 2016, J MED CHEM, V59, P6848, DOI 10.1021/acs.jmedchem.6b00674; Cambier CJ, 2014, NATURE, V505, P218, DOI 10.1038/nature12799; Choi HG, 2015, EUR J IMMUNOL, V45, P1957, DOI 10.1002/eji.201445329; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Commandeur S, 2013, J IMMUNOL, V190, P1659, DOI 10.4049/jimmunol.1201593; Dara M, 2014, EUR RESPIR J, V43, P24, DOI 10.1183/09031936.00113413; del Mar Serra-Vidal MA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00517; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Fletcher HA, 2016, T ROY SOC TROP MED H, V110, P212, DOI 10.1093/trstmh/trw016; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glaziou P, 2013, SEMIN RESP CRIT CARE, V34, P3, DOI 10.1055/s-0032-1333467; Gupta RK, 2010, MICROBIOL-SGM, V156, P2714, DOI 10.1099/mic.0.037622-0; Hammaren MM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004190; Hatzios SK, 2011, BIOORG MED CHEM LETT, V21, P4956, DOI 10.1016/j.bmcl.2011.06.057; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Kadam Prashant, 2010, Int J Ayurveda Res, V1, P55, DOI 10.4103/0974-7788.59946; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Kana BD, 2010, FEMS IMMUNOL MED MIC, V58, P39, DOI 10.1111/j.1574-695X.2009.00606.x; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Kaufmann SHE, 2017, INT J INFECT DIS, V56, P263, DOI 10.1016/j.ijid.2016.10.018; Lancioni CL, 2011, INFECT IMMUN, V79, P663, DOI 10.1128/IAI.00806-10; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li H, 2016, APOPTOSIS, V21, P795, DOI 10.1007/s10495-016-1249-y; Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohi O, 2013, ACTA PAEDIATR, V102, P104, DOI 10.1111/j.1651-2227.2012.02835.x; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; Mahmood A, 2011, FEBS J, V278, P341, DOI 10.1111/j.1742-4658.2010.07958.x; Malen H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-18; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Myllymaki H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00196; Myllymaki H, 2015, EXPERT OPIN DRUG DIS, V10, P871, DOI 10.1517/17460441.2015.1049529; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Oehlers SH, 2015, NATURE, V517, P612, DOI 10.1038/nature13967; Ojanen MJT, 2015, INFECT IMMUN, V83, P1431, DOI 10.1128/IAI.03135-14; Oksanen KE, 2016, DEV COMP IMMUNOL, V54, P89, DOI 10.1016/j.dci.2015.09.001; Oksanen KE, 2013, VACCINE, V31, P5202, DOI 10.1016/j.vaccine.2013.08.093; Organization WH, 2016, GLOBAL TUBERCULOSIS; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; Prouty MG, 2003, FEMS MICROBIOL LETT, V225, P177, DOI 10.1016/S0378-1097(03)00446-4; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Renshaw SA, 2012, DIS MODEL MECH, V5, P38, DOI 10.1242/dmm.007138; Riano F, 2012, TUBERCULOSIS, V92, P148, DOI 10.1016/j.tube.2011.12.005; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Romano M, 2012, MICROBES INFECT, V14, P86, DOI 10.1016/j.micinf.2011.08.011; Rossetti AO, 2017, CRIT CARE MED, V45, pE674, DOI 10.1097/CCM.0000000000002337; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Schiller I, 2009, CLIN VACCINE IMMUNOL, V16, P1314, DOI 10.1128/CVI.00151-09; Spertini F, 2013, TUBERCULOSIS, V93, P179, DOI 10.1016/j.tube.2012.10.011; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tang JS, 2016, TUBERCULOSIS, V98, P30, DOI 10.1016/j.tube.2016.02.005; Tiwari BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051686; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Torraca V, 2015, DIS MODEL MECH, V8, P253, DOI 10.1242/dmm.017756; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; van der Vaart M, 2014, CELL HOST MICROBE, V15, P753, DOI 10.1016/j.chom.2014.05.005; van Meijgaarden KE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004671; Velez DR, 2010, HUM GENET, V127, P65, DOI 10.1007/s00439-009-0741-7; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wittamer V, 2011, BLOOD, V117, P7126, DOI 10.1182/blood-2010-11-321448; Xin Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072745; Yeremeev VV, 2003, INFECT IMMUN, V71, P4789, DOI 10.1128/IAI.71.8.4789-4794.2003; Yoon S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126378	80	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181942	10.1371/journal.pone.0181942	http://dx.doi.org/10.1371/journal.pone.0181942			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742838	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000063
J	Wang, JJ; Tao, F; Tian, W; Guo, ZF; Chen, XM; Xu, XM; Shang, HS; Hu, XP				Wang, Junjuan; Tao, Fei; Tian, Wei; Guo, Zhongfeng; Chen, Xianming; Xu, Xiangming; Shang, Hongsheng; Hu, Xiaoping			The wheat WRKY transcription factors TaWRKY49 and TaWRKY62 confer differential high-temperature seedling-plant resistance to Puccinia striiformis f. sp tritici	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; DISEASE-RESISTANCE; STRIPE RUST; CELL-DEATH; RALSTONIA-SOLANACEARUM; HYDROGEN-PEROXIDE; OXIDATIVE BURST; POWDERY MILDEW; BREAD WHEAT; LEAF RUST	WRKY transcription factors (TFs) play crucial roles in plant resistance responses to pathogens. Wheat stripe rust, caused by the fungal pathogen Puccinia striiformis f. sp. tritici (Pst), is a destructive disease of wheat (Triticum aestivum) worldwide. In this study, the two WRKY genes TaWRKY49 and TaWRKY62 were originally identified in association with high-temperature seedling-plant resistance to Pst (HTSP) resistance in wheat cultivar Xiaoyan 6 by RNA-seq. Interestingly, the expression levels of TaWRKY49 and TaWRKY62 were down-and up-regulated, respectively, during HTSP resistance in response to Pst. Silencing of TaWRKY49 enhanced whereas silencing TaWRKY62 reduced HTSP resistance. The enhanced resistance observed on leaves following the silencing of TaWRKY49 was coupled with increased expression of salicylic acid (SA)-and jasmonic acid (JA)-responsive genes TaPR1.1 and TaAOS, as well as reactive oxygen species (ROS)-associated genes TaCAT and TaPOD; whereas the ethylene (ET)-responsive gene TaPIE1 was suppressed. The decreased resistance observed on leaves following TaWRKY62 silencing was associated with increased expression of TaPR1.1 and TaPOD, and suppression of TaAOS and TaPIE1. Furthermore, SA, ET, MeJA (methyl jasmonate), hydrogen peroxide (H2O2) and abscisic acid (ABA) treatments increased TaWRKY62 expression. On the other hand, MeJA did not affect the expression of TaWRKY49, and H2O2 reduced TaWRKY49 expression. In conclusion, TaWRKY49 negatively regulates while TaWRKY62 positively regulates wheat HTSP resistance to Pst by differential regulation of SA-, JA-, ET and ROS-mediated signaling.	[Wang, Junjuan; Tao, Fei; Tian, Wei; Guo, Zhongfeng; Shang, Hongsheng; Hu, Xiaoping] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Chen, Xianming] Washington State Univ, Dept Agr, Agr Res Serv, Pullman, WA USA; [Chen, Xianming] Washington State Univ, Dept Plant Pathol, Pullman, WA USA; [Xu, Xiangming] NIAB East Mailing Res, East Mailing, Kent, England	Northwest A&F University - China; United States Department of Agriculture (USDA); Washington State University; Washington State University	Hu, XP (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	xphu@nwsuaf.edu.cn		Hu, Xiaoping/0000-0002-8155-7040	National Natural Science Foundation of China [31271985]; National Basic Research Program of China [2013CB127700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China(no. 31271985) XH, http://www.nsfc.gov.cn/; the National Basic Research Program of China (no. 2013CB127700) XH.	Abbruscato P, 2012, MOL PLANT PATHOL, V13, P828, DOI 10.1111/j.1364-3703.2012.00795.x; AbuQamar S, 2006, PLANT J, V48, P28, DOI 10.1111/j.1365-313X.2006.02849.x; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; [安菲 An Fei], 2015, [麦类作物学报, Journal of Triticeae Crops], V35, P1314; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Bolwell PP, 2001, PROTOPLASMA, V217, P20, DOI 10.1007/BF01289409; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Chen BS, 2016, DNA RES, V23, P101, DOI 10.1093/dnares/dsv040; Chen LG, 2013, P NATL ACAD SCI USA, V110, pE1963, DOI 10.1073/pnas.1221347110; Chen LG, 2010, MOL PLANT MICROBE IN, V23, P558, DOI 10.1094/MPMI-23-5-0558; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Eulgem T, 2004, PLANT PHYSIOL, V135, P1129, DOI 10.1104/pp.104.040444; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gregersen PL, 1997, PHYSIOL MOL PLANT P, V51, P85, DOI 10.1006/pmpp.1997.0108; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Joseph LM, 1998, CAN J BOT, V76, P2119, DOI 10.1139/cjb-76-12-2119; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LEON J, 1995, PLANT PHYSIOL, V108, P1673, DOI 10.1104/pp.108.4.1673; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Liu JQ, 2016, PLANT PHYSIOL, V171, P1427, DOI 10.1104/pp.15.01921; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA Q, 2000, ACTA AGR BOREALI OCC, V9, P39, DOI DOI 10.3969/J.ISSN.1004-1389.2000.01.010; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Mukhtar MS, 2008, PLANT J, V56, P935, DOI 10.1111/j.1365-313X.2008.03651.x; Oh SK, 2008, NEW PHYTOL, V177, P977, DOI 10.1111/j.1469-8137.2007.02310.x; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Park CJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1932; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Plotnikova L Y, 2013, RUSS J GENET APPL RE, V3, P47, DOI DOI 10.1134/S2079059713010115; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Rushton PJ, 1998, CURR OPIN PLANT BIOL, V1, P311, DOI 10.1016/1369-5266(88)80052-9; Satapathy L, 2014, MOL GENET GENOMICS, V289, P1289, DOI 10.1007/s00438-014-0890-9; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Shang HongSheng, 1998, Scientia Agricultura Sinica, V31, P46; Shang HongSheng, 1997, Acta Phytophylacica Sinica, V24, P97; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Sol JF, 1990, ANNU REV PHYTOPATHOL, V28, P113; STATLER GD, 1993, CAN J PLANT PATHOL, V15, P97, DOI 10.1080/07060669309500833; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; TENHAKEN R, 1995, P NATL ACAD SCI USA, V92, P4158, DOI 10.1073/pnas.92.10.4158; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Villareal LMMA, 2002, APPL ENVIRON MICROB, V68, P6138, DOI 10.1128/AEM.68.12.6138-6145.2002; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang J, 2016, MOL PLANT PATHOL; Wang YN, 2013, MOL PLANT PATHOL, V14, P131, DOI 10.1111/j.1364-3703.2012.00836.x; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Xing DH, 2008, MOL PLANT, V1, P459, DOI 10.1093/mp/ssn020; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang PP, 2017, PLANT BREEDING, V136, P1, DOI 10.1111/pbr.12434; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	74	28	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181963	10.1371/journal.pone.0181963	http://dx.doi.org/10.1371/journal.pone.0181963			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742872	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000064
J	Leonard, JL; Leonard, DM; Wolfe, SA; Liu, JL; Rivera, J; Yang, M; Leonard, RT; Johnson, JPS; Kumar, P; Liebmann, KL; Tutto, AA; Mou, ZM; Simin, KJ				Leonard, Jack L.; Leonard, Deborah M.; Wolfe, Scot A.; Liu, Jilin; Rivera, Jaime; Yang, Michelle; Leonard, Ryan T.; Johnson, Jacob P. S.; Kumar, Prashant; Liebmann, Kate L.; Tutto, Amanda A.; Mou, Zhongming; Simin, Karl J.			The Dkk3 gene encodes a vital intracellular regulator of cell proliferation	PLOS ONE			English	Article							I-KAPPA-B; BETA-CATENIN; ZINC-FINGER; PROMOTER-HYPERMETHYLATION; SECRETED ANTAGONISTS; REIC/DKK-3 GENE; DOWN-REGULATION; BREAST-CANCER; WNT PATHWAY; EXPRESSION	Members of the Dickkopf (Dkk) family of Wnt antagonists interrupt Wnt-induced receptor assembly and participate in axial patterning and cell fate determination. One family member, DKK3, does not block Wnt receptor activation. Loss of Dkk3 expression in cancer is associated with hyperproliferation and dysregulated beta-catenin signaling, and ectopic expression of Dkk3 halts cancer growth. The molecular events mediating the DKK3-dependent arrest of beta-catenin-driven cell proliferation in cancer cells are unknown. Here we report the identification of a new intracellular gene product originating from the Dkk3 locus. This Dkk3b transcript originates from a second transcriptional start site located in intron 2 of the Dkk3 gene. It is essential for early mouse development and is a newly recognized regulator of beta-catenin signaling and cell proliferation. Dkk3b interrupts nuclear translocation beta-catenin by capturing cytoplasmic, unphosphorylated beta-catenin in an extra-nuclear complex with beta-TrCP. These data reveal a new regulator of one of the most studied signal transduction pathways in metazoans and provides a novel, completely untapped therapeutic target for silencing the aberrant beta-catenin signaling that drives hyperproliferation in many cancers.	[Leonard, Jack L.; Leonard, Ryan T.; Liebmann, Kate L.; Tutto, Amanda A.; Mou, Zhongming] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Leonard, Deborah M.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Wolfe, Scot A.; Yang, Michelle; Johnson, Jacob P. S.; Kumar, Prashant; Simin, Karl J.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Liu, Jilin] Univ Massachusetts, Sch Med, Dept Cell & Mol Physiol, Worcester, MA USA; [Rivera, Jaime] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA; [Liu, Jilin] Validars, Worcester, MA USA; [Yang, Michelle] Univ Vermont, Coll Med, Burlington, VT USA; [Kumar, Prashant] Inst Bioinformat, Bangalore, Karnataka, India	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont	Leonard, JL (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.	jack.leonard@umassmed.edu	Kumar, Prashant/O-9273-2015	Rivera-Perez, Jaime/0000-0001-5776-6291; , Dr. Prashant Kumar/0000-0001-8975-5108	National Institutes of Health [NIDDK: DK38772, DK060051]; Pancreatic Cancer Alliance Fund; Hyundai Hope on Wheels Scholar Program [80389MA]; PinkRevolution	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Alliance Fund; Hyundai Hope on Wheels Scholar Program; PinkRevolution	This work was supported by National Institutes of Health NIDDK: DK38772 and DK060051 to J.L.L., Pancreatic Cancer Alliance Fund (www.pancreaticalliance.org) 2014j to J.L.L., Hyundai Hope on Wheels Scholar Program (www.hyundaihopeonwheels.org) 80389MA to J.L.L. PinkRevolution,,www.PinkRevolution.org K.J.S.	Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Barrantes ID, 2006, MOL CELL BIOL, V26, P2317, DOI 10.1128/MCB.26.6.2317-2326.2006; Becker-Hapak M, 2003, CURR PROTOC CELL BIO; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chia IV, 2009, GENETICS, V181, P1359, DOI 10.1534/genetics.109.101055; Conner D A, 2001, Curr Protoc Mol Biol, VChapter 23, DOI 10.1002/0471142727.mb2302s51; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; FARWELL AP, 1989, J BIOL CHEM, V264, P20561; Fedders H, 2004, DEV GENES EVOL, V214, P72, DOI 10.1007/s00427-003-0378-9; Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326; Fujii Y, 2014, ACTA MED OKAYAMA, V68, P63; Gotze S, 2010, INT J CANCER, V126, P2584, DOI 10.1002/ijc.24981; Gu YM, 2011, WORLD J GASTROENTERO, V17, P3810, DOI 10.3748/wjg.v17.i33.3810; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Guder C, 2006, DEVELOPMENT, V133, P901, DOI 10.1242/dev.02265; Gupta A, 2012, NAT METHODS, V9, P588, DOI [10.1038/NMETH.1994, 10.1038/nmeth.1994]; Hajra KM, 1999, ONCOGENE, V18, P7274, DOI 10.1038/sj.onc.1203336; Hayakawa M, 2008, GENES CELLS, V13, P329, DOI 10.1111/j.1365-2443.2008.01168.x; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Hiraiwa A, 1996, VIRUS GENES, V12, P27, DOI 10.1007/BF00369998; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Huang ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-221; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kobayashi K, 2002, GENE, V282, P151, DOI 10.1016/S0378-1119(01)00838-1; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; Leonard DM, 2000, J BIOL CHEM, V275, P25194, DOI 10.1074/jbc.M002036200; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Li Q, 2007, ONCOGENE, V26, P6194, DOI 10.1038/sj.onc.1210438; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Low TY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005882; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Pietila I, 2011, DEV BIOL, V353, P50, DOI 10.1016/j.ydbio.2011.02.019; Roman-Gomez J, 2004, BRIT J CANCER, V91, P707, DOI 10.1038/sj.bjc.6602008; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Sieber OM, 2004, CANCER RES, V64, P8876, DOI 10.1158/0008-5472.CAN-04-2958; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stachelek SJ, 2000, J BIOL CHEM, V275, P31701, DOI 10.1074/jbc.M004221200; Stachelek SJ, 2001, J BIOL CHEM, V276, P35652, DOI 10.1074/jbc.M103331200; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; VERTINO PM, 1994, CELL GROWTH DIFFER, V5, P1395; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xiang TX, 2013, J CELL MOL MED, V17, P1236, DOI 10.1111/jcmm.12099; Xie R, 2011, GENESIS, V49, P98, DOI 10.1002/dvg.20703; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Yue W, 2008, CARCINOGENESIS, V29, P84, DOI 10.1093/carcin/bgm267; Zhu C, 2013, NUCLEIC ACIDS RES, V41, P2455, DOI 10.1093/nar/gks1357; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	74	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181724	10.1371/journal.pone.0181724	http://dx.doi.org/10.1371/journal.pone.0181724			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738084	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700063
J	Zhang, XL; Liu, Y; Wang, XZ; Sun, XY; Zhang, CY; Zheng, SG				Zhang, Xianli; Liu, Yang; Wang, Xiaozhe; Sun, Xiangyu; Zhang, Chenying; Zheng, Shuguo			Analysis of novel RUNX2 mutations in Chinese patients with cleidocranial dysplasia	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSF2/CBFA1; OSTEOBLAST DIFFERENTIATION; DNA RECOGNITION; CBF-BETA; GENE; BINDING; FAMILY; DOMAIN; AML1; TRANSACTIVATION	Cleidocranial dysplasia (CCD) is an autosomal dominant inheritable skeletal disorder characterized by cranial dysplasia, clavicle hypoplasia and dental abnormalities. This disease is mainly caused by heterozygous mutations in RUNX2, a gene that encodes an osteoblast-specific transcription factor. In the present study, mutational analyses of RUNX2 gene were performed on four unrelated Chinese patients with CCD. Four different RUNX2 mutations were detected in these patients, including one nonsense mutation (c.199C > T p.Q67X) and three missense mutations (c.338T > G p.L113R, c.557G > C p.R186T and c.673C > T p. R225W). Among them, two mutations (c.199C > T p.Q67X and c.557G > C p.R186T) were novel and the other two had been reported in previous literatures. Except for Q67X mutation located in the Q/A domain, other three mutations were clustered within the highly conserved Runt domain. Green fluorescent protein (GFP) and RUNX2 fusion protein analyses in vitro showed that nuclear accumulation of RUNX2 protein was disturbed by Q67X mutation, while the other two mutations (c.338T > G p.L113R and c.557G > C p.R186T) had no effects on the subcellular distribution of RUNX2. Luciferase reporter assay demonstrated that all the three novel RUNX2 mutations significantly reduced the transactivation activity of RUNX2 on osteocalcin promoter. Our findings enrich the evidence of molecular genetics that the mutations of RUNX2 gene are responsible for CCD.	[Zhang, Xianli; Liu, Yang; Wang, Xiaozhe; Sun, Xiangyu; Zhang, Chenying; Zheng, Shuguo] Peking Univ, Beijing Key Lab Digital Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Dept Prevent Dent,Sch & Hosp Stomatol, Beijing, Peoples R China	Peking University	Zhang, CY; Zheng, SG (corresponding author), Peking Univ, Beijing Key Lab Digital Stomatol, Natl Engn Lab Digital & Mat Technol Stomatol, Dept Prevent Dent,Sch & Hosp Stomatol, Beijing, Peoples R China.	zhangchy168@163.com; zhengsg86@gmail.com	Zheng, Shuguo/AAO-7612-2020; Sun, Xiangyu/T-8264-2019	Zheng, Shuguo/0000-0001-6717-5196	National Natural Science Foundation of China [81070815]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81070815).	Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19; Bufalino A, 2012, ORAL DIS, V18, P184, DOI 10.1111/j.1601-0825.2011.01862.x; CHITAYAT D, 1992, AM J MED GENET, V42, P298, DOI 10.1002/ajmg.1320420307; Cunningham ML, 2006, BIRTH DEFECTS RES A, V76, P78, DOI 10.1002/bdra.20231; Dincsoy Bir F, 2016, EUR J MED GENET; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Guo YW, 2015, INT J CLIN EXP PATHO, V8, P1057; Jaruga A, 2016, CLIN GENETICS; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kauffenstein G, 2016, ARTERIOSCL THROM VAS, V36, P1598, DOI 10.1161/ATVBAHA.116.307739; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Mastushita M, 2015, MOL SYNDROMOL, V6, P50, DOI 10.1159/000370337; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagata T, 2001, J MOL BIOL, V308, P191, DOI 10.1006/jmbi.2001.4596; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Quack I, 1999, AM J HUM GENET, V65, P1268, DOI 10.1086/302622; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Tessa Alessandra, 2003, Hum Mutat, V22, P104, DOI 10.1002/humu.9155; Thirunavukkarasu K, 1998, MOL CELL BIOL, V18, P4197, DOI 10.1128/MCB.18.7.4197; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zhang CY, 2009, J DENT RES, V88, P861, DOI 10.1177/0022034509342083; Zhang CY, 2010, MUTAGENESIS, V25, P589, DOI 10.1093/mutage/geq044; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	33	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181653	10.1371/journal.pone.0181653	http://dx.doi.org/10.1371/journal.pone.0181653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738062	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700059
J	Messerer, M; Fischer, W; Schubert, S				Messerer, Maxim; Fischer, Wolfgang; Schubert, Soeren			Investigation of horizontal gene transfer of pathogenicity islands in Escherichia coli using next-generation sequencing	PLOS ONE			English	Article							VIRULENCE; EVOLUTION; STRAINS	Horizontal gene transfer (HGT) contributes to the evolution of bacteria. All extraintestinal pathogenic Escherichia coli (ExPEC) harbour pathogenicity islands (PAIs), however relatively little is known about the acquisition of these PAIs. Due to these islands, ExPEC have properties to colonize and invade its hosts efficiently. Even though these PAIs are known to be acquired by HGT, only very few PAIs do carry mobilization and transfer genes required for the transmission by HGT. In this study, we apply for the first time next-generation sequencing (NGS) and in silico analyses in combination with in vitro experiments to decipher the mechanisms of PAI acquisition in ExPEC. For this, we investigated three neighbouring E. coli PAIs, namely the high-pathogenicity island (HPI), the pks and the serU island. As these PAIs contain no mobilization and transfer genes, they are immobile and dependent on transfer vehicles. By whole genome sequencing of the entire E. coli reference (ECOR) collection and by applying a phylogenetic approach we could unambiguously demonstrate that these PAIs are transmitted not only vertically, but also horizontally. Furthermore, we could prove in silico that distinct groups of PAIs were transferred "en bloc" in conjunction with the neighbouring chromosomal backbone. We traced this PAI transfer in vitro using an F'plasmid. Different lengths of transferred DNA were exactly detectable in the sequenced transconjugants indicating NGS as a powerful tool for determination of PAI transfer.	[Messerer, Maxim; Fischer, Wolfgang; Schubert, Soeren] Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany	University of Munich	Schubert, S (corresponding author), Max von Pettenkofer Inst Hyg & Med Mikrobiol, Munich, Germany.	schubert@med.uni-muenchen.de	Messerer, Maxim/GWU-5619-2022	Messerer, Maxim/0000-0003-0554-5045	ERANET "Transnational PathoGenoMics", BMBF	ERANET "Transnational PathoGenoMics", BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by a grant by the ERANET "Transnational PathoGenoMics", BMBF.; We thank Phillippe Glaser and his team for the sequencing of the E. coli isolates. This study was supported by a grant by the ERANET "Transnational PathoGenoMics", BMBF.	Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gordienko EN, 2013, J BACTERIOL, V195, P2786, DOI 10.1128/JB.02285-12; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Griffiths AJ, 1999, MODERN GENETIC ANAL; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HACKER J, 1992, ZBL BAKT-INT J MED M, V276, P165; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2001, J INFECT DIS, V184, P1556, DOI 10.1086/323891; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kohler CD, 2011, INT J MED MICROBIOL, V301, P642, DOI 10.1016/j.ijmm.2011.09.006; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lecointre G, 1998, MOL BIOL EVOL, V15, P1685, DOI 10.1093/oxfordjournals.molbev.a025895; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Martin P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003437; Milkman R, 1997, GENETICS, V146, P745; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-210; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Schubert S, 2010, INT J MED MICROBIOL, V300, P429, DOI 10.1016/j.ijmm.2010.02.006; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	35	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0179880	10.1371/journal.pone.0179880	http://dx.doi.org/10.1371/journal.pone.0179880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732043	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100002
J	Kadmiel, M; Matson, BC; Espenschied, ST; Lenhart, PM; Caron, KM				Kadmiel, Mahita; Matson, Brooke C.; Espenschied, Scott T.; Lenhart, Patricia M.; Caron, Kathleen M.			Loss of receptor activity-modifying protein 2 in mice causes placental dysfunction and alters PTH1R regulation	PLOS ONE			English	Article							CALCIUM-TRANSPORT; GENE-EXPRESSION; DRUG TARGETS; ADRENOMEDULLIN; DISTINCT; RAMPS; CELLS; OSTEOPOROSIS; INTERFACE; PTHRP	Receptor activity-modifying protein 2 (Ramp2) is a single-pass transmembrane protein that heterodimerizes with several family B G-protein coupled receptors to alter their function. Ramp2 has been primarily characterized in association with calcitonin receptor-like receptor (Calcrl, CLR), forming the canonical receptor complex for the endocrine peptide adrenomedullin (Adm, AM). However, we previously demonstrated that Ramp2(+/-) female mice display a constellation of endocrine-related phenotypes that are distinct from those of Adm (+/-) and Calcrl(+/-) mice, implying that RAMP2 has physiological functions beyond its canonical complex. Here, we localize Ramp2 expression in the mouse placenta, finding that Ramp2 is robustly expressed in the fetal labyrinth layer, and then characterize the effects of loss of Ramp2 on placental development. Consistent with the expression pattern of Ramp2 in the placenta, Ramp2(-/-) lacentas have a thinner labyrinth layer with significantly fewer trophoblast cells secondary to a reduction in trophoblast proliferation. We also find that absence of Ramp2 leads to failed spiral artery remodeling unaccompanied by changes in the uterine natural killer cell population. Furthermore, we assess changes in gene expression of other RAMP2-associated G-protein coupled receptors (GPCRs), concluding that Ramp2 loss decreases parathyroid hormone 1 receptor (Pthr1) expression and causes a blunted response to systemic parathyroid hormone (PTH) administration in mice. Ultimately, these studies provide in vivo evidence of a role for RAMP2 in placental development distinct from the RAMP2-CLR/AM signaling paradigm and identify additional pathways underlying the endocrine and fertility defects of the previously characterized Ramp2 heterozygous adult females.	[Kadmiel, Mahita; Matson, Brooke C.; Espenschied, Scott T.; Lenhart, Patricia M.; Caron, Kathleen M.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Caron, Kathleen M.] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Caron, KM (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; Caron, KM (corresponding author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.	kathleen_caron@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Espenschied, Scott T./AAO-2900-2020	Caron, Kathleen/0000-0002-7033-9232; Espenschied, Scott T./0000-0001-8885-7532	U.S. National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 HD060860, F30 HD085652]; American Heart Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060860] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	U.S. National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov) R01 HD060860 (to KMC) and F30 HD085652 (to BCM) and by an American Heart Association (www.heart.org) Predoctoral Fellowship (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2010, ONCOLOGIST, V15, P61, DOI 10.1634/theoncologist.2009-0185; Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dunworth WP, 2009, ARTERIOSCL THROM VAS, V29, P650, DOI 10.1161/ATVBAHA.109.185066; Eastabrook G, 2008, J OBSTET GYNAECOL CA, V30, P467, DOI 10.1016/S1701-2163(16)32862-6; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Kadmiel M, 2012, ADV EXP MED BIOL, V744, P49, DOI 10.1007/978-1-4614-2364-5_5; Kadmiel M, 2011, MOL ENDOCRINOL, V25, P1244, DOI 10.1210/me.2010-0400; Kechele DO, 2016, HYPERTENSION, V68, P667, DOI 10.1161/HYPERTENSIONAHA.116.07191; Klein KR, 2016, CRIT REV BIOCHEM MOL, V51, P65, DOI 10.3109/10409238.2015.1128875; Kovacs CS, 1996, P NATL ACAD SCI USA, V93, P15233, DOI 10.1073/pnas.93.26.15233; Kovacs CS, 2001, ENDOCRINOLOGY, V142, P4983, DOI 10.1210/en.142.11.4983; Kremer R, 2012, ADV EXP MED BIOL, V720, P145, DOI 10.1007/978-1-4614-0254-1_12; Kuwasako K, 2010, BIOCHEM BIOPH RES CO, V392, P380, DOI 10.1016/j.bbrc.2010.01.030; Li M, 2008, BIOL REPROD; Li MY, 2013, J CLIN INVEST, V123, P2408, DOI 10.1172/JCI67039; Makino Y, 2001, J CLIN ENDOCR METAB, V86, P5079, DOI 10.1210/jc.86.10.5079; Matson BC, 2014, INT J DEV BIOL, V58, P199, DOI 10.1387/ijdb.140032kc; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mosekilde L, 2011, CURR DRUG SAF, V6, P62, DOI 10.2174/157488611795684712; Sexton PM, 2012, ADV EXP MED BIOL, V744, P61, DOI 10.1007/978-1-4614-2364-5_6; Simmonds CS, 2010, J BONE MINER RES, V25, P594, DOI 10.1359/jbmr.090825; Toulis KA, 2011, HORM-INT J ENDOCRINO, V10, P174, DOI 10.14310/horm.2002.1308; Tucci J, 1996, J MOL ENDOCRINOL, V17, P159, DOI 10.1677/jme.0.0170159; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2016, J BIOL CHEM, V291, P11657, DOI 10.1074/jbc.M115.688218	30	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181597	10.1371/journal.pone.0181597	http://dx.doi.org/10.1371/journal.pone.0181597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727763	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500091
J	D'Abronzo, LS; Bose, S; Crapuchettes, ME; Beggs, RE; Vinall, RL; Tepper, CG; Siddiqui, S; Mudryj, M; Melgoza, FU; Durbin-Johnson, BP; White, RWD; Ghosh, PM				D'Abronzo, L. S.; Bose, S.; Crapuchettes, M. E.; Beggs, R. E.; Vinall, R. L.; Tepper, C. G.; Siddiqui, S.; Mudryj, M.; Melgoza, F. U.; Durbin-Johnson, B. P.; White, R. W. deVere; Ghosh, P. M.			The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer	ONCOGENE			English	Article							INITIATION-FACTOR 4E; CELL-PROLIFERATION; MAMMALIAN TARGET; RAPAMYCIN; TRANSLATION; GROWTH; ACTIVATION; PROTEIN; BICALUTAMIDE; MNK1	The antiandrogen bicalutamide is widely used in the treatment of advanced prostate cancer (PCa) in many countries, but its effect on castration-resistant PCa (CRPC) is limited. We previously showed that resistance to bicalutamide results from activation of mechanistic target of rapamycin (mTOR). Interestingly, clinical trials testing combinations of the mTOR inhibitor RAD001 with bicalutamide were effective in bicalutamide-naive CRPC patients, but not in bicalutamide-pretreated ones. Here we investigate causes for their difference in response. Evaluation of CRPC cell lines identified resistant vs sensitive in vitro models, and revealed that increased eIF4E(S209) phosphorylation is associated with resistance to the combination. We confirmed using a human-derived tumor xenograft mouse model that bicalutamide pre-treatment is associated with an increase in eIF4E(S209) phosphorylation. Thus, AR suppressed eukaryotic initiation factor 4E (eIF4E) phosphorylation, while the use of antiandrogens relieved this suppression, thereby triggering its increase. Additional investigation in human prostatectomy samples showed that increased eIF4E phosphorylation strongly correlated with the cell proliferation marker Ki67. Small interfering RNA-mediated knockdown (k/d) of eIF4E-sensitized CRPC cells to RAD001+bicalutamide, whereas eIF4E overexpression induced resistance. Inhibition of eIF4E phosphorylation by treatment with CGP57380 (an inhibitor of mitogen-activated protein kinase-interacting serine-threonine kinases MAP kinase-interacting kinase 1 (Mnk1/2), the eIF4E upstream kinase) or inhibitors of extracellular signal-regulated kinase 1/2 (ERK1/2), the upstream kinase-regulating Mnk1/2, also sensitized CRPC cells to RAD001+ bicalutamide. Examination of downstream targets of eIF4E-mediated translation, including survivin, demonstrated that eIF4E(S209) phosphorylation increased cap-independent translation, whereas its inhibition restored cap-dependent translation, which could be inhibited by mTOR inhibitors. Thus, our results demonstrate that while combinations of AR and mTOR inhibitors were effective in suppressing tumor growth by inhibiting both AR-induced transcription and mTOR-induced cap-dependent translation, pre-treatment with AR antagonists including bicalutamide increased eIF4E phosphorylation that induced resistance to combinations of AR and mTOR inhibitors by inducing cap-independent translation. We conclude that this resistance can be overcome by inhibiting eIF4E phosphorylation with Mnk1/2 or ERK1/2 inhibitors.	[D'Abronzo, L. S.; Crapuchettes, M. E.; Beggs, R. E.; Siddiqui, S.; Melgoza, F. U.; Ghosh, P. M.] Univ Calif Davis, VA Northern Calif Hlth Care Syst, Sacramento, CA 95817 USA; [D'Abronzo, L. S.; Bose, S.; Vinall, R. L.; White, R. W. deVere; Ghosh, P. M.] Univ Calif Davis, Sch Med, Dept Urol, 4860 Y St,Suite 3500, Sacramento, CA 95817 USA; [Vinall, R. L.] Calif Northstate Univ, Coll Pharm, Elk Grove, CA USA; [Tepper, C. G.; Ghosh, P. M.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Mudryj, M.] Univ Calif Davis, Dept Med Microbiol & Immunol, Sacramento, CA 95817 USA; [Durbin-Johnson, B. P.] Univ Calif Davis, Div Biostat, Dept Publ Hlth, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ghosh, PM (corresponding author), Univ Calif Davis, Sch Med, Dept Urol, 4860 Y St,Suite 3500, Sacramento, CA 95817 USA.	paghosh@ucdavis.edu	Tepper, Clifford G/H-6527-2011; Vinall, Ruth/L-7026-2019		Department of Veterans Affairs [I01BX000400]; National Institutes of Health [R01CA133209, R01CA185509]; NATIONAL CANCER INSTITUTE [R01CA133209, P30CA093373, R01CA185509] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003458, I01BX000400] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Novartis Pharmaceuticals for the gift of RAD001. We also thank Stephanie Soares, Department of Urology, University of California Davis, School of Medicine (Sacramento, CA, USA), for the construction of the tissue microarrays used in this study, and Yu Wang, Department of Urology, for assistance with mice experiments. Human PSA-luciferase construct was kindly provided by Dr XuBao Shi, University of California Davis, Department of Urology. CWR-R1 cells were provided by Dr Elizabeth Wilson (University of North Carolina), pRNS1-1 cells were from Dr Johng Rhim, University of the Health Sciences (Bethesda, MD, USA), whereas PC-346C cells were from Dr WM van Weerden, Josephine Nefkens Institute (Erasmus MC, Rotterdam, Netherlands). We also thank Dr Xinbin Chen (UC Davis School of Veterinary Medicine) for the pRL-HCV-FL plasmid, and Maitreyee K Jathal and Thomas M Steele (UC Davis, Department of Urology) for samples of 22Rv1 xenograft tumors. This work was supported by a Biomedical Laboratory Research and Development (BLRD) Merit Award (I01BX000400, to PMG) from the Department of Veterans Affairs, and by Awards R01CA133209 (to PMG) and R01CA185509 (to PMG) from the National Institutes of Health.	Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P97, DOI 10.3816/CGC.2008.n.015; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Canedo CS, 2010, AM J PHYSIOL-ENDOC M, V298, pE761, DOI 10.1152/ajpendo.00421.2009; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chamie K, 2008, AM J TRANSPLANT, V8, P2668, DOI 10.1111/j.1600-6143.2008.02430.x; Chen LQ, 2010, CANCER RES, V70, P5994, DOI 10.1158/0008-5472.CAN-09-4440; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chow H, 2016, CANCER-AM CANCER SOC, V122, P1897, DOI 10.1002/cncr.29927; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Edlind MP, 2014, ASIAN J ANDROL, V16, P378, DOI 10.4103/1008-682X.122876; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Gingras AC, 2001, GENE DEV, V15, P2852; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Idris AI, 2012, METHODS MOL BIOL, V816, P545, DOI 10.1007/978-1-61779-415-5_34; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; MacVicar GR, 2013, CURR OPIN ONCOL, V25, P252, DOI 10.1097/CCO.0b013e32835ff161; Mbatia HW, 2015, J MED CHEM, V58, P1900, DOI 10.1021/jm501792c; Mikhailova M, 2008, ADV EXP MED BIOL, V617, P397, DOI 10.1007/978-0-387-69080-3_38; Mooso Benjamin, 2010, Genes Cancer, V1, P927, DOI 10.1177/1947601910385450; Mooso BA, 2012, ENDOCR-RELAT CANCER, V19, P759, DOI 10.1530/ERC-12-0171; Nakabayashi M, 2012, BJU INT, V110, P1729, DOI 10.1111/j.1464-410X.2012.11456.x; R Core Team, 2022, R LANG ENV STAT COMP; Ramamurthy VP, 2015, ONCOTARGET, V6, P3195, DOI 10.18632/oncotarget.3084; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schayowitz A, 2010, BRIT J CANCER, V103, P1001, DOI 10.1038/sj.bjc.6605882; Sekiyama N, 2015, P NATL ACAD SCI USA, V112, pE4036, DOI 10.1073/pnas.1512118112; Shi XB, 2007, PROSTATE, V67, P591, DOI 10.1002/pros.20544; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Sonenberg N, 2008, BIOCHEM CELL BIOL, V86, P178, DOI 10.1139/O08-034; Squillace RM, 2012, INT J ONCOL, V41, P425, DOI 10.3892/ijo.2012.1487; Stead RL, 2013, FEBS LETT, V587, P2623, DOI 10.1016/j.febslet.2013.06.045; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Wang XR, 2007, MOL CELL BIOL, V27, P7405, DOI 10.1128/MCB.00760-07; Wang Y, 2008, ONCOGENE, V27, P7106, DOI 10.1038/onc.2008.318; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wen QY, 2016, ONCOTARGET, V7, P27787, DOI 10.18632/oncotarget.8497; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wu Y, 2010, ANTICANCER RES, V30, P3895; Zhang WS, 2009, CANCER RES, V69, P7466, DOI 10.1158/0008-5472.CAN-08-4385; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	48	26	27	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6359	6373		10.1038/onc.2017.233	http://dx.doi.org/10.1038/onc.2017.233			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28745319	Green Accepted, Green Submitted			2022-12-26	WOS:000415622900001
J	Kamgar-Parsi, K; Hong, L; Naito, A; Brooks, CL; Ramamoorthy, A				Kamgar-Parsi, Kian; Hong, Liu; Naito, Akira; Brooks, Charles L., III; Ramamoorthy, Ayyalusamy			Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; GENERALIZED BORN MODEL; STATE C-13 NMR; SALMON-CALCITONIN; MOLECULAR-DYNAMICS; STRUCTURAL-CHARACTERIZATION; AROMATIC INTERACTIONS; CLINICAL RESISTANCE; ALPHA-SYNUCLEIN; PAGETS-DISEASE	The role of the peptide hormone calcitonin in skeletal protection has led to its use as a therapeutic for osteoporosis. However, calcitonin aggregation into amyloid fibrils limits its therapeutic efficacy, necessitating a modification of calcitonin's aggregation kinetics. Here, we report a direct relationship between human calcitonin (hCT) concentration and aggregation lag time. This kinetic trend was contrary to the conventional understanding of amyloid aggregation and persisted over a range of aggregation conditions, as confirmed by thioflavin-T kinetics assays, CD spectroscopy, and transmission EM. Dynamic light scattering, 1H NMR experiments, and seeded thioflavin-T assay results indicated that differences in initial peptide species contribute to this trend more than variations in the primary nucleus formation rate. On the basis of kinetics modeling results, we propose a mechanism whereby a structural conversion of hCT monomers is needed before incorporation into the fibril. Our kinetic mechanism recapitulates the experimentally observed relationship between peptide concentration and lag time and represents a novel mechanism in amyloid aggregation. Interestingly, hCT at low pH and salmon calcitonin (sCT) exhibited the canonical inverse relationship between concentration and lag time. Comparative studies of hCT and sCT with molecular dynamics simulations and CD indicated an increased alpha-helical structure in sCT and low-pH hCT monomers compared with neutral-pH hCT, suggesting that alpha-helical monomers represent a growthcompetent species, whereas unstructured random coil monomers represent a growth-incompetent species. Our finding that initial monomer concentration is positively correlated with lag time in hCT aggregation could help inform future efforts for improving therapeutic applications of CT.	[Kamgar-Parsi, Kian] Univ Michigan, Appl Phys Program, Ann Arbor, MI 48109 USA; [Hong, Liu] Tsinghua Univ, Zhou Pei Yuan Ctr Appl Math, Beijing 100084, Peoples R China; [Naito, Akira] Yokohama Natl Univ, Grad Sch Engn, Hodogaya Ku, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan; [Brooks, Charles L., III; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Brooks, Charles L., III; Ramamoorthy, Ayyalusamy] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Tsinghua University; Yokohama National University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Ramamoorthy, A (corresponding author), Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu			National Institutes of Health [AG048934]; Protein Folding Disease center at the University of Michigan; NATIONAL INSTITUTE ON AGING [R01AG048934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding Disease center at the University of Michigan; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG048934 (to A. R.). This work was also supported by the Protein Folding Disease center at the University of Michigan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguiar J, 2003, J COLLOID INTERF SCI, V258, P116, DOI 10.1016/S0021-9797(02)00082-6; Amodeo P, 1999, J BIOMOL NMR, V13, P161, DOI 10.1023/A:1008365322148; Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200; Andreotti G, 2006, J BIOL CHEM, V281, P24193, DOI 10.1074/jbc.M603528200; Andreotti G, 2011, J BIOL CHEM, V286, P2707, DOI 10.1074/jbc.M110.182014; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Arthur EJ, 2016, J COMPUT CHEM, V37, P927, DOI 10.1002/jcc.24280; ARVINTE T, 1993, J BIOL CHEM, V268, P6415; ARVINTE T, 1993, J BIOL CHEM, V268, P6408; Avidan-Shpalter C, 2006, AMYLOID, V13, P216, DOI 10.1080/13506120600960643; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Batzli KM, 2015, MAT SCI ENG C-MATER, V48, P359, DOI 10.1016/j.msec.2014.09.015; BAUER HH, 1994, BIOCHEMISTRY-US, V33, P12276, DOI 10.1021/bi00206a034; Bertolani A, 2017, CHEM-EUR J, V23, P2051, DOI 10.1002/chem.201604639; Blancas-Mejia LM, 2017, BIOCHEMISTRY-US, V56, P757, DOI 10.1021/acs.biochem.6b01043; Brender JR, 2015, J PHYS CHEM B, V119, P2886, DOI 10.1021/jp511758w; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Chen JH, 2006, J AM CHEM SOC, V128, P3728, DOI 10.1021/ja057216r; Chesnut CH, 2008, OSTEOPOROSIS INT, V19, P479, DOI 10.1007/s00198-007-0490-1; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610; Dean DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40787; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Diociaiuti M, 2014, BBA-MOL BASIS DIS, V1842, P1622, DOI 10.1016/j.bbadis.2014.06.006; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; FELETTI C, 1979, NEPHRON, V24, P85, DOI 10.1159/000181689; Fowler SB, 2005, P NATL ACAD SCI USA, V102, P10105, DOI 10.1073/pnas.0501215102; Gaudiano MC, 2005, BBA-PROTEINS PROTEOM, V1750, P134, DOI 10.1016/j.bbapap.2005.04.008; GRAUER A, 1993, HORM METAB RES, V25, P486, DOI 10.1055/s-2007-1002156; Guo CA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13556; Gupta V, 2013, J CONTROL RELEASE, V172, P753, DOI 10.1016/j.jconrel.2013.09.004; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hingant E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003735; Hong L, 2012, J PHYS CHEM B, V116, P6611, DOI 10.1021/jp205702u; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Itoh-Watanabe H, 2013, PHYS CHEM CHEM PHYS, V15, P16956, DOI 10.1039/c3cp52810c; Itoh-Watanabe H, 2013, PHYS CHEM CHEM PHYS, V15, P8890, DOI 10.1039/c3cp44544e; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Kamgar-Parsi K, 2017, ISR J CHEM, V57, P634, DOI 10.1002/ijch.201600096; Kamihira M, 2000, PROTEIN SCI, V9, P867, DOI 10.1110/ps.9.5.867; KANAORI K, 1995, BIOCHEMISTRY-US, V34, P12138, DOI 10.1021/bi00038a006; Kashchiev D, 2017, J PHYS CHEM B, V121, P35, DOI 10.1021/acs.jpcb.6b09302; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim HJ, 2007, J MICROBIOL BIOTECHN, V17, P2027; Lakshmanan A, 2013, P NATL ACAD SCI USA, V110, P519, DOI 10.1073/pnas.1217742110; Levin A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6219; Matougui N, 2016, INT J PHARMACEUT, V502, P80, DOI 10.1016/j.ijpharm.2016.02.019; MEYER JP, 1991, BIOPOLYMERS, V31, P233, DOI 10.1002/bip.360310210; Milton NGN, 2013, MICRON, V44, P246, DOI 10.1016/j.micron.2012.07.001; Mok KH, 2007, BIOCHEM BIOPH RES CO, V354, P1, DOI 10.1016/j.bbrc.2006.12.167; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Ogi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06960; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Pettersson-Kastberg J, 2009, ANN MED, V41, P162, DOI 10.1080/07853890802502614; Qin ZJ, 2007, BIOCHEMISTRY-US, V46, P3521, DOI 10.1021/bi061716v; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Robbins KJ, 2011, J PHYS CHEM LETT, V2, P735, DOI 10.1021/jz200066b; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabate R, 2005, J PHYS CHEM B, V109, P11027, DOI 10.1021/jp050716m; Schneider D, 2002, AM FAM PHYSICIAN, V65, P2069; Shoffner SK, 2016, PHYS CHEM CHEM PHYS, V18, P21259, DOI 10.1039/c5cp07845h; Shtainfeld A, 2010, BIOCHEMISTRY-US, V49, P5299, DOI 10.1021/bi1002713; SILIGARDI G, 1994, EUR J BIOCHEM, V221, P1117, DOI 10.1111/j.1432-1033.1994.tb18832.x; SINGER FR, 1972, J CLIN INVEST, V51, P2331, DOI 10.1172/JCI107044; SINGER FR, 1980, ARTHRITIS RHEUM, V23, P1148, DOI 10.1002/art.1780231012; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Srinivasan J, 1998, J BIOMOL STRUCT DYN, V16, P671, DOI 10.1080/07391102.1998.10508279; Surmacz-Chwedoruk W, 2016, SCI REP-UK, V6, DOI 10.1038/srep32022; Umerska A, 2016, INT J PHARMACEUT, V506, P191, DOI 10.1016/j.ijpharm.2016.04.028; Walti MA, 2015, CHEMBIOCHEM, V16, P659, DOI 10.1002/cbic.201402595; Wagner K, 2004, BIOPHYS J, V87, P386, DOI 10.1529/biophysj.103.036921; Wang Q, 2014, LECT NOTES COMPUT SC, V8679, P1, DOI 10.1007/978-3-319-10581-9_1; Werle M, 2009, INT J PHARMACEUT, V370, P26, DOI 10.1016/j.ijpharm.2008.11.013; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Yoo HS, 2004, J PHARM SCI-US, V93, P488, DOI 10.1002/jps.10573; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309; Zaidi M, 2002, BONE, V30, P655, DOI 10.1016/S8756-3282(02)00688-9	82	11	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14963	14976		10.1074/jbc.M117.791236	http://dx.doi.org/10.1074/jbc.M117.791236			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739873	hybrid, Green Published			2022-12-26	WOS:000409902100020
J	Zeng, YJ; Stauffer, S; Zhou, JL; Chen, XC; Chen, YH; Dong, JX				Zeng, Yongji; Stauffer, Seth; Zhou, Jiuli; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin			Cyclin-dependent kinase 1 (CDK1)-mediated mitotic phosphorylation of the transcriptional co-repressor Vgll4 inhibits its tumor-suppressing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDK1 PHOSPHORYLATION; CELL-PROLIFERATION; GASTRIC-CANCER; HIPPO PATHWAY; SIZE-CONTROL; YAP; KIBRA; MITOSIS; TUMORIGENESIS; PROGRESSION	The Hippo pathway is an evolutionarily conserved signaling pathway that plays important roles in stem cell biology, tissue homeostasis, and cancer development. Vestigial-like 4 (Vgll4) functions as a transcriptional co-repressor in the Hippo-Yes-associated protein (YAP) pathway. Vgll4 inhibits cell proliferation and tumor growth by competing with YAP for binding to TEA-domain proteins (TEADs). However, the mechanisms by which Vgll4 itself is regulated are unclear. Here we identified a mechanism that regulates Vgll4's tumor-suppressing function. We found that Vgll4 is phosphorylated in vitro and in vivo by cyclin-dependent kinase 1 (CDK1) during antimitotic drug-induced mitotic arrest and also in normal mitosis. We further identified Ser-58, Ser-155, Thr-159, and Ser-280 as the main mitotic phosphorylation sites in Vgll4. We also noted that the nonphosphorylatable mutant Vgll4-4A (S58A/S155A/T159A/S280A) suppressed tumorigenesis in pancreatic cancer cells in vitro and in vivo to a greater extent than did wild-type Vgll4, suggesting that mitotic phosphorylation inhibits Vgll4's tumor-suppressive activity. Consistent with these observations, the Vgll4-4A mutant possessed higher-binding affinity to TEAD1 than wild-type Vgll4. Interestingly, Vgll4 and Vgll4-4A markedly suppressedYAPand beta-catenin signaling activity. Together, these findings reveal a previously unrecognized mechanism for Vgll4 regulation in mitosis and its role in tumorigenesis.	[Zeng, Yongji; Stauffer, Seth; Zhou, Jiuli; Chen, Xingcheng; Chen, Yuanhong; Dong, Jixin] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Zeng, Yongji; Stauffer, Seth; Zhou, Jiuli; Chen, Xingcheng; Dong, Jixin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Dong, Jixin] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu	Zeng, Yongji/AAY-1227-2021; Zeng, Yongji/AAM-8712-2021; Chen, Xingcheng/AAL-3210-2020	Zeng, Yongji/0000-0002-1184-1900; 	National Institutes of Health [P30 GM106397]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109066, P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Lei Zhang and Zhaocai Zhou for the Vgll4 cDNA. All fluorescence images were acquired by Zeiss LSM 710 confocal microscope at the Advanced Microscopy Core at the University of Nebraska Medical Center. The Core is supported in part by Grant P30 GM106397 from the National Institutes of Health. We also thank Dr. Joyce Solheim for critical reading and comments on the manuscript.	Chen XC, 2016, CELL SIGNAL, V28, P1826, DOI 10.1016/j.cellsig.2016.08.013; Chen XC, 2016, J BIOL CHEM, V291, P14761, DOI 10.1074/jbc.M116.722751; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Elcheva I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5372; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ji M, 2012, BIOCHEM J, V447, P93, DOI 10.1042/BJ20120751; Jiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14058; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Jube S, 2012, CANCER RES, V72, P3290, DOI 10.1158/0008-5472.CAN-11-3481; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; LI H, 2015, MED ONCOL, V32; Li N, 2015, AM J CANCER RES, V5, P1158; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Xiao L, 2011, J BIOL CHEM, V286, P7788, DOI 10.1074/jbc.M110.173468; Yang SP, 2015, ONCOTARGET, V6, P36019, DOI 10.18632/oncotarget.5935; Yang SP, 2015, J BIOL CHEM, V290, P6191, DOI 10.1074/jbc.M114.624411; Yang SP, 2014, CELL SIGNAL, V26, P343, DOI 10.1016/j.cellsig.2013.11.012; Yang SP, 2013, CANCER RES, V73, P6722, DOI 10.1158/0008-5472.CAN-13-2049; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang L, 2015, ONCOTARGET, V6, P31399, DOI 10.18632/oncotarget.5189; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	29	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15028	15038		10.1074/jbc.M117.796284	http://dx.doi.org/10.1074/jbc.M117.796284			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739871	hybrid, Green Published			2022-12-26	WOS:000409902100025
J	Huang, YH; Guan, HH; Chen, CJ; Huang, CY				Huang, Yen-Hua; Guan, Hong-Hsiang; Chen, Chun-Jung; Huang, Cheng-Yang			Staphylococcus aureus single-stranded DNA-binding protein SsbA can bind but cannot stimulate PriA helicase	PLOS ONE			English	Article							ESCHERICHIA-COLI SSB; CRYSTAL-STRUCTURE; DEINOCOCCUS-RADIODURANS; SULFOLOBUS-SOLFATARICUS; CHI SUBUNIT; C-TERMINUS; IN-VIVO; OB-FOLD; IDENTIFICATION; RESTART	Single-stranded DNA-binding protein (SSB) and PriA helicase play important roles in bacterial DNA replication restart process. The mechanism by which PriA helicase is bound and stimulated by SSB in Escherichia coli (Ec) has been established, but information on this process in Gram-positive bacteria are limited. We characterized the properties of SSB from Staphylococcus aureus (SaSsbA, a counterpart of EcSSB) and analyzed its interaction with SaPriA. The gel filtration chromatography analysis of purified SaSsbA showed a stable tetramer in solution. The crystal structure of SaSsbA determined at 1.82 angstrom resolution (PDB entry 5XGT) reveals that the classic oligonucleotide/oligosaccharide-binding folds are formed in the N-terminal DNA-binding domain, but the entire C-terminal domain is disordered. Unlike EcSSB, which can stimulate EcPriA via a physical interaction between EcPriA and the C-terminus of EcSSB (SSB-Ct), SaSsbA does not affect the activity of SaPriA. We also found that SaPriA can be bound by SaSsbA, but not by SaSsbA-Ct. Although no effect was found with SaSsbA, SaPriA can be significantly stimulated by the Gram-negative Klebsiella pneumoniae SSB (KpSSB). In addition, we found that the conserved SSB-Ct binding site of KpPriA (Trp82, Tyr86, Lys370, Arg697, and Gln701) is not present in SaPriA. Arg697 in KpPriA is known to play a critical role in altering the SSB35/SSB65 distribution, but this corresponding residue in SaPriA is Glu767 instead, which has an opposite charge to Arg. SaPriA E767R mutant was constructed and analyzed; however, it still cannot be stimulated by SaSsbA. Finally, we found that the conserved MDFDDD vertical bar PF motif in the Gram-negative bacterial SSB is D vertical bar SDDDLPF in SaSsbA, i.e., F172 in EcSSB and F168 in KpSSB is S161 in SaSsbA, not F. When acting with SaSsbA S161F mutant, the activity of SaPriA was dramatically enhanced elevenfold. Overall, the conserved binding sites, both in EcPriA and EcSSB, are not present in SaPriA and SaSsbA, thereby no stimulation occurs. Our observations through structure-sequence comparison and mutational analyses indicate that the case of EcPriA-EcSSB is not applicable to SaPriA-SaSsbA because of inherent differences among the species.	[Huang, Yen-Hua; Huang, Cheng-Yang] Chung Shan Med Univ, Sch Biomed Sci, Taichung, Taiwan; [Guan, Hong-Hsiang; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Inst Biotechnol, Tainan, Taiwan; [Chen, Chun-Jung] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan; [Chen, Chun-Jung] Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan; [Huang, Cheng-Yang] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; National Synchrotron Radiation Research Center; National Cheng Kung University; National Cheng Kung University; National Tsing Hua University; Chung Shan Medical University; Chung Shan Medical University Hospital	Huang, CY (corresponding author), Chung Shan Med Univ, Sch Biomed Sci, Taichung, Taiwan.; Chen, CJ (corresponding author), Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu, Taiwan.; Chen, CJ (corresponding author), Natl Cheng Kung Univ, Inst Biotechnol, Tainan, Taiwan.; Chen, CJ (corresponding author), Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan.; Chen, CJ (corresponding author), Natl Tsing Hua Univ, Dept Phys, Hsinchu, Taiwan.; Huang, CY (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	cjchen@nsrrc.org.tw; cyhuang@csmu.edu.tw	Chen, Chun-Jung/A-6880-2011	Chen, Chun-Jung/0000-0002-5157-4288	Ministry of Science and Technology, Taiwan [MOST 105-2320-B-040-026]; Ministry of Science and Technology, Taiwan, ROC	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 105-2320-B-040-026 to C.Y. Huang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the experimental facility and the technical services provided by the Synchrotron Radiation Protein Crystallography Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology and the National Synchrotron Radiation Research Center, a national user facility supported by the Ministry of Science and Technology, Taiwan, ROC.	ALLEN GC, 1993, CELL, V74, P713, DOI 10.1016/0092-8674(93)90518-U; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Bianco PR, 2017, PROTEIN SCI, V26, P638, DOI 10.1002/pro.3114; Bianco PR, 2017, PROTEIN SCI, V26, P227, DOI 10.1002/pro.3072; Bianco PR, 2016, BIOPHYS MOL BIOL; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briggs GS, 2012, J BACTERIOL, V194, P5162, DOI 10.1128/JB.00865-12; BRUAND C, 1995, EMBO J, V14, P2642, DOI 10.1002/j.1460-2075.1995.tb07262.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Dickey TH, 2013, STRUCTURE, V21, P1074, DOI 10.1016/j.str.2013.05.013; Filipkowski P, 2007, ACTA BIOCHIM POL, V54, P79, DOI 10.18388/abp.2007_3272; Filipkowski P, 2007, PROTEIN EXPRES PURIF, V53, P201, DOI 10.1016/j.pep.2006.11.006; Filipkowski P, 2006, EXTREMOPHILES, V10, P607, DOI 10.1007/s00792-006-0011-8; Filipkowski P, 2006, ARCH MICROBIOL, V186, P129, DOI 10.1007/s00203-006-0128-2; Flynn RL, 2010, CRIT REV BIOCHEM MOL, V45, P266, DOI 10.3109/10409238.2010.488216; Gamsjaeger R, 2014, BIOMOL NMR ASSIGN, V8, P243, DOI 10.1007/s12104-013-9492-4; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Ghalei H, 2014, NUCLEIC ACIDS RES, V42, P6698, DOI 10.1093/nar/gku259; Haseltine CA, 2002, MOL MICROBIOL, V43, P1505, DOI 10.1046/j.1365-2958.2002.02807.x; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Huang CY, 2012, STOICHIOMETRY AND RESEARCH - THE IMPORTANCE OF QUANTITY IN BIOMEDICINE, P235; Huang CC, 2016, BIOCHEM BIOPH RES CO, V477, P988, DOI 10.1016/j.bbrc.2016.07.016; Huang YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157593; Huang YH, 2015, PROTEIN J, V34, P169, DOI 10.1007/s10930-015-9609-y; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/573936; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/195162; Huang YH, 2013, BIOCHEM BIOPH RES CO, V442, P147, DOI 10.1016/j.bbrc.2013.11.069; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P146, DOI 10.1111/j.1365-2443.2011.01577.x; Huang YH, 2011, PROTEIN J, V30, P102, DOI 10.1007/s10930-011-9309-1; Jan HC, 2011, PROTEIN J, V30, P20, DOI 10.1007/s10930-010-9297-6; Kerr ID, 2003, EMBO J, V22, P2561, DOI 10.1093/emboj/cdg272; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Lindner C, 2004, J BACTERIOL, V186, P1097, DOI 10.1128/JB.186.4.1097-1105.2004; Liu Z, 2014, NUCLEIC ACIDS RES, V42, P9470, DOI 10.1093/nar/gku633; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Marston FY, 2010, NUCLEIC ACIDS RES, V38, P6930, DOI 10.1093/nar/gkq465; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Michel B, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00102-17; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Olszewski M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-260; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OUZOUNIS CA, 1991, NUCLEIC ACIDS RES, V19, P6953, DOI 10.1093/nar/19.24.6953; Paytubi S, 2012, P NATL ACAD SCI USA, V109, pE398, DOI 10.1073/pnas.1113277108; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Richard DJ, 2009, CRIT REV BIOCHEM MOL, V44, P98, DOI 10.1080/10409230902849180; Rolfsmeier ML, 2010, J MOL BIOL, V397, P31, DOI 10.1016/j.jmb.2010.01.004; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shishmarev D, 2014, NUCLEIC ACIDS RES, V42, P2750, DOI 10.1093/nar/gkt1238; Tan HY, 2017, PROTEIN SCI, V26, P700, DOI 10.1002/pro.3115; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Webster G, 1997, FEBS LETT, V411, P313, DOI 10.1016/S0014-5793(97)00747-3; Wessel SR, 2016, J BIOL CHEM, V291, P18384, DOI 10.1074/jbc.M116.738781; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Yu C, 2016, GENES CELLS, V21, P163, DOI 10.1111/gtc.12334; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	84	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182060	10.1371/journal.pone.0182060	http://dx.doi.org/10.1371/journal.pone.0182060			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750050	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700127
J	Jeon, AB; Obregon-Henao, A; Ackart, DF; Podell, BK; Belardinelli, JM; Jackson, M; Nguyen, TV; Blackledge, MS; Melander, RJ; Melander, C; Johnson, BK; Abramovitch, RB; Basaraba, RJ				Jeon, Albert B.; Obregon-Henao, Andres; Ackart, David F.; Podell, Brendan K.; Belardinelli, Juan M.; Jackson, Mary; Nguyen, Tuan V.; Blackledge, Meghan S.; Melander, Roberta J.; Melander, Christian; Johnson, Benjamin K.; Abramovitch, Robert B.; Basaraba, Randall J.			2-aminoimidazoles potentiate beta-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing beta-lactamase secretion and increasing cell envelope permeability	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; OUTER-MEMBRANE PERMEABILITY; 2-COMPONENT SYSTEM; TREATMENT REGIMENS; ETHIDIUM-BROMIDE; DRUG-RESISTANCE; LIPID-BILAYER; SIGMA-FACTORS; VIRULENCE; WALL	There is an urgent need to develop new drug treatment strategies to control the global spread of drug-sensitive and multidrug-resistant Mycobacterium tuberculosis (M. tuberculosis). The beta-lactam class of antibiotics is among the safest and most widely prescribed antibiotics, but they are not effective against M. tuberculosis due to intrinsic resistance. This study shows that 2-aminoimidazole (2-AI)-based small molecules potentiate beta-lactam antibiotics against M. tuberculosis. Active 2-AI compounds significantly reduced the minimal inhibitory and bactericidal concentrations of beta-lactams by increasing M. tuberculosis cell envelope permeability and decreasing protein secretion including beta-lactamase. Metabolic labeling and transcriptional profiling experiments revealed that 2-AI compounds impair mycolic acid biosynthesis, export and linkage to the mycobacterial envelope, counteracting an important defense mechanism reducing permeability to external agents. Additionally, other important constituents of the M. tuberculosis outer membrane including sulfolipid-1 and polyacyltrehalose were also less abundant in 2-AI treated bacilli. As a consequence of 2-AI treatment, M. tuberculosis displayed increased sensitivity to SDS, increased permeability to nucleic acid staining dyes, and rapid binding of cell wall targeting antibiotics. Transcriptional profiling analysis further confirmed that 2-AI induces transcriptional regulators associated with cell envelope stress. 2-AI based small molecules potentiate the antimicrobial activity of beta-lactams by a mechanism that is distinct from specific inhibitors of beta-lactamase activity and therefore may have value as an adjunctive anti-TB treatment.	[Jeon, Albert B.; Obregon-Henao, Andres; Ackart, David F.; Podell, Brendan K.; Belardinelli, Juan M.; Jackson, Mary; Basaraba, Randall J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Nguyen, Tuan V.; Melander, Roberta J.; Melander, Christian] North Carolina State Univ, Dept Chem, Raleigh, NC USA; [Blackledge, Meghan S.] High Point Univ, Dept Chem, High Point, NC USA; [Johnson, Benjamin K.; Abramovitch, Robert B.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Colorado State University; University of North Carolina; North Carolina State University; Michigan State University	Basaraba, RJ (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	randall.basaraba@colostate.edu	Jackson, Mary/D-5345-2017; Blackledge, Meghan/AAQ-6569-2020; Abramovitch, Robert/O-6798-2019; Belardinelli, Juan Manuel/N-7335-2019	Jackson, Mary/0000-0002-9212-0258; Abramovitch, Robert/0000-0002-4119-4169; Belardinelli, Juan Manuel/0000-0003-1336-9141; Blackledge, Meghan/0000-0001-9632-0567	NIH-NIAID [R01AI106733, R01AI116605];  [TBRU-U19AI111224];  [NIH-T32 4T320D010437-15]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116605, U19AI111224] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010437] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH-NIAID R01AI106733 (RJB), TBRU-U19AI111224 (RJB), NIH-NIAID R01AI116605 (RBA) and NIH-T32 4T320D010437-15 (ABJ) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackart DF, 2014, PATHOG DIS, V70, P359, DOI 10.1111/2049-632X.12144; Ackart DF, 2014, PATHOG DIS, V70, P370, DOI 10.1111/2049-632X.12143; Da Silva PEA, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI 10.1093/jac/dkr173; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Awofeso N., 2008, B WHO, V86; Banerjee A, 2014, FEBS OPEN BIO, V4, P251, DOI 10.1016/j.fob.2014.02.006; Bansal-Mutalik R, 2014, P NATL ACAD SCI USA, V111, P4958, DOI 10.1073/pnas.1403078111; Belardinelli JM, 2014, J BIOL CHEM, V289, P27952, DOI 10.1074/jbc.M114.581199; Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Brooks BE, 2008, BBA-BIOMEMBRANES, V1778, P1930, DOI 10.1016/j.bbamem.2007.06.005; CHAMBERS HF, 1995, ANTIMICROB AGENTS CH, V39, P2620, DOI 10.1128/AAC.39.12.2620; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Dainese E, 2006, INFECT IMMUN, V74, P2457, DOI 10.1128/IAI.74.4.2457-2461.2006; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P2503, DOI 10.1128/AAC.00298-08; Danilchanka O, 2015, ANTIMICROB AGENTS CH, V59, P2328, DOI 10.1128/AAC.04222-14; de Keijzer J., 2016, J PROTEOME RES, DOI 10.1021/acs.jproteome.5b01073; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Dhiman RK, 2011, J BACTERIOL, V193, P5802, DOI 10.1128/JB.05299-11; Diacon AH, 2016, NEW ENGL J MED, V375, P393, DOI 10.1056/NEJMc1513236; Dinesh N, 2013, ANTIMICROB AGENTS CH, V57, P1941, DOI 10.1128/AAC.01957-12; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dooley KE, 2013, J INFECT DIS, V207, P1352, DOI 10.1093/infdis/jis460; England K, 2012, ANTIMICROB AGENTS CH, V56, P3384, DOI 10.1128/AAC.05690-11; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; Harris TL, 2012, ANGEW CHEM INT EDIT, V51, P11254, DOI 10.1002/anie.201206911; Hartkoorn RC, 2014, ANTIMICROB AGENTS CH, V58, P2979, DOI 10.1128/AAC.00037-14; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Johnson BK, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0923-y; Joyce GF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001323; Kao FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034991; KASIK JE, 1968, BIOCHEM J, V107, P675, DOI 10.1042/bj1070675; Kaushik A, 2015, ANTIMICROB AGENTS CH, V59, P6561, DOI 10.1128/AAC.01158-15; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; Kremer L, 2002, LETT APPL MICROBIOL, V34, P233, DOI 10.1046/j.1472-765x.2002.01091.x; Kumar P, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02234-16; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; KWON HH, 1995, TUBERCLE LUNG DIS, V76, P141, DOI 10.1016/0962-8479(95)90557-X; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JH, 2008, J BACTERIOL, V190, P699, DOI 10.1128/JB.01273-07; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manganelli R, 2004, J BACTERIOL, V186, P895, DOI 10.1128/JB.186.4.895-902.2004; Manganelli R, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0007-2013; Mukhopadhyay S, 1997, ANTIMICROB AGENTS CH, V41, P1721, DOI 10.1128/AAC.41.8.1721; Nachega JB, 2003, CLIN INFECT DIS, V36, pS24, DOI 10.1086/344657; Nampoothiri KM, 2008, J APPL MICROBIOL, V105, P59, DOI 10.1111/j.1365-2672.2007.03721.x; Nguyen TV, 2017, ANGEW CHEM INT EDIT, V56, P3940, DOI 10.1002/anie.201612006; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; PAGE B, 1993, INT J ONCOL, V3, P473; PERKINS HR, 1969, BIOCHEM J, V111, P195, DOI 10.1042/bj1110195; Purdy GE, 2009, MOL MICROBIOL, V73, P844, DOI 10.1111/j.1365-2958.2009.06801.x; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodrigues L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-35; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Rustad Tige R., 2008, V465, P13, DOI 10.1007/978-1-59745-207-6_2; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Segura C, 1998, ANTIMICROB AGENTS CH, V42, P1524, DOI 10.1128/AAC.42.6.1524; Shukla J, 2014, ACTA CRYSTALLOGR D, V70, P1026, DOI 10.1107/S1399004714000121; Stephens MD, 2016, MEDCHEMCOMM, V7, P128, DOI 10.1039/c5md00353a; Stowe SD, 2015, CURR DRUG DELIV, V12, P223, DOI 10.2174/1567201811666140924125740; Stowe SD, 2011, MAR DRUGS, V9, P2010, DOI 10.3390/md9102010; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Veyrier F, 2008, J BACTERIOL, V190, P1891, DOI 10.1128/JB.01452-07; Vijay Srinivasan, 2014, Open Microbiol J, V8, P40, DOI 10.2174/1874285801408010040; Wallis RS, 2016, LANCET INFECT DIS, V16, pE34, DOI 10.1016/S1473-3099(16)00070-0; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Wang F, 2006, ANTIMICROB AGENTS CH, V50, P2762, DOI 10.1128/AAC.00320-06; Wiener MC, 2011, P NATL ACAD SCI USA, V108, P10929, DOI 10.1073/pnas.1106927108; WISE EM, 1965, P NATL ACAD SCI USA, V54, P75, DOI 10.1073/pnas.54.1.75; Wivagg CN, 2016, ACS INFECT DIS, V2, P104, DOI 10.1021/acsinfecdis.5b00119; Wivagg CN, 2014, J ANTIBIOT, V67, P645, DOI 10.1038/ja.2014.94; World Health Organization, 2016, GLOB REP DIAB, P978; Worthington RJ, 2013, J ORG CHEM, V78, P4207, DOI 10.1021/jo400236f; Worthington RJ, 2013, TRENDS BIOTECHNOL, V31, P177, DOI 10.1016/j.tibtech.2012.12.006; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07; Zumla A, 2015, LANCET RESP MED, V3, P220, DOI 10.1016/S2213-2600(15)00063-6	95	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180925	10.1371/journal.pone.0180925	http://dx.doi.org/10.1371/journal.pone.0180925			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749949	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700025
J	Siemers, NO; Holloway, JL; Chang, H; Chasalow, SD; Ross-MacDonald, PB; Voliva, CF; Szustakowski, JD				Siemers, Nathan O.; Holloway, James L.; Chang, Han; Chasalow, Scott D.; Ross-MacDonald, Petra B.; Voliva, Charles F.; Szustakowski, Joseph D.			Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors	PLOS ONE			English	Article							CTLA-4 BLOCKADE; PD-1 BLOCKADE; TRANSCRIPTION; IPILIMUMAB; RESISTANCE; MUTATIONS; RESPONSES; INSIGHTS; SAFETY; CELLS	Therapeutic options for the treatment of an increasing variety of cancers have been expanded by the introduction of a new class of drugs, commonly referred to as checkpoint blocking agents, that target the host immune system to positively modulate anti-tumor immune response. Although efficacy of these agents has been linked to a pre-existing level of tumor immune infiltrate, it remains unclear why some patients exhibit deep and durable responses to these agents while others do not benefit. To examine the influence of tumor genetics on tumor immune state, we interrogated the relationship between somatic mutation and copy number alteration with infiltration levels of 7 immune cell types across 40 tumor cohorts in The Cancer Genome Atlas. Levels of cytotoxic T, regulatory T, total T, natural killer, and B cells, as well as monocytes and M2 macrophages, were estimated using a novel set of transcriptional signatures that were designed to resist interference from the cellular heterogeneity of tumors. Tumor mutational load and estimates of tumor purity were included in our association models to adjust for biases in multi-modal genomic data. Copy number alterations, mutations summarized at the gene level, and position-specific mutations were evaluated for association with tumor immune infiltration. We observed a strong relationship between copy number loss of a large region of chromosome 9p and decreased lymphocyte estimates in melanoma, pancreatic, and head/neck cancers. Mutations in the oncogenes PIK3CA, FGFR3, and RAS/RAF family members, as well as the tumor suppressor TP53, were linked to changes in immune infiltration, usually in restricted tumor types. Associations of specific WNT/beta-catenin pathway genetic changes with immune state were limited, but we noted a link between 9p loss and the expression of the WNT receptor FZD3, suggesting that there are interactions between 9p alteration and WNT pathways. Finally, two different cell death regulators, CASP8 and DIDO1, were often mutated in head/neck tumors that had higher lymphocyte infiltrates. In summary, our study supports the relevance of tumor genetics to questions of efficacy and resistance in checkpoint blockade therapies. It also highlights the need to assess genome-wide influences during exploration of any specific tumor pathway hypothesized to be relevant to therapeutic response. Some of the observed genetic links to immune state, like 9p loss, may influence response to cancer immune therapies. Others, like mutations in cell death pathways, may help guide combination therapeutic approaches.	[Siemers, Nathan O.; Holloway, James L.] Bristol Myers Squibb, Translat Bioinformat, Redwood City, CA 94063 USA; [Chang, Han; Chasalow, Scott D.; Ross-MacDonald, Petra B.; Szustakowski, Joseph D.] Bristol Myers Squibb, Translat Bioinformat, Hopewell, NJ USA; [Voliva, Charles F.] Bristol Myers Squibb, Oncol Discovery, Lawrenceville, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Siemers, NO (corresponding author), Bristol Myers Squibb, Translat Bioinformat, Redwood City, CA 94063 USA.	genetics.and.io@fiveprime.org	Szustakowski, Joseph/HGB-2712-2022; Chasalow, Scott/AAE-9796-2020	Chasalow, Scott/0000-0003-1513-0249; Szustakowski, Joseph/0000-0001-7900-3973	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	All of the authors of this manuscript are salaried employees of Bristol-Myers Squibb Company, a Biopharma company in the business of developing and marketing therapeutic drugs. The Company did not influence study design, data collection, nor analysis, but supported our research in general, and approved the release of the publication. The specific roles of these authors are articulated in the 'author contributions' section.	Ando M, 2013, CANCER SCI, V104, P1002, DOI 10.1111/cas.12191; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; Dijkstra KK, 2016, JAMA ONCOL, V2, P1490, DOI 10.1001/jamaoncol.2016.2214; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gouas DA, 2010, CARCINOGENESIS, V31, P1475, DOI 10.1093/carcin/bgq118; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Huttenhower C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-250; Iyer G, 2013, UROL ONCOL-SEMIN ORI, V31, P303, DOI 10.1016/j.urolonc.2011.12.001; Ji RR, 2012, CANCER IMMUNOL IMMUN, V61, P1019, DOI 10.1007/s00262-011-1172-6; Knitr Xie Y., 2016, INTERNET; Knitr Xie Y., 2014, IMPLEMENTING REPRODU; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lepage P, ANTICANCER IMMUNOTHE; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Linsley PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109760; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Porta-Pardo E, 2016, CANCER IMMUNOL RES, V4, P789, DOI 10.1158/2326-6066.CIR-15-0233; R Core Team, 2016, R LAN GENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roemer MGM, 2016, J CLIN ONCOL, V34, P2690, DOI 10.1200/JCO.2016.66.4482; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rudd ML, 2011, CLIN CANCER RES, V17, P1331, DOI 10.1158/1078-0432.CCR-10-0540; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wickham H., 2009, GGPLOT2, DOI [10.1007/978-0-387-98141-3, DOI 10.1007/978-0-387-98141-3]; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wild Peter J, 2007, J Dtsch Dermatol Ges, V5, P456, DOI 10.1111/j.1610-0387.2007.06303.x; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Xie Y., 2015, INTERNET; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	50	133	135	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0179726	10.1371/journal.pone.0179726	http://dx.doi.org/10.1371/journal.pone.0179726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749946	gold, Green Submitted, Green Published			2022-12-26	WOS:000406575700004
J	Musuva, R; Shen, Y; Wei, XJ; Binder, S; Ivy, JA; Secor, WE; Montgomery, SP; King, CH; Mwinzi, PNM				Musuva, Rosemary; Shen, Ye; Wei, Xianjue; Binder, Sue; Ivy, Julianne A.; Secor, W. Evan; Montgomery, Susan P.; King, Charles H.; Mwinzi, Pauline N. M.			Change in children's school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2)	PLOS ONE			English	Article							SCHOOLCHILDREN; INFLAMMATION; PREVALENCE; IMPUTATION; INTENSITY; MORBIDITY; IMPACT	Background Schistosomiasis is a parasite-related chronic inflammatory condition that can cause anemia, decreased growth, liver abnormalities, and deficits in cognitive functioning among children. Methodology/Principal findings This study used the Behavior Assessment System for Children (BASC-2) to collect data on thirty-six 9-12 year old school-attending children's behavioral profiles in an Schistosoma mansoni-endemic area of western Kenya, before and after treatment with praziquantel for S. mansoni infection. BASC-2 T scores were significantly reduced post-treatment (p < 0.05) for each of the 'negative' behavior categories including externalizing problems (hyperactivity, aggression, and conduct problems that are disruptive in nature), internalizing problems (anxiety, depression, somatization, atypicality, and withdrawal), school problems (academic difficulties, included attention problems and learning problems), and the composite behavioral symptoms index (BSI), signifying improved behavior. While the observed improvement in the 'positive' behavior category of adaptive skills (adaptability, functional communication, social skills, leadership, and study skills) was not statistically significant, there were significant improvements in two adaptive skills subcategories: social skills and study skills. Conclusion/Significance Results of this study suggest that children have better school-related behaviors without heavy S. mansoni infection, and that infected children's behaviors, especially disruptive problem behaviors, improve significantly after praziquantel treatment.	[Musuva, Rosemary; Mwinzi, Pauline N. M.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Shen, Ye; Wei, Xianjue] Univ Georgia, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Binder, Sue; King, Charles H.] Univ Georgia, Schistosomiasis Consortium Operat Res & Evaluat, Athens, GA 30602 USA; [Ivy, Julianne A.; King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Secor, W. Evan; Montgomery, Susan P.] Ctr Dis Control & Prevent, Parasit Dis Branch, Div Parasit Dis & Malaria, Atlanta, GA USA	Kenya Medical Research Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Case Western Reserve University; Centers for Disease Control & Prevention - USA	King, CH (corresponding author), Univ Georgia, Schistosomiasis Consortium Operat Res & Evaluat, Athens, GA 30602 USA.; King, CH (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA.	chk@cwru.edu		King, Charles/0000-0001-8349-9270	University of Georgia Research Foundation, Inc. - Bill & Melinda Gates Foundation	University of Georgia Research Foundation, Inc. - Bill & Melinda Gates Foundation	These studies received financial support from the University of Georgia Research Foundation, Inc. which was funded by the Bill & Melinda Gates Foundation for the SCORE Project. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005372; [Anonymous], 2006, PREV CHEM HUM HELM C; Assis AMO, 2004, EUR J CLIN NUTR, V58, P1022, DOI 10.1038/sj.ejcn.1601926; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brundin L, 2015, ACTA PSYCHIAT SCAND, V132, P192, DOI 10.1111/acps.12458; Bustinduy AL, 2017, PARASITOLOGY, P1; Bustinduy AL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004946; Cody RP., 1987, APPL STAT SAS PROGRA; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Ezeamama AE, 2017, PLOS NEGL T IN PRESS; Ezeamama AE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1575-2; Fitzsimmons CM, 2004, INFECT IMMUN, V72, P4023, DOI 10.1128/IAI.72.7.4023-4030.2004; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Kabatereine NB, 2007, B WORLD HEALTH ORGAN, V85, P91, DOI 10.2471/BLT.06.030353; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; KING CH, 1989, ANN INTERN MED, V110, P290, DOI 10.7326/0003-4819-110-4-290; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kittur N, 2016, AM J TROP MED HYG, V94, P605, DOI 10.4269/ajtmh.15-0725; Mitra R, 2016, STAT METHODS MED RES, V25, P188, DOI 10.1177/0962280212445945; Mwinzi PNM, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00048; Nazel M W, 1999, J Egypt Public Health Assoc, V74, P97; Nokes C, 1999, AM J TROP MED HYG, V60, P556, DOI 10.4269/ajtmh.1999.60.556; Odiere MR, 2011, PARASITOLOGY, V138, P1569, DOI 10.1017/S003118201100059X; Onkanga IO, 2016, INT J PARASITOL, V46, P439, DOI 10.1016/j.ijpara.2016.01.006; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Reynolds CR., 2004, BEHAV ASSESSMENT SYS, V2, DOI [10.1002/9780470479216.corpsy0114, DOI 10.1002/9780470479216.CORPSY0114]; Samuels AM, 2012, AM J TROP MED HYG, V87, P874, DOI 10.4269/ajtmh.2012.12-0397; Sesay S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-14; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Verani JR, 2011, AM J TROP MED HYG, V84, P787, DOI 10.4269/ajtmh.2011.10-0685; World Health Organization, 2014, WKLY EPIDEMIOL REC, V91, P53	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181975	10.1371/journal.pone.0181975	http://dx.doi.org/10.1371/journal.pone.0181975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746403	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800073
J	Palangi, F; Samuel, SM; Thompson, IR; Triggle, CR; Emara, MM				Palangi, Freshteh; Samuel, Samson M.; Thompson, I. Richard; Triggle, Chris R.; Emara, Mohamed M.			Effects of oxidative and thermal stresses on stress granule formation in human induced pluripotent stem cells	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; PROCESSING BODIES; GENE-EXPRESSION; P-BODIES; EIF2-ALPHA PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; SELF-RENEWAL; HEAT-SHOCK; BINDING	Stress Granules (SGs) are dynamic ribonucleoprotein aggregates, which have been observed in cells subjected to environmental stresses, such as oxidative stress and heat shock (HS). Although pluripotent stem cells (PSCs) are highly sensitive to oxidative stress, the role of SGs in regulating PSC self-renewal and differentiation has not been fully elucidated. Here we found that sodium arsenite (SA) and HS, but not hydrogen peroxide (H2O2), induce SG formation in human induced (hi) PSCs. Particularly, we found that these granules contain the well-known SG proteins (G3BP, TIAR, eIF4E, eIF4A, eIF3B, eIF4G, and PABP), were found in juxtaposition to processing bodies (PBs), and were disassembled after the removal of the stress. Moreover, we showed that SA and HS, but not H2O2, promote eIF2a phosphorylation in hiPSCs forming SGs. Analysis of pluripotent protein expression showed that HS significantly reduced all tested markers (OCT4, SOX2, NANOG, KLF4, L1TD1, and LIN28A), while SA selectively reduced the expression levels of NANOG and L1TD1. Finally, in addition to LIN28A and L1TD1, we identified DPPA5 (pluripotent protein marker) as a novel component of SGs. Collectively, these results provide new insights into the molecular cues of hiPSCs responses to environmental insults.	[Palangi, Freshteh; Thompson, I. Richard; Emara, Mohamed M.] Hamad Bin Khalifs Univ, Qatar Biomed Res Inst, Qatar Fdn, Neurol Disorders Res Ctr, Doha, Qatar; [Samuel, Samson M.; Triggle, Chris R.] Qatar Fdn, Dept Pharmacol, Weill Cornell Med Coll Qatar, Doha, Qatar; [Emara, Mohamed M.] Cairo Univ, Sch Vet Med, Dept Virol, Cairo, Egypt	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Biomedical Research Institute (QBRI); Qatar Foundation (QF); Weill Cornell Medical College Qatar; Egyptian Knowledge Bank (EKB); Cairo University	Emara, MM (corresponding author), Hamad Bin Khalifs Univ, Qatar Biomed Res Inst, Qatar Fdn, Neurol Disorders Res Ctr, Doha, Qatar.; Emara, MM (corresponding author), Cairo Univ, Sch Vet Med, Dept Virol, Cairo, Egypt.	memara@hbku.edu.qa	Thompson, I Richard/J-9900-2016; Samuel, Samson Mathews/AAV-6263-2020	Thompson, I Richard/0000-0002-9554-550X; Mathews Samuel, Samson/0000-0002-5541-6623; Triggle, Christopher/0000-0001-5307-0537	QBRI-HBKU; NPRP [04-910-3-244]	QBRI-HBKU; NPRP	This work was supported by QBRI-HBKU and NPRP grant (04-910-3-244) awarded to CRT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Essam M. Abdelalim for providing the primers, and Dr. Tariq Ahmed and Dr. Kostas Vekrellis for critical revision of the manuscript. This work was supported by QBRI-HBKU and NPRP grant (04-910-3-244) awarded to Chris Triggle.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2015, BBA-GENE REGUL MECH, V1849, P861, DOI 10.1016/j.bbagrm.2014.11.009; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cassar PA, 2015, EMBO REP, V16, P1334, DOI 10.15252/embr.201540974; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Dannenmann B, 2015, STEM CELL REP, V4, P886, DOI 10.1016/j.stemcr.2015.04.004; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fahling M, 2009, J CELL MOL MED, V13, P2770, DOI 10.1111/j.1582-4934.2009.00875.x; Farley BM, 2008, CRIT REV BIOCHEM MOL, V43, P135, DOI [10.1080/10409230801921338, 10.1080/10409230801921338 ]; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; George S, 2009, PHOTOMED LASER SURG, V27, P669, DOI 10.1089/pho.2008.2354; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Huelgas-Morales G, 2016, G3-GENES GENOM GENET, V6, P1031, DOI 10.1534/g3.115.026815; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Ivanov VN, 2013, APOPTOSIS, V18, P188, DOI 10.1007/s10495-012-0779-1; Jevtov I, 2015, J CELL SCI, V128, P2497, DOI 10.1242/jcs.168724; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2009, PROG MOL BIOL TRANSL, V90, P155, DOI 10.1016/S1877-1173(09)90004-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khaperskyy DA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004217; Khong A, 2011, J VIROL, V85, P1439, DOI 10.1128/JVI.02220-10; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Koga M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4197; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Raaben M, 2007, CELL MICROBIOL, V9, P2218, DOI 10.1111/j.1462-5822.2007.00951.x; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Samuel SM, 2017, BIOCH PHARM; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schisa JA, 2014, WIRES RNA, V5, P231, DOI 10.1002/wrna.1204; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan FE, 2014, P NATL ACAD SCI USA, V111, pE1740, DOI 10.1073/pnas.1320873111; Thakar NY, 2015, STEM CELLS DEV, V24, P1888, DOI 10.1089/scd.2014.0587; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tower J, 2012, WIRES DEV BIOL, V1, P789, DOI 10.1002/wdev.56; Vinoth KJ, 2008, STEM CELLS DEV, V17, P599, DOI 10.1089/scd.2007.0088; Vinoth KJ, 2015, FOLIA HISTOCHEM CYTO, V53, P169, DOI 10.5603/FHC.a2015.0016; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293; Zhang X, 2011, CURR DRUG TARGETS, V12, P1267, DOI 10.2174/138945011796150325; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196	69	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0182059	10.1371/journal.pone.0182059	http://dx.doi.org/10.1371/journal.pone.0182059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746394	gold, Green Submitted, Green Published			2022-12-26	WOS:000406371800076
J	Wang, SX; Li, M; Liu, K; Tian, XH; Li, S; Chen, YL; Jia, Z				Wang, Shaoxia; Li, Meng; Liu, Ke; Tian, Xiaohong; Li, Shuo; Chen, Yanlong; Jia, Zhou			Effects of Zn, macronutrients, and their interactions through foliar applications on winter wheat grain nutritional quality	PLOS ONE			English	Article							ZINC CONCENTRATION; PHYTIC ACID; MICRONUTRIENT CONCENTRATIONS; NITROGEN MANAGEMENT; PHOSPHORUS; TRANSLOCATION; ROOT; IRON; UREA; BIOFORTIFICATION	Although application of Zn combined with macronutrients (K, P, and N) can be used to fortify wheat grain with Zn, little is known about their interactions when foliar application is employed or the influences of common soil fertility management practices (e.g. N and straw management) on their efficiency. Therefore, the effects of foliar-applied Zn and N, P, or K on grain nutritional quality (especially Zn) were investigated in wheat grown under different soil N rates at two sites with (Sanyuan) or without (Yangling) employing straw return. A 4-year-long field experiment was also conducted to evaluate the environmental stability of the foliar formulations. Across 6 site-years, foliar Zn application alone or combined with N, P, or K fertilizers resulted in 95.7%, 101%, 67.9% and 121% increases in grain Zn concentration, respectively. In terms of increasing grain Zn concentration, foliar-applied Zn positively interacted with N (at Sanyuan) and K (at Yangling), but negatively interacted with P at any condition tested, suggesting depressive effects of foliarly-applied P on physiological availability of Zn. Although these interaction effects were the major factor that governing the efficiency of foliar-applied Zn combined with N, P, or K on grain Zn concentration, the magnitude of the increase/decrease in grain Zn (-3.96 similar to 5.71 mg kg(-1)) due to these interactions was much less than the average increases following Zn+K (31.3), Zn+P (18.7), and Zn+N (26.5 mg kg(-1)) treatments relative to that observed in foliar Zn-only treatment. The combined foliar application of Zn with N, P, or K did not cause any adverse impact on grain yield and other nutritional quality and in some cases slightly increased grain yield and macronutrient concentrations. Grain phytic acid:Zn molar ratios were respectively 52.0%, 53.1%, 43.4% and 63.5% lower in the foliar Zn, Zn+N, Zn+P and Zn+K treatments than in the control treatment. These effects were consistent over four years and across three soil N rates. Overall, combined foliar application of Zn with N, P, or K can successfully fortify wheat grain with Zn (above 40 mg kg(-1)), and including Zn in foliar N or K application are preferred for practically increasing dietary Zn intake.	[Wang, Shaoxia; Liu, Ke; Tian, Xiaohong; Li, Shuo; Chen, Yanlong; Jia, Zhou] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Li, Meng] China Three Gorges Univ, Coll Hydraul & Environm Engn, Yichang, Hubei, Peoples R China; [Li, Meng] China Three Gorges Univ, Engn Res Ctr Ecoenvironm Gorges Reservoir Reg 3, Yichang, Hubei, Peoples R China; [Li, Meng] China Three Gorges Univ, Minist Educ, Yichang, Hubei, Peoples R China	Northwest A&F University - China; China Three Gorges University; China Three Gorges University; China Three Gorges University	Tian, XH (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.	txhong@hatmail.com	Chen, Yanlong/U-1885-2019	Chen, Yanlong/0000-0001-8657-5590	National Natural Sciences Foundation of China [41371288, 31662233]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financed by the National Natural Sciences Foundation of China (41371288, 31662233). Their recipient was Prof. Tian Xiaohong, who gave us some important suggestions about the conception, design, and performing of the experiment, and the writing of the manuscript.; We are deeply indebted to the National Natural Sciences Foundation of China (31662233, 41371288) for their support of this study. Their recipient was Prof. Tian Xiaohong, who gave us some important suggestion about the conception, design, and perforation of the experiment, and the writing of the manuscript.	Aciksoz SB, 2014, PHYSIOL PLANTARUM, V151, P348, DOI 10.1111/ppl.12198; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; BOWMAN DC, 1992, J AM SOC HORTIC SCI, V117, P75, DOI 10.21273/JASHS.117.1.75; Cakmak I., 2012, Better Crops with Plant Food, V96, P17; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; CAKMAK I, 1987, PHYSIOL PLANTARUM, V70, P13, DOI 10.1111/j.1399-3054.1987.tb08690.x; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Cui ZL, 2010, FIELD CROP RES, V116, P140, DOI 10.1016/j.fcr.2009.12.004; Dominguez E, 2011, NEW PHYTOL, V189, P938, DOI 10.1111/j.1469-8137.2010.03553.x; Dong SF, 2002, TREE PHYSIOL, V22, P1305, DOI 10.1093/treephys/22.18.1305; Erenoglu EB, 2011, IMPROVED NITROGEN NU; Fernandez V, 2009, CRIT REV PLANT SCI, V28, P36, DOI 10.1080/07352680902743069; Fernandez V., 2013, FOLIAR FERTILISATION; Fernandez V, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00289; Gargari BP, 2007, FOOD CHEM, V100, P1115, DOI 10.1016/j.foodchem.2005.11.018; Ghasemi S, 2013, J PLANT GROWTH REGUL, V32, P315, DOI 10.1007/s00344-012-9300-x; Ghasemi S, 2013, EUR J AGRON, V45, P68, DOI 10.1016/j.eja.2012.10.012; Gibson RS, 2012, PLANT SOIL, V361, P291, DOI 10.1007/s11104-012-1209-4; Goh TB, 1997, CAN J PLANT SCI, V77, P339, DOI 10.4141/P95-079; Gomez-Coronado F, 2016, PLANT SOIL, V401, P331, DOI 10.1007/s11104-015-2758-0; Gupta V. K., 1983, Haryana Agricultural University Journal of Research, V13, P140; Hussain S, 2012, PLANT SOIL, V361, P279, DOI 10.1007/s11104-012-1217-4; Kutman UB, 2012, PLANT SOIL, V361, P177, DOI 10.1007/s11104-012-1300-x; Kutman UB, 2011, PLANT SOIL, V342, P149, DOI 10.1007/s11104-010-0679-5; Li S, 2016, SOIL TILL RES, V157, P43, DOI 10.1016/j.still.2015.11.002; Liang JF, 2007, J SCI FOOD AGR, V87, P504, DOI 10.1002/jsfa.2747; Lu ZG, 1998, J PLANT NUTR, V21, P25, DOI 10.1080/01904169809365380; Maitra D. N., 2000, Agricultural Science Digest, V20, P75; Mengel K, 1987, PRINCIPLES PLANT NUT, V4th, DOI DOI 10.1093/AOB/MCH063; Milani N, 2012, J AGR FOOD CHEM, V60, P3991, DOI 10.1021/jf205191y; Mohammad F, 2006, PHOTOSYNTHETICA, V44, P471, DOI 10.1007/s11099-006-0053-2; Nichols BA, 2012, J PLANT NUTR, V35, P123, DOI 10.1080/01904167.2012.631672; Ova EA, 2015, PLANT SOIL, V393, P147, DOI 10.1007/s11104-015-2483-8; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Ryan MH, 2008, J SCI FOOD AGR, V88, P1208, DOI 10.1002/jsfa.3200; Shi RL, 2010, J CEREAL SCI, V51, P165, DOI 10.1016/j.jcs.2009.11.008; VARLEY JA, 1966, ANALYST, V91, P119, DOI 10.1039/an9669100119; Velu G, 2014, J CEREAL SCI, V59, P365, DOI 10.1016/j.jcs.2013.09.001; Wang SX, 2015, AGRON J, V107, P61, DOI 10.2134/agronj14.0414; Wang SX, 2014, AGRON J, V106, P1003, DOI 10.2134/agronj13.0354; Waters BM, 2009, J EXP BOT, V60, P4263, DOI 10.1093/jxb/erp257; WUEST SB, 1992, AGRON J, V84, P682, DOI 10.2134/agronj1992.00021962008400040028x; Xue YF, 2014, FIELD CROP RES, V161, P38, DOI 10.1016/j.fcr.2014.01.009; Yang XW, 2011, CEREAL RES COMMUN, V39, P535, DOI 10.1556/CRC.39.2011.4.8; Yang XW, 2011, J SCI FOOD AGR, V91, P2322, DOI 10.1002/jsfa.4459; You J, 2009, CAN J PLANT SCI, V87, P461; YOUNGDAHL LJ, 1977, CROP SCI, V17, P66, DOI 10.2135/cropsci1977.0011183X001700010019x; Zhang YQ, 2012, PLANT SOIL, V361, P143, DOI 10.1007/s11104-012-1238-z	48	14	15	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181276	10.1371/journal.pone.0181276	http://dx.doi.org/10.1371/journal.pone.0181276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746402	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800033
J	Ernst, G; Watne, LO; Frihagen, F; Wyller, TB; Dominik, A; Rostrup, M				Ernst, Gernot; Watne, Leiv Otto; Frihagen, Frede; Wyller, Torgeir Bruun; Dominik, Andreas; Rostrup, Morten			Decreases in heart rate variability are associated with postoperative complications in hip fracture patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; INCREASED MORTALITY; CIRCADIAN VARIATION; SPECTRAL-ANALYSIS; BLOOD-PRESSURE; RISK; HYPERTENSION; INFLAMMATION; PREDICTORS	Background To explore relevant associations between deviations in linear and nonlinear heart rate variability (HRV) scores, and short-term morbidity and mortality in patients undergoing hip-surgery after a fracture. Methods 165 patients with hip fractures being admitted for surgery at two hospitals were included in a prospective cohort study. A short-term ECG was recorded within 24 hours of arrival. 15 patients had to be excluded due to insufficient quality of the ECG recordings. 150 patients were included in the final analysis. Linear parameters were calculated in time domain: standard deviation of NN intervals (SDNN), root mean square of successive differences (rMSSD); and frequency domain: Total Power (TP), High Frequency Power (HF), Low Frequency Power (LF), Very Low Frequency Power (VLF), and the ratio of LF/HF. Postoperative outcome was evaluated at the time of discharge. This included occurrence of pneumonia, overall infection rate, stroke, myocardial infarction, and all-cause mortality. Results Patients experiencing complications had significantly lower rMSSD (p = 0.04), and TP (p = 0.03) preoperatively. Postoperative infections were predicted by decreased VLF preoperatively (p = 0.04). There was a significant association between pneumonia and LF/HF<1 (p = 0.03). The likelihood ratio to develop pneumonia when LF/HF <1 was 6,1. Conclusion HRV seems to reflect the general frailty of the patient with hip fracture and might be used to identify patients in need of increased surveillance or prophylactic treatment.	[Ernst, Gernot] Kongsberg Hosp, Dept Anaesthesiol, Kongsberg, Norway; [Ernst, Gernot; Rostrup, Morten] Oslo Univ Hosp, Sect Cardiovasc & Renal Res, Oslo, Norway; [Watne, Leiv Otto; Frihagen, Frede; Wyller, Torgeir Bruun] Univ Oslo, Inst Clin Med, Oslo, Norway; [Watne, Leiv Otto; Rostrup, Morten] Univ Oslo, Inst Basic Med Sci, Dept Behav Sci Med, Oslo, Norway; [Watne, Leiv Otto; Frihagen, Frede; Wyller, Torgeir Bruun] Oslo Univ Hosp, Oslo Delirium Res Grp, Dept Geriatr Med, Oslo, Norway; [Dominik, Andreas] THM Univ Appl Sci, KITE, Giessen, Germany	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Ernst, G (corresponding author), Kongsberg Hosp, Dept Anaesthesiol, Kongsberg, Norway.; Ernst, G (corresponding author), Oslo Univ Hosp, Sect Cardiovasc & Renal Res, Oslo, Norway.	bserng@vestreviken.no		Ernst, Gernot/0000-0001-5224-0338; Frihagen, Frede/0000-0002-4811-669X				Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Althaus M, 1998, PSYCHOPHYSIOLOGY, V35, P420, DOI 10.1017/S0048577298961418; Aubrun Frederic, 2011, Ann Fr Anesth Reanim, V30, pe37, DOI 10.1016/j.annfar.2011.08.010; AXELROD S, 1987, NEPHRON, V45, P202, DOI 10.1159/000184117; Bendixen KH, 2013, J OROFAC PAIN, V27, P243, DOI 10.11607/jop.1013; Benetos LS, 2007, INJURY, V38, P735, DOI 10.1016/j.injury.2007.01.001; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bhaskar D, 2011, INJURY, V42, P178, DOI 10.1016/j.injury.2010.07.501; Bonnemeier H, 2003, J CARDIOVASC ELECTR, V14, P791, DOI 10.1046/j.1540-8167.2003.03078.x; BURGOS LG, 1989, ANESTHESIOLOGY, V70, P591, DOI 10.1097/00000542-198904000-00006; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1996, EUR HEART J, V17, P354; Cansel M, 2014, ANATOL J CARDIOL, V14, P413, DOI 10.5152/akd.2014.5108; Celik A, 2012, ANATOL J CARDIOL, V12, P233, DOI 10.5152/akd.2012.067; Chamchad D, 2004, ANESTH ANALG, V99, P1818, DOI 10.1213/01.ANE.0000140953.40059.E6; Chen WR, 2013, J INTERV CARD ELECTR, V36, P267, DOI 10.1007/s10840-012-9728-8; Dahl OE, 2005, THROMB HAEMOSTASIS, V93, P860, DOI 10.1160/TH04-11-0769; de Bruyne MC, 1999, AM J EPIDEMIOL, V150, P1282; Dekker JM, 2000, CIRCULATION, V102, P1239, DOI 10.1161/01.CIR.102.11.1239; Eller-Berndl D., 2010, HERZRATENVARIABILITA; Ernst G., 2014, HEART RATE VARIABILI, DOI 10.1007/978-1-4471-4309-3_1; Farahmand BY, 2005, OSTEOPOROSIS INT, V16, P1583, DOI 10.1007/s00198-005-2024-z; Filipovic M, 2005, ANAESTHESIA, V60, P5, DOI 10.1111/j.1365-2044.2004.03996.x; Furukawa Y, 2006, PACE, V29, P479, DOI 10.1111/j.1540-8159.2006.00379.x; Goldberger AL, 1997, PERSPECT BIOL MED, V40, P543; Goldstein LB, 2007, CIRCULATION, V116, P1504, DOI 10.1161/CIRCULATIONAHA.106.670885; Grant CC, 2011, ANN NONINVAS ELECTRO, V16, P131, DOI 10.1111/j.1542-474X.2011.00422.x; Griffin MP, 2005, PEDIATRICS, V115, P937, DOI 10.1542/peds.2004-1393; Gupta H, 2013, MAYO CLIN PROC, V88, P1241, DOI 10.1016/j.mayocp.2013.06.027; Hadase M, 2004, CIRC J, V68, P343, DOI 10.1253/circj.68.343; Haensel A, 2008, PSYCHONEUROENDOCRINO, V33, P1305, DOI 10.1016/j.psyneuen.2008.08.007; Hernlund E, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0136-1; Ho CA, 2010, J ORTHOP SCI, V15, P30, DOI 10.1007/s00776-009-1425-9; HON EH, 1965, AM J OBSTET GYNECOL, V91, P56, DOI 10.1016/0002-9378(65)90586-7; Huang CJ, 2006, ACTA ANAESTH SCAND, V50, P542, DOI 10.1111/j.1399-6576.2006.001016.x; Jideus L, 2001, SCAND CARDIOVASC J, V35, P238; Juliebo V, 2010, J GERONTOL A-BIOL, V65, P442, DOI 10.1093/gerona/glp199; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kon H, 2006, INT HEART J, V47, P867, DOI 10.1536/ihj.47.867; Kop WJ, 2010, PSYCHOSOM MED, V72, P626, DOI 10.1097/PSY.0b013e3181eadd2b; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Lanza GA, 2006, AM J CARDIOL, V97, P1702, DOI 10.1016/j.amjcard.2006.01.029; Laulund AS, 2012, INJURY, V43, P1014, DOI 10.1016/j.injury.2011.12.008; Lin JL, 1999, AM HEART J, V137, P658, DOI 10.1016/S0002-8703(99)70219-X; Linear A S., 2004, BIOL RES NURS, V5, P211; Makikallio TH, 2005, EUR HEART J, V26, P762, DOI 10.1093/eurheartj/ehi188; Mamode N, 2001, EUR J VASC ENDOVASC, V22, P499, DOI 10.1053/ejvs.2001.1529; Mazzeo AT, 2011, ACTA ANAESTH SCAND, V55, P797, DOI 10.1111/j.1399-6576.2011.02466.x; Melenovsky V, 2005, AM J CARDIOL, V95, P999, DOI 10.1016/j.amjcard.2004.12.048; Norris PR, 2006, ANN SURG, V243, P804, DOI 10.1097/01.sla.0000219642.92637.fd; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; Palatini P, 2006, J HYPERTENS, V24, P1375, DOI 10.1097/01.hjh.0000234118.25401.1c; Pousset F, 1996, AM J CARDIOL, V77, P612, DOI 10.1016/S0002-9149(97)89316-2; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Sato N M S., 2005, J PHYSL ANTHR APPL H, V23, P215; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Shaffer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01040; Stoen RO, 2012, OSTEOPOROSIS INT, V23, P2527, DOI 10.1007/s00198-011-1888-3; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Thygesen K, 2012, NAT REV CARDIOL, V9, P620, DOI 10.1038/nrcardio.2012.122; van Meenen LCC, 2014, J AM GERIATR SOC, V62, P2383, DOI 10.1111/jgs.13138; vanRoon AM, 1995, HOMEOSTASIS HLTH DIS, V36, P316; Varadhan R, 2009, J GERONTOL A-BIOL, V64, P682, DOI 10.1093/gerona/glp013; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Vogele C, 2009, PHYSIOL BEHAV, V98, P229, DOI 10.1016/j.physbeh.2009.05.018; Watne LO, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-63; Yi G, 1997, HEART, P77	69	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180423	10.1371/journal.pone.0180423	http://dx.doi.org/10.1371/journal.pone.0180423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742855	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000011
J	Marini, A; Rossi, O; Aruta, MG; Micoli, F; Rondini, S; Guadagnuolo, S; Delany, I; Henderson, IR; Cunningham, AF; Saul, A; MacLennan, CA; Koeberling, O				Marini, Arianna; Rossi, Omar; Aruta, Maria Grazia; Micoli, Francesca; Rondini, Simona; Guadagnuolo, Serafina; Delany, Isabel; Henderson, Ian R.; Cunningham, Adam F.; Saul, Allan; MacLennan, Calman A.; Koeberling, Oliver			Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1	PLOS ONE			English	Article							BACTERICIDAL ANTIBODY-RESPONSES; MENINGITIDIS SEROGROUP-B; COMPLEMENT FACTOR-H; NEISSERIA-MENINGITIDIS; GENERALIZED MODULES; IMMUNE-RESPONSES; ANTIGENS GMMA; RECOMBINANT; ADJUVANT; DISEASE	Factor H-binding protein (fHbp) is an important meningococcal vaccine antigen. Native outer membrane vesicles with over-expressed fHbp (NOMV OE fHbp) have been shown to induce antibodies with broader functional activity than recombinant fHbp (rfHbp). Improved understanding of this broad coverage would facilitate rational vaccine design. We performed a pair-wise analysis of 48 surface-exposed amino acids involved in interacting with factor H, among 383 fHbp variant group 1 sequences. We generated isogenic NOMV-producing meningococcal strains from an African serogroup W isolate, each over-expressing one of four fHbp variant group 1 sequences (ID 1, 5, 9, or 74), including those most common among invasive African meningococcal isolates. Mice were immunised with each NOMV, and sera tested for IgG levels against each of the rfHbp ID and for ability to kill a panel of heterologous meningococcal isolates. At the fH-binding site, ID pairs differed by a maximum of 13 (27%) amino acids. ID 9 shared an amino acid sequence common to 83 ID types. The selected ID types differed by up to 6 amino acids, in the fH-binding site. All NOMV and rfHbp induced high IgG levels against each rfHbp. Serum killing from mice immunised with rfHbp was generally less efficient and more restricted compared to NOMV, which induced antibodies that killed most meningococci tested, with decreased stringency for ID type differences. Breadth of killing was mostly due to anti-fHbp antibodies, with some restriction according to ID type sequence differences. Nevertheless, under our experimental conditions, no relationship between antibody cross-reactivity and variation fH-binding site sequence was identified. NOMV over-expressing different fHbp IDs belonging to variant group 1 induce antibodies with fine specificities against fHbp, and ability to kill broadly meningococci expressing heterologous fHbp IDs. The work reinforces that meningococcal NOMV with OE fHbp is a promising vaccine strategy, and provides a basis for rational selection of antigen sequence types for over-expression on NOMV.	[Marini, Arianna; Cunningham, Adam F.; MacLennan, Calman A.] Univ Birmingham, Inst Immunol & Immunotherapy, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Marini, Arianna; Rossi, Omar; Aruta, Maria Grazia; Micoli, Francesca; Rondini, Simona; Saul, Allan; MacLennan, Calman A.; Koeberling, Oliver] GSK Vaccines Inst Global Hlth GVGH, Siena, Italy; [Guadagnuolo, Serafina; Delany, Isabel] GSK Vaccines, Siena, Italy; [Henderson, Ian R.] Univ Birmingham, Inst Microbiol & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Marini, Arianna; MacLennan, Calman A.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Rossi, Omar] Univ Cambridge, Dept Vet Med, Cambridge, England; [Guadagnuolo, Serafina] Policlin Univ St Orsola Malpighi, Bologna, Italy	University of Birmingham; GlaxoSmithKline; University of Birmingham; University of Oxford; Jenner Institute; University of Cambridge; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Koeberling, O (corresponding author), GSK Vaccines Inst Global Hlth GVGH, Siena, Italy.	oliver.x.koeberling@gsk.com	Saul, Allan J/I-6968-2013; Henderson, Ian/AAD-5369-2019; Saul, Allan/ABH-2091-2020; Rondini, Simona/GLN-4357-2022; Rossi, Omar/AAT-6743-2020	Saul, Allan J/0000-0003-0665-4091; Saul, Allan/0000-0003-0665-4091; Cunningham, Adam/0000-0003-0248-964X; Henderson, Ian/0000-0002-9954-4977	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/under REA grant [316940]; European Industrial Doctorate Programme VADER (Vaccine Design and Immune Responses); University of Birmingham	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/under REA grant; European Industrial Doctorate Programme VADER (Vaccine Design and Immune Responses); University of Birmingham	The research leading to this publication has received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/under REA grant agreement no 316940, European Industrial Doctorate Programme VADER (Vaccine Design and Immune Responses), whose beneficiaries were GSK Vaccines Institute for Global Health (former Novartis Vaccine Institute for Global Health) and University of Birmingham. GSK Vaccines Institute for Global Health and University of Birmingham also contributed. ID, OK, CM, FM, SR, and AS were employees of Novartis Vaccines and Diagnostics Srl at the time of the study. Following the acquisition of Novartis Vaccines by the GSK group of companies in March, 2015, MA, ID, OK, FM, SR, AS are now employees of the GSK group of companies. The funder provided support in the form of salaries for authors [AM, MA, ID, OK, FM, CM, SR, AS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AASE A, 1995, INFECT IMMUN, V63, P3531, DOI 10.1128/IAI.63.9.3531-3536.1995; Aghasadeghi MR, 2011, CURR HIV RES, V9, P630, DOI 10.2174/157016211798998772; [Anonymous], 2016, PEDIATRICS, V138; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Biagini M, 2016, P NATL ACAD SCI USA, V113, P2714, DOI 10.1073/pnas.1521142113; Brunelli B, 2011, VACCINE, V29, P1072, DOI 10.1016/j.vaccine.2010.11.064; Delany I, 2013, patent, Patent No. [CA 2861946 A1, 2861946]; Feavers IM, 2009, VACCINE, V27, pB42, DOI 10.1016/j.vaccine.2009.05.001; Findlow J, 2006, INFECT IMMUN, V74, P4557, DOI 10.1128/IAI.00466-06; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gandhi A, 2016, POSTGRAD MED, V128, P548, DOI 10.1080/00325481.2016.1203238; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Hou VC, 2005, J INFECT DIS, V192, P580, DOI 10.1086/432102; Ispasanie Emma, 2014, F1000Res, V3, P264, DOI 10.12688/f1000research.3881.1; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Johnson S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002981; Kattner C, 2014, J STRUCT BIOL, V185, P440, DOI 10.1016/j.jsb.2013.12.006; Keiser PB, 2011, VACCINE, V29, P1413, DOI 10.1016/j.vaccine.2010.12.039; Koeberling O, 2014, VACCINE, V32, P2688, DOI 10.1016/j.vaccine.2014.03.068; Konar M, 2013, J INFECT DIS, V208, P627, DOI 10.1093/infdis/jit239; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Marsay L, 2015, J INFECTION, V71, P326, DOI 10.1016/j.jinf.2015.05.006; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2009, VACCINE, V27, P3417, DOI 10.1016/j.vaccine.2009.01.075; Norheim G, 2005, VACCINE, V23, P3762, DOI 10.1016/j.vaccine.2005.02.021; Pajon R, 2015, VACCINE, V33, P1317, DOI 10.1016/j.vaccine.2015.01.057; Pajon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066536; Pajon R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001302; Perrett KP, 2015, VACCINE, V33, P5217, DOI 10.1016/j.vaccine.2015.06.103; Rondini S, 2015, INFECT IMMUN, V83, P996, DOI 10.1128/IAI.03079-14; Rossi O, 2015, MOL BIOTECHNOL, V57, P84, DOI 10.1007/s12033-014-9804-7; Sanders H, 2011, EXPERT REV VACCINES, V10, P323, DOI [10.1586/erv.11.10, 10.1586/ERV.11.10]; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Sikkema DJ, 2000, CLIN DIAGN LAB IMMUN, V7, P764, DOI 10.1128/CDLI.7.5.764-768.2000; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; Vesikari T, 2015, J PEDIAT INFECT DIS; WEDEGE E, 1986, INFECT IMMUN, V51, P571, DOI 10.1128/IAI.51.2.571-578.1986; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; WHO, 2015, WHO SURV B; Williams JN, 2014, VACCINE, V32, P1280, DOI 10.1016/j.vaccine.2013.12.070; Zughaier S, 2007, VACCINE, V25, P4401, DOI 10.1016/j.vaccine.2007.03.029	47	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181508	10.1371/journal.pone.0181508	http://dx.doi.org/10.1371/journal.pone.0181508			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742866	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000033
J	Tsai, FJ; Chen, SY; Liu, YC; Liao, HY; Chen, CJ				Tsai, Fuu-Jen; Chen, Shih-Yin; Liu, Yu-Ching; Liao, Hsin-Yi; Chen, Chao-Jung			The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; MASS-SPECTROMETRY; ANCHORCHIP(TM) TARGETS; BETA-HYDROXYBUTYRATE; MS; NITROCELLULOSE; QUANTITATION; MS/MS; MODEL; PROBE	In nanoflow liquid chromatography-matrix-assisted laser desorption/ ionization tandem timeof- flight (nanoLC-MALDI-TOF/TOF) approaches, it is critical to directly apply small amounts of the sample elutes on the sample target using a nanoLC system due to its low flow rate of 200 similar to 300 nl/min. It is recommended to apply a sheath liquid containing a matrix with a several mu L/min flow rate at the end of the nanoLC column to ensure a larger co-eluted droplet for more reproducible sample spotting and avoid the laborious task of post-manual matrix spotting. In this study, to achieve a better nanoLC-MALDI performance on sample spotting, we first compared a-Cyano-4-hydroxycinnamic acid (CHCA) solvent composition for efficiently concentrating nanoLC elutes on an anchor chip. The solvent composition of isopropanol (IPA): acetonitrile (ACN): acetone: 0.1% Trifluoroacetic acid (TFA) (2: 7: 7: 2) provided strong and homogeneous signals with higher peptide ion yields than the other solvent compositions. Then, nanoLC-MALDI-TOF/TOF was applied to study the impact of aflatoxin B1 on the liver proteome from diabetes mellitus type 1 mice. Aflatoxin B1 (AFB1), produced by Aspergillus flavus and Aspergillus parasiticus is a carcinogen and a known causative agent of liver cancer. To evaluate the effects of long-term exposure to AFB1 on type 1 diabetes mellitus (TIDM), the livers of T1DM control mice and mice treated with AFB1 were analyzed using isotope-coded protein labeling (ICPL)-based quantitative proteomics. Our results showed that gluconeogenesis, lipid, and oxidative phosphorylation mechanisms, normally elevated in T1DM, were disordered following AFB1 treatment. In addition, major urinary protein 1 (MUP1), an indicator of increased insulin sensitivity, was significantly decreased in the T1DM/AFB1 group and may have resulted in higher blood glucose levels compared to the T1DM group. These results indicate that T1DM patients should avoid the AFB1 intake, as they could lead to increased blood glucose levels and disorders of energy-producing mechanisms.	[Tsai, Fuu-Jen; Chen, Shih-Yin] China Med Univ, Grad Inst Chinese Med Sci, Coll Chinese Med, Taichung, Taiwan; [Tsai, Fuu-Jen; Chen, Shih-Yin] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan; [Liu, Yu-Ching; Liao, Hsin-Yi; Chen, Chao-Jung] China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan; [Chen, Chao-Jung] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, CJ (corresponding author), China Med Univ Hosp, Dept Med Res, Prote Core Lab, Taichung, Taiwan.; Chen, CJ (corresponding author), China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan.	cjchen@mail.cmu.edu.tw	Chen, Chao-Jung/E-5481-2011	Chen, Chao-Jung/0000-0003-3834-9243	China Medical University Hospital [DMR-105-090]; Ministry of Science and Technology [MOST1032113-M-039-001-MY2]; Taiwan Ministry of Health and Welfare Clinical Trialand Research Center of Excellence [MOHW105-TDU-B-212-133019]; Academia Sinica's Diabetes Biosignature Project [BM10601010027]	China Medical University Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taiwan Ministry of Health and Welfare Clinical Trialand Research Center of Excellence; Academia Sinica's Diabetes Biosignature Project	This work was supported by the China Medical University Hospital (DMR-105-090), the Ministry of Science and Technology (MOST1032113-M-039-001-MY2), Taiwan Ministry of Health and Welfare Clinical Trialand Research Center of Excellence (MOHW105-TDU-B-212-133019) and Academia Sinica's Diabetes Biosignature Project (BM10601010027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; Braga CP, 2016, OMICS, V20, P711, DOI 10.1089/omi.2016.0135; Chen SY, 2016, BIOMEDICINE-TAIWAN, V6, DOI 10.7603/s40681-016-0007-3; Cohen SL, 1996, ANAL CHEM, V68, P31, DOI 10.1021/ac9507956; FRITZ IB, 1961, PHYSIOL REV, V41, P52, DOI 10.1152/physrev.1961.41.1.52; Guerci B, 2005, DIABETES METAB, V31, P401, DOI 10.1016/S1262-3636(07)70211-2; Hioki Y, 2014, ANAL CHEM, V86, P2549, DOI 10.1021/ac4037069; Howard KL, 2007, ANAL CHEM, V79, P5980, DOI 10.1021/ac0705723; Johnson DT, 2009, AM J PHYSIOL-ENDOC M, V296, pE422, DOI 10.1152/ajpendo.90352.2008; Kouvonen P, 2009, PROTEOMICS, V9, P1662, DOI 10.1002/pmic.200800302; Kuzyk MA, 2009, PROTEOMICS, V9, P3328, DOI 10.1002/pmic.200800412; Leroy B, 2010, PROTEOMICS, V10, P2281, DOI 10.1002/pmic.200900286; Lin SY, 2014, BIOMEDICINE-TAIWAN, V4, P25, DOI 10.7603/s40681-014-0025-y; Lu XY, 2013, FOOD CHEM TOXICOL, V55, P444, DOI 10.1016/j.fct.2013.01.020; Luque-Garcia JL, 2006, ANAL CHEM, V78, P5102, DOI 10.1021/ac060344t; Padliya ND, 2004, PROTEOMICS, V4, P466, DOI 10.1002/pmic.200300567; Paradela A, 2010, TALANTA, V80, P1496, DOI 10.1016/j.talanta.2009.06.083; PRESTON LM, 1993, BIOL MASS SPECTROM, V22, P544, DOI 10.1002/bms.1200220908; Putz SM, 2012, J PROTEOME RES, V11, P2140, DOI 10.1021/pr200881c; Raimondo F, 2013, MOL BIOSYST, V9, P1139, DOI 10.1039/c2mb25396h; Rainczuk A, 2013, J PROTEOME RES, V12, P4074, DOI 10.1021/pr400618v; Schuerenbeg M, 2000, ANAL CHEM, V72, P3436, DOI 10.1021/ac000092a; Sheikh-Ali M, 2008, DIABETES CARE, V31, P643, DOI 10.2337/dc07-1683; Tan HT, 2011, METHODS MOL BIOL, V716, P207, DOI 10.1007/978-1-61779-012-6_13; TEASDALE RD, 1982, AUST J BIOL SCI, V35, P137, DOI 10.1071/BI9820137; Thomas H, 2004, RAPID COMMUN MASS SP, V18, P923, DOI 10.1002/rcm.1427; Turtoi A, 2010, TALANTA, V80, P1487, DOI 10.1016/j.talanta.2009.07.035; Ul Hassan Z, 2012, J SCI FOOD AGR, V92, P1540, DOI 10.1002/jsfa.4740; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Wu YC, 2006, RAPID COMMUN MASS SP, V20, P309, DOI 10.1002/rcm.2269; Xiong SX, 2003, PROTEOMICS, V3, P265, DOI 10.1002/pmic.200390039; ZALESKI J, 1978, BIOCHEM J, V176, P563, DOI 10.1042/bj1760563; Zhang XM, 2007, PROTEOMICS, V7, P2340, DOI 10.1002/pmic.200600184; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	34	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181423	10.1371/journal.pone.0181423	http://dx.doi.org/10.1371/journal.pone.0181423			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738076	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700040
J	Zerbato, C; Furlani, CEA; Ormond, ATS; Girlo, LADS; Carneiro, FM; da Silva, RP				Zerbato, Cristiano; Angeli Furlani, Carlos Eduardo; Santana Ormond, Antonio Tassio; da Silva Girlo, Lucas Augusto; Carneiro, Franciele Morlin; da Silva, Rouverson Pereira		Behalf Lab Agr Machinery Mec	Statistical process control applied to mechanized peanut sowing as a function of soil texture	PLOS ONE			English	Article							SEED	The successful establishment of agricultural crops depends on sowing quality, machinery performance, soil type and conditions, among other factors. This study evaluates the operational quality of mechanized peanut sowing in three soil types (sand, silt, and clay) with variable moisture contents. The experiment was conducted in three locations in the state of Sao Paulo, Brazil. The track-sampling scheme was used for 80 sampling locations of each soil type. Descriptive statistics and statistical process control (SPC) were used to evaluate the quality indicators of mechanized peanut sowing. The variables had normal distributions and were stable from the viewpoint of SPC. The best performance for peanut sowing density, normal spacing, and the initial seedling growing stand was found for clayey soil followed by sandy soil and then silty soil. Sandy or clayey soils displayed similar results regarding sowing depth, which was deeper than in the silty soil. Overall, the texture and the moisture of clayey soil provided the best operational performance for mechanized peanut sowing.	[Zerbato, Cristiano; Angeli Furlani, Carlos Eduardo; Santana Ormond, Antonio Tassio; da Silva Girlo, Lucas Augusto; Carneiro, Franciele Morlin; da Silva, Rouverson Pereira; Behalf Lab Agr Machinery Mec] Sao Paulo State Univ, Dept Agr Engn, Lab Agr Machinery & Mechanizat, Sao Paulo, Brazil	Universidade Estadual Paulista	Zerbato, C (corresponding author), Sao Paulo State Univ, Dept Agr Engn, Lab Agr Machinery & Mechanizat, Sao Paulo, Brazil.	costianozerbato@hotmail.com	da Silva, Rouverson Pereira/ABG-7394-2021; Zerbato, Cristiano/AAG-9129-2019; da Silva Girio, Lucas Augusto/H-4576-2017	da Silva, Rouverson Pereira/0000-0001-8852-2548; Angeli Furlani, Carlos Eduardo/0000-0002-1508-5372; Zerbato, Cristiano/0000-0002-4534-5454; Morlin Carneiro, Franciele/0000-0003-0117-7468; da Silva Girio, Lucas Augusto/0000-0002-2383-9779	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)	CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We wish to thank Universidade Estadual Paulista "Julio de Mesquita Filho" (UNESP/FCAV) and farmers Carlos Mantovani, Neto Carroceiro and Adalberto Trevizolli for their support. Cristiano Zerbato held a scholarship from CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiero D, 2010, DEV EVALUATION CONSE; Assis RL, 2009, ENG AGR, P558; Buol SW, 2011, SOIL GENESIS CLASSIF, P35; Carvalho NM, 2000, SEEDS SCI TECHNOLOGY; Cassia MT, 2013, CIENC RURAL, V43, P28, DOI 10.1590/S0103-84782012005000148; Grotta DCC, 2008, CIENC AGROTEC, V32, P547, DOI 10.1590/S1413-70542008000200031; CIIAGRO, 2015, INT CTR AGR INF; Coelho JLD, 1996, AGR MACHINE TESTING, P551; CONAB, 2015, MON BRAZ HARV GRAIN; EMBRAPA, 1997, MAN SOIL AN METH; Godoy IJ, 2014, REPORT CARD IAC 200, P22; Hiroaki Kurachi S. A., 1989, Bragantia, V48, P249, DOI 10.1590/S0006-87051989000200011; Katikar, 2012, INT J RES ENG APPL S, V2, P1211; Melo RP, 2013, REV CIENC AGRON, V44, P94, DOI 10.1590/S1806-66902013000100012; Melo RP, 2014, BIOENG, V8, P343; Montgomery D.C., 2011, INTRO STAT QUALITY C, V6th; Oliveira JB, 1999, PEDOLOGICAL MAP STAT; Paulini DG, 2009, CULTIVAR MAQUINAS, V85, P30; Pedo T., 2014, Revista Brasileira de Ciencias Agrarias (Agraria), V9, P59, DOI 10.5039/agraria.v9i1a3631; TAYLOR HM, 1991, SOIL TILL RES, V19, P111, DOI 10.1016/0167-1987(91)90080-H; Toledo A, 2009, REVENG, V17, P205; Voltarelli M. A., 2013, Australian Journal of Crop Science, V7, P1396; Zerbato C, 2014, AUST J CROP SCI, V8, P992	23	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180399	10.1371/journal.pone.0180399	http://dx.doi.org/10.1371/journal.pone.0180399			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742095	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700011
J	Nowicki-Osuch, K; Li, YY; Challinor, M; Gerrard, DT; Hanley, NA; Sharrocks, AD				Nowicki-Osuch, Karol; Li, Yaoyong; Challinor, Mairi; Gerrard, David T.; Hanley, Neil A.; Sharrocks, Andrew D.			EINCR1 is an EGF inducible lincRNA overexpressed in lung adenocarcinomas	PLOS ONE			English	Article							LONG NONCODING RNAS; GENE-EXPRESSION; PROSTATE-CANCER; RESPONSE GENES; TRANSCRIPTION; ACTIVATION; LANDSCAPE; DIFFERENTIATION; ALIGNER; PCR	Long non-coding RNAs are being increasingly recognised as important molecules involved in regulating a diverse array of biological functions. For example, many long non-coding RNAs have been associated with tumourigenesis and in this context their molecular functions often involves impacting on chromatin and transcriptional control processes. One important cellular control system that is often deregulated in cancer cells is the ERK MAP kinase pathway. Here we have investigated whether ERK pathway signaling in response to EGF stimulation, leads to changes in the production of long non-coding RNAs. We identify several different classes of EGF pathway-regulated lncRNAs. We focus on one of the inducible lincRNAs, EGF inducible long intergenic non-coding RNA 1 (EINCR1). EINCR1 is predominantly nuclear and shows delayed activation kinetics compared to other immediate-early EGF-inducible genes. In humans it is expressed in a tissue-specific manner and is mainly confined to the heart but it exhibits little evolutionary conservation. Importantly, in several cancers EINCR1 shows elevated expression levels which correlate with poor survival in lung adenocarcinoma patients. In the context of lung adenocarcinomas, EINCR1 expression is anti-correlated with the expression of several protein coding EGF-regulated genes. A potential functional connection is demonstrated as EINCR1 overexpression is shown to reduce the expression of EGF-regulated protein coding genes including FOS and FOSB.	[Nowicki-Osuch, Karol; Li, Yaoyong; Challinor, Mairi; Sharrocks, Andrew D.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci, Manchester, Lancs, England; [Gerrard, David T.; Hanley, Neil A.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Med Sci, Manchester, Lancs, England; [Hanley, Neil A.] Cent Manchester Univ Hosp NHS Fdn Trust, Endocrinol Dept, Manchester, Lancs, England; [Nowicki-Osuch, Karol] Univ Cambridge, MRC Canc Unit, Hutchison MRC Res Ctr, Cambridge, England	University of Manchester; University of Manchester; University of Manchester; University of Cambridge	Sharrocks, AD (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Sch Biol Sci, Manchester, Lancs, England.	andrew.d.sharrocks@manchester.ac.uk	Nowicki-Osuch, Karol/AAC-7872-2022	Nowicki-Osuch, Karol/0000-0003-3828-8620; Gerrard, Dave/0000-0001-6890-7213; Hanley, Neil/0000-0003-3234-4038	Wellcome Trust [WT088566MA]; Infrastructural Strategic Support Fund [WT097820]	Wellcome Trust(Wellcome TrustEuropean Commission); Infrastructural Strategic Support Fund	This work was supported by grants from the Wellcome Trust to ADS and to NAH (WT088566MA), including the Infrastructural Strategic Support Fund (WT097820). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004217; Andrews S, 2013, FASTQC; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Avraham R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000876; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Gerrard DT, 2016, ELIFE, V5, DOI 10.7554/eLife.15657; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Guo HY, 2016, NAT GENET, V48, P1142, DOI 10.1038/ng.3637; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Lin J, 2015, AM J PHYSIOL-RENAL, V309, pF901, DOI 10.1152/ajprenal.00290.2015; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Scherr M, 2001, BIOTECHNIQUES, V31, P520, DOI 10.2144/01313st05; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Vilborg A, 2015, MOL CELL, V59, P449, DOI 10.1016/j.molcel.2015.06.016; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012; 2014, NATURE, V511, P543, DOI DOI 10.1038/NATURE13385	40	1	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181902	10.1371/journal.pone.0181902	http://dx.doi.org/10.1371/journal.pone.0181902			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732076	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100069
J	Kasanke, CP; Leigh, MB				Kasanke, Christopher P.; Leigh, Mary Beth			Factors limiting sulfolane biodegradation in contaminated subarctic aquifer substrate	PLOS ONE			English	Article							NATURAL-GAS PLANT; GROUNDWATER SAMPLES; BACTERIA; SOIL; MINERALIZATION; OXIDATION; SEDIMENTS; CARBON; POPS; IRON	Sulfolane, a water-soluble organosulfur compound, is used industrially worldwide and is associated with one of the largest contaminated groundwater plumes in the state of Alaska. Despite being widely used, little is understood about the degradation of sulfolane in the environment, especially in cold regions. We conducted aerobic and anaerobic microcosm studies to assess the biological and abiotic sulfolane degradation potential of contaminated subarctic aquifer groundwater and sediment from Interior Alaska. We also investigated the impacts of nutrient limitations and hydrocarbon co-contamination on sulfolane degradation. We found that sulfolane underwent biodegradation aerobically but not anaerobically under nitrate, sulfate, or iron-reducing conditions. No abiotic degradation activity was detectable under either oxic or anoxic conditions. Nutrient addition stimulated sulfolane biodegradation in sediment slurries at high sulfolane concentrations (100 mg L-1), but not at low sulfolane concentrations (500 mu g L-1), and nutrient amendments were necessary to stimulate sulfolane biodegradation in incubations containing groundwater only. Hydrocarbon co-contamination retarded aerobic sulfolane biodegradation rates by similar to 30%. Our study is the first to investigate the sulfolane biodegradation potential of subarctic aquifer substrate and identifies several important factors limiting biodegradation rates. We concluded that oxygen is an important factor limiting natural attenuation of this sulfolane plume, and that nutrient amendments are unlikely to accelerate biodegradation within in the plume, although they may biostimulate degradation in ex situ groundwater treatment applications. Future work should be directed at elucidating the identity of indigenous sulfolane-degrading microorganisms and determining their distribution and potential activity in the environment.	[Kasanke, Christopher P.; Leigh, Mary Beth] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Kasanke, CP (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	cpkasanke@alaska.edu			Alaska Department of Environmental Conservation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103395]	Alaska Department of Environmental Conservation; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health	This project was funded by the Alaska Department of Environmental Conservation. Additional support was provided in the form of a graduate research fellowship to C.P.K. and a pilot awardto M.B.L. through an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103395. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatonovic V., 2005, SULFOLANE IMPACTED S; Alfreider A, 1997, WATER RES, V31, P832, DOI 10.1016/S0043-1354(96)00311-9; Angermann B, 2013, TECHNICAL MEMORANDUM; [Anonymous], 2017, 2017 REV ONS CLEAN P; ARCADIS U. S. Inc, 2014, 4 QUART 2013 GROUNDW; Augustin JC, 2000, APPL ENVIRON MICROB, V66, P1706, DOI 10.1128/AEM.66.4.1706-1710.2000; Beyer A, 2014, ELSEV INSIGHT, P557, DOI 10.1016/B978-0-12-800021-2.00025-X; Breivik K, 2004, ENVIRON POLLUT, V128, P3, DOI 10.1016/j.envpol.2003.08.031; Chou C., 1982, P 37 IND WAST C PURD, P559; Einsiedl F, 2015, GEOCHIM COSMOCHIM AC, V156, P207, DOI 10.1016/j.gca.2015.01.014; Fedorak PM, 1996, ENVIRON TECHNOL, V17, P1093, DOI 10.1080/09593331708616478; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; FREDRICKSON AG, 1981, SCIENCE, V213, P972, DOI 10.1126/science.7268409; Gieg LM, 1999, CAN J MICROBIOL, V45, P377, DOI 10.1139/cjm-45-5-377; Gouin T, 2000, ENVIRON SCI TECHNOL, V34, P881, DOI 10.1021/es991011z; Greene EA, 1998, WATER RES, V32, P3680, DOI 10.1016/S0043-1354(98)00139-0; Greene EA, 2001, ENVIRON TECHNOL, V22, P619, DOI 10.1080/09593332208618246; Greene EA, 1998, J MICROBIOL METH, V33, P255, DOI 10.1016/S0167-7012(98)00059-1; Greene EA, 2000, ARCH MICROBIOL, V174, P111, DOI 10.1007/s002030000184; Hamade A., 2014, ALASKA DEP ENV CONSE; Jones KC, 1999, ENVIRON POLLUT, V100, P209, DOI 10.1016/S0269-7491(99)00098-6; Kaiser E.-A., 1994, BODENK, V157, P271; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Kim CG, 1999, ENVIRON ENG RES, V4, P185; Laidler K J, 1979, Methods Enzymol, V63, P234; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McLeod D.W., 1991, P 46 IND WAST C, P99; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; MOSES CO, 1991, GEOCHIM COSMOCHIM AC, V55, P471, DOI 10.1016/0016-7037(91)90005-P; Passman F., 2003, FUEL FUEL SYSTEM MIC; Petersen D, 2012, PROVISIONAL PEER REV; Renewable Natural Resources Foundation, 2006, RENEW RESOUR J, V24, P1; Soto LM, 1998, J CHROMATOGR A, V824, P45, DOI 10.1016/S0021-9673(98)00583-4; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; The R Foundation for Statistical Computing, 2015, R VERS 3 2 1 WORLD F; Thompson CM, 2013, J APPL TOXICOL, V33, P1395, DOI 10.1002/jat.2799; Tindal M, 2006, CANADIAN ENV QUALITY; Valentin L., 2013, HDB ENV CHEM, P1, DOI DOI 10.1007/698_2012_208; van Breukelen BM, 2004, J CONTAM HYDROL, V73, P181, DOI 10.1016/j.jconhyd.2004.01.001; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9	42	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181462	10.1371/journal.pone.0181462	http://dx.doi.org/10.1371/journal.pone.0181462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727811	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500077
J	van Otterdijk, SD; Binder, AM; Szic, KSV; Schwald, J; Michels, KB				van Otterdijk, Sanne D.; Binder, Alexandra M.; Szic, Katarzyna Szarc Vel; Schwald, Julia; Michels, Karin B.			DNA methylation of candidate genes in peripheral blood from patients with type 2 diabetes or the metabolic syndrome	PLOS ONE			English	Article							CAUSES INSULIN-RESISTANCE; EPIGENETIC REGULATION; PANCREATIC-ISLETS; EXPRESSION; CANCER; MUSCLE; HYPERMETHYLATION; SUSCEPTIBILITY; INFLAMMATION; DYSFUNCTION	Introduction The prevalence of type 2 diabetes (T2D) and the metabolic syndrome (MetS) is increasing and several studies suggested an involvement of DNA methylation in the development of these metabolic diseases. This study was designed to investigate if differential DNA methylation in blood can function as a biomarker for T2D and/or MetS. Methods Pyrosequencing analyses were performed for the candidate genes KCNJ11, PPAR., PDK4, KCNQ1, SCD1, PDX1, FTO and PEG3 in peripheral blood leukocytes (PBLs) from 25 patients diagnosed with only T2D, 9 patients diagnosed with T2D and MetS and 11 control subjects without any metabolic disorders. Results No significant differences in gene-specific methylation between patients and controls were observed, although a trend towards significance was observed for PEG3. Differential methylation was observed between the groups in 4 out of the 42 single CpG loci located in the promoters regions of the genes FTO, KCNJ11, PPAR. and PDK4. A trend towards a positive correlation was observed for PEG3 methylation with HDL cholesterol levels. Discussion Altered levels of DNA methylation in PBLs of specific loci might serve as a biomarker for T2D or MetS, although further investigation is required.	[van Otterdijk, Sanne D.; Szic, Katarzyna Szarc Vel; Schwald, Julia; Michels, Karin B.] Univ Med Ctr Freiburg, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [van Otterdijk, Sanne D.; Szic, Katarzyna Szarc Vel] German Canc Consortium DKTK, Freiburg, Germany; [van Otterdijk, Sanne D.; Szic, Katarzyna Szarc Vel] German Canc Res Ctr, Heidelberg, Germany; [Binder, Alexandra M.; Michels, Karin B.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Michels, Karin B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA	University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michels, KB (corresponding author), Univ Med Ctr Freiburg, Inst Prevent & Canc Epidemiol, Freiburg, Germany.; Michels, KB (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.; Michels, KB (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA 02115 USA.	k.michels@ucla.edu			German Cancer consortium (DKTK); German Cancer Research Center (DKFZ)	German Cancer consortium (DKTK); German Cancer Research Center (DKFZ)(Helmholtz Association)	SvO and KSvS were supported by the German Cancer consortium (DKTK) and German Cancer Research Center (DKFZ) institutional funding.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Arner P, 2016, DIABETOLOGIA, V59, P2393, DOI 10.1007/s00125-016-4074-5; Bacos K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11089; Bal A, 2012, VIRCHOWS ARCH, V461, P305, DOI 10.1007/s00428-012-1286-z; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Crepin M, 2012, HUM MUTAT, V33, P180, DOI 10.1002/humu.21617; Dave A V, MUTAGENESIS, V30, P411; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dean CB, 2007, LIFETIME DATA ANAL, V13, P497, DOI 10.1007/s10985-007-9065-x; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Janssen BG, 2014, PLACENTA, V35, P665, DOI 10.1016/j.placenta.2014.06.371; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kulkarni SS, 2012, METABOLISM, V61, P175, DOI 10.1016/j.metabol.2011.06.014; Leclerc D, 2013, CANCER PREV RES, V6, P1171, DOI 10.1158/1940-6207.CAPR-13-0198; Li J, 2016, J DIABETES RES, V2016, DOI DOI 10.1155/2016/5957404; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Liu LM, 2013, DIABETOLOGIA, V56, P2609, DOI 10.1007/s00125-013-3031-9; Liu XQ, 2011, ADV NUTR, V2, P15, DOI 10.3945/an.110.000125; Loke YJ, 2013, TWIN RES HUM GENET, V16, P13, DOI 10.1017/thg.2012.114; Martin-Nunez GM, 2014, MOL NUTR FOOD RES, V58, P1528, DOI 10.1002/mnfr.201400079; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Nilsson E, 2014, DIABETES, V63, P2962, DOI 10.2337/db13-1459; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Petersen AK, 2014, HUM MOL GENET, V23, P534, DOI 10.1093/hmg/ddt430; Phillips T., 2008, NAT ED, V1, P116; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Remely M, 2014, GENE, V537, P85, DOI 10.1016/j.gene.2013.11.081; Reyes S, 2009, HUM GENET, V126, P779, DOI 10.1007/s00439-009-0731-9; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Toperoff G, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0069-1; Toperoff G, 2012, HUM MOL GENET, V21, P371, DOI 10.1093/hmg/ddr472; van Otterdijk SD, 2013, BIOCHEM SOC T, V41, P803, DOI 10.1042/BST20120358; VanderJagt TA, 2015, WORLD J DIABETES, V6, P1113, DOI 10.4239/wjd.v6.i9.1113; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Wheeler JMD, 2000, J MED GENET, V37, P588, DOI 10.1136/jmg.37.8.588; Wren JD, 2005, J BIOMED BIOTECHNOL, P104, DOI 10.1155/JBB.2005.104; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhang S, 2014, PIVOTAL ROLE PYRUVAT, V12, P10; Zhang Y, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-9; Zou L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/721493	50	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180955	10.1371/journal.pone.0180955	http://dx.doi.org/10.1371/journal.pone.0180955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727822	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500034
J	Yao, X; Liu, SQ				Yao, Xiang; Liu, Shiqing			In vitro study of accuracy of subaxial cervical pedicle screw insertion using calipers based on the gravity line	PLOS ONE			English	Article							VERTEBRAL ARTERY INJURY; SPINE SURGERY; CT-SCAN; PLACEMENT; FIXATION; SYSTEM	Object There is a high probability of iatrogenic perforation of the vertebral pedicle wall during the application of subaxial cervical pedicle screw (CPS). The goal of this study was to evaluate the accuracy of CPS insertion at C3-C7 in vitro using novel calipers based on the gravity line. Methods Nine cadaveric cervical spines underwent computed tomography scanning and preoperative design. A lateral fluoroscopic view was taken to measure the intra-operative sagittal angle by C-arm with hanging cross structured K-wires. By referring to the gravity line, caliper A was used to locate the entry point, while caliper B was employed to guide the screw insertion. Postoperative CT scans were performed to assess the accuracy of the screw placements, according to the Neo classification. Results Overall, 78 (88.6%) of the 88 pedicle screw placements were classified as grade 0 (correct position), 4 (4.5%) were grade 1 (non-critical perforation), 4 (4.5%) were grade 2 (critical perforation), and 2 (2.3%) were grade 3 (critical perforation). Conclusions Using our novel calipers and referring to the gravity line was helpful for locating and guiding individual cervical pedicle screw insertions.	[Yao, Xiang; Liu, Shiqing] Wuhan Univ, Renmin Hosp, Dept Orthoped, Wuhan, Hubei, Peoples R China	Wuhan University	Liu, SQ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Orthoped, Wuhan, Hubei, Peoples R China.	liushiqingwuhan@163.com		Yao, Xiang/0000-0003-0813-4591				Abumi K, 2000, SPINE, V25, P962, DOI 10.1097/00007632-200004150-00011; ABUMI K, 1994, J SPINAL DISORD, V7, P19, DOI 10.1097/00002517-199407010-00003; Abumi K, 2012, SPINE, V37, pE349, DOI 10.1097/BRS.0b013e318239cf1f; Chanplakorn P, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-125; Cong Yu, 2015, Med Sci Monit, V21, P2672, DOI 10.12659/MSM.894074; Gupta R, 2013, SURG RADIOL ANAT, V35, P181, DOI 10.1007/s00276-012-1013-0; Jo DJ, 2012, J KOREAN NEUROSURG S, V52, P459, DOI 10.3340/jkns.2012.52.5.459; Kaneyama S, 2015, SPINE, V40, pE341, DOI 10.1097/BRS.0000000000000772; Kantelhardt SR, 2010, ACTA NEUROCHIR, V152, P655, DOI 10.1007/s00701-009-0447-6; Karaikovic EE, 2000, J SPINAL DISORD, V13, P63, DOI 10.1097/00002517-200002000-00013; Kostrzewski S, 2012, INT J MED ROBOT COMP, V8, P184, DOI 10.1002/rcs.446; Kotani T, 2014, ASIAN SPINE J, V8, P331, DOI 10.4184/asj.2014.8.3.331; Lee DH, 2011, EUR SPINE J, V20, P905, DOI 10.1007/s00586-010-1655-8; Ludwig SC, 1999, CLIN ORTHOP RELAT R, P77; Ludwig SC, 2000, SPINE, V25, P1655, DOI 10.1097/00007632-200007010-00009; Mao GP, 2005, SPINE, V30, P1045, DOI 10.1097/01.brs.0000161011.08086.5b; Morishita K, 2008, MED SCI MONITOR, V14, pCR62; Neo M, 2005, SPINE, V30, P2800, DOI 10.1097/01.brs.0000192297.07709.5d; Neo M, 2008, SPINE, V33, P779, DOI 10.1097/BRS.0b013e31816957a7; Park JH, 2014, SPINE, V39, P280, DOI 10.1097/BRS.0000000000000133; Rahmathulla G, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13516; Rao RD, 2008, J BONE JOINT SURG AM, V90A, P1914, DOI 10.2106/JBJS.G.01166; Reinhold M, 2007, EUR SPINE J, V16, P47, DOI 10.1007/s00586-006-0104-1; Schaefer C, 2011, EUR SPINE J, V20, P977, DOI 10.1007/s00586-011-1775-9; Tian W, 2013, EUR SPINE J, V22, P148, DOI 10.1007/s00586-012-2494-6; Tofuku K, 2012, EUR SPINE J, V21, P353, DOI 10.1007/s00586-011-1969-1; Yoshimoto H, 2009, EUR SPINE J, V18, P1326, DOI 10.1007/s00586-009-1109-3; Yukawa Y, 2009, EUR SPINE J, V18, P1293, DOI 10.1007/s00586-009-1032-7; Zheng XJ, 2010, EUR SPINE J, V19, P105, DOI 10.1007/s00586-009-1213-4	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181324	10.1371/journal.pone.0181324	http://dx.doi.org/10.1371/journal.pone.0181324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727778	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500058
J	He, W; Felderman, M; Evans, AC; Geng, J; Homan, D; Bourguet, F; Fischer, NO; Li, YP; Lam, KS; Noy, A; Xing, L; Cheng, RH; Rasley, A; Blanchette, CD; Kamrud, K; Wang, N; Gouvis, H; Peterson, TC; Hubby, B; Coleman, MA				He, Wei; Felderman, Martina; Evans, Angela C.; Geng, Jia; Homan, David; Bourguet, Feliza; Fischer, Nicholas O.; Li, Yuanpei; Lam, Kit S.; Noy, Aleksandr; Xing, Li; Cheng, R. Holland; Rasley, Amy; Blanchette, Craig D.; Kamrud, Kurt; Wang, Nathaniel; Gouvis, Heather; Peterson, Todd C.; Hubby, Bolyn; Coleman, Matthew A.			Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHELATING NANOLIPOPROTEIN PARTICLES; MURIDARUM GENITAL-INFECTION; IMMUNE-RESPONSE; BILAYER NANODISCS; FREE EXPRESSION; LIPID-BILAYERS; TRACHOMATIS; CHALLENGE; PROTECTION; COMPLEX	Chlamydia is a prevalent sexually transmitted disease that infects more than 100 million people worldwide. Although most individuals infected with Chlamydia trachomatis are initially asymptomatic, symptoms can arise if left undiagnosed. Longterm infection can result in debilitating conditions such as pelvic inflammatory disease, infertility, and blindness. Chlamydia infection, therefore, constitutes a significant public health threat, underscoring the need for a Chlamydia-specific vaccine. Chlamydia strains express a major outer-membrane protein (MOMP) that has been shown to be an effective vaccine antigen. However, approaches to produce a functional recombinant MOMP protein for vaccine development are limited by poor solubility, low yield, and protein misfolding. Here, we used an Escherichia coli-based cell-free system to express a MOMP protein from the mouse-specific species Chlamydia muridarum (MoPn-MOMP or mMOMP). The codon-optimized mMOMP gene was co-translated with Delta 49apolipoprotein A1(Delta 49ApoA1), a truncated version of mouse ApoA1 in which the N-terminal 49 amino acids were removed. This co-translation process produced mMOMP supported within a telodendrimer nanolipoprotein particle (mMOMP-tNLP). The cell-free expressed mMOMP-tNLPs contain mMOMP multimers similar to the native MOMP protein. This cell-free process produced on average 1.5 mg of purified, water-soluble mMOMP-tNLP complex in a 1-ml cell-free reaction. The mMOMP-tNLP particle also accommodated the co-localization of CpG oligodeoxynucleotide 1826, a single-stranded synthetic DNA adjuvant, eliciting an enhanced humoral immune response in vaccinated mice. Using our mMOMP-tNLP formulation, we demonstrate a unique approach to solubilizing and administering membrane-bound proteins for future vaccine development. This method can be applied to other previously difficult-to-obtain antigens while maintaining full functionality and immunogenicity.	[He, Wei; Evans, Angela C.; Geng, Jia; Homan, David; Bourguet, Feliza; Fischer, Nicholas O.; Noy, Aleksandr; Rasley, Amy; Blanchette, Craig D.; Coleman, Matthew A.] Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA; [Felderman, Martina; Kamrud, Kurt; Wang, Nathaniel; Gouvis, Heather; Peterson, Todd C.; Hubby, Bolyn] Synthet Genom Vaccine Inc, La Jolla, CA 92037 USA; [Geng, Jia; Noy, Aleksandr] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Li, Yuanpei; Lam, Kit S.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Coleman, Matthew A.] Univ Calif Davis, Radiat Oncol, Sch Med, Sacramento, CA 95817 USA; [Xing, Li; Cheng, R. Holland] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95618 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Coleman, MA (corresponding author), Lawrence Livermore Natl Lab, 7000 East Ave, Livermore, CA 94550 USA.	coleman16@llnl.gov	Geng, Jia/AAR-2192-2021; He, Wei/X-1574-2019; Cheng, Holland/A-8973-2008; Geng, Jia/G-4332-2010; Fischer, Nicholas/AAE-2409-2019	He, Wei/0000-0003-2795-0324; Geng, Jia/0000-0003-4753-1039; Fischer, Nicholas/0000-0001-7575-4390; Bourguet, Feliza/0000-0003-3557-404X; Coleman, Matthew/0000-0003-1389-4018; Rasley, Amy/0000-0002-4767-6628; Noy, Aleksandr/0000-0003-4924-2652	United States Department of Energy [DE-AC52-07NA27344]; NCI, National Institutes of Health [R01CA115483, R01CA199668]; NIAID, National Institutes of Health [R21 RAI120925A]; Synthetic Genomics Vaccine Inc.; NATIONAL CANCER INSTITUTE [R01CA115483, R01CA199668, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120925] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Synthetic Genomics Vaccine Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by United States Department of Energy Contract DE-AC52-07NA27344; NCI, National Institutes of Health Grants R01CA115483 and R01CA199668; and NIAID, National Institutes of Health Grant R21 RAI120925A. M. Felderman, K. Kamrud, N. Wang, H. Gouvis, T.C. Peterson, and B. Hubby are employed by Synthetic Genomics Vaccine Inc. Synthetic Genomics Vaccine Inc. (La Jolla, CA) provided funding under a Work for Others Agreement to Lawrence Livermore National Laboratory. As a funding agency they had no role in study design or data collection and analysis for publication of the data. They do have a financial interest through the development of novel synthetic biology strategies for vaccine development. This does not alter the authors' adherence to all the JBC policies on sharing data and materials. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aistleitner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055010; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2006, ARCH BIOCHEM BIOPHYS, V450, P215, DOI 10.1016/j.abb.2006.03.013; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Blanchette CD, 2010, BIOCONJUGATE CHEM, V21, P1321, DOI 10.1021/bc100129s; Blanchette CD, 2009, BBA-BIOMEMBRANES, V1788, P724, DOI 10.1016/j.bbamem.2008.11.019; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Cappuccio Jenny A., 2009, V498, P273, DOI 10.1007/978-1-59745-196-3_18; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; Coleman MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150166; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10; Feher VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068934; Ferrara LGM, 2016, J MOL BIOL, V428, P4528, DOI 10.1016/j.jmb.2016.09.021; Findlay HE, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-5; Fischer NO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093342; Fischer NO, 2013, J AM CHEM SOC, V135, P2044, DOI 10.1021/ja3063293; Fischer NO, 2009, BIOCONJUGATE CHEM, V20, P460, DOI 10.1021/bc8003155; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; GABAY JE, 1985, J BACTERIOL, V162, P85, DOI 10.1128/JB.162.1.85-91.1985; Gao TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044911; Gao TJ, 2011, PROTEIN SCI, V20, P437, DOI 10.1002/pro.577; Garda HA, 2002, J BIOL CHEM, V277, P19773, DOI 10.1074/jbc.M110089200; Gogol EP, 2013, PROTEIN SCI, V22, P586, DOI 10.1002/pro.2241; Hafner LM, 2014, VACCINE, V32, P1563, DOI 10.1016/j.vaccine.2013.08.020; Haque F, 2013, NAT PROTOC, V8, P373, DOI 10.1038/nprot.2013.001; He W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12896; He W, 2013, PROTEIN SCI, V22, P1078, DOI 10.1002/pro.2292; JONAS A, 1984, J BIOL CHEM, V259, P6369; JONAS A, 1986, METHOD ENZYMOL, V128, P553; Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Lai G, 2015, BIOPHYS CHEM, V197, P47, DOI 10.1016/j.bpc.2015.01.006; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Luo JT, 2010, BIOCONJUGATE CHEM, V21, P1216, DOI 10.1021/bc1000033; MANNING DS, 1993, INFECT IMMUN, V61, P4093, DOI 10.1128/IAI.61.10.4093-4098.1993; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Pal S, 2001, INFECT IMMUN, V69, P6240, DOI 10.1128/IAI.69.10.6240-6247.2001; Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c; Proverbio D, 2013, BBA-BIOMEMBRANES, V1828, P2182, DOI 10.1016/j.bbamem.2013.05.031; Schoborg RV, 2011, MICROBES INFECT, V13, P649, DOI 10.1016/j.micinf.2011.03.004; SONAR S, 1993, BIOCHEMISTRY-US, V32, P13777, DOI 10.1021/bi00213a004; Stratton K. R., 2000, VACCINES 21 CENTURY, P362; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; Sun GF, 2009, VACCINE, V27, P5020, DOI 10.1016/j.vaccine.2009.05.008; Sunahara H, 2007, J AM CHEM SOC, V129, P5597, DOI 10.1021/ja068551y; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; Thomson NR, 2010, FUTURE MICROBIOL, V5, P555, DOI 10.2217/FMB.10.31; Tifrea DF, 2014, J IMMUNOL, V192, P5201, DOI 10.4049/jimmunol.1303392; Tifrea DF, 2011, VACCINE, V29, P4623, DOI 10.1016/j.vaccine.2011.04.065; Weilhammer DR, 2013, BIOMATERIALS, V34, P10305, DOI 10.1016/j.biomaterials.2013.09.038; Wen ZY, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0787-3; Xiao K, 2013, THER DELIV, V4, P1279, DOI [10.4155/tde.13.91, 10.4155/TDE.13.91]; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210	60	18	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15121	15132		10.1074/jbc.M117.784561	http://dx.doi.org/10.1074/jbc.M117.784561			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739800	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000409902100033
J	Chen, G; Wang, W; Chen, HL; Dai, WJ; Peng, XR; Li, XL; Tang, XD; Xu, L; Shen, ZY				Chen, Gong; Wang, Wei; Chen, Hongli; Dai, Weijiang; Peng, Xiangran; Li, Xiaoliang; Tang, Xudong; Xu, Li; Shen, Zhongyuan			Functional characterization of an aquaporin from a microsporidium, Nosema bombycis	PLOS ONE			English	Article							SPORE WALL PROTEIN; WATER; GERMINATION; DISCHARGE; DYNAMICS; INVASION; CHANNELS; PH	Microsporidia are a diverse group of eukaryotic organisms, capable of causing parasitic infections in both vertebrates and invertebrates. During the germination process, there is an increase in the osmotic pressure of microsporidian spores. As part of this study, we cloned a homologous aquaporin gene in Nosema bombycis, and named it Nosema bombycis aquaporin (NbAQP). Sequence analysis revealed that the NbAQP contains an open reading frame with a length of 750 bp and encodes a polypeptide of 249 amino acids. Amino acid sequence homology was greater than 50% that of five aquaporins from other microsporidian species. Indirect immunofluorescence (IFA) and immunogold electron microscopy showed NbAQP to be located predominantly in the spore wall of N. bombycis spores. The results of qRT-PCR analysis revealed that NbAQP expression remained high 0 h after inoculation and decreased sharply to 24 h, increased gradually from 2 days and peaked at 6 days. After expression of NbAQP in Xenopus laevis oocytes, it was observed that NbAQP can promote rapid penetration of water into oocytes. The associated permeation rate was 2-3 times that of the water-injected and uninjected oocytes. Antibody blocking experiments showed that the inhibition rate of spore germination was approximately 28% after antibody blocking. The difference in germination rate between the control group and the NbAQP group was significant (P < 0.05). This study shows for the first time that N. bombycis contains functional water channel proteins and provides a platform suitable for further research into the mechanisms underlying the regulation of NbAQP protein expression. Further study of NbAQP and their inhibitors may have significance for prevention of microsporidiosis.	[Chen, Gong; Wang, Wei; Chen, Hongli; Dai, Weijiang; Peng, Xiangran; Li, Xiaoliang; Tang, Xudong; Xu, Li; Shen, Zhongyuan] Jiangsu Univ Sci & Technol, Zhenjiang, Jiangsu, Peoples R China; [Tang, Xudong; Xu, Li; Shen, Zhongyuan] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Tang, Xudong; Xu, Li; Shen, Zhongyuan] Agr Minist, Key Lab Genet Improvement Silkworm & Mulberry, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences	Shen, ZY (corresponding author), Jiangsu Univ Sci & Technol, Zhenjiang, Jiangsu, Peoples R China.; Shen, ZY (corresponding author), Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China.; Shen, ZY (corresponding author), Agr Minist, Key Lab Genet Improvement Silkworm & Mulberry, Zhenjiang, Jiangsu, Peoples R China.	szysri@163.com			earmarked fund for the China Agriculture Research System	earmarked fund for the China Agriculture Research System	This work was supported by the earmarked fund for the China Agriculture Research System.; This work was supported by the earmarked fund for the China Agriculture Research System. We would like to thank the staffs in the animal center of Jiangsu University to provide helps for animal rearing and surgery. We are also grateful to all who provided the means for us to access free software, which we have used and cited in this article. We would also like to thank all partners and laboratory staff for kindly help and criticism.	Abascal F, 2014, BBA-GEN SUBJECTS, V1840, P1468, DOI 10.1016/j.bbagen.2013.12.001; Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Becnel JJ, 2005, FOLIA PARASIT, V52, P41, DOI 10.14411/fp.2005.006; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; Dietz S, 2011, NEW PHYTOL, V190, P927, DOI 10.1111/j.1469-8137.2011.03651.x; Dong SN, 2010, CURR MICROBIOL, V60, P30, DOI 10.1007/s00284-009-9495-7; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; FRIXIONE E, 1992, CELL MOTIL CYTOSKEL, V22, P38, DOI 10.1002/cm.970220105; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Ghosh K, 2006, INT J PARASITOL, V36, P57, DOI 10.1016/j.ijpara.2005.08.013; Goto SG, 2011, J INSECT PHYSIOL, V57, P1106, DOI 10.1016/j.jinsphys.2011.03.023; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; ISHIHARA R, 1967, CAN J MICROBIOL, V13, P1321, DOI 10.1139/m67-178; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Liu H, 2016, ACTA BIOCH BIOPH SIN, V48, P246, DOI 10.1093/abbs/gmv140; Madeira A, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00003; MEDWID RD, 1984, APPL ENVIRON MICROB, V48, P1067, DOI 10.1128/AEM.48.6.1067-1071.1984; Montalvetti A, 2004, J BIOL CHEM, V279, P38673, DOI 10.1074/jbc.M406304200; Morishita Y, 2005, MOL CELL BIOL, V25, P7770, DOI 10.1128/MCB.25.17.7770-7779.2005; Nehls U, 2014, APPL MICROBIOL BIOT, V98, P8835, DOI 10.1007/s00253-014-6049-0; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; Ohshima K., 1964, ANNOT ZOOL JPN, V37, P102; PLESHINGER J, 1985, J CELL BIOL, V100, P1834, DOI 10.1083/jcb.100.6.1834; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Sao SL, 2015, PLOS ONE, V10; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Southern TR, 2007, EUKARYOT CELL, V6, P1354, DOI 10.1128/EC.00113-07; Turgeman T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150543; Tyerman SD, 2002, PLANT CELL ENVIRON, V25, P173, DOI 10.1046/j.0016-8025.2001.00791.x; UNDEEN AH, 1983, J PROTOZOOL, V30, P274, DOI 10.1111/j.1550-7408.1983.tb02915.x; UNDEEN AH, 1988, J INVERTEBR PATHOL, V52, P84, DOI 10.1016/0022-2011(88)90106-1; Undeen AH, 1999, J INVERTEBR PATHOL, V73, P294, DOI 10.1006/jipa.1998.4834; UNDEEN AH, 1990, J THEOR BIOL, V142, P223, DOI 10.1016/S0022-5193(05)80223-1; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140	39	2	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181703	10.1371/journal.pone.0181703	http://dx.doi.org/10.1371/journal.pone.0181703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749993	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700075
J	Deng, MJ; Dong, YP; Zhao, ZL; Li, YS; Fan, GQ				Deng, Minjie; Dong, Yanpeng; Zhao, Zhenli; Li, Yongsheng; Fan, Guoqiang			Dissecting the proteome dynamics of the salt stress induced changes in the leaf of diploid and autotetraploid Paulownia fortunei	PLOS ONE			English	Article							WATER-DEFICIT; DROUGHT STRESS; ARABIDOPSIS; GENE; PLANT; EXPRESSION; REVEALS; OVEREXPRESSION; MECHANISMS; TOLERANCE	Exposure to high salinity can trigger acclimation in many plants. Such an adaptative response is greatly advantageous for plants and involves extensive reprogramming at the molecular level. Acclimation allows plants to survive in environments that are prone to increasing salinity. In this study, diploid and autotetraploid Paulownia fortunei seedlings were used to detect alterations in leaf proteins in plants under salt stress. Up to 152 differentially abundant proteins were identified by Multiplex run iTRAQ-based quantitative proteomic and LC-MS/MS methods. Bioinformatics analysis suggested that P. fortunei leaves reacted to salt stress through a combination of common responses, such as induced metabolism, signal transduction, and regulation of transcription. This study offers a better understanding of the mechanisms of salt tolerance in P. fortunei and provides a list of potential target genes that could be engineered for salt acclimation in plants, especially trees.	[Deng, Minjie; Dong, Yanpeng; Zhao, Zhenli; Li, Yongsheng; Fan, Guoqiang] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China; [Deng, Minjie; Dong, Yanpeng; Zhao, Zhenli; Li, Yongsheng; Fan, Guoqiang] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China.; Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.	guoqiangfan64@163.com			Fund of the Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Central Financial Forestry Science Promotion Project [GTH [2012]01]; Fund of the Technology Innovation Team Project of Zhengzhou [121PCXTD515]; National Natural Science Foundation of China (NSFC) [U1204309]; Fund of the Research Cooperation Project of Henan Province [152107000097]; Fund of Zhongyuan Scholarship Foundation of Henan Province [122101110700]	Fund of the Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Central Financial Forestry Science Promotion Project; Fund of the Technology Innovation Team Project of Zhengzhou; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fund of the Research Cooperation Project of Henan Province; Fund of Zhongyuan Scholarship Foundation of Henan Province	This work was supported by the Fund of the Transformation Project of the National Agricultural Scientific and Technological Achievement of China (2012GB2D000271), the Central Financial Forestry Science Promotion Project (GTH [2012]01), the Fund of the Technology Innovation Team Project of Zhengzhou (121PCXTD515), the Joint Funds of the National Natural Science Foundation of China (NSFC) (Grant No. U1204309), the Fund of the Research Cooperation Project of Henan Province (Grant No. 152107000097) and the Fund of Zhongyuan Scholarship Foundation of Henan Province (122101110700). we thank Z. W. for his interest and invaluable assistance during this work.	Abraham E, 2010, METHODS MOL BIOL, V639, P317, DOI 10.1007/978-1-60761-702-0_20; Alam I, 2010, PLANT SOIL, V333, P491, DOI 10.1007/s11104-010-0365-7; Chaires M, 2017, J PLANT INTERACT, V12, P128, DOI 10.1080/17429145.2017.1298851; Charkazi F, 2010, PLANT OMICS, V3, P194; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Dong YP, 2014, FUNCT INTEGR GENOMIC, V14, P479, DOI 10.1007/s10142-014-0373-4; Fan GQ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00384; Fan GQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149617; Fan GQ, 2014, INT J MOL SCI, V15, P23141, DOI 10.3390/ijms151223141; Fan HF, 2015, J PROTEOMICS, V125, P54, DOI 10.1016/j.jprot.2015.05.001; Feng K, 2016, SOD GENE FAMILY TOMA, V7, P1279; Fu M, 2014, PLANT CELL PHYSIOL, V55, P1892, DOI 10.1093/pcp/pcu118; Ge XY, 2015, J PROTEOME RES, V14, P268, DOI 10.1021/pr500688g; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Guo HL, 2014, BIORESOURCE TECHNOL, V171, P120, DOI 10.1016/j.biortech.2014.08.035; Hajheidari M, 2005, PROTEOMICS, V5, P950, DOI 10.1002/pmic.200401101; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hoque MA, 2007, J PLANT PHYSIOL, V164, P553, DOI 10.1016/j.jplph.2006.03.010; Hu LX, 2015, PLANT MOL BIOL REP, V33, P56, DOI 10.1007/s11105-014-0722-4; Huang J, 2000, PLANT PHYSIOL, V122, P747, DOI 10.1104/pp.122.3.747; Jiang QY, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600265; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Koh J, 2012, NEW PHYTOL, V196, P292, DOI 10.1111/j.1469-8137.2012.04251.x; Lan P, 2012, MOL CELL PROTEOMICS, V11, P1156, DOI 10.1074/mcp.M112.020461; Li YS, 2014, GENE, V553, P75, DOI 10.1016/j.gene.2014.09.057; Lin XQ, 2013, J PROTEOMICS, V91, P58, DOI 10.1016/j.jprot.2013.06.031; Maiwald D, 2003, PLANT PHYSIOL, V133, P191, DOI 10.1104/pp.103.024190; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Morris PC, 2010, NEW PHYTOL, V188, P641, DOI 10.1111/j.1469-8137.2010.03507.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Ngom M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01331; Orcutt DM, 2000, PHYSL PLANTS STRESS, P30; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Parent B, 2010, PLANT CELL ENVIRON, V33, P1256, DOI 10.1111/j.1365-3040.2010.02145.x; Pinheiro C, 2001, J EXP BOT, V52, P1063, DOI 10.1093/jexbot/52.358.1063; Qiao JJ, 2012, J PROTEOME RES, V11, P5286, DOI 10.1021/pr300504w; Rabey H. E., 2016, INT J GENOMICS, V2016; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Saleh B., 2011, J STRESS PHYSL BIOCH, V7; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; TAIZ L, 1992, J EXP BIOL, V172, P113; Tang Z, 2016, J PLANT GROWTH REGUL, V35, P618, DOI 10.1007/s00344-015-9567-9; Vaidyanathan H, 2003, PLANT SCI, V165, P1411, DOI 10.1016/j.plantsci.2003.08.005; Wei WX, 2001, HEREDITAS, V135, P227; Xiang JH, 2013, PLANT CELL REP, V32, P1795, DOI 10.1007/s00299-013-1492-4; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Zhang XS, 2014, INT J MOL SCI, V15, P5079, DOI 10.3390/ijms15035079; Zhou L, 2015, PLANT PHYSIOL BIOCH, V96, P311, DOI 10.1016/j.plaphy.2015.08.016	51	7	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181937	10.1371/journal.pone.0181937	http://dx.doi.org/10.1371/journal.pone.0181937			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750031	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700102
J	Doukhan, L; Bisbal, M; Chow-Chine, L; Sannini, A; Brun, JP; Cambon, S; Duong, LN; Faucher, M; Mokart, D				Doukhan, Laure; Bisbal, Magali; Chow-Chine, Laurent; Sannini, Antoine; Brun, Jean Paul; Cambon, Sylvie; Lam Nguyen Duong; Faucher, Marion; Mokart, Djamel			Respiratory events in ward are associated with later intensive care unit (ICU) admission and hospital mortality in onco-hematology patients not admitted to ICU after a first request	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CANCER-PATIENTS; DISTRESS-SYNDROME; PROGNOSTIC-FACTORS; DELAYED ADMISSION; OUTCOMES; DETERIORATION; DETERMINANTS; PREDICTORS; DECISIONS	Introduction Prognostic impact of delayed intensive care unit(ICU) admission in critically ill cancer patients remains debatable. We determined predictive factors for later ICU admission and mortality in cancer patients initially not admitted after their first ICU request. Methods All cancer patients referred for an emergency ICU admission between 1 January 2012 and 31 August 2013 were included. Results Totally, 246(54.8%) patients were immediately admitted. Among 203(45.2%) patients denied at the first request, 54(26.6%) were admitted later. A former ICU stay [OR: 2.75 (1.12-6.75)], a request based on a clinical respiratory event[OR: 2.6(1.35-5.02)] and neutropenia[OR: 2.25(1.06-4.8)] were independently associated with later ICU admission. Survival of patients admitted immediately and later did not differ at ICU(78.5% and 70.4%, respectively; p = 0.2) or hospital(74% and 66%, respectively; p = 0.24) discharge. Hospital mortality of patients initially not admitted was 29.7% and independently associated with malignancy progression[OR: 3.15(1.6-6.19)], allogeneic hematopoietic stem cell transplantation[OR: 2.5(1.06-5.89)], a request based on a clinical respiratory event[OR: 2.36(1.22-4.56)] and severe sepsis[OR: 0.27(0.08-0.99)]. Conclusion Compared with immediate ICU admission, later ICU admission was not associated with hospital mortality. Clinical respiratory events were independently associated with both later ICU admission and hospital mortality.	[Doukhan, Laure; Bisbal, Magali; Chow-Chine, Laurent; Sannini, Antoine; Brun, Jean Paul; Cambon, Sylvie; Lam Nguyen Duong; Faucher, Marion; Mokart, Djamel] Inst Paoli Calmettes, Intens Care Unit, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC)	Mokart, D (corresponding author), Inst Paoli Calmettes, Intens Care Unit, Marseille, France.	MOKARTD@ipc.unicancer.fr		BISBAL, MAGALI/0000-0001-6571-0861				Azoulay E, 2003, CRIT CARE MED, V31, P428, DOI 10.1097/01.CCM.0000048622.01013.88; Azoulay E, 2002, CRIT CARE MED, V30, P781, DOI 10.1097/00003246-200204000-00010; Azoulay E, 2000, INTENS CARE MED, V26, P1817, DOI 10.1007/s001340051350; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Azoulay E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-5; Azoulay E, 2010, CRIT CARE, V14, DOI 10.1186/cc8198; Cardoso LTQ, 2011, CRIT CARE, V15, DOI 10.1186/cc9975; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chaoui D, 2004, LEUKEMIA, V18, P670, DOI 10.1038/sj.leu.2403270; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen J, 2009, CRIT CARE MED, V37, P148, DOI 10.1097/CCM.0b013e3181928ce3; Cretikos MA, 2008, MED J AUSTRALIA, V188, P657; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Garrouste-Orgeas M, 2005, CRIT CARE MED, V33, P750, DOI 10.1097/01.CCM.0000157752.26180.F1; Garrouste-Orgeas M, 2003, INTENS CARE MED, V29, P774, DOI 10.1007/s00134-003-1709-z; Hampshire PA, 2009, CRIT CARE, V13, DOI 10.1186/cc8016; Jackson K, 2014, LEUKEMIA LYMPHOMA, V55, P97, DOI 10.3109/10428194.2013.796045; Jones DA, 2011, NEW ENGL J MED, V365, P139, DOI 10.1056/NEJMra0910926; Karlin L, 2005, BONE MARROW TRANSPL, V36, P245, DOI 10.1038/sj.bmt.1705037; Kuijsten HAJM, 2010, INTENS CARE MED, V36, P1765, DOI 10.1007/s00134-010-1918-1; Lee DS, 2015, CRIT CARE MED, V43, P1439, DOI 10.1097/CCM.0000000000000989; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Louriz M, 2012, INTENS CARE MED, V38, P830, DOI 10.1007/s00134-012-2517-0; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mokart D, 2015, INTENS CARE MED, V41, P296, DOI 10.1007/s00134-014-3615-y; Mokart D, 2013, LEUKEMIA LYMPHOMA, V54, P1724, DOI 10.3109/10428194.2012.753446; Mokart D, 2012, EUR RESPIR J, V40, P169, DOI 10.1183/09031936.00150611; O'Callaghan DJP, 2012, CRIT CARE, V16, DOI 10.1186/cc11650; Robert R, 2012, AM J RESP CRIT CARE, V185, P1081, DOI 10.1164/rccm.201104-0729OC; Rouby JJ, 2000, INTENS CARE MED, V26, P1046, DOI 10.1007/s001340051317; Soares M, 2010, CRIT CARE CLIN, V26, P41, DOI 10.1016/j.ccc.2009.09.005; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Song JU, 2012, INTENS CARE MED, V38, P1505, DOI 10.1007/s00134-012-2594-0; Staudinger T, 2000, CRIT CARE MED, V28, P1322, DOI 10.1097/00003246-200005000-00011; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487; Young MP, 2003, J GEN INTERN MED, V18, P77, DOI 10.1046/j.1525-1497.2003.20441.x	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e181808	10.1371/journal.pone.0181808	http://dx.doi.org/10.1371/journal.pone.0181808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749989	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700083
J	Pettazzoni, M; Froissart, R; Pagan, C; Vanier, MT; Ruet, S; Latour, P; Guffon, N; Fouilhoux, A; Germain, DP; Levade, T; Vianey-Saban, C; Piraud, M; Cheillan, D				Pettazzoni, Magali; Froissart, Roseline; Pagan, Cecile; Vanier, Marie T.; Ruet, Severine; Latour, Philippe; Guffon, Nathalie; Fouilhoux, Alain; Germain, Dominique P.; Levade, Thierry; Vianey-Saban, Christine; Piraud, Monique; Cheillan, David			LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASES; DRIED BLOOD SPOTS; GLOBOID-CELL LEUKODYSTROPHY; ENZYME REPLACEMENT THERAPY; GAUCHER-DISEASE; FABRY DISEASE; CHITOTRIOSIDASE; PSYCHOSINE; DIAGNOSIS; GENE	Background The biological diagnosis of sphingolipidoses currently relies on the measurement of specific enzymatic activities and/or genetic studies. Lysosphingolipids have recently emerged as potential biomarkers of sphingolipidoses and Niemann-Pick type C in plasma. Methodology We developed a sensitive and specific method enabling the simultaneous quantification of lysosphingolipids by LC-MS/MS: lysoglobotriaosylceramide for Fabry disease, lysohexosylceramide (i.e. lysoglucosylceramide and/or lysogalactosylceramide) for Gaucher and Krabbe diseases, lysosphingomyelin and its carboxylated analogue lysosphingomyelin-509 for Niemann-Pick type A or B, and C diseases, lysoGM1 ganglioside for GM1gangliosidosis and lysoGM2 ganglioside for GM2 gangliosidosis. Findings The diagnostic performances were validated in plasma samples analysing a large series of patients affected with sphingolipidoses and Niemann-Pick type C disease (n = 98), other inborn errors of metabolism (n = 23), and controls (n = 228). The multiplex measurement of lysosphingolipids allowed the screening of Fabry (including female patients and late-onset variants), Gaucher and infantile Krabbe, Niemann-Pick type A/B and C diseases with high sensitivity and specificity. LysoGM1 and LysoGM2 were elevated in most of the patients affected with GM1 and GM2 gangliosidosis respectively. In amniotic fluid supernatant from pregnancies presenting non-immune hydrops fetalis (n = 77, including previously diagnosed Gaucher (n = 5), GM1 gangliosidosis (n = 4) and galactosialidosis (n = 4) fetuses) and from normal pregnancies (n = 15), a specific and dramatic increase of lysohexosylceramide was observed only in the Gaucher amniotic fluid samples. Interpretation This multiplex assay which allows the simultaneous measurement of lysosphingolipids in plasma modifies the diagnostic strategy of sphingolipidoses and Niemann-Pick type C. Furthermore, in pregnancies presenting non-immune hydrops fetalis, lysohexosylceramide measurement in amniotic fluid offers a rapid screening of fetal Gaucher disease without waiting for glucocerebrosidase activity measurement in cultured amniocytes.	[Pettazzoni, Magali; Froissart, Roseline; Pagan, Cecile; Vanier, Marie T.] Hospices Civils Lyon, Ctr Biol & Pathol Est, Serv Biochim & Biol Mol Grand Est, Bron, France; [Pagan, Cecile; Latour, Philippe] Univ Claude Bernard Lyon 1, CNRS, Lyon, France; [Pagan, Cecile; Latour, Philippe; Guffon, Nathalie] INSERM, Lyon, France; [Pagan, Cecile; Vanier, Marie T.; Ruet, Severine] Hospices Civils Lyon, Ctr Biol & Pathol Est, Laboratoire Gillet Me rieux, Bron, France; [Vanier, Marie T.; Guffon, Nathalie; Fouilhoux, Alain] Hospices Civils Lyon, Ctr Biol & Pathol Est, Serv Biochimie & Biol Mol Grand Est, Unite Med Pathol Neurolog & cardiolog, Bron, France; [Pagan, Cecile; Guffon, Nathalie; Germain, Dominique P.] Hospices Civils Lyon, Bron, France; [Pagan, Cecile; Guffon, Nathalie; Germain, Dominique P.] Univ Versailles, Ctr Hosp Univ Toulouse, Montigny, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; CHU de Toulouse; UDICE-French Research Universities; Universite Paris Saclay	Pettazzoni, M (corresponding author), Hospices Civils Lyon, Ctr Biol & Pathol Est, Serv Biochim & Biol Mol Grand Est, Bron, France.	magali.pettazzoni@chu-lyon.fr	Carmen, Team1/Y-7382-2019; GERMAIN, Dominique P./AAD-6747-2020	Carmen, Team1/0000-0003-4234-1746; Lab, Carmen/0000-0002-5935-3236; cheillan, david/0000-0001-9535-2567				Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Boscaro F, 2002, RAPID COMMUN MASS SP, V16, P1507, DOI 10.1002/rcm.728; Boutin M, 2012, CLIN CHIM ACTA, V414, P273, DOI 10.1016/j.cca.2012.09.026; Burin MG, 2004, PRENATAL DIAG, V24, P653, DOI 10.1002/pd.967; Choi L, 2015, NEUROSCI LETT, V594, P163, DOI 10.1016/j.neulet.2015.01.084; Chuang WL, 2014, MOL GENET METAB, V111, P209, DOI 10.1016/j.ymgme.2013.11.012; Chuang WL, 2013, CLIN CHIM ACTA, V419, P73, DOI 10.1016/j.cca.2013.01.017; Colin E, 2016, JIMD REP, V28, P105, DOI 10.1007/8904_2015_516; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; Echevarria L, 2016, CLIN GENET, V89, P44, DOI 10.1111/cge.12613; El-Najjar N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140683; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Farfel-Becker T, 2014, HUM MOL GENET, V23, P843, DOI 10.1093/hmg/ddt468; Ferraz MJ, 2016, MOL GENET METAB, V117, P186, DOI 10.1016/j.ymgme.2015.12.006; Ferraz MJ, 2014, BBA-MOL CELL BIOL L, V1841, P811, DOI 10.1016/j.bbalip.2013.11.004; Germain DP, 2016, NEW ENGL J MED, V375, P545, DOI 10.1056/NEJMoa1510198; Giese AK, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0274-1; Gieselmann V, 2010, NEUROPEDIATRICS, V41, P1, DOI 10.1055/s-0030-1253412; Gimovsky AC, 2015, AM J OBSTET GYNECOL, V212, P281, DOI 10.1016/j.ajog.2014.10.007; IGISU H, 1988, LIPIDS, V23, P345, DOI 10.1007/BF02537346; Kattner E, 1997, EUR J PEDIATR, V156, P292, DOI 10.1007/s004310050603; Kodama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029074; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Krabbe JE, 1980, J LIPIDRES, V21, P53; Kuchar L, 2017, ANAL BIOCHEM, V17, P30099; Lloyd-Evans E, 2003, BIOCHEM J, V375, P561, DOI 10.1042/BJ20030613; Malagarie-Cazenave Sophie, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200546X; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Mirzaian M, 2017, CLIN CHIM ACTA, V466, P178, DOI 10.1016/j.cca.2017.01.014; Mirzaian M, 2015, J LIPID RES, V56, P936, DOI 10.1194/jlr.M057232; MIYATAKE T, 1972, BIOCHEM BIOPH RES CO, V48, P538, DOI 10.1016/0006-291X(72)90381-6; Motta M, 2016, CLIN GENET, V90, P220, DOI 10.1111/cge.12753; Murugesan V, 2016, AM J HEMATOL, V91, P1082, DOI 10.1002/ajh.24491; Niemann M, 2014, CIRC-CARDIOVASC GENE, V7, P8, DOI 10.1161/CIRCGENETICS.113.000249; Oder D, 2016, NEPHRON, V134, P30, DOI 10.1159/000448968; Piraud M, 2010, REV MED INTERNE, V31, pS270, DOI 10.1016/S0248-8663(10)70026-6; Piraud M, 1996, CLIN CHIM ACTA, V248, P143, DOI 10.1016/0009-8981(95)06250-5; Polo G, 2016, CLIN CHEM LAB MED, V17; Raymond K.M., 2015, J INHERIT METAB D S1, V38, pS36; Ries M, 2006, J INHERIT METAB DIS, V29, P647, DOI 10.1007/s10545-006-0363-3; Rolfs A, 2013, PLOS ONE, V8; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Smid BE, 2015, J MED GENET, V52, P262, DOI 10.1136/jmedgenet-2014-102872; Spassieva S, 2016, J NEUROSCI RES, V94, P974, DOI 10.1002/jnr.23888; Spiegel R, 2009, AM J MED GENET A, V149A, P446, DOI 10.1002/ajmg.a.32642; Turgeon CT, 2015, J INHERIT METAB DIS, V38, P923, DOI 10.1007/s10545-015-9822-z; Vanier MT, 2016, MOL GENET METAB, V118, P244, DOI 10.1016/j.ymgme.2016.06.004; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vedder AC, 2006, MOL GENET METAB, V89, P239, DOI 10.1016/j.ymgme.2006.04.013; Vianey-Saban C, 2016, J INHERIT METAB DIS, V39, P611, DOI 10.1007/s10545-016-9947-8; Wajner A, 2007, CLIN BIOCHEM, V40, P365, DOI 10.1016/j.clinbiochem.2006.12.003; Welford RWD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114669; Yue HW, 2015, BBA-MOL CELL BIOL L, V1851, P1186, DOI 10.1016/j.bbalip.2015.04.001	54	42	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181700	10.1371/journal.pone.0181700	http://dx.doi.org/10.1371/journal.pone.0181700			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749998	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700074
J	Rossi, DM; Pedroni, CR; Martins, J; de Oliveira, AS				Rossi, Denise Martineli; Pedroni, Cristiane Rodrigues; Martins, Jaqueline; de Oliveira, Anamaria Siriani			Intrarater and interrater reliability of three classifications for scapular dyskinesis in athletes	PLOS ONE			English	Article							CLINICAL-ASSESSMENT; KINEMATICS	Clinical evaluation of scapular dyskinesis (SD) aims to identify abnormal scapulothoracic movement, underlying causal factors, and the potential relationship with shoulder symptoms. The literature proposes different methods of dynamic clinical evaluation of SD, but improved reliability and agreement values are needed. The present study aimed to evaluate the intrarater and interrater agreement and reliability of three SD classifications: 1) 4-type classification, 2) Yes/No classification, and 3) scapular dyskinesis test (SDT). Seventy-five young athletes, including 45 men and 30 women, were evaluated. Raters evaluated the SD based on the three methods during one series of 8-10 cycles (at least eight and maximum of ten) of forward flexion and abduction with an external load under the observation of two raters trained to diagnose SD. The evaluation protocol was repeated after 3 h for intrarater analysis. The agreement percentage was calculated by dividing the observed agreement by the total number of observations. Reliability was calculated using Cohen Kappa coefficient, with a 95% confidence interval (CI), defined by Kappa coefficient +/- 1.96 multiplied by the measurement standard error. The interrater analyses showed an agreement percentage between 80% and 95.9% and an almost perfect reliability (k>0.81) for the three classification methods in all the test conditions, except the 4-type and SDT classification methods, which had substantial reliability (k<0.80) in shoulder abduction. Intrarater analyses showed agreement percentages between 80.7% and 89.3% and substantial reliability (0.67 to 0.81) for both raters in the three classifications. CIs ranged from moderate to almost perfect categories. This indicates that the three SD classification methods investigated in this study showed high reliability values for both intrarater and interrater evaluation throughout a protocol that provided SD evaluation training of raters and included several repetitions of arm movements with external load during a live assessment.	[Rossi, Denise Martineli; Martins, Jaqueline; de Oliveira, Anamaria Siriani] Univ Sao Paulo, Dept Biomech Med & Locomotor Apparat Rehabil, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Pedroni, Cristiane Rodrigues] Sao Paulo State Univ, Dept Physiotherapy & Occupat Therapy, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	de Oliveira, AS (corresponding author), Univ Sao Paulo, Dept Biomech Med & Locomotor Apparat Rehabil, Ribeirao Preto Med Sch, Sao Paulo, Brazil.	siriani@fmrp.usp.br	de Oliveira, Anamaria Siriani/S-6609-2019; Rossi, Denise/M-9163-2014; Rossi, Denise Martineli/K-3788-2019; martins, jaqueline/C-8145-2012; Martins, Jaqueline/AAJ-2608-2021; PEDRONI, CRISTIANE/H-7043-2018	de Oliveira, Anamaria Siriani/0000-0001-5854-0016; Rossi, Denise/0000-0003-0037-3387; Rossi, Denise Martineli/0000-0003-0037-3387; martins, jaqueline/0000-0002-7601-3209; Martins, Jaqueline/0000-0002-7601-3209; PEDRONI, CRISTIANE/0000-0001-6907-3345				Ben Kibler W, 2006, ATHLET THER TODAY, V11, P6; Ben Kibler W, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2013-092425; Ben Kibler W, 2002, J SHOULDER ELB SURG, V11, P550, DOI 10.1067/mse.2002.126766; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; D'hondt NE, 2016, PHYS THER, P96; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Huang TS, 2015, J SHOULDER ELB SURG, V24, P1227, DOI 10.1016/j.jse.2014.12.022; Huang TS, 2015, MANUAL THER, V20, P427, DOI 10.1016/j.math.2014.10.017; Kebaetse M, 1999, ARCH PHYS MED REHAB, V80, P945, DOI 10.1016/S0003-9993(99)90088-6; Kibler WB, 2010, BRIT J SPORT MED, V44, P300, DOI 10.1136/bjsm.2009.058834; Kibler WB, 2012, J AM ACAD ORTHOP SUR, V20, P364, DOI 10.5435/JAAOS-20-06-364; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Larsen CM, 2014, PHYSIOTHER THEOR PR, V30, P453, DOI 10.3109/09593985.2014.899414; McClure P, 2009, J ATHL TRAINING, V44, P160, DOI 10.4085/1062-6050-44.2.160; Struyf F, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2012-091059; Struyf F, 2009, J ATHL TRAINING, V44, P519, DOI 10.4085/1062-6050-44.5.519; Uhl TL, 2009, ARTHROSCOPY, V25, P1240, DOI 10.1016/j.arthro.2009.06.007; Willmore Elaine G, 2016, Shoulder Elbow, V8, P61, DOI 10.1177/1758573215618857; Wright AA, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2012-091573	20	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181518	10.1371/journal.pone.0181518	http://dx.doi.org/10.1371/journal.pone.0181518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749966	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700051
J	Evans, D; Schnippel, K; Govathson, C; Sineke, T; Black, A; Long, L; Berhanu, R; Rosen, S				Evans, Denise; Schnippel, Kathryn; Govathson, Caroline; Sineke, Tembeka; Black, Andrew; Long, Lawrence; Berhanu, Rebecca; Rosen, Sydney			Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa	PLOS ONE			English	Article							CARE-SEEKING; DISTANCE	Background In South Africa, roughly half of the drug-resistant TB cases diagnosed are reported to have been started on treatment. We determined the proportion of persons diagnosed with rifampicin resistant (RR-) TB who initiated treatment in Johannesburg after the introduction of decentralized RR-TB care in 2011. Methods We retrospectively matched adult patients diagnosed with laboratory-confirmed RR-TB in Johannesburg from 07/2011-06/2012 with records of patients initiating RR-TB treatment at one of the city's four public sector treatment sites (one centralized, three decentralized). Patients were followed from date of diagnosis until the earliest of RR-TB treatment initiation, death, or 6 months' follow-up. We report diagnostic methods and outcomes, proportions initiating treatment, and median time from diagnosis to treatment initiation. Results 594 patients were enrolled (median age 34 (IQR 29-42), 287 (48.3%) female). Diagnosis was by GenoType MTBDRplus (Hain-Life-Science) line probe assay (LPA) (281, 47.3%), Xpert MTB/RIF (Cepheid) (258, 43.4%), or phenotypic drug susceptibility testing (DST) (30, 5.1%) with 25 (4.2%) missing a diagnosis method. 320 patients (53.8%) had multi-drug resistant TB, 158 (26.6%) rifampicin resistant TB by Xpert MTB/RIF, 102 (17.2%) rifampicin mono-resistance, and 14 (2.4%) extensively drug-resistant TB. 256/594 (43.0%) patients initiated treatment, representing 70.7% of those who were referred for treatment (362/594). 338/594 patients (57.0%) did not initiate treatment, including 104 (17.5%) who died before treatment was started. The median time from sputum collection to treatment initiation was 33 days (IQR 12-52). Conclusion Despite decentralized RR-TB treatment, fewer than half the patients diagnosed in Johannesburg initiated appropriate treatment. Offering treatment at decentralized sites alone is not sufficient; improvements in linking patients diagnosed with RR- TB to effective treatment is essential.	[Evans, Denise; Schnippel, Kathryn; Govathson, Caroline; Sineke, Tembeka; Long, Lawrence; Rosen, Sydney] Univ Witwatersrand, Fac Hlth Sci, Hlth Econ & Epidemiol Res Off, Dept Internal Med,Sch Clin Med, Johannesburg, South Africa; [Schnippel, Kathryn] Right Care, Johannesburg, South Africa; [Schnippel, Kathryn] Univ Witwatersrand, Fac Hlth Sci, Clin HIV Res Unit, Dept Internal Med,Sch Clin Med, Johannesburg, South Africa; [Black, Andrew] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa; [Berhanu, Rebecca] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA; [Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of North Carolina; University of North Carolina Chapel Hill; Boston University	Evans, D (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Hlth Econ & Epidemiol Res Off, Dept Internal Med,Sch Clin Med, Johannesburg, South Africa.	devans@heroza.org	; Evans, Denise/C-8454-2018	Berhanu, Rebecca/0000-0002-9692-8748; Rosen, Sydney/0000-0002-6560-2964; Long, Lawrence/0000-0003-4986-4988; Schnippel, Kathryn/0000-0003-0757-4325; Evans, Denise/0000-0003-0698-1228	South Africa Mission of the US Agency for International Development (USAID) [674-A-12-00029]; USAID [674-A-12-00020, 674-12-00002]; USAID	South Africa Mission of the US Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	DE, TS, CG, RB, SR and LL are supported through the South Africa Mission of the US Agency for International Development (USAID) under the terms of cooperative agreement 674-A-12-00029 to the Health Economics and Epidemiology Research Office. KS and RB were supported by a cooperative agreement from the USAID to Right to Care 674-A-12-00020. AB was supported by USAID cooperative agreement number 674-12-00002 to Wits Reproductive Health and HIV Research Institute. This study was made possible by the generous support of the American people through USAID. The contents of the article are the responsibility of the authors and do not necessarily reflect the views of USAID or the Unites States Government. The funders had no role in the study design, collection, analysis and interpretation of the data, in manuscript preparation or the decision to publish.	Ardizzoni E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144656; Aye R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-10; Barker RD, 2002, INT J TUBERC LUNG D, V6, P98; Berhanu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164974; Bosworth B., 2014, S AFRICA BATTLES DRU; Cai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120088; Chen CC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1228-x; Cox H, 2015, 46 UN WORLD C LUNQ H; Cox H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002238; Cox HS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv014; Cremers AL, 2013, PUBLIC HEALTH ACTION, V3, P328, DOI 10.5588/pha.13.0038; De Lima YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049140; Eliseev P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152761; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finnie RKC, 2011, INT Q COMMUNITY HEAL, V31, P3, DOI 10.2190/IQ.31.1.b; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Harris RC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1524-0; Heinze G., SAS MACRO PSHREG; Jacobson KR, 2013, CLIN INFECT DIS, V56, P503, DOI 10.1093/cid/cis920; Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099; Lin CY, 2010, J FORMOS MED ASSOC, V109, P269, DOI 10.1016/S0929-6646(10)60052-6; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Malqvist M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-762; Mwansa-Kambafwile J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168659; National Department of Health, 2014, NAT TB MAN GUID; National Department of Health (NDoH), 2011, MULT RES TUB POL FRA; Ng E, 1993, Health Rep, V5, P179; NHLS, GEN XPERT NAT PRIOR; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Shisana O., 2012, INCIDENCE BEHAV SURV INCIDENCE BEHAV SURV; Stevens WS, 2015, INT J TUBERC LUNG D, V19, P216, DOI 10.5588/ijtld.14.0565; Sullivan BJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1290317; Tadesse, 2016, PLOS ONE, V11; The National Department of Health, 2009, NAT TUB MAN GUID, P117; Umanah TA, 2015, T ROY SOC TROP MED H, V109, P340, DOI 10.1093/trstmh/trv025; WHO, 2016, GLOB TUB REP; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2014, GLOB TUB REP	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181238	10.1371/journal.pone.0181238	http://dx.doi.org/10.1371/journal.pone.0181238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746344	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800031
J	Sharma, M; An, DS; Liu, T; Pinnock, T; Cheng, F; Voordouw, G				Sharma, Mohita; An, Dongshan; Liu, Tao; Pinnock, Tijan; Cheng, Frank; Voordouw, Gerrit			Biocide-mediated corrosion of coiled tubing	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; Q235 CARBON-STEEL; DESULFOVIBRIO-DESULFURICANS; MICROBIAL COMMUNITIES; PITTING CORROSION; STAINLESS-STEEL; BEHAVIOR; BIOFILM	Coiled tubing corrosion was investigated for 16 field water samples (S5 to S20) from a Canadian shale gas field. Weight loss corrosion rates of carbon steel beads incubated with these field water samples averaged 0.2 mm/yr, but injection water sample S19 had 1.25 +/- 0.07 mm/yr. S19 had a most probable number of zero acid-producing bacteria and incubation of S19 with carbon steel beads or coupons did not lead to big changes in microbial community composition. In contrast other field water samples had most probable numbers of APB of 10 2 /mL to 10(7)/mL and incubation of these field water samples with carbon steel beads or coupons often gave large changes in microbial community composition. HPLC analysis indicated that all field water samples had elevated concentrations of bromide (average 1.6 mM), which may be derived from bronopol, which was used as a biocide. S19 had the highest bromide concentration (4.2 mM) and was the only water sample with a high concentration of active bronopol (13.8 mM, 2760 ppm). Corrosion rates increased linearly with bronopol concentration, as determined by weight loss of carbon steel beads, for experiments with S19, with filtered S19 and with bronopol dissolved in defined medium. This indicated that the high corrosion rate found for S19 was due to its high bronopol concentration. The corrosion rate of coiled tubing coupons also increased linearly with bronopol concentration as determined by electrochemical methods. Profilometry measurements also showed formation of multiple pits on the surface of coiled tubing coupon with an average pit depth of 60 mu m after 1 week of incubation with 1 mM bronopol. At the recommended dosage of 100 ppm the corrosiveness of bronopol towards carbon steel beads was modest (0.011 mm/yr). Higher concentrations, resulting if biocide is added repeatedly as commonly done in shale gas operations, are more corrosive and should be avoided. Overdosing may be avoided by assaying the presence of residual biocide by HPLC, rather than by assaying the presence of residual surviving bacteria.	[Sharma, Mohita; An, Dongshan; Pinnock, Tijan; Voordouw, Gerrit] Univ Calgary, Petr Microbiol Res Grp, Dept Biol Sci, Calgary, AB, Canada; [Liu, Tao; Cheng, Frank] Univ Calgary, Dept Mech & Mfg Engn, Calgary, AB, Canada	University of Calgary; University of Calgary	Voordouw, G (corresponding author), Univ Calgary, Petr Microbiol Res Grp, Dept Biol Sci, Calgary, AB, Canada.	voordouw@ucalgary.ca	Voordouw, Gerrit/F-5327-2013	Cheng, Frank Y./0000-0002-3379-1828	NSERC Industrial Research Chair in Petroleum Microbiology; BP America Production Co.; Baker Hughes Canada; Computer Modeling Group Limited; ConocoPhillips Company; Dow Microbial Control; Enbridge; Enerplus Corporation; Intertek; Oil Search (PNG) Limited; Shell Global Solutions International; Suncor Energy Inc.; Yara Norge AS; Alberta Innovates; STEP Energy Services; National Oilwell Varco; Fusion Technologies Inc	NSERC Industrial Research Chair in Petroleum Microbiology; BP America Production Co.; Baker Hughes Canada; Computer Modeling Group Limited; ConocoPhillips Company; Dow Microbial Control; Enbridge; Enerplus Corporation; Intertek; Oil Search (PNG) Limited; Shell Global Solutions International; Suncor Energy Inc.; Yara Norge AS; Alberta Innovates; STEP Energy Services; National Oilwell Varco; Fusion Technologies Inc	This work was supported by an NSERC Industrial Research Chair in Petroleum Microbiology Award to GV, as well as by BP America Production Co., Baker Hughes Canada, Computer Modeling Group Limited, ConocoPhillips Company, Dow Microbial Control, Enbridge, Enerplus Corporation, Intertek, Oil Search (PNG) Limited, Shell Global Solutions International, Suncor Energy Inc., Yara Norge AS and Alberta Innovates. STEP Energy Services, National Oilwell Varco and Fusion Technologies Inc also supported this work and provided the field samples. Field operators from Fusion technologies Inc. collected the samples from the field and delivered them to our lab. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This work was supported by an NSERC Industrial Research Chair in Petroleum Microbiology Award to GV, as well as by BP America Production Co., Baker Hughes Canada, Computer Modeling Group Limited, ConocoPhillips Company, Dow Microbial Control, Enbridge, Enerplus Corporation, Intertek, Oil Search (PNG) Limited, Shell Global Solutions International, Suncor Energy Inc., Yara Norge AS and Alberta Innovates. STEP Energy Services, National Oilwell Varco and Fusion Technologies Inc also supported this work and provided the field samples. We thank Yin Shen and Dr. Shicliang Chen for technical support and Dr. Rhonda Clark for administrative support.	Ahmadun FR, 2009, J HAZARD MATER, V170, P530, DOI 10.1016/j.jhazmat.2009.05.044; AlAbbas FM, 2013, J MATER ENG PERFORM, V22, P3517, DOI 10.1007/s11665-013-0627-7; Amin MA, 2007, ELECTROCHIM ACTA, V52, P3588, DOI 10.1016/j.electacta.2006.10.019; BEECH IB, 1991, APPL MICROBIOL BIOT, V35, P65, DOI 10.1007/BF00180638; Chen SQ, 2016, MATER CORROS, V67, P340, DOI 10.1002/maco.201508555; Chen SQ, 2014, CORROS SCI, V87, P407, DOI 10.1016/j.corsci.2014.07.001; Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Dong X, 2017, BIORXIV, DOI DOI 10.1128/AEM.02848-13; Duncan KE, 2014, APPL MICROBIOL BIOT, V98, P907, DOI 10.1007/s00253-013-4906-x; Gaspar J, 2014, ENVIRON SCI TECH LET, V1, P465, DOI 10.1021/ez5003242; Gonzalez JEG, 1998, CORROS SCI, V40, P2141, DOI 10.1016/S0010-938X(98)00100-0; Hampson R, 2009, SPE ICOTA COIL TUB W; International Coiled Tubing Association, 2014, INTR COIL TUB; Johnston SL, 2012, ENVIRON SCI TECHNOL, V46, P9183, DOI 10.1021/es3019594; Kahrilas GA, 2015, ENVIRON SCI TECHNOL, V49, P16, DOI 10.1021/es503724k; Kajimura K, 2008, J HEALTH SCI, V54, P488, DOI 10.1248/jhs.54.488; Li HB, 2016, CORROS SCI, V111, P811, DOI 10.1016/j.corsci.2016.06.017; Liu HW, 2017, CORROS SCI, V114, P102, DOI 10.1016/j.corsci.2016.10.025; Luft B., 2013, COILED TUBING TIMES, V43, P36; MANSFELD F, 1981, CORROSION, V37, P301, DOI 10.5006/1.3621688; Meng GZ, 2008, CORROS SCI, V50, P3116, DOI 10.1016/j.corsci.2008.08.026; Nguyen TMP, 2008, IND ENG CHEM RES, V47, P4703, DOI 10.1021/ie071468e; Seal C, 2015, SPE ICOTA COIL TUB W; Sharma M, 2016, CORROSION; Sharma M, 2017, MICROBIALLY INFLUENC; Sheng XX, 2007, CORROS SCI, V49, P2159, DOI 10.1016/j.corsci.2006.10.040; Sherman S, 2015, SPE ICOTA COIL TUB W; Shi X, 2002, CORROSION-US, V58, P728, DOI 10.5006/1.3277655; Starosvetsky D, 2001, INT BIODETER BIODEGR, V47, P79, DOI 10.1016/S0964-8305(99)00081-5; Stevenson BS, 2011, ENVIRON MICROBIOL, V13, P1078, DOI 10.1111/j.1462-2920.2010.02413.x; Still J. W., 2003, NACE 03593; Stringfellow WT, 2014, J HAZARD MATER, V275, P37, DOI 10.1016/j.jhazmat.2014.04.040; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VOORDOUW G, 1995, APPL ENVIRON MICROB, V61, P2813, DOI 10.1128/AEM.61.8.2813-2819.1995; Voordouw G, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00351; Wang HF, 2002, J PHARMACEUT BIOMED, V29, P387, DOI 10.1016/S0731-7085(02)00078-X; Williams T. M., 2015, SPE INT S OILF CHEM; Wu JJ, 2016, CORROS SCI, V112, P552, DOI 10.1016/j.corsci.2016.04.047	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181934	10.1371/journal.pone.0181934	http://dx.doi.org/10.1371/journal.pone.0181934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746397	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800071
J	Al-Saad, S; Richardsen, E; Kilvaer, TK; Donnem, T; Andersen, S; Khanehkenari, M; Bremnes, RM; Busund, LT				Al-Saad, Samer; Richardsen, Elin; Kilvaer, Thomas K.; Donnem, Tom; Andersen, Sigve; Khanehkenari, Mehrdad; Bremnes, Roy M.; Busund, Lill-Tove			The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer	PLOS ONE			English	Article							GENE COPY NUMBER; HEPATOCYTE GROWTH-FACTOR; IN-SITU HYBRIDIZATION; C-MET; PROTEIN EXPRESSION; CLINICAL-SIGNIFICANCE; PROGNOSTIC IMPACT; SCATTER-FACTOR; RECEPTOR; RESISTANCE	Introduction To compare the efficacy of silver in situ hybridization (SISH) and immunohistochemistry (IHC) in detecting MET and IGF1R alterations and to investigate their prevalence and prognostic significance. A possible correlation between MET receptor expression, MET gene alterations and the two most frequent occurring EGFR gene mutations was also investigated. Materials and methods Stage I to IIIA tumors from 326 patients with NSCLC were immunohistochemically tested for protein expression of MET and IGF-1. Their cytoplasmic expression was compared with the gene copy number of the MET and IGF1R genes by SISH in paraffin-embedded, formalin-fixed material. Correlations were made with the immunohistochemical expression of two frequent EGFR mutations and clinicopathological variables. Univariate and multivariate survival analyses was used to evaluate the prognostic efficacy of the tested markers. Results In univariate analyses, high cytoplasmic MET expression showed a significant negative prognostic effect in adenocarcinoma patients (p = 0.026). MET gene to chromosome 7 ratio was a significant positive prognostic marker (p = 0.005), probably only due to the highly negative prognostic significance of chromosome 7 polysomy (p = 0.002). High IGF1R gene copy number was a negative prognostic marker for all NSCLC patients (p = 0.037). In the multivariate analysis, polysomy of chromosome 7 in tumor cells correlated significantly and independently with a poor prognosis (p = 0.011). In patients with adenocarcinoma, a high cytoplasmic MET expression was an independent negative prognostic marker (p = 0.013). In males a high IGF1R gene copy number to chromosome 15 count ratio was significantly and independently correlated to a poor prognosis (p = 0.018). Conclusion MET protein expression provides superior prognostic information compared with SISH. Polysomy of chromosome 7 is an independent negative prognostic factor in NSCLC patients. This finding has an important implication while examining genes located on chromosome 7 by means of SISH. High IGF1R gene copy number to chromosome 15 count ratio is an independent predictor of inferior survival in male patients with primary NSCLC.	[Al-Saad, Samer; Richardsen, Elin; Khanehkenari, Mehrdad; Busund, Lill-Tove] UiT Arctic Univ Norway, Inst Med Biol, Tromso, Norway; [Al-Saad, Samer; Richardsen, Elin; Busund, Lill-Tove] Univ Hosp Northern Norway, Dept Clin Pathol, Tromso, Norway; [Kilvaer, Thomas K.; Donnem, Tom; Andersen, Sigve; Bremnes, Roy M.] UiT Arctic Univ Norway, Inst Clin Med, Tromso, Norway; [Kilvaer, Thomas K.; Donnem, Tom; Andersen, Sigve; Bremnes, Roy M.] Univ Hosp Northern Norway, Dept Oncol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Al-Saad, S (corresponding author), UiT Arctic Univ Norway, Inst Med Biol, Tromso, Norway.; Al-Saad, S (corresponding author), Univ Hosp Northern Norway, Dept Clin Pathol, Tromso, Norway.	samer.al-saad@unn.no	Kilvaer, Thomas/AAI-7418-2020; Rakaee, Mehrdad/GMX-0729-2022	Kilvaer, Thomas/0000-0003-1669-0117; Rakaee, Mehrdad/0000-0002-9080-0153; Al-Saad, Samer/0000-0003-3707-9667	Northern Norway Regional Health Authority (Helse Nord) [SFP1032-12]; UiT The Arctic University of Norway	Northern Norway Regional Health Authority (Helse Nord); UiT The Arctic University of Norway	This research was funded by the Northern Norway Regional Health Authority (Helse Nord), Grant number SFP1032-12. The authors would like to acknowledge Roche Diagnostics Norway for providing our research laboratory with the two SISH antibodies MET gene and IGF1-R. Roche. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. The Northern Norway Regional Health Authority, The Arctic University of Norway, and Roche Diagnostics Norway had no role in study design, data collection and analysis, results, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Roche Diagnostics Norway for providing our research laboratory with the two SISH antibodies MET gene and IGF1R. The publication charges for this article have been funded by a grant from the publication fund of UiT The Arctic University of Norway. Roche Diagnostics Norway and the publication fund of UiT had no role in study design, data collection and analysis, results, decision to publish, or preparation of the manuscript.	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; AE D, 2016, J CLIN OONCOLOGY S, V34; Agullo-Ortuno MT, 2015, J CANCER RES CLIN, V141, P43, DOI 10.1007/s00432-014-1787-z; Al-Saad S, 2010, J THORAC ONCOL, V5, P1536, DOI 10.1097/JTO.0b013e3181ea510a; Ariyawutyakorn W, 2016, J CANCER, V7, P633, DOI 10.7150/jca.12663; Awad MM, 2016, J CLIN ONCOL, V34, P721, DOI 10.1200/JCO.2015.63.4600; Bazett M, 2012, J IMMUNOL, V188, P2297, DOI 10.4049/jimmunol.1102425; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Boch C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002560; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Cappuzzo F, 2010, ANN ONCOL, V21, P562, DOI 10.1093/annonc/mdp357; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Casadevall D, 2015, ONCOTARGET, V6, P16215, DOI 10.18632/oncotarget.3976; Castoldi R, 2013, ONCOGENE, V32, P5593, DOI 10.1038/onc.2013.245; Dimou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107677; Donnem T, 2007, CLIN CANCER RES, V13, P6649, DOI 10.1158/1078-0432.CCR-07-0414; Dua R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015932; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; Dziadziuszko R, 2012, J THORAC ONCOL, V7, P340, DOI 10.1097/JTO.0b013e318240ca0d; Dziadziuszko R, 2010, J CLIN ONCOL, V28, P2174, DOI 10.1200/JCO.2009.24.6611; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Go H, 2010, J THORAC ONCOL, V5, P305, DOI 10.1097/JTO.0b013e3181ce3d1d; Guo BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099399; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Hsu F, 2016, LUNG CANCER, V96, P101, DOI 10.1016/j.lungcan.2016.04.004; Ichimura E, 1996, JPN J CANCER RES, V87, P1063, DOI 10.1111/j.1349-7006.1996.tb03111.x; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kim IH, 2016, CLIN LUNG CANCER, V17, pE31, DOI 10.1016/j.cllc.2016.01.005; Kim JS, 2014, CLIN LUNG CANCER, V15, P213, DOI 10.1016/j.cllc.2013.12.006; Kim S-M, 2016, MOL CANC THER; Kos L, 1999, PIGM CELL RES, V12, P13, DOI 10.1111/j.1600-0749.1999.tb00503.x; Lapere C, 2017, AM J SURG PATHOL, V41, P414, DOI 10.1097/PAS.0000000000000810; Lee JM, 2016, ONCOGENE; Levallet G, 2012, J THORAC ONCOL, V7, P599, DOI 10.1097/JTO.0b013e3182417da5; Li F, 2016, CLIN GENET; Lim EH, 2009, J THORAC ONCOL, V4, P12, DOI 10.1097/JTO.0b013e3181913e28; Lu X, 2017, CANC RES; Masuya D, 2004, BRIT J CANCER, V90, P1555, DOI 10.1038/sj.bjc.6601718; Menu Eline, 2009, Archives of Physiology and Biochemistry, V115, P49, DOI 10.1080/13813450902736583; Nakagawa M, 2012, CLIN LUNG CANCER, V13, P136, DOI 10.1016/j.cllc.2011.10.006; Noonan SA, 2016, J THORAC ONCOL, V11, P1293, DOI 10.1016/j.jtho.2016.04.033; Ou SHI, 2011, J THORAC ONCOL, V6, P942, DOI 10.1097/JTO.0b013e31821528d3; Owusu BY, 2016, ONCOTARGET; Patane S, 2006, CANCER RES, V66, P4750, DOI 10.1158/0008-5472.CAN-05-4422; Park S, 2012, HISTOL HISTOPATHOL, V27, P197, DOI 10.14670/HH-27.197; Peng Z, 2015, MOL CANCER THER, V14, P2634, DOI 10.1158/1535-7163.MCT-15-0108; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Polonia A, 2016, VIRCHOWS ARCH, V468, P417, DOI 10.1007/s00428-016-1903-3; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Ricci G, 2006, J ENDOCRINOL, V191, P559, DOI 10.1677/joe.1.06879; Riely GJ, 2006, CLIN CANCER RES, V12, P839, DOI 10.1158/1078-0432.CCR-05-1846; Rossi S, 2016, MOL DIAGN THER, V20, P55, DOI 10.1007/s40291-015-0176-x; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Scartozzi M, 2010, CURR OPIN MOL THER, V12, P361; Siegfried JM, 1997, CANCER RES, V57, P433; Signaling C., 2017, EGF RECEPTOR E746 A7; Spigel DR, 2017, J CLIN ONCOL, V35, P412, DOI 10.1200/JCO.2016.69.2160; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Stabile LP, 2013, CLIN CANCER RES, V19, P380, DOI 10.1158/1078-0432.CCR-12-1555; Sun WZ, 2013, ONCOTARGETS THER, V6, P1315, DOI 10.2147/OTT.S50428; Technology CS, 2017, EGF RECEPTOR L858H M; Thompson JA, 2016, J NATL COMPR CANC NE, V14, P638, DOI 10.6004/jnccn.2016.0180; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tran TN, 2016, CLIN LUNG CANCER, V17, P30, DOI 10.1016/j.cllc.2015.08.002; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Tsiambas E, 2015, J BUON, V20, P1635; Tsuta K, 2013, HUM PATHOL, V44, P975, DOI 10.1016/j.humpath.2012.09.002; Tsuta K, 2012, J THORAC ONCOL, V7, P331, DOI 10.1097/JTO.0b013e318241655f; van der Wekken AJ, 2016, CRIT REV ONCOL HEMAT, V100, P107, DOI 10.1016/j.critrevonc.2016.01.024; Varkaris A, 2013, INT J CANCER, V133, P1536, DOI 10.1002/ijc.28169; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; WANG Y, 1994, J ANAT, V185, P543; Xian CJ, 2000, BRIT J CANCER, V82, P945, DOI 10.1054/bjoc.1999.1023; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739; Zhang Y, 2016, J THORAC ONCOL, V11, pE59, DOI 10.1016/j.jtho.2015.12.102; Zhao S, 2014, INT J CLIN EXP PATHO, V7, P6694; Zhen Q, 2015, CYTOGENET GENOME RES, V146, P1, DOI 10.1159/000434741	82	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181527	10.1371/journal.pone.0181527	http://dx.doi.org/10.1371/journal.pone.0181527			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742836	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000034
J	Frandsen, SK; Gehl, J				Frandsen, Stine Krog; Gehl, Julie			Effect of calcium electroporation in combination with metformin in vivo and correlation between viability and intracellular ATP level after calcium electroporation in vitro	PLOS ONE			English	Article							BLADDER-CANCER; ELECTROCHEMOTHERAPY; CELL; ELECTROPERMEABILIZATION; CYTOTOXICITY; HOMEOSTASIS; APOPTOSIS; TOXICITY	Background Calcium electroporation is a new experimental anti-cancer treatment where calcium is internalized into cells by application of short, high voltage pulses. Calcium electroporation has been shown to induce tumor necrosis associated with ATP depletion while the effect on normal fibroblasts was limited when investigated in a 3D in vitro spheroid model. We aimed to investigate the effect of calcium electroporation in combination with metformin, a drug that affects intracellular ATP level. We also aimed to study the relationship between the viability and intracellular ATP levels after calcium electroporation in vitro. Methods In this study, we investigated the effect of calcium electroporation with metformin on NMRI-Foxn1(nu) mice in vivo on tumor size, survival, and intracellular ATP. We further investigated viability and intracellular ATP level in vitro after calcium electroporation in two human cancer cell lines: Breast (MDA-MB231) and colon (HT29), and in normal human fibroblasts (HDF-n), as well as investigating viability in human bladder cancer cells (SW780) and human small cell lung cancer cells (H69) where we have previously published intracellular ATP levels. Results Calcium electroporation significantly reduced the size and ATP level of bladder cancer tumors treated in vivo but no increased effect of metformin combined with calcium electroporation was shown on neither tumor size, survival, nor ATP level. Calcium electroporation in vitro significantly decreased viability compared with calcium alone (p<0.0001 for calcium concentrations from 0.5 mM for H69, HDF-n, and MDA-MB231; p<0.0001 for calcium concentrations from 1 mM for HT29 and SW780). Intracellular ATP levels decreased significantly after calcium electroporation (p<0.05), however no correlation between intracellular ATP level and viability after treatment was observed. Conclusion Calcium electroporation caused reduced tumor size, increased survival, and acute ATP depletion in vivo. This effect was not augmented by metformin. Calcium electroporation is a possible novel anti-cancer treatment that has been shown to cause cell death associated with acute ATP depletion in vitro and in vivo.	[Frandsen, Stine Krog; Gehl, Julie] Univ Copenhagen, Ctr Expt Drug & Gene Elect, Dept Oncol, Herlev & Gentofte Hosp, Herlev, Denmark	University of Copenhagen	Gehl, J (corresponding author), Univ Copenhagen, Ctr Expt Drug & Gene Elect, Dept Oncol, Herlev & Gentofte Hosp, Herlev, Denmark.	Karen.Julie.Gehl@Regionh.dk		Frandsen, Stine/0000-0002-3133-5351; Gehl, Julie/0000-0003-3829-0210	University of Copenhagen; Danish Cancer Society [R110-A6996]; The Danish Cancer Society [R110-A6996] Funding Source: researchfish	University of Copenhagen; Danish Cancer Society(Danish Cancer Society); The Danish Cancer Society(Danish Cancer Society)	This work was supported by University of Copenhagen (S.K. Frandsen) and The Danish Cancer Society (grant number R110-A6996; J. Gehl). The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Aung CS, 2009, CARCINOGENESIS, V30, P1962, DOI 10.1093/carcin/bgp223; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brini M, 2000, CELL MOL LIFE SCI, V57, P354, DOI 10.1007/PL00000698; Campana LG, 2014, J SURG ONCOL, V109, P301, DOI 10.1002/jso.23512; Cho SW, 2014, MOL CELL ENDOCRINOL, V393, P24, DOI 10.1016/j.mce.2014.05.021; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Curatolo P, 2013, ACTA DERMATOVENER CR, V21, P132; Curatolo P, 2012, ANN SURG ONCOL, V19, P192, DOI 10.1245/s10434-011-1860-7; Davalos RV, 2015, PROSTATE, V75, P1114, DOI 10.1002/pros.22986; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fini M, 2013, CLIN EXP METASTAS, V30, P1033, DOI 10.1007/s10585-013-9601-x; Forde PF, 2016, ENDOSCOPY, V48, P477, DOI 10.1055/s-0042-101343; Frandsen SK, 2017, CANC RES IN PRESS; Frandsen SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144028; Frandsen SK, 2014, BBA-GEN SUBJECTS, V1840, P1204, DOI 10.1016/j.bbagen.2013.12.003; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Gehl J, 1998, ANTI-CANCER DRUG, V9, P319, DOI 10.1097/00001813-199804000-00005; Gjetting T, 2010, INT J NANOMED, V5, P371; Granata V, 2015, INT J SURG, V18, P230, DOI 10.1016/j.ijsu.2015.04.055; Guo LS, 2015, PHARMAZIE, V70, P123, DOI 10.1691/ph.2015.3936; Hansen EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122973; Heller R, 1998, CANCER-AM CANCER SOC, V83, P148, DOI 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W; Herbsleb M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-31; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Jaroszeski MJ, 2000, ANTI-CANCER DRUG, V11, P201, DOI 10.1097/00001813-200003000-00008; Kee ST, 2011, CLINICAL ASPECTS OF ELECTROPORATION, P1, DOI 10.1007/978-1-4419-8363-3; Landstrom FJ, 2015, ACTA OTO-LARYNGOL, V135, P90, DOI 10.3109/00016489.2014.947655; Li SJ, 2008, MATER SCI FORUM, V575-578, P1, DOI 10.4028/www.scientific.net/MSF.575-578.1; Markelc B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059557; Matthiessen LW, 2012, ACTA ONCOL, V51, P713, DOI 10.3109/0284186X.2012.685524; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Neal RE, 2015, IEEE T BIO-MED ENG, V62, P561, DOI 10.1109/TBME.2014.2360374; Neal RE, 2014, PROSTATE, V74, P458, DOI 10.1002/pros.22760; ORLOWSKI S, 1988, BIOCHEM PHARMACOL, V37, P4727, DOI 10.1016/0006-2952(88)90344-9; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pakhomova ON, 2014, BBA-BIOMEMBRANES, V1838, P2547, DOI 10.1016/j.bbamem.2014.06.015; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Pryor R, 2015, BIOCHEM J, V471, P307, DOI 10.1042/BJ20150497; ROLS MP, 1990, BIOPHYS J, V58, P1089, DOI 10.1016/S0006-3495(90)82451-6; SERSA G, 1995, CANCER RES, V55, P3450; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Vasquez JL, 2012, BIOELECTROCHEMISTRY, V88, P127, DOI 10.1016/j.bioelechem.2012.08.001; Vasquez JL, 2015, J UROLOGY, V193, P1009, DOI 10.1016/j.juro.2014.09.039; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zielichowska A, 2016, BIOELECTROCHEMISTRY, V109, P70, DOI 10.1016/j.bioelechem.2016.01.005	47	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181839	10.1371/journal.pone.0181839	http://dx.doi.org/10.1371/journal.pone.0181839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742810	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000059
J	Neira, V; Brito, B; Mena, J; Culhane, M; Apel, MI; Max, V; Perez, P; Moreno, V; Mathieu, C; Johow, M; Badia, C; Torremorell, M; Medina, R; Ortega, R				Neira, Victor; Brito, Barbara; Mena, Juan; Culhane, Marie; Apel, Maria Ignacia; Max, Vanessa; Perez, Patricio; Moreno, Valentina; Mathieu, Christian; Johow, Magdalena; Badia, Catalina; Torremorell, Montserrat; Medina, Rafael; Ortega, Rene			Epidemiological investigations of the introduction of porcine reproductive and respiratory syndrome virus in Chile, 2013-2015	PLOS ONE			English	Article							SYNDROME PRRS; VACCINE; EMERGENCE; EVOLUTION; PORK	Porcine reproductive and respiratory syndrome ( PRRS) is endemic in most pork producing countries. In Chile, eradication of PRRS virus ( PRRSV) was successfully achieved in 2009 as a result of the combined efforts of producers and the animal health authorities. In October 2013, after several years without detecting PRRSV under surveillance activities, suspected cases were confirmed on a commercial swine farm. Here, we describe the PRRS epidemic in Chile between October 2013 and April 2015, and we studied the origins and spread of PRRSV throughout the country using official surveillance data and Bayesian phylogenetic analysis. Our results indicate that the outbreaks were caused by a PRRSV closely related to viruses present in swine farms in North America, and different from the strain that circulated in the country before 2009. Using divergence time estimation analysis, we found that the 2013-2015 PRRSV may have been circulating in Chile for at least one month before the first detection. A single strain of PRRSV spread into a limited number of commercial and backyard swine farms. New infections in commercial systems have not been reported since October 2014, and eradication is underway by clearing the disease from the few commercial and backyard farms that remain positive. This is one of the few documented experiences of PRRSV introduction into a disease-free country.	[Neira, Victor; Brito, Barbara; Mena, Juan] Univ Chile, Fac Ciencias Vet & Pecuarias, Dept Med Prevent, Santiago, Chile; [Mena, Juan; Ortega, Rene] Univ Concepcion, Fac Ciencias Vet, Chillan, Chile; [Culhane, Marie; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA; [Apel, Maria Ignacia] ASPROCER, Asociac Gremial Prod Cerdo Chile, Santiago, Chile; [Max, Vanessa; Perez, Patricio] SAG, Div Protecc Pecuaria, Santiago, Chile; [Moreno, Valentina; Mathieu, Christian; Johow, Magdalena; Badia, Catalina] SAG, Lab & Estn Cuarentenaria Lo Aguirre, Santiago, Chile; [Medina, Rafael] Pontificia Univ Catolica Chile, Dept Enfermedades Infecciosas & Inmul Pediat, Escuela Med, Santiago, Chile; [Medina, Rafael] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Brito, Barbara] ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, USDA, Greenport, NY 11944 USA	Universidad de Chile; Universidad de Concepcion; University of Minnesota System; University of Minnesota Twin Cities; Pontificia Universidad Catolica de Chile; Icahn School of Medicine at Mount Sinai; United States Department of Agriculture (USDA)	Brito, B (corresponding author), Univ Chile, Fac Ciencias Vet & Pecuarias, Dept Med Prevent, Santiago, Chile.; Ortega, R (corresponding author), Univ Concepcion, Fac Ciencias Vet, Chillan, Chile.; Brito, B (corresponding author), ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, USDA, Greenport, NY 11944 USA.	barbara.brito.r@gmail.com; reortega@udec.cl	Medina, Rafael A./AAW-4418-2020; Culhane, Marie/H-3143-2019; Ramirez, Victor Manuel Neira/M-8736-2013; Brito, Barbara/H-5467-2017	Medina, Rafael A./0000-0002-5013-6884; Ramirez, Victor Manuel Neira/0000-0001-9062-9969; Brito, Barbara/0000-0001-6122-2596; Culhane, Marie/0000-0002-3547-7576	Asociacion Gremial de Productores de Cerdo de Chile (ASPROCER); FONDEF [14i10201]; CONICYT-PIA [Anillo1408]	Asociacion Gremial de Productores de Cerdo de Chile (ASPROCER); FONDEF; CONICYT-PIA	The Asociacion Gremial de Productores de Cerdo de Chile (ASPROCER-www.asprocer.cl) funded in part the sample collection and materials. FONDEF ID 14i10201 funded reagents/materials for sample processing and part of the stipend/salary of investigators. CONICYT-PIA Anillo1408 plays an important role in supporting collaborative projects, and funded in part the salary of investigators.	Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5; Alvarez J, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0019-0; Butler JE, 2014, IMMUNOL RES, V59, P81, DOI 10.1007/s12026-014-8549-5; Carlsson U, 2009, TRANSBOUND EMERG DIS, V56, P121, DOI 10.1111/j.1865-1682.2008.01065.x; Chang CC, 2002, J VIROL, V76, P4750, DOI 10.1128/JVI.76.10.4750-4763.2002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gonin P, 1999, J VET DIAGN INVEST, V11, P20, DOI 10.1177/104063879901100103; Hall W, 2015, TRANSBOUND EMERG DIS, V62, P350, DOI 10.1111/tbed.12163; Han J, 2006, VIRUS RES, V122, P175, DOI 10.1016/j.virusres.2006.06.003; Hao XF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-73; Holtkamp DJ, 2011, TIERAERZTL PRAX G N, V39, P101; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Linhares DCL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144265; Magar R, 2004, CAN J VET RES, V68, P259; Miller M.A., 2010, P GAT COMP ENV WORKS; Nathues C, 2016, TRANSBOUND EMERG DIS, V63, pE251, DOI 10.1111/tbed.12262; Nielsen HS, 2001, J GEN VIROL, V82, P1263, DOI 10.1099/0022-1317-82-6-1263; Nodelijk G, 2002, VET QUART, V24, P95, DOI 10.1080/01652176.2002.9695128; OIE World Organisation of Animal Health, 2013, PRRS DIS DIAGN PREV; Opriessnig T, 2002, J VIROL, V76, P11837, DOI 10.1128/JVI.76.23.11837-11844.2002; Papatsiros V. G., 2012, American Journal of Animal and Veterinary Sciences, V7, P149; Pirzadeh B, 1997, J GEN VIROL, V78, P1867, DOI 10.1099/0022-1317-78-8-1867; Provost C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-267; Rambaut A, 2007, TRACER VERSION 1 4 C; Rathkjen PH, 2017, ACTA VET SCAND, V59, DOI 10.1186/s13028-016-0270-z; Shi M, 2010, VIRUS RES, V154, P7, DOI 10.1016/j.virusres.2010.08.014; Skewes Oscar, 2015, Mastozool. neotrop., V22, P113; Stadejek T, 2013, VET MICROBIOL, V165, P21, DOI 10.1016/j.vetmic.2013.02.029; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torremorell M, 2002, ADVANCES IN PORK PRODUCTION, VOL 13, P169; Torremorell M, 2008, P 20 IPVS C DURB S A; Zhao HJ, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0735-3	34	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181569	10.1371/journal.pone.0181569	http://dx.doi.org/10.1371/journal.pone.0181569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742879	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000038
J	Yan, CC; Mou, BQ; Meng, Y; Tu, FY; Fan, ZX; Price, M; Yue, BS; Zhang, XY				Yan, Chaochao; Mou, Biqin; Meng, Yang; Tu, Feiyun; Fan, Zhenxin; Price, Megan; Yue, Bisong; Zhang, Xiuyue			A novel mitochondrial genome of Arborophila and new insight into Arborophila evolutionary history	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; PARTITIONING SCHEMES; GALLIFORM BIRDS; NUCLEAR; AVES; PHASIANIDAE; RADIATION; INFERENCE; GENES; HYBRIDIZATION	The lineage of the Bar-backed Partridge (Arborophila brunneopectus) was investigated to determine the phylogenetic relationships within Arborophila as the species is centrally distributed within an area covered by the distributions of 22 South-east Asian hill partridge species. The complete mitochondrial genome (mitogenome) of A. brunneopectus was determined and compared with four other hill partridge species mitogenomes. NADH subunit genes are radical in hill partridge mitogenomes and contain the most potential positive selective sites around where variable sites are abundant. Together with 44 other mitogenomes of closely related species, we reconstructed highly resolved phylogenetic trees using maximum likelihood (ML) and Bayesian inference (BI) analyses and calculated the divergence and dispersal history of Arborophila using combined datasets composed of their 13-protein coding sequences. Arborophila is reportedly be the oldest group in Phasianidae whose ancestors probably originated in Asia. A. rufipectus shares a closer relationship with A. ardens and A. brunneopectus compared to A. gingica and A. rufogularis, and such relationships were supported and profiled by NADH dehydrogenase subunit 5 (ND5). The intragenus divergence of all five Arborophila species occurred in the Miocene (16.84 similar to 5.69 Mya) when there were periods of climate cooling. We propose that these cooling events in the Miocene forced hill partridges from higher to lower altitudes, which led to geographic isolation and speciation. We demonstrated that the apparently deleterious + 1 frameshift mutation in NADH dehydrogenase subunit 3 (ND3) found in all Arborophila is an ancient trait that has been eliminated in some younger lineages, such as Passeriformes. It is unclear of the biological advantages of this elimination for the relevant taxa and this requires further investigation.	[Yan, Chaochao; Mou, Biqin; Meng, Yang; Tu, Feiyun; Zhang, Xiuyue] Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Sichuan, Peoples R China; [Tu, Feiyun] Jiangxi Acad Forestry, Inst Wildlife Conservat, Nanchang, Jiangxi, Peoples R China; [Fan, Zhenxin; Price, Megan; Yue, Bisong] Sichuan Univ, Coll Life Sci, Sichuan Key Lab Conservat Biol Endangered Wildlif, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Zhang, XY (corresponding author), Sichuan Univ, Coll Life Sci, Minist Educ, Key Lab Bioresources & Ecoenvironm, Chengdu, Sichuan, Peoples R China.	zhangxy317@126.com			Key Technology Research and Development Program of Sichuan Province [2014NZ0107]	Key Technology Research and Development Program of Sichuan Province	This research was funded by Key Technology Research and Development Program of Sichuan Province (2014NZ0107). Website: http://www.scst.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Cai Guo and Ranjiang Hong at Sichuan University for their help in sampling and valuable help with the manuscript. This research was funded by Key Technology Research and Development Program of Sichuan Province (2014NZ0107). The authors alone are responsible for the content and writing of the paper.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Armstrong MH, 2001, AUK, V118, P799, DOI 10.1642/0004-8038(2001)118[0799:PUOAOI]2.0.CO;2; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen D, 2015, ZOOL J LINN SOC-LOND, V175, P429, DOI 10.1111/zoj.12273; Chen D, 2015, MOL PHYLOGENET EVOL, V83, P167, DOI 10.1016/j.ympev.2014.11.006; Cheng K-m, 1998, CHINA RED DATA BOOK; Clements J.F., 2015, EBIRD CLEMENTS CHECK; Crowe TM, 2006, CLADISTICS, V22, P495, DOI 10.1111/j.1096-0031.2006.00120.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Fontenot BE, 2011, MOL PHYLOGENET EVOL, V59, P66, DOI 10.1016/j.ympev.2010.12.018; Gao Y, 1998, BIRD CONSERV INT, V9, P411, DOI DOI 10.1017/S0959270900002161; Gibson A, 2005, MOL BIOL EVOL, V22, P251, DOI 10.1093/molbev/msi012; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He LW, 2009, GENE, V435, P23, DOI 10.1016/j.gene.2009.01.001; HIJMANS RJ, 2015, GEOGRAPHIC DATA ANAL; Hill M, 2001, BIRD CONSERV INT, V11, P49, DOI 10.1017/S095927090100106X; Huang ZH, 2009, MOL PHYLOGENET EVOL, V53, P378, DOI 10.1016/j.ympev.2009.07.002; International B, 2016, END BIRD AR EBAS; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jiang LC, 2014, GENE, V539, P21, DOI 10.1016/j.gene.2014.01.067; Kimball RT, 2008, J AVIAN BIOL, V39, P438, DOI 10.1111/j.2008.0908-8857.04270.x; Kimball Rebecca T., 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/423938; Ksepka DT, 2009, CLADISTICS, V25, P173, DOI 10.1111/j.1096-0031.2009.00250.x; Lambkin CL, 2002, CLADISTICS, V18, P436, DOI 10.1111/j.1096-0031.2002.tb00159.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Li Xuejuan, 2014, Yichuan, V36, P912, DOI 10.3724/SP.J.1005.2014.0912; Liu FW, 2014, ZOOL SCI, V31, P160, DOI 10.2108/zsj.31.160; Liu ZF, 2012, GENE, V502, P125, DOI 10.1016/j.gene.2012.04.068; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma LL, 2010, MITOCHONDR DNA, V21, P5, DOI 10.3109/19401730903552026; Madge S, 2002, PHEASANTS PARTRIDGES, P321; Mayr G, 2008, CLADISTICS, V24, P74, DOI 10.1111/j.1096-0031.2007.00170.x; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Meng Y, 2008, BIOCHEM SYST ECOL, V36, P626, DOI 10.1016/j.bse.2008.01.007; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Mitchell SM, 2016, ECOL EVOL, V6, P3280, DOI 10.1002/ece3.2087; NatureServe Bla, 2015, NAT SERV BLA BIRD SP; Parham JF, 2006, MOL PHYLOGENET EVOL, V38, P50, DOI 10.1016/j.ympev.2005.07.015; Pereira SL, 2006, MOL PHYLOGENET EVOL, V38, P499, DOI 10.1016/j.ympev.2005.07.007; Powell AFLA, 2013, MOL PHYLOGENET EVOL, V66, P69, DOI 10.1016/j.ympev.2012.09.006; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Rambaut A., 2014, TRACER V1 6; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Richard A.B., 2016, MAPS DRAW GEOGRAPHIC; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Sambrook J., 2002, MOL CLONING LAB MANU; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; Shen YY, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-132; Shen YY, 2009, GENOME RES, V19, P1760, DOI 10.1101/gr.093138.109; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Tuinen M, 2004, MOL PHYLOGENET EVOL, V30, P74, DOI 10.1016/S1055-7903(03)00164-7; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Wang N, 2017, J BIOGEOGR, V44, P122, DOI 10.1111/jbi.12782; Wang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064312; Wiens JJ, 2010, BIOL J LINN SOC, V99, P445, DOI 10.1111/j.1095-8312.2009.01342.x; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; WYLES JS, 1983, P NATL ACAD SCI-BIOL, V80, P4394, DOI 10.1073/pnas.80.14.4394; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yan CC, 2014, MITOCHONDR DNA, V25, P259, DOI 10.3109/19401736.2013.800494; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu Chen-Xing, 2011, Zoological Research, V32, P549, DOI 10.3724/SP.J.1141.2011.05549; Yuri Tamaki, 2013, Biology - Basel, V2, P419, DOI 10.3390/biology2010419; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zheng X, 1978, CHINESE FAUNA AVES, VIV, P84; Zhou TC, 2014, MITOCHONDRION, V18, P70, DOI 10.1016/j.mito.2014.07.012	81	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181649	10.1371/journal.pone.0181649	http://dx.doi.org/10.1371/journal.pone.0181649			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742865	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000043
J	Boesmueller, S; Huf, W; Rettl, G; Dahm, F; Meznik, A; Muschitz, G; Kitzinger, H; Bukaty, A; Fialka, C; Vierhapper, M				Boesmueller, Sandra; Huf, Wolfgang; Rettl, Gregor; Dahm, Falko; Meznik, Alexander; Muschitz, Gabriela; Kitzinger, Hugo; Bukaty, Adam; Fialka, Christian; Vierhapper, Martin			The influence of sex and trauma impact on the rupture site of the ulnar collateral ligament of the thumb	PLOS ONE			English	Article							ORTHOPEDIC JOURNALS; INJURIES; POPULATION; EPIDEMIOLOGY; MANAGEMENT; FEMALES; GENDER; REPAIR; SKIERS; MALES	Purpose and hypothesis Although sex-and gender-specific analyses have been gaining more attention during the last years they have rarely been performed in orthopaedic literature. The primary purpose of this study was to investigate whether for injuries of the UCL the specific location of the rupture is influenced by sex. A secondary study question addressed the sex-independent effect of trauma intensity on the rupture site of the UCL. Methods This study is a retrospective analysis of all patients with either a proximal or distal bony avulsion or with a mid-substance tear or ligament avulsion of the UCL treated surgically between 1992 and 2015 at two level-I trauma centres. Trauma mechanisms leading to the UCL injury were classified into the following categories: (1) blunt trauma (i.e., strains), (2) low-velocity injuries (e.g., fall from standing height, assaults), and (3) high-velocity injuries (e.g., sports injuries, motor vehicle accidents). After reviewing the surgical records, patients were divided into three groups, depending upon the ligament rupture site: (1) mid-substance tears, (2) proximal ligament or bony avulsions and (3) distal ligament or bony avulsions. Dependencies between the specific rupture site and the explanatory variables (sex, age, and trauma intensity) were evaluated using chi(2) test and logistic regression analysis. Results In total, 1582 patients (1094 males, 488 females) met the inclusion criteria. Mean age was 41 years (range: 9-90 years). Taking into account the effects of sex on trauma intensity (p < 0.001) and of trauma intensity on rupture site (p < 0.001), mid-substance tears occurred more frequently in women, whereas men were more prone to distal ligament or bony avulsions (p < 0.001). In other words, sex and rupture site correlated due to the effects of sex on trauma intensity and of trauma intensity on rupture site, but taking into account those effects there still was a significant effect of sex on rupture site. Conclusions The results of this study demonstrate that with regression analysis both sex and trauma intensity allow to predict rupture site in UCL injuries.	[Boesmueller, Sandra; Dahm, Falko; Meznik, Alexander; Fialka, Christian] AUVA Trauma Ctr Meidling, Vienna, Austria; [Huf, Wolfgang] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Rettl, Gregor] Med Univ Vienna, Dept Trauma Surg, Vienna, Austria; [Muschitz, Gabriela; Kitzinger, Hugo; Vierhapper, Martin] Med Univ Vienna, Dept Plast & Reconstruct Surg, Vienna, Austria; [Bukaty, Adam] Med Univ Vienna, Div Gen Anaesthesia & Intens Care Med, Vienna, Austria; [Fialka, Christian] Sigmund Freud Univ Vienna, Dept Trauma, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Boesmueller, S (corresponding author), AUVA Trauma Ctr Meidling, Vienna, Austria.	sandra.boesmueller@auva.at						Anderson AF, 2001, AM J SPORT MED, V29, P58, DOI 10.1177/03635465010290011501; Avery DM, 2015, ORTHOP CLIN N AM, V46, P281, DOI 10.1016/j.ocl.2014.11.007; Bere T, 2014, BRIT J SPORT MED, V48, P36, DOI 10.1136/bjsports-2013-092206; CAMPBELL CS, 1955, J BONE JOINT SURG BR, V37, P148, DOI 10.1302/0301-620X.37B1.148; CARTER C, 1964, J BONE JOINT SURG BR, V46, P40, DOI 10.1302/0301-620X.46B1.40; Champely S., 2020, PWR BASIC FUNCTIONS; Chuter GSJ, 2009, INJURY, V40, P652, DOI 10.1016/j.injury.2009.01.107; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Crowley Timothy P, 2013, Tech Hand Up Extrem Surg, V17, P124, DOI 10.1097/BTH.0b013e318284dbd7; DERKASH RS, 1987, CLIN ORTHOP RELAT R, P29; Giddins GEB, 2015, J HAND SURG-EUR VOL, V40, P33, DOI 10.1177/1753193414548170; Harley BJ, 2004, J HAND SURG-AM, V29A, P915, DOI 10.1016/j.jhsa.2004.04.017; HARNER CD, 1994, AM J SPORT MED, V22, P37, DOI 10.1177/036354659402200107; Hettrich CM, 2015, CLIN ORTHOP RELAT R, V473, P3700, DOI 10.1007/s11999-015-4457-9; Kaplan SJ, 1998, J HAND SURG-AM, V23A, P833, DOI 10.1016/S0363-5023(98)80158-5; Ladd AL, 2015, CLIN ORTHOP RELAT RE; Ladd AL, 2014, CLIN ORTHOP RELAT R, V472, P793, DOI 10.1007/s11999-013-3456-y; Leopold S, 2015, CLIN ORTHOP RELAT R, V473, P3695, DOI 10.1007/s11999-015-4516-2; Leopold SS, 2014, CLIN ORTHOP RELAT R, V472, P391, DOI 10.1007/s11999-013-3397-5; Malik AK, 2009, J HAND SURG-EUR VOL, V34E, P363, DOI 10.1177/1753193408100957; Mayer SW, 2014, J HAND SURG-AM, V39, P474, DOI 10.1016/j.jhsa.2013.11.044; McKeon KE, 2013, J BONE JOINT SURG AM, V95A, P881, DOI 10.2106/JBJS.L.00204; Melone CP, 2000, HAND CLIN, V16, P345; Mountcastle SB, 2007, AM J SPORT MED, V35, P1635, DOI 10.1177/0363546507302917; MOUTET F, 1989, Annales de Chirurgie de la Main, V8, P99, DOI 10.1016/S0753-9053(89)80002-X; NICHOLAS JA, 1970, J AMER MED ASSOC, V212, P2236, DOI 10.1001/jama.212.13.2236; Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306; Pechlaner S., 1998, OPERATIONSATLAS HAND, Vxiii; Rhee PC, 2012, J BONE JOINT SURG AM, V94A, P2005, DOI 10.2106/JBJS.K.01024; Schroeder NS, 2015, CLIN SPORT MED, V34, P117, DOI 10.1016/j.csm.2014.09.004; Shelbourne KD, 1998, AM J SPORT MED, V26, P402, DOI 10.1177/03635465980260031001; SOURYAL TO, 1988, AM J SPORT MED, V16, P449, DOI 10.1177/036354658801600504; Sturnick DR, 2015, AM J SPORT MED, V43, P839, DOI 10.1177/0363546514563277; Sutton KM, 2013, J AM ACAD ORTHOP SUR, V21, P41, DOI 10.5435/JAAOS-21-01-41; Taylor KF, 2013, J HAND SURG-AM, V38A, P532, DOI 10.1016/j.jhsa.2012.12.003; Wojtys EM, 1998, AM J SPORT MED, V26, P614, DOI 10.1177/03635465980260050301; ZELISKO JA, 1982, AM J SPORT MED, V10, P297, DOI 10.1177/036354658201000507	37	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181754	10.1371/journal.pone.0181754	http://dx.doi.org/10.1371/journal.pone.0181754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738083	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700064
J	Li, GH; Zhao, B; Dong, ST; Zhang, JW; Liu, P; Vyn, TJ				Li, Guanghao; Zhao, Bin; Dong, Shuting; Zhang, Jiwang; Liu, Peng; Vyn, Tony J.			Impact of controlled release urea on maize yield and nitrogen use efficiency under different water conditions	PLOS ONE			English	Article							DRY-MATTER; CHINA; GRAIN	Controlled release urea (CRU) has been widely adopted to increase nitrogen (N) use efficiency and maize production, but the impacts can range widely depending on water availability in the soil. In an experiment using Zhengdan 958 (a popular summer maize hybrid), three levels of water treatments (adequate water condition [W3], which maintained soil moisture at about 75% +/- 5% of the soil's field capacity; mild water stress [W2], which maintained moisture content at 55% +/- 5% of field capacity; and severe water stress [W1], which had a moisture content of 35% +/- 5% of field capacity) and four levels of controlled release urea fertilizer (N0, N1, N2 and N3 were 0, 105, 210 and 315 kg N ha(-1), respectively) were compared in a rainout shelter system with soil. The results revealed that CRU had significant effects on maize yields and N use efficiencies under different water conditions. The mean yields increased with increasing water levels and showed significant differences. Under W1, the accumulation of dry matter and N were limited, and N internal efficiency (NIE) and the apparent recovery efficiency of applied N (REN) decreased with N increases; yields of N1, N2, and N3 were similar. Under W2, the dry matter and N accumulation, as well as the yield, showed an increasing trend with an increase in N application, and the NIE and REN of N3 showed no difference from N2. Under W3, yields of N2 and N3 were similar and they were significantly higher than that of N1, but the agronomic N use efficiency (ANUE), REN, and the physiological NUE (PNUE) of N2 were 54.2, 34.9, and 14.4% higher, respectively, than those of N3. N application beyond the optimal N rate did not consistently increase maize yield, and caused a decrease in N use efficiencies. Highest overall dry matter, N accumulation, and yields were observed with N3 under W2, and those showed no differences with N2 and N3 under W3. Under this experimental condition, the CRU of 210 kg ha(-1) was optimized when soil moisture content was 75% +/- 5% of field capacity, but an N rate of 315 kg ha(-1) was superior when soil moisture content during the entire growing season was maintained at 55% +/- 5% of field capacity.	[Li, Guanghao; Zhao, Bin; Dong, Shuting; Zhang, Jiwang; Liu, Peng] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Li, Guanghao; Zhao, Bin; Dong, Shuting; Zhang, Jiwang; Liu, Peng] Shandong Agr Univ, Coll Agron, Tai An, Shandong, Peoples R China; [Vyn, Tony J.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Shandong Agricultural University; Shandong Agricultural University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhao, B; Dong, ST (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.; Zhao, B; Dong, ST (corresponding author), Shandong Agr Univ, Coll Agron, Tai An, Shandong, Peoples R China.	zhaobin@sdau.edu.cn; stdong@sdau.edu.cn		Vyn, Tony/0000-0001-9860-4475	Natural Science Foundation of China [31171497, 31301274]; Funds of Shandong "Double Tops" Program [SYL2017XTTD14]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds of Shandong "Double Tops" Program	This research was supported by the Natural Science Foundation of China (No.31171497, No.31301274) and Funds of Shandong "Double Tops" Program (SYL2017XTTD14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the financial support of the Natural Science Foundation of China (No.31171497, No.31301274) and Funds of Shandong "Double Tops" Program (SYL2017XTTD14). We would also like to thank the reviewers for helping us improve our original manuscript. The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, please see: hiip://www.LexLcheck.com/certificate/h3YTkF	ALLISON JCS, 1966, ANN BOT-LONDON, V30, P365, DOI 10.1093/oxfordjournals.aob.a084082; Bhadra Parija, 2013, Journal of Plant Science Research, V29, P177; Chen KR, 2015, FIELD CROP RES, V183, P315, DOI 10.1016/j.fcr.2015.08.013; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Ciampitti IA, 2013, CROP SCI, V53, P366, DOI 10.2135/cropsci2012.07.0439; Ciampitti IA, 2012, CROP SCI, V52, P2728, DOI 10.2135/cropsci2012.05.0305; Ciampitti IA, 2011, FIELD CROP RES, V121, P2, DOI 10.1016/j.fcr.2010.10.009; Diez JA, 1994, NUTR CYCL AGROECOSYS, V43, P191; Duan YH, 2011, SOIL SCI SOC AM J, V75, P1562, DOI 10.2136/sssaj2010.0315; DUVICK DN, 1992, MAYDICA, V37, P69; EGHBALL B, 1991, COMMUN SOIL SCI PLAN, V22, P1367, DOI 10.1080/00103629109368498; Fang Q, 2008, J ENVIRON QUAL, V37, P2232, DOI 10.2134/jeq2007.0601; FREDERICK JR, 1990, ANN BOT-LONDON, V66, P407, DOI 10.1093/oxfordjournals.aob.a088042; Ge TD, 2012, ACTA PHYSIOL PLANT, V34, P1043, DOI 10.1007/s11738-011-0901-y; Geng J, 2016, AGRON J, V108, P1; Gheysari M, 2009, AGR WATER MANAGE, V96, P809, DOI 10.1016/j.agwat.2008.11.003; Gheysari M, 2009, AGR WATER MANAGE, V96, P946, DOI 10.1016/j.agwat.2009.01.005; Guo LW, 2016, EUR J AGRON, V75, P118, DOI 10.1016/j.eja.2016.01.010; Hu HY, 2013, FIELD CROP RES, V142, P85, DOI 10.1016/j.fcr.2012.12.001; Huang P, 2014, BIOL FERT SOILS, V51, P1; HUGGINS DR, 1993, AGRON J, V85, P898, DOI 10.2134/agronj1993.00021962008500040022x; Jia XC, 2014, AGR WATER MANAGE, V137, P92, DOI 10.1016/j.agwat.2014.02.010; Jiang PeiFu, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P1; Lal R, 2013, J PLANT NUTR SOIL SC, V176, P479, DOI 10.1002/jpln.201300189; Li GuangHao, 2015, Acta Agronomica Sinica, V41, P1406; Li YJ, 2013, AGR OUTLOOK, V07, P47; Lu RK, 2000, SOIL AGR CHEM ANAL M; Miao WenFang, 2011, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V19, P293, DOI 10.3724/SP.J.1011.2011.00293; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Mueller SM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00053; Nannen DU, 2011, NUTR CYCL AGROECOSYS, V68, P3; Paponov IA, 2005, J PLANT NUTR SOIL SC, V168, P447, DOI 10.1002/jpln.200520505; Peng Yu, 2014, Acta Agronomica Sinica, V40, P859; Shao GQ, 2013, J PLANT NUTR SOIL SC, V176, P595, DOI 10.1002/jpln.201100185; Shaviv A, 2001, ADV AGRON, V71, P1, DOI 10.1016/S0065-2113(01)71011-5; Teixeira AI, 2014, FIELD CROP RES, V168, P109, DOI 10.1016/j.fcr.2014.08.002; Tollenaar M, 2002, FIELD CROP RES, V75, P161, DOI 10.1016/S0378-4290(02)00024-2; [卫丽 Wei Li], 2010, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V16, P773; Wu Z-J, 2001, REV CHINA AGR SCI TE, V3, P73; Zhang M., 2001, J CHEM FERTILIZER IN, V28, P27; Zhang SL, 2014, FIELD CROP RES, V163, P55, DOI 10.1016/j.fcr.2014.04.003; Zhang WF, 2016, NATURE, V537, P671, DOI 10.1038/nature19368; Zhao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070569; Zhao Bin, 2010, Acta Agronomica Sinica, V36, P1760; [赵荣芳 Zhao Rongfang], 2009, [土壤学报, Acta Pedologica Sinica], V46, P684	45	22	22	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181774	10.1371/journal.pone.0181774	http://dx.doi.org/10.1371/journal.pone.0181774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738065	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700069
J	Brun, P; Scarpa, M; Marchiori, C; Sarasin, G; Caputi, V; Porzionato, A; Giron, MC; Palu, G; Castagliuolo, I				Brun, Paola; Scarpa, Melania; Marchiori, Chiara; Sarasin, Gloria; Caputi, Valentina; Porzionato, Andrea; Giron, Maria Cecilia; Palu, Giorgio; Castagliuolo, Ignazio			Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; QUALITY-OF-LIFE; ABDOMINAL-PAIN; DOUBLE-BLIND; INTESTINAL-MUCOSA; CONTROLLED-TRIAL; GUT MICROBIOTA; IMMUNE-SYSTEM; MAST-CELLS	Background We evaluated the effect of Saccharomyces boulardii CNCM I-745 on intestinal neuromuscular anomalies in an IBS-type mouse model of gastrointestinal motor dysfunctions elicited by Herpes Simplex Virus type 1 (HSV-1) exposure. Methods Mice were inoculated intranasally with HSV-1 (10(2) PFU) or vehicle at time 0 and 4 weeks later by the intragastric (IG) route (10(8) PFU). Six weeks after IG inoculum, mice were randomly allocated to receive oral gavage with either S. boulardii (10(7) CFU/day) or vehicle. After 4 weeks the following were determined: a) intestinal motility using fluorescein-isothiocyanate dextran distribution in the gut, fecal pellet expulsion, stool water content, and distal colonic transit of glass beads; b) integrity of the enteric nervous system (ENS) by immunohistochemistry on ileal whole-mount preparations and western blot of protein lysates from ileal longitudinal muscle and myenteric plexus; c) isometric muscle tension with electric field and pharmacological (carbachol) stimulation of ileal segments; and d) intestinal inflammation by levels of tumor necrosis factor a, interleukin(IL)-1 beta, IL-10 and IL-4. Results S. boulardii CNCM I-745 improved HSV-1 induced intestinal dysmotility and alteration of intestinal transit observed ten weeks after IG inoculum of the virus. Also, the probiotic yeast ameliorated the structural alterations of the ENS induced by HSV-1 (i.e., reduced peripherin immunoreactivity and expression, increased glial S100 beta protein immunoreactivity and neuronal nitric oxide synthase level, reduced substance P-positive fibers). Moreover, S. boulardii CNCM I-745 diminished the production of HSV-1 associated pro-inflammatory cytokines in the myenteric plexus and increased levels of anti-inflammatory interleukins. Conclusions S. boulardii CNCM I-745 ameliorated gastrointestinal neuromuscular anomalies in a mouse model of gut dysfunctions typically observed with irritable bowel syndrome.	[Brun, Paola; Scarpa, Melania; Marchiori, Chiara; Palu, Giorgio; Castagliuolo, Ignazio] Univ Padua, Dept Mol Med, Padua, Italy; [Sarasin, Gloria; Porzionato, Andrea] Univ Padua, Dept Neurosci, Padua, Italy; [Caputi, Valentina; Giron, Maria Cecilia] Univ Padua, Dept Pharmacol Sci, Padua, Italy	University of Padua; University of Padua; University of Padua	Brun, P (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	paola.brun.1@unipd.it	Scarpa, Melania/M-2777-2019; Giron, Maria Cecilia/AAL-4438-2021; Giron, Maria Cecilia/K-7557-2019; Brun, Paola/A-3380-2016	Scarpa, Melania/0000-0002-7055-635X; Giron, Maria Cecilia/0000-0002-0825-7965; Giron, Maria Cecilia/0000-0002-0825-7965; Brun, Paola/0000-0002-3279-9000	BIOCODEX S.A. (Gentilly, France); Biocodex	BIOCODEX S.A. (Gentilly, France); Biocodex	This work was financed by a grant allocated by BIOCODEX S.A. (Gentilly, France) to University of Padova. The funder had no role in study design, data collection and analysis or decision to publish. The authors declare no conflict of interests regarding the present study.; English editing and formatting of this manuscript was provided by Andrea Bothwell on behalf of Springer Healthcare Communications, with funding provided by Biocodex.	Abbas Z, 2014, EUR J GASTROEN HEPAT, V26, P630, DOI 10.1097/MEG.0000000000000094; Akbar A, 2008, GUT, V57, P923, DOI 10.1136/gut.2007.138982; Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671; BAFUTTO Mauro, 2013, Arq. Gastroenterol., V50, P304, DOI 10.1590/S0004-28032013000400012; Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barc MC, 2008, ANAEROBE, V14, P229, DOI 10.1016/j.anaerobe.2008.04.003; Borruel N, 2003, AM J GASTROENTEROL, V98, P865, DOI 10.1111/j.1572-0241.2003.07384.x; Brenner DM, 2009, AM J GASTROENTEROL, V104, P1033, DOI 10.1038/ajg.2009.25; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Brun P, 2010, GASTROENTEROLOGY, V138, P1790, DOI 10.1053/j.gastro.2010.01.036; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Chadwick VS, 2002, GASTROENTEROLOGY, V122, P1778, DOI 10.1053/gast.2002.33579; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954; Choi CH, 2011, J CLIN GASTROENTEROL, V45, P679, DOI 10.1097/MCG.0b013e318204593e; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; Cremon C, 2011, AM J GASTROENTEROL, V106, P1290, DOI 10.1038/ajg.2011.86; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Darbaky Y, 2017, J APPL MICROBIOL, V122, P188, DOI 10.1111/jam.13320; de Chambrun GP, 2015, DIGEST LIVER DIS, V47, P119, DOI 10.1016/j.dld.2014.11.007; De Giorgio R, 2004, GASTROENTEROLOGY, V126, P1872, DOI 10.1053/j.gastro.2004.02.024; de Vries P, 2010, AM J PHYSIOL-GASTR L, V299, pG539, DOI 10.1152/ajpgi.00092.2010; Demir IE, 2013, ACTA NEUROPATHOL, V125, P491, DOI 10.1007/s00401-013-1099-4; Di Nardo G, 2008, ALIMENT PHARM THER, V28, P25, DOI 10.1111/j.1365-2036.2008.03707.x; Didari T, 2015, WORLD J GASTROENTERO, V21, P3072, DOI 10.3748/wjg.v21.i10.3072; Dothel G, 2015, GASTROENTEROLOGY, V148, P1002, DOI 10.1053/j.gastro.2015.01.042; Floch MH, 2005, J CLIN GASTROENTEROL, V39, pS243, DOI 10.1097/01.mcg.0000156104.67505.5b; Ford AC, 2014, AM J GASTROENTEROL, V109, P1547, DOI 10.1038/ajg.2014.202; Fujikawa Y, 2015, NEUROGASTROENT MOTIL, V27, P1010, DOI 10.1111/nmo.12577; Garcia J H, 1995, Rev Neurol, V23, P1067; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Guslandi M, 2011, J CLIN GASTROENTEROL, V45, P740, DOI 10.1097/MCG.0b013e3182166c76; Guyonnet D, 2007, ALIMENT PHARM THER, V26, P475, DOI 10.1111/j.1365-2036.2007.03362.x; Hallett PJ, 2012, NEUROBIOL DIS, V47, P258, DOI 10.1016/j.nbd.2012.04.009; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; Kelesidis T, 2012, THER ADV GASTROENTER, V5, P111, DOI 10.1177/1756283X11428502; Keszthelyi D, 2013, EUR J PAIN, V17, P1299, DOI 10.1002/j.1532-2149.2013.00309.x; Lee SK, 2009, DIGEST DIS SCI, V54, P255, DOI 10.1007/s10620-008-0357-0; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Miquel S, 2016, SCI REP-UK, V6, DOI 10.1038/srep19399; Nagy A, 2006, CSH PROTOC, V1; Numazaki M, 2004, CNS NEUROL DISORD-DR, V3, P479, DOI 10.2174/1568007043336789; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; RAFFA RB, 1987, LIFE SCI, V41, P2229, DOI 10.1016/0024-3205(87)90520-0; Rajput IR, 2014, J CELL BIOCHEM, V115, P189, DOI 10.1002/jcb.24650; Ringel-Kulka T, 2014, ALIMENT PHARM THER, V40, P200, DOI 10.1111/apt.12800; Schwetz I, 2005, AM J PHYSIOL-GASTR L, V289, pG704, DOI 10.1152/ajpgi.00498.2004; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Spiegel Brennan M R, 2009, Curr Gastroenterol Rep, V11, P265; Swidsinski A, 2008, GASTROENTEROLOGY, V135, P568, DOI 10.1053/j.gastro.2008.04.017; Wang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20320; Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x; Zhang L, 2016, J NEUROGASTROENTEROL, V22, P181, DOI 10.5056/jnm15137	56	16	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181863	10.1371/journal.pone.0181863	http://dx.doi.org/10.1371/journal.pone.0181863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732069	Green Submitted, gold, Green Published			2022-12-26	WOS:000406643100066
J	Maknitikul, S; Luplertlop, N; Grau, GER; Ampawong, S				Maknitikul, Sitang; Luplertlop, Natthanej; Grau, Georges E. R.; Ampawong, Sumate			Dysregulation of pulmonary endothelial protein C receptor and thrombomodulin in severe falciparum malaria-associated ARDS relevant to hemozoin	PLOS ONE			English	Article							MODULATES APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; CELLS; PATHOGENESIS; INFLAMMATION; COAGULATION; MECHANISMS; PATHOLOGY; SEQUESTRATION	To investigate the role of the protein C system, endothelial protein C receptor (EPCR) and thrombomodulin (TM) in the pathogenesis of malaria-associated acute respiratory distress syndrome (ARDS) in relation to hemozoin and proinflammatory cytokines-induced type II pneumocyte injury and - aggravated pulmonary resolution. A total of 29 left-over lung specimens that were obtained from patients who died from severe falciparum malaria were examined. Histopathological, immunohistochemical and electron microscopic analyses revealed that ARDS coexisted with pulmonary edema and systemic bleeding; the severity was dependent on the level of hemozoin deposition in the lung and internal alveolar hemorrhaging. The loss of EPCR and TM was primarily identified in ARDS patients and was related to the level of hemozoin, parasitized red blood cell (PRBC) and white blood cell accumulation in the lung. Moreover, an in vitro analysis demonstrated that interleukin-13 and -31 and hemozoin induced pneumocytic cell injury and apoptosis, as assessed by EB/AO staining, electron microscopy and the up-regulation of CARD-9 mRNA (caspase recruitment domain-9 messenger-ribonucleic acid). The dysregulation of EPCR and TM in the lung, especially in those with increased levels of hemozoin, may play an important role in the pathogenesis of malaria-associated ARDS through an apoptotic pathway.	[Maknitikul, Sitang; Ampawong, Sumate] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Luplertlop, Natthanej] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Grau, Georges E. R.] Univ Sydney, Sydney Med Sch, Dept Pathol, Vasc Immunol, Camperdown, NSW, Australia	Mahidol University; Mahidol University; University of Sydney	Ampawong, S (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand.	am_sumate@hotmail.com	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; AMPAWONG, Sumate/0000-0002-5378-2996	Faculty of Tropical Medicine, Mahidol University, Thailand	Faculty of Tropical Medicine, Mahidol University, Thailand	This study was supported by Faculty of Tropical Medicine, Mahidol University, Thailand, Fiscal year 2014.	Aird WC, 2014, BLOOD, V123, P163, DOI 10.1182/blood-2013-09-521005; Ampawong S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0922-x; Angchaisuksiri P, 2014, THROMB RES, V133, P5, DOI 10.1016/j.thromres.2013.09.030; Aursudkij Boonrut, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P541; Avril M, 2016, MBIO, V7, DOI 10.1128/mBio.00615-16; Ayimba E, 2011, CLIN EXP IMMUNOL, V166, P218, DOI 10.1111/j.1365-2249.2011.04474.x; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; BROOKS MH, 1968, NEW ENGL J MED, V279, P732, DOI 10.1056/NEJM196810032791402; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; CROSS CE, 1990, ADV EXP MED BIOL, V264, P435; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; Fabbi M, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3958069; Fanelli Vito, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS3, DOI 10.1513/AnnalsATS.201407-340MG; FELDMAN RM, 1987, REV INFECT DIS, V9, P134; Finigan JH, 2009, MICROVASC RES, V77, P35, DOI 10.1016/j.mvr.2008.09.002; Foster KA, 2001, J PHARM PHARMACOL, V53, P57, DOI 10.1211/0022357011775190; Frank PG, 2008, AM J PHYSIOL-HEART C, V295, pH926, DOI 10.1152/ajpheart.00779.2008; Gillrie MR, 2015, CELL MICROBIOL, V17, P1883, DOI 10.1111/cmi.12479; Gillrie MR, 2012, AM J PATHOL, V180, P1028, DOI 10.1016/j.ajpath.2011.11.037; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P237, DOI 10.1164/ajrccm.161.1.9810007; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Jiang S, 2017, TOXICOL LETT, V273, P36, DOI 10.1016/j.toxlet.2017.03.015; LICHTMAN AR, 1990, CRIT CARE MED, V18, P666, DOI 10.1097/00003246-199006000-00020; Liu K, 2015, MED SCI MONIT BASIC, V21, P15, DOI 10.12659/MSMBR.893327; Liu LH, 2012, ONCOL REP, V27, P1497, DOI 10.3892/or.2012.1663; Milner D, 2013, HUM PATHOL, V44, P2719, DOI 10.1016/j.humpath.2013.07.018; Mosnier LO, 2016, THROMB RES, V141, pS46, DOI 10.1016/S0049-3848(16)30364-4; Moxon CA, 2013, BLOOD, V122, P842, DOI 10.1182/blood-2013-03-490219; N'Dilimabaka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090692; Naka I, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-105; Neyrinck AP, 2009, BRIT J PHARMACOL, V158, P1034, DOI 10.1111/j.1476-5381.2009.00251.x; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Percario S, 2012, INT J MOL SCI, V13, P16346, DOI 10.3390/ijms131216346; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Punsawad C, 2015, INT J CLIN EXP PATHO, V8, P10002; Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260; Rasmussen BS, 2016, THROMB RES, V139, P82, DOI 10.1016/j.thromres.2016.01.015; Scaccabarozzi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143195; Song Yong, 1999, Zhonghua Jiehe He Huxi Zazhi, V22, P610; Srinivas R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-42; TATKE M, 1990, J TROP MED HYG, V93, P377; Turner L, 2013, NATURE, V498, P502, DOI 10.1038/nature12216; Uematsu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17577; van den Brand JMA, 2014, J COMP PATHOL, V151, P83, DOI 10.1016/j.jcpa.2014.01.004; van der Poll T, 2013, BLOOD, V122, P624, DOI 10.1182/blood-2013-06-508531; Viriyavejakul P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-106; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; WHITE NJ, 1992, ADV PARASIT, V31, P83, DOI 10.1016/S0065-308X(08)60021-4; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, V2nd; Yamazaki T, 2008, J CHEMOTHERAPY, V20, P428, DOI 10.1179/joc.2008.20.4.428; ZAPOL WM, 1979, AM REV RESPIR DIS, V119, P547	56	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181674	10.1371/journal.pone.0181674	http://dx.doi.org/10.1371/journal.pone.0181674			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732053	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100055
J	Pathak, V; Prasad, A; Pospisil, P				Pathak, Vinay; Prasad, Ankush; Pospisil, Pavel			Formation of singlet oxygen by decomposition of protein hydroperoxide in photosystem II	PLOS ONE			English	Article							LINOLEIC-ACID HYDROPEROXIDE; DONOR-SIDE PHOTOINHIBITION; MOLECULAR-OXYGEN; LIPID HYDROPEROXIDES; ELECTRON-TRANSPORT; FLUORESCENT-PROBE; PHOTON-EMISSION; WATER OXIDATION; CORE COMPLEXES; MECHANISM	Singlet oxygen (O-1(2)) is formed by triplet-triplet energy transfer from triplet chlorophyll to O-2 via Type II photosensitization reaction in photosystem II (PSII). Formation of triplet chlorophyll is associated with the change in spin state of the excited electron and recombination of triplet radical pair in the PSII antenna complex and reaction center, respectively. Here, we have provided evidence for the formation of O-1(2) by decomposition of protein hydroperoxide in PSII membranes deprived of Mn4O5Ca complex. Protein hydroperoxide is formed by protein oxidation initiated by highly oxidizing chlorophyll cation radical and hydroxyl radical formed by Type I photosensitization reaction. Under highly oxidizing conditions, protein hydroperoxide is oxidized to protein peroxyl radical which either cyclizes to dioxetane or recombines with another protein peroxyl radical to tetroxide. These highly unstable intermediates decompose to triplet carbonyls which transfer energy to O-2 forming O-1(2). Data presented in this study show for the first time that O-1(2) is formed by decomposition of protein hydroperoxide in PSII membranes deprived of Mn4O5Ca complex.	[Pathak, Vinay; Prasad, Ankush; Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, Olomouc, Czech Republic	Palacky University Olomouc	Pospisil, P (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, Olomouc, Czech Republic.	pavel.pospisil@upol.cz	POSPÍŠIL, Pavel/AAH-4451-2019; Prasad, Ankush/G-6690-2011	POSPÍŠIL, Pavel/0000-0001-9126-2011; Prasad, Ankush/0000-0002-2009-8987	Ministry of Education, Youth and Sports of the Czech Republic [LO1204]; Palacky University [IGA_PrF_2017_017]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Palacky University	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic grant no. LO1204 (National Program of Sustainability I) and Palacky University students project no. IGA_PrF_2017_017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; Bao H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00578; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Birtic S, 2011, PLANT J, V67, P1103, DOI 10.1111/j.1365-313X.2011.04646.x; Boekema EJ, 2009, EMBO J, V28, p3052 ; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Chatterjee R, 2016, CHEM SCI, V7, P5236, DOI [10.1039/C6SC00512H, 10.1039/c6sc00512h]; Davies MJ, 2016, BIOCHEM J, V473, P805, DOI 10.1042/BJ20151227; Faller P, 2001, P NATL ACAD SCI USA, V98, P14368, DOI 10.1073/pnas.251382598; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Fischer BB, 2013, ANTIOXID REDOX SIGN, V18, P2145, DOI 10.1089/ars.2012.5124; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Havaux M, 2006, TRENDS PLANT SCI, V11, P480, DOI 10.1016/j.tplants.2006.08.001; Khorobrykh AA, 2015, PHOTOSYNTH RES, V126, P417, DOI 10.1007/s11120-015-0135-8; Khorobrykh SA, 2011, BIOCHEMISTRY-US, V50, P10658, DOI 10.1021/bi200945v; Kobayashi M, 2007, BBA-BIOENERGETICS, V1767, P596, DOI 10.1016/j.bbabio.2007.02.015; Mano CM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05938; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Miyamoto S, 2003, J AM CHEM SOC, V125, P6172, DOI 10.1021/ja029115o; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; MORI H, 1995, BBA-BIOENERGETICS, V1228, P37, DOI 10.1016/0005-2728(94)00156-Y; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Nadtochenko VA, 2014, BBA-BIOENERGETICS, V1837, P1384, DOI 10.1016/j.bbabio.2014.01.026; Nelson N, 2015, ANNU REV BIOCHEM, V84, P659, DOI 10.1146/annurev-biochem-092914-041942; Perez-Navarro M, 2016, CURR OPIN CHEM BIOL, V31, P113, DOI 10.1016/j.cbpa.2016.02.007; Pospisil P, 2017, BBA-GEN SUBJECTS, V1861, P457, DOI 10.1016/j.bbagen.2016.10.005; Pospisil P, 2014, J PHOTOCH PHOTOBIO B, V137, P39, DOI 10.1016/j.jphotobiol.2014.04.025; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; POU S, 1994, ANAL BIOCHEM, V217, P76, DOI 10.1006/abio.1994.1085; Prasad A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01211; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Rinalducci S, 2008, BBA-BIOENERGETICS, V1777, P417, DOI 10.1016/j.bbabio.2008.02.005; RUSSELL GA, 1957, J AM CHEM SOC, V79, P3871, DOI 10.1021/ja01571a068; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmitt FJ, 2014, BBA-BIOENERGETICS, V1837, P835, DOI 10.1016/j.bbabio.2014.02.005; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; Soh N, 2006, BIOORG MED CHEM LETT, V16, P2943, DOI 10.1016/j.bmcl.2006.02.078; Soh N, 2007, ORG BIOMOL CHEM, V5, P3762, DOI 10.1039/b713223a; Telfer A, 2014, PLANT CELL PHYSIOL, V55, P1216, DOI 10.1093/pcp/pcu040; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tyystjarvi E, 2013, INT REV CEL MOL BIO, V300, P243, DOI 10.1016/B978-0-12-405210-9.00007-2; van Amerongen H, 2013, PHOTOSYNTH RES, V116, P251, DOI 10.1007/s11120-013-9824-3; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Wobbe L, 2016, TRENDS PLANT SCI, V21, P55, DOI 10.1016/j.tplants.2015.10.004; Yadav DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045883; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Yanykin DV, 2010, BBA-BIOENERGETICS, V1797, P516, DOI 10.1016/j.bbabio.2010.01.014; Zabelin AA, 2016, BBA-BIOENERGETICS, V1857, P782, DOI 10.1016/j.bbabio.2016.03.029; Zhang H, 2000, FEBS LETT, V473, P58, DOI 10.1016/S0014-5793(00)01498-8	53	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181732	10.1371/journal.pone.0181732	http://dx.doi.org/10.1371/journal.pone.0181732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732060	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100060
J	Stanifer, JW; Karia, F; Maro, V; Kilonzo, K; Qin, XJ; Patel, UD; Hauser, ER				Stanifer, John W.; Karia, Francis; Maro, Venance; Kilonzo, Kajiru; Qin, Xuejun; Patel, Uptal D.; Hauser, Elizabeth R.			APOL1 risk alleles among individuals with CKD in Northern Tanzania: A pilot study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SUB-SAHARAN AFRICA; HUMAN HEREDITY; VARIANTS; POPULATION; BURDEN; FREQUENCY; HEALTH; INCOME	Introduction In sub-Saharan Africa, approximately 100 million people have CKD, yet genetic risk factors are not well-understood. Despite the potential importance of understanding APOL1 risk allele status among individuals with CKD, little genetic research has been conducted. Therefore, we conducted a pilot study evaluating the feasibility of and willingness to participate in genetic research on kidney disease, and we estimated APOL1 risk allele frequencies among individuals with CKD. ethods In 2014, we conducted a community-based field study evaluating CKD epidemiology in northern Tanzania. We assessed for CKD using urine albumin and serum creatinine to estimate GFR. We invited participants with CKD to enroll in an additional genetic study. We obtained dried-blood spots on filter cards, from which we extracted DNA using sterile punch biopsies. We genotyped for two single nucleotide polymorphisms (SNPs) defining the APOL1 G1 risk allele and an insertion/deletion polymorphism defining the G2 risk allele. Genotyping was performed in duplicate. Results We enrolled 481 participant, 57 (12%) of whom had CKD. Among these, enrollment for genotyping was high (n = 48; 84%). We extracted a median of 19.4 ng of DNA from each driedblood spot sample, and we genotyped the two APOL1 G1 SNPs and the APOL1 G2 polymorphism. Genotyping quality was high, with all duplicated samples showing perfect concordance. The frequency of APOL1 risk variants ranged from 7.0% to 11.0%, which was similar to previously-reported frequencies from the general population of northern Tanzania (p > 0.2). Discussion In individuals with CKD from northern Tanzania, we demonstrated feasibility of genotyping APOL1 risk alleles. We successfully genotyped three risk variants from DNA extracted from filter cards, and we demonstrated a high enrollment for participation. In this population, more extensive genetic studies of kidney disease may be well-received and will be feasible.	[Stanifer, John W.; Patel, Uptal D.; Hauser, Elizabeth R.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Stanifer, John W.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Stanifer, John W.] Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA; [Karia, Francis; Maro, Venance; Kilonzo, Kajiru] Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Qin, Xuejun; Hauser, Elizabeth R.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Hauser, Elizabeth R.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA.	john.stanifer@duke.edu		Hauser, Elizabeth/0000-0003-0367-9189	NIH Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; International Society of Nephrology Global Outreach Committee; Duke O'Brien Center; National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health [P30DK096493]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Society of Nephrology Global Outreach Committee; Duke O'Brien Center; National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an NIH Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and the Duke O'Brien Center, the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health (P30DK096493). There was no involvement by the funding sources in the design, analysis, or writing of this study. All authors had full access to the data and had final responsibility for the decision to publish.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Bowcock A M, 1991, Gene Geogr, V5, P151; Central Census Office and National Bureau of Statistics, 2013, UN REP TANZ 2012 POP; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Janmohamed MN, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-183; JORDE LB, 1995, AM J HUM GENET, V57, P523; Kalyesubula R, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0521-x; Ko WY, 2013, AM J HUM GENET, V93, P54, DOI 10.1016/j.ajhg.2013.05.014; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Lunyera Joseph, 2016, BMC Res Notes, V9, P97, DOI 10.1186/s13104-016-1897-6; Matimba Alice, 2009, Human Genomics, V3, P169; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Osafo C, 2016, KIDNEY INT, V90, P2, DOI 10.1016/j.kint.2015.12.059; Osafo C, 2015, CLIN J AM SOC NEPHRO, V10, P2279, DOI 10.2215/CJN.11951214; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; R Development Core Team, 2012, R LANG ENV STAT COMP; Rajeevan H, 2012, NUCLEIC ACIDS RES, V40, pD1010, DOI 10.1093/nar/gkr924; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164428; Stanifer JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156336; Stanifer JW, 2016, NEPHROL DIAL TRANSPL, V31, P868, DOI 10.1093/ndt/gfv466; Stanifer JW, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2912-5; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Tzur S, 2012, NEPHROL DIAL TRANSPL, V27, P1498, DOI 10.1093/ndt/gfr796; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7; Zekraoui L, 1997, HUM BIOL, V69, P575	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181811	10.1371/journal.pone.0181811	http://dx.doi.org/10.1371/journal.pone.0181811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732083	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100064
J	Gibbs, A; Carpenter, B; Crankshaw, T; Hannass-Hancock, J; Smit, J; Tomlinson, M; Butler, L				Gibbs, Andrew; Carpenter, Bradley; Crankshaw, Tamaryn; Hannass-Hancock, Jill; Smit, Jennifer; Tomlinson, Mark; Butler, Lisa			Prevalence and factors associated with recent intimate partner violence and relationships between disability and depression in postpartum women in one clinic in eThekwini Municipality, South Africa	PLOS ONE			English	Article							HEALTH; RISK; MULTICOUNTRY; PEOPLE	Intimate partner violence (IPV) experienced by pregnant and post-partum women has negative health effects for women, as well as the foetus, and the new-born child. In this study we sought to assess the prevalence and factors associated with recent IPV amongst post-partum women in one clinic in eThekwini Municipality, South Africa, and explore the relationship between IPV, depression and functional limitations/disabilities. Past 12 month IPV-victimisation was 10.55%. Logistic regression modelled relationships between IPV, functional limitations, depressive symptoms, socio-economic measures, and sexual relationship power. In logistic regression models, overall severity of functional limitations were not associated with IPV-victimisation when treated as a continuous overall score. In this model relationship power (aOR0.22, p = 0.001) and depressive symptoms (aOR1.26, p = 0.001) were significant. When the different functional limitations were separated out in a second model, significant factors were relationship power (aOR0.20, p = 0.001), depressive symptoms (aOR1.20, p = 0.011) and mobility limitations (aOR2.96, p = 0.024). The study emphasises that not all functional limitations are associated with IPV-experience, that depression and disability while overlapping can also be considered different drivers of vulnerability, and that women's experience of IPV is not dependent on pregnancy specific factors, but rather wider social factors that all women experience.	[Gibbs, Andrew] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gibbs, Andrew; Carpenter, Bradley; Crankshaw, Tamaryn] Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa; [Carpenter, Bradley; Hannass-Hancock, Jill] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa; [Smit, Jennifer] Univ Witwatersrand, Fac Hlth Sci, Dept Obstet & Gynaecol, MatCH Res Unit, Johannesburg, South Africa; [Tomlinson, Mark] Stellenbosch Univ, Dept Psychol, Stellenbosch, South Africa; [Butler, Lisa] Univ Connecticut, Inst Collaborat Hlth Intervent & Policy, Storrs, CT USA	South African Medical Research Council; University of Kwazulu Natal; South African Medical Research Council; University of Witwatersrand; Stellenbosch University; University of Connecticut	Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Gibbs, A (corresponding author), Univ KwaZulu Natal, Hlth Econ & HIV AIDS Res Div HEARD, Durban, South Africa.	Andrew.gibbs@mrc.ac.za	Carpenter, Bradley/F-2554-2015; Hanass-Hancock, Jill/AAV-7141-2021	Carpenter, Bradley/0000-0002-2968-1968; Hanass-Hancock, Jill/0000-0003-3662-8548; Crankshaw, Tamaryn/0000-0001-6974-1593; Gibbs, Andrew/0000-0003-2812-5377	Swedish International Development Agency (Sida); Norwegian Agency for Development Cooperation (Norad), through HEARD, UKZN; AG the South African Medical Research Council; National Research Foundation, South Africa; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA022919] Funding Source: NIH RePORTER	Swedish International Development Agency (Sida); Norwegian Agency for Development Cooperation (Norad), through HEARD, UKZN; AG the South African Medical Research Council(South African Medical Research Council); National Research Foundation, South Africa(National Research Foundation - South Africa); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The original project was funded by the Swedish International Development Agency (Sida), Norwegian Agency for Development Cooperation (Norad), through HEARD, UKZN. Funding for this analysis comes from: AG the South African Medical Research Council. However, the views expressed and information contained within are not necessarily those of or endorsed by Sida or Norad, which can accept no responsibility for such views or information or for any reliance placed on them. MT is a lead investigator with the Centre of Excellence in Human Development, University Witwatersrand, South Africa, and is supported by the National Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MT is a lead investigator with the Centre of Excellence in Human Development, University Witwatersrand, South Africa, and is supported by the National Research Foundation, South Africa. We thank the participants and field staff who collected the data.	Abramsky T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-109; Bingham N.H., 2010, REGRESSION LINEAR MO; Brownridge DA, 2006, VIOLENCE AGAINST WOM, V12, P805, DOI 10.1177/1077801206292681; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; De Beaudrap P, 2017, LANCET HIV, V4, pE161, DOI 10.1016/S2352-3018(16)30209-0; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Dickman B., 2006, DISABILITY SOCIAL CH, P116; Fong S, 2016, INT J GYNECOLOGY OBS; Foran HM, 2008, CLIN PSYCHOL REV, V28, P1222, DOI 10.1016/j.cpr.2008.05.001; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gender Links, 2011, WAR HOM PREL FIND GA; Gibbs A, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17362; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; Groves AK, 2014, RELATIONSHIP FACTORS; Hanass-Hancock J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143936; Health Do, 2014, S AFR NAT ANT HIV PR; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Jewkes R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1325; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Krishnan S, 2008, ANN NY ACAD SCI, V1136, P101, DOI 10.1196/annals.1425.013; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kvam MH, 2008, SEX ABUSE-J RES TR, V20, P5, DOI 10.1177/1079063208314817; Machisa M., 2011, WAR HOME GENDER BASE; Machisa MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175240; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Shamu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109447; Shamu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017591; Van Der Heijden I, 2014, WHAT WORKS PREVENT V; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; Wachs TD, 2009, CHILD DEV PERSPECT, V3, P51, DOI 10.1111/j.1750-8606.2008.00077.x; World Health Organization, 2021, VIOL WOM PREV EST 20	36	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181236	10.1371/journal.pone.0181236	http://dx.doi.org/10.1371/journal.pone.0181236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727838	Green Published, gold			2022-12-26	WOS:000406634500048
J	Miki, T; Naito, T; Fujiwara, M; Araki, R; Kiyoi, R; Shiode, Y; Fujiwara, A; Morizane, Y; Shiraga, F				Miki, Takako; Naito, Tomoko; Fujiwara, Miyuki; Araki, Ryoichi; Kiyoi, Rieko; Shiode, Yusuke; Fujiwara, Atsushi; Morizane, Yuki; Shiraga, Fumio			Effects of pre-surgical administration of prostaglandin analogs on the outcome of trabeculectomy	PLOS ONE			English	Article							UPPER EYELID SULCUS; TOPICAL ANTIGLAUCOMA MEDICATION; OPEN-ANGLE GLAUCOMA; ORBITAL FAT; INTRAOCULAR-PRESSURE; LID SULCUS; BIMATOPROST; DIFFERENTIATION; LATANOPROST; TRAVOPROST	For primary open angle glaucoma (POAG), laser treatment or surgery is used when the target intraocular pressure (IOP) cannot be achieved by pharmacological agents, such as prostaglandin (PG) analogs; these drugs also have varied effects. We retrospectively reviewed the medical records of 74 POAG patients (74 eyes) whose IOP was inadequately controlled by PG analogs (bimatoprost [13 eyes], latanoprost [34 eyes], tafluprost [11 eyes], and travoprost [16 eyes]) and underwent primary trabeculectomy. The proportion of patients with no recurrent IOP elevation within 24 months post-trabeculectomy was significantly (P < 0.001) lower in the bimatoprost group (31.3%) than in the latanoprost (83.2%), tafluprost (45.5%), or travoprost groups (65.6%). Deepening of the upper eyelid sulcus (DUES) was observed before trabeculectomy in 18 of 74 eyes (24.3%) treated with bimatoprost (9 eyes; 50.0%), latanoprost (3 eyes; 16.7%), tafluprost (1 eye; 5.5%) and travoprost (5 eyes; 27.8%). The proportion of patients with no recurrent IOP elevation up to 24 months post-trabeculectomy was significantly (P < 0.0001) lower in the DUES(+) group (34.7%) than in the DUES(-) group (74.3%). Multivariate stepwise logistic regression analysis, with no recurrent IOP elevation used as dependent variable, and bimatoprost, latanoprost, travoprost, tafluprost, beta-blocker, carbonic anhydrase inhibitor, brimonidine, gender, age, preoperative IOP, mean deviation, duration of PG analog use before surgery, and the number of ophthalmic solutions used as independent variables, identified only bimatoprost as a significant independent factor (P = 0.0368). Thus, the outcome of trabeculectomy varied depending on the PG analog used preoperatively, and bimatoprost use was associated with a high risk of recurrent IOP elevation up to 2 years post-trabeculectomy. This may indicate that the incidence of DUES differed with the PG analog used. Patients with glaucoma who are treated with bimatoprost should be monitored for DUES, and when these patients undergo trabeculectomy, the postoperative course of IOP should be followed carefully.	[Miki, Takako; Naito, Tomoko; Fujiwara, Miyuki; Araki, Ryoichi; Shiode, Yusuke; Fujiwara, Atsushi; Morizane, Yuki; Shiraga, Fumio] Okayama Univ, Dept Ophthalmol, Grad Sch Med, Okayama, Japan; [Kiyoi, Rieko] Japanese Red Cross Okayama Hosp, Okayama, Japan	Okayama University	Miki, T (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med, Okayama, Japan.	higo_oka@yahoo.co.jp						Aihara M, 2011, JPN J OPHTHALMOL, V55, P600, DOI 10.1007/s10384-011-0075-6; Aihara M, 2010, CLIN OPHTHALMOL, V4, P163; Alm A, 2008, SURV OPHTHALMOL, V53, pS93, DOI 10.1016/j.survophthal.2008.08.004; Ayala M, 2012, J OCUL PHARMACOL TH, V28, P118, DOI 10.1089/jop.2011.0084; Aydin S, 2010, CUTAN OCUL TOXICOL, V29, P212, DOI 10.3109/15569521003796860; BAUDOUIN C, 1994, OPHTHALMOLOGY, V101, P454; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Berke SJ, 2012, REV OPHTHALMOLOGY, V19, P70; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1437, DOI 10.1001/archopht.1994.01090230051020; Choi HY, 2012, J OCUL PHARMACOL TH, V28, P146, DOI 10.1089/jop.2011.0160; Crawley L, 2012, OPHTHALMOL EYE DIS, V4, P43, DOI 10.4137/OED.S4909; Filippopoulos T, 2008, OPHTHAL PLAST RECONS, V24, P302, DOI 10.1097/IOP.0b013e31817d81df; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Ichhpujani P, 2012, J OCUL PHARMACOL TH, V28, P134, DOI 10.1089/jop.2011.0097; Inoue K, 2013, J GLAUCOMA, V22, P626, DOI 10.1097/IJG.0b013e31824d8d7c; Ishida N, 2006, CARDIOVASC DRUG REV, V24, P1, DOI 10.1111/j.1527-3466.2006.00001.x; Kucukevcilioglu M, 2014, CLIN EXP OPHTHALMOL, V42, P126, DOI 10.1111/ceo.12163; Kulkarni Sadhana V, 2008, Patient Prefer Adherence, V2, P303; Lin L, 2014, ANN PHARMACOTHER, V48, P1585, DOI 10.1177/1060028014548569; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Ogundele AB, 2010, CLIN OPHTHALMOL, V4, P1447, DOI 10.2147/OPTH.S15521; Park J, 2011, JPN J OPHTHALMOL, V55, P22, DOI 10.1007/s10384-010-0904-z; Peplinski LS, 2004, OPTOMETRY VISION SCI, V81, P574, DOI 10.1097/01.opx.0000141791.16683.4a; Sakata R, 2014, EYE, V28, P1446, DOI 10.1038/eye.2014.224; Sakata R, 2013, JPN J OPHTHALMOL, V57, P179, DOI 10.1007/s10384-012-0219-3; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Sethi HS, 2015, ASTROCYTE, V2, P126; Shah M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061638; Singh D, 2009, EYE, V23, P2194, DOI 10.1038/eye.2009.1; Sjoquist B, 2002, SURV OPHTHALMOL, V47, pS6, DOI 10.1016/S0039-6257(02)00302-8; Taketani Y, 2014, INVEST OPHTH VIS SCI, V55, P1269, DOI 10.1167/iovs.13-12589; Tappeiner C, 2008, KLIN MONATSBL AUGENH, V225, P443, DOI 10.1055/s-2008-1027362; Yam JC, 2009, J OCUL PHARMACOL, V53, P176; Yang HK, 2009, JPN J OPHTHALMOL, V53, P176, DOI 10.1007/s10384-008-0623-x; 이중원, 2007, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V48, P332	37	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181550	10.1371/journal.pone.0181550	http://dx.doi.org/10.1371/journal.pone.0181550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727804	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500085
J	Vartanian, V; Tumova, J; Dobrzyn, P; Dobrzyn, A; Nakabeppu, Y; Lloyd, RS; Sampath, H				Vartanian, Vladimir; Tumova, Jana; Dobrzyn, Pawel; Dobrzyn, Agnieszka; Nakabeppu, Yusaku; Lloyd, R. Stephen; Sampath, Harini			8-oxoguanine DNA glycosylase (OGG1) deficiency elicits coordinated changes in lipid and mitochondrial metabolism in muscle	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; ALZHEIMERS-DISEASE BRAIN; BASE EXCISION-REPAIR; SKELETAL-MUSCLE; INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE DAMAGE; SACCHAROMYCES-CEREVISIAE; SER326CYS POLYMORPHISM; PARKINSONS-DISEASE	Oxidative stress resulting from endogenous and exogenous sources causes damage to cellular components, including genomic and mitochondrial DNA. Oxidative DNA damage is primarily repaired via the base excision repair pathway that is initiated by DNA glycosylases. 8-oxoguanine DNA glycosylase (OGG1) recognizes and cleaves oxidized and ring-fragmented purines, including 8-oxoguanine, the most commonly formed oxidative DNA lesion. Mice lacking the OGG1 gene product are prone to multiple features of the metabolic syndrome, including high-fat diet-induced obesity, hepatic steatosis, and insulin resistance. Here, we report that OGG1-deficient mice also display skeletal muscle pathologies, including increased muscle lipid deposition and alterations in genes regulating lipid uptake and mitochondrial fission in skeletal muscle. In addition, expression of genes of the TCA cycle and of carbohydrate and lipid metabolism are also significantly altered in muscle of OGG1-deficient mice. These tissue changes are accompanied by marked reductions in markers of muscle function in OGG1-deficient animals, including decreased grip strength and treadmill endurance. Collectively, these data indicate a role for skeletal muscle OGG1 in the maintenance of optimal tissue function.	[Vartanian, Vladimir; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Tumova, Jana; Sampath, Harini] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ USA; [Dobrzyn, Pawel; Dobrzyn, Agnieszka] Nencki Inst Expt Biol, Warsaw, Poland; [Nakabeppu, Yusaku] Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka, Japan; [Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Sampath, Harini] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ USA; [Sampath, Harini] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Ctr Digest Hlth, New Brunswick, NJ USA	Oregon Health & Science University; Rutgers State University New Brunswick; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Kyushu University; Oregon Health & Science University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Sampath, H (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ USA.; Nakabeppu, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Neurofunct Genom, Dept Immunobiol & Neurosci, Fukuoka, Japan.; Sampath, H (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ USA.; Sampath, H (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Ctr Digest Hlth, New Brunswick, NJ USA.	yusaku@bioreg.kyushu-u.ac.jp; sampath@ifnh.rutgers.edu	Tumova, Jana/A-2260-2010; Nakabeppu, Yusaku/A-8902-2011; Dobrzyn, Agnieszka/R-4073-2016; Dobrzyn, Pawel/R-4076-2016	Tumova, Jana/0000-0003-1625-4737; Nakabeppu, Yusaku/0000-0002-6739-242X; Dobrzyn, Agnieszka/0000-0002-6331-9460; Lloyd, R. Stephen/0000-0001-7273-372X; Dobrzyn, Pawel/0000-0002-2433-1897	NIH [DK100640, DK075974]; Grants-in-Aid for Scientific Research [17H01391] Funding Source: KAKEN	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by NIH DK100640 to HS and NIH DK075974 to RSL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani N, 2016, MECH AGEING DEV; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Audebert M, 2000, CANCER RES, V60, P4740; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bordoni A, 1992, Cardiologia, V37, P631; Carcamo JM, 2006, MUTAT RES, V593, P64; Cardozo-Pelaez F, 2005, GENE EXPRESSION, V12, P315, DOI 10.3727/000000005783992007; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Daimon M, 2009, BIOCHEM BIOPH RES CO, V386, P26, DOI 10.1016/j.bbrc.2009.05.119; Dezor M, 2011, FOLIA NEUROPATHOL, V49, P123; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Dorszewska J, 2009, DNA CELL BIOL, V28, P579, DOI 10.1089/dna.2009.0926; Fisher RM, 2005, CURR OPIN LIPIDOL, V16, P173, DOI 10.1097/01.mol.0000162322.39548.b1; Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; German P, 2013, DNA REPAIR, V12, P856, DOI 10.1016/j.dnarep.2013.06.006; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; Holloway GP, 2008, ACTA PHYSIOL, V194, P293, DOI 10.1111/j.1748-1716.2008.01878.x; Iida T, 2002, ACTA NEUROPATHOL, V103, P20, DOI 10.1007/s004010100418; Itoh K, 2012, TRENDS CELL BIOL; Jeromson S, 2015, MAR DRUGS, V13, P6977, DOI 10.3390/md13116977; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P589, DOI 10.1093/abbs/gmr053; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Klungland A, 2007, DNA REPAIR, V6, P481, DOI 10.1016/j.dnarep.2006.10.012; Kuroki T, 1998, BIOCHEM BIOPH RES CO, V247, P473, DOI 10.1006/bbrc.1998.8814; Le Page F, 2000, P NATL ACAD SCI USA, V97, P8397, DOI 10.1073/pnas.140137297; Li C, 2000, ENDOTEXT; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luiken JJFP, 2001, INT J SPORT NUTR EXE, V11, pS92, DOI 10.1123/ijsnem.11.s1.s92; Luo JX, 2014, FREE RADICAL BIO MED, V73, P430, DOI 10.1016/j.freeradbiomed.2014.03.030; Madani S, 2004, J BIOL CHEM, V279, P1176, DOI 10.1074/jbc.M306252200; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; McAinch AJ, 2003, OBES RES, V11, P1471, DOI 10.1038/oby.2003.197; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MILLER WC, 1984, J APPL PHYSIOL, V56, P78, DOI 10.1152/jappl.1984.56.1.78; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nakabeppu Y, 2007, J NEUROSCI RES, V85, P919, DOI 10.1002/jnr.21191; Nakabeppu Y, 2014, INT J MOL SCI, V15, P12543, DOI 10.3390/ijms150712543; NEMETH PM, 1992, AM J PHYSIOL, V262, pC282, DOI 10.1152/ajpcell.1992.262.2.C282; Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637; Okasaka T, 2009, J HUM GENET, V54, P739, DOI 10.1038/jhg.2009.108; Osterod M, 2001, CARCINOGENESIS, V22, P1459, DOI 10.1093/carcin/22.9.1459; Pan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43297; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Pastukh V, 2015, AM J PHYSIOL-LUNG C, V309, pL1367, DOI 10.1152/ajplung.00236.2015; Patkova J, 2014, CELL PHYSIOL BIOCHEM, V33, P1439, DOI 10.1159/000358709; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Paz-Elizur T, 2008, CANCER LETT, V266, P60, DOI 10.1016/j.canlet.2008.02.032; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Ritter O, 2015, J MOL MED, V93, P831, DOI 10.1007/s00109-015-1310-2; Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429; Russo MT, 2007, MUTAT RES-FUND MOL M, V614, P69, DOI 10.1016/j.mrfmmm.2006.03.007; Sakumi K, 2003, CANCER RES, V63, P902; Sampath H, 2014, ENVIRON MOL MUTAGEN, V55, P689, DOI 10.1002/em.21886; Sampath H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051697; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Seifermann M., 2016, FREE RADIC BIOL MED; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Thameem F, 2010, HUM HERED, V70, P97, DOI 10.1159/000291964; Thomas D, 1997, MOL GEN GENET, V254, P171, DOI 10.1007/s004380050405; Torres-Gonzalez M, 2014, AM J PHYSIOL-CELL PH, V306, pC221, DOI 10.1152/ajpcell.00140.2013; Trapp C, 2007, MUTAT RES-FUND MOL M, V625, P155, DOI 10.1016/j.mrfmmm.2007.06.006; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Yan MH, 2012, FREE RADIC BIOL MED; Yuzefovych LV, 2013, ENDOCRINOLOGY, V154, P2640, DOI 10.1210/en.2013-1076; Zhou XL, 2016, CELL SIGNAL, V28, P1163, DOI 10.1016/j.cellsig.2016.05.021	80	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181687	10.1371/journal.pone.0181687	http://dx.doi.org/10.1371/journal.pone.0181687			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727777	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500104
J	Benn, A; Hiepen, C; Osterland, M; Schutte, C; Zwijsen, A; Knaus, P				Benn, Andreas; Hiepen, Christian; Osterland, Marc; Schuette, Christof; Zwijsen, An; Knaus, Petra			Role of bone morphogenetic proteins in sprouting angiogenesis: differential BMP receptor-dependent signaling pathways balance stalk vs. tip cell competence	FASEB JOURNAL			English	Article						ALK2; ALK3; SMAD1/5; p38 MAPK; cell migration	ENDOTHELIAL-CELLS; TGF-BETA; ALK1; KINASE; ACTIVATION; NOTCH; MIGRATION; VEGF; EXPRESSION; BINDING	Before the onset of sprouting angiogenesis, the endothelium is prepatterned for the positioning of tip and stalk cells. Both cell identities are not static, as endothelial cells (ECs) constantly compete for the tip cell position in a dynamic fashion. Here, we show that both bone morphogenetic protein 2 (BMP2) and BMP6 are proangiogenic in vitro and ex vivo and that the BMP type I receptors, activin receptor-like kinase 3 (ALK3) and ALK2, play crucial and distinct roles in this process. BMP2 activates the expression of tip cell-associated genes, such as delta-like ligand 4 (DLL4) and kinase insert domain receptor (KDR), and p38-heat shock protein 27 (HSP27)-dependent cell migration, thereby generating tip cell competence. Whereas BMP6 also triggers collective cell migration via the p38-HSP27 signaling axis, BMP6 induces in addition SMAD1/5 signaling, thereby promoting the expression of stalk cell-associated genes, such as hairy and enhancer of split 1 (HES1) and fms-like tyrosine kinase 1 (FLT1). Specifically, ALK3 is required for sprouting from HUVEC spheroids, whereas ALK2 represses sprout formation. We demonstrate that expression levels and respective complex formation of BMP type I receptors in ECs determine stalk vs. tip cell identity, thus contributing to endothelial plasticity during sprouting angiogenesis. As antiangiogenic monotherapies that target the VEGF or ALK1 pathways have not fulfilled efficacy objectives in clinical trials, the selective targeting of the ALK2/3 pathways may be an attractive new approach.	[Benn, Andreas; Hiepen, Christian; Knaus, Petra] Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany; [Osterland, Marc; Schuette, Christof] Free Univ Berlin, Inst Math, Berlin, Germany; [Benn, Andreas; Knaus, Petra] Berlin Sch Integrat Oncol, Deutsch Forsch Gemeinschaft DFG Grad Sch 1093, Berlin, Germany; [Benn, Andreas; Hiepen, Christian; Knaus, Petra] Berlin Brandenburg Sch Regenerat Therapies, DFG Grad Sch 203, Berlin, Germany; [Benn, Andreas; Zwijsen, An] VIB, Ctr Brain & Dis Res, Leuven, Belgium; [Benn, Andreas; Zwijsen, An] Katholieke Univ KU Leuven, Dept Human Genet, Leuven, Belgium; [Osterland, Marc; Schuette, Christof] Zuse Inst Berlin, Berlin, Germany	Free University of Berlin; Free University of Berlin; Flanders Institute for Biotechnology (VIB); KU Leuven; Zuse Institute Berlin	Knaus, P (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Thielallee 63, D-14195 Berlin, Germany.	knaus@chemie.fu-berlin.de	Zwijsen, An/AAK-2897-2020; Hiepen, Christian/AAI-3685-2021; Hiepen, Christian/AAY-3399-2020	Hiepen, Christian/0000-0001-7345-6496; Zwijsen, An/0000-0002-8583-1721	Berlin School of Integrative Oncology [Deutsche Forschungsgemeinschaft (DFG) Graduate School [1093]; Berlin School for Regenerative Therapies (DFG Graduate School) [203]; European Molecular Biology Organization; Flanders Research Foundation [FWO G.0542.13]; German Research Foundation DFG [SFB958]	Berlin School of Integrative Oncology [Deutsche Forschungsgemeinschaft (DFG) Graduate School; Berlin School for Regenerative Therapies (DFG Graduate School); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Flanders Research Foundation(FWO); German Research Foundation DFG(German Research Foundation (DFG))	The authors thank Karen Beets, Isabel Casanova, Alexander Hron, Patrizia Weigell, and Johanna Scholz for experimental technical assistance; Steffen Prohaska (Berlin, Germany) for technical and analytical assistance on chemotaxis analyses; Mario Lorenz, Verena Stangl, and Axel Pries (Berlin, Germany) for kindly providing HUVECs and HAECs; James Kirkpatrick (Mainz, Germany) for providing HPMECs; Walter Sebald (Wurzburg, Germany) for providing recombinant BMP2; Slobodan Vukicevic (Zagreb, Croatia) for providing recombinant BMP6; and Alex Bullock (Oxford University, Oxford, United Kingdom) for providing K02288. This work was supported by the Berlin School of Integrative Oncology [Deutsche Forschungsgemeinschaft (DFG) Graduate School 1093, fellowship to A.B.], the Berlin School for Regenerative Therapies (DFG Graduate School 203, fellowship to A.B.), the European Molecular Biology Organization (fellowship to A.B.), the Flanders Research Foundation FWO G.0542.13 (to A.Z.), and the German Research Foundation DFG SFB958 (to P.K.). The authors thank all lab members for vivid discussions and valuable comments. The authors declare no conflicts of interest.	Akiyama I, 2014, REPROD SCI, V21, P477, DOI 10.1177/1933719113503411; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Arai H, 2002, BIOCHEM BIOPH RES CO, V299, P116, DOI 10.1016/S0006-291X(02)02588-3; Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benn A, 2016, J CELL SCI, V129, P206, DOI 10.1242/jcs.179960; Bongrazio M, 2000, CARDIOVASC RES, V47, P384, DOI 10.1016/S0008-6363(00)00111-5; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; Cunha SI, 2015, CANCER RES, V75, P2445, DOI 10.1158/0008-5472.CAN-14-3706; Cunha SI, 2011, BLOOD, V117, P6999, DOI 10.1182/blood-2011-01-330142; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; de Vinuesa AG, 2016, CYTOKINE GROWTH F R, V27, P65, DOI 10.1016/j.cytogfr.2015.12.005; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Ebisawa T, 1999, J CELL SCI, V112, P3519; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Guzman A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.387639; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hawinkels LJAC, 2016, CLIN CANCER RES, V22, P96, DOI 10.1158/1078-0432.CCR-15-0743; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiepen C, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-43; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Holderfield MT, 2006, BIOCHEM BIOPH RES CO, V346, P637, DOI 10.1016/j.bbrc.2006.05.177; Huth J, 2011, COMPUT METH PROG BIO, V104, P227, DOI 10.1016/j.cmpb.2011.06.002; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jimeno A, 2016, CANCER-AM CANCER SOC, V122, P3641, DOI 10.1002/cncr.30317; Jonker L, 2014, MICROCIRCULATION, V21, P93, DOI 10.1111/micc.12099; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kerr G, 2015, ANGIOGENESIS, V18, P209, DOI 10.1007/s10456-014-9457-y; Kieran MW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006593; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Korff T, 1999, J CELL SCI, V112, P3249; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Langenfeld EM, 2004, MOL CANCER RES, V2, P141; Larrivee B, 2012, DEV CELL, V22, P489, DOI 10.1016/j.devcel.2012.02.005; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lorenz M, 2015, ATHEROSCLEROSIS, V240, P61, DOI 10.1016/j.atherosclerosis.2015.02.018; Makker V, 2015, GYNECOL ONCOL, V138, P24, DOI 10.1016/j.ygyno.2015.04.006; Metzner P, 2009, MULTISCALE MODEL SIM, V7, P1192, DOI 10.1137/070699500; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Mouillesseaux KP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13247; Mountzios G, 2014, PHARMACOL THERAPEUT, V141, P117, DOI 10.1016/j.pharmthera.2013.09.003; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Prinz JH, 2011, MULTISCALE MODEL SIM, V9, P545, DOI 10.1137/100789191; Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sanvitale CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062721; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Tillet E, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00456; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; van Meeteren LA, 2012, J BIOL CHEM, V287, P18551, DOI 10.1074/jbc.M111.338103; Vitorino P, 2011, MOL CELL BIOL, V31, P342, DOI 10.1128/MCB.00800-10; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	83	45	48	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4720	4733		10.1096/fj.201700193RR	http://dx.doi.org/10.1096/fj.201700193RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28733457	Green Published			2022-12-26	WOS:000413398500006
J	Rahman, MF; Askwith, C; Govindarajan, R				Rahman, Md Fazlur; Askwith, Candice; Govindarajan, Rajgopal			Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENTED HYPERTRICHOTIC DERMATOSIS; H-SYNDROME; FUNCTIONAL-CHARACTERIZATION; FAISALABAD HISTIOCYTOSIS; NUCLEOBASE TRANSPORTER; HUMAN INTESTINE; ENT FAMILY; SLC29A3; MUTATIONS; PROTEIN	Equilibrative nucleoside transporters (ENTs) translocate hydrophilic nucleosides across cellular membranes and are essential for salvage nucleotide synthesis and purinergic signaling. Unlike the prototypic human ENT members hENT1 and hENT2, which mediate plasma membrane nucleoside transport at pH 7.4, hENT3 is an acidic pH-activated lysosomal transporter partially localized to mitochondria. Recent studies demonstrate that hENT3 is indispensable for lysosomal homeostasis, and that mutations in hENT3 can result in a spectrum of lysosomal storage-like disorders. However, despite hENT3's prominent role in lysosome pathophysiology, the molecular basis of hENT3-mediated transport is unknown. Therefore, we sought to examine the mechanistic basis of acidic pH-driven hENT3nucleoside transport with site-directed mutagenesis, homology modeling, and [H-3] adenosine flux measurements in mutant RNA-injected Xenopus oocytes. Scanning mutagenesis of putative residues responsible for pH-dependent transport via hENT3 revealed that the ionization states of Asp-219 and Glu-447, and not His, strongly determined the pH-dependent transport permissible-impermissible states of the transporter. Except for substitution with certain isosteric and polar residues, substitution of either Asp-219 or Glu-447 with any other residues resulted in robust activity that was pH-independent. Dual substitution of Asp-219 and Glu-447 to Ala sustained pH-independent activity over a broad range of physiological pH (pH 5.5-7.4), which also maintained stringent substrate selectivity toward endogenous nucleosides and clinically used nucleoside drugs. Our results suggest a putative pH-sensing role for Asp-219 and Glu-447 in hENT3 and that the size, ionization state, or electronegative polarity at these positions is crucial for obligate acidic pH-dependent activity.	[Rahman, Md Fazlur; Govindarajan, Rajgopal] Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, Comprehens Canc Ctr, 500 W 12Th Ave, Columbus, OH 43210 USA; [Askwith, Candice] Ohio State Univ, Dept Neurosci, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Govindarajan, Rajgopal] Ohio State Univ, Translat Therapeut Program, Comprehens Canc Ctr, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Govindarajan, R (corresponding author), Ohio State Univ, Pharmaceut & Pharmaceut Chem, Coll Pharm, 542 Riffe Bldg,12th Ave, Columbus, OH 43210 USA.	govindarajan.21@osu.edu			National Institutes of Health [R03AR063326, R01CA188464]; NATIONAL CANCER INSTITUTE [R01CA188464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR063326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS104177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R03AR063326 (to R. G.) and R01CA188464 (to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achilonu I, 2012, BIOCHEMISTRY-US, V51, P995, DOI 10.1021/bi201541w; Al-Haggar M, 2015, PEDIATR DIABETES, V16, P305, DOI 10.1111/pedi.12160; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Boswell-Casteel RC, 2014, J BIOL CHEM, V289, P24440, DOI 10.1074/jbc.M114.553503; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Cano-Soldado P, 2012, AM J PHYSIOL-CELL PH, V302, pC257, DOI 10.1152/ajpcell.00198.2011; Cauet E, 2005, J CHEM THEORY COMPUT, V1, P472, DOI 10.1021/ct049875k; Cliffe ST, 2009, HUM MOL GENET, V18, P2257, DOI 10.1093/hmg/ddp161; Colmenero I, 2012, AM J DERMATOPATH, V34, P315, DOI 10.1097/DAD.0b013e31823b99fc; de Jesus J, 2013, DIABETES METAB, V39, P281, DOI 10.1016/j.diabet.2013.03.007; Di Russo NV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002761; Dougherty DA, 2007, J NUTR, V137, p1516S; Elbarbary NS, 2013, PEDIATR DIABETES, V14, P466, DOI 10.1111/j.1399-5448.2012.00925.x; Endres CJ, 2005, MOL PHARMACOL, V67, P837, DOI 10.1124/mol.104.008102; Farooq M, 2012, DERMATOLOGY, V224, P277, DOI 10.1159/000338886; Felipe A, 1998, BIOCHEM J, V330, P997, DOI 10.1042/bj3300997; FERROLUZZIAMES G, 1976, P NATL ACAD SCI USA, V73, P1877, DOI 10.1073/pnas.73.6.1877; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Govindarajan R, 2007, AM J PHYSIOL-REG I, V293, pR1809, DOI 10.1152/ajpregu.00293.2007; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Hirschi M, 2017, NATURE, V545, P66, DOI 10.1038/nature22057; Hsu CL, 2012, SCIENCE, V335, P89, DOI 10.1126/science.1213682; Hyde RJ, 2001, MOL MEMBR BIOL, V18, P53, DOI 10.1080/09687680110033765; Johnson ZL, 2012, NATURE, V483, P489, DOI 10.1038/nature10882; Kang N, 2010, J BIOL CHEM, V285, P28343, DOI 10.1074/jbc.M110.109199; Larrayoz IM, 2006, AM J PHYSIOL-CELL PH, V291, pC1395, DOI 10.1152/ajpcell.00110.2006; Lee EW, 2006, J BIOL CHEM, V281, P16700, DOI 10.1074/jbc.M513825200; Mangravite LM, 2003, AM J PHYSIOL-RENAL, V284, pF902, DOI 10.1152/ajprenal.00215.2002; Molho-Pessach V, 2008, AM J HUM GENET, V83, P529, DOI 10.1016/j.ajhg.2008.09.013; Morgan NV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000833; Mueller DS, 2008, BIOCHEM SOC T, V36, P43, DOI 10.1042/BST0360043; Ngo LY, 2001, AM J PHYSIOL-GASTR L, V280, pG475, DOI 10.1152/ajpgi.2001.280.3.G475; Pastor-Anglada M, 2008, XENOBIOTICA, V38, P972, DOI 10.1080/00498250802069096 ; Pennycooke M, 2001, BIOCHEM BIOPH RES CO, V280, P951, DOI 10.1006/bbrc.2000.4205; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Priya TP, 2010, BRIT J DERMATOL, V162, P1132, DOI 10.1111/j.1365-2133.2010.09653.x; Ramot Y, 2010, INT J PEDIATR OTORHI, V74, P825, DOI 10.1016/j.ijporl.2010.03.053; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Rotzschke O, 2002, P NATL ACAD SCI USA, V99, P16946, DOI 10.1073/pnas.212643999; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; STENNICKE HR, 1994, PROTEIN ENG, V7, P911, DOI 10.1093/protein/7.7.911; Visser F, 2002, J BIOL CHEM, V277, P395, DOI 10.1074/jbc.M105324200; Visser F, 2007, J BIOL CHEM, V282, P14148, DOI 10.1074/jbc.M701735200; Wang S, 2014, P NATL ACAD SCI USA, V111, P12734, DOI 10.1073/pnas.1414093111; Warraich S, 2013, J BONE MINER RES, V28, P1135, DOI 10.1002/jbmr.1826; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007	54	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14775	14785		10.1074/jbc.M117.787952	http://dx.doi.org/10.1074/jbc.M117.787952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729424	hybrid, Green Published			2022-12-26	WOS:000409902100006
J	Tan, EP; McGreal, SR; Graw, S; Tessman, R; Koppel, SJ; Dhakal, P; Zhang, Z; Machacek, M; Zachara, NE; Koestler, DC; Peterson, KR; Thyfault, JP; Swerdlow, RH; Krishnamurthy, P; DiTacchio, L; Apte, U; Slawson, C				Tan, Ee Phie; McGreal, Steven R.; Graw, Stefan; Tessman, Robert; Koppel, Scott J.; Dhakal, Pramod; Zhang, Zhen; Machacek, Miranda; Zachara, Natasha E.; Koestler, Devin C.; Peterson, Kenneth R.; Thyfault, John P.; Swerdlow, Russell H.; Krishnamurthy, Partha; DiTacchio, Luciano; Apte, Udayan; Slawson, Chad			Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; ALZHEIMERS-DISEASE; 3T3-L1 ADIPOCYTES; HIGH GLUCOSE; CROSS-TALK; PHOSPHORYLATION; PROTEIN; NEURODEGENERATION	Dysfunctional mitochondria and generation of reactive oxygen species (ROS) promote chronic diseases, which have spurred interest in the molecular mechanisms underlying these conditions. Previously, we have demonstrated that disruption of post-translational modification of proteins with beta-linked N-acetylglucosamine (O-GlcNAcylation) via overexpression of the O-GlcNAc-regulating enzymes O-GlcNAc transferase (OGT) or O-GlcNAcase (OGA) impairs mitochondrial function. Here, we report that sustained alterations in O-GlcNAcylation either by pharmacological or genetic manipulation also alter metabolic function. Sustained O-GlcNAcelevation inSH-SY5Yneuroblastoma cells increased OGA expression and reduced cellular respiration and ROS generation. Cells with elevated O-GlcNAc levels had elongated mitochondria and increased mitochondrial membrane potential, and RNA-sequencing analysis indicated transcriptome reprogramming and down-regulation of the NRF2-mediated antioxidant response. Sustained O-GlcNAcylation in mouse brain and liver validated the metabolic phenotypes observed in the cells, and OGT knockdown in the liver elevated ROS levels, impaired respiration, and increased the NRF2 antioxidant response. Moreover, elevated O-GlcNAc levels promoted weight loss and lowered respiration in mice and skewed the mice toward carbohydrate-dependent metabolism as determined by indirect calorimetry. In summary, sustained elevation in O-GlcNAcylation coupled with increased OGA expression reprograms energy metabolism, a finding that has potential implications for the etiology, development, and management of metabolic diseases.	[Tan, Ee Phie; Zhang, Zhen; Machacek, Miranda; Peterson, Kenneth R.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [McGreal, Steven R.; Tessman, Robert; Krishnamurthy, Partha; DiTacchio, Luciano; Apte, Udayan] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS USA; [Graw, Stefan; Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS USA; [Koppel, Scott J.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS USA; [Dhakal, Pramod; Machacek, Miranda; Thyfault, John P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS USA; [Swerdlow, Russell H.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS USA; [Swerdlow, Russell H.; Krishnamurthy, Partha; Slawson, Chad] Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA; [Zachara, Natasha E.] Johns Hopkins Univ Med, Dept Biol Chem, Baltimore, MD 21205 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; Johns Hopkins University	Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA.; Slawson, C (corresponding author), Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA.	cslawson@kumc.edu	Tan, Ee Phie/AAC-8378-2021	Koppel, Scott/0000-0001-9001-4454; Graw, Stefan/0000-0002-6386-8267	Electron Microscope (EM) Core Facility - National Institutes of Health NIGMS COBRE [P20GM104936]; National Institutes of Health [1S10RR027564]; National Institutes of Health NIGMS COBRE [P30GM103326]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057850] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098414, R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, P30GM103326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002567] Funding Source: NIH RePORTER	Electron Microscope (EM) Core Facility - National Institutes of Health NIGMS COBRE; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIGMS COBRE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Christy Hagan, Kay Minn, Heather Wilkins, and Ian Weilding for their technical support. We thank both Barbara Fegley and Pat St. John for their help and the support of the Electron Microscope (EM) Core Facility, sponsored in part by National Institutes of Health NIGMS COBRE Grant P20GM104936 and National Institutes of Health Grant 1S10RR027564. We also thank Richard Hasting and the Flow Cytometry Laboratory, sponsored by the National Institutes of Health NIGMS COBRE Grant P30GM103326.	Baffou G, 2014, NAT METHODS, V11, P899, DOI 10.1038/nmeth.3073; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Butkinaree C, 2008, J BIOL CHEM, V283, P23557, DOI 10.1074/jbc.M804116200; Chaves I, 2014, CURR BIOL, V24, P1248, DOI 10.1016/j.cub.2014.04.018; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Dassanayaka S, 2015, BIOCHEM J, V467, P115, DOI 10.1042/BJ20141018; Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x; Facundo HT, 2012, AM J PHYSIOL-HEART C, V302, pH2122, DOI 10.1152/ajpheart.00775.2011; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Hart GW, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00183; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Klein AL, 2009, MOL CELL PROTEOMICS, V8, P2733, DOI 10.1074/mcp.M900207-MCP200; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lezi E, 2016, BIOCHEM PHARMACOL, V99, P88, DOI 10.1016/j.bcp.2015.11.002; Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12; Li H. H., 2017, PLANT CELL TISSUE OR, V2017, P1, DOI DOI 10.1016/J.EC0LM0DEL.2017.01.003; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Ma JF, 2015, J BIOL CHEM, V290, P29141, DOI 10.1074/jbc.M115.691741; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Macauley MS, 2008, J BIOL CHEM, V283, P34687, DOI 10.1074/jbc.M804525200; Makino A, 2015, AM J PHYSIOL-CELL PH, V309, pC593, DOI 10.1152/ajpcell.00069.2015; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Mosconi L, 2011, J ALZHEIMERS DIS, V27, P483, DOI 10.3233/JAD-2011-110866; Mueller CFH, 2005, ARTERIOSCL THROM VAS, V25, P274, DOI 10.1161/01.ATV.0000149143.04821.eb; Muthusamy S, 2015, J BIOL CHEM, V290, P31013, DOI 10.1074/jbc.M115.677534; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; OBRIG TG, 1971, J BIOL CHEM, V246, P174; Pendergast DR, 2000, J AM COLL NUTR, V19, P345, DOI 10.1080/07315724.2000.10718930; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sacoman JL, 2017, J BIOL CHEM, V292, P4499, DOI 10.1074/jbc.M116.726752; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Stivers PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145151; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Tangmansakulchai K, 2016, MITOCHONDRION, V30, P151, DOI 10.1016/j.mito.2016.07.009; Trapannone R, 2016, BIOCHEM J, V473, P1693, DOI 10.1042/BCJ20160092; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-42; Yuzwa SA, 2014, J MOL BIOL, V426, P1736, DOI 10.1016/j.jmb.2014.01.004; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zhang Z, 2016, J BIOL CHEM, V291, P15628, DOI 10.1074/jbc.M116.721928; Zhang Z, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00206	60	53	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14940	14962		10.1074/jbc.M117.797944	http://dx.doi.org/10.1074/jbc.M117.797944			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739801	hybrid, Green Published			2022-12-26	WOS:000409902100019
J	Long, ZH; Duan, GY; Li, H; Yi, TT; Wu, XX; Chen, F; Wu, ZX; Gao, YQ				Long, Zonghong; Duan, Guangyou; Li, Hong; Yi, Tingting; Wu, Xiaoxiao; Chen, Feng; Wu, Zhuoxi; Gao, Yuqi			Ubiquinol-cytochrome c reductase core protein 1 may be involved in delayed cardioprotection from preconditioning induced by diazoxide	PLOS ONE			English	Article							K-ATP CHANNELS; MITOCHONDRIAL PROTEINS; PROTEOMIC ANALYSIS; MOLECULAR-BASIS; ISCHEMIA; HEART; MYOCARDIUM; EXPRESSION; INJURY; PRE	This study aimed to use long-term diazoxide treatment to establish a loss-of-cardioprotection model and then perform proteomics analysis to explore which proteins of mitochondrial inner membrane (MIM) are potentially involved in delayed cardioprotection. Rats received 1 to 8 weeks of diazoxide treatments (20 mg.kg(-1).d(-1)) to establish a loss-of-cardioprotection model in different groups. Detection of serum cTnl levels and cell apoptosis assays in heart tissue were performed. Then, rats MIM after 0, 4 and 6 weeks of diazoxide treatment was isolated and proteomics analysis was performed. An invitro model of H9C2 cells was performed to explore the effects of targeted protein on delayed cardioprotection. The effect of delayed cardioprotection by diazoxide preconditioning disappeared when diazoxide treatments were given for six weeks or longer. Ubiquinol-cytochrome c reductase core protein 1 (UQCRC1) was identified in the proteomics analysis. UQCRC1 expression was upregulated by diazoxide treatment in H9C2 cells, and UQCRC1 down-regulation could increase the lactate dehydrogenase release and apoptosis rate after injury induced by oxygen glucose deprivation. These results showed that UQCRC1 might contribute to the loss-of-cardioprotection model induced by long-term diazoxide treatment and play a role in delayed cardioprotection.	[Long, Zonghong; Duan, Guangyou; Li, Hong; Yi, Tingting; Wu, Xiaoxiao; Chen, Feng; Wu, Zhuoxi] Third Mil Med Univ, Xingiao Hosp, Dept Anesthesiol, Chongqing, Peoples R China; [Gao, Yuqi] Third Mil Med Univ, Key Lab High Altitude Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, H (corresponding author), Third Mil Med Univ, Xingiao Hosp, Dept Anesthesiol, Chongqing, Peoples R China.	lh78553@163.com			National Natural Science Foundation of China [81070094, 81571870]; Natural Science Foundation Project of Chongqing [cstc20136jjB10026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing)	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), No. 81070094 and No. 81571870, HL; Natural Science Foundation Project of Chongqing (http://www.cstc.gov.cn/), No. cstc20136jjB10026, HL.	Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8; Cabrera JA, 2012, AM J PHYSIOL-HEART C, V302, pH1974, DOI 10.1152/ajpheart.00372.2011; Chen YX, 2015, CARDIOVASC RES, V105, P192, DOI 10.1093/cvr/cvu256; Cui F, 2006, PROTEOMICS, V6, P498, DOI 10.1002/pmic.200500218; Da Cruz Sandrine, 2008, V432, P101, DOI 10.1007/978-1-59745-028-7_7; Dyballa-Rukes N, 2014, CELL PHYSIOL BIOCHEM, V33, P967, DOI 10.1159/000358668; Essop MF, 2011, CARDIOVASC J AFR, V22, P175, DOI 10.5830/CVJA-2010-058; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Friedman David B, 2007, Methods Mol Biol, V367, P219; Fryer RM, 2000, AM J PHYSIOL-HEART C, V278, pH305, DOI 10.1152/ajpheart.2000.278.1.H305; GROSS GJ, 1992, CIRC RES, V70, P223, DOI 10.1161/01.RES.70.2.223; Hashimi MW, 1998, MOL CELL BIOCHEM, V186, P19, DOI 10.1023/A:1006876627227; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Huang SP, 2016, ENVIRON TOXICOL PHAR, V46, P301, DOI 10.1016/j.etap.2016.08.011; Kalenka A, 2006, ACTA ANAESTH SCAND, V50, P414, DOI 10.1111/j.1399-6576.2006.00984.x; Kim N, 2006, PROTEOMICS, V6, P1237, DOI 10.1002/pmic.200500291; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; KUZUYA T, 1993, CIRC RES, V72, P1293, DOI 10.1161/01.RES.72.6.1293; Liu XH, 2004, PROTEOMICS, V4, P3167, DOI 10.1002/pmic.200300845; Loubani M, 2002, J THORAC CARDIOV SUR, V124, P750, DOI 10.1067/mtc.2002.126037; Lu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147792; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Mykytenko J, 2008, BASIC RES CARDIOL, V103, P472, DOI 10.1007/s00395-008-0731-2; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Penna C, 2009, BBA-BIOENERGETICS, V1787, P781, DOI 10.1016/j.bbabio.2009.02.008; Sato T, 2000, CIRCULATION, V101, P2418, DOI 10.1161/01.CIR.101.20.2418; Senthil S, 2007, TOXICOL PATHOL, V35, P418, DOI 10.1080/01926230701230312; Shibanuma M, 2011, FREE RADICAL RES, V45, P672, DOI 10.3109/10715762.2011.564169; Song JR, 2011, J CELL BIOCHEM, V112, P3406, DOI 10.1002/jcb.23274; Sun JH, 2015, CARDIOVASC RES, V106, P227, DOI 10.1093/cvr/cvv044; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Wong R, 2010, AM J PHYSIOL-HEART C, V298, pH75, DOI 10.1152/ajpheart.00515.2009; Xiao YY, 2011, ANESTH ANALG, V113, P224, DOI 10.1213/ANE.0b013e3182239b71; Yi TT, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1314297; Zhang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114963; Zhang LY, 2013, CIRC-HEART FAIL, V6, P1039, DOI 10.1161/CIRCHEARTFAILURE.112.000228; Zuo YB, 2016, CELL PHYSIOL BIOCHEM, V39, P1021, DOI 10.1159/000447809	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181903	10.1371/journal.pone.0181903	http://dx.doi.org/10.1371/journal.pone.0181903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750029	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700099
J	de Abreu, VG; Martins, CJD; de Oliveira, PAC; Francischetti, EA				de Abreu, Virginia Genelhu; de Moraes Martins, Cyro Jose; Cardoso de Oliveira, Patricia Aguiar; Francischetti, Emilio Antonio			High-molecular weight adiponectin/HOMA-IR ratio as a biomarker of metabolic syndrome in urban multiethnic Brazilian subjects	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; INSULIN-RESISTANCE; JAPANESE POPULATION; HEALTH; RISK; HYPOADIPONECTINEMIA; PREVALENCE; PROTEIN; PLASMA; IMPACT	Metabolic syndrome (MetS) has an important epidemiological relevance due to its increasing prevalence and association with type 2 diabetes and cardiovascular disease. Insulin resistance is a core feature of the MetS. HOMA-IR is a robust clinical and epidemiological marker of MetS. Adiponectin is an adipokine with insulin-sensitizing and anti-inflammatory functions; its levels decrease as number of components of MetS increases. High-molecular weight adiponectin (HMWA) is the multimer responsible for the relationship of adiponectin with insulin sensitivity. HOMA-IR and HMWA are suitable candidates for MetS biomarkers. The ratio of adiponectin to HOMA-IR has been validated as a powerful index of MetS and considered a better marker of its presence, than either HOMA-IR or adiponectin alone, in selected homogeneous populations. We compared the strength of association between HMWA, HOMA-IR and HMWA/HOMA-IR ratio with MetS and its key components. Our data have shown that the median (25(th), 75(th) percentile) of HMWA/HOMA-IR ratio was lower in subjects with MetS [0.51 (0.33, 1.31)] as compared to those without it [2.19 (1.13, 4.71)]. The correlation coefficient (r) was significantly higher for HMWA/HOMA-IR ratio as compared to HMWA for waist circumference (-0.65; -0.40, respectively); mean blood pressure (-0.27; -0.14, respectively); fasting glucose (-0.38; -0.19, respectively); HDL-cholesterol (0.44; 0.40, respectively); and triglycerides (-0.35; -0.18, respectively). In a multivariable logistic regression analysis, the HMWA/HOMA-IR ratio was a sensitive predictor for MetS, being the only marker that was significantly associated with each and all the individual components of the syndrome. These results expand on previous studies in that we used the active circulating form of adiponectin, i.e. HMWA, and represent a typical Brazilian cohort characterized by intense interethnic admixture. Thus, the HMWA/HOMA-IR ratio is a minimally invasive biomarker for MetS that could be clinically useful in prognosing patient outcome.	[de Abreu, Virginia Genelhu; Cardoso de Oliveira, Patricia Aguiar; Francischetti, Emilio Antonio] Grande Rio Univ, Postgrad Program Translat Biomed, Duque De Caxias, Brazil; [de Moraes Martins, Cyro Jose] Univ Estado Rio De Janeiro, Lab Clin & Expt Pathophysiol, Rio De Janeiro, Brazil; [Francischetti, Emilio Antonio] Grande Rio Univ, Pro Rectorate Res & Postgrad Programs, Duque De Caxias, Brazil	Universidade do Grande Rio; Universidade do Estado do Rio de Janeiro; Universidade do Grande Rio	Francischetti, EA (corresponding author), Grande Rio Univ, Postgrad Program Translat Biomed, Duque De Caxias, Brazil.; Francischetti, EA (corresponding author), Grande Rio Univ, Pro Rectorate Res & Postgrad Programs, Duque De Caxias, Brazil.	francischetti@globo.com	Martins, Cyro/AAC-2261-2020; Francischetti, Emilio/AAX-8544-2020	MARTINS, Cyro/0000-0002-0140-2920	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [111.957/2010]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http//www.faperj.br); Research Grant Number 111.957/2010; EAF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; de Luis DA, 2011, ANN NUTR METAB, V58, P301, DOI 10.1159/000331216; Martins CJD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142728; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; Ding YS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/607364; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Geloneze B, 2006, DIABETES RES CLIN PR, V72, P219, DOI 10.1016/j.diabres.2005.10.017; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kahn R, 2008, LANCET, V371, P1892, DOI 10.1016/S0140-6736(08)60731-X; Khan UI, 2012, METABOLISM, V61, P1261, DOI 10.1016/j.metabol.2012.02.005; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Liu Y, 2007, J CLIN ENDOCR METAB, V92, P4313, DOI 10.1210/jc.2007-0890; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2007, DIABETES CARE, V30, P1219, DOI 10.2337/dc06-2484; Mohan V, 2005, METABOLISM, V54, P476, DOI 10.1016/j.metabol.2004.10.016; Nakatochi M, 2011, DIABETES RES CLIN PR, V92, pE61, DOI 10.1016/j.diabres.2011.02.029; O'Neill S, 2016, TRENDS ENDOCRIN MET, V27, P363, DOI 10.1016/j.tem.2016.03.012; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pletcher MJ, 2011, CIRCULATION, V123, P1116, DOI 10.1161/CIRCULATIONAHA.110.943860; Rabu R, 2007, DIABETES, V56, P2174; Ryu HK, 2010, J AM COLL NUTR, V29, P171, DOI 10.1080/07315724.2010.10719831; Seino Y, 2009, METABOLISM, V58, P355, DOI 10.1016/j.metabol.2008.10.008; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Vaidya D, 2007, DIABETES CARE, V30, P2086, DOI 10.2337/dc07-0147; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamamoto Y, 2004, J CLIN ENDOCR METAB, V89, P87, DOI 10.1210/jc.2003-031163	32	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180947	10.1371/journal.pone.0180947	http://dx.doi.org/10.1371/journal.pone.0180947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746378	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800022
J	Estevo, CA; Nagy-Reis, MB; Nichols, JD				Estevo, Cesar Augusto; Nagy-Reis, Mariana Baldy; Nichols, James D.			When habitat matters: Habitat preferences can modulate co-occurrence patterns of similar sympatric species	PLOS ONE			English	Article							TINAMOU TINAMUS-SOLITARIUS; BODY-SIZE; FOREST; CONSERVATION; FRAGMENTATION; ASSEMBLAGES; COMPETITION; DIVERSITY; MECHANISM; TINAMIDAE	Disentangling the role of competition in regulating the distribution of sympatric species can be difficult because species can have different habitat preferences or time use that introduce non-random patterns that are not related to interspecific interactions. We adopted a multi-step approach to systematically incorporate habitat preferences while investigating the co-occurrence of two presumed competitors, morphologically similar, and closely related ground-dwelling birds: the brown tinamou (Crypturellus obsoletus) and the tataupa tinamou (C. tataupa). First, we used single-species occupancy models to identify the main landscape characteristics affecting site occupancy, while accounting for detection probability. We then used these factors to control for the effect of habitat while investigating species co-occurrence. In addition, we investigated species present-time partitioning by measuring the degree of overlap in their activity time. Both species were strictly diurnal and their activity time highly overlapped (i.e., the species are not present-time partitioning). The distribution of the two species varied across the landscape, and they seemed to occupy opposite portions of the study area, but co-occurrence models and species interaction factors suggested that the tinamous have independent occupancy and detection. In addition, co-occurrence models that accounted for habitat performed better than models without habitat covariates. The observed co-occurrence pattern is more likely related to habitat preferences, wherein species segregated by elevation. These results provide evidence that habitat characteristics can play a bigger role than interspecific interactions in regulating co-existence of some species. Therefore, exploring habitat preferences while analyzing co-occurrence patterns is essential, in addition to being a feasible approach to achieve more accurate estimation of parameters reflecting species interactions. Occupancy models can be a valuable tool in such modeling.	[Nagy-Reis, Mariana Baldy] Univ Estadual Campinas, Dept Anim Biol, Campinas, SP, Brazil; [Nichols, James D.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	Universidade Estadual de Campinas; State University System of Florida; University of Florida		cesar_estevo@hotmail.com	Nichols, James/AAF-7336-2020; Nichols, James/AAG-1500-2019		Coordination for the Improvement of Higher Education Personnel (CAPES); Idea Wild	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Idea Wild	MBNR received a scholarship from the Coordination for the Improvement of Higher Education Personnel (CAPES). CAE received equipment support from IDEA WILD.; We are thankful to Jundiai City Hall and all private owners for permission to conduct this project at Serra do Japi, and to Coordination for the Improvement of Higher Education Personnel (CAPES) and Idea Wild for main financial and equipment support. We are also grateful to J. E. Hines for assisting in our data analysis.	[Anonymous], 1992, HIST NATURAL SERRA J; Arlettaz R, 1999, J ANIM ECOL, V68, P460, DOI 10.1046/j.1365-2656.1999.00293.x; Bailey LL, 2009, BIOL CONSERV, V142, P2983, DOI 10.1016/j.biocon.2009.07.028; BAUR E. H, 2008, THESIS; Bennett G., 2006, REV EXPERIENCE ECOLO; Bertelli S, 2004, ORNITOL NEOTROP, V15, P293; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Bicknell J, 2010, FOREST ECOL MANAG, V259, P2267, DOI 10.1016/j.foreco.2010.02.027; Brennan PLR, 2004, ORNITOL NEOTROP, V15, P329; Brooks DM, 2004, ORNITOL NEOTROP, V15, P323; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Buckley LB, 2005, J BIOGEOGR, V32, P2113, DOI 10.1111/j.1365-2699.2005.01340.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabot J., 1992, P112; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Dellinger RL, 2007, AUK, V124, P1425, DOI 10.1642/0004-8038(2007)124[1425:HPOFST]2.0.CO;2; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Endo W, 2010, BIOTROPICA, V42, P251, DOI 10.1111/j.1744-7429.2009.00546.x; ESRI, 2009, ARCGIS; Farris ZJ, 2014, INT J PRIMATOL, V35, P859, DOI 10.1007/s10764-014-9786-0; FREEMARK KE, 1986, BIOL CONSERV, V36, P115, DOI 10.1016/0006-3207(86)90002-9; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Guerta RS, 2014, ORNITOL NEOTROP, V25, P73; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; INPE, 2014, TOP BANC DAD GEOM BR; Jones M, 2001, ECOLOGY, V82, P2164, DOI 10.1890/0012-9658(2001)082[2164:COTPSM]2.0.CO;2; Negret PJ, 2015, AUK, V132, P533, DOI 10.1642/AUK-14-116.1; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; Kuhnen VV, 2013, BIRD CONSERV INT, V23, P78, DOI 10.1017/S0959270912000147; Laiolo P, 2013, OECOLOGIA, V171, P207, DOI 10.1007/s00442-012-2392-y; LANCASTER D. A., 1964, CONDOR, V66, P253, DOI 10.2307/1365285; Lu X, 2011, EVOL BIOL, V38, P79, DOI 10.1007/s11692-010-9102-7; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2004, J ANIM ECOL, V73, P546, DOI 10.1111/j.0021-8790.2004.00828.x; Mahendiran M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160175; Mosquera-Muñoz Diana Marcela, 2014, Bol. Cient. Mus. Hist. Nat. Univ. Caldas, V18, P144; Meredith M, 2014, OVERLAP ESTIMATES CO, P4; Miller DAW, 2012, J ANIM ECOL, V81, P1288, DOI 10.1111/j.1365-2656.2012.02001.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagy-Reis MB, 2017, ANIM CONSERV, V20, P520, DOI 10.1111/acv.12346; Nagy-Reis MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168441; Neteler M, 2012, ENVIRON MODELL SOFTW, V31, P124, DOI 10.1016/j.envsoft.2011.11.014; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; O'Brien TG, 2008, BIRD CONSERV INT, V18, pS144, DOI 10.1017/S0959270908000348; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Presence Hines J., 2006, SOFTWARE ESTIMATE PA; Pritchard JR, 2001, EVOL ECOL RES, V3, P209; QGIS Development Team, 2013, QUANT GIS GEOGR INF; R Core Team, 2015, R LANG ENV STAT COMP; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; Dias LCS, 2016, WILSON J ORNITHOL, V128, P885; Schelsky WM, 2004, ORNITOL NEOTROP, V15, P317; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Sick H., 1993, BIRDS BRAZIL NATURAL; Steen DA, 2014, J ANIM ECOL, V83, P286, DOI 10.1111/1365-2656.12121; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Team Network, 2011, TERR VERT PROT IMPL, V3; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thornton DH, 2012, ORYX, V46, P567, DOI 10.1017/S0030605311001451; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; ZIV Y, 1993, OIKOS, V66, P237, DOI 10.2307/3544810	71	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0179489	10.1371/journal.pone.0179489	http://dx.doi.org/10.1371/journal.pone.0179489			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746414	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800006
J	Attia, MI; Eldehna, WM; Afifi, SA; Keeton, AB; Piazza, GA; Abdel-Aziz, HA				Attia, Mohamed I.; Eldehna, Wagdy M.; Afifi, Samar A.; Keeton, Adam B.; Piazza, Gary A.; Abdel-Aziz, Hatem A.			New hydrazonoindolin-2-ones: Synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres	PLOS ONE			English	Article							IN-VITRO; ANTIMICROBIAL ACTIVITY; ANTITUMOR-ACTIVITY; MANNICH-BASES; ISATIN; MICROPARTICLES; ANTICANCER; RELEASE; SCHIFF; CANCER	The synthesis and molecular characterization of new isatin-based hydrazonoindolin-2-ones 4a-o and 7a-e are reported. The in vitro anti-proliferative potential of the synthesized compounds 4a-o and 7a-e was examined against HT-29 (colon), ZR-75 (breast) and A549 (lung) human cancer cell lines. Compounds 7b, 7d and 7e were the most active congeners against the tested human cancer cell lines with average IC50 values of 4.77, 3.39 and 2.37 mu M, respectively, as compared with the reference isatin-based drug, sunitinib, which exhibited an average IC50 value of 8.11 mu M. Compound 7e was selected for further pharmacological evaluation in order to gain insight into its possible mechanism of action. It increased caspase 3/7 activity by 2.4-and 1.85-fold between 4 and 8 h of treatment, respectively, at 10 mu M and it caused a decrease in the percentage of cells in the G1 phase of the cell cycle with a corresponding increase in the S-phase. In addition, compound 7e increased phosphorylated tyrosine (p-Tyr) levels nearly two-fold with an apparent IC50 value of 3.8 mu M. The 7e-loaded PLGA microspheres were prepared using a modified emulsion-solvent diffusion method. The average encapsulation efficiency of the 7e-loaded PLGA microspheres was 85% +/- 1.3. While, the in vitro release profile of the 7e-loaded microspheres was characterized by slow and continuous release of compound 7e during 21 days and the release curve was fitted to zero order kinetics. Incorporation of 7e into PLGA microspheres improved its in vitro anti-proliferative activity toward the human cancer cell line A549 after 120 h incubation period with an IC50 value less than 0.8 mu M.	[Attia, Mohamed I.] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia; [Attia, Mohamed I.] Natl Res Ctr ID 60014618, Med & Pharmaceut Chem Dept, Pharmaceut & Drug Ind Res Div, Giza, Egypt; [Eldehna, Wagdy M.] Kafrelsheikh Univ, Dept Pharmaceut Chem, Fac Pharm, Kafrelsheikh, Egypt; [Afifi, Samar A.] Natl Org Drug Control & Res, Dept Pharmaceut, Giza, Egypt; [Afifi, Samar A.] King Saud Univ, Dept Pharmaceut, Coll Pharm, Riyadh, Saudi Arabia; [Keeton, Adam B.; Piazza, Gary A.] Univ S Alabama, Dept Oncol Sci & Pharmacol, Drug Discovery Res Ctr, Mitchell Canc Inst, Mobile, AL USA; [Abdel-Aziz, Hatem A.] Natl Res Ctr ID 60014618, Dept Appl Organ Chem, Giza, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Kafrelsheikh University; National Organization for Drug Control & Research (NODCAR); King Saud University; University of South Alabama; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Attia, MI (corresponding author), King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, Riyadh, Saudi Arabia.; Attia, MI (corresponding author), Natl Res Ctr ID 60014618, Med & Pharmaceut Chem Dept, Pharmaceut & Drug Ind Res Div, Giza, Egypt.; Abdel-Aziz, HA (corresponding author), Natl Res Ctr ID 60014618, Dept Appl Organ Chem, Giza, Egypt.	mattia@ksu.edu.sa; hatem_741@yahoo.com	Eldehna, Wagdy/AAK-6871-2020; Abdel-Aziz, Hatem/E-7250-2014	Eldehna, Wagdy/0000-0001-6996-4017; Piazza, Gary/0000-0003-4418-887X; Attia, Mohamed I./0000-0002-5019-6086; Abdel-Aziz, Hatem/0000-0002-2606-2504	National Plan for Science, Technology and Innovation (MAARIFAH); King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [11-MED1924-02]	National Plan for Science, Technology and Innovation (MAARIFAH); King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number 11-MED1924-02.	Abdelhameed AS, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7060617; Azouz SM, 2008, J THORAC CARDIOV SUR, V135, P1014, DOI 10.1016/j.jtcvs.2007.12.011; Chohan ZH, 2004, J ENZYM INHIB MED CH, V19, P417, DOI 10.1080/14756360410001710383; Dias DJ, 2015, J BIOPHYS CHEM, V6, P1, DOI [10.4236/jbpc.2015.61001, DOI 10.4236/jbpc.2015.61001]; Dubey SK, 2016, INT J SCI ENG RES, V7, P671; Eldehna WM, 2015, EUR J MED CHEM, V90, P684, DOI 10.1016/j.ejmech.2014.12.010; Ghahremanzadeh R, 2009, J COMB CHEM, V11, P393, DOI 10.1021/cc8001958; Griffith R, 2006, MINI-REV MED CHEM, V6, P1101, DOI 10.2174/138955706778560184; Guo WJ, 2015, ASIAN J PHARM SCI, V10, P405, DOI 10.1016/j.ajps.2015.06.001; de la Ossa DHP, 2013, J DRUG TARGET, V21, P710, DOI 10.3109/1061186X.2013.809089; Hoessel R, 1999, NAT CELL BIOL, V1, P60, DOI 10.1038/9035; Kang YQ, 2008, EUR J PHARM BIOPHARM, V70, P85, DOI 10.1016/j.ejpb.2008.03.011; Karki SS, 2007, BIOORGAN MED CHEM, V15, P6632, DOI 10.1016/j.bmc.2007.08.014; Karki SS, 2013, MED CHEM RES, V22, P2014, DOI 10.1007/s00044-012-0184-x; Karki SS, 2009, J ENZYM INHIB MED CH, V24, P537, DOI [10.1080/14756360802234885, 10.1080/14756360802234885 ]; Khan KM, 2009, BIOORGAN MED CHEM, V17, P7795, DOI 10.1016/j.bmc.2009.09.028; Liang CY, 2014, EUR J MED CHEM, V74, P742, DOI 10.1016/j.ejmech.2013.04.040; Liang XJ, 2012, METHOD MOL BIOL, V596, P467; Mahboubian A, 2010, IRAN J PHARM RES, V9, P369; Mankala SK, 2011, STAMFORD J PHARM SCI, V4, P38, DOI DOI 10.3329/SJPS.V4I1.8865; Martins KF, 2014, MATER RES-IBERO-AM J, V17, P650, DOI [10.1590/S1516-14392014005000028, 10.1590/S1516-14392014000300016]; Masaeli R, 2016, IRAN J PHARM RES, V15, P205; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Mukerjee A, 2009, ANTICANCER RES, V29, P3867; Nandagiri VK, 2012, CURR RES PHARM SCI, V2, P81; Noolvi MN, 2012, EUR J MED CHEM, V54, P447, DOI 10.1016/j.ejmech.2012.05.028; Pandeya S N, 1999, Pharm Acta Helv, V74, P11; Pandeya SN, 2000, ARZNEIMITTEL-FORSCH, V50, P55; Pandit B, 2006, BIOORGAN MED CHEM, V14, P6492, DOI 10.1016/j.bmc.2006.06.017; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Sahoo SK, 2013, ACTA POL PHARM, V70, P123; SARANGAPANI M, 1994, INDIAN J HETEROCY CH, V3, P257; Senwar KR, 2016, EUR J MED CHEM, V118, P34, DOI 10.1016/j.ejmech.2016.04.025; Sharma V, 2006, POL J CHEM, V80, P387; Shingade SG, 2012, MED CHEM RES, V21, P1302, DOI 10.1007/s00044-011-9644-y; Shmidt MS, 2008, MOLECULES, V13, P831, DOI 10.3390/molecules13040831; SINGH SP, 1983, CURR SCI INDIA, V52, P766; SOULE HD, 1990, CANCER RES, V50, P6075; Sridhar SK, 2002, EUR J PHARM SCI, V16, P129, DOI 10.1016/S0928-0987(02)00077-5; Thirupathy A, 2011, INT J PHARM PHARM SC, V3, P187; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Verma Manjusha, 2004, Acta Pharmaceutica (Zagreb), V54, P49; Wang ZH, 2009, CHINESE CHEM LETT, V20, P542, DOI 10.1016/j.cclet.2008.12.011; Xiang QF, 2011, CELL ONCOL, V34, P33, DOI 10.1007/s13402-010-0003-7; Xiao ZJ, 2002, LEUKEMIA LYMPHOMA, V43, P1763, DOI 10.1080/1042819021000006295; Xie X, 2014, PLOS ONE, V9; Xie XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125953; Zaki NM, 2013, INT J PHARM PHARM SC, V5, P161; Zhang DY, 2012, INT J MOL SCI, V13, P1109, DOI 10.3390/ijms13011109; Zhou L, 2006, J MED CHEM, V49, P3440, DOI 10.1021/jm0602357	50	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e018124 1	10.1371/journal.pone.0181241	http://dx.doi.org/10.1371/journal.pone.0181241			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742842	gold, Green Submitted, Green Published			2022-12-26	WOS:000406370000024
J	Li, R; Wang, HX; Shi, QF; Wang, N; Zhang, ZJ; Xiong, CL; Liu, JX; Chen, Y; Jiang, LF; Jiang, QW				Li, Rui; Wang, Hexing; Shi, Qingfeng; Wang, Na; Zhang, Zhijie; Xiong, Chenglong; Liu, Jianxiang; Chen, Yue; Jiang, Lufang; Jiang, Qingwu			Effects of oral florfenicol and azithromycin on gut microbiota and adipogenesis in mice	PLOS ONE			English	Article							BILE-ACID METABOLISM; ANTIBIOTIC EXPOSURE; CHILDHOOD OVERWEIGHT; LIPID-METABOLISM; OBESITY; COMMUNITY; IMPACT; RISK; DIET; POPULATION	Certain antibiotics detected in urine are associated with childhood obesity. In the current experimental study, we investigated two representative antibiotics detected in urine, florfenicol and azithromycin, for their early effects on adipogenesis, gut microbiota, short-chain fatty acids (SCFAs), and bile acids in mice. Thirty C57BL/6 mice aged four weeks were randomly divided into three groups (florfenicol, azithromycin and control). The two experimental groups were administered florfenicol or azithromycin at 5 mg/kg/day for four weeks. Body weight was measured weekly. The composition of the gut microbiota, body fat, SCFAs, and bile acids in colon contents were measured at the end of the experiment. The composition of the gut microbiota was determined by sequencing the bacterial 16S rRNA gene. The concentration of SCFAs and bile acids was determined using gas chromatography and liquid chromatography coupled to tandem mass spectrometry, respectively. The composition of the gut microbiota indicated that the two antibiotics altered the gut microbiota composition and decreased its richness and diversity. At the phylum level, the ratio of Firmicutes/Bacteroidetes increased significantly in the antibiotic groups. At the genus level, there were declines in Christensenella, Gordonibacter and Anaerotruncus in the florfenicol group, in Lactobacillus in the azithromycin group, and in Alistipes, Desulfovibrio, Parasutterella and Rikenella in both the antibiotic groups. The decrease in Rikenella in the azithromycin group was particularly noticeable. The concentration of SCFAs and secondary bile acids decreased in the colon, but the concentration of primary bile acids increased. These findings indicated that florfenicol and azithromycin increased adipogenesis and altered gut microbiota composition, SCFA production, and bile acid metabolism, suggesting that exposure to antibiotics might be one risk factor for childhood obesity. More studies are needed to investigate the specific mechanisms.	[Li, Rui; Wang, Hexing; Shi, Qingfeng; Wang, Na; Zhang, Zhijie; Xiong, Chenglong; Liu, Jianxiang; Jiang, Lufang; Jiang, Qingwu] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Chen, Yue] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada	Fudan University; University of Ottawa	Jiang, LF (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China.	jianglufang@fudan.edu.cn	Xiong, Chenglong/K-2967-2019	Xiong, Chenglong/0000-0003-4750-3572	Natural Science Foundation of Shanghai [16ZR1403400]; Shanghai Key Discipline Construction Project of Shanghai Municipal Public Health [15GWZK0801]; The Fourth Round of Three-year Public Health Action Plan of Shanghai [15GWZK0202]; Starting Foundation for New Teachers of Fudan University [JIF201111]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Key Discipline Construction Project of Shanghai Municipal Public Health; The Fourth Round of Three-year Public Health Action Plan of Shanghai; Starting Foundation for New Teachers of Fudan University	This work was supported by the Natural Science Foundation of Shanghai (No. 16ZR1403400), the Shanghai Key Discipline Construction Project of Shanghai Municipal Public Health (Grant No. 15GWZK0801), The Fourth Round of Three-year Public Health Action Plan of Shanghai (No. 15GWZK0202) and the Starting Foundation for New Teachers of Fudan University (No. JIF201111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of Shanghai (No. 16ZR1403400), the Shanghai Key Discipline Construction Project of Shanghai Municipal Public Health (Grant No. 15GWZK0801), The Fourth Round of Three-year Public Health Action Plan of Shanghai (No. 15GWZK0202) and the Starting Foundation for New Teachers of Fudan University (No. JIF201111).	Afgan E, 2016, NUCLEIC ACIDS RES, V44; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Azad MB, 2014, INT J OBESITY, V38, P1290, DOI 10.1038/ijo.2014.119; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2010, NATURE; Chang CJ, 2015, NATURE; Chen X, 2011, EXP DIABETES RES, V2011; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Fei N, 2013, ISME J, V7, P880, DOI 10.1038/ismej.2012.153; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Frommherz L, 2015, ANN NUTR METAB, V67, P269; Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014; Ha CWY, 2014, WORLD J GASTROENTERO, V20, P16498, DOI 10.3748/wjg.v20.i44.16498; HIRANO S, 1981, APPL ENVIRON MICROB, V41, P737, DOI 10.1128/AEM.41.3.737-745.1981; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Hoverstad T, 2009, SCAND J GASTROENTERO, V21, P997; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; James PT, 2001, WORLDWIDE OBESITY EP; James WPT, 2008, INT J OBESITY, V32, pS120, DOI 10.1038/ijo.2008.247; Jin YX, 2017, ENVIRON POLLUT, V222, P1, DOI 10.1016/j.envpol.2016.11.045; Jin YX, 2016, TOXICOL SCI, V154, P140, DOI 10.1093/toxsci/kfw150; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Khan I, 2016, FRONT PHARMACOL, V7, P327; Kimura I, 2014, FRONT ENDOCRINOL, V5, P840; Krebs NF, 2007, PEDIATRICS; Kumari M, 2017, OBES REV, V18, P18, DOI 10.1111/obr.12484; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Ley RE, 2006, NATURE; Lin SW, 2015, OBESITY, V23, P862, DOI 10.1002/oby.21020; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Mansi Y, 2011, NEONATOLOGY, V100, P290, DOI 10.1159/000327536; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Reyes LM, 2016, INT J FOOD SCI NUTR, V67, P470, DOI 10.3109/09637486.2016.1162770; Mikkelsen KH, 2017, DIABETIC MED, V34, P272, DOI 10.1111/dme.13262; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murugesan S, 2015, EUR J CLIN MICROBIOL, V34, P1337, DOI 10.1007/s10096-015-2355-4; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Paulson JN, 2013, NATURE METHODS; Pihl AF, 2016, CHILD OBES; Polansky O, 2016, APPL ENVIRON MICROB, V82, P1569, DOI 10.1128/AEM.03473-15; Prawitt J, 2011, CURR DIABETES REP, V11, P160, DOI 10.1007/s11892-011-0187-x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RCore Team, 2020, R LANG ENV STAT COMP; RETSEMA J, 1987, ANTIMICROB AGENTS CH, V31, P1939, DOI 10.1128/AAC.31.12.1939; Robinson CJ, 2010, GUT MICROBES, V1, P279, DOI 10.4161/gmic.1.4.12614; Saari A, 2015, PEDIATRICS, V135, P617, DOI 10.1542/peds.2014-3407; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tulstrup MVL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144854; Varma KJ, 1991, ACTA VET; Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang HX, 2016, ENVIRON INT, V89-90, P204, DOI 10.1016/j.envint.2016.02.005; Wang HX, 2016, ENVIRON SCI TECHNOL, V50, P2692, DOI 10.1021/acs.est.5b05749; Waxman A, 2005, WORLD REV NUTR DIET, V95, P162, DOI 10.1159/000088302; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Yallapragada SG, 2015, PEDIATR ANN, V44, pE265, DOI 10.3928/00904481-20151112-09; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	69	32	37	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181690	10.1371/journal.pone.0181690	http://dx.doi.org/10.1371/journal.pone.0181690			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742883	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000049
J	Rosler, L; End, A; Gamer, M				Rosler, Lara; End, Albert; Gamer, Matthias			Orienting towards social features in naturalistic scenes is reflexive	PLOS ONE			English	Article							VISUAL-ATTENTION; EYE-MOVEMENTS; FACES; GAZE; INFORMATION; INHIBITION; SELECTION; CAPTURE; SHIFTS; OVERT	Saliency-based models of visual attention postulate that, when a scene is freely viewed, attention is predominantly allocated to those elements that stand out in terms of their physical properties. However, eye-tracking studies have shown that saliency models fail to predict gaze behavior accurately when social information is included in an image. Notably, gaze pattern analyses revealed that depictions of human beings are heavily prioritized independent of their low-level physical saliency. What remains unknown, however, is whether the prioritization of such social features is a reflexive or a voluntary process. To investigate the early stages of social attention in more detail, participants viewed photographs of naturalistic scenes with and without social features (i.e., human heads or bodies) for 200 ms while their eye movements were being recorded. We observed significantly more first eye movements to regions containing social features than would be expected from a chance level distribution of saccades. Additionally, a generalized linear mixed model analysis revealed that the social content of a region better predicted first saccade direction than its saliency suggesting that social features partially override the impact of low-level physical saliency on gaze patterns. Given the brief image presentation time that precluded visual exploration, our results provide compelling evidence for a reflexive component in social attention. Moreover, the present study emphasizes the importance of considering social influences for a more coherent understanding of human attentional selection.	[Rosler, Lara; Gamer, Matthias] Julius Maximilians Univ Wurzburg, Dept Psychol, Wurzburg, Germany; [End, Albert; Gamer, Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Rosler, L (corresponding author), Julius Maximilians Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	lara.roesler@uni.wuerzburg.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038	European Research Council [ERC-2013-StG-336305]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by a grant from the European Research Council (ERC-2013-StG-336305) to Matthias Gamer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NC, 2015, J VISION, V15, DOI 10.1167/15.5.9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bindemann M, 2005, PSYCHON B REV, V12, P1048, DOI 10.3758/BF03206442; Bindemann M, 2007, J VISION, V7, DOI 10.1167/7.10.15; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2009, VISION RES, V49, P2992, DOI 10.1016/j.visres.2009.09.014; Birmingham E, 2009, VIS COGN, V17, P904, DOI 10.1080/13506280902758044; Birmingham E, 2009, ANN NY ACAD SCI, V1156, P118, DOI 10.1111/j.1749-6632.2009.04468.x; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cerf M., 2008, ADV NEURAL INFORM PR, V20, P241, DOI DOI 10.1145/2185520.2185525; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; End A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00418; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Hall C, 2011, J SEX RES, V48, P461, DOI 10.1080/00224499.2010.521899; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Itier RJ, 2007, NEUROPSYCHOLOGIA, V45, P1019, DOI 10.1016/j.neuropsychologia.2006.09.004; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Judd T., 2012, TECHNICAL REPORT; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Mack A, 2002, CONSCIOUS COGN, V11, P488, DOI 10.1016/S1053-8100(02)00028-4; Mackay M, 2012, J VISION, V12, DOI 10.1167/12.4.9; Marchewka A, 2014, BEHAV RES METHODS, V46, P596, DOI 10.3758/s13428-013-0379-1; McCulloch CE, 2011, STAT SCI, V26, P388, DOI 10.1214/11-STS361; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; Nystrom M, 2008, J EYE MOVEMENT RES, V2, P1, DOI DOI 10.16910/JEMR.2.2.2; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Ristic J, 2005, COGNITION, V94, pB55, DOI 10.1016/j.cognition.2004.04.005; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Shelley-Tremblay J, 1999, PSYCHOL SCI, V10, P508, DOI 10.1111/1467-9280.00197; SMIT AC, 1987, VISION RES, V27, P1745, DOI 10.1016/0042-6989(87)90104-0; Suda Y, 2015, SCI REP-UK, V4, DOI 10.1038/srep07666; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Vecera SP, 2004, NEUROPSYCHOLOGIA, V42, P1657, DOI 10.1016/j.neuropsychologia.2004.04.009; Vuilleumier P, 2000, NEUROPSYCHOLOGIA, V38, P693, DOI 10.1016/S0028-3932(99)00107-4	54	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0182037	10.1371/journal.pone.0182037	http://dx.doi.org/10.1371/journal.pone.0182037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8DV	28742873	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000068
J	Lages, FS; Douglas-de-Oliveira, DW; Ibelli, GS; Assaf, F; Queiroz, TP; Costa, FO				Lages, Frederico Santos; Douglas-de-Oliveira, Dhelfeson Willya; Ibelli, Guilherme Siqueira; Assaf, Fatimah; Queiroz, Thallita Pereira; Costa, Fernando Oliveira			Relationship between implant stability on the abutment and platform level by means of resonance frequency analysis: A cross-sectional study	PLOS ONE			English	Article							TITANIUM IMPLANTS; IMMEDIATE; VIVO	Resonance frequency analysis (RFA) has become the main tool used to assess the osseointegration of dental implants. The objective of this study was to verify the relationship between the ISQ values with different prosthetic abutments and with the implant platform. The hypothesis was that ISQ values changes according to the abutment height. Twelve patients were included, whose contribution to the study was 31 dental implants (external hexagon connection implants, 4.1x10 mm). The temporary implant-supported crown and prosthetic components were removed and the following smartpegs were inserted, one at a time: type 1, in the implant platform (G1); type A3, in the microunit component with 1mm transmucosal height (G2) and type A3, in the microunit component with 5mm transmucosal height (G3). In all the smartpegs, RFA measurements were taken on mesial, distal, buccal and lingual surfaces. All evaluations were performed by a single calibrated examiner (ICC = 0.989). Data were analyzed by Friedman and Spearman correlation tests and log-linear marginal regression (p<0.05). The mean age of participants was 52.83 (+/- 3.77) years. There was statistically significant difference (p<0.001) among the mean ISQ of G1 (88.27 +/- 5.70); G2 (72.75 +/- 4.73) and G3 (66.33 +/- 3.67). There was statistically significant negative correlation between the ISQ and the measurement distance (rs:-0.852; p<0.001; R2:0.553). Measurement distance was significantly associated (p< 0.001) with ISQ value in the log-linear regression. The abutment height has a significant impact on resonance frequency analysis measurements. The higher the transmucosal abutment height, the lower the implant stability quotient value. Clinically, the ISQ measured on the abutment cannot be compared with values measured on the implant platform.	[Lages, Frederico Santos; Douglas-de-Oliveira, Dhelfeson Willya; Costa, Fernando Oliveira] Univ Fed Minas Gerais, Dept Periodontol, Belo Horizonte, MG, Brazil; [Ibelli, Guilherme Siqueira; Assaf, Fatimah; Queiroz, Thallita Pereira] Univ Ctr Araraquara, Dept Implantol, Sao Paulo, Brazil	Universidade Federal de Minas Gerais	Lages, FS (corresponding author), Univ Fed Minas Gerais, Dept Periodontol, Belo Horizonte, MG, Brazil.	fredlages@hotmail.com	Lages, Frederico S/D-7531-2016; Queiroz, Thallita/C-5085-2012; Douglas-de-Oliveira, Dhelfeson Willya/K-6586-2012	COSTA, FERNANDO/0000-0002-7687-1238; Santos Lages, Frederico/0000-0002-8885-1138; Queiroz, Thallita/0000-0002-2464-8181; Douglas-de-Oliveira, Dhelfeson Willya/0000-0002-8628-3122	Research Support Foundation of Minas Gerais - FAPEMIG	Research Support Foundation of Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The authors would like to thank the Research Support Foundation of Minas Gerais - FAPEMIG for the scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the Research Support Foundation of Minas Gerais-FAPEMIG for the scholarship. The authors declare no competing financial interests.	Bornstein MM, 2010, J PERIODONTOL, V81, P809, DOI 10.1902/jop.2010.090727; Choi HH, 2014, IMPLANT DENT, V23, P51, DOI 10.1097/ID.0000000000000000; Elsyad MA, 2014, J ORAL REHABIL, V41, P608, DOI 10.1111/joor.12182; Fischer K, 2009, CLIN IMPLANT DENT R, V11, P69, DOI 10.1111/j.1708-8208.2008.00096.x; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Griffin TJ, 2004, J PROSTHET DENT, V92, P139, DOI 10.1016/j.prosdent.2004.05.010; Gupta Rajiv K, 2011, Indian J Dent Res, V22, P567, DOI 10.4103/0970-9290.90300; Kokovic V, 2014, CLIN ORAL IMPLAN RES, V25, pE114, DOI 10.1111/clr.12072; Koutouzis T, 2013, INT J ORAL MAX IMPL, V28, P807, DOI 10.11607/jomi.3022; Krafft T, 2015, J ORAL IMPLANTOL, V41, pE133, DOI 10.1563/AAID-JOI-D-13-00172; Kuchler U, 2017, CLIN ORAL IMPLAN RES, V28, P109, DOI 10.1111/clr.12768; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lozano-Carrascal N, 2016, MED ORAL PATOL ORAL, V21, pE214, DOI 10.4317/medoral.21024; McCullagh P, 1989, GEN LINEAR MODELS; Meredith N, 1997, CLIN ORAL IMPLAN RES, V8, P226, DOI 10.1034/j.1600-0501.1997.080309.x; Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x; Micarelli C, 2015, INT J PROSTHODONT, V28, P282, DOI 10.11607/ijp.4147; Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P520, DOI 10.1111/j.1600-0501.2004.01059.x; Ohta K, 2010, J ORAL REHABIL, V37, P131, DOI 10.1111/j.1365-2842.2009.02032.x; Pozzi A, 2014, CLIN IMPLANT DENT R, V16, P96, DOI 10.1111/j.1708-8208.2012.00465.x; Queiroz TP, 2015, CLIN ORAL IMPLAN RES, V26, P1036, DOI 10.1111/clr.12394; Ramakrishna R, 2007, S INDIAN J DENT RES, V18, P168; Rasmusson L, 1997, CLIN ORAL IMPLAN RES, V8, P316, DOI 10.1034/j.1600-0501.1997.080410.x; Schliephake H, 2012, J CLIN PERIODONTOL, V39, P188, DOI 10.1111/j.1600-051X.2011.01816.x; Sim CPC, 2010, CLIN ORAL IMPLAN RES, V21, P598, DOI 10.1111/j.1600-0501.2009.01878.x; Simunek A, 2012, INT J ORAL MAX IMPL, V27, P619; Staedt H, 2017, IMPLANT DENT, V26, P250, DOI 10.1097/ID.0000000000000531; Swami Vasanthi, 2016, J Indian Prosthodont Soc, V16, P124, DOI 10.4103/0972-4052.176539; Tallarico M, 2011, QUINTESSENCE INT, V42, P635; Valderrama P, 2007, J PERIODONTOL, V78, P262, DOI 10.1902/jop.2007.060143; Xiao JR, 2012, BRIT J ORAL MAX SURG, V50, P161, DOI 10.1016/j.bjoms.2011.01.010	31	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181873	10.1371/journal.pone.0181873	http://dx.doi.org/10.1371/journal.pone.0181873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742164	Green Submitted, gold, Green Published			2022-12-26	WOS:000406362700083
J	Perera, RS; Dissanayake, PH; Senarath, U; Wijayaratne, LS; Karunanayake, AL; Dissanayake, VHW				Perera, Romain Shanil; Dissanayake, Poruwalage Harsha; Senarath, Upul; Wijayaratne, Lalith Sirimevan; Karunanayake, Aranjan Lional; Dissanayake, Vajira Harshadeva Weerabaddana			Variants of ACAN are associated with severity of lumbar disc herniation in patients with chronic low back pain	PLOS ONE			English	Article							DEGENERATION; PREVALENCE; OBESITY; POLYMORPHISMS; EPIDEMIOLOGY; RISK; VNTR	Introduction Disc herniation is a complex spinal disorder associated with disability and high healthcare cost. Lumbar disc herniation is strongly associated with disc degeneration. Candidate genes of the aggrecan metabolic pathway may associate with the severity of lumbar disc herniation. Objectives This study evaluated the association of single nucleotide variants (SNVs) of the candidate genes of the aggrecan metabolic pathway with the severity of lumbar disc herniation in patients with chronic mechanical low back pain. In addition, we assessed the in-silico functional analysis of the significant SNVs and association of their haplotypes with the severity of lumbar disc herniation. Methods A descriptive cross sectional study was carried out on 106 patients. Severity of disc herniation and disc degeneration were assessed on T2-weighted mid sagittal lumbar MRI scan. Sixty two exonic SNVs of ten candidate genes of aggrecan metabolic pathway (ACAN, IL1A, IL1B, IL6, MMP3, ADAMTS4, ADAMTS5, TIMP1, TIMP2 and TIMP3) were genotyped on a Sequenom MassARRAY iPLEX platform. Multivariable linear regression analysis was carried out using PLINK 1.9 software adjusting for age, gender, body mass index and severity of disc degeneration. Four online bioinformatics tools (Provean, SIFT, PolyPhen and Mutation Taster) were used for in-silico functional analysis. Results Mean age was 52.42 +/- 9.42 years and 69.8% were females. The mean severity of disc herniation was 2.81 +/- 1.98. The rs2272023, rs35430524, rs2882676, rs2351491, rs938609, rs3825994, rs1042630, rs698621 and rs3817428 variants and their haplotypes of ACAN were associated with the severity of lumbar disc herniation. However, only the rs35430524, rs938609 and rs3817428 variants of ACAN were detected as pathogenic by in-silico functional analysis. Conclusions SNVs of ACAN and their haplotypes are associated with the severity of lumbar disc herniation. Functional genetic studies are necessary to identify the role of these significant SNVs in the pathogenesis of disc herniation.	[Perera, Romain Shanil] Univ Colombo, Dept Allied Hlth Sci, Fac Med, Colombo 8, Sri Lanka; [Dissanayake, Poruwalage Harsha] Univ Sri Jayewardenepura, Dept Anat, Fac Med Sci, Nugegoda, Sri Lanka; [Senarath, Upul] Univ Colombo, Dept Community Med, Fac Med, Colombo 8, Sri Lanka; [Wijayaratne, Lalith Sirimevan] Natl Hosp Sri Lanka, Colombo 10, Sri Lanka; [Karunanayake, Aranjan Lional] Univ Kelaniya, Dept Anat, Fac Med, Ragama, Sri Lanka; [Dissanayake, Vajira Harshadeva Weerabaddana] Univ Colombo, Dept Anat, Human Genet Unit, Fac Med, Colombo 8, Sri Lanka	University of Colombo; University Sri Jayewardenepura; University of Colombo; University Kelaniya; University of Colombo	Perera, RS (corresponding author), Univ Colombo, Dept Allied Hlth Sci, Fac Med, Colombo 8, Sri Lanka.	romaingl@med.cmb.ac.lk	Perera, Romain Shanil/J-3983-2019; Dissanayake, Vajira/ABE-8419-2020	Perera, Romain Shanil/0000-0002-9682-5642; 	University Grants Commission, Sri Lanka [UGC/ICD/2/RG2011/02/08]; University of Colombo, Sri Lanka [AP/3/2012/PG/03]	University Grants Commission, Sri Lanka(University Grants Commission, India); University of Colombo, Sri Lanka	This work was funded by the University Grants Commission, Sri Lanka (UGC/ICD/2/RG2011/02/08) and the University of Colombo, Sri Lanka (AP/3/2012/PG/03). The funders provided funds for study design, data collection and analysis.	Adams MA, 2012, J ANAT, V221, P497, DOI 10.1111/j.1469-7580.2012.01551.x; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arambepola C, 2007, PREV MED, V44, P129, DOI 10.1016/j.ypmed.2006.11.004; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cong L, 2014, CONNECT TISSUE RES, V55, P384, DOI 10.3109/03008207.2014.959117; Eser B, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038669; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Friedly J, 2010, PHYS MED REH CLIN N, V21, P659, DOI 10.1016/j.pmr.2010.08.002; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Huang XY, 2017, GENET TEST MOL BIOMA, V21, P17, DOI 10.1089/gtmb.2016.0189; Jacobsen LM, 2013, CLIN J PAIN, V29, P967, DOI 10.1097/AJP.0b013e31827df7fd; Kadow T, 2015, CLIN ORTHOP RELAT R, V473, P1903, DOI 10.1007/s11999-014-3774-8; Katsonis P, 2014, PROTEIN SCI, V23, P1650, DOI 10.1002/pro.2552; Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANE NE, 1993, J RHEUMATOL, V20, P1911; Manek NJ, 2005, CURR OPIN RHEUMATOL, V17, P134; Mill J, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-3; Omair A, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-105; Perera RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169835; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Promega Corporation, QUANTIFLUOR DSDNA SY; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QIAGEN, QIAAMP DNA MIN MIN 2; Rajasekaran S, 2013, SPINE J, V13, P1309, DOI 10.1016/j.spinee.2013.05.019; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Sivan SS, 2014, EUR SPINE J, V23, pS344, DOI 10.1007/s00586-013-2767-8; Takatalo J, 2009, SPINE, V34, P1716, DOI 10.1097/BRS.0b013e3181ac5fec; Videman T, 2009, ARTHRITIS RHEUM-US, V60, P470, DOI 10.1002/art.24268; Walker BF, 2009, MANUAL THER, V14, P314, DOI 10.1016/j.math.2008.04.003; Whitley AS., 2005, CLARKS POSITIONING R	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181580	10.1371/journal.pone.0181580	http://dx.doi.org/10.1371/journal.pone.0181580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742099	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700055
J	Grigoriev, P; Jasilionis, D; Stumbrys, D; Stankuniene, V; Shkolnikov, VM				Grigoriev, Pavel; Jasilionis, Domantas; Stumbrys, Daumantas; Stankuniene, Vladislava; Shkolnikov, Vladimir M.			Individual- and area-level characteristics associated with alcohol-related mortality among adult Lithuanian males: A multilevel analysis based on census-linked data	PLOS ONE			English	Article							MARITAL-STATUS; PROSPECTIVE COHORT; ALL-CAUSE; RUSSIA; HEALTH; MEN; DEATH; LIFE; INEQUALITIES; CONSUMPTION	Background Although excessive alcohol-related mortality in the post-Soviet countries remains the major public health threat, determinants of this phenomenon are still poorly understood. Aims We assess simultaneously individual-and area-level factors associated with an elevated risk of alcohol-related mortality among Lithuanian males aged 30-64. Methods Our analysis is based on a census-linked dataset containing information on individual-and area-level characteristics and death events which occurred between March 1 st, 2011 and December 31 st, 2013. We limit the analysis to a few causes of death which are directly linked to excessive alcohol consumption: accidental poisonings by alcohol (X45) and liver cirrhosis (K70 and K74). Multilevel Poisson regression models with random intercepts are applied to estimate mortality rate ratios (MRR). Results The selected individual-level characteristics are important predictors of alcohol-related mortality, whereas area-level variables show much less pronounced or insignificant effects. Compared to married men, never married (MRR = 1.9, CI: 1.6-2.2), divorced (MRR = 2.6, CI: 2.3-2.9), and widowed (MRR = 2.4, CI: 1.8-3.1) men are disadvantaged groups. Men who have the lowest level of educational attainment have the highest mortality risk (MRR = 1.7 CI: 1.4-2.1). Being unemployed is associated with a five-fold risk of alcohol-related death (MRR = 5.1, CI: 4.4-5.9), even after adjusting for all other individual variables. Lithuanian males have an advantage over Russian (MRR = 1.3, CI: 1.1-1.6) and Polish (MRR = 1.8, CI: 1.5-2.2) males. After adjusting for all individual characteristics, only two out of seven area-level variables D i.e., the share of ethnic minorities in the population and the election turnout D have statistically significant direct associations. These variables contribute to a higher risk of alcohol-related mortality at the individual level. Conclusions The huge and increasing socio-economic disparities in alcohol-related mortality indicate that recently implemented anti-alcohol measures in Lithuania should be reinforced by specific measures targeting the most disadvantaged population groups and geographical areas.	[Grigoriev, Pavel; Jasilionis, Domantas; Shkolnikov, Vladimir M.] Max Planck Inst Demog Res, Rostock, Germany; [Jasilionis, Domantas; Stumbrys, Daumantas; Stankuniene, Vladislava] Vytautas Magnus Univ, Demog Res Ctr, Kaunas, Lithuania; [Shkolnikov, Vladimir M.] Natl Res Univ Higher Sch Econ, Moscow, Russia	Max Planck Society; Vytautas Magnus University; HSE University (National Research University Higher School of Economics)	Grigoriev, P (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	Grigoriev@demogr.mpg.de		Stumbrys, Daumantas/0000-0002-1324-5758; Jasilionis, Domantas/0000-0001-9959-9292	Research Council of Lithuania [TAP LB-17-027]; Russian Academic Excellence Project [5-100]	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Russian Academic Excellence Project(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The study has been conducted in the framework of the project "Contemporary demographic problems in Belarus and Lithuania: variations, similarities, and ways for transition to sustainable development" (TAP LB-17-027) funded by the Research Council of Lithuania on the basis of the bilateral agreement on the partnership in the areas of science and technology between Lithuania and Belarus http://www.lmt.lt/en/rnd/intergov/lt-by. html. The participation of VMS was partially supported by the Russian Academic Excellence Project 5-100 (http://5top100.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2001, CHALLENGING INEQUITI, P49; Bates D, LME4 LINEAR MIXED EF, P1; Baubiniene A, 1993, MEDICINA, V2, P46; Benosis A, 2014, SVEIK MOKSL, V24, P10, DOI [10.5200/sm-hs.2014.002, DOI 10.5200/SM-HS.2014.002]; Benosis A., 2008, SVEIKATOS MOKSLAI, V1, P1499; Blomgren J, 2004, SOC SCI MED, V58, P2523, DOI 10.1016/j.socscimed.2003.09.027; Brainerd E, 2005, J ECON PERSPECT, V19, P107, DOI 10.1257/0895330053147921; Burneika D., 2013, ETHNICITY STUDIES, V2, P49; Dasgupta P, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-36; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Grabauskas V, 2013, HLTH BEHAV LITHUANIA; Grabauskas V, 2009, MEDICINA-LITHUANIA, V45, P1000, DOI 10.3390/medicina45120128; Grigoriev P, 2015, EUR J PUBLIC HEALTH, P1; Jasilionis D., 2015, LIETUVOS DEMOGRAFINI; Jasilionis D., 2006, SOCIODEMOGRAPHIC MOR; Jasilionis D., 2012, SOCIOECONOMIC DIFFER; Jasilionis D, 2007, POPULATION, V62, P707; Jasilionis D, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2011.133967; Jasilionis D, 2011, EUR J POPUL, V27, P403, DOI 10.1007/s10680-011-9243-0; Jurkynas M., 2012, ELECT STUD, V34, P291; Kunst AE, 1998, REV EPIDEMIOL SANTE, V46, P467; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Mackenbach JP, 2015, SOC SCI MED, V127, P51, DOI 10.1016/j.socscimed.2014.05.021; Mackenbach JP, 2015, J EPIDEMIOL COMMUN H, V69, P207, DOI 10.1136/jech-2014-204319; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; Martikainen P, 2004, EUR J POPUL, V20, P323, DOI 10.1007/s10680-004-3807-1; MARTIKAINEN PT, 1990, BMJ-BRIT MED J, V301, P407, DOI 10.1136/bmj.301.6749.407; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Mirowsky J, 1998, RES AGING, V20, P415, DOI 10.1177/0164027598204003; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Mirowsky J, 2005, AGEING INT, V30, P27, DOI 10.1007/BF02681006; Paukste E, 2014, ADDICTION, V109, P711, DOI 10.1111/add.12495; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Pridemore WA, 2010, EUR J PUBLIC HEALTH, V20, P569, DOI 10.1093/eurpub/ckq019; Probst C, 2014, INT J EPIDEMIOL, V43, P1314, DOI 10.1093/ije/dyu043; Radisauskas R, 2011, ALCOHOL ALCOHOLISM, V46, P614, DOI 10.1093/alcalc/agr068; Ramonaite A., 2014, POLITOLOGIJA, V1, P3; Rehm J, 2017, ADDICTION, V112, P968, DOI 10.1111/add.13757; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Saburova L, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-481; Sauliune S., 2008, ALCOHOL ALCOHOLISM, V47, P458; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Shkolnikov VM, 2007, SOC SCI MED, V64, P1392, DOI 10.1016/j.socscimed.2006.11.014; Shkolnikov VM, 2004, HYGIEA INT, V4, P29, DOI DOI 10.3384/HYGIEA.1403-8668.044129; SKOG OJ, 1995, ADDICTION, V90, P490, DOI 10.1111/j.1360-0443.1995.tb02182.x; Stelemekas M, 2012, VISUOMENES SVEIKATA, V4, P26; Stickley A, 2007, EUR J PUBLIC HEALTH, P1; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274; Vallin J., 1979, READINGS POPUL RES M, V2, P957; Veryga A, 2009, ADDICTION, V104, P1259, DOI 10.1111/j.1360-0443.2009.02654.x; Voss M, 2004, AM J PUBLIC HEALTH, V94, P2155, DOI 10.2105/AJPH.94.12.2155; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; *WHO, EUR HLTH ALL DAT HFA	57	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181622	10.1371/journal.pone.0181622	http://dx.doi.org/10.1371/journal.pone.0181622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732032	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100050
J	Kawalek, A; Glabski, K; Bartosik, AA; Fogtman, A; Jagura-Burdzy, G				Kawalek, Adam; Glabski, Krzysztof; Bartosik, Aneta Agnieszka; Fogtman, Anna; Jagura-Burdzy, Grazyna			Increased ParB level affects expression of stress response, adaptation and virulence operons and potentiates repression of promoters adjacent to the high affinity binding sites parS3 and parS4 in Pseudomonas aeruginosa	PLOS ONE			English	Article							CHROMOSOME PARTITIONING PROTEINS; ANTIBIOTIC-RESISTANCE; REPLICATION INITIATION; ACTIVE SEGREGATION; SOS RESPONSE; CELL-CYCLE; DNA; SPO0J; ORIGIN; SPORULATION	Similarly to its homologs in other bacteria, Pseudomonas aeruginosa partitioning protein ParB facilitates segregation of newly replicated chromosomes. Lack of ParB is not lethal but results in increased frequency of anucleate cells production, longer division time, cell elongation, altered colony morphology and defective swarming and swimming motility. Unlike in other bacteria, inactivation of parB leads to major changes of the transcriptome, suggesting that, directly or indirectly, ParB plays a role in regulation of gene expression in this organism. ParB overproduction affects growth rate, cell division and motility in a similar way as ParB deficiency. To identify primary ParB targets, here we analysed the impact of a slight increase in ParB level on P. aeruginosa transcriptome. ParB excess, which does not cause changes in growth rate and chromosome segregation, significantly alters the expression of 176 loci. Most notably, the mRNA level of genes adjacent to high affinity ParB binding sites parS1-4 close to oriC is reduced. Conversely, in cells lacking either parB or functional parS sequences the orfs adjacent to parS3 and parS4 are upregulated, indicating that direct ParB- parS3/parS4 interactions repress the transcription in this region. In addition, increased ParB level brings about repression or activation of numerous genes including several transcriptional regulators involved in SOS response, virulence and adaptation. Overall, our data support the role of partitioning protein ParB as a transcriptional regulator in Pseudomonas aeruginosa.	[Kawalek, Adam; Glabski, Krzysztof; Bartosik, Aneta Agnieszka; Jagura-Burdzy, Grazyna] Polish Acad Sci, Inst Biochem & Biophys, Dept Microbial Biochem, Warsaw, Poland; [Fogtman, Anna] Polish Acad Sci, Inst Biochem & Biophys, Lab Microarray Anal, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Jagura-Burdzy, G (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Microbial Biochem, Warsaw, Poland.	gjburdzy@ibb.waw.pl	Kawalek, Adam/ABG-9427-2022; Bartosik, Aneta/AAR-9347-2021; Jagura-Burdzy, Grazyna/AAU-7423-2021	Kawalek, Adam/0000-0001-8219-8724; Bartosik, Aneta/0000-0002-2091-3101; Fogtman, Anna/0000-0002-5331-7840; Jagura-Burdzy, Grazyna/0000-0002-0794-2565	Polish National Science Centre [2013/11/B/NZ2/02555]	Polish National Science Centre	This work was supported by the Polish National Science Centre, grant no 2013/11/B/NZ2/02555 awarded to GJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank dr Paulina Jecz for the construction of pPJB132. We thank dr Joanna Empel (National Medicines Institute, Epidemiology and Clinical Microbiology Department) for the expertise in MIC assays. This work was supported by the Polish National Science Centre grant no 2013/11/B/NZ2/02555 awarded to GJB.	Attaiech L, 2015, MBIO, V6, DOI 10.1128/mBio.00662-15; Baek JH, 2014, MBIO, V5, DOI 10.1128/mBio.01061-14; Baharoglu Z, 2014, FEMS MICROBIOL REV, V38, P1126, DOI 10.1111/1574-6976.12077; Bartosik AA, 2009, MICROBIOL-SGM, V155, P1080, DOI 10.1099/mic.0.024661-0; Bartosik AA, 2004, J BACTERIOL, V186, P6983, DOI 10.1128/JB.186.20.6983-6998.2004; Bartosik AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087276; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Broedersz CP, 2014, P NATL ACAD SCI USA, V111, P8809, DOI 10.1073/pnas.1402529111; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Donczew M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150263; El-Sayed AK, 2001, MICROBIOL-SGM, V147, P2127, DOI 10.1099/00221287-147-8-2127; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Funnel BE, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00044; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hajduka IV, 2016, SEMIN CELL DEV BIOL, V53, P2, DOI 10.1016/j.semcdb.2015.11.012; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hay T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056858; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hittle LE, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv053; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Iniesta AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086897; Irani VR, 1997, BIOTECHNIQUES, V22, P54, DOI 10.2144/97221bm09; IRETON K, 1994, J BACTERIOL, V176, P5320, DOI 10.1128/JB.176.17.5320-5329.1994; Jecz P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120867; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kreuzer KN, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012674; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; Lagage V, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006428; Lasocki K, 2007, J BACTERIOL, V189, P5762, DOI 10.1128/JB.00371-07; Lee PS, 2006, MOL MICROBIOL, V60, P853, DOI 10.1111/j.1365-2958.2006.05140.x; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Liang Y, 2016, MICROB PATHOGENESIS, V101, P126, DOI 10.1016/j.micpath.2016.09.019; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Ludwiczak M, 2013, PLASMID, V70, P131, DOI 10.1016/j.plasmid.2013.03.007; Mac Aogain M, 2012, MICROBIOL-SGM, V158, P2598, DOI 10.1099/mic.0.058636-0; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; MATSUI H, 1993, J BACTERIOL, V175, P1257, DOI 10.1128/JB.175.5.1257-1263.1993; McFarland KA, 2015, P NATL ACAD SCI USA, V112, P8433, DOI 10.1073/pnas.1506299112; Mierzejewska J, 2012, MICROBIOL-SGM, V158, P1183, DOI 10.1099/mic.0.056234-0; Miller JH, 1972, EXPT MOL GENETICS, P580; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Modell JW, 2011, GENE DEV, V25, P1328, DOI 10.1101/gad.2038911; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Murray H, 2008, CELL, V135, P74, DOI 10.1016/j.cell.2008.07.044; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Penterman J, 2014, J BACTERIOL, V196, P3351, DOI 10.1128/JB.01889-14; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saint-Dic D, 2006, J BACTERIOL, V188, P5626, DOI 10.1128/JB.00250-06; Salje J, 2010, CRIT REV BIOCHEM MOL, V45, P296, DOI 10.3109/10409238.2010.494657; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sams T, 2016, ISR J CHEM, V56, P282, DOI 10.1002/ijch.201400128; Scholefield G, 2011, MOL MICROBIOL, V79, P1089, DOI 10.1111/j.1365-2958.2010.07507.x; Sharpe ME, 1996, MOL MICROBIOL, V21, P501, DOI 10.1111/j.1365-2958.1996.tb02559.x; Shen LX, 2012, J ANTIBIOT, V65, P59, DOI 10.1038/ja.2011.111; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solovjev V, 2011, METAGENOMICITAPP, P61; Soukas A, 2000, GENE DEV, V14, P963; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; Taylor JA, 2015, NUCLEIC ACIDS RES, V43, P719, DOI 10.1093/nar/gku1295; Turner KH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000779; Valentini M, 2016, J BIOL CHEM, V291, P12547, DOI 10.1074/jbc.R115.711507; Vallet-Gely I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003492; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wade DS, 2005, J BACTERIOL, V187, P4372, DOI 10.1128/JB.187.13.4372-4380.2005; Wang BB, 2016, MICROB PATHOGENESIS, V91, P5, DOI 10.1016/j.micpath.2015.11.003; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; Winsor GL, 2005, NUCLEIC ACIDS RES, V33, pD338, DOI 10.1093/nar/gki047; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; Yamaichi Y, 2000, P NATL ACAD SCI USA, V97, P14656, DOI 10.1073/pnas.97.26.14656; Yamamoto M, 2009, MICROBIOL-SGM, V155, P3312, DOI 10.1099/mic.0.028993-0; Zheng P, 2007, J BIOTECHNOL, V132, P342, DOI 10.1016/j.jbiotec.2007.08.013	91	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181726	10.1371/journal.pone.0181726	http://dx.doi.org/10.1371/journal.pone.0181726			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732084	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100059
J	Rose, K; Agius, J; Hall, J; Thompson, P; Eden, JS; Srivastava, M; Tiernan, B; Jenkins, C; Phalen, D				Rose, Karrie; Agius, Jessica; Hall, Jane; Thompson, Paul; Eden, John-Sebastian; Srivastava, Mukesh; Tiernan, Brendan; Jenkins, Cheryl; Phalen, David			Emergent multisystemic Enterococcus infection threatens endangered Christmas Island reptile populations	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; IDENTIFICATION; EPIDEMIOLOGY; EXTINCTION; VIRULENCE; BACTERIA; WATER; VENOM	Multisystemic infections with a morphologically unusual bacterium were first observed in captive critically endangered Lister's geckos (Lepidodactylus listeri) on Christmas Island in October 2014. Since then the infection was identified in another captive critically endangered lizard species, the blue-tailed skink (Cryptoblepharus egeriae) and two species of invasive geckos; the four clawed gecko (Gehyra mutilata) and Asian house gecko (Hemidactylus frenatus), in a wide geographic range across the east side of the island. The Gram and periodic acid-Schiff positive cocci to diplococci have a propensity to form chains surrounded by a matrix, which ultrastructurally appears to be formed by fibrillar capsular projections. The bacterium was associated with severe and extensive replacement of tissues, but minimal host inflammatory response. Attempts to grow the organism in culture and in embryonated eggs were unsuccessful. Molecular characterisation of the organism placed it as a novel member of the genus Enterococcus. Disease Risk Analyses including this organism should now be factored into conservation management actions and island biosecurity.	[Rose, Karrie; Hall, Jane; Thompson, Paul] Taronga Conservat Soc Australia, Sydney, NSW, Australia; [Rose, Karrie] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Agius, Jessica; Phalen, David] Univ Sydney, Sydney Sch Vet Sci, Fac Vet Sci, Sydney, NSW, Australia; [Eden, John-Sebastian] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Eden, John-Sebastian] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Srivastava, Mukesh; Jenkins, Cheryl] New South Wales Dept Primary Ind, Elizabeth Macarthur Agr Inst, Camden, NSW, Australia; [Tiernan, Brendan] Christmas Isl Natl Pk, Drumsite, CX, Australia	James Cook University; University of Sydney; University of Sydney; University of Sydney; NSW Department of Primary Industries	Rose, K (corresponding author), Taronga Conservat Soc Australia, Sydney, NSW, Australia.; Rose, K (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.	krose@zoo.nsw.gov.au	Hall, Jane/ABC-6552-2021; Jenkins, Cheryl/N-1937-2015	Hall, Jane/0000-0001-9310-5140; Jenkins, Cheryl/0000-0002-5966-072X; Eden, John-Sebastian/0000-0003-1374-3551; Agius, Jessica/0000-0001-8735-1222	Christmas Island National Park, Parks Australia; Faculty of Veterinary Science, Sydney School of Veterinary Science, University of Sydney; Taronga Conservation Society Australia; National Significant Disease Investigation Scheme of Animal Health Australia; Wildlife Health Australia	Christmas Island National Park, Parks Australia; Faculty of Veterinary Science, Sydney School of Veterinary Science, University of Sydney; Taronga Conservation Society Australia; National Significant Disease Investigation Scheme of Animal Health Australia; Wildlife Health Australia	We acknowledge Christmas Island National Park, Parks Australia and the Faculty of Veterinary Science, Sydney School of Veterinary Science, University of Sydney and Taronga Conservation Society Australia for their financial and logistical support. Further financial support for this project was provided by the National Significant Disease Investigation Scheme of Animal Health Australia and Wildlife Health Australia. We also thank Kim Ho, Melinda Micallef, Dr. Richmond Loh, and Dr. Bernard Hudson for their assistance with attempts to culture the organism described. Drs. David Spratt and Peter Harlow kindly reviewed the manuscript Sharon Candy and Dr. Hannah Bender contributed to image editing, and Dr. Justin Welbergen provided the images of the live gecko in Figure 2.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson ET, 2010, J ZOO WILDLIFE MED, V41, P745, DOI 10.1638/2010-0096.1; Andrew P, 2016, ORYX, P1; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chinnadurai Sathya K, 2009, Vet Clin North Am Exot Anim Pract, V12, P583, DOI 10.1016/j.cvex.2009.06.008; Cogger HG, 2000, TERRESTRIAL REPTILES; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Dahlen Gunnar, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10855; Director of National Parks, 2014, CHRISTM ISL BIOD CON; Distel JW, 2002, J ENDODONT, V28, P689, DOI 10.1097/00004770-200210000-00003; Fisher K, 2009, MICROBIOL-SGM, V155, P1749, DOI 10.1099/mic.0.026385-0; Gilmore MS, 2013, CURR OPIN MICROBIOL, V16, P10, DOI 10.1016/j.mib.2013.01.006; Goldstein EJC, 2013, J ZOO WILDLIFE MED, V44, P262, DOI 10.1638/2012-0022R.1; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Hall J, 2011, ASSESSMENT REPTILE M, P178; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Hayes JR, 2003, APPL ENVIRON MICROB, V69, P7153, DOI 10.1128/AEM.69.12.7153-7160.2003; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Huebner RA, 2013, PLOS ONE, V8; Innis C, 2010, CHELONIAN CONSERV BI, V9, P205, DOI 10.2744/CCB-0838.1; Innis CJ, 2014, JAVMA-J AM VET MED A, V245, P315, DOI 10.2460/javma.245.3.315; Jacobson ER, 2014, VET J, V201, P257, DOI 10.1016/j.tvjl.2014.05.039; Jakob-Hoff RM., 2014, MANUAL PROCEDURES WI; Cabanes FJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004367; Jay J.M., 2005, MODERN FOOD MICROBIO, V7th; Jho Yeon-Sook, 2011, Lab Anim Res, V27, P213, DOI 10.5625/lar.2011.27.3.213; John VU, 2011, [Frontiers in Biology, 生物学前沿], V6, P357; Johnson J., 2001, P 8 ANN C ASS REPT A, P147; Johnston LM, 2004, APPL ENVIRON MICROB, V70, P3133, DOI 10.1128/AEM.70.5.3133-3137.2004; Jones K, 2016, VET J, V212, P48, DOI 10.1016/j.tvjl.2015.10.041; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; KUMAR A, 1978, A VAN LEEUW J MICROB, V44, P219, DOI 10.1007/BF00643224; Lebreton F, 2017, CELL, V169, P849, DOI 10.1016/j.cell.2017.04.027; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; MCDONALD IJ, 1975, CAN J MICROBIOL, V21, P1198, DOI 10.1139/m75-179; MCNAMARA TS, 1994, J ZOO WILDLIFE MED, V25, P161; Mohamed JA, 2007, J MED MICROBIOL, V56, P1581, DOI 10.1099/jmm.0.47331-0; MUNDT JO, 1963, APPL MICROBIOL, V11, P136, DOI 10.1128/AEM.11.2.136-140.1963; Naser S, 2005, J CLIN MICROBIOL, V43, P2224, DOI 10.1128/JCM.43.5.2224-2230.2005; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; OBOEGBULEM SI, 1985, INT J ZOONOSES, V12, P228; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; REUTER G, 1992, INT J FOOD MICROBIOL, V17, P101, DOI 10.1016/0168-1605(92)90109-G; Sabia C, 2008, J APPL MICROBIOL, V104, P970, DOI 10.1111/j.1365-2672.2007.03612.x; Schroeter Matthias, 2005, Journal of Herpetological Medicine and Surgery, V15, P53; Schroter M, 2005, J HERPETOL MED SURG, V15, P3; Schumacher J, 2006, J EXOT PET MED, V15, P18, DOI 10.1053/j.jepm.2005.11.004; Singh BR, 2014, J MICROBIOL RES, V4, P78; Singh BR, 2013, INT J MICROBIOL; SLANETZ LW, 1957, J BACTERIOL, V74, P591, DOI 10.1128/JB.74.5.591-595.1957; Smith MJ, 2012, HERPETOL CONSERV BIO, V7, P206; STALEY JT, 1968, J BACTERIOL, V95, P1921, DOI 10.1128/JB.95.5.1921-1942.1968; STEWART JS, 1990, J ZOO WILDLIFE MED, V21, P180; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEAKSTON RDG, 1990, T ROY SOC TROP MED H, V84, P875, DOI 10.1016/0035-9203(90)90112-R; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zwart P, 1972, 14 INT S ERKR ZOOT W, P265	61	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181240	10.1371/journal.pone.0181240	http://dx.doi.org/10.1371/journal.pone.0181240			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727845	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500049
J	Ye, J; Wei, X; Shang, Y; Pan, Q; Yang, M; Tian, Y; He, Y; Peng, Z; Chen, L; Chen, W; Wang, R				Ye, J.; Wei, X.; Shang, Y.; Pan, Q.; Yang, M.; Tian, Y.; He, Y.; Peng, Z.; Chen, L.; Chen, W.; Wang, R.			Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity	ONCOGENE			English	Article							MESENCHYMAL-TRANSITION; SPONTANEOUS COLITIS; PANCREATIC-CANCER; TUMOR-GROWTH; GLYCOSYLATION; METASTASIS; SUPPRESSES; SYNTHASE; TRANSCRIPTION; FIBRONECTIN	The attachment of cell-surface carbohydrates to proteins mediated by the amino acids serine or threonine (O-glycan) is involved in tumor metastasis; the roles of O-glycans vary depending on their structure, but the detailed mechanisms by which O-glycans trigger signaling to control tumor metastasis are largely unknown. In this study, we found that the reduced expression of core 3 synthase correlated with metastasis to lymph nodes and distant organs, resulting in poor prognosis for colorectal cancer (CRC) patients. Mechanically, we revealed that mucin-type core 3 O-glycan was synthesized at the membrane-tethered MUC1 N terminus because of core 3 synthase expression in colon cancer cells. This further inhibited the translocation of MUC1-C to the nucleus, initiated p53 gene transcription that was dependent on the inhibition of MUC1-C nucleus translocation, activated p53-mediated miR-200c expression and resulted in mesenchymal-epithelial transition (MET). Inhibition of MUC1 via small interfering RNA (siRNA) in re-expressed core 3 synthase colon cancer cells further inhibited MUC1-C nucleus translocation, increased p53 and miR-200c expression, and enhanced MET. However, inhibition of p53 via siRNA or miR-200c via miR-200c inhibitor in re-expressed core 3 synthase colon cancer cells promoted the epithelial-mesenchymal transition (EMT) in a reversible manner. Core 3 synthase mRNA levels and the p53 mRNA levels or miR-200c levels in the colon cancerous samples were positively correlated. Our findings suggest a novel mechanism linking mucin-type core 3 O-glycan to the EMT-MET plasticity of CRC cells via MUC1/p53/miR-200c-dependent signaling cascade and shed light on therapeutic strategies to treat this malignancy.	[Ye, J.; Wei, X.; Shang, Y.; Pan, Q.; Yang, M.; Tian, Y.; He, Y.; Peng, Z.; Chen, L.; Chen, W.; Wang, R.] Third Mil Med Univ, Inst Gastroenterol PLA, Southwest Hosp, Dept Gastroenterol, Gaotanyan Main St 30, Chongqing 400038, Peoples R China	Army Medical University	Wang, R (corresponding author), Third Mil Med Univ, Inst Gastroenterol PLA, Southwest Hosp, Dept Gastroenterol, Gaotanyan Main St 30, Chongqing 400038, Peoples R China.	rongquanw@hotmail.com		ye, jun/0000-0002-0631-556X; shang, yangyang/0000-0003-0764-0572; Wang, Rongquan/0000-0001-5307-0086	National Natural Science Foundation of China [81500410, 81170340, 81372557]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the following awards: 81500410 (to YT), 81170340 and 81372557 (to RW) from the National Natural Science Foundation of China.	Bergstrom K, 2017, MUCOSAL IMMUNOL, V10, P91, DOI 10.1038/mi.2016.45; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chou CH, 2015, ONCOTARGET, V6, P6123, DOI 10.18632/oncotarget.3045; Dimitroff CJ, 2015, CANCER RES, V75, P3195, DOI 10.1158/0008-5472.CAN-15-0834; Du J, 2015, J BIOL CHEM, V290, P12000, DOI 10.1074/jbc.M115.636969; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Gabriel M, 2005, CLIN ORAL INVEST, V9, P284, DOI 10.1007/s00784-005-0007-2; Gao N, 2016, AM J PHYSIOL-GASTR L, V311, pG74, DOI 10.1152/ajpgi.00060.2016; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Iwai T, 2005, P NATL ACAD SCI USA, V102, P4572, DOI 10.1073/pnas.0407983102; Iwai T, 2002, J BIOL CHEM, V277, P12802, DOI 10.1074/jbc.M112457200; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Kufe D, 2010, ONCOGENE, V29, P5663, DOI 10.1038/onc.2010.334; Lee SH, 2009, J BIOL CHEM, V284, P17157, DOI 10.1074/jbc.M109.010934; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Pan Q, 2013, J BIOL CHEM, V288, P5407, DOI 10.1074/jbc.M112.408245; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Radhakrishnan P, 2013, INT J CANCER, V133, P2824, DOI 10.1002/ijc.28322; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Shamir ER, 2014, J CELL BIOL, V204, P839, DOI 10.1083/jcb.201306088; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Springer SA, 2016, J PROTEOMICS, V135, P90, DOI 10.1016/j.jprot.2015.11.022; Tagde A, 2016, BLOOD, V127, P2587, DOI 10.1182/blood-2015-07-659151; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tian Y, 2014, J BIOL CHEM, V289, P36101, DOI 10.1074/jbc.M114.598383; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579; Ye J, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0078-9; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	44	14	17	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6391	6407		10.1038/onc.2017.241	http://dx.doi.org/10.1038/onc.2017.241			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28745318				2022-12-26	WOS:000415622900004
J	Wen, L; Fu, LZ; Shi, YB				Wen, Luan; Fu, Liezhen; Shi, Yun-Bo			Histone methyltransferase Dot1L is a coactivator for thyroid hormone receptor during Xenopus development	FASEB JOURNAL			English	Article						epigenetics; histone modification; activation mark; organogenesis	IN-VIVO ANALYSIS; AMPHIBIAN METAMORPHOSIS; POSTEMBRYONIC DEVELOPMENT; TRANSCRIPTIONAL ACTIVATION; LAEVIS METAMORPHOSIS; COREPRESSOR COMPLEX; GENE REPRESSION; MEDIATED TRANSCRIPTION; HUMAN GENOME; SET-DOMAIN	Histone modifications are associated with transcriptional regulation by diverse transcription factors. Genome-wide correlation studies have revealed that histone activation marks and repression marks are associated with activated and repressed gene expression, respectively. Among the histone activation marks is histone H3 K79 methylation, which is carried out by only a single methyltransferase, disruptor of telomeric silencing-1-like (DOT1L). We have been studying thyroid hormone (T3)-dependent amphibian metamorphosis in two highly related species, the pseudo-tetraploid Xenopus laevis and diploid Xenopus tropicalis, as a model for postembryonic development, a period around birth in mammals that is difficult to study. We previously showed that H3K79 methylation levels are induced at T3 target genes during natural and T3-induced metamorphosis and that Dot1L is itself a T3 target gene. These suggest that T3 induces Dot1L expression, and Dot1L in turn functions as a T3 receptor (TR) coactivator to promote vertebrate development. We show here that in cotransfection studies or in the reconstituted frog oocyte in vivo transcription system, overexpression of Dot1L enhances gene activation by TR in the presence of T3. Furthermore, making use of the ability to carry out transgenesis in X. laevis and gene knockdown in X. tropicalis, we demonstrate that endogenous Dot1L is critical for T3-induced activation of endogenous TR target genes while transgenic Dot1L enhances endogenous TR function in premetamorphic tadpoles in the presence of T3. Our studies thus for the first time provide complementary gain- and loss-of functional evidence in vivo for a cofactor, Dot1L, in gene activation by TR during vertebrate development.	[Wen, Luan; Fu, Liezhen; Shi, Yun-Bo] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Morphogenesis, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shi, YB (corresponding author), NICHHD, NIH, Bldg 49,Room 6A82,18 Lib Dr,MSC 5431, Bethesda, MD 20892 USA.	shi@helix.nih.gov	Wen, Luan/ABH-3991-2020	Wen, Luan/0000-0001-9408-8709; Shi, Yun-Bo/0000-0002-6330-0639	U.S. National Institutes of Health, National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008858, ZIAHD001901] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in part, by the Intramural Research Program of the U.S. National Institutes of Health, National Institute of Child Health and Human Development. The authors declare no conflicts of interest.	Amaya E, 1998, TRENDS GENET, V14, P253, DOI 10.1016/S0168-9525(98)01506-6; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; ATKINSON BG, 1994, DEV GENET, V15, P313, DOI 10.1002/dvg.1020150402; Bagamasbad PD, 2015, MOL ENDOCRINOL, V29, P856, DOI 10.1210/me.2014-1349; Barry ER, 2010, EXPERT OPIN THER TAR, V14, P405, DOI 10.1517/14728221003623241; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bilesimo P, 2011, MOL ENDOCRINOL, V25, P225, DOI 10.1210/me.2010-0269; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Buchholz DR, 2003, MOL CELL BIOL, V23, P6750, DOI 10.1128/MCB.23.19.6750-6758.2003; Buchholz DR, 2006, GEN COMP ENDOCR, V145, P1, DOI 10.1016/j.ygcen.2005.07.009; Buchholz DR, 2004, MOL CELL BIOL, V24, P9026, DOI 10.1128/MCB.24.20.9026-9037.2004; Burke LJ, 2000, FASEB J, V14, P1876, DOI 10.1096/fj.99-0943rev; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Choi JY, 2015, ENDOCRINOLOGY, V156, P735, DOI 10.1210/en.2014-1554; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dodd M.H.I., 1976, P467; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fu LZ, 2006, J BIOL CHEM, V281, P16870, DOI 10.1074/jbc.M603041200; Fu LZ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-81; Fu LZ, 2002, MOL REPROD DEV, V62, P470, DOI 10.1002/mrd.10137; Fujimoto K, 2012, ENDOCRINOLOGY, V153, P5082, DOI 10.1210/en.2012-1308; Furlow JD, 1999, MOL ENDOCRINOL, V13, P2076, DOI 10.1210/me.13.12.2076; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guo XG, 2014, DEVELOPMENT, V141, P707, DOI 10.1242/dev.099853; Havis E, 2003, EMBO REP, V4, P883, DOI 10.1038/sj.embor.embor908; Heimeier RA, 2008, MOL ENDOCRINOL, V22, P1065, DOI 10.1210/me.2007-0492; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Jones PL, 2001, J BIOL CHEM, V276, P8807, DOI 10.1074/jbc.C000879200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lei Y, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-21; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li JW, 2000, MOL CELL BIOL, V20, P2031, DOI 10.1128/MCB.20.6.2031-2042.2000; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Matsuda H, 2007, MOL ENDOCRINOL, V21, P1082, DOI 10.1210/me.2006-0448; Matsuda H, 2010, STEM CELLS, V28, P2073, DOI 10.1002/stem.529; Matsuda H, 2009, MOL CELL BIOL, V29, P745, DOI 10.1128/MCB.00827-08; Matsuura K, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-25; Matsuura K, 2012, ENDOCRINOLOGY, V153, P961, DOI 10.1210/en.2011-1736; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; McKenna NJ, 2001, ANN NY ACAD SCI, V949, P3; Nakade S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6560; Nakajima K, 2003, DEV DYNAM, V227, P246, DOI 10.1002/dvdy.10300; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Nieuwkoop P.D., 1965, NORMAL TABLE XENOPUS; Paul BD, 2005, J BIOL CHEM, V280, P27165, DOI 10.1074/jbc.M503999200; Paul BD, 2005, MOL CELL BIOL, V25, P5712, DOI 10.1128/MCB.25.13.5712-5724.2005; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Paul DB, 2003, CELL RES, V13, P459, DOI 10.1038/sj.cr.7290188; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sachs LM, 2002, MOL CELL BIOL, V22, P8527, DOI 10.1128/MCB.22.24.8527-8538.2002; Sato Y, 2007, MECH DEVELOP, V124, P476, DOI 10.1016/j.mod.2007.03.006; Schreiber AM, 2001, P NATL ACAD SCI USA, V98, P10739, DOI 10.1073/pnas.191361698; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Shi YB, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-42; Shi ZY, 2015, FASEB J, V29, P4914, DOI 10.1096/fj.15-273425; Singer MS, 1998, GENETICS, V150, P613; Sterling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047407; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; TATA JR, 1993, BIOESSAYS, V15, P239, DOI 10.1002/bies.950150404; Tomita A, 2004, MOL CELL BIOL, V24, P3337, DOI 10.1128/MCB.24.8.3337-3346.2004; Tomita A, 2003, J BIOL CHEM, V278, P30788, DOI 10.1074/jbc.M303309200; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang FQ, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0006-1; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang XD, 2008, ENDOCRINOLOGY, V149, P5610, DOI 10.1210/en.2008-0751; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wen L, 2015, FASEB J, V29, P385, DOI 10.1096/fj.14-252171; Wen L, 2015, ENDOCRINOLOGY, V156, P721, DOI 10.1210/en.2014-1439; Wen LA, 2010, DEV DYNAM, V239, P2198, DOI 10.1002/dvdy.22356; WONG JM, 1995, J BIOL CHEM, V270, P18479, DOI 10.1074/jbc.270.31.18479; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Wong JM, 1997, EMBO J, V16, P3158, DOI 10.1093/emboj/16.11.3158; Yen PM, 2015, CELL BIOSCI, V5, DOI 10.1186/2045-3701-5-8; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	88	11	11	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4821	4831		10.1096/fj.201700131R	http://dx.doi.org/10.1096/fj.201700131R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28739643	Green Published			2022-12-26	WOS:000413398500014
J	Gliniak, CM; Brown, JM; Noy, N				Gliniak, Christy M.; Brown, J. Mark; Noy, Noa			The retinol-binding protein receptor STRA6 regulates diurnal insulin responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; VITAMIN-A; LIPID MOBILIZATION; METABOLIC SYNDROME; CIRCADIAN-RHYTHMS; CIRCULATING RBP4; GENE-EXPRESSION; CELLULAR UPTAKE; SHIFT WORK; RESISTANCE	It has long been appreciated that insulin action is closely tied to circadian rhythms. However, the mechanisms that dictate diurnal insulin sensitivity in metabolic tissues are not well understood. Retinol-binding protein 4 (RBP4) has been implicated as a driver of insulin resistance in rodents and humans, and it has become an attractive drug target in type II diabetes. RBP4 is synthesized primarily in the liver where it binds retinol and transports it to tissues throughout the body. The retinolRBP4 complex (holo-RBP) can be recognized by a cell-surface receptor known as stimulated by retinoic acid 6 (STRA6), which transports retinol into cells. Coupled to retinol transport, holo-RBP can activate STRA6-driven Janus kinase (JAK) signaling and downstream induction of signal transducer and activator of transcription (STAT) target genes. STRA6 signaling in white adipose tissue has been shown to inhibit insulin receptor responses. Here, we examined diurnal rhythmicity of the RBP4/STRA6 signaling axis and investigated whether STRA6 is necessary for diurnal variations in insulin sensitivity. We show that adipose tissue STRA6 undergoes circadian patterning driven in part by the nuclear transcription factor REV-ERB alpha. Furthermore, STRA6 is necessary for diurnal rhythmicity of insulin action and JAK/STAT signaling in adipose tissue. These findings establish that holo-RBP and its receptor STRA6 are potent regulators of diurnal insulin responses and suggest that the holo-RBP/STRA6 signaling axis may represent a novel therapeutic target in type II diabetes.	[Gliniak, Christy M.; Brown, J. Mark; Noy, Noa] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Brown, J. Mark] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44195 USA; [Gliniak, Christy M.; Brown, J. Mark] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Brown, JM (corresponding author), Cleveland Clin, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	brownm5@ccf.org		Gliniak, Christy/0000-0003-3806-6112	National Institutes of Health [R01 DK060684, R01 HL122283, P50 AA024333]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA024333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health Grants R01 DK060684 (to N.N. and J.M.B.), R01 HL122283 (to J.M.B.), and P50 AA024333 (to J.M.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010; Berry DC, 2014, CANCER RES, V74, P6341, DOI 10.1158/0008-5472.CAN-14-1052; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, MOL CELL BIOL, V32, P3851, DOI 10.1128/MCB.00775-12; Berry DC, 2012, MOL CELL BIOL, V32, P3164, DOI 10.1128/MCB.00505-12; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Boden G, 2013, OBESITY, V21, P1208, DOI 10.1002/oby.20134; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Carrasco-Benso MP, 2016, FASEB J, V30, P3117, DOI 10.1096/fj.201600269RR; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chen Y, 2016, SCIENCE, V353, DOI 10.1126/science.aad8266; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Emilsson V, 1999, FEBS LETT, V455, P170, DOI 10.1016/S0014-5793(99)00874-1; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; GIBSON T, 1972, LANCET, V2, P947; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Guo FJ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003619; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Hirashima Y, 2003, J ENDOCRINOL, V179, P253, DOI 10.1677/joe.0.1790253; Hogan JC, 2005, DIABETES, V54, P1968, DOI 10.2337/diabetes.54.7.1968; Hughey JJ, 2016, J BIOL RHYTHM, V31, P588, DOI 10.1177/0748730416668049; Jha PK, 2015, MOL CELL ENDOCRINOL, V418, P74, DOI 10.1016/j.mce.2015.01.024; Kaltenecker D, 2017, DIABETOLOGIA, V60, P296, DOI 10.1007/s00125-016-4152-8; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma X, 2016, DIABETOLOGIA, V59, P354, DOI 10.1007/s00125-015-3807-1; Marwarha G, 2014, FASEB J, V28, P26, DOI 10.1096/fj.13-234310; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Mody N, 2014, BIOCHEM PHARMACOL, V91, P277, DOI 10.1016/j.bcp.2014.07.012; Nagaya T, 2002, INT ARCH OCC ENV HEA, V75, P562, DOI 10.1007/s00420-002-0370-0; Napoli Joseph L, 2016, Subcell Biochem, V81, P21; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Pfeffer B, 2004, MOL VIS, V10, P23; Prasai MJ, 2013, DIABETES, V62, P1981, DOI 10.2337/db11-1740; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Saad A, 2012, DIABETES, V61, P2691, DOI 10.2337/db11-1478; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Shostak A, 2013, DIABETES, V62, P2195, DOI 10.2337/db12-1449; SMITH JE, 1973, J BIOL CHEM, V248, P1544; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; Szeto W, 2001, CANCER RES, V61, P4197; Thompson SJ, 2017, DIABETES, V66, P58, DOI 10.2337/db16-0286; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; White UA, 2016, AM J PHYSIOL-ENDOC M, V310, pE129, DOI 10.1152/ajpendo.00068.2015; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	78	12	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15080	15093		10.1074/jbc.M117.782334	http://dx.doi.org/10.1074/jbc.M117.782334			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28733465	Green Published, hybrid			2022-12-26	WOS:000409902100030
J	Korkmaz, G; Sanyal, S				Korkmaz, Gurkan; Sanyal, Suparna			R213I mutation in release factor 2 (RF2) is one step forward for engineering an omnipotent release factor in bacteria Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATION TERMINATION; POLYPEPTIDE RELEASE; STOP-CODON; PEPTIDE RELEASE; MESSENGER-RNA; AMINO-ACID; RIBOSOME; RECOGNITION; SPECIFICITY; ACCURACY	The current understanding of the specificity of the bacterial class I release factors (RFs) in decoding stop codons has evolved beyond a simple tripeptide anticodon model. A recent molecular dynamics study for deciphering the principles for specific stop codon recognition by RFs identified Arg-213 as a crucial residue on Escherichia coli RF2 for discriminating guanine in the third position (G3). Interestingly, Arg-213 is highly conserved in RF2 and substituted by Ile-196 in the corresponding position in RF1. Another similar pair is Leu-126 in RF1 and Asp-143 in RF2, which are also conserved within their respective groups. With the hypothesis that replacement of Arg-213 and Asp-143 with the corresponding RF1 residues will reduce G3 discrimination by RF2, we swapped these residues between E. coli RF1 and RF2 by site-directed mutagenesis and characterized their preference for different codons using a competitive peptide release assay. Among these, the R213I mutant of RF2 showed 5-fold improved reading of the RF1-specific UAG codon relative to UAA, the universal stop codon, compared with the wild type (WT). In-depth fast kinetic studies revealed that the gain in UAG reading by RF2 R213I is associated with a reduced efficiency of termination on the cognate UAA codon. Our work highlights the notion that stop codon recognition involves complex interactions with multiple residues beyond the PXT/SPF motifs. We propose that the R213I mutation in RF2 brings us one step forward toward engineering an omnipotent RF in bacteria, capable of reading all three stop codons.	[Korkmaz, Gurkan; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, BMC, Box 596, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se		Korkmaz, Gurkan/0000-0003-1911-027X	Swedish Research Council [2016-06264, 2013-8778, 2014-4423, 2008-6593]; Knut and Alice Wallenberg Foundation [KAW2011.0081]; Sven and Lilly Lawski Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sven and Lilly Lawski Foundation	This work was supported by research grants from Swedish Research Council 2016-06264, 2013-8778, and 2014-4423 (to S.S.) and 2008-6593 (Linnaeus grant to Uppsala RNA Research Center) and by the Knut and Alice Wallenberg Foundation to RiboCORE (KAW2011.0081). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the Sven and Lilly Lawski Foundation for Scientific Research.	Bouakaz L, 2006, J BIOL CHEM, V281, P4548, DOI 10.1074/jbc.M510433200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dincbas-Renqvist V, 2000, EMBO J, V19, P6900, DOI 10.1093/emboj/19.24.6900; Field A, 2010, BIOCHEMISTRY-US, V49, P9385, DOI 10.1021/bi1012047; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; He SL, 2010, NAT STRUCT MOL BIOL, V17, P465, DOI 10.1038/nsmb.1766; Heurgue-Hamard V, 2002, EMBO J, V21, P769, DOI 10.1093/emboj/21.4.769; Indrisiunaite G, 2015, J MOL BIOL, V427, P1848, DOI 10.1016/j.jmb.2015.01.007; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, P NATL ACAD SCI USA, V95, P8165, DOI 10.1073/pnas.95.14.8165; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Korkmaz G, 2014, J BIOL CHEM, V289, P30334, DOI 10.1074/jbc.M114.606632; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Lind C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3940; Mandava CS, 2012, NUCLEIC ACIDS RES, V40, P2054, DOI 10.1093/nar/gkr1031; Pallesen J, 2013, ELIFE, V2, DOI 10.7554/eLife.00411; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; Sund J, 2010, NATURE, V465, P947, DOI 10.1038/nature09082; Trappl K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094058; Uno M, 1996, BIOCHIMIE, V78, P935, DOI 10.1016/S0300-9084(97)86715-6; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Youngman EA, 2008, ANNU REV MICROBIOL, V62, P353, DOI 10.1146/annurev.micro.61.080706.093323	29	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15134	15142		10.1074/jbc.M117.785238	http://dx.doi.org/10.1074/jbc.M117.785238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28743745	hybrid, Green Published			2022-12-26	WOS:000409902100035
J	Lee, B; Moon, T; Yoon, S; Weissman, T				Lee, Byunghan; Moon, Taesup; Yoon, Sungroh; Weissman, Tsachy			DUDE-Seq: Fast, flexible, and robust denoising for targeted amplicon sequencing	PLOS ONE			English	Article							ACCURATE ERROR-CORRECTION; SHORT READS; GENERATION; TOOL	We consider the correction of errors from nucleotide sequences produced by next-generation targeted amplicon sequencing. The next-generation sequencing (NGS) platforms can provide a great deal of sequencing data thanks to their high throughput, but the associated error rates often tend to be high. Denoising in high-throughput sequencing has thus become a crucial process for boosting the reliability of downstream analyses. Our methodology, named DUDE-Seq, is derived from a general setting of reconstructing finite-valued source data corrupted by a discrete memoryless channel and effectively corrects substitution and homopolymer indel errors, the two major types of sequencing errors in most high-throughput targeted amplicon sequencing platforms. Our experimental studies with real and simulated datasets suggest that the proposed DUDE-Seq not only outperforms existing alternatives in terms of error-correction capability and time efficiency, but also boosts the reliability of downstream analyses. Further, the flexibility of DUDE-Seq enables its robust application to different sequencing platforms and analysis pipelines by simple updates of the noise model. DUDE-Seq is available at http://data.snu.ac.kr/pub/dude-seq.	[Lee, Byunghan; Yoon, Sungroh] Seoul Natl Univ, Elect & Comp Engn, Seoul, South Korea; [Moon, Taesup] Sungkyunkwan Univ, Coll Informat & Commun Engn, Suwon, South Korea; [Yoon, Sungroh] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Yoon, Sungroh] Stanford Univ, Neurol & Neurol Sci, Stanford, CA 94305 USA; [Weissman, Tsachy] Stanford Univ, Elect Engn, Stanford, CA 94305 USA	Seoul National University (SNU); Sungkyunkwan University (SKKU); Seoul National University (SNU); Stanford University; Stanford University	Yoon, S (corresponding author), Seoul Natl Univ, Elect & Comp Engn, Seoul, South Korea.; Moon, T (corresponding author), Sungkyunkwan Univ, Coll Informat & Commun Engn, Suwon, South Korea.; Yoon, S (corresponding author), Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea.; Yoon, S (corresponding author), Stanford Univ, Neurol & Neurol Sci, Stanford, CA 94305 USA.	tsmoon@skku.edu; sryoon@snu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning) [2014M3A9E2064434, 2016M3A7B4911115]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [HI14C3405030014]; National Research Foundation of Korea [NRF-2016R1C1B2012170]; ICT R&D program of MSIP/IITP [2016-0-00563]; NIH [5U01CA198943-03]; NATIONAL CANCER INSTITUTE [U01CA198943] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning); Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare; National Research Foundation of Korea(National Research Foundation of Korea); ICT R&D program of MSIP/IITP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT and Future Planning) [2014M3A9E2064434 and 2016M3A7B4911115], in part by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare [HI14C3405030014], in part by the Basic Science Research Program through the National Research Foundation of Korea [NRF-2016R1C1B2012170], in part by the ICT R&D program of MSIP/IITP [2016-0-00563, Research on Adaptive Machine Learning Technology Development for Intelligent Autonomous Digital Companion], and in part by NIH Grant 5U01CA198943-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science, ICT and Future Planning) [2014M3A9E2064434 and 2016M3A7B4911115], in part by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare [HI14C3405030014], in part by the Basic Science Research Program through the National Research Foundation of Korea [NRF-2016R1C1B2012170], in part by the ICT R&D program of MSIP/IITP [2016-0-00563, Research on Adaptive Machine Learning Technology Development for Intelligent Autonomous Digital Companion], and in part by NIH Grant 5U01CA198943-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks251; Astbury WT, 1961, MOL BIOL ULTRASTRUCT; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bateson W., 1894, MAT STUDY VARIATION; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Dembo A, 2005, IEEE T INFORM THEORY, V51, P1507, DOI 10.1109/TIT.2005.844104; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fichot EB, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-10; Gemelos GA, 2006, IEEE T SIGNAL PROCES, V54, P2263, DOI 10.1109/TSP.2006.874295; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Greenfield P, 2014, BIOINFORMATICS, V30, P2723, DOI 10.1093/bioinformatics/btu368; Heo Y, 2014, BIOINFORMATICS; Ilie L, 2011, BIOINFORMATICS, V27, P295, DOI 10.1093/bioinformatics/btq653; Jain M, 2015, NAT METHODS, V12, P351, DOI [10.1038/NMETH.3290, 10.1038/nmeth.3290]; Jamuar SS, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0031-5; Kao WC, 2011, GENOME RES, V21, P1181, DOI 10.1101/gr.111351.110; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; KWON S, 2014, BMC BIOINFORMATICS, V15, DOI DOI 10.HTTPS://D0I.0RG/10.1186/1471-2105-15-S9-S10; Laehnemann D, 2016, BRIEF BIOINFORM, V17, P154, DOI 10.1093/bib/bbv029; LaFave MC, 2014, SAM2PAIRWISE VERSION; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim EC, 2014, BIOINFORMATICS; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marinier E, 2015, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0435-6; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Medvedev P, 2011, BIOINFORMATICS, V27, pI137, DOI 10.1093/bioinformatics/btr208; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Moon T, 2016, P NEUR INF PROC SYST; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Nikolenko SI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S7; Ochoa I, 2016, BIOINFORMAT IN PRESS; Pfitzner D, 2009, KNOWL INF SYST, V19, P361, DOI 10.1007/s10115-008-0150-6; Qu W, 2009, GENOME RES, V19, P1309, DOI 10.1101/gr.089151.108; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Salmela L, 2011, BIOINFORMATICS, V27, P1455, DOI 10.1093/bioinformatics/btr170; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Schroder J, 2009, BIOINFORMATICS, V25, P2157, DOI 10.1093/bioinformatics/btp379; Schulz MH, 2014, BIOINFORMATICS, V30, pI356, DOI 10.1093/bioinformatics/btu440; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Weissman T, 2005, IEEE T INFORM THEORY, V51, P5, DOI 10.1109/TIT.2004.839518; Wijaya Edward, 2009, Genome Inform, V23, P189; Witten I. H., 2005, DATA MINING PRACTICA; Yan B, 2016, J CLIN PATHOL, V69, P801, DOI 10.1136/jclinpath-2015-203580; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Yang X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S52; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468; Yin X, 2013, IEEE INT SYMP INFO, P1626, DOI 10.1109/ISIT.2013.6620502	61	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181463	10.1371/journal.pone.0181463	http://dx.doi.org/10.1371/journal.pone.0181463			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749987	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700048
J	Moyano, M; Candebat, C; Ruhbaum, Y; Alvarez-Fernandez, S; Claireaux, G; Zambonino-Infante, JL; Peck, MA				Moyano, Marta; Candebat, Caroline; Ruhbaum, Yannick; Alvarez-Fernandez, Santiago; Claireaux, Guy; Zambonino-Infante, Jose-Luis; Peck, Myron A.			Effects of warming rate, acclimation temperature and ontogeny on the critical thermal maximum of temperate marine fish larvae	PLOS ONE			English	Article							CRITICAL SWIMMING SPEED; CLIMATE-CHANGE; SALINITY TOLERANCE; NORTHERN PIKE; REEF FISHES; SEA-BASS; SURVIVAL; GROWTH; EGGS; REQUIREMENTS	Most of the thermal tolerance studies on fish have been performed on juveniles and adults, whereas limited information is available for larvae, a stage which may have a particularly narrow range in tolerable temperatures. Moreover, previous studies on thermal limits for marine and freshwater fish larvae (53 studies reviewed here) applied a wide range of methodologies (e.g. the static or dynamic method, different exposure times), making it challenging to compare across taxa. We measured the Critical Thermal Maximum (CTmax) of Atlantic herring (Clupea harengus) and European seabass (Dicentrarchus labrax) larvae using the dynamic method (ramping assay) and assessed the effect of warming rate (0.5 to 9 degrees C h(-1)) and acclimation temperature. The larvae of herring had a lower CTmax (lowest and highest values among 222 individual larvae, 13.1-27.0 degrees C) than seabass (lowest and highest values among 90 individual larvae, 24.2-34.3 degrees C). At faster rates of warming, larval CTmax significantly increased in herring, whereas no effect was observed in seabass. Higher acclimation temperatures led to higher CTmax in herring larvae (2.7 +/- 0.9 degrees C increase) with increases more pronounced at lower warming rates. Pre-trials testing the effects of warming rate are recommended. Our results for these two temperate marine fishes suggest using a warming rate of 3-6 degrees C h(-1) : CTmax is highest in trials of relatively short duration, as has been suggested for larger fish. Additionally, time-dependent thermal tolerance was observed in herring larvae, where a difference of up to 8 degrees C was observed in the upper thermal limit between a 0.5- or 24-h exposure to temperatures >18 degrees C. The present study constitutes a first step towards a standard protocol for measuring thermal tolerance in larval fish.	[Moyano, Marta; Candebat, Caroline; Ruhbaum, Yannick; Peck, Myron A.] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil CEN, Olbersweg 24, Hamburg, Germany; [Alvarez-Fernandez, Santiago] Alfred Wegener Inst Helmholtz Zentrum Polar & Mee, Biol Anstalt Helgoland, Helgoland, Germany; [Claireaux, Guy] Univ Bretagne Occidentale, Ctr Ifremer Bretagne, LEMAR UMR 6539, Unite PFOM ARN, Plouzane, France; [Zambonino-Infante, Jose-Luis] IFREMER, Ctr Ifremer Bretagne, LEMAR UMR 6539, Unite PFOM ARN, Plouzane, France	University of Hamburg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Moyano, M (corresponding author), Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Ctr Earth Syst Res & Sustainabil CEN, Olbersweg 24, Hamburg, Germany.	marta.moyano@uni-hamburg.de	Peck, Myron A/H-6164-2011; ZAMBONINO-INFANTE, Jose L/F-9828-2010	Peck, Myron A/0000-0001-7423-1854; ZAMBONINO-INFANTE, Jose L/0000-0001-8436-4773; Moyano, Marta/0000-0002-3026-9225	FITNESS project (Deutsche Forschungemeinschaft) [PE 1157/8-1]; European Union's Horizon 2020 research and innovation programme [678193]	FITNESS project (Deutsche Forschungemeinschaft)(German Research Foundation (DFG)); European Union's Horizon 2020 research and innovation programme	This work was partially funded by the FITNESS project (Deutsche Forschungemeinschaft, http://www.dfg.de/en/, PE 1157/8-1). This work also received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 678193 (CERES, Climate Change and European Aquatic Resources, contribution nr. 6), and contributes to the ERANet program CLIMAR "Climate-driven changes in the Habitat Suitability of Marine Organisms" (BMBF DLR 01DN17019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; BARKER SL, 1981, FISH B-NOAA, V79, P198; BECKER CD, 1979, ENVIRON BIOL FISH, V4, P245, DOI 10.1007/BF00005481; BISHAI H. M., 1965, HYDROBIOLOGIA, V25, P473, DOI 10.1007/BF00838508; BISHAI H. M., 1960, JOUR CONSEIL PERM INTERNATL EXPLOR MER, V25, P134; BLAXTER JHS, 1960, J MAR BIOL ASSOC UK, V39, P605, DOI 10.1017/S0025315400013576; BONIN JD, 1978, COMP BIOCHEM PHYS A, V59, P245, DOI 10.1016/0300-9629(78)90154-8; Bonner TH, 1998, T AM FISH SOC, V127, P971, DOI 10.1577/1548-8659(1998)127<0971:EOTOEP>2.0.CO;2; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Brinkman SF, 2013, T AM FISH SOC, V142, P824, DOI 10.1080/00028487.2013.765503; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Claireaux G, 2016, J FISH BIOL, V88, P232, DOI 10.1111/jfb.12833; Claireaux G, 2013, AQUAT TOXICOL, V130, P160, DOI 10.1016/j.aquatox.2013.01.004; Das T, 2005, J THERM BIOL, V30, P378, DOI 10.1016/j.jtherbio.2005.03.001; DAVENPORT J, 1986, J MAR BIOL ASSOC UK, V66, P145, DOI 10.1017/S0025315400039710; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Drost HE, 2016, J FISH BIOL, V88, P718, DOI 10.1111/jfb.12807; ELLIOTT JM, 1995, J FISH BIOL, V47, P917, DOI 10.1111/j.1095-8649.1995.tb06014.x; Elliott JM, 2002, J FISH BIOL, V60, P1338, DOI 10.1006/jfbi.2002.1934; Enzor LA, 2013, COMP BIOCHEM PHYS A, V164, P154, DOI 10.1016/j.cbpa.2012.07.016; Farrell AP, 2008, J FISH BIOL, V72, P693, DOI 10.1111/j.1095-8649.2007.01759.x; Fey DP, 2001, J FISH BIOL, V58, P1257, DOI [10.1006/jfbi.2000.1529, 10.1111/j.1095-8649.2001.tb02284.x]; Fischer K, 2011, OECOLOGIA, V166, P23, DOI 10.1007/s00442-011-1917-0; Fry F. E. J., 1947, University of Toronto Studies Biological Series, VNo. 55, P1; Fry F. E. J., 1946, U TORONTO BIOL SER, V54, P9; Galleher SN, 2010, FISH PHYSIOL BIOCHEM, V36, P731, DOI 10.1007/s10695-009-9347-1; Guan Jian, 2012, Yuye Kexue Jinzhan, V33, P34; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; HASSLER TJ, 1982, PROG FISH CULT, V44, P174, DOI 10.1577/1548-8659(1982)44[174:EOTOSO]2.0.CO;2; HEATH S, 1994, CAN J FISH AQUAT SCI, V51, P437, DOI 10.1139/f94-045; Hokanson K.E.F., 1974, P437; HOKANSON KE, 1973, T AM FISH SOC, V102, P89, DOI 10.1577/1548-8659(1973)102<89:TRFEAL>2.0.CO;2; HOKANSON KEF, 1977, J FISH RES BOARD CAN, V34, P1524, DOI 10.1139/f77-217; Hufnagl M, 2011, ICES J MAR SCI, V68, P1170, DOI 10.1093/icesjms/fsr078; Irvin D.N., 1974, P449; Ishibashi Y, 2003, NIPPON SUISAN GAKK, V69, P36, DOI 10.2331/suisan.69.36; ITZKOWITZ N, 1983, FISH B-NOAA, V81, P913; Iversen S.A., 1984, Flodevigen Rapportserie, V1, P49; Jorgensen C, 2012, BIOL LETTERS, V8, P900, DOI 10.1098/rsbl.2012.0609; Kappenman KM, 2009, T AM FISH SOC, V138, P927, DOI 10.1577/T07-265.1; KELLOGG RL, 1984, T AM FISH SOC, V113, P794, DOI 10.1577/1548-8659(1984)113<794:TMPEFE>2.0.CO;2; KELLOGG RL, 1982, PROG FISH CULT, V44, P63, DOI 10.1577/1548-8659(1982)44[63:TRFTSA]2.0.CO;2; Kingsolver JG, 2016, J EXP BIOL, V219, P1290, DOI 10.1242/jeb.138321; Koenigstein S, 2016, FISH FISH, V17, P972, DOI 10.1111/faf.12155; Komoroske LM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou008; Lefevre S, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow009; Leis JM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0327; LEWIS RM, 1965, T AM FISH SOC, V94, P409, DOI 10.1577/1548-8659(1965)94[409:TEOMTO]2.0.CO;2; Li AJ, 2015, J THERM BIOL, V54, P98, DOI 10.1016/j.jtherbio.2014.09.011; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Madeira D, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2803-9; Madeira D, 2012, J SEA RES, V70, P32, DOI 10.1016/j.seares.2012.03.002; Mauduit F, 2016, AQUAT TOXICOL, V178, P197, DOI 10.1016/j.aquatox.2016.07.019; MAY RC, 1975, FISH B-NOAA, V73, P249; MCCORMICK JH, 1971, J FISH RES BOARD CAN, V28, P924, DOI 10.1139/f71-134; MCCORMICK JH, 1977, J FISH RES BOARD CAN, V34, P1019, DOI 10.1139/f77-154; MCCORMICK JH, 1978, PROG FISH CULT, V40, P133, DOI 10.1577/1548-8659(1978)40[133:EOTOHS]2.0.CO;2; MCCORMICK JH, 1981, T AM FISH SOC, V110, P417, DOI 10.1577/1548-8659(1981)110<417:ROLBFD>2.0.CO;2; Meyer S, 2012, J MARINE SYST, V93, P11, DOI 10.1016/j.jmarsys.2011.09.010; Miller IR, 2016, J APPL ICHTHYOL, V32, P272, DOI 10.1111/jai.12994; Mora C, 2006, J THERM BIOL, V31, P337, DOI 10.1016/j.jtherbio.2006.01.005; Mora C, 2001, MAR BIOL, V139, P765; Morley SA, 2016, J MAR BIOL ASSOC UK, V96, P159, DOI 10.1017/S0025315414000307; Moyano M, 2016, COMP BIOCHEM PHYS A, V197, P23, DOI 10.1016/j.cbpa.2016.02.020; Oeberst R, 2009, ICES J MAR SCI, V66, P1696, DOI 10.1093/icesjms/fsp193; Ouchi K., 1977, Bulletin Japan Sea reg Fish Res Lab, VNo. 28, P1; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Pinheiro J, 2013, R DEV CORE TEAM; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; POTTER I C, 1975, Acta Zoologica (Stockholm), V56, P85; Powles P.M., 1974, P373; Prokesova M, 2015, J APPL ICHTHYOL, V31, P18, DOI 10.1111/jai.12849; R Core Team, 2021, R LANGUAGE ENV STAT; RANA KJ, 1990, AQUACULTURE, V87, P165, DOI 10.1016/0044-8486(90)90273-P; Rasband WS, 2014, IMAGEJ; Recsetar MS, 2013, T AM FISH SOC, V142, P373, DOI 10.1080/00028487.2012.741551; REYNOLDS WW, 1976, J EXP MAR BIOL ECOL, V24, P73, DOI 10.1016/0022-0981(76)90044-7; Ribeiro PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032083; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Roze T, 2013, J THERM BIOL, V38, P98, DOI 10.1016/j.jtherbio.2012.12.001; Rummer JL, 2014, GLOBAL CHANGE BIOL, V20, P1055, DOI 10.1111/gcb.12455; Saiki MK, 1999, ENVIRON POLLUT, V105, P37, DOI 10.1016/S0269-7491(98)00212-7; Salinas S, 2012, ECOL LETT, V15, P159, DOI 10.1111/j.1461-0248.2011.01721.x; Sandblom E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11447; SANTERRE MT, 1976, J EXP MAR BIOL ECOL, V21, P51, DOI 10.1016/0022-0981(76)90068-X; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; SHRODE JB, 1975, PHYSIOL ZOOL, V48, P378, DOI 10.1086/physzool.48.4.30155663; Storms KG, 1986, P ANN C SE FISH WILD, V40, P57; SUBASINGHE R P, 1992, Aquaculture and Fisheries Management, V23, P31, DOI 10.1111/j.1365-2109.1992.tb00593.x; SYLVESTER JR, 1975, T AM FISH SOC, V104, P144, DOI 10.1577/1548-8659(1975)104<144:TTOEAL>2.0.CO;2; TANG J, 1987, PROG FISH CULT, V49, P167, DOI 10.1577/1548-8640(1987)49&lt;167:EOTEOT&gt;2.0.CO;2; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; THOMPSON BM, 1987, J MAR BIOL ASSOC UK, V67, P263, DOI 10.1017/S0025315400026588; Troia MJ, 2015, ENVIRON BIOL FISH, V98, P395, DOI 10.1007/s10641-014-0270-7; Vinagre C, 2015, J THERM BIOL, V47, P19, DOI 10.1016/j.jtherbio.2014.10.012; Vinagre C, 2012, MAR ECOL PROG SER, V464, P237, DOI 10.3354/meps09885; Wexler JB, 2011, J EXP MAR BIOL ECOL, V404, P63, DOI 10.1016/j.jembe.2011.05.002; YIN MC, 1987, J EXP MAR BIOL ECOL, V107, P279, DOI 10.1016/0022-0981(87)90044-X; Zeigler MP, 2013, T AM FISH SOC, V142, P1395, DOI 10.1080/00028487.2013.811104; ZHDANCVA N. N., 1966, TR AZOV NAUCH ISSLED INST RYBN KHOZ, V8, P79; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	108	41	41	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0179928	10.1371/journal.pone.0179928	http://dx.doi.org/10.1371/journal.pone.0179928			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749960	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700006
J	Placek, MM; Wachel, P; Iskander, DR; Smielewski, P; Uryga, A; Mielczarek, A; Szczepanski, TA; Kasprowicz, M				Placek, Michal M.; Wachel, Pawel; Iskander, D. Robert; Smielewski, Peter; Uryga, Agnieszka; Mielczarek, Arkadiusz; Szczepanski, Tomasz A.; Kasprowicz, Magdalena			Applying time-frequency analysis to assess cerebral autoregulation during hypercapnia	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; VALSALVA MANEUVER; ARTERIAL-PRESSURE; DYNAMICS; HUMANS; HEMODYNAMICS; COHERENCE; DOMAIN; FLUCTUATIONS; HYPERTENSION	Objective Classic methods for assessing cerebral autoregulation involve a transfer function analysis performed using the Fourier transform to quantify relationship between fluctuations in arterial blood pressure (ABP) and cerebral blood flow velocity (CBFV). This approach usually assumes the signals and the system to be stationary. Such an presumption is restrictive and may lead to unreliable results. The aim of this study is to present an alternative method that accounts for intrinsic non-stationarity of cerebral autoregulation and the signals used for its assessment. Methods Continuous recording of CBFV, ABP, ECG, and end-tidal CO2 were performed in 50 young volunteers during normocapnia and hypercapnia. Hypercapnia served as a surrogate of the cerebral autoregulation impairment. Fluctuations in ABP, CBFV, and phase shift between them were tested for stationarity using sphericity based test. The Zhao-Atlas-Marks distribution was utilized to estimate the time-frequency coherence (TFCoh) and phase shift (TFPS) between ABP and CBFV in three frequency ranges: 0.02-0.07 Hz (VLF),0.07-0.20 Hz (LF), and 0.20-0.35 Hz (HF). TFPS was estimated in regions locally validated by statistically justified value of TFCoh. The comparison of TFPS with spectral phase shift determined using transfer function approach was performed. Results The hypothesis of stationarity for ABP and CBFV fluctuations and the phase shift was rejected. Reduced TFPS was associated with hypercapnia in the VLF and the LF but not in the HF. Spectral phase shift was also decreased during hypercapnia in the VLF and the LF but increased in the HF. Time-frequency method led to lower dispersion of phase estimates than the spectral method, mainly during normocapnia in the VLF and the LF. Conclusion The time-frequency method performed no worse than the classic one and yet may offer benefits from lower dispersion of phase shift as well as a more in-depth insight into the dynamic nature of cerebral autoregulation.	[Placek, Michal M.; Wachel, Pawel; Iskander, D. Robert; Uryga, Agnieszka; Kasprowicz, Magdalena] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland; [Wachel, Pawel] Wroclaw Univ Sci & Technol, Fac Elect, Dept Control Syst & Mechatron, Wroclaw, Poland; [Smielewski, Peter] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Mielczarek, Arkadiusz] Wroclaw Univ Sci & Technol, Fac Elect, Dept Cybernet & Robot, Wroclaw, Poland; [Szczepanski, Tomasz A.] Lower Silesia Specialist Hosp, Dept Neurosurg, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw University of Science & Technology; University of Cambridge; Wroclaw University of Science & Technology	Placek, MM (corresponding author), Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland.	michal.placek@pwr.edu.pl	Iskander, D Robert/E-3576-2017; Uryga, Agnieszka/GOP-0526-2022	Iskander, D Robert/0000-0002-5962-6206; Uryga, Agnieszka/0000-0001-8183-7643; Mielczarek, Arkadiusz/0000-0001-5229-853X; Kasprowicz, Magdalena/0000-0002-2271-7737	National Science Centre, Poland [DEC-2013/10/E/ST7/00117]; Medical Research Council [G0600986] Funding Source: researchfish; MRC [G0600986] Funding Source: UKRI	National Science Centre, Poland(National Science Centre, Poland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research supported by National Science Centre, Poland, grant no. DEC-2013/10/E/ST7/00117 (www.ncn.gov.pl). MK MMP PW AU TAS AM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Ainslie PN, 2008, BRAIN RES, V1230, P115, DOI 10.1016/j.brainres.2008.07.048; Auger F, 1996, TIME FREQUENCY TOOLB; Baraniuk RG, 2001, IEEE T INFORM THEORY, V47, P1391, DOI 10.1109/18.923723; Blaber AP, 1997, STROKE, V28, P1686, DOI 10.1161/01.STR.28.9.1686; Brcich RF, 2006, IEEE ICASSP P, P464; Brockwell PJ, 2013, TIME SERIES THEORY M, P448; CARTER GC, 1987, P IEEE, V75, P236, DOI 10.1109/PROC.1987.13723; Castro PM, 2014, J APPL PHYSIOL, V117, P205, DOI 10.1152/japplphysiol.00893.2013; Chacon M, 2011, MED ENG PHYS, V33, P180, DOI 10.1016/j.medengphy.2010.09.023; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Claassen JAHR, 2009, J APPL PHYSIOL, V106, P153, DOI 10.1152/japplphysiol.90822.2008; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; De Smet D, 2010, ADV EXP MED BIOL, V662, P219, DOI 10.1007/978-1-4419-1241-1_31; Dineen NE, 2010, J APPL PHYSIOL, V108, P604, DOI 10.1152/japplphysiol.01157.2009; Edwards MR, 2002, AM J PHYSIOL-REG I, V283, pR653, DOI 10.1152/ajpregu.00452.2001; Giller CA, 2003, MED ENG PHYS, V25, P633, DOI 10.1016/S1350-4533(03)00028-6; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Gommer ED, 2012, J ALZHEIMERS DIS, V30, P805, DOI 10.3233/JAD-2012-111628; Gong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077802; Haubrich C, 2003, STROKE, V34, P1881, DOI 10.1161/01.STR.0000080936.36601.34; Hu K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002601; Janzarik WG, 2014, HYPERTENSION, V63, P161, DOI 10.1161/HYPERTENSIONAHA.113.01667; Katsogridakis E, 2016, PHYSIOL MEAS, V37, P1056, DOI 10.1088/0967-3334/37/7/1056; Kostoglou K, 2014, MED ENG PHYS, V36, P592, DOI 10.1016/j.medengphy.2013.10.011; Kuo TBJ, 1998, J CEREBR BLOOD F MET, V18, P311, DOI 10.1097/00004647-199803000-00010; LASSEN NA, 1964, CIRC RES, V15, P201; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Lavinio A, 2007, STROKE, V38, P402, DOI 10.1161/01.STR.0000254551.92209.5c; Lewis Philip M, 2012, Acta Neurochir Suppl, V114, P141, DOI 10.1007/978-3-7091-0956-4_26; Lipsitz LA, 2000, STROKE, V31, P1897, DOI 10.1161/01.STR.31.8.1897; Liu J, 2014, MED ENG PHYS, V36, P1636, DOI 10.1016/j.medengphy.2014.09.005; Liu J, 2010, PHYSIOL MEAS, V31, P1291, DOI 10.1088/0967-3334/31/10/001; Marmarelis VZ, 2014, IEEE T BIO-MED ENG, V61, P694, DOI 10.1109/TBME.2013.2287120; Matz G, 2000, PROCEEDINGS OF THE TENTH IEEE WORKSHOP ON STATISTICAL SIGNAL AND ARRAY PROCESSING, P554, DOI 10.1109/SSAP.2000.870186; Meel-van den Abeelen ASS, 2014, MED ENG PHYS, V36, P563, DOI 10.1016/j.medengphy.2014.02.001; Mitsis GD, 2002, ANN BIOMED ENG, V30, P555, DOI 10.1114/1.1477448; Mitsis GD, 2006, J APPL PHYSIOL, V101, P354, DOI 10.1152/japplphysiol.00548.2005; Muller M, 2003, STROKE, V34, P1197, DOI 10.1161/01.STR.0000068409.81859.C5; Muma M, 2010, IEEE T BIO-MED ENG, V57, P373, DOI 10.1109/TBME.2009.2032531; Ocon AJ, 2009, AM J PHYSIOL-HEART C, V297, pH2084, DOI 10.1152/ajpheart.00705.2009; Orini M, 2012, PHYSIOL MEAS, V33, P315, DOI 10.1088/0967-3334/33/3/315; PAGANI M, 1988, HYPERTENSION, V12, P600, DOI 10.1161/01.HYP.12.6.600; PAN J, 1985, SYSTEMS MAN CYBERN A, P230; Panerai RB, 2010, J APPL PHYSIOL, V109, P1860, DOI 10.1152/japplphysiol.00857.2010; Panerai RB, 1999, PHYSIOL MEAS, V20, P265, DOI 10.1088/0967-3334/20/3/304; Panerai RB, 2004, MED ENG PHYS, V26, P43, DOI 10.1016/j.medengphy.2003.08.001; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Panerai RB, 2006, AM J PHYSIOL-HEART C, V291, pH251, DOI 10.1152/ajpheart.01348.2005; Panerai RB, 2014, MED ENG PHYS, V36, P576, DOI 10.1016/j.medengphy.2013.09.004; Peng TY, 2008, ANN BIOMED ENG, V36, P308, DOI 10.1007/s10439-007-9412-9; Peng TY, 2010, IEEE T BIO-MED ENG, V57, P960, DOI 10.1109/TBME.2009.2024265; Placek MM, 2015, IEEE ENG MED BIO, P7700, DOI 10.1109/EMBC.2015.7320176; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Reinhard M, 2001, NEUROL RES, V23, P55, DOI 10.1179/016164101101198299; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Tiecks FP, 1996, STROKE, V27, P1177, DOI 10.1161/01.STR.27.7.1177; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tzeng YC, 2012, AM J PHYSIOL-HEART C, V303, pH658, DOI 10.1152/ajpheart.00328.2012; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; WHITE LB, 1990, IEEE T INFORM THEORY, V36, P830, DOI 10.1109/18.53742; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zhang R, 2009, J PHYSIOL-LONDON, V587, P2567, DOI 10.1113/jphysiol.2008.168302; ZHAO YX, 1990, IEEE T ACOUST SPEECH, V38, P1084, DOI 10.1109/29.57537	66	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181851	10.1371/journal.pone.0181851	http://dx.doi.org/10.1371/journal.pone.0181851			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750024	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700090
J	Wu, CY; Wang, XF				Wu, Chunyan; Wang, Xuefeng			Preliminary research on the identification system for anthracnose and powdery mildew of sandalwood leaf based on image processing	PLOS ONE			English	Article							CLASSIFICATION; DISEASE	This paper presents a survey on a system that uses digital image processing techniques to identify anthracnose and powdery mildew diseases of sandalwood from digital images. Our main objective is researching the most suitable identification technology for the anthracnose and powdery mildew diseases of the sandalwood leaf, which provides algorithmic support for the real-time machine judgment of the health status and disease level of sandalwood. We conducted real-time monitoring of Hainan sandalwood leaves with varying severity levels of anthracnose and powdery mildew beginning in March 2014. We used image segmentation, feature extraction and digital image classification and recognition technology to carry out a comparative experimental study for the image analysis of powdery mildew, anthracnose disease and healthy leaves in the field. Performing the actual test for a large number of diseased leaves pointed to three conclusions: (1) Distinguishing effects of BP (Back Propagation) neural network method, in all kinds of classical methods, for sandalwood leaf anthracnose and powdery mildew disease are relatively good; the size of the lesion areas were closest to the actual. (2) The differences between two diseases can be shown well by the shape feature, color feature and texture feature of the disease image. (3) Identifying and diagnosing the diseased leaves have ideal results by SVM, which is based on radial basis kernel function. The identification rate of the anthracnose and healthy leaves was 92% respectively, and that of powdery mildew was 84%. Disease identification technology lays the foundation for remote monitoring disease diagnosis, preparing for remote transmission of the disease images, which is a very good guide and reference for further research of the disease identification and diagnosis system in sandalwood and other species of trees.	[Wu, Chunyan; Wang, Xuefeng] Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forest Resources Information Technique, CAF	Wang, XF (corresponding author), Chinese Acad Forestry, Res Inst Forest Resource Informat Tech, Beijing, Peoples R China.	xuefeng@ifrit.ac.cn			Central Public-interest Scientific Institution Basal Research Fund [CAFYBB2014MA006]	Central Public-interest Scientific Institution Basal Research Fund	This project was supported by the Central Public-interest Scientific Institution Basal Research Fund (CAFYBB2014MA006).	Brown AE, 1996, PHYTOPATHOLOGY, V86, P523, DOI 10.1094/Phyto-86-523; Camargo A, 2009, COMPUT ELECTRON AGR, V66, P121, DOI 10.1016/j.compag.2009.01.003; [曹学仁 Cao Xueren], 2015, [植物病理学报, Acta Phytopathologica Sinica], V45, P626; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Desprez-Loustau ML, 2016, ANN FOREST SCI, V73, P45, DOI 10.1007/s13595-015-0487-4; El-Helly M, 2003, IND INT C ART INT II, P1182; Feng R, 2007, J YULIN COLL, V17, P20; Gowda ANS, 1987, IN VITRO COMP MORPHO; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Iyengar A. V. V., 1960, Indian Forester, V86, P220; Kuriakose S, 2012, FOOD CHEM, V135, P213, DOI 10.1016/j.foodchem.2012.04.073; Li GuanLin, 2012, Journal of China Agricultural University, V17, P72; Liang KM, 2004, PROCEEDINGS OF INTERNATIONAL CONFERENCE ON INTELLIGENT SENSING AND INFORMATION PROCESSING, P97; [刘倩丽 Liu Qianli], 2014, [热带作物学报, Chinese Journal of Tropical Crops], V35, P2266; Liu T, 2015, AGR TECHNOLOGY SERVI, V32, P107; Mao HanPing, 2003, Transactions of the Chinese Society of Agricultural Engineering, V19, P133; Marcais B, 2014, ANN FOREST SCI, V71, P633, DOI 10.1007/s13595-012-0252-x; Markus Andreas S., 1995, STORAGE RETRIEVAL IM, P381, DOI [10.1117/12.205308, DOI 10.1117/12.205308]; MCNITTGRAY MF, 1995, IEEE T MED IMAGING, V14, P537, DOI 10.1109/42.414619; Meunkaewjinda A, 2008, ECTI-CON 2008: PROCEEDINGS OF THE 2008 5TH INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING/ELECTRONICS, COMPUTER, TELECOMMUNICATIONS AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P513, DOI 10.1109/ECTICON.2008.4600483; Misra BB, 2012, LETT APPL MICROBIOL, V55, P476, DOI 10.1111/lam.12005; Nagaveni H. C., 2014, Journal on New Biological Reports, V3, P120; NAYAR R, 1980, Indian Journal of Forestry, V3, P24; Nelson Scot C., 2008, COLL TROPICAL AGR HU, V48; Norris RV, 1930, NATURE, V126, P311, DOI 10.1038/126311a0; Patil JK, 2011, J ADV BIOINFORM APPL, V2, P135; Phadikar S, 2013, COMPUT ELECTRON AGR, V90, P76, DOI 10.1016/j.compag.2012.11.001; Ral S. N., 1990, P S SAND PAC, P66; Sammany M, 2006, P INT COMP ENG C; Sasaki Y., 1999, Journal of the Japanese Society of Agricultural Machinery, V61, P119; Sawsana AI-R, 2015, J MED BIOENGINEERING; Su Jing, 2015, IND CONTROL COMPUTER, V28, P29; Suphamitmongkol W, 2013, COMPUT ELECTRON AGR, V91, P87, DOI 10.1016/j.compag.2012.11.014; Tian YouWen, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P175; [田媛媛 Tian Yuanyuan], 2015, [生物技术通报, Biotechnology Bulletin], V31, P158; TROOIEN TP, 1992, T ASAE, V35, P1709, DOI 10.13031/2013.28787; Tzionas P., 2005, 5 INT C TECHN AUT TH, P365; Vapnik V., 2013, NATURE STAT LAERNING; Wu PY, 2015, PROTECTION FOREST SC, V146, P63; Yang Jie, 2007, MICROCOMPUTER APPL, V28, P627; Zhang D. W., 2009, J SHENYANG JIANZHU U, V25, P574; Zhang GX, 2004, STUDY CLASSIFICATION; Zhang JianHua, 2011, Nongye Jixie Xuebao = Transactions of the Chinese Society for Agricultural Machinery, V42, P178; Zhang Yueqin, 2011, COMPUTER DEV APPL, V24, P16	44	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181537	10.1371/journal.pone.0181537	http://dx.doi.org/10.1371/journal.pone.0181537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749977	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700054
J	O'Brien, WG; Ling, HS; Zhao, ZY; Lee, CC				O'Brien, William G., III; Ling, Han Shawn; Zhao, Zhaoyang; Lee, Cheng Chi			New insights on the regulation of the adenine nucleotide pool of erythrocytes in mouse models	PLOS ONE			English	Article							ADENOSINE; ATP; PERFORMANCE; INJURY; AMP; HYPOMETABOLISM; CHANNELS; RELEASE; KINASE; SIGNAL	The observation that induced torpor in non-hibernating mammals could result from an increased AMP concentration in circulation led our investigation to reveal that the added AMP altered oxygen transport of erythrocytes. To further study the effect of AMP in regulation of erythrocyte function and systemic metabolism, we generated mouse models deficient in key erythrocyte enzymes in AMP metabolism. We have previously reported altered erythrocyte adenine nucleotide levels corresponding to altered oxygen saturation in mice deficient in both CD73 and AMPD3. Here we further investigate how these Ampd3(-/-) /Cd73(-/-) mice respond to the administered dose of AMP in comparison with the control models of single enzyme deficiency and wild type. We found that Ampd3(-/-) /Cd73(-/-) mice are more sensitive to AMP-induced hypometabolism than mice with a single enzyme deficiency, which are more sensitive than wild type. A dose-dependent rightward shift of erythrocyte p50 values in response to increasing amounts of extracellular AMP was observed. We provide further evidence for the direct uptake of AMP by erythrocytes that is insensitive to dipyridamole, a blocker for ENT1. The uptake of AMP by the erythrocytes remained linear at the highest concentration tested, 10mM. We also observed competitive inhibition of AMP uptake by ATP and ADP but not by the other nucleotides and metabolites tested. Importantly, our studies suggest that AMP uptake is associated with an erythrocyte ATP release that is partially sensitive to inhibition by TRO19622 and Ca++ ion. Taken together, our study suggests a novel mechanism by which erythrocytes recycle and maintain their adenine nucleotide pool through AMP uptake and ATP release.	[O'Brien, William G., III; Ling, Han Shawn; Zhao, Zhaoyang; Lee, Cheng Chi] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Zhao, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	Zhaoyang.zhao@uth.tmc.edu			NIH [DP1 0D000895, R01 GM104510]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104510] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH DP1 0D000895. This funding supported the on-set of this project and generation of the animal models use. NIH R01 GM104510; this funding helped the final stage of the study described here.	ARCH JRS, 1978, BIOCHEM J, V174, P965, DOI 10.1042/bj1740965; Baranowska-Bosiacka I, 2004, POL J ENVIRON STUD, V13, P467; Bhatt DP, 2012, J CHROMATOGR B, V889, P110, DOI 10.1016/j.jchromb.2012.02.005; Bouma HR, 2012, J CELL PHYSIOL, V227, P1285, DOI 10.1002/jcp.22850; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Daniels IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075418; Daniels IS, 2010, J BIOL CHEM, V285, P20716, DOI 10.1074/jbc.M109.090845; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Fiermonte G, 2009, J BIOL CHEM, V284, P18152, DOI 10.1074/jbc.M109.014118; Goldman D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00246; GUARNONE R, 1995, HAEMATOLOGICA, V80, P426; Gutierrez-Aguilar M, 2013, BIOCHEM J, V454, P371, DOI 10.1042/BJ20121753; KLINGENBERG M, 1985, BIOCHEMISTRY-US, V24, P3650, DOI 10.1021/bi00335a038; Mathews WB, 2005, MOL IMAGING BIOL, V7, P203, DOI 10.1007/s11307-005-4118-6; Miao YF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/520745; Miao ZM, 2013, RHEUMATOL INT, V33, P2085, DOI 10.1007/s00296-013-2676-5; Miao ZM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/459617; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Muzzi M, 2013, J CEREBR BLOOD F MET, V33, P171, DOI 10.1038/jcbfm.2012.181; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; O'Brien WG, 2015, SCI REP-UK, V5, DOI 10.1038/srep13147; Prenni JE, 2012, BLOOD CELL MOL DIS, V49, P74, DOI 10.1016/j.bcmd.2012.05.002; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sridharan M, 2012, AM J PHYSIOL-HEART C, V302, pH553, DOI 10.1152/ajpheart.00998.2011; STOCCHI V, 1985, ANAL BIOCHEM, V146, P118, DOI 10.1016/0003-2697(85)90405-1; Swoap SJ, 2007, AM J PHYSIOL-REG I, V293, pR468, DOI 10.1152/ajpregu.00888.2006; Tao ZY, 2011, AM J TRANSL RES, V3, P351; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0; Wang TF, 1996, J BIOL CHEM, V271, P9898, DOI 10.1074/jbc.271.17.9898; Wang YL, 2014, J GASTROEN HEPATOL, V29, P742, DOI 10.1111/jgh.12448; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhang YQ, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0178-3; Zhao ZY, 2014, METABOLOMICS, V10, P63, DOI 10.1007/s11306-013-0552-7; Zhao ZY, 2011, PHYSIOL GENOMICS, V43, P325, DOI 10.1152/physiolgenomics.00174.2010	38	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180948	10.1371/journal.pone.0180948	http://dx.doi.org/10.1371/journal.pone.0180948			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746349	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800023
J	Ojanguren-Affilastro, AA; Adilardi, RS; Cajade, R; Ramirez, MJ; Ceccarelli, FS; Mola, LM				Ojanguren-Affilastro, Andres A.; Adilardi, Renzo S.; Cajade, Rodrigo; Ramirez, Martin J.; Sara Ceccarelli, F.; Mola, Liliana M.			Multiple approaches to understanding the taxonomic status of an enigmatic new scorpion species of the genus Tityus (Buthidae) from the biogeographic island of Paraje Tres Cerros (Argentina)	PLOS ONE			English	Article							CYTOGENETIC ANALYSIS; BRAZIL SCORPIONES; HETEROCHROMATIN; BOTHRIURIDAE; LOCATION; COMPLEX; UPLIFT; GENES; RDNA	Tityus curupi n. sp., belonging to the bolivianus complex, is described from the biogeogra-phically distinct area of Paraje Tres Cerros in north-eastern Argentina. We also present a molecular species delimitation analysis between Tityus curupi n. sp. and its sister species Tityus uruguayensis Borelli 1901 to confirm species integrity. Furthermore, a cytogenetic analysis is presented for these two species which contain different multivalent associations in meiosis, as a consequence of chromosome rearrangements, and the highest chromosome numbers in the genus.	[Ojanguren-Affilastro, Andres A.; Ramirez, Martin J.; Sara Ceccarelli, F.] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Adilardi, Renzo S.; Mola, Liliana M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Lab Citogenet & Evoluc, Dept Ecol Genet & Evoluc,IEGEBA CONICET UBA, Buenos Aires, DF, Argentina; [Cajade, Rodrigo] Univ Nacl Nordeste, Fac Ciencias Exactas & Nat & Agrimensura, Dept Biol, Lab Herpetol, Corrientes, Argentina; [Sara Ceccarelli, F.] Ctr Invest Cient & Educ Super Ensenada, Dept Biol Conservat, Ensenada, Baja California, Mexico	Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); University of Buenos Aires; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Ojanguren-Affilastro, AA (corresponding author), Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina.	ojanguren@macn.gov.ar	Mola, Liliana Maria/AAN-6792-2020; Ceccarelli, F. Sara/L-3208-2019	Adilardi, Renzo/0000-0001-7279-3853; Mola, Liliana Maria/0000-0003-2511-8067	National Council of Scientific and Technological Research (CONICET) [PIP 00107]; University of Buenos Aires (UBA) [0694BA]; National Agency for Scientific and Technological Promotion (ANPCyT) [PICT 2010-1665]; ANPCyT [PICT 2010-1764, PICT 2011-1007, PIP 2012-943]	National Council of Scientific and Technological Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); National Agency for Scientific and Technological Promotion (ANPCyT)(ANPCyT); ANPCyT(ANPCyT)	This work was supported by grants from the National Council of Scientific and Technological Research (CONICET, PIP 00107), University of Buenos Aires (UBA, 0694BA) and National Agency for Scientific and Technological Promotion (ANPCyT, PICT 2010-1665) to L. Poggio and L. Mola, and ANPCyT (PICT 2010-1764) to A. A. Ojanguren-Affilastro, and PICT 2011-1007 and PIP 2012-943 to M.J. Ramirez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Council of Scientific and Technological Research (CONICET, PIP 00107), University of Buenos Aires (UBA, 0694 BA) and National Agency for Scientific and Technological Promotion (ANPCyT, PICT 2010-1665) to L. Poggio and L. Mola, and ANPCyT (PICT 2010-1764) to A. A. Ojanguren-Affilastro, and PICT 2011-1007 and PIP 2012-943 to M.J. Ramirez. The authors wish to thank to Jose Ochoa, Rafael Braga Almeida, Gonzalo Rubio, Andres Porta, Nahuel Acufia-Sureda, and Luis Piacentini for their help during the field work. Finally we wish to thank to the Fundacion Amado Bonpland for kindly hosting us during our field work at the Reserva Natural Privada Paraje Tres Cerros.	Aceolaza FG, 2007, SERIE CORRELACION GE, V22; Affilastro AAO, 2003, J ARACHNOL, V31, P55, DOI 10.1636/0161-8202(2003)031[0055:BJANSS]2.0.CO;2; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cajade R, 2013, CONSERVACION SOC, V16, P147; Cajade R, 2013, ZOOTAXA, V3709, P162; Camacho J.P.M., 2014, PROTOCOLS CYTOGENETI, P416, DOI [10.1201/b17450-12., DOI 10.1201/B17450-12]; Ceccarelli F. S., 2016, BIOL J LINN SOC; De Souza CAR, 2009, ZOOTAXA, P1; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Ghosh P, 2006, SCIENCE, V311, P511, DOI 10.1126/science.1119365; Grummer JA, 2014, SYST BIOL, V63, P119, DOI 10.1093/sysbio/syt069; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Herbst R., 1999, ORBIGNYANA, V2, P1; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kovarik F., 2009, EUSCORPIUS, P1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lourenco WR, 2007, AMAZONIANA, V19, P77; LOURENCO W R, 1980, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V2, P793; LOURENCO W R, 1981, Revista Brasileira de Biologia, V41, P351; LOURENCO W R, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P349; Lourenco Wilson R., 2006, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V14, P307; Lourenco Wilson R., 2006, Boletin de la SEA, V39, P55; Lourenco WR, 1985, REV ARACHNOL, V6, P107; Luceno M, 1996, CARYOLOGIA, V49, P301, DOI 10.1080/00087114.1996.10797374; Mattoni CI, 2005, J ARACHNOL, V33, P735, DOI 10.1636/H04-31.1; Mattos VF, 2014, ZOOL SCI, V31, P603, DOI 10.2108/zs140005; Mattos VF, 2013, CHROMOSOME RES, V21, P121, DOI 10.1007/s10577-013-9342-3; Maury E. A., 1970, PHYSIS, V29, P405; MEREGALLI M., 1998, KAKTEEN ANDERE SUKKU, V49, P283; Mola LM, 2011, BAG-J BASIC APPL GEN, V22, P1; Ochoa JA, 2011, B AM MUS NAT HIST, P1; Ojanguren Affilastro AA, 2005, REV IBER ARACNOL, V11, P75; Ojanguren-Affilastro AA, 2017, MOL PHYLOGENET EVOL, V110, P39, DOI 10.1016/j.ympev.2017.02.018; Ojanguren-Affilastro AA, 2016, MOL PHYLOGENET EVOL, V94, P159, DOI 10.1016/j.ympev.2015.08.007; Pisa S. de T., 1950, Cienc Cult, V2, P202; Piza ST, 1952, SCI GENETICA, V4, P162; Piza ST, 1948, REV AGR, V24, P177; Piza ST, 1947, LUIZ QUEIROZ, V4, P169; Prendini L, 2000, CLADISTICS, V16, P1, DOI 10.1111/j.1096-0031.2000.tb00348.x; Ravenna P., 2009, ONIRA BOT LEAFLETS, V12, P1; RAVENNA P., 2003, ONIRA, V9, P9; de Almeida BRR, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0494-6; Sadilek D, 2015, BIOL J LINN SOC, V115, P69, DOI 10.1111/bij.12488; Ceccarelli FS, 2016, J BIOGEOGR, V43, P1942, DOI 10.1111/jbi.12760; Schneider MC, 2014, CYTOGENET GENOME RES, V144, P341, DOI 10.1159/000375388; Schneider MC, 2009, J HERED, V100, P545, DOI 10.1093/jhered/esp023; Schneider MC, 2009, CHROMOSOME RES, V17, P883, DOI 10.1007/s10577-009-9076-4; Adilardi RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164427; Adilardi RS, 2015, GENETICA, V143, P393, DOI 10.1007/s10709-015-9838-1; Adilardi RS, 2014, COMP CYTOGENET, V8, P81, DOI 10.3897/CompCytogen.v8i2.6461; Shanahan CM, 1989, GENOME, V32, P889; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Vachon M, 1974, B MUSEUM NATL DHISTO, V3, P857; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	58	12	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181337	10.1371/journal.pone.0181337	http://dx.doi.org/10.1371/journal.pone.0181337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746406	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800034
J	Huh, JH; Kim, JY; Choi, E; Kim, JS; Chang, Y; Sung, KC				Huh, Ji Hye; Kim, Jang Young; Choi, Eunhee; Kim, Jae Seok; Chang, Yoosoo; Sung, Ki-Chul			The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; RECEPTOR BLOCKER; RISK-FACTORS; PREVALENCE; STEATOSIS; FIBROSIS; OBESITY; POPULATION	Background Although non-alcoholic fatty liver disease (NAFLD) is considered to be associated with chronic kidney disease (CKD), long-term follow up data is lacking. We investigated whether NAFLD, as determined by the fatty liver index (FLI), could predict incident CKD in 10-year prospective cohort study. We also assessed the clinical utility of FLI to predict the development of CKD. Methods 6,238 adults aged 40 to 69 years without baseline CKD from the Ansan-Ansung cohort were examined. Patients were classified according to FLI as follows: FLI < 30, no NAFLD; FLI >= 60, NAFLD; and 30 <= FLI < 60, intermediate. Incident CKD was defined as estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m(2). The clinical utility of FLI in predicting incident CKD was estimated via area under the receiver-operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI) analyses. Results During an average of 10 years of follow-up, 724 subjects (15.21%) developed CKD. The adjusted hazard ratio [95% confidence interval (CI)] for incident CKD increased in a graded manner with FLI increased (< 30 vs. 30-59 vs. >= 60 = 1 vs. 1.17 [0.997-1.375] vs. 1.459 [1.189-1.791], respectively, P for trend = 0.0012). Incorporation of FLI into traditional risk factors of CKD significantly increased prediction of incident CKD based on NRI (17%; 95% CI, 8.9-25%; P-value < 0.001) and IDI (0.002; 95% CI, 0.0046-0.0143; P-value = 0.046). Conclusions FLI, a surrogate marker of NAFLD, was an independent risk factor for incident CKD. FLI provides meaningful incremental risk reclassification beyond that of conventional risk factors of CKD.	[Huh, Ji Hye; Kim, Jang Young; Kim, Jae Seok] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea; [Choi, Eunhee] Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA; [Chang, Yoosoo] Sungkyunkwan Univ, Sch Med, Dept Occupat & Environm Med, Kangbuk Samsung Hosp, Seoul, South Korea; [Sung, Ki-Chul] Sungkyunkwan Univ, Sch Med, Div Cardiol, Dept Med,Kangbuk Samsung Hosp, Seoul, South Korea	Yonsei University; Harvard University; Beth Israel Deaconess Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea.; Choi, E (corresponding author), Beth Israel Deaconess Med Ctr, Smith Ctr Outcomes Res Cardiol, Boston, MA 02215 USA.	kimjang@gmail.com; eunhee_cho@yonsei.ac.kr		Chang, Yoosoo/0000-0002-6945-9050; Choi, Eunhee/0000-0002-3449-0672	Korea Centers for Disease Control and Prevention [2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00]; Gangwon branch of Korean Endocrine Society	Korea Centers for Disease Control and Prevention; Gangwon branch of Korean Endocrine Society	This study was supported in part by grants of the Korea Centers for Disease Control and Prevention (2005-E71013-00, 2006-E71002-00, 2007-E71013-00, 2008-E71004-00, 2009-E71006-00, 2010-E71003-00) and Gangwon branch of Korean Endocrine Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsic N, 2012, WORLD J GASTROENTERO, V18, P3945, DOI 10.3748/wjg.v18.i30.3945; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Carrero JJ, 2009, SEMIN DIALYSIS, V22, P381, DOI 10.1111/j.1525-139X.2009.00585.x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chang Y, 2008, METABOLISM, V57, P569, DOI 10.1016/j.metabol.2007.11.022; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Souza Mônica Rodrigues de Araújo, 2012, Arq. Gastroenterol., V49, P89, DOI 10.1590/S0004-28032012000100015; de Vries APJ, 2014, LANCET DIABETES ENDO, V2, P417, DOI 10.1016/S2213-8587(14)70065-8; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kang HT, 2013, NEPHROL DIAL TRANSPL, V28, P927, DOI 10.1093/ndt/gfs535; Kato J, 2012, INT J MOL MED, V30, P107, DOI 10.3892/ijmm.2012.958; Kim JH, 2011, LIVER INT, V31, P1600, DOI 10.1111/j.1478-3231.2011.02580.x; Kozakova M, 2012, HEPATOLOGY, V55, P1406, DOI 10.1002/hep.25555; Lee YH, 2015, J HEPATOL, V63, P486, DOI 10.1016/j.jhep.2015.02.051; Lee YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107584; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Lim S, 2006, J ENDOCRINOL INVEST, V29, P313, DOI 10.1007/BF03344102; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Osawa H, 1996, J CLIN ULTRASOUND, V24, P25, DOI 10.1002/(SICI)1097-0096(199601)24:1<25::AID-JCU4>3.0.CO;2-N; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Parikh CR, 2014, J AM SOC NEPHROL, V25, P1621, DOI 10.1681/ASN.2013121300; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, DIABETOLOGIA, V53, P1341, DOI 10.1007/s00125-010-1720-1; Targher G, 2008, J AM SOC NEPHROL, V19, P1564, DOI 10.1681/ASN.2007101155; Targher G, 2011, J HEPATOL, V54, P1020, DOI 10.1016/j.jhep.2010.11.007; Yoo HJ, 2015, DIABETES METAB J, V39, P10, DOI 10.4093/dmj.2015.39.1.10; Zelber-Sagi S, 2013, WORLD J GASTROENTERO, V19, P57, DOI 10.3748/wjg.v19.i1.57; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	41	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180951	10.1371/journal.pone.0180951	http://dx.doi.org/10.1371/journal.pone.0180951			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738057	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700023
J	Ng, TP; Jin, A; Chow, KY; Feng, L; Nyunt, MSZ; Yap, KB				Ng, Tze Pin; Jin, Aizhen; Chow, Khuan Yew; Feng, Liang; Nyunt, Ma Shwe Zin; Yap, Keng Bee			Age-dependent relationships between body mass index and mortality: Singapore longitudinal ageing study	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEART-FAILURE; OLDER-PEOPLE; FOLLOW-UP; MEN; WEIGHT; WOMEN; OBESITY; BMI; ASSOCIATION	Objectives The relationship between body mass index (BMI) with mortality risk, in particular the BMI category associated with the lowest all-cause and CVD-and-stroke mortality and the BMI threshold for defining overweight or obesity in older persons is controversial. This study investigated the age-dependent associations of BMI categories with all-cause and cardiovascular disease (CVD) and stroke mortality. Method Prospective cohort study (Singapore Longitudinal Ageing Studies) of older adults aged 55 and above, followed up from 2003 to 2011. Participants were 2605 Chinese with baseline BMI and other variables. Outcome Measurement: Mortality hazard ratios (HR) for all-cause and CVD and stroke mortality. Results Overall, BMI showed a U-shaped relationship with all-cause and CVD and stroke mortality, being lowest at Normal Weight-II category (BMI 23.0-24.9 kg/m2). Most evidently among the middle-aged (55-64 years), all-cause mortality risks relative to Normal Weight-II were elevated for underweight (<BMI 18.5; HR = 4.92, p<0.0138), Normal Weight-I (BMI 18.5-22.9; HR = 3.41, p = 0.0149), and Overweight-Obese (BMI>30.0; HR = 4.05, p = 0.0423). Among the old (>= 65 years), however, Overweight and Obese categories were not significantly associated with increased all-cause mortality (HR from 0.98 to 1.29), but Overweight-Obese was associated with increased CVD and stroke mortality (HR = 10.0, p = 0.0086). Conclusion BMI showed a U-shaped relationship with mortality. Among older persons aged 65 and above, the overweight-or-obese category of BMI was not associated with excess all-cause mortality.	[Ng, Tze Pin; Feng, Liang; Nyunt, Ma Shwe Zin] Natl Univ Singapore, Dept Psychol Med, Gerontol Res Programme, Singapore, Singapore; [Jin, Aizhen; Chow, Khuan Yew] Hlth Promot Board, Natl Dis Registry Off, Singapore, Singapore; [Yap, Keng Bee] Alexandra Hosp, Dept Med, Singapore, Singapore	National University of Singapore	Ng, TP (corresponding author), Natl Univ Singapore, Dept Psychol Med, Gerontol Res Programme, Singapore, Singapore.	pcmngtp@nus.edu.sg		NYUNT, Shwe/0000-0001-9353-7269	Agency for Science Technology and Research (A*STAR) Biomedical Research Council (BMRC) [08/1/21/19/567]; National Medical Research Council [NMRC/1108/2007]; Geylang East Home for the Aged; Presbyterian Community Services; St Luke's Eldercare Services; Thye Hua Kwan Moral Society (Moral Neighbourhood Links); Yuhua Neighbourhood Link; Henderson Senior Citizens' Home; NTUC Eldercare Co-op Ltd; Thong Kheng Seniors Activity Centre (Queenstown Centre); Redhill Moral Seniors Activity Centre	Agency for Science Technology and Research (A*STAR) Biomedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Geylang East Home for the Aged; Presbyterian Community Services; St Luke's Eldercare Services; Thye Hua Kwan Moral Society (Moral Neighbourhood Links); Yuhua Neighbourhood Link; Henderson Senior Citizens' Home; NTUC Eldercare Co-op Ltd; Thong Kheng Seniors Activity Centre (Queenstown Centre); Redhill Moral Seniors Activity Centre	The study was supported by research grants from the Agency for Science Technology and Research (A*STAR) Biomedical Research Council (BMRC) [Grant: 08/1/21/19/567] and from the National Medical Research Council [Grant: NMRC/1108/2007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the following voluntary welfare organizations for their support and contributions in kind: Geylang East Home for the Aged, Presbyterian Community Services, St Luke's Eldercare Services, Thye Hua Kwan Moral Society (Moral Neighbourhood Links), Yuhua Neighbourhood Link, Henderson Senior Citizens' Home, NTUC Eldercare Co-op Ltd, Thong Kheng Seniors Activity Centre (Queenstown Centre) and Redhill Moral Seniors Activity Centre.	Beleigoli AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052111; Bouillanne O, 2009, AM J CLIN NUTR, V90, P505, DOI 10.3945/ajcn.2009.27819; Chapman IM, 2010, INTERD T GERONT GERI, V37, P20, DOI 10.1159/000319992; Chung WS, 2015, PUBLIC HEALTH NUTR, V18, P1839, DOI 10.1017/S136898001400281X; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Davos CH, 2003, J CARD FAIL, V9, P29, DOI 10.1054/jcaf.2003.4; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Heymsfield SB, 2013, JAMA-J AM MED ASSOC, V309, P87, DOI 10.1001/jama.2012.185445; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Landi F, 2000, ARCH INTERN MED, V160, P2641, DOI 10.1001/archinte.160.17.2641; LEE IM, 1992, JAMA-J AM MED ASSOC, V268, P2045, DOI 10.1001/jama.268.15.2045; Lissin LW, 2002, J CARD FAIL, V8, P206, DOI 10.1054/jcaf.2002.126812; Misra A, 2009, J Assoc Physicians India, V57, P163; Mosterd A, 2001, EUR HEART J, V22, P1318, DOI 10.1053/euhj.2000.2533; Nagai M, 2010, J EPIDEMIOL, V20, P398, DOI 10.2188/jea.JE20090204; National Institutes of Health, 1998, OBES RES S2, V6, p51S, DOI DOI 10.1002/J.1550-8528.1998.TB00690.X; Niti M, 2008, INT PSYCHOGERIATR, V20, P237, DOI 10.1017/S1041610207006655; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Pan WH, 2012, ASIA PAC J CLIN NUTR, V21, P577; Ross R, 2004, OBES RES, V12, P789, DOI 10.1038/oby.2004.95; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; SLEMENDA CW, 1990, ANN INTERN MED, V112, P96, DOI 10.7326/0003-4819-112-2-96; Song YM, 2007, ANN EPIDEMIOL, V17, P556, DOI 10.1016/j.annepidem.2007.01.028; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Tamakoshi A, 2010, OBESITY, V18, P362, DOI 10.1038/oby.2009.190; Tsugane S, 2002, INT J OBESITY, V26, P529, DOI 10.1038/sj.ijo.0801961; Villareal DT, 2005, OBES RES, V13, P1849, DOI 10.1038/oby.2005.228; WANG J, 1994, AM J CLIN NUTR, V60, P23, DOI 10.1093/ajcn/60.1.23; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zhang X, 2008, INT J OBESITY, V32, P1130, DOI 10.1038/ijo.2008.63	44	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180818	10.1371/journal.pone.0180818	http://dx.doi.org/10.1371/journal.pone.0180818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28738068	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700018
J	Sato, D; Yamazaki, Y; Takahashi, A; Uetake, Y; Nakano, S; Iguchi, K; Baba, Y; Nara, R; Shimoyama, Y				Sato, Daisuke; Yamazaki, Yudai; Takahashi, Akari; Uetake, Yoshihito; Nakano, Saki; Iguchi, Kaho; Baba, Yasuhiro; Nara, Rio; Shimoyama, Yoshimitsu			Water immersion decreases sympathetic skin response during color-word Stroop test	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; COGNITIVE PERFORMANCE; PREFRONTAL ACTIVATION; EXERCISE; CONDUCTANCE; AROUSAL; HUMANS; INTERFERENCE; VASOPRESSIN	Water immersion alters the autonomic nervous system (ANS) response in humans. The effect of water immersion on executive function and ANS responses related to executive function tasks was unknown. Therefore, this study aimed to determine whether water immersion alters ANS response during executive tasks. Fourteen healthy participants performed color-word-matching Stroop tasks before and after non-immersion and water immersion intervention for 15 min in separate sessions. The Stroop task-related skin conductance response (SCR) was measured during every task. In addition, the skin conductance level (SCL) and electrocardiograph signals were measured over the course of the experimental procedure. The main findings of the present study were as follows: 1) water immersion decreased the executive task-related sympathetic nervous response, but did not affect executive function as evaluated by Stroop tasks, and 2) decreased SCL induced by water immersion was maintained for at least 15 min after water immersion. In conclusion, the present results suggest that water immersion decreases the sympathetic skin response during the color-word Stroop test without altering executive performance.	[Sato, Daisuke; Yamazaki, Yudai] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Niigata, Japan; [Sato, Daisuke; Yamazaki, Yudai; Uetake, Yoshihito; Shimoyama, Yoshimitsu] Niigata Univ Hlth & Welf, Grad Sch Major Hlth Sci, Niigata, Niigata, Japan; [Sato, Daisuke; Takahashi, Akari; Nakano, Saki; Iguchi, Kaho; Baba, Yasuhiro; Nara, Rio; Shimoyama, Yoshimitsu] Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Niigata, Japan	Niigata University; Niigata University; Niigata University	Sato, D (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Niigata, Japan.; Sato, D (corresponding author), Niigata Univ Hlth & Welf, Grad Sch Major Hlth Sci, Niigata, Niigata, Japan.; Sato, D (corresponding author), Niigata Univ Hlth & Welf, Dept Hlth & Sports, Niigata, Niigata, Japan.	daisuke@nuhw.ac.jp		Nara, Rio/0000-0002-6435-3126; Yamazaki, Yudai/0000-0002-4714-0823; Sato, Daisuke/0000-0003-3227-3129	JSPS KAKENHI [15K12712]; Niigata University of Health and Welfare	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Niigata University of Health and Welfare	This study was supported by JSPS KAKENHI Grant Number 15K12712 and Grant-in-Aid for Scientific Research from the Niigata University of Health and Welfare, 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by JSPS KAKENHI Grant Number 15K12712 and Grant-in-Aid for Scientific Research from the Niigata University of Health and Welfare, 2015.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Andreassi JL., 2000, PSYCHOPHYSIOLOGY HUM, Vxxvi; Balconi M, 2015, BRAIN COGNITION, V95, P67, DOI 10.1016/j.bandc.2015.02.001; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P402, DOI 10.1016/S1388-2457(03)00343-2; BERNTSON GG, 1994, PSYCHOPHYSIOLOGY, V31, P44, DOI 10.1111/j.1469-8986.1994.tb01024.x; Best JR, 2015, J AM GERIATR SOC, V63, P1112, DOI 10.1111/jgs.13444; Bressel E, 2011, MED SCI SPORT EXER, V43, P1927, DOI 10.1249/MSS.0b013e318219dae7; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; CACIOPPO JT, 1994, PSYCHOPHYSIOLOGY, V31, P412, DOI 10.1111/j.1469-8986.1994.tb02449.x; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; EPSTEIN M, 1992, PHYSIOL REV, V72, P563, DOI 10.1152/physrev.1992.72.3.563; Fechir M, 2010, NEUROIMAGE, V50, P847, DOI 10.1016/j.neuroimage.2009.12.004; Gabrielsen A, 2000, AM J PHYSIOL-REG I, V278, pR1583, DOI 10.1152/ajpregu.2000.278.6.R1583; Gianaros PJ, 2004, PSYCHOPHYSIOLOGY, V41, P521, DOI 10.1111/1469-8986.2004.00179.x; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; HAYANO J, 1994, AM J PHYSIOL, V267, pH33, DOI 10.1152/ajpheart.1994.267.1.H33; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hyodo K, 2012, NEUROBIOL AGING, V33, P2621, DOI 10.1016/j.neurobiolaging.2011.12.022; Ito H, 2011, PSYCHOPHYSIOLOGY, V48, P1562, DOI 10.1111/j.1469-8986.2011.01220.x; Kishi T, 2012, CIRC J, V76, P1934, DOI 10.1253/circj.CJ-12-0276; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lim CL, 1997, INT J PSYCHOPHYSIOL, V25, P97, DOI 10.1016/S0167-8760(96)00713-1; Man IOW, 2003, MED SCI SPORT EXER, V35, P630, DOI 10.1249/01.MSS.0000058432.29149.08; Martin I, 1980, TECHNIQUES IN PSYCHO, Vxiv; Mathewson KJ, 2010, INT J PSYCHOPHYSIOL, V76, P123, DOI 10.1016/j.ijpsycho.2010.02.007; Miwa C, 1997, AVIAT SPACE ENVIR MD, V68, P1109; Mourot L, 2008, AVIAT SPACE ENVIR MD, V79, P14, DOI 10.3357/ASEM.2147.2008; Mourot L, 2007, AUTON NEUROSCI-BASIC, V137, P27, DOI 10.1016/j.autneu.2007.06.284; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Nakamitsu S, 1985, J APPL PHYSIOL, V1994, P77; NORSK P, 1986, EUR J APPL PHYSIOL O, V54, P608, DOI 10.1007/BF00943349; Park Kwon Sik, 1999, Applied Human Science, V18, P233; Pendergast DR, 2009, J APPL PHYSIOL, V106, P276, DOI 10.1152/japplphysiol.90984.2008; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Sato D, 2017, ADV EXP MED BIOL IN; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Sato D, 2015, AGING CLIN EXP RES, V27, P149, DOI 10.1007/s40520-014-0252-9; Sato D, 2012, BRAIN TOPOGR, V25, P220, DOI 10.1007/s10548-011-0204-z; Schipke JD, 2001, BRIT J SPORT MED, V35, P174, DOI 10.1136/bjsm.35.3.174; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Shattock MJ, 2012, J PHYSIOL-LONDON, V590, P3219, DOI 10.1113/jphysiol.2012.229864; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; VaezMousavi SM, 2007, ACTA NEUROBIOL EXP, V67, P461; Vaile J, 2011, BRIT J SPORT MED, V45, P825, DOI 10.1136/bjsm.2009.067272; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023	52	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180765	10.1371/journal.pone.0180765	http://dx.doi.org/10.1371/journal.pone.0180765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28742137	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700016
J	Skappak, C; Ilarraza, R; Wu, YQ; Drake, MG; Adamko, DJ				Skappak, Christopher; Ilarraza, Ramses; Wu, Ying-qi; Drake, Matthew G.; Adamko, Darryl J.			Virus-induced asthma attack: The importance of allergic inflammation in response to viral antigen in an animal model of asthma	PLOS ONE			English	Article							MUSCARINIC RECEPTOR DYSFUNCTION; RESPIRATORY SYNCYTIAL VIRUS; BRONCHIAL EPITHELIAL-CELLS; CD4(+) T-CELLS; GUINEA-PIG; INFECTION DETERMINES; SPUTUM EOSINOPHILS; RHINOVIRUS; GLUCOCORTICOIDS; EXACERBATIONS	Asthma exacerbation can be a life-threatening condition, and is most often triggered by common respiratory viruses. Poor asthma control and worsening of respiratory function is associated with increased airway inflammation, including eosinophilia. Prevention of asthma exacerbation relies on treatment with corticosteroids, which preferentially inhibit allergic inflammation like eosinophils. Human studies demonstrate that inactivated virus can trigger eosinophil activation in vitro through antigen presentation and memory CD4+ lymphocytes. We hypothesized that animals with immunologic memory to a respiratory virus would also develop airway hyperresponsiveness in response to a UV-inactivated form of the virus if they have pre-existing allergic airway inflammation. Guinea pigs were ovalbumin-sensitized, infected with live parainfluenza virus (PIV), aerosol-challenged with ovalbumin, and then reinoculated 60 days later with live or UV-inactivated PIV. Some animals were either treated with dexamethasone prior to the second viral exposure. Lymphocytes were isolated from parabronchial lymph nodes to confirm immunologic memory to the virus. Airway reactivity was measured and inflammation was assessed using bronchoalveolar lavage and lung histology. The induction of viral immunologic memory was confirmed in infected animals. Allergen sensitized and challenged animals developed airway hyperreactivity with eosinophilic airway inflammation when re-exposed to UV-inactivated PIV, while non-sensitized animals did not. Airway hyperreactivity in the sensitized animals was inhibited by pre-treatment with dexamethasone. We suggest that the response of allergic inflammation to virus antigen is a significant factor causing asthma exacerbation. We propose that this is one mechanism explaining how corticosteroids prevent virus-induced asthma attack.	[Skappak, Christopher] McMaster Univ, Div Emergency Med, Hamilton, ON, Canada; [Ilarraza, Ramses; Wu, Ying-qi; Adamko, Darryl J.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Drake, Matthew G.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Adamko, Darryl J.] Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada	McMaster University; University of Alberta; Oregon Health & Science University; University of Saskatchewan	Adamko, DJ (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.; Adamko, DJ (corresponding author), Univ Saskatchewan, Dept Pediat, Saskatoon, SK, Canada.	dadamko@usask.ca		Drake, Matthew/0000-0001-5476-0361	Canadian Allergy and Immune Disease Training Award from AllerGen NCE (National Centre of Excellence); Women and Children's Health Research Institute's (WCHRI) Graduate Studentship; Alberta Queen Elizabeth II Graduate Scholarship; AllerGen NCE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL121254, T32HL083808] Funding Source: NIH RePORTER	Canadian Allergy and Immune Disease Training Award from AllerGen NCE (National Centre of Excellence); Women and Children's Health Research Institute's (WCHRI) Graduate Studentship; Alberta Queen Elizabeth II Graduate Scholarship; AllerGen NCE; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CS was supported by a Canadian Allergy and Immune Disease Training Award from AllerGen NCE (National Centre of Excellence) (http://allergen-nce.ca), the Women and Childrens Health Research Institute's (WCHRI) Graduate Studentship (http://www.wchri.org), and by the Alberta Queen Elizabeth II Graduate Scholarship (http://studentaid.alberta.ca/scholarships/alberta-scholarships/?SK=221). DJA was supported by an operating grant from AllerGen NCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 1999, J EXP MED, V190, P1465, DOI 10.1084/jem.190.10.1465; Adamko DJ, 2003, AM J RESP CRIT CARE, V167, P550, DOI 10.1164/rccm.200206-506OC; ALFARO C, 1989, ANN ALLERGY, V63, P251; BARDIN PG, 1994, CLIN EXP ALLERGY, V24, P457, DOI 10.1111/j.1365-2222.1994.tb00934.x; Barnes PJ, 2014, CHEM IMMUNOL ALLERGY, V100, P311, DOI 10.1159/000359984; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; Blomqvist GAM, 2002, CONTEMP TOP LAB ANIM, V41, P53; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Canning BJ, 2004, J PHYSIOL-LONDON, V557, P543, DOI 10.1113/jphysiol.2003.057885; Chu EK, 2005, AM J RESP CRIT CARE, V171, P1202, DOI 10.1164/rccm.200502-257OE; Committee CReaobottahsoeotCCoACCG, 2010, CCAC GUIDELINES, V1, P1; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Davoine F, 2008, J ALLERGY CLIN IMMUN, V122, P69, DOI 10.1016/j.jaci.2008.03.028; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Dixon WE, 1903, J PHYSIOL-LONDON, V29, P97; DRAZEN JM, 1974, J CLIN INVEST, V53, P1679, DOI 10.1172/JCI107719; Evans CM, 2001, AM J RESP CRIT CARE, V163, P1484, DOI 10.1164/ajrccm.163.6.2007047; Fujimoto K, 1997, CHEST, V112, P1241, DOI 10.1378/chest.112.5.1241; Furuya Y, 2014, J VIROL, V88, P9166, DOI 10.1128/JVI.00265-14; Gibson PG, 2003, THORAX, V58, P116, DOI 10.1136/thorax.58.2.116; Harvey A M, 1949, Trans Am Clin Climatol Assoc, V61, P221; Hastie AT, 2010, J ALLERGY CLIN IMMUN, V125, P1028, DOI 10.1016/j.jaci.2010.02.008; Ilarraza R, 2013, J ALLERGY CLIN IMMUN, V131, P395, DOI 10.1016/j.jaci.2012.11.041; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kato M, 2012, INT ARCH ALLERGY IMM, V158, P11, DOI 10.1159/000337752; Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC; KUMMER W, 1992, NEUROSCIENCE, V49, P715, DOI 10.1016/0306-4522(92)90239-X; LAITINEN LA, 1980, EUR J RESPIR DIS, V61, P51; Lee YM, 2008, AM J RESP CRIT CARE, V177, P208, DOI 10.1164/rccm.200612-1890OC; Meagher LC, 1996, J IMMUNOL, V156, P4422; Moreno L, 2003, AM J PHYSIOL-LUNG C, V285, pL451, DOI 10.1152/ajplung.00046.2003; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Padilla-Carlin DJ, 2008, COMPARATIVE MED, V58, P324; PARTANEN M, 1982, HISTOCHEMISTRY, V76, P175, DOI 10.1007/BF00501920; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Steinke JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115271; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Winther B, 2007, J MED VIROL, V79, P1606, DOI 10.1002/jmv.20956; Wissinger EL, 2008, J IMMUNOL, V180, P2957, DOI 10.4049/jimmunol.180.5.2957	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181425	10.1371/journal.pone.0181425	http://dx.doi.org/10.1371/journal.pone.0181425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742120	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700041
J	Silva, JBL; Alves, DM; Bottino-Rojas, V; Pereira, TN; Sorgine, MHF; Caragata, EP; Moreira, LA				Lopes Silva, Jessica Barreto; Alves, Debora Magalhaes; Bottino-Rojas, Vanessa; Pereira, Thiago Nunes; Ferreira Sorgine, Marcos Henrique; Caragata, Eric Pearce; Moreira, Luciano Andrade			Wolbachia and dengue virus infection in the mosquito Aedes fluviatilis (Diptera: Culicidae)	PLOS ONE			English	Article							GLOBAL DISTRIBUTION; ZIKA VIRUS; TRANSMISSION; STRAIN; ESTABLISHMENT; POPULATIONS; ACTIVATION; ALBOPICTUS; BLOCKING; PATHWAY	Dengue represents a serious threat to human health, with billions of people living at risk of the disease. Wolbachia pipientis is a bacterial endosymbiont common to many insect species. Wolbachia transinfections in mosquito disease vectors have great value for disease control given the bacterium's ability to spread into wild mosquito populations, and to interfere with infections of pathogens, such as dengue virus. Aedes fluviatilis is a mosquito with a widespread distribution in Latin America, but its status as a dengue vector has not been clarified. Ae. fluviatilis is also naturally infected by the wFlu Wolbachia strain, which has been demonstrated to enhance infection with the avian malarial parasite Plasmodium gallinaceum. We performed experimental infections of Ae. fluviatilis with DENV-2 and DENV-3 isolates from Brazil via injection or oral feeding to provide insight into its competence for the virus. We also examined the effect of the native Wolbachia infection on the virus using a mosquito line where the wFlu infection had been cleared by antibiotic treatment. Through RT-qPCR, we observed that Ae. fluviatilis could become infected with both viruses via either method of infection, although at a lower rate than Aedes aegypti, the primary dengue vector. We then detected DENV-2 and DENV-3 in the saliva of injected mosquitoes, and observed that injection of DENV-3-infected saliva produced subsequent infections in naive Ae. aegypti. However, across our data we observed no difference in prevalence of infection and viral load between Wolbachia-infected and -uninfected mosquitoes, suggesting that there is no effect of wFlu on dengue virus. Our results highlight that Ae. fluviatilis could potentially serve as a dengue vector under the right circumstances, although further testing is required to determine if this occurs in the field.	[Lopes Silva, Jessica Barreto; Alves, Debora Magalhaes; Pereira, Thiago Nunes; Caragata, Eric Pearce; Moreira, Luciano Andrade] Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil; [Bottino-Rojas, Vanessa; Ferreira Sorgine, Marcos Henrique] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Moreira, LA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Grp Mosquitos Vetores Endossimbiontes & Interacao, Belo Horizonte, MG, Brazil.	luciano@cpqrr.fiocruz.br	Bottino-Rojas, Vanessa/AAX-2172-2020	Bottino-Rojas, Vanessa/0000-0001-8019-9942; Moreira, Luciano/0000-0002-9240-3506	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular (ICNT-EM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular (ICNT-EM)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (EPC, LAM); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (EPC, LAM); Institutos Nacionais de Ciencia e Tecnologia-Entomologia Molecular (ICNT-EM) (LAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792; Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677; Auguste AJ, 2010, AM J TROP MED HYG, V83, P1262, DOI 10.4269/ajtmh.2010.10-0280; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; Caragata EP, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3441-4; Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011; Caragata EP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005158; Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689; Consoli RA, 1983, MEM I O CRUZ, V78, P37; Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152; Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965; Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370; Fialho RF, 2000, P ROY SOC B-BIOL SCI, V267, P1469, DOI 10.1098/rspb.2000.1166; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066; Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434; Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Molloy JC, 2015, VIRUSES-BASEL, V7, P4624, DOI 10.3390/v7082836; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932; Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525; Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Sanchez-Vargas I, 2009, PLOS PATHOG, V5; Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005; Tason de Camargo M.V., 1983, Memorias do Instituto Oswaldo Cruz, V78, P83; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607; ZCHORIFEIN E, 1995, INSECT MOL BIOL, V4, P173, DOI 10.1111/j.1365-2583.1995.tb00023.x; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837; Zug R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01201; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	56	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181678	10.1371/journal.pone.0181678	http://dx.doi.org/10.1371/journal.pone.0181678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732048	Green Submitted, gold, Green Published			2022-12-26	WOS:000406643100056
J	Passos, LF; Garcia, G; Young, RJ				Passos, Luiza Figueiredo; Garcia, Gerardo; Young, Robert John			Neglecting the call of the wild: Captive frogs like the sound of their own voice	PLOS ONE			English	Article							DART-POISON FROG; MANTELLA-AURANTIACA; AGONISTIC BEHAVIOR; RANA-CLAMITANS; COMMUNICATION; MADAGASCAR; FEMORALIS; SIGNAL; SIZE	Acoustic communication is highly influential in the expression of social behavior by anuran amphibians, transmitting information about the individual's physical condition and motivation. We studied the phonotactic (approach movements) responses of wild and captive male golden mantella frogs to conspecific wild and captive playback calls to determine the impact of captivity on social behaviour mediated by vocalisations. Calls were recorded from one wild and two captive populations. Phonotaxis experiments were then conducted by attracting M. aurantiaca males across a PVC grid on the forest floor or enclosure floor to a speaker. For each playback, the following parameters were recorded to define the accuracy of phonotaxis: (1) number of jumps; (2) jump angles; (3) jump distances; (4) path straightness. During this experiment we observed that wild frogs had a similar behavioural (phonotaxis) response to calls independent of their source while frogs from Chester Zoo had a significantly stronger response to calls of other conspecifics held separately at Chester Zoo. The lack of appropriate phonotaxis response by captive bred frogs to the calls of wild conspecifics could have serious negative conservation implications, if the captive bred individuals were released back to the wild.	[Passos, Luiza Figueiredo; Young, Robert John] Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England; [Passos, Luiza Figueiredo; Garcia, Gerardo] Chester Zoo, Cedar House, Chester, Cheshire, England		Young, RJ (corresponding author), Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England.	r.j.young@salford.ac.uk	Young, Robert/B-7356-2013	Young, Robert/0000-0002-8407-2348	CAPES [6060-13-7]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.; The authors are grateful to Chester Zoo, Mitsinjo Association (Devin Edmonds), Madagasikara-Voakajy, the University of Manchester (Dr Richard Preziosi) for the chance of undertaking this project at their facilities and for the logistical support. LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.	Audacity Team, AUD R FREE AUD ED RE; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Bee MA, 2003, BEHAV ECOL SOCIOBIOL, V54, P601, DOI 10.1007/s00265-003-0657-5; Bee MA, 2007, BEHAV ECOL SOCIOBIOL, V61, P955, DOI 10.1007/s00265-006-0324-8; BRENOWITZ EA, 1989, ETHOLOGY, V83, P69; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Caldart VM, 2016, ACTA ETHOL, V19, P151, DOI 10.1007/s10211-016-0235-2; Dietz J. M., 1994, P32; Duellman W. E., 1986, BIOL AMPHIBIANS; Edmonds D, 2015, SALAMANDRA, V51, P315; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; GERHARDT HC, 1980, NATURWISSENSCHAFTEN, V67, P362, DOI 10.1007/BF01106598; Gilligan DM, 2003, CONSERV GENET, V4, P189, DOI 10.1023/A:1023391905158; Johnson K., 2008, AMPHIBIAN ARK SPECIE; Kaiser K, 2011, BEHAVIOUR, V148, P215, DOI 10.1163/000579510X551660; Marshall VT, 2003, ANIM BEHAV, V65, P1223, DOI 10.1006/anbe.2003.2134; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; Mayer M, 2014, ANIM BEHAV, V89, P45, DOI 10.1016/j.anbehav.2013.12.013; McClelland BE, 1996, J EXP BIOL, V199, P1907; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; R Studio Team, 2015, RSTUDIO INT DEV R; RAHBEK C, 1993, BIODIVERS CONSERV, V2, P426, DOI 10.1007/BF00114044; Randrianavelona R, 2010, AFR J HERPETOL, V59, P65, DOI 10.1080/04416651.2010.481761; Ryan M.J., 1988, P637; Sciencedirect S, 2014, ANIM BEHAV, V87, pI; Slade B, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0656; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Ursprung E, 2009, BEHAVIOUR, V146, P153, DOI 10.1163/156853909X410711; Vence M, 2009, IUCN RED LIST THREAT, P1; WELLS KD, 1978, ANIM BEHAV, V26, P1051, DOI 10.1016/0003-3472(78)90094-5	33	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181931	10.1371/journal.pone.0181931	http://dx.doi.org/10.1371/journal.pone.0181931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732034	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000406643100070
J	Yadav, PK; Antonyraj, CB; Ahamed, SIB; Srinivas, S				Yadav, Pradeep K.; Antonyraj, Christian B.; Ahamed, Syed Ibrahim Basheer; Srinivas, Sistla			Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies	PLOS ONE			English	Article							BIOSPECIFIC INTERACTION ANALYSIS; COAGULATION-FACTOR-V; SERINE PROTEINASES; ESSENTIAL DYNAMICS; TRYPSIN; INHIBITOR; HEMOSTASIS; CLEAVAGE; COMPLEX; BINDING	Blood coagulation factor V (FV) is activated either by Factor X or thrombin, cleaving at three different sites viz., Site I (Arg709-Ser710), site II (Arg1018-Thr1019), and site III (Arg1545-Ser1546). Russell's viper venom factor V activator (RVV-V) is a thrombin-like serine proteinase that activates FV with selective, single cleavage at site III. A long lasting effort is being pending in understanding the 'selective' binding specificity of the RVV-V towards site III. Here, we present the binding kinetic study of RVV-V with two designed peptides corresponding to the regions from site I (Gln699-Asn713) and site II (1008Lys-Pro1022), respectively, that include 15 amino acids. Our investigation for justifying the binding efficacy and kinetics of peptides includes SPR method, protein-peptide docking, molecular dynamics simulation, and principal component analysis (PCA). Surprisingly, the SPR experiment disclosed that the Peptide II showed a lower binding affinity with K-D of 2.775 mM while the Peptide I showed none. Docking and simulation of both the peptides with RVV-V engaged either rooted or shallow binding for Peptide II and Peptide I respectively. The peptide binding resulted in global conformational changes in the native fold of RVV-V, whereas the similar studies for thrombin failed to make major changes in the native fold. In support, the PCA analysis for RVV-V showed the dislocation of catalytic triad upon binding both the peptides. Hence, RVV-V, a serine protease, is incompetent in cleaving these two sites. This study suggests a transition in RVV-V from the native rigid to the distorted flexible structure and paves a way to design a new peptide substrate/inhibitor.	[Yadav, Pradeep K.; Antonyraj, Christian B.; Ahamed, Syed Ibrahim Basheer] Pondicherry Univ, Ctr Bioinformat, Pondicherry, India; [Srinivas, Sistla] GE Healthcare Life Sci, John F Welch Technol Ctr, EPIP, Bengaluru, India	Pondicherry University; General Electric	Ahamed, SIB (corresponding author), Pondicherry Univ, Ctr Bioinformat, Pondicherry, India.	ibrahim.bic@pondiuni.edu.in	Bharathi, Christian/G-5790-2015; Sistla, Srinivas/H-3335-2019; Yadav, Pradeep Kumar/GZA-4317-2022	Sistla, Srinivas/0000-0003-3693-8597; basheer ahamed, syed ibrahim/0000-0002-5619-5981	SERB [SR/FT/LS-89/2011]	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	The project was funded by the following agency to Dr. Syed Ibrahim Bahseer Ahamed, and the grant number is mentioned: SERB (SR/FT/LS-89/2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Centre for Bioinformatics, Pondicherry University, for providing the computational facilities and BSI expresses its gratitude to SERB (SR/FT/LS-89/2011) for funding the project.	Altis A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945165; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Blaszczyk M, 2016, METHODS, V93, P72, DOI 10.1016/j.ymeth.2015.07.004; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; de Souza ON, 1999, J BIOMOL STRUCT DYN, V16, P1205, DOI 10.1080/07391102.1999.10508328; Duga S, 2004, INT J BIOCHEM CELL B, V36, P1393, DOI 10.1016/j.biocel.2003.08.002; ESMON C T, 1973, Thrombosis Research, V2, P509, DOI 10.1016/0049-3848(73)90004-2; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Ibrahim BS, 2005, J MOL BIOL, V348, P1191, DOI 10.1016/j.jmb.2005.03.034; Ibrahim BS, 2004, J BIOMOL STRUCT DYN, V21, P737, DOI 10.1080/07391102.2004.10506964; Ibrahim BS, 2004, BIOCHEM BIOPH RES CO, V313, P8, DOI 10.1016/j.bbrc.2003.11.082; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; KISIEL W, 1979, J BIOL CHEM, V254, P2230; Kurcinski M, 2015, NUCLEIC ACIDS RES, V43, pW419, DOI 10.1093/nar/gkv456; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Maisuradze GG, 2007, PROTEINS, V67, P569, DOI 10.1002/prot.21344; Maroun RC, 2001, HAEMOSTASIS, V31, P247; Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Miszkiel A, 2011, J MOL MODEL, V17, P3103, DOI 10.1007/s00894-011-1003-x; Nakayama D, 2011, FEBS LETT, V585, P3020, DOI 10.1016/j.febslet.2011.08.022; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Perchuc AM, 2010, TOXINS HEMOSTASIS BE, P747; Riley BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep35385; SCHIFFMAN S, 1969, BIOCHEMISTRY-US, V8, P1397, DOI 10.1021/bi00832a014; Segers K, 2006, PROTEINS, V64, P968, DOI 10.1002/prot.21051; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Serrano SMT, 2013, TOXICON, V62, P19, DOI 10.1016/j.toxicon.2012.09.003; Silva A, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-26; Wisner A, 2001, HAEMOSTASIS, V31, P133; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30; Zelanis A, 2015, J PROTEOMICS, V113, P260, DOI 10.1016/j.jprot.2014.10.002	36	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181216	10.1371/journal.pone.0181216	http://dx.doi.org/10.1371/journal.pone.0181216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732041	Green Submitted, gold, Green Published			2022-12-26	WOS:000406643100028
J	Di Biagio, A; Riccardi, N; Signori, A; Maserati, R; Nozza, S; Gori, A; Bonora, S; Borderi, M; Ripamonti, D; Rossi, MC; Orofino, G; Quirino, T; Nunnari, G; Celesia, BM; Martini, S; Sagnelli, C; Mazzola, G; Colletti, P; Bartolozzi, D; Bini, T; Ladisa, N; Castelnuovo, F; Saracino, A; Lo Caputo, S				Di Biagio, Antonio; Riccardi, Niccolo; Signori, Alessio; Maserati, Renato; Nozza, Silvia; Gori, Andrea; Bonora, Stefano; Borderi, Marco; Ripamonti, Diego; Rossi, Maria Cristina; Orofino, Giancarlo; Quirino, Tiziana; Nunnari, Giuseppe; Celesia, Benedetto Maurizio; Martini, Salvatore; Sagnelli, Caterina; Mazzola, Giovanni; Colletti, Pietro; Bartolozzi, Dario; Bini, Teresa; Ladisa, Nicoletta; Castelnuovo, Filippo; Saracino, Annalisa; Lo Caputo, Sergio			PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; AFRICAN WOMEN; KNOWLEDGE; MEN; TENOFOVIR; THERAPY; TRIAL; RISK	Several studies have demonstrated the efficacy of the oral pre-exposure prophylaxis (PrEP) with tenofovir (with or without emtricitabine) on preventing HIV-negative partners of HIV infected patients to become infected through sexual contacts. PrEP is already available in the United States and now is approved by European Medicine Agency. In this setting we would like to gauge physicians' knowledge, acquaintance with and attitude to include PrEP in their clinical practice. A cross sectional survey was conducted among Italian physicians expert on antiretroviral therapy. Out of 146 physicians, 35% of participants declared to be familiar with PrEP but only 46% of them believed that, currently, there are not enough reasons to make it available in Italy. 51% of physicians have already been attracted to prescribe it and 63.4% have been openly asked about PrEP. The main concerns noticed were: the risk of acquire other sexual transmitted diseases (STDs) (70% of physicians feared that PrEP could favor STDs spread), the potential harmful of PrEP if not adequately implemented and, especially the risk of possible side effects if not properly used. Nevertheless, 55.9% of participants believed that Health Authorities face an ethical obligation to make PrEP available as part of the strategies to protect from HIV transmission and half of the respondents asked for further researches to better define the role for PrEP. Attitudes regarding PrEP impact on Italian National Health Organization were also very interesting: 57.5% of participants did not believe that investing in PrEP would be an appropriate use of healthcare resources, while 70.6% affirmed that PrEP's financial coverage should not be funded by the Italian National System of Health (SSN). This survey showed a high awareness of PrEP potential among Italian physicians coupled with a great deal of skepticism about how and if implementing it in clinical practice.	[Di Biagio, Antonio; Riccardi, Niccolo] Osped Policlin San Martino, Dept Internal Med, Infect Dis Clin, Genoa, Italy; [Signori, Alessio] Univ Genoa, Dept Hlth Sci, Biostat, Genoa, Italy; [Maserati, Renato] Fdn IRCCS Policlin San Matteo Pavia, Malattie Infett, Pavia, Italy; [Nozza, Silvia] IRCCS San Raffaele, Dept Infect Dis, Milan, Italy; [Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Clin Infect Dis, Monza, Italy; [Bonora, Stefano] Univ Turin, Dept Med Sci, Infect Dis Unit, Turin, Italy; [Borderi, Marco] Univ Bologna, St Orsola Hosp, Infect Dis Unit, Bologna, Italy; [Ripamonti, Diego] AO Papa Giovanni XXIII, Infect Dis Unit, Bergamo, Italy; [Rossi, Maria Cristina] Osped Reg Treviso, Infect Dis Unit, Treviso, Italy; [Orofino, Giancarlo] Osped Amedeo Savoia, Infect Dis Unit, Div A, Turin, Italy; [Quirino, Tiziana] Osped Busto Arsizio, Infect Dis Unit, Varese, Italy; [Nunnari, Giuseppe] Univ Messina, Dept Clin & Expt Med, Infect Dis Unit, Messina, Italy; [Celesia, Benedetto Maurizio] Univ Catania, ARNAS Garibaldi, Dept Clin & Mol Biomed, Div Infect Dis, Catania, Italy; [Martini, Salvatore; Sagnelli, Caterina] Univ Naples 2, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy; [Mazzola, Giovanni; Colletti, Pietro] Paolo Giaccone Polyclin Univ Hosp, Dept Med Clin & Emerging Dis, Palermo, Italy; [Bartolozzi, Dario] Careggi Univ Hosp, Infect Dis Unit, Florence, Italy; [Bini, Teresa] San Paolo Hosp, Clin Infect Dis, Milan, Italy; [Ladisa, Nicoletta; Saracino, Annalisa; Lo Caputo, Sergio] Univ Bari, Inst Infect Dis, Bari, Italy; [Castelnuovo, Filippo] Spedali Civili Hosp, Infect Dis, Brescia, Italy	University of Genoa; University of Genoa; IRCCS Fondazione San Matteo; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; San Gerardo Hospital; University of Milano-Bicocca; University of Turin; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; ASST Papa Giovanni XXIII; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Ospedale di Busto Arsizio; University of Messina; University of Catania; Universita della Campania Vanvitelli; University of Palermo; Policlinico Paolo Giaccone; University of Florence; Azienda Ospedaliero Universitaria Careggi; San Paolo-Polo Universitaria Hospital; Universita degli Studi di Bari Aldo Moro; Hospital Spedali Civili Brescia	Riccardi, N (corresponding author), Osped Policlin San Martino, Dept Internal Med, Infect Dis Clin, Genoa, Italy.	niccolo.riccardi@yahoo.it	Gori, Andrea/AAC-6078-2022; Sagnelli, Caterina/AAD-4950-2022; NOZZA, SILVIA/AAC-5445-2022; Signori, Alessio/L-3081-2016; Nunnari, Giuseppe/AAC-1928-2019; Di Biagio, Antonio/J-4901-2019; Riccardi, Niccolò/ABG-7609-2020; celesia, benedetto maurizio/E-4562-2017	Sagnelli, Caterina/0000-0002-6413-7810; Signori, Alessio/0000-0001-6289-9144; Nunnari, Giuseppe/0000-0002-8113-8452; Di Biagio, Antonio/0000-0003-1436-5089; Riccardi, Niccolò/0000-0002-2947-4707; , salvatore/0000-0002-1551-1271; celesia, benedetto maurizio/0000-0002-6919-1955; Lo Caputo, Sergio/0000-0002-4729-7548				[Anonymous], 2017, NOTIZIARIO I SUPER S, V30; [Anonymous], 2014, PREEXP PROPH PREV HI; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McCormack S, LANCET; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Ouellet E, 2015, CAN J INFECT DIS MED, V26, P23, DOI 10.1155/2015/964512; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Parikh UM, 2016, CURR OPIN HIV AIDS, V11, P49, DOI 10.1097/COH.0000000000000209; Rodger A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-296; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; UNAIDS, 2014, GAP REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; Wilton J, 2015, HIV AIDS-RES PALLIAT, V7, P125, DOI 10.2147/HIV.S50025; World Health Organization, 2014, POL BRIEF CONS GUID	24	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181433	10.1371/journal.pone.0181433	http://dx.doi.org/10.1371/journal.pone.0181433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727818	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500073
J	McKee, CD; Kosoy, MY; Bai, Y; Osikowicz, LM; Franka, R; Gilbert, AT; Boonmar, S; Rupprecht, CE; Peruski, LF				McKee, Clifton D.; Kosoy, Michael Y.; Bai, Ying; Osikowicz, Lynn M.; Franka, Richard; Gilbert, Amy T.; Boonmar, Sumalee; Rupprecht, Charles E.; Peruski, Leonard F.			Diversity and phylogenetic relationships among Bartonella strains from Thai bats	PLOS ONE			English	Article							FLIES DIPTERA NYCTERIBIIDAE; MOLECULAR CHARACTERIZATION; CTENOCEPHALIDES-FELIS; GENETIC DIVERSITY; RESERVOIR HOSTS; SPP.; IDENTIFICATION; TRANSMISSION; ECTOPARASITES; STREBLIDAE	Bartonellae are phylogenetically diverse, intracellular bacteria commonly found in mammals. Previous studies have demonstrated that bats have a high prevalence and diversity of Bartonella infections globally. Isolates (n = 42) were obtained from five bat species in four provinces of Thailand and analyzed using sequences of the citrate synthase gene (gltA). Sequences clustered into seven distinct genogroups; four of these genogroups displayed similarity with Bartonella spp. sequences from other bats in Southeast Asia, Africa, and Eastern Europe. Thirty of the isolates representing these seven genogroups were further characterized by sequencing four additional loci (ftsZ, nuoG, rpoB, and ITS) to clarify their evolutionary relationships with other Bartonella species and to assess patterns of diversity among strains. Among the seven genogroups, there were differences in the number of sequence variants, ranging from 1-5, and the amount of nucleotide divergence, ranging from 0.035-3.9%. Overall, these seven genogroups meet the criteria for distinction as novel Bartonella species, with sequence divergence among genogroups ranging from 6.4-15.8%. Evidence of intra- and intercontinental phylogenetic relationships and instances of homologous recombination among Bartonella genogroups in related bat species were found in Thai bats.	[McKee, Clifton D.; Kosoy, Michael Y.; Bai, Ying; Osikowicz, Lynn M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA; [McKee, Clifton D.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Franka, Richard; Gilbert, Amy T.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Gilbert, Amy T.] APHIS, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA; [Boonmar, Sumalee] Rajapruk Univ, Fac Sci & Publ Hlth, Nonthaburi, Thailand; [Rupprecht, Charles E.] LYSSA LLC, Lawrenceville, GA USA; [Peruski, Leonard F.] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Colorado State University; Centers for Disease Control & Prevention - USA; United States Department of Agriculture (USDA); Centers for Disease Control & Prevention - USA	McKee, CD (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.; McKee, CD (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	xmm9@cdc.gov	McKee, Clifton/I-4603-2019; Rupprecht, Charles/AAI-1544-2020	McKee, Clifton/0000-0002-6149-0598; Gilbert, Amy T./0000-0002-8256-0081	US Centers for Disease Control and Prevention; US Centers for Disease Control and Prevention, Center for Global Health, Global Disease Detection Technical Support Corps funds; LYSSA LLC	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Centers for Disease Control and Prevention, Center for Global Health, Global Disease Detection Technical Support Corps funds; LYSSA LLC	This study was supported by the US Centers for Disease Control and Prevention, Center for Global Health, Global Disease Detection Technical Support Corps funds to MYK and CER. LYSSA LLC provided support in the form of salary for CER, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Ahamad M, 2013, J MED ENTOMOL, V50, P140, DOI 10.1603/ME11240; Alvarez James D.V., 2015, Check List, V11, P1509; Aroon S., 2015, International Journal of Agricultural Technology, V11, P1781; Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346; Azhar Isham, 2015, Check List, V11, P1777; Bai Y, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003478; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Bai Y, 2010, VET MICROBIOL, V146, P314, DOI 10.1016/j.vetmic.2010.05.017; BECK AJ, 1971, J MED ENTOMOL, V8, P147, DOI 10.1093/jmedent/8.2.147; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Billeter SA, 2012, PARASITOLOGY, V139, P324, DOI 10.1017/S0031182011002113; Bouhsira E, 2013, COMP IMMUNOL MICROB, V36, P105, DOI 10.1016/j.cimid.2012.10.004; Breitschwerdt EB, 2010, J VET EMERG CRIT CAR, V20, P8, DOI 10.1111/j.1476-4431.2009.00496.x; Brook CE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003532; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Buffet JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068956; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Bush SE, 2012, INT J ACAROL, V38, P1, DOI 10.1080/01647954.2011.569509; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chaloner GL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001248; Chomel BB, 2010, J APPL MICROBIOL, V109, P743, DOI 10.1111/j.1365-2672.2010.04679.x; Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996; Cicuttin GL, 2017, COMP IMMUNOL MICROB, V52, P1, DOI 10.1016/j.cimid.2017.04.004; Colborn JM, 2010, J CLIN MICROBIOL, V48, P4630, DOI 10.1128/JCM.00470-10; Concannon R, 2005, PARASITOLOGY, V131, P489, DOI 10.1017/S0031182005008097; Corpuz-Raros LA, 2015, MUSEUM PUBL NAT HIST, V4, P26; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davoust B, 2016, VECTOR-BORNE ZOONOT, V16, P516, DOI 10.1089/vbz.2015.1918; Dietrich M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152077; Domrow R., 1962, TREUBIA, V26, P1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Han HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167915; Loan HK, 2015, VECTOR-BORNE ZOONOT, V15, P40, DOI 10.1089/vbz.2014.1604; Hornok S, 2012, VET MICROBIOL, V159, P541, DOI 10.1016/j.vetmic.2012.04.003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janes JK, 2017, MOL ECOL, V38, P42; Jobling B., 1934, PARASITOLOGY; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Judson SD, 2015, ZOONOSES PUBLIC HLTH, V62, P609, DOI 10.1111/zph.12188; Kading RC, 2013, J GEN VIROL, V94, P2393, DOI 10.1099/vir.0.053983-0; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kernif T, 2014, MOL ECOL, V23, P1204, DOI 10.1111/mec.12663; Klangthong K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140856; Kosoy MY, 2010, BIOL BULL+, V37, P716, DOI 10.1134/S1062359010070071; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Kosoy MY, 2012, INT C EM INF DIS PRO, P129; La Scola B, 2003, TRENDS MICROBIOL, V11, P318, DOI 10.1016/S0966-842X(03)00143-4; Lei BNR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002738; Leulmi H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1316-9; Leulmi H, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003789; Lilley TM, 2015, VECTOR-BORNE ZOONOT, V15, P706, DOI 10.1089/vbz.2015.1783; Lilley TM, 2017, VECTOR BORNE ZOONOTI, VXX; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Lin JW, 2012, VET MICROBIOL, V156, P119, DOI 10.1016/j.vetmic.2011.09.031; Loftis AD, 2005, J MED ENTOMOL, V42, P473, DOI 10.1603/0022-2585(2005)042[0473:DORBAB]2.0.CO;2; MAA T. C., 1962, PACIFIC INSECTS, V4, P417; Maa T.C., 1974, Pacific Insects, V16, P465; Mariana A., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1125; McKee CD, 2016, INFECT GENET EVOL, V44, P382, DOI 10.1016/j.meegid.2016.07.033; Morick D, 2013, APPL ENVIRON MICROB, V79, P1258, DOI 10.1128/AEM.03011-12; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; NADCHATRAM M, 1980, J MED ENTOMOL, V17, P324, DOI 10.1093/jmedent/17.4.324; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Anh PH, 2015, EMERG INFECT DIS, V21, P1266, DOI 10.3201/eid2107.141760; Podsiadly E, 2011, VECTOR-BORNE ZOONOT, V11, P985, DOI 10.1089/vbz.2010.0080; Pritchard JK, 2000, GENETICS, V155, P945; Reeves WK, 2007, J VECTOR ECOL, V32, P118, DOI 10.3376/1081-1710(2007)32[118:AOBWTF]2.0.CO;2; Reeves WK, 2005, J VECTOR ECOL, V30, P339; Reeves WK, 2016, J MED ENTOMOL, V53, P1218, DOI 10.1093/jme/tjw078; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stuckey MJ, 2017, EMERG INFECT DIS, V23, P539, DOI 10.3201/eid2303.160934; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THEODOR O, 1973, J MED ENTOMOL, V10, P556, DOI 10.1093/jmedent/10.6.556; Traub R, 1977, P INT C FLEAS, P79; Tsai YL, 2011, COMP IMMUNOL MICROB, V34, P299, DOI 10.1016/j.cimid.2011.04.005; Uchikawa K., 1978, Contributions from the Biological Laboratory Kyoto University, V25, P249; Urushadze L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005428; Vayssier-Taussat M, 2016, EMERG INFECT DIS, V22, P457, DOI 10.3201/eid2203.150269; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Diniz PPVD, 2007, VET RES, V38, P697, DOI 10.1051/vetres:2007023; Wilkinson DA, 2016, APPL ENVIRON MICROB, V82, P1778, DOI 10.1128/AEM.03505-15; WILLIAMS JE, 1976, B WORLD HEALTH ORGAN, V53, P365; WILSON N, 1970, Oriental Insects, V4, P37; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Zade V, 2012, BIOL FORUM, V4, P35; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P3641, DOI 10.1128/JCM.40.10.3641-3647.2002	93	21	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181696	10.1371/journal.pone.0181696	http://dx.doi.org/10.1371/journal.pone.0181696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727827	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500105
J	Makondi, PT; Chu, CM; Wei, PL; Chang, YJ				Makondi, Precious Takondwa; Chu, Chi-Ming; Wei, Po-Li; Chang, Yu-Jia			Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; THYMIDYLATE-SYNTHASE; ADJUVANT TREATMENT; LIVER METASTASES; BINDING PEPTIDE; MOLECULAR-BASIS; TUMOR-CELLS; CHEMOTHERAPY; BIOMARKERS; THERAPY	Background Acquired drug resistance to the chemotherapeutic drug irinotecan (the active metabolite of which is SN-38) is one of the significant obstacles in the treatment of advanced colorectal cancer (CRC). The molecular mechanism or targets mediating irinotecan resistance are still unclear. It is urgent to find the irinotecan response biomarkers to improve CRC patients' therapy. Methods Genetic Omnibus Database GSE42387 which contained the gene expression profiles of parental and irinotecan-resistant HCT-116 cell lines was used. Differentially expressed genes (DEGs) between parental and irinotecan-resistant cells, protein-protein interactions (PPIs), gene ontologies (GOs) and pathway analysis were performed to identify the overall biological changes. The most common DEGs in the PPIs, GOs and pathways were identified and were validated clinically by their ability to predict overall survival and disease free survival. The gene-gene expression correlation and gene-resistance correlation was also evaluated in CRC patients using The Cancer Genomic Atlas data (TCGA). Results The 135 DEGs were identified of which 36 were upregulated and 99 were down regulated. After mapping the PPI networks, the GOs and the pathways, nine genes (GNAS, PRKACB, MECOM, PLA2G4C, BMP6, BDNF, DLG4, FGF2 and FGF9) were found to be commonly enriched. Signal transduction was the most significant GO and MAPK pathway was the most significant pathway. The five genes (FGF2, FGF9, PRKACB, MECOM and PLA2G4C) in the MAPK pathway were all contained in the signal transduction and the levels of those genes were upregulated. The FGF2, FGF9 and MECOM expression were highly associated with CRC patients' survival rate but not PRKACB and PLA2G4C. In addition, FGF9 was also associated with irinotecan resistance and poor disease free survival. FGF2, FGF9 and PRKACB were positively correlated with each other while MECOM correlated positively with FGF9 and PLA2G4C, and correlated negatively with FGF2 and PRKACB after doing gene-gene expression correlation. Conclusion Targeting the MAPK signal transduction pathway through the targeting of the FGF2, FGF9, MECOM, PLA2G4C and PRKACB might increase tumor responsiveness to irinotecan treatment.	[Makondi, Precious Takondwa] Taipei Med Univ, Coll Med, Int PhD Program Med, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Div Colorectal Surg, Dept Surg, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Div Colorectal Surg, Dept Surg, Taipei, Taiwan.; Wei, PL; Chang, YJ (corresponding author), Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.	poliwei@tmu.edu.tw; r5424012@tmu.edu.tw						Afzal S, 2011, PHARMACOGENOMICS, V12, P1257, DOI [10.2217/PGS.11.83, 10.2217/pgs.11.83]; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Asghar U, 2010, CLIN COLORECTAL CANC, V9, P274, DOI 10.3816/CCC.2010.n.040; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bordonaro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027308; Ciaparrone M, 2006, ONCOLOGY-BASEL, V70, P366, DOI 10.1159/000098110; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Des Guetz G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007046.pub2; Dorman SN, 2016, MOL ONCOL, V10, P85, DOI 10.1016/j.molonc.2015.07.006; Dutta P, 2013, MOL ONCOL, V7, P647, DOI 10.1016/j.molonc.2013.02.008; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Gongora C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-64; Grothey A, 2004, J CLIN ONCOL, V22, P1209, DOI 10.1200/JCO.2004.11.037; Hou AW, 2016, ONCOTARGETS THER, V9, P315, DOI 10.2147/OTT.S95831; Jang JH, 2001, CANCER RES, V61, P3541; Jensen NF, 2015, MOL ONCOL, V9, P1169, DOI 10.1016/j.molonc.2015.02.008; Jensen NF, 2012, SCAND J GASTROENTERO, V47, P340, DOI 10.3109/00365521.2012.640835; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Lavallee VP, 2015, BLOOD, V125, P140, DOI 10.1182/blood-2014-07-591529; Levina V, 2008, INT J CANCER, V123, P2031, DOI 10.1002/ijc.23732; Lurje G, 2009, MOL CANCER THER, V8, P1000, DOI 10.1158/1535-7163.MCT-08-0219; Macedo LT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-89; Maurel J, 2015, CURR CANCER DRUG TAR, V15, P703, DOI 10.2174/156800961508151001102822; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mizukami T, 2016, MOL CARCINOG; Nanashima N, 2015, BIOCHEM J, V469, P315, DOI 10.1042/BJ20150064; Nesterova MV, 2005, CLIN CANCER RES, V11, P5950, DOI 10.1158/1078-0432.CCR-05-0624; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olsen RS, 2016, ACTA ONCOL, V55, P474, DOI 10.3109/0284186X.2015.1073350; Paillas S, 2012, AUTOPHAGY, V8, P1098, DOI 10.4161/auto.20268; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Peng CJ, 2011, INT J GYNECOL CANCER, V21, P280, DOI 10.1097/IGC.0b013e31820aaadb; Perea J, 2011, REV ESP ENFERM DIG, V103, P29, DOI 10.4321/s1130-01082011000100006; Qiu H, 2011, CANCER LETT, V307, P47, DOI 10.1016/j.canlet.2011.03.015; Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross JS, 2010, AM J CLIN PATHOL, V134, P478, DOI 10.1309/AJCP2Y8KTDPOAORH; Rudolf E, 2013, MUTAT RES-FUND MOL M, V741, P27, DOI 10.1016/j.mrfmmm.2013.02.002; Ruers T, 2002, EUR J CANCER, V38, P1023, DOI 10.1016/S0959-8049(02)00059-X; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Thomaidis T, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0083-8; Van Cutsem E, 2010, ANN ONCOL, V21, pv93, DOI 10.1093/annonc/mdq222; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Venook Alan P, 2014, Am Soc Clin Oncol Educ Book, P83, DOI 10.14694/EdBook_AM.2014.34.83; Wang C, 2010, CANCER SCI, V101, P1212, DOI 10.1111/j.1349-7006.2010.01501.x; Wu XP, 2010, J CELL MOL MED, V14, P351, DOI 10.1111/j.1582-4934.2008.00506.x; Yatsula B, 2005, J BIOL CHEM, V280, P30712, DOI 10.1074/jbc.M504293200; Zlobec Inti, 2013, Expert Opin Med Diagn, V7, P137, DOI 10.1517/17530059.2013.753054; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	61	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180616	10.1371/journal.pone.0180616	http://dx.doi.org/10.1371/journal.pone.0180616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749961	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700013
J	Panpetch, W; Somboonna, N; Bulan, DE; Issara-Amphorn, J; Finkelman, M; Worasilchai, N; Chindamporn, A; Palaga, T; Tumwasorn, S; Leelahavanichkul, A				Panpetch, Wimonrat; Somboonna, Naraporn; Bulan, Dewi Embong; Issara-Amphorn, Jiraphorn; Finkelman, Malcolm; Worasilchai, Navaporn; Chindamporn, Ariya; Palaga, Tanapat; Tumwasorn, Somying; Leelahavanichkul, Asada			Oral administration of live- or heat-killed Candida albicans worsened cecal ligation and puncture sepsis in a murine model possibly due to an increased serum (1 -> 3)-beta-D-glucan	PLOS ONE			English	Article							BROAD-SPECTRUM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; NECROSIS-FACTOR-ALPHA; GASTROINTESTINAL COLONIZATION; BETA-GLUCANS; LACTOBACILLUS; CELLS; YEAST; MICE; GUT	Candida albicans is the most common fungus in the human intestinal microbiota but not in mice. To make a murine sepsis model more closely resemble human sepsis and to explore the role of intestinal C. albicans, in the absence of candidemia, in bacterial sepsis, live-or heat-killed C. albicans was orally administered to mice at 3h prior to cecal ligation and puncture (CLP). A higher mortality rate of CLP was demonstrated with Candida-administration (live-or heat-killed) prior to CLP. Fecal Candida presented only in experiments with live-Candida administration. Despite the absence of candidemia, serum (1 -> 3)-beta-D-glucan (BG) was higher in CLP with Candida-administration than CLP-controls (normal saline administration) at 6h and/or 18h post-CLP. Interestingly, flucona-zole attenuated the fecal Candida burden and improved survival in mice with live-Candida administration, but not CLP-control. Microbiota analysis revealed increased Bacteroides spp. and reduced Lactobacillus spp. in feces after Candida administration. Additionally, synergy in the elicitation of cytokine production from bone marrow-derived macrophages, in vitro, was demonstrated by co-exposure to heat-killed E. coli and BG. In conclusion, intestinal abundance of fungi and/or fungal-molecules was associated with increased bacterial sepsis-severity, perhaps through enhanced cytokine elicitation induced by synergistic responses to molecules from gut-derived bacteria and fungi. Conversely, reducing intestinal fungal burdens decreased serum BG and attenuated sepsis in our model.	[Panpetch, Wimonrat] Chulalongkorn Univ, Grad Sch, Interdisciplinary Program Med Microbiol, Bangkok, Thailand; [Panpetch, Wimonrat; Issara-Amphorn, Jiraphorn; Worasilchai, Navaporn; Chindamporn, Ariya; Tumwasorn, Somying; Leelahavanichkul, Asada] Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand; [Somboonna, Naraporn; Palaga, Tanapat] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand; [Somboonna, Naraporn] Chulalongkorn Univ, Fac Sci, Omics Sci & Bioinformat Ctr, Bangkok, Thailand; [Bulan, Dewi Embong] Mulawarman Univ, Fac Fisheries & Marine Sci, Dept Water Resources Management, Samarinda, East Kalimantan, Indonesia; [Finkelman, Malcolm] Associates Cape Cod Inc, East Falmouth, MA USA; [Leelahavanichkul, Asada] Fac Med, Ctr Excellence Immunol & Immune Mediated Dis, Dept Microbiol, Bangkok, Thailand; [Leelahavanichkul, Asada] Chulalongkorn Univ, Fac Dent, STAR Craniofacial & Skeleton Disorders, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Universitas Mulawarman; Chulalongkorn University	Tumwasorn, S; Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Dept Microbiol, Fac Med, Bangkok, Thailand.; Leelahavanichkul, A (corresponding author), Fac Med, Ctr Excellence Immunol & Immune Mediated Dis, Dept Microbiol, Bangkok, Thailand.; Leelahavanichkul, A (corresponding author), Chulalongkorn Univ, Fac Dent, STAR Craniofacial & Skeleton Disorders, Bangkok, Thailand.	Somying.T@chula.ac.th; aleelahavanit@gmail.com			Ratchadapiseksompotch Fund, Faculty of Medicine, Grant for Development of New Faculty Staff Chulalongkorn University [RA60/035]; Thailand Research fund [RSA60]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0316/2552]; Associates of Cape Cod, Inc.	Ratchadapiseksompotch Fund, Faculty of Medicine, Grant for Development of New Faculty Staff Chulalongkorn University; Thailand Research fund(Thailand Research Fund (TRF)); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Associates of Cape Cod, Inc.	This study was funded by Ratchadapiseksompotch Fund (RA60/035), Faculty of Medicine, Grant for Development of New Faculty Staff Chulalongkorn University and Thailand Research fund (RSA60). WP was supported by Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (PHD/0316/2552). BG assays were partly supported by Associates of Cape Cod, Inc. The Associates of Cape Cod, Inc., provided support in the form of salaries for authors [ME], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge KE, 2003, ANTIMICROB AGENTS CH, V47, P148, DOI 10.1128/AAC.47.1.148-153.2003; Boonyatecha N, 2012, MOL IMMUNOL, V51, P255, DOI 10.1016/j.molimm.2012.03.017; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cavaillon JM, 2005, CRIT CARE MED, V33, pS506, DOI 10.1097/01.CCM.0000185502.21012.37; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Eggimann P, 2014, INTENS CARE MED, V40, P1429, DOI 10.1007/s00134-014-3355-z; Goldstein EJC, 1996, CLIN INFECT DIS, V23, pS97, DOI 10.1093/clinids/23.Supplement_1.S97; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; HOFFMAN OA, 1993, IMMUNOL LETT, V37, P19, DOI 10.1016/0165-2478(93)90127-N; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hsu JL, 2011, CRIT REV MICROBIOL, V37, P277, DOI 10.3109/1040841X.2011.581223; HYDE SR, 1990, INFECT IMMUN, V58, P619, DOI 10.1128/IAI.58.3.619-624.1990; Jang HR, 2009, AM J PHYSIOL-RENAL, V297, pF1457, DOI 10.1152/ajprenal.90769.2008; Kikkert R, 2007, J ENDOTOXIN RES, V13, P140, DOI 10.1177/0968051907080024; KINSMAN OS, 1989, MYCOSES, V32, P664, DOI 10.1111/j.1439-0507.1989.tb02199.x; Koh AY, 2013, EUKARYOT CELL, V12, P1416, DOI 10.1128/EC.00196-13; Lai CW, 2013, J TRAUMA ACUTE CARE, V74, P203, DOI 10.1097/TA.0b013e3182788083; Leelahavanichkul A, 2016, GASTROINTESTINAL LEA; Leelahavanichkul A, FEMS MICROBIOL LETT; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Panpetch W, GASTROINTESTINAL COL; Reid G, 1999, APPL ENVIRON MICROB, V65, P3763; Ruhnke M, 2012, ANN ONCOL, V23, P823, DOI 10.1093/annonc/mdr407; SAMONIS G, 1993, ANTIMICROB AGENTS CH, V37, P51, DOI 10.1128/AAC.37.1.51; SAMONIS G, 1994, ANTIMICROB AGENTS CH, V38, P602, DOI 10.1128/AAC.38.3.602; SAMONIS G, 1994, EUR J CLIN MICROBIOL, V13, P665, DOI 10.1007/BF01973996; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seong Su Kyoung, 2010, Mycobiology, V38, P144, DOI 10.4489/MYCO.2010.38.2.144; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Somboonna N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094236; Srisawat N, 2011, CURR OPIN CRIT CARE, V17, P548, DOI 10.1097/MCC.0b013e32834cd349; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Vardakas KZ, 2009, CLIN MICROBIOL INFEC, V15, P289, DOI 10.1111/j.1469-0691.2008.02653.x; Wen K, 2012, VACCINE, V30, P1198, DOI 10.1016/j.vaccine.2011.11.107; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yamaguchi N, 2005, J NUTR, V135, P109, DOI 10.1093/jn/135.1.109; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752	39	42	42	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181439	10.1371/journal.pone.0181439	http://dx.doi.org/10.1371/journal.pone.0181439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750040	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700046
J	Rogers, PB; Driessnack, MG; Schwartz, EH				Rogers, Peter B.; Driessnack, Michelle G.; Schwartz, Elizabeth Hiltbold			Analysis of the developmental stages, kinetics, and phenotypes exhibited by myeloid cells driven by GM-CSF in vitro	PLOS ONE			English	Article							MOUSE BONE-MARROW; HEMATOPOIETIC PROGENITOR CELLS; DENDRITIC CELLS; BACTERIAL-INFECTION; BLOOD MONOCYTES; GENE-EXPRESSION; SELF-RENEWAL; STEADY-STATE; FLT3 LIGAND; C/EBP-ALPHA	The developmental progression of conventional DC has been quite well defined, yet the developmental pathway of monocyte-derived, GM-CSF-driven DC is less well understood. We addressed this issue by establishing an isolation strategy that identifies five distinct GMCSF derived cell types. Expression of Ly6C and CD115 (Csf-1R) was used to identify and isolate four populations. One of the populations could be further separated based on CD11c expression, distinguishing five populations. We further defined these cells based on expression of transcription factors and markers of early and later stages of myeloid development. These discreet developmental stages corresponded well with previously defined populations: Common Myeloid Progenitors (CMP), Granulocyte/Macrophage Progenitors (GMP), Monocytes, as well as Monocyte-derived macrophages (moMac) and Monocyte-derived DC (moDC). Finally, within the moMac population we also identified moDC precursor activity (moDP) that could be distinguished from moMac and moDC based on their level of MHC class II expression and developmental plasticity.	[Rogers, Peter B.; Driessnack, Michelle G.; Schwartz, Elizabeth Hiltbold] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University	Schwartz, EH (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	ehs0009@auburn.edu			National Institute of Allergy and Infectious Diseases [R15 AI107773]; National Institutes of Health/NIAID [R15 AI107773]; Cellular and Molecular Biosciences Program at Auburn University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI107773] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cellular and Molecular Biosciences Program at Auburn University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported National Institute of Allergy and Infectious Diseases, grant # R15 AI107773. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Ashley Landuyt for technical assistance, Alison Church Bird and the flow cytometry core facility at Auburn University for cell sorting, and Aaron Rashotte and Paul Zwack for help with PCR analysis. We are also grateful for the support of the Cellular and Molecular Biosciences Program at Auburn University for summer support of PBR. This work was supported by grant R15 AI107773 from the National Institutes of Health/NIAID to EHS.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Auffray C, 2009, J EXP MED, V206, P595, DOI 10.1084/jem.20081385; Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Chan JYH, 2001, BRIT J HAEMATOL, V112, P541, DOI 10.1046/j.1365-2141.2001.02439.x; Chopin M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00026; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hubert P, 1998, CANCER IMMUNOL IMMUN, V47, P81, DOI 10.1007/s002620050507; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Karsunky H, 2005, EXP HEMATOL, V33, P173, DOI 10.1016/j.exphem.2004.10.010; Katayama H, 2005, TRANSPL P, V37, P17, DOI 10.1016/j.transproceed.2005.02.017; King IL, 2010, J EXP MED, V207, P953, DOI 10.1084/jem.20091844; Ko HJ, 2014, J IMMUNOL, V192, P2202, DOI 10.4049/jimmunol.1302040; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Mody N, 2015, EXPERT REV CLIN IMMU, V11, P213, DOI 10.1586/1744666X.2015.987663; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Nikolic T, 2003, INT IMMUNOL, V15, P515, DOI 10.1093/intimm/dxg050; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Onai N, 2010, METHODS MOL BIOL, V595, P195, DOI 10.1007/978-1-60761-421-0_13; Pizzurro GA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00091; Polyzoidis S, 2014, BRIT J NEUROSURG, P1; Pyzer AR, 2014, HUM VACC IMMUNOTHER, V10, P3125, DOI 10.4161/21645515.2014.982993; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sere KM, 2012, EUR J CELL BIOL, V91, P515, DOI 10.1016/j.ejcb.2011.09.007; Swiggard WJ., 2001, CURR PROTOC IMMUNOL, V86, P1, DOI [DOI 10.1002/0471142735.IM0307S25, 10.1002/0471142735.im0307s25]; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Watowich SS, 2010, IMMUNOL REV, V238, P76, DOI 10.1111/j.1600-065X.2010.00949.x; Welner RS, 2013, BLOOD, V121, P4073, DOI 10.1182/blood-2012-10-463448; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang DE, 1996, CURR TOP MICROBIOL, V211, P137; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006; Zhang YY, 2000, BLOOD, V95, P138	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181985	10.1371/journal.pone.0181985	http://dx.doi.org/10.1371/journal.pone.0181985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750033	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700109
J	Kiebacher, T; Keller, C; Scheidegger, C; Bergamini, A				Kiebacher, Thomas; Keller, Christine; Scheidegger, Christoph; Bergamini, Ariel			Epiphytes in wooded pastures: Isolation matters for lichen but not for bryophyte species richness	PLOS ONE			English	Article							LOBARIA-PULMONARIA; SOLAR-RADIATION; DIVERSITY; FOREST; CONSERVATION; DISPERSAL; RARE; CONNECTIVITY; PATTERNS; ECOLOGY	Sylvo-pastoral systems are species-rich man-made landscapes that are currently often severely threatened by abandonment or management intensification. At low tree densities, single trees in these systems represent habitat islands for epiphytic cryptogams. Here, we focused on sycamore maple (Acer pseudoplatanus) wooded pastures in the northern European Alps. We assessed per tree species richness of bryophytes and lichens on 90 sycamore maple trees distributed across six study sites. We analysed the effects of a range of explanatory variables (tree characteristics, environmental variables and isolation measures) on the richness of epiphytic bryophytes and lichens and various functional subgroups (based on diaspore size, habitat preference and red list status). Furthermore, we estimated the effect of these variables on the occurrence of two specific bryophyte species (Tayloria rudolphiana, Orthotrichum rogeri) and one lichen species (Lobaria pulmonaria) of major conservation concern. Bryophytes and lichens, as well as their subgroups, were differently and sometimes contrastingly affected by the variables considered: tree diameter at breast height had no significant effect on bryophytes but negatively affected many lichen groups; tree phenological age positively affected red-listed lichens but not red-listed bryophytes; increasing isolation from neighbouring trees negatively affected lichens but not bryophytes. However, the high-priority bryophyte species T. rudolphiana was also negatively affected by increased isolation at small spatial scales. Orthotrichum rogeri was more frequent on young trees and L. pulmonaria was more frequent on trees with thin stems and large crowns. The results indicate that local dispersal is important for lichens, whereas long distance dispersal seems to be more important for colonisation by bryophytes. Furthermore, our study highlights that different conservation measures need to be taken depending on the taxonomic and functional species group or the individual species that is addressed. In practice, for the conservation of a high overall richness in sylvo-pastoral systems, it is crucial to sustain not only old and large trees but rather a wide range of tree sizes and ages.	[Kiebacher, Thomas; Keller, Christine; Scheidegger, Christoph; Bergamini, Ariel] Swiss Fed Inst Forest Snow & Landscape Res WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Canton Of Zuric, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Kiebacher, T (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Canton Of Zuric, Switzerland.	thomas.kiebacher@wsl.ch	Scheidegger, Christoph/C-6547-2011; Bergamini, Ariel/H-8420-2014	Scheidegger, Christoph/0000-0003-3713-5331; Bergamini, Ariel/0000-0001-8816-1420	Swiss Federal Office for the Environment FOEN; Naturpark Diemtigtal	Swiss Federal Office for the Environment FOEN; Naturpark Diemtigtal	The main financier of the project was the Bristol Stiftung (http://www.bristol-stiftung.ch/; no grant number available). Additional financial support was provided by the Swiss Federal Office for the Environment FOEN (https://www.bafu.admin.ch/; grant number 06.0126.PZ) and the Naturpark Diemtigtal (http://www.diemtigtal.ch/; no grant number available). The funds were allocated to the project and were used to pay expenses and the salary of TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand M, 2005, CONSERV BIOL, V19, P955, DOI 10.1111/j.1523-1739.2005.00571.x; Aragon G, 2012, SCI TOTAL ENVIRON, V426, P188, DOI 10.1016/j.scitotenv.2012.03.053; Barkman J. J., 1958, Phytosociology and ecology of cryptogamic epiphytes, including a taxonomic survey and description of their vegetation units in Europe.; BARTON K, 2015, MUMIN MULTIMODEL INF, V15, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumgartner A, 1983, WASSERHAUSHALT ALPEN; Beaufoy G, 1998, J APPL ECOL, V35, P974, DOI 10.1111/j.1365-2664.1998.tb00017.x; Bergamini A, 2005, CONSERV BIOL, V19, P1051, DOI 10.1111/j.1523-1739.2005.00086.x; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boudreault C, 2000, BRYOLOGIST, V103, P725, DOI 10.1639/0007-2745(2000)103[0725:ELABOP]2.0.CO;2; Buckley HL, 2014, PEERJ, V2, DOI 10.7717/peerj.573; Buckley HL, 2011, J VEG SCI, V22, P1062, DOI 10.1111/j.1654-1103.2011.01315.x; Budel B., 1996, LICHEN BIOL PP, P37; Burgess-Jones T C., 2013, POPULATION GENETICS; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CLAUZADE G, 1985, B SOC BOTANIQUE CTR, V7, P1; Clerc P., 2012, CATALOGUE LICHENS SU; Council of Europe, 1979, BERN CONV CONV CONS; Dal Grande F, 2012, MOL ECOL, V21, P3159, DOI 10.1111/j.1365-294X.2012.05482.x; During Heinjo J., 1992, P1; Frahm J. P, 1992, MOOSFLORA; Fritz O, 2009, BIODIVERS CONSERV, V18, P289, DOI 10.1007/s10531-008-9483-4; Fritz O, 2009, BRYOLOGIST, V112, P488, DOI 10.1639/0007-2745-112.3.488; Fritz O, 2009, APPL VEG SCI, V12, P93, DOI 10.1111/j.1654-109X.2009.01007.x; Gjerde I, 2015, ECOGRAPHY, V38, P939, DOI 10.1111/ecog.01047; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Gu WD, 2001, ECOGRAPHY, V24, P139, DOI 10.1034/j.1600-0587.2001.240204.x; GUSTAFSSON L, 1992, LICHENOLOGIST, V24, P255, DOI 10.1017/S0024282992000367; Hartel T, 2013, BIOL CONSERV, V166, P267, DOI 10.1016/j.biocon.2013.06.020; Hedenas H, 2003, J VEG SCI, V14, P233, DOI 10.1658/1100-9233(2003)014[0233:SDOEOP]2.0.CO;2; Heylen O, 2005, BIOL CONSERV, V126, P371, DOI 10.1016/j.biocon.2005.06.014; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Hofmann H, 2006, MERKBLATTER ARTENSCH; Honegger R, 2008, LICHEN BIOLOGY, 2ND EDITION, P69, DOI 10.1017/CBO9780511790478.006; Hylander K, 2005, ECOL APPL, V15, P674, DOI 10.1890/04-0570; Hylander K, 2009, ECOLOGY, V90, P160, DOI 10.1890/08-0042.1; [Игнатова Елена А. Ignatova Elena A.], 2011, [Arctoa, Arctoa], V20, P137; Jofre J, 2011, NOVA HEDWIGIA, V92, P317, DOI 10.1127/0029-5035/2011/0092-0317; Johansson V, 2012, ECOLOGY, V93, P235, DOI 10.1890/11-0760.1; Kaufmann E, 2005, SCHWEIZERISCHES LAND; Kiebacher T, 2016, BIODIVERS CONSERV, V25, P1605, DOI 10.1007/s10531-016-1144-4; Kiraly I, 2013, BIODIVERS CONSERV, V22, P209, DOI 10.1007/s10531-012-0415-y; Koponen A., 1992, BRYOBROTHERA, V1, P57; Koponen A., 1977, BRYOPHYTORUM BIBLIOT, V13, P535; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Korner-Nievergelt F, 2015, BAYESIAN DATA ANAL E; Kristinsson H, 1972, SURTSEY RES PROGR RE, V5, P77; Kumar L, 1997, INT J GEOGR INF SCI, V11, P475, DOI 10.1080/136588197242266; Lara F., 2014, FLORA BRIOFITICA IBE, P50; Lie MH, 2009, BIODIVERS CONSERV, V18, P3579, DOI 10.1007/s10531-009-9661-z; Limpricht KG., 1895, LAUBMOOSE DEUTSCHLAN; Lindenmayer DB, 2014, CONSERV LETT, V7, P61, DOI 10.1111/conl.12013; Lobel S, 2006, ECOGRAPHY, V29, P169, DOI 10.1111/j.2006.0906-7590.04348.x; Lobel S, 2009, J ECOL, V97, P176, DOI 10.1111/j.1365-2745.2008.01459.x; Loppi S, 1999, CRYPTOGAMIE MYCOL, V20, P127, DOI 10.1016/S0181-1584(99)80016-5; LOVETT GM, 1990, ATMOS ENVIRON A-GEN, V24, P2767, DOI 10.1016/0960-1686(90)90164-I; Luth M, 2010, HERZOGIA, V23, P121; Martinez K, 2011, CRYPTOGAMIE BRYOL, V32, P3, DOI 10.7872/cryb.v32.iss1.2011.003; McCune B, 2002, BRYOLOGIST, V105, P439, DOI 10.1639/0007-2745(2002)105[0439:CORELA]2.0.CO;2; Meinunger L., 2007, VERBREITUNGSATLAS MO; Michel AK, 2009, FOREST ECOL MANAG, V257, P1453, DOI 10.1016/j.foreco.2008.11.027; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Munk K, 2007, STUDIE POTENTIELLEN; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nascimbene J, 2010, ECOL INDIC, V10, P353, DOI 10.1016/j.ecolind.2009.06.013; Nascimbene J, 2009, BIODIVERS CONSERV, V18, P1509, DOI 10.1007/s10531-008-9537-7; Nebel M, 2005, MOOSE BADEN WURTTEMB, V3; Nebel M, 2000, MOOSE BADEN WURTTEMB, V1; Nebel M, 2001, MOOSE BADEN WURTTEMB, V2; Odor P, 2013, FOREST ECOL MANAG, V306, P256, DOI 10.1016/j.foreco.2013.07.001; Paltto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024675; PEARSON LC, 1969, ECOLOGY, V50, P740, DOI 10.2307/1936275; Price MF, 2013, MOUNTAIN GEOGRAPHY: PHYSICAL AND HUMAN DIMENSIONS, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rigueiro-Rodriguez A., 2009, V6, P43; Rose F., 1991, POLLARD VETERAN TREE, P28; Rose Francis, 1992, P211; Rosso AL, 2000, BRYOLOGIST, V103, P117, DOI 10.1639/0007-2745(2000)103[0117:EACOAR]2.0.CO;2; Saag L, 2009, LICHENOLOGIST, V41, P25, DOI 10.1017/S0024282909007993; Sammul M, 2008, AGR FOOD SCI, V17, P413, DOI 10.2137/145960608787235513; Scheidegger C, 2002, NATO SCI S SS IV EAR, V7, P359; SCHEIDEGGER C, 1995, LICHENOLOGIST, V27, P361, DOI 10.1017/S0024282995000478; Scheidegger C., 2002, ROTE LISTE GEFAHRDET; Scheidegger Christoph, 2009, Fungal Biology Reviews, V23, P55, DOI 10.1016/j.fbr.2009.10.003; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schnyder N., 2004, ROTE LISTE GEFAHRDET; Sillett SC, 2000, ECOL APPL, V10, P789, DOI 10.1890/1051-0761(2000)010[0789:DLOELR]2.0.CO;2; SILLETT SC, 1995, BRYOLOGIST, V98, P251, DOI 10.2307/3243312; SMITH AJE, 2004, MOSS FLORA BRITAIN I; Smith CW, 2009, LICHENS BRITAIN IREL; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Soderstrom Lars, 2002, Lindbergia, V27, P3; Soderstrom L, 2007, CRYPTOGAMIE BRYOL, V28, P299; Stofer S, 2006, LICHENOLOGIST, V38, P331, DOI 10.1017/S0024282906006207; Sundberg S, 2013, ECOGRAPHY, V36, P364, DOI 10.1111/j.1600-0587.2012.07664.x; Sundqvist MK, 2013, ANNU REV ECOL EVOL S, V44, P261, DOI 10.1146/annurev-ecolsys-110512-135750; Tan B., 2000, MOSSES LIVERWORTS HO, P77; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; Walser JC, 2001, MOL ECOL, V10, P2129, DOI 10.1046/j.1365-294X.2001.01353.x; Weddeling K, 2005, EUROPAISCHE SCHUTZGE, V1, P207; Werth S, 2006, MOL ECOL, V15, P911, DOI 10.1111/j.1365-294X.2006.02838.x; Werth S, 2006, ECOLOGY, V87, P2037, DOI 10.1890/0012-9658(2006)87[2037:QDAELI]2.0.CO;2; WIRTH V., 2013, FLECHTEN DEUTSCHLAND; Yahr R, 2004, MOL ECOL, V13, P3367, DOI 10.1111/j.1365-294X.2004.02350.x; Yang K, 2002, SOL ENERGY, V72, P177, DOI 10.1016/S0038-092X(01)00084-6; Zotz G., 2009, V70, P147, DOI 10.1007/978-3-540-68421-3_7	109	10	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0182065	10.1371/journal.pone.0182065	http://dx.doi.org/10.1371/journal.pone.0182065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742881	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000070
J	Ma, J; Yang, YJ; Luo, W; Yang, CC; Ding, PY; Liu, YX; Qiao, LY; Chang, ZJ; Geng, HW; Wang, PH; Jiang, QT; Wang, JR; Chen, GY; Wei, YM; Zheng, YL; Lan, XJ				Ma, Jian; Yang, Yujie; Luo, Wei; Yang, Congcong; Ding, Puyang; Liu, Yaxi; Qiao, Linyi; Chang, Zhijian; Geng, Hongwei; Wang, Penghao; Jiang, Qiantao; Wang, Jirui; Chen, Guoyue; Wei, Yuming; Zheng, Youliang; Lan, Xiujin			Genome-wide identification and analysis of the MADS-box gene family in bread wheat (Triticum aestivum L.)	PLOS ONE			English	Article							REPRODUCTIVE DEVELOPMENT; DRAFT GENOME; CLUSTAL-W; MIKC-TYPE; EXPRESSION; EVOLUTION; DIVERGENCE; PROTEINS	The MADS-box genes encode transcription factors with key roles in plant growth and development. A comprehensive analysis of the MADS-box gene family in bread wheat ( Triticum aestivum) has not yet been conducted, and our understanding of their roles in stress is rather limited. Here, we report the identification and characterization of the MADS-box gene family in wheat. A total of 180 MADS-box genes classified as 32 M alpha, 5 M gamma, 5 M delta, and 138 MIKC types were identified. Evolutionary analysis of the orthologs among T. urartu, Aegilops tauschii and wheat as well as homeologous sequences analysis among the three sub-genomes in wheat revealed that gene loss and chromosomal rearrangements occurred during and/or after the origin of bread wheat. Forty wheat MADS-box genes that were expressed throughout the investigated tissues and development stages were identified. The genes that were regulated in response to both abiotic stresses (i.e., phosphorus deficiency, drought, heat, and combined drought and heat) and biotic stresses (i.e., Fusarium graminearum, Septoria tritici, stripe rust and powdery mildew) were detected as well. A few notable MADS-box genes were specifically expressed in a single tissue and those showed relatively higher expression differences between the stress and control treatment. The expression patterns of considerable MADS-box genes differed from those of their orthologs in Brachypodium, rice, and Arabidopsis. Collectively, the present study provides new insights into the possible roles of MADS-box genes in response to stresses and will be valuable for further functional studies of important candidate MADS-box genes.	[Ma, Jian; Yang, Yujie; Luo, Wei; Yang, Congcong; Ding, Puyang; Liu, Yaxi; Jiang, Qiantao; Wang, Jirui; Chen, Guoyue; Wei, Yuming; Zheng, Youliang; Lan, Xiujin] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Qiao, Linyi; Chang, Zhijian] Shanxi Acad Agr Sci, Inst Crop Sci, Shanxi Key Lab Crop Genet & Mol Improvement, Taiyuan, Shanxi, Peoples R China; [Geng, Hongwei] Xinjiang Agr Univ, Coll Agron, Urumqi, Peoples R China; [Wang, Penghao] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia	Sichuan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University; Xinjiang Agricultural University; Murdoch University	Ma, J; Lan, XJ (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China.	jianma@sicau.edu.cn; lanxiujin@163.com	Ma, Jian/M-3639-2019; Jiang, Qiantao/C-6229-2017	Ma, Jian/0000-0001-6265-7911; Jiang, Qiantao/0000-0003-3192-3732; Wang, Penghao/0000-0002-3751-3921	National Natural Science Foundation of China [31601292, 31570335]; International Science and Technology Cooperation and Exchanges Program of Science and Technology Department of Sichuan Province [2017HH0076]; Applied Basic Research Programs of Science and Technology Department of Sichuan Province [2016JY0010]; National Key Research and Development Program of China [2016YFD0101000, 2016YFD0102000, 2016YFD0100100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation and Exchanges Program of Science and Technology Department of Sichuan Province; Applied Basic Research Programs of Science and Technology Department of Sichuan Province; National Key Research and Development Program of China	This work is supported by the National Natural Science Foundation of China (31601292 and 31570335), the International Science and Technology Cooperation and Exchanges Program of Science and Technology Department of Sichuan Province (2017HH0076), the Applied Basic Research Programs of Science and Technology Department of Sichuan Province (2016JY0010), and the National Key Research and Development Program of China (2016YFD0101000, 2016YFD0102000, and 2016YFD0100100).	Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; ANGENENT GC, 1995, PLANT CELL, V7, P1569, DOI 10.1105/tpc.7.10.1569; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Berkman PJ, 2013, PLANT BIOTECHNOL J, V11, P564, DOI 10.1111/pbi.12044; Borrill P, 2016, PLANT PHYSIOL, V170; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; COLOMBO L, 1995, PLANT CELL, V7, P1859, DOI 10.1105/tpc.7.11.1859; Davies B, 1994, Results Probl Cell Differ, V20, P235; De Bodt S, 2003, TRENDS PLANT SCI, V8, P475, DOI 10.1016/j.tplants.2003.09.006; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Fan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062288; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Ghosh A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0773-9; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo J, 2013, BIOL PLANTARUM, V57, P540, DOI 10.1007/s10535-012-0297-6; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuo MH, 1997, MOL CELL BIOL, V17, P819, DOI 10.1128/MCB.17.2.819; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Ma J, 2017, PLANT GROWTH REGUL, V82, P281, DOI 10.1007/s10725-017-0258-3; Ma J, 2017, GENOME, V60, P208, DOI 10.1139/gen-2016-0076; Ma J, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0313-5; Ma J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113309; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Murai K., 1998, Proceedings of the Ninth International Wheat Genetics Symposium, Saskatoon, Saskatchewan, Canada, 2-7 August 1998., P89; Oi LL, 2006, GENOME, V49, P1628, DOI 10.1139/G06-123; Paollacci AR, 2007, MOL GENET GENOMICS, V278, P689, DOI 10.1007/s00438-007-0285-2; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0692-1; Qiao LY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00770; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084781; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhao T, 2006, MOL GENET GENOMICS, V276, P334, DOI 10.1007/s00438-006-0147-3; Zhao Y, 2011, PLANT CELL TISS ORG, V105, P159, DOI 10.1007/s11240-010-9848-8	50	51	57	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181443	10.1371/journal.pone.0181443	http://dx.doi.org/10.1371/journal.pone.0181443			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742823	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000031
J	Kheitan, S; Minuchehr, Z; Soheil, ZS				Kheitan, Samira; Minuchehr, Zarrin; Soheil, Zahra-Soheila			Exploring the cross talk between ER stress and inflammation in age-related macular degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; COMPLEMENT ACTIVATION; ALPHA-SYNUCLEIN; GENE; DRUSEN; EXPRESSION; SUSCEPTIBILITY	Increasing evidence demonstrates that inflammation and endoplasmic reticulum (ER) stress is implicated in the development and progression of age-related macular degeneration (AMD), a multifactorial neurodegenerative disease. However the cross talk between these cellular mechanisms has not been clearly and fully understood. The present study investigates a possible intersection between ER stress and inflammation in AMD. In this study, we recruited two collections of involved protein markers to retrieve their interaction information from IMEx-curated databases, which are the most well-known protein-protein interaction collections, allowing us to design an intersection network for AMD that is unprecedented. In order to find expression activated subnetworks, we utilized AMD expression profiles in our network. In addition, we studied topological characteristics of the most expressed active subnetworks to identify the hubs. With regard to topological quantifications and expressional activity, we reported a list of the most pivotal hubs which are potentially applicable as probable therapeutic targets. Furthermore, we introduced MAPK signaling pathway as a significantly involved pathway in the association between ER stress and inflammation, leading to promising new directions in discovering AMD formation mechanisms and possible treatments.	[Kheitan, Samira; Minuchehr, Zarrin] Natl Inst Genet Engn & Biotechnol, Syst Biotechnol Dept, Tehran, Iran; [Soheil, Zahra-Soheila] Natl Inst Genet Engn & Biotechnol, Mol Med Dept, Tehran, Iran		Minuchehr, Z (corresponding author), Natl Inst Genet Engn & Biotechnol, Syst Biotechnol Dept, Tehran, Iran.	minuchehr@nigeb.ac.ir	Minuchehr, Zarrin/ABD-9983-2021; Soheili, Zahra-Soheila/W-8316-2018	Minuchehr, Zarrin/0000-0002-3734-745X; Soheili, Zahra-Soheila/0000-0003-1292-465X	Iran National Science Foundation (INSF) [93036935]	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This work was supported by Iran National Science Foundation (INSF) (www.insf.org) under grant number: 93036935. ZM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Iran National Science Foundation (INSF) under grant number: 93036935 and done at the Bioinformatics Lab of the National Institute of Genetic Engineering and Biotechnology.	Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6; Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Bian ZM, 2008, INVEST OPHTH VIS SCI, V49, P5593, DOI 10.1167/iovs.08-2116; Cano M, 2014, FREE RADICAL BIO MED, V69, P1, DOI 10.1016/j.freeradbiomed.2014.01.004; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DAVIS RJ, 1994, TRENDS BIOCHEM SCI, V19, P470, DOI 10.1016/0968-0004(94)90132-5; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dugel PU, 2017, OPHTHALMOLOGY; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Goverdhan SV, 2005, AGE, V1726, P1734; Grek C, 2014, ENDOPLASMIC RETICULU, V1, P4, DOI 10.2478/ersc-2013-0001; Grimm C, 2000, MOL VIS, V6, P252; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Heier JS, 2017, LANCET; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hussien Y, 2014, GLIA, V62, P680, DOI 10.1002/glia.22634; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kalariya NM, 2009, EXP EYE RES, V89, P494, DOI 10.1016/j.exer.2009.05.011; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komurasaki R, 2010, DRUG METAB PHARMACOK, V25, P84, DOI 10.2133/dmpk.25.84; Leung KW, 2009, MOL IMMUNOL, V46, P1374, DOI 10.1016/j.molimm.2008.12.001; Li Y, 2014, REDOX BIOL, V2, P485, DOI 10.1016/j.redox.2014.01.023; Libby RT, 2010, ADV EXP MED BIOL, V664, P403, DOI 10.1007/978-1-4419-1399-9_46; Lu HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087530; Marnef A, 2010, BIOCHEM SOC T, V38, P1602, DOI 10.1042/BST0381602; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Moore P, 2010, MOL BIOL CELL, V21, P1305, DOI 10.1091/mbc.E09-09-0826; Nakanishi T, 2013, J NEUROCHEM, V125, P111, DOI 10.1111/jnc.12116; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Peng YT, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0481-8; Pons M, 2011, AM J PATHOL, V178, P2665, DOI 10.1016/j.ajpath.2011.02.006; Reynolds AD, 2008, J NEUROIMMUNE PHARM, V3, P59, DOI 10.1007/s11481-008-9100-z; Ricci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066978; Diez GR, 2013, EXP EYE RES, V113, P172, DOI 10.1016/j.exer.2013.05.019; Roduit R, 2008, APOPTOSIS, V13, P343, DOI 10.1007/s10495-008-0179-8; Sakaguchi H, 2002, EXP EYE RES, V74, P547, DOI 10.1006/exer.2002.1186; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; SanGiovanni JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071239; Santiago JA, 2014, TRENDS MOL MED, V20, P694, DOI 10.1016/j.molmed.2014.10.002; Scardoni G., 2014, F1000RES, V3, P139, DOI [10.12688/f1000research.4477.1, DOI 10.12688/f1000research.4477.2]; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P300, DOI 10.1001/archopht.125.3.300; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; Schutt F, 2002, FEBS LETT, V528, P217, DOI 10.1016/S0014-5793(02)03312-4; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stahl A, 2013, ANGIOGENESIS, V16, P101, DOI 10.1007/s10456-012-9302-0; Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Uehling DE, 2015, BIOORG MED CHEM LETT, V25, P4047, DOI 10.1016/j.bmcl.2015.07.093; Watanabe Kenya, 2006, Fukushima J Med Sci, V52, P1; Weber CK, 2010, RHEUMATOLOGY, V49, P2255, DOI 10.1093/rheumatology/keq272; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yamada Y, 2008, J NEUROCHEM, V105, P1187, DOI 10.1111/j.1471-4159.2008.05211.x; Yang SQ, 2016, DRUG DES DEV THER, V10, P1857, DOI 10.2147/DDDT.S97653; Zareparsi S, 2005, HUM MOL GENET, V14, P1449, DOI 10.1093/hmg/ddi154; Zheng PZ, 1998, P NATL ACAD SCI USA, V95, P14745, DOI 10.1073/pnas.95.25.14745; Zhong Y, 2012, PLOS ONE, V7; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	78	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181667	10.1371/journal.pone.0181667	http://dx.doi.org/10.1371/journal.pone.0181667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742151	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700060
J	Ono, Y; Sakamoto, K				Ono, Yuko; Sakamoto, Kazuho			Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-kappa B signaling pathway and myoblast-derived tumor necrosis factor-alpha	PLOS ONE			English	Article							INTERLEUKIN-8 GENE-EXPRESSION; GUT BACTERIAL TRANSLOCATION; UBIQUITIN-PROTEASOME SYSTEM; SKELETAL-MUSCLE; TNF-ALPHA; INFLAMMATORY CYTOKINES; SEVERE SEPSIS; INSULIN-RESISTANCE; REGULATORY FACTORS; AUTOCRINE LOOP	Background Circulating lipopolysaccharide (LPS) concentrations are often elevated in patients with sepsis or with various endogenous diseases that are associated with metabolic endotoxemia. Involuntary loss of skeletal muscle, termed muscle wasting, is commonly observed in these conditions, suggesting that circulating LPS might play an essential role in its development. Although impairment of muscle regeneration is an important determinant of skeletal muscle wasting, it is unclear whether LPS affects this process and, if so, by what mechanism. Here, we used the C2C12 myoblast cell line to investigate the effects of LPS on myogenesis. Methods C2C12 myoblasts were grown to 80% confluence and induced to differentiate in the absence or presence of LPS (0.1 or 1 mu g/mL); TAK- 242 (1 mu M), a specific inhibitor of Tolllike receptor 4 (TLR4) signaling; and a tumor necrosis factor (TNF)- a neutralizing antibody (5 mu g/mL). Expression of a skeletal muscle differentiation marker (myosin heavy chain II), two essential myogenic regulatory factors (myogenin and MyoD), and a muscle negative regulatory factor (myostatin) was analyzed by western blotting. Nuclear factor-kappa B (NF-.B) DNA-binding activity was measured using an enzyme-linked immunosorbent assay. Results LPS dose-dependently and significantly decreased the formation of multinucleated myotubes and the expression of myosin heavy chain II, myogenin, and MyoD, and increased NF-kappa B DNA-binding activity and myostatin expression. The inhibitory effect of LPS on myogenic differentiation was reversible, suggesting that it was not caused by nonspecific toxicity. Both TAK-242 and anti-TNF-alpha reduced the LPS-induced increase in NF-kappa B DNA-binding activity, downregulation of myogenic regulatory factors, and upregulation of myostatin, thereby partially rescuing the impairment of myogenesis. Conclusions Our data suggest that LPS inhibits myogenic differentiation via a TLR4-NF-kappa B-dependent pathway and an autocrine/paracrine TNF-alpha-induced pathway. These pathways may be involved in the development of muscle wasting caused by sepsis or metabolic endotoxemia.	[Ono, Yuko; Sakamoto, Kazuho] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan; [Ono, Yuko] Fukushima Med Univ Hosp, Emergency & Crit Care Med Ctr, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Sakamoto, K (corresponding author), Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan.	kazuho@fmu.ac.jp	Ono, Yuko/Q-9426-2018	Ono, Yuko/0000-0002-5953-3042	JSPS KAKENHI [15K20349, 25460338]; Grants-in-Aid for Scientific Research [15K20349] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI grant numbers 15K20349 to YO (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-15K20349/) and 25460338 to KS (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25460338/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; Bergen HR, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0047-5; Bollinger LM, 2015, OBESITY, V23, P1185, DOI 10.1002/oby.21081; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Buijs J, 2006, CLIN MICROBIOL INFEC, V12, P1105, DOI 10.1111/j.1469-0691.2006.01503.x; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; Dehoux MJM, 2003, FEBS LETT, V544, P214, DOI 10.1016/S0014-5793(03)00505-2; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Drummond MJ, 2013, AM J PHYSIOL-REG I, V305, pR216, DOI 10.1152/ajpregu.00072.2013; Frisard MI, 2010, AM J PHYSIOL-ENDOC M, V298, pE988, DOI 10.1152/ajpendo.00307.2009; Frost RA, 2006, AM J PHYSIOL-REG I, V290, pR773, DOI 10.1152/ajpregu.00490.2005; Frost RA, 2004, AM J PHYSIOL-CELL PH, V287, pC1605, DOI 10.1152/ajpcell.00010.2004; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Garcia PS, 2010, ANESTH ANALG, V111, P707, DOI 10.1213/ANE.0b013e3181eac1c9; Ghosh S, 2015, J GERONTOL A-BIOL, V70, P232, DOI 10.1093/gerona/glu067; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Guergnon J, 2003, CELL MICROBIOL, V5, P709, DOI 10.1046/j.1462-5822.2003.00314.x; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hu JP, 2008, ENDOCRINOLOGY, V149, P5384, DOI 10.1210/en.2008-0132; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; Huerta-Yepez S, 2006, CLIN IMMUNOL, V120, P297, DOI 10.1016/j.clim.2006.03.015; Hughes DC, 2016, BIOGERONTOLOGY, V17, P619, DOI 10.1007/s10522-015-9621-9; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jiang YJ, 2014, J CLIN GASTROENTEROL, V48, P131, DOI 10.1097/01.mcg.0000436437.83015.17; John SG, 2011, CLIN J AM SOC NEPHRO, V6, P2389, DOI 10.2215/CJN.11211210; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kuno R, 2005, J NEUROIMMUNOL, V162, P89, DOI 10.1016/j.jneuroim.2005.01.015; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lang CH, 2003, SHOCK, V19, P538, DOI 10.1097/01.shk.0000055237.25446.80; Lang CH, 2001, FASEB J, V15, P1807, DOI 10.1096/fj.00-0849fje; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Layne MD, 1999, EXP CELL RES, V249, P177, DOI 10.1006/excr.1999.4465; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Li YP, 2001, FASEB J, V15, P1413, DOI 10.1096/fj.00-0632fje; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lin SY, 2016, J GASTROEN HEPATOL, V31, P890, DOI 10.1111/jgh.13159; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Marinelli C, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0458-6; Martin AI, 2012, J PHYSIOL PHARMACOL, V63, P649; Mastronarde JG, 1998, J INFECT DIS, V177, P1275, DOI 10.1086/515279; Matsuguchi T, 2000, BLOOD, V95, P1378, DOI 10.1182/blood.V95.4.1378.004k08_1378_1385; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mi L, 2012, HEPATO-GASTROENTEROL, V59, P2348, DOI 10.5754/hge11810; Miyazaki Y, 2003, INT J OBESITY, V27, P88, DOI 10.1038/sj.ijo.0802187; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Opal SM, 2013, JAMA-J AM MED ASSOC, V309, P1154, DOI 10.1001/jama.2013.2194; Pansters NAM, 2011, CELL MOL LIFE SCI, V68, P523, DOI 10.1007/s00018-010-0467-7; Passey SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146882; Podbregar M, 2013, SCI WORLD J, DOI 10.1155/2013/617170; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Sakamoto K, 2009, J PHYSIOL-LONDON, V587, P5345, DOI 10.1113/jphysiol.2009.172080; Schefold JC, 2010, J CACHEXIA SARCOPENI, V1, P147, DOI 10.1007/s13539-010-0010-6; Schmidt FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121971; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Shang K, 2015, MOL BIOL REP, V42, P1281, DOI 10.1007/s11033-015-3869-7; Shebl FM, 2012, AIDS RES HUM RETROV, V28, P809, DOI [10.1089/aid.2011.0144, 10.1089/AID.2011.0144]; Shi KH, 2014, DIGEST DIS SCI, V59, P2109, DOI 10.1007/s10620-014-3202-7; Shikama Y, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-42; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smith IJ, 2010, J CELL BIOCHEM, V111, P1059, DOI 10.1002/jcb.22796; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Szalay K, 1997, EUR J CELL BIOL, V74, P391; TACHIYAMA G, 1988, JPN J SURG, V18, P403, DOI 10.1007/BF02471464; Thomas SS, 2013, CLIN EXP NEPHROL, V17, P174, DOI 10.1007/s10157-012-0729-9; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Vassallo M, 2013, J NEUROVIROL, V19, P376, DOI 10.1007/s13365-013-0181-y; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Wang F, 2012, J HUAZHONG U SCI-MED, V32, P534, DOI 10.1007/s11596-012-0092-9; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Watanabe T, 2004, P NATL ACAD SCI USA, V101, P3563, DOI 10.1073/pnas.0400557101; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; WU S, 1993, CANCER RES, V53, P1939; Xing LY, 2005, J IMMUNOL, V174, P6195, DOI 10.4049/jimmunol.174.10.6195; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Yarasheski K E, 2002, J Nutr Health Aging, V6, P343; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	96	43	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0182040	10.1371/journal.pone.0182040	http://dx.doi.org/10.1371/journal.pone.0182040			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742154	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700094
J	Shin, HJ; Kim, TO; Oh, HJ; Park, HY; Chang, JS; Ahn, S; Kim, YI; Lim, SC; Kwon, YS				Shin, Hong-Joon; Kim, Tae-Ok; Oh, Hyung-Joo; Park, Ha-Young; Chang, Jin-Sun; Ahn, Seong; Kim, Yu-Il; Lim, Sung-Chul; Kwon, Yong-Soo			Impact of diabetes mellitus on indeterminate results of the QuantiFERON TB Gold In-Tube test: A propensity score matching analysis	PLOS ONE			English	Article							INTERFERON-GAMMA RELEASE; TUBERCULOSIS PATIENTS; ASSAYS	Background The sensitivity of interferon-gamma release assays (IGRAs) in the detection of Mycobacterium tuberculosis infection could be affected by conditions of immune dysregulation. For this reason, diabetes mellitus (DM) may increase the frequency of indeterminate results of IGRAs. However, there have been inconsistent reports of role of DM on indeterminate IGRA results. Methods We retrospectively reviewed all patients who underwent QuantiFERON-TB Gold In-Tube testing (QFT-GIT) at Chonnam National University Hospital. We collected the clinical and laboratory data of these patients. Results Of all 3,391 subjects, 1,265 (37.3%) had a positive QFT-GIT result, 266 (7.8%) had an indeterminate result, and 1,860 (54.9%) had a negative result. The mean age was 54.8 +/- 18.1 years and 55.0% of the patients were male. There were 512 (15.1%) patients with DM. Multivariable analysis revealed that systemic corticosteroid use, tuberculosis, lymphocytopenia, low serum albumin, and high serum C-reactive protein (CRP) levels were significantly associated with indeterminate QFT-GIT results. However, DM was not associated with indeterminate QFT-GIT results (adjusted odds ratio, 0.98; 95% confidence interval, 0.69-1.41; P = 0.939). After propensity score matching, DM was not associated with indeterminate results of QFT-GIT. Conclusion In this large cohort study, DM does not affect the incidence of indeterminate results of QFT-GIT.	[Shin, Hong-Joon; Kim, Tae-Ok; Oh, Hyung-Joo; Park, Ha-Young; Chang, Jin-Sun; Ahn, Seong; Kim, Yu-Il; Lim, Sung-Chul; Kwon, Yong-Soo] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea	Chonnam National University	Kwon, YS (corresponding author), Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea.	yskwon@jnu.ac.kr	Kwon, Yong-Soo/AAH-6718-2019	Kwon, Yong-Soo/0000-0001-5121-4488	National Research Foundation of Korea - Korean Government [2016R1D1A1B03931132]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This study was supported by the National Research Foundation of Korea funded by the Korean Government (Grant 2016R1D1A1B03931132). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Research Foundation of Korea funded by the Korean Government (Grant 2016R1D1A1B03931132).	Austin PC, 2011, STAT MED, V30, P1292, DOI 10.1002/sim.4200; Chee CBE, 2008, J CLIN MICROBIOL, V46, P1935, DOI 10.1128/JCM.02403-07; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Fabre V, 2014, OPEN FORUM INFECT DI, V1, DOI [10.1093/ofid/ofu046, 10.1093/ofid/ofu088]; Faurholt-Jepsen D, 2014, SCAND J INFECT DIS, V46, P384, DOI 10.3109/00365548.2014.885657; Gan SH, 2014, EUR RESPIR J, V44, P805, DOI 10.1183/09031936.00226613; Hermansen T, 2014, TUBERCULOSIS, V94, P616, DOI 10.1016/j.tube.2014.09.003; Huang CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep19972; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jeong SJ, 2011, J INFECTION, V62, P347, DOI 10.1016/j.jinf.2011.03.004; Jung HJ, 2014, RHEUMATOL INT, V34, P1711, DOI 10.1007/s00296-014-3033-z; Jung JY, 2012, J INFECTION, V64, P188, DOI 10.1016/j.jinf.2011.09.008; Kumar NP, 2014, J INFECT DIS, V210, P1670, DOI 10.1093/infdis/jiu329; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Kwon YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129792; Lange B, 2010, EUR RESPIR J, V35, P1179, DOI 10.1183/09031936.00122109; Lewinsohn DM, 2016, CLIN INFECT DIS; Pizzol D, 2016, TROP MED INT HEALTH, V21, P694, DOI 10.1111/tmi.12704; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2014, DIABETES RES CLIN PR, V106, P191, DOI 10.1016/j.diabres.2014.06.011; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Talati NJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-15; Tebruegge M, 2014, J CLIN MICROBIOL, V52, P2694, DOI 10.1128/JCM.00814-14; Walsh MC, 2011, INT J TUBERC LUNG D, V15, P179; World Health Organization, HAEM CONC DIAGN AN A; Yoon YS, 2016, THORAX	29	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181887	10.1371/journal.pone.0181887	http://dx.doi.org/10.1371/journal.pone.0181887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732078	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100068
J	Fan, CSD; Zhu, XY; Dosch, HG; von Stutterheim, C; Rupp, A				Fan, Christina Siu-Dschu; Zhu, Xingyu; Dosch, Hans Guenter; von Stutterheim, Christiane; Rupp, Andre			Language related differences of the sustained response evoked by natural speech sounds	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; EVENT-RELATED POTENTIALS; LATERAL HESCHLS GYRUS; BRAIN-STEM; PITCH; ORGANIZATION; PERCEPTION; REPRESENTATION; METAANALYSIS; INFORMATION	In tonal languages, such as Mandarin Chinese, the pitch contour of vowels discriminates lexical meaning, which is not the case in non-tonal languages such as German. Recent data provide evidence that pitch processing is influenced by language experience. However, there are still many open questions concerning the representation of such phonological and language-related differences at the level of the auditory cortex (AC). Using magnetoencephalography (MEG), we recorded transient and sustained auditory evoked fields (AEF) in native Chinese and German speakers to investigate language related phonological and semantic aspects in the processing of acoustic stimuli. AEF were elicited by spoken meaningful and meaningless syllables, by vowels, and by a French horn tone. Speech sounds were recorded from a native speaker and showed frequency-modulations according to the pitch-contours of Mandarin. The sustained field (SF) evoked by natural speech signals was significantly larger for Chinese than for German listeners. In contrast, the SF elicited by a horn tone was not significantly different between groups. Furthermore, the SF of Chinese subjects was larger when evoked by meaningful syllables compared to meaningless ones, but there was no significant difference regarding whether vowels were part of the Chinese phonological system or not. Moreover, the N100m gave subtle but clear evidence that for Chinese listeners other factors than purely physical properties play a role in processing meaningful signals. These findings show that the N100 and the SF generated in Heschl's gyrus are influenced by language experience, which suggests that AC activity related to specific pitch contours of vowels is influenced in a top-down fashion by higher, language related areas. Such interactions are in line with anatomical findings and neuroimaging data, as well as with the dual-stream model of language of Hickok and Poeppel that highlights the close and reciprocal interaction between superior temporal gyrus and sulcus.	[Fan, Christina Siu-Dschu; Dosch, Hans Guenter] Inst Theoret Phys, Heidelberg, Germany; [Fan, Christina Siu-Dschu] Storz Med AG, Tagerwilen, Switzerland; [Zhu, Xingyu; von Stutterheim, Christiane] Heidelberg Univ, Dept Gen & Appl Linguist, Heidelberg, Germany; [Rupp, Andre] Heidelberg Univ, Dept Neurol, Sect Biomagnetism, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Rupp, A (corresponding author), Heidelberg Univ, Dept Neurol, Sect Biomagnetism, Heidelberg, Germany.	andre.rupp@uni-heidelberg.de			Innovationfond FRONTIER of the Excellence Initiative of the University of Heidelberg [ZUK 49/1 TP 1-19]	Innovationfond FRONTIER of the Excellence Initiative of the University of Heidelberg	This study was supported by the grant ZUK 49/1 TP 1-19 of the Innovationfond FRONTIER of the Excellence Initiative of the University of Heidelberg (https.//www.uni.heidelberg.de/ exzellenzinitiative/zukunftskonzept/frontier_de.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author CF is employed by Storz Medical AG, Switzerland. The funder only provided support in the form of salaries for author CF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	ABRAMSON AS, 1978, LANG SPEECH, V21, P319, DOI 10.1177/002383097802100406; Adank P, 2012, NEUROIMAGE, V63, P1601, DOI 10.1016/j.neuroimage.2012.07.027; Andermann M, 2011, NEUROIMAGE, P1; Ash R, 2012, AUDACITY COMPUTER PR; Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Bidelman GM, 2015, NEUROIMAGE, V120, P191, DOI 10.1016/j.neuroimage.2015.06.087; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; BODDY J, 1986, PSYCHOPHYSIOLOGY, V23, P232, DOI 10.1111/j.1469-8986.1986.tb00624.x; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; CHAN YYF, 1974, PERCEPTUAL STUDY TON; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chechik G, 2012, P NATL ACAD SCI USA, V109, P18968, DOI 10.1073/pnas.1111242109; Diesch E, 1996, BRAIN LANG, V53, P143, DOI 10.1006/brln.1996.0042; Garagnani M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.010.2009; Gockel HE, 2011, JARO-J ASSOC RES OTO, V12, P767, DOI 10.1007/s10162-011-0284-1; Goto M., 2003, P 4 INT C MUS INF RE, P229; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2010, CURR BIOL, V20, P1128, DOI 10.1016/j.cub.2010.04.044; Gutschalk A, 2004, NEUROIMAGE, V22, P755, DOI 10.1016/j.neuroimage.2004.01.025; Gutschalk A, 2002, NEUROIMAGE, V15, P207, DOI 10.1006/nimg.2001.0949; Gutschalk A, 2011, NEUROIMAGE, V56, P1578, DOI 10.1016/j.neuroimage.2011.02.026; Gutschalk A, 2010, J NEUROPHYSIOL, V103, P2015, DOI 10.1152/jn.01005.2009; Hackett Troy A, 2015, Handb Clin Neurol, V129, P27, DOI 10.1016/B978-0-444-62630-1.00002-0; Hackett TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00072; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Helenius P, 2002, J NEUROSCI, V22, P2936, DOI 10.1523/JNEUROSCI.22-07-02936.2002; Hewson-Stoate N, 2006, EUR J NEUROSCI, V24, P2661, DOI 10.1111/j.1460-9568.2006.05096.x; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jao T, 2009, IEEE ENG MED BIO, P4779, DOI 10.1109/IEMBS.2009.5334211; Kanwal JS, 2011, AUDITORY CORTEX, P343, DOI 10.1007/978-1-4419-0074-6_16; Krishnan A, 2017, BRAIN LANG, V169, P22, DOI 10.1016/j.bandl.2017.01.014; Krishnan A, 2010, J NEUROLINGUIST, V23, P81, DOI 10.1016/j.jneuroling.2009.09.001; Krishnan A, 2009, NEUROREPORT, V20, P408, DOI 10.1097/WNR.0b013e3283263000; Krumbholz K, 2003, CEREB CORTEX, V13, P765, DOI 10.1093/cercor/13.7.765; Kujala A, 2004, COGNITIVE BRAIN RES, V21, P106, DOI 10.1016/j.cogbrainres.2004.05.011; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1982, NEUROPSYCHOLOGIA, V20, P579, DOI 10.1016/0028-3932(82)90031-8; KUTAS M, 1988, ELECTROEN CLIN NEURO, V69, P218, DOI 10.1016/0013-4694(88)90131-9; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Liebenthal E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00289; MacGregor LJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1715; Makela AM, 2001, NEUROREPORT, V12, P249; Malmierca MS, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00019; Manca AD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01413; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Meyer M, 2008, Z NEUROPSYCHOL, V19, P101, DOI 10.1024/1016-264X.19.2.101; Nelken I, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00106; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PICTON TW, 1978, ELECTROEN CLIN NEURO, V45, P186, DOI 10.1016/0013-4694(78)90003-2; Plack C.J., 2005, PITCH NEURAL CODING, DOI [10.1007/0-387-28958-5, DOI 10.1007/0-387-28958-5]; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; Schirmer A, 2012, NEUROIMAGE, V63, P137, DOI 10.1016/j.neuroimage.2012.06.025; Schneider P, 2005, NAT NEUROSCI, V8, P1241, DOI 10.1038/nn1530; Schonwiesner M, 2008, EXP BRAIN RES, V187, P97, DOI 10.1007/s00221-008-1286-z; Sieroka N, 2003, NEUROIMAGE, V20, P1697, DOI 10.1016/S1053-8119(03)00445-2; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Song JH, 2008, J COGNITIVE NEUROSCI, V20, P1892, DOI 10.1162/jocn.2008.20131; Stebbings KA, 2014, HEARING RES, V314, P51, DOI 10.1016/j.heares.2014.05.004; Swaminathan J, 2008, NEUROREPORT, V19, P1163, DOI 10.1097/WNR.0b013e3283088d31; Tang YC, 2010, NEUROIMAGE, V51, P33, DOI 10.1016/j.neuroimage.2010.01.111; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Turkeltaub PE, 2010, BRAIN LANG, V114, P1, DOI 10.1016/j.bandl.2010.03.008; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Wang X., 2013, CLOUD MANUFACTURING, V2013, P1, DOI DOI 10.1155/2013/569161.ARTICLE; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WOLLBERG Z, 1972, SCIENCE, V175, P212, DOI 10.1126/science.175.4018.212; Yrttiaho S, 2008, J ACOUST SOC AM, V123, P2191, DOI 10.1121/1.2888489	72	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180441	10.1371/journal.pone.0180441	http://dx.doi.org/10.1371/journal.pone.0180441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727776	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500022
J	Lorenzo, MM; Sanchez-Puig, JM; Blasco, R				Lorenzo, Maria M.; Sanchez-Puig, Juana M.; Blasco, Rafael			Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; INDUCED RESISTANCE; INFLUENZA-VIRUS; MONKEYPOX VIRUS; HIV-1 INFECTION; INHIBITION; GENE; RESCUE; IDENTIFICATION; GLYCOPROTEIN	MxA protein is expressed in response to type I and type III Interferon and constitute an important antiviral factor with broad antiviral activity to diverse RNA viruses. In addition, some studies expand the range of MxA antiviral activity to include particular DNA viruses like Monkeypox virus (MPXV) and African Swine Fever virus (ASFV). However, a broad profile of activity of MxA to large DNA viruses has not been established to date. Here, we investigated if some well characterized DNA viruses belonging to the Poxviridae family are sensitive to human MxA. A cell line inducibly expressing MxA to inhibitory levels showed no anti-Vaccinia virus (VACV) virus activity, indicating either lack of susceptibility of the virus, or the existence of viral factors capable of counteracting MxA inhibition. To determine if VACV resistance to MxA was due to a virus-encoded anti-MxA activity, we performed coinfections of VACV and the MxA-sensitive Vesicular Stomatitis virus (VSV), and show that VACV does not protect VSV from MxA inhibition in trans. Those results were extended to several VACV strains and two CPXV strains, thus confirming that those Orthopoxviruses do not block MxA action. Overall, these results point to a lack of susceptibility of the Poxviridae to MxA antiviral activity.	[Lorenzo, Maria M.; Sanchez-Puig, Juana M.; Blasco, Rafael] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Blasco, R (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotecnol, Madrid, Spain.	blasco@inia.es	Lorenzo, Maria M./ABH-4437-2020; Blasco, Rafael/B-5829-2016; Eyré, Juana Sánchez-Puig/ABF-8080-2020	Sanchez-Puig Eyre, Juana/0000-0002-3966-3499; Lorenzo, Maria M./0000-0001-7588-673X; Blasco, Rafael/0000-0002-8819-5767	Ministerio de Economia y Competitividad, Plan Estatal de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica [RTA2013-00021-00, E-RTA2014-00006]	Ministerio de Economia y Competitividad, Plan Estatal de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica	This work was supported by grants RTA2013-00021-00 and E-RTA2014-00006 from Ministerio de Economia y Competitividad, Plan Estatal de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica (http://ww.idi.mineco. gob.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Americo JL, 2014, VIROLOGY, V449, P120, DOI 10.1016/j.virol.2013.11.017; Americo JL, 2010, J VIROL, V84, P8172, DOI 10.1128/JVI.00621-10; Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Arndt WD, 2015, J VIROL, V89, P10489, DOI 10.1128/JVI.00304-15; Arsenio J, 2008, VIROLOGY, V377, P124, DOI 10.1016/j.virol.2008.04.014; Beier KT, 2011, P NATL ACAD SCI USA, V108, P15414, DOI 10.1073/pnas.1110854108; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; BLASCO R, 1991, J VIROL, V65, P5910, DOI 10.1128/JVI.65.11.5910-5920.1991; Busnadiego I, 2014, J VIROL, V88, P7738, DOI 10.1128/JVI.00214-14; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cotter CA, 2017, CURR PROTOC MOL BIOL, V117, P1; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; FRESE M, 1995, J VIROL, V69, P3904, DOI 10.1128/JVI.69.6.3904-3909.1995; Frese M, 1996, J VIROL, V70, P915, DOI 10.1128/JVI.70.2.915-923.1996; Fricke T, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0068-x; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Johnston SC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-5; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Lai F, 2008, J VIROL METHODS, V153, P276, DOI 10.1016/j.jviromet.2008.07.001; Landis H, 1998, J VIROL, V72, P1516, DOI 10.1128/JVI.72.2.1516-1522.1998; Maarifi G, 2016, J VIROL, V90, P6598, DOI 10.1128/JVI.00722-16; Moss B, 2015, VIROLOGY, V479, P619, DOI 10.1016/j.virol.2015.02.003; Netherton CL, 2009, J VIROL, V83, P2310, DOI 10.1128/JVI.00781-08; Nurnberger C, 2016, J VIROL, V90, P10682, DOI 10.1128/JVI.01213-16; PAVLOVIC J, 1990, J VIROL, V64, P3370, DOI 10.1128/JVI.64.7.3370-3375.1990; Sanchez-Puig JM, 2005, BIOTECHNIQUES, V39, P665, DOI 10.2144/000112012; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Sanchez-Puig Juana M, 2012, Methods Mol Biol, V890, P93, DOI 10.1007/978-1-61779-876-4_5; Shors ST, 1998, J INTERF CYTOK RES, V18, P721, DOI 10.1089/jir.1998.18.721; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; STAEHELI P, 1991, J VIROL, V65, P4498, DOI 10.1128/JVI.65.8.4498-4501.1991; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; THACORE HR, 1973, VIROLOGY, V56, P512, DOI 10.1016/0042-6822(73)90054-8; Verhelst J, 2013, MICROBIOL MOL BIOL R, V77, P551, DOI 10.1128/MMBR.00024-13; WHITAKERDOWLING P, 1983, VIROLOGY, V131, P128, DOI 10.1016/0042-6822(83)90539-1; YOUNGNER JS, 1972, J VIROL, V10, P171, DOI 10.1128/JVI.10.2.171-178.1972	43	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181459	10.1371/journal.pone.0181459	http://dx.doi.org/10.1371/journal.pone.0181459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727764	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500076
J	Miller, LC; Fleming, DS; Li, XD; Bayles, DO; Blecha, F; Sang, YM				Miller, Laura C.; Fleming, Damarius S.; Li, Xiangdong; Bayles, Darrell O.; Blecha, Frank; Sang, Yongming			Comparative analysis of signature genes in PRRSV-infected porcine monocyte-derived cells to different stimuli	PLOS ONE			English	Article							PROTEOGLYCANS; MACROPHAGES; PATHOGENESIS; ACTIVATION; EXPRESSION; AUTOPHAGY; DECORIN; PAMPS; DAMPS	Monocyte-derived DCs (mDCs) are major target cells in porcine reproductive and respiratory syndrome virus (PRRSV) pathogenesis; however, the plasticity of mDCs in response to activation stimuli and PRRSV infection remains unstudied. In this study, we polarized mDCs, and applied genome-wide transcriptomic analysis and predicted protein-protein interaction networks to compare signature genes involved in mDCs activation and response to PRRSV infection. Porcine mDCs were polarized with mediators for 30 hours, then mock-infected, infected with PRRSV strain VR2332, or a highly pathogenic PRRSV strain (rJXwn06), for 5 h. Total RNA was extracted and used to construct sequencing libraries for RNA-Seq. Comparisons were made between each polarized and unpolarized group (i.e. mediator vs. PBS), and between PRRSV-infected and uninfected cells stimulated with the same mediator. Differentially expressed genes (DEG) from the comparisons were used for prediction of interaction networks affected by the viruses and mediators. The results showed that PRRSV infection inhibited M1-prone immune activity, downregulated genes, predicted network interactions related to cellular integrity, and inflammatory signaling in favor of M2 activity. Additionally, the number of DEG and predicted network interactions stimulated in HP-PRRSV infected mDCs was superior to the VR-2332 infected mDCs and conformed with HP-PRRSV pathogenicity.	[Miller, Laura C.; Fleming, Damarius S.] USDA ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, 1920 Dayton Ave, Ames, IA 50010 USA; [Li, Xiangdong] Natl Res Ctr Vet Med, Cuiwei Rd, Luoyang, Henan, Peoples R China; [Bayles, Darrell O.] USDA ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, 1920 Dayton Ave, Ames, IA USA; [Blecha, Frank; Sang, Yongming] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Sang, Yongming] Tennessee State Univ, Coll Agr Human & Nat Sci, Dept Agr & Environm Sci, 3500 John A Merritt Blvd, Nashville, TN 37203 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Kansas State University; Tennessee State University	Miller, LC (corresponding author), USDA ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, 1920 Dayton Ave, Ames, IA 50010 USA.; Sang, YM (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA.; Sang, YM (corresponding author), Tennessee State Univ, Coll Agr Human & Nat Sci, Dept Agr & Environm Sci, 3500 John A Merritt Blvd, Nashville, TN 37203 USA.	laura.miller@ars.usda.gov; ysang@tnstate.edu	Miller, Laura/B-2268-2017; li, xiangdong/T-6019-2017	Miller, Laura/0000-0002-8946-9416; li, xiangdong/0000-0002-4635-1602	United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative [2013-67015-21236, 2015-67015-23216]; DOE [DE-AC05-060R23100]; USDA NIFA AFRI [2013-67015-21236, 2015-67015-23216]	United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE)); USDA NIFA AFRI(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative 2013-67015-21236, https.//nifa. usda.gov/; United States Department of Agriculture National Institute of Food and Agriculture Agriculture and Food Research Initiative 2015-67015-23216, https://nifa.usda.gov/. Damarius Fleming's appointment to the Agricultural Research Service Research Participation Program was administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the US Department of Energy (DOE) and the US Department of Agriculture. 0 RISE is managed by Oak Ridge Associated Universities under DOE contract no. DE-AC05-060R23100, https://orrise.orau.gov/about-orise/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was mainly supported by the USDA NIFA AFRI 2013-67015-21236, and in part by USDA NIFA AFRI 2015-67015-23216. We would like to thank Barbara Lutjemeier, Qinfang Liu, and Sarah Anderson for their excellent technical support, and Sue Ohlendorf for secretarial assistance in preparation of the manuscript.	Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; DAVID JR, 1975, ACTA ENDOCRINOL-COP, V78, P245; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Garcia-Nicolas O, 2014, VIRUS RES, V179, P204, DOI 10.1016/j.virusres.2013.08.009; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Koltes JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1635-9; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; LAGER KM, 1995, CAN J VET RES, V59, P187; Liu XD, 2011, J IMMUNOL, V186, P3031, DOI 10.4049/jimmunol.0902687; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Moller ASW, 2005, CYTOKINE, V32, P304, DOI 10.1016/j.cyto.2005.11.008; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; OLDBERG A, 1990, BIOCHEM SOC T, V18, P789, DOI 10.1042/bst0180789; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sang Y, 2015, J CLIN CELL IMMUNOL, V6; Sang YM, 2014, J VIROL, V88, P11395, DOI 10.1128/JVI.01714-14; Sang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087613; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; YANAGISHITA M, 1993, ACTA PATHOL JAPON, V43, P283; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhao JH, 2016, ANTIVIR RES, V132, P268, DOI 10.1016/j.antiviral.2016.07.001	38	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181256	10.1371/journal.pone.0181256	http://dx.doi.org/10.1371/journal.pone.0181256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727780	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500051
J	Pascual, T; Apellaniz-Ruiz, M; Pernaut, C; Cueto-Felgueroso, C; Villalba, P; Alvarez, C; Manso, L; Inglada-Perez, L; Robledo, M; Rodriguez-Antona, C; Ciruelos, E				Pascual, Tomas; Apellaniz-Ruiz, Maria; Pernaut, Cristina; Cueto-Felgueroso, Cecilia; Villalba, Pablo; Alvarez, Carlos; Manso, Luis; Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina; Ciruelos, Eva			Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PLUS EXEMESTANE; CALCINEURIN-INHIBITORS; MTOR INHIBITORS; THERAPY; RESISTANCE; PATHWAY; TRANSPLANTATION; PROGRESSION; BOLERO-2	Purpose Metastatic breast cancer (MBC) progressing after endocrine therapy frequently activates PI3K/AKT/mTOR pathway. The BOLERO-2 trial showed that everolimus-exemestane achieves increased progression free survival (PFS) compared with exemestane. However, there is great inter-patient variability in toxicity and response to exemestane-everolimus treatment. The objective of this study was to perform an exploratory study analyzing the implication of single nucleotide polymorphisms (SNPs) on outcomes from this treatment through a pharmacogenetic analysis. Patients and methods Blood was collected from 90 postmenopausal women with hormone receptor-positive, HER2-negative MBC treated with exemestane-everolimus following progression after prior treatment with a non-steroidal aromatase inhibitor. Everolimus pharmacokinetics was measured in 37 patients. Twelve SNPs in genes involved in everolimus pharmacokinetics and pharmacodynamics were genotyped and associations assessed with drug plasma levels, clinically relevant toxicities (non-infectious pneumonitis, mucositis, hyperglycemia and hematological toxicities), dose reductions or treatment suspensions due to toxicity, progression free survival (PFS) and overall survival. Results We found that CYP3A4 rs35599367 variant (CYP3A4*22 allele) carriers had higher everolimus blood concentration compared to wild type patients (P = 0.019). ABCB1 rs1045642 was associated with risk of mucositis (P = 0.031), while PIK3R1 rs10515074 and RAPTOR rs9906827 were associated with hyperglycemia and non-infectious pneumonitis (P = 0.016 and 0.024, respectively). Furthermore, RAPTOR rs9906827 was associated with PFS (P = 0.006). Conclusions CYP3A4*22 allele influenced plasma concentration of everolimus and several SNPs in PI3K/AKT/mTOR pathway genes were associated with treatment toxicities and prognosis. These results require replication, but suggest that germline variation could influence everolimus outcomes in MBC.	[Pascual, Tomas; Pernaut, Cristina; Ciruelos, Eva] 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain; [Apellaniz-Ruiz, Maria; Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, Human Canc Genet Programme, Madrid, Spain; [Cueto-Felgueroso, Cecilia; Villalba, Pablo; Alvarez, Carlos; Manso, Luis] 12 Octubre Univ Hosp, Dept Biochem, Madrid, Spain; [Inglada-Perez, Lucia; Robledo, Mercedes; Rodriguez-Antona, Cristina] CIBERER, Madrid, Spain; [Pascual, Tomas] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain	Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona	Ciruelos, E (corresponding author), 12 Octubre Univ Hosp, Dept Med Oncol, Madrid, Spain.	eva.ciruelos@gmail.com	Rodriguez-Antona, Cristina/E-1073-2011; Apellaniz-Ruiz, Maria/AAO-9961-2020; Pascual, Tomas/AAH-8993-2019; Robledo, Mercedes/O-2230-2013; Inglada-Perez, Lucia/Z-3020-2019; Apellaniz-Ruiz, Maria/L-7634-2019; manso, luis/AGZ-6467-2022	Rodriguez-Antona, Cristina/0000-0001-8750-7338; Apellaniz-Ruiz, Maria/0000-0002-2137-1439; Pascual, Tomas/0000-0001-8431-3183; Robledo, Mercedes/0000-0001-6256-5902; manso, luis/0000-0002-1683-550X	Mutua Madrilena [2012/0088]; Spanish Ministry of Economy and Competiveness [SAF2012-35779]	Mutua Madrilena; Spanish Ministry of Economy and Competiveness(Spanish Government)	This work was supported by projects from Mutua Madrilena (project number 2012/0088, Principal Investigator: Dr E. Ciruelos) and the Spanish Ministry of Economy and Competiveness (grant number SAF2012-35779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Beck JT, 2014, BREAST CANCER RES TR, V143, P459, DOI 10.1007/s10549-013-2814-5; Beeram M, 2007, ANN ONCOL, V18, P1323, DOI 10.1093/annonc/mdm170; Bellister SA, 2013, J CLIN ONCOL, V31, DOI 10.1200/jco.2013.31.4_suppl.163; Cardoso F, 2016, ANN ONCOL; Chen M, 2010, CARCINOGENESIS, V31, P1387, DOI 10.1093/carcin/bgq110; Chen QR, 2010, J PROTEOME RES, V9, P373, DOI 10.1021/pr900701v; Ciruelos E, 2013, ANTI-CANCER DRUG, V24, P769, DOI 10.1097/CAD.0b013e328363adc5; Dai D, 2001, PHARMACOGENETICS, V11, P597, DOI 10.1097/00008571-200110000-00006; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Gabriella Jerusalem GM, 2014, CANC RES S, V75, P5; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hortobagyi G. N., 2015, J CLIN ONCOL; Hronova K, 2014, EXPERT REV CLIN PHAR, V7, P821, DOI 10.1586/17512433.2014.966811; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Jerusalem G, 2016, ANN ONCOL, V27, P1719, DOI 10.1093/annonc/mdw249; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kirchner GI, 2004, CLIN PHARMACOKINET, V43, P83, DOI 10.2165/00003088-200443020-00002; Kniepeiss D, 2011, CLIN TRANSPLANT, V25, P146, DOI 10.1111/j.1399-0012.2009.01198.x; Knops N, 2013, INT J PHARMACEUT, V452, P14, DOI 10.1016/j.ijpharm.2013.05.033; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lemaitre F, 2012, THER DRUG MONIT, V34, P686, DOI 10.1097/FTD.0b013e318273c899; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Margariti N, 2011, BREAST CANCER RES TR, V128, P599, DOI 10.1007/s10549-010-0986-9; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Moes DJAR, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2013.78; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Schoeppler KE, 2014, CLIN TRANSPLANT, V28, P590, DOI 10.1111/ctr.12350; Serra S, 2012, CANCER RES, V72, P5683, DOI 10.1158/0008-5472.CAN-12-2102; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Staatz CE, 2010, CLIN PHARMACOKINET, V49, P207, DOI 10.2165/11317550-000000000-00000; Tryfonidis K, 2016, CANCER TREAT REV, V50, P68, DOI 10.1016/j.ctrv.2016.08.008; Vicier C, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3618; Villarreal-Garza C, 2012, ANN ONCOL, V23, P2526, DOI 10.1093/annonc/mds075; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yardley DA, 2013, ADV THER, V30, P870, DOI 10.1007/s12325-013-0060-1	40	23	23	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180192	10.1371/journal.pone.0180192	http://dx.doi.org/10.1371/journal.pone.0180192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727815	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500018
J	Blaszczyk, AJ; Wang, B; Silakov, A; Ho, JV; Booker, SJ				Blaszczyk, Anthony J.; Wang, Bo; Silakov, Alexey; Ho, Jackson V.; Booker, Squire J.			Efficient methylation of C2 in L-tryptophan by the cobalamin-dependent radical S-adenosylmethionine methylase TsrM requires an unmodified N1 amine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATECHOL O-METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; SAM ENZYME; THIOPEPTIDE ANTIBIOTICS; IRON-SULFUR; BIOSYNTHESIS; THIOSTREPTON; CATALYSIS; SYNTHASE; NUCLEOPHILICITY	TsrM catalyzes the methylation of C2 in L-tryptophan (Trp). This reaction is the first step in the biosynthesis of the quinaldic acid moiety of the thiopeptide antibiotic thiostrepton, which exhibits potent activity against Gram-positive pathogens. TsrM is a member of the radical S-adenosylmethionine (SAM) superfamily of enzymes, but it does not catalyze the formation of 5' -deoxyadenosin-5' -yl or any other SAM-derived radical. In addition to a [4Fe-4S] cluster, TsrM contains a cobalamin cofactor that serves as an intermediate methyl carrier in its reaction. However, how this cofactor donates a methyl moiety to the Trp substrate is unknown. Here, we showed that the unmodified N1 position of Trp is important for turnover and that 1-thia-Trp and 1-oxa-Trp serve as competitive inhibitors. We also showed that beta-cyclopropyl-Trp undergoes C2 methylation in the absence of cyclopropyl ring opening, disfavoring mechanisms that involve unpaired electron density at C3 of the indole ring. Moreover, we showed that all other indole-substituted analogs of Trp undergo methylation at varying but measurable rates and that the analog 7-aza-Trp, which is expected to temper the nucleophilicity of C2 in Trp, is a very poor substrate. Last, no formation of cob(II) alamin or substrate radicals was observed during the reaction with Trp or any molecule within a tested panel of Trp analogs. In summary, our results are most consistent with a mechanism that involves two polar nucleophilic displacements, the second of which requires deprotonation of the indole nitrogen in Trp during its attack on methylcobalamin.	[Blaszczyk, Anthony J.; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Wang, Bo; Silakov, Alexey; Ho, Jackson V.; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Booker, Squire J.] Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Booker, SJ (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.	squire@psu.edu	Silakov, Alexey/D-6318-2018	Silakov, Alexey/0000-0002-9285-1253; Ho, Jackson/0000-0002-6195-1235	National Institutes of Health [GM-103268, GM-101957, GM-122595, AI-111419]; Penn State Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122595, R01GM101957, R01GM103268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM-103268, GM-101957, GM-122595, and AI-111419 and by Penn State Funds for Undergraduate Research (to J. V. H.).	Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Bandarian V, 2004, METHOD ENZYMOL, V380, P152; Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Bauerle MR, 2015, J BIOL CHEM, V290, P3995, DOI 10.1074/jbc.R114.607044; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Benjdia A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9377; Bhandari DM, 2015, BIOCHEMISTRY-US, V54, P4767, DOI 10.1021/acs.biochem.5b00764; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Bridwell-Rabb J, 2017, NATURE, V544, P322, DOI 10.1038/nature21689; Chamorro E, 2016, THEOR CHEM ACC, V135, DOI 10.1007/s00214-016-1974-x; Dunn MF, 2008, TRENDS BIOCHEM SCI, V33, P254, DOI 10.1016/j.tibs.2008.04.008; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2003, CHEM REV, V103, P2129, DOI 10.1021/cr020422m; Frisch M. J., 2004, REVISION E 01; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Hughes RA, 2007, ANGEW CHEM INT EDIT, V46, P7930, DOI 10.1002/anie.200700728; Ilu W, 2010, ORG LETT, V12, P956; Iwig DF, 2004, BIOCHEMISTRY-US, V43, P13496, DOI 10.1021/bi048693+; Ji XJ, 2015, ANGEW CHEM INT EDIT, V54, P9021, DOI 10.1002/anie.201503976; Joule J.A., 2010, HETEROCYCLIC CHEM, P373; Just-Baringo X, 2014, ANGEW CHEM INT EDIT, V53, P6602, DOI 10.1002/anie.201307288; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lakhdar S, 2006, J ORG CHEM, V71, P9088, DOI 10.1021/jo0614339; Lanz ND, 2012, METHOD ENZYMOL, V516, P125, DOI 10.1016/B978-0-12-394291-3.00030-7; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li CX, 2010, NAT PROD REP, V27, P153, DOI 10.1039/b922434c; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Limbach M, 2005, EUR J ORG CHEM, V2005, P610, DOI 10.1002/ejoc.200400617; LOTT WB, 1995, J AM CHEM SOC, V117, P12194, DOI 10.1021/ja00154a020; Marous DR, 2015, P NATL ACAD SCI USA, V112, P10354, DOI 10.1073/pnas.1508615112; MARTIN BD, 1992, J AM CHEM SOC, V114, P585, DOI 10.1021/ja00028a027; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Parent A, 2016, J AM CHEM SOC, V138, P15515, DOI 10.1021/jacs.6b06697; Phillips RS, 2004, TETRAHEDRON-ASYMMETR, V15, P2787, DOI 10.1016/j.tetasy.2004.06.054; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Podea PV, 2008, TETRAHEDRON-ASYMMETR, V19, P500, DOI 10.1016/j.tetasy.2008.01.031; Rassolov VA, 2001, J COMPUT CHEM, V22, P976, DOI 10.1002/jcc.1058; Sharma PK, 2007, P NATL ACAD SCI USA, V104, P9661, DOI 10.1073/pnas.0702238104; Stoll S, 2011, J AM CHEM SOC, V133, P18098, DOI 10.1021/ja208462t; TAYLOR RT, 1966, J BIOL CHEM, V241, P3641; Walsh CT, 2014, ACS CHEM BIOL, V9, P2718, DOI 10.1021/cb500695k; Wang YY, 2017, J AM CHEM SOC, V139, P1742, DOI 10.1021/jacs.6b10901; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; YAGIL G, 1967, TETRAHEDRON, V23, P2855, DOI 10.1016/0040-4020(67)85151-2; Zhang FF, 2016, ACS CHEM BIOL, V11, P415, DOI 10.1021/acschembio.5b00731; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	53	24	24	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15456	15467		10.1074/jbc.M117.778548	http://dx.doi.org/10.1074/jbc.M117.778548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747433	hybrid, Green Published			2022-12-26	WOS:000410809800025
J	Limay-Rios, V; Miller, JD; Schaafsma, AW				Limay-Rios, Victor; Miller, J. David; Schaafsma, Arthur W.			Occurrence of Penicillium verrucosum, ochratoxin A, ochratoxin B and citrinin in on-farm stored winter wheat from the Canadian Great Lakes Region	PLOS ONE			English	Article							BREAKFAST CEREALS; WATER ACTIVITY; GRAIN; MYCOTOXINS; STORAGE; TEMPERATURE; MARKET; FUNGI	The occurrence of P. verrucosum and ochratoxin A (OTA) were surveyed for 3 and 4 years, respectively. A total of 250 samples was collected from an average of 30 farms during the 2011, 2012, 2013 and 2014 winter seasons. Most storage bins surveyed were typically 11 m high round bins made of corrugated, galvanized steel, with flat-bottoms and conical roofs. Samples of clumped grain contained the most P. verrucosum (p<0.05, n = 10) followed by samples taken from the first load (n = 24, mean = 147 +/- 87 CFU/g) and last load (n = 17, mean = 101 +/- 77 CFU/g). Five grain samples (2.2%) tested positive for OTA, citrinin and OTB at concentrations of 14.7 +/- 7.9, 4.9 +/- 1.9 and 1.2 +/- 0.7 ng/g, with only three samples exceeding 5 ng/g. Grain samples positive for OTA were related to moisture resulting from either condensation or migrating moist warm air in the bin or areas where precipitation including snow entered the bin. Bins containing grain and clumps contaminated with OTA were studied in detail. A number of statistically-significant risk factors for OTA contamination were identified. These included 1) grain clumps accumulated around or directly under manhole openings, 2) debris and residue of old grain or grain clumps collected from the bin walls or left on storage floor and augers and 3) grain clumps accumulated around side doors. Even when grain enters storage below the 14.5% threshold of moisture, condensation and moisture migration occurs in hotspots in modern corrugated steel storage bins. Hot spots of OTA contamination were most often in areas affected by moisture migration due to inadequate aeration and exposure to moisture from precipitation or condensation. Further, we found that the nature of the condensation affects the nature and distribution of small and isolated areas with high incidence of toxin contamination and/or P. verrucosum prevalence in the grain bins examined.	[Limay-Rios, Victor; Schaafsma, Arthur W.] Univ Guelph, Dept Plant Agr, Ridgetown, ON, Canada; [Miller, J. David] Carleton Univ, Dept Chem, Ottawa, ON, Canada	University of Guelph; Carleton University	Limay-Rios, V (corresponding author), Univ Guelph, Dept Plant Agr, Ridgetown, ON, Canada.	vlimayri@uoguelph.ca		Limay-Rios, Victor/0000-0002-0866-3568; Schaafsma, Arthur W/0000-0002-5527-5664	Grain Farmers of Ontario; Agricultural Adaptation Council through the Canadian Agricultural Adaptation Program [AAC CARP 0113]	Grain Farmers of Ontario; Agricultural Adaptation Council through the Canadian Agricultural Adaptation Program	Funding for this project was provided by the Grain Farmers of Ontario and the Agricultural Adaptation Council (http://www.adaptcouncil.org) through the Canadian Agricultural Adaptation Program (AAC CARP 0113).	Armitage D, 2001, SUPPLEMENTAL AERATIO; Bucklin R, 2007, HDB FARM DAIRY FOOD, P113; Burlakoti P, 2012, DIL PLAT KEY FACT SU; CFIA, 2009, HLTH HAZ AL HEINZ MI; Collins SH, 1965, CANADIAN AGR ENG, V7, P4; Currie LA, 1999, ANAL CHIM ACTA, V391, P105, DOI 10.1016/S0003-2670(99)00104-X; Czaban J, 2006, POL J MICROBIOL, V55, P321; Dhuyvetter KC, 2000, 2474 MF KANS STAT U; Elmholt S., 2005, DAR COFENEWS NEWSLET; FUNNELL HS, 1979, CAN J COMP MED, V43, P243; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Huybrechts B, 2010, EVALUATION IMMUNOASS; IARC, 1997, SOM NAT OCC SUBST FO; Jayas DS, 2003, FOOD CONTROL, V14, P255, DOI 10.1016/S0956-7135(03)00014-8; Jia CC, 2001, J STORED PROD RES, V37, P165, DOI 10.1016/S0022-474X(00)00017-5; Jian FJ, 2009, J STORED PROD RES, V45, P82, DOI 10.1016/j.jspr.2008.09.004; Nguyen KTN, 2014, FOOD CONTROL, V40, P140, DOI 10.1016/j.foodcont.2013.11.041; Kuiper-Goodman T, 2010, FOOD ADDIT CONTAM A, V27, P212, DOI 10.1080/02652030903013278; Lindblad M, 2004, J APPL MICROBIOL, V97, P609, DOI 10.1111/j.1365-2672.2004.02332.x; MAGAN N, 1984, T BRIT MYCOL SOC, V82, P83, DOI 10.1016/S0007-1536(84)80214-4; MIKETINAC MJ, 1986, CAN AGR ENG, V28, P23; MILLER JD, 1995, J STORED PROD RES, V31, P1, DOI 10.1016/0022-474X(94)00039-V; Mills J T, 1995, Mycotoxin Res, V11, P25, DOI 10.1007/BF03192059; Mills J.T., 1989, SPOILAGE HEATING STO; Montross M, 1998, 2001 ASAE ANN M AM S, P1; Ng W, 2009, J FOOD PROTECT, V72, P890, DOI 10.4315/0362-028X-72.4.890; NORTHOLT MD, 1979, J FOOD PROTECT, V42, P485, DOI 10.4315/0362-028X-42.6.485; OMAFRA, 2002, HARV STOR AGR GUID F, P192; OMAFRA, 2015, FIELD CROP REP; Pardo E, 2006, FOOD ADDIT CONTAM A, V23, P398, DOI 10.1080/02652030500376102; Roscoe V, 2008, FOOD ADDIT CONTAM A, V25, P347, DOI 10.1080/02652030701551826; Rychlik M, 2008, ANAL BIOANAL CHEM, V390, P617, DOI 10.1007/s00216-007-1717-x; Samson RA, 2004, STUD MYCOL, P175; SAS Institute, 2008, SAS STAT 9 2 US GUID; SCOTT PM, 1970, CAN J PLANT SCI, V50, P583, DOI 10.4141/cjps70-108; Scott PM, 1998, FOOD ADDIT CONTAM A, V15, P555, DOI 10.1080/02652039809374681; SHOTWELL O L, 1970, Cereal Chemistry, V47, P700; SHOTWELL OL, 1969, APPL MICROBIOL, V17, P765, DOI 10.1128/AEM.17.5.765-766.1969; SINHA RN, 1965, CAN J PLANT SCI, V45, P48, DOI 10.4141/cjps65-006; Statistics Canada AD, 2012, FIELD CROP REP SER; Sulyok M, 2006, RAPID COMMUN MASS SP, V20, P2649, DOI 10.1002/rcm.2640; Tabata S, 2008, J FOOD HYG SOC JPN, V49, P111, DOI 10.3358/shokueishi.49.111; Tittlemier SA, 2014, FOOD ADDIT CONTAM A, V31, P910, DOI 10.1080/19440049.2014.888498; TUITE J, 1979, ANNU REV PHYTOPATHOL, V17, P343, DOI 10.1146/annurev.py.17.090179.002015; Whitaker TB, 2015, WORLD MYCOTOXIN J, P1	45	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181239	10.1371/journal.pone.0181239	http://dx.doi.org/10.1371/journal.pone.0181239			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749978	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700034
J	Wang, XF; Yamada, S; LaRiviere, WB; Ye, H; Bakeberg, JL; Irazabal, MV; Chebib, FT; van Deursen, J; Harris, PC; Sussman, CR; Behfar, A; Ward, CJ; Torres, VE				Wang, Xiaofang; Yamada, Satsuki; LaRiviere, Wells B.; Ye, Hong; Bakeberg, Jason L.; Irazabal, Maria V.; Chebib, Fouad T.; van Deursen, Jan; Harris, Peter C.; Sussman, Caroline R.; Behfar, Atta; Ward, Christopher J.; Torres, Vicente E.			Generation and phenotypic characterization of Pde1a mutant mice	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; CYST EPITHELIAL-CELLS; JUXTAGLOMERULAR CELLS; VASCULAR EXPRESSION; CAMP; VASOPRESSIN; PROLIFERATION; RAT; CALCIUM	It has been proposed that a reduction in intracellular calcium causes an increase in intracellular cAMP and PKA activity through stimulation of calcium inhibitable adenylyl cyclase 6 and inhibition of phosphodiesterase 1 (PDE1), the main enzymes generating and degrading cAMP in the distal nephron and collecting duct, thus contributing to the development and progression of autosomal dominant polycystic kidney disease (ADPKD). In zebrafish pde1a depletion aggravates and overexpression ameliorates the cystic phenotype. To study the role of PDE1A in a mammalian system, we used a TALEN pair to Pde1a exon 7, targeting the histidine-aspartic acid dipeptide involved in ligating the active site Zn++ ion to generate two Pde1a null mouse lines. Pde1a mutants had a mild renal cystic disease and a urine concentrating defect (associated with upregulation of PDE4 activity and decreased protein kinase A dependent phosphorylation of aquaporin-2) on a wild-type genetic background and aggravated renal cystic disease on a Pkd2 WS25/-background. Pde1a mutants additionally had lower aortic blood pressure and increased left ventricular (LV) ejection fraction, without a change in LV mass index, consistent with the high aortic and low cardiac expression of Pde1a in wild-type mice. These results support an important role of PDE1A in the renal pathogenesis of ADPKD and in the regulation of blood pressure.	[Wang, Xiaofang; LaRiviere, Wells B.; Ye, Hong; Irazabal, Maria V.; Chebib, Fouad T.; Harris, Peter C.; Sussman, Caroline R.; Torres, Vicente E.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA; [Yamada, Satsuki; Behfar, Atta] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA; [Bakeberg, Jason L.; Ward, Christopher J.] Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66103 USA; [van Deursen, Jan; Harris, Peter C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Kansas; University of Kansas Medical Center; Mayo Clinic	Torres, VE (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55902 USA.; Ward, CJ (corresponding author), Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66103 USA.	cward6@kumc.edu; Torres.vicente@mayo.edu		Torres, Vicente/0000-0003-2008-1576; Irazabal, Maria V./0000-0002-9904-7778; Behfar, Atta/0000-0003-3775-5784; Sussman, Caroline/0000-0003-3965-256X	National Institutes of Health [DK44863, DK90728]; Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044863, P30DK090728, R56DK044863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (DK44863 and DK90728) and by the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center. VET is PI for DK44863 and DK90728 and Director of the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center. CJW was Co-Investigator in the same grants. PCH is Co-Investigator in the same grants and Co-Director of the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Institutes of Health (DK44863 and DK90728) and by the Mayo Clinic Robert M. and Billie Kelley Pirnie Translational PKD Research Center.	Ahmad F, 2012, HORM METAB RES, V44, P776, DOI 10.1055/s-0032-1312646; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Balbo BE, 2016, KIDNEY INT, V90, P580, DOI 10.1016/j.kint.2016.04.028; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bobin P, 2016, ARCH CARDIOVASC DIS, V109, P431, DOI 10.1016/j.acvd.2016.02.004; Boda H, 2016, J HUM GENET, V61, P701, DOI 10.1038/jhg.2016.32; BODE DC, 1991, CIRC RES, V68, P1070, DOI 10.1161/01.RES.68.4.1070; Brescia M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101672; Cai YJ, 2015, CIRC RES, V116, P1120, DOI 10.1161/CIRCRESAHA.116.304408; calmodulin- dependent phosphodiesterase (PDE1), 2005, CELL SIG, V17, P789; Calvet JP, 2015, ROLE CALCIUM CYCLIC; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Caroli A, 2013, LANCET, V382, P1485, DOI 10.1016/S0140-6736(13)61407-5; Chan S, 2011, CURR OPIN PHARMACOL, V11, P720, DOI 10.1016/j.coph.2011.09.002; Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59; Chebib FT, 2015, NAT REV NEPHROL, V11, P451, DOI 10.1038/nrneph.2015.39; Chebib FT, 2017, AUTOSOMAL DOMINANT P; Cheng JF, 2006, EXP BIOL MED, V231, P288; Cheng JF, 2004, AM J PHYSIOL-RENAL, V287, pF940, DOI 10.1152/ajprenal.00079.2004; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Dousa TP, 1999, KIDNEY INT, V55, P29, DOI 10.1046/j.1523-1755.1999.00233.x; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Ecder T, 2013, CURR HYPERTENS REV, V9, P2, DOI 10.2174/1573402111309010002; Friis UG, 2013, PFLUG ARCH EUR J PHY, V465, P25, DOI 10.1007/s00424-012-1126-7; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Griffin MD, 1997, J AM SOC NEPHROL, V8, P616; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hopp K, 2015, AM J PHYSL; Jeon KI, 2010, FEBS J, V277, P5026, DOI 10.1111/j.1742-4658.2010.07908.x; Johnson WB, 2012, LIFE SCI, V90, P328, DOI 10.1016/j.lfs.2011.11.016; Kakkar R, 1999, CELL MOL LIFE SCI, V55, P1164, DOI 10.1007/s000180050364; Knight WE, 2016, P NATL ACAD SCI; Kokkonen K, 2016, ANN REV PHARM TOXICO; Kostic MM, 1997, J MOL CELL CARDIOL, V29, P3135, DOI 10.1006/jmcc.1997.0544; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P16604, DOI 10.1073/pnas.1415933111; Kurihara I, 1996, NEPHRON, V73, P629; KUSANO E, 1985, AM J PHYSIOL, V249, pF956, DOI 10.1152/ajprenal.1985.249.6.F956; Kusano E, 2001, TOHOKU J EXP MED, V193, P207, DOI 10.1620/tjem.193.207; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Lukyanenko YO, 2016, J MOL CELL CARDIOL, V98, P73, DOI 10.1016/j.yjmcc.2016.06.064; Matousovic K, 1997, J LAB CLIN MED, V130, P487, DOI 10.1016/S0022-2143(97)90125-6; Miller CL, 2011, BASIC RES CARDIOL, V106, P1023, DOI 10.1007/s00395-011-0228-2; Miller CL, 2009, CIRC RES, V105, P956, DOI 10.1161/CIRCRESAHA.109.198515; Mokni W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014227; Mutig K, 2007, AM J PHYSIOL-RENAL, V293, pF1166, DOI 10.1152/ajprenal.00196.2007; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; O'Sullivan DA, 1997, J AM SOC NEPHROL, V8, p376A; Ong ACM, 2015, LANCET, V385, P1993, DOI 10.1016/S0140-6736(15)60907-2; Ortiz-Capisano MC, 2009, AM J PHYSIOL-REG I, V297, pR1469, DOI 10.1152/ajpregu.00121.2009; Osinski MT, 2000, BIOCHEM PHARMACOL, V60, P381, DOI 10.1016/S0006-2952(00)00328-2; Paavola J, 2013, J MOL CELL CARDIOL, V58, P199, DOI 10.1016/j.yjmcc.2013.01.015; Pedrozo Z, 2015, CIRCULATION, V131, P2131, DOI 10.1161/CIRCULATIONAHA.114.013537; Pinto CS, 2016, J AM SOC NEPHROL, V27, P1124, DOI 10.1681/ASN.2015010047; Rees S, 2014, J AM SOC NEPHROL, V25, P232, DOI 10.1681/ASN.2013010077; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; Sarmiento JM, 2005, KIDNEY INT, V68, P487, DOI 10.1111/j.1523-1755.2005.00426.x; Sharma RK, 2006, INT J MOL MED, V18, P95; Sonnenburg WK, 1998, METHODS, V14, P3, DOI 10.1006/meth.1997.0561; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Sussman CR, 2014, J AM SOC NEPHROL, V25, P2222, DOI 10.1681/ASN.2013040421; Sussman CR, 2015, AM SOC NEPHROLOGY KI; TAKEDA S, 1991, ENDOCRINOLOGY, V129, P287, DOI 10.1210/endo-129-1-287; Torres VE, 2004, NAT MED, V10, P363, DOI 10.1038/nm1004; Torres VE, 2001, J AM SOC NEPHROL, V12, P1, DOI 10.1681/ASN.V1211; Torres VE, 2014, J AM SOC NEPHROL, V25, P18, DOI 10.1681/ASN.2013040398; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Tragante V, 2014, AM J HUM GENET, V94, P349, DOI 10.1016/j.ajhg.2013.12.016; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Volk T, 2003, CARDIOVASC RES, V58, P76, DOI 10.1016/S0008-6363(02)00858-1; Wallis RM, 1999, AM J CARDIOL, V83, p3C; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Wang XF, 2010, KIDNEY INT, V77, P129, DOI 10.1038/ki.2009.438; WHITFIELD JF, 1973, J CELL PHYSIOL, V81, P241, DOI 10.1002/jcp.1040810212; Yamaguchi T, 2003, KIDNEY INT, V63, P1983, DOI 10.1046/j.1523-1755.2003.00023.x; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; YAMAKI M, 1992, AM J PHYSIOL, V262, pF957, DOI 10.1152/ajprenal.1992.262.6.F957; Ye H, 2016, J AM SOC NEPHROL, V27, P1312, DOI 10.1681/ASN.2015010057; Yu TM, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002623	81	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181087	10.1371/journal.pone.0181087	http://dx.doi.org/10.1371/journal.pone.0181087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750036	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700030
J	Dower, K; Zhao, SR; Schlerman, FJ; Savary, L; Campanholle, G; Johnson, BG; Xi, L; Nguyen, V; Zhan, YT; Lech, MP; Wang, J; Nie, Q; Karsdal, MA; Genovese, F; Boucher, G; Brown, TP; Zhang, BH; Homer, BL; Martinez, RV				Dower, Ken; Zhao, Shanrong; Schlerman, Franklin J.; Savary, Leigh; Campanholle, Gabriela; Johnson, Bryce G.; Xi, Li; Vuong Nguyen; Zhan, Yutian; Lech, Matthew P.; Wang, Ju; Nie, Qing; Karsdal, Morten A.; Genovese, Federica; Boucher, Germaine; Brown, Thomas P.; Zhang, Baohong; Homer, Bruce L.; Martinez, Robert V.			High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/fa(CP) rats, a model of type 2 diabetic nephropathy	PLOS ONE			English	Article							COLLAGEN DEGRADATION; TUBEROUS SCLEROSIS; PODOCYTE NUMBER; PATHOGENIC ROLE; KIDNEY-DISEASE; FIBROSIS; OBESE; GLOMERULOSCLEROSIS; INJURY; IDENTIFICATION	ZSF1 rats exhibit spontaneous nephropathy secondary to obesity, hypertension, and diabetes, and have gained interest as a model system with potentially high translational value to progressive human disease. To thoroughly characterize this model, and to better understand how closely it recapitulates human disease, we performed a high resolution longitudinal analysis of renal disease progression in ZSF1 rats spanning from early disease to end stage renal disease. Analyses included metabolic endpoints, renal histology and ultrastructure, evaluation of a urinary biomarker of fibrosis, and transcriptome analysis of glomerular-enriched tissue over the course of disease. Our findings support the translational value of the ZSF1 rat model, and are provided here to assist researchers in the determination of the model's suitability for testing a particular mechanism of interest, the design of therapeutic intervention studies, and the identification of new targets and biomarkers for type 2 diabetic nephropathy.	[Dower, Ken; Schlerman, Franklin J.; Campanholle, Gabriela; Johnson, Bryce G.; Lech, Matthew P.; Wang, Ju; Martinez, Robert V.] Pfizer Worldwide Res & Dev, Inflammat & Immunol, Cambridge, MA 02139 USA; [Zhao, Shanrong; Xi, Li; Zhang, Baohong] Pfizer Worldwide Res & Dev, Clin Bioinformat, Early Clin Dev, Cambridge, MA USA; [Savary, Leigh; Vuong Nguyen; Zhan, Yutian; Nie, Qing; Homer, Bruce L.] Pfizer Worldwide Res & Dev, Drug Safety, Andover, MA USA; [Karsdal, Morten A.; Genovese, Federica] Nord Biosci AS, Herlev, Denmark; [Boucher, Germaine; Brown, Thomas P.] Pfizer Worldwide Res & Dev, Drug Safety, Groton, CT USA	Pfizer; Pfizer; Pfizer; Nordic Bioscience; Pfizer	Dower, K; Martinez, RV (corresponding author), Pfizer Worldwide Res & Dev, Inflammat & Immunol, Cambridge, MA 02139 USA.	ken.dower@pfizer.com; robert.martinez@pfizer.com		Genovese, Federica/0000-0003-1984-1881; Karsdal, Morten/0000-0001-5026-8740				Alpers CE, 2011, CURR OPIN NEPHROL HY, V20, P278, DOI 10.1097/MNH.0b013e3283451901; Andeen NK, 2015, KIDNEY INT, V88, P1099, DOI 10.1038/ki.2015.273; Bai XY, 2011, AM J NEPHROL, V33, P91, DOI 10.1159/000322701; Barascuk N, 2010, CLIN BIOCHEM, V43, P899, DOI 10.1016/j.clinbiochem.2010.03.012; Betz B, 2014, NEPHRON EXP NEPHROL, V126, P191, DOI 10.1159/000363300; Bilan VP, 2011, J ENDOCRINOL, V210, P293, DOI 10.1530/JOE-11-0122; Boustany-Kari CM, 2016, J PHARMACOL EXP THER, V356, P712, DOI 10.1124/jpet.115.230706; Brosius FC, 2013, CURR OPIN NEPHROL HY, V22, P17, DOI 10.1097/MNH.0b013e32835b3766; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Flanc RS, 2007, KIDNEY INT, V72, P698, DOI 10.1038/sj.ki.5002404; Floege J, 1997, KIDNEY INT, V51, P230, DOI 10.1038/ki.1997.28; Francescato HDC, 2007, NEPHROL DIAL TRANSPL, V22, P2138, DOI 10.1093/ndt/gfm144; Genovese F, 2016, NEPHROL DIAL TRANSPL, V31, P472, DOI 10.1093/ndt/gfv301; Griffin KA, 2007, AM J PHYSIOL-RENAL, V293, pF1605, DOI 10.1152/ajprenal.00511.2006; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Henske EP, 2005, PEDIATR NEPHROL, V20, P854, DOI 10.1007/s00467-004-1795-3; Herman WH, 2013, DIABETES CARE, V36, P775, DOI 10.2337/dc13-0270; Hodgin JB, 2013, DIABETES, V62, P299, DOI 10.2337/db11-1667; HOLDSWORTH SR, 1978, NEPHRON, V22, P454, DOI 10.1159/000181513; Ijaz A, 2009, KIDNEY INT, V75, P381, DOI 10.1038/ki.2008.559; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jefferson JA, 2008, KIDNEY INT, V74, P22, DOI 10.1038/ki.2008.128; Joshi D, 2009, J CARDIOVASC PHARM, V54, P72, DOI 10.1097/FJC.0b013e3181ac3a34; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kwiatkowski DJ, 2014, NEW ENGL J MED, V371, P778, DOI 10.1056/NEJMcibr1406613; Lemley KV, 2013, J AM SOC NEPHROL, V24, P1193, DOI 10.1681/ASN.2012111078; Leoncini G, 2010, CURR HYPERTENS REP, V12, P335, DOI 10.1007/s11906-010-0141-3; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim AKH, 2011, AM J NEPHROL, V34, P337, DOI 10.1159/000331058; Ma FY, 2007, J AM SOC NEPHROL, V18, P472, DOI 10.1681/ASN.2006060604; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mohanan A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/751513; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Papasotiriou M, 2015, NEPHROL DIAL TRANSPL, V30, P1112, DOI 10.1093/ndt/gfv063; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Puelles VG, 2015, CURR OPIN NEPHROL HY, V24, P224, DOI 10.1097/MNH.0000000000000121; Rafikova O, 2008, METABOLISM, V57, P1434, DOI 10.1016/j.metabol.2008.05.014; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Samuel T, 2007, J ANAT, V210, P578, DOI 10.1111/j.1469-7580.2007.00715.x; Saran R, 2016, AM J KIDNEY DIS, V67, pS1, DOI 10.1053/j.ajkd.2015.12.014; Satchell SC, 2008, DIABETOLOGIA, V51, P714, DOI 10.1007/s00125-008-0961-8; Schneider RRS, 2017, AGING-US, V9, P524, DOI 10.18632/aging.101176; Su Z, 2016, AM J NEPHROL, V44, P339, DOI 10.1159/000449324; Tofovic SP, 2000, RENAL FAILURE, V22, P387, DOI 10.1081/JDI-100100882; Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x; Tofovic SP, 2016, J PHARMACOL EXP THER, V356, P333, DOI 10.1124/jpet.115.228841; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Veidal SS, 2010, LIVER INT, V30, P1293, DOI 10.1111/j.1478-3231.2010.02309.x; Vora JP, 1996, J AM SOC NEPHROL, V7, P113; Wang Y, 2007, LIFE SCI, V80, P2067, DOI 10.1016/j.lfs.2007.03.010; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wiggins JE, 2012, J GERONTOL A-BIOL, V67, P1358, DOI 10.1093/gerona/gls157; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yang JC, 2012, CURR OPIN NEPHROL HY, V21, P97, DOI 10.1097/MNH.0b013e32834de526; Zhao SR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1308-8	59	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181861	10.1371/journal.pone.0181861	http://dx.doi.org/10.1371/journal.pone.0181861			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746409	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800065
J	Thivolet, C; Vial, G; Cassel, R; Rieusset, J; Madec, AM				Thivolet, Charles; Vial, Guillaume; Cassel, Romeo; Rieusset, Jennifer; Madec, Anne-Marie			Reduction of endoplasmic reticulummitochondria interactions in beta cells from patients with type 2 diabetes	PLOS ONE			English	Article							HEPATIC INSULIN-RESISTANCE; RETICULUM STRESS; MITOCHONDRIA; ISLETS; MASS; APOPTOSIS; MECHANISMS; RECEPTORS; INTEGRITY; DYNAMICS	Type 2 diabetes develops when beta cells are not able to fulfill insulin needs. The role of the endoplasmic reticulum-mitochondria junction in coordinating the functions of these two organelles throughout the natural history of type 2 diabetes is determinant and may explain the alterations of insulin biosynthesis. Our goal was to study endoplasmic reticulum and mitochondrial interactions in human beta cells from organ donors with type 2 diabetes. Pancreas samples were obtained via the network for pancreatic organ donors with diabetes (nPOD) based on disease status with 12 subjects with type 2 diabetes and 9 nondiabetic controls. We examined pancreatic specimens by immunofluorescence, in situ hybridization and in situ proximity ligation assay and compared the results to an in vitro model of beta-cell dysfunction. Expression of proteins that enable tethering and exchanges between endoplasmic reticulum (ER) and mitochondria and quantification of interconnection through mitochondria associated membranes (MAM) was investigated. In beta cells from type 2 diabetic cases as compared to controls, there was a significant increase in reticular expression of inositol triphosphate receptor-2 (IP3R2) both at the protein and mRNA levels, no difference in mitochondrial transit peptide receptor TOM20 and mitofusin-2 expressions, and a decrease in the expression of voltage-dependent anion channel-1 (VDAC-1). The number of IP3R2-VDAC-1 complexes identified by in situ proximity ligation assay was significantly lower in diabetic islets and in beta cells of diabetics as compared to controls. Treatment of Min6-B1 cells with palmitate altered glucose-stimulated insulin secretion, increased ER stress and significantly reduced ER-mitochondrial interactions. We can conclude that specific changes in reticular and mitochondrial beta cell proteins characterize human type 2 diabetes with reduction in organelle interactions. This finding opens new targets of intervention.	[Thivolet, Charles; Vial, Guillaume; Cassel, Romeo; Rieusset, Jennifer; Madec, Anne-Marie] Univ 1 Lyon, CarMeN Lab, INSERM, INRA U1235,UMR 1060, Lyon, France; [Thivolet, Charles] Lyon Sud Hosp, Hosp Civils Lyon, Dept Endocrinol & Diabet, Pierre Benite, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Thivolet, C (corresponding author), Univ 1 Lyon, CarMeN Lab, INSERM, INRA U1235,UMR 1060, Lyon, France.; Thivolet, C (corresponding author), Lyon Sud Hosp, Hosp Civils Lyon, Dept Endocrinol & Diabet, Pierre Benite, France.	charles.thivolet@chu-lyon.fr	Carmen, Team2/Y-7383-2019; Rieusset, Jennifer/F-1595-2018	Carmen, Team2/0000-0001-9867-5724; Rieusset, Jennifer/0000-0002-1587-2253; Vial, Guillaume/0000-0002-7333-8526; Lab, Carmen/0000-0002-5935-3236	Association pour la Recherche sur le diabete; nPOD; Juvenile Diabetes Research Foundation International	Association pour la Recherche sur le diabete(Fondation ARC pour la Recherche sur le Cancer); nPOD; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	This study was supported by the Association pour la Recherche sur le diabete (ARD, http://www.a-rd.fr). This research was performed with support of nPOD, a collaborative T1D research project sponsored by the Juvenile Diabetes Research Foundation International. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Bonner-Weir S, 2008, DIABETES, V57, P2899, DOI 10.2337/db07-1842; Bravo-Sagua R, 2013, CURR MOL MED, V13, P317, DOI 10.2174/156652413804810781; Chen CG, 2016, DIABETES, V65, P2676, DOI 10.2337/db15-1718; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Galbiati F, 2002, ENDOCRINOLOGY, V143, P4018, DOI 10.1210/en.2002-220200; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Madec AM, 2013, FASEB J, V27, P5122, DOI 10.1096/fj.13-234104; Meier JJ, 2013, DIABETES CARE, V36, pS113, DOI 10.2337/dcS13-2008; Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rieusset J, 2016, DIABETOLOGIA, V59, P614, DOI 10.1007/s00125-015-3829-8; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Schrader M, 2015, FRONT CELL DEV BIOL, V56, P1; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Varadi A, 1996, BIOCHEM J, V319, P521, DOI 10.1042/bj3190521; Vermassen E, 2004, BIOL CELL, V96, P3, DOI 10.1016/j.biolcel.2003.11.004; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	31	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0182027	10.1371/journal.pone.0182027	http://dx.doi.org/10.1371/journal.pone.0182027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742858	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000067
J	Wu, YH; Vidal, JS; de Rotrou, J; Sikkes, SAM; Rigaud, AS; Plichart, M				Wu, Ya-Huei; Vidal, Jean-Sebastien; de Rotrou, Jocelyne; Sikkes, Sietske A. M.; Rigaud, Anne-Sophie; Plichart, Matthieu			Can a tablet-based cancellation test identify cognitive impairment in older adults?	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; EXECUTIVE DYSFUNCTION; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; COMPUTER USE; DISEASE; DEMENTIA; PERFORMANCE; DEFICITS; PROFILE	Background and objective There has been a growing interest in using computerized cognitive assessment to detect age-related cognitive disorders. We have developed a tablet-based cancellation test (e-CT), previously shown as a reliable measure of executive functions and free of effect of familiarity with computer-based devices in healthy older adults. This study aimed to investigate the influence of demographics and current daily use of computer-based devices in older adults with Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD). We further studied the ability of the e-CT to discriminate MCI and AD patients from older adults with normal cognition (NC). Methods The e-CT was administered to 325 older adults (NC = 112, MCI = 129, AD = 84). Subjects also performed the K-T test, a paper-and-pencil cancellation test from which the e-CT was developed. Multiple linear regression analyses were conducted to assess the contribution of demographics and current daily use of computer-based devices on the e-CT in patient groups. The Receiver Operating Characteristic (ROC) curves and the Area Under the Curve (AUC) were established to compare the efficacy of the e-CT and the K-T test to classify subjects into diagnostic groups. Results In the MCI group, age (B = -0.37, p<0.001) and current daily use of computer-based devices (B = 5.85, p<0.001) were associated with the number of correct cancellations of the e-CT. In the AD group, only current daily use of a computer-based device was a significant contributor (B = 6.28, p<0.001). The e-CT (AUC = 0.811; 95% confidence interval [CI]: 0.756-0.867) and the K-T (AUC = 0.837; CI: 0.787-0.887) showed good and comparable diagnostic accuracy to discriminate between MCI and NC subjects. To discriminate between NC and AD, both tests showed high diagnostic accuracy, with the AUC values of 0.923 (CI: 0.876-0.971) and 0.929 (95% CI: 0.886-0.972) for the e-CT and the K-T, respectively. Conclusion The e-CT presents satisfying discriminative validity and is a promising tool for detection of early cognitive impairment in older adults.	[Wu, Ya-Huei; Vidal, Jean-Sebastien; de Rotrou, Jocelyne; Rigaud, Anne-Sophie; Plichart, Matthieu] Hop Broca, AP HP, Paris, France; [Wu, Ya-Huei; Vidal, Jean-Sebastien; de Rotrou, Jocelyne; Rigaud, Anne-Sophie; Plichart, Matthieu] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France; [Sikkes, Sietske A. M.] Vrije Univ Amsterdam, Alzheimer Ctr, Med Ctr, Amsterdam, Netherlands; [Sikkes, Sietske A. M.] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Med Ctr, Amsterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Wu, YH (corresponding author), Hop Broca, AP HP, Paris, France.; Wu, YH (corresponding author), Paris Descartes Univ, Sorbonne Paris Cite, Paris, France.	yahuei.mu@brc.aphp.fr	Vidal, Jean-Sebastien/D-1941-2016	Vidal, Jean-Sebastien/0000-0001-6770-0720	AIXPe: Aide a l'experimentation	AIXPe: Aide a l'experimentation	This work was supported by AIXPe: Aide a l'experimentation 2013, https://www.iledefrance.fr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Amieva H, 2004, BRAIN COGNITION, V54, P212, DOI 10.1016/j.bandc.2004.02.003; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Bordone V, 2015, INTELLIGENCE, V52, P90, DOI 10.1016/j.intell.2015.07.005; Byrd DA, 2004, J INT NEUROPSYCH SOC, V10, P401, DOI 10.1017/S1355617704103081; Czaja SJ, 2006, PSYCHOL AGING, V21, P333, DOI 10.1037/0882-7974.21.2.333; Delano-Wood L, 2009, J INT NEUROPSYCH SOC, V15, P906, DOI 10.1017/S1355617709990257; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; DEROTROU J, 1991, INT J GERIATR PSYCH, V6, P501, DOI 10.1002/gps.930060706; Brucki SMD, 2008, ARCH CLIN NEUROPSYCH, V23, P139, DOI 10.1016/j.acn.2007.11.003; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Ewers M, 2012, NEUROBIOL AGING, V33, P1203, DOI 10.1016/j.neurobiolaging.2010.10.019; Flehmig H. C., 2007, PSYCHOL SCI, V49, P132; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gifford DR, 1999, NEUROLOGY, V52, P224, DOI 10.1212/WNL.52.2.224; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Halter C., 1958, TEST ATTENTION K T M; Hansen TI, 2015, J CLIN EXP NEUROPSYC, V37, P581, DOI 10.1080/13803395.2015.1038220; Heaton RK, 1991, COMPREHENSIVE NORMS; Johns EK, 2012, J INT NEUROPSYCH SOC, V18, P541, DOI 10.1017/S1355617712000069; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kaye J, 2014, ALZHEIMERS DEMENT, V10, P10, DOI 10.1016/j.jalz.2013.01.011; Kesse-Guyot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047831; Koski L, 2011, HIV MED, V12, P472, DOI 10.1111/j.1468-1293.2010.00910.x; Lowery N, 2004, APPL NEUROPSYCHOL, V11, P218; Maruff Paul, 2013, BMC Psychol, V1, P30, DOI 10.1186/2050-7283-1-30; McGuinness B, 2010, INT J GERIATR PSYCH, V25, P562, DOI 10.1002/gps.2375; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Reitan RM, 1992, TRAIL MAKING TEST MA; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Rozzini L, 2007, INT J GERIATR PSYCH, V22, P1217, DOI 10.1002/gps.1816; Sikkes SAM, 2014, NEURODEGENER DIS MAN, V4, P393, DOI [10.2217/NMT.14.24, 10.2217/nmt.14.24]; Silverberg Nina B, 2011, Alzheimers Dement, V7, pe60; Snyder PJ, 2011, ALZHEIMERS DEMENT, V7, P338, DOI 10.1016/j.jalz.2011.03.009; Solfrizzi V, 2002, J GERIATR PSYCH NEUR, V15, P99, DOI 10.1177/089198870201500209; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tun PA, 2010, PSYCHOL AGING, V25, P560, DOI 10.1037/a0019543; Van der Linden M, 2004, MEMBRES GREMEM EVALU, P25; Vataja R, 2003, EUR J NEUROL, V10, P625, DOI 10.1046/j.1468-1331.2003.00676.x; Wechsler D., 1997, WECHSLER ADULT INTEL; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Wu YH, 2016, J CLIN EXP NEUROPSYC, V38, P1094, DOI 10.1080/13803395.2016.1196164; Wu YH, 2015, AM J GERIAT PSYCHIAT, V23, P1154, DOI 10.1016/j.jagp.2015.05.012; Wu YH, 2013, AGING NEUROPSYCHOL C, V20, P429, DOI 10.1080/13825585.2012.727975; Zheng DM, 2014, NEUROBIOL AGING, V35, P548, DOI 10.1016/j.neurobiolaging.2013.09.007; Zygouris S, 2015, AM J ALZHEIMERS DIS, V30, P13, DOI 10.1177/1533317514522852	48	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181809	10.1371/journal.pone.0181809	http://dx.doi.org/10.1371/journal.pone.0181809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28742136	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700075
J	Kanda, K; Sakuma, J; Akimoto, T; Kawakami, Y; Suzuki, K				Kanda, Kazue; Sakuma, Jun; Akimoto, Takayuki; Kawakami, Yasuo; Suzuki, Katsuhiko			Detection of titin fragments in urine in response to exercise-induced muscle damage	PLOS ONE			English	Article							IMMOBILIZED PH GRADIENTS; ECCENTRIC EXERCISE; SKELETAL-MUSCLE; SORENESS; INFLAMMATION; BIOMARKERS; SEQUENCES; DATABASES; PEPTIDES; HUMANS	Many studies have attempted to determine the associations between blood biomarkers and exercise-induced muscle damage. However, poor correlations between the changes in biomarker levels and the magnitude of muscle symptoms have been reported. Recent advances in proteomic tools offer a strategy for the comprehensive analysis of protein expression, which can be used to identify biomarkers. Here, we used a proteomic analysis to identify urinary proteins that appear in response to a calf-raise exercise, including repetitive eccentric muscle contractions, and found that a titin (also known as connectin) N-terminal fragment molecule appears in the urine after eccentric exercise. We measured the titin fragment in urine samples from nine individuals before and after eccentric exercise using a newly-established enzyme-linked immunosorbent assay and found that the titin fragment excretion rate increased 96 h after the exercise (5.1 to 77.6 pg/min, p < 0.01). The changes in the titin fragment excretion rate were correlated strongly with blood markers of muscle damage and with muscle symptoms. These findings suggest that the urinary titin fragment is potentially a noninvasive biomarker of muscle damage.	[Kanda, Kazue; Suzuki, Katsuhiko] Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo, Japan; [Sakuma, Jun] Musashigaoka Jr Coll, Dept Hlth Sci, Saitama, Japan; [Akimoto, Takayuki] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Div Regenerat Med Engn,Bunkyo Ku, Tokyo, Japan; [Akimoto, Takayuki; Kawakami, Yasuo; Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University; University of Tokyo; Waseda University	Suzuki, K (corresponding author), Waseda Univ, Inst Nanosci & Nanotechnol, Shinjuku Ku, Tokyo, Japan.; Suzuki, K (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	katsu.suzu@waseda.jp	Akimoto, Takayuki/H-6704-2012; Kawakami, Yasuo/AFM-0651-2022; Kawakami, Yasuo/AAH-3075-2022; Suzuki, Katsuhiko/AAI-2197-2019	Akimoto, Takayuki/0000-0002-8874-7779; Kawakami, Yasuo/0000-0003-0588-4039; Kawakami, Yasuo/0000-0003-0588-4039; Suzuki, Katsuhiko/0000-0002-6572-5809	Ministry of Education, Culture, Sports, Science, and Technology, Japan [23240097, 15H0183]; Grants-in-Aid for Scientific Research [16H01870, 15H01833] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grant-in Aid for Scientific Research (A) (23240097, 15H0183) and the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1984, MED SCI SPORT EXER, V16, P529; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Beaton LJ, 2002, CAN J APPL PHYSIOL, V27, P516, DOI 10.1139/h02-028; Bennett S, 2012, ALZ DIS ASSOC DIS, V26, P329, DOI 10.1097/WAD.0b013e318239dcbd; Brancaccio P, 2008, CLIN SPORT MED, V27, P1, DOI 10.1016/j.csm.2007.09.005; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freiburg A, 2000, CIRC RES, V86, P1114; Granzier H, 2007, MUSCLE NERVE, V36, P740, DOI 10.1002/mus.20886; Kanda K, 2014, EXERC IMMUNOL REV, V20, P39; Kanda K, 2013, EXERC IMMUNOL REV, V19, P72; Kruger M, 2011, J BIOL CHEM, V286, P9905, DOI 10.1074/jbc.R110.173260; Labeit S, 2006, J MOL BIOL, V362, P664, DOI 10.1016/j.jmb.2006.07.077; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; Malm C, 2000, J PHYSL, V592, P243; Malm C, 2012, HISTOCHEM CELL BIOL, V138, P89, DOI 10.1007/s00418-012-0946-z; Mann M, 1996, TRENDS BIOCHEM SCI, V21, P494, DOI 10.1016/S0968-0004(96)30042-X; MOKUNO K, 1987, MUSCLE NERVE, V10, P459, DOI 10.1002/mus.880100513; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Nosaka K, 2002, SCAND J MED SCI SPOR, V12, P337, DOI 10.1034/j.1600-0838.2002.10178.x; Ottenheijm CAC, 2010, ADV EXP MED BIOL, V682, P105, DOI 10.1007/978-1-4419-6366-6_6; Peake J, 2005, EXERC IMMUNOL REV, V11, P64; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Sanchez JC, 1997, ELECTROPHORESIS, V18, P324, DOI 10.1002/elps.1150180305; Sietsema KE, 2010, BIOMARKERS, V15, P249, DOI 10.3109/13547500903502802; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Wada S, 2011, J BIOL CHEM, V286, P38456, DOI 10.1074/jbc.M111.271270; Wang Chenchen, 2013, Methods Mol Biol, V984, P1, DOI 10.1007/978-1-62703-296-4_1; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016	32	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181623	10.1371/journal.pone.0181623	http://dx.doi.org/10.1371/journal.pone.0181623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727760	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500095
J	Wang, PY; Bi, SM; Wu, F; Xu, PZ; Shen, XJ; Zhao, QL				Wang, Pingyang; Bi, Simin; Wu, Fan; Xu, Pingzhen; Shen, Xingjia; Zhao, Qiaoling			Differentially expressed genes in the head of the 2nd instar pre-molting larvae of the nm2 mutant of the silkworm, Bombyx mori	PLOS ONE			English	Article							JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; MANDUCA-SEXTA; POLYTENE CHROMOSOMES; CUTICULAR PROTEIN; NUCLEAR RECEPTORS; CHITIN SYNTHASES; CUTICLE PROTEIN; CORPORA ALLATA; IN-VITRO	Molting is an important physiological process in the larval stage of Bombyx mori and is controlled by various hormones and peptides. The silkworm mutant that exhibits the phenotype of non-molting in the 2nd instar (nm2) is incapable of molting in the 2nd instar and dies after seven or more days. The ecdysone titer in the nm2 mutant is lower than that in the wild-type, and the mutant can be rescued by feeding with 20E and cholesterol. The results of positional cloning indicated that structural alteration of BmCPG10 is responsible for the phenotype of the nm2 mutant. To explore the possible relationship between BmCPG10 and the ecdysone titer as well as the genes affected by BmCPG10, digital gene expression (DGE) profile analysis was conducted in the nm2 mutant, with the wildtype strain C603 serving as the control. The results revealed 1727 differentially expressed genes, among which 651 genes were upregulated and 1076 were downregulated in nm2. BLASTGO analysis showed that these differentially expressed genes were involved in various biological processes, cellular components and molecular functions. KEGG analysis indicated an enrichment of these differentially expressed genes in 240 pathways, including metabolic pathways, pancreatic secretion, protein digestion and absorption, fat digestion and absorption and glycerolipid metabolism. To verify the accuracy of the DGE results, quantitative reverse transcription PCR (qRT-PCR) was performed, focusing on key genes in several related pathways, and the results were highly consistent with the DGE results. Our findings indicated significant differences in cuticular protein genes, ecdysone biosynthesis genes and ecdysone-related nuclear receptors genes, but no significant difference in juvenile hormone and chitin biosynthesis genes was detected. Our research findings lay the foundation for further research on the formation mechanism of the nm2 mutant.	[Wang, Pingyang; Bi, Simin; Xu, Pingzhen; Shen, Xingjia; Zhao, Qiaoling] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China; [Wang, Pingyang; Bi, Simin; Xu, Pingzhen; Shen, Xingjia; Zhao, Qiaoling] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China; [Wu, Fan] Hubei Acad Agr Sci, Ind Crops Inst, Wuhan, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences	Zhao, QL (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang, Jiangsu, Peoples R China.; Zhao, QL (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang, Jiangsu, Peoples R China.	qlzhao302@126.com		Wang, Pingyang/0000-0003-3908-6561	National Natural Science Foundation of China [31372378]; Jiangsu University of Science and Technology [YCX16B-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu University of Science and Technology	This work was supported by the funding of the National Natural Science Foundation of China (No. 31372378, Qiaoling Zhao) and the Graduate Student Innovation Program of Jiangsu University of Science and Technology (No. YCX16B-02, Pingyang Wang).; This work was supported by grants from the National Natural Science Foundation of China (No. 31372378).; This work was also supported by the Graduate Student Innovation Program of Jiangsu University of Science and Technology (No. YCX16B-02).	Ali MS, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev019; Asano T, 2013, INSECT BIOCHEM MOLEC, V43, P344, DOI 10.1016/j.ibmb.2013.01.001; ASHBURNER M, 1980, NATURE, V285, P435, DOI 10.1038/285435a0; ASHBURNER M, 1974, DEV BIOL, V39, P141, DOI 10.1016/S0012-1606(74)80016-3; ASHBURNER M, 1973, DEV BIOL, V35, P47, DOI 10.1016/0012-1606(73)90006-7; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Benjamini Y, 2001, ANN STAT, V29, P1165; Bonneton F, 2008, INSECT BIOCHEM MOLEC, V38, P416, DOI 10.1016/j.ibmb.2007.10.006; Busse MS, 2007, EMBO J, V26, P3826, DOI 10.1038/sj.emboj.7601798; CANDY DJ, 1962, J EXP BIOL, V39, P129; CATALAN RE, 1982, COMP BIOCHEM PHYS B, V71, P301, DOI 10.1016/0305-0491(82)90259-0; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Christiaens O., 2013, KEY ROLE DIVERSITY E; Cohen E, 2001, PEST MANAG SCI, V57, P946, DOI 10.1002/ps.363; Cruz J, 2008, DEV DYNAM, V237, P3179, DOI 10.1002/dvdy.21728; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Graebin NG, 2016, MOLECULES, V21, DOI 10.3390/molecules21081074; [郭恩恩 GUO EnEn], 2008, [蚕业科学, Acta Sericologica Sinica], V34, P370; Hiruma K, 2001, DEV BIOL, V232, P265, DOI 10.1006/dbio.2001.0165; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Ito Y, 2008, ZOOL SCI, V25, P721, DOI 10.2108/zsj.25.721; Jasrapuria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049844; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Liang JB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; Mauchamp B, 1999, INSECT BIOCHEM MOLEC, V29, P475, DOI 10.1016/S0965-1748(99)00044-2; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mesce KA, 2002, FRONT NEUROENDOCRIN, V23, P179, DOI 10.1006/frne.2002.0228; Muramatsu D, 2008, MECH DEVELOP, V125, P411, DOI 10.1016/j.mod.2008.02.001; Nita M, 2009, COMP BIOCHEM PHYS B, V153, P101, DOI 10.1016/j.cbpb.2009.02.005; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Qiao L, 2014, GENETICS, V196, P1103, DOI 10.1534/genetics.113.158766; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; SHARON N, 1993, SCI AM, V268, P82, DOI 10.1038/scientificamerican0193-82; Soares MPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020513; Steiner B, 1999, J INSECT PHYSIOL, V45, P401, DOI 10.1016/S0022-1910(98)00139-5; Sui YP, 2009, INSECT MOL BIOL, V18, P353, DOI 10.1111/j.1365-2583.2009.00879.x; Teets NM, 2014, J EXP BIOL, V217, P84, DOI 10.1242/jeb.089490; Wu F, 2016, GENE, V586, P170, DOI 10.1016/j.gene.2016.04.021; Wu F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153549; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xu JJ, 2010, J INSECT PHYSIOL, V56, P1471, DOI 10.1016/j.jinsphys.2010.04.004; Yamada M, 2000, DEVELOPMENT, V127, P5083; Zhao Xiao-Fan, 2007, Chinese Bulletin of Entomology, V44, P323; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005	62	2	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180160	10.1371/journal.pone.0180160	http://dx.doi.org/10.1371/journal.pone.0180160			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727825	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500015
J	Voloshanenko, O; Gmach, P; Winter, J; Kranz, D; Boutros, M				Voloshanenko, Oksana; Gmach, Philipp; Winter, Jan; Kranz, Dominique; Boutros, Michael			Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families	FASEB JOURNAL			English	Article						multiplex sgRNA; canonical Wnt signaling; FZD receptors; Cas9	CHROMOSOMAL REARRANGEMENTS; PROTEIN; POLARITY; CELLS; MEMBRANE; WINGLESS; PATHWAY; CANCER; GROWTH; RECOGNITION	Signaling pathway modules are often encoded by several closely related paralogous genes that can have redundant roles and are therefore difficult to analyze by loss-of-function analysis. A typical example is the Wnt signaling pathway, which in mammals is mediated by 19 Wnt ligands that can bind to 10 Frizzled (FZD) receptors. Although significant progress in understanding Wnt-FZD receptor interactions has been made in recent years, tools to generate systematic interaction maps have been largely lacking. Here we generated cell lines with multiplex mutant alleles of FZD1, FZD2, and FZD7 and demonstrate that these cells are unresponsive to canonical Wnt ligands. Subsequently, we performed genetic rescue experiments with combinations of FZDs and canonical Wnts to create a functional ligand-receptor interaction map. These experiments showed that whereas several Wnt ligands, such as Wnt3a, induce signaling through a broad spectrum of FZD receptors, others, such as Wnt8a, act through a restricted set of FZD genes. Together, our results map functional interactions of FZDs and 10 Wnt ligands and demonstrate how multiplex targeting by clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 can be used to systematically elucidate the functions of multigene families.	German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; Heidelberg Univ, Dept Cell & Mol Biol, Med Fac Mannheim, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Voloshanenko, O; Boutros, M (corresponding author), German Canc Res Ctr, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	o.voloshanenko@dkfz.de; m.boutros@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Kranz, Dominique/0000-0003-3604-7647; Gmach, Philipp/0000-0002-5258-0321	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank members of the M.B. group for helpful discussions and F. Reuter [German Cancer Research Center (DKFZ)] for help with experiments. The authors are particularly grateful to B. Rauscher for help with computational analysis and F. Heigwer (both from the DKFZ) for the help with E-CRISP and the design of sgRNAs. The authors thank M. Waterman (University of California, Irvine, Irvine, CA USA), D. Virshup (Duke-National University of Singapore Medical School, Singapore), and F. Zhang (Broad Institute, Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA.) for plasmids received through Addgene. Work in the laboratory of M.B. was in part supported by the German Research Foundation (DFG). The authors declare no conflicts of interest.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Blasco RB, 2014, CELL REP, V9, P1219, DOI 10.1016/j.celrep.2014.10.051; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Carmon KS, 2008, BIOCHEM BIOPH RES CO, V368, P285, DOI 10.1016/j.bbrc.2008.01.088; Carmon KS, 2010, ANAL BIOCHEM, V401, P288, DOI 10.1016/j.ab.2010.03.009; Chang H, 2013, P NATL ACAD SCI USA, V110, pE908, DOI 10.1073/pnas.1301430110; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Choi PS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4728; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Gazit A, 1999, ONCOGENE, V18, P5959, DOI 10.1038/sj.onc.1202985; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; He ZY, 2015, BIOTECHNOL BIOENG, V112, P1060, DOI 10.1002/bit.25490; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hua ZL, 2014, DEVELOPMENT, V141, P3944, DOI 10.1242/dev.110189; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Maddalo D, 2014, NATURE, V516, P423, DOI 10.1038/nature13902; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nickles D, 2012, MOL CELL BIOL, V32, P3372, DOI 10.1128/MCB.06739-11; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nile AH, 2016, NAT CHEM BIOL, V12, P60, DOI [10.1038/NCHEMBIO.2005, 10.1038/nchembio.2005]; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spanjer AIR, 2016, FASEB J, V30, P1823, DOI 10.1096/fj.201500129; Stanganello E, 2016, J CELL SCI, V129, P665, DOI 10.1242/jcs.182469; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wang Y, 2012, CELL SIGNAL, V24, P2389, DOI 10.1016/j.cellsig.2012.08.009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304	60	62	62	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4832	4844		10.1096/fj.201700144R	http://dx.doi.org/10.1096/fj.201700144R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28733458	Green Published			2022-12-26	WOS:000413398500015
J	Hendershot, JM; O'Brien, PJ				Hendershot, Jenna M.; O'Brien, Patrick J.			Search for DNA damage by human alkyladenine DNA glycosylase involves early intercalation by an aromatic residue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN 3-METHYLADENINE-DNA GLYCOSYLASE; BASE EXCISION; REPAIR; BINDING; CELLS; AAG	DNA repair enzymes recognize and remove damaged bases that are embedded in the duplex. To gain access, most enzymes use nucleotide flipping, whereby the target nucleotide is rotated 180 degrees into the active site. In human alkyladenine DNA glycosylase (AAG), the enzyme that initiates base excision repair of alkylated bases, the flipped-out nucleotide is stabilized by intercalation of the side chain of tyrosine 162 that replaces the lesion nucleobase. Previous kinetic studies provided evidence for the formation of a transient complex that precedes the stable flipped-out complex, but it is not clear how this complex differs from nonspecific complexes. We used site-directed mutagenesis and transient-kinetic approaches to investigate the timing of Tyr(162) intercalation for AAG. The tryptophan substitution (Y162W) appeared to be conservative, because the mutant protein retained a highly favorable equilibrium constant for flipping the 1,N-6-ethenoadenine (epsilon A) lesion, and the rate of N-glycosidic bond cleavage was identical to that of the wild-type enzyme. We assigned the tryptophan fluorescence signal from Y162W by removing two native tryptophan residues (W270A/W284A). Stopped-flow experiments then demonstrated that the change in tryptophan fluorescence of the Y162W mutant is extremely rapid upon binding to either damaged or undamaged DNA, much faster than the lesion-recognition and nucleotide flipping steps that were independently determined by monitoring the epsilon A fluorescence. These observations suggest that intercalation by this aromatic residue is one of the earliest steps in the search for DNA damage and that this interaction is important for the progression of AAG from nonspecific searching to specific-recognition complexes.	[Hendershot, Jenna M.; O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Med Sch, 5301 MSRB 3,1150 W Med Ctr Dr,SPC 5606, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	O'Brien, PJ (corresponding author), Univ Michigan, Dept Biol Chem, Med Sch, 5301 MSRB 3,1150 W Med Ctr Dr,SPC 5606, Ann Arbor, MI 48109 USA.	pjobrien@umich.edu			NIGMS of the National Institutes of Health [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727, P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM108022] Funding Source: NIH RePORTER	NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the O'Brien laboratory for helpful discussions and comments on the manuscript. The University of Michigan Comprehensive Cancer Center is supported by NIGMS of the National Institutes of Health Grant P30CA036727.	Cao CY, 2006, J AM CHEM SOC, V128, P13034, DOI 10.1021/ja062978n; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Engelward BP, 1997, P NATL ACAD SCI USA, V94, P13087, DOI 10.1073/pnas.94.24.13087; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Hedglin M, 2008, BIOCHEMISTRY-US, V47, P11434, DOI 10.1021/bi801046y; Hendershot JM, 2014, NUCLEIC ACIDS RES, V42, P12681, DOI 10.1093/nar/gku919; Hendershot JM, 2011, BIOCHEMISTRY-US, V50, P1864, DOI 10.1021/bi101856a; Hsieh J, 2009, RNA, V15, P224, DOI 10.1261/rna.1309409; IBEANU G, 1992, CARCINOGENESIS, V13, P1989, DOI 10.1093/carcin/13.11.1989; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; Lau AY, 2000, P NATL ACAD SCI USA, V97, P13573, DOI 10.1073/pnas.97.25.13573; Li DY, 2012, J AM CHEM SOC, V134, P8896, DOI 10.1021/ja3010094; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lingaraju GM, 2011, J BIOL CHEM, V286, P13205, DOI 10.1074/jbc.M110.192435; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE2091, DOI 10.1073/pnas.1400386111; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; O'Brien PJ, 2003, BIOCHEMISTRY-US, V42, P12418, DOI 10.1021/bi035177v; OCONNOR TR, 1993, NUCLEIC ACIDS RES, V21, P5561; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Scharer OD, 1998, J BIOL CHEM, V273, P8592, DOI 10.1074/jbc.273.15.8592; Setser JW, 2012, BIOCHEMISTRY-US, V51, P382, DOI 10.1021/bi201484k; Wolfe AE, 2009, BIOCHEMISTRY-US, V48, P11357, DOI 10.1021/bi9015082	26	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16070	16080		10.1074/jbc.M117.782813	http://dx.doi.org/10.1074/jbc.M117.782813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28747435	hybrid, Green Published			2022-12-26	WOS:000412109400008
J	Bsteh, G; Ehling, R; Walchhofer, LM; Hegen, H; Auer, M; Wurth, S; Di Pauli, F; Wagner, M; Reindl, M; Deisenhammer, F; Berger, T				Bsteh, Gabriel; Ehling, Rainer; Walchhofer, Lisa-Maria; Hegen, Harald; Auer, Michael; Wurth, Sebastian; Di Pauli, Franziska; Wagner, Michaela; Reindl, Markus; Deisenhammer, Florian; Berger, Thomas			Paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis do not indicate benign prognosis-The PaSiMS II study	PLOS ONE			English	Article							SUBCUTANEOUS INTERFERON BETA-1A; DEMYELINATING EVENT; CONTROLLED PHASE-3; DISABILITY; TRIAL; EPILEPSY; PREVALENCE; CONVERSION; CRITERIA; THERAPY	Background Paroxysmal (PS) and unusual symptoms (US) account for approximately 1.6% of initial manifestations of multiple sclerosis (MS) and have comparable conversion rates to clinically definite MS (CDMS) as classical bout onset symptoms (CS). However, long-term prognosis and clinical outcome of patients experiencing PS or US as first clinical manifestation are unclear. Methods Clinical, MRI and cerebrospinal fluid data were obtained retrospectively and patients presenting with PS or US were compared to patients with CS presentation. Results In a cohort of 532 relapsing onset MS patients followed for a mean period of 11.4 years (SD 3.6), 10 (1.9%) patients initially presented with PS/US. PS/US patients received disease modifying treatment (DMT) in a significantly smaller proportion immediately after the first clinical symptom (30% vs. 61.7%; p = 0.021) and during the observation period (60% vs. 83.5%; p = 0.033). In multivariate models correcting for sex, age at initial symptoms, complete remission of initial symptoms, total number of T2 and contrast-enhancing lesions, presence of oligoclonal bands and DMT exposure, PS/US were not associated with lower annualized relapse rate or lower EDSS over time. Conclusion In addition to a similar conversion rate to CDMS, patients presenting with PS/US at disease onset display very similar relapse and disability rates as patients with CS onset. Consequently, initial presentation with PS/US does not indicate benign or atypical MS, but requires DMT initiation based on the same criteria as in CS patients.	[Bsteh, Gabriel; Ehling, Rainer; Hegen, Harald; Auer, Michael; Wurth, Sebastian; Di Pauli, Franziska; Reindl, Markus; Deisenhammer, Florian; Berger, Thomas] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Ehling, Rainer] Clin Rehabil Muenster, Dept Neurol, Munster, Germany; [Walchhofer, Lisa-Maria; Wagner, Michaela] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Bsteh, G (corresponding author), Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria.	Gabriel.bsteh@i-med.ac.at	Berger, Thomas U/HGA-3594-2022; Reindl, Markus/ABE-5880-2020	Reindl, Markus/0000-0003-2817-1402	Biogen; Merck Serono; Novartis; Genzyme; Teva Ratiopharm; Bayer; Stryker; Bayer Schering; Sanofi Genzyme; Allergan; Ipsen Pharma; Roche; Bayer Healthcare; Genzyme-Sanofi; Merck; Novartis Pharma; TEVA; Octapharma; Ratiopharm; Sanofi Aventis; Alexion; Bohringer Ingelheim; Novartis Pharma GmbH; Ottobock	Biogen(Biogen); Merck Serono(Merck & Company); Novartis(Novartis); Genzyme(Sanofi-AventisGenzyme Corporation); Teva Ratiopharm(Teva Pharmaceutical Industries); Bayer(Bayer AG); Stryker; Bayer Schering(Bayer AG); Sanofi Genzyme(Sanofi-AventisGenzyme Corporation); Allergan(AbbVieAllergan); Ipsen Pharma(Ipsen); Roche(Roche Holding); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Genzyme-Sanofi(Sanofi-AventisGenzyme Corporation); Merck(Merck & Company); Novartis Pharma; TEVA(Teva Pharmaceutical Industries); Octapharma; Ratiopharm; Sanofi Aventis(Sanofi-Aventis); Alexion; Bohringer Ingelheim; Novartis Pharma GmbH; Ottobock	Markus Reindl is an academic editor for PLOS ONE. We declare the following conflicts of interest. GB has participated in meetings sponsored by Biogen, Merck Serono, Novartis, Genzyme and Teva Ratiopharm. RE has participated in meetings sponsored by and received honoraria (lectures and consultations) from Biogen, Merck Serono and Teva Ratiopharm, has received grants for educational purposes from Biogen, Bohringer Ingelheim, Merck Serono, Novartis Pharma GmbH, Ottobock and Teva Ratiopharm, and has received honoraria for acting as consultant for Teva Pharmaceuticals Europe. LMW has participated in meetings sponsored by Bayer and Stryker. HH has participated in meetings sponsored by, received speaker honoraria or travel funding from Bayer Schering, Biogen, Merck Serono and Novartis, and received honoraria for acting as consultant for Teva Pharmaceuticals Europe. MA received speaker honoraria from Novartis. SW has participated in meetings sponsored by, received honoraria or travel funding from Biogen, Merck Serono, Novartis, Sanofi Genzyme, Teva Ratiopharm, Allergan, Ipsen Pharma and Roche. FDP has received speaking honoraria from Biogen-Idec and Sanofi-Aventis Austria. MW reports no conflict of interest. MR reports no conflict of interest. FD has participated in meetings sponsored by or received honoraria for acting as an advisor/speaker for Bayer Healthcare, Biogen, Genzyme-Sanofi, Merck, Novartis Pharma, Roche and TEVA. TB has participated in meetings sponsored by and received honoraria (lectures, advisory boards, consultations) from pharmaceutical companies marketing treatments for MS: Bayer, Biogen, Genzyme, Merck, Novartis, Octapharma, Ratiopharm, Roche, Sanofi Aventis, TEVA. His institution has received financial support in the past 12 months by unrestricted research grants (Biogen, Bayer, Merck, Novartis, Ratiopharm, Sanofi Aventis) and for participation in clinical trials in multiple sclerosis sponsored by Alexion, Bayer, Biogen, Merck, Novartis, Octapharma, Roche, Sanofi Aventis, TEVA. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Allen AN, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-189; Amato M. P., 2000, Neurological Sciences, V21, pS831, DOI 10.1007/s100720070021; Asamer E-M, 2014, CENSUS 2011 AUSTRIA, P1; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Baumhackl U., 2014, MULTIPLE SKLEROSE PR, P22; Bsteh G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158978; Calabrese M, 2012, J NEUROL NEUROSUR PS, V83, P49, DOI 10.1136/jnnp-2011-300414; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2012, LANCET NEUROL, V11, P33, DOI 10.1016/S1474-4422(11)70262-9; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Ebers GC, 2010, J NEUROL NEUROSUR PS, V81, P907, DOI 10.1136/jnnp.2009.204123; Ehling R, 2016, MULT SCLER RELAT DIS, V9, P150, DOI 10.1016/j.msard.2016.07.014; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; GOODKIN DE, 1991, NEUROLOGY, V41, P332, DOI 10.1212/WNL.41.2_Part_1.332; Hauser SL, 2016, N ENGL J MED; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P944, DOI 10.1212/01.wnl.0000237994.95410.ce; Kappos L, 2015, NEW ENGL J MED, V373, P1418, DOI 10.1056/NEJMoa1501481; KINNUNEN E, 1986, EPILEPSIA, V27, P729, DOI 10.1111/j.1528-1157.1986.tb03602.x; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Miller AE, 2014, LANCET NEUROL, V13, P977, DOI 10.1016/S1474-4422(14)70191-7; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Tintore M, 2000, AM J NEURORADIOL, V21, P702; Tintore M, 2015, BRAIN, V138, P1863, DOI 10.1093/brain/awv105; Uribe-San-Martin R, 2014, SEIZURE-EUR J EPILEP, V23, P81, DOI 10.1016/j.seizure.2013.09.008; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181458	10.1371/journal.pone.0181458	http://dx.doi.org/10.1371/journal.pone.0181458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749974	gold, Green Submitted, Green Published			2022-12-26	WOS:000406575700047
J	Ilyushina, NA; Lugovtsev, VY; Samsonova, AP; Sheikh, FG; Bovin, NV; Donnelly, RP				Ilyushina, Natalia A.; Lugovtsev, Vladimir Y.; Samsonova, Anastasia P.; Sheikh, Faruk G.; Bovin, Nicolai V.; Donnelly, Raymond P.			Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses	PLOS ONE			English	Article							NS1 PROTEIN; H5N1 INFLUENZA; FUNCTIONAL BALANCE; BETA-INTERFERON; HIGH VIRULENCE; BINDING-SITES; I INTERFERON; RNA-BINDING; RIG-I; NEURAMINIDASE	Influenza A viruses pose a constant potential threat to human health. In view of the innate antiviral activity of interferons (IFNs) and their potential use as anti-influenza agents, it is important to know whether viral resistance to these antiviral proteins can arise. To examine the likelihood of emergence of IFN-lambda 1-resistant H1N1 variants, we serially passaged the A/California/04/09 (H1N1) strain in a human lung epithelial cell line (Calu-3) in the presence of increasing concentrations of recombinant IFN-lambda 1 protein. To monitor changes associated with adaptation of this virus to growth in Calu-3 cells, we also passaged the wild-type virus in the absence of IFN-lambda 1. Under IFN-lambda 1 selective pressure, the parental virus developed two neuraminidase (NA) mutations, S79L and K331N, which significantly reduced NA enzyme activity (down arrow 1.4-fold) and sensitivity to IFN-lambda 1 (down arrow > 20-fold), respectively. These changes were not associated with a reduction in viral replication levels. Mutants carrying either K331N alone or S79L and K331N together induced weaker phosphorylation of IFN regulatory factor 3 (IRF3), and, as a consequence, much lower expression of the IFN genes (IFNB1, IFNL1 and IFNL2/3) and proteins (IFN-lambda 1 and IFN-lambda 2/3). The lower levels of IFN expression correlated with weaker induction of tyrosine-phosphorylated STAT1 and reduced RIG-I protein levels. Our findings demonstrate that influenza viruses can develop increased resistance to the antiviral activity of type III interferons.	[Ilyushina, Natalia A.; Sheikh, Faruk G.; Donnelly, Raymond P.] US FDA, Div Biotechnol Res & Review 2, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Lugovtsev, Vladimir Y.; Samsonova, Anastasia P.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Bovin, Nicolai V.] Russian Acad Sci, Shemyakin Inst Bioorgan Chem, Carbohydrate Chem Lab, Moscow, Russia	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Ilyushina, NA; Donnelly, RP (corresponding author), US FDA, Div Biotechnol Res & Review 2, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	Natalia.Ilyushina@fda.hhs.gov; Raymond.Donnelly@fda.hhs.gov	Donnelly, Raymond P./AFT-8600-2022	Donnelly, Raymond P./0000-0002-0695-5276; Lugovtsev, Vladimir/0000-0003-0573-1497	FDA Medical Countermeasures Initiative [2011094]; RAS Presidium Grant in Molecular and Cell Biology; Oak Ridge Institute for Science and Education	FDA Medical Countermeasures Initiative; RAS Presidium Grant in Molecular and Cell Biology; Oak Ridge Institute for Science and Education(General Electric)	This study was supported by Grant No. 2011094 from the FDA Medical Countermeasures Initiative program to RPD, by an RAS Presidium Grant in Molecular and Cell Biology to NVB, and by a Senior Postgraduate Research Fellowship Award to NAI from the Oak Ridge Institute for Science and Education.	Beilharz MW, 2007, BIOCHEM BIOPH RES CO, V355, P740, DOI 10.1016/j.bbrc.2007.02.019; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Donnelly RP, 2011, TRENDS IMMUNOL, V32, P443, DOI 10.1016/j.it.2011.07.002; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GAMBARYAN AS, 1992, J VIROL METHODS, V39, P111, DOI 10.1016/0166-0934(92)90130-6; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Govorkova EA, 2004, ANTIMICROB AGENTS CH, V48, P4855, DOI 10.1128/AAC.48.12.4855-4863.2004; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Hata M, 2007, JPN J INFECT DIS, V60, P202; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hernandez JE, 2011, CLIN INFECT DIS, V52, P695, DOI 10.1093/cid/cir001; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hsu ACY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032947; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ilyushina NA, 2014, ANTIVIR RES, V111, P112, DOI 10.1016/j.antiviral.2014.09.008; Ilyushina NA, 2012, J VIROL, V86, P4724, DOI 10.1128/JVI.06774-11; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Kamali Amanda, 2013, Infect Drug Resist, V6, P187, DOI 10.2147/IDR.S36601; Kiso M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000786; Kiso M, 2010, P NATL ACAD SCI USA, V107, P882, DOI 10.1073/pnas.0909603107; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lackenby A, 2008, Euro Surveill, V13; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li WZ, 2014, J VIROL, V88, P10432, DOI 10.1128/JVI.01383-14; Liedmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6645; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Marathe BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071401; MATROSOVICH MN, 1993, VIROLOGY, V196, P111, DOI 10.1006/viro.1993.1459; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Mossad SB, 2009, CLEV CLIN J MED, V76, P337, DOI 10.3949/ccjm.76a.09047; Nicoll A, 2008, EUROSURVEILLANCE, V13, P5; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Patel D, 2013, VIRUS RES, V172, P75, DOI 10.1016/j.virusres.2012.12.003; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Riegger D, 2015, J VIROL, V89, P2241, DOI 10.1128/JVI.02406-14; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Scagnolari C, 2011, J INTERFERON CYTOKIN, V31, P475, DOI DOI 10.1089/JIR.2010.0125; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sleeman K, 2010, ANTIMICROB AGENTS CH, V54, P2517, DOI 10.1128/AAC.01739-09; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wright PF., 2013, FIELDS VIROLOGY, V6th ed., P1186; Xia C, 2016, J VIROL, V90, P2403, DOI 10.1128/JVI.02749-15; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12	69	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181999	10.1371/journal.pone.0181999	http://dx.doi.org/10.1371/journal.pone.0181999			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750037	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700112
J	Szostakiwskyj, JMH; Willatt, SE; Cortese, F; Protzner, AB				Szostakiwskyj, Jessie M. H.; Willatt, Stephanie E.; Cortese, Filomeno; Protzner, Andrea B.			The modulation of EEG variability between internally-and externally-driven cognitive states varies with maturation and task performance	PLOS ONE			English	Article							BRAIN SIGNAL VARIABILITY; NOISE; CHILDREN; MEMORY	Increasing evidence suggests that brain signal variability is an important measure of brain function reflecting information processing capacity and functional integrity. In this study, we examined how maturation from childhood to adulthood affects the magnitude and spatial extent of state-to-state transitions in brain signal variability, and how this relates to cognitive performance. We looked at variability changes between resting-state and task (a symbol-matching task with three levels of difficulty), and within trial (fixation, post-stimulus, and post-response). We calculated variability with multiscale entropy (MSE), and additionally examined spectral power density (SPD) from electroencephalography (EEG) in children aged 8-14, and in adults aged 18-33. Our results suggest that maturation is characterized by increased local information processing (higher MSE at fine temporal scales) and decreased long-range interactions with other neural populations (lower MSE at coarse temporal scales). Children show MSE changes that are similar in magnitude, but greater in spatial extent when transitioning between internally-and externally-driven brain states. Additionally, we found that in children, greater changes in task difficulty were associated with greater magnitude of modulation in MSE. Our results suggest that the interplay between maturational and state-to-state changes in brain signal variability manifest across different spatial and temporal scales, and influence information processing capacity in the brain.	[Szostakiwskyj, Jessie M. H.; Willatt, Stephanie E.; Protzner, Andrea B.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Cortese, Filomeno; Protzner, Andrea B.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary	Szostakiwskyj, JMH (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	jmhart@ucalgary.ca	Cortese, Filomeno/AAG-7559-2020	Cortese, Filomeno/0000-0001-8736-2853; Protzner, Andrea/0000-0001-8062-2923	Natural Sciences and Engineering Research Council of Canada [418454-2013]; Canadian Foundation for Innovation Leaders Opportunity Fund [30320]; Alberta Enterprise and Advanced Education Research Capacity Program, Alberta Alignment Grant [RCP-13-38-SEG]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alberta Enterprise and Advanced Education Research Capacity Program, Alberta Alignment Grant	The research was funded by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (418454-2013, http://www.nserc-crsng.gc.ca/index_eng.asp), a Canadian Foundation for Innovation Leaders Opportunity Fund (30320, https://www.innovation.ca/ and an Alberta Enterprise and Advanced Education Research Capacity Program, Alberta Alignment Grant (RCP-13-38-SEG, http://economic.alberta.ca/Research-CapacityProgram.asp) to ABP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; COURCHESNE E, 1977, SCIENCE, V197, P589, DOI 10.1126/science.877575; Courtiol J, 2016, J NEUROSCI METH, V273, P175, DOI 10.1016/j.jneumeth.2016.09.004; Cragg L, 2011, DEVELOPMENTAL SCI, V14, P935, DOI 10.1111/j.1467-7687.2010.01031.x; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; DUSTMAN RE, 1969, ELECTROEN CLIN NEURO, V26, P2, DOI 10.1016/0013-4694(69)90028-5; Efron B, 1994, INTRO BOOTSTRAP; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Garrett DD, 2012, CEREB CORTEX; Garrett Douglas D, 2014, Cereb Cortex, V24, P2931, DOI 10.1093/cercor/bht150; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Good P., 2000, PERMUTATION TESTS; He BJ, 2013, J NEUROSCI, V33, P4672, DOI 10.1523/JNEUROSCI.2922-12.2013; Heisz JJ, 2012, NEUROIMAGE, V63, P1384, DOI 10.1016/j.neuroimage.2012.08.018; Itier RJ, 2004, J COGNITIVE NEUROSCI, V16, P487, DOI 10.1162/089892904322926818; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Lippe Sarah, 2009, Front Hum Neurosci, V3, P48, DOI 10.3389/neuro.09.048.2009; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; McIntosh AR, 2014, CEREB CORTEX, V24, P1806, DOI 10.1093/cercor/bht030; McIntosh AR, 2010, ARCH ITAL BIOL, V148, P323; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; MCINTOSH AR, 1991, BRAIN RES, V547, P295, DOI 10.1016/0006-8993(91)90974-Z; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Misic B, 2010, J NEUROPHYSIOL, V104, P2667, DOI 10.1152/jn.00648.2010; Oram MW, 2011, J NEUROPHYSIOL, V105, P942, DOI 10.1152/jn.00711.2009; Pedhazur E. J., 1982, MULTIPLE REGRESSION; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004445; Ponce-Alvarez A, 2013, P NATL ACAD SCI USA, V110, P13162, DOI 10.1073/pnas.1300098110; Protzner AB, 2010, ARCH ITAL BIOL, V148, P289; Protzner AB, 2013, J NEUROSCI, V33, P9855, DOI 10.1523/JNEUROSCI.3009-12.2013; Sleimen-Malkoun R, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0067-14.2015; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wang HY, 2016, J COGNITIVE NEUROSCI, V28, P971, DOI 10.1162/jocn_a_00947	44	15	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181894	10.1371/journal.pone.0181894	http://dx.doi.org/10.1371/journal.pone.0181894			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750035	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700098
J	Candia, E; Reyes, P; Covian, C; Rodriguez, F; Wainstein, N; Morales, J; Mosso, C; Rosemblatt, M; Fierro, JA				Candia, Enzo; Reyes, Paz; Covian, Camila; Rodriguez, Francisco; Wainstein, Nicolas; Morales, Jorge; Mosso, Claudio; Rosemblatt, Mario; Alberto Fierro, Juan			Single and combined effect of retinoic acid and rapamycin modulate the generation, activity and homing potential of induced human regulatory T cells	PLOS ONE			English	Article							FOXP3 EXPRESSION; TGF-BETA; MAMMALIAN TARGET; IL-2 RECEPTOR; VITAMIN-A; IN-VITRO; EX-VIVO; EXPANSION; INDUCTION; CD4(+)	Adoptive transfer of CD4+CD25+FOXP3+regulatory T cells (Treg cells) has been successfully utilized to treat graft versus host disease and represents a promising strategy for the treatment of autoimmune diseases and transplant rejection. The aim of this study was to evaluate the effects of all-trans retinoic acid (atRA) and rapamycin (RAPA) on the number, phenotype, homing markers expression, DNA methylation, and function of induced human Treg cells in short-term cultures. Naive T cells were polyclonally stimulated and cultured for five days in the presence of different combinations of IL-2, TGF-beta 1, atRA and RAPA. The resulting cells were characterized by the expression of FOXP3, activation, surface and homing markers. Methylation of the Conserved Non-coding Sequence 2 was also evaluated. Functional comparison of the different culture conditions was performed by suppression assays in vitro. Culturing naive human T cells with IL-2/TGF beta 1 resulted in the generation of 54.2% of Treg cells (CD4+CD25+FOXP3+) whereas the addition of 100 nM atRA increased the yield of Treg cells to 66% (p = 0.0088). The addition of RAPA did not increase the number of Treg cells in any of these settings. Treg cells generated in the presence of atRA had an increased expression of the beta 7 integrin to nearly 100% of the generated Treg cells, while RAPA treated cells showed enhanced expression of CXCR4. The differential expression of homing molecules highlights the possibility of inducing Treg cells with differential organ-specific homing properties. Neither atRA nor RAPA had an effect on the highly methylated CNS2 sites, supporting reports that their contribution to the lineage stability of Treg cells is not mediated by methylation changes in this locus. Treg cells generated in the presence of RAPA show the most potent suppression effect on the proliferation of effector cells.	[Candia, Enzo; Morales, Jorge; Mosso, Claudio; Alberto Fierro, Juan] Clin Las Condes, Ctr Trasplantes, Santiago, Chile; [Reyes, Paz; Rosemblatt, Mario] Fdn Ciencia & Vida, Santiago, Chile; [Covian, Camila; Rodriguez, Francisco; Wainstein, Nicolas; Rosemblatt, Mario] Univ Andres Bello, Fac Ciencias Biol, Santiago, Chile; [Rosemblatt, Mario] Univ Chile, Fac Ciencias, Dept Biol, Santiago, Chile	Clinica Las Condes; Universidad Andres Bello; Universidad de Chile	Fierro, JA (corresponding author), Clin Las Condes, Ctr Trasplantes, Santiago, Chile.	afierro@clc.cl			Fondecyt [1120731]; Conicyt Proyecto basal [PFB-16]; Direccion Academica Clinica Las Condes	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Conicyt Proyecto basal; Direccion Academica Clinica Las Condes	This work was supported by Fondecyt 1120731, Conicyt Proyecto basal PFB-16, Direccion Academica Clinica Las Condes 2011, Julio Krauss Rotter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Aoyama K, 2013, BLOOD, V122, P2125, DOI 10.1182/blood-2012-11-470252; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Baan CC, 2005, TRANSPLANTATION, V80, P110, DOI 10.1097/01.TP.0000164142.98167.4B; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Battaglia M, 2012, METHODS MOL BIOL, V821, P279, DOI 10.1007/978-1-61779-430-8_17; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Brown CC, 2015, EUR J IMMUNOL, V45, P1287, DOI 10.1002/eji.201344398; Brunstein CG, 2016, BLOOD, V127, P1044, DOI 10.1182/blood-2015-06-653667; Canavan JB, 2016, GUT, V65, P584, DOI 10.1136/gutjnl-2014-306919; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Chen LC, 2016, J IMMUNOL, V197, P1137, DOI 10.4049/jimmunol.1600696; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; DIIANNI M, 2011, BLOOD, V117, P3921, DOI [DOI 10.1182/blood-2010-10-311894, DOI 10.1182/BLOOD-2010-10-311894]; Ding YZ, 2012, TRENDS IMMUNOL, V33, P174, DOI 10.1016/j.it.2012.01.002; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Duhen T, 2012, BLOOD, V119, P4430, DOI 10.1182/blood-2011-11-392324; Dunkin D, 2014, DIGEST DIS, V32, P61, DOI 10.1159/000367827; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Engelhardt BG, 2011, BONE MARROW TRANSPL, V46, P436, DOI 10.1038/bmt.2010.127; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Evans-Marin HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134100; Fantus D, 2015, AM J TRANSPLANT, V15, P891, DOI 10.1111/ajt.13151; Fantus D, 2015, TRANSPLANTATION, V99, pE117, DOI 10.1097/TP.0000000000000803; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gallon L, 2015, TRANSPLANTATION, V99, P1774, DOI 10.1097/TP.0000000000000717; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Geem D, 2015, INFLAMM BOWEL DIS, V21, P1409, DOI 10.1097/MIB.0000000000000343; Geissler EK, 2013, CURR OPIN ORGAN TRAN, V18, P408, DOI 10.1097/MOT.0b013e328363319d; Geissler EK, 2012, TRANSPLANT RES, V1, DOI [10.1186/2047-1440-1-10, 10.1186/2047-1440-1-11]; Gerriets VA, 2016, NAT IMMUNOL, V17, P1459, DOI 10.1038/ni.3577; Golovina TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015868; Guo YX, 2015, PHYSIOL REV, V95, P125, DOI 10.1152/physrev.00032.2013; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Heazlewood SY, 2014, ANN NY ACAD SCI, V1310, P119, DOI 10.1111/nyas.12329; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Himmel ME, 2012, IMMUNOLOGY, V136, P115, DOI 10.1111/j.1365-2567.2012.03572.x; Hippen KL, 2011, AM J TRANSPLANT, V11, P1148, DOI 10.1111/j.1600-6143.2011.03558.x; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2012, NAT IMMUNOL, V13, P943, DOI 10.1038/ni.2424; Hornero RA, 2017, TRANSPLANTATION, V101, P302, DOI 10.1097/TP.0000000000001278; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Huter EN, 2008, EUR J IMMUNOL, V38, P1814, DOI 10.1002/eji.200838346; Issa F, 2013, TRENDS IMMUNOL, V34, P107, DOI 10.1016/j.it.2012.11.003; Issa F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053331; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; James CR, 2016, IMMUNOL CELL BIOL; Jhunjhunwala S, 2013, J LEUKOCYTE BIOL, V94, P981, DOI 10.1189/jlb.0312167; Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kawamoto K, 2010, TRANSPL IMMUNOL, V23, P28, DOI 10.1016/j.trim.2010.03.004; Kim CH, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/416910; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim KW, 2015, IMMUNOLOGY, V144, P68, DOI 10.1111/imm.12351; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Koenecke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038252; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Lee JH, 2007, J IMMUNOL, V178, P301, DOI 10.4049/jimmunol.178.1.301; Levitsky J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156535; Lewis M, 2008, IMMUNOL CELL BIOL, V86, P226, DOI 10.1038/sj.icb.7100132; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2008, J AUTOIMMUN, V30, P293, DOI 10.1016/j.jaut.2007.12.012; Lu L, 2014, P NATL ACAD SCI USA, V111, pE3432, DOI 10.1073/pnas.1408780111; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015150; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; LU Y, 2014, J IMMUNOL RES, V2014, DOI DOI 10.1155/2014/989434; Ma JL, 2014, J LEUKOCYTE BIOL, V95, P275, DOI 10.1189/jlb.0513297; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McMurchy AN, 2012, EUR J IMMUNOL, V42, P27, DOI 10.1002/eji.201141651; Michael M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/608951; Miyara M, 2016, ONCOTARGET; Miyara M, 2014, NAT REV RHEUMATOL, V10, P543, DOI 10.1038/nrrheum.2014.105; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Moore C, 2015, EUR J IMMUNOL, V45, P452, DOI 10.1002/eji.201444743; Moreira-Teixeira L, 2012, J IMMUNOL, V188, P624, DOI 10.4049/jimmunol.1102281; Morikawa H, 2014, IMMUNOL REV, V259, P192, DOI 10.1111/imr.12174; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nair VS, 2016, J IMMUNOL, V196, P2119, DOI 10.4049/jimmunol.1502352; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Okada M, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0129-1; Pilat N, 2012, CURR OPIN ORGAN TRAN, V17, P63, DOI 10.1097/MOT.0b013e32834ee68b; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Qian XF, 2011, INT IMMUNOPHARMACOL, V11, P630, DOI 10.1016/j.intimp.2010.11.036; Bono MR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060349; Ruiz P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00596; Safinia N, 2016, ONCOTARGET, V7, P7563, DOI 10.18632/oncotarget.6927; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Sato K, 2002, J IMMUNOL, V168, P6263, DOI 10.4049/jimmunol.168.12.6263; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Schmidt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148474; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Scotta C, 2013, HAEMATOLOGICA, V98, P1291, DOI 10.3324/haematol.2012.074088; Shi XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093995; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Simonetta F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113314; Singh K, 2012, AM J TRANSPLANT, V12, P1441, DOI 10.1111/j.1600-6143.2011.03963.x; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Tollervey JR, 2012, EPIGENETICS-US, V7, P823, DOI 10.4161/epi.21141; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Tran Dat Q, 2013, Methods Mol Biol, V979, P199, DOI 10.1007/978-1-62703-290-2_16; Trzonkowski P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7721; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Valmori D, 2006, J IMMUNOL, V177, P944, DOI 10.4049/jimmunol.177.2.944; Veerapathran A, 2011, BLOOD, V118, P5671, DOI 10.1182/blood-2011-02-337097; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Zundler S, 2015, CLIN EXP RHEUMATOL, V33, pS19	131	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0182009	10.1371/journal.pone.0182009	http://dx.doi.org/10.1371/journal.pone.0182009			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746369	Green Submitted, gold, Green Published			2022-12-26	WOS:000406371800074
J	Hoffmann, SA; Wohltat, C; Muller, KM; Arndt, KM				Hoffmann, Stefan A.; Wohltat, Christian; Mueller, Kristian M.; Arndt, Katja M.			A user-friendly, low-cost turbidostat with versatile growth rate estimation based on an extended Kalman filter	PLOS ONE			English	Article							BACTERIA; CULTURE	For various experimental applications, microbial cultures at defined, constant densities are highly advantageous over simple batch cultures. Due to high costs, however, devices for continuous culture at freely defined densities still experience limited use. We have developed a small-scale turbidostat for research purposes, which is manufactured from inexpensive components and 3D printed parts. A high degree of spatial system integration and a graphical user interface provide user-friendly operability. The used optical density feedback control allows for constant continuous culture at a wide range of densities and offers to vary culture volume and dilution rates without additional parametrization. Further, a recursive algorithm for on-line growth rate estimation has been implemented. The employed Kalman filtering approach based on a very general state model retains the flexibility of the used control type and can be easily adapted to other bioreactor designs. Within several minutes it can converge to robust, accurate growth rate estimates. This is particularly useful for directed evolution experiments or studies on metabolic challenges, as it allows direct monitoring of the population fitness.	[Hoffmann, Stefan A.; Wohltat, Christian; Arndt, Katja M.] Univ Potsdam, Inst Biochem & Biol, Mol Biotechnol, Potsdam, Germany; [Mueller, Kristian M.] Bielefeld Univ, Fac Technol, Cellular & Mol Biotechnol, Bielefeld, Germany	University of Potsdam; University of Bielefeld	Arndt, KM (corresponding author), Univ Potsdam, Inst Biochem & Biol, Mol Biotechnol, Potsdam, Germany.	katja.arndt@uni-potsdam.de		Arndt, Katja/0000-0001-9220-0920; Hoffmann, Stefan/0000-0002-3184-8640	Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Potsdam	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam	We acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam.	Avrahami-Moyal L, 2012, FEMS YEAST RES, V12, P521, DOI 10.1111/j.1567-1364.2012.00803.x; BENNETT WN, 1990, ARCH ENVIRON CON TOX, V19, P118, DOI 10.1007/BF01059819; BLUMWALD E, 1984, PLANT PHYSIOL, V74, P183, DOI 10.1104/pp.74.1.183; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gresham D, 2014, GENOMICS, V104, P399, DOI 10.1016/j.ygeno.2014.09.015; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Matteau D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133384; Miller AW, 2013, JOVE-J VIS EXP, DOI 10.3791/50262; Nisamedtinov I, 2011, APPL MICROBIOL BIOT, V89, P1029, DOI 10.1007/s00253-010-2946-z; OZAKI M, 1991, MOL GEN GENET, V230, P17, DOI 10.1007/BF00290644; Takahashi CN, 2015, ACS SYNTH BIOL, V4, P32, DOI 10.1021/sb500165g; Toprak E, 2012, NAT GENET, V44, P101, DOI 10.1038/ng.1034	17	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181923	10.1371/journal.pone.0181923	http://dx.doi.org/10.1371/journal.pone.0181923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746418	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800070
J	Wei, LS; Peng, J; Liu, W; Wang, XM; Liu, F				Wei, Longsheng; Peng, Jian; Liu, Wei; Wang, Xinmei; Liu, Feng			Modelling saliency attention to predict eye direction by topological structure and earth mover's distance	PLOS ONE			English	Article							VISUAL-ATTENTION	A saliency attention model for predicting eye direction is proposed in this paper. This work is inspired by the success of the topological structure and Earth Mover's Distance (EMD) approach. Firstly, we extract visual saliency features such as color contrast, intensity contrast, orientation, and texture. Then, we eliminate disconnected regions in the feature maps to keep topological structure. Secondly, we calculate center surround difference using across-scale EMD between different scales feature maps, rather than utilizing the Difference of Gaussian (DoG), which is used in many other saliency attention models. Thirdly, we across-scale fuse the feature maps in different scale and same feature. Lastly, we take advantage of competition function to calculate feature maps in same feature to form a saliency map, which is use to predict eye direction. Experimental results demonstrated the proposed model outperformed the state-of-the-art schemes in eye direction prediction community.	[Wei, Longsheng; Peng, Jian; Liu, Wei; Wang, Xinmei; Liu, Feng] China Univ Geosci, Sch Automat, Wuhan, Hubei, Peoples R China; [Wei, Longsheng; Peng, Jian; Liu, Wei; Wang, Xinmei; Liu, Feng] Hubei Key Lab Adv Control & Intelligent Automat C, Wuhan, Hubei, Peoples R China; [Wei, Longsheng] Harvard Med Sch, Boston, MA USA	China University of Geosciences; Harvard University; Harvard Medical School	Peng, J (corresponding author), China Univ Geosci, Sch Automat, Wuhan, Hubei, Peoples R China.; Peng, J (corresponding author), Hubei Key Lab Adv Control & Intelligent Automat C, Wuhan, Hubei, Peoples R China.	pengjian@cug.edu.cn			National Natural Science Foundation of China [61603357, 61603358, 61503349, 61472374]; Research Center for Advanced Control of Complex Systems and Intelligent Geoscience Instrument, China University of Geosciences (Wuhan) [AU2015CJ017, AU2015CJ017, AU2016CJ021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Center for Advanced Control of Complex Systems and Intelligent Geoscience Instrument, China University of Geosciences (Wuhan)	This work was supported by the National Natural Science Foundation of China under contracts (61603357, 61603358, 61503349, 61472374), the URL is http://www.nsfc.gov.cn/. The Open Research Fund of Research Center for Advanced Control of Complex Systems and Intelligent Geoscience Instrument, China University of Geosciences (Wuhan) (AU2015CJ017, AU2016CJ021), the URL is http://au.cug.edu.cn/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Chen L, 2005, VIS COGN, V12, P553, DOI 10.1080/13506280444000256; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; Erdem E, 2013, J VISION, V13, DOI 10.1167/13.4.11; Han JW, 2016, IEEE T CYBERNETICS, V46, P487, DOI 10.1109/TCYB.2015.2404432; Hou XD, 2012, IEEE T PATTERN ANAL, V34, P194, DOI 10.1109/TPAMI.2011.146; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, J ELECTRON IMAGING, V10, P161, DOI 10.1117/1.1333677; Judd T, 2009, IEEE I CONF COMP VIS, P2106, DOI 10.1109/ICCV.2009.5459462; Levina E, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P251, DOI 10.1109/ICCV.2001.937632; Li J, 2013, IEEE T PATTERN ANAL, V35, P996, DOI 10.1109/TPAMI.2012.147; Ling H, 2007, IEEE T PATTERN ANAL, V29, P840, DOI 10.1109/TPAMI.2007.1058; Liu T, 2011, IEEE T PATTERN ANAL, V33, P353, DOI 10.1109/TPAMI.2010.70; Lu HC, 2017, IEEE T IMAGE PROCESS, V26, P414, DOI 10.1109/TIP.2016.2627804; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Schauerte B, 2012, LECT NOTES COMPUT SC, V7573, P116, DOI 10.1007/978-3-642-33709-3_9; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wei LS, 2015, OPTIK, V126, P522, DOI 10.1016/j.ijleo.2015.01.004; Zhang JM, 2016, IEEE T PATTERN ANAL, V38, P889, DOI 10.1109/TPAMI.2015.2473844; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32; Zhao Q, 2011, J VISION, V11, DOI 10.1167/11.3.9	21	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181543	10.1371/journal.pone.0181543	http://dx.doi.org/10.1371/journal.pone.0181543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746351	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800042
J	Bhatti, MS; Tang, TB; Laude, A				Bhatti, Mehwish Saba; Tang, Tong Boon; Laude, Augustinus			Effects of water drinking test on ocular blood flow waveform parameters: A laser speckle flowgraphy study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTIC-NERVE HEAD; ANKLE VASCULAR INDEX; INTRAOCULAR-PRESSURE; PERFUSION-PRESSURE; GLOBAL PREVALENCE; MACULAR DEGENERATION; ARTERIAL STIFFNESS; MICROCIRCULATION; AUTOREGULATION	The water-drinking test (WDT) is a provocative test used in glaucoma research to assess the effects of elevated intraocular pressure (IOP). Defective autoregulation due to changes in perfusion pressure may play a role in the pathophysiology of several ocular diseases. This study aims to examine the effects of WDT on ocular blood flow (in the form of pulse waveform parameters obtained using laser speckle flowgraphy) to gain insight into the physiology of ocular blood flow and its autoregulation in healthy individuals. Changes in pulse waveform parameters of mean blur rate (MBR) in the entire optic nerve head (ONH), the vasculature of the ONH, the tissue area of the ONH, and the avascular tissue area located outside of the ONH were monitored over time. Significant increases in the falling rate of MBR over the entire ONH and its tissue area and decreases in blowout time (BOT) of the tissue area were observed only at 10 minutes after water intake. Significant increases in the skew of the waveform and the falling rate were observed in the vasculature of the ONH at 40 and 50 minutes after water intake, respectively. In the avascular region of the choroid, the average MBR increased significantly up to 30 minutes after water intake. Furthermore, the rising rate in this region increased significantly at 20 and 40 minutes, and the falling rate and acceleration-time index were both significantly increased at 40 minutes after water intake. Our results indicate the presence of effective autoregulation of blood flow at the ONH after WDT. However, in the choroidal region, outside of the ONH, effective autoregulation was not observed until 30 minutes after water intake in healthy study participants. These pulse waveform parameters could potentially be used in the diagnosis and/or monitoring of patients with glaucoma.	[Bhatti, Mehwish Saba; Tang, Tong Boon] Univ Teknol PETRONAS, Ctr Intelligent Signal & Imaging Res CISIR, Bandar Seri Iskandar, Perak Darul Rid, Malaysia; [Laude, Augustinus] Tan Tock Seng Hosp, Eye Inst, Natl Healthcare Grp, Singapore, Singapore	Universiti Teknologi Petronas; Tan Tock Seng Hospital	Tang, TB (corresponding author), Univ Teknol PETRONAS, Ctr Intelligent Signal & Imaging Res CISIR, Bandar Seri Iskandar, Perak Darul Rid, Malaysia.	tongboon.tang@utp.edu.my		Tang, Tong Boon/0000-0002-5721-6828	Ministry of Education Malaysia [210 ERGS/1/2013/TK02/UTP/02/12, ERGS/1/2013/TK02/UTP/02/12]; National Healthcare 211 Group [NHG CSCS/12004]; HiCOE grant	Ministry of Education Malaysia(Ministry of Education, Malaysia); National Healthcare 211 Group; HiCOE grant	The study was partly funded by the Ministry of Education Malaysia (Grant no: 210 ERGS/1/2013/TK02/UTP/02/12), HiCOE grant to CISIR, and National Healthcare 211 Group (Grant no: NHG CSCS/12004).; The study was partly funded by the Ministry of Education Malaysia (Grant no: ERGS/1/2013/TK02/UTP/02/12), a HiCOE grant to CISIR, and the National Healthcare Group (Grant no: NHG CSCS/12004).	Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Amemiya T, 2003, RETINAL CHOROIDAL VA; Arora N, 1982, INVESTIG OPHTHALMOLO, V54, P15; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Brucculeri M, 1999, J GLAUCOMA, V8, P111; Campbell BCV, 2014, INT J STROKE, V9, P126, DOI 10.1111/ijs.12206; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Chung HS, 1999, SURV OPHTHALMOL, V43, pS43, DOI 10.1016/S0039-6257(99)00050-8; Costa VP, 2008, REV OPHTHALMOL, V15, P38; DIESTELHORST M, 1994, GRAEF ARCH CLIN EXP, V232, P145, DOI 10.1007/BF00176783; Feke GT, 2008, OPHTHALMOLOGY, V115, P246, DOI 10.1016/j.ophtha.2007.04.055; Flammer J, 1998, PROG RETIN EYE RES, V17, P267, DOI 10.1016/S1350-9462(97)00006-2; Frank Netter, 2011, ATLAS HUMAN ANATOMY; Fuchsjager-Mayrl G, 2004, INVEST OPHTH VIS SCI, V45, P834, DOI 10.1167/iovs.03-0461; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS144, DOI 10.1016/j.survophthal.2007.08.010; Guedes Guilherme, 2011, Curr Aging Sci, V4, P110; He Z, 2011, CLIN EXP OPTOM, V94, P133, DOI 10.1111/j.1444-0938.2010.00564.x; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Jordan J, 2000, CIRCULATION, V101, P504, DOI 10.1161/01.CIR.101.5.504; Kersey T, 2013, INDIAN J MED RES, V137, P659; Klein BEK, 2005, BRIT J OPHTHALMOL, V89, P284, DOI 10.1136/bjo.2004.048710; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; LEYDHECKER W, 1950, BRIT J OPHTHALMOL, V34, P457, DOI 10.1136/bjo.34.8.457; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Luft N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168190; Mansouri K, 2008, BRIT J OPHTHALMOL, V92, P332, DOI 10.1136/bjo.2007.123042; Marx H., 1925, KLIN WOCHENSCHR, V4, P2339; Medeiros FA, 2002, J OCUL PHARMACOL TH, V18, P489, DOI 10.1089/108076802321021036; Mendonca GV, 2013, EXP PHYSIOL, V98, P1133, DOI 10.1113/expphysiol.2013.071886; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Prunte C, 1998, Curr Opin Ophthalmol, V9, P50, DOI 10.1097/00055735-199804000-00010; Raman R, 2011, INVEST OPHTH VIS SCI, V52, P4592, DOI 10.1167/iovs.10-6903; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P1752; RIVA CE, 1981, INVEST OPHTH VIS SCI, V21, P34; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Shiba T, 2016, J HYPERTENS, V34, pE486, DOI 10.1097/01.hjh.0000501307.42081.00; Shiba T, 2017, GRAEF ARCH CLIN EXP, V255, P99, DOI 10.1007/s00417-016-3521-9; Shiba T, 2016, GRAEF ARCH CLIN EXP, V254, P1195, DOI 10.1007/s00417-016-3289-y; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; SPAETH GL, 1967, ARCH OPHTHALMOL-CHIC, V77, P50, DOI 10.1001/archopht.1967.00980020052011; Sugiyama T, 2014, PHOTONICS, V1, P220, DOI 10.3390/photonics1030220; Susanna R, 2005, BRIT J OPHTHALMOL, V89, P1298, DOI 10.1136/bjo.2005.070649; Susanna R, 2012, EXPERT REV OPHTHALMO, V7, P413, DOI 10.1586/EOP.12.51; TACHIBANA H, 1982, STROKE, V13, P149, DOI 10.1161/01.STR.13.2.149; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tsai JC, 2009, GLAUCOMA TODAY, P31; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Ulas F, 2014, J GLAUCOMA, V23, P101, DOI 10.1097/IJG.0b013e318264ce7c; Vasconcelos De Moraes C, 2009, GRAEF ARCH CLIN EXP, V247, P385, DOI 10.1007/s00417-008-0969-2; Venkataraman ST, 2010, MICROCIRCULATION, V17, P568, DOI 10.1111/j.1549-8719.2010.00045.x; Vetrugno M, 2005, J OCUL PHARMACOL TH, V21, P250, DOI 10.1089/jop.2005.21.250; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yun C, 2016, INVEST OPHTH VIS SCI, V57, P6604, DOI 10.1167/iovs.16-19989	58	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181512	10.1371/journal.pone.0181512	http://dx.doi.org/10.1371/journal.pone.0181512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742142	Green Submitted, gold, Green Published			2022-12-26	WOS:000406362700048
J	Reindl-Schwaighofer, R; Kainz, A; Kammer, M; Dumfarth, A; Oberbauer, R				Reindl-Schwaighofer, Roman; Kainz, Alexander; Kammer, Michael; Dumfarth, Alexandra; Oberbauer, Rainer			Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5	PLOS ONE			English	Article							PATIENTS STARTING DIALYSIS; RENAL REPLACEMENT THERAPY; QUALITY-OF-LIFE; DISEASE; MANAGEMENT; OUTCOMES; OCTOGENARIANS	Elderly patients represent a growing population among people suffering from ESRD. So far only limited data on actual survival benefits of elderly adults initiating dialysis have been published. Besides the high burden of preexisting comorbidities, dialysis treatment itself may be associated with a further deterioration in functional status in this population. We retrospectively analyzed the Austrian Dialysis and Transplant Registry and identified 8,622 patients who started maintenance hemodialysis after the age of 65 years between 2002 and 2009. We compared this data set to a cohort of 174 patients aged over 65 years with CKD stage 5 who progressed to an eGFR < 10ml/min/and were managed conservatively in the same era. All patients who died of malignant disease were excluded from this analysis. The risk of mortality was analyzed using multivariable Cox proportional hazards models. Furthermore, a parametric model of time to event analysis was used for visualization of changing risk over time and precise calculation of time to equal risk assuming a Weibull distribution. Hemodialysis treatment was associated with a decreased risk for death with a HR of 0.23 (95% CI 0.18 to 0.29; p<0.001) compared to conservative treatment. The time to event analysis however showed, that although survival was initially superior in the hemodialysis group, hazards crossed thereafter. Time to equal risk was 2.9 months and 1.9 months for female and male patient aged 65, respectively, and decreased to one month in the very elderly aged 95. Elderly patients with ERSD did benefit from initiation of hemodialysis, as the conservative group showed a very high initial mortality rate. This survival benefit of dialysis treatment however did not persist beyond the first two months compared to survivors of the conservative group.	[Reindl-Schwaighofer, Roman; Kainz, Alexander; Dumfarth, Alexandra; Oberbauer, Rainer] Krankenhaus Elisabethinen, Dept Nephrol, Linz, Austria; [Reindl-Schwaighofer, Roman; Kainz, Alexander; Kammer, Michael; Oberbauer, Rainer] Med Univ Vienna, Dept Nephrol, Vienna, Austria; [Kammer, Michael] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Ordensklinikum Linz Elisabethinen; Medical University of Vienna; Medical University of Vienna	Oberbauer, R (corresponding author), Krankenhaus Elisabethinen, Dept Nephrol, Linz, Austria.; Oberbauer, R (corresponding author), Med Univ Vienna, Dept Nephrol, Vienna, Austria.	rainer.oberbauer@meduniwien.ac.at	Kainz, Alexander/AAM-7296-2021	Kammer, Michael/0000-0003-4821-9928				Berger JR, 2012, CLIN J AM SOC NEPHRO, V7, P1039, DOI 10.2215/CJN.10411011; Burns A, 2010, HEMODIAL INT, V14, pS32, DOI 10.1111/j.1542-4758.2010.00488.x; Canaud B, 2011, CLIN J AM SOC NEPHRO, V6, P1651, DOI 10.2215/CJN.03530410; Caplin B, 2011, NEPHROL DIAL TRANSPL, V26, P2656, DOI 10.1093/ndt/gfq763; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Chandna SM, 2011, NEPHROL DIAL TRANSPL, V26, P1608, DOI 10.1093/ndt/gfq630; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; Couchoud C, 2009, NEPHROL DIAL TRANSPL, V24, P1553, DOI 10.1093/ndt/gfn698; Da Silva-Gane M, 2012, CLIN J AM SOC NEPHRO, V7, P2002, DOI 10.2215/CJN.01130112; Hecking M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001750; Hussain JA, 2013, PALLIATIVE MED, V27, P829, DOI 10.1177/0269216313484380; Jassal SV, 2009, NEW ENGL J MED, V361, P1612, DOI 10.1056/NEJMc0905289; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Lamping DL, 2000, LANCET, V356, P1543, DOI 10.1016/S0140-6736(00)03123-8; Lee SML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107567; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Morton RL, 2012, AM J KIDNEY DIS, V59, P419, DOI 10.1053/j.ajkd.2011.08.024; Moss AH, 2010, CLIN J AM SOC NEPHRO, V5, P2380, DOI 10.2215/CJN.07170810; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; O'Connor NR, 2012, J PALLIAT MED, V15, P228, DOI 10.1089/jpm.2011.0207; Renal Physicians Association/American Society of Nephrology Working Group, 2000, J AM SOC NEPHROL, V11, P1788; Rettig RA, 2011, NEW ENGL J MED, V364, P596, DOI 10.1056/NEJMp1014193; Shum CK, 2014, J GERONTOL A-BIOL, V69, P308, DOI 10.1093/gerona/glt098; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; United States Renal Data System, 2014, 2014 ANN DAT REP EP; van Walraven C, 2014, AM J KIDNEY DIS, V63, P491, DOI 10.1053/j.ajkd.2013.09.011; Verdalles U, 2010, NEPHRON CLIN PRACT, V115, pE28, DOI 10.1159/000286347	28	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181345	10.1371/journal.pone.0181345	http://dx.doi.org/10.1371/journal.pone.0181345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742145	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700037
J	Reis, VM; Garrido, ND; Vianna, J; Sousa, AC; Alves, JV; Marques, MC				Reis, Victor Machado; Garrido, Nuno Domingos; Vianna, Jeferson; Sousa, Ana Catarina; Alves, Jose Vilaca; Marques, Mario Cardoso			Energy cost of isolated resistance exercises across low-to high-intensities	PLOS ONE			English	Article							BENCH PRESS; MECHANICAL LOAD; ARM-CRANKING; EXPENDITURE; RESPONSES; LACTATE; BLOOD	This study aimed to estimate the energy cost across various intensities at eight popular resistance exercises: half squat, 45 E inclined leg press, leg extension, horizontal bench press, 45 E inclined bench press, lat pull down, triceps extension and biceps curl. 58 males (27.5 +/- 4.9 years, 1.78 +/- 0.06 m height, 78.67 +/- 10.7 kg body mass and 11.4 +/- 4.1% estimated body fat) were randomly divided into four groups of 14 subjects each. For each group, two exercises were randomly assigned and on different days, they performed four bouts of 5-min constant-intensity for each of the two assigned exercises: 12%, 16%, 20% and 24% 1-RM. Later, the subjects performed exhaustive bouts at 80% 1-RM in the same two exercises. The mean values of VO2 at the last 30s of exercise at 12, 16, 20 and 24% 1-RM bouts were plotted against relative intensity (% 1-RM) in a simple linear regression mode. The regressions were then used to predict O-2 demand for the higher intensity (80% 1-RM). Energy cost rose linearly with exercise intensity in every exercise with the lowest mean values were found in biceps curl and the highest in half squat exercise (p<0.001). Half squat exercise presented significant (p<0.001) higher values of energy cost in all intensities, when compared with the remaining exercises. This study revealed that low-intensity resistance exercise provides energy cost comprised between 3 and 10 kcal.min(-1). Energy cost rose past 20 kcal.min(-1) at 80% 1-RM in leg exercise. In addition, at 80% 1-RM, it was found that upper body exercises are less anaerobic than lower-body exercises.	[Reis, Victor Machado; Garrido, Nuno Domingos; Sousa, Ana Catarina; Alves, Jose Vilaca; Marques, Mario Cardoso] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal; [Reis, Victor Machado; Garrido, Nuno Domingos; Alves, Jose Vilaca] Univ Tras Os Montes & Alto Douro, Vila Real, Portugal; [Vianna, Jeferson] Univ Fed Juiz de Fora, Juiz De Fora, MG, Brazil; [Sousa, Ana Catarina] Polytech Inst Viana do Castelo, Viana Do Castelo, Portugal; [Marques, Mario Cardoso] Univ Beira Interior, Dept Sport Sci, Covilha, Portugal	University of Tras-os-Montes & Alto Douro; Universidade Federal de Juiz de Fora; Polytechnic Institute of Viana do Castelo; Universidade da Beira Interior	Reis, VM (corresponding author), CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, Vila Real, Portugal.; Reis, VM (corresponding author), Univ Tras Os Montes & Alto Douro, Vila Real, Portugal.	vmreis@utad.pt	Vianna, Jeferson Macedo/GON-5641-2022; Vianna, Jeferson/AAP-6548-2020; Garrido, Nuno Domingos/K-6842-2014; MARQUES, MÁRIO C/E-8613-2010; Alves, José Vilaça/I-3965-2012; REIS, VICTOR/M-3531-2013	Vianna, Jeferson Macedo/0000-0003-1594-4429; Garrido, Nuno Domingos/0000-0002-8105-7580; Alves, José Vilaça/0000-0001-5399-7797; REIS, VICTOR/0000-0002-4996-1414				Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alves JV, 2012, J STRENGTH COND RES, V26, P1872, DOI 10.1519/JSC.0b013e318238e852; Ballor D, 1989, J STRENGTH COND RES, V3, P7; Benito PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164349; Bernasconi S, 2006, APPL PHYSIOL NUTR ME, V31, P414, DOI 10.1139/H06-021; Buitrago S, 2014, APPL PHYSIOL NUTR ME, V39, P345, DOI 10.1139/apnm-2013-0214; Buitrago S, 2013, J STRENGTH COND RES, V27, P1091, DOI 10.1519/JSC.0b013e318260ec77; Cohen J.E., 1988, STAT POWER ANAL BEHA; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Drummond MJ, 2005, J STRENGTH COND RES, V19, P332; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Garnacho-Castano MV, 2015, INT J SPORTS MED, V36, P371, DOI 10.1055/s-0034-1398495; Gastin P. B., 1994, Scandinavian Journal of Medicine and Science in Sports, V4, P91; Hunter GR, 2003, J STRENGTH COND RES, V17, P76, DOI 10.1519/00124278-200302000-00013; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Kraemer W, 1995, PHYSL ASSESSMENT HUM, P115; McLaughlin JE, 2001, INT J SPORTS MED, V22, P280, DOI 10.1055/s-2001-13816; Medbo JI, 2001, JPN J PHYSIOL, V51, P303, DOI 10.2170/jjphysiol.51.303; Muraki S, 2004, EUR J APPL PHYSIOL, V91, P246, DOI 10.1007/s00421-003-0962-8; Pichon CE, 1996, J STRENGTH COND RES, V10, P153; Reis VM, 2010, EUR J APPL PHYSIOL, V109, P1129, DOI 10.1007/s00421-010-1460-4; ROBERGS RA, 1991, J APPL PHYSIOL, V70, P1700, DOI 10.1152/jappl.1991.70.4.1700; Robergs RA, 2007, J STRENGTH COND RES, V21, P123, DOI 10.1519/00124278-200702000-00023; Scott C, 2014, EUR J HUM MOV, V33, P70; Scott CB, 2006, J STRENGTH COND RES, V20, P404; Scott CB, 2011, J STRENGTH COND RES, V25, P903, DOI 10.1519/JSC.0b013e3181c6a128; Tian Y, 2015, INT J SPORTS MED, V36, P357, DOI 10.1055/s-0034-1395520; Welch WA, 2015, INT J SPORTS MED, V36, P414, DOI 10.1055/s-0034-1398575	30	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181311	10.1371/journal.pone.0181311	http://dx.doi.org/10.1371/journal.pone.0181311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742112	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700036
J	Walsh, ES; Kreakie, BJ; Cantwell, MG; Nacci, D				Walsh, Eric S.; Kreakie, Betty J.; Cantwell, Mark G.; Nacci, Diane			A Random Forest approach to predict the spatial distribution of sediment pollution in an estuarine system	PLOS ONE			English	Article							WATER TREATMENT PLANTS; NARRAGANSETT BAY; REGRESSION TREES; ENVIRONMENTAL FATE; URBAN ESTUARY; RHODE-ISLAND; TRICLOSAN; CLASSIFICATION; TRICLOCARBAN; CONTAMINATION	Modeling the magnitude and distribution of sediment-bound pollutants in estuaries is often limited by incomplete knowledge of the site and inadequate sample density. To address these modeling limitations, a decision-support tool framework was conceived that predicts sediment contamination from the sub-estuary to broader estuary extent. For this study, a Random Forest (RF) model was implemented to predict the distribution of a model contaminant, triclosan (5-chloro-2-(2,4-dichlorophenoxy) phenol) (TCS), in Narragansett Bay, Rhode Island, USA. TCS is an unregulated contaminant used in many personal care products. The RF explanatory variables were associated with TCS transport and fate (proxies) and direct and indirect environmental entry. The continuous RF TCS concentration predictions were discretized into three levels of contamination (low, medium, and high) for three different quantile thresholds. The RF model explained 63% of the variance with a minimum number of variables. Total organic carbon (TOC) (transport and fate proxy) was a strong predictor of TCS contamination causing a mean squared error increase of 59% when compared to permutations of randomized values of TOC. Additionally, combined sewer overflow discharge (environmental entry) and sand (transport and fate proxy) were strong predictors. The discretization models identified a TCS area of greatest concern in the northern reach of Narragansett Bay (Providence River sub-estuary), which was validated with independent test samples. This decision-support tool performed well at the sub-estuary extent and provided the means to identify areas of concern and prioritize bay-wide sampling.	[Walsh, Eric S.; Kreakie, Betty J.; Cantwell, Mark G.; Nacci, Diane] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Atlantic Ecol Div, Narragansett, RI 02882 USA; [Walsh, Eric S.] Univ Idaho, Dept Forest Rangeland & Fire Sci, Moscow, ID 83843 USA	United States Environmental Protection Agency; Idaho; University of Idaho	Nacci, D (corresponding author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Atlantic Ecol Div, Narragansett, RI 02882 USA.	nacci.diane@epa.gov	Walsh, Eric/ABH-5950-2020	Walsh, Eric/0000-0003-0077-3639				Adams C, 2002, J ENVIRON ENG-ASCE, V128, P253, DOI 10.1061/(ASCE)0733-9372(2002)128:3(253); Barber LB, 2013, ENVIRON SCI TECHNOL, V47, P2177, DOI 10.1021/es303720g; Barber LB, 2011, ENVIRON SCI TECHNOL, V45, P2575, DOI 10.1021/es104138y; Benotti MJ, 2007, ENVIRON SCI TECHNOL, V41, P5795, DOI 10.1021/es0629965; Bradley PM, 2014, J AM WATER RESOUR AS, V50, P388, DOI 10.1111/jawr.12165; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Budzinski H, 1997, MAR CHEM, V58, P85, DOI 10.1016/S0304-4203(97)00028-5; Calabretta CJ, 2008, MAR POLLUT BULL, V56, P1680, DOI 10.1016/j.marpolbul.2008.07.012; Cantwell MG, 2010, CHEMOSPHERE, V78, P347, DOI 10.1016/j.chemosphere.2009.11.021; Christiansen T, 2000, ESTUAR COAST SHELF S, V50, P315, DOI 10.1006/ecss.2000.0548; Conn KE, 2006, ENVIRON SCI TECHNOL, V40, P7358, DOI 10.1021/es0605117; Curriero FC, 2006, MATH GEOL, V38, P907, DOI 10.1007/s11004-006-9055-7; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; EPA US, 2010, US EPA ENV MON ASS P; Feng H, 1998, MAR ENVIRON RES, V45, P69, DOI 10.1016/S0141-1136(97)00025-1; Fernandes M, 2011, J ENVIRON MONITOR, V13, P801, DOI 10.1039/c0em00612b; Ferreras P, 2001, BIOL CONSERV, V100, P125, DOI 10.1016/S0006-3207(00)00213-5; Furlong ET, 2010, FATE ESTROGENIC COMP; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Genuer R, 2015, R J, V7, P19; Ghadeer SG, 2011, J GEOL SOC LONDON, V168, P1121, DOI 10.1144/0016-76492010-016; Gibs J., 2008, SCI TOTAL ENVIRON, V458-460, P107, DOI DOI 10.1016/J.SCIT0TENV.2013.03.076; Glassmeyer ST, 2005, ENVIRON SCI TECHNOL, V39, P5157, DOI 10.1021/es048120k; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Hayes T, 2015, PSYCHOL AGING, V30, P911, DOI 10.1037/pag0000046; Katz DR, 2013, SCI TOTAL ENVIRON, V443, P123, DOI 10.1016/j.scitotenv.2012.10.052; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kremer J.N., 1978, COASTAL MARINE ECOSY; Kumar KS, 2010, ARCH ENVIRON CON TOX, V58, P275, DOI 10.1007/s00244-009-9383-y; Lin H, 2011, ENVIRON TOXICOL CHEM, V30, P2416, DOI 10.1002/etc.642; Little LS, 1997, J EXP MAR BIOL ECOL, V213, P1, DOI 10.1016/S0022-0981(97)00006-3; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MACZM, 2008, BATH FATH MASS AD CO; McAvoy DC, 2002, ENVIRON TOXICOL CHEM, V21, P1323, DOI 10.1897/1551-5028(2002)021<1323:MOTIWT>2.0.CO;2; McCave I. N., 1984, GEOL SOC SPEC PUBL, V15, P35, DOI DOI 10.1144/GSL.SP.1984.015.01.03; Meng L, 2001, ESTUARIES, V24, P576, DOI 10.2307/1353258; Miller TR, 2008, ENVIRON SCI TECHNOL, V42, P4570, DOI 10.1021/es702882g; Murray DW, 2007, PHYS PROPERTY CHEM C; NOAA CSC, 2001, NARR BAY BATH; Oczkowski A, 2008, ESTUAR COAST, V31, P53, DOI 10.1007/s12237-007-9029-0; Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1897/1551-5028(2002)021<1338:ATOT>2.0.CO;2; Oviatt CA, 2008, SPRINGER SER ENV MAN, P523, DOI 10.1007/978-0-387-35299-2_18; Pettus P, 2015, ENVIRON POLLUT, V207, P68, DOI 10.1016/j.envpol.2015.08.025; R Core Team, 2021, R LANGUAGE ENV STAT; RIDEM, 2014, RI DEP ENV MAN LIST; River F., 2015, COMBINED SEWER OVERF; Sabaliunas D, 2003, WATER RES, V37, P3145, DOI 10.1016/S0043-1354(03)00164-7; Sheng Y. P., 1987, 3 DIMENSIONAL MODELS, V45, P35, DOI [10.1016/S0422-9894(08)70441-0, DOI 10.1016/S0422-9894(08)70441-0]; SHIMMIELD GB, 1990, GEOL SOC SPEC PUBL, V49, P759, DOI 10.1144/GSL.SP.1992.049.01.46; Siroky DS, 2009, STAT SURV, V3, P147, DOI 10.1214/07-SS033; Smital T, 2004, MUTAT RES-FUND MOL M, V552, P101, DOI 10.1016/j.mrfmmm.2004.06.006; Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Taylor DL, 2012, MAR POLLUT BULL, V64, P807, DOI 10.1016/j.marpolbul.2012.01.013; Thompson A, 2005, WATER ENVIRON RES, V77, P63, DOI 10.2175/106143005X41636; Tixier C, 2002, ENVIRON SCI TECHNOL, V36, P3482, DOI 10.1021/es025647t; Vadeboncoeur MA, 2010, ESTUAR COAST, V33, P1113, DOI 10.1007/s12237-010-9320-3; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; van Maren DS, 2015, CONT SHELF RES, V95, P1, DOI 10.1016/j.csr.2014.12.010; Wang XK, 2014, ENVIRON SCI POLLUT R, V21, P7065, DOI 10.1007/s11356-014-2617-1; Winkler G, 2007, ENG LIFE SCI, V7, P42, DOI 10.1002/elsc.200620158; Xie ZY, 2008, ENVIRON POLLUT, V156, P1190, DOI 10.1016/j.envpol.2008.04.008; Ying GG, 2007, ENVIRON POLLUT, V150, P300, DOI 10.1016/j.envpol.2007.02.013; Yu CP, 2009, CHEMOSPHERE, V75, P1281, DOI 10.1016/j.chemosphere.2009.03.043	68	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0179473	10.1371/journal.pone.0179473	http://dx.doi.org/10.1371/journal.pone.0179473			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738089	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700008
J	Chang, TY; Tsai, WC; Huang, TS; Su, SH; Chang, CY; Ma, HY; Wu, CH; Yang, CY; Lin, CH; Huang, PH; Cheng, CC; Cheng, SM; Wang, HW				Chang, Ting-Yu; Tsai, Wei-Chi; Huang, Tse-Shun; Su, Shu-Han; Chang, Chih-Young; Ma, Hsiu-Yen; Wu, Chun-Hsien; Yang, Chih-Yung; Lin, Chi-Hung; Huang, Po-Hsun; Cheng, Cheng-Chung; Cheng, Shu-Meng; Wang, Hsei-Wei			Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and-146b in cardiovascular disease patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PROGENITOR CELLS; GASTRIC-CANCER; VASCULAR REPAIR; SERUM MICRORNAS; BIOMARKERS; ANGIOGENESIS; EXPRESSION; OUTGROWTH; PATHOGENESIS	Functional impairment of endothelial colony-forming cells (ECFCs), a specific cell lineage of endothelial progenitor cells (EPCs) is highly associated with the severity of coronary artery disease (CAD), the most common type of cardiovascular disease (CVD). Emerging evidence show that circulating microRNAs (miRNAs) in CAD patients' body fluid hold a great potential as biomarkers. However, our knowledge of the role of circulating miRNA in regulating the function of ECFCs and the progression of CAD is still in its infancy. We showed that when ECFCs from healthy volunteers were incubated with conditioned medium or purified exosomes of cultured CAD ECFCs, the secretory factors from CAD ECFCs dysregulated migration and tube formation ability of healthy ECFCs. It is known that exosomes influence the physiology of recipient cells by introducing RNAs including miRNAs. By using small RNA sequencing (smRNA-seq), we deciphered the circulating miRNome in the plasma of healthy individual and CAD patients, and found that the plasma miRNA spectrum from CAD patients was significantly different from that of healthy control. Interestingly, smRNA-seq of both healthy and CAD ECFCs showed that twelve miRNAs that had a higher expression in the plasma of CAD patients also showed higher expression in CAD ECFCs when compared with healthy control. This result suggests that these miRNAs may be involved in the regulation of ECFC functions. For identification of potential mRNA targets of the differentially expressed miRNA in CAD patients, cDNA microarray analysis was performed to identify the angiogenesis-related genes that were down-regulated in CAD ECFCs and Pearson's correlation were used to identify miRNAs that were negatively correlated with the identified angiogenesis- related genes. RT-qPCR analysis of the five miRNAs that negatively correlated with the down-regulated angiogenesis-related genes in plasma and ECFC of CAD patients showed miR-146a-5p and miR-146b-5p up-regulation compared to healthy control. Knockdown of miR-146a-5p or miR-146b-5p in CAD ECFCs enhanced migration and tube formation activity in diseased ECFCs. Contrarily, overexpression of miR-146a-5p or miR146b-5p in healthy ECFC repressed migration and tube formation in ECFCs. TargetScan analysis showed that miR-146a-5p and miR-146b-5p target many of the angiogenesis-elated genes that were down-regulated in CAD ECFCs. Knockdown of miR-146a-5p or miR-146b-5p restores CAV1 and RHOJ levels in CAD ECFCs. Reporter assays confirmed the direct binding and repression of miR-146a-5p and miR-146b-5p to the 3'-UTR of mRNA of RHOJ, a positive regulator of angiogenic potential in endothelial cells. Consistently, RHOJ knockdown inhibited the migration and tube formation ability in ECFCs. Collectively, we discovered the dysregulation of miR-146a-5p/RHOJ and miR-146b-5p/RHOJ axis in the plasma and ECFCs of CAD patients that could be used as biomarkers or therapeutic targets for CAD and other angiogenesis-related diseases.	[Chang, Ting-Yu] Taipei Med Univ, Res Ctr Translat Med, Taipei, Taiwan; [Tsai, Wei-Chi; Wu, Chun-Hsien; Cheng, Cheng-Chung; Cheng, Shu-Meng] Tri Serv Gen Hosp, Div Cardiol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Wei-Chi; Huang, Tse-Shun; Su, Shu-Han; Chang, Chih-Young; Ma, Hsiu-Yen; Wu, Chun-Hsien; Yang, Chih-Yung; Lin, Chi-Hung; Wang, Hsei-Wei] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Huang, Tse-Shun] Univ Calif San Diego, Inst Engn Med, San Diego, CA 92103 USA; [Huang, Po-Hsun] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Huang, Po-Hsun] Inst Clin Med, Taipei, Taiwan	Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; University of California System; University of California San Diego; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Cheng, SM (corresponding author), Tri Serv Gen Hosp, Div Cardiol, Dept Internal Med, Natl Def Med Ctr, Taipei, Taiwan.	dmscmsc@yahoo.com.tw			Tri-Service General Hospital [TSGH C105-007-S02, TSGH-C106-005-007-S02, TSGH-C106-005-007-S03]; Ministry of Science and Technology [104-2911-1-010-506]; Personal Genomics, Inc.; Quark Biosciences, Inc.; National Health Research Institutes [NHRI-EX104-10254SI]; Taipei City Hospital [10401-62-014]; Ministry of Health and Welfare [MOHW105-TDU-B-212-134-001, MOHW106-TDU-B-212-144001]	Tri-Service General Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Personal Genomics, Inc.; Quark Biosciences, Inc.; National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	Funding for this study was received from Tri-Service General Hospital (TSGH C105-007-S02, TSGH-C106-005-007-S02, TSGH-C106-005-007-S03), Ministry of Science and Technology (104-2911-1-010-506), Personal Genomics, Inc., Quark Biosciences, Inc., National Health Research Institutes (NHRI-EX104-10254SI), Taipei City Hospital (10401-62-014) and Ministry of Health and Welfare (MOHW105-TDU-B-212-134-001, MOHW106-TDU-B-212-144001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bakogiannis C, 2012, CURR MED CHEM, V19, P2597, DOI 10.2174/092986712800492995; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Cassar A, 2009, MAYO CLIN PROC, V84, P1130, DOI 10.4065/mcp.2009.0391; Cheng WC, 2013, NUCLEIC ACIDS RES, V41, pD285, DOI 10.1093/nar/gks1238; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Di YF, 2015, INT J CLIN EXP MED, V8, P11759; Donahue M, 2013, BIOL CHEM, V394, P1241, DOI 10.1515/hsz-2013-0110; Echavarria R, 2015, CARDIOVASC RES, V106, P465, DOI 10.1093/cvr/cvv120; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gomez-Banoy N, 2016, REV MED CHILE, V144, P355, DOI 10.4067/S0034-98872016000300011; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Han H, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.81; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Iguchi Haruhisa, 2010, Curr Drug Discov Technol, V7, P95; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Jialal I, 2010, ATHEROSCLEROSIS, V211, P297, DOI 10.1016/j.atherosclerosis.2010.01.036; Jin Y, 2015, MOL CELL BIOCHEM, V402, P111, DOI 10.1007/s11010-014-2319-5; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kim C, 2014, CANCER CELL, V25, P102, DOI 10.1016/j.ccr.2013.12.010; Kogo R, 2011, CLIN CANCER RES, V17, P4277, DOI 10.1158/1078-0432.CCR-10-2866; Kuehbacher A, 2008, TRENDS PHARMACOL SCI, V29, P12, DOI 10.1016/j.tips.2007.10.014; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Liu P, 2017, ONCOTARGET, V8, P1993, DOI 10.18632/oncotarget.12888; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu HQ, 2013, J GERIATR CARDIOL, V10, P34, DOI [10.3969/j.issn.1671-5411.2013.01.007, 10.3724/SP.J.1263.2013.01011]; Medina RJ, 2017, STEM CELL TRANSL MED, V6, P1316, DOI 10.1002/sctm.16-0360; Medina RJ, 2013, STEM CELLS, V31, P1657, DOI 10.1002/stem.1414; Medina RJ, 2011, MOL MED, V17, P1045, DOI 10.2119/molmed.2011.00129; Medina RJ, 2010, INVEST OPHTH VIS SCI, V51, P5906, DOI 10.1167/iovs.09-4951; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Pan Qunwen, 2016, Front Physiol, V7, P692, DOI 10.3389/fphys.2016.00692; Poitevin S, 2014, CARDIOVASC RES, V103, P121, DOI 10.1093/cvr/cvu104; Real Carla, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P185, DOI 10.2174/187152908785849071; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Shi TT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6386412; Smythe J, 2008, TISSUE ENG PT C-METH, V14, P59, DOI 10.1089/tec.2007.0251; Su SH, 2017, J VASC RES, V54, P22, DOI 10.1159/000449202; Sun M, 2015, CANCER BIOMARK, V15, P33, DOI 10.3233/CBM-140431; Tagawa S, 2015, INT J VASC MED, V2015, DOI 10.1155/2015/674213; Tasev D, 2016, TISSUE ENG PART B-RE, V22, P371, DOI 10.1089/ten.teb.2016.0050; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wang HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098070; Wang HW, 2014, ARTERIOSCL THROM VAS, V34, P857, DOI 10.1161/ATVBAHA.113.303001; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Wang SX, 2016, CARDIOVASC THER, V34, P199, DOI 10.1111/1755-5922.12187; Werner N, 2007, BASIC RES CARDIOL, V102, P565, DOI 10.1007/s00395-007-0680-1; Wittmann J, 2010, BBA-REV CANCER, V1806, P200, DOI 10.1016/j.bbcan.2010.07.002; Wotschofsky Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148746; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yang RQ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027826; Yao QY, 2013, CANCER LETT, V335, P219, DOI 10.1016/j.canlet.2013.02.031; Ye E-A., 2016, MEDIATORS INFLAMM, V2016, P1; Yoon SO, 2016, ONCOTARGET, V7, P2475, DOI 10.18632/oncotarget.6542; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119	62	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181562	10.1371/journal.pone.0181562	http://dx.doi.org/10.1371/journal.pone.0181562			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727754	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500088
J	Jeong, S; Kim, JY; Jeong, SC; Kang, ST; Moon, JK; Kim, N				Jeong, Seongmun; Kim, Jae-Yoon; Jeong, Soon-Chun; Kang, Sung-Taeg; Moon, Jung-Kyung; Kim, Namshin			GenoCore: A simple and fast algorithm for core subset selection from large genotype datasets	PLOS ONE			English	Article							RESOURCES	Selecting core subsets from plant genotype datasets is important for enhancing cost-effectiveness and to shorten the time required for analyses of genome-wide association studies (GWAS), and genomics-assisted breeding of crop species, etc. Recently, a large number of genetic markers (>100,000 single nucleotide polymorphisms) have been identified from high-density single nucleotide polymorphism (SNP) arrays and next-generation sequencing (NGS) data. However, there is no software available for picking out the efficient and consistent core subset from such a huge dataset. It is necessary to develop software that can extract genetically important samples in a population with coherence. We here present a new program, GenoCore, which can find quickly and efficiently the core subset representing the entire population. We introduce simple measures of coverage and diversity scores, which reflect genotype errors and genetic variations, and can help to select a sample rapidly and accurately for crop genotype dataset. Comparison of our method to other core collection software using example datasets are performed to validate the performance according to genetic distance, diversity, coverage, required system resources, and the number of selected samples. GenoCore selects the smallest, most consistent, and most representative core collection from all samples, using less memory with more efficient scores, and shows greater genetic coverage compared to the other software tested. GenoCore was written in R language, and can be accessed online with an example dataset and test results at https://github.com/lovemun/Genocore.	[Jeong, Seongmun; Kim, Jae-Yoon; Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Div Strateg Res Grp, Daejeon, South Korea; [Kim, Jae-Yoon; Kim, Namshin] Korea Univ Sci & Technol, KRIBB Sch, Dept Biol Sci, Daejeon, South Korea; [Jeong, Soon-Chun] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju, Chungbuk, South Korea; [Kang, Sung-Taeg] Dankook Univ, Dept Crop Sci & Biotechnol, Cheonan, Chungnam, South Korea; [Moon, Jung-Kyung] Rural Dev Adm, Natl Inst Crop Sci, Jeonju, Jeonbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dankook University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science	Kim, N (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Div Strateg Res Grp, Daejeon, South Korea.; Kim, N (corresponding author), Korea Univ Sci & Technol, KRIBB Sch, Dept Biol Sci, Daejeon, South Korea.; Moon, JK (corresponding author), Rural Dev Adm, Natl Inst Crop Sci, Jeonju, Jeonbuk, South Korea.	moonjk2@korea.kr; deepreds@kribb.re.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Moon, Jung-Kyung/0000-0002-5394-617X; Jeong, Soon-Chun/0000-0003-0223-1155; Jeong, Seongmun/0000-0002-0038-461X	National Research Foundation of Korea [NRF-2011-0030049, NRF-2014M3C9A3064552]; Next-Gen Bio-Green21 [PJ011929]; KRIBB initiative program	National Research Foundation of Korea(National Research Foundation of Korea); Next-Gen Bio-Green21; KRIBB initiative program	This work was supported by the National Research Foundation of Korea (NRF-2011-0030049 and NRF-2014M3C9A3064552) (http://www.nrf.re.kr); Next-Gen Bio-Green21 (PJ011929) (http://www.rda.go.kr); and the KRIBB initiative program (http://www.kribb.re.kr) to NK.; This work was supported by grants from the National Research Foundation of Korea (NRF-2011-0030049, NRF-2014M3C9A3064552), Next-Gen Bio-Green21 PJ011929, and the KRIBB initiative program.	Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Lee YG, 2015, PLANT J, V81, P625, DOI 10.1111/tpj.12755; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Wilkinson PA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-219; Wright S, 1978, VARIABILITY NATURAL, V4; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780	12	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181420	10.1371/journal.pone.0181420	http://dx.doi.org/10.1371/journal.pone.0181420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727806	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500069
J	Uribe, DJ; Mandell, EK; Watson, A; Martinez, JD; Leighton, JA; Ghosh, S; Rothlin, CV				Uribe, Diana J.; Mandell, Edward K.; Watson, Adam; Martinez, Jesse D.; Leighton, Jonathan A.; Ghosh, Sourav; Rothlin, Carla V.			The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer	PLOS ONE			English	Article							TAM RECEPTORS; EXPRESSION; FAMILY; MER; CABOZANTINIB; TYRO3; NEUROPILIN-1; INHIBITOR; REGULATOR; SURVIVAL	The receptor tyrosine kinases (RTKs) TYRO3, AXL and MERTK (TAM) have well-described oncogenic functions in a number of cancers. Notwithstanding, TAM RTKs are also potent and indispensable inhibitors of inflammation. The combined deletion of Axl and Mertk in mice enhances chronic inflammation and autoimmunity, including increased inflammation in the gut and colitis-associated cancer. On the other hand, deletion of Tyro3 increases the risk of allergic responses. Therefore, the indiscriminate inhibition of these TAM RTKs could result in undesirable immunological diseases. Here we show that AXL, but not MERTK or TYRO3 expression is enhanced in late stage colorectal cancer (CRC) and AXL expression associates with a cell migration gene signature. Silencing AXL or the inhibition of AXL kinase activity significantly inhibits tumor cell migration and invasion. These results indicate that the selective inhibition of AXL alone might confer sufficient therapeutic benefit in CRC, while preserving at least some of the beneficial, anti-inflammatory effects of MERTK and TYRO3 RTKs.	[Uribe, Diana J.; Mandell, Edward K.; Watson, Adam; Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; [Leighton, Jonathan A.] Mayo Clin Arizona, Div Gastroenterol, Scottsdale, AZ USA; [Ghosh, Sourav] Yale Univ, Sch Med, Dept Neurol, Pharmacol, New Haven, CT 06510 USA; [Ghosh, Sourav; Rothlin, Carla V.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Rothlin, Carla V.] Yale Univ, Sch Med, Dept Immunobiol, Pharmacol, New Haven, CT 06510 USA; [Uribe, Diana J.] Ventana Med Syst Inc, Tucson, AZ USA	Arizona Center Cancer Care; University of Arizona; Mayo Clinic; Mayo Clinic Phoenix; Yale University; Yale University; Yale University; Roche Holding; Ventana Medical Systems, Inc.	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Neurol, Pharmacol, New Haven, CT 06510 USA.; Ghosh, S; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.; Rothlin, CV (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, Pharmacol, New Haven, CT 06510 USA.	sourav.ghosh@yale.edu; carla.rothlin@yale.edu		Watson, Adam/0000-0002-8871-9479; Rothlin, Carla V/0000-0002-5693-5572; Ghosh, Sourav/0000-0001-5990-8708	National Institutes of Health [R01 A1089824, R01 CA212376, R01 CA149258-S]; Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01 A1089824 to C.V.R., R01 CA212376 to C.V.R. and S.G., and R01 CA149258-S to D.J.U.) and Crohn's and Colitis Foundation (to C.V.R and S.G.). C.V.R. is an HHMI Faculty Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake-Kawano R, 2013, CARCINOGENESIS, V34, P1567, DOI 10.1093/carcin/bgt069; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bosurgi L, 2013, P NATL ACAD SCI USA, V110, P13091, DOI 10.1073/pnas.1302507110; Brandao Luis, 2011, Critical Reviews in Oncogenesis, V16, P47; Chan PY, 2016, SCIENCE, V352, P99, DOI 10.1126/science.aaf1358; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; Chien CW, 2016, ONCOGENE, V35, P5872, DOI 10.1038/onc.2016.120; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; Dunne PD, 2014, CLIN CANCER RES, V20, P164, DOI 10.1158/1078-0432.CCR-13-1354; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Ha SY, 2014, J CLIN PATHOL, V67, P576, DOI 10.1136/jclinpath-2013-202163; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Howlader N., 2016, SEER CANC STAT REV 1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]; Kimani SG, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0142-1; LAI C, 1991, NEURON, V6, P691, DOI 10.1016/0896-6273(91)90167-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Linger RM, 2012, ONCOGENE; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinelli E, 2015, ONCOTARGET, V6, P23281, DOI 10.18632/oncotarget.3962; Maurer CA, 1998, INT J CANCER, V79, P76, DOI 10.1002/(SICI)1097-0215(19980220)79:1<76::AID-IJC15>3.0.CO;2-F; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ochiumi T, 2006, INT J ONCOL, V29, P105; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Rothlin CV, 2014, INFLAMM BOWEL DIS, V20, P1472, DOI 10.1097/MIB.0000000000000050; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Silva EAC, 2013, IMMUNITY, V39, P160, DOI 10.1016/j.immuni.2013.06.010; Smith MR, 2014, J CLIN ONCOL, V32, P3391, DOI 10.1200/JCO.2013.54.5954; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; von Massenhausen A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010007; Wu CW, 2002, ANTICANCER RES, V22, P1071; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang SD, 2016, ONCOL LETT, V11, P1223, DOI 10.3892/ol.2015.3999	52	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0179979	10.1371/journal.pone.0179979	http://dx.doi.org/10.1371/journal.pone.0179979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727830	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500011
J	Umeda, Y; Hasegawa, Y; Otsuka, M; Ariki, S; Takamiya, R; Saito, A; Uehara, Y; Saijo, H; Kuronuma, K; Chiba, H; Ohnishi, H; Sakuma, Y; Takahashi, H; Kuroki, Y; Takahashi, M				Umeda, Y.; Hasegawa, Y.; Otsuka, M.; Ariki, S.; Takamiya, R.; Saito, A.; Uehara, Y.; Saijo, H.; Kuronuma, K.; Chiba, H.; Ohnishi, H.; Sakuma, Y.; Takahashi, H.; Kuroki, Y.; Takahashi, M.			Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; PULMONARY COLLECTINS; INNATE IMMUNITY; MECHANISM; BINDING; DISEASE; DOMAIN; LIPOPOLYSACCHARIDE	Tyrosine kinase inhibitor (TKI)-sensitive and TKI-resistant mutations of epidermal growth factor receptor (EGFR) are associated with lung adenocarcinoma. EGFR mutants were previously shown to exhibit ligand-independent activation. We have previously demonstrated that pulmonary surfactant protein D (SP-D, SFTPD) suppressed wild-type EGFR signaling by blocking ligand binding to EGFR. We herein demonstrate that SFTPD downregulates ligand-independent signaling in cells harboring EGFR mutations such as TKI-sensitive exon 19 deletion (Ex19del) and L858R mutation as well as TKI-resistant T790M mutation, subsequently suppressing cellular growth and motility. Lectin blotting and ligand blotting in lung cancer cell lines suggested that EGFR mutants express oligomannose-type N-glycans and interact with SFTPD directly. Cross-linking assay indicated that SFTPD inhibits ligand-independent dimerization of EGFR mutants. We also demonstrated that SFTPD reduced dimerization-independent phosphorylation of Ex19del and T790M EGFR mutants using point mutations that disrupted the asymmetric dimer interface. It was confirmed that SFTPD augmented the viability-suppressing effects of EGFR-TKIs. Furthermore, retrospective analysis of 121 patients with lung adenocarcinoma to examine associations between serum SFTPD levels and clinical outcome indicated that in TKI-treated patients with lung cancer harboring EGFR mutations, including Ex19del or L858R, high serum SFTPD levels correlated with a lower number of distant metastases and prolonged overall survival and progression-free survival. These findings suggest that SFTPD downregulates both TKI-sensitive and -resistant EGFR mutant signaling, and SFTPD level is correlated with clinical outcome. These findings illustrate the use of serum SFTPD level as a potential marker to estimate the efficacy of EGFR-TKIs.	[Umeda, Y.; Hasegawa, Y.; Otsuka, M.; Saito, A.; Uehara, Y.; Saijo, H.; Kuronuma, K.; Chiba, H.; Takahashi, H.] Sapporo Med Univ, Res Inst Frontier Med, Dept Resp Med & Allergol, Sch Med, Sapporo, Hokkaido, Japan; [Hasegawa, Y.; Ariki, S.; Takamiya, R.; Saito, A.; Uehara, Y.; Kuroki, Y.; Takahashi, M.] Sapporo Med Univ, Res Inst Frontier Med, Dept Biochem, Sch Med, Sapporo, Hokkaido, Japan; [Ohnishi, H.] Sapporo Med Univ, Res Inst Frontier Med, Dept Publ Hlth, Sch Med, Sapporo, Hokkaido, Japan; [Sakuma, Y.] Sapporo Med Univ, Res Inst Frontier Med, Dept Mol Med, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Takahashi, M (corresponding author), Sapporo Med Univ, Res Inst Frontier Med, Dept Biochem, Sch Med,Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	takam@sapmed.ac.jp	Saito, Atsushi/M-7382-2018; Ariki, Shigeru/E-3861-2014; Sakuma, Yuji/HGC-0692-2022; Takahashi, Motoko/I-3154-2013	Saito, Atsushi/0000-0003-3430-884X; Ariki, Shigeru/0000-0001-5838-499X; Sakuma, Yuji/0000-0003-2298-1359; UMEDA, YASUAKI/0000-0001-9577-3353; Uehara, Yasuaki/0000-0002-6439-2715; Ohnishi, Hirofumi/0000-0002-5873-6438; Takahashi, Motoko/0000-0002-2112-6142	Japan Society for the Promotion of Science [26860611]; Northern Advancement Center for Science Technology [H26 T-1-35]; Ito Foundation [H26-23]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Northern Advancement Center for Science Technology; Ito Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (26860611), grants from the Northern Advancement Center for Science & Technology (H26 T-1-35) and grants from the Ito Foundation (H26-23).	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; BETZ C, 1995, CANCER RES, V55, P4283; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Cho J, 2013, CANCER RES, V73, P6770, DOI 10.1158/0008-5472.CAN-13-1145; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Dokala A, 2017, ONCOGENE, V36, P2337, DOI 10.1038/onc.2016.393; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Hasegawa Y, 2015, ONCOGENE, V34, P838, DOI [10.1038/onc.2014.20, 10.1038/onc.2015.266]; Ishii T, 2012, COPD, V9, P409, DOI 10.3109/15412555.2012.676110; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Pan JB, 2014, CLIN LAB, V60, P1439, DOI 10.7754/Clin.Lab.2013.131002; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Sawada K, 2010, J BIOL CHEM, V285, P8434, DOI 10.1074/jbc.M109.074765; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P1109, DOI 10.1164/ajrccm.162.3.9910080; Takahashi H, 2000, AM J RESP CRIT CARE, V162, P258, DOI 10.1164/ajrccm.162.1.9903014; Takahashi H, 1996, RESPIRATION, V63, P390; Takahashi M, 2013, J BIOL CHEM, V288, P32910, DOI 10.1074/jbc.M113.491902; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Voynow JA, 2005, AM J RESP CRIT CARE, V172, P1013, DOI 10.1164/rccm.200410-1398OC; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Romero-Ventosa EY, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0891-0; Yamaguchi H, 2011, CANCER CHEMOTH PHARM, V67, P331, DOI 10.1007/s00280-010-1325-x; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Yu HA, 2014, CLIN CANCER RES, V20, P5898, DOI 10.1158/1078-0432.CCR-13-2437; Zhang F, 2004, CHEST, V125, p109S, DOI 10.1378/chest.125.5_suppl.109S; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	49	16	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6432	6445		10.1038/onc.2017.253	http://dx.doi.org/10.1038/onc.2017.253			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28745320				2022-12-26	WOS:000415622900007
J	Bermek, O; Weller, SK; Griffith, JD				Bermek, Oya; Weller, Sandra K.; Griffith, Jack D.			The UL8 subunit of the helicase-primase complex of herpes simplex virus promotes DNA annealing and has a high affinity for replication forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; BINDING-PROTEIN; UL52 SUBUNITS; TYPE-1 ICP8; RECOMBINATION; NUCLEASE; EXCHANGE; GENE; INTERDEPENDENCE; VISUALIZATION	During lytic infection, herpes simplex virus (HSV) DNA is replicated by a mechanism involving DNA recombination. For instance, replication of the HSV-1 genome produces X-and Y-branched structures, reminiscent of recombination intermediates. HSV-1's replication machinery includes a trimeric helicase-primase composed of helicase (UL5) and primase (UL52) subunits and a third subunit, UL8. UL8 has been reported to stimulate the helicase and primase activities of the complex in the presence of ICP8, an HSV-1 protein that functions as an annealase, a protein that binds complementary single-stranded DNA (ssDNA) and facilitates its annealing to duplex DNA. UL8 also influences the intracellular localization of the UL5/UL52 subunits, but UL8' s catalytic activities are not known. In this study we used a combination of biochemical techniques and transmission electron microscopy. First, we report that UL8 alone forms protein filaments in solution. Moreover, we also found that UL8 binds to ssDNAs >50-nucletides long and promotes the annealing of complementary ssDNA to generate highly branched duplexDNAstructures. Finally, UL8 has a very high affinity for replication fork structures containing a gap in the lagging strand as short as 15 nucleotides, suggesting that UL8 may aid in directing or loading the trimeric complex onto a replication fork. The properties of UL8 uncovered here suggest that UL8 may be involved in the generation of the X-and Y-branched structures that are the hallmarks of HSV replication.	[Bermek, Oya; Griffith, Jack D.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA; [Weller, Sandra K.] Univ Connecticut, Ctr Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Weller, Sandra K.] Univ Connecticut, Ctr Hlth, Mol Biol & Biochem Grad Program, Farmington, CT 06030 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Connecticut; University of Connecticut	Bermek, O (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	oya_bermek@med.unc.edu			National Institutes of Health [GM31819, CA19014, AI021747]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021747, R01AI069136, R01AI021747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM31819 and CA19014 ( to J.D.G.) and AI021747 ( to S.K.W.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barnard EC, 1997, VIROLOGY, V237, P97, DOI 10.1006/viro.1997.8763; BARRY J, 1994, J BIOL CHEM, V269, P33049; Bermek O, 2015, J BIOL CHEM, V290, P2539, DOI 10.1074/jbc.M114.623009; Biswas N, 2001, J BIOL CHEM, V276, P17610, DOI 10.1074/jbc.M010107200; Blumel J, 2000, VIROLOGY, V276, P445, DOI 10.1006/viro.2000.0574; BOEHMER PE, 1993, J VIROL, V67, P711, DOI 10.1128/JVI.67.2.711-715.1993; CALDER JM, 1990, NUCLEIC ACIDS RES, V18, P3573, DOI 10.1093/nar/18.12.3573; CARMICHAEL EP, 1989, J VIROL, V63, P591, DOI 10.1128/JVI.63.2.591-599.1989; Chen Y, 2005, J VIROL, V79, P9088, DOI 10.1128/JVI.79.14.9088-9096.2005; Chen Y, 2011, J VIROL, V85, P968, DOI 10.1128/JVI.01690-10; Darwish AS, 2016, J VIROL, V90, P2561, DOI 10.1128/JVI.02854-15; DODSON MS, 1991, P NATL ACAD SCI USA, V88, P1105, DOI 10.1073/pnas.88.4.1105; DRACHEVA S, 1995, J BIOL CHEM, V270, P14148, DOI 10.1074/jbc.270.23.14148; DUTCH RE, 1993, J VIROL, V67, P6945, DOI 10.1128/JVI.67.12.6945-6949.1993; Falkenberg M, 1997, J BIOL CHEM, V272, P22766, DOI 10.1074/jbc.272.36.22766; FRIEDMANN A, 1977, J GEN VIROL, V34, P507, DOI 10.1099/0022-1317-34-3-507; GORBALENYA AE, 1988, NUCLEIC ACIDS RES, V16, P7734, DOI 10.1093/nar/16.15.7734; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Grady LM, 2014, METHODS MOL BIOL, V1144, P293, DOI 10.1007/978-1-4939-0428-0_20; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hamatake RK, 1997, J GEN VIROL, V78, P857, DOI 10.1099/0022-1317-78-4-857; JACOB RJ, 1977, J VIROL, V23, P394, DOI 10.1128/JVI.23.2.394-411.1977; KLINEDINST DK, 1994, J VIROL, V68, P3693, DOI 10.1128/JVI.68.6.3693-3701.1994; KOPS AD, 1988, CELL, V55, P857, DOI 10.1016/0092-8674(88)90141-9; LeGac NT, 1996, J BIOL CHEM, V271, P21645; Makhov AM, 2009, J MOL BIOL, V386, P273, DOI 10.1016/j.jmb.2008.12.059; Makhov AM, 2006, J MOL BIOL, V355, P911, DOI 10.1016/j.jmb.2005.11.022; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Ozgur S, 2014, J VIROL, V88, P8687, DOI 10.1128/JVI.03652-13; Ozgur S, 2011, J STRUCT BIOL, V174, P37, DOI 10.1016/j.jsb.2010.10.015; PARRY ME, 1993, J GEN VIROL, V74, P607, DOI 10.1099/0022-1317-74-4-607; Reuven NB, 2004, J MOL BIOL, V342, P57, DOI 10.1016/j.jmb.2004.07.012; Reuven NB, 2004, J VIROL, V78, P4599, DOI 10.1128/JVI.78.9.4599-4608.2004; Reuven NB, 2003, J VIROL, V77, P7425, DOI 10.1128/JVI.77.13.7425-7433.2003; RUYECHAN WT, 1983, J VIROL, V46, P661, DOI 10.1128/JVI.46.2.661-666.1983; RUYECHAN WT, 1984, J VIROL, V52, P727, DOI 10.1128/JVI.52.3.727-733.1984; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Severini A, 1996, J VIROL, V70, P3169, DOI 10.1128/JVI.70.5.3169-3175.1996; SEVERINI A, 1994, VIROLOGY, V200, P428, DOI 10.1006/viro.1994.1206; SHERMAN G, 1992, J VIROL, V66, P4884, DOI 10.1128/JVI.66.8.4884-4892.1992; SHLOMAI J, 1976, VIROLOGY, V69, P647, DOI 10.1016/0042-6822(76)90493-1; Smith S, 2015, FUTURE VIROL, V10, P383, DOI 10.2217/FVL.15.18; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; TENNEY DJ, 1994, J BIOL CHEM, V269, P5030; Tolun G, 2013, NUCLEIC ACIDS RES, V41, P5927, DOI 10.1093/nar/gkt266; Weller SK, 2014, ANNU REV MICROBIOL, V68, P237, DOI 10.1146/annurev-micro-091313-103424; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Wilkinson DE, 2003, IUBMB LIFE, V55, P451, DOI 10.1080/15216540310001612237; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100	49	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15611	15621		10.1074/jbc.M117.799064	http://dx.doi.org/10.1074/jbc.M117.799064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28743747	hybrid, Green Published			2022-12-26	WOS:000411512200003
J	Choi, J; Hoffman, EA; Lin, CL; Milhem, MM; Tessier, J; Newell, JD				Choi, Jiwoong; Hoffman, Eric A.; Lin, Ching-Long; Milhem, Mohammed M.; Tessier, Jean; Newell, John D., Jr.			Quantitative computed tomography determined regional lung mechanics in normal nonsmokers, normal smokers and metastatic sarcoma subjects	PLOS ONE			English	Article							VOLUMETRIC CT IMAGES; CUBIC B-SPLINE; TISSUE DEFORMATION; BONE METASTASIS; REGISTRATION; VENTILATION; MODEL; OSTEOSARCOMA; ENDOTHELIUM; ATLAS	Objectives Extra-thoracic tumors send out pilot cells that attach to the pulmonary endothelium. We hypothesized that this could alter regional lung mechanics (tissue stiffening or accumulation of fluid and inflammatory cells) through interactions with host cells. We explored this with serial inspiratory computed tomography (CT) and image matching to assess regional changes in lung expansion. Materials and methods We retrospectively assessed 44 pairs of two serial CT scans on 21 sarcoma patients: 12 without lung metastases and 9 with lung metastases. For each subject, two or more serial inspiratory clinically-derived CT scans were retrospectively collected. Two research-derived control groups were included: 7 normal nonsmokers and 12 asymptomatic smokers with two inspiratory scans taken the same day or one year apart respectively. We performed image registration for local-to-local matching scans to baseline, and derived local expansion and density changes at an acinar scale. Welch two sample t test was used for comparison between groups. Statistical significance was determined with a p value < 0.05. Results Lung regions of metastatic sarcoma patients (but not the normal control group) demonstrated an increased proportion of normalized lung expansion between the first and second CT. These hyper-expanded regions were associated with, but not limited to, visible metastatic lung lesions. Compared with the normal control group, the percent of increased normalized hyper-expanded lung in sarcoma subjects was significantly increased (p < 0.05). There was also evidence of increased lung "tissue" volume (non-air components) in the hyper-expanded regions of the cancer subjects relative to non-hyper-expanded regions. "Tissue" volume increase was present in the hyper-expanded regions of metastatic and non-metastatic sarcoma subjects. This putatively could represent regional inflammation related to the presence of tumor pilot cell-host related interactions. Conclusions This new quantitative CT (QCT) method for linking serial acquired inspiratory CT images may provide a diagnostic and prognostic means to objectively characterize regional responses in the lung following oncological treatment and monitoring for lung metastases.	[Choi, Jiwoong; Hoffman, Eric A.; Newell, John D., Jr.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Choi, Jiwoong; Lin, Ching-Long] Univ Iowa, IIHR Hydrosci & Engn, Iowa City, IA USA; [Hoffman, Eric A.; Newell, John D., Jr.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Hoffman, Eric A.; Milhem, Mohammed M.] Univ Iowa, Dept Med, Iowa City, IA 52242 USA; [Tessier, Jean] Roche Innovat Ctr, Pharma Res & Early Dev, Basel, Switzerland	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Roche Holding	Newell, JD (corresponding author), Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA.; Newell, JD (corresponding author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.	john-newell@uiowa.edu		Milhem, Mohammed/0000-0003-4663-6824; Newell, John/0000-0002-7337-5001; Hoffman, Eric/0000-0001-8456-9437	F. Hoffmann-La Roche Ltd; NIH [R01 HL-112986, R01-HL-094315, S10-RR-022421, U01 HL114494]; Melanoma and Sarcoma Tissue and Epidemiology Resource (MAST); NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma and Sarcoma Tissue and Epidemiology Resource (MAST); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a Postdoctoral Fellowship grant from F. Hoffmann-La Roche Ltd, NIH grants R01 HL-112986, R01-HL-094315, S10-RR-022421 and U01 HL114494, and the Melanoma and Sarcoma Tissue and Epidemiology Resource (MAST). Through JT, F. Hoffmann-La Roche Ltd. proditional roles in study design and analysis, decision to publish, or preparation of the manuscript (conceptualization, project administration, supervision, avided support in the form of salaries for JC, and also did adnd writing review and editing). The specific roles of JT are articulated in the 'author contributions' section.; This work was supported in part by the Postdoctoral Fellowship Program of F. Hoffmann-La Roche Ltd and the Melanoma and Sarcoma Tissue and Epidemiology Resource (MAST).	Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Choi S, 2014, J APPL PHYSIOL, V117, P593, DOI 10.1152/japplphysiol.00280.2014; Choi S, 2013, J APPL PHYSIOL, V115, P730, DOI 10.1152/japplphysiol.00113.2013; Couper D, 2014, THORAX, V69, P491, DOI 10.1136/thoraxjnl-2013-203897; Ding K, 2012, MED PHYS, V39, P5084, DOI 10.1118/1.4736808; Ding K, 2009, LECT NOTES COMPUT SC, V5761, P739, DOI 10.1007/978-3-642-04268-3_91; Ellingwood ND, 2016, COMPUT METH PROG BIO, V127, P290, DOI 10.1016/j.cmpb.2015.12.018; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Jahani N, 2014, J BIOMECH, V47, P1626, DOI 10.1016/j.jbiomech.2014.02.040; Li BJ, 2012, ACAD RADIOL, V19, P1368, DOI 10.1016/j.acra.2012.04.025; Li BJ, 2008, MED PHYS, V35, P5575, DOI 10.1118/1.3005633; Li BJ, 2003, ACAD RADIOL, V10, P255, DOI 10.1016/S1076-6332(03)80099-5; Lietman Steven A, 2010, Cleve Clin J Med, V77 Suppl 1, pS8, DOI 10.3949/ccjm.77.s1.02; Lin CL, 2013, WIRES SYST BIOL MED, V5, P643, DOI 10.1002/wsbm.1234; Ma JF, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-59; McCarville M, 2001, CANCER, V91, P1170, DOI 10.1002/1097-0142(20010315)91:6<1170::AID-CNCR1114>3.0.CO;2-B; Murrell Z, 2013, J PEDIATR SURG, V48, P1020, DOI 10.1016/j.jpedsurg.2013.02.018; Reinhardt JM, 2008, MED IMAGE ANAL, V12, P752, DOI 10.1016/j.media.2008.03.007; Sethi N, 2011, BRIT J CANCER, V105, P1805, DOI 10.1038/bjc.2011.497; Sethi Nilay, 2012, Bonekey Rep, V1, P3, DOI 10.1038/bonekey.2012.2; Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Sethi N, 2011, BONE, V48, P16, DOI 10.1016/j.bone.2010.07.005; Yin YB, 2013, J COMPUT PHYS, V244, P168, DOI 10.1016/j.jcp.2012.12.007; Yin YB, 2010, LECT NOTES COMPUT SC, V6362, P578; Yin YB, 2011, PHYS MED BIOL, V56, P203, DOI 10.1088/0031-9155/56/1/013; Yin YB, 2009, MED PHYS, V36, P4213, DOI 10.1118/1.3193526	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0179812	10.1371/journal.pone.0179812	http://dx.doi.org/10.1371/journal.pone.0179812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749945	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700005
J	Lin, B; Sun, XG; Su, SL; Lv, CX; Zhang, XF; Lin, L; Wang, R; Fu, JH; Kang, DM				Lin, Bin; Sun, Xiaoguang; Su, Shengli; Lv, Cuixia; Zhang, Xiaofei; Lin, Lin; Wang, Rui; Fu, Jihua; Kang, Dianmin			HIV drug resistance in HIV positive individuals under antiretroviral treatment in Shandong Province, China	PLOS ONE			English	Article							TRANSCRIPTASE INHIBITOR RESISTANCE; IMMUNODEFICIENCY-VIRUS TYPE-1; SUBTYPE DIVERSITY; MUTATIONS; SUSCEPTIBILITY; INFECTION; PATTERNS; THERAPY; ADHERENCE; IMPACT	The efficacy of antiretroviral drugs is limited by the development of drug resistance. Therefore, it is important to examine HIV drug resistance following the nationwide implementation of drug resistance testing in China since 2009. We conducted drug resistance testing in patients who were already on or new to HIV antiretroviral therapy (ART) in Shandong Province, China, from 2011 to 2013, and grouped them based on the presence or absence of drug resistance to determine the effects of age, gender, ethnicity, marital status, educational level, route of transmission and treatment status on drug resistance. We then examined levels of drug resistance the following year. The drug resistance rates of HIV patients on ART in Shandong from 2011 to 2013 were 3.45% (21/608), 3.38% (31/916), and 4.29% (54/1259), per year, respectively. M184V was the most frequently found point mutation, conferring resistance to the nucleoside reverse transcriptase inhibitor, while Y181C, G190A, K103N and V179D/E/F were the most frequent point mutations conferring resistance to the non-nucleoside reverse transcriptase inhibitor. In addition, the protease inhibitor drug resistance mutations I54V and V82A were identified for the first time in Shandong Province. Primary resistance accounts for 20% of the impact factors for drug resistance. Furthermore, it was found that educational level and treatment regimen were high-risk factors for drug resistance in 2011 (P < 0.05), while treatment regimen was a high risk factor for drug resistance in 2012 and 2013 (P < 0.05). Among the 106 drug-resistant patients, 77 received immediate adjustment of treatment regimen following testing, and 69 (89.6%) showed a reduction in drug resistance the following year. HIV drug resistance has a low prevalence in Shandong Province. However, patients on second line ART regimens and those with low educational level need continuous monitoring. Active drug resistance testing can effectively prevent the development of drug resistance.	[Lin, Bin; Sun, Xiaoguang; Su, Shengli; Lv, Cuixia; Zhang, Xiaofei; Lin, Lin; Fu, Jihua; Kang, Dianmin] Shandong Ctr Dis Control & Prevent, Shandong Ctr AIDS Control & Prevent, Jinan, Shandong, Peoples R China; [Wang, Rui] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China	Shandong University	Fu, JH; Kang, DM (corresponding author), Shandong Ctr Dis Control & Prevent, Shandong Ctr AIDS Control & Prevent, Jinan, Shandong, Peoples R China.	fujihua1958@163.com; dmkang1962@163.com			National Science and Technology Key Projects on Major Infectious Diseases [2014ZX10001002-001-003]	National Science and Technology Key Projects on Major Infectious Diseases	The payment of publishing this research paper was supported by National Science and Technology Key Projects on Major Infectious Diseases (2014ZX10001002-001-003).	[Anonymous], ADV MAT SCI ENG, DOI DOI 10.1016/J.SURFC0AT.2015.10.001; Avila-Rios S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164156; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Dunne AL, 2001, AIDS, V15, P1471, DOI 10.1097/00002030-200108170-00003; ERICE A, 1993, NEW ENGL J MED, V328, P1163, DOI 10.1056/NEJM199304223281605; Eron JJ, 2007, JAIDS-J ACQ IMM DEF, V45, P249, DOI 10.1097/QAI.0b013e318050d61f; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; FuJie Z., 2016, CHINAS NATL FREE ANT, P27; Geretti Anna Maria, 2006, J HIV Ther, V11, P72; Haaland RE, 2013, PUBLIC HEALTH GENOM, V16, P31, DOI 10.1159/000345935; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hatano H, 2007, BRIT MED J, V334, P1124, DOI 10.1136/bmj.39205.386609.80; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Jiao Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0689-7; Keulen W, 1996, ANTIVIR RES, V31, P45, DOI 10.1016/0166-3542(96)00944-8; Kiertiburanakul S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147945; Kulkarni R, 2012, JAIDS-J ACQ IMM DEF, V59, P47, DOI 10.1097/QAI.0b013e31823aca74; Li JY, 2010, CHIN J AIDS STD, V16, P195; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Lin B., 2010, PREV MED TRIB, V16, P207; Melikian GL, 2012, ANTIMICROB AGENTS CH, V56, P2305, DOI 10.1128/AAC.05487-11; Mendoza Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154317; Menendez-Arias L, 2002, PROG NUCLEIC ACID RE, V71, P91, DOI 10.1016/S0079-6603(02)71042-8; Meresse M, 2014, HIV MED, V15, P478, DOI 10.1111/hiv.12140; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Palmer S, 1998, AIDS RES HUM RETROV, V14, P157, DOI 10.1089/aid.1998.14.157; Qin BY, 2012, PRACTICAL PREVENTIVE, V19, P964; Reuman EC, 2010, J ANTIMICROB CHEMOTH, V65, P1477, DOI 10.1093/jac/dkq140; Ross L, 2004, AIDS, V18, P1691, DOI 10.1097/01.aids.0000131355.44834.e4; Rusconi Stefano, 2006, J HIV Ther, V11, P81; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064345; Santoro Maria Mercedes, 2013, ISRN Microbiol, V2013, P481314, DOI 10.1155/2013/481314; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shao Y., 2010, MONITORING STRATEGIE, P53; Sui HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091803; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tong Y, 2016, CLIN RES PRACT, V1, P100; van Westen GJP, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002899; Wainberg MA, 2010, VIRUSES-BASEL, V2, P2493, DOI 10.3390/v2112493; Wang Ning, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1205; Wang Y, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-40; WHO, 2012, WHO GLOB STRAT SURV; Wu H, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-2; Yu A, 2016, CHINESE J AIDS STD, V22, P864; [袁源 Yuan Yuan], 2016, [中国病原生物学杂志, Journal of Pathogen Biology], V11, P329; Zang X, 2015, CHINESE J PUBLIC HLT, V14, P574; Zheng J, 2011, CHINESE J AIDS STD, V17, P529	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181997	10.1371/journal.pone.0181997	http://dx.doi.org/10.1371/journal.pone.0181997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750025	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700111
J	Mornand, P; Verret, C; Minodier, P; Faye, A; Thellier, M; Imbert, P				Mornand, Pierre; Verret, Catherine; Minodier, Philippe; Faye, Albert; Thellier, Marc; Imbert, Patrick		Pediatric Imported Malaria Study	Severe imported malaria in children in France. A national retrospective study from 1996 to 2005	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MULTIORGAN DYSFUNCTION SCORE; INTENSIVE-CARE-UNIT; AFRICAN CHILDREN; RISK-FACTORS; CEREBRAL MALARIA; CHILDHOOD MALARIA; DISEASE SEVERITY; MORTALITY; TRANSMISSION	Backgrounds Malaria is a leading cause of imported febrile illnesses in pediatric travelers, but few studies have addressed severe imported pediatric malaria. We aimed to determine the risk factors and the features of imported pediatric severe malaria. Methods We conducted a retrospective, descriptive study using the French National Reference Center for Imported Malaria database, in children aged 0-15 years who were hospitalized with a falciparum malaria from January 1st 1996 to December 31th 2005. Uncomplicated and severe cases of falciparum malaria were compared to identify risk factors for severe cases. In the hospitals that reported more than five severe cases during the study period, we evaluated severe cases for prognostic factors and assessed the accuracy WHO criteria for predicting severity. Given the rarity of deaths, adverse outcomes were defined as requiring major therapeutic procedures (MTPs)-e.g., sedation, mechanical ventilation, nasal oxygen therapy, blood transfusions, hemodialysis, fluid resuscitation-or pediatric intensive care unit (PICU) admission. Results Of 4150 pediatric malaria cases included in the study, 3299 were uncomplicated and 851 (20.5%) were severe. Only one death was recorded during this period. Predictors for severe falciparum malaria were: age <2 years (OR = 3.2, 95% CI = 2.5-4.0, p < 0.0001) and a travel in the Sahelian region (OR = 1.7, 95% CI = 1.3-2.0, p = 0.0001). Of 422 severe malaria cases, a stay in a Sahelian region, lack of chemoprophylaxis, age < 2 years or thrombocytopenia < 100 x 10<^>3/mm<^>3 predicted adverse outcomes. Except for the hyperparasitemia threshold of 4%, the main WHO 2000 criteria for severe malaria reliably predicted adverse outcomes. In our study, the threshold of parasitemia most predictive of a poor outcome was 8%. Conclusion In imported pediatric malaria, children younger than 2 years deserve particular attention. The main WHO 2000 criteria for severity are accurate, except for the threshold of hyperparasitemia, which should be revised.	[Mornand, Pierre] Hop Enfants A Trousseau, Serv Pediat Gen, 26 Ave Dr Arnold Netter, F-75571 Paris 12, France; [Verret, Catherine] Inst Rech Biomed Armees, BP 73, Bretigny Sur Orge, France; [Minodier, Philippe] CHU Nord, Urgences Pediat, Chemin Bourrely, Marseille, France; [Faye, Albert] Hop Robert Debre, AP HP, Serv Pediat Gen, Paris, France; [Faye, Albert] Univ Paris Diderot, Paris Sorbonne Cite, INSERM 1123, Paris, France; [Thellier, Marc] Hop La Pitie Salpetriere, AP HP, Serv Parasitol Mycol, Ctr Natl Reference Paludisme, Paris, France; [Thellier, Marc] UPMC, INSERM, CIMI PARIS, U1135, Paris, France; [Imbert, Patrick] Hop Instruct Armees Begin, Ctr Vaccinat Int, St Mande, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mornand, P (corresponding author), Hop Enfants A Trousseau, Serv Pediat Gen, 26 Ave Dr Arnold Netter, F-75571 Paris 12, France.	pierre.mornand@aphp.fr	Parola, Philippe/AAY-4346-2021; Thellier, Marc/AAI-3311-2021	Parola, Philippe/0000-0002-1061-1927; Thellier, Marc/0000-0003-4867-2423; Verret, Catherine/0000-0002-6418-3403; Ajzenberg, Daniel/0000-0002-5357-3318				Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Caillet-Gossot S, 2013, J TRAVEL MED, V20, P171, DOI 10.1111/jtm.12016; Conroy AL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0773-4; Cserti-Gazdewich CM, 2013, AM J TROP MED HYG, V88, P747, DOI 10.4269/ajtmh.12-0668; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Garbash M, 2010, PEDIATR INFECT DIS J, V29, P1140, DOI 10.1097/INF.0b013e3181fca9f9; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Gerardin P, 2007, MALARIA J, V6, P1; Gerardin P, 2006, PEDIATR CRIT CARE ME, V7, P45, DOI 10.1097/01.PCC.0000192321.66637.E6; Hanson J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0324-5; Haut Conseil de la Sante A Publique, 2013, PALUD GRAV CHEZ ADUL; Helbok R, 2003, AM J TROP MED HYG, V68, P372, DOI 10.4269/ajtmh.2003.68.372; Helbok R, 2006, AM J TROP MED HYG, V75, P443, DOI 10.4269/ajtmh.2006.75.443; Imbert P, 2003, Bull Soc Pathol Exot, V96, P156; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; Kitchen S.F., 1949, MALARIOLOGY COMPREHE, VII, P966; Krause G, 2006, EMERG INFECT DIS, V12, P447, DOI 10.3201/eid1203.050736; Krishnan A, 2003, CRIT CARE MED, V31, P2278, DOI 10.1097/01.CCM.0000079603.82822.69; Ladhani S, 2005, PEDIATR INFECT DIS J, V24, P1017, DOI 10.1097/01.inf.0000183774.22593.7c; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Ladhani S, 2007, LANCET INFECT DIS, V7, P349, DOI 10.1016/S1473-3099(07)70110-X; Ladhani S, 2010, PEDIATR INFECT DIS J, V29, P434, DOI 10.1097/INF.0b013e3181c4d97c; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Lampah DA, 2015, J INFECT DIS, V211, P623, DOI 10.1093/infdis/jiu487; Legros F, 2007, EMERG INFECT DIS, V13, P883, DOI 10.3201/eid1305.060955; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Maitland K, 2005, BRIT MED J, V331, P337, DOI 10.1136/bmj.331.7512.337; Maitland K, 2005, TRENDS PARASITOL, V21, P11, DOI 10.1016/j.pt.2004.10.010; Manguin S., 2008, BIODIVERSITY MALARIA, P64; Manning L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-107; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Minodier P, 2005, ARCH PEDIATRIE, V12, P787, DOI 10.1016/j.arcped.2005.03.029; MOLYNEUX ME, 1989, Q J MED, V71, P441; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Pinsent A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-298; Recommandations pour la pratique clinique, 2007, MED MAL ING, P1; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Sowunmi A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-268; Stager K, 2009, EMERG INFECT DIS, V15, P185, DOI 10.3201/eid1502.080712; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; van Genderen PJJ, 2005, J TRAVEL MED, V12, P261, DOI 10.2310/7060.2005.12504; WALKER O, 1992, T ROY SOC TROP MED H, V86, P491, DOI 10.1016/0035-9203(92)90082-N; Whitehorn J, 2010, T ROY SOC TROP MED H, V104, P240, DOI 10.1016/j.trstmh.2009.08.004; Winkler AS, 2008, J TROP PEDIATRICS, V54, P184, DOI 10.1093/tropej/fmm108; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2015, GUID TREATM MAL, Vthird	49	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180758	10.1371/journal.pone.0180758	http://dx.doi.org/10.1371/journal.pone.0180758			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749962	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700016
J	Potter, GDM; Cade, JE; Hardie, LJ				Potter, Gregory D. M.; Cade, Janet E.; Hardie, Laura J.			Longer sleep is associated with lower BMI and favorable metabolic profiles in UK adults: Findings from the National Diet and Nutrition Survey	PLOS ONE			English	Article							LIFE-STYLE; WAIST CIRCUMFERENCE; DURATION; OBESITY; RISK; METAANALYSIS; CHILDREN	Ever more evidence associates short sleep with increased risk of metabolic diseases such as obesity, which may be related to a predisposition to non-homeostatic eating. Few studies have concurrently determined associations between sleep duration and objective measures of metabolic health as well as sleep duration and diet, however. We therefore analyzed associations between sleep duration, diet and metabolic health markers in UK adults, assessing associations between sleep duration and 1) adiposity, 2) selected metabolic health markers and 3) diet, using National Diet and Nutrition Survey data. Adults (n = 1,615, age 19-65 years, 57.1% female) completed questions about sleep duration and 3 to 4 days of food diaries. Blood pressure and waist circumference were recorded. Fasting blood lipids, glucose, glycated haemoglobin (HbA1c), thyroid hormones, and high-sensitivity C-reactive protein (CRP) were measured in a subset of participants. We used regression analyses to explore associations between sleep duration and outcomes. After adjustment for age, ethnicity, sex, smoking, and socioeconomic status, sleep duration was negatively associated with body mass index (-0.46 kg/m(2) per hour, 95% CI -0.69 to -0.24 kg/m(2), p < 0.001) and waist circumference (-0.9 cm per hour, 95% CI -1.5 to -0.3cm, p = 0.004), and positively associated with high-density lipoprotein cholesterol (0.03 mmol/L per hour, 95% CI 0.00 to 0.05, p = 0.03). Sleep duration tended to be positively associated with free thyroxine levels and negatively associated with HbA1c and CRP (p = 0.09 to 0.10). Contrary to our hypothesis, sleep duration was not associated with any dietary measures (p >= 0.14). Together, our findings show that short-sleeping UK adults are more likely to have obesity, a disease with many comorbidities.	[Potter, Gregory D. M.; Hardie, Laura J.] Univ Leeds, Div Epidemiol & Biostat, Sch Med, Leeds, W Yorkshire, England; [Cade, Janet E.] Univ Leeds, Nutr Epidemiol Grp, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Potter, GDM (corresponding author), Univ Leeds, Div Epidemiol & Biostat, Sch Med, Leeds, W Yorkshire, England.	umgdmp@leeds.ac.uk	Hardie, Laura/AAY-6724-2020; Cade, Janet/G-4250-2016	Hardie, Laura/0000-0001-5039-2100; Potter, Gregory/0000-0003-1995-7040; Cade, Janet/0000-0003-3421-0121	Medical Research Council; Medical Research Council [1495612] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	G.D.M.P. is supported by a Medical Research Council Doctoral Training Grant. No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho V, 2016, SCI REP-UK, V6, DOI 10.1038/srep24828; Al Khatib HK, 2017, EUR J CLIN NUTR, V71, P614, DOI 10.1038/ejcn.2016.201; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Bates B LA, 2014, EXECUTIVE SUMMARY, P1; Bates BLA., 2014, NATL DIET NUTR SURVE, DOI DOI 10.1017/CB09781107415324.004; Capers PL, 2015, OBES REV, V16, P771, DOI 10.1111/obr.12296; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Celis-Morales C, 2017, AM J CLIN NUTR, V105, P980, DOI 10.3945/ajcn.116.147231; Cespedes EM, 2016, AM J EPIDEMIOL, V183, P561, DOI 10.1093/aje/kwv251; Chapman CD, 2012, AM J CLIN NUTR, V96, P492, DOI 10.3945/ajcn.112.039750; Chaput JP, 2014, PHYSIOL BEHAV, V134, P86, DOI 10.1016/j.physbeh.2013.09.006; Dashti HS, 2015, ADV NUTR, V6, P648, DOI 10.3945/an.115.008623; Eckel RH, 2011, DIABETES CARE, V34, P1424, DOI 10.2337/dc11-0447; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; Fitt E, 2015, PUBLIC HEALTH NUTR, V18, P234, DOI 10.1017/S1368980014000342; Gil A, 2015, NUTR HOSP, V31, P128, DOI 10.3305/nh.2015.31.sup3.8761; Harrell FE, 2001, REGRESSION MODELING; Hex N, 2012, DIABETIC MED, V29, P855, DOI 10.1111/j.1464-5491.2012.03698.x; HSCIC, 2015, 2 HSCIC, P1; International Diabetes Federation, 2006, IDF CONS WORLDW DEF; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Kaneita Y, 2008, SLEEP, V31, P645, DOI 10.1093/sleep/31.5.645; Kessler L, 2010, SLEEP, V33, P1115, DOI 10.1093/sleep/33.8.1115; Killick R, 2015, CLIN ENDOCRINOL, V83, P498, DOI 10.1111/cen.12747; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Leproult R, 2015, SLEEP, V38, P708, DOI 10.5665/sleep.4660; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nicholson S, 2014, NATL DIET NUTR SURVE, P1; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Potter GD, 2016, ENDOCR REV, V105, P980; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Sato-Mito N, 2011, SLEEP MED, V12, P289, DOI 10.1016/j.sleep.2010.09.012; Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073; Spaeth AM, 2015, OBESITY, V23, P2349, DOI 10.1002/oby.21198; Sperry SD, 2015, SLEEP, V38, P1269, DOI 10.5665/sleep.4906; Tasali E, 2014, APPETITE, V80, P220, DOI 10.1016/j.appet.2014.05.021; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Xi B, 2014, SLEEP MED REV, V18, P293, DOI 10.1016/j.smrv.2013.06.001; Zhu Y, 2015, J DIABETES, V7, P10, DOI 10.1111/1753-0407.12138	44	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182195	10.1371/journal.pone.0182195	http://dx.doi.org/10.1371/journal.pone.0182195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750055	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700141
J	Al-Mahrouki, A; Giles, A; Hashim, A; Kim, HC; El-Falou, A; Rowe-Magnus, D; Farhat, G; Czarnota, GJ				Al-Mahrouki, Azza; Giles, Anoja; Hashim, Amr; Kim, Hyunjung Christina; El-Falou, Ahmad; Rowe-Magnus, Dean; Farhat, Golnaz; Czarnota, Gregory J.			Microbubble-based enhancement of radiation effect: Role of cell membrane ceramide metabolism	PLOS ONE			English	Article							FREQUENCY POWER DOPPLER; ULTRASOUND-TRIGGERED DRUG; GENE-EXPRESSION; SPHINGOLIPIDS; SYNTHASE; THERAPY; APOPTOSIS; TUMORS; PCR	Ultrasound (US) stimulated microbubbles (MB) is a new treatment approach that sensitizes cancer cells to radiation (XRT). The molecular pathways in this response remain unelucidated, however, previous data has supported a role for cell membrane-metabolism related pathways including an up regulation of UDP glycosyltransferase 8 (UGT8), which catalyzes the transfer of galactose to ceramide, a lipid that is associated with the induction of apoptotic signalling. In this study, the role of UGT8 in responses of prostate tumours to ultrasound-stimulated microbubble radiation enhancement therapy is investigated. Experiments were carried out with cells in vitro and tumours in vivo in which UGT8 levels had been up regulated or down regulated. Genetically modified PC3 cells were treated with XRT, US+MB, or a combination of XRT+US+MB. An increase in the immunolabelling of ceramide was observed in cells where UGT8 was down-regulated as opposed to cells where UGT8 was either not regulated or was up-regulated. Clonogenic assays have revealed a decreased level of cellular survival with the down-regulation of UGT8. Xenograft tumours generated from stably transfected PC3 cells were also treated with US+MB, XRT or US+MB+XRT. Histology demonstrated more cellular damage in tumours with down-regulated UGT8 in comparison with control tumours. In contrast, tumours with up-regulated UGT8 had less damage than control tumours. Power Doppler imaging indicated a reduction in the vascular index with UGT8 down-regulation and photoacoustic imaging revealed a reduction in oxygen saturation. This was contrary to when UGT8 was up regulated. The down regulation of UGT8 led to the accumulation of ceramide resulting in more cell death signalling and therefore, a greater enhancement of radiation effect when vascular disruption takes place through the use of ultrasound-stimulated microbubbles.	[Al-Mahrouki, Azza; Giles, Anoja; Hashim, Amr; Kim, Hyunjung Christina; El-Falou, Ahmad; Farhat, Golnaz; Czarnota, Gregory J.] Sunnybrook Hlth Sci Ctr, Radiat Oncol & Phys Sci, Toronto, ON, Canada; [Al-Mahrouki, Azza; Giles, Anoja; Hashim, Amr; Kim, Hyunjung Christina; El-Falou, Ahmad; Farhat, Golnaz; Czarnota, Gregory J.] Sunnybrook Res Inst, Toronto, ON, Canada; [Al-Mahrouki, Azza; Giles, Anoja; Hashim, Amr; Kim, Hyunjung Christina; El-Falou, Ahmad; Farhat, Golnaz; Czarnota, Gregory J.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Al-Mahrouki, Azza; Giles, Anoja; Hashim, Amr; Kim, Hyunjung Christina; El-Falou, Ahmad; Farhat, Golnaz; Czarnota, Gregory J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rowe-Magnus, Dean] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Indiana University System; Indiana University Bloomington	Czarnota, GJ (corresponding author), Sunnybrook Res Inst, Toronto, ON, Canada.	gregory.czarnota@sunnybrook.ca		Rowe-Magnus, Dean/0000-0001-5133-4463	Canadian Institutes of Health Research, National Institutes of Health; Terry Fox New Frontiers Project Program; University of Toronto James and Mary Davie Chair in Breast Cancer Imaging and Ablation	Canadian Institutes of Health Research, National Institutes of Health(Canadian Institutes of Health Research (CIHR)); Terry Fox New Frontiers Project Program; University of Toronto James and Mary Davie Chair in Breast Cancer Imaging and Ablation	The funding agencies are: Canadian Institutes of Health Research, National Institutes of Health and the Terry Fox New Frontiers Project Program. GJC is supported through a University of Toronto James and Mary Davie Chair in Breast Cancer Imaging and Ablation.; The authors thank the many funding agency; Canadian Institutes of Health Research, National Institutes of Health and the Terry Fox New Frontiers Project Program for supporting thisstudy. GJC is supported through a University of Toronto James and Mary Davie Chair in Breast Cancer Imaging and Ablation.	Abou-Elkacem L, 2015, EUR J RADIOL, V84, P1685, DOI 10.1016/j.ejrad.2015.03.016; Al-Mahrouki Azza A, 2015, Oncoscience, V2, P944; Al-Mahrouki AA, 2014, DIS MODEL MECH, V7, P363, DOI 10.1242/dmm.012922; Al-Mahrouki AA, 2012, ULTRASOUND MED BIOL, V38, P1958, DOI 10.1016/j.ultrasmedbio.2012.07.009; Briggs K, 2014, TECHNOL CANCER RES T, V13, P435, DOI [10.7785/tcrtexpress.2013.600266, 10.7785/tcrt.2013.600266]; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; Dziegiel P, 2010, BRIT J CANCER, V103, P524, DOI 10.1038/sj.bjc.6605750; Ekiz HA, 2010, INT J CANCER, V127, P1497, DOI 10.1002/ijc.25478; El Kaffas A, 2015, FUTURE ONCOL, V11, P1093, DOI 10.2217/fon.15.19; El Kaffas A, 2013, ANGIOGENESIS, V16, P443, DOI 10.1007/s10456-012-9329-2; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Henry Brian, 2013, Handb Exp Pharmacol, P77, DOI 10.1007/978-3-7091-1368-4_4; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hua Guoqiang, 2013, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-7091-1511-4_2; Huang WC, 2011, J LIPIDS, V2011, DOI 10.1155/2011/565316; Kim HC, 2013, ULTRASOUND MED BIOL, V39, P1376, DOI 10.1016/j.ultrasmedbio.2013.01.012; Kwok SJJ, 2013, ULTRASOUND MED BIOL, V39, P1983, DOI 10.1016/j.ultrasmedbio.2013.03.025; Lai Priscilla, 2016, Oncoscience, V3, P98, DOI 10.18632/oncoscience.299; Lee HJ, 2016, ULTRASONOGRAPHY; Liu YY, 2011, CANCER RES, V71, P6295, DOI 10.1158/0008-5472.CAN-11-0700; Liu YY, 2011, CANCER RES, V71, P2276, DOI 10.1158/0008-5472.CAN-10-3107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livak KJ, 1997, USER B PE APPL BIOSY, V2; Nowak M, 2013, FOLIA HISTOCHEM CYTO, V51, P164, DOI 10.5603/FHC.2013.0024; Owczarek TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084191; Pagano RE, 1998, ANN NY ACAD SCI, V845, P152, DOI 10.1111/j.1749-6632.1998.tb09668.x; Patwardhan GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006938; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pinter SZ, 2009, ULTRASOUND MED BIOL, V35, P1217, DOI 10.1016/j.ultrasmedbio.2009.01.010; Ponnusamy S, 2010, FUTURE ONCOL, V6, P1603, DOI 10.2217/FON.10.116; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Rao SS, 2014, RADIOTHER ONCOL, V111, P88, DOI 10.1016/j.radonc.2014.02.010; Ruckhaberle E, 2009, J CANCER RES CLIN, V135, P1005, DOI 10.1007/s00432-008-0536-6; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Tinkov S, 2010, J CONTROL RELEASE, V143, P143, DOI 10.1016/j.jconrel.2009.12.026; Tinkov S, 2009, J PHARM SCI-US, V98, P1935, DOI 10.1002/jps.21571; Tran WT, 2012, BRIT J CANCER, V107, P469, DOI 10.1038/bjc.2012.279; Tran William T, 2016, Oncoscience, V3, P122, DOI 10.18632/oncoscience.302; Wang SW, 2015, BBA-MOL CELL BIOL L, V1851, P1482, DOI 10.1016/j.bbalip.2015.08.002	42	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181951	10.1371/journal.pone.0181951	http://dx.doi.org/10.1371/journal.pone.0181951			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746357	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800072
J	Gaspar, P; Lalire, M				Gaspar, Philippe; Lalire, Maxime			A model for simulating the active dispersal of juvenile sea turtles with a case study on western Pacific leatherback turtles	PLOS ONE			English	Article							CENTRAL NORTH PACIFIC; DERMOCHELYS-CORIACEA; CARETTA-CARETTA; SATELLITE TRACKING; BODY TEMPERATURES; POPULATION; MOVEMENT; TRAJECTORIES; BEHAVIOR; WATERS	Oceanic currents are known to broadly shape the dispersal of juvenile sea turtles during their pelagic stage. Accordingly, simple passive drift models are widely used to investigate the distribution at sea of various juvenile sea turtle populations. However, evidence is growing that juveniles do not drift purely passively but also display some swimming activity likely directed towards favorable habitats. We therefore present here a novel Sea Turtle Active Movement Model (STAMM) in which juvenile sea turtles actively disperse under the combined effects of oceanic currents and habitat-driven movements. This model applies to all sea turtle species but is calibrated here for leatherback turtles (Dermochelys coriacea). It is first tested in a simulation of the active dispersal of juveniles originating from Jamursba-Medi, a main nesting beach of the western Pacific leatherback population. Dispersal into the North Pacific Ocean is specifically investigated. Simulation results demonstrate that, while oceanic currents broadly shape the dispersal area, modeled habitat-driven movements strongly structure the spatial and temporal distribution of juveniles within this area. In particular, these movements lead juveniles to gather in the North Pacific Transition Zone (NPTZ) and to undertake seasonal north-south migrations. More surprisingly, juveniles in the NPTZ are simulated to swim mostly towards west which considerably slows down their progression towards the American west coast. This increases their residence time, and hence the risk of interactions with fisheries, in the central and eastern part of the North Pacific basin. Simulated habitat-driven movements also strongly reduce the risk of cold-induced mortality. This risk appears to be larger among the juveniles that rapidly circulate into the Kuroshio than among those that first drift into the North Equatorial Counter Current (NECC). This mechanism might induce marked interannual variability in juvenile survival as the strength and position of the NECC are directly linked to El Nino activity.	[Gaspar, Philippe; Lalire, Maxime] Collecte Localisat Satellite, Sustainable Management Marine Resources, Ramonville St Agne, France		Gaspar, P (corresponding author), Collecte Localisat Satellite, Sustainable Management Marine Resources, Ramonville St Agne, France.	pgaspar@cls.fr		Gaspar, Philippe/0000-0002-1477-1215; Maxime, Lalire/0000-0002-3933-8047	French Ministry of Higher Education and Research through Paul Sabatier University (Toulouse, France)	French Ministry of Higher Education and Research through Paul Sabatier University (Toulouse, France)	This work is part of ML Ph.D. thesis funded by the French Ministry of Higher Education and Research through Paul Sabatier University (Toulouse, France).	Abecassis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073274; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Blanke B, 1997, J PHYS OCEANOGR, V27, P1038, DOI 10.1175/1520-0485(1997)027<1038:KOTPEU>2.0.CO;2; Bostrom BL, 2007, COMP BIOCHEM PHYS A, V147, P323, DOI 10.1016/j.cbpa.2006.10.032; Bostrom BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013925; Briscoe DK, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0087-4; Briscoe DK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0690; Burns TJ, 2015, J THERM BIOL, V51, P15, DOI 10.1016/j.jtherbio.2015.03.001; Carr AF, 1986, SEA TURTLE SO EXCELL; Casey J, 2010, J EXP BIOL, V213, P3961, DOI 10.1242/jeb.048611; Casey JP, 2014, J EXP BIOL, V217, P2331, DOI 10.1242/jeb.100347; Dalleau M, 2014, MAR BIOL, V161, P1835, DOI 10.1007/s00227-014-2465-z; Drake DL, 2000, THERMAL TOLERANCES T, P174; Dutton PH, 2007, CHELONIAN CONSERV BI, V6, P47, DOI 10.2744/1071-8443(2007)6[47:SAGSON]2.0.CO;2; Eckert K., 2012, US DEP INTER FISH WI, P158; Eckert SA, 2002, J EXP BIOL, V205, P3689; Faugeras B, 2007, J THEOR BIOL, V247, P837, DOI 10.1016/j.jtbi.2007.04.012; Ferry N., 2010, MERCATOR OCEAN Q NEW, V36, P15; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fossette Sabrina, 2008, Endangered Species Research, V4, P33, DOI 10.3354/esr00039; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hays GC, 1997, CAN J ZOOL, V75, P40, DOI 10.1139/z97-005; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Hitipeuw C, 2007, CHELONIAN CONSERV BI, V6, P28, DOI 10.2744/1071-8443(2007)6[28:PSAIMO]2.0.CO;2; Howell Evan A., 2008, Endangered Species Research, V5, P267, DOI 10.3354/esr00096; Hughes G.R., 1974, SEA TURTLES S E AFRI; James MC, 2004, CAN J ZOOL, V82, P1302, DOI 10.1139/z04-110; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Jones TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045447; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; Lehodey P, 2008, PROG OCEANOGR, V78, P304, DOI 10.1016/j.pocean.2008.06.004; LUTCAVAGE ME, 1992, CAN J ZOOL, V70, P348, DOI 10.1139/z92-051; Mansfield KL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3039; Mansfield KL, 2012, MAR ECOL PROG SER, V457, P181, DOI 10.3354/meps09485; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; Paladino Frank V., 1996, Chelonian Conservation and Biology, V2, P223; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; PETERSON CC, 1990, P NATL ACAD SCI USA, V87, P2324, DOI 10.1073/pnas.87.6.2324; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Putman NF, 2015, CURR BIOL, V25, P1221, DOI 10.1016/j.cub.2015.03.014; Putman NF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0345; Putman NF, 2012, MAR BIOL, V159, P2117, DOI 10.1007/s00227-012-1995-5; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Putman NF, 2010, INTEGR COMP BIOL, V50, P305, DOI 10.1093/icb/icq041; Saba VS, 2011, BIOGEOSCIENCES, V8, P489, DOI 10.5194/bg-8-489-2011; Saba VS, 2008, ECOLOGY, V89, P1414, DOI 10.1890/07-0364.1; Saba VS, 2008, DEEP-SEA RES PT I, V55, P646, DOI 10.1016/j.dsr.2008.02.006; Scott R, 2014, ECOLOGY, V95, P2840, DOI 10.1890/13-2164.1; Scott R, 2012, MAR BIOL, V159, P481, DOI 10.1007/s00227-011-1825-1; Scott RB, 2012, OCEAN DYNAM, V62, P1091, DOI 10.1007/s10236-012-0548-2; Seney EE, 2010, J EXP MAR BIOL ECOL, V384, P61, DOI 10.1016/j.jembe.2010.01.002; Soslau G, 2004, COMP BIOCHEM PHYS B, V138, P399, DOI 10.1016/j.cbpc.2004.05.004; Southwood AL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P285, DOI 10.1086/427048; Spotila J. R., THERMAL BIOL BIOL SE, P297; VIDELER JJ, 1990, COMP BIOCHEM PHYS A, V97, P91, DOI 10.1016/0300-9629(90)90155-L; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023; Zhao J, 2013, J GEOPHYS RES-OCEANS, V118, P2828, DOI 10.1002/jgrc.20196	64	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181595	10.1371/journal.pone.0181595	http://dx.doi.org/10.1371/journal.pone.0181595			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746389	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800044
J	Napolitano, F; Warren, EB; Migliarini, S; Punzo, D; Errico, F; Li, Q; Thiolat, ML; Vescovi, AL; Calabresi, P; Bezard, E; Morelli, M; Konradi, C; Pasqualetti, M; Usiello, A				Napolitano, Francesco; Warren, Emily Booth; Migliarini, Sara; Punzo, Daniela; Errico, Francesco; Li, Qin; Thiolat, Marie-Laure; Vescovi, Angelo Luigi; Calabresi, Paolo; Bezard, Erwan; Morelli, Micaela; Konradi, Christine; Pasqualetti, Massimo; Usiello, Alessandro			Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques	PLOS ONE			English	Article							GTP-BINDING PROTEIN; DOPA-INDUCED DYSKINESIA; HUNTINGTONS-DISEASE; SYNAPTIC PLASTICITY; MUTANT-HUNTINGTIN; MOTOR BEHAVIOR; STRIATUM; EXPRESSION; MODEL; SCHIZOPHRENIA	In rodent and human brains, the small GTP-binding protein Rhes is highly expressed in virtually all dopaminoceptive striatal GABAergic medium spiny neurons, as well as in large aspiny cholinergic interneurons, where it is thought to modulate dopamine-dependent signaling. Consistent with this knowledge, and considering that dopaminergic neurotransmission is altered in neurological and psychiatric disorders, here we sought to investigate whether Rhes mRNA expression is altered in brain regions of patients with Parkinson's disease (PD), Schizophrenia (SCZ), and Bipolar Disorder (BD), when compared to healthy controls (about 200 post-mortem samples). Moreover, we performed the same analysis in the putamen of non-human primate Macaca Mulatta, lesioned with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Overall, our data indicated comparable Rhes mRNA levels in the brain of patients with SCZ and BD, and their respective healthy controls. In sharp contrast, the putamen of patients suffering from PD showed a significant 35% reduction of this transcript, compared to healthy subjects. Interestingly, in line with observations obtained in humans, we found 27% decrease in Rhes mRNA levels in the putamen of MPTP-treated primates. Based on the established inhibitory influence of Rhes on dopamine-related responses, we hypothesize that its striatal downregulation in PD patients and animal models of PD might represent an adaptive event of the dopaminergic system to functionally counteract the reduced nigrostriatal innervation.	[Napolitano, Francesco; Punzo, Daniela; Errico, Francesco; Usiello, Alessandro] Ceinge Biotecnol Avanzate, Naples, Italy; [Napolitano, Francesco; Errico, Francesco] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Warren, Emily Booth; Konradi, Christine] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Migliarini, Sara] Univ Pisa, Dept Biol, Unit Cell & Dev Biol, Pisa, Italy; [Punzo, Daniela; Usiello, Alessandro] Univ Campania, Dept Environm Biol & Pharmaceut Sci & Technol, Luigi Vanvitelli, Italy; [Li, Qin; Bezard, Erwan] Motac Neurosci, Manchester M15 6WE, Lancs, England; [Li, Qin; Bezard, Erwan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Thiolat, Marie-Laure; Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, Bordeaux, France; [Thiolat, Marie-Laure; Bezard, Erwan] Inst Malad Neurodegenerat, CNRS, UMR 5293, Bordeaux, France; [Vescovi, Angelo Luigi] ISBReMIT Inst Stem Cell Biol Regenerat Med & Inno, IRCSS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy; [Calabresi, Paolo] Univ Perugia & Clin Neurol, Santa Maria Misericordia Hosp, Dept Med, Perugia, Italy; [Morelli, Micaela] CNR, Natl Res Council Italy, Neurosci Inst, Cagliari, Italy; [Morelli, Micaela] Univ Cagliari, Sect Neuropsychopharmacol, Dept Biomed Sci, Cagliari, Italy; [Pasqualetti, Massimo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst, Rovereto, TN, Italy; [Pasqualetti, Massimo] CNR, Natl Res Council, Neurosci Inst, Pisa, Italy	CEINGE Biotecnologie Avanzate; University of Naples Federico II; Vanderbilt University; University of Pisa; Universita della Campania Vanvitelli; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; IRCCS Casa Sollievo Della Sofferenza; Hospital Santa Maria della Misericordia; Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR)	Napolitano, F (corresponding author), Ceinge Biotecnol Avanzate, Naples, Italy.; Napolitano, F (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.; Usiello, A (corresponding author), Univ Campania, Dept Environm Biol & Pharmaceut Sci & Technol, Luigi Vanvitelli, Italy.	napolitano@ceinge.unina.it; usiello@ceinge.unina.it	Calabresi, Paolo/G-8496-2011; Bezard, Erwan/ABD-5153-2021; Vescovi, Angelo Luigi/A-4919-2015	Calabresi, Paolo/0000-0003-0326-5509; Vescovi, Angelo Luigi/0000-0002-1742-4112; Migliarini, Sara/0000-0003-2741-269X; Warren, Emily/0000-0002-3561-3478; Pasqualetti, Massimo/0000-0002-0844-8139; Napolitano, Francesco/0000-0003-0884-1851; Bezard, Erwan/0000-0002-0410-4638	Programma "Futuro in Ricerca" [RBFR13S4LE]; Agence Nationale dela Recherche [ANR-07-JCJC-0090, ANR-08-MNP-018, ANR-07-MNP-Trafinlid]; NIH-NeuroBiobank [HHSN-271-2013-00030C]; NATIONAL CANCER INSTITUTE [F32CA090073] Funding Source: NIH RePORTER	Programma "Futuro in Ricerca"; Agence Nationale dela Recherche(French National Research Agency (ANR)); NIH-NeuroBiobank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	FN was supported by Programma "Futuro in Ricerca 2013" - RBFR13S4LE. MRT and EB were supported by grants from the Agence Nationale dela Recherche grants (ANR-07-JCJC-0090; ANR-08-MNP-018; ANR-07-MNP-Trafinlid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Harvard Brain Tissue Resource Center, funded through NIH-NeuroBiobank HHSN-271-2013-00030C (The National Institute of Mental Health (NIMH), National Institute of Neurological Diseases and Stroke (NINDS) and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and brain donors and their families for the tissue samples used in these studies. We thank the NIH NeuroBioBank (Human Brain and Spinal Fluid Resource Center, VA West Los Angeles Healthcare Center, Los Angeles, CA 90073), for providing us samples from both Dorsolateral Prefrontal Cortex and Hippocampus of SCZ patients and non-psychiatric controls. In addition, we are also grateful to MRC London Neurodegenerative Diseases Brain Bank for providing us post mortem Prefrontal Cortex and Putamen samples, and Stanley Medical Research Institute that gave us post mortem Anterior Cingulate Cortex samples. Finally, we are grateful to Anders Borgkvist and Egle De Stefano for their excellent critical reading of the manuscript, as well as Vittorio Lucignano for his very good technical support.	Aubert I, 2007, BIOL PSYCHIAT, V61, P836, DOI 10.1016/j.biopsych.2006.06.038; Bang S, 2012, NEUROSCI LETT, V521, P142, DOI 10.1016/j.neulet.2012.05.073; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Brugnoli A, 2016, NEUROBIOL DIS, V85, P155, DOI 10.1016/j.nbd.2015.10.020; Calon F, 2004, BRAIN, V127, P1075, DOI 10.1093/brain/awh128; Decressac M, 2013, J PARKINSON DIS, V3, P13, DOI 10.3233/JPD-120155; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Ghiglieri V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10933; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Harrison LM, 2013, NEUROSCIENCE, V236, P21, DOI 10.1016/j.neuroscience.2012.12.062; Harrison LM, 2013, EXP CELL RES, V319, P2310, DOI 10.1016/j.yexcr.2013.03.033; Harrison LM, 2011, J NEUROSCI RES, V89, P874, DOI 10.1002/jnr.22604; Harrison LM, 2008, BRAIN RES, V1245, P16, DOI 10.1016/j.brainres.2008.09.066; Harrison LM, 2006, NEUROSCIENCE, V137, P483, DOI 10.1016/j.neuroscience.2005.08.017; Karege F, 2012, J AFFECT DISORDERS, V136, P185, DOI 10.1016/j.jad.2011.09.024; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Liu YL, 2008, BIOL PSYCHIAT, V64, P789, DOI 10.1016/j.biopsych.2008.04.035; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; Manson A, 2012, J PARKINSON DIS, V2, P189, DOI 10.3233/JPD-2012-120103; Mealer RG, 2014, J BIOL CHEM, V289, P3547, DOI 10.1074/jbc.M113.536912; Mealer RG, 2013, J NEUROSCI, V33, P4206, DOI 10.1523/JNEUROSCI.3730-12.2013; Mikula S, 2007, NEUROIMAGE, V35, P9, DOI 10.1016/j.neuroimage.2006.11.053; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Pinna A, 2016, MOVEMENT DISORD, V31, P583, DOI 10.1002/mds.26489; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Sbodio JI, 2013, CELL REP, V4, P890, DOI 10.1016/j.celrep.2013.08.001; Sciamanna G, 2015, NEUROBIOL DIS, V78, P146, DOI 10.1016/j.nbd.2015.03.021; Seredenina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022231; Shahani N, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6670; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Swarnkar S, 2015, NEUROBIOL DIS, V82, P66, DOI 10.1016/j.nbd.2015.05.011; USUI H, 1994, J NEUROSCI, V14, P4915; Vallortigara J, 2009, J NEUROENDOCRINOL, V21, P49, DOI 10.1111/j.1365-2826.2008.01802.x; Vallortigara J, 2008, NEUROBIOL DIS, V31, P378, DOI 10.1016/j.nbd.2008.05.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargiu P, 2004, ONCOGENE, V23, P559, DOI 10.1038/sj.onc.1207161; Vargiu P, 2001, MOL BRAIN RES, V94, P1, DOI 10.1016/S0169-328X(01)00140-1; Vitucci D, 2016, NEUROPSYCHOPHARMACOL, V41, P916, DOI 10.1038/npp.2015.228	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181677	10.1371/journal.pone.0181677	http://dx.doi.org/10.1371/journal.pone.0181677			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742811	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000047
J	Torrens, G; Perez-Gallego, M; Moya, B; Munar-Bestard, M; Zamorano, L; Cabot, G; Blazquez, J; Ayala, JA; Oliver, A; Juan, C				Torrens, Gabriel; Perez-Gallego, Marcelo; Moya, Bartolome; Munar-Bestard, Marta; Zamorano, Laura; Cabot, Gabriel; Blazquez, Jesus; Ayala, Juan A.; Oliver, Antonio; Juan, Carlos			Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; GRAM-NEGATIVE BACTERIA; PENICILLIN-BINDING PROTEINS; LYSOZYME INHIBITOR IVY; RECOGNITION PROTEINS; ANTIMICROBIAL ACTIVITY; ESCHERICHIA-COLI; AMPD; LACTOFERRIN; MICROBIOME	Antimicrobial resistance is a continuously increasing threat that severely compromises our antibiotic arsenal and causes thousands of deaths due to hospital-acquired infections by pathogens such as Pseudomonas aeruginosa, situation further aggravated by the limited development of new antibiotics. Thus, alternative strategies such as those targeting bacterial resistance mechanisms, virulence or potentiating the activity of our immune system resources are urgently needed. We have recently shown that mutations simultaneously causing the peptidoglycan recycling blockage and the beta-lactamase AmpC overexpression impair the virulence of P. aeruginosa. These findings suggested that peptidoglycan metabolism might be a good target not only for fighting antibiotic resistance, but also for the attenuation of virulence and/ or potentiation of our innate immune weapons. Here we analyzed the activity of the innate immune elements peptidoglycan recognition proteins (PGRPs) and lysozyme against P. aeruginosa. We show that while lysozyme and PGRPs have a very modest basal effect over P. aeruginosa, their bactericidal activity is dramatically increased in the presence of subinhibitory concentrations of the permeabilizing agent colistin. We also show that the P. aeruginosa lysozyme inhibitors seem to play a very residual protective role even in permeabilizing conditions. In contrast, we demonstrate that, once the permeability barrier is overpassed, the activity of lysozyme and PGRPs is dramatically enhanced when inhibiting key peptidoglycan recycling components (such as the 3 AmpDs, AmpG or NagZ), indicating a decisive protective role for cell-wall recycling and that direct peptidoglycan-binding supports, at least partially, the activity of these enzymes. Finally, we show that recycling blockade when occurring simultaneously with AmpC overexpression determines a further decrease in the resistance against PGRP2 and lysozyme, linked to quantitative changes in the cell-wall. Thus, our results help to delineate new strategies against P. aeruginosa	[Torrens, Gabriel; Perez-Gallego, Marcelo; Moya, Bartolome; Munar-Bestard, Marta; Zamorano, Laura; Cabot, Gabriel; Oliver, Antonio; Juan, Carlos] Hosp Son Espases, Inst Invest Sanitaria Baleares IdISBa, Serv Microbiol, Palma De Mallorca, Spain; [Torrens, Gabriel; Perez-Gallego, Marcelo; Moya, Bartolome; Munar-Bestard, Marta; Zamorano, Laura; Cabot, Gabriel; Oliver, Antonio; Juan, Carlos] Hosp Son Espases, Inst Invest Sanitaria Baleares IdISBa, Unidad Invest, Palma De Mallorca, Spain; [Blazquez, Jesus] Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain; [Ayala, Juan A.] Ctr Biol Mol Severo Ochoa, Dept Virol & Microbiol, Madrid, Spain	Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Hospital Universitari Son Espases; Institut Investigacio Sanitaria Illes Balears (IdISBa); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Juan, C (corresponding author), Hosp Son Espases, Inst Invest Sanitaria Baleares IdISBa, Serv Microbiol, Palma De Mallorca, Spain.; Juan, C (corresponding author), Hosp Son Espases, Inst Invest Sanitaria Baleares IdISBa, Unidad Invest, Palma De Mallorca, Spain.	carlos.juan@ssib.es	Oliver, Antonio/E-4048-2012; Torrens, Gabriel/AAD-9304-2021; Moya Canyelles, Tomeu/AAG-9154-2019; Ayala, Juan A/AAI-4458-2021; Cabot, Gabriel/I-8848-2016; Blazquez, Jesus/T-4680-2017; Oliver, Antonio/V-5541-2019; Juan, Carlos/AAB-2183-2020; Cabot, Gabriel/AAE-4828-2021	Oliver, Antonio/0000-0001-9327-1894; Moya Canyelles, Tomeu/0000-0001-6404-246X; Ayala, Juan A/0000-0002-0577-7498; Blazquez, Jesus/0000-0003-0495-3848; Oliver, Antonio/0000-0001-9327-1894; Juan, Carlos/0000-0002-1402-3516; Cabot, Gabriel/0000-0002-6452-9945; Munar Bestard, Marta/0000-0002-9035-1335; Torrens Ribot, Gabriel/0000-0002-0450-1430; ZAMORANO, LAURA/0000-0003-1676-9626	Ministerio de Economia y Competitividad of Spain; Instituto de Salud CarlosIII; European Regional Development Fund "Away to achieve Europe" ERDF,through the Spanish Network for the Research in Infectious Diseases [RD12/0015, CP12/03324, SAF201238539, PI12/00103, PI15/00088, PI15/02212]	Ministerio de Economia y Competitividad of Spain(Spanish Government); Instituto de Salud CarlosIII(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund "Away to achieve Europe" ERDF,through the Spanish Network for the Research in Infectious Diseases	This work was supported by the Ministerio de Economia y Competitividad of Spain and Instituto de Salud CarlosIII-co-financed by European Regional Development Fund "Away to achieve Europe" ERDF,through the Spanish Network for the Research in Infectious Diseases (RD12/0015) and grants CP12/03324,SAF201238539, PI12/00103, PI15/00088 and PI15/02212. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Benachour A, 2012, J BACTERIOL, V194, P6066, DOI 10.1128/JB.00981-12; Bernal-Cabas M, 2015, J BACTERIOL, V197, P603, DOI 10.1128/JB.02449-14; Bishop JL, 2007, P NATL ACAD SCI USA, V104, P691, DOI 10.1073/pnas.0611133104; Bobrovsky P, 2016, INFECT IMMUN, V84, P2124, DOI 10.1128/IAI.01495-15; Boneca IG, 2009, CELL HOST MICROBE, V5, P109, DOI 10.1016/j.chom.2009.01.007; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Clarke CA, 2010, J BIOL CHEM, V285, P14843, DOI 10.1074/jbc.C110.120931; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; Deckers D, 2008, APPL ENVIRON MICROB, V74, P4434, DOI 10.1128/AEM.00589-08; Delhaye A, 2016, MBIO, V7, DOI 10.1128/mBio.00047-16; Derbise A, 2013, J INFECT DIS, V207, P1535, DOI 10.1093/infdis/jit057; Dorr T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004433; Dziarski R, 2012, MICROB DRUG RESIST, V18, P280, DOI 10.1089/mdr.2012.0002; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Fisher JF, 2014, BIOORG CHEM, V56, P41, DOI 10.1016/j.bioorg.2014.05.011; Ganz T, 2003, BLOOD, V101, P2388, DOI 10.1182/blood-2002-07-2319; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gowda RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137129; Hamou-Segarra M, 2017, J ANTIMICRO IN PRESS; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Juan C, 2006, ANTIMICROB AGENTS CH, V50, P1780, DOI 10.1128/AAC.50.5.1780-1787.2006; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kashyap DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004280; Kashyap DR, 2011, NAT MED, V17, P676, DOI 10.1038/nm.2357; Lamers RP, 2016, FUTURE MED CHEM, V8, P975, DOI 10.4155/fmc-2016-0017; Lee J, 2012, INFECT IMMUN, V80, P2645, DOI 10.1128/IAI.00168-12; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Mark BL, 2012, FUTURE MICROBIOL, V7, P306; Mark BL, 2011, FUTURE MICROBIOL, V6, P1415, DOI [10.2217/FMB.11.128, 10.2217/fmb.11.128]; Martinez JG, 2009, BIOCHEM J, V419, P193, DOI 10.1042/BJ20081505; Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003; Maura D, 2016, CURR OPIN MICROBIOL, V33, P41, DOI 10.1016/j.mib.2016.06.001; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Melnyk AH, 2015, EVOL APPL, V8, P273, DOI 10.1111/eva.12196; Palomino MM, 2009, RES MICROBIOL, V160, P117, DOI 10.1016/j.resmic.2008.10.011; Morosini MI, 2000, ANTIMICROB AGENTS CH, V44, P3137, DOI 10.1128/AAC.44.11.3137-3143.2000; Napier BA, 2013, MBIO, V4, DOI 10.1128/mBio.00021-13; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Oliver Antonio, 2008, P433; Perez-Gallego M, 2016, MBIO, V7, DOI 10.1128/mBio.01783-16; Perley-Robertson GE, 2016, ACS CHEM BIOL, V11, P2626, DOI 10.1021/acschembio.6b00552; Raivio TL., 2013, BIOCH BIOPHYS ACTA; RAPHAEL GD, 1989, J CLIN INVEST, V84, P1528, DOI 10.1172/JCI114329; Ropy A, 2015, ANTIMICROB AGENTS CH, V59, P3925, DOI 10.1128/AAC.05150-14; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Scanlon TC, 2010, ACS CHEM BIOL, V5, P809, DOI 10.1021/cb1001119; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Stubbs KA, 2013, CHEMBIOCHEM, V14, P1973, DOI 10.1002/cbic.201300395; Teneback CC, 2014, BIOENGINEERED, V5, P143; Turner RD, 2014, MOL MICROBIOL, V91, P862, DOI 10.1111/mmi.12513; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; Yakhnina AA, 2015, MOL MICROBIOL, V97, P957, DOI 10.1111/mmi.13077; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zamorano L, 2011, ANTIMICROB AGENTS CH, V55, P1990, DOI 10.1128/AAC.01688-10; Zamorano L, 2010, ANTIMICROB AGENTS CH, V54, P3557, DOI 10.1128/AAC.00385-10; Zhang WL, 2013, J AM CHEM SOC, V135, P4950, DOI 10.1021/ja400970n	71	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181932	10.1371/journal.pone.0181932	http://dx.doi.org/10.1371/journal.pone.0181932			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742861	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000062
J	Wang, JG; Zhang, D; Jakovlic, I; Wang, WM				Wang, Ju-Guang; Zhang, Dong; Jakovlic, Ivan; Wang, Wei-Min			Sequencing of the complete mitochondrial genomes of eight freshwater snail species exposes pervasive paraphyly within the Viviparidae family (Caenogastropoda)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENE ORDER; GASTROPODA; EVOLUTION; REARRANGEMENTS; NEOGASTROPODA; DUPLICATION; HYMENOPTERA; MODEL; INDEX	Phylogenetic relationships among snails (Caenogastropoda) are still unresolved, and many taxonomic categories remain non-monophyletic. Paraphyly has been reported within a large family of freshwater snails, Viviparidae, where the taxonomic status of several species remains questionable. As many endemic Chinese viviparid species have become endangered during the last few decades, this presents a major obstacle for conservation efforts. Mitochondrial genomes (mitogenomes) carry a large amount of data, so they can often provide a much higher resolution for phylogenetic analyses in comparison to the traditionally used molecular markers. To help resolve their phylogenetic relationships, the complete mitogenomes of eight Chinese viviparid snails, Viviparus chui, Cipangopaludina chinensis, C. ussuriensis, C. dianchiensis (endangered), Margarya melanioides (endangered), M. monodi (critically endangered), Bellamya quadrata and B. aeruginosa, were sequenced and compared to almost all of the available caenogastropod mitogenomes. Viviparidae possess the largest mitogenomes (16 392 to 18 544 bp), exhibit the highest A+T bias (72.5% on average), and some exhibit unique gene orders (a rearrangement of the standard MYCWQGE box), among the Caenogastropoda. Apart from the Vermetidae family and Cerithioidea superfamily, which possessed unique gene orders, the remaining studied caenogastropod mitogenomes exhibited highly conserved gene order, with minimal variations. Maximum likelihood and Bayesian inference analyses, used to reconstruct the phylogenetic relationships among 49 almost complete (all 37 genes) caenogastropod mitogenomes, produced almost identical tree topologies. Viviparidae were divided into three clades: a) Margarya and Cipangopaludina (except C. ussuriensis), b) Bellamya and C. ussuriensis, c) Viviparus chui. Our results present evidence that some Cipangopaludina species (dianchiensis and cathayensis) should be renamed into the senior genus Margarya. The phylogenetic resolution obtained in this study is insufficient to fully resolve the relationships within the 'b' clade, but if C. chinensis proves to be a valid representative of the genus, C. ussuriensis may have to be reassigned a different genus (possibly Bellamya, or even a new genus). Non-monophyly also remains pervasive among the higher (above the family-level) Caenogastropod taxonomic classes. Gene order distance matrix produced a different phylogenetic signal from the nucleotide sequences, which indicates a limited usability of this approach for inferring caenogastropod phylogenies. As phenotypic homoplasy appears to be widespread among some viviparid genera, in order to effectively protect the rapidly diminishing endemic Viviparid populations in China, further detailed molecular phylogenetic studies are urgently needed to resolve the taxonomic status of several species.	[Wang, Ju-Guang; Wang, Wei-Min] Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Hubei, Peoples R China; [Wang, Ju-Guang; Wang, Wei-Min] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China; [Zhang, Dong] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Zhang, Dong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jakovlic, Ivan] Wuhan Inst Biotechnol, Biotransduct Lab, Wuhan, Hubei, Peoples R China; [Wang, Wei-Min] Collaborat Innovat Ctr Efficient & Hlth Prod Fish, Changde, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, WM (corresponding author), Huazhong Agr Univ, Coll Fisheries, Minist Agr, Key Lab Freshwater Anim Breeding, Wuhan, Hubei, Peoples R China.; Wang, WM (corresponding author), Freshwater Aquaculture Collaborat Innovat Ctr Hub, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.; Wang, WM (corresponding author), Collaborat Innovat Ctr Efficient & Hlth Prod Fish, Changde, Peoples R China.	wangwm@mail.hzau.edu.cn		Jakovlic, Ivan/0000-0002-2461-3712	major Chinese "National Water Pollution Control and Management Technology" Projects [2012ZX07203-006, 2014ZX07203010-4]	major Chinese "National Water Pollution Control and Management Technology" Projects	This study was supported by the two major Chinese "National Water Pollution Control and Management Technology" Projects: 2012ZX07203-006 and 2014ZX07203010-4. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annandale N, 1924, P R SOC LOND B-CONTA, V96, P60, DOI 10.1098/rspb.1924.0011; Babbucci M, 2014, GENOME BIOL EVOL, V6, P3326, DOI 10.1093/gbe/evu265; Bandyopadhyay PK, 2006, TOXICON, V48, P29, DOI 10.1016/j.toxicon.2006.04.013; Barghi N, 2015, MITOCHONDR DNA, V27, P1; Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Burland T G, 2000, Methods Mol Biol, V132, P71; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Chen PW, 2016, MITOCHONDRIAL DNA B, V1, P493, DOI 10.1080/23802359.2016.1192502; Colgan DJ, 2007, MOL PHYLOGENET EVOL, V42, P717, DOI 10.1016/j.ympev.2006.10.009; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Deans AR, 2012, TRENDS ECOL EVOL, V27, P78, DOI 10.1016/j.tree.2011.11.007; DeJong RJ, 2004, J PARASITOL, V90, P991, DOI 10.1645/GE-284R; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Du L, 2013, CHINESE SCI BULL, V58, P2154, DOI 10.1007/s11434-012-5632-y; Feldmeyer B, GENEIOUS VERSION 10; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Hao ZL, 2016, MITOCHONDRIAL DNA B, V1, P220, DOI 10.1080/23802359.2016.1155421; Hilgers L, 2016, MITOCHONDRIAL DNA B, V1, P330, DOI 10.1080/23802359.2016.1172046; Hirano T., 2015, J MOLLUSCAN STUDIES; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Huang XY, 2008, J HYDROECOLOGY, V1, P106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, IUCN RED LIST THREAT; Jakovlic I, 2013, ARCH BIOL SCI, V65, P1463, DOI 10.2298/ABS1304463J; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2002, MOL BIOL EVOL, V19, P163, DOI 10.1093/oxfordjournals.molbev.a004068; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li J., 2011, THESIS; [梁中耀 Liang Zhongyao], 2014, [环境科学学报, Acta Scientiae Circumstantiae], V34, P754; Liu Y, 1995, DISTRIBUTION FAMILY; Liu YY, 1979, EC FAUNA SINICA CHIN; Lu Hong-Fa, 2014, Zoological Research, V35, P510, DOI 10.13918/j.issn.2095-8137.2014.6.510; Luo Min-bo, 2006, Marine Fisheries, V28, P71; Marques JP, 2016, MARINE GENOMICS; Marquez EJ, 2016, MITOCHONDRIAL DNA A, V27, P1516, DOI 10.3109/19401736.2014.953118; Marquez EJ, 2014, MITOCHONDRIAL GENOME, V27, P1; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029; NCBI, GEN COD 2016; Neiman M, 2010, MOL BIOL EVOL, V27, P954, DOI 10.1093/molbev/msp300; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Osca D, 2015, MOL PHYLOGENET EVOL, V93, P118, DOI 10.1016/j.ympev.2015.07.011; Osca D, 2014, GENE, V547, P257, DOI 10.1016/j.gene.2014.06.040; Rawlings TA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-440; San Mauro D, 2006, MOL BIOL EVOL, V23, P227, DOI 10.1093/molbev/msj025; Sengupta ME, 2009, MOL PHYLOGENET EVOL, V52, P797, DOI 10.1016/j.ympev.2009.05.007; Shi W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1581-6; Shu F, 1877, SHELL RADULAR MORPHO; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Strong EE, 2008, HYDROBIOLOGIA, V595, P149, DOI 10.1007/s10750-007-9012-6; Sung JM, 2016, MITOCHONDRIAL DNA B, V1, P468, DOI 10.1080/23802359.2016.1186516; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchang X, 1949, REVISION GENUS MARGA, P1; Tian M, 2015, J KUNMING MED U, V36, P4; Uribe JE, 2016, MOL PHYLOGENET EVOL, V104, P21, DOI 10.1016/j.ympev.2016.07.021; Wang Chou-Ming, 2011, Zoological Research, V32, P212, DOI 10.3724/SP.J.1141.2011.02212; Wang H., 2009, ENV SCI SURV, V28, P57, DOI DOI 10.13623/2009.03012.[; Wang ML, 2016, MITOCHONDRIAL DNA A, V27, P1734, DOI 10.3109/19401736.2014.961145; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xiong G, 2015, MITOCHONDR DNA, V26, P187, DOI 10.3109/19401736.2013.873935; Yamauchi MM, 2004, INSECT MOL BIOL, V13, P435, DOI 10.1111/j.0962-1075.2004.00505.x; Yang HR, 2016, MITOCHONDRIAL DNA A, V27, P1892, DOI 10.3109/19401736.2014.971274; Yang Q, 2016, MITOCHONDRIAL GENOME, P1; Yen TC, 1942, J MOLLUSCAN STUDIES; Zeng T, 2015, MITOCHONDR DNA, V26, P897, DOI 10.3109/19401736.2013.861449; Zhang L, 1993, 3 C AC SEM 4 TIM MOL; Zhang L., 1990, ZOOLOGICAL SYSTEMATI, P28; Zhang LJ, 2015, ZOOL J LINN SOC-LOND, V174, P760, DOI 10.1111/zoj.12260; Zhou X, 2014, MITOCHONDR DNA, V27, P884	77	60	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181699	10.1371/journal.pone.0181699	http://dx.doi.org/10.1371/journal.pone.0181699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742843	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000050
J	Fresiello, L; Rademakers, F; Claus, P; Ferrari, G; Di Molfetta, A; Meyns, B				Fresiello, Libera; Rademakers, Frank; Claus, Piet; Ferrari, Gianfranco; Di Molfetta, Arianna; Meyns, Bart			Exercise physiology with a left ventricular assist device: Analysis of heart-pump interaction with a computational simulator	PLOS ONE			English	Article							BLOOD-FLOW; SKELETAL-MUSCLE; FAILURE; SUPPORT; SPEED; PRESSURE; HEMODYNAMICS; PERFORMANCE; MECHANISM; CONSTANT	Patients with a Ventricular Assist Device (VAD) are hemodynamically stable but show an impaired exercise capacity. Aim of this work is to identify and to describe the limiting factors of exercise physiology with a VAD. We searched for data concerning exercise in heart failure condition and after VAD implantation from the literature. Data were analyzed by using a cardiorespiratory simulator that worked as a collector of inputs coming from different papers. As a preliminary step the simulator was used to reproduce the evolution of hemodynamics from rest to peak exercise (ergometer cycling) in heart failure condition. Results evidence an increase of cardiac output of +2.8 l/min and a heart rate increase to 67% of the expected value. Then, we simulated the effect of a continuous-flow VAD at both rest and exercise. Total cardiac output increases of +3.0 l/min (+0.9 l/min due to the VAD and +2.1 l/min to the native ventricle). Since the left ventricle works in a non-linear portion of the diastolic stiffness line, we observed a consistent increase of pulmonary capillary wedge pressure (from 14 to 20 mmHg) for a relatively small increase of end-diastolic volume (from 182 to 189 cm 3). We finally increased VAD speed during exercise to the maximum possible value and we observed a reduction of wedge pressure (-4.5 mmHg), a slight improvement of cardiac output (8.0 l/min) and a complete unloading of the native ventricle. The VAD can assure a proper hemodynamics at rest, but provides an insufficient unloading of the left ventricle and does not prevent wedge pressure from rising during exercise. Neither the VAD provides major benefits during exercise in terms of total cardiac output, which increases to a similar extend to an unassisted heart failure condition. VAD speed modulation can contribute to better unload the ventricle but the maximal flow reachable with the current devices is below the cardiac output observed in a healthy heart.	[Fresiello, Libera; Meyns, Bart] Katholieke Univ Leuven, Dept Cardiac Surg, Leuven, Belgium; [Fresiello, Libera] CNR, Inst Clin Physiol, Pisa, Italy; [Rademakers, Frank; Claus, Piet] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [Ferrari, Gianfranco] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Di Molfetta, Arianna] Pediat Hosp Bambino Gesu, Med & Surg Dept Pediat Cardiol, Rome, Italy	KU Leuven; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); KU Leuven; Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; IRCCS Bambino Gesu	Fresiello, L (corresponding author), Katholieke Univ Leuven, Dept Cardiac Surg, Leuven, Belgium.; Fresiello, L (corresponding author), CNR, Inst Clin Physiol, Pisa, Italy.	libera.fresiello@gmail.com	Rademakers, Frank E/B-5622-2013; Fresiello, Libera/Q-2850-2017; Claus, Piet/ABB-5756-2021	Rademakers, Frank E/0000-0002-7786-4179; Fresiello, Libera/0000-0003-0972-8340; Claus, Piet/0000-0002-2013-639X	Marie Curie Scholarship ("VAD and exercise") [PIEF-GA-2013-624296]; Belgian Fund for Cardiac Surgery	Marie Curie Scholarship ("VAD and exercise"); Belgian Fund for Cardiac Surgery	This work was funded by a Marie Curie Scholarship ("VAD and exercise", GA N. PIEF-GA-2013-624296) and supported by the Belgian Fund for Cardiac Surgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brassard P, 2011, CIRC-HEART FAIL, V4, P554, DOI 10.1161/CIRCHEARTFAILURE.110.958041; CHENG CP, 1993, CIRC RES, V72, P795, DOI 10.1161/01.RES.72.4.795; CHENG CP, 1992, CIRC RES, V70, P9, DOI 10.1161/01.RES.70.1.9; de Jonge N, 2001, J AM COLL CARDIOL, V37, P1794, DOI 10.1016/S0735-1097(01)01268-2; Drakos SG, 2011, CURR OPIN CARDIOL, V26, P245, DOI 10.1097/HCO.0b013e328345af13; DREXLER H, 1987, CIRCULATION, V76, P1344, DOI 10.1161/01.CIR.76.6.1344; Fresiello L, 2016, EUROPEAN J CARDIOTHO; Fresiello L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00189; Hayward CS, 2016, CURR OPIN CARDIOL, V31, P292, DOI 10.1097/HCO.0000000000000285; Jacquet L, 2011, ARTIF ORGANS, V35, P682, DOI 10.1111/j.1525-1594.2011.01227.x; Jakovljevic DG, 2010, HEART, V96, P1390, DOI 10.1136/hrt.2010.193698; Jung MH, 2015, ASAIO J, V61, P307, DOI 10.1097/MAT.0000000000000194; Jung MH, 2015, J HEART LUNG TRANSPL, V34, P489, DOI 10.1016/j.healun.2014.11.001; Jung MH, 2014, EUR J HEART FAIL, V16, P403, DOI 10.1002/ejhf.52; KIRLIN PC, 1984, CLIN CARDIOL, V7, P205, DOI 10.1002/clc.4960070404; Klotz S, 2005, CIRCULATION, V112, P364, DOI 10.1161/CIRCULATIONAHA.104.515106; Lewis GD, 2011, CIRC-HEART FAIL, V4, P276, DOI 10.1161/CIRCHEARTFAILURE.110.959437; Loyaga-Rendon RY, 2015, J HEART LUNG TRANSPL, V34, P1005, DOI 10.1016/j.healun.2014.12.006; Madigan JD, 2001, J THORAC CARDIOV SUR, V121, P902, DOI 10.1067/mtc.2001.112632; Mancini D, 1998, CIRCULATION, V98, P1178, DOI 10.1161/01.CIR.98.12.1178; Muthiah K, 2015, J HEART LUNG TRANSPL, V34, P522, DOI 10.1016/j.healun.2014.11.004; Noor MR, 2012, EUR J HEART FAIL, V14, P613, DOI 10.1093/eurjhf/hfs042; Phillips SA, 2015, HEART FAIL CLIN, V11, P1, DOI 10.1016/j.hfc.2014.08.009; Plehn G, 2010, AM J CARDIOL, V105, P116, DOI 10.1016/j.amjcard.2009.08.662; Sagawa K., 1988, CARDIAC CONTRACTION; SULLIVAN MJ, 1989, CIRCULATION, V80, P769, DOI 10.1161/01.CIR.80.4.769; SULLIVAN MJ, 1992, CHEST, V101, pS340, DOI 10.1378/chest.101.5.340S; ten Brinke EA, 2010, HEART, V96, P213, DOI 10.1136/hrt.2009.176248; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2; WILSON JR, 1986, CIRCULATION, V74, P775, DOI 10.1161/01.CIR.74.4.775	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181879	10.1371/journal.pone.0181879	http://dx.doi.org/10.1371/journal.pone.0181879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738087	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700084
J	Lin, LC; Chuang, HS				Lin, Li-Chun; Chuang, Han-Sheng			Analyzing the locomotory gaitprint of Caenorhabditis elegans on the basis of empirical mode decomposition	PLOS ONE			English	Article							COLLAGEN; ENCODES; GENES; SQT-1	The locomotory gait analysis of the microswimmer, Caenorhabditis elegans, is a commonly adopted approach for strain recognition and examination of phenotypic defects. Gait is also a visible behavioral expression of worms under external stimuli. This study developed an adaptive data analysis method based on empirical mode decomposition (EMD) to reveal the biological cues behind intricate motion. The method was used to classify the strains of worms according to their gaitprints (i.e., phenotypic traits of locomotion). First, a norm of the locomotory pattern was created from the worm of interest. The body curvature of the worm was decomposed into four intrinsic mode functions (IMFs). A radar chart showing correlations between the predefined database and measured worm was then obtained by dividing each IMF into three parts, namely, head, mid-body, and tail. A comprehensive resemblance score was estimated after k-means clustering. Simulated data that use sinusoidal waves were generated to assess the feasibility of the algorithm. Results suggested that temporal frequency is the major factor in the process. In practice, five worm strains, including wildtype N2, TJ356 (zIs356), CL2070 (dvIs70), CB0061 (dpy-5), and CL2120 (dvIs14), were investigated. The overall classification accuracy of the gaitprint analyses of all the strains reached nearly 89%. The method can also be extended to classify some motor neuron-related locomotory defects of C. elegans in the same fashion.	[Lin, Li-Chun; Chuang, Han-Sheng] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Chuang, Han-Sheng] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Chuang, HS (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Chuang, HS (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	oswaldchuang@mail.ncku.edu.tw	Chuang, Han-Sheng/ABH-3992-2020	Chuang, Han-Sheng/0000-0002-7257-6565	Ministry of Science and Technology [105-2221-E-006-090-, 104-2221-E-006-093-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Ministry of Science and Technology under the grant numbers 105-2221-E-006-090- and 104-2221-E-006-093-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Ministry of Science and Technology under the grant numbers 105-2221-E-006-090- and 104-2221-E-006-093-MY3. The authors are grateful to the kind share of worms from Prof. C. S. Chen in the Institute of Biochemistry and Molecular Biology at National Cheng Kung University.	Boyle JH, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00010; BRENNER S, 1974, GENETICS, V77, P71; Brown AEX, 2013, AUTOMATED BEHAV FING, V1301, P1; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chuang HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28064; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Dimitriadi M, 2010, NEUROBIOL DIS, V40, P4, DOI 10.1016/j.nbd.2010.05.012; FRANCIS GR, 1985, J CELL BIOL, V101, P1532, DOI 10.1083/jcb.101.4.1532; Hirotsu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118699; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Johari S, 2012, MATER SCI FORUM, V700, P182, DOI 10.4028/www.scientific.net/MSF.700.182; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Kinser HE, 2016, MOL CELL NEUROSCI; Koren Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122326; Krajacic P, 2012, GENETICS, V191, P1015, DOI 10.1534/genetics.112.141176; KRAMER JM, 1993, GENETICS, V135, P1035; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Kuo WJ, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4872061; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, V64, P1; Road H., 1983, GENETICS, V103; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Thacker C, 2006, CELL MOL LIFE SCI, V63, P1193, DOI 10.1007/s00018-006-6012-z; Ventoso C, 2014, PLOS ONE, V10, P1; Wang G, 2010, ADV DATA SCI ADAPT, V2, P277, DOI 10.1142/S1793536910000549; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P339, DOI 10.1142/S1793536909000187; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Zhou D, 2016, CHEMOSPHERE, V154, P546, DOI 10.1016/j.chemosphere.2016.04.011	37	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181469	10.1371/journal.pone.0181469	http://dx.doi.org/10.1371/journal.pone.0181469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742107	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700045
J	Refos, JM; Vonk, AG; ten Kate, MT; Eadie, K; Verbrugh, HA; Bakker-Woudenberg, IAJM; van de Sande, WWJV				Refos, Jeannine M.; Vonk, Alieke G.; ten Kate, Marian T.; Eadie, Kimberly; Verbrugh, Henri A.; Bakker-Woudenberg, Irma A. J. M.; van de Sande, Wendy W. J.			Addition of 17-(allylamino)-17-demethoxy-geldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy	PLOS ONE			English	Article							SHOCK-PROTEIN 90; AMPHOTERICIN-B; COMBINATION THERAPY; HSP90; STRESS; CALCINEURIN; PARAMETERS; MANAGEMENT; RESISTANCE; SURVIVAL	Caspofungin (CAS) which is used as salvage therapy in patients with invasive pulmonary aspergillosis (IPA) inhibits the 1,3-beta-D-glucan synthesis in Aspergillus fumigatus. Inhibiting 1,3-beta-D-glucan synthesis induces a stress response and in an invertebrate model it was demonstrated that inhibiting this response with geldamycin enhanced the therapeutic efficacy of CAS. Since geldamycin itself is toxic to mammalians, the therapeutic efficacy of combining geldamycin with CAS was not studied in rodent models. Therefore in this study we investigated if the geldamycin derivate 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) was able to enhance the therapeutic efficacy of CAS in vitro and in our IPA model in transiently neutropenic rats. In vitro we confirmed the earlier demonstrated synergy between 17-AAG and CAS in ten A. fumigatus isolates. In vivo we treated A. fumigatus infected neutropenic rats with a sub-optimal dose of 0.75 mg/kg/day CAS and 1 mg/kg/day 17-AAG for ten days. Survival was monitored for 21 days after fungal inoculation. It appeared that the addition 17-AAG delayed death but did not improve overall survival of rats with IPA. Increasing the doses of 17-AAG was not possible due to hepatic toxicity. This study underlines the need to develop less toxic and more fungal specific geldamycin derivatives and the need to test such drugs not only in invertebrate models but also in mammalian models.	[Refos, Jeannine M.; Vonk, Alieke G.; ten Kate, Marian T.; Eadie, Kimberly; Verbrugh, Henri A.; Bakker-Woudenberg, Irma A. J. M.; van de Sande, Wendy W. J.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van de Sande, WWJV (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	w.vandesande@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021	van de Sande, Wendy/0000-0002-8652-8783	ErasmusMC grant from the ErasmusMC University	ErasmusMC grant from the ErasmusMC University	This study was supported by an ErasmusMC grant from the ErasmusMC University. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bakker-woudenberg I. A. J. M., 1999, RAT MODEL OF INVASIV; Becker MJ, 2006, MED MYCOL, V44, P133, DOI 10.1080/13693780500271749; Becker MJ, 2002, J ANTIMICROB CHEMOTH, V49, P813, DOI 10.1093/jac/dkf010; Bonapace CR, 2002, DIAGN MICR INFEC DIS, V44, P363, DOI 10.1016/S0732-8893(02)00473-X; Bugli F, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/403121; Chamilos G, 2005, DRUG RESIST UPDATE, V8, P344, DOI 10.1016/j.drup.2006.01.001; Chandenier J, 2009, MYCOSES, V52, P239, DOI 10.1111/j.1439-0507.2009.01695.x; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000471; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; den Hollander JG, 1998, ANTIMICROB AGENTS CH, V42, P744, DOI 10.1128/AAC.42.4.744; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Imai J, 2000, MOL CELL BIOL, V20, P9262, DOI 10.1128/MCB.20.24.9262-9270.2000; Kaufman HL, 2008, TARGETING MOL CHAPER, V90, P84; Lamoth F, 2016, CRIT REV MICROBIOL, V42, P310, DOI 10.3109/1040841X.2014.947239; Lamoth F, 2012, EUKARYOT CELL, V11, P1324, DOI 10.1128/EC.00032-12; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Matos TGF, 2013, MED MYCOL, V51, P413, DOI 10.3109/13693786.2012.725481; Mennink-Kersten MASH, 2011, EUR J CLIN MICROBIOL, V30, P551, DOI 10.1007/s10096-010-1118-5; Morrison Vicki A, 2006, Expert Rev Anti Infect Ther, V4, P325, DOI 10.1586/14787210.4.2.325; NCCLS, 2002, M38A NCCLS; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Ruijgrok EJ, 2006, ANTIMICROB AGENTS CH, V50, P1852, DOI 10.1128/AAC.50.5.1852-1854.2006; Ruijgrok EJ, 2005, J PHARM PHARMACOL, V57, P1289, DOI 10.1211/jpp.57.10.0007; Ruijgrok EJ, 2001, J ANTIMICROB CHEMOTH, V48, P89, DOI 10.1093/jac/48.1.89; Snelders E, 2011, FUTURE MICROBIOL, V6, P335, DOI [10.2217/FMB.11.4, 10.2217/fmb.11.4]; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Trojandt S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-16; van de Sande WWJ, 2008, ANTIMICROB AGENTS CH, V52, P1345, DOI 10.1128/AAC.00536-07; Van de Sande WWJ, 2010, MED MYCOL, V48, P48, DOI 10.3109/13693780802713497; van de Sande WWJ, 2009, ANTIMICROB AGENTS CH, V53, P2005, DOI 10.1128/AAC.01556-08; van Vianen W, 2006, J ANTIMICROB CHEMOTH, V57, P732, DOI 10.1093/jac/dkl015; Verwer PEB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075848; Wax S, 2003, ARTHRITIS RHEUM, V48, P541, DOI 10.1002/art.10780; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	39	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180961	10.1371/journal.pone.0180961	http://dx.doi.org/10.1371/journal.pone.0180961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742113	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700024
J	Timperio, AM; Gorrasi, S; Zolla, L; Fenice, M				Timperio, Anna Maria; Gorrasi, Susanna; Zolla, Lello; Fenice, Massimiliano			Evaluation of MALDI-TOF mass spectrometry and MALDI BioTyper in comparison to 16S rDNA sequencing for the identification of bacteria isolated from Arctic sea water	PLOS ONE			English	Article							DESORPTION-IONIZATION-TIME; ASSISTED-LASER-DESORPTION/IONIZATION; GRAM-POSITIVE COCCI; ROUTINE IDENTIFICATION; RAPID IDENTIFICATION; MS; EXTRACTION; DIVERSITY; DIFFERENTIATION; DISCRIMINATION	MALDI-TOF Mass Spectrometry in association with the MALDI BioTyper 3.1 software has been evaluated for the identification and classification of 45 Arctic bacteria isolated from Kandalaksha Bay (White Sea, Russia). The high reliability of this method has been already demonstrated, in clinical microbiology, by a number of studies showing high attribution concordance with other credited analyses. Recently, it has been employed also in other branches of microbiology with controversial performance. The phyloproteomic results reported in this study were validated with those obtained by the "gold standard" 16S rDNA analysis. Concordance between the two methods was 100% at the genus level, while at the species level it was 48%. These percentages appeared to be quite high compared with other studies regarding environmental bacteria. However, the performance of MALDI BioTyper changed in relation to the taxonomical group analyzed, reflecting known identification problems related to certain genera. In our case, attribution concordance for Pseudomonas species was rather low (29%), confirming the problematic taxonomy of this genus, whereas that of strains from other genera was quite high (> 60%). Among the isolates tested in this study, two strains (Exiguobacterium oxidotolerans and Pseudomonas costantinii) were misidentified by MALDI BioTyper due to absence of reference spectra in the database. Accordingly, missing spectra were acquired for the database implementation.	[Timperio, Anna Maria; Gorrasi, Susanna; Fenice, Massimiliano] Univ Tuscia, Dipartimento Ecol & Biol, Viterbo, Italy; [Zolla, Lello] Univ Tuscia, Dipartimento Sci Agr & Forestali, Viterbo, Italy; [Fenice, Massimiliano] Univ Tuscia, Lab Microbiol Marina Applicata, CONISMA, Viterbo, Italy	Tuscia University; Tuscia University; CoNISMa; Tuscia University	Fenice, M (corresponding author), Univ Tuscia, Dipartimento Ecol & Biol, Viterbo, Italy.; Fenice, M (corresponding author), Univ Tuscia, Lab Microbiol Marina Applicata, CONISMA, Viterbo, Italy.	fenice@unitus.it	Gorrasi, Susanna/AAR-7488-2021; Fenice, Massimiliano/L-9195-2014	Gorrasi, Susanna/0000-0003-2225-2586; Fenice, Massimiliano/0000-0001-8504-0885				Akova A A, 2015, MICROB ECOL, V69, P293; Alatoom AA, 2011, J CLIN MICROBIOL, V49, P2868, DOI 10.1128/JCM.00506-11; Alispahic M, 2010, J MED MICROBIOL, V59, P295, DOI 10.1099/jmm.0.016576-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Bohme K, 2010, ANAL METHODS-UK, V2, P1941, DOI 10.1039/c0ay00457j; Camara JE, 2007, ANAL BIOANAL CHEM, V389, P1633, DOI 10.1007/s00216-007-1558-7; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; Cousin S, 2008, INT MICROBIOL, V11, P91, DOI 10.2436/20.1501.01.48; Davies AP, 2012, J CLIN MICROBIOL, V50, P4087, DOI 10.1128/JCM.02387-12; Dieckmann R, 2005, APPL MICROBIOL BIOT, V67, P539, DOI 10.1007/s00253-004-1812-2; Drevinek M, 2012, LETT APPL MICROBIOL, V55, P40, DOI 10.1111/j.1472-765X.2012.03255.x; Dybwad M, 2012, APPL ENVIRON MICROB, V78, P1917, DOI 10.1128/AEM.07212-11; Edwards-Jones V, 2000, J MED MICROBIOL, V49, P295, DOI 10.1099/0022-1317-49-3-295; Emonet S, 2010, CLIN MICROBIOL INFEC, V16, P1604, DOI 10.1111/j.1469-0691.2010.03368.x; Fournier R, 2012, ANAEROBE, V18, P294, DOI 10.1016/j.anaerobe.2012.03.008; Ghyselinck J, 2011, J MICROBIOL METH, V86, P327, DOI 10.1016/j.mimet.2011.06.004; Haigh J, 2011, J CLIN MICROBIOL, V49, P3441, DOI 10.1128/JCM.00576-11; Hijazin M, 2012, J MED MICROBIOL, V61, P457, DOI 10.1099/jmm.0.035774-0; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Khot PD, 2012, J CLIN MICROBIOL, V50, P3845, DOI 10.1128/JCM.00626-12; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Kopcakova A, 2014, CHEM PAP, V68, P1435, DOI 10.2478/s11696-014-0612-0; Koubek J, 2012, INT BIODETER BIODEGR, V69, P82, DOI 10.1016/j.ibiod.2011.12.007; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Neville SA, 2011, J CLIN MICROBIOL; Ng LS, 2012, EUR J CLIN MICROBIOL, V31; Oberbeckmann S, 2011, FEMS MICROBIOL ECOL, V75, P145, DOI 10.1111/j.1574-6941.2010.00998.x; Pesciaroli C, 2015, ANN MICROBIOL, V65, P2405, DOI 10.1007/s13213-015-1083-4; Pesciaroli C, 2012, POLAR BIOL, V35, P435, DOI 10.1007/s00300-011-1091-1; Rahi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01359; Ryzhov V, 2000, APPL ENVIRON MICROB, V66, P3828, DOI 10.1128/AEM.66.9.3828-3834.2000; Santos IC, 2016, ANALYST, V141, P2827, DOI 10.1039/c6an00131a; Schrottner P, 2014, DIAGN MICR INFEC DIS, V79, P155, DOI 10.1016/j.diagmicrobio.2014.02.002; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sogawa K, 2011, ANAL BIOANAL CHEM, V400, P1905, DOI 10.1007/s00216-011-4877-7; Stafsnes MH, 2013, ANTON LEEUW INT J G, V103, P603, DOI 10.1007/s10482-012-9844-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tayeb LA, 2008, RES MICROBIOL, V159, P169, DOI 10.1016/j.resmic.2007.12.005; Uhlik O, 2011, APPL ENV MICROB; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; Viver T, 2015, SYST APPL MICROBIOL, V38, P266, DOI 10.1016/j.syapm.2015.02.002; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047152; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	49	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181860	10.1371/journal.pone.0181860	http://dx.doi.org/10.1371/journal.pone.0181860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738078	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700081
J	Carrel, M; Beltran, MA; Morales, VL; Derlon, N; Morgenroth, E; Kaufmann, R; Holzner, M				Carrel, Maxence; Beltran, Mario A.; Morales, Veronica L.; Derlon, Nicolas; Morgenroth, Eberhard; Kaufmann, Rolf; Holzner, Markus			Biofilm imaging in porous media by laboratory X-Ray tomography: Combining a non-destructive contrast agent with propagation-based phase-contrast imaging tools	PLOS ONE			English	Article							BACTERIAL BIOFILMS; GROWTH; IMPACT; FLOW; GROUNDWATER; DETACHMENT; RETRIEVAL; STRATIFICATION; BIODEGRADATION; BIOREMEDIATION	X-ray tomography is a powerful tool giving access to the morphology of biofilms, in 3D porous media, at the mesoscale. Due to the high water content of biofilms, the attenuation coefficient of biofilms and water are very close, hindering the distinction between biofilms and water without the use of contrast agents. Until now, the use of contrast agents such as barium sulfate, silver-coated micro-particles or 1-chloronaphtalene added to the liquid phase allowed imaging the biofilm 3D morphology. However, these contrast agents are not passive and potentially interact with the biofilm when injected into the sample. Here, we use a natural inorganic compound, namely iron sulfate, as a contrast agent progressively bounded in dilute or colloidal form into the EPS matrix during biofilm growth. By combining a very long source-to-detector distance on a X-ray laboratory source with a Lorentzian filter implemented prior to tomographic reconstruction, we substantially increase the contrast between the biofilm and the surrounding liquid, which allows revealing the 3D biofilm morphology. A comparison of this new method with the method proposed by Davit et al (Davit et al., 2011), which uses barium sulfate as a contrast agent to mark the liquid phase was performed. Quantitative evaluations between the methods revealed substantial differences for the volumetric fractions obtained from both methods. Namely, contrast agent D biofilm interactions (e.g. biofilm detachment) occurring during barium sulfate injection caused a reduction of the biofilm volumetric fraction of more than 50% and displacement of biofilm patches elsewhere in the column. Two key advantages of the newly proposed method are that passive addition of iron sulfate maintains the integrity of the biofilm prior to imaging, and that the biofilm itself is marked by the contrast agent, rather than the liquid phase as in other available methods. The iron sulfate method presented can be applied to understand biofilm development and bioclogging mechanisms in porous materials and the obtained biofilm morphology could be an ideal basis for 3D numerical calculations of hydrodynamic conditions to investigate biofilm-flow coupling.	[Carrel, Maxence; Morales, Veronica L.; Derlon, Nicolas; Morgenroth, Eberhard; Holzner, Markus] Swiss Fed Inst Technol, Inst Environm Engn, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland; [Beltran, Mario A.; Kaufmann, Rolf] Swiss Fed Labs Mat Sci & Technol EMPA, Dubendorf, Switzerland; [Morales, Veronica L.] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA; [Derlon, Nicolas; Morgenroth, Eberhard] Swiss Fed Inst Aquat Sci & Technol EAWAG, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Holzner, M (corresponding author), Swiss Fed Inst Technol, Inst Environm Engn, Stefano Franscini Pl 5, CH-8093 Zurich, Switzerland.	holzner@ifu.baug.ethz.ch	Morales, Veronica L/C-7617-2014; Morgenroth, Eberhard/G-1723-2010; Holzner, Markus/A-6215-2008	Morales, Veronica L/0000-0002-9595-6026; Morgenroth, Eberhard/0000-0002-1217-269X; Holzner, Markus/0000-0003-2702-8612; derlon, nicolas/0000-0003-4240-9827	Swiss National Science Foundation (SNF) [144645]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Financial support is acknowledged from the Swiss National Science Foundation (SNF grant number 144645) for M.G. and M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support is acknowledged from the Swiss National Science Foundation (SNF grant number 144645) for M.C. and M.H. The authors thank Toni Blunschi for manufacturing the tubular reactor, Daniel Braun and Lucien Biolley for providing some of the hardware necessary for this study as well as Michele Griffa for some interesting discussions related to the segmentation. Part of this work has been performed by the use of the Empa Platform for Image Analysis (http://empa.ch/web/s499/software-/-imaging-platform) at Empa's Center for X-ray Analytics. The authors declare that there is no conflict of interest.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Arhatari BD, 2010, J APPL PHYS, V107, DOI 10.1063/1.3298930; Baffin T. J., 2007, NATURE REV MICROBIOL, V5, P76; Baveye P, 1998, CRIT REV ENV SCI TEC, V28, P123, DOI 10.1080/10643389891254197; Beltran MA, 2011, PHYS MED BIOL, V56, P7353, DOI 10.1088/0031-9155/56/23/002; Beltran MA, 2010, OPT EXPRESS, V18, P6423, DOI 10.1364/OE.18.006423; Benner SG, 2002, APPL GEOCHEM, V17, P301, DOI 10.1016/S0883-2927(01)00084-1; Blauert F, 2015, BIOTECHNOL BIOENG, V112, P1893, DOI 10.1002/bit.25590; Blowes DW, 2000, J CONTAM HYDROL, V45, P123, DOI 10.1016/S0169-7722(00)00122-4; Bouwer H, 2002, HYDROGEOL J, V10, P121, DOI 10.1007/s10040-001-0182-4; Burvall A, 2011, OPT EXPRESS, V19, P10359, DOI 10.1364/OE.19.010359; Carrel M., DIGITAL ROCKS DATA R; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; CUNNINGHAM AB, 1991, ENVIRON SCI TECHNOL, V25, P1305, DOI 10.1021/es00019a013; Davit Y, 2011, J MICROSC-OXFORD, V242, P15, DOI 10.1111/j.1365-2818.2010.03432.x; Davit Y, 2010, ADV WATER RESOUR, V33, P1075, DOI 10.1016/j.advwatres.2010.06.013; Derlon N, 2008, WATER RES, V42, P2102, DOI 10.1016/j.watres.2007.11.016; Derlon N, 2012, WATER RES, V46, P3323, DOI 10.1016/j.watres.2012.03.031; Downie H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044276; du Roscoat SR, 2014, BIOTECHNOL BIOENG, V111, P1265, DOI 10.1002/bit.25168; Dupin HJ, 2000, ENVIRON SCI TECHNOL, V34, P1513, DOI 10.1021/es990452f; Ebigbo A, 2010, ADV WATER RESOUR, V33, P762, DOI 10.1016/j.advwatres.2010.04.004; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Golfier F, 2009, ADV WATER RESOUR, V32, P463, DOI 10.1016/j.advwatres.2008.11.012; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Gureyev TE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226794; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Holzner M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.013015; Iltis GC, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009410; In Paganin D., 2006, COHERENT XRAY OPTICS, P411; Ivankovic T, 2016, BIOFOULING, V32, P1235, DOI 10.1080/08927014.2016.1249865; Kapellos GE, 2010, MATH BIOSCI, V225, P83, DOI 10.1016/j.mbs.2010.03.003; Kone T, 2014, WATER RESOUR RES, V50, P9103, DOI 10.1002/2013WR015213; LAPPINSCOTT HM, 1988, APPL ENVIRON MICROB, V54, P1373, DOI 10.1128/AEM.54.6.1373-1382.1988; Leemann A, 2010, CEMENT CONCRETE COMP, V32, P116, DOI 10.1016/j.cemconcomp.2009.11.007; Li L, 2005, GROUND WATER, V43, P582, DOI 10.1111/j.1745-6584.2005.0042.x; Mayo SC, 2003, OPT EXPRESS, V11, P2289, DOI 10.1364/OE.11.002289; Meckenstock RU, 2015, ENVIRON SCI TECHNOL, V49, P7073, DOI 10.1021/acs.est.5b00715; Milferstedt K, 2009, BIOTECHNOL BIOENG, V102, P368, DOI 10.1002/bit.22075; Mitchell AC, 2013, INT J GREENH GAS CON, V15, P86, DOI 10.1016/j.ijggc.2013.02.001; Mohle RB, 2007, BIOTECHNOL BIOENG, V98, P747, DOI 10.1002/bit.21448; Munch B., EMPA BUNDLE IMAGE J; Myers GR, 2008, OPT EXPRESS, V16, P10736, DOI 10.1364/OE.16.010736; Omoregie EO, 2013, APPL ENVIRON MICROB, V79, P4325, DOI 10.1128/AEM.00683-13; Orgogozo L, 2010, ADV WATER RESOUR, V33, P585, DOI 10.1016/j.advwatres.2010.03.004; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Paulsen JE, 1997, WATER SCI TECHNOL, V36, P1, DOI 10.1016/S0273-1223(97)00317-X; Peszynska M, 2016, ADV WATER RESOUR, V95, P288, DOI 10.1016/j.advwatres.2015.07.008; Pintelon TRR, 2009, BIOTECHNOL BIOENG, V103, P767, DOI 10.1002/bit.22303; Plouraboue F, 2004, J MICROSC-OXFORD, V215, P139, DOI 10.1111/j.0022-2720.2004.01362.x; Rochex A, 2009, J IND MICROBIOL BIOT, V36, P467, DOI 10.1007/s10295-009-0543-x; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Sand W, 2003, GEOTHERMICS, V32, P655, DOI 10.1016/S0375-6505(03)00058-0; Seymour JD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198103; Sharp RR, 1999, WATER SCI TECHNOL, V39, P195, DOI 10.2166/wst.1999.0359; Stoodley P, 2005, BIOFOULING, V21, P161, DOI 10.1080/08927010500375524; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; STOODLEY P, 1994, APPL ENVIRON MICROB, V60, P2711, DOI 10.1128/AEM.60.8.2711-2716.1994; TAYLOR SW, 1990, WATER RESOUR RES, V26, P2171, DOI 10.1029/WR026i009p02171; Teixeira S, 2014, INT J PHYTOREMEDIAT, V16, P1228, DOI 10.1080/15226514.2013.821454; Thullner M, 2002, TRANSPORT POROUS MED, V49, P99, DOI 10.1023/A:1016030112089; Vayenas DV, 2002, ADV WATER RESOUR, V25, P203, DOI 10.1016/S0309-1708(01)00023-9; Vogt SJ, 2013, BIOTECHNOL BIOENG, V110, P1366, DOI 10.1002/bit.24803; von der Schulenburg DAG, 2008, BIOTECHNOL BIOENG, V101, P602, DOI 10.1002/bit.21913; von der Schulenburg DAG, 2009, AICHE J, V55, P494, DOI 10.1002/aic.11674; Wagner M, 2010, BIOTECHNOL BIOENG, V107, P844, DOI 10.1002/bit.22864; Wagner M, 2010, BIOTECHNOL BIOENG, V107, P172, DOI 10.1002/bit.22784; Weiner ER, 2013, APPL ENV AQUATIC CHE, P592; Wildenschild D, 2002, J HYDROL, V267, P285, DOI 10.1016/S0022-1694(02)00157-9; Wildenschild D, 2013, ADV WATER RESOUR, V51, P217, DOI 10.1016/j.advwatres.2012.07.018; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Xi CW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209962	73	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180374	10.1371/journal.pone.0180374	http://dx.doi.org/10.1371/journal.pone.0180374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732010	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100006
J	Rossi, N; Dattner, N; Cavassini, M; Peters, S; Hugli, O; Darling, KEA				De Rossi, Noemy; Dattner, Nicolas; Cavassini, Matthias; Peters, Solange; Hugli, Olivier; Darling, Katharine E. A.			Patient and doctor perspectives on HIV screening in the emergency department: A prospective cross-sectional study	PLOS ONE			English	Article							SEXUAL HISTORY; IMPLEMENTATION; IDENTIFICATION; ATTITUDES; RISK	Background The emergency department (ED) is mentioned specifically in the Swiss HIV testing recommendations as a site at which patients can benefit from expanded HIV testing to optimise early HIV diagnosis. At our centre, where local HIV seroprevalence is 0.2-0.4%, 1% of all patients presenting to the ED are tested for HIV. Barriers to HIV testing, from the patient and doctor perspective, and patient acceptability of rapid HIV testing were examined in this study. Methods Between October 2014 and May 2015, 100 discrete patient-doctor encounter pairs undertook a survey in the ED of Lausanne University Hospital, Switzerland. Patients completed a questionnaire on HIV risk factors and were offered free rapid HIV testing (INSTI (TM)). For every patient included, the treating doctor was asked if HIV testing had 1) been indicated according to the national testing recommendations, 2) mentioned, and 3) offered during the consultation. Results Of 100 patients, 30 had indications for HIV testing through risk factors or a suggestive presenting complaint (PC). Fifty patients accepted rapid testing; no test was reactive. Of 50 patients declining testing, 82% considered themselves not at risk or had recently tested negative and 16% wished to focus on their PC. ED doctors identified 20 patients with testing indications, mentioned testing to nine and offered testing to six. The main reason for doctors not mentioning or not offering testing was the wish to focus on the PC. Discussion Patients and doctors at our ED share the testing barrier of wishing to focus on the PC. Rapid HIV testing offered in parallel to the patient-doctor consultation increased the testing rate from 6% (offered by doctors) to 50%. Introducing this service would enable testing of patients not offered tests by their doctors and reduce missed opportunities for early HIV diagnosis.	[De Rossi, Noemy; Dattner, Nicolas] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Cavassini, Matthias; Darling, Katharine E. A.] Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Peters, Solange] Lausanne Univ Hosp, Dept Oncol, Lausanne, Switzerland; [Hugli, Olivier] Lausanne Univ Hosp, Emergency Dept, Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Darling, KEA (corresponding author), Lausanne Univ Hosp, Infect Dis Serv, Lausanne, Switzerland.	Katharine.Darling@chuv.ch	peters, solange/ABF-2187-2020; Hugli, Olivier/AAA-7057-2020; cavassini, matthias/F-8987-2017	Darling, Katharine/0000-0003-1449-3873; Friedrich-De Rossi, Noemy/0000-0001-6928-0889; cavassini, matthias/0000-0003-0933-7833	infectious diseases service existing research funds	infectious diseases service existing research funds	This study was funded by the infectious diseases service existing research funds. The funding body had no role in the study design, in the collection, analysis or interpretation of the data, or in the drafting of this manuscript.	Adebajo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081981; Albrecht E, 2012, HIV MED, V13, P439, DOI 10.1111/j.1468-1293.2012.00993.x; Arbelaez C, 2012, J EMERG MED, V42, P7, DOI 10.1016/j.jemermed.2009.07.038; Bares S, 2014, J INT ASS PROVID AID; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brennan MB, 2015, J INFECT PUBLIC HEAL, V8, P161, DOI 10.1016/j.jiph.2014.08.010; Choo EK, 2012, ACAD EMERG MED, V19, P318, DOI 10.1111/j.1553-2712.2012.01299.x; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; Czarnogorski M, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/879065; Darling KEA, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14348; Darling KEA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072812; Darling KEA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039299; ENDE J, 1984, ARCH INTERN MED, V144, P558, DOI 10.1001/archinte.144.3.558; Favre-Bulle T, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14206; FOPH, 2013, B OFSP, P1; Geren KI, 2014, ANN EMERG MED, V64, P537, DOI 10.1016/j.annemergmed.2014.05.021; Hachfeld A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20317; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; Hecht CR, 2011, ANN EMERG MED, V58, pS28, DOI 10.1016/j.annemergmed.2011.03.020; Jenkins WD, 2015, J EMERG MED, V48, P143, DOI 10.1016/j.jemermed.2014.06.051; Jones J, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-708; Kohler P, 2015, AIDS, V29, P2509, DOI 10.1097/QAD.0000000000000878; Office fe A de A ral de la sante A publique, 2013, B OFSP, P1; Office fe A de A ral de la sante A publique, B OFSP; Office federal de la sante A publique, 2010, B OFSP, P364; Office federal de la sante publique, 2007, B OFSP, P371; Ohmann C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-85; Pringle K, 2013, AIDS PATIENT CARE ST, V27, P573, DOI 10.1089/apc.2013.0013; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Schechter-Perkins EM, 2014, EMERG MED J, V31, P736, DOI 10.1136/emermed-2013-202806; Schnall R, 2013, ACAD EMERG MED, V20, P279, DOI 10.1111/acem.12084; Vilpert S., 2013, 32013 OBS SUISS SANT	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180389	10.1371/journal.pone.0180389	http://dx.doi.org/10.1371/journal.pone.0180389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732088	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100007
J	Ducheix, S; Montagner, A; Polizzi, A; Lasserre, F; Regnier, M; Marmugi, A; Benhamed, F; Bertrand-Michel, J; Mselli-Lakhal, L; Loiseau, N; Martin, PG; Lobaccaro, JM; Ferrier, L; Postic, C; Guillou, H				Ducheix, Simon; Montagner, Alexandra; Polizzi, Arnaud; Lasserre, Frederic; Regnier, Marion; Marmugi, Alice; Benhamed, Fadila; Bertrand-Michel, Justine; Mselli-Lakhal, Laila; Loiseau, Nicolas; Martin, Pascal G.; Lobaccaro, Jean-Marc; Ferrier, Laurent; Postic, Catherine; Guillou, Herve			Dietary oleic acid regulates hepatic lipogenesis through a liver X receptor-dependent signaling	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; ELEMENT-BINDING PROTEIN; FATTY-ACIDS; NONALCOHOLIC STEATOHEPATITIS; GENE-EXPRESSION; ADIPOSE-TISSUE; OBESE MICE; LXR-ALPHA; OLIVE OIL; OXYSTEROL RECEPTORS	Olive oil consumption is beneficial for health as it is associated with a decreased prevalence of cancer and cardiovascular diseases. Oleic acid is, by far, the most abundant component of olive oil. Since it can be made through de novo synthesis in animals, it is not an essential fatty acid. While it has become clear that dietary oleic acid regulates many biological processes, the signaling pathway involved in these regulations remains poorly defined. In this work we tested the impact of an oleic acid-rich diet on hepatic gene expression. We were particularly interested in addressing the contribution of Liver X Receptors (LXR) in the control of genes involved in hepatic lipogenesis, an essential process in whole body energy homeostasis. We used wild-type mice and transgenic mice deficient for both a and beta Liver X Receptor isoforms (LXR-/-) fed a control or an oleate enriched diet. We observed that hepatic-lipid accumulation was enhanced as well as the expression of lipogenic genes in the liver of wild-type mice fed the oleate enriched diet. In contrast, none of these changes occurred in the liver of LXR-/-mice. Strikingly, oleate-rich diet reduced cholesterolemia in wild-type mice and induced signs of liver inflammation and damage in LXR-/-mice but not in wild-type mice. This work suggests that dietary oleic acid reduces cholesterolemia while promoting LXR-dependent hepatic lipogenesis without detrimental effects to the liver.	[Ducheix, Simon; Montagner, Alexandra; Polizzi, Arnaud; Lasserre, Frederic; Regnier, Marion; Marmugi, Alice; Mselli-Lakhal, Laila; Loiseau, Nicolas; Martin, Pascal G.; Ferrier, Laurent; Guillou, Herve] INRA, ToxAlim, Toulouse, France; [Ducheix, Simon; Montagner, Alexandra; Polizzi, Arnaud; Lasserre, Frederic; Regnier, Marion; Marmugi, Alice; Mselli-Lakhal, Laila; Loiseau, Nicolas; Martin, Pascal G.; Ferrier, Laurent; Guillou, Herve] Univ Toulouse, INP, UPS, ToxAlim, Toulouse, France; [Benhamed, Fadila; Postic, Catherine] INSERM, Inst Cochin, U1016, Paris, France; [Benhamed, Fadila; Postic, Catherine] CNRS, UMR8104, Paris, France; [Bertrand-Michel, Justine] INSERM, MetaToul, Plateau Lipid, Toulouse, France; [Lobaccaro, Jean-Marc] Univ Blaise Pascal, Clermont Univ, Genet Reprod & Dev, Clermont Ferrand, France; [Lobaccaro, Jean-Marc] CNRS, GReD, UMR 6293, Aubiere, France; [Lobaccaro, Jean-Marc] INSERM, U1103, GReD, Aubiere, France; [Lobaccaro, Jean-Marc] Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France; [Postic, Catherine] Univ Paris 05, Sorbonne Paris Cite, Paris, France	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Guillou, H (corresponding author), INRA, ToxAlim, Toulouse, France.; Guillou, H (corresponding author), Univ Toulouse, INP, UPS, ToxAlim, Toulouse, France.	herve.guillou@toulouse.inra.fr	LOISEAU, Nicolas/ADN-2394-2022; Guillou, Herve/AAG-2826-2020; Postic, Catherine/P-2271-2017; Lobaccaro, Jean-Marc A./U-1928-2019; Lobaccaro, Jean-Marc/Q-3926-2019; Guillou, Hervé/AGL-0750-2022	LOISEAU, Nicolas/0000-0003-3783-0879; Guillou, Herve/0000-0002-5363-9081; Postic, Catherine/0000-0002-1875-6960; Lobaccaro, Jean-Marc/0000-0001-9890-2392; Guillou, Hervé/0000-0002-5363-9081; Martin, Pascal/0000-0002-4271-658X; Ferrier, Laurent/0000-0003-2981-7375; Ducheix, Simon/0000-0001-6676-4263; REGNIER, Marion/0000-0002-5005-0597; Montagner, Alexandra/0000-0002-4800-5105; Rayah Benhamed, Fadila/0000-0003-4905-6585	ANR; Region Occitanie	ANR(French National Research Agency (ANR)); Region Occitanie(Region Occitanie)	This work was funded by grants from ANR and Region Occitanie (HG).	Archer A, 2013, J LIPID RES, V54, P1300, DOI 10.1194/jlr.M033977; Beaven SW, 2011, GASTROENTEROLOGY, V140, P1052, DOI 10.1053/j.gastro.2010.11.053; Bedi S, 2017, J LIPID RES, V58, P393, DOI 10.1194/jlr.M072447; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bindesboll C, 2015, J LIPID RES, V56, P771, DOI 10.1194/jlr.M049130; Bravi F, 2006, ANN ONCOL, V17, P1014, DOI 10.1093/annonc/mdl080; Burhans MS, 2015, J LIPID RES, V56, P304, DOI 10.1194/jlr.M054429; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chen C, 2008, CELL METAB, V7, P135, DOI 10.1016/j.cmet.2007.12.003; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; De Boussac H, 2013, EXPERT OPIN THER TAR, V17, P1029, DOI 10.1517/14728222.2013.820708; Ducheix S, 2013, BIOCHEM PHARMACOL, V86, P96, DOI 10.1016/j.bcp.2013.03.016; Ducheix S, 2013, J HEPATOL, V58, P984, DOI 10.1016/j.jhep.2013.01.006; Reyes-Quiroz ME, 2014, EUR J NUTR, V53, P1707, DOI 10.1007/s00394-014-0677-0; Finucane OM, 2015, DIABETES, V64, P2116, DOI 10.2337/db14-1098; Flowers MT, 2006, J LIPID RES, V47, P2668, DOI 10.1194/jlr.M600203-JLR200; Flowers MT, 2012, J LIPID RES, V53, P1646, DOI 10.1194/jlr.M027508; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Han S, 2017, NATURE, V544, P185, DOI 10.1038/nature21686; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hu FB, 2003, NEW ENGL J MED, V348, P2595, DOI 10.1056/NEJMp030069; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Jump DB, 2011, CURR OPIN CLIN NUTR, V14, P115, DOI 10.1097/MCO.0b013e328342991c; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; Lee JY, 2011, DIABETES METAB J, V35, P489, DOI 10.4093/dmj.2011.35.5.489; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lim JH, 2013, J BIOL CHEM, V288, P7117, DOI 10.1074/jbc.M112.415729; Liu XQ, 2016, J HEPATOL, V65, P103, DOI 10.1016/j.jhep.2016.03.001; Lodhi IJ, 2011, TRENDS ENDOCRIN MET, V22, P1, DOI 10.1016/j.tem.2010.09.002; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Martin M, 2010, BBA-MOL CELL BIOL L, V1801, P934, DOI 10.1016/j.bbalip.2010.03.011; Mendis S, 2010, PROG CARDIOVASC DIS, V53, P10, DOI 10.1016/j.pcad.2010.01.001; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Mujico JR, 2013, BRIT J NUTR, V110, P711, DOI 10.1017/S0007114512005612; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Talukdar S, 2006, J LIPID RES, V47, P2451, DOI 10.1194/jlr.M600276-JLR200; Tanaka N, 2009, J GASTROENTEROL, V44, P983, DOI 10.1007/s00535-009-0088-9; Teratani T, 2012, GASTROENTEROLOGY, V142, P152, DOI 10.1053/j.gastro.2011.09.049; Uno S, 2009, BIOCHEM PHARMACOL, V77, P186, DOI 10.1016/j.bcp.2008.10.007; van der Veen JN, 2009, J BIOL CHEM, V284, P19211, DOI 10.1074/jbc.M109.014860; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yasuda Y, 2010, CANCER SCI, V101, P1701, DOI 10.1111/j.1349-7006.2010.01579.x; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang X, 2014, J HEPATOL, V61, P1365, DOI 10.1016/j.jhep.2014.07.006	64	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181393	10.1371/journal.pone.0181393	http://dx.doi.org/10.1371/journal.pone.0181393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732092	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100033
J	Meens, MJ; Kutkut, I; Rochemont, V; Dubrot, J; Kaladji, FR; Sabine, A; Lyons, O; Hendrikx, S; Bernier-Latmani, J; Kiefer, F; Smith, A; Hugues, S; Petrova, TV; Kwak, BR				Meens, Merlijn J.; Kutkut, Issa; Rochemont, Viviane; Dubrot, Juan; Kaladji, Fouad R.; Sabine, Amelie; Lyons, Oliver; Hendrikx, Stefanie; Bernier-Latmani, Jeremiah; Kiefer, Friedemann; Smith, Alberto; Hugues, Stephanie; Petrova, Tatiana V.; Kwak, Brenda R.			Cx47 fine-tunes the handling of serum lipids but is dispensable for lymphatic vascular function	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; ATHEROSCLEROTIC PLAQUE; CONTRACTILE ACTIVITY; VALVE DEVELOPMENT; DENDRITIC CELLS; KNOCKOUT MICE; GAP-JUNCTIONS; CONNEXINS; VESSELS; EXPRESSION	Mutations in the gap junction protein connexin47 (Cx47) are associated with lymphedema. However, the role of Cx47 in lymphatic pathophysiology is unknown. We demonstrate that Cx47 is expressed in lymphatic endothelial cells by whole-mount immunostaining and qPCR. To determine if Cx47 plays a role in lymphatic vessel function we analysed Cx47(-/-) mice. Cx47-deficiency did not affect lymphatic contractility (contractile amplitude or frequency) or lymphatic morphology (vessel diameter or number of valves). Interstitial fluid drainage or dendritic cell migration through lymphatic vessels was also not affected by Cx47-deficiency. Cx47 is dispensable for long-chain fatty acid absorption from the gut but rather promotes serum lipid handling as prolonged elevated triglyceride levels were observed in Cx47-deficient mice after oral lipid tolerance tests. When crossed with Apolipoprotein E-deficient (Apoe(-/-)) mice, LDL-cholesterol was decreased in young Cx47(-/-) Apoe(-/-) adults as compared to Apoe(-/-) mice, which was inverted later in life. Finally, advanced atherosclerotic plaques in thoracic-abdominal aortas of 15 months-old mice tended to be larger in Cx47(-/-) Apoe(-/-) mice. These plaques contained fewer macrophages but similar amounts of T lymphocytes, collagen and lipids than plaques of Apoe(-/-) mice. In conclusion, Cx47 is expressed in lymphatic endothelium and seems modestly implicated in multiple aspects of lymphatic pathophysiology.	[Meens, Merlijn J.; Kutkut, Issa; Rochemont, Viviane; Dubrot, Juan; Kaladji, Fouad R.; Hugues, Stephanie; Kwak, Brenda R.] Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland; [Sabine, Amelie; Hendrikx, Stefanie; Bernier-Latmani, Jeremiah; Petrova, Tatiana V.] Univ Lausanne, CHUV, Dept Fundamental Oncol, Lausanne, Switzerland; [Sabine, Amelie; Hendrikx, Stefanie; Bernier-Latmani, Jeremiah; Petrova, Tatiana V.] CHU Vaudois, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Lyons, Oliver; Smith, Alberto] Kings Coll London, BHF Ctr Res Excellence, Dept Vasc Surg, Cardiovasc Div, London, England; [Lyons, Oliver; Smith, Alberto] Kings Hlth Partners, St Thomas Hosp, NIHR Biomed Res Ctr, London, England; [Kiefer, Friedemann] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Mammalian Cell Signalling Lab, Munster, Germany; [Petrova, Tatiana V.] Swiss Fed Inst Technol Lausanne, Swiss Inst Expt Canc Res, Sch Life Sci, Lausanne, Switzerland; [Kwak, Brenda R.] Univ Geneva, Dept Med Specialties Cardiol, Geneva, Switzerland	University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Geneva	Meens, MJ (corresponding author), Univ Geneva, Dept Pathol & Immunol, Geneva, Switzerland.	merlijn.meens@unige.ch	Dubrot, Juan/ABI-1676-2020	Dubrot, Juan/0000-0002-8093-2208; Kwak, Brenda/0000-0003-0015-0044; hugues, stephanie/0000-0002-1031-5909; Bernier-Latmani, Jeremiah/0000-0002-6407-1049; Kiefer, Friedemann/0000-0002-3002-8237; Lyons, Oliver/0000-0002-7731-7343	Swiss National Science Foundation [310030_162579/1, CRSI13_141811]; Leenaards Foundation; Fondation Carlos et Elsie De Reuter; MRC [G1000327] Funding Source: UKRI; Academy of Medical Sciences (AMS) [SGL016\\1019] Funding Source: researchfish; Medical Research Council [G1000327] Funding Source: researchfish; National Institute for Health Research [ACF-2008-17-021] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Leenaards Foundation; Fondation Carlos et Elsie De Reuter; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by Swiss National Science Foundation grant numbers 310030_162579/1 and CRSI13_141811 (http:// www.snf.ch/en/Pages/default_aspx), Leenaards Foundation (http://www.leenaards.ch/), and Fondation Carlos et Elsie De Reuter (http:// fondation-de- reuter.ch/).	Bernier-Latmani J, 2015, J CLIN INVEST, V125, P4572, DOI 10.1172/JCI82045; Brice G, 2013, CLIN GENET, V84, P378, DOI 10.1111/cge.12158; Brouillard P, 2014, J CLIN INVEST, V124, P898, DOI 10.1172/JCI71614; Bruinstroop E, 2015, INT J OBESITY, V39, P1655, DOI 10.1038/ijo.2015.122; Camare C, 2017, REDOX BIOL, V12, P18, DOI 10.1016/j.redox.2017.01.007; Chadjichristos CE, 2010, CIRCULATION, V121, P123, DOI 10.1161/CIRCULATIONAHA.109.867176; Chaytor AT, 1997, J PHYSIOL-LONDON, V503, P99, DOI 10.1111/j.1469-7793.1997.099bi.x; Dubrot J, 2014, J EXP MED, V211, P1153, DOI 10.1084/jem.20132000; Ferrell RE, 2010, AM J HUM GENET, V86, P943, DOI 10.1016/j.ajhg.2010.04.010; Finegold DN, 2012, CLIN CANCER RES, V18, P2382, DOI 10.1158/1078-0432.CCR-11-2303; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; GOFMAN JW, 1950, SCIENCE, V111, P166, DOI 10.1126/science.111.2877.166; Gong XQ, 2007, J BIOL CHEM, V282, P19190, DOI 10.1074/jbc.M609653200; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Humbert M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2016.00684; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Kanady JD, 2015, DEV BIOL, V405, P33, DOI 10.1016/j.ydbio.2015.06.004; Kanady JD, 2011, DEV BIOL, V354, P253, DOI 10.1016/j.ydbio.2011.04.004; Kim MS, 2013, BIOCHEM J, V452, P249, DOI 10.1042/BJ20121821; Koval M, 2014, FEBS LETT, V588, P1193, DOI 10.1016/j.febslet.2014.02.025; Kreiner G, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00056; Kutkut I, 2015, EUR J CLIN INVEST, V45, P100, DOI 10.1111/eci.12372; Kwak BR, 1999, J PHYSIOL-LONDON, V516, P679, DOI 10.1111/j.1469-7793.1999.0679u.x; Kwak BR, 2003, CIRCULATION, V107, P1033, DOI 10.1161/01.CIR.0000051364.70064.D1; Kwak BR, 2014, EUR HEART J, V35, P3013, DOI 10.1093/eurheartj/ehu353; Licht CMM, 2010, J CLIN ENDOCR METAB, V95, P2458, DOI 10.1210/jc.2009-2801; Lim HY, 2013, CELL METAB, V17, P671, DOI 10.1016/j.cmet.2013.04.002; Lyons O, 2017, J EXP MED IN PRESS; Martel C, 2013, J CLIN INVEST, V123, P1571, DOI 10.1172/JCI63685; May D, 2013, J NEUROSCI, V33, P7985, DOI 10.1523/JNEUROSCI.5874-12.2013; MCHALE NG, 1992, J PHYSIOL-LONDON, V450, P503, DOI 10.1113/jphysiol.1992.sp019139; Meens MJ, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0110-1; Meens MJ, 2015, CELL MOL LIFE SCI, V72, P2779, DOI 10.1007/s00018-015-1959-2; Meens MJ, 2014, FEBS LETT, V588, P1271, DOI 10.1016/j.febslet.2014.01.011; Mendoza-Naranjo A, 2011, J IMMUNOL, V187, P3121, DOI 10.4049/jimmunol.1100378; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Mizuno K, 2016, HEPATOL RES; Morbiducci U, 2016, THROMB HAEMOSTASIS, V115, P484, DOI 10.1160/TH15-07-0597; Munger SJ, 2017, DEV BIOL, V421, P204, DOI 10.1016/j.ydbio.2016.11.017; Munger SJ, 2016, DEV BIOL, V412, P173, DOI 10.1016/j.ydbio.2016.02.033; Nagy JI, 2003, GLIA, V44, P205, DOI 10.1002/glia.10278; Odermatt B, 2003, J NEUROSCI, V23, P4549; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; Pfenniger A, 2013, BBA-BIOMEMBRANES, V1828, P157, DOI 10.1016/j.bbamem.2012.05.011; Russo E, 2016, CELL REP, V14, P1723, DOI 10.1016/j.celrep.2016.01.048; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Teijeira A, 2017, CELL REP, V18, P857, DOI 10.1016/j.celrep.2016.12.078; Tress O, 2012, J NEUROSCI, V32, P7499, DOI 10.1523/JNEUROSCI.0392-12.2012; Tress O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002146; van Hinsbergh VWM, 2015, CURR OPIN LIPIDOL, V26, P405, DOI 10.1097/MOL.0000000000000210; Vuorio T, 2014, ARTERIOSCL THROM VAS, V34, P1162, DOI 10.1161/ATVBAHA.114.302528; WARNER A, 1995, J PHYSIOL-LONDON, V488, P721, DOI 10.1113/jphysiol.1995.sp021003; White TW, 2003, NEWS PHYSIOL SCI, V18, P95, DOI 10.1152/nips.01430.2002; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Wong CW, 2003, CELL COMMUN ADHES, V10, P395, DOI 10.1080/714040458; Zawieja David C., 2009, Lymphatic Research and Biology, V7, P87, DOI 10.1089/lrb.2009.0007; ZAWIEJA DC, 1993, AM J PHYSIOL, V264, pH1283, DOI 10.1152/ajpheart.1993.264.4.H1283; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	63	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181476	10.1371/journal.pone.0181476	http://dx.doi.org/10.1371/journal.pone.0181476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732089	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100039
J	Morales, MA; Zink, AG				Morales, Manuel A.; Zink, Andrew G.			Mechanisms of aggregation in an ant-tended treehopper: Attraction to mutualists is balanced by conspecific competition	PLOS ONE			English	Article							PATCH SIZE; JALMENUS-EVAGORAS; PARENTAL CARE; LIFE-HISTORY; DENSITY; COEXISTENCE; POLLINATION; BENEFITS; BEHAVIOR; COOPERATION	Understanding the spatial structure of populations and communities has been a dominant focus of ecological research, and spatial structure is increasingly seen as critical for understanding population dynamics. Habitat (or host) preference is a proximate mechanism that can generate aggregation or overdispersion, lending insight into the ultimate consequences of observed spatial distributions. Publilia concava is a univoltine phloem-feeding insect that forms mutualistic associations with ants, which consume honeydew and protect treehoppers from predation. Treehopper adults and nymphs are aggregated at the scale of golden-rod plant stems, and previous studies have suggested that this aggregation is an adaptive response that increases feeding performance or maximizes benefits of ant-tending. Previous studies have also shown experimentally that individual treehoppers preferentially oviposit on plants with ants present, but a complimentary hypothesis that treehoppers prefer to oviposit near conspecifics (e.g., to take advantage of density-dependent ant attraction) remains untested. We show that, as expected, the probability of treehopper oviposition increases with ant-presence and relative ant abundance. However, we also find that treehopper oviposition decreases with increasing treehopper density. Thus our results are inconsistent with the hypothesis that treehopper aggregation is a socially cooperative strategy to attract ants; we suggest that aggregation is a form of conflict and an unavoidable by-product of individual responses to ant-tending levels.	[Morales, Manuel A.] Williams Coll, Dept Biol, Williamstown, MA 01267 USA; [Zink, Andrew G.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	Williams College; California State University System; San Francisco State University	Morales, MA (corresponding author), Williams Coll, Dept Biol, Williamstown, MA 01267 USA.	mmorales@williams.edu			National Science Foundation; Division of Environmental Biology [145746]; MAM; Division of Integrative Organismal Systems [1258133]; Division Of Integrative Organismal Systems [1258133] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); MAM; Division of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (http://www.nsf.gov); Division of Environmental Biology, 145746, MAM and the Division of Integrative Organismal Systems, 1258133, AGZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; Axen AH, 1998, BEHAV ECOL, V9, P109, DOI 10.1093/beheco/9.2.109; Barker JL, 2017, EVOLUTION, V71, P814, DOI 10.1111/evo.13174; Begon M, 2005, ECOLOGY; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BRETON LM, 1992, ECOLOGY, V73, P2175, DOI 10.2307/1941465; BRISTOW CM, 1983, SCIENCE, V220, P532, DOI 10.1126/science.220.4596.532; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; Cocroft RB, 1996, NATURE, V382, P679, DOI 10.1038/382679a0; Cunningham SA, 2000, P ROY SOC B-BIOL SCI, V267, P1149, DOI 10.1098/rspb.2000.1121; CUSHMAN JH, 1991, AM NAT, V138, P851, DOI 10.1086/285256; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Flatt T, 2000, ECOLOGY, V81, P3522, DOI 10.1890/0012-9658(2000)081[3522:TEOMAO]2.0.CO;2; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GREZ AA, 1995, OECOLOGIA, V103, P471, DOI 10.1007/BF00328685; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; Inouye BD, 1999, J ANIM ECOL, V68, P150, DOI 10.1046/j.1365-2656.1999.00272.x; IVES AR, 1993, ECOLOGY, V74, P1929, DOI 10.2307/1940836; IVES AR, 1991, ECOL MONOGR, V61, P75, DOI 10.2307/1943000; JENNERSTEN O, 1988, CONSERV BIOL, V2, P359, DOI 10.1111/j.1523-1739.1988.tb00200.x; JENNERSTEN O, 1993, OIKOS, V68, P283, DOI 10.2307/3544841; KRANNITZ PG, 1991, CAN J BOT, V69, P394, DOI 10.1139/b91-054; LEVIN SA, 1976, ANNU REV ECOL SYST, V7, P287, DOI 10.1146/annurev.es.07.110176.001443; Lin CP, 2006, J NAT HIST, V40, P1887, DOI 10.1080/00222930601046618; MCEVOY P B, 1979, Miscellaneous Publications of the Entomological Society of America, V11, P1; Morales M. N, 1999, THESIS; Morales MA, 2002, ECOL ENTOMOL, V27, P247, DOI 10.1046/j.1365-2311.2002.00398.x; Morales MA, 2000, ECOLOGY, V81, P482, DOI 10.2307/177441; Morales MA, 2000, OIKOS, V90, P469, DOI 10.1034/j.1600-0706.2000.900305.x; Morales MA, 2006, ANN ENTOMOL SOC AM, V99, P545, DOI 10.1603/0013-8746(2006)99[545:EOHPQA]2.0.CO;2; Morales MA, 2008, P ROY SOC B-BIOL SCI, V275, P1935, DOI 10.1098/rspb.2008.0410; Morales MA, 2011, ECOLOGY, V92, P709, DOI 10.1890/10-1154.1; PIERCE NE, 1987, BEHAV ECOL SOCIOBIOL, V21, P237, DOI 10.1007/BF00292505; PIERCE NE, 1985, BEHAV ECOL SOCIOBIOL, V16, P209, DOI 10.1007/BF00310983; R Core Team, 2021, R LANGUAGE ENV STAT; SCHEMSKE DW, 1980, BIOTROPICA, V12, P169, DOI 10.2307/2387968; SIH A, 1987, ECOLOGY, V68, P1679, DOI 10.2307/1939860; Stadler B, 1999, ECOL ENTOMOL, V24, P363, DOI 10.1046/j.1365-2311.1999.00195.x; Stephens DW, 1987, FORAGING THEORY; Thompson J. N., 1982, INTERACTION COEVOLUT; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Turchin Peter, 1998; van Dyck H, 2000, P ROY SOC B-BIOL SCI, V267, P861, DOI 10.1098/rspb.2000.1082; Wilson WG, 2003, ECOL MONOGR, V73, P397, DOI 10.1890/02-0297; WOOD TK, 1982, ANN ENTOMOL SOC AM, V75, P649, DOI 10.1093/aesa/75.6.649; Zink AG, 2003, BEHAV ECOL, V14, P687, DOI 10.1093/beheco/arg044; Zink AG, 2003, BEHAV ECOL SOCIOBIOL, V54, P406, DOI 10.1007/s00265-003-0649-5; Zink AG, 2015, ETHOLOGY, V121, P823, DOI 10.1111/eth.12383	51	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181429	10.1371/journal.pone.0181429	http://dx.doi.org/10.1371/journal.pone.0181429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732064	gold, Green Submitted, Green Published			2022-12-26	WOS:000406643100035
J	Caesar, M; Grandcolas, P; Pellens, R				Caesar, Maram; Grandcolas, Philippe; Pellens, Roseli			Outstanding micro-endemism in New Caledonia: More than one out of ten animal species have a very restricted distribution range	PLOS ONE			English	Article							BIODIVERSITY; CONSERVATION; EXTINCTION; EVOLUTION; RICHNESS; RARITY; ISLAND; CLADE	New Caledonia is a biodiversity hotspot, with an extremely high number of endemic species with narrow distribution ranges that are at high risk of extinction due to open-cast nickel mining, invasive species and seasonal man-induced fires. Mentions of micro-endemism permeate the literature on the biota of this archipelago. However, so far there has been no research comparing distribution range in different animal groups. The aim of this study is to examine the implication of different sampling effort variables in order to distinguish microendemicity from data deficiency, and evaluate the distribution range, frequency, and extent to which micro-endemism is common to several groups of organisms. We compiled a dataset derived from publications in Zoologia Neocaledonica, comprising 1,149 species, of which 86% are endemic to New Caledonia. We found that the sampling effort variables that were best correlated with distribution range were the number of sampling dates and the number of collectors per species. The median value of sampling dates was used to establish a cut-off point for defining adequately sampled species. We showed that, although only 52% of species were sampled adequately enough to determine their distribution range, the number of species with a very narrow distribution range was still high. Among endemics from New Caledonia, 12% (116 species) have ranges <= 5.2km(2) and 3.9% (38 species) have ranges between 23 and 100 km(2). Surprisingly, a similar trend was observed in non-endemic species: 22% occurred in areas <= 5.2 km(2), and 8% in areas 23-100 km(2), suggesting that environmental dissimilarity may play an important role in the distribution of these species. Micro-endemic species were predominant in 18 out of 20 orders. These results will contribute to a re-assessment of the IUCN red list of species in this archipelago, indicating that at least 116 species are probably critically endangered.	[Caesar, Maram; Grandcolas, Philippe; Pellens, Roseli] Sorbonne Univ, CNRS UPMC EPHE, Museum Natl Hist Nat, Inst Systemat Evolut Biodivers, CP 50,45 Rue Buffon, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Caesar, M (corresponding author), Sorbonne Univ, CNRS UPMC EPHE, Museum Natl Hist Nat, Inst Systemat Evolut Biodivers, CP 50,45 Rue Buffon, Paris, France.	maram.caesar@edu.mnhn.fr		Grandcolas, Philippe/0000-0003-1374-1222	Syrian government (Syrian government-BGF)	Syrian government (Syrian government-BGF)	MC has a Ph.D. grant from the Syrian government (grant from the Syrian government-BGF), http://www.syrie.carnpusfrance.org; http://www.campusfrance.org/fr; http://labex-bcdiv. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was carried out within the framework of the Ph.D. thesis of Maram Caesar at the ED 227 of the Museum National d'Histoire Naturelle and ISYEB. MC has a Ph.D. grant from the Syrian government (Grant from the Syrian government-BGF).	Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bauer Aaron M., 2006, Proceedings of the California Academy of Sciences, V57, P503; BOUCHET P, 1995, BIODIVERS CONSERV, V4, P415, DOI 10.1007/BF00058425; Chazeau J., 1991, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V149, P1; Chazeau J., 1993, Biodiversity Letters, V1, P123, DOI 10.2307/2999756; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; Crisp MD, 2001, J BIOGEOGR, V28, P183, DOI 10.1046/j.1365-2699.2001.00524.x; Espeland M, 2010, J BIOGEOGR, V37, P879, DOI 10.1111/j.1365-2699.2009.02263.x; Gaston K. J, 1994, RARITY, V13, P1; Grandcolas P., 2016, 10 FALSE IDEAS NEW C; Grandcolas P, 2008, PHILOS T R SOC B, V363, P3309, DOI 10.1098/rstb.2008.0122; Grandcolas Philippe, 2009, Memoires du Museum National d'Histoire Naturelle, V198, P1; Grandcolas Philippe, 2008, P1; Guilbert E, 2014, MEM MUS NAT HIST NAT, V206, P1; Haase M, 1998, HYDROBIOLOGIA, V367, P43, DOI 10.1023/A:1003219931171; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Mace G, 2005, MILLENIUM ECOSYSTEM; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Morat P, 1999, B SOC BOT SUD OUEST, V19, P129; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Murienne J, 2008, CLADISTICS, V24, P802, DOI 10.1111/j.1096-0031.2008.00204.x; Murienne J, 2005, CLADISTICS, V21, P2, DOI 10.1111/j.1096-0031.2004.00042.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Najt Judith, 2002, Memoires du Museum National d'Histoire Naturelle, V187, P1; Najt Judith, 1997, Memoires du Museum National d'Histoire Naturelle, V171, P1; Nattier R, 2016, SCI REPORTS IN PRESS; Nattier R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080811; Nattier R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048047; Pascal M, 2008, CONSERV BIOL, V22, P498, DOI 10.1111/j.1523-1739.2008.00889.x; Pellens R, 2016, TOP BIODIV CON, V14, P237, DOI 10.1007/978-3-319-22461-9_12; Pellens R, 2010, ENVIRON SCI ENG TECH, P139; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Schulman L, 2007, BIODIVERS CONSERV, V16, P3011, DOI 10.1007/s10531-007-9158-6; Sharma P, 2009, CLADISTICS, V25, P279, DOI 10.1111/j.1096-0031.2009.00252.x; Tillier S., 1988, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V142, P1; Tillier S, 1993, MEMOIRES MUSEUM NATL, V157, P1; Townsend Peterson A., 1998, Diversity & Distributions, V4, P189, DOI 10.1046/j.1472-4642.1998.00021.x; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Wulff AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073371	46	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181437	10.1371/journal.pone.0181437	http://dx.doi.org/10.1371/journal.pone.0181437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727847	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500075
J	da Silva, VM; Sato, JAP; Araujo, JN; Squina, FM; Muniz, JRC; Riske, KA; Garcia, W				da Silva, Viviam M.; Sato, Juliana A. P.; Araujo, Juscemacia N.; Squina, Fabio M.; Muniz, Joao R. C.; Riske, Karin A.; Garcia, Wanius			Systematic studies of the interactions between a model polyphenol compound and microbial beta-glucosidases	PLOS ONE			English	Article							LIGNOCELLULOSIC BIOMASS; CELLULASE; BINDING; INHIBITION; PRETREATMENT; HYDROLYSIS; BEHAVIOR; LIGNIN; FORCE; ACID	Lignin is a major obstacle for cost-effective conversion of cellulose into fermentable sugars. Non-productive adsorption onto insoluble lignin fragments and interactions with soluble phenols are important inhibition mechanisms of cellulases, including beta-glucosidases. Here, we examined the inhibitory effect of tannic acid (TAN), a model polyphenolic compound, on beta-glucosidases from the bacterium Thermotoga petrophila (TpBGL1 and TpBGL3) and archaeon Pyrococcus furiosus (PfBGL1). The results revealed that the inhibition effects on beta-glucosidases were TAN concentration-dependent. TpBGL1 and TpBGL3 were more tolerant to the presence of TAN when compared with PfBGL1, while TpBGL1 was less inhibited when compared with TpBGL3. In an attempt to better understand the inhibitory effect, the interaction between TAN and beta-glucosidases were analyzed by isothermal titration calorimetry (ITC). Furthermore, the exposed hydrophobic surface areas in beta-glucosidases were analyzed using a fluorescent probe and compared with the results of inhibition and ITC. The binding constants determined by ITC for the interactions between TAN and beta-glucosidases presented the same order of magnitude. However, the number of binding sites and exposed hydrophobic surface areas varied for the beta-glucosidases studied. The binding between TAN and beta-glucosidases were driven by enthalpic effects and with an unfavorable negative change in entropy upon binding. Furthermore, the data suggest that there is a high correlation between exposed hydrophobic surface areas and the number of binding sites on the inhibition of microbial beta-glucosidases by TAN. These studies can be useful for biotechnological applications.	[da Silva, Viviam M.; Sato, Juliana A. P.; Araujo, Juscemacia N.; Garcia, Wanius] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Squina, Fabio M.] Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Muniz, Joao R. C.] Univ Sao Paulo, IFSC, Sao Carlos, SP, Brazil; [Riske, Karin A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sorocaba; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Garcia, W (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil.	wanius.garcia@ufabc.edu.br	Muniz, Joao R/B-7782-2016; Silva, Wanius J. G./L-3948-2016; Riske, Karin A/F-2314-2014; Araujo, Juscemácia/AAQ-7299-2020; Squina, Fabio/J-8130-2012; Araujo, Juscemácia Nascimento/N-2245-2017	Muniz, Joao R/0000-0003-2731-3966; Araujo, Juscemácia/0000-0001-9034-1463; Squina, Fabio/0000-0002-8154-7459; Araujo, Juscemácia Nascimento/0000-0001-9034-1463	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2015/02897-3, 442333/2014-5, 310186/2014-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) via grants number 2015/02897-3 (FAPESP), 442333/2014-5 (CNPq), and 310186/2014-3 (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Arouri A, 2007, EUR BIOPHYS J BIOPHY, V36, P647, DOI 10.1007/s00249-007-0140-8; Azqueta A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120785; Berlin A, 2006, J BIOTECHNOL, V125, P198, DOI 10.1016/j.jbiotec.2006.02.021; Chamani J, 2006, J COLLOID INTERF SCI, V293, P52, DOI 10.1016/j.jcis.2005.06.015; Colussi F, 2015, AMINO ACIDS, V47, P937, DOI 10.1007/s00726-015-1923-3; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Colussi F, 2012, EUR BIOPHYS J BIOPHY, V41, P89, DOI 10.1007/s00249-011-0762-8; COSTAS M, 1994, J CHEM SOC FARADAY T, V90, P1513, DOI 10.1039/ft9949001513; Cota J, 2015, NEW BIOTECHNOL, V32, P13, DOI 10.1016/j.nbt.2014.07.009; da Silva VM, 2016, ENZYME MICROB TECH, V87-88, P1, DOI 10.1016/j.enzmictec.2016.02.007; Garcia W, 2007, BIOCHEMISTRY-US, V46, P11101, DOI 10.1021/bi700702w; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Kado Y, 2011, ACTA CRYSTALLOGR F, V67, P1473, DOI 10.1107/S1744309111035238; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mhlongo SI, 2015, ENZYME MICROB TECH, V81, P16, DOI 10.1016/j.enzmictec.2015.07.005; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moghaddam MM, 2014, LUMINESCENCE, V29, P314, DOI 10.1002/bio.2546; Moosavi-Movahedi Z, 2006, PROTEIN J, V25, P193, DOI 10.1007/s10930-006-9002-y; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Oliveira LC, 2015, PLOS ONE, V10; Olsen SN, 2011, ENZYME MICROB TECH, V49, P353, DOI 10.1016/j.enzmictec.2011.06.015; Omidvar Z, 2013, J SOLUTION CHEM, V42, P1005, DOI 10.1007/s10953-013-0009-7; Ozdal T, 2013, FOOD RES INT, V51, P954, DOI 10.1016/j.foodres.2013.02.009; Pinelo M, 2017, BIOFUELS BIOPRO BIOR; Pozzo T, 2010, J MOL BIOL, V397, P724, DOI 10.1016/j.jmb.2010.01.072; Qin CR, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-65; Ramirez-Coronel MA, 2003, MICROBIOL-SGM, V149, P2941, DOI 10.1099/mic.0.26346-0; Rezende CA, 2011, BIOTECHNOL BIOFUELS, V4, P1, DOI 10.1186/1754-6834-4-54; Segato F, 2014, MICROBIOL MOL BIOL R, V78, P588, DOI 10.1128/MMBR.00019-14; SEMISOTNOV GV, 1987, FEBS LETT, V224, P9, DOI 10.1016/0014-5793(87)80412-X; Silva V.M., 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0092996; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Tejirian A, 2011, ENZYME MICROB TECH, V48, P239, DOI 10.1016/j.enzmictec.2010.11.004; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Ximenes E, 2011, ENZYME MICROB TECH, V48, P54, DOI 10.1016/j.enzmictec.2010.09.006; Ximenes E, 2010, ENZYME MICROB TECH, V46, P170, DOI 10.1016/j.enzmictec.2009.11.001; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h	43	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181629	10.1371/journal.pone.0181629	http://dx.doi.org/10.1371/journal.pone.0181629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727856	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500096
J	Okely, JA; Shaheen, SO; Weiss, A; Gale, CR				Okely, Judith A.; Shaheen, Seif O.; Weiss, Alexander; Gale, Catharine R.			Wellbeing and chronic lung disease incidence: The Survey of Health, Ageing and Retirement in Europe	PLOS ONE			English	Article							QUALITY-OF-LIFE; OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE AFFECT; SOCIOECONOMIC-STATUS; D SCALE; RISK; DEPRESSION; DETERMINANTS; INFLAMMATION; PREVALENCE	Background Previous studies indicate that psychosocial factors can impact COPD prevalence. However, research into this association has predominantly focused on negative factors such as depression. The aim of this study was to examine whether high subjective wellbeing is associated with a lower risk of developing COPD. Methods The sample consisted of 12,246 participants aged -50 years from the Survey of Health, Ageing and Retirement in Europe. We used Cox proportional hazards regression to examine the relationship between wellbeing (measured using the CASP-12) and incidence of COPD over a follow-up period of 9 years. Results There was a significant association between wellbeing and COPD risk. In age-adjusted analyses, a standard deviation increase in CASP-12 score was associated with a reduced risk of COPD; hazard ratios (95% confidence intervals) for men and women were 0.67 (0.60-0.75) and 0.80 (0.73-0.87) respectively. After additional adjustment for demographic and health behaviour variables, this association remained significant for men but not for women: the fully-adjusted hazard ratios were 0.80 (0.70-0.91) and 0.91 (0.82-1.03) respectively. Conclusions Greater wellbeing is associated with a reduced risk of COPD, particularly in men. Future research is needed to establish whether gender reliably moderates this association.	[Okely, Judith A.; Gale, Catharine R.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Shaheen, Seif O.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England; [Weiss, Alexander] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Gale, Catharine R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Edinburgh; University of London; Queen Mary University London; University of Edinburgh; University of Southampton	Okely, JA (corresponding author), Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	Judy.Okely@ed.ac.uk	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); MRC [G0400491, MC_U147585819, MC_UU_12011/2, MC_U147585827] Funding Source: UKRI; Medical Research Council [MC_U147585824, 1578662, MC_UU_12011/1, MR/K026992/1, MC_U147585827, MC_UU_12011/2, MC_U147585819, MC_UP_A620_1014, G0400491, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Judith A. Okely and Catharine R. Gale are members of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcser KH, 2005, SURVEY HLTH AGING RE; [Anonymous], 2015, TAK HER BREATH AW RI; Atlantis E, 2013, CHEST, V144, P766, DOI 10.1378/chest.12-1911; Barr RG, 2009, AM J MED, V122, P348, DOI 10.1016/j.amjmed.2008.09.042; Borsch-Supan A, 2008, START LONGITUD DIMEN; Borsch-Supan A, 2013, INT J EPIDEMIOL; Brett CE, 2012, QUAL LIFE RES, V21, P505, DOI 10.1007/s11136-011-9951-2; Castro-Costa E, 2008, INT J METH PSYCH RES, V17, P12, DOI 10.1002/mpr.236; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Ellison-Loschmann L, 2007, EUR RESPIR J, V29, P897, DOI 10.1183/09031936.00101606; Friedli L., 2004, SOCIAL PRESCRIBING M; Gale CR, 2015, PSYCHOSOM MED; Garson D., 2015, MISSING VALUES ANAL; GOLD, 2018, GLOBAL STRATEGY DIAG; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Harik-Khan RI, 2002, CHEST, V121, P370, DOI 10.1378/chest.121.2.370; Hobbs FDR, 2002, EUR HEART J, V23, P1867, DOI 10.1053/euhj.2002.3255; HUNT SM, 1985, J ROY COLL GEN PRACT, V35, P185; Hyde M, 2003, AGING MENT HEALTH, V7, P186, DOI 10.1080/1360786031000101157; Jenkins A, 2013, LEARNING WELLBEING T; Kahn R., 1981, WORK AND HLTH; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Kubzansky LD, 2006, THORAX, V61, P863, DOI 10.1136/thx.2005.050971; Kubzansky LD, 2002, ANN BEHAV MED, V24, P345, DOI 10.1207/S15324796ABM2404_11; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martin LM, 2000, AM J PREV MED, V18, P215, DOI 10.1016/S0749-3797(99)00158-0; MENAGHAN EG, 1984, J HEALTH SOC BEHAV, V25, P406, DOI 10.2307/2136379; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Okely JA, 2016, ANN BEHAV MED, P1; Omland O, 2014, SCAND J WORK ENV HEA, V40, P19, DOI 10.5271/sjweh.3400; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Pembroke TPI, 2006, J EPIDEMIOL COMMUN H, V60, P789, DOI 10.1136/jech.2005.042150; Perez-Rojo G., 2017, AGING MENTAL HLTH, P1; Pinquart M, 2000, PSYCHOL AGING, V15, P187, DOI 10.1037//0882-7974.15.2.187; Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P330, DOI 10.1192/bjp.174.4.330; Rippe JM, 1998, OBES RES, V6, P208, DOI 10.1002/j.1550-8528.1998.tb00339.x; Rod NH, 2012, ALLERGY, V67, P1408, DOI 10.1111/j.1398-9995.2012.02882.x.; Rosenberg SR, 2015, SEMIN RESP CRIT CARE, V36, P457, DOI 10.1055/s-0035-1555607; Rovina N, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/413735; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Stafford M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126683; Stellar JE, 2015, EMOTION, V15, P129, DOI 10.1037/emo0000033; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Stewart JC, 2009, BRAIN BEHAV IMMUN, V23, P936, DOI 10.1016/j.bbi.2009.04.011; Stocks J, 2013, THER ADV RESPIR DIS, V7, P161, DOI 10.1177/1753465813479428; Varraso R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h286; Ward K, 2011, J EPIDEMIOL COMMUN H, V65, P226, DOI 10.1136/jech.2009.096792; Watson L, 2004, RESP MED, V98, P1207, DOI 10.1016/j.rmed.2004.05.004; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181320	10.1371/journal.pone.0181320	http://dx.doi.org/10.1371/journal.pone.0181320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727748	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500057
J	Schlegel, V; Treuner-Kaueroff, T; Seehofer, D; Berg, T; Becker, S; Ceglarek, U; Thiery, J; Kaiser, T				Schlegel, Valentin; Treuner-Kaueroff, Theresa; Seehofer, Daniel; Berg, Thomas; Becker, Susen; Ceglarek, Uta; Thiery, Joachim; Kaiser, Thorsten			Low PCSK9 levels are correlated with mortality in patients with end-stage liver disease	PLOS ONE			English	Article							LDL RECEPTOR; MODEL; DEGRADATION; CHOLESTEROL; DECREASES; SURVIVAL	Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in the cholesterol metabolism and is synthesized by the liver. It interacts with the LDL-receptor to promote its degradation. The model of end-stage liver disease (MELD) score is a well-established tool to estimate the risk of mortality in patients with end-stage chronic liver disease. The study aims to assess the associations between PCSK9, hypocholesterinemia, liver synthesis, cholestasis, MELD score and mortality in patients with end-stage liver disease. Methods Serum samples were obtained from 74 patients with severe liver disease. The study participants were aged between 23 and 70 y (mean: 55.8 y; 47 males [63.5%], 27 females [36.5%]). Samples were selected from those with a wide range of MELD scores (7 to 40). Patients that underwent liver transplantation (17 / 74) were censored at the time of transplantation for mortality analysis. Results PCSK9 values ranged from 31.47 ng/mL to 261.64 ng/mL. The median value was 106.39 ng/ml. PCSK9 was negatively correlated with markers of liver function and cholestasis (INR, bilirubin). Over a 90-d follow-up, 15 of 57 (26,3%) patients died within the 90-d follow-up without receiving liver transplantation. Thirteen of 31 (42%) patients with PCSK9 levels below the median died compared to 2/26 (8%) patients with higher PCSK9 levels (p = 0.006). In this cohort, there were no significant correlations between PCSK9, cholesterol, its precursors and several phytosterols. Conclusions Low PCSK9 serum concentrations were associated with higher mortality in patients with end-stage liver disease. The mean PCSK9 levels in the study population were much lower than those found in normal or healthy populations. Further studies are required to acquire a more detailed understanding of the role of PCSK9 in liver-related mortality.	[Schlegel, Valentin; Treuner-Kaueroff, Theresa; Becker, Susen; Ceglarek, Uta; Thiery, Joachim; Kaiser, Thorsten] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Seehofer, Daniel] Univ Hosp Leipzig, Dept Visceral Vasc Thorac & Transplant Surg, Leipzig, Germany; [Berg, Thomas] Univ Hosp Leipzig, Sect Hepatol, Dept Gastroenterol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Kaiser, T (corresponding author), Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany.	thorsten.kaiser@medizin.uni-leipzig.de	Ceglarek, Uta/GOE-5561-2022; Seehofer, Daniel/X-1933-2019	Berg, Thomas/0000-0003-0003-6241	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Becker S, 2015, ANAL BIOANAL CHEM, V407, P5227, DOI 10.1007/s00216-015-8731-1; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cariou B, 2015, CURR OPIN LIPIDOL, V26, P155, DOI 10.1097/MOL.0000000000000180; Chang JM, 2009, P INT C UBIQ INFORM, P20; Cohen JC, 2006, REV PORT CARDIOL, V25, P769; Ghosh M, 2015, J LIPID RES, V56, P463, DOI 10.1194/jlr.M055780; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Janicko M, 2013, ANN HEPATOL, V12, P413; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Li S, 2015, ONCOTARGET; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Manka P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102351; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Peterson AS, 2008, J LIPID RES, V49, P1595, DOI 10.1194/jlr.CX00001-JLR200; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wijers M, 2015, CURR OPIN LIPIDOL, V26, P82, DOI 10.1097/MOL.0000000000000157; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	26	10	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181540	10.1371/journal.pone.0181540	http://dx.doi.org/10.1371/journal.pone.0181540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727814	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500084
J	Aguila, S; Izaguirre, G; Martinez-Martinez, I; Vicente, V; Olson, ST; Corral, J				Aguila, Sonia; Izaguirre, Gonzalo; Martinez-Martinez, Irene; Vicente, Vicente; Olson, Steven T.; Corral, Javier			Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; HEPARIN ACTIVATION; FACTOR-XA; BETA-ANTITHROMBIN; RAPID INHIBITION; CAMBRIDGE-II; FACTOR-IXA; BINDING; AFFINITY; EXOSITE	Antithrombin mainly inhibits factor Xa and thrombin. The reactive center loop (RCL) is crucial for its interactions with its protease targets and is fully inserted into the A-sheet after its cleavage, causing translocation of the covalently linked protease to the opposite end of the A-sheet. Antithrombin variants with altered RCL hinge residues behave as substrates rather than inhibitors, resulting in stoichiometries of inhibition greater than one. Other antithrombin residues have been suggested to interfere with RCL insertion or the stability of the antithrombin-protease complex, but available crystal structures or mutagenesis studies have failed to identify such residues. Here, we characterized two mutations, S365L and I207T, present in individuals with type II antithrombin deficiency and identified a new antithrombin functional domain. S365L did not form stable complexes with thrombin or factor Xa, and the I207T/I207A variants inhibited both proteases with elevated stoichiometries of inhibition. Close proximity of Ile-207 and Ser-365 to the inserted RCL suggested that the preferred reaction of these mutants as protease substrates reflects an effect on the rate of the RCL insertion and protease translocation. However, both residues lie within the final docking site for the protease in the antithrombin-protease complex, supporting the idea that the enhanced substrate reactions may result from an increased dissociation of the final complexes. Our findings demonstrate that the distal end of the antithrombin A-sheet is crucial for the last steps of protease inhibition either by affecting the rate of RCL insertion or through critical interactions with proteases at the end of the A-sheet.	[Aguila, Sonia; Martinez-Martinez, Irene; Vicente, Vicente; Corral, Javier] Univ Murcia, Inst Murciano Invest Biosanit IMIB Virgen de la A, Ctr Reg Hemodonac, Murcia 30003, Spain; [Aguila, Sonia; Martinez-Martinez, Irene; Vicente, Vicente; Corral, Javier] Univ Murcia, Inst Murciano Invest Biosanit IMIB Virgen de la A, Hosp Univ Morales Meseguer, Murcia 30003, Spain; [Izaguirre, Gonzalo; Olson, Steven T.] Univ Illinois, Dept Periodont, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Martinez-Martinez, Irene; Vicente, Vicente; Corral, Javier] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28029, Spain	University of Murcia; Meseguer General University Hospital Morales; University of Murcia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Martinez-Martinez, I (corresponding author), Ctr Reg Hemodonac, Ronda Garay S-N, Murcia 30003, Spain.; Olson, ST (corresponding author), 801 S Paulina St,MC 860, Chicago, IL 60612 USA.	immlgi@um.es; stolson@uic.edu	Vicente, Vicente/L-6185-2019; Aguila, Sonia/Q-2822-2019; Martínez-Martínez, Irene/AAM-8862-2020	Vicente, Vicente/0000-0002-4278-3264; Aguila, Sonia/0000-0001-5794-5177; Martínez-Martínez, Irene/0000-0002-1067-6464; Corral, Javier/0000-0003-0288-1107	Instituto de Salud Carlos III; Fundacion Seneca; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Seneca(Fundacion Seneca); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Bohdan, J. Padilla, S. Espin, and Lixin Qi for their excellent technical assistance, and Instituto de Salud Carlos III and Fundacion Seneca for supporting this work.	Aguila S, 2014, J THROMB HAEMOST, V12, P1131, DOI 10.1111/jth.12606; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; Backovic M, 2002, J PROTEOME RES, V1, P367, DOI 10.1021/pr025515z; Carrell RW, 2003, BIOCHEM SOC SYMP, V70, P163, DOI 10.1042/bss0700163; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; Chuang YJ, 1999, J BIOL CHEM, V274, P28142, DOI 10.1074/jbc.274.40.28142; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; DEVRAJKIZUK R, 1988, BLOOD, V72, P1518; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gils A, 1998, THROMB HAEMOSTASIS, V80, P531; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2004, J BIOL CHEM, V279, P4913, DOI 10.1074/jbc.M311644200; KOIDE T, 1984, P NATL ACAD SCI-BIOL, V81, P289, DOI 10.1073/pnas.81.2.289; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; Maddur AA, 2013, J BIOL CHEM, V288, P32020, DOI 10.1074/jbc.M113.510990; Martinez-Martinez I, 2012, BLOOD, V120, P900, DOI 10.1182/blood-2012-01-406207; Martinez-Martinez I, 2010, HAEMATOL-HEMATOL J, V95, P1358, DOI 10.3324/haematol.2009.015487; Mushunje A, 2003, BLOOD, V102, P4028, DOI 10.1182/blood-2003-05-1560; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; Peterson FC, 2000, BIOCHEMISTRY-US, V39, P11884, DOI 10.1021/bi001152+; Picard V, 2000, BRIT J HAEMATOL, V110, P731, DOI 10.1046/j.1365-2141.2000.02245.x; PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026; Quinsey NS, 2004, INT J BIOCHEM CELL B, V36, P386, DOI 10.1016/S1357-2725(03)00244-9; Raja SM, 2003, J BIOL CHEM, V278, P13688, DOI 10.1074/jbc.M300062200; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; Yang LK, 2002, J BIOL CHEM, V277, P50756, DOI 10.1074/jbc.M208485200	37	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16513	16520		10.1074/jbc.M117.787325	http://dx.doi.org/10.1074/jbc.M117.787325			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28743742	Green Published, hybrid			2022-12-26	WOS:000412414800010
J	Lee, WC; Fang, HY; Chen, HC; Chen, CJ; Yang, CH; Hang, CL; Wu, CJ; Fang, CY				Lee, Wei-Chieh; Fang, Hsiu-Yu; Chen, Huang-Chung; Chen, Chien-Jen; Yang, Cheng-Hsu; Hang, Chi-Ling; Wu, Chiung-Jen; Fang, Chih-Yuan			Anemia: A significant cardiovascular mortality risk after ST-segment elevation myocardial infarction complicated by the comorbidities of hypertension and kidney disease	PLOS ONE			English	Article							ADMISSION HEMOGLOBIN LEVELS; HEART-FAILURE; IMPACT; ASSOCIATION; MORBIDITY; INTERVAL; OUTCOMES	Background The effect of anemia on patients with ST-segment elevation myocardial infarction (STEMI) remains a controversial issue. The aim of this study was to explore the effect of anemia on STEMI patients. Methods and results From January 2005 to December 2014, 1751 patients experienced STEMI checked serum hemoglobin initially before any administration of fluids or IV medications. 1751 patients then received primary percutaneous intervention immediately. A total of 1388 patients were enrolled in the non-anemia group because their serum hemoglobin level was more than 13 g/L in males, and 12 g/L in females. A total of 363 patients were enrolled in the anemia group because their serum hemoglobin level was less than 13 g/L in males, and 12 g/L in females. Higher incidences of major adverse cerebral cardiac events (22.9% vs. 33.8%; p<0.001) were also noted in the anemia group, and these were related to higher incidence of cardiovascular mortality (6.5% vs. 20.4%; p<0.001). A higher incidence of all-cause mortality (8.6% vs. 27.7%; p<0.001) was also noted in the anemia group. A Kaplan-Meier curve of one-year cardiovascular mortality showed significant differences between the non-anemia and anemia group in all patients (P<0.001), and the patients with hypertension (P<0.001), and chronic kidney disease (CKD) (P = 0.011). Conclusion Anemia is a marker of an increased risk in one-year cardiovascular mortality in patients with STEMI. If the patients have comorbidities such as hypertension, or CKD, the effect of anemia is very significant.	[Lee, Wei-Chieh; Fang, Hsiu-Yu; Chen, Huang-Chung; Chen, Chien-Jen; Yang, Cheng-Hsu; Hang, Chi-Ling; Wu, Chiung-Jen; Fang, Chih-Yuan] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Cardiol,Dept Internal Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Lee, WC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Div Cardiol,Dept Internal Med, Kaohsiung, Taiwan.	leeweichieh@yahoo.com.tw		, Chen/0000-0002-4423-9246				Al Falluji N, 2002, AM HEART J, V144, P636, DOI 10.1067/mhj.2002.124351; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bolinska S, 2011, KARDIOL POL, V69, P33; Brener SJ, 2017, AM J CARDIOL, V119, P1710, DOI 10.1016/j.amjcard.2017.02.052; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Garadah TS, 2010, CLIN MED INSIGHTS-CA, V4, P31; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Gustavsson C G, 1997, J Cardiovasc Risk, V4, P37; Ioana Mozos, 2015, BIOMED RES INT, V2015; Isma'eel H, 2009, INT J CARDIOL, V132, P453, DOI 10.1016/j.ijcard.2007.08.103; Levy PS, 1996, J TRAUMA, V41, P416, DOI 10.1097/00005373-199609000-00006; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mamas MA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003348; MOST AS, 1986, CIRCULATION, V74, P1085, DOI 10.1161/01.CIR.74.5.1085; Mozos I, 2012, INT J COLLAB RES INT, V4, P2084; Paul B, 2008, CLIN EXP PHARMACOL P, V35, P1461, DOI 10.1111/j.1440-1681.2008.05031.x; Peterson ED, 2010, HEART, V96, P1798, DOI 10.1136/hrt.2010.200261; Rathod KS, 2014, CORONARY ARTERY DIS, V25, P52, DOI 10.1097/MCA.0000000000000038; Riley RF, 2013, EUR HEART J-ACUTE CA, V2, P35, DOI 10.1177/2048872612471216; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Santos IS, 2015, ARQ BRAS CARDIOL, V105, P53, DOI 10.5935/abc.20150044; Shacham Y, 2015, CAN J CARDIOL, V31, P50, DOI 10.1016/j.cjca.2014.11.001; Shacham Y, 2014, CLIN CARDIOL, V37, P73, DOI 10.1002/clc.22215; Shu DH, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-8; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Young JB, 2008, AM J CARDIOL, V101, P223, DOI 10.1016/j.amjcard.2007.07.067	31	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180165	10.1371/journal.pone.0180165	http://dx.doi.org/10.1371/journal.pone.0180165			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749948	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700008
J	Merk, B; Litskevich, D; Bankhead, M; Taylor, RJ				Merk, Bruno; Litskevich, Dzianis; Bankhead, Mark; Taylor, Richard J.			An innovative way of thinking nuclear waste management - Neutron physics of a reactor directly operating on SNF	PLOS ONE			English	Article								A solution for the nuclear waste problem is the key challenge for an extensive use of nuclear reactors as a major carbon free, sustainable, and applied highly reliable energy source. Partitioning and Transmutation (P&T) promises a solution for improved waste management. Current strategies rely on systems designed in the 60's for the massive production of plutonium. We propose an innovative strategic development plan based on invention and innovation described with the concept of developments in s-curves identifying the current boundary conditions, and the evolvable objectives. This leads to the ultimate, universal vision for energy production characterized by minimal use of resources and production of waste, while being economically affordable and safe, secure and reliable in operation. This vision is transformed into a mission for a disruptive development of the future nuclear energy system operated by burning of existing spent nuclear fuel (SNF) without prior reprocessing. This highly innovative approach fulfils the sustainability goals and creates new options for P&T. A proof on the feasibility from neutronic point of view is given demonstrating sufficient breeding of fissile material from the inserted SNF. The system does neither require new resources nor produce additional waste, thus it provides a highly sustainable option for a future nuclear system fulfilling the requests of P&T as side effect. In addition, this nuclear system provides enhanced resistance against misuse of Pu and a significantly reduced fuel cycle. However, the new system requires a demand driven rethinking of the separation process to be efficient.	[Merk, Bruno; Litskevich, Dzianis] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Merk, Bruno; Bankhead, Mark] Natl Nucl Lab, Chadwick House, Warrington, Cheshire, England; [Taylor, Richard J.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England	University of Liverpool; University of Manchester	Merk, B (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.; Merk, B (corresponding author), Natl Nucl Lab, Chadwick House, Warrington, Cheshire, England.	b.merk@liverpool.ac.uk		Litskevich, Dzianis/0000-0002-3207-3058	Royal Academy of Engineering; National Nuclear Laboratory of the United Kingdom	Royal Academy of Engineering(Royal Academy of Engineering - UK); National Nuclear Laboratory of the United Kingdom	In addition the main author wants to thank the Royal Academy of Engineering and the National Nuclear Laboratory of the United Kingdom for sponsoring the NNL/RAEng research chair position which creates space and time to develop highly innovative thinking for the future success of nuclear systems.	acatech, 2014, PART TRANSM NUCL WAS; [Anonymous], 2011, SSP 11 452 REV 1; [Anonymous], TRANSM RAD WAST; Buongiorno J, 2010, PWR DESCRIPTION MIT; Engel J. R., 1978, ORNLTM6413; Evaluation and Viability of Liquid Fuel Fast Reactor System EVOL, DELIVERABLE D2 1 DES; Everett M., ROGERS DIFFUSION INN; Ignatiev V, 2012, ICAPP 12; Kozlowski Tomasz, OECD NEA AND US NRC; MACPHERSON HG, 1985, NUCL SCI ENG, V90, P374, DOI 10.13182/NSE90-374; Malik F., 2013, STRATEGY NAVIGATING; Merk B, 2017, DEMAND DRIVEN SALT C; Merk B., PLOS ONE; Merk B, 2016, 14 INF EXCH M HILT S; Merk B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180703; Merk B, 2017, ENERGIES, V10, DOI 10.3390/en10070867; Merk B, 2015, ENERGIES, V8, P12557, DOI 10.3390/en81112328; Merk B, 2015, APPL ENERG, V147, P104, DOI 10.1016/j.apenergy.2015.02.023; Merk B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092776; Merk B, 2014, ANN NUCL ENERGY, V64, P441, DOI 10.1016/j.anucene.2013.07.014; Nash KL, 2015, WOODHEAD PUBLISHING, V79; OECD Nuclear Energy Agency for the Generation IV international Forum, 2014, TECHN ROADM UPD GEN; Poinssot C, 2014, ENERGY, V69, P199, DOI 10.1016/j.energy.2014.02.069; Rachamin R, 2013, ANN NUCL ENERGY, V55, P194, DOI 10.1016/j.anucene.2012.11.030; Roehrlich E, 2013, 60 YEARS ATOMS PEACE; Spent Nuclear Fuel Reprocessing Flowsheet, 2012, REP WPFC EXP GROUP C; Villarino EA, 1992, NUCL SCI ENG, P112	27	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180703	10.1371/journal.pone.0180703	http://dx.doi.org/10.1371/journal.pone.0180703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749952	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700015
J	de la Flor, M; Chen, LJ; Manson-Bishop, C; Chu, TC; Zamora, K; Robbins, D; Gunaratne, G; Roman, G				de la Flor, Miguel; Chen, Lijian; Manson-Bishop, Claire; Chu, Tzu-Chun; Zamora, Kathya; Robbins, Danielle; Gunaratne, Gemunu; Roman, Gregg			Drosophila increase exploration after visually detecting predators	PLOS ONE			English	Article							SPINY MICE; OPEN-FIELD; HABITUATION; BEHAVIOR; DEFENSE; OWL; MELANOGASTER; RESPONSES; PARADIGM; ESCAPE	Novel stimuli elicit behaviors that are collectively known as specific exploration. These behaviors allow the animal to become more familiar with the novel objects within its environment. Specific exploration is frequently suppressed by defensive reactions to predator cues. Herein, we examine if this suppression occurs in Drosophila melanogaster by measuring the response of these flies to wild harvested predators. The flies used in our experiments have been cultured and had not lived under predator threat for multiple decades. In a circular arena with centrally-caged predators, wild type Drosophila actively avoided the pantropical jumping spider, Plexippus paykulli, and the Texas unicorn mantis, Phyllovates chlorophaena, indicating an innate defensive reaction to these predators. Interestingly, wild type Drosophila males also avoided a centrally-caged mock spider, and the avoidance of the mock spider became exaggerated when it was made to move within the cage. Visually impaired Drosophila failed to detect and avoid the Plexippus paykulli and the moving mock spider, while the broadly anosmic orco(2) mutants were fully capable of detecting and avoiding Plexippus paykulli, indicating that these flies principally relied upon vison to perceive the predator stimuli. During early exploration of the arena, exploratory activity increased in the presence of Plexippus paykulli and the moving mock spider. The elevated activity induced by Plexippus paykulli disappeared after the fly had finished exploring, suggesting the flies were capable of habituating the predator cues. Taken together, these results indicate that despite being isolated from predators for decades Drosophila will visually detect these predators, retain innate defensive behaviors, respond by increasing exploratory activity in the arena rather than suppressing activity, and may habituate to normal predator cues.	[de la Flor, Miguel; Manson-Bishop, Claire; Chu, Tzu-Chun; Zamora, Kathya; Robbins, Danielle; Roman, Gregg] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [de la Flor, Miguel; Roman, Gregg] Univ Houston, Biol Behav Inst, Houston, TX 77004 USA; [Chen, Lijian; Gunaratne, Gemunu] Univ Houston, Dept Phys, Houston, TX USA; [Roman, Gregg] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; University of Houston System; University of Houston; University of Mississippi	Roman, G (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.; Roman, G (corresponding author), Univ Houston, Biol Behav Inst, Houston, TX 77004 USA.; Roman, G (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	groman@olemiss.edu	Roman, Gregg/W-1586-2019	Roman, Gregg/0000-0003-1519-4699	National Institute of Mental Health [MH091304]; Biology of Behavior Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biology of Behavior Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Grant MH091304 was awarded to GR by the National Institute of Mental Health: nimh.nih.gov. A BoBI Summer Scholarship was awarded to MdIF, by the Biology of Behavior Institute: http://behave.uh.edun The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2013, J EXP BIOL, V216, P4608, DOI 10.1242/jeb.094482; [Anonymous], 1956, LEARNING INSTINCT AN; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P289, DOI 10.1111/j.2044-8295.1958.tb00667.x; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; BERLYNE DE, 1966, SCIENCE, V153, P25, DOI 10.1126/science.153.3731.25; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Blanchard R. J., 1990, ETHOEXPERIMENTAL ANA; Blanchard RJ, 1997, NEUROSCI BIOBEHAV R, V21, P783, DOI 10.1016/S0149-7634(96)00062-0; Chance M. R. A., 1955, Behaviour, V8, P174, DOI 10.1163/156853955X00210; Cooper WE, 2009, BEHAV ECOL, V20, P542, DOI 10.1093/beheco/arp029; Dacier A, 2006, BEHAV PROCESS, V71, P66, DOI 10.1016/j.beproc.2005.09.006; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Edut S, 2004, BEHAV BRAIN RES, V155, P207, DOI 10.1016/j.bbr.2004.04.018; Edut S., 2003, BMC ECOL, V3, P1; Eilam D, 1999, ANIM BEHAV, V58, P1085, DOI 10.1006/anbe.1999.1224; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Eilam David, 2004, BMC Ecology, V4, P16, DOI 10.1186/1472-6785-4-16; Elias DO, 2006, J EXP BIOL, V209, P1074, DOI 10.1242/jeb.02104; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; Fotowat H, 2009, J NEUROPHYSIOL, V102, P875, DOI 10.1152/jn.00073.2009; Glaudas X, 2006, ETHOLOGY, V112, P608, DOI 10.1111/j.1439-0310.2005.01183.x; GOTZ KG, 1985, J COMP PHYSIOL A, V156, P329, DOI 10.1007/BF00610726; Gotz KG, 1980, BASIC LIFE SCI, V16, P391, DOI [10.1007/978-1-4684-7968-3_28, DOI 10.1007/978-1-4684-7968-3%5F28]; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Harris JD, 1943, PSYCHOL BULL, V40, P385, DOI 10.1037/h0053918; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HEBB DO, 1946, PSYCHOL REV, V53, P259, DOI 10.1037/h0061690; Hendrie CA, 1998, J ZOOL, V245, P439, DOI 10.1017/S0952836998008073; Hendrie CA, 1996, PHARMACOL BIOCHEM BE, V54, P13, DOI 10.1016/0091-3057(95)02176-0; HENDRIE CA, 1994, ETHOLOGY AND PSYCHOPHARMACOLOGY, P111; HENGSTEN, 1967, KYBERNETIK, V3, P276; HINDE RA, 1954, PROC R SOC SER B-BIO, V142, P306, DOI 10.1098/rspb.1954.0028; Kacsoh BZ, 2015, GENETICS, V199, P1143, DOI 10.1534/genetics.114.172221; Kacsoh BZ, 2015, COMMUNICATION, P4; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Mohammad F, 2016, CURR BIOL, V26, P981, DOI 10.1016/j.cub.2016.02.031; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Schleidt W. M., 1961, Zeitschrift fuer Tierpsychologie, V18, P534; Schleidt W, 2011, J COMP PSYCHOL, V125, P121, DOI 10.1037/a0022068; Seitz A., 1948, Zeitschrift fuer Tierpsychologie Berlin, V4, P40; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Soibam B, 2014, EUR PHYS J-SPEC TOP, V223, P1787, DOI 10.1140/epjst/e2014-02226-7; Soibam B, 2013, BEHAV PROCESS, V97, P63, DOI 10.1016/j.beproc.2013.04.005; Soibam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046570; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; STADDON JER, 1975, AM NAT, V109, P541, DOI 10.1086/283025; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Tinbergen N., 1948, Wilson Bulletin, V60, P6; TINBERGEN N., 1939, BIRD LORE, V41, P23; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Welker W., 1961, FUNCT VARIED EXPER, P175; Yerkes RM, 1936, J COMP PSYCHOL, V21, P53, DOI 10.1037/h0058825; ZIMBARDO PG, 1957, PSYCHOL REP, V3, P589; Zylberberg Joel, 2011, Front Comput Neurosci, V5, P20, DOI 10.3389/fncom.2011.00020	63	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180749	10.1371/journal.pone.0180749	http://dx.doi.org/10.1371/journal.pone.0180749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8EN	28746346	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800018
J	Han, JF; Wang, W				Han, Jianfeng; Wang, Wei			Effects of tanshinol on markers of bone turnover in ovariectomized rats and osteoblast cultures	PLOS ONE			English	Article							ESTROGEN DEFICIENCY; IN-VITRO; OSTEOPOROSIS; CELLS; DIFFERENTIATION; PROLIFERATION; APOPTOSIS; EXTRACT	This study was aimed to explore the role of tanshinol in osteoblastic cells, and the role in vivo using an ovariectomized (OVX) rat model of osteoporosis. MC3T3-E1 cells were pre-treated with 0-400 mu g/mL tanshinol, and then cell viability, apoptosis, alkaline phosphatase (ALP) activity and the expressions of Collagen Type I Alpha 1 (Col1A1), Runt Related Transcription Factor 2 (Runx2) and osteocalcin (OCN) were respectively detected. Rats underwent OVX surgery was intervened with 5 mg/kg tanshinol or 25 mu g/kg beta-estradiol (E2) for 12 weeks. The triglycerides (TG), total cholesterol (TC), high and low density lipoprotein cholesterol (HDL-C and LDL-C), ALP, OCN and Tartrate-resistant acid phosphatase-5b (TRACP-5b) contents were measured. Besides, the expressions of main factors in nuclear factor-kappa B (NF-kappa B) pathway were detected. The results showed that tanshinol significantly promoted MC3T3-E1 cells viability and ALP activity, while inhibited apoptosis (P < 0.05); Col1A1, Runx2 and OCN were all up-regulated by tanshinol (P < 0.05). In OVX rats, the contents of TG, TC, LDL-C, ALP, OCN and TRACP-5b were all increased (P < 0.05), while HDL-C was decreased (P < 0.05). Tanshinol significantly alleviated these aberrant regulations (P < 0.05). Inhibitory subunit of NF-kappa B (I kappa B alpha) and p65 were both remarkably phosphorylated by OVX, while this phosphorylation was partially neutralized by tanshinol (P < 0.05). In conclusion, we demonstrated that tanshinol exerted a bone-protective function by modulating the markers of bone turnover possibly via blocking NF-kappa B pathway. This study will provide new evidence that tanshinol is a potential therapeutic option for the relief of estrogen deficiency-induced osteoporosis.	[Han, Jianfeng] Harbin Med Univ, Affiliated Hosp 2, Dept Orthoped, Harbin, Heilongjiang, Peoples R China; [Wang, Wei] Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, W (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Endocrinol, Harbin, Heilongjiang, Peoples R China.	wangwei1586@126.com						Abuohashish HM, 2015, ACTA PHARMACOL SIN, V36, P209, DOI 10.1038/aps.2014.111; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Choi JH, 2013, J EXERC REHABIL, V9, P457, DOI 10.12965/jer.130055; Chong CM, 2013, NEUROSCI LETT, V543, P121, DOI 10.1016/j.neulet.2013.02.069; Cieniewicz B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01202; Cui L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034647; Cui L, 2009, ACTA PHARMACOL SIN, V30, P321, DOI 10.1038/aps.2009.9; Deshaies Y, 1997, AM J PHYSIOL-ENDOC M, V273, pE355, DOI 10.1152/ajpendo.1997.273.2.E355; Du L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32261; Gu X, 2016, ONCOTARGET, DOI 10.18632/oncotarget. 10490.; Hassan HA, 2013, CYTOTECHNOLOGY, V65, P609, DOI 10.1007/s10616-012-9514-6; Hassan HA, 2012, J PHYSIOL BIOCHEM, V68, P247, DOI 10.1007/s13105-011-0137-8; Havill LM, 2006, J MED PRIMATOL, V35, P97, DOI 10.1111/j.1600-0684.2006.00150.x; Jeon EJ, 2016, MOL NUTR FOOD RES, V60, P2587, DOI 10.1002/mnfr.201600257; Jin P, 2015, YONSEI MED J, V56, P760, DOI 10.3349/ymj.2015.56.3.760; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Lane NE, 2003, ARTHRITIS RES THER, V5, P214, DOI 10.1186/ar797; Li AG, 2015, MOL CELLS, V38, P941, DOI 10.14348/molcells.2015.2353; Li J, 2015, INT J CLIN EXP PATHO, V8, P13695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo SY, 2016, J ORTHOP TRANSL, V4, P35, DOI 10.1016/j.jot.2015.07.002; Maruyama W, 2016, BIOCHEM BIOPH RES CO, V478, P1466, DOI 10.1016/j.bbrc.2016.08.148; Ngo Sock ET, 2016, PLOS ONE, V11; Nik J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1686-x; Pan XW, 2015, INT J MOL SCI, V16, P13908, DOI 10.3390/ijms160613908; Park MH, 2016, NUTR RES PRACT, V10, P148, DOI 10.4162/nrp.2016.10.2.148; Polak-Jonkisz D, 1998, NEPHROLOGY, V4, P339, DOI 10.1111/j.1440-1797.1998.tb00369.x; Schreiweis MA, 2007, J CELL BIOCHEM, V101, P466, DOI 10.1002/jcb.21196; Sinnesael M, 2013, CURR OPIN ENDOCRINOL, V20, P240, DOI 10.1097/MED.0b013e32835f7d04; Yang Y, 2016, TANSHINOL RESCUES IM, V2016; Yang Y., 2013, OXIDATIVE MED CELLUL, V2013, DOI DOI 10.1155/2013/351895; Zhang DW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-484; Zhao X, 2011, J ETHNOPHARMACOL, V137, P1083, DOI 10.1016/j.jep.2011.07.017	34	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181175	10.1371/journal.pone.0181175	http://dx.doi.org/10.1371/journal.pone.0181175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746340	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800027
J	Ti, JF; Li, ZJ; Li, XL; Lu, YJ; Diao, YX; Li, F				Ti, Jinfeng; Li, Zhijie; Li, Xiuli; Lu, Yunjian; Diao, Youxiang; Li, Fang			Identification of one B-cell epitope from NS1 protein of duck Tembusu virus with monoclonal antibodies	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; WEST NILE VIRUS; NONSTRUCTURAL PROTEIN; PROTECTIVE IMMUNITY; COMPLETE GENOME; FLAVIVIRUS; CHINA; MICE; INFECTIONS	This study describes the identification of one linear B-cell epitope on TMUV NS1 protein with monoclonal antibody (mAb) 3G2 by indirect enzyme-linked immunosorbent assay (ELISA). In this study, NS1 protein was expressed in prokaryotic expression system and purified. One mAb against NS1 protein was generated from Balb/c mice immunized with recombinant protein NS1. A set of 35 partially-overlapping polypeptides covering the entire NS1 protein was expressed with PGEX-6P-1 vector and screened with mAb 3G2. One polypeptide against the mAb was acquired and identified by indirect ELISA and western-blot. To map the epitope accurately, one or two amino acid residues were removed from the carboxy and amino terminal of polypeptide sequentially. A series of truncated oligopeptides were expressed and purified. The minimal determinant of the linear B-cell epitope was recognized and identified with mAb 3G2. The accurate linear B-cell epitope was 269 DEKEIV 274 located in NS1 protein. Furthermore, sequence alignment showed that the epitope was highly conserved and specific among TMUV strains and other flavivirus respectively. The linear B-cell epitope of TMUV NS1 protein could benefit the development of new vaccines and diagnostic assays.	[Ti, Jinfeng; Li, Xiuli; Lu, Yunjian; Diao, Youxiang] Shan Dong Agr Univ, Zool Inst, Tai An, Shandong, Peoples R China; [Ti, Jinfeng; Li, Zhijie; Li, Fang] Shandong Vocat Anim Sci & Vet Coll, Weifang, Shandong, Peoples R China		Diao, YX (corresponding author), Shan Dong Agr Univ, Zool Inst, Tai An, Shandong, Peoples R China.	yxdiao@126.com			National Key Research and Development Project [2016YFD0500107]; National Waterfowl Industry Technology System [CARS-43-10]; National Natural Science Foundation of China [31272583, 31472199]; Shandong Science and Technology Development Program [2014GNC111023]; Shandong Agriculture Significant Application and Technology Innovation Project; Shandong Science and Technology Plan Program of College and University [J16LF58]	National Key Research and Development Project; National Waterfowl Industry Technology System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Program; Shandong Agriculture Significant Application and Technology Innovation Project; Shandong Science and Technology Plan Program of College and University	This study was supported by the National Key Research and Development Project (2016YFD0500107) to Youxiang Diao, the National Waterfowl Industry Technology System (CARS-43-10) to Youxiang Diao, the National Natural Science Foundation of China (31272583) to Youxiang Diao, the National Natural Science Foundation of China (31472199) to Youxiang Diao, the Shandong Science and Technology Development Program (2014GNC111023) to Youxiang Diao, the Shandong Agriculture Significant Application and Technology Innovation Project of 2016 to Youxiang Diao, and the Shandong Science and Technology Plan Program of College and University (J16LF58) to Dr. Jinfeng Ti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Wang B, 2009, VIRUS RES, V141, P90, DOI 10.1016/j.virusres.2009.01.004; Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890; Chen Y, 2010, VIROLOGY, V398, P290, DOI 10.1016/j.virol.2009.12.010; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Hua RH, 2004, BIOCHEM BIOPH RES CO, V319, P929, DOI 10.1016/j.bbrc.2004.05.066; Hua RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067553; Kitai Y, 2007, CLIN VACCINE IMMUNOL, V14, P1024, DOI 10.1128/CVI.00051-07; Kitai Y, 2011, J VIROL METHODS, V171, P123, DOI 10.1016/j.jviromet.2010.10.012; Konishi E, 2004, J CLIN MICROBIOL, V42, P5087, DOI 10.1128/JCM.42.11.5087-5093.2004; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Li GX, 2014, VIROLOGY, V450, P233, DOI 10.1016/j.virol.2013.12.028; Li S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-260; Lin J, 2015, AVIAN DIS, V59, P244, DOI 10.1637/10960-101514-Reg; Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998; Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997; Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0; Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Schlesinger JJ, 2006, P NATL ACAD SCI USA, V103, P18879, DOI 10.1073/pnas.0609522103; Silva BM, 2011, ARCH VIROL, V156, P1275, DOI 10.1007/s00705-011-0969-0; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Sun EC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-160; Sun EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031434; Tafuku S, 2012, MICROBES INFECT, V14, P169, DOI 10.1016/j.micinf.2011.09.004; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P152, DOI 10.1111/j.1865-1682.2012.01328.x; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P336, DOI 10.1111/j.1865-1682.2011.01275.x; Volpina OM, 2005, VIRUS RES, V112, P95, DOI 10.1016/j.virusres.2005.03.026; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Xu GY, 2004, VACCINE, V22, P1846, DOI 10.1016/j.vaccine.2003.09.015; Yun T, 2012, J VIROL, V86, P3406, DOI 10.1128/JVI.07132-11	33	8	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181177	10.1371/journal.pone.0181177	http://dx.doi.org/10.1371/journal.pone.0181177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746401	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800028
J	Zeh, R; Sheikh, S; Xia, L; Pierce, J; Newton, A; Predina, J; Cho, S; Nasrallah, M; Singhai, S; Dorsey, J; Lee, JYK				Zeh, Ryan; Sheikh, Saad; Xia, Leilei; Pierce, John; Newton, Andrew; Predina, Jarrod; Cho, Steve; Nasrallah, MacLean; Singhai, Sunil; Dorsey, Jay; Lee, John Y. K.			The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma	PLOS ONE			English	Article							INDOCYANINE GREEN; RESECTION; MULTIFORME; SURVIVAL; EXTENT; IDENTIFICATION; SURGERY; PERMEABILITY; ONCOLOGY; GLIOMA	Introduction Fluorescence-guided surgery has emerged as a powerful tool to detect, localize and resect tumors in the operative setting. Our laboratory has pioneered a novel way to administer an FDA-approved near-infrared (NIR) contrast agent to help surgeons with this task. This technique, coined Second Window ICG, exploits the natural permeability of tumor vasculature and its poor clearance to deliver high doses of indocyanine green (ICG) to tumors. This technique differs substantially from established ICG video angiography techniques that visualize ICG within minutes of injection. We hypothesized that Second Window ICG can provide NIR optical contrast with good signal characteristics in intracranial brain tumors over a longer period of time than previously appreciated with ICG video angiography alone. We tested this hypothesis in an intracranial mouse glioblastoma model, and corroborated this in a human clinical trial. Methods Intracranial tumors were established in 20 mice using the U251-Luc-GFP cell line. Successful grafts were confirmed with bioluminescence. Intravenous tail vein injections of 5.0 mg/kg (high dose) or 2.5 mg/kg (low dose) ICG were performed. The Perkin Elmer IVIS Spectrum (closed field) was used to visualize NIR fluorescence signal at seven delayed time points following ICG injection. NIR signals were quantified using LivingImage software. Based on the success of our results, human subjects were recruited to a clinical trial and intravenously injected with high dose 5.0 mg/kg. Imaging was performed with the VisionSense Iridium (open field) during surgery one day after ICG injection. Results In the murine model, the NIR signal-to-background ratio (SBR) in gliomas peaks at one hour after infusion, then plateaus and remains strong and stable for at least 48 hours. Higher dose 5.0 mg/kg improves NIR signal as compared to lower dose at 2.5 mg/kg (SBR = 3.5 vs. 2.8; P = 0.0624). Although early (<= 6 hrs) visualization of the Second Window ICG accumulation in gliomas is stronger than late (>= 24 hrs) visualization (SBR = 3.94 vs. 2.32; p< 0.05) there appears to be a long plateau period of stable ICG NIR signal accumulation within tumors in the murine model. We call this long plateau period the "Second Window" of ICG. In glioblastoma patients, the delayed visualization of intratumoral NIR signal was strong (SBR 7.50 +/- 0.74), without any significant difference within the 19 to 30 hour visualization window (R-2 = 0.019). Conclusion The Second Window ICG technique allows neurosurgeons to deliver NIR optical contrast agent to human glioblastoma patients, thus providing real-time tumor identification in the operating room. This nonspecific tumor accumulation of ICG within the tumor provides strong signal to background contrast, and is not significantly time dependent between 6 hours to 48 hours, providing a broad plateau for stable visualization. This finding suggests that optimal imaging of the "Second Window of ICG" may be within this plateau period, thus providing signal uniformity across subjects.	[Zeh, Ryan; Pierce, John; Lee, John Y. K.] Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Zeh, Ryan; Xia, Leilei; Pierce, John; Newton, Andrew; Predina, Jarrod; Singhai, Sunil; Lee, John Y. K.] Hosp Univ Penn, Ctr Precis Surg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Sheikh, Saad; Dorsey, Jay] Hosp Univ Penn, Dept Radiat Oncol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Xia, Leilei; Newton, Andrew; Predina, Jarrod; Singhai, Sunil] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA; [Nasrallah, MacLean] Hosp Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, JYK (corresponding author), Hosp Univ Penn, Dept Neurosurg, 3400 Spruce St, Philadelphia, PA 19104 USA.; Lee, JYK (corresponding author), Hosp Univ Penn, Ctr Precis Surg, 3400 Spruce St, Philadelphia, PA 19104 USA.	leejohn@uphs.upenn.edu			National Institutes of Health [R01 CA193556]; Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania (JYKL); National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000003]; NATIONAL CANCER INSTITUTE [R01CA181429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania (JYKL); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by the National Institutes of Health R01 CA193556 (SS), and the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania (JYKL). In addition, research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000003 (JKYL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan S, 2011, Asian J Neurosurg, V6, P88, DOI 10.4103/1793-5482.92168; Baumann BC, 2012, JOVE-J VIS EXP, DOI 10.3791/4089; Bloch O, 2012, J NEUROSURG, V117, P1032, DOI 10.3171/2012.9.JNS12504; Chen B, 2012, INT J MED SCI, V9, P708, DOI 10.7150/ijms.4843; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Hardesty Douglas A, 2012, Front Neurol, V3, P140, DOI 10.3389/fneur.2012.00140; Jiang JX, 2015, AM J NUCL MED MOLEC, V5, P390; Keating J, 2017, ANN THORAC SURG, V103, P390, DOI 10.1016/j.athoracsur.2016.08.079; Keating J, 2016, J SURG ONCOL, V113, P508, DOI 10.1002/jso.24167; Keating J, 2016, BMC MED IMAGING, V16, DOI 10.1186/s12880-016-0120-5; Keating JJ, 2015, J THORAC CARDIOV SUR, V149, pE51, DOI 10.1016/j.jtcvs.2014.10.081; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lee JYK, 2016, NEUROSURGERY, V79, P856, DOI 10.1227/NEU.0000000000001450; Luo SL, 2011, BIOMATERIALS, V32, P7127, DOI 10.1016/j.biomaterials.2011.06.024; Madajewski B, 2012, CLIN CANCER RES, V18, P5741, DOI 10.1158/1078-0432.CCR-12-1188; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Newton AD, 2016, J THORAC DIS, V8, pS697, DOI 10.21037/jtd.2016.09.50; Okusanya OT, 2014, ANN THORAC SURG, V98, P1223, DOI 10.1016/j.athoracsur.2014.05.026; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; SIMPSON JR, 1993, INT J RADIAT ONCOL, V26, P239, DOI 10.1016/0360-3016(93)90203-8; Singhal S, 2010, ANNU REV MED, V61, P359, DOI 10.1146/annurev.med.60.052907.094936; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, p[564, 76]; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275	26	61	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0182034	10.1371/journal.pone.0182034	http://dx.doi.org/10.1371/journal.pone.0182034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738091	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700093
J	Gong, XM; Marisiddaiah, R; Rubin, LP				Gong, Xiaoming; Marisiddaiah, Raju; Rubin, Lewis P.			Inhibition of pulmonary beta-carotene 15, 15'-oxygenase expression by glucocorticoid involves PPAR alpha	PLOS ONE			English	Article							VITAMIN-A SUPPLEMENTATION; RETINOIC ACID; 15,15'-MONOOXYGENASE GENE; DEXAMETHASONE TREATMENT; ALVEOLUS FORMATION; LIPID-METABOLISM; CRITICAL PERIOD; PERINATAL RAT; LUNG; DEFICIENCY	beta-carotene 15,15'-oxygenase (BCO1) catalyzes the first step in the conversion of dietary provitamin A carotenoids to vitamin A. This enzyme is expressed in a variety of developing and adult tissues, suggesting that its activity may regulate local retinoid synthesis. Vitamin A and related compounds (retinoids) are critical regulators of lung epithelial development, integrity, and injury repair. A balance between the actions of retinoids and glucocorticoids (GCs) promotes normal lung development and, in particular, alveolarization. Alterations in this balance, including vitamin A deficiency and GC excess, contribute to the development of chronic lung disorders. Consequently, we investigated if GCs counteract retinoid effects in alveolar epithelial cells by mechanisms involving BCO1-dependent local vitamin A metabolism. We demonstrate that BCO1 is expressed in human fetal lung tissue and human alveolar epithelial-like A549 cells. Our results indicate A549 cells metabolize beta-carotene to retinal and retinoic acid (RA). GCs exposure using dexamethasone (DEX) decreases BCO1 mRNA and protein levels in A549 cells and reduces BCO1 promoter activity via inhibiting peroxisome proliferator-activated receptor. (PPAR alpha) DNA binding. DEX also induces expression of PPAR alpha, which in turn most likely causes a decrease in PPAR gamma/RXR alpha heterodimer binding to the bco1 gene promoter and consequent inhibition of bco1 gene expression. PPARa knockdown with siRNA abolishes DEX-induced suppression of BCO1 expression, confirming the requirement for PPAR alpha in this DEX-mediated BCO1 mechanism. Taken together, these findings provide the first evidence that GCs regulate vitamin A (retinoid) signaling via inhibition of bco1 gene expression in a PPAR alpha-dependent manner. These results explicate novel aspects of local GC: retinoid interactions that may contribute to alveolar tissue remodeling in chronic lung diseases that affect children and, possibly, adults.	[Gong, Xiaoming; Rubin, Lewis P.] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Paul L Foster Sch Med, El Paso, TX 79905 USA; [Marisiddaiah, Raju] All Childrens Res Inst, St Petersburg, FL USA; [Rubin, Lewis P.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University	Gong, XM; Rubin, LP (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Paul L Foster Sch Med, El Paso, TX 79905 USA.; Rubin, LP (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Paul L Foster Sch Med, El Paso, TX 79905 USA.	xiaoming.gong@ttuhsc.edu; Lewis.rubin@ttuhsc.edu		Gong, Xiaoming/0000-0003-1560-5611	National Institutes of Health [HD42174, RR18722]; Muma Family Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muma Family Foundation	This work was supported, in part, by grants from National Institutes of Health (HD42174 and RR18722) and from the Muma Family Foundation.	Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644; Bachmann H, 2002, J NUTR, P132; Baskaran V, 2003, LIPIDS, V38, P705, DOI 10.1007/s11745-003-1118-5; Baybutt RC, 2000, J NUTR, V130, P1159, DOI 10.1093/jn/130.5.1159; Baybutt RC, 2007, VITAM HORM, V75, P385, DOI 10.1016/S0083-6729(06)75014-2; Becker J, 2008, PULM PHARMACOL THER, V21, P324, DOI 10.1016/j.pupt.2007.08.001; Bompart G, 2001, EUR J PHARMACOL, V415, P19, DOI 10.1016/S0014-2999(01)00828-7; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Burri BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P110, DOI 10.1016/j.abb.2004.04.028; Chan LSA, 2009, PPAR RES, V2009, DOI 10.1155/2009/925309; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Cuzzocrea S, 2008, MOL PHARMACOL, V73, P323, DOI 10.1124/mol.107.041475; Dirami G, 2004, AM J PHYSIOL-LUNG C, V286, pL249, DOI 10.1152/ajplung.00140.2003; During A, 1998, BIOCHEM BIOPH RES CO, V249, P467, DOI 10.1006/bbrc.1998.9160; Frey G, 2004, BIOL NEONATE, V86, P259, DOI 10.1159/000079983; GEEVARGHESE SK, 1994, BIOCHEM BIOPH RES CO, V200, P529, DOI 10.1006/bbrc.1994.1480; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Gong XM, 2013, ARCH BIOCHEM BIOPHYS, V539, P230, DOI 10.1016/j.abb.2013.09.013; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hind M, 2004, EUR RESPIR J, V23, P20, DOI 10.1183/09031936.03.00119103; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kim YK, 2015, ARCH BIOCHEM BIOPHYS, V572, P11, DOI 10.1016/j.abb.2015.01.002; Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; Lasa M, 2001, MOL CELL BIOL, V21, P771, DOI 10.1128/MCB.21.3.771-780.2001; LEMBERGER T, 1994, J BIOL CHEM, V269, P24527; Lemke SL, 2003, J LIPID RES, V44, P1591, DOI 10.1194/jlr.M300116-JLR200; Lietz G, 2012, MOL NUTR FOOD RES, V56, P241, DOI 10.1002/mnfr.201100387; Lindqvist A, 2004, J HISTOCHEM CYTOCHEM, V52, P491, DOI 10.1177/002215540405200407; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; Maden M, 2004, CURR TOP DEV BIOL, V61, P153, DOI 10.1016/S0070-2153(04)61007-6; Maden M, 2004, PHILOS T R SOC B, V359, P799, DOI 10.1098/rstb.2004.1470; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL715, DOI 10.1152/ajplung.00166.2004; Massaro D, 2003, AM J RESP CELL MOL, V28, P271, DOI 10.1165/rcmb.F263; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Massaro GD, 1997, NAT MED, V3, P675, DOI 10.1038/nm0697-675; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305, DOI 10.1152/ajplung.1996.270.2.L305; MCGOWAN SE, 1995, AM J PHYSIOL-LUNG C, V269, pL463, DOI 10.1152/ajplung.1995.269.4.L463; Mollard R, 2000, INT J DEV BIOL, V44, P457; NG PC, 1993, ARCH DIS CHILD-FETAL, V68, P330, DOI 10.1136/adc.68.3_Spec_No.330; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; SHENAI JP, 1981, J PEDIATR-US, V99, P302, DOI 10.1016/S0022-3476(81)80484-2; SHENAI JP, 1994, INT J VITAM NUTR RES, V64, P93; SHENAI JP, 1985, PEDIATR RES, V19, P185, DOI 10.1203/00006450-198502000-00007; Sugawara T, 2001, J NUTR, V131, P2921, DOI 10.1093/jn/131.11.2921; Takitani K, 2006, EUR J NUTR, V45, P320, DOI 10.1007/s00394-006-0601-3; Tyson JE, 1999, NEW ENGL J MED, V340, P1962, DOI 10.1056/NEJM199906243402505; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521	52	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7								10.1371/journal.pone.0181466	http://dx.doi.org/10.1371/journal.pone.0181466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732066	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100037
J	Hasegawa, S; Matsui, T; Hane, Y; Abe, J; Hatahira, H; Motooka, Y; Sasaoka, S; Fukuda, A; Naganuma, M; Hirade, K; Takahashi, Y; Kinosada, Y; Nakamura, M				Hasegawa, Shiori; Matsui, Toshinobu; Hane, Yuuki; Abe, Junko; Hatahira, Haruna; Motooka, Yumi; Sasaoka, Sayaka; Fukuda, Akiho; Naganuma, Misa; Hirade, Kouseki; Takahashi, Yukiko; Kinosada, Yasutomi; Nakamura, Mitsuhiro			Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database	PLOS ONE			English	Article							ORAL-CONTRACEPTIVE USE; VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; SIGNAL-DETECTION; ODDS RATIO; RISK; THROMBOSIS; ASSOCIATION; SYSTEM; WOMEN	Combined estrogen-progestin preparations (CEPs) are associated with thromboembolic (TE) side effects. The aim of this study was to evaluate the incidence of TE using the Japanese Adverse Drug Event Report (JADER) database. Adverse events recorded from April 2004 to November 2014 in the JADER database were obtained from the Pharmaceuticals and Medical Devices Agency (PMDA) website (www.pmda.go.jp). We calculated the reporting odds ratios (RORs) of suspected CEPs, analyzed the time-to-onset profile, and assessed the hazard type using Weibull shape parameter (WSP). Furthermore, we used the applied association rule mining technique to discover undetected relationships such as the possible risk factors. The total number of reported cases in the JADER contained was 338,224. The RORs (95% confidential interval, CI) of drospirenone combined with ethinyl estradiol (EE, Dro-EE), norethisterone with EE (Ne-EE), levonorgestrel with EE (Lev-EE), desogestrel with EE (Des-EE), and norgestrel with EE (Nor-EE) were 56.2 (44.3-71.4), 29.1 (23.5-35.9), 42.9 (32.3-57.0), 44.7 (32.7-61.1), and 38.6 (26.3-56.7), respectively. The medians (25%-75%) of the time-to-onset of Dro-EE, Ne-EE, Lev-EE, Des-EE, and Nor-EE were 150.0 (75.3-314.0), 128.0 (27.0-279.0), 204.0 (44.0-660.0), 142.0 (41.3-344.0), and 16.5 (8.8-32.0) days, respectively. The 95% CIs of the WSP-beta for Ne-EE, Lev-EE, and Nor-EE were lower and excluded 1. Association rule mining indicated that patients with anemia had a potential risk of developing a TE when using CEPs. Our results suggest that it is important to monitor patients administered CEP for TE. Careful observation is recommended, especially for those using Nor-EE, and this information may be useful for efficient therapeutic planning.	[Hasegawa, Shiori; Matsui, Toshinobu; Hane, Yuuki; Abe, Junko; Hatahira, Haruna; Motooka, Yumi; Sasaoka, Sayaka; Fukuda, Akiho; Naganuma, Misa; Nakamura, Mitsuhiro] Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Japan; [Abe, Junko] Med Database Co Ltd, Shibuya Ku, Tokyo, Japan; [Hirade, Kouseki] Kizawa Mem Hosp, Gifu, Japan; [Takahashi, Yukiko] Gifu Univ, Sch Med, Crit Care & Surg Nursing, Gifu, Japan; [Kinosada, Yasutomi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu Pharmaceutical University; Gifu University; Gifu University	Nakamura, M (corresponding author), Gifu Pharmaceut Univ, Lab Drug Informat, Gifu, Japan.	mnakamura@gifu-pu.ac.jp		Hirade, Kouseki/0000-0001-8367-602X; Hasegawa, Shiori/0000-0003-0444-7945; Nakamura, Mitsuhiro/0000-0002-5062-5522	JSPS KAKENHI [24390126, 17K08452]; Grants-in-Aid for Scientific Research [17K08452] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by JSPS KAKENHI Grant Number, 24390126 and 17K08452. JA was an employee of Medical Database Co., LTD during the time of the study and received a salary. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe J, 2015, STEVENS JOHNSON SYND, P277; Abe J, 2016, J PHARM HEALTH CARE, V2, DOI 10.1186/s40780-016-0048-5; Abe J, 2015, INT J MED SCI, V12, P312, DOI 10.7150/ijms.10703; Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case- control study, 1997, LANCET, V349, P1202; Agrawal R., 1994, P 20 INT C VER LARG, P487; [Anonymous], 2014, INTRO GUIDE STANDARD; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Bateson D, 2016, AUST FAM PHYSICIAN, V45, P59; Bloemenkamp KWM, 2000, ARCH INTERN MED, V160, P49, DOI 10.1001/archinte.160.1.49; Borgelt C, 2005, P 1 INT WORKSHOP OPE, P1, DOI DOI 10.1145/1133905.1133907; Canonico M, 2008, BMJ-BRIT MED J, V336, P1227, DOI 10.1136/bmj.39555.441944.BE; Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x; Committee on Gynecologic Practice, 2012, Obstet Gynecol, V120, P1239, DOI http://10.1097/AOG.0b013e318277c93b; Cornelius VR, 2012, DRUG SAFETY, V35, P599, DOI 10.2165/11599740-000000000-00000; Coutinho JM, 2015, STROKE, V46, P2735, DOI 10.1161/STROKEAHA.115.009843; CROFT P, 1989, BRIT MED J, V298, P165, DOI 10.1136/bmj.298.6667.165; DuMouchel W., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P67, DOI 10.1145/502512.502526; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; FARLEY TMM, 1995, LANCET, V346, P1582; Fujiwara M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154425; Gupta S HP, 1999, INSERTED J FAMILY PL; Hahsler M., 2005, J STAT SOFTW, V14, P1, DOI DOI 10.18637/JSS.V014.I15; Han JW, 2000, SIGMOD RECORD, V29, P1; Harpaz R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S7; Heinemann K, 2011, J FAM PLAN REPROD H, V37, P132, DOI 10.1136/jfprhc-2011-14524; Holt VL, 2002, OBSTET GYNECOL, V99, P820, DOI 10.1016/S0029-7844(02)01939-7; Hugon-Rodin J, 2014, EUR J ENDOCRINOL, V171, pR221, DOI 10.1530/EJE-14-0527; Jick H, 2000, BMJ-BRIT MED J, V321, P1190, DOI 10.1136/bmj.321.7270.1190; Kahn SR, 2002, BLOOD REV, V16, P155, DOI 10.1016/S0268-960X(02)00008-5; Khader YS, 2003, CONTRACEPTION, V68, P11, DOI 10.1016/S0010-7824(03)00073-8; Kurth T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2610; Lidegaard O, 2002, CONTRACEPTION, V65, P187, DOI 10.1016/S0010-7824(01)00307-9; Lidegaard O, 2012, NEW ENGL J MED, V366, P2257, DOI 10.1056/NEJMoa1111840; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lidegaard Ojvind, 2009, BMJ, V339, pb2890, DOI 10.1136/bmj.b2890; Margolis KL, 2007, FERTIL STERIL, V88, P310, DOI 10.1016/j.fertnstert.2006.11.206; Matsui T, 2017, INT J MED SCI, V14, P102, DOI 10.7150/ijms.17025; Meissner MH, 2012, J VASC SURG, V55, P1449, DOI 10.1016/j.jvs.2011.12.081; Nakamura M, 2015, J PHARM HEALTH CARE, V1, DOI 10.1186/s40780-015-0035-2; Nightingale A L, 2000, Eur J Contracept Reprod Health Care, V5, P265, DOI 10.1080/13625180008500402; Nomura K, 2015, DRUG DES DEV THER, V9, P3031, DOI 10.2147/DDDT.S81998; Odlind V, 2002, ACTA OBSTET GYN SCAN, V81, P482, DOI 10.1034/j.1600-0412.2002.810603.x; Petitti DB, 2003, NEW ENGL J MED, V349, P1443, DOI 10.1056/NEJMcp030751; Poluzzi E, 2012, DATA MINING APPLICATIONS IN ENGINEERING AND MEDICINE, P265, DOI 10.5772/50095; Pomp ER, 2008, J THROMB HAEMOST, V6, P632, DOI 10.1111/j.1538-7836.2008.02921.x; Pomp ER, 2008, AM J HEMATOL, V83, P97, DOI 10.1002/ajh.21059; Pomp ER, 2007, BRIT J HAEMATOL, V139, P289, DOI 10.1111/j.1365-2141.2007.06780.x; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 1996, LANCET, V348, P498; Rosendaal FR, 2003, J THROMB HAEMOST, V1, P1371, DOI 10.1046/j.1538-7836.2003.00264.x; Rothman KJ, 2004, PHARMACOEPIDEM DR S, V13, P519, DOI 10.1002/pds.1001; Said AM, 2009, INT J COMPUT SCI NET, V9, P266; Sasaoka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164309; Sauzet O, 2013, DRUG SAFETY, V36, P995, DOI 10.1007/s40264-013-0061-7; Sidney S, 2004, CONTRACEPTION, V70, P3, DOI 10.1016/j.contraception.2004.02.010; Sonalkar S, 2000, CONTRACEPTION; Stocco B, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000385; Suissa S, 1997, CONTRACEPTION, V56, P141, DOI 10.1016/S0010-7824(97)00119-4; Suzuki Y, 2015, BIOL PHARM BULL, V38, P680, DOI 10.1248/bpb.b14-00191; Szarfman A, 2002, DRUG SAFETY, V25, P381, DOI 10.2165/00002018-200225060-00001; Ueda N, 2015, BIOL PHARM BULL, V38, P1638, DOI 10.1248/bpb.b15-00253; Umetsu R, 2015, BIOL PHARM BULL, V38, P1689, DOI 10.1248/bpb.b15-00243; Umetsu R, 2014, YAKUGAKU ZASSHI, V134, P299, DOI 10.1248/yakushi.13-00225; van der Heijden PGM, 2002, STAT MED, V21, P2027, DOI 10.1002/sim.1157; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; Vessey M, 2003, LANCET, V362, P185, DOI 10.1016/S0140-6736(03)13907-4; Vinogradova Y, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2135; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921; Walker AM, 1998, CONTRACEPTION, V57, P169, DOI 10.1016/S0010-7824(98)00014-6; Waller P, 2004, PHARMACOEPIDEM DR S, V13, P525, DOI 10.1002/pds.1002; Wu B, 2008, THIRD 2008 INTERNATIONAL CONFERENCE ON CONVERGENCE AND HYBRID INFORMATION TECHNOLOGY, VOL 1, PROCEEDINGS, P1099, DOI 10.1109/ICCIT.2008.109; Yang L, 2009, STROKE, V40, P1050, DOI 10.1161/STROKEAHA.108.531913; Yildirim P, 2015, APPL CLIN INFORM, V6, P728, DOI 10.4338/ACI-2015-06-RA-0076; Zaki M. J., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P283; Zhu Ai -Ling, 2003, AMIA Annu Symp Proc, P758	75	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0182045	10.1371/journal.pone.0182045	http://dx.doi.org/10.1371/journal.pone.0182045			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732067	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100074
J	Park, JE; Ryu, KH; Kim, HS; Kim, HW; Shim, WH; Jung, SC; Choi, CG; Kim, SJ; Kim, JH				Park, Ji Eun; Ryu, Kyoung Hwa; Kim, Ho Sung; Kim, Hyo Won; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Jeong Hoon			Perfusion of surgical cavity wall enhancement in early post-treatment MR imaging may stratify the time-to-progression in glioblastoma	PLOS ONE			English	Article							SPIN-LABELING PERFUSION; BLOOD-FLOW; CANCER; NORMALIZATION; VASCULATURE; BEVACIZUMAB; SURVIVAL; THERAPY; TUMORS; HEAD	Objective To determine if perfusion in surgical cavity wall enhancement (SCWE) obtained in early post-treatment MR imaging can stratify time-to-progression (TTP) in glioblastoma. Materials and methods This study enrolled 60 glioblastoma patients with more than 5-mm-thick SCWEs as detected on contrast-enhanced MR imaging after concurrent chemoradiation therapy. Two independent readers categorized the shape and perfusion state of SCWEs as nodular or non-nodular and as having positive or negative perfusion compared with the contralateral grey matter on arterial spin labeling (ASL). The perfusion fraction on ASL within the contrast-enhancing lesion was calculated. The independent predictability of TTP was analyzed using the Kaplan-Meier method and Cox proportional hazards modelling. Results The perfusion fraction was higher in the non-progression group, significantly for reader 2 (P = 0.03) and borderline significantly for reader 1 (P = 0.08). A positive perfusion state and (P = 0.02) a higher perfusion fraction of the SCWE were found to become an independent predictor of longer TTP (P = 0.001 for reader 1 and P < 0.001 for reader 2). The contrast enhancement pattern did not become a TTP predictor. Conclusion Assessment of perfusion in early post-treatment MR imaging can stratify TTP in patients with glioblastoma for adjuvant temozolomide therapy. Positive perfusion in SCWEs can become a predictor of a longer TTP.	[Park, Ji Eun; Kim, Ho Sung; Kim, Hyo Won; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Ji Eun; Kim, Ho Sung; Kim, Hyo Won; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Ryu, Kyoung Hwa] Gyeongsang Natl Univ, Changwon Hosp, Sch Med, Dept Radiol, Chang Won, South Korea; [Kim, Jeong Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurosurg, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Gyeongsang National University; University of Ulsan; Asan Medical Center	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, HS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.	radhskim@gmail.com		Kim, Ho Sung/0000-0002-9477-7421; Park, Ji Eun/0000-0002-4419-4682	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2017R1A2A2A05001217]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1090]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: NRF-2017R1A2A2A05001217) and by through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Institutional Review Board of Asan Medical Center approved this study ([http://eirb.amc.seoul.kr]: S2015-1270) and wavied the requirement for written informed consent. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant number: NRF-2017R1A2A2A05001217) and by through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1090).	BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Choi YJ, 2013, ACTA RADIOL, V54, P448, DOI 10.1177/0284185112474916; Dangouloff-Ros V, 2016, RADIOLOGY; Ekinci G, 2003, EUR J RADIOL, V45, P99, DOI 10.1016/S0720-048X(02)00027-X; Farace P, 2013, J NEURO-ONCOL, V111, P177, DOI 10.1007/s11060-012-0997-y; Goel S, 2011, PHYSIOL REV, V91, P1071, DOI 10.1152/physrev.00038.2010; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; da Cruz LCH, 2011, AM J NEURORADIOL, V32, P1978, DOI 10.3174/ajnr.A2397; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; Jiang JJ, 2014, INT J CLIN EXP PATHO, V7, P2790; KELLY PJ, 1987, MAYO CLIN PROC, V62, P450, DOI 10.1016/S0025-6196(12)65470-6; Kim BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166096; Kim C, 2017, RADIOLOGY, V282, P212, DOI 10.1148/radiol.2016152152; Majos C, 2016, EUR RADIOL, V26, P1048, DOI 10.1007/s00330-015-3914-x; Noguchi T, 2008, AM J NEURORADIOL, V29, P688, DOI 10.3174/ajnr.A0903; Peus D, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-72; Pope WB, 2011, CURR NEUROL NEUROSCI, V11, P336, DOI 10.1007/s11910-011-0179-x; Qiao XJ, 2015, AM J NEURORADIOL, V36, P672, DOI 10.3174/ajnr.A4196; Rini BI, 2010, J CLIN ONCOL, V28, P2137, DOI 10.1200/JCO.2009.26.5561; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmitt P, 2003, RADIOTHER ONCOL, V67, P27, DOI 10.1016/S0167-8140(03)00024-0; Schor-Bardach R, 2009, RADIOLOGY, V251, P731, DOI 10.1148/radiol.2521081059; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Ye J, 2016, EXP THER MED, V11, P2432, DOI 10.3892/etm.2016.3225	29	2	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181933	10.1371/journal.pone.0181933	http://dx.doi.org/10.1371/journal.pone.0181933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732091	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100071
J	Ahmad, T; Munir, A; Bhatti, SH; Aftab, M; Raza, MA				Ahmad, Tanvir; Munir, Assia; Bhatti, Sajjad Haider; Aftab, Muhammad; Raza, Muhammad Ali			Survival analysis of heart failure patients: A case study	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; RISK PREDICTION; TERM MORTALITY; TRIAL; MODEL	This study was focused on survival analysis of heart failure patients who were admitted to Institute of Cardiology and Allied hospital Faisalabad-Pakistan during April-December (2015). All the patients were aged 40 years or above, having left ventricular systolic dysfunction, belonging to NYHA class III and IV. Cox regression was used to model mortality considering age, ejection fraction, serum creatinine, serum sodium, anemia, platelets, creatinine phosphokinase, blood pressure, gender, diabetes and smoking status as potentially contributing for mortality. Kaplan Meier plot was used to study the general pattern of survival which showed high intensity of mortality in the initial days and then a gradual increase up to the end of study. Martingale residuals were used to assess functional form of variables. Results were validated computing calibration slope and discrimination ability of model via bootstrapping. For graphical prediction of survival probability, a nomogram was constructed. Age, renal dysfunction, blood pressure, ejection fraction and anemia were found as significant risk factors for mortality among heart failure patients.	[Ahmad, Tanvir; Munir, Assia; Bhatti, Sajjad Haider; Aftab, Muhammad; Raza, Muhammad Ali] Govt Coll Univ, Dept Stat, Faisalabad, Pakistan	Government College University Faisalabad	Bhatti, SH (corresponding author), Govt Coll Univ, Dept Stat, Faisalabad, Pakistan.	sajjad.haider@gcuf.edu.pk	Ahmad, Tanvir/AAW-4050-2020; Aftab, Muhammad/H-4918-2015; Raza, Ali/AAM-2971-2020; Aftab, Muhammad/O-5160-2019	Aftab, Muhammad/0000-0002-2465-9964; Aftab, Muhammad/0000-0002-2465-9964; , Tanvir/0000-0002-0079-0415; Bhatti, Sajjad Haider/0000-0002-3206-4565				Al-Shifa IH, 2016, CARDIAC DIS PAKISTAN; Barlera S, 2013, CIRC-HEART FAIL, V6, P31, DOI 10.1161/CIRCHEARTFAILURE.112.967828; Cheraghi M, 2010, ARYA ATHEROSCLER, V6, P111; Collett, 2003, MODELLING SURVIVAL D; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Fitrianto A., 2013, INT J MATH ANAL, V7, P2645; Gillespie B., 2006, CHECKING ASSUMPTIONS; Gustafsson F, 2004, EUR HEART J, V25, P1711, DOI 10.1016/j.ehj.2004.07.007; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA; Otero-Ravina F, 2009, INT J CARDIOL, V136, P56, DOI 10.1016/j.ijcard.2008.04.025; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Pillai HS, 2013, CURR CARDIOL REV, V9, P102, DOI 10.2174/1573403X11309020003; Rahimi K, 2014, JACC-HEART FAIL, V2, P440, DOI 10.1016/j.jchf.2014.04.008; Redondo-Bermejo B, 2007, REV ESP CARDIOL, V60, P1135, DOI 10.1157/13111785; Roman AV, 2005, REV ESP CARDIOL, V58, P1171; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Tavazzi L, 2013, CIRC-HEART FAIL, V6, P473, DOI 10.1161/CIRCHEARTFAILURE.112.000161; Varela-Roman A, 2005, EUR J HEART FAIL, V7, P859, DOI 10.1016/j.ejheart.2005.01.017; WHO, 2016, FACT SHEET ON CVDS; Yang D., 2013, P SAS GLOB FOR 2013	23	47	47	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181001	10.1371/journal.pone.0181001	http://dx.doi.org/10.1371/journal.pone.0181001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727739	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500036
J	Ray, S; Maitra, A; Biswas, A; Panjikar, S; Mondal, J; Anand, R				Ray, Shamayeeta; Maitra, Anwesha; Biswas, Anwesha; Panjikar, Santosh; Mondal, Jagannath; Anand, Ruchi			Functional insights into the mode of DNA and ligand binding of the TetR family regulator TylP from Streptomyces fradiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; TYLOSIN PRODUCTION; PROTEIN CPRB; EFFLUX PUMP; REPRESSOR; BIOSYNTHESIS; RESISTANCE; GENES; ROLES	Tetracycline repressors (TetRs) modulate multidrug efflux pathways in several pathogenic bacteria. In Streptomyces, they additionally regulate secondary metabolic pathways like antibiotic production. For instance, in the antibiotic producer Streptomyces fradiae, a layered network of TetRs regulates the levels of the commercially important antibiotic tylosin, with TylP occupying the top of this cascading network. TetRs exist in two functional states, the DNA-bound and the ligand-bound form, which are allosterically regulated. Here, to develop deeper insights into the factors that govern allostery, the crystal structure of TylP was solved to a resolution of 2.3 angstrom. The structure revealed that TylP possesses several unique features; notably, it harbors a unique C-terminal helix-loop extension that spans the entire length of the structure. This anchor connects the DNA-binding domain (DBD) with the ligand-binding domain (LBD) via a mix of positively charged and hydrogen-bonding interactions. Supporting EMSA studies with a series of Delta C truncated versions show that a systematic deletion of this region results in complete loss of DNA binding. The structure additionally revealed that TylP is markedly different in the orientation of its DBD and LBD architecture and the dimeric geometry from its hypothesized Streptomyces homologue CprB, which is a gamma-butyrolactone regulator. Rather, TylP is closer in structural design to macrolide-binding TetRs found in pathogens. Supporting molecular dynamic studies suggested that TylP binds a macrolide intermediate in the tylosin pathway. Collectively, the structure along with corroborating biochemical studies provided insights into the novel mode of regulation of TetRs in antibiotic-producing organisms.	[Ray, Shamayeeta; Maitra, Anwesha; Biswas, Anwesha; Anand, Ruchi] Indian Inst Technol, Dept Chem, Bombay 400076, Maharashtra, India; [Ray, Shamayeeta] IITB Monash Res Acad, Bombay 400076, Maharashtra, India; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Panjikar, Santosh] Australian Synchrotron, Clayton, Vic 3168, Australia; [Mondal, Jagannath] Ctr Interdisciplinary Sci, TIFR, Hyderabad, Andhra Pradesh 500075, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Anand, R (corresponding author), Indian Inst Technol, Dept Chem, Struct Biochem Lab, Mumbai 400076, Maharashtra, India.	ruchi@chem.iitb.ac.in	Panjikar, Santosh/D-2709-2012; Ray, Shamayeeta/HCH-9284-2022	Panjikar, Santosh/0000-0001-7429-3879; Anand, Ruchi/0000-0002-2045-3758; Ray, Shamayeeta/0000-0001-7906-0572	Department of Science & Technology (DST), Government of India [EMR/2015/002121]; Board of Research in Nuclear Sciences (BRNS), Government of India [37(1)/14/05/2017-BRNS/37039]; Australia-India Council grant; TIFR; DST-SERB	Department of Science & Technology (DST), Government of India(Department of Science & Technology (India)); Board of Research in Nuclear Sciences (BRNS), Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); Australia-India Council grant; TIFR; DST-SERB	This work was supported by Department of Science & Technology (DST), Government of India, Grant EMR/2015/002121, Board of Research in Nuclear Sciences (BRNS), Government of India, Grant 37(1)/14/05/2017-BRNS/37039, Australia-India Council grant, and start-up funds provided by TIFR. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ramanujan fellowship provided by DST-SERB.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bate N, 2002, MOL MICROBIOL, V43, P449, DOI 10.1046/j.1365-2958.2002.02756.x; Bate N, 1999, CHEM BIOL, V6, P617, DOI 10.1016/S1074-5521(99)80113-6; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bhukya H, 2017, J INDIAN I SCI, V97, P245, DOI 10.1007/s41745-017-0025-5; Bhukya H, 2014, NUCLEIC ACIDS RES, V42, P10122, DOI 10.1093/nar/gku587; Bignell DRD, 2007, MOL MICROBIOL, V63, P838, DOI 10.1111/j.1365-2958.2006.05541.x; Biswas A, 2014, J PHYS CHEM B, V118, P10035, DOI 10.1021/jp503589h; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHMAN SE, 1987, P NATL ACAD SCI USA, V84, P8248, DOI 10.1073/pnas.84.23.8248; Fouces R, 1999, MICROBIOL-UK, V145, P855, DOI 10.1099/13500872-145-4-855; Fujihashi M, 2014, PROTEINS, V82, P1301, DOI 10.1002/prot.24496; Hernandez A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002103; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Itou H, 2010, J MOL BIOL, V403, P174, DOI 10.1016/j.jmb.2010.07.042; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J AM CHEM SOC, V105, P1407, DOI 10.1021/ja00344a001; Le TBK, 2011, NUCLEIC ACIDS RES, V39, P9433, DOI 10.1093/nar/gkr640; Liang I., 1998, PROTEIN SCI, V7, P1884; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Natsume R, 2004, J MOL BIOL, V336, P409, DOI 10.1016/j.jmb.2003.12.040; Onaka H, 1998, MOL MICROBIOL, V28, P743, DOI 10.1046/j.1365-2958.1998.00832.x; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Premkumar L, 2007, PROTEINS, V68, P418, DOI 10.1002/prot.21436; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sengupta S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00047; Stratigopoulos G, 2002, MOL MICROBIOL, V45, P735, DOI 10.1046/j.1365-2958.2002.03044.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Veal WL, 2002, J BACTERIOL, V184, P5619, DOI 10.1128/JB.184.20.5619-5624.2002; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yamazaki H, 2000, J BACTERIOL, V182, P4596, DOI 10.1128/JB.182.16.4596-4605.2000; Zheng JT, 2009, J MOL BIOL, V387, P1250, DOI 10.1016/j.jmb.2009.02.058	41	9	12	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15301	15311		10.1074/jbc.M117.788000	http://dx.doi.org/10.1074/jbc.M117.788000			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28739805	Green Published, hybrid			2022-12-26	WOS:000410809800012
J	Du, W; Hu, JKH; Du, W; Klein, OD				Du, Wei; Hu, Jimmy Kuang-Hsien; Du, Wen; Klein, Ophir D.			Lineage tracing of epithelial cells in developing teeth reveals two strategies for building signaling centers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL ECTODERMAL RIDGE; TOOTH DEVELOPMENT; SONIC-HEDGEHOG; ENAMEL KNOT; MOUSE MOLAR; 3-DIMENSIONAL RECONSTRUCTION; FLOOR PLATE; STEM-CELLS; MORPHOGENESIS; EXPRESSION	An important event in organogenesis is the formation of signaling centers, which are clusters of growth factor-secreting cells. In the case of tooth development, sequentially formed signaling centers known as the initiation knot (IK) and the enamel knot (EK) regulate morphogenesis. However, despite the importance of signaling centers, their origin, as well as the fate of the cells composing them, remain open questions. Here, using lineage tracing of distinct epithelial populations, we found that the EK of the mouse incisor is derived de novo from a group of SRY-box 2 (Sox2)-expressing cells in the posterior half of the tooth germ. Specifically, EK progenitors are located in the posterior ventral basal layer, as demonstrated by DiI labeling of cells. Lineage tracing the formed EK with Shh(CreER), which encodes an inducible Cre recombinase under the control of the Sonic hedgehog promoter, at subsequent developmental stages showed that, once formed, some EK cells in the incisor give rise to differentiated cells, whereas in the molar, EK cells give rise to the buccal secondary EK. This work thus establishes the developmental origin as well as the fate of the EK and reveals two strategies for the emergence of serially formed signaling centers: one through de novo establishment and the other by incorporation of progeny from previously formed signaling centers.	[Du, Wei; Du, Wen] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China; [Du, Wei; Hu, Jimmy Kuang-Hsien; Du, Wen; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Du, Wei; Hu, Jimmy Kuang-Hsien; Du, Wen; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	Sichuan University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Klein, OD (corresponding author), Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94143 USA.; Klein, OD (corresponding author), Univ Calif San Francisco, Program Craniofacial Biol, San Francisco, CA 94143 USA.; Klein, OD (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.; Klein, OD (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	ophir.klein@ucsf.edu		Klein, Ophir/0000-0002-6254-7082; Hu, Jimmy/0000-0003-1035-0779; Du, Wen/0000-0002-3361-088X	National Institutes of Health [R35-DE026602]; NIDCR [F32-DE023705, K99-DE025874]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R35DE026602, K99DE025874, F32DE023705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R35-DE026602 (to O.D.K.) and F32-DE023705 and K99-DE025874 (to J.K.H.) from the NIDCR. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahtiainen L, 2016, J CELL BIOL, V214, P753, DOI 10.1083/jcb.201512074; Alexandre P, 2003, DEVELOPMENT, V130, P5331, DOI 10.1242/dev.00756; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Cho SW, 2007, DIFFERENTIATION, V75, P441, DOI 10.1111/j.1432-0436.2006.00153.x; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Coin R, 1999, INT J DEV BIOL, V43, P261; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Haara O, 2012, DEVELOPMENT, V139, P3189, DOI 10.1242/dev.079558; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hovorakova M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162523; Hovorakova M, 2013, J EXP ZOOL PART B, V320, P455, DOI 10.1002/jez.b.22522; Hovorakova M, 2011, J EXP ZOOL PART B, V316B, P347, DOI 10.1002/jez.b.21408; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jussila M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008425; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kieffer S, 1999, INT J DEV BIOL, V43, P531; Kimmel RA, 2000, GENE DEV, V14, P1377; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Le Douarin NM, 2000, CURR OPIN NEUROBIOL, V10, P23, DOI 10.1016/S0959-4388(99)00062-8; Lesot H, 1996, INT J DEV BIOL, V40, P1017; Li CY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12133; Louvi A, 2003, DEVELOPMENT, V130, P5319, DOI 10.1242/dev.00736; Matalova E, 2005, DEV DYNAM, V233, P754, DOI 10.1002/dvdy.20396; Miard S, 1999, INT J DEV BIOL, V43, P517; Mitsiadis TA, 2008, DEV BIOL, V320, P39, DOI 10.1016/j.ydbio.2008.04.006; Morita R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161336; Mucchielli ML, 1997, DEV BIOL, V189, P275, DOI 10.1006/dbio.1997.8672; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nonomura K, 2013, DEV CELL, V27, P621, DOI 10.1016/j.devcel.2013.11.015; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Peterkova R, 1996, INT J DEV BIOL, V40, P1009; Peterkova R, 2002, CONNECT TISSUE RES, V43, P120, DOI 10.1080/03008200290000745; Prochazka J, 2010, P NATL ACAD SCI USA, V107, P15497, DOI 10.1073/pnas.1002784107; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shirokova V, 2013, DEV DYNAM, V242, P593, DOI 10.1002/dvdy.23952; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Viriot L, 2000, INT J DEV BIOL, V44, P233; Wassef M, 1997, PERSPECT DEV NEUROBI, V5, P3; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001	52	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15062	15069		10.1074/jbc.M117.785923	http://dx.doi.org/10.1074/jbc.M117.785923			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28733464	Green Published, hybrid			2022-12-26	WOS:000409902100028
J	Perichart-Perera, O; Munoz-Manrique, C; Reyes-Lopez, A; Tolentino-Dolores, M; Sosa, SEY; Ramirez-Gonzalez, MC				Perichart-Perera, Otilia; Munoz-Manrique, Cinthya; Reyes-Lopez, Angelica; Tolentino-Dolores, Maricruz; Espino y Sosa, Salvador; Cristina Ramirez-Gonzalez, Ma.			Metabolic markers during pregnancy and their association with maternal and newborn weight status	PLOS ONE			English	Article							INFANT BIRTH-WEIGHT; INSULIN-RESISTANCE; LEPTIN LEVELS; FETAL-GROWTH; SERUM LEPTIN; CORD BLOOD; OBESITY; OVERWEIGHT; GLUCOSE; INFLAMMATION	Background/Aims Obesity during pregnancy increases the risk of adverse clinical outcomes and is associated with low-grade chronic inflammation. We describe maternal metabolic risk and inflammation by maternal weight status, and evaluate the association of metabolic and inflammatory markers with birthweight in a group of pregnant Mexican women. Methods This study derived from a prospective cohort of healthy pregnant women <14 weeks of gestation, receiving prenatal care at National Institute of Perinatology (Mexico, 2009-2013). Metabolic and inflammatory markers were measured in maternal serum in all three pregnancy trimesters (1st: 11.42 +/- 1.7; 2nd: 21.06 +/- 2.4; 3rd: 32.74 +/- 2.3 weeks). Pregestational weight was self-reported, and body mass index (BMI) was calculated. Gestational weight gain was evaluated in the third trimester. Newborn's weight was measured at birth. We carried out correlations, general mixed linear model and regression analyses, based on pregestational weight (self-reported), body mass index (BMI), gestational weight gain (evaluated in the third trimester) and newborn weight (measured at birth). Results Of the 177 women included in the study (mean age = 26.93 +/- 8.49), thirty-eight percent (n = 67) were overweight or had obesity, and 32.8% (n = 58) showed excessive gestational weight gain. We found insulin, lipids (including total cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides-TG), leptin and interleukin 1b (IL-1b) all increased significantly (p<0.05) during pregnancy. Pregestational maternal weight status altered longitudinal concentrations of insulin, leptin, adiponectin, TG and C reactive protein. Excessive gestational weight gain was associated with higher maternal insulin in the third trimester (p<0.05). Early pregnancy leptin and TNF alpha were determinants of birthweight in women with normal weight, but not in overweight or obese women. Conclusions Maternal weight status affected the concentrations of insulin, leptin, adiponectin, triglycer-ides and C reactive protein throughout pregnancy. The role of early leptin and TNF alpha in fetal growth need further study given the association was only observed in normal weight women. This study presents data distribution of metabolic and inflammatory markers of normal weight and overweight/obese women that did not develop GDM, preeclampsia nor macrosomia.	[Perichart-Perera, Otilia; Munoz-Manrique, Cinthya; Reyes-Lopez, Angelica; Tolentino-Dolores, Maricruz; Cristina Ramirez-Gonzalez, Ma.] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Nutr & Bioprogramming Dept, Mexico City, DF, Mexico; [Espino y Sosa, Salvador] Inst Nacl Perinatol, Clin Res Subdirect, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Perichart-Perera, O (corresponding author), Inst Nacl Perinatol Isidro Espinosa de los Reyes, Nutr & Bioprogramming Dept, Mexico City, DF, Mexico.	otiliaperichart@inper.gob.mx	Espino, Salvador/ABE-5440-2021	Espino y Sosa, Salvador/0000-0001-7276-8463	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (MEXICO); Fondo Sectorial en Salud [86840];  [08311]	CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (MEXICO)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondo Sectorial en Salud; 	This work was supported by CONSEJO NACIONAL DE CIENCIA Y TECNOLOGIA (MEXICO); Fondo Sectorial en Salud 86840. Funding for data collection, equipment and human resources; and INSTITUTO NACIONAL DE PERINATOLOGIA. Internal Funding. Laboratory analysis, data analysis and data publication. Project No. 08311.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Abell SK, 2015, INT J MOL SCI, V16, P13442, DOI 10.3390/ijms160613442; [Anonymous], 2016, DIABETES CARE, V39, pS1, DOI 10.2337/dc16-S001; Aye ILMH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116186; Bao W, 2015, METABOLISM, V64, P756, DOI 10.1016/j.metabol.2015.01.013; Barrett HL, 2014, DIABETES CARE, V37, P1484, DOI 10.2337/dc13-1934; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dimasuay K G, 2016, FRONT PHYSIOL, V29, P7, DOI DOI 10.3389/FPHYS.2016.0001; Drake AJ, 2010, REPRODUCTION, V140, P387, DOI 10.1530/REP-10-0077; Ferguson KK, 2016, AM J OBSTET GYNECOL, P46465; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Geraghty AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161206; Hull HR, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.796; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Josefson JL, 2014, HORM RES PAEDIAT, V81, P13, DOI 10.1159/000355387; Karakosta P, 2011, PAEDIATR PERINAT EP, V25, P150, DOI 10.1111/j.1365-3016.2010.01163.x; Kulkarni SR, 2013, DIABETES CARE, V36, P2706, DOI 10.2337/dc12-2445; Lau EY, 2014, J OBES, V2014, DOI 10.1155/2014/524939; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Misra VK, 2013, OBESITY, V21, P1064, DOI 10.1002/oby.20128; Misra VK, 2011, OBESITY, V19, P416, DOI 10.1038/oby.2010.172; Mossayebi E, 2014, PEDIATR NEONATOL, V55, P28, DOI 10.1016/j.pedneo.2013.05.006; Nathanielsz PW, 2013, NUTR REV, V71, pS78, DOI 10.1111/nure.12062; Norman JE, 2011, P NUTR SOC, V70, P450, DOI 10.1017/S0029665111003077; Retnakaran R, 2012, CAN MED ASSOC J, V184, P1353, DOI 10.1503/cmaj.111154; Segovia SA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/418975; Song YN, 2016, CLIN CHIM ACTA, V458, P133, DOI 10.1016/j.cca.2016.04.036; Trinder P., 1969, ANN CLIN BIOCHEM, V6, P4; vila M, 2016, ENCUESTA NACL SALUD; Walsh JM, 2014, OBESITY, V22, P1594, DOI 10.1002/oby.20753; Walsh JM, 2014, EARLY HUM DEV, V90, P271, DOI 10.1016/j.earlhumdev.2014.03.007; Westermeier F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/917672; Wilkinson AL, 2017, TROP MED INT HEALTH, V22, P52, DOI 10.1111/tmi.12799; World Health Organization, 2016, BEST START LIF; World Health Organization Expert Committee on Physical Status, 1995, TECHNICAL REPORT SER, V854	40	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180874	10.1371/journal.pone.0180874	http://dx.doi.org/10.1371/journal.pone.0180874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749954	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700021
J	Wang, WD; Gordon, JL; Philbrick, KA; Yang, XJ; Branscum, AJ; Lohr, CV; Haschek, WM; Turner, RT; Iwaniec, UT; Helferich, WG				Wang, Wendan; Gordon, Jody L.; Philbrick, Kenneth A.; Yang, Xujuan; Branscum, Adam J.; Lohr, Christiane V.; Haschek, Wanda M.; Turner, Russell T.; Iwaniec, Urszula T.; Helferich, William G.			Low calcium diet increases 4T1 mammary tumor carcinoma cell burden and bone pathology in mice	PLOS ONE			English	Article							BREAST-CARCINOMA; LYSYL OXIDASE; METASTASES; GROWTH; SUPPLEMENTATION; DEFICIENCY; RECEPTOR; RISK	Breast cancer metastasizes to bone in the majority of patients with advanced disease. We investigated the effects of inadequate dietary calcium (Ca) on bone turnover, tumor growth, and bone response to tumor in tibia inoculated with 4T1 mammary carcinoma cells. Ninemonth- old female Balb/c mice were placed on an adequate Ca (5 g/kg diet, n = 30) or low Ca (80 mg/kg diet, n = 31) diet for 14 days, then injected intratibially with 1,000 4T1 cells (transfected with luciferase for bioluminescence imaging), and sacrificed at 5, 10, or 21 days post-inoculation (n = 7-10 mice/group). Control mice (n = 6/group) were injected with carrier and sacrificed at 10 days post-inoculation. Tibiae with muscle intact were excised and evaluated by microcomputed tomography and histology. In vivo bioluminescent imaging revealed that 4T1 cells metastasized to lung. Therefore, lungs were removed for quantification of tumor. Mice fed low Ca exhibited higher bone turnover and higher tibial lesion scores than mice fed adequate Ca. Lesion severity, manifested as cortical osteolysis and periosteal woven bone formation, and tumor cell infiltration to muscle, increased with time, irrespective of diet. However, for most skeletal endpoints the rates of increase were greater in mice consuming low Ca compared to mice consuming adequate Ca. Infiltration of tumor cells into adjacent muscle, but not metastasis to lung, was also greater in mice consuming low Ca diet. The findings suggest that high bone turnover due to Ca insufficiency results in greater local mammary tumor cell growth, cortical osteolysis, woven bone formation, and invasion to muscle in mice.	[Wang, Wendan; Yang, Xujuan; Helferich, William G.] Univ Illinois, Food Sci & Human Nutr, Urbana, IL 61801 USA; [Gordon, Jody L.; Philbrick, Kenneth A.; Turner, Russell T.; Iwaniec, Urszula T.] Oregon State Univ, Coll Publ Hlth & Human Sci, Skeletal Biol Lab, Corvallis, OR 97331 USA; [Branscum, Adam J.] Oregon State Univ, Coll Publ Hlth & Human Sci, Biostat, Corvallis, OR 97331 USA; [Lohr, Christiane V.] Oregon State Univ, Coll Vet Med, Biomed Sci, Corvallis, OR 97331 USA; [Haschek, Wanda M.] Univ Illinois, Coll Vet Med, Pathobiol, Urbana, IL 61801 USA; [Turner, Russell T.; Iwaniec, Urszula T.] Oregon State Univ, Ctr Hlth Aging Res, Corvallis, OR 97331 USA	University of Illinois System; University of Illinois Urbana-Champaign; Oregon State University; Oregon State University; Oregon State University; University of Illinois System; University of Illinois Urbana-Champaign; Oregon State University	Helferich, WG (corresponding author), Univ Illinois, Food Sci & Human Nutr, Urbana, IL 61801 USA.	helferic@illinois.edu	Löhr, C. V./AAU-4902-2020	Löhr, C. V./0000-0003-3787-5583	Department of Defense Breast Cancer Research Program [W81XWH-09-1-0689 BC085882]; National Center for Complementary and Integrative Health (NCCIH) [P50AT006268]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); National Institute of Environmental Health Sciences (NIEHS) [P30 ES000210]	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Center for Complementary and Integrative Health (NCCIH); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by grant W81XWH-09-1-0689 BC085882 (WGH) from the Department of Defense Breast Cancer Research Program, grant P50AT006268 (WGH, UTI, RTT) from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS) and the National Cancer Institute (NCI), and grant P30 ES000210 (CL) from the National Institute of Environmental Health Sciences (NIEHS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCIH, ODS, NCI, NIEHS, or the National Institutes of Health.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Chen YC, 2013, INT J CANCER, V133, P2054, DOI 10.1002/ijc.28224; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Cox TR, 2016, CANCER RES, V76, P188, DOI 10.1158/0008-5472.CAN-15-2306; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; El-Haibi CP, 2012, P NATL ACAD SCI USA, V109, P17460, DOI 10.1073/pnas.1206653109; Guise TA, 2013, CELL, V154, P957, DOI 10.1016/j.cell.2013.08.020; Heaney RP, 2007, J BONE MINER RES, V22, pV25, DOI 10.1359/JBMR.07S205; Hoey RP, 2003, BRIT J CANCER, V88, P567, DOI 10.1038/sj.bjc.6600757; Holen I, 2016, CLIN EXP METASTAS, V33, P211, DOI 10.1007/s10585-015-9770-x; Iwaniec Urszula T., 2008, V447, P325, DOI 10.1007/978-1-59745-242-7_21; James JJ, 2003, BRIT J CANCER, V89, P660, DOI 10.1038/sj.bjc.6601198; KRISHNAMURTHY GT, 1977, JAMA-J AM MED ASSOC, V237, P2504, DOI 10.1001/jama.237.23.2504; Lowry MB, 2008, ENDOCRINOLOGY, V149, P5735, DOI 10.1210/en.2008-0134; Martin M, 2012, CLIN CANCER RES, V18, P4841, DOI 10.1158/1078-0432.CCR-11-3310; Mathis S, 2010, REV NEUROL-FRANCE, V166, P295, DOI 10.1016/j.neurol.2009.05.020; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nordin BEC, 1997, NUTRITION, V13, P664, DOI 10.1016/S0899-9007(97)00136-6; Ottewell PD, 2016, J BONE ONCOL, V5, P124, DOI 10.1016/j.jbo.2016.03.007; Ottewell PD, 2015, INT J CANCER, V137, P968, DOI 10.1002/ijc.29439; Plaza JA, 2008, CANCER-AM CANCER SOC, V112, P193, DOI 10.1002/cncr.23151; PRICE JE, 1994, INT J ONCOL, V5, P459; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; RADER JI, 1979, AM J PHYSIOL, V236, pE118, DOI 10.1152/ajpendo.1979.236.2.E118; Reginster JY, 2005, CURR MED RES OPIN, V21, P579, DOI 10.1185/030079905X41435; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; Rock CL, 2011, NESTLE NUTR WORKS SE, V67, P173, DOI 10.1159/000325583; Salemis Nikolaos S, 2015, Breast Dis, V35, P37, DOI 10.3233/BD-140384; Team RC, 2015, R LANG ENV STAT COMP; Tester AM, 2001, CLIN EXP METASTAS, V18, P553, DOI 10.1023/A:1011953118186; TURNER RT, 1994, ENDOCR REV, V15, P275, DOI 10.1210/er.15.3.275; Wang WD, 2016, CLIN EXP METASTAS, V33, P475, DOI 10.1007/s10585-016-9792-z; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; Zheng Y, 2007, CANCER RES, V67, P9542, DOI 10.1158/0008-5472.CAN-07-1046	35	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180886	10.1371/journal.pone.0180886	http://dx.doi.org/10.1371/journal.pone.0180886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750038	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700024
J	Zhao, L; Xu, J; Ding, JC; Liu, AM; Li, L				Zhao, Lin; Xu, Jian; Ding, Jicheng; Liu, Aimeng; Li, Liang			Direction-of-arrival estimation of multipath signals using independent component analysis and compressive sensing	PLOS ONE			English	Article							ROBUST DOA ESTIMATION; ICA	Multipath signal is often considered an interference that must be removed. The coherence between multipath and direct component makes it difficult to use conventional direction-of-arrival (DOA) estimation methods in a smart antenna system. This study demonstrates a new multipath signal DOA estimation technique. Unlike the common methods, without decoherence preprocessing, the proposed algorithm first apply a complex fast independent component analysis (cFastlCA) algorithm to obtain the steering vectors with multipath information that corresponds to each source signal. Then, according to the special structure of the obtained steering vectors and spatial sparsity of the multipath signal components, the algorithm uses the solution of the sparse signal reconstruction problem in the compressive sensing (CS) theory, and the DOA estimation of the multipath signal is translated into an l1 norm minimization problem. Finally, we search the space spectrums to acquire the DOAs for each direct component and multipath component. Comparative simulation tests and analysis prove the effectiveness of the proposed algorithm in estimation accuracy in under-determined conditions.	[Zhao, Lin; Xu, Jian; Ding, Jicheng; Liu, Aimeng; Li, Liang] Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Xu, J (corresponding author), Harbin Engn Univ, Coll Automat, Harbin, Heilongjiang, Peoples R China.	xu@hrbeu.edu.cn	Xu, Jian/AHE-8331-2022		National Natural Science Foundation of China [61304234, 61633008, 61304235]; Fundamental Research Funds for the Central Universities [HEUCFX041403]; Post-Doctoral Scientific Research Foundation, Heilongjiang Province [LBH-Q15033, LBH-Q14054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Post-Doctoral Scientific Research Foundation, Heilongjiang Province	The joint financial support from the National Natural Science Foundation of China (under grant nos. 61304234, 61633008, 61304235), the Fundamental Research Funds for the Central Universities (HEUCFX041403), and the Post-Doctoral Scientific Research Foundation, Heilongjiang Province (LBH-Q15033 and LBH-Q14054) is gratefully acknowledged.	Al-Ardi EM, 2005, IEEE INT SYMP CIRC S, P3805, DOI 10.1109/ISCAS.2005.1465459; Amari S, 1996, ADV NEUR IN, V8, P757; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bilik I, 2011, IEEE T AERO ELEC SYS, V47, P1754, DOI 10.1109/TAES.2011.5937263; Bingham E, 2000, Int J Neural Syst, V10, P1, DOI 10.1142/S0129065700000028; Bingham E, 2000, IEEE IJCNN, P357, DOI 10.1109/IJCNN.2000.861330; Blunt SD, 2011, IEEE T AERO ELEC SYS, V47, P332, DOI 10.1109/TAES.2011.5705679; Candes E, 2005, I1 MAGIC RECOVERY SP, V4, P46; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; CARDOSO JF, 1993, IEE PROC-F, V140, P362, DOI 10.1049/ip-f-2.1993.0054; Chang AC, 2007, WIRELESS PERS COMMUN, V43, P1435, DOI 10.1007/s11277-007-9317-9; Chen J, 2006, IEEE T SIGNAL PROCES, V54, P4634, DOI 10.1109/TSP.2006.881263; Chen SW, 2009, NEURAL COMPUT APPL, V18, P381, DOI 10.1007/s00521-008-0189-z; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; CHEN YM, 1991, IEEE T SIGNAL PROCES, V39, P194, DOI 10.1109/78.80780; Chi YJ, 2011, IEEE T SIGNAL PROCES, V59, P2182, DOI 10.1109/TSP.2011.2112650; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; HAMZA R, 1994, IEEE T SIGNAL PROCES, V42, P2520, DOI 10.1109/78.317877; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Hyvarinen A., 1997, AC SPEECH SIGN PROC, P5; Kim J.M., 2010, ARXIV10044398; Li X, 2013, APPL ACOUST, V74, P926, DOI 10.1016/j.apacoust.2013.01.005; LINEBARGER DA, 1994, IEEE T SIGNAL PROCES, V42, P2136, DOI 10.1109/78.301848; Ma GW, 2014, SIGNAL IMAGE VIDEO P, V8, P543, DOI 10.1007/s11760-013-0553-z; Malioutov D, 2005, IEEE T SIGNAL PROCES, V53, P3010, DOI 10.1109/TSP.2005.850882; PILLAI SU, 1989, IEEE T ACOUST SPEECH, V37, P8, DOI 10.1109/29.17496; ROY R, 1986, IEEE T ACOUST SPEECH, V34, P1340, DOI 10.1109/TASSP.1986.1164935; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; SHAN TJ, 1985, IEEE T ACOUST SPEECH, V33, P806, DOI 10.1109/TASSP.1985.1164649; Wang X, 2013, NEUROCOMPUTING, V101, P204, DOI 10.1016/j.neucom.2012.09.003; Zhang Y, 2011, J ELECTROMAGNET WAVE, V25, P1081, DOI 10.1163/156939311795762024; Zhang Y, 2014, COMPUTATIONAL MATH M; Zhang YD, 2015, INFORM SCIENCES, V322, P115, DOI 10.1016/j.ins.2015.06.017; Zhao L., 2009, ICA ALGORITHM ITS AP; Zhu W, 2015, MULTIDIM SYST SIGN P, V26, P113, DOI 10.1007/s11045-013-0239-2; Zou X, 2010, J ELECT COMPUTER ENG, V2010, P36	37	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181838	10.1371/journal.pone.0181838	http://dx.doi.org/10.1371/journal.pone.0181838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749995	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700087
J	Canepa, A; Fuentes, V; Bosch-Belmar, M; Acevedo, M; Toledo-Guedes, K; Ortiz, A; Dura, E; Bordehore, C; Gili, JM				Canepa, Antonio; Fuentes, Veronica; Bosch-Belmar, Mar; Acevedo, Melissa; Toledo-Guedes, Kilian; Ortiz, Antonio; Dura, Elia; Bordehore, Cesar; Gili, Josep-Maria			Environmental factors influencing the spatiotemporal distribution of Carybdea marsupialis (Lineo, 1978, Cubozoa) in South-Western Mediterranean coasts	PLOS ONE			English	Article							CHIRONEX-FLECKERI; TEMPORAL VARIATIONS; CNIDARIA CUBOZOA; JELLYFISH; ECOLOGY; SEA; PROLIFERATIONS; ZOOPLANKTON; DYNAMICS; PATTERNS	Jellyfish blooms cause important ecological and socio-economic problems. Among jellyfish, cubozoans are infamous for their painful, sometimes deadly, stings and are a major public concern in tropical to subtropical areas; however, there is little information about the possible causes of their outbreaks. After a bloom of the cubomedusa Carybdea marsupialis (Carybdeidae) along the coast of Denia (SW Mediterranean, Spain) in 2008 with negative consequences for local tourism, the necessity to understand the ecological restrictions on medusae abundance was evident. Here we use different models (GAM and zero-inflated models) to understand the environmental and human related factors influencing the abundance and distribution of C. marsupialis along the coast of Denia. Selected variables differed among medusae size classes, showing different environmental restriction associated to the developmental stages of the species. Variables implicated with dispersion (e.g. wind and current) affected mostly small and medium size classes. Sea surface temperature, salinity and proxies of primary production (chl a, phosphates, nitrates) were related to the abundances of small and large size classes, highlighting the roles of springtime salinity changes and increased primary production that may promote and maintain high densities of this species. The increased primary (and secondary) production due to anthropogenic impact is implicated as the factor enabling high numbers of C. marsupialis to thrive. Recommendations for monitoring blooms of this species along the study area and applicable to Mediterranean Sea include focus effort in coastal waters where productivity have been enriched by anthropogenic activities.	[Canepa, Antonio] Pontificia Univ Catolica Valparaiso, Escuela Ciencias Mar, Valparaiso, Chile; [Canepa, Antonio; Fuentes, Veronica; Acevedo, Melissa; Gili, Josep-Maria] CSIC, Inst Ciencies Mar, Marine Biol & Oceanog Dept, Barcelona, Spain; [Bosch-Belmar, Mar] Univ Salento, Dipartimento Sci & Tecnol Biol & Ambientali, Lecce, Italy; [Toledo-Guedes, Kilian] Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain; [Ortiz, Antonio; Dura, Elia; Bordehore, Cesar] Univ Alicante, Dept Ecol, Alicante, Spain; [Ortiz, Antonio; Dura, Elia; Bordehore, Cesar] Univ Alicante, Inst Multidisciplinar Estudio Medio Ramon Margale, Alicante, Spain	Pontificia Universidad Catolica de Valparaiso; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Salento; Universitat d'Alacant; Universitat d'Alacant; Universitat d'Alacant	Canepa, A (corresponding author), Pontificia Univ Catolica Valparaiso, Escuela Ciencias Mar, Valparaiso, Chile.; Canepa, A (corresponding author), CSIC, Inst Ciencies Mar, Marine Biol & Oceanog Dept, Barcelona, Spain.	antoniacanepa@pucv.cl	Bordehore, Cesar/H-2773-2014; Toledo-Guedes, Kilian/N-7802-2015; Canepa, Antonio/R-5260-2018	Bordehore, Cesar/0000-0002-2816-0538; Toledo-Guedes, Kilian/0000-0002-6819-1902; Canepa, Antonio/0000-0002-0608-2743; Bosch Belmar, Maria del Mar/0000-0002-1712-5745	European Commission LIFE program [LIFE08 NAT ES 64 CUBOMED]; Fundacion Biodiversidad; Ministerio de Agricultura; Alimentacion y Medio Ambiente; Generalitat Valenciana; O.A. Parques Nacionales of Spain	European Commission LIFE program; Fundacion Biodiversidad(European Commission); Ministerio de Agricultura; Alimentacion y Medio Ambiente; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); O.A. Parques Nacionales of Spain	This study was conducted with the support of the European Commission LIFE program (LIFE08 NAT ES 64 CUBOMED) with the support of the following Spanish public institutions: Fundacion Biodiversidad, Ministerio de Agricultura, Alimentacion y Medio Ambiente, Generalitat Valenciana, and O.A. Parques Nacionales of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted with the support of the European Commission LIFE program (LIFE08 NAT ES 64 CUBOMED) with the support of the following Spanish public institutions: Fundacion Biodiversidad, Ministerio de Agricultura, Alimentacion y Medio Ambiente, Generalitat Valenciana, and O. A. Parques Nacionales of Spain. We also are grateful for the collaboration of Balearia Foundation and the Marina El Portet de Denia-Licuas. This research has been conducted partially in Montgo A Research Station in Denia, Alicante. The authors thanks Mr. Isidro Rico for field and laboratory assistance and especially thank to Dr. Jennifer Purcell for her guidance and contributions to the manuscript. We would also like to show our gratitude to Dr. Ferdinando Boero for his review and improvement to the manuscript.	Acevedo M, 2016, THESIS; Acevedo MJ, 2013, J EXP MAR BIOL ECOL, V439, P84, DOI 10.1016/j.jembe.2012.10.007; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Azorin-Molina C, 2011, INT J CLIMATOL, V31, P468, DOI 10.1002/joc.2064; Ballesteros Enric, 1993, Collectanea Botanica (Barcelona), V22, P5; Barry SC, 2002, ECOL MODEL, V157, P179, DOI 10.1016/S0304-3800(02)00194-1; Bazairi H, 2010, MEDITERRANEAN SEA BI; Bentlage B, 2009, MAR ECOL PROG SER, V384, P121, DOI 10.3354/meps08012; Boero F., 1986, Bollettino del Museo Civico di Storia Naturale di Venezia, V35, P179; Boero F., 2016, EXPLAINING OCEAN WAR, P213, DOI DOI 10.2305/IUCN.CH.2016.08.EN; Boero F., 2013, STUD REV GEN FISH CO, V92, P53; Bordehore C, 2011, MAR BIODIVERS REC, V4, P1, DOI [10.1017/S1755267211000650, DOI 10.1017/S1755267211000650]; Bordehore C, 2015, J TRAVEL MED, V22, P61, DOI 10.1111/jtm.12153; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Brown T, 1973, CHIRONEZ FLECKERI DI; Cabello M, 2010, RENEW SUST ENERG REV, V14, P3185, DOI 10.1016/j.rser.2010.07.002; Canepa A, 2014, J PLANKTON RES, V36, P585, DOI 10.1093/plankt/fbt124; Canepa Antonio, 2014, P237; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Chiaverano LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077039; Claus C., 1878, ARBEITEN ZOOLOGISCHE, V1, P1; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; De Donno A, 2014, INT J ENV RES PUB HE, V11, P2488, DOI 10.3390/ijerph110302488; Decker MB, 2007, MAR ECOL PROG SER, V329, P99, DOI 10.3354/meps329099; Di Camillo C, 2006, J MAR BIOL ASSOC UK, V86, P705, DOI 10.1017/S0025315406013609; Duarte CM, 1999, PROG OCEANOGR, V44, P245, DOI 10.1016/S0079-6611(99)00028-2; Gadea I, 2013, THALASSAS, V29, P35; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Gershwin LA, 2013, ADV MAR BIOL, V66, P1, DOI 10.1016/B978-0-12-408096-6.00001-8; Gilbes F, 1996, J PLANKTON RES, V18, P29, DOI 10.1093/plankt/18.1.29; Gili Josep-Maria, 2005, Bolleti de la Societat d'Historia Natural de les Balears, V48, P9; Gonzalez Hidalgo JC, 2003, THEOR APPL CLIMATOL, V75, P117, DOI 10.1007/s00704-002-0718-0; Gordon M, 2004, HYDROBIOLOGIA, V530, P339, DOI 10.1007/s10750-004-2655-7; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; HARTWICK RF, 1991, HYDROBIOLOGIA, V216, P181, DOI 10.1007/BF00026460; Kingsford MJ, 2012, HYDROBIOLOGIA, V690, P257, DOI 10.1007/s10750-012-1041-0; Kingsford Michael J., 2014, P267; Kogovsek T, 2010, HYDROBIOLOGIA, V645, P81, DOI 10.1007/s10750-010-0217-8; Lewis C, 2005, MAR BIOL, V147, P477, DOI 10.1007/s00227-005-1602-0; Liu H, 2011, J AGR BIOL ENVIR ST, V16, P185, DOI 10.1007/s13253-010-0044-4; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Ludwig W, 2009, PROG OCEANOGR, V80, P199, DOI 10.1016/j.pocean.2009.02.001; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Matsumoto GI, 1995, MAR FRESHW BEHAV PHY, V26, P139, DOI 10.1080/10236249509378935; Mooney CJ, 2012, HYDROBIOLOGIA, V690, P269, DOI 10.1007/s10750-012-1049-5; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; Olivos Ortiz Aramis, 2002, Ciencias Marinas, V28, P393; OMORI M, 1982, MAR BIOL, V72, P193, DOI 10.1007/BF00396920; Peca G, 1997, CONTACT DERMATITIS, V36, P124, DOI 10.1111/j.1600-0536.1997.tb00392.x; Penston MJ, 2008, J FISH DIS, V31, P361, DOI 10.1111/j.1365-2761.2008.00915.x; Pitt KA., 2013, JELLYFISH BLOOMS; Pope LG, 2007, SEXUAL DIMORPHISM SY; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; ROTTINI G, 1995, TOXICON, V33, P315, DOI 10.1016/0041-0101(94)00174-7; Sarda R, 2000, ICES J MAR SCI, V57, P1446, DOI 10.1006/jmsc.2000.0922; Sebastia MT, 2012, REV TELEDETEC, P23; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Tahera Q, 2008, MAR BIODIVERS REC, V1, P1; Tibballs J, 2006, TOXICON, V48, P830, DOI 10.1016/j.toxicon.2006.07.020; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; YOSHIOKA PM, 1985, J PLANKTON RES, V7, P733, DOI 10.1093/plankt/7.6.733; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	67	8	8	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181611	10.1371/journal.pone.0181611	http://dx.doi.org/10.1371/journal.pone.0181611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746410	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800045
J	Cantres-Rosario, YM; Acevedo-Mariani, FM; Perez-Laspiur, J; Haskins, WE; Plaud, M; Cantres-Rosario, YM; Skolasky, R; Mendez-Bermudez, I; Wojna, V; Melendez, LM				Cantres-Rosario, Yisel M.; Acevedo-Mariani, Frances M.; Perez-Laspiur, Juliana; Haskins, William E.; Plaud, Marines; Cantres-Rosario, Yadira M.; Skolasky, Richard; Mendez-Bermudez, Israel; Wojna, Valerie; Melendez, Loyda M.			Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment	PLOS ONE			English	Article							IMPROVES MEMORY DEFICITS; BETA-SECRETASE SITE; CATHEPSIN-B; AMYLOID-BETA; WILD-TYPE; ALZHEIMERS-DISEASE; MITOCHONDRIAL DYSFUNCTION; CEREBROSPINAL-FLUID; PROTEIN EXPRESSION; STATISTICAL-MODEL	Objective HIV-infected monocytes can infiltrate the blood brain barrier as differentiated macrophages to the central nervous system, becoming the primary source of viral and cellular neurotoxins. The final outcome is HIV-associated cognitive impairment (HACI), which remain prevalent today, possibly due to the longer life-span of the patients treated with combined anti-retroviral therapy. Our main goal was to characterize the proteome of monocyte-derived macrophages (MDM) from HACI patients, and its association with their cognitive status, to find novel targets for therapy. Methods MDM were isolated from the peripheral blood of 14 HIV-seropositive women characterized for neurocognitive function, including: four normal cognition (NC), five asymptomatic (A), and five with cognitive impaired (CI). Proteins from macrophage lysates were isobaric labeled with the microwave and magnetic (M2) sample preparation method followed by liquid chromatography-tandem mass spectrometry-based protein identification and quantification. Differences in protein abundance across groups classified by HACI status were determined using analysis of variance. Results A total of 2,519 proteins were identified with 2 or more peptides and 28 proteins were quantified as differentially expressed. Statistical analysis revealed increased abundance of 17 proteins in patients with HACI (p<0.05), including several enzymes associated to the glucose metabolism. Western blot confirmed increased expression of 6-Phosphogluconate dehydrogenase and L-Plastin in A and CI patients over NC and HIV seronegatives. Conclusions This is the first quantitative proteomics study exploring the changes in protein abundance of macrophages isolated from patients with HACI. Further studies are warranted to determine if these proteins may be target candidates for therapy development against HACI.	[Cantres-Rosario, Yisel M.; Melendez, Loyda M.] Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA; [Acevedo-Mariani, Frances M.] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA; [Perez-Laspiur, Juliana; Plaud, Marines; Cantres-Rosario, Yadira M.; Melendez, Loyda M.] Univ Puerto Rico, RCMI Translat Prote Ctr, Med Sci Campus, San Juan, PR 00936 USA; [Haskins, William E.] Univ Texas San Antonio, San Antonio, TX USA; [Skolasky, Richard] Johns Hopkins Univ, Dept Orthoped Surg, Baltimore, MD USA; [Mendez-Bermudez, Israel] Univ Puerto Rico, Dept Biostat & Epidemiol, Med Sci Campus, San Juan, PR 00936 USA; [Wojna, Valerie] Univ Puerto Rico, Dept Med, Neurol Div, Med Sci Campus, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Texas System; University of Texas at San Antonio (UTSA); Johns Hopkins University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Melendez, LM (corresponding author), Univ Puerto Rico, Dept Microbiol & Med Zool, Med Sci Campus, San Juan, PR 00936 USA.; Melendez, LM (corresponding author), Univ Puerto Rico, RCMI Translat Prote Ctr, Med Sci Campus, San Juan, PR 00936 USA.	loyda.melendez@upr.edu		Cantres-Rosario, Yisel/0000-0002-0630-5695; Wojna, Valerie/0000-0002-4014-9921	Translational Proteomics Center [R01-MH08316, MARC 5T34GM007821-34/35, SNRP-NINDS-1-U54NS43011, INBRE P20RR016470-12, SC1 GM113691, NIMHHD 8G12-MD007600]; University of Texas San Antonio Pilot project program, IDeA Networks of Biomedical Research Excellence (INBRE-PR) [G12M D007591, P20RR016470, RISE R25GM061838, PRCTRC-NCRR-P20RR11126]; NIH [R01-MH08316-01]; RCMI Translational Proteomics Center NIMHH [8G12-MD007600]; IDeA Networks of Biomedical Research Excellence (INBRE-PR) [P20RR016470]; MARC [RISE R25GM061838, PRCTRC-NCRR-P20RR11126, 5T34GM007821-34, 5T34GM007821-35, SC1GM113691-03]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016470, P20RR011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007821, SC1GM113691, R25GM086262, P20GM103475, R25GM061838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS043011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, G12MD007600] Funding Source: NIH RePORTER	Translational Proteomics Center; University of Texas San Antonio Pilot project program, IDeA Networks of Biomedical Research Excellence (INBRE-PR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCMI Translational Proteomics Center NIMHH; IDeA Networks of Biomedical Research Excellence (INBRE-PR); MARC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by R01-MH08316, MARC 5T34GM007821-34/35, SNRP-NINDS-1-U54NS43011, INBRE P20RR016470-12, SC1 GM113691, and NIMHHD 8G12-MD007600 Translational Proteomics Center and G12M D007591 from University of Texas San Antonio Pilot project program, IDeA Networks of Biomedical Research Excellence (INBRE-PR) P20RR016470, RISE R25GM061838, and PRCTRC-NCRR-P20RR11126. Laboratory space provided by the UPR-Comprehensive Cancer Center (CCC) through a memorandum of understanding between the UPR-CCC and the UPR Medical Sciences Campus. The content is solely the responsibility of the authors and does not necessarily represent the official views of the University of Puerto Rico Comprehensive Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NIH grants R01-MH08316-01, RCMI Translational Proteomics Center NIMHH (8G12-MD007600), SNRP-NINDS-1-U54NS43011, IDeA Networks of Biomedical Research Excellence (INBRE-PR) P20RR016470, MARC 5T34GM007821-34 and 5T34GM007821-35, RISE R25GM061838, PRCTRC-NCRR-P20RR11126, and SC1GM113691-03. We thank the contribution of Yolanda Rodriguez for macrophage isolation and culture. We thank the contributions of Dr. David Black (Protein Biomarker Core, University of Texas, San Antonio, Texas) for helping in the preparation of samples, and their analysis. We thank the Comprehensive Cancer Center U54 NIH-NCI CA 096297 for the proteomics laboratory facilities.	Aebersold R, 2013, W BLOTS VERSUS SELEC; Anderson I, HEAT SHOCK PROTEIN 9; Andras IE, 2013, IUBMB LIFE, V65, P43, DOI 10.1002/iub.1106; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; BENES FM, 1991, NEUROSCIENCE, V42, P651, DOI 10.1016/0306-4522(91)90034-L; Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; Brown LAM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-40; Cantres-Rosario Y, CATHEPSIN B CYSTATIN; Cantres-Rosario Y, 2013, AIDS, V27, P347, DOI 10.1097/QAD.0b013e32835b3e47; Cantres-Rosario YM, 2015, AIDS, V29, P2081, DOI 10.1097/QAD.0000000000000823; Chaudhary P, 2015, NUCL ACIDS RES; Chen Xuesong, 2014, J Parkinsons Dis Alzheimers Dis, V1; Ciborowski P, 2007, INVESTIGATING HUMAN; Colon K, 2015, PROTEOMICS CLIN APPL; Deshmane SL, 2009, J BIOL CHEM, V284, P11364, DOI 10.1074/jbc.M809266200; Dickens Alex M, 2015, AIDS, V29, P559, DOI 10.1097/QAD.0000000000000580; Dubey M, 2015, L PLASTIN S GLUTATHI; Elbim C, 2001, J CLIN VIROL, V20, P99, DOI 10.1016/S1386-6532(00)00133-5; Evans Teresa M, 2014, Transl Proteom, V3, P10; Gao W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1343-5; Gauthier Sebastien, 2011, Front Biosci (Schol Ed), V3, P541, DOI 10.2741/s170; Gerena Y, 2015, J NEUROVIROL, V21, P113, DOI 10.1007/s13365-014-0310-2; Gill AJ, 2013, CRIT REV IMMUNOL, V33, P307, DOI 10.1615/critrevimmunol.2013007247; HIGGINS GA, 1988, P NATL ACAD SCI USA, V85, P1297, DOI 10.1073/pnas.85.4.1297; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/NEU.2013.2944, 10.1089/neu.2013.2944]; Hook V, 2012, BBA-PROTEINS PROTEOM, V1824, P89, DOI 10.1016/j.bbapap.2011.08.015; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hook VYH, 2009, BIOCHEM BIOPH RES CO, V386, P284, DOI 10.1016/j.bbrc.2009.05.131; Irani DN, 2006, ANN NEUROL, V59, P237, DOI 10.1002/ana.20786; Ivanov AV, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8910396; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Kadiu I, 2009, CELL IMMUNOL, V258, P44, DOI 10.1016/j.cellimm.2009.03.012; Kallianpur KJ, 2016, MITOCHONDRION, V28, P8, DOI 10.1016/j.mito.2016.02.006; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kindy MS, 2012, J ALZHEIMERS DIS, V29, P827, DOI 10.3233/JAD-2012-111604; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Kraft-Terry S, 2010, PROTEOM CLIN APPL, V4, P706, DOI 10.1002/prca.201000010; KSIEZAKREDING H, 1987, P NATL ACAD SCI USA, V84, P3410, DOI 10.1073/pnas.84.10.3410; Liebler DC, TARGETED QUANTITATIO; LONDONO D, 1988, NATURE, V332, P141, DOI 10.1038/332141a0; Lu R-C, HEAT SHOCK PROTEIN 7; Mahesula S, 2012, ELECTROPHORESIS, V33, P3820, DOI 10.1002/elps.201200515; Manuscript A, 2011, NIH PUBLIC ACCESS, V4, P158; Marder K, 2003, NEUROLOGY, V60, P1467, DOI 10.1212/01.WNL.0000064172.46685.82; Mares J, 2009, NEUROL SCI, V30, P1, DOI 10.1007/s10072-008-0005-7; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ortega M, 2014, J NEUROIMMUNE PHARM, V9, P483, DOI 10.1007/s11481-014-9546-0; Paul S, 2014, MOL CELL BIOCHEM, V386, P45, DOI 10.1007/s11010-013-1844-y; PERRY G, 1987, P NATL ACAD SCI USA, V84, P3033, DOI 10.1073/pnas.84.9.3033; Price TO, 2005, BRAIN RES, V1045, P57, DOI 10.1016/j.brainres.2005.03.031; Ramamoorthy H, 2014, J BIOCHEM MOL TOXIC, V28, P246, DOI 10.1002/jbt.21560; Ramesh G, 2013, CYTOKINES CHEMOKINES; Raphael I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06210; Raphael I, 2012, ELECTROPHORESIS, V33, P3810, DOI 10.1002/elps.201200200; Ratovitski T, 2016, J PROTEOME RES, V15, P3266, DOI 10.1021/acs.jproteome.6b00448; Repetto M, 1996, CLIN CHIM ACTA, V255, P107, DOI 10.1016/0009-8981(96)06394-2; Rivera-Rivera L, J NEUROVIROL; Rodriguez-Franco EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036571; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Skerget K, 2010, J BIOL CHEM, V285, P3201, DOI 10.1074/jbc.M109.024620; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Sundman M H., 2014, J ALZHEIMERS DIS PAR, P4, DOI [10.4172/2161-0460.1000137, DOI 10.4172/2161-0460.1000137]; Valcour V, 2004, MITOCHONDRION, V4, P119, DOI 10.1016/j.mito.2004.05.009; Vehmas A, 2004, J NEUROIMMUNOL, V157, P99, DOI 10.1016/j.jneuroim.2004.08.035; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Wojna V, 2006, J NEUROVIROL, V12, P356, DOI 10.1080/13550280600964576; Zekry D, 2003, IUBMB LIFE, V55, P307, DOI 10.1080/1521654031000153049; Zenon F, 2014, J NEUROIMMUNE PHARM, V9, P703, DOI 10.1007/s11481-014-9563-z; Zhang Lijun, 2010, Genomics Proteomics & Bioinformatics, V8, P1, DOI 10.1016/S1672-0229(10)60001-0; Zhong XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055328	75	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181779	10.1371/journal.pone.0181779	http://dx.doi.org/10.1371/journal.pone.0181779			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746408	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800060
J	Alperin, BR; Gustafsson, H; Smith, C; Karalunas, SL				Alperin, Brittany R.; Gustafsson, Hanna; Smith, Christiana; Karalunas, Sarah L.			The relationship between early and late event-related potentials and temperament in adolescents with and without ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; FACIAL EXPRESSIONS; DEVELOPMENTAL PSYCHOPATHOLOGY; EMOTION DYSREGULATION; INTEGRATIVE THEORY; BRAIN POTENTIALS; FACE PERCEPTION; CHILDREN; RECOGNITION	Differences in emotional processing are prevalent in adolescents with attention deficit/hyperactivity disorder (ADHD) and are related to clinical impairment, but substantial heterogeneity exists. Within ADHD, some individuals experience difficulty with positive/approach emotions, negative/withdrawal emotions, or both. These problems may reflect differences in emotional reactivity, emotion regulation, or a combination, and the neurophysiological correlates remain unclear. Event-related potentials were collected from 109 adolescents (49 with ADHD) while they completed an emotional go/no-go task with three conditions: happy (positive/approach), fear (negative/withdrawal), and neutral. The P1 and N170 were used as a marker of early emotional processing and the P3b and late positive potential (LPP) were used as markers of later elaborative emotional processing. Emotional response style was assessed with parent and adolescent report on the Early Adolescent Temperament Questionnaire. There were no effects of emotion or group for the P1. Typically-developing adolescents exhibited a larger N170 to emotional vs. neutral faces while adolescents with ADHD showed the opposite pattern. All adolescents exhibited a larger P3b to fearful versus other faces and a larger LPP to emotional vs. non-emotional faces. Within the ADHD group, N170 responses to happy faces predicted parent ratings of positive/approach emotions. Findings highlight the importance of considering within-group heterogeneity when studying clinical populations and help clarify the time-locked neurophysiological correlates of emotion dysregulation.	[Alperin, Brittany R.; Karalunas, Sarah L.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Gustafsson, Hanna; Smith, Christiana; Karalunas, Sarah L.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Alperin, BR (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	alperinb@ohsu.edu	Karalunas, Sarah/AAU-1998-2021	Karalunas, Sarah/0000-0003-3082-7458; Gustafsson, Hanna/0000-0002-8258-4921; Alperin, Brittany/0000-0002-3361-5082	National Institute of Mental Health [R37 MH59105, K23 MH108656]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH108656] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Mental Health; www.nimh.nih.gov: R37 MH59105; K23 MH108656; SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastopoulos AD, 2011, J ATTEN DISORD, V15, P583, DOI 10.1177/1087054710370567; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bunford N, 2015, CLIN CHILD FAM PSYCH, V18, P185, DOI 10.1007/s10567-015-0187-5; Capaldi DM., 1992, J EARLY ADOLESCENCE, V12, P153, DOI 10.1177/0272431692012002002; Chai H, 2012, NEUROPHYSIOL CLIN, V42, P369, DOI 10.1016/j.neucli.2012.04.087; Churches O, 2010, NEUROREPORT, V21, P399, DOI 10.1097/WNR.0b013e328334311b; Collin L, 2013, RES DEV DISABIL, V34, P1505, DOI 10.1016/j.ridd.2013.01.008; Conners C.K., 2001, CONNERS RATING SCALE; Corbett B, 2000, CHILD NEUROPSYCHOL, V6, P144, DOI 10.1076/chin.6.2.144.7056; Degabriele R, 2012, NEUROREPORT, V23, P152, DOI 10.1097/WNR.0b013e32834f218c; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Dias TGC, 2015, DEV COGN NEUROS-NETH, V11, P155, DOI 10.1016/j.dcn.2014.12.005; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DuPaul GJ, 1998, J PSYCHOPATHOL BEHAV, V20, P83, DOI 10.1023/A:1023087410712; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Ellis L. K., 2001, BIENN M SOC RES CHIL; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Ibanez A, 2014, SOC COGN AFFECT NEUR, V9, P939, DOI 10.1093/scan/nst067; Johnstone SJ, 2013, CLIN NEUROPHYSIOL, V124, P644, DOI 10.1016/j.clinph.2012.09.006; Karalunas SL, 2014, JAMA PSYCHIAT, V71, P1015, DOI 10.1001/jamapsychiatry.2014.763; Kats-Gold I, 2007, J ABNORM CHILD PSYCH, V35, P363, DOI 10.1007/s10802-006-9096-x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kochel A, 2014, J CHILD NEUROL, V29, P459, DOI 10.1177/0883073813476139; LAURIAN S, 1991, INT J PSYCHOPHYSIOL, V10, P231, DOI 10.1016/0167-8760(91)90033-T; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Lopez-Martin S, 2015, PSYCHOL MED, V45, P2057, DOI 10.1017/S0033291714003195; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Martens U, 2010, COGN AFFECT BEHAV NE, V10, P505, DOI 10.3758/CABN.10.4.505; McCulloch C. E., 2000, GEN LINEAR MIXED MOD; McRae K, 2012, SOC COGN AFFECT NEUR, V7, P253, DOI 10.1093/scan/nsq103; Mini A, 1996, PERCEPT MOTOR SKILL, V83, P143, DOI 10.2466/pms.1996.83.1.143; Nigg JT, 2006, J CHILD PSYCHOL PSYC, V47, P395, DOI 10.1111/j.1469-7610.2006.01612.x; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Nigg JT, 2004, J CLIN CHILD ADOLESC, V33, P42, DOI 10.1207/S15374424JCCP3301_5; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pelham WE, 2005, J CLIN CHILD ADOLESC, V34, P449, DOI 10.1207/s15374424jccp3403_5; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RADILOVA J, 1982, ACTIV NERV SUPER, P334; Raz S, 2015, CLIN NEUROPHYSIOL, V126, P514, DOI 10.1016/j.clinph.2014.06.023; Rosen PJ, 2015, J ATTEN DISORD, V19, P779, DOI 10.1177/1087054712463064; Rossion B, 2014, TRENDS COGN SCI, V18, P310, DOI 10.1016/j.tics.2014.02.013; Rothbart MK, 2007, CURR DIR PSYCHOL SCI, V16, P207, DOI 10.1111/j.1467-8721.2007.00505.x; ROTHBART MK, 1994, J ABNORM PSYCHOL, V103, P55, DOI 10.1037/0021-843X.103.1.55; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Shaw Philip, 2016, Focus (Am Psychiatr Publ), V14, P127, DOI 10.1176/appi.focus.140102; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Sibley MH, 2012, J CONSULT CLIN PSYCH, V80, P139, DOI 10.1037/a0026577; Sibley MH, 2010, J ABNORM CHILD PSYCH, V38, P645, DOI 10.1007/s10802-010-9404-3; Singh SD, 1998, BEHAV MODIF, V22, P128, DOI 10.1177/01454455980222002; Singhai A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00119; *SPSS, 2005, LIN MIX EFF MOD SPSS; Steinberg EA, 2015, CHILD PSYCHIAT HUM D, V46, P951, DOI 10.1007/s10578-015-0534-2; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tye C, 2014, BIOL PSYCHOL, V103, P125, DOI 10.1016/j.biopsycho.2014.08.013; Verbeke G, 2000, LINEAR MIXED MODELS; Wechsler D, 1974, WECHSLER INTELLIGENC; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Williams LM, 2008, BIOL PSYCHIAT, V63, P917, DOI 10.1016/j.biopsych.2007.11.022; Zhang DD, 2013, BRAIN RES, V1512, P78, DOI 10.1016/j.brainres.2013.03.044	71	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180627	10.1371/journal.pone.0180627	http://dx.doi.org/10.1371/journal.pone.0180627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8DV	28742874	gold, Green Submitted, Green Published			2022-12-26	WOS:000406370000016
J	de Jong, JJA; Christen, P; Plett, RM; Chapurlat, R; Geusens, PP; van den Bergh, JPW; Muller, R; van Rietbergen, B				de Jong, Joost J. A.; Christen, Patrik; Plett, Ryan M.; Chapurlat, Roland; Geusens, Piet P.; van den Bergh, Joop P. W.; Mueller, Ralph; van Rietbergen, Bert			Feasibility of rigid 3D image registration of high-resolution peripheral quantitative computed tomography images of healing distal radius fractures	PLOS ONE			English	Article							TRABECULAR BONE; MICROARCHITECTURE	For accurate analysis of bone formation and resorption during fracture healing, correct registration of follow-up onto baseline image is required. A per-fragment approach could improve alignment compared to standard registration based on the whole fractured region. In this exploratory study, we tested the effect of fragment size and displacement on a per-fragment registration, and compared the results of this per-fragment registration to the results of the standard registration in two stable fractures and one unstable fracture. To test the effect of fragment size and displacement, high-resolution peripheral quantitative computed tomography (HR-pQCT) scans of three unfractured radii were divided into subvolumes. Different displacements in x-, y, or z-direction or rotations around each axis were applied, and each subvolume was registered onto the initial volume to realign it. Next, registration of follow-up onto baseline scan was performed in two stable and one unstable fracture. After coarsely aligning the follow-up onto the baseline scan, a more accurate registration was performed of the whole fracture, i.e. the standard registration, and of each fracture fragment separately, i.e. per-fragment registration. Alignment was checked using overlay images showing baseline, follow-up and overlap between these scans, and by comparing correlation coefficients between the standard and per-fragment registration. Generally, subvolumes as small as 300 mm 3 that were displaced up to 0.82 mm in x- or y-, or up to 1.64 mm in z-direction could be realigned correctly. For the fragments of all fractures, correlation coefficients were higher after per-fragment registration compared to standard registration. Most improvement was found in the unstable fracture and one fragment of the unstable fracture did not align correctly. This exploratory study showed that image registration of individual subvolumes, such as fracture fragments, is feasible in both stable and unstable fractures, and leads to better alignment of these fragments compared to an approach that is based on registration using the whole fractured region. This result is promising for additional analysis of bone formation and resorption in HR-pQCT studies on fracture healing.	[de Jong, Joost J. A.; van den Bergh, Joop P. W.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [de Jong, Joost J. A.; Geusens, Piet P.; van den Bergh, Joop P. W.] Maastricht Univ, Med Ctr, Dept Rheumatol, Maastricht, Netherlands; [Christen, Patrik; Plett, Ryan M.; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Chapurlat, Roland] Univ Lyon, INSERM French Natl Inst Hlth & Med Res, Lyon, France; [Geusens, Piet P.] Maastricht Univ, Med Ctr, CAPHRI, Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Geusens, Piet P.; van den Bergh, Joop P. W.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [van den Bergh, Joop P. W.] VieCuri Med Ctr, Dept Internal Med, Venlo, Netherlands; [van Rietbergen, Bert] Eindhoven Univ Technol, Sect Orthopaed Biomech, Fac Biomed Engn, Eindhoven, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut National de la Sante et de la Recherche Medicale (Inserm); Maastricht University; Maastricht University Medical Centre (MUMC); Hasselt University; VieCuri Medical Center; Eindhoven University of Technology	de Jong, JJA (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.; de Jong, JJA (corresponding author), Maastricht Univ, Med Ctr, Dept Rheumatol, Maastricht, Netherlands.	joost.dejong@maastrichtuniversity.nl	CHAPURLAT, ROLAND/AAU-1165-2021; Müller, Ralph/A-1198-2008	Müller, Ralph/0000-0002-5811-7725; Plett, Ryan/0000-0002-0555-1974; Christen, Patrik/0000-0001-8854-0682; Chapurlat, Roland/0000-0001-8214-6385; van den Bergh, Joop/0000-0003-3984-2232	Weijerhorst Foundation [WH-2]	Weijerhorst Foundation	This study was supported by a grant of the Weijerhorst Foundation (grant no. WH-2) (http://www.deweijerhorst.nl/weijerhorst/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bours S, 2012, J BONE MINERAL RE S1, V27; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; de Jong JJ, 2015, J BONE MINER RES; de Jong JJA, 2014, BONE, V64, P65, DOI 10.1016/j.bone.2014.03.043; Ellouz R, 2014, BONE, V63, P147, DOI 10.1016/j.bone.2014.03.001; Hegde V, 2016, OSTEOPOROSIS INT, V27, P861, DOI 10.1007/s00198-015-3331-7; Lynch JA, 2004, J ORTHOP RES, V22, P362, DOI 10.1016/S0736-0266(03)00197-9; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Oliveira FPM, 2014, COMPUT METHOD BIOMEC, V17, P73, DOI 10.1080/10255842.2012.670855; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Tassani S, 2012, J BIOMECH, V45, P2035, DOI 10.1016/j.jbiomech.2012.05.019; Topfer D, 2015, RHEUMATOLOGY, V54, P2171, DOI 10.1093/rheumatology/kev256; Verhulp E, 2004, J BIOMECH, V37, P1313, DOI 10.1016/j.jbiomech.2003.12.036; Wells W M 3rd, 1996, Med Image Anal, V1, P35	17	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0179413	10.1371/journal.pone.0179413	http://dx.doi.org/10.1371/journal.pone.0179413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742828	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000002
J	Hill, SE; Nguyen, E; Ukachukwu, CU; Freeman, DM; Quirk, S; Lieberman, RL				Hill, Shannon E.; Elaine Nguyen; Ukachukwu, Chiamaka U.; Freeman, Dana M.; Quirk, Stephen; Lieberman, Raquel L.			Metal ion coordination in the E. coli Nudix hydrolase dihydroneopterin triphosphate pyrophosphatase: New clues into catalytic mechanism	PLOS ONE			English	Article							PROTEIN STRUCTURES; FOLIC-ACID; BIOSYNTHESIS; PURIFICATION; ALIGNMENT; BACTERIA; FEATURES; PATHWAY; FAMILY; TOOL	Dihydroneopterin triphosphate pyrophosphatase (DHNTPase), a member of the Mg2+ dependent Nudix hydrolase superfamily, is the recently-discovered enzyme that functions in the second step of the pterin branch of the folate biosynthetic pathway in E. coli. DHNTPase is of interest because inhibition of enzymes in bacterial folate biosynthetic pathways is a strategy for antibiotic development. We determined crystal structures of DHNTPase with and without activating, Mg2+-mimicking metals Co2+ and Ni2+. Four metal ions, identified by anomalous scattering, and stoichiometrically confirmed in solution by isothermal titration calorimetry, are held in place by Glu56 and Glu60 within the Nudix sequence motif, Glu117, waters, and a sulfate ion, of which the latter is further stabilized by a salt bridge with Lys7. In silico docking of the DHNTP substrate reveals a binding mode in which the pterin ring moiety is nestled in a largely hydrophobic pocket, the beta-phosphate activated for nucleophilic attack overlays with the crystallographic sulfate and is in line with an activated water molecule, and remaining phosphate groups are stabilized by all four identified metal ions. The structures and binding data provide new details regarding DHNTPase metal requirements, mechanism, and suggest a strategy for efficient inhibition.	[Hill, Shannon E.; Elaine Nguyen; Ukachukwu, Chiamaka U.; Freeman, Dana M.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Quirk, Stephen] Kimberly Clark Inc, Roswell, GA USA	University System of Georgia; Georgia Institute of Technology; Kimberly-Clark	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	Raquel.lieberman@chemistry.gatech.edu		Quirk, Stephen/0000-0002-4497-1023	Directorate for Biological Sciences [0845445]; Kimberly-Clark Foundation; Office of Science [W-31-109-Eng-38]	Directorate for Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Kimberly-Clark Foundation; Office of Science(United States Department of Energy (DOE))	This work was supported by the Directorate for Biological Sciences, 0845445, to Prof Raquel L. Lieberman; Kimberly-Clark Foundation, to Prof Raquel L. Lieberman; and Office of Science, W-31-109-Eng-38, Not applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Barta ML, 2014, BIOCHEMISTRY-US, V53, P214, DOI 10.1021/bi401473e; Bermingham A, 2002, BIOESSAYS, V24, P637, DOI 10.1002/bies.10114; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BROWN ID, 1988, ACTA CRYSTALLOGR B, V44, P545, DOI 10.1107/S0108768188007712; Conyers GB, BIOCHEMISTRY; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Harding MM, 2010, CRYSTALLOGR REV, V16, P247, DOI 10.1080/0889311X.2010.485616; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hong MK, 2014, ACTA CRYSTALLOGR D, V70, P1297, DOI 10.1107/S1399004714002570; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klaus SMJ, 2005, J BIOL CHEM, V280, P5274, DOI 10.1074/jbc.M413759200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sharma A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19981; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; SUZUKI Y, 1974, J BIOL CHEM, V249, P2405; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; WILSON JE, 1991, ANAL BIOCHEM, V193, P16, DOI 10.1016/0003-2697(91)90036-S	34	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180241	10.1371/journal.pone.0180241	http://dx.doi.org/10.1371/journal.pone.0180241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742822	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000010
J	Vu, TT; Kim, H; Tran, VK; Vu, HD; Hoang, TX; Hang, JW; Choi, YH; Jang, KS; Choi, GJ; Kim, JC				Thuy Thu Vu; Kim, Hun; Vu Khac Tran; Hoang Dinh Vu; Tien Xuan Hoang; Hang, Jae Woo; Choi, Yong Ho; Jang, Kyoung Soo; Choi, Gyung Ja; Kim, Jin-Cheol			Antibacterial activity of tannins isolated from Sapium baccatum extract and use for control of tomato bacterial wilt	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; RALSTONIA-SOLANACEARUM; TERMINALIA-CHEBULA; HYDROLYZABLE TANNINS; DISEASE-CONTROL; PESTICIDES; POLYPHENOLS; LEAVES; FRUITS; AGENT	In the search for new antibacterial agents from natural sources, we revealed that a crude methanol extract of Sapium baccatum was highly active against Ralstonia solanacearum, a causal agent of a serious disease called bacterial wilt of tomato. The bioassay-guided fractionation of this extract resulted in the isolation of seven known active compounds, including gallic acid, methyl gallate, corilagin, tercatain, chebulagic acid, chebulinic acid, and quercetin 3-O-alpha-L-arabinopyranoside. Their chemical structures were determined by electrospray ionization mass spectrometry and nuclear magnetic resonance spectroscopy. An in vitro antibacterial bioassay using a broth microdilution method revealed that, except for quercetin 3-O-alpha-L-arabinopyranoside (MIC = 250 mu g/mL),the isolated compounds exhibited strong antibacterial activity against R. solanacearum (MIC = 26-52 mu g/mL). Among the seven compounds, methyl gallate exhibited the strongest broad-spectrum activity against most of the plant pathogenic bacteria tested (MIC = 26-250 mu g/mL). In the in vivo experiments, the crude extract of S. baccatum at 2000 and 1000 mu g/mL reduced the development of tomato bacterial wilt by 83 and 63%, respectively, under greenhouse conditions after 14 days of infection. The results suggested that the extracts of S. baccatum or isolated tannins could be used as natural bactericides for the control of bacterial wilt of tomato.	[Thuy Thu Vu; Kim, Hun; Choi, Gyung Ja] Korea Univ Sci & Technol, Dept Green Chem & Environm Biotechnol, Daejeon, South Korea; [Thuy Thu Vu; Kim, Hun; Hang, Jae Woo; Choi, Yong Ho; Jang, Kyoung Soo; Choi, Gyung Ja] Korea Res Inst Chem Technol, Ctr Ecofriendly New Mat, Daejeon, South Korea; [Vu Khac Tran; Hoang Dinh Vu; Tien Xuan Hoang] Hanoi Univ Sci & Technol, Dept Pharmaceut Chem & Pesticides Technol, Hanoi, Vietnam; [Kim, Jin-Cheol] Chonnam Natl Univ, Dept Agr Chem, Coll Agr & Life Sci, Gwangju, South Korea	University of Science & Technology (UST); Korea Research Institute of Chemical Technology (KRICT); Hanoi University of Science & Technology; Chonnam National University	Choi, GJ (corresponding author), Korea Univ Sci & Technol, Dept Green Chem & Environm Biotechnol, Daejeon, South Korea.; Choi, GJ (corresponding author), Korea Res Inst Chem Technol, Ctr Ecofriendly New Mat, Daejeon, South Korea.; Kim, JC (corresponding author), Chonnam Natl Univ, Dept Agr Chem, Coll Agr & Life Sci, Gwangju, South Korea.	kjchoi@krict.re.kr; kjinc@jnu.ac.kr		Vu, Hoang/0000-0002-2112-6732; Kim, Jin-Cheol/0000-0003-0753-1966	Korea Research Institute of Chemical Technology [KK1606-M02]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries through the Advanced Production Technology Development Program - Ministry of Agriculture, Food and Rural Affairs [315007-03]	Korea Research Institute of Chemical Technology; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries through the Advanced Production Technology Development Program - Ministry of Agriculture, Food and Rural Affairs	This study was supported by the Korea Research Institute of Chemical Technology (Project KK1606-M02) (http://www.krict.re.kr/) and the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries through the Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (315007-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 2010, FOOD CHEM TOXICOL, V48, P549, DOI 10.1016/j.fct.2009.11.030; Al Muqarrabun LMR, 2014, J ETHNOPHARMACOL, V155, P9, DOI 10.1016/j.jep.2014.05.028; Bhagat S, 2014, ADV PLANT BIOPESTICI, P119, DOI DOI 10.1007/978-81-322-2006-07; Chen JN, 2016, MOLECULES, V21, DOI 10.3390/molecules21111501; Deberdt P, 2012, PLANT DIS, V96, P687, DOI 10.1094/PDIS-07-11-0601; Derib Alemu, 2013, Plant Pathology Journal (Faisalabad), V12, P61, DOI 10.3923/ppj.2013.61.70; Dubey NK, 2011, NATURAL PRODUCTS IN PLANT PEST MANAGEMENT, P1, DOI 10.1079/9781845936716.0001; El-Wakeil NE, 2013, GESUNDE PFLANZ, V65, P125, DOI 10.1007/s10343-013-0308-3; Feng Wei-Sheng, 2009, Chinese Journal of Natural Medicines, V7, P37, DOI 10.3724/SP.J.1009.2009.00037; Gaitonde SS, 2016, P NATL ACAD SCI IN B; Gurjar M. S., 2012, Agricultural Sciences, V3, P425, DOI 10.4236/as.2012.33050; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; HE LY, 1983, PLANT DIS, V67, P1357, DOI 10.1094/PD-67-1357; Ji P, 2005, PLANT DIS, V89, P497, DOI 10.1094/PD-89-0497; KADOTA S, 1990, CHEM PHARM BULL, V38, P2687, DOI 10.1248/cpb.38.2687; Koh YJ, 2010, NEW ZEAL J CROP HORT, V38, P275, DOI 10.1080/01140671.2010.512624; Kubo I, 2004, J AGR FOOD CHEM, V52, P1072, DOI 10.1021/jf034774l; Le DQ, 2014, J AGR FOOD CHEM, V62, P3363; Lee Hyoung Ju, 2011, [Research in Plant Disease, 식물병 연구], V17, P326; LEE SH, 1991, PHYTOCHEMISTRY, V30, P1251, DOI 10.1016/S0031-9422(00)95211-7; LEE SH, 1995, ARCH PHARM RES, V18, P118, DOI 10.1007/BF02979144; Lee YH, 2012, PLANT PATHOLOGY J, V28, P32, DOI 10.5423/PPJ.OA.10.2011.0200; Li N, 2013, PHYTOTHER RES, V27, P1517, DOI 10.1002/ptr.4891; Li SL, 2016, MOLECULES, V21, DOI 10.3390/molecules21060754; Marutescu L., 2017, NEW PESTICIDES SOIL, P311, DOI DOI 10.1016/B978-0-12-804299-1.00009-6; Miyasaki Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064777, 10.1371/journal.pone.0061594]; Montesinos E, 2008, CHEM BIODIVERS, V5, P1225, DOI 10.1002/cbdv.200890111; Muh L, 2014, AUST J BASIC APPL SC, V8, P432; NAWWAR MAM, 1994, PHYTOCHEMISTRY, V36, P793, DOI 10.1016/S0031-9422(00)89820-9; Obradovic A., 2008, V3, P211, DOI 10.1007/978-1-4020-8571-0_11; Ooshiro A, 2011, J PESTIC SCI, V36, P240, DOI 10.1584/jpestics.G10-84; Pfundstein B, 2010, PHYTOCHEMISTRY, V71, P1132, DOI 10.1016/j.phytochem.2010.03.018; Prabu GR, 2006, J APPL MICROBIOL, V101, P487, DOI 10.1111/j.1365-2672.2006.02912.x; Pradhanang PM, 2003, PLANT DIS, V87, P423, DOI 10.1094/PDIS.2003.87.4.423; Shimizu M, 2001, ANTIMICROB AGENTS CH, V45, P3198, DOI 10.1128/AAC.45.11.3198-3201.2001; Sieniawska E, 2017, PHARMACOGNOSY: FUNDAMENTALS, APPLICATIONS AND STRATEGIES, P199, DOI 10.1016/B978-0-12-802104-0.00010-X; Singh S, 2015, EUR J PLANT PATHOL, V143, P205, DOI 10.1007/s10658-015-0690-z; Sudjaroen Y, 2012, PHYTOCHEMISTRY, V77, P226, DOI 10.1016/j.phytochem.2011.12.008; TANAKA T, 1986, CHEM PHARM BULL, V34, P1039; Vu TT, 2013, PLANT DIS, V97, P1593, DOI 10.1094/PDIS-04-13-0350-RE; Vidaver AK, 2002, CLIN INFECT DIS, V34, pS107, DOI 10.1086/340247; Vvedenskaya IO, 2004, J AGR FOOD CHEM, V52, P188, DOI 10.1021/jf034970s; Yuan GQ, 2012, PLANT DIS, V96, P1143, DOI 10.1094/PDIS-03-11-0150-RE; Yuliar, 2015, MICROBES ENVIRON, V30, P1, DOI 10.1264/jsme2.ME14144; ZAPESOCHNAYA G G, 1979, Chemistry of Natural Compounds (English Translation of Khimiya Prirodnykh Soedinenii), V15, P17, DOI 10.1007/BF00570842; Zou DL, 2016, J SEP SCI, V39, P1278, DOI 10.1002/jssc.201501358	46	23	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181499	10.1371/journal.pone.0181499	http://dx.doi.org/10.1371/journal.pone.0181499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742863	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000032
J	Alghamdi, M; Al-Mallah, M; Keteylan, S; Brawner, C; Ehrman, J; Sakr, S				Alghamdi, Manal; Al-Mallah, Mouaz; Keteylan, Steven; Brawner, Clinton; Ehrman, Jonathan; Sakr, Sherif			Predicting diabetes mellitus using SMOTE and ensemble machine learning approach: The Henry Ford ExercIse Testing (FIT) project	PLOS ONE			English	Article							IDENTIFICATION; CLASSIFICATION; FITNESS	Machine learning is becoming a popular and important approach in the field of medical research. In this study, we investigate the relative performance of various machine learning methods such as Decision Tree, Naive Bayes, Logistic Regression, Logistic Model Tree and Random Forests for predicting incident diabetes using medical records of cardiorespiratory fitness. In addition, we apply different techniques to uncover potential predictors of diabetes. This FIT project study used data of 32,555 patients who are free of any known coronary artery disease or heart failure who underwent clinician-referred exercise treadmill stress testing at Henry Ford Health Systems between 1991 and 2009 and had a complete 5-year follow-up. At the completion of the fifth year, 5,099 of those patients have developed diabetes. The dataset contained 62 attributes classified into four categories: demographic characteristics, disease history, medication use history, and stress test vital signs. We developed an Ensembling-based predictive model using 13 attributes that were selected based on their clinical importance, Multiple Linear Regression, and Information Gain Ranking methods. The negative effect of the imbalance class of the constructed model was handled by Synthetic Minority Oversampling Technique (SMOTE). The overall performance of the predictive model classifier was improved by the Ensemble machine learning approach using the Vote method with three Decision Trees (Naive Bayes Tree, Random Forest, and Logistic Model Tree) and achieved high accuracy of prediction (AUC = 0.92). The study shows the potential of ensembling and SMOTE approaches for predicting incident diabetes using cardiorespiratory fitness data.	[Alghamdi, Manal; Al-Mallah, Mouaz; Sakr, Sherif] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Alghamdi, Manal; Al-Mallah, Mouaz; Sakr, Sherif] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Al-Mallah, Mouaz; Keteylan, Steven; Brawner, Clinton; Ehrman, Jonathan] Henry Ford Hosp Syst, Inst Heart & Vasc, Detroit, MI USA	King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Henry Ford Health System	Sakr, S (corresponding author), King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.; Sakr, S (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.	sakrs@ksau-hs.edu.sa	Sakr, Sherif/B-1439-2018; Brawner, Clinton A./K-6859-2019	Sakr, Sherif/0000-0002-2503-523X; Al-Mallah, Mouaz/0000-0003-2348-0484	King Abdullah International Medical Research Center [SP16/100]	King Abdullah International Medical Research Center	Funding was provided by King Abdullah International Medical Research Center. Funding grant number SP16/100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P457; Al-Mallah MH, 2014, CLIN CARDIOL, V37, P456, DOI 10.1002/clc.22302; Alhyas L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040948; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Blagus R, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0723-9; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Breault JL, 2002, ARTIF INTELL MED, V26, P37, DOI 10.1016/S0933-3657(02)00051-9; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chawla NV, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P853, DOI 10.1007/0-387-25465-X_40; Farran B, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002457; Ganganwar V., 2012, INT J EMERGING TECHN, V2, P42; Garcia V, 2006, LECT NOTES COMPUT SC, V4224, P371; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Habibi Shafi, 2015, Glob J Health Sci, V7, P304, DOI 10.5539/gjhs.v7n5p304; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; John GHG, 1995, P 11 C UNC ART INT, P338, DOI [DOI 10.1109/TGRS.2004.834800, 10.1.1.8. 3257.]; Juraschek SP, 2015, DIABETES CARE, V38, P1075, DOI 10.2337/dc14-2714; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kotsiantis S. B., 2007, SUPERVISED MACHINE L; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Leahy S, 2015, DIABETES RES CLIN PR, V110, P241, DOI 10.1016/j.diabres.2015.10.015; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; Liu B, 2016, IEEE T NANOBIOSCI, V15, P328, DOI 10.1109/TNB.2016.2555951; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Menardi G, 2014, DATA MIN KNOWL DISC, V28, P92, DOI 10.1007/s10618-012-0295-5; Meng XH, 2013, KAOHSIUNG J MED SCI, V29, P93, DOI 10.1016/j.kjms.2012.08.016; National Toxicology Program, 1999, NIH PUBL, V99-3962; Poolsawad N., 2014, P WORLD C ENG, V1, P237; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ross K.A., 2009, ENCYCL DATABASE SYST, P532, DOI [DOI 10.1007/978-0-387-39940-9_565, 10.1007/978-0-387-39940-9]; Ryden L, 2007, EUR HEART J SUPPL, V9, pC3, DOI 10.1093/eurheartj/ehl261; Seni G., 2010, SYNTHESIS LECT DATA, V2, P1, DOI DOI 10.2200/S00240ED1V01Y200912DMK002; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Sumner M, 2005, LECT NOTES ARTIF INT, V3721, P675; Tomar D., 2013, INT J BIOSCI BIOTECH, V5, P241, DOI DOI 10.14257/IJBSBT.2013.5.5.25; Wang CY, 2015, GENET MOL RES, V14, P123, DOI 10.4238/2015.January.15.15; Wang J., 2006, 2006 8 INT C SIGN PR, V3, P1, DOI DOI 10.1109/ICOSP.2006.345752; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams PT, 2008, MED SCI SPORT EXER, V40, P998, DOI 10.1249/MSS.0b013e31816722a9; Zhang Y., 2014, ABSTR APPL AN, V2014; Zhu MY, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0042-1	53	119	124	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0179805	10.1371/journal.pone.0179805	http://dx.doi.org/10.1371/journal.pone.0179805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738059	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700009
J	Gillooly, KM; Pulicicchio, C; Pattoli, MA; Cheng, LH; Skala, S; Heimrich, EM; McIntyre, KW; Taylor, TL; Kukral, DW; Dudhgaonkar, S; Nagar, J; Banas, D; Watterson, SH; Tino, JA; Fura, A; Burke, JR				Gillooly, Kathleen M.; Pulicicchio, Claudine; Pattoli, Mark A.; Cheng, Lihong; Skala, Stacey; Heimrich, Elizabeth M.; McIntyre, Kim W.; Taylor, Tracy L.; Kukral, Daniel W.; Dudhgaonkar, Shailesh; Nagar, Jignesh; Banas, Dana; Watterson, Scott H.; Tino, Joseph A.; Fura, Aberra; Burke, James R.			Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; MODIFYING ANTIRHEUMATIC DRUGS; B-CELL; BTK INHIBITOR; BONE LOSS; T-CELLS; METHOTREXATE; MICE; ACTIVATION	Bruton's tyrosine kinase (BTK) regulates critical signal transduction pathways involved in the pathobiology of rheumatoid arthritis (RA) and other autoimmune disorders. BMS-986142 is a potent and highly selective reversible small molecule inhibitor of BTK currently being investigated in clinical trials for the treatment of both RA and primary Sjogren's syndrome. In the present report, we detail the in vitro and in vivo pharmacology of BMS-986142 and show this agent provides potent and selective inhibition of BTK (IC50 = 0.5 nM), blocks antigen receptor-dependent signaling and functional endpoints (cytokine production, co-stimulatory molecule expression, and proliferation) in human B cells (IC50 <= 5 nM), inhibits Fc. receptor-dependent cytokine production from peripheral blood mononuclear cells, and blocks RANK-L-induced osteoclastogenesis. Through the benefits of impacting these important drivers of autoimmunity, BMS-986142 demonstrated robust efficacy in murine models of rheumatoid arthritis (RA), including collagen-induced arthritis (CIA) and collagen antibody-induced arthritis (CAIA). In both models, robust efficacy was observed without continuous, complete inhibition of BTK. When a suboptimal dose of BMS-986142 was combined with other agents representing the current standard of care for RA (e.g., methotrexate, the TNF alpha antagonist etanercept, or the murine form of CTLA4-Ig) in the CIA model, improved efficacy compared to either agent alone was observed. The results suggest BMS-986142 represents a potential therapeutic for clinical investigation in RA, as monotherapy or co-administered with agents with complementary mechanisms of action.	[Gillooly, Kathleen M.; Pulicicchio, Claudine; Pattoli, Mark A.; Cheng, Lihong; Skala, Stacey; Heimrich, Elizabeth M.; McIntyre, Kim W.; Taylor, Tracy L.; Burke, James R.] Bristol Myers Squibb Res & Dev, Immunosci Discovery Biol, Princeton, NJ 08543 USA; [Kukral, Daniel W.] Bristol Myers Squibb Res & Dev, Exploratory Clin & Translat Res, Imaging, Princeton, NJ USA; [Dudhgaonkar, Shailesh; Nagar, Jignesh] Syngene Int Ltd, Biocon Bristol Myers Squibb Res Ctr, Dis Sci & Technol, Bangalore, Karnataka, India; [Banas, Dana] Bristol Myers Squibb Res & Dev, Discovery Translat Sci, Princeton, NJ USA; [Watterson, Scott H.; Tino, Joseph A.] Bristol Myers Squibb Res & Dev, Immunosci Discovery Chem, Princeton, NJ USA; [Fura, Aberra] Bristol Myers Squibb Res & Dev, Dept Pharmaceut Candidate Optimizat, Princeton, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Syngene International Limited; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Burke, JR (corresponding author), Bristol Myers Squibb Res & Dev, Immunosci Discovery Biol, Princeton, NJ 08543 USA.	james.burke@bms.com		Watterson, Scott/0000-0001-9315-177X	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	All authors have a commercial affiliation with Bristol-Myers Squibb, the funder of this work. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bevaart L, 2010, METHODS MOL BIOL, V602, P181, DOI 10.1007/978-1-60761-058-8_11; Blom AB, 2003, ARTHRITIS RHEUM, V48, P1002, DOI 10.1002/art.10871; Braun T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3380; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; BUGATTI S, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/681678; Chang BY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3400; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DEWEERS M, 1993, EUR J IMMUNOL, V23, P3109, DOI 10.1002/eji.1830231210; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Evans EK, 2013, J PHARMACOL EXP THER, V346, P219, DOI 10.1124/jpet.113.203489; Firestein GS, 2005, J RHEUMATOL, V32, P8; Fischer JAA, 2015, ARTHRITIS RHEUMATOL, V67, P51, DOI 10.1002/art.38896; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Gillooly KM, 2009, J PHARMACOL EXP THER, V331, P349, DOI 10.1124/jpet.109.156018; Glassford J, 2003, ONCOGENE, V22, P2248, DOI 10.1038/sj.onc.1206425; Heiberg MS, 2006, ANN RHEUM DIS, V65, P1379, DOI 10.1136/ard.2006.051540; Iyer AS, 2011, J BIOL CHEM, V286, P9503, DOI 10.1074/jbc.M110.165613; Jongstra-Bilen J, 2008, J IMMUNOL, V181, P288, DOI 10.4049/jimmunol.181.1.288; Kagari T, 2003, J IMMUNOL, V170, P4318, DOI 10.4049/jimmunol.170.8.4318; Kelly V, 2013, RHEUMATOLOGY, V52, P1155, DOI 10.1093/rheumatology/kes367; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; Lee SH, 2008, J BIOL CHEM, V283, P11526, DOI 10.1074/jbc.M708935200; Lee YH, 2015, RHEUMATOL INT, V35, P1965, DOI 10.1007/s00296-015-3291-4; Liu LC, 2011, J PHARMACOL EXP THER, V338, P154, DOI 10.1124/jpet.111.181545; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; McIntyre KW, 2003, ARTHRITIS RHEUM-US, V48, P2652, DOI 10.1002/art.11131; Middendorp S, 2003, J IMMUNOL, V171, P5988, DOI 10.4049/jimmunol.171.11.5988; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1847; Nandakumar KS, 2004, ARTHRITIS RES THER, V6, pR544, DOI 10.1186/ar1217; Pavelka K, 2012, RHEUMATOLOGY, V51, pV12, DOI 10.1093/rheumatology/kes111; Seetharaman R, 1999, J IMMUNOL, V163, P1577; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Shinohara M, 2014, BONE, V60, P8, DOI 10.1016/j.bone.2013.11.025; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; Strand V, 2017, ARTHRIT CARE RES, V69, P592, DOI 10.1002/acr.23004; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Theill LE, 2002, ANNU REV IMMUNOL, V20, P795, DOI 10.1146/annurev.immunol.20.100301.064753; van Vollenhoven RF, 2013, NAT REV RHEUMATOL, V9, P510, DOI 10.1038/nrrheum.2013.118; Watterson SH, 2016, J MED CHEM, V59, P9173, DOI 10.1021/acs.jmedchem.6b01088; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Yanaba K, 2007, J IMMUNOL, V179, P1369, DOI 10.4049/jimmunol.179.2.1369	44	37	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181782	10.1371/journal.pone.0181782	http://dx.doi.org/10.1371/journal.pone.0181782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742141	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700070
J	Tremblay, A; Namjoshi, J; Spinelli, E; Broersma, M; Cho, T; Kim, S; Martinez-Garcia, MT; Connell, K				Tremblay, Annie; Namjoshi, Jui; Spinelli, Elsa; Broersma, Mirjam; Cho, Taehong; Kim, Sahyang; Martinez-Garcia, Maria Teresa; Connell, Katrina			Experience with a second language affects the use of fundamental frequency in speech segmentation	PLOS ONE			English	Article							STATISTICS; LANGUAGE; CUES	This study investigates whether listeners' experience with a second language learned later in life affects their use of fundamental frequency (F0) as a cue to word boundaries in the segmentation of an artificial language (AL), particularly when the cues to word boundaries conflict between the first language (L1) and second language (L2). F0 signals phrase-final (and thus word-final) boundaries in French but word-initial boundaries in English. Participants were functionally monolingual French listeners, functionally monolingual English listeners, bilingual L1-English L2-French listeners, and bilingual L1-French L2-English listeners. They completed the AL-segmentation task with F0 signaling word-final boundaries or without prosodic cues to word boundaries (monolingual groups only). After listening to the AL, participants completed a forced-choice word-identification task in which the foils were either nonwords or part-words. The results show that the monolingual French listeners, but not the monolingual English listeners, performed better in the presence of F0 cues than in the absence of such cues. Moreover, bilingual status modulated listeners' use of F0 cues to word-final boundaries, with bilingual French listeners performing less accurately than monolingual French listeners on both word types but with bilingual English listeners performing more accurately than monolingual English listeners on non-words. These findings not only confirm that speech segmentation is modulated by the L1, but also newly demonstrate that listeners' experience with the L2 (French or English) affects their use of F0 cues in speech segmentation. This suggests that listeners' use of prosodic cues to word boundaries is adaptive and non-selective, and can change as a function of language experience.	[Tremblay, Annie; Connell, Katrina] Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA; [Namjoshi, Jui] Univ Illinois, Dept French & Italian, Urbana, IL 61801 USA; [Spinelli, Elsa] Univ Grenoble Alpes, Lab Psychol & Neurocognit, Grenoble, France; [Broersma, Mirjam] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands; [Cho, Taehong] Hanyang Univ, Dept English Language & Literature, Seoul, South Korea; [Kim, Sahyang] Hongik Univ, Dept English Educ, Seoul, South Korea; [Martinez-Garcia, Maria Teresa] Hankuk Univ Foreign Studies, Dept Occidental Languages, Seoul, South Korea	University of Kansas; University of Illinois System; University of Illinois Urbana-Champaign; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Radboud University Nijmegen; Hanyang University; Hongik University; Hankuk University Foreign Studies	Tremblay, A (corresponding author), Univ Kansas, Dept Linguist, Lawrence, KS 66045 USA.	atrembla@ku.edu	Martinez-Garcia, Maria Teresa/AAV-2819-2020; Broersma, Mirjam/B-2032-2015	Martinez-Garcia, Maria Teresa/0000-0003-3187-0853; Broersma, Mirjam/0000-0001-8511-2877	National Science Foundation [BCS-1423905]; Language Learning small research grant; Netherlands Organisation for Scientific Research; Division Of Behavioral and Cognitive Sci [1423905] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Language Learning small research grant; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This material is based upon work supported by the National Science Foundation under grant no. BCS-1423905 awarded to Dr. Annie Tremblay. Support for this research also comes from a Language Learning small research grant awarded to Dr. Annie Tremblay, and a Vidi grant from the Netherlands Organisation for Scientific Research awarded to the fourth author (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research is based upon work supported by the National Science Foundation under grant no. BCS-1423905 awarded to the first author (AT). Support for this research also comes from a Language Learning small research grant awarded to the first author, and a Vidi grant from the Netherlands Organisation for Scientific Research awarded to the fourth author (MB).	Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bagou O., 2002, SPEECH PROSODY, V2002, P159; Beckman Mary E., 1986, PHONOLOGY YB, V3, P255, DOI [10.1017/S095267570000066X, DOI 10.1017/S095267570000066X]; Christophe A, 2004, J MEM LANG, V51, P523, DOI 10.1016/j.jml.2004.07.001; Clopper C., 2002, IULC WORKING PAPERS, P2; Cunillera T, 2006, BRAIN RES, V1123, P168, DOI 10.1016/j.brainres.2006.09.046; Cutler A., 1987, Computer Speech and Language, V2, P133, DOI 10.1016/0885-2308(87)90004-0; Finn AS, 2008, COGNITION, V108, P477, DOI 10.1016/j.cognition.2008.04.002; JUN SA, 2002, PROBUS, V14, P147, DOI DOI 10.1515/PRBS.2002.002; Kim S, 2012, STUD SECOND LANG ACQ, V34, P415, DOI 10.1017/S0272263112000137; Michelas A, 2010, SPEECH PROSODY 2010; Monaghan P, 2005, COGNITION, V96, P143, DOI 10.1016/j.cognition.2004.09.001; Ordin M, 2016, LANG LEARN DEV, V12, P461, DOI 10.1080/15475441.2016.1154858; Ordin M, 2013, LANG LEARN, V63, P800, DOI 10.1111/lang.12024; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 2001, J MEM LANG, V44, P493, DOI 10.1006/jmla.2000.2759; Shukla M, 2007, COGNITIVE PSYCHOL, V54, P1, DOI 10.1016/j.cogpsych.2006.04.002; Toro JM, 2011, J MEM LANG, V64, P171, DOI 10.1016/j.jml.2010.11.005; Toro JM, 2009, EUR J COGN PSYCHOL, V21, P786, DOI 10.1080/09541440802405584; Tremblay A., 2012, LAB PHONOL, V3, P385, DOI [10.1515/lp-2012-0018, DOI 10.1515/LP-2012-0018]; Tremblay A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00985; Tremblay A, 2011, STUD SECOND LANG ACQ, V33, P339, DOI 10.1017/S0272263111000015; Tyler MD, 2009, J ACOUST SOC AM, V126, P367, DOI 10.1121/1.3129127; VROOMEN J, 1995, J EXP PSYCHOL HUMAN, V21, P98, DOI 10.1037/0096-1523.21.1.98; Welby P, 2006, J PHONETICS, V34, P343, DOI 10.1016/j.wocn.2005.09.001	27	8	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181709	10.1371/journal.pone.0181709	http://dx.doi.org/10.1371/journal.pone.0181709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28738093	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700061
J	Commisso, M; Bianconi, M; Di Carlo, F; Poletti, S; Bulgarini, A; Munari, F; Negri, S; Stocchero, M; Ceoldo, S; Avesani, L; Assfalg, M; Zoccatelli, G; Guzzo, F				Commisso, Mauro; Bianconi, Martino; Di Carlo, Flavia; Poletti, Stefania; Bulgarini, Alessandra; Munari, Francesca; Negri, Stefano; Stocchero, Matteo; Ceoldo, Stefania; Avesani, Linda; Assfalg, Michael; Zoccatelli, Gianni; Guzzo, Flavia			Multi-approach metabolomics analysis and artificial simplified phytocomplexes reveal cultivar-dependent synergy between polyphenols and ascorbic acid in fruits of the sweet cherry (Prunus avium L.)	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; CIRCULATING CONCENTRATIONS; CHEMICAL-CONSTITUENTS; POSTHARVEST STORAGE; PHENOLIC-COMPOUNDS; HUMAN HEALTH; CONSUMPTION; ANTHOCYANINS; PERFORMANCE; MECHANISMS	Fruits of the sweet cherry (Prunus avium L.) accumulate a range of antioxidants that can help to prevent cardiovascular disease, inflammation and cancer. We tested the in vitro antioxidant activity of 18 sweet cherry cultivars collected from 12 farms in the protected geographical indication region of Marostica (Vicenza, Italy) during two growing seasons. Multiple targeted and untargeted metabolomics approaches (NMR, LC-MS, HPLC-DAD, HPLC-UV) as well as artificial simplified phytocomplexes representing the cultivars Sandra Tardiva, Sandra and Grace Star were then used to determine whether the total antioxidant activity reflected the additive effects of each compound or resulted from synergistic interactions. We found that the composition of each cultivar depended more on genetic variability than environmental factors. Furthermore, phenolic compounds were the principal source of antioxidant activity and experiments with artificial simplified phytocomplexes indicated strong synergy between the anthocyanins and quercetins/ascorbic acid specifically in the cultivar Sandra Tardiva. Our data therefore indicate that the total antioxidant activity of sweet cherry fruits may originate from cultivar-dependent interactions among different classes of metabolite.	[Commisso, Mauro; Bianconi, Martino; Poletti, Stefania; Bulgarini, Alessandra; Munari, Francesca; Negri, Stefano; Ceoldo, Stefania; Avesani, Linda; Assfalg, Michael; Zoccatelli, Gianni; Guzzo, Flavia] Univ Verona, Dept Biotechnol, Verona, Italy; [Di Carlo, Flavia] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [Stocchero, Matteo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	University of Verona; University of Palermo; University of Padua	Guzzo, F (corresponding author), Univ Verona, Dept Biotechnol, Verona, Italy.	flavia.guzzo@univr.it	Commisso, Mauro/M-5616-2016	Commisso, Mauro/0000-0001-6474-8577; Munari, Francesca/0000-0002-8217-1481	Regione Veneto; Veneto Agricoltura within the project "Caratterizzazione qualitativa dei principali prodotti ortofrutticoli veneti e del loro ambiente di produzione" [DGR 2860]	Regione Veneto(Regione Veneto); Veneto Agricoltura within the project "Caratterizzazione qualitativa dei principali prodotti ortofrutticoli veneti e del loro ambiente di produzione"	This work was supported by Regione Veneto and Veneto Agricoltura within the project "Caratterizzazione qualitativa dei principali prodotti ortofrutticoli veneti e del loro ambiente di produzione", DGR 2860 30/12/2013. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Apak R, 2016, J AGR FOOD CHEM, V64, P997, DOI 10.1021/acs.jafc.5b04739; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Ballistreri G, 2013, FOOD CHEM, V140, P630, DOI 10.1016/j.foodchem.2012.11.024; Bastos C, 2015, FOOD CHEM, V173, P1045, DOI 10.1016/j.foodchem.2014.10.145; Benzie IFF, 1999, J AGR FOOD CHEM, V47, P633, DOI 10.1021/jf9807768; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chaovanalikit A, 2004, J FOOD SCI, V69; Chockchaisawasdee S, 2016, TRENDS FOOD SCI TECH, V55, P72, DOI 10.1016/j.tifs.2016.07.002; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Crupi P, 2014, J MASS SPECTROM, V49, P1025, DOI 10.1002/jms.3423; Dever MC, 1996, HORTSCIENCE, V31, P150, DOI 10.21273/HORTSCI.31.1.150; Diaz-Mula H, 2010, FOOD SCI TECHNOL INT; Faniadis D, 2010, SCI HORTIC-AMSTERDAM, V125, P301, DOI 10.1016/j.scienta.2010.04.013; Farhadfar S., 2016, International Journal of Agriculture and Forestry, V6, P20; Ferretti G, 2010, MOLECULES, V15, P6993, DOI 10.3390/molecules15106993; Galgano E, 2002, ITALIAN J FOOD SCI, V14; Gallo V, 2015, ANAL CHEM, V87, P6709, DOI 10.1021/acs.analchem.5b00919; Garcia-Montiel F, 2010, SPAN J AGRIC RES, V8, P1118; Goncalves B, 2004, J SCI FOOD AGR, V84, P1013, DOI 10.1002/jsfa.1752; Goncalves B, 2004, J AGR FOOD CHEM, V52, P523, DOI 10.1021/jf030595s; Goncalves B, 2007, FOOD CHEM, V103, P976, DOI 10.1016/j.foodchem.2006.08.039; Gonzalez-Gomez D, 2010, J FOOD COMPOS ANAL, V23, P533, DOI 10.1016/j.jfca.2009.02.008; Habib M, 2015, CRIT REV FO IN PRESS; Hajimehdipoor H, 2014, RES J PHARMACOGN, V1, P35; Hayaloglu AA, 2016, J FOOD SCI, V81, pC7, DOI 10.1111/1750-3841.13175; Hayaloglu AA, 2015, J FOOD SCI, V80, pC564, DOI 10.1111/1750-3841.12781; Herrera E, 2009, NUTR REV, V67, pS140, DOI 10.1111/j.1753-4887.2009.00177.x; Hidalgo M, 2010, FOOD CHEM, V121, P691, DOI 10.1016/j.foodchem.2009.12.097; Iacopini P, 2008, J FOOD COMPOS ANAL, V21, P589, DOI 10.1016/j.jfca.2008.03.011; Jacob RA, 2003, J NUTR, V133, P1826, DOI 10.1093/jn/133.6.1826; Kappel F, 2002, HORTSCIENCE, V37, P139, DOI 10.21273/HORTSCI.37.1.139; Kappel F, 2006, CAN J PLANT SCI, V86, P1197, DOI 10.4141/P05-244; Karlidag H, 2009, BIOTECHNOL BIOTEC EQ, V23, P1325, DOI 10.1080/13102818.2009.10817663; Kelebek H, 2011, INT J FOOD SCI TECH, V46, P2530, DOI 10.1111/j.1365-2621.2011.02777.x; Kelley DS, 2013, J NUTR, V143, P340, DOI 10.3945/jn.112.171371; Kelley DS, 2006, J NUTR, V136, P981, DOI 10.1093/jn/136.4.981; Kim DO, 2005, J AGR FOOD CHEM, V53, P9921, DOI 10.1021/jf0518599; Kurin E, 2012, MOLECULES, V17, P14336, DOI 10.3390/molecules171214336; Liu Y, 2011, J FOOD SCI, V76, pC633, DOI 10.1111/j.1750-3841.2011.02150.x; Liu ZH, 2016, J FOOD SCI, V81, pC1091, DOI 10.1111/1750-3841.13292; Lopez-Alarcon C, 2013, ANAL CHIM ACTA, V763, P1, DOI 10.1016/j.aca.2012.11.051; Marquardt KC, 2013, POLYPHENOLS PUBLIC H; McCune LM, 2011, CRIT REV FOOD SCI, V51, P1, DOI 10.1080/10408390903001719; Milinovic B, 2016, J APPL BOT FOOD QUAL, P89; Mozetic B, 2006, FOOD CHEM, V97, P302, DOI 10.1016/j.foodchem.2005.04.018; Nagy-Gasztonyi M, 2010, CHROMATOGRAPHIA, V71, pS99, DOI 10.1365/s10337-010-1590-1; Olmstead JW, 2007, J AM SOC HORTIC SCI, V132, P697, DOI 10.21273/JASHS.132.5.697; Perez-Sanchez R, 2008, SPAN J AGRIC RES, V6, P42, DOI 10.5424/sjar/2008061-293; Prvulovic D., 2011, WORLD ACAD SCI ENG T, V59, P1149; Schuster M, 2012, SCI HORTIC-AMSTERDAM, V148, P59, DOI 10.1016/j.scienta.2012.09.012; Seeram NP, 2003, NUTR CANCER, V46, P101, DOI 10.1207/S15327914NC4601_13; Serrano M, 2005, J AGR FOOD CHEM, V53, P2741, DOI 10.1021/jf0479160; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087221; Wang X., 2014, FRUIT VEGETABLE CONS; Zhang YQ, 2012, ARTHRITIS RHEUM-US, V64, P4004, DOI 10.1002/art.34677	57	31	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180889	10.1371/journal.pone.0180889	http://dx.doi.org/10.1371/journal.pone.0180889			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732012	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100013
J	Janssen, M; Scheerder, J; Thibaut, E; Brombacher, A; Vos, S				Janssen, Mark; Scheerder, Jeroen; Thibaut, Erik; Brombacher, Aarnout; Vos, Steven			Who uses running apps and sports watches? Determinants and consumer profiles of event runners' usage of running-related smartphone applications and sports watches	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; PSYCHOGRAPHICS; EXPENDITURES; CONSUMPTION; LEISURE; DEMAND	Individual and unorganized sports with a health-related focus, such as recreational running, have grown extensively in the last decade. Consistent with this development, there has been an exponential increase in the availability and use of electronic monitoring devices such as smartphone applications (apps) and sports watches. These electronic devices could provide support and monitoring for unorganized runners, who have no access to professional trainers and coaches. The purpose of this paper is to gain insight into the characteristics of event runners who use running-related apps and sports watches. This knowledge is useful from research, design, and marketing perspectives to adequately address unorganized runners' needs, and to support them in healthy and sustainable running through personalized technology. Data used in this study are drawn from the standardized online Eindhoven Running Survey 2014 (ERS14). In total, 2,172 participants in the Half Marathon Eindhoven 2014 completed the questionnaire (a response rate of 40.0%). Binary logistic regressions were used to analyze the impact of socio-demographic variables, running-related variables, and psychographic characteristics on the use of running-related apps and sports watches. Next, consumer profiles were identified. The results indicate that the use of monitoring devices is affected by socio-demographics as well as sports-related and psychographic variables, and this relationship depends on the type of monitoring device. Therefore, distinctive consumer profiles have been developed to provide a tool for designers and manufacturers of electronic running-related devices to better target (unorganized) runners' needs through personalized and differentiated approaches. Apps are more likely to be used by younger, less experienced and involved runners. Hence, apps have the potential to target this group of novice, less trained, and unorganized runners. In contrast, sports watches are more likely to be used by a different group of runners, older and more experienced runners with higher involvement. Although apps and sports watches may potentially promote and stimulate sports participation, these electronic devices do require a more differentiated approach to target specific needs of runners. Considerable efforts in terms of personalization and tailoring have to be made to develop the full potential of these electronic devices as drivers for healthy and sustainable sports participation.	[Janssen, Mark; Vos, Steven] Fontys Univ Appl Sci, Sch Sports Studies, Eindhoven, Netherlands; [Janssen, Mark; Brombacher, Aarnout; Vos, Steven] Eindhoven Univ Technol, Dept Ind Design, Eindhoven, Netherlands; [Scheerder, Jeroen; Thibaut, Erik; Vos, Steven] Univ Leuven, Policy Sports & Phys Act Res Grp, Leuven, Belgium	Eindhoven University of Technology; KU Leuven	Janssen, M (corresponding author), Fontys Univ Appl Sci, Sch Sports Studies, Eindhoven, Netherlands.; Janssen, M (corresponding author), Eindhoven Univ Technol, Dept Ind Design, Eindhoven, Netherlands.	mark.janssen@fontys.nl	Scheerder, Jeroen/Q-3848-2017	Scheerder, Jeroen/0000-0002-7430-0861; Janssen, Mark/0000-0002-4151-6906				American Psychological Association, 1953, IN DRAFT PRINC, DOI 10.1037/1061-4087.45.2.10; Andreff W., 2001, EC DU SPORT; AppBrain, 2015, ANDR MARK STATS; Arnott I., 2008, INT BUS RES, V1, P3; Barry J, 2009, J MARKET MANAG-UK, V25, P315, DOI 10.1362/026725709X429773; Borgers J, 2016, INT J SPORT POLICY P, V8, P287, DOI 10.1080/19406940.2015.1116458; Bredeweg SW, 2012, BMC MUSCULOSKEL DIS, V46, P196; Buist I, 2010, BRIT J SPORT MED, V44, P598, DOI 10.1136/bjsm.2007.044677; Burgers J, 2015, RUNNING ACROSS EUROPE: THE RISE AND SIZE OF ONE OF THE LARGEST SPORT MARKETS, P28; CASE R., 2001, INT SPORTS J, V5, P118; Clingman J. M., 1987, Journal of Sport Behavior, V10, P123; Dallinga JM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2165-8; Downward P, 2004, J POST KEYNESIAN EC, V26, P371; Downward P., 2007, THE INTERNATIONAL RE, V21, P633, DOI DOI 10.1080/02692170701474710; Downward P, 2010, EUR SPORT MANAG Q, V10, P189, DOI 10.1080/16184740903552037; Eber N., 2003, Journal of Sports Economics, V4, P126, DOI 10.1177/1527002503004002003; Eime RM, 2015, SPORT MANAG REV, V18, P207, DOI 10.1016/j.smr.2014.05.004; Fanning J, 2012, J MED INTERNET RES, V14, P159, DOI 10.2196/jmir.2171; Fiordelli M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2430; Forsberg P, 2015, RUNNING ACROSS EUROPE: THE RISE AND SIZE OF ONE OF THE LARGEST SPORT MARKETS, P59; Fox S, 2012, MOBILE HLTH 2012; Glynn LG, 2014, BRIT J GEN PRACT, V64, pE384, DOI 10.3399/bjgp14X680461; Greenwell T. C., 2002, Sport Marketing Quarterly, V11, P233; Grinblatt M, 2008, REV ECON STAT, V90, P735, DOI 10.1162/rest.90.4.735; Hallmann K, 2012, INT J EVENT FESTIV M, V3, P171, DOI 10.1108/17582951211229717; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Koo GY, 2009, INT J SPORT MANAG, V10, P307; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Lamb K. L., 1992, Leisure Studies, V11, P19, DOI 10.1080/02614369100390281; Lera-Lopez F., 2005, EUR SPORT MANAG Q, V5, P167, DOI [DOI 10.1080/16184740500188656, 10.1080/16184740500188656]; Lera-Lopez F, 2007, J SPORT MANAGE, V21, P103, DOI 10.1123/jsm.21.1.103; McGehee NG, 2003, J SPORT MANAGE, V17, P305, DOI 10.1123/jsm.17.3.305; Middelweerd A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0097-9; Nagel S., 2015, SPORT CLUBS EUROPE C, P7; Nielsen, 2015, STAT MOB APPS; Oga J, 1998, J SPORT MANAGE, V12, P63, DOI 10.1123/jsm.12.1.63; Ogles B. M., 2003, Journal of Sport Behavior, V26, P69; Ohl F., 2007, International Journal of Sport Management and Marketing, V2, P160, DOI 10.1504/IJSMM.2007.011406; Pawlowski T, 2012, ROUT INT HANDB, P354; Rogers E.M., 1983, DIFFUSION INNOVATION, V3rd, P1; Rohm A. J., 2006, Sport Marketing Quarterly, V15, P29; Running USA, 2014, STAT SPORT 2; Scheerder J, 2015, RUNNING ACROSS EUROPE: THE RISE AND SIZE OF ONE OF THE LARGEST SPORT MARKETS, P1, DOI 10.1057/9781137446374; Scheerder J, 2009, FLANDERS RUN SOCIAL; Scheerder J, 2015, RUNNING ACROSS EUROPE: THE RISE AND SIZE OF ONE OF THE LARGEST SPORT MARKETS, P1; Scheerder J, 2011, EUR SPORT MANAG Q, V11, P251, DOI 10.1080/16184742.2011.577931; Shilbury D., 2014, STRATEGIC SPORT MARK, V4th ed; Smith A, 2015, US SMARTPHONE USE 20; Smits T., 2009, VLAANDEREN LOOPT SOC, P291; Sutton W, 2014, SPORT MARKETING; Swan M, 2012, J SENS ACTUAR NETW, V1, P217, DOI 10.3390/jsan1030217; Taks M., 1999, EUR J SPORT MANAG, V6, P4; Taks M., 1995, EUROPEAN J SPORT MAN, V2, P4; Taylor P, 2000, EC SPORT RECREATION; Thibaut E, 2016, INT J SPORT IN PRESS; Thibaut E, 2016, SPORT MANAG REV; Thibaut E, 2014, SPORT MANAG REV, V17, P444, DOI 10.1016/j.smr.2013.12.001; Trail G. T., 2001, Journal of Sport Behavior, V24, P108; Trail G.T., 2003, SPORT MARKET Q, V12, P217; Videbaek S, 2015, SPORTS MED, V45, P1017, DOI 10.1007/s40279-015-0333-8; Vos S, 2016, PROCEDIA ENG ISEA, P1; Vos S., 2014, VRIJETIJDSSTUDIES, V32, P19; Vos S., 2009, VLAANDEREN LOOPT SOC, P267; Vos S, 2015, EUR SPORT MAN C 2015; Vos S., 2014, EASS C UTR, P49; WELLS WD, 1975, J MARKETING RES, V12, P196, DOI 10.2307/3150443; West JH, 2012, J MED INTERNET RES, V14, P184, DOI 10.2196/jmir.1977; Wicker P., 2012, International Journal of Sport Management and Marketing, V12, P1, DOI 10.1504/IJSMM.2012.051246; Wicker P., 2010, SPORT MARKETING QUAR, V13, P214, DOI [DOI 10.1016/J.SMR.2009.07.001, 10.1016/j.smr.2009.07.001, DOI 10.1016/j.smr.2009.07.001]; Wilson T. C., 2002, International Review for the Sociology of Sport, V37, P5, DOI 10.1177/1012690202037001001	70	44	44	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181167	10.1371/journal.pone.0181167	http://dx.doi.org/10.1371/journal.pone.0181167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732074	gold, Green Submitted, Green Published			2022-12-26	WOS:000406643100025
J	Kalimuthu, S; Oh, JM; Gangadaran, P; Zhu, LY; Lee, HW; Jeon, YH; Jeong, SY; Lee, SW; Lee, J; Ahn, BC				Kalimuthu, Senthilkumar; Oh, Ji Min; Gangadaran, Prakash; Zhu, Liya; Lee, Ho Won; Jeon, Yong Hyun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol			Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer	PLOS ONE			English	Article							BREAST-CANCER; TRANSGENE EXPRESSION; RESPONSIVE PROMOTERS; MAMMALIAN-CELLS; TIGHT CONTROL; THERAPY; MICE; MELANOMA; VECTORS; MODEL	Anaplastic thyroid cancer (ATC) is the most aggressive malignancy of the thyroid, during which undifferentiated tumors arise from the thyroid follicular epithelium. ATC has a very poor prognosis due to its aggressive behavior and poor response to conventional therapies. Gene-directed enzyme/prodrug therapy using genetically engineered mesenchymal stromal cells (MSC) is a promising therapeutic strategy. The doxycycline (DOX)-controlled Tet inducible system is the most widely utilized regulatory system and could be a useful tool for therapeutic gene-based therapies. For example, use a synthetic "tetracycline-on" switch system to control the expression of the therapeutic gene thymidine kinase, which converts prodrugs to active drugs. The aim of this study was to develop therapeutic MSCs, harboring an inducible suicide gene, and to validate therapeutic gene expression using optical molecular imaging of ATC. We designed the Tet-On system using a retroviral vector expressing herpes simplex virus thymidine kinase (HSV1-sr39TK) with dual reporters (eGFP-Fluc2). Mouse bone marrow-derived mesenchymal stromal cells (BM-MSC) were transduced using this system with (MSC-Tet-TK/Fluc2) or without (MSC-TK/Fluc) the Tet-On system. Transduced cells were screened and characterized. Engineered MSCs were co-cultured with ATC (CAL62/Rluc) cells in the presence of the prodrug ganciclovir (GCV) and stimulated with DOX. The efficiency of cell killing monitored by assessing Rluc (CAL62/Rluc) and Fluc (MSC-Tet-TK/Fluc and MSC-TK/Fluc) activities using IVIS imaging. Fluc activity increased in MSC-Tet-TK/Fluc cells in a dose dependent manner following DOX treatment (R2 = 0.95), whereas no signal was observed in untreated cells. eGFP could also be visualized after induction with DOX, and the HSV1-TK protein could be detected by western blotting. In MSC-TK/Fluc cells, the Fluc activity increased with increasing cell number (R2 = 0.98), and eGFP could be visualized by fluorescence microscopy. The Fluc activity and cell viability of MSC-Tet-TK/Fluc and MSC-TK/Fluc cells decreased significantly following GCV treatment. A bystander effect of the therapeutic cells confirmed in co-cultures of CAL62 cells, an anaplastic thyroid cancer cell line, with either MSC-Tet-TK/Fluc cells or MSC-TK/Fluc cells. The Rluc activity in MSC-Tet-TK/Fluc co-cultures, derived from the CAL62/Rluc cells, decreased significantly with GCV treatment of DOX treated cultures, whereas no significant changes were observed in untreated cultures. In addition, the Fluc activity of MSC-Tet-TK/Fluc cells also decreased significantly with DOX treatment whereas no signal was present in untreated cultures. A bystander effect also be demonstrated in co-cultures with MSC-TK/Fluc cells and CAL62/Rluc; both the Rluc activity and the Fluc activity were significantly decreased following GCV treatment. We have successfully developed a Tet-On system of gene-directed enzyme/prodrug delivery using MSCs. We confirmed the therapeutic bystander effect in CAL62/Rluc cells with respect to MSC-Tet-TK/Fluc and MSC-TK/Fluc cells after GCV treatment with and without DOX. Our results confirm the therapeutic efficiency of a suicide gene, with or without the Tet-On system, for ATC therapy. In addition, our findings provide an innovative therapeutic approach for using the Tet-On system to eradicate tumors by simple, repeated administration of MSC-Tet-TK/Fluc cells with DOX and GCV.	[Kalimuthu, Senthilkumar; Oh, Ji Min; Gangadaran, Prakash; Zhu, Liya; Lee, Ho Won; Jeon, Yong Hyun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med Hosp, Dept Nucl Med, Daegu, South Korea	Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med Hosp, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Jeon, Yong hyun/N-6910-2019; Lee, Jaetae/AAR-3317-2021; Lee, Jaetae/ABF-3980-2020; Gangadaran, Prakash/AAV-3102-2021	Jeon, Yong hyun/0000-0003-3161-7698; Gangadaran, Prakash/0000-0002-0658-4604; Ahn, Byeong-Cheol/0000-0001-7700-3929	National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [2012M2A2A7014020]; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI16C1501]; Medical Cluster R&D Support Project of Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF); Ministry of Health & Welfare, Republic of Korea [HT13C0002, H115C0001]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF- 2015M2A2A7A01045177]; basic science research program through the NRF - ministry of education [NRF-2016R1D1A1A02936968]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER	National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology; Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Medical Cluster R&D Support Project of Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF) grant - Korean government (MSIP); basic science research program through the NRF - ministry of education(National Research Foundation of Korea); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Nuclear R&D Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (No. 2012M2A2A7014020), a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI16C1501), a grant from the Medical Cluster R&D Support Project of Daegu-Gyeongbuk Medical Innovation Foundation (DGMIF) funded by the Ministry of Health & Welfare, Republic of Korea (HT13C0002), and a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H115C0001). This work was also supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. NRF- 2015M2A2A7A01045177). Also this research was supported by basic science research program through the NRF funded by the ministry of education (NRF-2016R1D1A1A02936968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BC, 2012, THERANOSTICS, V2, P392, DOI 10.7150/thno.3722; Amano S, 2009, INT J ONCOL, V35, P1265, DOI 10.3892/ijo_00000443; Amer MH, 2014, MOL CELL THER, V2, P1; Barese CN, 2012, MOL THER, V20, P1932, DOI 10.1038/mt.2012.166; Bonini C, 2007, MOL THER, V15, P1248, DOI 10.1038/sj.mt.6300190; Cavarretta IT, 2010, MOL THER, V18, P223, DOI 10.1038/mt.2009.237; de Melo SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128922; Dwyer RM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt25; Fillat C., 2003, Current Gene Therapy, V3, P13, DOI 10.2174/1566523033347426; Gebremedhin S, 2014, EUR J PHARM SCI, V60, P72, DOI 10.1016/j.ejps.2014.03.003; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Han Y, 2010, GENE THER, V17, P616, DOI 10.1038/gt.2010.6; Hoyng SA, 2014, GENE THER, V21, P549, DOI 10.1038/gt.2014.22; Josiah DT, 2010, MOL THER, V18, P377, DOI 10.1038/mt.2009.265; Kim JE, 2015, NUCL MED MOLEC IMAG, V49, P3, DOI 10.1007/s13139-014-0309-x; Kim KB, 2004, CANCER-AM CANCER SOC, V101, P596, DOI 10.1002/cncr.20403; Kis Z, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1000; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Koponen JK, 2003, GENE THER, V10, P459, DOI 10.1038/sj.gt.3301889; Kucerova L, 2008, J GENE MED, V10, P1071, DOI 10.1002/jgm.1239; Kucerova L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-129; Latta-Mahieu M, 2002, HUM GENE THER, V13, P1611, DOI 10.1089/10430340260201707; Leng L, 2014, BIOMATERIALS, V35, P5162, DOI 10.1016/j.biomaterials.2014.03.014; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Mader EK, 2009, CLIN CANCER RES, V15, P7246, DOI 10.1158/1078-0432.CCR-09-1292; Matuskova M, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0149-2; Mizuguchi H, 2003, HUM GENE THER, V14, P1265, DOI 10.1089/104303403767740803; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Nouri FS, 2015, J CONTROL RELEASE, V200, P179, DOI 10.1016/j.jconrel.2015.01.003; Patel Kepal N, 2006, Cancer Control, V13, P119; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Rodenhuis S, 2003, NEW ENGL J MED, V349, P7, DOI 10.1056/NEJMoa022794; Schmeisser F, 2002, HUM GENE THER, V13, P2113, DOI 10.1089/104303402320987815; Sekar TV, 2014, THERANOSTICS, V4, P460, DOI 10.7150/thno.8077; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Strachan T, 1999, GENE THERAPY OTHER M; Su H, 2004, MOL IMAGING BIOL, V6, P139, DOI 10.1016/j.mibio.2004.02.001; Torsvik A, 2013, CANCER TREAT REV, V39, P180, DOI 10.1016/j.ctrv.2012.03.005; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vilalta M, 2009, GENE THER, V16, P547, DOI 10.1038/gt.2008.176; Wang LN, 2013, CURR PHARM BIOTECHNO, V14, P683; Weichselbaum RR, 1997, LANCET, V349, pS10, DOI 10.1016/S0140-6736(97)90013-1; Yong RL, 2009, CANCER RES, V69, P8932, DOI 10.1158/0008-5472.CAN-08-3873; Zeng ZJ, 2006, CANCER GENE THER, V13, P290, DOI 10.1038/sj.cgt.7700889; Zhang TY, 2015, J CONTROL RELEASE, V209, P260, DOI 10.1016/j.jconrel.2015.05.007; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780	49	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181318	10.1371/journal.pone.0181318	http://dx.doi.org/10.1371/journal.pone.0181318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727740	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500056
J	Pandey, R; Kumar, B; Meena, B; Srivastava, M; Mishra, T; Tiwari, V; Pal, M; Nair, NK; Upreti, DK; Rana, TS				Pandey, Renu; Kumar, Brijesh; Meena, Baleshwar; Srivastava, Mukesh; Mishra, Tripti; Tiwari, Vandana; Pal, Mahesh; Nair, Narayanan K.; Upreti, Dalip K.; Rana, Tikam Singh			Major bioactive phenolics in Bergenia species from the Indian Himalayan region: Method development, validation and quantitative estimation using UHPLC-QqQ(LIT)-MS/MS	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHIC DETERMINATION; THIN-LAYER-CHROMATOGRAPHY; MASS-SPECTROMETRY; GALLIC ACID; SIMULTANEOUS QUANTIFICATION; LIGULATA; LEAVES; HPLC; ANTIOXIDANT; CRASSIFOLIA	Bergenia species are important medicinal plants used in indigenous systems of medicine for their antilithiatic and diuretic properties. An ultra-high performance liquid chromatography coupled to hybrid linear ion trap triple quadrupole mass spectrometry (UHPLC-QqQLIT-MS/MS) method has been developed and validated for the estimation of quantitative variation of eight major bioactive phenolics in the rhizomes (150 samples) of four species of this herb, Bergenia (B. ciliata, B. ligulata, B. purpurascens and B. stracheyi). Chromatographic separation was obtained on a Waters ACQUITY UPLC (TM) BEH (ethylene bridged hybrid) C-18 column with a mobile phase consisting of 0.1% (v/v) formic acid aqueous solution and acetonitrile under a gradient elution manner. A hybrid linear ion trap triple quadrupole mass spectrometer was operated in negative electrospray ionization mode with multiple reactions monitoring for detection and quantification of the eight compounds. The validated method demonstrated good linearity (r(2) >= 0.9991), precision (RSD <= 1.87%) and accuracy (95.16 - 102.11%, RSD <= 1.83%) for all reference analytes. The quantitative results revealed that B. ligulata contains the highest amount of the major active marker-bergenin. The results also suggest that sensitive UHPLC-QqQLIT-MS/MS method, a sensitive, accurate and convenient one, could be helpful in identification of potential accession(s), rapid quality control and establishing authenticity of Bergenia species as raw material for pharmaceutical industries.	[Pandey, Renu; Kumar, Brijesh] CSIR Cent Drug Res Inst, Sophisticated Analyt Instrument Facil, Lucknow, Uttar Pradesh, India; [Pandey, Renu; Kumar, Brijesh; Srivastava, Mukesh] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Meena, Baleshwar; Tiwari, Vandana; Nair, Narayanan K.; Upreti, Dalip K.; Rana, Tikam Singh] CSIR Natl Bot Res Inst, Plant Divers Systemat & Herbarium Div, Lucknow, Uttar Pradesh, India; [Srivastava, Mukesh] CSIR Cent Drug Res Inst, Biometry & Stat Div, Lucknow, Uttar Pradesh, India; [Mishra, Tripti; Pal, Mahesh] CSIR Natl Bot Res Inst, Phytochem Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Kumar, B (corresponding author), CSIR Cent Drug Res Inst, Sophisticated Analyt Instrument Facil, Lucknow, Uttar Pradesh, India.; Kumar, B (corresponding author), Acad Sci & Innovat Res AcSIR, New Delhi, India.; Rana, TS (corresponding author), CSIR Natl Bot Res Inst, Plant Divers Systemat & Herbarium Div, Lucknow, Uttar Pradesh, India.	brijesh_kumar@cdri.res.IN; ranats@nbri.res.in	Kumar, Prof. Brijesh/A-7485-2012; PANDEY, RENU/M-9265-2019; PANDEY, RENU/U-6994-2019; Kumar, Brijesh/GPP-3392-2022	Kumar, Prof. Brijesh/0000-0003-0271-3445; Kumar, Brijesh/0000-0003-0271-3445; MISHRA, Dr. TRIPTI/0000-0002-8918-2749; Pandey, Renu/0000-0003-1892-2495	Biopros-PR [BSC-0106]; Council of Scientific and Industrial Research, New Delhi; Council of Scientific and Industrial Research, New Delhi under the project 'Biopros-PR [BSC-0106]	Biopros-PR; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, New Delhi under the project 'Biopros-PR	This work was supported by Biopros-PR (BSC-0106); Council of Scientific and Industrial Research, New Delhi. Dr. D. K. Upreti, CSIR-National Botanical Research Institute, Lucknow 226001, India.; The authors are thankful to the Director CSIR-National Botanical Research Institute for facilities and encouragements, and the Council of Scientific and Industrial Research, New Delhi for financial support under the project 'Biopros-PR (BSC-0106)'.	Aggarwal D, 2014, J ETHNOPHARMACOL, V158, P85, DOI 10.1016/j.jep.2014.10.013; Bagul M. S., 2003, Journal of Natural Remedies, V3, P83; Boros B, 2014, CHROMATOGRAPHIA, V77, P1129, DOI 10.1007/s10337-014-2624-x; Byahatti VV, 2010, ANC SCI LIFE, V30, P14; Chauhan R., 2013, INT J PHARM PHARM SC, V5, P9; Chernetsova ES, 2012, RAPID COMMUN MASS SP, V26, P1329, DOI 10.1002/rcm.6226; Chitme HR, 2010, INT J PHARM SCI RES, V1, P24, DOI 10.13040/IJPSR.0975-8232.1(2).24-31; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Dhalwal K, 2008, J FOOD COMPOS ANAL, V21, P496, DOI 10.1016/j.jfca.2008.02.008; Dharmender R., 2010, PHARM ANAL ACTA 1, V104, P2153, DOI [10.4172/2153-2435.1000104, DOI 10.4172/2153-2435.1000104]; Fang NB, 2002, J AGR FOOD CHEM, V50, P3579, DOI 10.1021/jf0201327; Faried A, 2007, INT J ONCOL, V30, P605; Gaur R., 1999, FLORA DISTRICT GARHW; Hossain MB, 2010, J AGR FOOD CHEM, V58, P10576, DOI 10.1021/jf102042g; Huang WY, 2010, NUTR CANCER, V62, P1, DOI 10.1080/01635580903191585; Kraujaliene V, 2016, IND CROP PROD, V89, P390, DOI 10.1016/j.indcrop.2016.05.034; Kunle O. F., 2012, International Journal of Biodiversity and Conservation, V4, P101, DOI 10.5897/IJBC11.163; Liu Y, 2009, J MASS SPECTROM, V44, P1182, DOI 10.1002/jms.1593; Norden B, 2005, CHEM BIODIVERS, V2, P1487, DOI 10.1002/cbdv.200590120; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS165; Pozharitskaya ON, 2007, J SEP SCI, V30, P2447, DOI 10.1002/jssc.200700178; Pushpalatha HB, 2015, PHARMACOGN MAG, V11, pS60, DOI 10.4103/0973-1296.157690; Reddy UDC, 1999, PHYTOCHEM ANALYSIS, V10, P44, DOI 10.1002/(SICI)1099-1565(199901/02)10:1&lt;44::AID-PCA424&gt;3.0.CO;2-4; Ren YP, 2013, CHIN PHARM J, V6, P477; Ruby K.M., 2012, INT J PHARM PHARM SC, V1, P100; Ruby KM, 2015, ASIAN J PLANT SCI RE, V5, P34; Rychlinska I, 2012, NOT BOT HORTI AGROBO, V40, P109; Salminen JP, 2014, NAT PROD RES, V28, P1530, DOI 10.1080/14786419.2014.923999; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Singh DP, 2007, ACTA CHROMATOGR, V19, P246; Song HJ, 2013, BIOMED CHROMATOGR, V27, P1398, DOI 10.1002/bmc.2934; Srivastava N, 2016, J CHROMATOGR SCI, V54, P460, DOI 10.1093/chromsci/bmv154; Srivastava N, 2015, J LIQ CHROMATOGR R T, V38, P1722, DOI 10.1080/10826076.2015.1091012; Srivastava N, 2015, J LIQ CHROMATOGR R T, V38, P1207, DOI 10.1080/10826076.2015.1025145; Srivastava N, 2014, RSC ADV, V4, P52647, DOI 10.1039/c4ra09330e; Srivastava N, 2014, JPC-J PLANAR CHROMAT, V27, P69, DOI 10.1556/JPC.27.2014.1.13; Srivastava S, 2008, J SCI IND RES INDIA, V67, P65; Tiwari V, 2015, BIOCHEM SYST ECOL, V60, P165, DOI 10.1016/j.bse.2015.04.018; Uddin G, 2014, TROP BIOMED, V31, P143; Vinesh Kumar, 2013, International Journal of Current Microbiology and Applied Sciences, V2, P328; Yilmaz Y, 2006, TRENDS FOOD SCI TECH, V17, P64, DOI 10.1016/j.tifs.2005.10.005; Zhang YS, 2011, J MED PLANTS RES, V5, P4396; Zhao JY, 2006, FLAVOUR FRAG J, V21, P431, DOI 10.1002/ffj.1689	43	10	11	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180950	10.1371/journal.pone.0180950	http://dx.doi.org/10.1371/journal.pone.0180950			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749965	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700026
J	Patino-Ruiz, M; Ganea, C; Fendler, K; Calinescu, O				Patino-Ruiz, Miyer; Ganea, Constanta; Fendler, Klaus; Calinescu, Octavian			Competition is the basis of the transport mechanism of the NhaB Na+/H+ exchanger from Klebsiella pneumoniae	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIPORTER NHAA; PH REGULATION; MEMBRANE; BINDING; GENE; ADAPTATION; EXPRESSION; ALIGNMENT; CLONING	Na+/H+ exchange is essential for survival of all organisms, having a role in the regulation of the intracellular Na+ concentration, pH and cell volume. Furthermore, Na+/H+ exchangers were shown to be involved in the virulence of the bacterium Yersinia pestis, indicating they might be potential targets for novel antibiotic treatments. The model system for Na+/H+ exchangers is the NhaA transporter from Escherichia coli, EcNhaA. Therefore, the general transport mechanism of NhaA exchangers is currently well characterized. However, much less is known about NhaB exchangers, with only a limited number of studies available. The pathogen Klebsiella pneumoniae, which is a major source of nosocomial infection, possesses three electrogenic Na+/H+ exchangers, KpNhaA1, KpNhaA2 and KpNhaB, none of which have been previously investigated. Our aim in this study was to functionally characterize KpNhaB using solid supported membrane-based electrophysiology as the main investigation technique, and thus provide the first electrophysiological investigation of an NhaB Na+/H+ exchanger. We found that NhaB can be described by the same competition-based mechanism that was shown to be valid for electrogenic NhaA and NapA, and for electroneutral NhaP Na+/H+ exchangers. For comparison we also characterized the activity of KpNhaA1 and KpNhaA2 and found that the three exchangers have complementary activity profiles, which is likely a survival advantage for K. pneumoniae when faced with environments of different salinity and pH. This underlines their importance as potential antibiotic drug targets.	[Patino-Ruiz, Miyer; Ganea, Constanta; Fendler, Klaus; Calinescu, Octavian] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Ganea, Constanta; Calinescu, Octavian] Carol Davila Univ Med & Pharm, Dept Biophys, Bucharest, Romania	Max Planck Society; Carol Davila University of Medicine & Pharmacy	Calinescu, O (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.; Calinescu, O (corresponding author), Carol Davila Univ Med & Pharm, Dept Biophys, Bucharest, Romania.	octavian.calinescu@gmail.com	Ganea, Constanta/A-8561-2011; Calinescu, Octavian/P-4278-2014	Ganea, Constanta/0000-0003-3489-6901; Calinescu, Octavian/0000-0001-8003-0442; Patino-Ruiz, Miyer Fabian/0000-0003-0607-4281	Romanian National Authority for Scientific Research and Innovation, CNCS - UEFISCDI [PN-II-RU-TE-2014-4-0604]; DIP (Deutsche Forschungsgemeinschaft, dfg.de, German-Israeli Project Cooperation) [LA3655/1-1]	Romanian National Authority for Scientific Research and Innovation, CNCS - UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); DIP (Deutsche Forschungsgemeinschaft, dfg.de, German-Israeli Project Cooperation)	OC and CG were supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CNCS - UEFISCDI (uefiscdi.ro), project number PN-II-RU-TE-2014-4-0604. MPR and KF were supported by the DIP (Deutsche Forschungsgemeinschaft, dfg.de, German-Israeli Project Cooperation #LA3655/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; Calinescu O, 2017, J BIOL CHEM, V292, P7932, DOI 10.1074/jbc.M117.778175; Calinescu O, 2016, J BIOL CHEM, V291, P26786, DOI 10.1074/jbc.M116.761080; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Calinescu O, 2014, FEBS LETT, V588, P3111, DOI 10.1016/j.febslet.2014.05.066; Calinescu O, 2014, J BIOL CHEM, V289, P13168, DOI 10.1074/jbc.M113.542993; Dover N, 1996, J BACTERIOL, V178, P6508, DOI 10.1128/jb.178.22.6508-6517.1996; Enomoto H, 1998, BBA-BIOMEMBRANES, V1370, P77, DOI 10.1016/S0005-2736(97)00245-9; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; Gerchman Y, 2001, BIOCHEMISTRY-US, V40, P3403, DOI 10.1021/bi002669o; Gomez-Simmonds A, 2017, J INFECT DIS, V215, pS18, DOI 10.1093/infdis/jiw378; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; The HC, 2015, EMBO MOL MED, V7, P227, DOI 10.15252/emmm.201404767; Herz K, 2003, J BACTERIOL, V185, P1236, DOI 10.1128/JB.185.4.1236-1244.2003; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kiriyama W, 2013, MICROBIOL-SGM, V159, P2191, DOI 10.1099/mic.0.070656-0; Kiriyama W, 2012, BIOCHEMISTRY-US, V51, P7766, DOI 10.1021/bi300738v; Kurz Matthias, 2006, Saline Syst, V2, P10, DOI 10.1186/1746-1448-2-10; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Lentes CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101575; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Minato Y, 2013, INFECT IMMUN, V81, P3163, DOI 10.1128/IAI.00071-13; Nakamura T, 2001, J BACTERIOL, V183, P5762, DOI 10.1128/JB.183.19.5762-5767.2001; Nozaki K, 1996, BIOCHEM BIOPH RES CO, V222, P774, DOI 10.1006/bbrc.1996.0820; PADAN E, 1989, J BIOL CHEM, V264, P20297; PADAN E, 1994, J EXP BIOL, V196, P443; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Padan E, 2014, BBA-BIOENERGETICS, V1837, P1047, DOI 10.1016/j.bbabio.2013.12.007; Padan E, 2009, J EXP BIOL, V212, P1593, DOI 10.1242/jeb.026708; Paulino C, 2014, ELIFE, V3, DOI 10.7554/eLife.03583; PINNER E, 1992, J BIOL CHEM, V267, P11064; PINNER E, 1993, J BIOL CHEM, V268, P1729; PINNER E, 1994, J BIOL CHEM, V269, P26274; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Pragai Z, 2001, J BACTERIOL, V183, P2505, DOI 10.1128/JB.183.8.2505-2515.2001; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Tadini-Buoninsegni F, 2015, CHEM ANAL SERIES MON, P147; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Uzdavinys P, 2017, P NATL ACAD SCI USA, V114, pE1101, DOI 10.1073/pnas.1614521114; Venturi M, 2003, MEMBRANE PROTEIN PUR, P179; Wang YH, 2017, CAN J MICROBIOL, V63, P596, DOI 10.1139/cjm-2017-0104; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Wohlert D, 2014, ELIFE, V3, DOI 10.7554/eLife.03579; Xu LF, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0191-3; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	57	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182293	10.1371/journal.pone.0182293	http://dx.doi.org/10.1371/journal.pone.0182293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750048	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700143
J	Sharma, P; Finley, R; Weese, S; Glass-Kaastra, S; McIsaac, W				Sharma, Prateek; Finley, Rita; Weese, Scott; Glass-Kaastra, Shiona; McIsaac, Warren			Antibiotic prescriptions for outpatient acute rhinosinusitis in Canada, 2007-2013	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE SINUSITIS; NATIONAL TRENDS; VISIT RATES; CHILDREN; ADULTS; GUIDELINES; PROGRAM; DISEASE	Introduction Acute rhinosinusitis (ARS) is a respiratory disease commonly caused by viral infections. Physicians regularly prescribe antibiotics despite bacterial etiologies being uncommon. This is of concern, as this use adds to the selection pressure for resistance. Here we present the descriptive epidemiology of acute rhinosinusitis and corresponding antibiotic prescribing practices by Canadian outpatient physicians from 2007-2013. Materials/Methods Diagnosis and antibiotic prescription data for ARS were extracted from the Canadian Disease and Therapeutic Index for 2007 to 2013, and population data were acquired from Statistics Canada. ARS diagnosis and antibiotic prescription rates and frequencies of antibiotic classes were calculated. Results Eighty-eight percent of patients diagnosed with ARS in 2013 were adults, with a greater rate of antibiotic prescriptions observed among the adults relative to the pediatric patients (1632.9 and 468.6 antibiotic prescriptions per 10,000 inhabitants). Between 2007 and 2013, the ARS diagnosis rate decreased from 596 to 464 diagnoses per 10,000 inhabitants, while the percentage of diagnoses with antibiotic prescriptions at the national level remained stable (87% to 84%). From 2007 to 2013, prescription rates for macrolides decreased from 203.5 to 105.4 prescriptions per 10,000 inhabitants. In 2013, penicillins with extended spectrum were more commonly prescribed compared to macrolides among adult patients (153.5 and 105.4 prescriptions per 10,000 inhabitants, respectively). Conclusion This study is the first to describe physician antibiotic prescribing practices for treatment of ARS in Canada. Results show that antibiotic treatment for ARS represents an area for implementing antimicrobial stewardship, and through it, managing antibiotic resistance. Further work is required to better understand diagnosing practices and treatment criteria for ARS, and use this information to further assist physicians to limit unnecessary antibiotic prescribing practices.	[Sharma, Prateek; Weese, Scott] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Finley, Rita; Glass-Kaastra, Shiona] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [McIsaac, Warren] Mt Sinai Hosp, Ray D Wolfe Dept Family Med, Granovsky Gluskin Family Med Ctr, Toronto, ON, Canada; [McIsaac, Warren] Univ Toronto, Dept Community & Family Med, Toronto, ON, Canada	University of Guelph; Public Health Agency of Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Finley, R (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada.	rita.finley@phac-aspc.gc.ca						Ahovuo-Saloranta A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000243.pub3; [Anonymous], 2012, GUIDELINES ATC CLASS; [Anonymous], 1997, EAR NOSE THROAT J, V76, P1; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2012, ANTIINFECTIVE REV PA; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Blondel-Hill E., 2012, BUGS DRUGS 2012; Bulloch AGM, 2012, CAN J PSYCHIAT, V57, P263, DOI 10.1177/070674371205700410; Chow AW, 2012, CLIN INFECT DIS, V54, pE72, DOI [10.1093/cid/cis370, 10.1093/cid/cir1043]; Desrosiers M, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-2; Fairlie T, 2012, ARCH INTERN MED, V172, P1513, DOI 10.1001/archinternmed.2012.4089; Finley R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076398; Fuertes EI, 2010, CAN J PUBLIC HEALTH, V101, P304, DOI 10.1007/BF03405291; Kellner JD, 2011, PAED CHILD HEALT-CAN, V16, P233, DOI 10.1093/pch/16.4.233; Mckay RM, 2011, CAN J INFECT DIS MED, V22, P19, DOI 10.1155/2011/745090; Meeker D, 2014, JAMA INTERN MED, V174, P425, DOI 10.1001/jamainternmed.2013.14191; Mol PGM, 2005, J ANTIMICROB CHEMOTH, V55, P550, DOI 10.1093/jac/dki037; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Morris A, 2012, ANTIMICROBIAL STEWAR; Parkins MD, 2009, CANADIAN J INFECT DI, V20, P81; Public Health Agency of Canada, 2015, HUM ANT US REP 2014; Public Health Agency of Canada, 2014, 20122013 PUBL HLT AG; Public Health England, 2016, COST EFFECTIVE COMMI, P1; Shapiro DJ, 2011, PEDIATRICS, V127, P28, DOI 10.1542/peds.2010-1340; Smith SS, 2013, OTOLARYNG HEAD NECK, V148, P852, DOI 10.1177/0194599813479768; Statistics Canada, 2011, DEM DIV DEM EST SECT; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Worrall G, 2011, CAN FAM PHYSICIAN, V57, P565	28	7	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181957	10.1371/journal.pone.0181957	http://dx.doi.org/10.1371/journal.pone.0181957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750020	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700106
J	Xu, LL; Qin, Y; Yang, J; Han, W; Lei, YJ; Feng, HX; Zhu, XY; Li, YM; Yu, HJ; Feng, LZ; Shi, Y				Xu, Lili; Qin, Ying; Yang, Juan; Han, Wei; Lei, Youju; Feng, Huaxiang; Zhu, Xiaoyun; Li, Yanming; Yu, Hongjie; Feng, Luzhao; Shi, Yan			Coverage and factors associated with influenza vaccination among kindergarten children 2-7 years old in a low-income city of north-western China (2014-2016)	PLOS ONE			English	Article							PANDEMIC INFLUENZA; ADULTS; POPULATION; ATTITUDES; BELIEFS	Influenza vaccination has been shown to be the most effective preventive measure to reduce influenza virus infection and its related morbidity and mortality. Young children aged 6-59 months are recommended as one of the priority groups for seasonal influenza vaccination in China. Our study was conducted to evaluate the level of influenza vaccination coverage during 2014-15 and 2015-16 influenza seasons among kindergarten children aged 2-7 years in Xining, a low-income city of north-western China, and to explore potential factors for noncompliance associated with influenza vaccination. The coverage rate of influenza vaccination was 12.2% (95 CI: 10.6-14.2%) in 2014-15 and 12.8% (95 CI: 11.1-14.7%) in 2015-16. The low coverage rate was found to be primarily associated with the lack of knowledge about influenza vaccine in children's parents. The most common reason for vaccine declination was the concern about adverse reactions of vaccine. Therefore tailored information should be provided by clinician and public health doctors for targeted groups through effective methods to improve public understanding of vaccination.	[Xu, Lili; Han, Wei; Lei, Youju; Feng, Huaxiang; Zhu, Xiaoyun; Li, Yanming; Shi, Yan] Qinghai Prov Ctr Dis Control & Prevent, Inst Infect Dis Control & Prevent, Xining, Qinghai, Peoples R China; [Xu, Lili] Western China Field Epidemiol Training Program, Beijing, Peoples R China; [Qin, Ying; Yang, Juan; Yu, Hongjie; Feng, Luzhao] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Shi, Y (corresponding author), Qinghai Prov Ctr Dis Control & Prevent, Inst Infect Dis Control & Prevent, Xining, Qinghai, Peoples R China.; Feng, LZ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	fenglz@chinacdc.cn; qhcdcshy@126.com	Yu, Hongjie/GZK-5351-2022; li, yan/GTI-4638-2022; xu, li/GNH-3667-2022	Xu, Lili/0000-0002-6590-8189				Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Cohen B, 2012, J EPIDEMIOL COMMUN H, V66, P204, DOI 10.1136/jech.2009.099879; Fang R, 2016, VACCINE; Feng LZ, 2015, HUM VACC IMMUNOTHER, V11, P2077, DOI 10.1080/21645515.2015.1027470; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Guiney H, 2014, NEW ZEAL MED J, V127, P28; Heikkinen T, 2006, EUR J PEDIATR, V165, P223, DOI 10.1007/s00431-005-0040-9; Hofmann F, 2006, INFECTION, V34, P142, DOI 10.1007/s15010-006-5109-5; Huang T, 2014, MODERN PREVENTIVE ME, V41; Kittikraisak W, 2015, INFLUENZA OTHER RESP, V9, P85, DOI 10.1111/irv.12302; Lau JTF, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4164; Lin CJ, 2006, J URBAN HEALTH, V83, P874, DOI 10.1007/s11524-006-9084-z; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Manzoli L, 2012, HUM VACC IMMUNOTHER, V8, P851, DOI 10.4161/hv.19917; Mereckiene J, 2014, EUROSURVEILLANCE B E, V19, P4361; Olivier CW, 2012, HUM VACC IMMUNOTHER, V8, P107, DOI 10.4161/hv.8.1.18278; Oria PA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-391; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pfeil A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-402; Santibanez TA, 2014, PUBLIC HEALTH REP, V129, P417, DOI 10.1177/003335491412900505; Schult TM, 2012, INFECT CONT HOSP EP, V33, P924, DOI 10.1086/667370; Talbot HK, 2011, J INFECT DIS, V203, P500, DOI 10.1093/infdis/jiq076; Webster RG, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P1, DOI 10.1002/9781118636817; Wu S., 2013, BMC PUBLIC HEALTH, V13, P1; Wu ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169199; Yang J, 2016, VACCINE, V34, P5724, DOI 10.1016/j.vaccine.2016.10.013; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073724; [朱小凤 Zhu Xiaofeng], 2013, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V13, P543	29	3	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181539	10.1371/journal.pone.0181539	http://dx.doi.org/10.1371/journal.pone.0181539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749980	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700055
J	Soberg, K; Moen, LV; Skalhegg, BS; Laerdahl, JK				Soberg, Kristoffer; Moen, Line Victoria; Skalhegg, Bjorn Steen; Laerdahl, Jon Kristen			Evolution of the cAMP-dependent protein kinase (PKA) catalytic subunit isoforms	PLOS ONE			English	Article							SPLICE VARIANTS; C-BETA; GENE; PHOSPHORYLATION; EXPRESSION; SWITCH; HOLOENZYMES; DEAMIDATION; C-BETA-2; INSIGHTS	The 3', 5'-cyclic adenosine monophosphate (cAMP)-dependent protein kinase, or protein kinase A (PKA), pathway is one of the most versatile and best studied signaling pathways in eukaryotic cells. The two paralogous PKA catalytic subunits C alpha and C beta, encoded by the genes PRKACA and PRKACB, respectively, are among the best understood model kinases in signal transduction research. In this work, we explore and elucidate the evolution of the alternative 5' exons and the splicing pattern giving rise to the numerous PKA catalytic subunit isoforms. In addition to the universally conserved C alpha 1/C beta 1 isoforms, we find kinase variants with short N-termini in all main vertebrate classes, including the sperm-specific C alpha 2 isoform found to be conserved in all mammals. We also describe, for the first time, a PKA C alpha isoform with a long N-terminus, paralogous to the PKA C beta 2 N-terminus. An analysis of isoform-specific variation highlights residues and motifs that are likely to be of functional importance.	[Soberg, Kristoffer; Moen, Line Victoria; Skalhegg, Bjorn Steen] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Soberg, Kristoffer] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, Oslo, Norway; [Laerdahl, Jon Kristen] Natl Hosp Norway, Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Laerdahl, Jon Kristen] Univ Oslo, Dept Informat, Bioinformat Core Facil, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo	Skalhegg, BS (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway.	b.s.skalhegg@medisin.uio.no	Skålhegg, Bjørn Steen/AAZ-2976-2021	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Laerdahl, Jon Kristen/0000-0002-0826-9464	University of Oslo; Throne Hoist	University of Oslo; Throne Hoist	This work was supported by University of Oslo (BSS)_2015/2017, http://www.uio.no/; Norwegian Cancer Society # 2284135, https:// kreftforeningen.no/; Throne Hoist (BSS) 2015/2016, http://www.uio.no/for-ansatte/arbeidsstotte/ fa/finansiering/internt/med/imb/throne-holst/.	ADAMS JA, 1993, PROTEIN SCI, V2, P2177, DOI 10.1002/pro.5560021217; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Desseyn JL, 2000, P NATL ACAD SCI USA, V97, P6433, DOI 10.1073/pnas.97.12.6433; Funderud A, 2009, CELL SIGNAL, V21, P274, DOI 10.1016/j.cellsig.2008.10.013; Funderud Ane, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-20; Gaffarogullari EC, 2011, J MOL BIOL, V411, P823, DOI 10.1016/j.jmb.2011.06.034; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hereng TH, 2012, J STRUCT BIOL, V178, P300, DOI 10.1016/j.jsb.2012.03.013; Higuchi H, 2003, EMBO J, V22, P1790, DOI 10.1093/emboj/cdg177; Hille F, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0496; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jedrzejewski PT, 1998, PROTEIN SCI, V7, P457; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Knape MJ, 2015, ACS CHEM BIOL, V10, P2303, DOI 10.1021/acschembio.5b00271; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kvissel AK, 2004, CELL SIGNAL, V16, P577, DOI 10.1016/j.cellsig.2003.08.014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen ACV, 2008, FEBS J, V275, P250, DOI 10.1111/j.1742-4658.2007.06195.x; Lowe CJ, 2015, NATURE, V520, P456, DOI 10.1038/nature14434; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Orstavik S, 2001, EUR J BIOCHEM, V268, P5066, DOI 10.1046/j.0014-2956.2001.02429.x; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pepperkok R, 2000, J CELL BIOL, V148, P715, DOI 10.1083/jcb.148.4.715; Reinton N, 2000, BIOL REPROD, V63, P607, DOI 10.1095/biolreprod63.2.607; Reinton N, 1998, GENOMICS, V49, P290, DOI 10.1006/geno.1998.5240; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; San Agustin JT, 1998, J BIOL CHEM, V273, P24874, DOI 10.1074/jbc.273.38.24874; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; Schiebel K, 1997, HUM MOL GENET, V6, P1985, DOI 10.1093/hmg/6.11.1985; Sjoberg TJ, 2010, PROTEIN SCI, V19, P1213, DOI 10.1002/pro.400; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Soberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060935; Stanger SJ, 2016, FASEB J, V30, P2777, DOI 10.1096/fj.201500136R; Susuki-Miyata S, 2015, P NATL ACAD SCI US; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Tholey A, 2001, BIOCHEMISTRY-US, V40, P225, DOI 10.1021/bi0021277; Thullner S, 2000, BIOCHEM J, V351, P123, DOI 10.1042/0264-6021:3510123; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Vetter MM, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-40; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WIEMANN S, 1991, J BIOL CHEM, V266, P5140; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zhang P, 2015, STRUCTURE, V23, P1563, DOI 10.1016/j.str.2015.07.007; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	64	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181091	10.1371/journal.pone.0181091	http://dx.doi.org/10.1371/journal.pone.0181091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742821	gold, Green Submitted, Green Published			2022-12-26	WOS:000406370000022
J	Brunelli, A; Kampuansai, J; Seielstad, M; Lomthaisong, K; Kangwanpong, D; Ghirottol, S; Kutanan, W				Brunelli, Andrea; Kampuansai, Jatupol; Seielstad, Mark; Lomthaisong, Khemika; Kangwanpong, Daoroong; Ghirottol, Silvia; Kutanan, Wibhu			Y chromosomal evidence on the origin of northern Thai people	PLOS ONE			English	Article							GENETIC-STRUCTURE; GEOGRAPHY	The Khon Mueang represent the major group of people present in today's northern Thailand. While linguistic and genetic data seem to support a shared ancestry between Khon Mueang and other Tai-Kadai speaking people, the possibility of an admixed origin with contribution from local Mon-Khmer population could not be ruled out. Previous studies conducted on northern Thai people did not provide a definitive answer and, in addition, have largely overlooked the distribution of paternal lineages in the area. In this work we aim to provide a comprehensive analysis of Y paternal lineages in northern Thailand and to explicitly model the origin of the Khon Mueang population. We obtained and analysed new Y chromosomal haplogroup data from more than 500 northern Thai individuals including Khon Mueang, Mon-Khmer and Tai-Kadai. We also explicitly simulated different demographic scenarios, developed to explain the Khon Mueang origin, employing an ABC simulation framework on both mitochondrial and Y microsatellites data. Our results highlighted a similar haplogroup composition of Khon Mueang and Tai-Kadai populations in northern Thailand, with shared high frequencies of haplogroups O-PK4, O-M117 and O-M111. Our ABC simulations also favoured a model in which the ancestors of modern Khon Mueang originated recently after a split from the other Tai-Kadai populations. Our different analyses concluded that the ancestors of Khon Mueang are likely to have originated from the same source of the other Tai-Kadai groups in southern China, with subsequent admixture events involving native Mon-Khmer speakers restricted to some specific populations.	[Brunelli, Andrea; Ghirottol, Silvia] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy; [Kampuansai, Jatupol; Ghirottol, Silvia] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Kampuansai, Jatupol] Chiang Mai Univ, Ctr Excellence Bioresources Agr Ind & Med, Chiang Mai, Thailand; [Seielstad, Mark] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Lomthaisong, Khemika] Khon Kaen Univ, Forens Sci Program, Fac Sci, Khon Kaen, Thailand; [Kutanan, Wibhu] Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand	University of Ferrara; Chiang Mai University; Chiang Mai University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Khon Kaen University; Khon Kaen University	Ghirottol, S (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy.; Kutanan, W (corresponding author), Khon Kaen Univ, Dept Biol, Fac Sci, Khon Kaen, Thailand.	ghrsiv@unife.it; wibhu@kku.ac.th	Seielstad, Mark/T-7841-2019; Kutanan, Wibhu/AAG-5801-2019	Seielstad, Mark/0000-0001-5783-1401	ERC [295733]; Khon Kaen University; Faculty of Science, Khon Kaen University	ERC(European Research Council (ERC)European Commission); Khon Kaen University; Faculty of Science, Khon Kaen University	AB was supported by the ERC Advanced Grant Agreement No 295733, 'LanGeLin' project. WK was financial supported by the young researcher development project of Khon Kaen University and co-funding from Faculty of Science, Khon Kaen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all volunteers for providing their blood samples and the village chiefs for their coordination. We thank Vikrant Kumar for technical assistance and Sukhum Ruangchai for English approval. AB was supported by the ERC Advanced Grant Agreement No 295733, 'LanGeLin' project. WK was financial supported by the young researcher development project of Khon Kaen University and co-funding from Faculty of Science, Khon Kaen University.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Barbieri C, 2016, HUM GENET, V135, P541, DOI 10.1007/s00439-016-1651-0; Bhumisak J., 1990, ORIGIN SIAM TAI LAOS; Blum SD, 2002, J ASIAN STUD, V61, P1287, DOI 10.2307/3096443; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; Charoenmuang T., 2001, KHON MUEANG; Condominas G., 1990, LAWA MON SAA THAI HI; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Grundy-Warr C, 2003, SINGAPORE J TROP GEO, V24, P1, DOI 10.1111/1467-9493.00139; He JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036437; International Society of Genetic Genealogy, 2016, Y DNA HAPL TREE 2016; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jurinke C, 2005, MUTAT RES-FUND MOL M, V573, P83, DOI 10.1016/j.mrfmmm.2005.01.007; Kampuansai J, 2017, FORENSIC SCI INT-GEN, V27, P92, DOI 10.1016/j.fsigen.2016.11.008; KIMURA M, 1964, GENETICS, V49, P561; Kutanan W, 2017, HUM GENET, V136, P85, DOI 10.1007/s00439-016-1742-y; Kutanan W, 2014, J HUM GENET, V59, P512, DOI 10.1038/jhg.2014.64; Kutanan W, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-56; Kutanan W, 2011, CHIANG MAI J SCI, V38, P295; Kutanan W, 2011, J HUM GENET, V56, P130, DOI 10.1038/jhg.2010.135; LaPolla RJ, 2001, AREAL DIFFUSION GENE, P225; Lewis M. P., ETHNOLOGUE LANGUAGES; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Ning C, 2016, EUR J HUM GENET, V24, P307, DOI 10.1038/ejhg.2015.183; Oota H, 2005, PLOS BIOL, V3, P536, DOI 10.1371/journal.pbio.0030071; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Penth Hans, 2000, BRIEF HIST LAN NA CI; Petkova D, 2016, NAT GENET, V48, P94, DOI 10.1038/ng.3464; PITTAYAPORN P, 2014, J HUMANITIES, V20, P47; Schliesinger J, 2000, ETHNIC GROUPS THAILA; Schliesinger J., 2001, TAI GROUPS THAILAND, V1; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; SOKAL RR, 1988, P NATL ACAD SCI USA, V85, P1722, DOI 10.1073/pnas.85.5.1722; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Wang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103772; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	43	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181935	10.1371/journal.pone.0181935	http://dx.doi.org/10.1371/journal.pone.0181935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742125	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700088
J	Galilee, A; Stefanidou, C; McCleery, JP				Galilee, Alena; Stefanidou, Chrysi; McCleery, Joseph P.			Atypical speech versus non-speech detection and discrimination in 4-to 6-yr old children with autism spectrum disorder: An ERP study	PLOS ONE			English	Article							BRAIN ACTIVITY; LANGUAGE; ORGANIZATION; PERCEPTION; ATTENTION; PATTERNS; PROSODY; SOUNDS; CORTEX	Previous event-related potential (ERP) research utilizing oddball stimulus paradigms suggests diminished processing of speech versus non-speech sounds in children with an Autism Spectrum Disorder (ASD). However, brain mechanisms underlying these speech processing abnormalities, and to what extent they are related to poor language abilities in this population remain unknown. In the current study, we utilized a novel paired repetition paradigm in order to investigate ERP responses associated with the detection and discrimination of speech and non-speech sounds in 4-to 6-year old children with ASD, compared with gender and verbal age matched controls. ERPs were recorded while children passively listened to pairs of stimuli that were either both speech sounds, both non-speech sounds, speech followed by non-speech, or non-speech followed by speech. Control participants exhibited N330 match/mismatch responses measured from temporal electrodes, reflecting speech versus non-speech detection, bilaterally, whereas children with ASD exhibited this effect only over temporal electrodes in the left hemisphere. Furthermore, while the control groups exhibited match/mismatch effects at approximately 600 ms (central N600, temporal P600) when a non-speech sound was followed by a speech sound, these effects were absent in the ASD group. These findings suggest that children with ASD fail to activate right hemisphere mechanisms, likely associated with social or emotional aspects of speech detection, when distinguishing non-speech from speech stimuli. Together, these results demonstrate the presence of atypical speech versus non-speech processing in children with ASD when compared with typically developing children matched on verbal age.	[Galilee, Alena] Dalhousie Univ, Sch Psychol & Neurosci, Halifax, NS, Canada; [Stefanidou, Chrysi; McCleery, Joseph P.] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England; [McCleery, Joseph P.] Childrens Hosp Philadelphia, Ctr Autism Res, Philadelphia, PA 19104 USA	Dalhousie University; University of Birmingham; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Galilee, A (corresponding author), Dalhousie Univ, Sch Psychol & Neurosci, Halifax, NS, Canada.	alena.galilee@dal.ca			Autistica	Autistica(Autistica)	This work was supported by Autistica (https://www.autistica.org.uk).	Alku P, 1999, CLIN NEUROPHYSIOL, V110, P1329, DOI 10.1016/S1388-2457(99)00088-7; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bidet-Caulet A, 2017, J NEURODEV DISORD, V9, DOI 10.1186/s11689-017-9194-9; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Brennan JR, 2016, NEUROREPORT, V27, P982, DOI 10.1097/WNR.0000000000000643; Carver LJ, 2002, MOL PSYCHIATR, V7, pS18, DOI 10.1038/sj.mp.4001168; Ceponiene R, 2008, CLIN NEUROPHYSIOL, V119, P1560, DOI 10.1016/j.clinph.2008.03.005; Ceponiene R, 2005, PSYCHOPHYSIOLOGY, V42, P391, DOI 10.1111/j.1469-8986.2005.00305.x; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Constantino JN, 2016, LANCET NEUROL, V15, P279, DOI 10.1016/S1474-4422(15)00151-9; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-11; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Elliott C. D., 1997, TECHNICAL MANUAL BRI; Eyler LT, 2012, BRAIN, V135, P949, DOI 10.1093/brain/awr364; Fan Yang-Teng, 2014, Soc Cogn Affect Neurosci, V9, P1203, DOI 10.1093/scan/nst101; Guiraud JA, 2011, NEUROREPORT, V22, P845, DOI 10.1097/WNR.0b013e32834c0bec; Harris GJ, 2006, BRAIN COGNITION, V61, P54, DOI 10.1016/j.bandc.2005.12.015; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2013, NEUROSCI BIOBEHAV R, V37, P697, DOI 10.1016/j.neubiorev.2013.01.006; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Lai G, 2012, BRAIN, V135, P961, DOI 10.1093/brain/awr335; Lepisto T, 2006, CLIN NEUROPHYSIOL, V117, P2161, DOI 10.1016/j.clinph.2006.06.709; Lepisto T, 2005, BRAIN RES, V1066, P147, DOI 10.1016/j.brainres.2005.10.052; Lepisto T, 2007, NEUROSCI LETT, V414, P136, DOI 10.1016/j.neulet.2006.12.009; Lindstrom R, 2016, NEUROSCI LETT, V628, P47, DOI 10.1016/j.neulet.2016.06.016; Lloyd-Fox S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3026; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; McCleery J. P., 2011, NEURODEVELOPMENT SOC, V5; Mills DL, 2004, J COGNITIVE NEUROSCI, V16, P1452, DOI 10.1162/0898929042304697; Minagawa-Kawai Y, 2011, DEV COGN NEUROS-NETH, V1, P217, DOI 10.1016/j.dcn.2011.03.005; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mullen E. M, 1995, MULLEN SCALES EARLY; O'Connor K, 2012, NEUROSCI BIOBEHAV R, V36, P836, DOI 10.1016/j.neubiorev.2011.11.008; Orekhova EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039906; Redcay E., 2008, NEUROSCI BIOBEHAV RE; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Rutter M., 2003, SOCIAL COMMUNICATION; Srinivasan R, 1996, BRAIN TOPOGR, V8, P355, DOI 10.1007/BF01186911; Stroganova TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069100; Volkmar FR, 2014, ANNU REV CLIN PSYCHO, V10, P193, DOI 10.1146/annurev-clinpsy-032813-153710; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Webb SJ, 2006, J AUTISM DEV DISORD, V36, P881, DOI 10.1007/s10803-006-0126-x; Whitehouse AJO, 2008, DEVELOPMENTAL SCI, V11, P516, DOI 10.1111/j.1467-7687.2008.00697.x; Yau SH, 2016, DEVELOPMENTAL SCI, V19, P834, DOI 10.1111/desc.12328	48	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181354	10.1371/journal.pone.0181354	http://dx.doi.org/10.1371/journal.pone.0181354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28738063	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700038
J	Regos, A; Tapia, L; Gil-Carrera, A; Dominguez, J				Regos, Adrian; Tapia, Luis; Gil-Carrera, Alberto; Dominguez, Jesus			Monitoring protected areas from space: A multi-temporal assessment using raptors as biodiversity surrogates	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CLIMATE-CHANGE; TOP PREDATORS; LAND-USE; HABITAT SUITABILITY; CONSERVATION; DISTRIBUTIONS; SELECTION; SPAIN; LANDSCAPE	Monitoring protected areas (PAs) is essential for systematic evaluation of their effectiveness in terms of habitat protection, preservation and representativeness. This study illustrates how the use of species distribution models that combine remote sensing data and information about biodiversity surrogates can contribute to develop a systematic protocol for monitoring PAs. In particular, we assessed the effectiveness of the Natura 2000 (N2000) network, for conserving and preserving the representativeness of seven raptor species in a highly-dynamic landscape in northwest Spain between 2001 and 2014. We also evaluated the cost-effectiveness of the N2000 network by using the total area under protection as a proxy for conservation costs. Overall, the N2000 network was found to poorly represent the habitats of the raptor species. Despite the low representativeness, this network showed a high degree of effectiveness due to increased overall habitat availability for generalist and forest specialist species between 2001 and 2014. Nevertheless, additional protected areas should be established in the near future to increase their representativeness, and thus ensure the protection of open-habitat specialist species and their priority habitats. In addition, proactive conservation measures in natural and semi-natural ecosystems (in particular, montane heathlands) will be essential for long-term protection of Montagu's harrier (species listed in the Annex I of the Bird Directive), and thus complying with the current European Environmental Legislation. This study sheds light on how the development and application of new protected area indices based on the combined use of freely-available satellite data and species distribution models may contribute substantially to the cost-efficiency of the PA monitoring systems, and to the 'Fitness Check' process of EU Nature Directives.	[Regos, Adrian] CIBIO InBIO, Res Ctr Biodivers & Genet Resources, Predict Ecol Grp, Campus Agr Vairao, Vairao, Portugal; [Regos, Adrian; Tapia, Luis; Dominguez, Jesus] Univ Santiago de Compostela, Dept Zooloxia Xenet & Antrolopoxia Fis, Campus Sur, Santiago De Compostela, La Coruna, Spain; [Regos, Adrian] InForest Joint Res Unit CEMFOR CTFC, Solsona, Spain; [Gil-Carrera, Alberto] GREFA Grp Rehabil Fauna Autoctona & Habitat, Monte del Pilar S-N, Madrid, Spain; [Gil-Carrera, Alberto] EBX, Lobios, Galicia, Spain	Universidade do Porto; Universidade de Santiago de Compostela; Centre Tecnologic Forestal de Catalunya (CTFC)	Regos, A (corresponding author), CIBIO InBIO, Res Ctr Biodivers & Genet Resources, Predict Ecol Grp, Campus Agr Vairao, Vairao, Portugal.; Regos, A (corresponding author), Univ Santiago de Compostela, Dept Zooloxia Xenet & Antrolopoxia Fis, Campus Sur, Santiago De Compostela, La Coruna, Spain.; Regos, A (corresponding author), InForest Joint Res Unit CEMFOR CTFC, Solsona, Spain.	adrian.regos@usc.es	Regos, Adrian/M-5207-2014	Regos, Adrian/0000-0003-1983-936X; Dominguez, Jesus/0000-0002-8669-022X	EU BON (European Commission) [308454]; FORESTCAST [CGL2014-59742]; TRUSTEE [RURAGRI ERA-NET 235175]; NEWFORESTS (EU Seventh Framework Programme) [PIRSES-GA-2013-612645]; Xunta de Galicia [ED48182016/084-0]; Department of Environment of Galician Government (Xunta de Galicia) [PGIDTO1MAM20001 PR]	EU BON (European Commission); FORESTCAST; TRUSTEE; NEWFORESTS (EU Seventh Framework Programme); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Department of Environment of Galician Government (Xunta de Galicia)	This work was partly funded by the EU BON (308454; FP7-ENV-2012, European Commission), FORESTCAST (CGL2014-59742), TRUSTEE (RURAGRI ERA-NET 235175) and NEWFORESTS (EU Seventh Framework Programme, PIRSES-GA-2013-612645) projects. A.R. was funded by the Xunta de Galicia (post-doctoral fellowship ED48182016/084-0). Fieldwork was partially supported by the Department of Environment of Galician Government through the PGIDTO1MAM20001 PR (Xunta de Galicia) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly funded by the EU BON (308454; FP7-ENV-2012, European Commission), FORESTCAST (CGL2014-59742) and NEWFORESTS (EU Seventh Framework Programme, PIRSES-GA-2013-612645) projects. A.R. was funded by the Xunta de Galicia (postdoctoral fellowship ED481B2016/084-0). Fieldwork was partially supported by the Department of Environment of Galician Government through the PGIDTO1MAM20001PR (Xunta de Galicia) project. We also thank to two anonymous referees for their useful comments and suggestions on earlier versions of this manuscript.	Abellan MD, 2011, ENVIRON MANAGE, V47, P983, DOI 10.1007/s00267-011-9640-5; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Altmoos M, 2010, ACTA OECOL, V36, P548, DOI 10.1016/j.actao.2010.08.001; Alves C, 2016, J NAT CONSERV, V29, P105, DOI 10.1016/j.jnc.2015.12.004; Andersen David E., 2007, P89; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Barnes M, 2015, DIVERS DISTRIB, V21, P368, DOI 10.1111/ddi.12274; Barton PS, 2014, J APPL ECOL, V51, P1434, DOI 10.1111/1365-2664.12290; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Birdlife International I., 2004, BIRDS EUR POP EST TR; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brambilla M., 2014, EUROPEAN J WILDLIFE, V61, P35, DOI DOI 10.1007/S10344-014-0864-6; Brotons Lluis, 2008, Revista Catalana d'Ornitologia, V24, P118; Burgas D, 2014, J APPL ECOL, V51, P786, DOI 10.1111/1365-2664.12229; Campbell J, 2008, INTRO REMOTE SENSING; Cancela M, 2012, FOR ECOL MANAG, V270, P153, DOI DOI 10.1016/J.F0REC0.2012.01.019; Carvalho SB, 2016, J APPL ECOL, V53, P1305, DOI 10.1111/1365-2664.12505; CBD, 2010, TECHNICAL REPORT; Chakraborty A, 2011, J R STAT SOC C-APPL, V60, P757, DOI 10.1111/j.1467-9876.2011.01023.x; Chas-Amil ML, 2010, WIT TRANS ECOL ENVIR, V137, P247, DOI 10.2495/FIVA100221; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cord AF, 2013, J BIOGEOGR, V40, P2226, DOI 10.1111/jbi.12199; Di Cola V, 2017, ECOGRAPHY, V40, P774, DOI 10.1111/ecog.02671; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gross JE, 2009, REMOTE SENS ENVIRON, V113, P1343, DOI 10.1016/j.rse.2008.12.013; Gruber B, 2012, NAT CONSERV, V3, P45, DOI [DOI 10.3897/NATURECONSERVATION.3.3732, 10.3897/natureconservation.3.3732, DOI 10.3897/NATUREC0NSERVATI0N.3.3732]; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Hochkirch A, 2013, CONSERV LETT, V6, P462, DOI 10.1111/conl.12006; Hole DG, 2009, ECOL LETT, V12, P420, DOI 10.1111/j.1461-0248.2009.01297.x; Ihlow F, 2015, AQUAT CONSERV, V25, P544, DOI 10.1002/aqc.2473; Johnston A, 2013, NAT CLIM CHANGE, V3, P1055, DOI 10.1038/NCLIMATE2035; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Larsen FW, 2012, J APPL ECOL, V49, P349, DOI 10.1111/j.1365-2664.2011.02094.x; Lentini PE, 2015, ECOGRAPHY, V38, P1101, DOI 10.1111/ecog.01252; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Lohmus Asko, 2004, P279; Arcos JM, 2012, BIOL CONSERV, V156, P30, DOI 10.1016/j.biocon.2011.12.011; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; MAUKAMA, 2017, RED NAT 2000 ESP; Mazaris AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059640; Nagendra H, 2013, ECOL INDIC, V33, P45, DOI 10.1016/j.ecolind.2012.09.014; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pellissier V, 2013, ANIM CONSERV, V16, P566, DOI 10.1111/acv.12030; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0190; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piquer-Rodriguez M, 2012, J NAT CONSERV, V20, P326, DOI 10.1016/j.jnc.2012.07.001; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; R-Core-Team, 2015, LANG ENV STAT COMP; Regos A, 2016, DIVERS DISTRIB, V22, P83, DOI 10.1111/ddi.12375; Rhodes CJ, 2015, METHODS ECOL EVOL, V6, P772, DOI 10.1111/2041-210X.12385; Richards J. A., 2006, REMOTE SENSING DIGIT; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez-Estrella R, 1998, CONSERV BIOL, V12, P921, DOI 10.1046/j.1523-1739.1998.97044.x; Rodriguez-Guitian M.A, 2007, RECURSOS RURAIS REV, V1, P31, DOI [DOI 10.15304/RR.ID5318, 10.15304/rr.id5318]; Rose RA, 2015, CONSERV BIOL, V29, P350, DOI 10.1111/cobi.12397; Rubio-Salcedo M, 2013, J NAT CONSERV, V21, P1, DOI 10.1016/j.jnc.2012.06.001; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2008, J APPL ECOL, V45, P992, DOI 10.1111/j.1365-2664.2008.01484.x; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Sergio F, 2006, BIOL CONSERV, V133, P32, DOI 10.1016/j.biocon.2006.05.015; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Singh NJ, 2011, J APPL ECOL, V48, P35, DOI 10.1111/j.1365-2664.2010.01905.x; Tapia L, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1097-2; Tapia Luis, 2007, P153; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; van Proosdij ASJ, 2016, ECOGRAPHY, V39, P542, DOI 10.1111/ecog.01509; Wang K, 2010, SENSORS-BASEL, V10, P9647, DOI 10.3390/s101109647; Wiens J, 2009, REMOTE SENS ENVIRON, V113, P1370, DOI 10.1016/j.rse.2008.06.020; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Xie YC, 2008, J PLANT ECOL, V1, P9, DOI 10.1093/jpe/rtm005; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	88	6	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181769	10.1371/journal.pone.0181769	http://dx.doi.org/10.1371/journal.pone.0181769			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738072	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700068
J	Voldoire, E; Brunet, F; Naville, M; Volff, JN; Galiana, D				Voldoire, Emilien; Brunet, Frederic; Naville, Magali; Volff, Jean-Nicolas; Galiana, Delphine			Expansion by whole genome duplication and evolution of the sox gene family in teleost fish	PLOS ONE			English	Article							SEX-DETERMINING REGION; PHYLOGENETIC ANALYSIS; EXPRESSION PATTERNS; SEQUENCE ALIGNMENT; CLUSTAL-W; SUBFUNCTIONALIZATION; DIVERSIFICATION; CONSEQUENCES; DIVERGENCE; INSIGHTS	It is now recognized that several rounds of whole genome duplication (WGD) have occurred during the evolution of vertebrates, but the link between WGDs and phenotypic diversification remains unsolved. We have investigated in this study the impact of the teleost-specific WGD on the evolution of the sox gene family in teleostean fishes. The sox gene family, which encodes for transcription factors, has essential role in morphology, physiology and behavior of vertebrates and teleosts, the current largest group of vertebrates. We have first redrawn the evolution of all sox genes identified in eleven teleost genomes using a comparative genomic approach including phylogenetic and synteny analyses. We noticed, compared to tetrapods, an important expansion of the sox family: 58% (11/19) of sox genes are duplicated in teleost genomes. Furthermore, all duplicated sox genes, except sox17 paralogs, are derived from the teleost-specific WGD. Then, focusing on five sox genes, analyzing the evolution of coding and non-coding sequences, as well as the expression patterns in fish embryos and adult tissues, we demonstrated that these paralogs followed lineage-specific evolutionary trajectories in teleost genomes. This work, based on whole genome data from multiple teleostean species, supports the contribution of WGDs to the expansion of gene families, as well as to the emergence of genomic differences between lineages that might promote genetic and phenotypic diversity in teleosts.	[Voldoire, Emilien; Brunet, Frederic; Naville, Magali; Volff, Jean-Nicolas; Galiana, Delphine] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Galiana, D (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon, Lyon, France.	delphine.galiana@ens-lyon.fr		Brunet, Frederic/0000-0001-5145-8925	La region Rhone-Alpes, France; Agence Nationale de la Recherche (ANR)	La region Rhone-Alpes, France(Region Auvergne-Rhone-Alpes); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by a PhD fellowship from "La region Rhone-Alpes, France" to EV, by grants from "La region Rhone-Alpes, France" to DG and by Agence Nationale de la Recherche (ANR) given to JEan-Nicolas Volff.	Ahn D, 2012, MOL BIOL EVOL, V29, P3959, DOI 10.1093/molbev/mss199; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Braasch I, 2006, MOL BIOL EVOL, V23, P1192, DOI 10.1093/molbev/msk003; Braasch I, 2009, GENOME BIOL EVOL, V1, P479, DOI 10.1093/gbe/evp050; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Chain FJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-43; Chain FJJ, 2006, PLOS GENET, V2, P478, DOI 10.1371/journal.pgen.0020056; Chiang EFL, 2001, MOL BIOL EVOL, V18, P542, DOI 10.1093/oxfordjournals.molbev.a003833; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Cresko WA, 2003, DEV DYNAM, V228, P480, DOI 10.1002/dvdy.10424; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; De Martino S, 2000, DEV DYNAM, V217, P279, DOI 10.1002/(SICI)1097-0177(200003)217:3<279::AID-DVDY6>3.0.CO;2-S; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Haldane JBS, 1934, GENETICS, V19, P0412; HAWKINS JR, 1993, HUM MUTAT, V2, P347, DOI 10.1002/humu.1380020504; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hokamp Karsten, 2003, Journal of Structural and Functional Genomics, V3, P95, DOI 10.1023/A:1022661917301; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kluver N, 2005, DEV GENES EVOL, V215, P297, DOI 10.1007/s00427-005-0477-x; Koopman P, 2004, GENE, V328, P177, DOI 10.1016/j.gene.2003.12.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee AP, 2011, MOL BIOL EVOL, V28, P1205, DOI 10.1093/molbev/msq304; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mavropoulos A, 2005, DEV BIOL, V285, P211, DOI 10.1016/j.ydbio.2005.06.024; NUSSLEINVOLLHAR.C, 2002, ZEBRAFISH PRACTICAL; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Okuda Y, 2006, DEV DYNAM, V235, P811, DOI 10.1002/dvdy.20678; Opazo JC, 2013, MOL BIOL EVOL, V30, P140, DOI 10.1093/molbev/mss212; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Raes Jeroen, 2003, Appl Bioinformatics, V2, P91; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Rytkonen KT, 2014, GENE, V541, P60, DOI 10.1016/j.gene.2014.03.007; Santos ME, 2012, SCIENCE, V338, P619, DOI 10.1126/science.1224818; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Semon M, 2008, P NATL ACAD SCI USA, V105, P8333, DOI 10.1073/pnas.0708705105; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Soltis Pamela S, 2014, Methods Mol Biol, V1110, P85, DOI 10.1007/978-1-4614-9408-9_4; Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wagner GP, 2005, J MOL EVOL, V60, P665, DOI 10.1007/s00239-004-0252-z; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang LH, 2008, COMP BIOCHEM PHYS B, V149, P345, DOI 10.1016/j.cbpb.2007.10.006; Zhang LH, 2010, COMP BIOCHEM PHYS B, V157, P415, DOI 10.1016/j.cbpb.2010.09.004	82	25	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180936	10.1371/journal.pone.0180936	http://dx.doi.org/10.1371/journal.pone.0180936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738066	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700022
J	Bogaerts, S; Carvalho, CD; Scheys, L; Desloovere, K; D'hooge, J; Maes, F; Suetens, P; Peers, K				Bogaerts, Stijn; Carvalho, Catarina De Brito; Scheys, Lennart; Desloovere, Kaat; D'hooge, Jan; Maes, Frederik; Suetens, Paul; Peers, Koen			Evaluation of tissue displacement and regional strain in the Achilles tendon using quantitative high-frequency ultrasound	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; IMAGE REGISTRATION; PATELLAR TENDON; TENDINOPATHY; PATTERNS; DEFORMATION	The Achilles tendon has a unique structure-function relationship thanks to its innate hierarchical architecture in combination with the rotational anatomy of the sub-tendons from the triceps surae muscles. Previous research has provided valuable insight in global Achilles tendon mechanics, but limitations with the technique used remain. Furthermore, given the global approach evaluating muscle-tendon junction to insertion, regional differences in tendon mechanical properties might be overlooked. However, recent advancements in the field of ultrasound imaging in combination with speckle tracking have made an intratendinous evaluation possible. This study uses high-frequency ultrasound to allow for quantification of regional tendon deformation. Also, an interactive application was developed to improve clinical applicability. A dynamic ultrasound of both Achilles tendons of ten asymptomatic subjects was taken. The displacement and regional strain in the superficial, middle and deep layer were evaluated during passive elongation and isometric contraction. Building on previous research, results showed that the Achilles tendon displaces non-uniformly with a higher displacement found in the deep layer of the tendon. Adding to this, a non-uniform regional strain behavior was found in the Achilles tendon during passive elongation, with the highest strain in the superficial layer. Further exploration of tendon mechanics will improve the knowledge on etiology of tendinopathy and provide options to optimize existing therapeutic loading programs.	[Bogaerts, Stijn; Peers, Koen] KULeuven, Dept Dev & Regenerat, Leuven, Belgium; [Bogaerts, Stijn; Peers, Koen] Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium; [Carvalho, Catarina De Brito; Maes, Frederik; Suetens, Paul] KULeuven, MIRC, ESAT PSI, Leuven, Belgium; [Carvalho, Catarina De Brito; Maes, Frederik; Suetens, Paul] KULeuven, MIRC, UZ Leuven, Leuven, Belgium; [Carvalho, Catarina De Brito; Desloovere, Kaat; Maes, Frederik; Suetens, Paul] Univ Hosp Leuven, Leuven, Belgium; [Scheys, Lennart] KULeuven, IORT, Dept Dev & Regenerat, Leuven, Belgium; [Scheys, Lennart] Univ Hosp Leuven, Div Orthoped, Leuven, Belgium; [Desloovere, Kaat] KULeuven, Dept Rehabil Sci, Clin Mot Anal Lab, Leuven, Belgium; [D'hooge, Jan] Univ Hosp Leuven, Dept Cardiovasc Sci, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Bogaerts, S (corresponding author), KULeuven, Dept Dev & Regenerat, Leuven, Belgium.; Bogaerts, S (corresponding author), Univ Hosp Leuven, Dept Phys Med & Rehabil, Leuven, Belgium.	stijn_bogaerts@hotmail.com	Scheys, Lennart/K-6511-2019; Desloovere, Kaat/F-3240-2014; Maes, Frederik/I-7572-2013; Carvalho, Catarina/AAA-9158-2019; Scheys, Lennart/A-3584-2019	Scheys, Lennart/0000-0002-1727-533X; Desloovere, Kaat/0000-0002-8507-5276; Maes, Frederik/0000-0003-0027-1479; Carvalho, Catarina/0000-0002-6408-6339; Scheys, Lennart/0000-0002-1727-533X; Bogaerts, Stijn/0000-0001-5708-2439; D'hooge, Jan/0000-0002-2346-142X				Almekinders LC, 2002, KNEE SURG SPORT TR A, V10, P2, DOI 10.1007/s001670100224; [Anonymous], 2016, J BIOMECH, V49, P3122, DOI 10.1016/j.jbiomech.2016.06.028; Arndt A, 2012, KNEE SURG SPORT TR A, V20, P1868, DOI 10.1007/s00167-011-1801-9; Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8; Arnoczky SP, 2007, INT J EXP PATHOL, V88, P217, DOI 10.1111/j.1365-2613.2007.00548.x; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bey MJ, 2002, J ORTHOPAED RES, V20, P869, DOI 10.1016/S0736-0266(01)00177-2; Bogaerts S, 2016, J BIOMECH, V49, P1411, DOI 10.1016/j.jbiomech.2016.02.057; Bojsen-Moller J, 2015, EXERC SPORT SCI REV, V43, P190, DOI 10.1249/JES.0000000000000062; BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1, DOI 10.1109/T-SU.1978.30978; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chang YJ, 2015, J PHYSIOL-LONDON, V593, P3373, DOI 10.1113/JP270220; Child S, 2010, AM J SPORT MED, V38, P1885, DOI 10.1177/0363546510366234; Chimenti RL, 2016, J ORTHOP RES; Chimenti RL, 2016, J BIOMECH, V49, P39, DOI 10.1016/j.jbiomech.2015.11.008; Couppe A C, 2015, J ORTHOP SPORT PHYS, V45, P1; Farris DJ, 2013, J EXP BIOL, V216, P594, DOI 10.1242/jeb.077131; Finni T, 2012, SCAND J MED SCI SPOR, V2015, P26; Froberg A, 2016, ACTA RADIOL, V57, P1223, DOI 10.1177/0284185115626471; Handsfield GG, 2017, J BIOMECH, V51, P17, DOI 10.1016/j.jbiomech.2016.11.062; Haraldsson BT, 2008, MATRIX BIOL, V27, P86, DOI 10.1016/j.matbio.2007.09.001; Haraldsson BT, 2005, J APPL PHYSIOL, V98, P1006, DOI 10.1152/japplphysiol.00482.2004; Heyde B, 2013, ULTRASOUND MED BIOL, V39, P1688, DOI 10.1016/j.ultrasmedbio.2013.02.463; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kulig K, 2016, ULTRASOUND MED BIOL, V42, P664, DOI 10.1016/j.ultrasmedbio.2015.11.013; Lavagnino M, 2008, AM J SPORT MED, V36, P2110, DOI 10.1177/0363546508322496; Lersch C, 2012, CLIN BIOMECH, V27, P955, DOI 10.1016/j.clinbiomech.2012.07.001; Lyman J, 2004, AM J SPORT MED, V32, P457, DOI 10.1177/0095399703258621; Maganaris CN, 2008, DISABIL REHABIL, V30, P1542, DOI 10.1080/09638280701785494; Magnusson SP, 2010, NAT REV RHEUMATOL, V6, P262, DOI 10.1038/nrrheum.2010.43; Pearson SJ, 2014, SPORTS MED, V44, P1101, DOI 10.1007/s40279-014-0201-y; Pekala PA, 2017, SCAND J MED SCI SPOR, V27, P1705, DOI 10.1111/sms.12835; Podilchuk C, 2012, IEEE SIG PROC MED; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Screen HRC, 2004, STRAIN, V40, P157, DOI 10.1111/j.1475-1305.2004.00164.x; Seynnes OR, 2015, J APPL PHYSIOL, V118, P133, DOI 10.1152/japplphysiol.00849.2014; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; Silbernagel KG, 2015, J ORTHOP SPORT PHYS, V45, P876, DOI 10.2519/jospt.2015.5885; Slagmolen P, 2011, J ORTHOP RES, V29, P1931; Slane LC, 2017, EUR RADIOL, V27, P474, DOI 10.1007/s00330-016-4409-0; Slane LC, 2015, MED ENG PHYS, V37, P712, DOI 10.1016/j.medengphy.2015.04.004; Slane LC, 2014, J BIOMECH, V47, P2831, DOI 10.1016/j.jbiomech.2014.07.032; Slane LC, 2014, THESIS; Svensson RB, 2017, ACTA BIOMATER, V50, P293, DOI 10.1016/j.actbio.2017.01.006; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; Szaro P, 2009, ANN ANAT, V191, P586, DOI 10.1016/j.aanat.2009.07.006; Thorpe CT, 2015, SCAND J MED SCI SPOR, V25, pe381, DOI 10.1111/sms.12333; Thorpe CT, 2015, J MECH BEHAV BIOMED, V52, P85, DOI 10.1016/j.jmbbm.2015.04.009; Wood LK, 2016, J ORTHOP RES, V34, P346, DOI 10.1002/jor.22824	51	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181364	10.1371/journal.pone.0181364	http://dx.doi.org/10.1371/journal.pone.0181364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727745	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500063
J	Carillion, A; Feldman, S; Na, N; Biais, M; Carpentier, W; Birenbaum, A; Cagnard, N; Loyer, X; Bonnefont-Rousselot, D; Hatem, S; Riou, B; Amour, J				Carillion, Aude; Feldman, Sarah; Na, Na; Biais, Matthieu; Carpentier, Wassila; Birenbaum, Aurelie; Cagnard, Nicolas; Loyer, Xavier; Bonnefont-Rousselot, Dominique; Hatem, Stephane; Riou, Bruno; Amour, Julien			Atorvastatin reduces beta-Adrenergic dysfunction in rats with diabetic cardiomyopathy	PLOS ONE			English	Article							CONTRACTILE RESPONSE; STATIN THERAPY; MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES; NONCARDIAC SURGERY; CARDIAC MYOCYTES; PROTEIN MRP4; NITRIC-OXIDE; STIMULATION; MORTALITY	Background In the diabetic heart the beta-adrenergic response is altered partly by down-regulation of the beta 1-adrenoceptor, reducing its positive inotropic effect and up-regulation of the beta 3-adrenoceptor, increasing its negative inotropic effect. Statins have clinical benefits on morbidity and mortality in diabetic patients which are attributed to their "pleiotropic" effects. The objective of our study was to investigate the role of statin treatment on beta-adrenergic dysfunction in diabetic rat cardiomyocytes. Methods beta-adrenergic responses were investigated in vivo (echocardiography) and ex vivo (left ventricular papillary muscles) in healthy and streptozotocin-induced diabetic rats, who were pre-treated or not by oral atorvastatin over 15 days (50 mg.kg(-1).day(-1)). Micro-array analysis and immunoblotting were performed in left ventricular homogenates. Data are presented as mean percentage of baseline +/- SD. Results Atorvastatin restored the impaired positive inotropic effect of beta-adrenergic stimulation in diabetic hearts compared with healthy hearts both in vivo and ex vivo but did not suppress the diastolic dysfunction of diabetes. Atorvastatin changed the RNA expression of 9 genes in the beta-adrenergic pathway and corrected the protein expression of beta 1-adrenoceptor and beta 1/beta 3-adrenoceptor ratio, and multidrug resistance protein 4 (MRP4). Nitric oxide synthase (NOS) inhibition abolished the beneficial effects of atorvastatin on the beta-adrenoceptor response. Conclusions Atorvastatin restored the positive inotropic effect of the beta-adrenoceptor stimulation in diabetic cardiomyopathy. This effect is mediated by multiple modifications in expression of proteins in the beta-adrenergic signaling pathway, particularly through the NOS pathway.	[Carillion, Aude; Feldman, Sarah; Na, Na; Biais, Matthieu; Birenbaum, Aurelie; Riou, Bruno; Amour, Julien] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMR 1166,IHU ICAN, Paris, France; [Carillion, Aude; Feldman, Sarah; Birenbaum, Aurelie; Amour, Julien] Hop La Pitie Salpetriere, APHP, Dept Anesthesiol & Crit Care Med, Paris, France; [Na, Na; Riou, Bruno] Hop La Pitie Salpetriere, APHP, Dept Emergency Med & Surg, Paris, France; [Biais, Matthieu] Univ Bordeaux Segalen, Hop Pellegrin, Dept Anesthesiol & Crit Care, Bordeaux, France; [Carpentier, Wassila] UPMC Univ Paris 06, Sorbonne Univ, Postgenom Platform, Paris, France; [Cagnard, Nicolas] Univ Paris 05, Sorbonne Univ, Bioinformat Platform, Paris, France; [Loyer, Xavier] Univ Paris 05, Sorbonne Univ, Hop Europeen Georges Pompidou, APHP,UMRS,INSERM,U970,Cardiovasc Res Ctr, Paris, France; [Bonnefont-Rousselot, Dominique] Paris Descartes Univ, La Pitie Salpetriere Charles Foix Univ Hosp, AP HP,Fac Pharm,Sorbonne Paris Cite, Dept Metab Biochem,CNRS,UMR8258,INSERM,U1022, Paris, France; [Hatem, Stephane] UPMC Univ Paris 06, Sorbonne Univ, Hop Pitie Salpetriere, APHP,UMR 1166,INSERM,IHU ICAN, Paris, France; [Carillion, Aude; Feldman, Sarah; Na, Na; Carpentier, Wassila; Birenbaum, Aurelie; Bonnefont-Rousselot, Dominique; Riou, Bruno; Amour, Julien] Hop La Pitie Salpetriere, 47-83 Blvd Hop, Paris, France; [Biais, Matthieu] Hop Pellegrin, Pl Amelie Rabba Leon, Bordeaux, France; [Cagnard, Nicolas] Hop Necker Enfants Malad, 149 Rue Sevres, Paris, France; [Loyer, Xavier] Hop Europeen Georges Pompidou, 20 Rue Leblanc, Paris, France; [Hatem, Stephane] INSERM, UMR 1166, 91 Blvd Hop, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Amour, J (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMR 1166,IHU ICAN, Paris, France.; Amour, J (corresponding author), Hop La Pitie Salpetriere, APHP, Dept Anesthesiol & Crit Care Med, Paris, France.; Amour, J (corresponding author), Hop La Pitie Salpetriere, 47-83 Blvd Hop, Paris, France.	julien.amour@aphp.fr	LOYER, Xavier/AAR-2492-2020; LOYER, Xavier/O-7281-2017; FELDMAN, SARAH/F-8423-2013; Rousselot, Bonnefont/U-7434-2019; Cagnard, Nicolas/K-2754-2014	LOYER, Xavier/0000-0003-4294-3608; LOYER, Xavier/0000-0003-4294-3608; FELDMAN, SARAH/0000-0002-1671-9365; Bonnefont-Rousselot, Dominique/0000-0003-4689-9202; Cagnard, Nicolas/0000-0002-9051-1896; Feldman, Sarah/0000-0001-8264-5184	Fondation pour la Recherche Medicale (Paris, France) [DEA200961244]; (European Society of Anaesthesiology (ESA)) from European Society of Anaesthesiology	Fondation pour la Recherche Medicale (Paris, France)(Fondation pour la Recherche Medicale); (European Society of Anaesthesiology (ESA)) from European Society of Anaesthesiology	Support was provided solely from institutional and/or departmental sources. Dr. Aude Carillion was the recipient of a research grant (FRM grant number DEA200961244) from the Fondation pour la Recherche Medicale (Paris, France). Pr Julien Amour was the recipient of research grant (European Society of Anaesthesiology (ESA) Research grant 2009) from European Society of Anaesthesiology.	Amour J, 2008, ANESTH ANALG, V107, P1130, DOI 10.1213/ane.0b013e3181806903; Amour J, 2008, ANESTHESIOLOGY, V108, P524, DOI 10.1097/ALN.0b013e3181649369; Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; Beloeil H, 2005, BRIT J ANAESTH, V95, P782, DOI 10.1093/bja/aei259; Blanco-Rivero J, 2011, BRIT J PHARMACOL, V162, P271, DOI 10.1111/j.1476-5381.2010.01030.x; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Carillion A, 2015, ANESTHESIOLOGY, V122, P334, DOI 10.1097/ALN.0000000000000526; Chen Y, 2007, CIRC J, V71, P144, DOI 10.1253/circj.71.144; Dai QM, 2011, CHINESE MED J-PEKING, V124, P89, DOI 10.3760/cma.j.issn.0366-6999.2011.01.017; Datar R, 2010, BRIT J PHARMACOL, V160, P1765, DOI 10.1111/j.1476-5381.2010.00817.x; Dernellis J, 2006, HEART, V92, P1645, DOI 10.1136/hrt.2005.085530; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; Hammill BG, 2008, ANESTHESIOLOGY, V108, P559, DOI 10.1097/ALN.0b013e31816725ef; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Jiang C, 2015, CRIT CARE MED, V43, pE241, DOI 10.1097/CCM.0000000000000999; Kang L, 2007, PHARMACOLOGY, V80, P120, DOI 10.1159/000103251; Koh GCKW, 2012, CRIT CARE MED, V40, P1835, DOI 10.1097/CCM.0b013e31824e1696; Kojda G, 1996, CIRC RES, V78, P91, DOI 10.1161/01.RES.78.1.91; Martin JH, 2010, INT J CARDIOL, V143, P353, DOI 10.1016/j.ijcard.2009.03.098; McAuley DF, 2014, NEW ENGL J MED, V371, P1695, DOI 10.1056/NEJMoa1403285; Mohan P, 1996, CIRCULATION, V93, P1223, DOI 10.1161/01.CIR.93.6.1223; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Oudit GY, 2009, CARDIOVASC RES, V82, P250, DOI 10.1093/cvr/cvp014; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Pugh SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106905; ROTH DA, 1995, J MOL CELL CARDIOL, V27, P2315, DOI 10.1016/S0022-2828(95)91875-2; Sassi Y, 2012, FASEB J, V26, P1009, DOI 10.1096/fj.11-194027; Van Linthout S, 2007, DIABETOLOGIA, V50, P1977, DOI 10.1007/s00125-007-0719-8; Xie F, 2011, ACTA PHARMACOL SIN, V32, P321, DOI 10.1038/aps.2010.221; Zaitone SA, 2012, EUR J PHARMACOL, V691, P134, DOI 10.1016/j.ejphar.2012.06.022; Zheng X, 2006, HEART VESSELS, V21, P116, DOI 10.1007/s00380-005-0868-y	32	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180103	10.1371/journal.pone.0180103	http://dx.doi.org/10.1371/journal.pone.0180103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727746	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500013
J	Steiner, N; Hajek, R; Sevcikova, S; Borjan, B; Johrer, K; Gobel, G; Untergasser, G; Gunsilius, E				Steiner, Normann; Hajek, Roman; Sevcikova, Sabina; Borjan, Bojana; Joehrer, Karin; Goebel, Georg; Untergasser, Gerold; Gunsilius, Eberhard			High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; POTENTIAL ROLE; FLT3 LIGAND; ANGIOGENESIS; ANGIOPOIETIN-2; ENDOSTATIN; TIE2; OSTEOCLASTOGENESIS	Introduction Multiple myeloma (MM) is still incurable due to resistance against various therapies. Thus, the identification of biomarkers predicting progression is urgently needed. Here, we evaluated four biomarkers in bone marrow and peripheral blood of MM patients for their prognostic significance. Materials & methods Bone marrow- and peripheral blood plasma levels of FLT3-L, soluble TIE2, endostatin, and osteoactivin were determined in patients with monoclonal gammopathy of undetermined significance (MGUS, n = 14/n = 4), patients with newly diagnosed MM (NDMM, n = 42/n = 31) and patients with relapsed/refractory MM (RRMM, n = 27/n = 16) by sandwich ELISA. Results Median FLT3-L expression increased from MGUS (58.77 pg/ml in bone marrow; 80.40 pg/ml in peripheral blood) to NDMM (63.15 pg/ml in bone marrow; 85.05 pg/ml in peripheral blood) and was maximal in RRMM (122 pg/ml in bone marrow; 160.47 pg/ml in peripheral blood; NDMM vs. RRMM p<0.001). A cut-off value of FLT3-L >92 pg/ml in bone marrow and >121 pg/ml in peripheral blood was associated with relapse or refractoriness in MM patients. FLT3-L was found to be a high predictive marker for discrimination between NDMM and RRMM as well in bone marrow as in peripheral blood (AUC 0.75 in bone marrow; vs 0.84 in peripheral blood). Conclusion High levels of FLT3-L in bone marrow and peripheral blood of MM patients identify patients with progressive disease and are associated with relapse or refractoriness in MM patients. FLT3-L could be useful as a marker to identify RRMM patients and should be evaluated as target for future therapies.	[Steiner, Normann; Untergasser, Gerold; Gunsilius, Eberhard] Innsbruck Med Univ, Dept Internal Med Hematol & Med Oncol 5, Anichstr 35, Innsbruck, Austria; [Steiner, Normann; Borjan, Bojana; Gunsilius, Eberhard] Innsbruck Med Univ, Lab Tumor Biol & Angiogenesis, Innrain 66, Innsbruck, Austria; [Hajek, Roman] Univ Ostrava, Fac Med, Ostrava, Czech Republic; [Hajek, Roman] Univ Hosp Ostrava, Dept Hematol Oncol, Ostrava, Czech Republic; [Sevcikova, Sabina] Masaryk Univ, Fac Med, Dept Pathol Physiol, Babak Myeloma Grp, Brno, Czech Republic; [Sevcikova, Sabina] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic; [Borjan, Bojana; Joehrer, Karin; Untergasser, Gerold] Tyrolean Canc Res Inst, Innrain 66, Innsbruck, Austria; [Goebel, Georg] Innsbruck Med Univ, Dept Med Stat Informat & Hlth Econ, Schopfstr 41, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; University of Ostrava; University Hospital Ostrava; Masaryk University Brno; University Hospital Brno; Medical University of Innsbruck	Steiner, N (corresponding author), Innsbruck Med Univ, Dept Internal Med Hematol & Med Oncol 5, Anichstr 35, Innsbruck, Austria.; Steiner, N (corresponding author), Innsbruck Med Univ, Lab Tumor Biol & Angiogenesis, Innrain 66, Innsbruck, Austria.	normann.steiner@i-med.ac.at	Sevcikova, Sabina/AAB-4267-2021; Jöhrer, Karin/H-9143-2019; Gunsilius, Eberhard/AAI-9333-2021; Hajek, Roman/I-6639-2017	Jöhrer, Karin/0000-0002-6400-6175; Gunsilius, Eberhard/0000-0003-1327-2921; Hajek, Roman/0000-0001-6955-6267				Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Antonysamy MA, 2000, CYTOKINE, V12, P87, DOI 10.1006/cyto.1999.0540; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Babarovic E, 2016, PATHOL RES PRACT, V212, P509, DOI 10.1016/j.prp.2015.11.021; Belloni D, 2015, EXP CELL RES, V330, P1, DOI 10.1016/j.yexcr.2014.10.017; Buza-Vidas N, 2007, BLOOD, V110, P424, DOI 10.1182/blood-2006-09-047480; Campochiaro PA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0816-5; Ergun S, 2001, ANGIOGENESIS, V4, P193, DOI DOI 10.1023/A:1014027218980; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Ferrarini M, 2011, CURR MED CHEM, V18, P5185, DOI 10.2174/092986711798184316; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Fowler JA, 2012, CANCER RES, V72, P2183, DOI 10.1158/0008-5472.CAN-11-2067; Gentile M, 2013, EXPERT OPIN BIOL TH, V13, pS1, DOI 10.1517/14712598.2013.799132; Greystoke A, 2011, BRIT J CANCER, V104, P719, DOI 10.1038/sj.bjc.6606082; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hu XF, 2013, J CELL BIOCHEM, V114, P2729, DOI 10.1002/jcb.24621; Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005; Kokonozaki M, 2015, LEUKEMIA RES, V39, P1467, DOI 10.1016/j.leukres.2015.10.009; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; McClanahan T, 1996, BLOOD, V88, P3371, DOI 10.1182/blood.V88.9.3371.bloodjournal8893371; Moreau Philippe, 2015, Am Soc Clin Oncol Educ Book, pe504, DOI 10.14694/EdBook_AM.2015.35.e504; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pappa CA, 2014, J CANCER RES CLIN, V140, P1801, DOI 10.1007/s00432-014-1731-2; Pappa CA, 2013, CANCER INVEST, V31, P385, DOI 10.3109/07357907.2013.800093; Pour L, 2010, NEOPLASMA, V57, P29, DOI 10.4149/neo_2010_01_029; Pour L, 2010, ANN HEMATOL, V89, P385, DOI 10.1007/s00277-009-0834-3; Rajkumar SV, 2002, CLIN CANCER RES, V8, P2210; Ribatti D, 2006, ONCOGENE, V25, P4257, DOI 10.1038/sj.onc.1209456; Ribatti Domenico, 2016, Cancer Treat Res, V169, P51; Ribatti D, 2012, CURR CANCER DRUG TAR, V12, P768, DOI 10.2174/156800912802429346; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Silvestris F, 2011, ADV EXP MED BIOL, V714, P113, DOI 10.1007/978-94-007-0782-5_5; Solanilla A, 2000, LEUKEMIA, V14, P153, DOI 10.1038/sj.leu.2401635; Sondag GR, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.78; Urbanska-Rys H, 2003, MEDIAT INFLAMM, V12, P229, DOI 10.1080/09629350310001599675; Vacca A, 2006, LEUKEMIA, V20, P193, DOI 10.1038/sj.leu.2404067; Vacca A, 2003, HAEMATOLOGICA, V88, P176; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Wen W, 1999, CANCER RES, V59, P6052; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	44	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181487	10.1371/journal.pone.0181487	http://dx.doi.org/10.1371/journal.pone.0181487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727816	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500078
J	Zhao, HZ; Liu, FX; Li, LY				Zhao, Hui-zhen; Liu, Fu-xian; Li, Long-yue			Improving deep convolutional neural networks with mixed maxout units	PLOS ONE			English	Article								Motivated by insights from the maxout-units-based deep Convolutional Neural Network (CNN) that "non-maximal features are unable to deliver" and "feature mapping subspace pooling is insufficient," we present a novel mixed variant of the recently introduced maxout unit called a mixout unit. Specifically, we do so by calculating the exponential probabilities of feature mappings gained by applying different convolutional transformations over the same input and then calculating the expected values according to their exponential probabilities. Moreover, we introduce the Bernoulli distribution to balance the maximum values with the expected values of the feature mappings subspace. Finally, we design a simple model to verify the pooling ability of mixout units and a Mixout-units-based Network-in-Network (NiN) model to analyze the feature learning ability of the mixout models. We argue that our proposed units improve the pooling ability and that mixout models can achieve better feature learning and classification performance.	[Zhao, Hui-zhen; Liu, Fu-xian; Li, Long-yue] Air Force Engn Univ, Air & Missile Def Coll, Xian, Shaanxi, Peoples R China	Air Force Engineering University	Zhao, HZ (corresponding author), Air Force Engn Univ, Air & Missile Def Coll, Xian, Shaanxi, Peoples R China.	margeryzhao@outlook.com	Li, Longyue/P-1802-2018	Li, Longyue/0000-0001-5234-2625	National Natural Science Foundation of China [61601499, 61272011]; Air Force Engineering University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Air Force Engineering University	This work was supported by the National Natural Science Foundation of China (61601499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China under Grant No.61601499, No 61272011 and two grants from Air Force Engineering University. All the funds above can cover the costs to publish in open access. The authors would like to thank all of the team members of D605 Laboratory.	Chang J.R., 2015, COMPUTER SCI; Goodfellow IJ, ARXIV13024389, P1319; He K., 2016, CVPR, P770; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; Jin XJ, 2016, AAAI CONF ARTIF INTE, P1737; Krizhevsky A, 2009, THESIS U TORONTO TOR; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Li J, 2013, 38 IEEE INT C AC SPE; Liao Z, 2016, APPL COMP VIS WACV 2; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Maas A.L., 2013, INT C MACHINE LEARNI, V30, P3, DOI DOI 10.1016/0010-0277(84)90022-2; Nair V., 2010, P 27 INT C INT C MAC, P807; Netzer Y., 2011, READING DIGITS NATUR, DOI DOI 10.2118/18761-MS; Springenberg J. T., 2013, ARXIV13126116; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tompson J, 2015, P IEEE C COMP VIS PA; Wan L., 2013, INT C MACHINE LEARNI, VVolume 28, P1058; Wang S., 2013, P 30 INT C MACH LEAR, P118; Weinberger K.Q., 2013, ADV NEURAL INFORM PR, P3084; Xu B., 2015, ARXIV150500853, V1505, P853; Yu D, 2014, INT C ROUGH SETS KNO; Zeiler M.D., 2013, ARXIV13013557	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180049	10.1371/journal.pone.0180049	http://dx.doi.org/10.1371/journal.pone.0180049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727737	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500012
J	Awad, AM; Venkataramanan, S; Nag, A; Galivanche, AR; Bradley, MC; Neves, LT; Douglass, S; Clarke, CF; Johnson, TL				Awad, Agape M.; Venkataramanan, Srivats; Nag, Anish; Galivanche, Anoop Raj; Bradley, Michelle C.; Neves, Lauren T.; Douglass, Stephen; Clarke, Catherine F.; Johnson, Tracy L.			Chromatin-remodeling SWI/SNF complex regulates coenzyme Q(6) synthesis and a metabolic shift to respiration in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; SUCCINIC-DEHYDROGENASE; PROTEIN PHOSPHATASE; STRESS RESPONSES; Q BIOSYNTHESIS; MESSENGER-RNA; TRANSCRIPTION; DELETION; GENOME	Despite its relatively streamlined genome, there are many important examples of regulated RNA splicing in Saccharomyces cerevisiae. Here, we report a role for the chromatin remodeler SWI/SNF in respiration, partially via the regulation of splicing. We find that a nutrient-dependent decrease in Snf2 leads to an increase in splicing of the PTC7 transcript. The spliced PTC7 transcript encodes a mitochondrial phosphatase regulator of biosynthesis of coenzyme Q6 (ubiquinone or CoQ6) and a mitochondrial redox- active lipid essential for electron and proton transport in respiration. Increased splicing of PTC7 increases CoQ6 levels. The increase in PTC7 splicing occurs at least in part due to down-regulation of ribosomal protein gene expression, leading to the redistribution of spliceosomes from this abundant class of intron-containing RNAs to otherwise poorly spliced transcripts. In contrast, a protein encoded by the non-spliced isoform of PTC7 represses CoQ6 biosynthesis. Taken together, these findings uncover a link between Snf2 expression and the splicing of PTC7 and establish a previously unknown role for the SWI/SNF complex in the transition of yeast cells from fermentative to respiratory modes of metabolism.	[Awad, Agape M.; Nag, Anish; Bradley, Michelle C.; Clarke, Catherine F.] UCLA, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 156905, Los Angeles, CA 90095 USA; [Awad, Agape M.; Venkataramanan, Srivats; Nag, Anish; Bradley, Michelle C.; Neves, Lauren T.; Clarke, Catherine F.; Johnson, Tracy L.] UCLA, Mol Biol Inst, Los Angeles, CA 90095 USA; [Venkataramanan, Srivats; Galivanche, Anoop Raj; Neves, Lauren T.; Douglass, Stephen; Johnson, Tracy L.] UCLA, Dept Mol Cell & Dev Biol, 610 Charles E Young Dr S, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, CF (corresponding author), UCLA, Dept Chem & Biochem, 607 Charles E Young Dr E,Box 156905, Los Angeles, CA 90095 USA.; Johnson, TL (corresponding author), UCLA, Dept Mol Cell & Dev Biol, 610 Charles E Young Dr S, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu; tljohnson@ucla.edu		Venkataramanan, Srivats/0000-0002-2507-401X; Galivanche, Anoop/0000-0003-3362-1930	National Science Foundation [MCB-1330803, 1518316]; NIGMS, National Institutes of Health [GM-085474]; Whitcome Pre-doctoral Fellowship in Molecular Biology; Ruth L. Kirschstein National Service [GM-007185]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085474, T32GM007185] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Whitcome Pre-doctoral Fellowship in Molecular Biology; Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grants MCB-1330803 and 1518316, and by NIGMS, National Institutes of Health, Grant GM-085474; the Whitcome Pre-doctoral Fellowship in Molecular Biology (to S. V.); and Ruth L. Kirschstein National Service Award GM-007185 (to M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; [Anonymous], RNA, P1138; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; DE P, 1962, EXP CELL RES, V27, P172, DOI 10.1016/0014-4827(62)90061-7; DE P, 1962, EXPERIENTIA, V18, P562, DOI 10.1007/BF02172179; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826; Dutta A, 2017, CELL REP, V18, P2124, DOI 10.1016/j.celrep.2017.01.058; Dutta A, 2014, GENE DEV, V28, P2314, DOI 10.1101/gad.243584.114; Gabunilas J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005999; Gonzalez-Mariscal I, 2017, MICROB CELL, V4, P38, DOI 10.15698/mic2017.02.556; Gonzalez-Mariscal I, 2014, MOL SYNDROMOL, V5, P107, DOI 10.1159/000362897; Grate L, 2002, METHOD ENZYMOL, V350, P380, DOI 10.1016/S0076-6879(02)50975-7; Guo X, 2017, CELL REP, V18, P307, DOI 10.1016/j.celrep.2016.12.049; Hossain MA, 2016, MOL CELL, V62, P346, DOI 10.1016/j.molcel.2016.04.012; Hossain MA, 2011, NUCLEIC ACIDS RES, V39, P8612, DOI 10.1093/nar/gkr497; Jiang LH, 2002, FEBS LETT, V527, P323, DOI 10.1016/S0014-5793(02)03247-7; Johnson TL, 2012, BBA-GENE REGUL MECH, V1819, P538, DOI 10.1016/j.bbagrm.2011.12.011; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; LIU J, 2017, SCI REP UK, V7; Liu XY, 2017, NATURE, V544, P440, DOI 10.1038/nature22036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marshall AN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003376; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Martin-Montalvo A, 2013, J BIOL CHEM, V288, P28126, DOI 10.1074/jbc.M113.474494; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; MCEWEN BS, 1963, J BIOL CHEM, V238, P2571; Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170; Munding EM, 2013, MOL CELL, V51, P338, DOI 10.1016/j.molcel.2013.06.012; Naftelberg S, 2015, ANNU REV BIOCHEM, V84, P165, DOI 10.1146/annurev-biochem-060614-034242; NEIGEBORN L, 1984, GENETICS, V108, P845; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Quinzii CM, 2014, MOL SYNDROMOL, V5, P141, DOI 10.1159/000360490; Sharmin D, 2014, YEAST, V31, P393, DOI 10.1002/yea.3032; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Venkataramanan S, 2017, NUCLEIC ACIDS RES, V45, P7708, DOI 10.1093/nar/gkx373; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Wang A, 2016, ONCOTARGET, V7, P80131, DOI 10.18632/oncotarget.12560; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328	49	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14851	14866		10.1074/jbc.M117.798397	http://dx.doi.org/10.1074/jbc.M117.798397			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739803	Green Published, hybrid			2022-12-26	WOS:000409902100013
J	Chansaenroj, J; Tuanthap, S; Thanusuwannasak, T; Duang-in, A; Klinfueng, S; Thaneskongtong, N; Vutithanachot, V; Vongpunsawad, S; Poovorawan, Y				Chansaenroj, Jira; Tuanthap, Supansa; Thanusuwannasak, Thanundorn; Duang-in, Ausanee; Klinfueng, Sirapa; Thaneskongtong, Napha; Vutithanachot, Viboonsuk; Vongpunsawad, Sompong; Poovorawan, Yong			Human enteroviruses associated with and without diarrhea in Thailand between 2010 and 2016	PLOS ONE			English	Article							NON-POLIO; MOLECULAR CHARACTERIZATION; HUMAN RHINOVIRUS; CHILDREN; VIRUSES; GASTROENTERITIS; PREVALENCE; ROTAVIRUS; INFECTION; NOROVIRUS	Non-bacterial acute gastroenteritis (AGE) associated with virus infection affects individuals living in developing countries, especially children. To investigate whether shedding of certain human enterovirus (EV) is more frequently detected in the stool of individuals with AGE of unknown etiology than individuals without AGE symptoms, we tested fecal samples collected from 2,692 individuals with diarrhea between January 2010 and December 2016. Samples were tested for rotavirus, norovirus, and EV by reverse-transcription polymerase chain reaction (RT-PCR) and adenovirus by PCR. EV-positive samples were subjected to sequencing and phylogenetic analysis to identify EV species and types. Findings were compared to EV found in 1,310 fecal samples from individuals without AGE who were diagnosed with hand, foot, and mouth disease (HFMD). While the majority of viruses identified in AGE consisted of human rotavirus (22.7%), norovirus (11.4%) and adenovirus (9.3%), we identified EV (6.2%) belonging mainly to species B, C, and rhinovirus. In contrast, >92% of EV found without AGE symptoms belonged to species A. Although AGE symptoms are not often attributed to EV infection, EV was associated with diarrhea of unknown etiology at least in 3.4% of AGE cases. While CV-A6 was most likely to be found in stools of HFMD patients, rhinovirus A and C were the two most common EV species associated with AGE. Elucidating group-specific EV infection in diseases with and without AGE will be useful in assisting identification, clinical management, and the surveillance of EV infection in the community.	[Chansaenroj, Jira; Tuanthap, Supansa; Thanusuwannasak, Thanundorn; Duang-in, Ausanee; Klinfueng, Sirapa; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand; [Thaneskongtong, Napha; Vutithanachot, Viboonsuk] Chum Phae Hosp, Khon Kaen, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Chansaenroj, Jira/0000-0003-2610-1355; Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728; Tuanthap, Supansa/0000-0001-9167-194X	National Research Council of Thailand; National Research University Project; Office of Higher Education Commission [NRU-59-002-HR]; Outstanding Professor of Thailand Research Fund [DPG5480002]; National Science and Technology Development Agency [P-15-50004]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Center of Excellence in Clinical Virology at King Chulalongkom Memorial Hospital [GCE 58-014-30-004]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0196/2556]; 100th Anniversary Chulalongkorn University doctoral scholarship	National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Research University Project; Office of Higher Education Commission(Office of Higher Education Commission (OHEC)); Outstanding Professor of Thailand Research Fund; National Science and Technology Development Agency; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Chulalongkorn University Centenary Academic Development Project; Center of Excellence in Clinical Virology at King Chulalongkom Memorial Hospital; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); 100th Anniversary Chulalongkorn University doctoral scholarship	This work was supported by The National Research Council of Thailand, The National Research University Project, The Office of Higher Education Commission (NRU-59-002-HR), The Outstanding Professor of Thailand Research Fund (DPG5480002), The Research Chair Grant from the National Science and Technology Development Agency (P-15-50004), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), Chulalongkorn University Centenary Academic Development Project (CU56-HR01), and The Center of Excellence in Clinical Virology at King Chulalongkom Memorial Hospital (GCE 58-014-30-004). This research was also supported by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program to Jira Chansaenroj (PHD/0196/2556) and 100th Anniversary Chulalongkorn University doctoral scholarship to Supansa Tuanthap.	Chaimongkol N, 2012, CLIN LAB, V58, P117; Chieochansin T, 2016, INFECT GENET EVOL, V37, P129, DOI 10.1016/j.meegid.2015.11.011; Dong WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19247; Harvala H, 2012, J MED VIROL, V84, P536, DOI 10.1002/jmv.23203; HELFAND RF, 1995, J INFECT DIS, V172, P1206, DOI 10.1093/infdis/172.5.1206; Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5; Holmes CW, 2016, J CLIN VIROL, V81, P90, DOI 10.1016/j.jcv.2016.06.007; Holtz LR, 2014, VIROLOGY, V468, P556, DOI 10.1016/j.virol.2014.09.012; Honkanen H, 2013, J CLIN VIROL, V56, P250, DOI 10.1016/j.jcv.2012.11.020; Jalava K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104713; Jubelt B, 2014, HAND CLINIC, V123, P379, DOI 10.1016/B978-0-444-53488-0.00018-3; Kawada J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33452; Khananurak K, 2010, INFECT GENET EVOL, V10, P537, DOI 10.1016/j.meegid.2010.02.003; Khoonta P, 2017, J MED VIROL, V89, P801, DOI 10.1002/jmv.24698; Knowles NJ, 2012, VIRUS TAXONOMY CLASS; Kollaritsch H, 2015, CLIN MICROBIOL INFEC, V21, P735, DOI 10.1016/j.cmi.2015.01.027; Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; Mauleekoonphairoj J, 2013, SE ASIAN J TROP MED, V46, P1013; O'Ryan M, 2017, PEDIATR INFECT DIS J, V36, P127, DOI 10.1097/INF.0000000000001369; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Pallansch M, 2013, FIELDS VIROLOGY, V1, P490; Patil PR, 2015, J MED VIROL, V87, P154, DOI 10.1002/jmv.23992; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Phan TG, 2005, J MED VIROL, V77, P257, DOI 10.1002/jmv.20445; Phumpholsup T, 2015, ARCH VIROL, V160, P2603, DOI 10.1007/s00705-015-2545-5; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Rao DC, 2014, J CLIN VIROL, V61, P125, DOI 10.1016/j.jcv.2014.05.015; Rao DC, 2013, INFECT GENET EVOL, V17, P153, DOI 10.1016/j.meegid.2013.04.011; Roivainen M, 1998, J MED VIROL, V56, P74, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;74::AID-JMV12&gt;3.0.CO;2-W; Rovida F, 2013, DIAGN MICR INFEC DIS, V77, P231, DOI 10.1016/j.diagmicrobio.2013.07.020; Saikruang W, 2014, ARCH VIROL, V159, P3371, DOI 10.1007/s00705-014-2191-3; Silva PA, 2008, J MED VIROL, V80, P1790, DOI 10.1002/jmv.21231; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; Sugawara T, 2009, JPN J INFECT DIS, V62, P51; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thongprachum A, 2015, J MED VIROL, V87, P1141, DOI 10.1002/jmv.24155; Verboon-Maciolek MA, 2002, J MED VIROL, V66, P241, DOI 10.1002/jmv.2136; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x	48	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182078	10.1371/journal.pone.0182078	http://dx.doi.org/10.1371/journal.pone.0182078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750058	gold, Green Submitted, Green Published			2022-12-26	WOS:000406575700130
J	Kishimoto, Y; Ohkawara, B; Sakai, T; Ito, M; Masuda, A; Ishiguro, N; Shukunami, C; Docheva, D; Ohno, K				Kishimoto, Yasuzumi; Ohkawara, Bisei; Sakai, Tadahiro; Ito, Mikako; Masuda, Akio; Ishiguro, Naoki; Shukunami, Chisa; Docheva, Denitsa; Ohno, Kinji			Wnt/beta-catenin signaling suppresses expressions of Scx, Mkx, and Tnmd in tendon-derived cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TGF-BETA; GROWTH-FACTORS; FLEXOR TENDON; IN-VIVO; PROGENITOR CELLS; GENE-EXPRESSION; TENOMODULIN; SCLERAXIS; DIFFERENTIATION	After tendon injuries, biomechanical properties of the injured tendon are not fully recovered in most cases. Modulation of signaling pathways, which are involved in tendon development and tendon repair, is one of attractive modalities to facilitate proper regeneration of the injured tendon. The roles of TGF-beta signaling in tendon homeostasis and tendon development have been elucidated. In contrast, the roles of Wnt/beta-catenin signaling in tendon remain mostly elusive. We found that the number of beta-catenin-positive cells was increased at the injured site, suggesting involvement of Wnt/beta-catenin signaling in tendon healing. Activation of Wnt/beta-catenin signaling suppressed expressions of tenogenic genes of Scx, Mkx, and Tnmd in rat tendon-derived cells (TDCs) isolated from the Achilles tendons of 6-week old rats. Additionally, activation of Wnt/beta-catenin reduced the amounts of Smad2 and Smad3, which are intracellular mediators for TGF-beta signaling, and antagonized upregulation of Scx induced by TGF-beta signaling in TDCs. We found that Wnt/beta-catenin decreased Mkx and Tnmd expressions without suppressing Scx expression in Scx-programmed tendon progenitors. Our studies suggest that Wnt/beta-catenin signaling is a repressor for tenogenic gene expressions.	[Kishimoto, Yasuzumi; Ohkawara, Bisei; Ito, Mikako; Masuda, Akio; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi, Japan; [Kishimoto, Yasuzumi; Sakai, Tadahiro; Ishiguro, Naoki] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Shukunami, Chisa] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Dent Sci, Dept Mol Biol & Biochem, Hiroshima, Japan; [Docheva, Denitsa] Univ Regensburg, Med Ctr, Dept Trauma Surg, Expt Trauma Surg, Regensburg, Germany	Nagoya University; Nagoya University; Hiroshima University; University of Regensburg	Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi, Japan.	ohnok@med.nagoya-u.ac.jp	Shukunami, Chisa/G-2887-2019; Docheva, Denitsa/R-1259-2018; Ohno, Kinji/H-4020-2012; Ohno, Kinji/ABD-5787-2020; Ito, Mikako/I-1941-2012	Shukunami, Chisa/0000-0001-5616-6761; Docheva, Denitsa/0000-0002-7588-1290; Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; Ohkawara, Bisei/0000-0002-1987-458X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Ministry of Health, Labor and Welfare (MHLW); Japan Agency for Medical Research and Development (AMED); Hori Sciences & Arts Foundation; Grants-in-Aid for Scientific Research [15H04840] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hori Sciences & Arts Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Ministry of Health, Labor and Welfare (MHLW), the Japan Agency for Medical Research and Development (AMED), and the Hori Sciences & Arts Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150; Arai K, 2002, MATRIX BIOL, V21, P243, DOI 10.1016/S0945-053X(02)00005-7; Bayer ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086078; Berglund ME, 2010, J HAND SURG-AM, V35A, P1842, DOI 10.1016/j.jhsa.2010.06.031; Berthet E, 2013, J ORTHOP RES, V31, P1475, DOI 10.1002/jor.22382; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; Branford OA, 2014, J HAND SURG-EUR VOL, V39, P60, DOI 10.1177/1753193413509231; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Chen CH, 2008, J HAND SURG-AM, V33A, P1834, DOI 10.1016/j.jhsa.2008.07.003; Chen X, 2012, SCI REP-UK, V2, DOI 10.1038/srep00977; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dao DY, 2007, ANN NY ACAD SCI, V1116, P82, DOI 10.1196/annals.1402.082; Dex S, 2016, GENE, V587, P1, DOI 10.1016/j.gene.2016.04.051; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Docheva D, 2015, ADV DRUG DELIVER REV, V84, P222, DOI 10.1016/j.addr.2014.11.015; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Farhat YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051411; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Gungormus C, 2012, CONNECT TISSUE RES, V53, P485, DOI 10.3109/03008207.2012.694511; Guo J, 2016, EXP CELL RES, V341, P1, DOI 10.1016/j.yexcr.2016.01.007; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Hosaka Y, 2005, CONNECT TISSUE RES, V46, P9, DOI 10.1080/03008200590935510; Hsieh CF, 2016, NANOMEDICINE-UK, V11, P1153, DOI 10.2217/nnm.16.34; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kimura N, 2008, CIRCULATION, V118, P1737, DOI 10.1161/CIRCULATIONAHA.108.780031; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Lui PPY, 2013, RHEUMATOLOGY, V52, P1609, DOI 10.1093/rheumatology/ket214; Miyabara Shihori, 2014, Journal of Equine Science, V25, P7, DOI 10.1294/jes.25.7; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Omachi T, 2015, J ORTHOP SCI, V20, P380, DOI 10.1007/s00776-014-0684-2; Oshima Y, 2004, J CELL SCI, V117, P2731, DOI 10.1242/jcs.01112; Otabe K, 2015, J ORTHOP RES, V33, P1, DOI 10.1002/jor.22750; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Qi J, 2012, J APPL PHYSIOL, V113, P861, DOI 10.1152/japplphysiol.00198.2012; Qiu YW, 2013, CELLS TISSUES ORGANS, V197, P27, DOI 10.1159/000341426; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Stapp AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086432; Takamatsu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092699; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Tokunaga T, 2015, AM J SPORT MED, V43, P2411, DOI 10.1177/0363546515597488; Tsubone T, 2004, ANN PLAS SURG, V53, P393, DOI 10.1097/01.sap.0000125501.72773.01; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Yoshimoto Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45010; Zhu XM, 2012, DEV BIOL, V365, P328, DOI 10.1016/j.ydbio.2012.02.019	46	30	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							0182051	10.1371/journal.pone.0182051	http://dx.doi.org/10.1371/journal.pone.0182051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750046	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700122
J	Choi, CY; Park, JS; Yoon, KT; Gil, HW; Lee, EY; Hong, SY				Choi, Chi-Young; Park, Jae Seok; Yoon, Kyu Tae; Gil, Hyo Wook; Lee, Eun Young; Hong, Sae Yong			Intra-dialytic hypertension is associated with high mortality in hemodialysis patients	PLOS ONE			English	Article							BLOOD-PRESSURE; INTRADIALYTIC HYPERTENSION; DIETARY POTASSIUM; DIALYSIS; ERYTHROPOIETIN; PREVALENCE	Background Intra-dialytic hypertension (IDH) is emerging as an important issue in hemodialysis patients. Its risk factors and clinical outcomes are unclear. Methods A total of 73 prevalent hemodialysis patients were enrolled. They included 14 (19.2%) patients with baseline IDH and 59 patients without IDH. Their clinical parameters, laboratory parameters, and mortality were investigated over 78 months. Results The risks factor of IDH included low serum potassium levels, low ultrafiltration, and low arm muscle area. Lower median survival was evident in the IDH group compared to the non-IDH group, but was not significantly different. After adjusting for relevant confounders for age, the IDH group displayed 2.846 times higher mortality rate than the non-IDH Group (adjusted hazard ratio: 2.846; 95% confidence interval: 1.081-7.490; P = 0.034). Conclusion IDH is associated with high mortality in hemodialysis patients. Clinicians should be aware of the risk factors. Future research studies are needed to explore the mechanisms involved in the association between IDH and mortality.	[Choi, Chi-Young; Park, Jae Seok; Yoon, Kyu Tae; Gil, Hyo Wook; Lee, Eun Young; Hong, Sae Yong] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea	Soonchunhyang University	Lee, EY (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	eylee@sch.ac.kr	Lee, Eun Young/Q-6592-2019	Lee, Eun Young/0000-0002-4513-9888; hong, saeyong/0000-0001-7854-3871	National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A1A03032522]; Soonchunhyang University	National Research Foundation of Korea (NRF) - Ministry of Education; Soonchunhyang University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A1A03032522) and Soonchunhyang University Research Fund.; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A1A03032522) and Soonchunhyang University Research Fund.	ABRAHAM PA, 1991, J AM SOC NEPHROL, V2, P927; Amerling R, 1995, CLIN DIALYSIS, V3, P235; Ando K, 2010, CURR VASC PHARMACOL, V8, P59, DOI 10.2174/157016110790226561; Azadbakht L, 2005, DIABETES CARE, V28, P2823, DOI 10.2337/diacare.28.12.2823; Bazzato G, 1983, CONTRIBUTIONS NEPHRO, V41, P292; BodeBoger SM, 1996, KIDNEY INT, V50, P1255, DOI 10.1038/ki.1996.435; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; Chou KJ, 2006, KIDNEY INT, V69, P1833, DOI 10.1038/sj.ki.5000266; CIRIT M, 1995, NEPHROL DIAL TRANSPL, V10, P1417; Dwyer JT, 2002, J RENAL NUTR, V12, P213, DOI 10.1053/jren.2002.35297; Fellner SK, 1993, SEMINARS DIALYSIS; Foley RN, 1998, J NEPHROL, V11, P239; FUJITA T, 1984, HYPERTENSION, V6, P184, DOI 10.1161/01.HYP.6.2_Pt_1.184; Grekas D, 2000, CLIN NEPHROL, V53, P164; Inrig JK, 2007, KIDNEY INT, V71, P454, DOI 10.1038/sj.ki.5002077; Inrig JK, 2011, CLIN J AM SOC NEPHRO, V6, P2016, DOI 10.2215/CJN.11351210; Inrig JK, 2010, AM J KIDNEY DIS, V55, P580, DOI 10.1053/j.ajkd.2009.08.013; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; LAWTON WJ, 1990, CIRCULATION, V81, P173, DOI 10.1161/01.CIR.81.1.173; Levin NW, 1993, SEMINARS DIALYSIS; Movilli E, 2013, AM J NEPHROL, V38, P413, DOI 10.1159/000355974; POULTER NR, 1985, CLIN EXP PHARMACOL P, V12, P211, DOI 10.1111/j.1440-1681.1985.tb02633.x; Raj DSC, 2002, KIDNEY INT, V61, P697, DOI 10.1046/j.1523-1755.2002.00150.x; Sarkar SR, 2005, CLIN DIALYSIS, V4, P237; Seok Su Jin, 2010, Korean Journal of Internal Medicine, V25, P188, DOI 10.3904/kjim.2010.25.2.188; Tayyem RF, 2008, J RENAL NUTR, V18, P202, DOI 10.1053/j.jrn.2007.10.001; Van Buren PN, 2012, INT J ARTIF ORGANS, V35, P1031, DOI 10.5301/ijao.5000126	27	2	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181060	10.1371/journal.pone.0181060	http://dx.doi.org/10.1371/journal.pone.0181060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742805	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000021
J	Persyn, E; Karakachoff, M; Le Scouarnec, S; Le Clezio, C; Campion, D; Consortium, FE; Schott, JJ; Redon, R; Bellanger, L; Dina, C				Persyn, Elodie; Karakachoff, Matilde; Le Scouarnec, Solena; Le Clezio, Camille; Campion, Dominique; Consortium, French Exome; Schott, Jean-Jacques; Redon, Richard; Bellanger, Lise; Dina, Christian			DoEstRare: A statistical test to identify local enrichments in rare genomic variants associated with disease	PLOS ONE			English	Article							COMMON DISEASES; SEQUENCING DATA; GENES; RISK	Next-generation sequencing technologies made it possible to assay the effect of rare variants on complex diseases. As an extension of the "common disease-common variant" paradigm, rare variant studies are necessary to get a more complete insight into the genetic architecture of human traits. Association studies of these rare variations show new challenges in terms of statistical analysis. Due to their low frequency, rare variants must be tested by groups. This approach is then hindered by the fact that an unknown proportion of the variants could be neutral. The risk level of a rare variation may be determined by its impact but also by its position in the protein sequence. More generally, the molecular mechanisms underlying the disease architecture may involve specific protein domains or intergenic regulatory regions. While a large variety of methods are optimizing functionality weights for each single marker, few evaluate variant position differences between cases and controls. Here, we propose a test called DoEstRare, which aims to simultaneously detect clusters of disease risk variants and global allele frequency differences in genomic regions. This test estimates, for cases and controls, variant position densities in the genetic region by a kernel method, weighted by a function of allele frequencies. We compared DoEstRare with previously published strategies through simulation studies as well as reanalysis of real datasets. Based on simulation under various scenarios, DoEstRare was the sole to consistently show highest performance, in terms of type I error and power both when variants were clustered or not. DoEstRare was also applied to Brugada syndrome and early-onset Alzheimer's disease data and provided complementary results to other existing tests. DoEstRare, by integrating variant position information, gives new opportunities to explain disease susceptibility. DoEstRare is implemented in a user-friendly R package.	[Persyn, Elodie; Karakachoff, Matilde; Le Scouarnec, Solena; Schott, Jean-Jacques; Redon, Richard; Dina, Christian] Univ Nantes, CNRS, INSERM, Inst Thorax, Nantes, France; [Karakachoff, Matilde; Schott, Jean-Jacques; Redon, Richard; Dina, Christian] CHU Nantes, Inst Thorax, Nantes, France; [Le Clezio, Camille; Campion, Dominique] Normandy Univ, Rouen Univ, Normandy Ctr Genom Med & Personalized Med, Inserm,U1079, Rouen, France; [Bellanger, Lise] UMR CNRS 6629, Lab Math Jean Leray, Nantes, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Dina, C (corresponding author), Univ Nantes, CNRS, INSERM, Inst Thorax, Nantes, France.; Dina, C (corresponding author), CHU Nantes, Inst Thorax, Nantes, France.; Bellanger, L (corresponding author), UMR CNRS 6629, Lab Math Jean Leray, Nantes, France.	lisa.bellanger@univ-nantes.fr; christian.dina@urev-nantes.fr	Le Scouarnec, Solena/D-3547-2015; Genin, Emmanuelle/C-4974-2013; Dina, Christian R/D-3535-2015; Charbonnier, Camille/AAZ-5543-2020; Schott, jean-Jacques/F-8842-2013; Redon, Richard/F-3303-2014	Le Scouarnec, Solena/0000-0003-3444-2125; Genin, Emmanuelle/0000-0003-4117-2813; Dina, Christian R/0000-0002-7722-7348; Charbonnier, Camille/0000-0003-1172-0196; Schott, jean-Jacques/0000-0002-9578-9475; Redon, Richard/0000-0001-7751-2280; Ludwig, Thomas/0000-0002-9996-1084; Persyn, Elodie/0000-0001-9104-1972	French Regional Council of Pays de la Loire (RFIVaCaRMe:Recherche,Formation et Innovation,Vaincrelesmaladies Cardiovaculaires, Respiratoires et Metaboliques)	French Regional Council of Pays de la Loire (RFIVaCaRMe:Recherche,Formation et Innovation,Vaincrelesmaladies Cardiovaculaires, Respiratoires et Metaboliques)	This work was supported by a grant from The French Regional Council of Pays de la Loire (RFIVaCaRMe:Recherche,Formation et Innovation,Vaincrelesmaladies Cardiovaculaires, Respiratoires et Metaboliques).The website for this project is available at the following URL address http://www.vacarme-project.org/.	[Anonymous], 1971, INTRO PROBABILITY TH; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bellanger L, 2014, EXPLORATION DONNEES; Bodenhofer U., 2015, R PACKAGE ASS TESTIN; Che RL, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-9; Chen YC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003224; Cheung YH, 2012, GENET EPIDEMIOL, V36, P675, DOI 10.1002/gepi.21662; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Fier H, 2012, BIOINFORMATICS, V28, P3027, DOI 10.1093/bioinformatics/bts568; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Le Scouarnec S, 2015, HUM MOL GENET, V24, P2757, DOI 10.1093/hmg/ddv036; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094337; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085728; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Moutsianas L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005165; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nicolas G, 2015, MOL PSYCHIAT; O'Connor TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065834; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schaid DJ, 2013, HUM GENET, V132, P1301, DOI 10.1007/s00439-013-1335-y; Silverman B.W., 1986, DENSITY ESTIMATION S; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	39	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0179364	10.1371/journal.pone.0179364	http://dx.doi.org/10.1371/journal.pone.0179364			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742119	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700007
J	Liu, XD; Sun, L; Chen, JG; Jin, YY; Liu, Q; Xia, ZN; Wang, L; Li, JJ				Liu, Xudong; Sun, Lin; Chen, Jugang; Jin, Yingying; Liu, Qing; Xia, Zhongnan; Wang, Liang; Li, Jingjie			Effects of local cardiac denervation on cardiac innervation and ventricular arrhythmia after chronic myocardial infarction	PLOS ONE			English	Article							SUDDEN-DEATH; SYMPATHETIC DENERVATION; STELLATE GANGLION; HEART-FAILURE; CANINE MODEL; STIMULATION; PREVENTION; INHIBITION; METOPROLOL; ISCHEMIA	Background Modulation of the autonomic nervous system (ANS) has already been demonstrated to display antiarrhythmic effects in patients and animals with MI. In this study, we investigated whether local cardiac denervation has any beneficial effects on ventricular electrical stability and cardiac function in the chronic phase of MI. Methods Twenty-one anesthetized dogs were randomly assigned into the sham-operated, MI and MI-ablation groups, respectively. Four weeks after local cardiac denervation, LSG stimulation was used to induce VPCs and VAs. The ventricular fibrillation threshold (VFT) and the incidence of inducible VPCs were measured with electrophysiological protocol. Cardiac innervation was determined with immunohistochemical staining of growth associated protein-43 (GAP43) and tyrosine hydroxylase (TH). The global cardiac and regional ventricular function was evaluated with doppler echocardiography in this study. Results Four weeks after operation, the incidence of inducible VPC and VF in MI-ablation group were significantly reduced compared to the MI dogs (p<0.05). Moreover, local cardiac denervation significantly improved VFT in the infarcted border zone (p<0.05). The densities of GAP43 and TH-positive nerve fibers in the infarcted border zone in the MI-ablation group were lower than those in the MI group (p<0.05). However, the local cardiac denervation did not significantly improve cardiac function in the chronic phase of MI, determined by the left ventricle diameter (LV), left atrial diameter (LA), ejection fraction (EF). Conclusions Summarily, in the chronic phase of MI, local cardiac denervation reduces the ventricular electrical instability, and attenuates spatial heterogeneity of sympathetic nerve reconstruction. Our study suggests that this methodology might decrease malignant ventricular arrhythmia in chronic MI, and has a great potential for clinical application.	[Liu, Xudong; Sun, Lin; Jin, Yingying; Liu, Qing; Xia, Zhongnan; Wang, Liang; Li, Jingjie] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Chen, Jugang] Xingxiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Xinxiang City, Henan, Peoples R China	Harbin Medical University; Xinxiang Medical University	Li, JJ (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.	lijingjie1968@126.com		Li, Jing-jie/0000-0001-6569-9578	Scientific Research Projects of Heilongjiang Province [201403, 201607]	Scientific Research Projects of Heilongjiang Province	This work was supported by Scientific Research Projects of Heilongjiang Province, Award Number 201403 (Recipient: Jingjie Li); and Scientific Research Projects of Heilongjiang Province, Award Number: 201607 (Recipient: Jingjie Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTZ M, 1995, J CARDIOVASC PHARM, V26, P627, DOI 10.1097/00005344-199510000-00019; Bangalore S, 2007, J AM COLL CARDIOL, V50, P563, DOI 10.1016/j.jacc.2007.04.060; BARBER MJ, 1983, CIRCULATION, V67, P787, DOI 10.1161/01.CIR.67.4.787; BISTENI A, 1953, CIRCULATION, V7, P523, DOI 10.1161/01.CIR.7.4.523; Cao JM, 2000, CIRCULATION, V101, P1960, DOI 10.1161/01.CIR.101.16.1960; Chen JG, 2015, INT J CARDIOL, V184, P667, DOI 10.1016/j.ijcard.2015.03.057; COETZEE WA, 1987, CIRC RES, V61, P157, DOI 10.1161/01.RES.61.2.157; Grimaldi R, 2012, HEART RHYTHM, V9, P1884, DOI 10.1016/j.hrthm.2012.08.007; Han S, 2012, J AM COLL CARDIOL, V59, P954, DOI 10.1016/j.jacc.2011.11.030; He B, 2013, INT J CARDIOL, V168, P86, DOI 10.1016/j.ijcard.2012.09.067; Issa ZF, 2005, CIRCULATION, V111, P3217, DOI 10.1161/CIRCULATIONAHA.104.507897; Linz D, 2013, HEART RHYTHM, V10, P1525, DOI 10.1016/j.hrthm.2013.07.015; Manousiouthakis E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4918; OLSSON G, 1985, J AM COLL CARDIOL, V5, P1428, DOI 10.1016/S0735-1097(85)80360-0; Pouliopoulos J, 2009, PACE, V32, P851, DOI 10.1111/j.1540-8159.2009.02399.x; Samaan A, 1935, J PHYSIOL-LONDON, V83, P332, DOI 10.1113/jphysiol.1935.sp003232; STEINBECK G, 1992, NEW ENGL J MED, V327, P987, DOI 10.1056/NEJM199210013271404; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Ukena C, 2012, CLIN RES CARDIOL, V101, P63, DOI 10.1007/s00392-011-0365-5; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028; Yan SH, 2008, CLIN INVEST MED, V31, pE198; Zhou S, 2008, HEART RHYTHM, V5, P131, DOI 10.1016/j.hrthm.2007.09.007; Zhou SM, 2004, CIRC RES, V95, P76, DOI 10.1161/01.RES.0000133678.22968.e3; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	25	7	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181322	10.1371/journal.pone.0181322	http://dx.doi.org/10.1371/journal.pone.0181322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732009	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100031
J	Oh, TK; Jeon, JH; Lee, JM; Kim, MS; Kim, JH; Cho, H; Kim, SE; Eom, W				Oh, Tak Kyu; Jeon, Jae Hyun; Lee, Jong Mog; Kim, Moon Soo; Kim, Jee Hee; Cho, Hyeyeon; Kim, Seong-eun; Eom, Woosik			Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; ANESTHETIC TECHNIQUE; RECURRENCE; PROGRESSION; RESECTION; RECEPTOR; IMPACT	Opioids are commonly used for postoperative pain control in cancer patients. In addition to pain control, an association between opioid use and long-term oncologic outcomes, such as recurrence or overall survival, has been postulated. The aim of this study was to determine whether postoperative opioid use in patients with non-small cell lung cancer is associated with long-term oncologic outcomes, including recurrence and death. Data obtained from 1009 medical records of patients who underwent curative resection at the National Cancer Center, Korea between January 2006 and December 2010 were retrospectively analyzed. Seven-day opioid use was divided into four quartiles to analyze probability of recurrence and death. Multivariate regression analyses of recurrence and death was conducted, including the calculation of odds ratios. A total of 871 patients were analyzed. When opioid dosage was examined by quartiles, the probability of death and recurrence increased gradually with increasing opioid use. However, in the multivariate regression analysis, the amount of opioid usage did not affect the risk of recurrence or death of lung cancer (P = 0.520 for recurrence; P = 0.659 for death). Opioid use was correlated with outcome when stratified by lung cancer stage (P = 0.004 for recurrence; P = 0.049 for death); however, the odds ratios only slightly increased (1.001 for stage IA-IIIA) for both outcomes. In non-small cell lung cancer patients, the amount of opioid usage does not affect the risk of recurrence and death of lung cancer. There was an association with stage (IA-IIIA), but the effect was negligible. A well-designed prospective study is needed.	[Oh, Tak Kyu] Seoul Natl Univ, Dept Anesthesiol & Pain Med, Bundang Hosp, Seongnam, Gyeonggi Do, South Korea; [Jeon, Jae Hyun; Lee, Jong Mog; Kim, Moon Soo] Natl Canc Ctr, Dept Thorac Surg, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea; [Kim, Jee Hee; Cho, Hyeyeon; Eom, Woosik] Natl Canc Ctr, Dept Anesthesiol & Pain Med, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea; [Kim, Seong-eun] Seoul Natl Univ, Bundang Hosp, Dept Neurol, Seongnam, Gyeonggi Do, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU)	Eom, W (corresponding author), Natl Canc Ctr, Dept Anesthesiol & Pain Med, 323 Ilsan Ro, Goyang Si, Gyeonggi Do, South Korea.	uchic@ncc.re.kr	Lee, Jeong Min/V-3429-2019	Lee, Jeong Min/0000-0003-0561-8777; eom, woosik/0000-0003-1524-0325				Benzon H, 2008, RAJS PRACTICAL MANAG; Bharati SJ, 2016, J CANCER RES THER, V12, P464, DOI 10.4103/0973-1482.148670; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Cata JP, 2011, EUR J PAIN S, V5, P345, DOI DOI 10.1016/J.EUJPS.2011.08.017; Cata JP, 2014, CANCER MED-US, V3, P900, DOI 10.1002/cam4.236; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Hesker Pamela Rose, 2013, Front Biosci (Schol Ed), V5, P575; JACOX A, 1994, AM FAM PHYSICIAN, V49, P1853; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Law WL, 2007, ANN SURG ONCOL, V14, P2559, DOI 10.1245/s10434-007-9434-4; Lennon FE, 2012, ANESTHESIOLOGY, V116, P940, DOI 10.1097/ALN.0b013e31824b9512; Lerut T, 2009, ANN SURG, V250, P798, DOI 10.1097/SLA.0b013e3181bdd5a8; Maher DP, 2014, BRIT J ANAESTH, V113, P88, DOI 10.1093/bja/aeu192; Mathew B, 2011, ANESTH ANALG, V112, P558, DOI 10.1213/ANE.0b013e31820568af; O'Bryant Cindy L, 2008, J Pain Palliat Care Pharmacother, V22, P282, DOI 10.1080/15360280802537241; Patanwala AE, 2007, ANN PHARMACOTHER, V41, P255, DOI 10.1345/aph.1H421; Pearson FG, 1999, CHEST, V116, p500S, DOI 10.1378/chest.116.suppl_3.500S; SJOSTROM S, 1987, ANESTHESIOLOGY, V67, P877; Taylor MD, 2012, ANN THORAC SURG, V93, P1813, DOI 10.1016/j.athoracsur.2012.03.031; Zylla D, 2014, BR J ANAESTH	21	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181672	10.1371/journal.pone.0181672	http://dx.doi.org/10.1371/journal.pone.0181672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732026	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100054
J	Waseem, M; Sahu, U; Salman, M; Choudhury, A; Kar, S; Tabassum, H; Parvez, S				Waseem, Mohammad; Sahu, Upasana; Salman, Mohd.; Choudhury, Arnab; Kar, Sudeshna; Tabassum, Heena; Parvez, Suhel			Melatonin pre-treatment mitigates SHSY-5Y cells against oxaliplatin induced mitochondrial stress and apoptotic cell death	PLOS ONE			English	Article							OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASE; DAMAGE; NEUROTOXICITY; PLATINUM; BAX; QUANTITATION; INVOLVEMENT; DYSFUNCTION; INHIBITION	Oxaliplatin (Oxa) treatment to SH-SY5Y human neuroblastoma cells has been shown by previous studies to induce oxidative stress, which in turn modulates intracellular signaling cascades resulting in cell death. While this phenomenon of Oxa-induced neurotoxicity is known, the underlying mechanisms involved in this cell death cascade must be clarified. Moreover, there is still little known regarding the roles of neuronal mitochondria and cytosolic compartments in mediating Oxa-induced neurotoxicity. With a better grasp of the mechanisms driving neurotoxicity in Oxa-treated SH-SY5Y cells, we can then identify certain pathways to target in protecting against neurotoxic cell damage. Therefore, the purpose of this study was to determine whether one such agent, melatonin (Mel), could confer protection against Oxa-induced neurotoxicity in SH-SY5Y cells. Results from the present study found Oxa to significantly reduce SH-SY5Y cell viability in a dose-dependent manner. Alternatively, we found Mel pre-treatment to SH-SY5Y cells to attenuate Oxa-induced toxicity, resulting in a markedly increased cell viability. Mel exerted its protective effects by regulating reactive oxygen species (ROS) production and reducing superoxide radicals inside Oxaexposed. In addition, we observed pre-treatment with Mel to rescue Oxa-treated cells by protecting mitochondria. As Oxa-treatment alone decreases mitochondrial membrane potential (..m), resulting in an altered Bcl-2/Bax ratio and release of sequestered cytochrome c, so Mel was shown to inhibit these pathways. Mel was also found to inhibit proteolytic activation of caspase 3, inactivation of Poly (ADP Ribose) polymerase, and DNA damage, thereby allowing SH-SY5Y cells to resist apoptotic cell death. Collectively, our results suggest a role for melatonin in reducing Oxa induced neurotoxicity. Further studies exploring melatonin's protective effects may prove successful in eliciting pathways to further alter the neurotoxic pathways of platinum compounds in cancer treatment.	[Waseem, Mohammad; Sahu, Upasana; Salman, Mohd.; Parvez, Suhel] Jamia Hamdard, Dept Med Elementol & Toxicol, New Delhi, India; [Sahu, Upasana; Choudhury, Arnab; Kar, Sudeshna] Jamia Hamdard, Jamia Hamdard Inst Mol Med, New Delhi, India; [Tabassum, Heena] Jamia Hamdard, Dept Biochem, New Delhi, India	Jamia Hamdard University; Jamia Hamdard University; Jamia Hamdard University	Parvez, S (corresponding author), Jamia Hamdard, Dept Med Elementol & Toxicol, New Delhi, India.	drsuhelparvez@yahoo.com	Waseem, Mohammad/ABB-4658-2021; Salman, Mohd/AAN-8924-2021	Salman, Mohd/0000-0002-7330-8108; Kar, Sudeshna/0000-0002-4991-9240; Sahu, Upasana/0000-0003-2473-9312; Choudhury, Arnab/0000-0003-3227-3831	University Grants Commission Basic Science Research [(UGC-BSR)] [-F-7/91/2007]; Department of Science and Technology, Government of India [SR/CSI/PDF-76/ 2012]; Science and Engineering Research Board, New Delhi, Government of India [2016/001070/HS]	University Grants Commission Basic Science Research [(UGC-BSR)]; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Science and Engineering Research Board, New Delhi, Government of India	Dr. Mohammad Waseem was a recipient of a Senior Research Fellowship from University Grants Commission Basic Science Research [(UGC-BSR)], Grant No. -F-7/91/2007). Dr. Heena Tabassum is grateful to Department of Science and Technology, Government of India, for financial grant (DST Cognitive Science Initiative Program, sanction no. SR/CSI/PDF-76/ 2012). The Grant no. [2016/001070/HS)], received as Extramural Research Grant from the Science and Engineering Research Board, New Delhi, Government of India, to Prof. Suhel Parvez is also thankfully acknowledged.	Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; Andrabi S.S., 2015, ADV PHARM SCI, V2015; Andrabi SA, 2004, FASEB J, V18, P869, DOI 10.1096/fj.03-1031fje; Areti A, 2014, REDOX BIOL, V2, P289, DOI 10.1016/j.redox.2014.01.006; Auger C, 2015, FRONT CELL DEV BIOL, V25, P33; Bilginoglu A, 2014, TURK KARDIYOL DERN A, V42, P265, DOI 10.5543/tkda.2014.36089; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bresciani G, 2015, ADV CLIN CHEM, V68, P87, DOI 10.1016/bs.acc.2014.11.001; Chan A, 2001, GLIA, V33, P87, DOI 10.1002/1098-1136(20010101)33:1<87::AID-GLIA1008>3.0.CO;2-S; Chetsawang B, 2006, J PINEAL RES, V41, P116, DOI 10.1111/j.1600-079X.2006.00335.x; Donzelli E, 2004, J NEURO-ONCOL, V67, P65, DOI 10.1023/B:NEON.0000021787.70029.ce; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Espinet C, 2015, CURR DRUG TARGETS, V16, P20, DOI 10.2174/1389450116666150107153233; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Ghirardi O, 2005, ANTICANCER RES, V25, P2681; Gill JS, 1998, J CLIN INVEST, V101, P2842, DOI 10.1172/JCI1130; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; Janjetovic K, 2012, EXP NEUROL, V238, P12; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lee C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/313510; Lehky RJ, 2004, MUSCLE NERVE, V29, P387, DOI 10.1002/mus.10559; Leon J, 2004, LIFE SCI, V75, P765, DOI 10.1016/j.lfs.2004.03.003; Li ZG, 2004, LIFE SCI, V76, P249, DOI 10.1016/j.lfs.2004.03.039; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lismont C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00035; Maddirala Y, 2015, BRAIN RES, V1608, P157, DOI 10.1016/j.brainres.2015.02.006; Mannelli LD, 2013, FREE RADICAL BIO MED, V61, P143, DOI 10.1016/j.freeradbiomed.2013.03.019; Massicot F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066830; McKeage MJ, 2001, BRIT J CANCER, V85, P1219, DOI 10.1054/bjoc.2001.2024; Nakamura T, 2012, EXP NEUROL, V238, P12, DOI 10.1016/j.expneurol.2012.06.032; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Park JS, 2011, CANCER RES TREAT, V43, P236, DOI 10.4143/crt.2011.43.4.236; Pawlowski J, 2000, P NATL ACAD SCI USA, V97, P529, DOI 10.1073/pnas.97.2.529; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; ROSS RA, 1983, J NATL CANCER I, V71, P741; Sahu U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066430; Seetapun S, 2013, BIOSCIENCE REP, V30, P33; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Solesio ME, 2012, BIOCHIM BIOPHYS ACTA, V1832, P174; Suresh C, 2006, INT J TOXICOL, V25, P459, DOI 10.1080/10915810600959576; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Um HJ, 2010, J PINEAL RES, V49, P283, DOI 10.1111/j.1600-079X.2010.00793.x; Vaisman A, 2001, J BIOL CHEM, V276, P18999, DOI 10.1074/jbc.M007805200; Waseem M, 2016, MITOCHONDRI IN PRESS; Waseem M, 2016, MITOCHONDRION, V30, P168, DOI 10.1016/j.mito.2016.08.001; Waseem M, 2016, PROTOPLASMA, V253, P417, DOI 10.1007/s00709-015-0821-6; Wisessmith W, 2009, J PINEAL RES, V46, P433, DOI 10.1111/j.1600-079X.2009.00680.x; Woynarowski JM, 2000, MOL PHARMACOL, V58, P920, DOI 10.1124/mol.58.5.920; Zheng H, 2012, EXP NEUROL, V238, P225, DOI 10.1016/j.expneurol.2012.08.023	56	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180953	10.1371/journal.pone.0180953	http://dx.doi.org/10.1371/journal.pone.0180953			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732061	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100017
J	Amara, VR; Surapaneni, SK; Tikoo, K				Amara, Venkateswara Rao; Surapaneni, Sunil Kumar; Tikoo, Kulbhushan			Dysregulation of microRNAs and reninangiotensin system in high salt diet-induced cardiac dysfunction in uninephrectomized rats	PLOS ONE			English	Article							ANGIOTENSIN-II; CALCIUM-CHANNELS; BLOOD-PRESSURE; FOLLOW-UP; HYPERTENSION; HYPERTROPHY; HEART; ACTIVATION; MECHANISMS; IMPAIRMENT	Uninephrectomy is not associated with major adverse events in cardiovascular and renal functions of live kidney donors. The effect of high salt diet on the quality of life of live kidney donors is largely unknown. Hence in this study, we aimed to determine the effect of high salt diet on the alterations of renin-angiotensin system and microRNAs leading to CV and renal dysfunction in uninephrectomized rats. In order to mimic clinical scenario, uninephrectomized male Sprague Dawley rats were fed initially with normal pellet diet for 12 weeks and then for 20 weeks with high salt (10% w/w NaCl) diet. At the end of the study, biochemical, functional, histological and molecular parameters were measured. High salt diet feeding resulted in renal dysfunction & fibrosis, decreased baroreflex sensitivity, increased in vivo cardiovascular reactivity to angiotensin II owing to upregulation of angiotensin II type 1 receptors and L-type calcium channels leading to cardiovascular dysfunction in uninephrectomized rats (UNX+ HSD) worse than that of normal (binephric) rats fed with high salt diet (HSD). Protein expression of functional and hypertrophic protein markers revealed decreased SERCA, p-AMPK and increased p-AKT. Interestingly, levels of miR-25, miR-451 and miR-155 increased and miR-99 decreased in heart of uninephrectomized rats fed with high salt. However, circulating miR-25 and miR-451 levels decreased and miR-99b increased in these animals. Our study points out that since tissue and circulating levels of miRNAs are not similar, caution must be exercised during the usage of miRs as diagnostic or prognostic biomarkers. To our knowledge, we are the first to show that epigenetic alterations result in cardiac dysfunction in uninephrectomized rats fed with high salt diet.	[Amara, Venkateswara Rao; Surapaneni, Sunil Kumar; Tikoo, Kulbhushan] NIPER, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Sas Nagar, Punjab, India	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Tikoo, K (corresponding author), NIPER, Dept Pharmacol & Toxicol, Lab Epigenet & Dis, Sas Nagar, Punjab, India.	tikoo.k@gmail.com	Amara, Venkateswara Rao/AGJ-6417-2022; Amara, Venkateswara Rao/U-1081-2019; Amara, Venkateswara Rao/AGP-0388-2022		National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar; National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar, India	National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar; National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar, India	National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wholeheartedly thank National Institute of Pharmaceutical Education and Research (NIPER) S.A.S. Nagar, India for supporting this research work. We are grateful to Umashanker Navik for his selfless help in histological data collection and analysis. We owe a lot to Pinakin Arun Karpe, Yogesh Kumar Bulani, Krishna Prahlad Maremanda, Sandeep Kumar and Sabbir Khan for their technical advice.	Arsenijevic D, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00195; Arun KHS, 2005, CARDIOVASC RES, V65, P374, DOI 10.1016/j.cardiores.2004.10.010; Belke DD, 2004, CURR HYPERTENS REP, V6, P424, DOI 10.1007/s11906-004-0035-3; Bernardi S, 2012, NEPHROL DIAL TRANSPL, V27, P1793, DOI 10.1093/ndt/gfr600; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhat S, 2010, INDIAN J UROL, V26, P167, DOI 10.4103/0970-1591.65381; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Carlstrom M, 2007, HYPERTENSION, V49, P1342, DOI 10.1161/HYPERTENSIONAHA.107.087213; Crestani S, 2014, VASC PHARMACOL, V60, P67, DOI 10.1016/j.vph.2013.12.001; Delanaye P, 2012, NEPHROL DIAL TRANSPL, V27, P41, DOI 10.1093/ndt/gfr669; Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Gai ZB, 2014, BBA-MOL BASIS DIS, V1842, P1870, DOI 10.1016/j.bbadis.2014.07.001; Gao F, 2014, PPAR RES, V2014, DOI 10.1155/2014/491963; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Gupta Sushil, 2013, Indian J Endocrinol Metab, V17, P806, DOI 10.4103/2230-8210.117212; HALL JE, 1986, J HYPERTENS, V4, pS57; Holte K, 2002, BRIT J ANAESTH, V89, P622, DOI 10.1093/bja/aef220; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Joly E, 2005, CLIN EXP PHARMACOL P, V32, P241, DOI 10.1111/j.1440-1681.2005.04181.x; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kanaide H, 2003, CIRC RES, V93, P1015, DOI 10.1161/01.RES.0000105920.33926.60; Kanellis J, 2010, NEPHROLOGY, V15, pS72, DOI 10.1111/j.1440-1797.2009.01212.x; Karpe PA, 2012, J HYPERTENS, V30, P132, DOI 10.1097/HJH.0b013e32834d9efe; Katori M, 2006, J PHARMACOL SCI, V100, P370, DOI 10.1254/jphs.CRJ06003X; Khaliq F, 2013, CARDIOVASC TOXICOL, V13, P68, DOI 10.1007/s12012-012-9187-6; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kuwabara Y, 2015, CIRC RES, V116, P279, DOI 10.1161/CIRCRESAHA.116.304707; Landsberg L, 2013, OBESITY, V21, P8, DOI 10.1002/oby.20181; Lang HM, 2015, BRIT J PHARMACOL, V172, P5548, DOI 10.1111/bph.12987; Lehnart SE, 1998, ANN NY ACAD SCI, V853, P220, DOI 10.1111/j.1749-6632.1998.tb08270.x; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Luke Robert G, 2007, Trans Am Clin Climatol Assoc, V118, P1; Pacurari M, 2014, INT J INFLAMM, V2014, DOI 10.1155/2014/689360; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Radhika G, 2007, J Assoc Physicians India, V55, P405; Ramcharan T, 2002, AM J TRANSPLANT, V2, P959, DOI 10.1034/j.1600-6143.2002.21013.x; Rao AD, 2016, DIABETES, V65, P209, DOI 10.2337/db15-0871; Romaine SPR, 2015, HEART, V101, P921, DOI 10.1136/heartjnl-2013-305402; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Schefold JC, 2016, NAT REV NEPHROL, V12, P610, DOI 10.1038/nrneph.2016.113; Schroder F, 1998, CIRCULATION, V98, P969, DOI 10.1161/01.CIR.98.10.969; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Taylor TA, 2003, HYPERTENSION, V41, P657, DOI 10.1161/01.HYP.0000048193.85814.78; Ufnal M, 2011, BRIT J NUTR, V106, P292, DOI 10.1017/S0007114511000110; United States Renal Data System, 2016, EXPL TRIAL EV SAF IM; Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073; Wang F, 2014, FRONT MED-PRC, V8, P404, DOI 10.1007/s11684-014-0379-2; Wang HX, 2013, MICRO NANO LETT, V8, P11, DOI 10.1049/mnl.2012.0776; WCRFI Alliance TN, 2014, LINK FOOD NUTR DIET; Wende AR, 2015, MOL CELL BIOL, V35, P831, DOI 10.1128/MCB.01109-14; Williams JM, 2004, HYPERTENSION, V44, P770, DOI 10.1161/01.HYP.0000144073.42537.06; Yamanaka Y, 2009, BLOOD, V114, P3265, DOI 10.1182/blood-2009-06-222794	56	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180490	10.1371/journal.pone.0180490	http://dx.doi.org/10.1371/journal.pone.0180490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727756	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500023
J	Ellis-Soto, D; Blake, S; Soultan, A; Guezou, A; Cabrera, F; Lotters, S				Ellis-Soto, Diego; Blake, Stephen; Soultan, Alaaeldin; Guezou, Anne; Cabrera, Fredy; Loetters, Stefan			Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate change	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; SEED DISPERSAL; DISTRIBUTIONS; VEGETATION; INVASIONS; IMPACT; CONSEQUENCES; ECOSYSTEMS; ISLANDS; MODELS	Native biodiversity on the Galapagos Archipelago is severely threatened by invasive alien species. On Santa Cruz Island, the abundance of introduced plant species is low in the arid lowlands of the Galapagos National Park, but increases with elevation into unprotected humid highlands. Two common alien plant species, guava (Psidium guajava) and passion fruit (Passiflora edulis) occur at higher elevations yet their seeds are dispersed into the lowlands by migrating Galapagos tortoises (Chelonoidis spp.). Tortoises transport large quantities of seeds over long distances into environments in which they have little or no chance of germination and survival under current climate conditions. However, climate change is projected to modify environmental conditions on Galapagos with unknown consequences for the distribution of native and introduced biodiversity. We quantified seed dispersal of guava and passion fruit in tortoise dung piles and the distribution of adult plants along two elevation gradients on Santa Cruz to assess current levels of 'wasted' seed dispersal. We computed species distribution models for both taxa under current and predicted future climate conditions. Assuming that tortoise migratory behaviour continues, current levels of "wasted" seed dispersal in lowlands were projected to decline dramatically in the future for guava but not for passion fruit. Tortoises will facilitate rapid range expansion for guava into lowland areas within the Galapagos National Park where this species is currently absent. Coupled with putative reduction in arid habitat for native species caused by climate change, tortoise driven guava invasion will pose a serious threat to local plant communities.	[Ellis-Soto, Diego; Blake, Stephen; Soultan, Alaaeldin] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Ellis-Soto, Diego; Soultan, Alaaeldin] Univ Konstanz, Dept Biol, Constance, Germany; [Ellis-Soto, Diego; Loetters, Stefan] Trier Univ, Biogeog, Trier, Germany; [Blake, Stephen] Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA; [Blake, Stephen] St Louis Zoo, WildCare Inst, St Louis, MO USA; [Blake, Stephen] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Blake, Stephen] SUNY Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Blake, Stephen; Guezou, Anne; Cabrera, Fredy] Charles Darwin Fdn, Santa Cruz, Galapagos, Ecuador	Max Planck Society; University of Konstanz; Universitat Trier; University of Missouri System; University of Missouri Saint Louis; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Ellis-Soto, D (corresponding author), Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany.; Ellis-Soto, D (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; Ellis-Soto, D (corresponding author), Trier Univ, Biogeog, Trier, Germany.	dellis@orn.mpg.de	Soultan, Alaaeldin/AGW-5311-2022	Soultan, Alaaeldin/0000-0002-3976-2657	National Science Foundation [1258062]; National Geographic Society Committee for Research and Exploration; Swiss Friends of Galapagos; Galapagos Conservation Trust; Max Planck Institute for Ornithology; Direct For Biological Sciences [1258062] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee for Research and Exploration(National Geographic Society); Swiss Friends of Galapagos; Galapagos Conservation Trust; Max Planck Institute for Ornithology(Max Planck Society); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors (SB) received funding from the National Science Foundation Grant No. 1258062 https://www.nsf.gov/awardsearch/ showAward?AWD_ID=1258062), the National Geographic Society Committee for Research and Exploration, the Swiss Friends of Galapagos, the Galapagos Conservation Trust, and the Max Planck Institute for Ornithology.	[Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], CAN WE INFER ISLAND; [Anonymous], BIOMOD2 ENSEMBLE PLA; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Auffret AG, 2014, DIVERS DISTRIB, V20, P1450, DOI 10.1111/ddi.12251; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bensted-Smith, 2002, BIODIVERSITY VISION; Bertelsmeier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075438; Blake S, 2015, BIOTROPICA, V47, P246, DOI 10.1111/btp.12195; Blake S, 2013, J ANIM ECOL, V82, P310, DOI 10.1111/1365-2656.12020; Blake S, 2012, J BIOGEOGR, V39, P1961, DOI 10.1111/j.1365-2699.2011.02672.x; Booth TH, 2014, DIVERS DISTRIB, V20, P1, DOI 10.1111/ddi.12144; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Buddenhagen C, 2006, ORNITOL NEOTROP, V17, P73; BUSBY J R, 1991, Plant Protection Quarterly, V6, P8; Caccone A, 2002, EVOLUTION, V56, P2052; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Cain ML, 2003, ECOLOGY, V84, P1943, DOI 10.1890/01-0614; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Clarke L, 2007, SCENARIOS GREENHOUSE, V6; Colinvaux PA, KEY ENV GALAPAGOS; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dullinger S, 2004, J ECOL, V92, P241, DOI 10.1111/j.0022-0477.2004.00872.x; Dulloo ME, 2002, INT FOREST REV, V4, P277, DOI 10.1505/ifor.4.4.277.40525; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elton C. S., 1958, ECOLOGY INVASIONS AN; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Fryxell JM, 2013, ECOLOGY, V94, P1274, DOI 10.1890/12-0668.1; Gardener MR, 2010, RESTOR ECOL, V18, P20, DOI 10.1111/j.1526-100X.2009.00614.x; Goodland T. C. R., 1998, CONTROL MANAGEMENT I; Guezou A, 2014, C DARWIN FDN GALAPAG, P180; Heleno R, 2011, INTEGR ZOOL, V6, P110, DOI 10.1111/j.1749-4877.2011.00236.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hijmans RJ, 2012, SPECIES DISTRIBUTION; Hosmer DW, 1997, STAT MED, V16, P965; Jager H, 2007, BIOL CONSERV, V140, P297, DOI 10.1016/j.biocon.2007.08.014; Jaramillo Diaz P, 2014, C DARWIN FDN GALAPAG; Kluzek E, 2010, TECHNICAL DESCRIPTIO; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; Leon MG, 2012, INFORME GALAPAGOS, P44; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meyer JY, 1996, J BIOGEOGR, V23, P775, DOI 10.1111/j.1365-2699.1996.tb00038.x; Middleton AD, 2013, ECOLOGY, V94, P1245, DOI 10.1890/11-2298.1; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Orwa C, 2009, AGROFORESTRY TREE DA; Cordeiro JLP, 2016, PEERJ, V4, DOI 10.7717/peerj.2456; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poulakakis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138779; Poulakakis N, 2012, MOL ECOL, V21, P160, DOI 10.1111/j.1365-294X.2011.05370.x; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Rojas- Sandoval J, 2016, COMPENDIUM; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sheppard CS, 2014, GLOBAL CHANGE BIOL, V20, P2800, DOI 10.1111/gcb.12531; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Trueman M, 2014, BIOL CONSERV, V172, P37, DOI 10.1016/j.biocon.2014.02.005; Trueman Mandy, 2010, Galapagos Research, V67, P26; Trueman M, 2010, BIOL INVASIONS, V12, P3949, DOI 10.1007/s10530-010-9822-8; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2001, Weed risk assessment, P153; Venables WN., 2002, MODERN APPL STAT S 4; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Watson J, 2010, ORYX, V44, P79, DOI 10.1017/S0030605309990226; Weber E., 2003, INVASIVE PLANT SPECI; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiggins IL, 1971, FLORA GALAPAGOS ISLA; Yackulic CB, J ANIM ECOL; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	83	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181333	10.1371/journal.pone.0181333	http://dx.doi.org/10.1371/journal.pone.0181333			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727747	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500059
J	Alkhalil, M; Biasiolli, L; Char, JT; Galassi, F; Lie, L; Darby, C; Halliday, A; Hands, L; Magee, T; Perkins, J; Sideso, E; Jezzard, P; Robson, MD; Handa, A; Choudhury, RP				Alkhalil, Mohammad; Biasiolli, Luca; Char, Joshua T.; Galassi, Francesca; Lie, Linqing; Darby, Christopher; Halliday, Alison; Hands, Linda; Magee, Timothy; Perkins, Jeremy; Sideso, Ed; Jezzard, Peter; Robson, Matthew D.; Handa, Ashok; Choudhury, Robin P.			Quantification of carotid plaque lipid content with magnetic resonance T2 mapping in patients undergoing carotid endarterectomy	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; ARTERY STENOSIS; REDUCING LIPIDS; STROKE RISK; ATHEROSCLEROSIS; PREVENTION; SYMPTOMS; EFFICACY; SAFETY; TRIAL	Background and purpose Techniques to stratify subgroups of patients with asymptomatic carotid artery disease are urgently needed to guide decisions on optimal treatment. Reliance on estimates of % luminal stenosis has not been effective, perhaps because that approach entirely disregards potentially important information on the pathological process in the wall of the artery. Methods Since plaque lipid is a key determinant of plaque behaviour we used a newly validated, high-sensitivity T2-mapping MR technique for a systematic survey of the quantity and distribution of plaque lipid in patients undergoing endarterectomy. Lipid percentage was quantified in 50 carotid endarterectomy patients. Lipid distribution was tested, using two imaging indices (contribution of the largest lipid deposit towards total lipid (LLD %) and a newly-developed LAI 'lipid aggregation index'). Results The bifurcation contained maximal lipid volume. Lipid percentage was higher in symptomatic vs. asymptomatic patients with degree of stenosis (DS >= 50%) and in the total cohort (P = 0.013 and P = 0.005, respectively). Both LLD % and LAI was higher in symptomatic patients (P = 0.028 and P = 0.018, respectively), suggesting that for a given plaque lipid volume, coalesced deposits were more likely to be associated with symptomatic events. There was no correlation between plaque volume or lipid content and degree of luminal stenosis measured on ultrasound duplex (r = -0.09, P = 0.53 and r = -0.05, P = 0.75), respectively. However, there was a strong correlation in lipid between left and right carotid arteries (r = 0.5, P < 0.0001, respectively). Conclusions Plaque lipid content and distribution is associated with symptomatic status of the carotid plaque. Importantly, plaque lipid content was not related to the degree of luminal stenosis assessed by ultrasound. Determination of plaque lipid content may prove useful for stratification of asymptomatic patients, including selection of optimal invasive treatments.	[Alkhalil, Mohammad; Biasiolli, Luca; Char, Joshua T.; Galassi, Francesca; Robson, Matthew D.; Choudhury, Robin P.] Univ Oxford, Radcliffe Dept Med, Acute Vasc Imaging Ctr, Oxford, England; [Lie, Linqing; Jezzard, Peter] Univ Oxford, Nuffield Dept Clin Neurosci, FMRIB Ctr, Oxford, England; [Darby, Christopher; Halliday, Alison; Hands, Linda; Magee, Timothy; Perkins, Jeremy; Sideso, Ed; Handa, Ashok] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Choudhury, RP (corresponding author), Univ Oxford, Radcliffe Dept Med, Acute Vasc Imaging Ctr, Oxford, England.	robin.choudhury@cardiov.ox.ac.uk	Halliday, Alison/AAA-2230-2022; ALKHALIL, MOHAMMAD/AAK-3456-2020	Halliday, Alison/0000-0001-9828-3579; ALKHALIL, MOHAMMAD/0000-0002-3088-8878; Jezzard, Peter/0000-0001-7912-2251; Biasiolli, Luca/0000-0002-0452-8756	BHF [PG/11/120/29302, PG/15/74/31747]; NIHR Oxford Biomedical Research Centre; Dunhill Medical Trust; British Heart Foundation [PG/11/120/29302, PG/15/74/31747, PG/15/110/31936] Funding Source: researchfish	BHF(British Heart Foundation); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Dunhill Medical Trust(Dunhill Medical Trust); British Heart Foundation(British Heart Foundation)	This work was supported from BHF (grant PG/11/120/29302 & PG/15/74/31747), the NIHR Oxford Biomedical Research Centre, and the Dunhill Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GJ, 2002, STROKE, V33, P2575, DOI 10.1161/01.STR.0000035736.30488.7A; Alkhalil M, 2017, EUR HEART J-CARD PHA, V3, P58, DOI 10.1093/ehjcvp/pvw034; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Biasiolli L, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-69; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Brugaletta S, 2011, JACC-CARDIOVASC IMAG, V4, P647, DOI 10.1016/j.jcmg.2011.03.013; Chai JT, 2017, JACC-CARDIOVASC IMAG, V10, P747, DOI 10.1016/j.jcmg.2016.06.013; Constantinou J, 2013, J VASC SURG, V58, P1129, DOI 10.1016/j.jvs.2013.06.085; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Gupta A, 2013, STROKE, V44, P3071, DOI 10.1161/STROKEAHA.113.002551; Halliday A, 2004, LANCET, V363, P1491; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Howard DPJ, 2015, STROKE, V46, P182, DOI 10.1161/STROKEAHA.114.007221; Li L, 2014, RADIOLOGY, DOI DOI 10.1148/RADIOL.14131717; Li LQ, 2012, MAGN RESON MED, V68, P1423, DOI 10.1002/mrm.24142; Madjid M, 2004, ARTERIOSCL THROM VAS, V24, P1775, DOI 10.1161/01.ATV.0000142373.72662.20; Matsumoto S, 2010, CEREBROVASC DIS, V29, P468, DOI 10.1159/000297962; Naylor AR, 2012, NAT REV CARDIOL, V9, P116, DOI 10.1038/nrcardio.2011.151; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Selwaness M, 2014, STROKE, V45, P3226, DOI 10.1161/STROKEAHA.114.005202; Sun J, 2017, JACC-CARDIOVASC IMAG, V10, P241, DOI 10.1016/j.jcmg.2016.06.017; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; von Reutern GM, 2012, STROKE, V43, P916, DOI 10.1161/STROKEAHA.111.636084; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wang Q, 2004, J CARDIOVASC MAGN R, V6, P895, DOI 10.1081/JCMR-200036198; Zavodni AEH, 2014, RADIOLOGY, V271, P381, DOI 10.1148/radiol.14131020	30	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181668	10.1371/journal.pone.0181668	http://dx.doi.org/10.1371/journal.pone.0181668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746385	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800047
J	Barbieri, R; Meknl, R; Levasseur, A; Chabriere, E; Signoll, M; Tzortzis, S; Aboudharam, G; Drancourt, M				Barbieri, Remi; Meknl, Rania; Levasseur, Anthony; Chabriere, Eric; Signoll, Michel; Tzortzis, Stefan; Aboudharam, Gerard; Drancourt, Michel			Paleoproteomics of the Dental Pulp: The plague paradigm	PLOS ONE			English	Article							YERSINIA-PESTIS; PROTEOMIC ANALYSIS; ANCIENT BONE; BLACK-DEATH; DNA; IDENTIFICATION; PROTEINS; FOSSILS; REMAINS; GENOME	Chemical decomposition and fragmentation may limit the detection of ancient host and microbial DNA while some proteins can be detected for extended periods of time. We applied paleoproteomics on 300-year-old dental pulp specimens recovered from 16 individuals in two archeological funeral sites in France, comprising one documented plague site and one documented plague-negative site. The dental pulp paleoproteome of the 16 teeth comprised 439 peptides representative of 30 proteins of human origin and 211 peptides representative of 27 proteins of non-human origin. Human proteins consisted of conjunctive tissue and blood proteins including IgA immunoglobulins. Four peptides were indicative of three presumable Yersinia pestis proteins detected in 3/8 dental pulp specimens from the plague-positive site but not in the eight dental pulp specimens collected in the plague-negative site. Paleoproteomics applied to the dental pulp is a new and innovative approach to screen ancient individuals for the detection of blood-borne pathogens and host inflammatory response.	[Barbieri, Remi; Meknl, Rania; Levasseur, Anthony; Chabriere, Eric; Aboudharam, Gerard; Drancourt, Michel] Aix Marseille Univ, URMITE, CNRS, Fac Med IHU Mediterranee Infect, Marseille, France; [Signoll, Michel; Tzortzis, Stefan] Aix Marseille Univ, EFS, CNRS, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Drancourt, M (corresponding author), Aix Marseille Univ, URMITE, CNRS, Fac Med IHU Mediterranee Infect, Marseille, France.	Michel.Drancourt@univ-amu.fr		Levasseur, Anthony/0000-0003-2989-7539	Fondation Mediterranee Infection	Fondation Mediterranee Infection	This work was funded by the Fondation Mediterranee Infection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboudharam G, 2005, MICROB PATHOGENESIS, V38, P47, DOI 10.1016/j.micpath.2004.10.004; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; Biagini P, 2012, NEW ENGL J MED, V367, P2057, DOI 10.1056/NEJMc1208124; Bianucci R, 2007, CR BIOL, V330, P747, DOI 10.1016/j.crvi.2007.07.007; Bos KI, 2016, ELIFE, V5, DOI 10.7554/eLife.12994; Bos KI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0375; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Buckley M, 2014, PALAEOGEOGR PALAEOCL, V416, P69, DOI 10.1016/j.palaeo.2014.06.026; Cappellini E, 2012, J PROTEOME RES, V11, P917, DOI 10.1021/pr200721u; Corthals A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041244; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Donoghue HD, 2015, TUBERCULOSIS, V95, pS140, DOI 10.1016/j.tube.2015.02.020; Dorm M, 2012, NANCY MEURTHE ET MOS, V4; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Drancourt M, 2007, EMERG INFECT DIS, V13, P332, DOI 10.3201/eid1302.060197; Eckhardt A, 2014, J ENDODONT, V40, P1961, DOI 10.1016/j.joen.2014.07.001; GURLEY LR, 1991, J PROTEIN CHEM, V10, P75, DOI 10.1007/BF01024658; Hollemeyer K, 2008, RAPID COMMUN MASS SP, V22, P2751, DOI 10.1002/rcm.3679; Huynh HT, 2015, MOL ORAL MICROBIOL; Huynh HTT, 2016, SCI REP IN PRESS; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lowenstein JM, 1993, ORGANIC GEOCHEMISTRY, P817; Maixner F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099994; Maixner F, 2013, CELL MOL LIFE SCI, V70, P3709, DOI 10.1007/s00018-013-1360-y; Malou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031744; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Nguyen-Hieu T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015405; Papagrigorakis MJ, 2006, INT J INFECT DIS, V10, P206, DOI 10.1016/j.ijid.2005.09.001; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Signoli M, 1995, PREHISTORIE ANTHR ME, V4, P173; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Tran-Hung L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001062; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Wagner DM, 2014, LANCET INFECT DIS, V14, P319, DOI 10.1016/S1473-3099(13)70323-2; Warinner C, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0376; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906	39	17	19	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180552	10.1371/journal.pone.0180552	http://dx.doi.org/10.1371/journal.pone.0180552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746380	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800015
J	Butterfield, NC; Qian, C; Logan, MPO				Butterfield, Natalie C.; Qian, Chen; Logan, Malcolm P. O.			Pitx1 determines characteristic hindlimb morphologies in cartilage micromass culture	PLOS ONE			English	Article							CHICK LIMB BUD; SKELETAL DEVELOPMENT; VERTEBRATE LIMB; GENE-EXPRESSION; CHONDROCYTE DIFFERENTIATION; SONIC-HEDGEHOG; MESSENGER-RNA; COLLAGEN GENE; FEEDBACK LOOP; CHONDROGENESIS	The shapes of homologous skeletal elements in the vertebrate forelimb and hindlimb are distinct, with each element exquisitely adapted to their divergent functions. Many of the signals and signalling pathways responsible for patterning the developing limb bud are common to both forelimb and hindlimb. How disparate morphologies are generated from common signalling inputs during limb development remains poorly understood. We show that, similar to what has been shown in the chick, characteristic differences in mouse forelimb and hindlimb cartilage morphology are maintained when chondrogenesis proceeds in vitro away from the endogenous limb bud environment. Chondrogenic nodules that form in high-density micromass cultures derived from forelimb and hindlimb buds are consistently different in size and shape. We described analytical tools we have developed to quantify these differences in nodule morphology and demonstrate that characteristic hindlimb nodule morphology is lost in the absence of the hindlimb-restricted limb modifier gene Pitx1. Furthermore, we show that ectopic expression of Pitx1 in the forelimb is sufficient to generate nodule patterns characteristic of the hindlimb. We also demonstrate that hindlimb cells are less adhesive to the tissue culture substrate and, within the limb environment, to the extracellular matrix and to each other. These results reveal autonomously programmed differences in forelimb and hindlimb cartilage precursors of the limb skeleton are controlled, at least in part, by Pitx1 and suggest this has an important role in generating distinct limb-type morphologies. Our results demonstrate that the micromass culture system is ideally suited to study cues governing morphogenesis of limb skeletal elements in a simple and experimentally tractable in vitro system that reflects in vivo potential.	[Butterfield, Natalie C.; Logan, Malcolm P. O.] Natl Inst Med Res, MRC, Div Dev Biol, London, England; [Qian, Chen] Natl Inst Med Res, MRC, Confocal Image Anal Lab, London, England; [Butterfield, Natalie C.] Imperial Coll, Div Med, Dept Med, Mol Endocrinol Lab, London, England; [Qian, Chen] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Logan, Malcolm P. O.] Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Imperial College London; University of London; Queen Mary University London; University of Sussex; University of London; King's College London	Logan, MPO (corresponding author), Natl Inst Med Res, MRC, Div Dev Biol, London, England.; Logan, MPO (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Guys Campus, London, England.	malcolm.logan@kcl.ac.uk	Butterfield, Natalie/AAV-5483-2020	Butterfield, Natalie/0000-0002-5209-7508; Logan, Malcolm/0000-0002-2068-3115	Medical Research Council [MC_PC_13052]; MRC [MC_PC_13052] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council grant MC_PC_13052 awarded to MPOL (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DG, 2002, NATURE, V417, P754, DOI 10.1038/nature00814; AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; BENNETT VD, 1991, J BIOL CHEM, V266, P5918; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Butterfield NC, 2010, CURR TOP DEV BIOL, V90, P319, DOI 10.1016/S0070-2153(10)90009-4; Cash DE, 1997, J CELL BIOL, V136, P445, DOI 10.1083/jcb.136.2.445; Chen HX, 1999, CELL TISSUE RES, V296, P67, DOI 10.1007/s004410051267; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; Cho JY, 2001, AM J MED GENET, V106, P251, DOI 10.1002/ajmg.10230; COTTRILL CP, 1987, DEV BIOL, V122, P503, DOI 10.1016/0012-1606(87)90314-9; COTTRILL CP, 1987, DEV BIOL, V119, P143, DOI 10.1016/0012-1606(87)90216-8; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; DESSAU W, 1980, J EMBRYOL EXP MORPH, V57, P51; DOWNIE SA, 1994, DEV BIOL, V162, P195, DOI 10.1006/dbio.1994.1078; Downie SA, 1995, DEV BIOL, V172, P519, DOI 10.1006/dbio.1995.8068; Duboc V, 2011, DEVELOPMENT, V138, P5301, DOI 10.1242/dev.074153; Duboc V, 2011, DEV DYNAM, V240, P1017, DOI 10.1002/dvdy.22582; Duboc V, 2009, CURR OPIN GENET DEV, V19, P497, DOI 10.1016/j.gde.2009.07.002; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; FOGARTY WM, 1973, APPL MICROBIOL, V26, P185, DOI 10.1128/AEM.26.2.185-190.1973; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gehris AL, 1996, DEV DYNAM, V206, P219, DOI 10.1002/(SICI)1097-0177(199606)206:2<219::AID-AJA11>3.0.CO;2-Y; Grant TD, 2000, DEV DYNAM, V218, P394, DOI 10.1002/(SICI)1097-0177(200006)218:2<394::AID-DVDY12>3.0.CO;2-I; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hall BK, 1995, INT J DEV BIOL, V39, P881; Hasson P, 2007, DEVELOPMENT, V134, P85, DOI 10.1242/dev.02622; Hasson P, 2010, DEV CELL, V18, P148, DOI 10.1016/j.devcel.2009.11.013; HEINTZELMAN KF, 1978, J EMBRYOL EXP MORPH, V47, P1; Hogan B, 1994, MANIPULATING MOUSE E; IDE H, 1994, DEV BIOL, V162, P71, DOI 10.1006/dbio.1994.1067; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kaufman M.H., 1992, ATLAS MOUSE DEV; KOSHER RA, 1986, J CELL BIOL, V102, P1151, DOI 10.1083/jcb.102.4.1151; Lanctot C, 1999, DEVELOPMENT, V126, P1805; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Margulies EH, 2001, GENOME RES, V11, P1686, DOI 10.1101/gr.192601; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Minguillon C, 2009, P NATL ACAD SCI USA, V106, P21726, DOI 10.1073/pnas.0910153106; Ng JK, 2002, DEVELOPMENT, V129, P5161; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; OLIVER MH, 1989, J CELL SCI, V92, P513; Orend G, 2006, CANCER LETT, V244, P143, DOI 10.1016/j.canlet.2006.02.017; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Park S, 2014, J EXP ZOOL PART B, V322, P156, DOI 10.1002/jez.b.22554; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Shou SM, 2005, DEV DYNAM, V234, P74, DOI 10.1002/dvdy.20514; Shwartz Y, 2013, DIFFERENTIATION, V86, P104, DOI 10.1016/j.diff.2013.07.003; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484	58	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180453	10.1371/journal.pone.0180453	http://dx.doi.org/10.1371/journal.pone.0180453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746404	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800013
J	Kim, HH; Jeong, IH; Hyun, JS; Kong, BS; Kim, HJ; Park, SJ				Kim, Hyun-Hwi; Jeong, In Hye; Hyun, Ja-Shil; Kong, Byung Soo; Kim, Ho Jin; Park, Sung Jean			Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance	PLOS ONE			English	Article							PROTON MR SPECTROSCOPY; MYELIN LIPID-SYNTHESIS; NMR-BASED METABOLOMICS; CEREBROSPINAL-FLUID; N-ACETYLASPARTATE; MITOCHONDRIAL DYSFUNCTION; DIAGNOSTIC-CRITERIA; MARKER; SERUM; ACID	Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory diseases of the central nervous system. Although several studies have characterized the metabolome in the cerebrospinal fluid (CSF) from MS and NMOSD patients, comparative analyses between them and between the relapse and the remission of each disease have not been performed. Both univariate and multivariate analyses were used to compare 1H-NMR spectra of CSF from MS, NMOSD, and healthy controls (HCs). The statistical analysis showed alterations of eight metabolites that were dependent on the disease. Levels of 2-hydroxybutyrate, acetone, formate, and pyroglutamate were higher and levels of acetate and glucose were lower in both MS and NMOSD. Citrate was lower in MS patients, whereas lactate was higher in only NMOSD specifically. The shared feature of metabolic changes between MS and NMOSD may be related to altered energy metabolism and fatty acid biosynthesis in the brain. Another analysis to characterize relapse and remission status showed that isoleucine and valine were down -regulated in MS relapse compared to MS remission. The other metabolites identified in the disease comparison showed the same alterations regardless of disease activity. These findings would be helpful in understanding the biological background of these diseases, and distinguishing between MS and NMOSD, as well as determining the disease activity.	[Kim, Hyun-Hwi; Hyun, Ja-Shil; Park, Sung Jean] Gachon Univ, Coll Pharm, Incheon, South Korea; [Kim, Hyun-Hwi; Hyun, Ja-Shil; Park, Sung Jean] Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea; [Jeong, In Hye; Kong, Byung Soo; Kim, Ho Jin] Res Inst & Hosp Natl Canc Ctr, Dept Neurol, Goyang, South Korea	Gachon University; Gachon University; National Cancer Center - Korea (NCC)	Park, SJ (corresponding author), Gachon Univ, Coll Pharm, Incheon, South Korea.; Park, SJ (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, Incheon, South Korea.; Kim, HJ (corresponding author), Res Inst & Hosp Natl Canc Ctr, Dept Neurol, Goyang, South Korea.	hojinkim@ncc.re.kr; psjnmr@gachon.ac.kr		Kim, Hyunhwi/0000-0003-1738-3506; Kong, ByungSoo/0000-0002-7916-7422	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP [NRF-2014M3A9B6069340]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2013R1A1A2064418, 2016R1D1A1B03931783]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIP; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This research was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIP (NRF-2014M3A9B6069340). This work was also supported by grants from the Basic Science Research Program (2013R1A1A2064418 and 2016R1D1A1B03931783) through the National Research Foundation of Korea, funded by the Ministry of Education, Science, and Technology.	Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CALABRESE V, 1994, INT J CLIN PHARM RES, V14, P119; Calabrese V, 2002, J NEUROSCI RES, V70, P580, DOI 10.1002/jnr.10408; Calder PC, 2006, J NUTR, V136, p288S, DOI 10.1093/jn/136.1.288S; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; Chan A. W., 2015, BRIT J CANCER, V114, P59, DOI DOI 10.1038/BJC.2015.414; Cocco E, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000185; Craig A, 2006, ANAL CHEM, V78, P2262, DOI 10.1021/ac0519312; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dickens AM, 2014, NEUROLOGY, V83, P1492, DOI 10.1212/WNL.0000000000000905; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2012, NEUROBIOL DIS, V45, P108, DOI 10.1016/j.nbd.2010.12.003; Emwas AH, 2016, J PROTEOME RES, V15, P360, DOI 10.1021/acs.jproteome.5b00885; Emwas AH, 2015, METABOLOMICS, V11, P872, DOI 10.1007/s11306-014-0746-7; Eriksson L, 2008, CHEMOMETRICS, V2, P594; Fujihara K, 2011, J NEUROL SCI, V306, P183, DOI 10.1016/j.jns.2011.02.018; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gebregiworgis T, 2016, J PROTEOME RES, V15, P659, DOI 10.1021/acs.jproteome.5b01111; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; HOFFMANN GF, 1993, J INHERIT METAB DIS, V16, P648, DOI 10.1007/BF00711898; Inarrea P, 2014, MOL NEUROBIOL, V49, P1, DOI 10.1007/s12035-013-8481-z; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Jarius S, 2013, MED HYPOTHESES, V81, P1090, DOI 10.1016/j.mehy.2013.10.011; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Karelson G, 2003, NMR BIOMED, V16, P413, DOI 10.1002/nbm.845; Kim HJ, 2015, NEUROLOGY, V84, P1165, DOI 10.1212/WNL.0000000000001367; Kim SH, 2012, MULT SCLER J, V18, P1480, DOI 10.1177/1352458512439439; Kirov II, 2013, NEUROLOGY, V80, P39, DOI 10.1212/WNL.0b013e31827b1a8c; KUHARA T, 1983, CLIN CHIM ACTA, V133, P133; Kullgren A, 2010, AM J PHYSIOL-REG I, V299, pR1440, DOI 10.1152/ajpregu.00281.2010; Kumar A, 2012, CURR SCI INDIA, V102, P288; Kumar D, 2016, EXPERT REV MOL DIAGN, V16, P651, DOI 10.1586/14737159.2016.1164037; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lutz NW, 2011, CURR PHARM BIOTECHNO, V12, P1016; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; Madhavarao CN, 2005, P NATL ACAD SCI USA, V102, P5221, DOI 10.1073/pnas.0409184102; Mathur D, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00250; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Mehrpour M, 2013, MAGN RESON CHEM, V51, P102, DOI 10.1002/mrc.3915; Min JH, 2012, MULT SCLER J, V18, P113, DOI 10.1177/1352458511431973; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Monirujjaman M., 2014, ADV MOL BIOL, V2014, P1, DOI [10.1155/2014/364976, DOI 10.1155/2014/364976]; Moussallieh FM, 2014, MULT SCLER J, V20, P558, DOI 10.1177/1352458513504638; Nijland PG, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0261-8; PAXTON R, 1986, BIOCHEM J, V234, P295, DOI 10.1042/bj2340295; PETTERSEN JE, 1973, CLIN CHIM ACTA, V48, P213, DOI 10.1016/0009-8981(73)90367-7; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reinke SN, 2014, MULT SCLER J, V20, P1396, DOI 10.1177/1352458513516528; Simone IL, 1996, J NEUROL SCI, V144, P182, DOI 10.1016/S0022-510X(96)00224-9; Sinclair AJ, 2010, NMR BIOMED, V23, P123, DOI 10.1002/nbm.1428; Spurrier JD, 2003, J NONPARAMETR STAT, V15, P685, DOI 10.1080/10485250310001634719; Staffen W, 2005, J NEUROPSYCH CLIN N, V17, P357, DOI 10.1176/appi.neuropsych.17.3.357; Stoyanova R, 2001, NMR BIOMED, V14, P271, DOI 10.1002/nbm.700; Tavazzi B, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/167156; Tian Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14869; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vingara LK, 2013, NEUROIMAGE, V82, P586, DOI 10.1016/j.neuroimage.2013.05.125; von Morze C, 2016, MAGN RESON MED, V75, P1894, DOI 10.1002/mrm.25716; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Wold S., 1993, 3D QSAR DRUG DESIGN, P523, DOI DOI 10.1007/0-306-46858-1; Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011; Wyss MT, 2011, J CEREBR BLOOD F MET, V31, P1668, DOI 10.1038/jcbfm.2011.84; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zeis T, 2015, BRAIN BEHAV IMMUN, V48, P313, DOI 10.1016/j.bbi.2015.04.013	78	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181758	10.1371/journal.pone.0181758	http://dx.doi.org/10.1371/journal.pone.0181758			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746356	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800059
J	Zhao, LY; Yang, SM; Cheng, YY; Hou, C; You, XY; Zhao, J; Zhang, Y; He, WJ				Zhao, Luyao; Yang, Shuming; Cheng, Yongyou; Hou, Can; You, Xinyong; Zhao, Jie; Zhang, Ying; He, Wenjing			Identification of transcriptional biomarkers by RNA-sequencing for improved detection of beta(2)-agonists abuse in goat skeletal muscle	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; MESSENGER-RNA; CLENBUTEROL; TOOL	In this paper, high-throughput RNA-sequencing (RNA-seq) was used to search for transcriptional biomarkers for beta(2)-agonists. In combination with drug mechanisms, a smaller group of genes with higher detection accuracy was screened out. Unknown samples were first predicted by this group of genes, and liquid chromatograph tandem mass spectrometer (LCMS/ MS) was applied to positive samples to validate the biomarkers. The results of principal component analysis (PCA), hierarchical cluster analysis (HCA) and discriminant analysis (DA) indicated that the eight genes screened by high-throughput RNA-seq were able to distinguish samples in the experimental group and control group. Compared with the nine genes selected from an earlier literature, 17 genes including these nine genes were proven to have a more satisfactory effect, which validated the accuracy of gene selection by RNAseq. Then, six key genes were selected from the 17 genes according to the variable importance in projection (VIP) value of greater than 1. The test results using the six genes and 17 genes were similar, revealing that the six genes were critical genes. By using the six genes, three positive samples possibly treated with drugs were screened out from 25 unknown samples through DA and partial least squares discriminant analysis (PLS-DA). Then, the three samples were verified by a standard method, and mapenterol was detected in a sample. Therefore, the six genes can be used as biomarkers to detect beta(2)-agonists. Compared with the previous study, accurate detection of beta(2)-agonists abuse using six key genes is an improvement method, which show great significance in the monitoring of beta(2)-agonists abuse in animal husbandry.	[Zhao, Luyao; Yang, Shuming; Cheng, Yongyou; Hou, Can; You, Xinyong; Zhao, Jie; Zhang, Ying; He, Wenjing] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Livestock Prod Qual & Safety Res Div, Key Lab, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Yang, SM (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol Agroprod, Livestock Prod Qual & Safety Res Div, Key Lab, Beijing, Peoples R China.	yangshumingcaas@sina.com			Special Fund for Agro-scientific Research in the Public Interest [201203023]	Special Fund for Agro-scientific Research in the Public Interest	This work is supported by Special Fund for Agro-scientific Research in the Public Interest 201203023.	Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Blanca J, 2005, ANAL CHIM ACTA, V529, P199, DOI 10.1016/j.aca.2004.09.061; Courant F, 2009, ANALYST, V134, P1637, DOI 10.1039/b901813a; DePianto DJ, 2015, THORAX, V70, P48, DOI 10.1136/thoraxjnl-2013-204596; GRANT AL, 1993, J ANIM SCI, V71, P3319, DOI 10.2527/1993.71123319x; Gunawan AM, 2007, J ANIM SCI, V85, P2115, DOI 10.2527/jas.2006-540; Guy L, 2014, J NEUROINFLAMM, V1, P11; Halsey CHC, 2011, J ANIM SCI, V89, P1011, DOI 10.2527/jas.2010-3269; Hodgkinson A, 2015, SCI, V344, P413; Ijiri D, 2014, GEN COMP ENDOCR, V206, P111, DOI 10.1016/j.ygcen.2014.07.023; Jeffrey L, 2002, J ALLERGY CLIN IMMUN, V110, P229; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Keller MJ, 2014, FEBS LETT, V588, P4686, DOI 10.1016/j.febslet.2014.10.041; Kinoshita A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146670; McNamee EN, 2010, NEUROPHARMACOLOGY, V59, P37, DOI 10.1016/j.neuropharm.2010.03.014; Miller EK, 2012, J ANIM SCI, V90, P1317, DOI 10.2527/jas.2011-4589; Pan YJ, 2015, MOL PHARMACEUT, V12, P4375, DOI 10.1021/acs.molpharmaceut.5b00580; Prescott AR, 2014, J CELL SCI, V127, P812, DOI 10.1242/jcs.137703; Riedmaier I, 2014, FOOD ADDIT CONTAM A, V31, P641, DOI 10.1080/19440049.2014.886341; Riedmaier I, 2012, ANAL CHEM, V84, P6863, DOI 10.1021/ac301433d; Riedmaier I, 2009, ANAL CHIM ACTA, V638, P106, DOI 10.1016/j.aca.2009.02.014; Sato S, 2008, J PHARMACOL SCI, V107, P393, DOI 10.1254/jphs.08097FP; Shibata K, 2015, J CELL PHYSIOL, V230, P1352, DOI 10.1002/jcp.24878; Shishani E, 2003, ANAL CHIM ACTA, V483, P137, DOI 10.1016/S0003-2670(03)00120-X; Song D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/873590; Spurlock DM, 2006, BMC GENOMICS, V320, P464; Stephen B, 2002, J ALLERGY CLIN IMM S, V10, P223; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Tara GM, 2004, PHYSIOL GENOMICS, V16, P275; Zhang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-433; Zhao LY, 2016, J AGR FOOD CHEM, V64, P1861, DOI 10.1021/acs.jafc.5b04956	31	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181695	10.1371/journal.pone.0181695	http://dx.doi.org/10.1371/journal.pone.0181695			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8EN	28746361	Green Submitted, Green Published, gold			2022-12-26	WOS:000406371800051
J	Cowger, TL; Burns, CC; Sharif, S; Gary, HE; Iber, J; Henderson, E; Malik, F; Zaidi, SSZ; Shaukat, S; Rehman, L; Pallansch, MA; Orenstein, WA				Cowger, Tori L.; Burns, Cara C.; Sharif, Salmaan; Gary, Howard E., Jr.; Iber, Jane; Henderson, Elizabeth; Malik, Farzana; Zaidi, Syed Sohail Zahoor; Shaukat, Shahzad; Rehman, Lubna; Pallansch, Mark A.; Orenstein, Walter A.			The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan-2011-2013	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUSES; ERADICATION; CIRCULATION; PROGRESS; POLIOMYELITIS; OUTBREAK; SEWAGE; RISKS	Background More than 99% of poliovirus infections are non-paralytic and therefore, not detected by acute flaccid paralysis (AFP) surveillance. Environmental surveillance (ES) can detect circulating polioviruses from sewage without relying on clinical presentation. With extensive ES and continued circulation of polioviruses, Pakistan presents a unique opportunity to quantify the impact of ES as a supplement to AFP surveillance on overall completeness and timeliness of poliovirus detection. Methods Genetic, geographic and temporal data were obtained for all wild poliovirus (WPV) isolates detected in Pakistan from January 2011 through December 2013. We used viral genetics to assess gaps in AFP surveillance and ES as measured by detection of 'orphan viruses' (>= 1.5% different in VP1 capsid nucleotide sequence). We compared preceding detection of closely related circulating isolates (>= 99% identity) detected by AFP surveillance or ES to determine which surveillance system first detected circulation before the presentation of each polio case. Findings A total of 1,127 WPV isolates were detected by AFP surveillance and ES in Pakistan from 2011 - 2013. AFP surveillance and ES combined exhibited fewer gaps (i.e., % orphan viruses) in detection than AFP surveillance alone (3.3% vs. 7.7%, respectively). ES detected circulation before AFP surveillance in nearly 60% of polio cases (200 of 346). For polio cases reported from provinces conducting ES, ES detected circulation nearly four months sooner on average (117.6 days) than did AFP surveillance. Interpretation Our findings suggest ES in Pakistan is providing earlier, more sensitive detection of wild polioviruses than AFP surveillance alone. Overall, targeted ES through strategic selection of sites has important implications in the eradication endgame strategy.	[Cowger, Tori L.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Burns, Cara C.; Iber, Jane; Henderson, Elizabeth; Pallansch, Mark A.] Ctr Dis Control & Prevent CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Sharif, Salmaan; Malik, Farzana; Shaukat, Shahzad; Rehman, Lubna] NIH, WHO Reg Reference Lab Polio Eradicat Initiat, Dept Virol, Islamabad, Pakistan; [Gary, Howard E., Jr.] Ctr Dis Control & Prevent CDC, Global Immunizat Div, Ctr Global Hlth, Atlanta, GA USA; [Zaidi, Syed Sohail Zahoor] NIH, Dept Virol, Islamabad, Pakistan; [Orenstein, Walter A.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA USA; [Cowger, Tori L.] Ctr Dis Control & Prevent CDC, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA USA	Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; Centers for Disease Control & Prevention - USA	Burns, CC (corresponding author), Ctr Dis Control & Prevent CDC, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	cburns@cdc.gov	Shaukat, Shahzad/HHZ-1088-2022					Alam MM, 2014, J INFECT DIS, V210, pS324, DOI 10.1093/infdis/jiu160; Alexander Jim, 2011, Morbidity and Mortality Weekly Report, V60, P1523; Angez M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-51; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P528; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P501; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P503; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P575; Asghar H, 2014, J INFECT DIS, V210, pS294, DOI 10.1093/infdis/jiu384; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Blomqvist S, 2012, APPL ENVIRON MICROB, V78, P5406, DOI 10.1128/AEM.00491-12; Burns CC, 2016, METHODS MOL BIOL, V1387, P177, DOI 10.1007/978-1-4939-3292-4_9; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Chatterjee A, 2013, VACCINE, V31, P1268, DOI 10.1016/j.vaccine.2012.12.060; Chowdhary R, 2008, J MED VIROL, V80, P1477, DOI 10.1002/jmv.21230; Deshpande JM, 2003, APPL ENVIRON MICROB, V69, P2919, DOI 10.1128/AEM.69.5.2919-2927.2003; Dowdle W, 2006, RISK ANAL, V26, P1449, DOI 10.1111/j.1539-6924.2006.00844.x; Dunkle Stacie, 2012, Morbidity and Mortality Weekly Report, V61, P899; El Bassioni L, 2003, AM J EPIDEMIOL, V158, P807, DOI 10.1093/aje/kwg202; Hovi T, 2006, BIOLOGICALS, V34, P123, DOI 10.1016/j.biologicals.2006.02.009; Hovi T, 2005, J VIROL METHODS, V126, P127, DOI 10.1016/j.jviromet.2005.02.002; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; HOVI T, 1986, LANCET, V1, P1427; Initiative GPE, 2013, POL ER ENDG STRAT PL; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Lowther SA, 2013, MMWR-MORBID MORTAL W, V62, P335; Manor Y, 2007, APPL ENVIRON MICROB, V73, P5954, DOI 10.1128/AEM.02537-06; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; Morales M, 2016, MMWR-MORBID MORTAL W, V65, P470, DOI 10.15585/mmwr.mm6518a4; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Poyry T, 1988, APPL ENVIRON MICROB; Ranta J, 2001, RISK ANAL, V21, P1087, DOI 10.1111/0272-4332.t01-1-216174; Shaukat S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107697; Shulman LM, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.7.20709; Sutter R.W., 1993, VACCINES-BASEL, V6th ed., P598, DOI DOI 10.1016/B978-1-4557-0090-5.00035-5; Tebbens RJD, 2010, VACCINE, V29, P334, DOI 10.1016/j.vaccine.2010.10.026; Webeck Jenna, 2012, Morbidity and Mortality Weekly Report, V61, P790; Wolfe S., 2012, EPIDEMIOLOGY PREVENT, V12; World Health Organization, 2004, POL LAB MAN, V4th	38	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180608	10.1371/journal.pone.0180608	http://dx.doi.org/10.1371/journal.pone.0180608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742803	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000015
J	Merdan, M; Bekiryazici, Z; Kesemen, T; Khanlyev, T				Merdan, Mehmet; Bekiryazici, Zafer; Kesemen, Tulay; Khanlyev, Tahir			Deterministic stability and random behavior of a Hepatitis C model	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; BRUCELLOSIS MODEL; GLOBAL-STABILITY; DISEASE	The deterministic stability of a model of Hepatitis C which includes a term defining the effect of immune system is studied on both local and global scales. Random effect is added to the model to investigate the random behavior of the model. The numerical characteristics such as the expectation, variance and confidence interval are calculated for random effects with two different distributions from the results of numerical simulations. In addition, the compliance of the random behavior of the model and the deterministic stability results is examined.	[Merdan, Mehmet] Gumushane Univ, Dept Math Engn, Gumushane, Turkey; [Bekiryazici, Zafer] Recep Tayyip Erdogan Univ, Dept Math, Rize, Turkey; [Kesemen, Tulay] Karadeniz Tech Univ, Dept Math, Trabzon, Turkey; [Khanlyev, Tahir] TOBB Univ Econ & Technol, Dept Ind Engn, Ankara, Turkey	Gumushane University; Recep Tayyip Erdogan University; Karadeniz Technical University; TOBB Ekonomi ve Teknoloji University	Merdan, M (corresponding author), Gumushane Univ, Dept Math Engn, Gumushane, Turkey.	mmerdan@gumushane.edu.tr	Bekiryazici, Zafer/AAQ-7932-2020; Kesemen, Tulay/AAM-8319-2021	Bekiryazici, Zafer/0000-0001-5671-9995; 				Aggarwala B., 2013, P WORLD C ENG COMP S, V2; Ahmed E, 2010, Nonlinear Biomed Phys, V4, P1, DOI 10.1186/1753-4631-4-1; [Anonymous], 2015, HEP C REP; Castillo-Chavez C, 2002, IMA VOL MATH APPL, V126, P261; Chong SiewFang [Chong S. F. M. ], 2015, Modern Applied Science, V9, P250; Dahari H, 2007, J THEOR BIOL, V247, P371, DOI 10.1016/j.jtbi.2007.03.006; Diekmann O, 2009, J ROYAL SOC INTERFAC; Din Q, 2016, ADV DIFFER EQU-NY, V2016, P96; Imran M, 2013, J BIOL DYNAM, V7, P276, DOI 10.1080/17513758.2013.859856; Khan MA, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-015-0429-3; La Salle J., 2012, MATH SCI ENG, V4; Lahrouz A, 2015, ARAB J MATH, V4, P101, DOI 10.1007/s40065-014-0119-0; Li L., 2016, J CARDIOVASC PHARM T, P1, DOI DOI 10.1111/JORS.12276; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li MT, 2014, APPL MATH COMPUT, V237, P582, DOI 10.1016/j.amc.2014.03.094; Li MY, 1996, SIAM J MATH ANAL, V27, P1070, DOI 10.1137/S0036141094266449; LYAPUNOV AM, 1992, INT J CONTROL, V55, P531, DOI 10.1080/00207179208934253; MARTIN RH, 1974, J MATH ANAL APPL, V45, P432, DOI 10.1016/0022-247X(74)90084-5; Merdan M., 2008, INT J BIOTECHNOLOGY, V4, P75; Merdan M, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1191-5; Pang LY, 2015, APPL MATH COMPUT, V259, P497, DOI 10.1016/j.amc.2015.02.078; Sahu GP, 2012, APPL MATH MODEL, V36, P908, DOI 10.1016/j.apm.2011.07.044; Sun GQ, 2017, NONLINEAR DYNAM, V88, P1385, DOI 10.1007/s11071-016-3317-9; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Sun GQ, 2014, APPL MATH COMPUT, V246, P336, DOI 10.1016/j.amc.2014.08.028; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Trivedi, 2012, ADV APPL SCI RES, V3, P3200; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vargas-De-Leon C, 2011, CHAOS SOLITON FRACT, V44, P1106, DOI 10.1016/j.chaos.2011.09.002; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857	32	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181571	10.1371/journal.pone.0181571	http://dx.doi.org/10.1371/journal.pone.0181571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742831	Green Submitted, gold, Green Published			2022-12-26	WOS:000406370000039
J	Ribera, J; Estupinan, M; Fuentes, A; Fillet, A; Martinez, J; Diaz, P				Ribera, Judit; Estupinan, Monica; Fuentes, Alba; Fillet, Amanda; Martinez, Josefina; Diaz, Pilar			Bacillus sp JR3 esterase LipJ: A new mesophilic enzyme showing traces of a thermophilic past	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; BIOTECHNOLOGICAL APPLICATIONS; GEOBACILLUS-THERMOLEOVORANS; PSEUDOMONAS-FLUORESCENS; CARBOXYL ESTERASES; CANDIDA-RUGOSA; 1ST MEMBER; LIPASE; CLONING; FAMILY	A search for extremophile enzymes from ancient volcanic soils in El Hierro Island (Canary Islands, Spain) allowed isolation of a microbial sporulated strain collection from which several enzymatic activities were tested. Isolates were obtained after sample cultivation under several conditions of nutrient contents and temperature. Among the bacterial isolates, supernatants from the strain designated JR3 displayed high esterase activity at temperatures ranging from 30 to 100 degrees C, suggesting the presence of at least a hyper-thermophilic extracellular lipase. Sequence alignment of known thermophilic lipases allowed design of degenerated consensus primers for amplification and cloning of the corresponding lipase, named LipJ. However, the cloned enzyme displayed maximum activity at 30 degrees C and pH 7, showing a different profile from that observed in supernatants of the parental strain. Sequence analysis of the cloned protein showed a pentapeptide motif-GHSMG-distinct from that of thermophilic lipases, and much closer to that of esterases. Nevertheless, the 3D structural model of LipJ displayed the same folding as that of thermophilic lipases, suggesting a common evolutionary origin. A phylogenetic study confirmed this possibility, positioning LipJ as a new member of the thermophilic family of bacterial lipases 1.5. However, LipJ clusters in a clade close but separated from that of Geobacillus sp. thermophilic lipases. Comprehensive analysis of the cloned enzyme suggests a common origin of LipJ and other bacterial thermophilic lipases, and highlights the most probable divergent evolutionary pathway followed by LipJ, which during the harsh past times would have probably been a thermophilic enzyme, having lost these properties when the environment changed to more benign conditions.	[Ribera, Judit; Estupinan, Monica; Fuentes, Alba; Fillet, Amanda; Martinez, Josefina; Diaz, Pilar] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Ave Diagonal 643, Barcelona, Spain; [Estupinan, Monica; Martinez, Josefina; Diaz, Pilar] Univ Barcelona, Inst Nanosci & Nanotechnol IN2UB, Ave Diagonal 643, Barcelona, Spain	University of Barcelona; University of Barcelona	Diaz, P (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Stat, Ave Diagonal 643, Barcelona, Spain.; Diaz, P (corresponding author), Univ Barcelona, Inst Nanosci & Nanotechnol IN2UB, Ave Diagonal 643, Barcelona, Spain.	pdiaz@ub.edu	Martinez, Josefina Martinez/K-3025-2017; Estupinan, Monica/L-1438-2017; Diaz, Pilar/I-2465-2014	Martinez, Josefina Martinez/0000-0002-2411-8818; Estupinan, Monica/0000-0001-7347-3341; Diaz, Pilar/0000-0003-4008-0669	Scientific and Technological Research Council (MINECO, Spain) [CTQ2014-59632-R, CTQ2013-48995-C2-2-R, AC2015-00008-00-00]; Pla de Recerca de Catalunya [2009SGR-819, 2014SGR-534 00327]; PCI-AECID project [A203563511]; Generalitat de Catalunya	Scientific and Technological Research Council (MINECO, Spain)(Spanish Government); Pla de Recerca de Catalunya; PCI-AECID project; Generalitat de Catalunya(Generalitat de Catalunya)	This work was financed by the Scientific and Technological Research Council (MINECO, Spain), grants CTQ2014-59632-R, CTQ2013-48995-C2-2-R and AC2015-00008-00-00, by the Pla de Recerca de Catalunya, grants 2009SGR-819 and 2014SGR-534 00327, by PCI-AECID project A203563511, and by the Generalitat de Catalunya to the Xarxa de Referencia en Biotecnologia (XRB).	Adlercreutz P, 2013, CHEM SOC REV, V42, P6406, DOI 10.1039/c3cs35446f; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angajala G, 2016, BIOCATAL AGRIC BIOTE, V7, P257, DOI 10.1016/j.bcab.2016.07.001; Antranikian G, 2010, CHEMCATCHEM, V2, P879, DOI 10.1002/cctc.201000228; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Barriuso J, 2016, BIOTECHNOL ADV, V34, P874, DOI 10.1016/j.biotechadv.2016.05.004; Bassegoda A, 2012, APPL ENVIRON MICROB, V78, P1724, DOI 10.1128/AEM.06332-11; Bell PJL, 2002, MICROBIOL-SGM, V148, P2283, DOI 10.1099/00221287-148-8-2283; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Biundo A, 2016, APPL MICROBIOL BIOT, V100, P1753, DOI 10.1007/s00253-015-7031-1; Bofill C, 2010, BIOCHIMIE, V92, P307, DOI 10.1016/j.biochi.2009.11.005; Bornscheuer UT, 2006, HYDROLASES IN ORGANIC SYNTHESIS: REGIO- AND STEREOSELECTIVE BIOTRANSFORMATIONS, 2ND EDITION, P1; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Bornscheuer UT, 2013, SYNLETT, V24, P150, DOI 10.1055/s-0032-1317498; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Castilla A, 2017, ENZYME MICROB TECH, V98, P86, DOI 10.1016/j.enzmictec.2016.12.010; Charbonneau DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076675; Diaz P, 1999, BIOTECHNIQUES, V27, P696, DOI 10.2144/99274bm14; Drepper Thomas, 2006, Biotechnology Journal, V1, P777, DOI 10.1002/biot.200600059; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Espinosa-Luna G, 2016, MOL BIOTECHNOL, V58, P37, DOI 10.1007/s12033-015-9901-2; Ewis HE, 2004, GENE, V329, P187, DOI 10.1016/j.gene.2003.12.029; Falcocchio S, 2005, CAN J MICROBIOL, V51, P753, DOI [10.1139/w05-059, 10.1139/W05-059]; Ferrer M, 2015, BIOCATAL BIOTRANSFOR, V33, P235, DOI 10.3109/10242422.2016.1151416; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fojan P, 2000, BIOCHIMIE, V82, P1033, DOI 10.1016/S0300-9084(00)01188-3; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gupta R, 2015, PROG LIPID RES, V57, P40, DOI 10.1016/j.plipres.2014.12.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Imamura S, 2000, J BIOCHEM-TOKYO, V127, P419, DOI 10.1093/oxfordjournals.jbchem.a022623; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jeong ST, 2002, J BIOL CHEM, V277, P17041, DOI 10.1074/jbc.M200640200; Jeong ST, 2001, ACTA CRYSTALLOGR D, V57, P1300, DOI 10.1107/S0907444901010332; Kapoor M, 2012, PROCESS BIOCHEM, V47, P555, DOI 10.1016/j.procbio.2012.01.011; Kelley LA, 2015, NAT PROTOC, V10; Khalameyzer V, 1999, APPL ENVIRON MICROB, V65, P477; Kim K, 2002, NOVEL ZINC BINDING C, DOI [10.1074/jbc.M200640200, DOI 10.1074/JBC.M200640200]; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Narancic T, 2015, BIOTECHNOL LETT, V37, P943, DOI 10.1007/s10529-014-1762-4; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nazina TN, 2001, INT J SYST EVOL MICR, V51, P433, DOI 10.1099/00207713-51-2-433; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Panizza P, 2013, J APPL MICROBIOL, V114, P722, DOI 10.1111/jam.12089; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prim N, 2006, BIOCHIMIE, V88, P859, DOI 10.1016/j.biochi.2006.02.011; Prim N, 2005, J BIOTECHNOL, V118, pS120; Prim N, 2000, RES MICROBIOL, V151, P303, DOI 10.1016/S0923-2508(00)00150-9; Prim N, 2003, J MOL CATAL B-ENZYM, V22, P339, DOI 10.1016/S1381-1177(03)00048-1; Prim N, 2001, CURR MICROBIOL, V42, P237, DOI 10.1007/s002840010210; Quintana-Castro R, 2009, MOL BIOTECHNOL, V42, P75, DOI 10.1007/s12033-008-9136-6; Rauwerdink A, 2015, ACS CATAL, V5, P6153, DOI 10.1021/acscatal.5b01539; Rengachari S, 2013, J BIOL CHEM, V288, P31093, DOI 10.1074/jbc.M113.491415; Ruiz C, 2005, LETT APPL MICROBIOL, V40, P218, DOI 10.1111/j.1472-765X.2005.01660.x; Ruiz C, 2004, BBA-GEN SUBJECTS, V1672, P184, DOI 10.1016/j.bbagen.2004.03.010; Ruiz C, 2003, LETT APPL MICROBIOL, V37, P354, DOI 10.1046/j.1472-765X.2003.01413.x; Ruiz C, 2002, FEMS MICROBIOL LETT, V217, P263, DOI 10.1111/j.1574-6968.2002.tb11485.x; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Siddiqui KS, 2015, BIOTECHNOL ADV, V33, P1912, DOI 10.1016/j.biotechadv.2015.11.001; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; ZOCK J, 1994, GENE, V151, P37, DOI 10.1016/0378-1119(94)90630-0	75	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181029	10.1371/journal.pone.0181029	http://dx.doi.org/10.1371/journal.pone.0181029			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742841	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000020
J	Karetnikova, V; Osokina, A; Gruzdeva, O; Uchasova, E; Zykov, M; Kalaeva, V; Kashtalap, V; Shafranskaya, K; Barbarash, O				Karetnikova, Victoria; Osokina, Anastasia; Gruzdeva, Olga; Uchasova, Evgenya; Zykov, Michael; Kalaeva, Victoria; Kashtalap, Vasiliy; Shafranskaya, Kristina; Barbarash, Olga			Serum neutrophil gelatinase-associated lipocalin the estimation of hospital prognosis in patients with ST-elevated myocardial infarction	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NGAL	We aimed to assess the clinical significance of serum levels of neutrophil gelatinase-associated lipocalin (sNGAL) for predicting in-hospital outcomes in patients with ST-elevated myocardial infarction (STEMI). Patients admitted within 24 hours of developing STEMI clinical symptoms were evaluated for sNGAL on hospitalization days 1 and 12. Recurrent myocardial infarction, early post-infarction angina, acute cerebrovascular accident, and death were assessed as adverse outcomes during hospitalization. The actors associated with adverse outcome were evaluated using univariate and multivariate regression analysis. Among the 260 STEMI patients included, 32% had >= 1 adverse in-hospital outcome, and significantly higher sNGAL on day 12, (but not on day 1) compared to sNGAL in patients with favorable outcome (p = 0.033). Type-2 diabetes mellitus, age > 60 years, reduced glomerular filtration rate during hospitalization, and high sNGAL on day 12 were identified as risk factors for adverse in-hospital outcome, associated with a 14% increase for each 1-year increment in age after 60 years, and a dramatic increase (3.2 times) for high sNGAL on day 12, with sNGAL >= 1.046 ng/ml indicating complicated hospitalization course. sNGAL concentration on the 12th day was associated with the existing adverse outcomes, acting as a marker of MI severity.	[Karetnikova, Victoria; Osokina, Anastasia; Gruzdeva, Olga; Uchasova, Evgenya; Zykov, Michael; Kalaeva, Victoria; Kashtalap, Vasiliy; Shafranskaya, Kristina; Barbarash, Olga] Fed State Budgetary Inst, Res Inst Complex Issues Cardiovasc Dis, Kemerovo, Russia; [Karetnikova, Victoria; Osokina, Anastasia; Kashtalap, Vasiliy; Barbarash, Olga] Kemerovo State Med Acad, Minist Hlth Russian Federat, Fed State Budget Educ Inst Higher Profess Educ, Kemerovo, Russia	Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical Academy; Ministry of Health of the Russian Federation	Uchasova, E (corresponding author), Fed State Budgetary Inst, Res Inst Complex Issues Cardiovasc Dis, Kemerovo, Russia.	evg.uchasova@yandex.ru	Uchasova, Evgenya/N-8584-2019; Barbarash, Olga/A-4834-2017; Gruzdeva, Olga/P-9723-2015; Kashtalap, Vasily/N-1491-2016	Uchasova, Evgenya/0000-0003-4321-8977; Barbarash, Olga/0000-0002-4642-3610; Gruzdeva, Olga/0000-0002-7780-829X; Kashtalap, Vasily/0000-0003-3729-616X				Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Erlikh A D, 2012, Vestn Ross Akad Med Nauk, P30; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maisel AS, 2011, EUR J HEART FAIL, V13, P846, DOI 10.1093/eurjhf/hfr087; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mukhin N, 2014, TERAPEVT ARKH, V86, P4; Siew ED, 2010, CLIN J AM SOC NEPHRO, V5, P1497, DOI 10.2215/CJN.09061209; Siew ED, 2009, J AM SOC NEPHROL, V20, P1823, DOI 10.1681/ASN.2008070673; Smirnov AV, 2009, CLIN NEPHROLOGY S1, V1, P11; Soto K, 2013, CLIN J AM SOC NEPHRO, V8, P2053, DOI 10.2215/CJN.12181212; Wang L, 2008, NEPHRON CLIN PRACT, V108, pC176, DOI 10.1159/000117814; Zoccali C, 2008, CONTRIB NEPHROL, V161, P63, DOI 10.1159/000129755	14	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180816	10.1371/journal.pone.0180816	http://dx.doi.org/10.1371/journal.pone.0180816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742104	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700017
J	Nagoshi, RN; Koffi, D; Agboka, K; Tounou, KA; Banerjee, R; Jurat-Fuentes, JL; Meagher, RL				Nagoshi, Rodney N.; Koffi, Djima; Agboka, Komi; Tounou, Kodjo Agbeko; Banerjee, Rahul; Jurat-Fuentes, Juan Luis; Meagher, Robert L.			Comparative molecular analyses of invasive fall armyworm in Togo reveal strong similarities to populations from the eastern United States and the Greater Antilles	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; CORN-STRAIN POPULATIONS; NOCTUIDAE HOST STRAINS; SOUTH-AMERICA; PUERTO-RICO; BT MAIZE; IDENTIFICATION; RESISTANCE; SEQUENCE; TEXAS	The fall armyworm (Spodoptera frugiperda, J. E. Smith) is a noctuid moth that is a major and ubiquitous agricultural pest in the Western Hemisphere. Infestations have recently been identified in several locations in Africa, indicating its establishment in the Eastern Hemisphere where it poses an immediate and significant economic threat. Genetic methods were used to characterize noctuid specimens infesting multiple cornfields in the African nation of Togo that were tentatively identified as fall armyworm by morphological criteria. Species identification was confirmed by DNA barcoding and the specimens were found to be primarily of the subgroup that preferentially infests corn and sorghum in the Western Hemisphere. The mitochondrial haplotype configuration was most similar to that found in the Caribbean region and the eastern coast of the United States, identifying these populations as the likely originating source of the Togo infestations. A genetic marker linked with resistance to the Cry1Fa toxin from Bacillus thuringiensis (Bt) expressed in transgenic corn and common in Puerto Rico fall armyworm populations was not found in the Togo collections. These observations demonstrate the usefulness of genetic surveys to characterize fall armyworm populations from Africa.	[Nagoshi, Rodney N.; Meagher, Robert L.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32611 USA; [Koffi, Djima] Univ Ghana, Africa Reg Postgrad Programme Insect Sci, Accra, Ghana; [Agboka, Komi; Tounou, Kodjo Agbeko] Univ Lome, Ecole Super Agron, Lome, Togo; [Banerjee, Rahul; Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	United States Department of Agriculture (USDA); University of Ghana; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Nagoshi, RN (corresponding author), ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL 32611 USA.	rodney.nagoshi@ars.usda.gov			National Institute of Food and Agriculture [2011-67003-30209]; National Institute of Food and Agriculture, Biotechnology Risk Assessment Research Grants Program [2014-33522-22215]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institute of Food and Agriculture, Biotechnology Risk Assessment Research Grants Program	This work was supported by the National Institute of Food and Agriculture under Agreement No. 2011-67003-30209 (https://nifa.usda.gov/grants) to RNN RLM and the National Institute of Food and Agriculture, Biotechnology Risk Assessment Research Grants Program under Agreement No. 2014-33522-22215 (https://nifa.usda.gov/funding-opportunity/biotechnology-risk-assessment-research-grants-program-brag) to RB JLJ-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Farias JR, 2016, PEST MANAG SCI, V72, P2295, DOI 10.1002/ps.4274; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Juarez ML, 2014, ENTOMOL EXP APPL, V152, P182, DOI 10.1111/eea.12215; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Li GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154492; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; Lu Y.-J., 1994, Insect Molecular Biology, V3, P123, DOI 10.1111/j.1365-2583.1994.tb00159.x; Lu YJ, 1996, FLA ENTOMOL, V79, P48, DOI 10.2307/3495753; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; Meagher RL, 2004, ECOL ENTOMOL, V29, P614, DOI 10.1111/j.0307-6946.2004.00629.x; MITCHELL ER, 1991, J ENTOMOL SCI, V26, P39, DOI 10.18474/0749-8004-26.1.39; Nagoshi RN, 2016, INSECT MOL BIOL, V25, P324, DOI 10.1111/imb.12223; Nagoshi RN, 2006, J ECON ENTOMOL, V99, P671, DOI 10.1603/0022-0493-99.3.671; Nagoshi RN, 2004, FLA ENTOMOL, V87, P440, DOI 10.1653/0015-4040(2004)087[0440:BADOTT]2.0.CO;2; Nagoshi RN, 2004, ENVIRON ENTOMOL, V33, P881, DOI 10.1603/0046-225X-33.4.881; Nagoshi RN, 2017, PLOS ONE IN PRESS; Nagoshi RN, 2007, J ECON ENTOMOL, V100, P954, DOI 10.1603/0022-0493(2007)100[954:COHFDF]2.0.CO;2; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2008, J ECON ENTOMOL, V101, P742, DOI 10.1603/0022-0493(2008)101[742:UHTMTM]2.0.CO;2; Nagoshi RN, 2015, J ECON ENTOMOL, V108, P135, DOI 10.1093/jee/tou044; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2012, ANN ENTOMOL SOC AM, V105, P351, DOI 10.1603/AN11138; Nagoshi RN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.15401; Nagoshi RN, 2010, J ECON ENTOMOL, V103, P360, DOI 10.1603/EC09253; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Nagoshi RN, 2008, FLA ENTOMOL, V91, P546; PAIR SD, 1991, FLA ENTOMOL, V74, P200, DOI 10.2307/3495298; Pashley D. P., 1989, ELECTROPHORETIC STUD, P103; PASHLEY DP, 1988, EVOLUTION, V42, P93, DOI 10.1111/j.1558-5646.1988.tb04110.x; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1987, LA AGR, V30, P8; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; PASHLEY DP, 1992, ANN ENTOMOL SOC AM, V85, P400, DOI 10.1093/aesa/85.4.400; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Storer NP, 2012, J INVERTEBR PATHOL, V110, P294, DOI 10.1016/j.jip.2012.04.007; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040	42	49	58	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181982	10.1371/journal.pone.0181982	http://dx.doi.org/10.1371/journal.pone.0181982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738081	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700091
J	Rasmussen, S; Ebbing, C; Irgens, LM				Rasmussen, Svein; Ebbing, Cathrine; Irgens, Lorentz M.			Predicting preeclampsia from a history of preterm birth	PLOS ONE			English	Article							PREGNANCY-INDUCED HYPERTENSION; FETAL-GROWTH RESTRICTION; POPULATION-BASED COHORT; INFLAMMATORY RESPONSE; PERINATAL-MORTALITY; 2ND PREGNANCY; RISK; INFECTION; WEIGHT; RECURRENCE	Objective To assess whether women with a history of preterm birth, independent on the presence of prelabour rupture of the membranes (PROM) and growth deviation of the newborn, are more likely to develop preeclampsia with preterm or preterm birth in a subsequent pregnancy. Methods We conducted a population-based cohort study, based on Medical Birth Registry of Norway between 1967 and 2012, including 742,980 women with singleton pregnancies who were followed up from their 1st to 2nd pregnancy. In the analyses we included 712,511 women after excluding 30,469 women with preeclampsia in the first pregnancy. Results After preterm birth without preeclampsia in the first pregnancy, the risk of preterm preeclampsia in the second pregnancy was 4-7 fold higher than after term birth (odds ratios 3.5; 95% confidence interval (CI) 3.0-4.0 to 6.5; 95% CI 5.1-8.2). The risk of term preeclampsia in the pregnancy following a preterm birth was 2-3 times higher than after term birth (odds ratios 1.6; 95% CI 1.5-1.8 to 2.6; 95% CI 2.0-3.4). After spontaneous non-PROM preterm birth and preterm PROM, the risk of preterm preeclampsia was 3.3-3.6 fold higher than after spontaneous term birth. Corresponding risks of term preeclampsia was 1.6-1.8 fold higher. No significant time trends were found in the effect of spontaneous preterm birth in the first pregnancy on preterm or term preeclampsia in the second pregnancy. Conclusions The results suggest that preterm birth, regardless of the presence of PROM, and preeclampsia share pathophysiologic mechanisms. These mechanisms may cause preterm birth in one pregnancy and preeclampsia in a subsequent pregnancy in the same woman. The association was particularly evident with preterm preeclampsia.	[Rasmussen, Svein] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Rasmussen, Svein; Ebbing, Cathrine] Haukeland Hosp, Dept Obstet & Gynaecol, Bergen, Norway; [Irgens, Lorentz M.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH)	Rasmussen, S (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Rasmussen, S (corresponding author), Haukeland Hosp, Dept Obstet & Gynaecol, Bergen, Norway.	Svein.Rasmussen@uib.no	Ebbing, Cathrine/ABC-9123-2020	Ebbing, Cathrine/0000-0002-4331-1250				Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; ARIAS F, 1993, AM J OBSTET GYNECOL, V168, P585, DOI 10.1016/0002-9378(93)90499-9; Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Ebbing C, 2017, ACTA OBSTET GYN SCAN, V96, P243, DOI 10.1111/aogs.13066; Ghidini A, 2005, ACTA OBSTET GYN SCAN, V84, P547, DOI 10.1111/j.0001-6349.2005.00694.x; Innes KE, 2003, AM J EPIDEMIOL, V158, P861, DOI 10.1093/aje/kwg211; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS53, DOI 10.1016/j.ajog.2015.08.041; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Melve KK, 1999, AM J EPIDEMIOL, V150, P756; Mor G, 2015, AM J OBSTET GYNECOL, V213, pS131, DOI 10.1016/j.ajog.2015.06.039; Naimy Z, 2015, BJOG-INT J OBSTET GY, V122, P859, DOI 10.1111/1471-0528.12978; Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501; Rasmussen S, 2000, OBSTET GYNECOL, V96, P696, DOI 10.1016/S0029-7844(00)01008-5; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Rasmussen S, 2014, BJOG-INT J OBSTET GY, V121, P1351, DOI 10.1111/1471-0528.12677; Rasmussen S, 2008, HYPERTENSION, V51, P1231, DOI 10.1161/HYPERTENSIONAHA.107.096248; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Romero R, 2016, AM J REPROD IMMUNOL; Thomsen LCV, 2013, ACTA OBSTET GYN SCAN, V92, P943, DOI 10.1111/aogs.12159; Vangen S, 2002, INT J EPIDEMIOL, V31, P654, DOI 10.1093/ije/31.3.654	27	14	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181016	10.1371/journal.pone.0181016	http://dx.doi.org/10.1371/journal.pone.0181016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738075	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000406362700025
J	Xia, T; Miao, ZY; Chen, SS; Wang, HZ; Yao, YF				Xia, Tian; Miao, Zhiying; Chen, Shanshan; Wang, Hongzhi; Yao, Yefeng			Theory and development of biplanar active shim coils for a permanent NMR analyzer	PLOS ONE			English	Article							TARGET-FIELD METHOD; RELAXATION; DESIGN; MRI	The general expression for magnetic induction in the z axis direction is derived from magnetic scalar potential, and magnetic induction for biplanar shimming coils (BSCs) is also derived from magnetic vector potentials and Green functions, which simultaneously include Sin and Cos harmonic fields. The relationship between these expressions is discussed, and we show they are partially consistent. Magnetic induction generated Sin and Cos stream functions, which are presented and discussed, and we conclude that the type of stream function determines the type of harmonic field, and that BSCs can not only generate specific harmonic fields directly using Cos stream function, but also generate the rest of the harmonic fields through some specific operations. The detailed design process is presented in the form of a diagram. Subsequently, nine BSCs were calculated using the proposed method and applied to a low field NMR relaxation analyzer. The magnetic field homogeneity after shimming increases significantly, which verifies its practical value.	[Xia, Tian; Wang, Hongzhi; Yao, Yefeng] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China; [Xia, Tian; Chen, Shanshan] Shanghai Univ Med & Hlth Sci, Med Imaging Coll, Shanghai, Peoples R China; [Miao, Zhiying] Univ Shanghai Sci & Technol, Sch Opt Elect & Comp Engn, Shanghai, Peoples R China	East China Normal University; Shanghai University of Medicine & Health Sciences; University of Shanghai for Science & Technology	Xia, T; Wang, HZ (corresponding author), East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China.; Xia, T (corresponding author), Shanghai Univ Med & Hlth Sci, Med Imaging Coll, Shanghai, Peoples R China.	Bruce_xiatian@163.com; wanghzhi2000@sina.com		Xia, Tian/0000-0002-0589-8193	Ministry of Science and Technology of China [2013YQ170463]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	Support for this program was provided by the National Science and Technology Major Project of the Ministry of Science and Technology of China (Grant 2013YQ170463). The URL of funder's website is http://www.most.gov.cnitztg/201309/t20130904_109149.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown R. W., 1999, MAGNETIC RESONANCE I; Evdokimov IN, 2003, FUEL, V82, P817, DOI 10.1016/S0016-2361(02)00336-8; Forbes LK, 2001, J PHYS D APPL PHYS, V34, P3447, DOI 10.1088/0022-3727/34/24/305; Forbes LK, 2002, J PHYS D APPL PHYS, V35, P839, DOI 10.1088/0022-3727/35/9/303; Forbes LK, 2001, MED PHYS, V28, P1644, DOI 10.1118/1.1388538; Guthausen A, 2004, J AM OIL CHEM SOC, V81, P727, DOI 10.1007/s11746-004-0969-5; Hills B, 2004, APPL MAGN RESON, V26, P543, DOI 10.1007/BF03166582; Hu G., 2014, IEEE T APPL SUPERCON, V24, P1; Hu GL, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2179396; Keating K, 2008, J APPL GEOPHYS, V66, P188, DOI 10.1016/j.jappgeo.2007.09.001; Liu WT, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/1/018701; Liu W, 2007, J PHYS D APPL PHYS, V40, P4418, DOI 10.1088/0022-3727/40/15/005; Liu WT, 2010, CONCEPT MAGN RESON B, V37B, P29, DOI 10.1002/cmr.b.20153; Milton Abramowitz, HDB MATH FUNCTIONS F; ROMEO F, 1984, MAGNET RESON MED, V1, P44, DOI 10.1002/mrm.1910010107; Trbovic N, 2008, PROTEINS, V71, P684, DOI 10.1002/prot.21750; TURNER R, 1986, J PHYS D APPL PHYS, V19, pL147, DOI 10.1088/0022-3727/19/8/001; You XF, 2010, IEEE T APPL SUPERCON, V20, P1045, DOI 10.1109/TASC.2010.2041537	18	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181552	10.1371/journal.pone.0181552	http://dx.doi.org/10.1371/journal.pone.0181552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742132	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700054
J	Abubakar, B; Zawawi, N; Omar, AR; Ismail, M				Abubakar, Bilyaminu; Zawawi, Norhasnida; Omar, Abdul Rahman; Ismail, Maznah			Predisposition to insulin resistance and obesity due to staple consumption of rice: Amylose content versus germination status	PLOS ONE			English	Article							BROWN RICE; RISK-FACTORS; STARCH DIGESTIBILITY; AMYLOPECTIN STARCH; GLYCEMIC INDEX; WHITE RICE; METABOLISM; GLUCOSE; MEN	Type 2 diabetes is a metabolic disorder with established, well-defined precursors. Obesity and insulin resistance are amongst most important factors in predisposition to diabetes. Rice is a staple for about half the global population and its consumption has been strongly linked with diabetogenesis. We assert that tackling the prevalence of predisposing factors by modifying certain rice cultivars could reduce the global burden of obesity and insulin resistance, and by extension type 2 diabetes. Several rice cultivars with various properties were fed to nulliparous rats (five weeks old at the start of the experiment) for 90 days. They were then returned to a diet of standard pellets and mated with males raised on a standard diet. The resulting pups and dams were investigated for obesity and insulin resistance markers. We found that germination did more to reduce predisposition to obesity and insulin resistance than high amylose content. The combined reducing effect of germination and high amylose content on predisposition to obesity and insulin resistance was greater than the sum of their independent effects. Polished (white) rice with a low amylose content predisposed dams on a high-fat diet to markers of insulin resistance and obesity and this predisposition was inherited (in biochemical terms) by their F1 offspring. Overall, the results suggest that harnessing the beneficial properties of germination and amylose in rice would reduce the burden of obesity and insulin resistance, which are known to be key risk factors for development of type 2 diabetes.	[Abubakar, Bilyaminu; Ismail, Maznah] Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang, Selangor, Malaysia; [Abubakar, Bilyaminu] Usmanu Danfodiyo Univ, Dept Pharmacol & Toxicol, Sokoto, Nigeria; [Zawawi, Norhasnida] Univ Putra Malaysia, Fac Food Sci & Technol, Dept Food Sci, Serdang, Selangor, Malaysia; [Omar, Abdul Rahman] Univ Putra Malaysia, Fac Vet Med, Dept Anim Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Abubakar, B; Ismail, M (corresponding author), Univ Putra Malaysia, Inst Biosci, Lab Mol Biomed, Serdang, Selangor, Malaysia.; Abubakar, B (corresponding author), Usmanu Danfodiyo Univ, Dept Pharmacol & Toxicol, Sokoto, Nigeria.	abu3163abu@yahoo.co.uk; myhome.e@gmail.com	Zawawi, Norhasnida/AAI-6421-2021; Abubakar, Bilyaminu/AAC-5821-2019	Zawawi, Norhasnida/0000-0001-7459-5025; 	Padi Beras Nasional Berhad (BERNAS); Universiti Putra Malaysia (UPM); Bernas Sdn. Bhd	Padi Beras Nasional Berhad (BERNAS); Universiti Putra Malaysia (UPM); Bernas Sdn. Bhd	The authors wish to express their gratitude towards Padi Beras Nasional Berhad (BERNAS) and Universiti Putra Malaysia (UPM) for sponsoring this research (vote no. 63536).; The authors wish to acknowledge Dr Asfaliza Ramli of the Malaysian Agricultural Research and Development Institute for providing the samples, and Bernas Sdn. Bhd. for providing funds for the conduct of this research.	Batres-Marquez SP, 2009, J AM DIET ASSOC, V109, P1719, DOI 10.1016/j.jada.2009.07.010; BEHALL KM, 1989, AM J CLIN NUTR, V49, P337, DOI 10.1093/ajcn/49.2.337; Coll JL, 2015, OBESITY FACTS, V8, P220, DOI 10.1159/000435826; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Denardin CC, 2012, CIENC RURAL, V42, P381, DOI 10.1590/S0103-84782012005000002; Frei M, 2003, FOOD CHEM, V83, P395, DOI 10.1016/S0308-8146(03)00101-8; Graus-Nunes F, 2015, NUTRITION, V31, P380, DOI 10.1016/j.nut.2014.08.002; Hall KD, 2015, CELL METAB, V22, P427, DOI 10.1016/j.cmet.2015.07.021; Ho JN, 2012, BIOSCI BIOTECH BIOCH, V76, P1068, DOI 10.1271/bbb.110666; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Imam MU, 2013, NUTRIENTS, V5, P468, DOI 10.3390/nu5020468; Imam MU, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/816501; Imam MU, 2012, INT J MOL SCI, V13, P12952, DOI 10.3390/ijms131012952; International Diabetic Federation, 2015, DIAB FACTS FIG; International Standard Organisation, RIC DET AM CONT; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Lanas F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163727; Lim SM, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1116-y; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nanri A, 2010, AM J CLIN NUTR, V92, P1468, DOI 10.3945/ajcn.2010.29512; Ooi DJ, 2012, MOLECULES, V17, P11139, DOI 10.3390/molecules170911139; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; Wang SJ, 2013, FOOD FUNCT, V4, P1564, DOI 10.1039/c3fo60258c; WHO, 2016, GLOB REP PSOR; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181309	10.1371/journal.pone.0181309	http://dx.doi.org/10.1371/journal.pone.0181309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727791	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000406634500054
J	Chen, W; Zhou, FJ; Hall, BJ; Tucker, JD; Latkin, C; Renzaho, AMN; Ling, L				Chen, Wen; Zhou, Fangjing; Hall, Brian J.; Tucker, Joseph D.; Latkin, Carl; Renzaho, Andre M. N.; Ling, Li			Is there a relationship between geographic distance and uptake of HIV testing services? A representative population-based study of Chinese adults in Guangzhou, China	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; COST-EFFECTIVENESS; MIGRANTS; COMMUNITY; COUNTRIES; PATTERNS; FRANCE; ACCESS; TIME; AREA	Achieving high coverage of HIV testing services is critical in many health systems, especially where HIV testing services remain centralized and inconvenient for many. As a result, planning the optimal spatial distribution of HIV testing sites is increasingly important. We aimed to assess the relationship between geographic distance and uptake of HIV testing services among the general population in Guangzhou, China. Utilizing spatial epidemiological methods and stratified household random sampling, we studied 666 adults aged 18-59. Computer-assisted interviews assessed self-reported HIV testing history. Spatial scan statistic assessed the clustering of participants who have ever been tested for HIV, and two-level logistic regression models assessed the association between uptake of HIV testing and the mean driving distance from the participant's residence to all HIV testing sites in the research sites. The percentage of participants who have ever been tested for HIV was 25.2% (168/666, 95% CI: 21.9%, 28.5%), and the majority (82.7%) of participants tested for HIV in Centres for Disease Control and Prevention, public hospitals or STIs clinics. None reported using self-testing. Spatial clustering analyses found a hotspot included 48 participants who have ever been tested for HIV and 25.8 expected cases (Rate Ratio = 1.86, P = 0.002). Adjusted two-level logistic regression found an inverse relationship between geographic distance (kilometers) and ever being tested for HIV (aOR = 0.90, 95% CI: 0.84, 0.96). Married or cohabiting participants (aOR = 2.14, 95% CI: 1.09, 4.20) and those with greater social support (aOR = 1.04, 95% CI: 1.01, 1.07) were more likely to be tested for HIV. Our findings underscore the importance of considering the geographical distribution of HIV testing sites to increase testing. In addition, expanding HIV testing coverage by introducing non-facility based HIV testing services and self-testing might be useful to achieve the goal that 90% of people living with HIV knowing their HIV status by the year 2020.	[Chen, Wen; Ling, Li] Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Chen, Wen; Zhou, Fangjing; Hall, Brian J.; Tucker, Joseph D.; Ling, Li] Sun Yat Sen Univ, Ctr Migrant Hlth Policy, Guangzhou, Guangdong, Peoples R China; [Chen, Wen; Renzaho, Andre M. N.] Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia; [Zhou, Fangjing] Ctr TB Control Guangdong Prov, Dept Prevent & Treatment, Guangzhou, Guangdong, Peoples R China; [Hall, Brian J.] Univ Macau, Dept Psychol, Fac Social Sci, Global & Community Mental Hlth Res Grp, Macau, Peoples R China; [Hall, Brian J.; Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Tucker, Joseph D.] UNC Project China, Guangzhou, Guangdong, Peoples R China; [Tucker, Joseph D.] Univ North Carolina Chapel Hill, UNC Global Hlth & Infect Dis, Chapel Hill, NC USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Sun Yat Sen University; Sun Yat Sen University; Western Sydney University; University of Macau; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chen, W; Ling, L (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Fac Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China.; Chen, W; Ling, L (corresponding author), Sun Yat Sen Univ, Ctr Migrant Hlth Policy, Guangzhou, Guangdong, Peoples R China.; Chen, W (corresponding author), Western Sydney Univ, Sch Social Sci & Psychol, Penrith, NSW, Australia.	chenwen200485@163.com; lingli@mail.sysu.edu.cn	Hall, Brian J./B-7694-2016; Renzaho, Andre M.N./AAH-7679-2021	Hall, Brian J./0000-0001-9358-2377; RENZAHO, ANDRE/0000-0002-6844-0833	Fogarty Global Health Fellows Program Consortium of the University of North Carolina, John Hopkins Bloomberg School of Public Health, Morehouse and Tulane [5R25TW009340-02, 1R25TW009340-01]; University of Macau [SRG2014-00001-FSS, MYRG2015-00124-FSS, MYRG2015-00109-FSS]; NIH (NIAID) [1R01A1114310, 1D43TW009532]; Australian Research Council's Future Fellowship [FT110100345]; China Medical Board [12-111]; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310, P30AI050410] Funding Source: NIH RePORTER	Fogarty Global Health Fellows Program Consortium of the University of North Carolina, John Hopkins Bloomberg School of Public Health, Morehouse and Tulane; University of Macau; NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Australian Research Council's Future Fellowship(Australian Research Council); China Medical Board; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by Fogarty Global Health Fellows Program Consortium comprised of the University of North Carolina, John Hopkins Bloomberg School of Public Health, Morehouse and Tulane http://globalhealth.unc.edu/ujmt-fogarty-global-health-fellowship/ (5R25TW009340-02, 1R25TW009340-01). Professor Hall received additional support from grants SRG2014-00001-FSS, MYRG2015-00124-FSS and MYRG2015-00109-FSS awarded by the University of Macauhttp://www.umac.mo/research/aboutus.html. Professor Tucker received support from the NIH https.//www.nih.gov/ (NIAID 1R01A1114310, 1D43TW009532). Professor Renzaho is funded by an Australian Research Council's Future Fellowship http.//www.arc.gov.au/ (FT110100345). Professor Ling is funded by the China Medical Boardhttp://www.chinamedicalboard.org/ (12-111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 2014, AM J TROP MED HYG, V90, P224, DOI 10.4269/ajtmh.13-0181; ACTON JP, 1975, J POLIT ECON, V83, P595, DOI 10.1086/260342; [Anonymous], 2014, GLOB UPD HLTH SECT R; Arcury TA, 2005, HEALTH SERV RES, V40, P135, DOI 10.1111/j.1475-6773.2005.00346.x; Babor TF., 2001, AUDIT ALCOHOL USE DI; Bing L, 2003, CHINESE MENTAL HLTH, V17, P1; Blondell SJ, 2015, AIDS BEHAV, V19, P2012, DOI 10.1007/s10461-015-1095-x; Bolsewicz K, 2015, AIDS CARE, V27, P570, DOI 10.1080/09540121.2014.986050; Buskin Susan E, 2002, J Public Health Manag Pract, V8, P38; Cai R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079320; Chen W, 2016, SEX TRANSM INFECT, V92, P316, DOI 10.1136/sextrans-2015-052268; *CHIN MIN HLTH, 2003, JOINT ASS HIV AIDS P; Cook PA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-78; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han L, 2014, JAIDS-J ACQ IMM DEF, V67, P216, DOI 10.1097/QAI.0000000000000278; He X, 2015, GUANGZHOU DAILY; Hoi CK, 2015, J PAC RIM PSYCHOL, V9, P120, DOI 10.1017/prp.2015.12; Huang W, 2014, PREV SCI, V15, P329, DOI 10.1007/s11121-013-0423-5; Huntington S, 2011, HIV MED, V12, P361, DOI 10.1111/j.1468-1293.2010.00891.x; Jacobsen MM, 2016, CURR HIV-AIDS REP, V13, P64, DOI 10.1007/s11904-016-0303-2; Jarvis M, 2015, CURR PHARM TEACH LEA, V7, P137, DOI 10.1016/j.cpil.2014.09.002; Joint United Nations Programme on HIV/AIDS, 2014, AMB TREATM TARG WRIT; Juan S, 2017, CHINA DAILY; Kulldorff M, 2002, INT J EPIDEMIOL, V31, P495, DOI 10.1093/ije/31.2.495; Lapostolle A, 2011, AIDS CARE, V23, P1117, DOI 10.1080/09540121.2011.554522; Leibowitz AA, 2007, MED CARE RES REV, V64, P568, DOI 10.1177/1077558707304634; Li G, 2014, GUANGZHOU DAILY; Lucas A, 2013, AIDS, V27, P795, DOI 10.1097/QAD.0b013e32835c54f9; MCGUIRK MA, 1984, INQUIRY-J HEALTH CAR, V21, P84; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; National AIDS Control Organization, 2008, NAT BEH SURV SURV BS; National Center for HIV/ AIDS Viral Hepatitis STD and TB Prevention, 2016, CDC FACT SHEET HIV T; National Health and Family Planning Commission of the People's Republic of China, 2015, 2015 CHIN AIDS RESP; Ojikutu B, 2013, AIDS PATIENT CARE ST, V27, P45, DOI 10.1089/apc.2012.0312; Organization WH, 2015, PREV HIV AD AG 15 49; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Renzi C, 2001, PREV MED, V32, P40, DOI 10.1006/pmed.2000.0778; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Shisana O., 2014, AFRICAN NATL HIV P; States CfDCaPiU, 2015, TRENDS PREV SEX BEH; Thornton AC, 2012, HIV MED, V13, P416, DOI 10.1111/j.1468-1293.2012.00992.x; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; Wang P, 2014, YANGCHENG EVENING NE; Wei CY, 2011, SEX TRANSM INFECT, V87, P225, DOI 10.1136/sti.2010.047407; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, GUID HIV SELF TEST P; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; Wu Di, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P1095; Wu ZY, 2006, SCIENCE, V312, P1475, DOI 10.1126/science.1120682; Wu ZY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001874; Xiao S, 1999, MENTAL HEALTH SCALE; Xiao S.Y., 1987, CHIN MENT HLTH J, V4, P183; Zou X, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-490	54	10	10	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180801	10.1371/journal.pone.0180801	http://dx.doi.org/10.1371/journal.pone.0180801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727786	gold, Green Published			2022-12-26	WOS:000406634500029
J	Larifla, L; Armand, C; Bangou, J; Blanchet-Deverly, A; Numeric, P; Fonteau, C; Michel, CT; Ferdinand, S; Bourrhis, V; Velayoudom-Cephise, FL				Larifla, Laurent; Armand, Christophe; Bangou, Jacqueline; Blanchet-Deverly, Anne; Numeric, Patrick; Fonteau, Christiane; Michel, Carl-Thony; Ferdinand, Severine; Bourrhis, Veronique; Velayoudom-Cephise, Fritz-Line			Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; HEART-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ADULT-POPULATION; RISK-FACTORS; E GENOTYPES; SMOKING; FREQUENCY; MEN	Objectives Apolipoprotein E gene (APOE) polymorphism is associated with the lipid profile and cardiovascular disease. However, these relationships vary between ethnic groups. We evaluated, for the first time in an Afro-Caribbean population, the distribution of APOE polymorphisms and their associations with coronary artery disease (CAD), the lipid profile and other cardio-metabolic risk factors. Methods We studied 712 Afro-Caribbean subjects including 220 with documented CAD and 492 healthy subjects. TaqMan assays were performed to genotype rs7412 and rs429358, the two variants that determine the APOE alleles epsilon 2, epsilon 3 and epsilon 4. The association between APOE genotype and the lipid profile was analysed by comparing epsilon 2 carriers, epsilon 3 homozygotes and epsilon 4 carriers. Results The frequencies of epsilon 2, epsilon 3 and epsilon 4 in the overall sample were 8%, 70% and 22%, respectively. CAD was not associated with APOE polymorphism. The total cholesterol level was higher in epsilon 4 carriers compared with epsilon 2 carriers: 5.07 vs 4.59 mmol/L (P = 0.016). The LDL-cholesterol level was lower in APOE epsilon 2 carriers compared with epsilon 3 homozygotes and epsilon 4 carriers: 2.65 vs 3.03 and 3.17 mmol/L, respectively (p = 0.002). The total cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol ratios were similar in the three allelic groups. APOE polymorphism was not associated with diabetes, hypertension, waist circumference or body mass index. Conclusions Our results indicate that APOE gene polymorphism is associated with the lipid profile but not with CAD in Afro-Caribbean people. This lack of association with CAD may be explained by the low atherogenic profile observed in epsilon 4 carriers, which may warrant further investigation.	[Larifla, Laurent; Armand, Christophe; Bangou, Jacqueline; Blanchet-Deverly, Anne; Velayoudom-Cephise, Fritz-Line] Univ Antilles, ECM LAMIA EA 4540, Res Grp Clin Epidemiol & Med, Pointe a Pitre, Guadeloupe, France; [Larifla, Laurent; Michel, Carl-Thony] Univ Hosp Guadeloupe, Dept Cardiol, Pointe a Pitre, Guadeloupe, France; [Armand, Christophe; Ferdinand, Severine] Univ Hosp Guadeloupe, Dept Med Informat & Publ Hlth, Pointe a Pitre, Guadeloupe, France; [Bangou, Jacqueline] Univ Hosp Guadeloupe, Biochem Unit, Pointe a Pitre, Guadeloupe, France; [Numeric, Patrick] Univ Hosp Martinique, Dept Internal Med Unit, Fort De France, France; [Fonteau, Christiane] Univ Hosp Martinique, Biochem Unit, Fort De France, France; [Bourrhis, Veronique] Univ Hosp Guadeloupe, Dept Med, Pointe a Pitre, Guadeloupe, France; [Velayoudom-Cephise, Fritz-Line] Univ Hosp Guadeloupe, Dept Endocrinol & Diabetol, Pointe a Pitre, Guadeloupe, France	Universite des Antilles; CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; CHU Martinique; CHU Martinique; CHU Guadeloupe; CHU Guadeloupe	Larifla, L (corresponding author), Univ Antilles, ECM LAMIA EA 4540, Res Grp Clin Epidemiol & Med, Pointe a Pitre, Guadeloupe, France.; Larifla, L (corresponding author), Univ Hosp Guadeloupe, Dept Cardiol, Pointe a Pitre, Guadeloupe, France.	laurent.larifla@chu-guadeloupe.fr		FERDINAND, Severine/0000-0001-8258-5089; Larifla, Laurent/0000-0002-1447-7753	"Programme Hospitalier pour la Recherche Clinique (PHRC)", France	"Programme Hospitalier pour la Recherche Clinique (PHRC)", France	This study was supported by grants from the "Programme Hospitalier pour la Recherche Clinique (PHRC)", France.	Anuurad E, 2006, J LIPID RES, V47, P2475, DOI 10.1194/jlr.M600288-JLR200; Atadzhanov Masharip, 2014, BMC Res Notes, V7, P194, DOI 10.1186/1756-0500-7-194; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Chang MH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-62; Chaturvedi N, 2003, HEART, V89, P681, DOI 10.1136/heart.89.6.681; CHATURVEDI N, 1994, DIABETOLOGIA, V37, P765, DOI 10.1007/s001250050177; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Foucan L, 2001, EUR J EPIDEMIOL, V17, P1089, DOI 10.1023/A:1021213729434; Foucan L, 2000, DIABETES METAB, V26, P473; Grammer TB, 2013, EUR HEART J, V34, P1298, DOI 10.1093/eurheartj/eht001; Gustavsson J, 2012, ATHEROSCLEROSIS, V220, P486, DOI 10.1016/j.atherosclerosis.2011.10.011; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; Holmes MV, 2014, ATHEROSCLEROSIS, V237, P5, DOI 10.1016/j.atherosclerosis.2014.07.038; Inamo J, 2011, J HYPERTENS, V29, P1494, DOI 10.1097/HJH.0b013e328348fd95; Isles CG, 2000, QJM-INT J MED, V93, P567, DOI 10.1093/qjmed/93.9.567; KINOSIAN B, 1995, J INVEST MED, V43, P443; Kolovou GD, 2007, AGEING RES REV, V6, P94, DOI 10.1016/j.arr.2006.11.001; Kypreos KE, 2009, FEBS J, V276, P5720, DOI 10.1111/j.1742-4658.2009.07301.x; Lahoz C, 2001, ATHEROSCLEROSIS, V154, P529, DOI 10.1016/S0021-9150(00)00570-0; Lee MJ, 2013, CLIN CHIM ACTA, V416, P31, DOI 10.1016/j.cca.2012.10.054; Loktionov A, 1999, ATHEROSCLEROSIS, V145, P125, DOI 10.1016/S0021-9150(99)00022-2; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Masemola ML, 2007, SCAND J PUBLIC HEALT, V35, P60, DOI 10.1080/14034950701355635; Nam BH, 2006, AM J CARDIOL, V97, P372, DOI 10.1016/j.amjcard.2005.08.055; Novotny D, 2014, CLIN BIOCHEM, V47, P1015, DOI 10.1016/j.clinbiochem.2014.03.015; Ordovas JM, 1999, CURR OPIN LIPIDOL, V10, P15, DOI 10.1097/00041433-199902000-00004; Rubin J, 2002, CURR OPIN LIPIDOL, V13, P25, DOI 10.1097/00041433-200202000-00005; SANDHOLZER C, 1995, HUM GENET, V95, P46; Stoumpos S, 2013, J HUM HYPERTENS, V27, P245, DOI 10.1038/jhh.2012.37; Talmud PJ, 2005, ANN HUM GENET, V69, P613, DOI 10.1111/j.1529-8817.2005.00205.x; Talmud PJ, 2004, ATHEROSCLEROSIS, V177, P105, DOI 10.1016/j.atherosclerosis.2004.06.008; Tan CE, 2003, ATHEROSCLEROSIS, V170, P253, DOI 10.1016/S0021-9150(03)00232-6; Tao MH, 2011, METABOLISM, V60, P1488, DOI 10.1016/j.metabol.2011.03.004; Ward H, 2009, ARCH INTERN MED, V169, P1424, DOI 10.1001/archinternmed.2009.234; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Willis F, 2003, J NATL MED ASSOC, V95, P71	37	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181620	10.1371/journal.pone.0181620	http://dx.doi.org/10.1371/journal.pone.0181620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727855	Green Submitted, gold, Green Published			2022-12-26	WOS:000406634500093
J	Pirie-Shepherd, SR; Painter, C; Whalen, P; Vizcarra, P; Roy, M; Qian, J; Franks, T; Coskran, T; Golas, J; Deng, SB; Zhong, WY; Tucker, E; Marrinucci, D; Gerber, HP; Powell, EL				Pirie-Shepherd, Steven R.; Painter, Cory; Whalen, Pamela; Vizcarra, Pamela; Roy, Marc; Qian, Jesse; Franks, Tania; Coskran, Tim; Golas, Jon; Deng, Shibing; Zhong, Wenyan; Tucker, Eric; Marrinucci, Dena; Gerber, Hans-Peter; Powell, Eric L.			Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients	PLOS ONE			English	Article							BREAST-CANCER; ANTIGEN; CELLS; ANTIBODY; HER2	The fetal oncogene 5T4 is a cell surface protein, with overexpression observed in a variety of cancers as compared to normal adult tissue. The ability to select patients with tumors that express high levels of 5T4 may enrich a clinical trial cohort with patients most likely to respond to 5T4 targeted therapy. To that end, we developed assays to measure 5T4 in both tumors and in circulating tumor cells (CTCs). We identified the presence of 5T4 in both adenocarcinoma and squamous cell carcinoma of lung, in all clinical stages and grades of disease. CTCs were identified in peripheral blood from the majority of patients with NSCLC, and 5T4 was detectable in most samples. Although 5T4 was present in both CTCs and tumors in most patients, there was no concordance between relative amount in either sample type. Clinical response rates of patients treated with the therapies directed against 5T4 in early stage clinical trials, as determined by these assays, may provide important insights into the biology of 5T4 in tumors and the mechanisms of action of 5T4-targeting therapy.	[Pirie-Shepherd, Steven R.; Painter, Cory; Whalen, Pamela; Vizcarra, Pamela; Deng, Shibing; Powell, Eric L.] Pfizer Inc, WRD, EORCD, La Jolla, CA USA; [Roy, Marc; Qian, Jesse; Franks, Tania; Coskran, Tim] Pfizer Inc, WRD, IPL, Groton, CT 06340 USA; [Golas, Jon; Zhong, Wenyan; Gerber, Hans-Peter] Pfizer Inc, WRD, OTTD, Pearl River, NY USA; [Tucker, Eric; Marrinucci, Dena] Epic Sci, San Diego, CA USA; [Marrinucci, Dena] Truvian Sci, San Diego, CA USA; [Gerber, Hans-Peter] Harpoon Therapeut Inc, Brisbane, CA USA	Pfizer; Pfizer; Pfizer	Pirie-Shepherd, SR (corresponding author), Pfizer Inc, WRD, EORCD, La Jolla, CA USA.	steven.pirie-shepherd@pfizer.com			Pfizer Inc.	Pfizer Inc.(Pfizer)	This work was funded by Pfizer Inc. We can state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Damelin M, 2011, CANCER RES, V71, P4236, DOI 10.1158/0008-5472.CAN-10-3919; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Liu Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-202; Marrinucci D, 2009, ARCH PATHOL LAB MED, V133, P1468, DOI 10.1043/1543-2165-133.9.1468; Munzone E, 2010, CLIN BREAST CANCER, V10, P392, DOI 10.3816/CBC.2010.n.052; Naganuma H, 2002, ANTICANCER RES, V22, P1033; Nieva J, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016004; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Perez EA, 2011, ONCOLOGIST, V16, P20, DOI 10.1634/theoncologist.2011-S1-20; Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7; Sapra P, 2013, MOL CANCER THER, V12, P38, DOI 10.1158/1535-7163.MCT-12-0603; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SOUTHALL PJ, 1990, BRIT J CANCER, V61, P89, DOI 10.1038/bjc.1990.20; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Turner N, 2014, CANCERS, V6, P684, DOI 10.3390/cancers6020684; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; WRIGLEY E, 1995, INT J GYNECOL CANCER, V5, P269, DOI 10.1046/j.1525-1438.1995.05040269.x; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	20	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0179561	10.1371/journal.pone.0179561	http://dx.doi.org/10.1371/journal.pone.0179561			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727782	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500005
J	Perillo, LN; Neves, FD; Antonini, Y; Martins, RP				Perillo, Lucas Neves; Neves, Frederico de Siqueira; Antonini, Yasmine; Martins, Rogerio Parentoni			Compositional changes in bee and wasp communities along Neotropical mountain altitudinal gradient	PLOS ONE			English	Article							TRAP-NESTING BEES; FUNCTIONAL BETA DIVERSITY; SPECIES RICHNESS; GEOMETRID MOTHS; ENVIRONMENTAL GRADIENTS; INSECT HERBIVORES; AREA RELATIONSHIP; SOLITARY WASPS; HYMENOPTERA; PATTERNS	Climate conditions tend to differ along an altitudinal gradient, resulting in some species groups' patterns of lower species richness with increasing altitude. While this pattern is well understood for tropical mountains, studies investigating possible determinants of variation in beta-diversity at its different altitudes are scarce. We sampled bee and wasp communities (Hymenoptera: Aculeata) along an altitudinal gradient (1,000-2,000 m.a.s.l.) in a tropical mountainous region of Brazil. Trap nests and Moericke traps were established at six sampling points, with 200 m difference in altitude between each point. We obtained average climate data (1970-2000) from Worldclim v2 for altitudes at each sampling site. Nest traps captured 17 bee and wasp species from six families, and Moericke traps captured 124 morphospecies from 13 families. We found a negative correlation between altitude and species richness and abundance. Temperature, precipitation, water vapor pressure, and wind speed influenced species richness and abundance, and were correlated with altitude. beta-diversity was primarily determined by species turnover as opposed to nestedness, and Aculeate community similarity was higher for more similar altitudinal ranges. Moericke traps seem to be more efficient for altitudinal surveys compared to nest traps. We found high occurrence of singleton and doubleton species at all altitudes, highlighting the need for longterm studies to efficiently assess hymenopteran diversity in these environments.	[Perillo, Lucas Neves; Neves, Frederico de Siqueira] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Antonini, Yasmine] Univ Fed Ouro Preto, Dept Biodiversidade Evolucao & Meio Ambiente, Ouro Preto, MG, Brazil; [Martins, Rogerio Parentoni] Univ Fed Ceara, Programa Posgrad Ecol & Recursos Nat, Fortaleza, Ceara, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto; Universidade Federal do Ceara	Perillo, LN (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.	lucasnevesperillo@gmail.com	Perillo, Lucas/ABG-5303-2020; Neves, Frederico/E-5777-2013	Perillo, Lucas/0000-0003-4291-4452; Neves, Frederico/0000-0002-2691-3743; Antonini, Yasmine/0000-0002-5582-8193	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); United States Fish & Wildlife Services; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); United States Fish & Wildlife Services; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Our study was supported by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), United States Fish & Wildlife Services and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - first author's scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamczyk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027115; Alves RJV, 2014, BRAZ J BIOL, V74, P355, DOI 10.1590/1519-6984.23212; [Anonymous], 2011, TAXONOMIC FUNCTIONAL; Antonini Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175884; Araujo PCS, 2016, NEOTROP ENTOMOL, V45, P482, DOI 10.1007/s13744-016-0395-9; Araujo VA, 2006, NEOTROP ENTOMOL, V35, P30, DOI 10.1590/S1519-566X2006000100005; Azevedo A, 2008, FAUNA ABELHAS HYMENO, V4, P154; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2013, ECOGRAPHY, V36, P124, DOI 10.1111/j.1600-0587.2012.00124.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Beck J, 2002, J TROP ECOL, V18, P33, DOI 10.1017/S026646740200202X; Beck J, 2007, J ANIM ECOL, V76, P230, DOI 10.1111/j.1365-2656.2006.01189.x; Bishop TR, 2015, J BIOGEOGR, V42, P1776, DOI 10.1111/jbi.12537; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; Buschini MLT, 2006, APIDOLOGIE, V37, P58, DOI 10.1051/apido:2005059; Carneiro Marco Antonio A., 1995, Revista Brasileira de Entomologia, V39, P597; Castellano S, 2002, EVOLUTION, V56, P1871; Cleary DFR, 2006, BIODIVERS CONSERV, V15, P517, DOI 10.1007/s10531-005-2353-4; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Costa FV, 2015, SOCIOBIOLOGY, V62, P228; Crawley M. J., 2013, R BOOK; Cuartas-Hernandez SE, 2015, NEOTROP ENTOMOL, V44, P214, DOI 10.1007/s13744-014-0265-2; Da Silva-Pereira V, 2006, NEOTROP ENTOMOL, V35, P165, DOI 10.1590/S1519-566X2006000200003; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Faria-Mucci G.M., 2003, APOIDEA NEOTROPICA H, P241; FERNANDES G. W., 2016, ECOLOGY CONSERVATION, V1, P345; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; Ferreira RP, 2013, NEOTROP ENTOMOL, V42, P466, DOI 10.1007/s13744-013-0145-1; Garcete-Barrett BR, 2011, ZOOTAXA, P1; GATHMANN A, 1994, OECOLOGIA, V98, P8, DOI 10.1007/BF00326084; Giulietti A.M., 1997, CTR PLANT DIVERSITY, V3, P397; Gontijo BM, 2008, MEGADIVERSIDADE, V4, p270 ; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hepp LU, 2013, HYDROBIOLOGIA, V703, P239, DOI 10.1007/s10750-012-1367-7; Hilario SD, 2012, IHERINGIA SER ZOOL, V102, P269, DOI 10.1590/S0073-47212012000300004; Hilt N, 2006, J TROP ECOL, V22, P155, DOI 10.1017/S0266467405003056; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hoiss B, 2012, P ROY SOC B-BIOL SCI, V279, P4447, DOI 10.1098/rspb.2012.1581; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hozumi S, 2010, NEOTROP ENTOMOL, V39, P826, DOI 10.1590/S1519-566X2010000500024; ISHAY JS, 1973, EXPERIENTIA, V28, P128; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; Karger DN, 2015, ECOGRAPHY, V38, P1243, DOI 10.1111/ecog.01322; KLEINERT-GIOVANNINI A, 1982, Revista Brasileira de Entomologia, V26, P1; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 2002, MOUNTAIN BIODIVERSITY: A GLOBAL ASSESSMENT, P3; Kumar A, 2009, BIOTROPICA, V41, P338, DOI 10.1111/j.1744-7429.2008.00483.x; LAWTON JH, 1987, J ANIM ECOL, V56, P147, DOI 10.2307/4805; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lobo JM, 1999, ACTA OECOL, V20, P587, DOI 10.1016/S1146-609X(99)00105-8; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Loyola RD, 2008, BASIC APPL ECOL, V9, P735, DOI 10.1016/j.baae.2007.06.016; Loyola RD, 2006, NEOTROP ENTOMOL, V35, P41, DOI 10.1590/S1519-566X2006000100006; Macedo-Reis LE, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew027; Mani M.S., 1962, INTRO HIGH ALTITUDE; Martins Cristiane, 2012, MG Biota, V5, P21; Martins R, 2016, RESTOR ECOL, V24, P373, DOI 10.1111/rec.12324; Mazon M, 2008, EUR J ENTOMOL, V105, P879, DOI 10.14411/eje.2008.116; MCCOY ED, 1990, OIKOS, V58, P313, DOI 10.2307/3545222; Morato EF, 2006, NEOTROP ENTOMOL, V35, P285, DOI 10.1590/S1519-566X2006000300001; Morris RJ, 2015, ECOGRAPHY, V38, P792, DOI 10.1111/ecog.01078; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nemesio A, 2013, BIODIVERS CONSERV, V22, P1647, DOI 10.1007/s10531-013-0500-x; NOYES JS, 1989, J NAT HIST, V23, P285, DOI 10.1080/00222938900770181; Nunes CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157442; Oliveira CT, 2011, BRAZ J BOT, V34, P241; Oliveira Filho A. T., 1999, Cerne, V5, P51; Oliveira-Filho A. T., 1994, Edinburgh Journal of Botany, V51, P355; Peters MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13736; Peters RS, 2017, CURR BIOL, V27, P1013, DOI 10.1016/j.cub.2017.01.027; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Ribeiro SP, 1998, J INSECT CONSERV, V2, P107, DOI 10.1023/A:1009669405776; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rosen M, 1995, TOPSAFE '95 - INTERNATIONAL EAST-WEST TOPICAL MEETING: SAFETY OF OPERATING NUCLEAR POWER PLANTS, VOL I, P1; Sabino WD, 2011, J KANSAS ENTOMOL SOC, V84, P78, DOI 10.2317/JKES100321.1; Schaefer C.E.G.R., 2016, ECOLOGY CONSERVATION, P15, DOI [10.1007/978-3-319-29808-5_2, DOI 10.1007/978-3-319-29808-5_2]; Sheffield CS, 2008, CAN ENTOMOL, V140, P235, DOI 10.4039/N07-058; Silva MD, 2014, NEOTROP ENTOMOL, V43, P307, DOI 10.1007/s13744-014-0219-8; SILVEIRA FA, 1993, STUD NEOTROP FAUNA E, V28, P47, DOI 10.1080/01650529309360887; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Taki H, 2008, J INSECT CONSERV, V12, P15, DOI 10.1007/s10841-006-9058-1; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; Vasconcelos HL, 2010, J BIOGEOGR, V37, P432, DOI 10.1111/j.1365-2699.2009.02230.x; Veijalainen A, 2014, INSECT CONSERV DIVER, V7, P496, DOI 10.1111/icad.12073; Wang JJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P743, DOI 10.1111/j.1466-8238.2011.00718.x; Weisser WW, 1997, J ANIM ECOL, V66, P386, DOI 10.2307/5984; WOLDA H, 1987, BIOL J LINN SOC, V30, P313, DOI 10.1111/j.1095-8312.1987.tb00305.x; Yoon HJ, 2015, J ASIA-PAC ENTOMOL, V18, P695, DOI 10.1016/j.aspen.2015.08.004; Zanette LRS, 2004, TROP ZOOL, V17, P145, DOI 10.1080/03946975.2004.10531204	93	36	39	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0182054	10.1371/journal.pone.0182054	http://dx.doi.org/10.1371/journal.pone.0182054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746420	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800075
J	Zong, GH; Yan, XJ; Bi, JW; Jiang, R; Qin, YN; Yuan, HZ; Lu, HZ; Dong, YH; Jin, SH; Zhang, JJ				Zong, Guanghui; Yan, Xiaojing; Bi, Jiawei; Jiang, Rui; Qin, Yinan; Yuan, Huizhu; Lu, Huizhe; Dong, Yanhong; Jin, Shuhui; Zhang, Jianjun			Synthesis, fungicidal evaluation and 3D-QSAR studies of novel 1,3,4-thiadiazole xylofuranose derivatives	PLOS ONE			English	Article							NATURAL-PRODUCTS; DESIGN	1,3,4-Thiadiazole and sugar-derived molecules have proven to be promising agrochemicals with growth promoting, insecticidal and fungicidal activities. In the research field of agricultural fungicide, applying union of active group we synthesized a new set of 1,3,4-thiadiazole xylofuranose derivatives and all of the compounds were characterized by H-1 NMR and HRMS. In precise toxicity measurement, some of compounds exhibited more potent fungicidal activities than the most widely used commercial fungicide Chlorothalonil, promoting further research and development. Based on our experimental data, 3D-QSAR (three-dimensional quantitative structure-activity relationship) was established and investigated using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) techniques, helping to better understand the structural requirements of lead compounds with high fungicidal activity and environmental compatibility.	[Zong, Guanghui; Bi, Jiawei; Jiang, Rui; Qin, Yinan; Lu, Huizhe; Dong, Yanhong; Jin, Shuhui; Zhang, Jianjun] China Agr Univ, Coll Sci, Key Lab Pesticide Chem & Applicat Technol, Beijing, Peoples R China; [Yan, Xiaojing; Yuan, Huizhu] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, HZ; Zhang, JJ (corresponding author), China Agr Univ, Coll Sci, Key Lab Pesticide Chem & Applicat Technol, Beijing, Peoples R China.	luhz@cau.edu.cn; zhangjianjun@cau.edu.cn	Zong, Guanghui/P-2703-2019; Zong, Guanghui/W-9826-2019	Zong, Guanghui/0000-0002-7335-039X; 	NSFC [21172257]; National S&T Pillar Program of China [2015BAK45B01]	NSFC(National Natural Science Foundation of China (NSFC)); National S&T Pillar Program of China	This work was supported by the NSFC (21172257) and the National S&T Pillar Program (2015BAK45B01) of China.; This work was supported by the NSFC (21172257) and the National S&T Pillar Program (2015BAK45B01) of China. The researcher Yao Jianhua who comes from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CAS) has made a great contribution to the toxicity determination of the compounds and the value of logP.	Chen CJ, 2007, BIOORGAN MED CHEM, V15, P3981, DOI 10.1016/j.bmc.2007.04.014; Chen CB, 2007, CHINESE J ORG CHEM, V27, P1444; [陈莉 Chen Li], 2002, [应用化学, Chinese Journal of Applied Chemistry], V19, P212; Clerici F, 2001, J MED CHEM, V44, P931, DOI 10.1021/jm001027w; Copping LG, 2007, PEST MANAG SCI, V63, P524, DOI 10.1002/ps.1378; Cui ZN, 2016, SCI REP-UK, V6, DOI 10.1038/srep20204; Dai H, 2016, BIOORG MED CHEM LETT, V26, P3818, DOI 10.1016/j.bmcl.2016.04.094; Fen L., 2014, SCI WORLD J, V2014, DOI DOI 10.1016/J.AP0R.2014.01.002; He LE, 2015, J HETEROCYCLIC CHEM, V52, P1308, DOI 10.1002/jhet.2160; Hu Y, 2014, CHEM REV, V114, P5572, DOI 10.1021/cr400131u; Huang GL, 2014, CURR DRUG TARGETS, V15, P780, DOI 10.2174/1389450115666140617153348; Jain AK, 2013, CHEM BIOL DRUG DES, V81, P557, DOI 10.1111/cbdd.12125; Krueger EB, 2002, J COMB CHEM, V4, P229, DOI 10.1021/cc010078r; Li JJ, 2010, J AGR FOOD CHEM, V58, P2659, DOI 10.1021/jf903665f; Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300; McCranie EK, 2014, NAT PROD REP, V31, P1026, DOI 10.1039/c3np70128j; Mehnaz Kamal, 2011, International Journal of Biomedical Research, V2, P41; Oruc EE, 2004, J MED CHEM, V47, P6760, DOI 10.1021/jm0495632; Tisler M., 1956, CROAT CHEM ACTA, V28, P147; Uday Kalidhar, 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P1091; Varaprasad CVNS, 2006, BIOORG MED CHEM LETT, V16, P3975, DOI 10.1016/j.bmcl.2006.05.019; Wang TT, 2011, CHINESE J CHEM, V29, P959, DOI 10.1002/cjoc.201190196; Wang X, 2016, J CHEM INF MODEL, V56, P1175, DOI 10.1021/acs.jcim.5b00690; [杨旭 Yang Xu], 2004, [农药学学报, Chinese journal of pesticide science], V6, P22; Zong GH, 2014, MOLECULES, V19, P7832, DOI 10.3390/molecules19067832	25	5	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181646	10.1371/journal.pone.0181646	http://dx.doi.org/10.1371/journal.pone.0181646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746366	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800046
J	Pires, VB; Simoes, R; Mamchaoui, K; Carvalho, C; Carmo-Fonseca, M				Pires, Vanessa Borges; Simoes, Ricardo; Mamchaoui, Kamel; Carvalho, Celia; Carmo-Fonseca, Maria			Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes	PLOS ONE			English	Article							ANTISENSE OLIGONUCLEOTIDES; MESSENGER-RNA; DESIGN; LNA; THERAPY; HEPATITIS; EFFICIENT; EFFICACY; SAFETY; DNA	Splice-switching antisense oligonucleotides (SSOs) offer great potential for RNA-targeting therapies, and two SSO drugs have been recently approved for treating Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA). Despite promising results, new developments are still needed for more efficient chemistries and delivery systems. Locked nucleic acid (LNA) is a chemically modified nucleic acid that presents several attractive properties, such as high melting temperature when bound to RNA, potent biological activity, high stability and low toxicity in vivo. Here, we designed a series of LNA-based SSOs complementary to two sequences of the human dystrophin exon 51 that are most evolutionary conserved and evaluated their ability to induce exon skipping upon transfection into myoblasts derived from a DMD patient. We show that 16-mers with 60% of LNA modification efficiently induce exon skipping and restore synthesis of a truncated dystrophin isoform that localizes to the plasma membrane of patient-derived myotubes differentiated in culture. In sum, this study underscores the value of short LNA-modified SSOs for therapeutic applications.	[Pires, Vanessa Borges; Simoes, Ricardo; Carvalho, Celia; Carmo-Fonseca, Maria] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Mamchaoui, Kamel] UPMC Univ Paris 06, Sorbonne Univ, Ctr Res Myol, CNRS FRE3617,INSERM UMRS974, Paris, France	Universidade de Lisboa; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Carvalho, C; Carmo-Fonseca, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	hcelia@medicina.ulisboa.pt; carmo.fonseca@medicina.ulisboa.pt	Barreto Carvalho, Célia/AAY-8962-2021	Mamchaoui, kamel/0000-0002-0323-9290; Carvalho, Celia/0000-0002-5980-595X	Fundagao para a Ciencia e Tecnologia, Portugal [FCT-ANR/BIM-ONC/0009/2013]; Faculdade de Medicina da Universidade de Lisboa; Gabinete de Apoio a Investigacao Cientifica; Tecnologica e Inovacao, Portugal [GAPIC 2012009 GAPIC 20130041]; Fundação para a Ciência e a Tecnologia [FCT-ANR/BIM-ONC/0009/2013] Funding Source: FCT	Fundagao para a Ciencia e Tecnologia, Portugal; Faculdade de Medicina da Universidade de Lisboa; Gabinete de Apoio a Investigacao Cientifica; Tecnologica e Inovacao, Portugal; Fundação para a Ciência e a Tecnologia	This work was supported by Fundagao para a Ciencia e Tecnologia, Portugal (FCT-ANR/BIM-ONC/0009/2013), http://www.fct.pt/; Faculdade de Medicina da Universidade de Lisboa, Gabinete de Apoio a Investigacao Cientifica, Tecnologica e Inovacao, Portugal (GAPIC 2012009 GAPIC 20130041 (RS)), http//www.medicina.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2004, GENE THER, V11, P1391, DOI 10.1038/sj.gt.3302313; Aartsma-Rus A, 2010, OLIGONUCLEOTIDES, V20, P69, DOI 10.1089/oli.2009.0215; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Anderson LVB, 1999, AM J PATHOL, V154, P1017, DOI 10.1016/S0002-9440(10)65354-0; Bondensgaard K, 2000, CHEM-EUR J, V6, P2687, DOI 10.1002/1521-3765(20000804)6:15<2687::AID-CHEM2687>3.0.CO;2-U; Braasch DA, 2001, CHEM BIOL, V8, P1, DOI 10.1016/S1074-5521(00)00058-2; Caceres EF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r143; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Corey DR, 2017, NAT NEUROSCI, V20, P497, DOI 10.1038/nn.4508; Echigoya Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120058; Flanigan KM, 2014, NEUROL CLIN, V32, P671, DOI 10.1016/j.ncl.2014.05.002; Franck N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107487; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goemans NM, 2011, NEW ENGLAND J MED; Graziewicz MA, 2008, MOL THER, V16, P1316, DOI 10.1038/mt.2008.85; Guterstam P, 2008, BIOCHEM J, V412, P307, DOI 10.1042/BJ20080013; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ittig D, 2004, NUCLEIC ACIDS RES, V32, P346, DOI 10.1093/nar/gkh187; KANDIMALLA ER, 1995, NUCLEIC ACIDS RES, V23, P3578, DOI 10.1093/nar/23.17.3578; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KOENIG M, 1989, AM J HUM GENET, V45, P498; Kole R, 2015, ADV DRUG DELIVER REV, V87, P104, DOI 10.1016/j.addr.2015.05.008; Lennox KA, 2011, GENE THER, V18, P1111, DOI 10.1038/gt.2011.100; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Lundin KE, 2013, ADV GENET, V82, P47, DOI 10.1016/B978-0-12-407676-1.00002-0; Mamchaoui K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-34; McClorey G, 2015, CURR OPIN PHARMACOL, V24, P52, DOI 10.1016/j.coph.2015.07.005; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Obad S, 2011, NAT GENET, V43, P371, DOI 10.1038/ng.786; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Popplewell LJ, 2009, MOL THER, V17, P554, DOI 10.1038/mt.2008.287; Pramono ZAD, 2012, HUM GENE THER, V23, P781, DOI 10.1089/hum.2011.205; Roberts J, 2006, MOL THER, V14, P471, DOI 10.1016/j.ymthe.2006.05.017; Schuler A, 2014, MOL BIOL EVOL, V31, P3164, DOI 10.1093/molbev/msu249; Shimo T, 2014, NUCLEIC ACIDS RES, V42, P8174, DOI 10.1093/nar/gku512; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Straarup EM, 2010, NUCLEIC ACIDS RES, V38, P7100, DOI 10.1093/nar/gkq457; Tanganyika-de Winter CL, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.38; van der Ree MH, 2014, ANTIVIR RES, V111, P53, DOI 10.1016/j.antiviral.2014.08.015; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Yamamoto T, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/707323; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yilmaz-Elis AS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.58; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	51	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181065	10.1371/journal.pone.0181065	http://dx.doi.org/10.1371/journal.pone.0181065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742140	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700026
J	Abana, CO; Bingham, BS; Cho, JH; Graves, AJ; Koyama, T; Pilarski, RT; Chakravarthy, AB; Xia, F				Abana, Chike O.; Bingham, Brian S.; Cho, Ju Hwan; Graves, Amy J.; Koyama, Tatsuki; Pilarski, Robert T.; Chakravarthy, A. Bapsi; Xia, Fen			IL-6 variant is associated with metastasis in breast cancer patients	PLOS ONE			English	Article							TCF7L2 GENE POLYMORPHISMS; INTERLEUKIN-6; RISK; PROGNOSIS; PROMOTER; SURVIVAL	Introduction Although tumor metastases remain significant drivers of mortality, the genetic factors that increase the risks of metastases are not fully identified. Interleukin 6 (IL-6) has emerged as an important factor in breast cancer progression with IL-6 single nucleotide polymorphism (SNP) variants shown to affect survival. We hypothesized that SNPs of the IL-6 promoter at rs1800795 in breast cancer patients are associated with distant metastases. Methods We performed an initial case-control study using Vanderbilt University Medical Center's BioVU, a genomic biobank linked to de-identified electronic medical records in the Synthetic Derivative database, to identify germline SNPs that may predict the development of metastatic disease to any site from any solid tumor including breast cancer. We identified a SNP in IL-6: rs1800795 to be of significance and evaluated this finding using a separate, matched-pair cohort of breast cancer patients with and without metastases from The Ohio State University Wexner Medical Center. Results The initial study suggested that GG relative to CG at rs1800795 (OR 1.52; 95% CI 1.14-2.02; p = 0.004) was significantly associated with the development of metastases. This association was also observed in the Ohio State University cohort (OR 2.23; 95% CI 1.06-4.71; p = 0.001). There were no significant relationships between rs1800795 status and any patient or tumor characteristics, including estrogen receptor status. Conclusions These findings suggest that GG SNP at IL-6: rs1800795 may indicate an increased risk of metastasis of primary breast cancer. Further studies in larger population sets are warranted as advanced screening and prophylactic intervention might be employed in GG carriers.	[Abana, Chike O.; Bingham, Brian S.; Chakravarthy, A. Bapsi] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37235 USA; [Cho, Ju Hwan] Ohio State Univ, Ctr Comprehens Canc, Dept Radiat Oncol, James Canc Hosp & Solove Res Inst, Columbus, OH 43210 USA; [Graves, Amy J.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Graves, Amy J.; Koyama, Tatsuki] Vanderbilt Univ, Med Ctr, Dept Biostat, Ctr Quantitat Sci, Nashville, TN USA; [Pilarski, Robert T.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Xia, Fen] Univ Arkansas Med Sci, Dept Radiat Oncol, Little Rock, AR 72205 USA	Vanderbilt University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Vanderbilt University; Vanderbilt University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Chakravarthy, AB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN 37235 USA.	bapsi.chak@vanderbilt.edu	Pilarski, Robert/X-3256-2019		NIH [CM 18158, CA 188500]; Susan G. Komen Breast Cancer Research Award [BCTR0201704]; Vanderbilt CTSA from NCATS/NIH [UL1TR000445]; NIH-NCI Cancer Center [P30 CA0068485]; NIH; National Institute of General Medical Sciences of the NIH [T32 GM007347];  [1S10RR025141-01]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Research Award(Susan G. Komen Breast Cancer Foundation); Vanderbilt CTSA from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH-NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); 	This study was funded by the following grants: NIH grant CM 18158, CA 188500, and Susan G. Komen Breast Cancer Research Award BCTR0201704 to FX. The datasets used for the analyses described were obtained from Vanderbilt University Medical Center's BioVU, which is supported by institutional funding, the 1S10RR025141-01 instrumentation award, and by the Vanderbilt CTSA grant UL1TR000445 from NCATS/NIH. The research in this publication was supported, in part, through funding from the NIH-NCI Cancer Center Support Grant P30 CA0068485. This study was also partially funded by the NIH and the National Institute of General Medical Sciences of the NIH grant T32 GM007347 to COA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalliu I, 2008, PROSTATE, V68, P740, DOI 10.1002/pros.20732; Chen JK, 2013, 2013 SIXTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P7, DOI 10.1109/ICACI.2013.6748465; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Choi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103593; Connor AE, 2012, BREAST CANCER RES TR, V136, P593, DOI 10.1007/s10549-012-2299-7; DeMichele A, 2003, CANCER RES, P63; DeMichele A, 2009, CANCER RES, V69, P4184, DOI 10.1158/0008-5472.CAN-08-2989; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Folsom AR, 2008, DIABETES CARE, V31, P905, DOI 10.2337/dc07-2131; Hefler LA, 2003, CANCER RES, V63, P3066; Hohaus S, 2007, ANN ONCOL, V18, P1376, DOI 10.1093/annonc/mdm132; Hu XB, 2013, GENET TEST MOL BIOMA, V17, P453, DOI 10.1089/gtmb.2012.0494; Huerta-Chagoya A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126408; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; Lin SC, 2015, TUMORI J, V101, P535, DOI 10.5301/tj.5000357; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu XP, 2015, GENET MOL RES, V14, P2860, DOI 10.4238/2015.March.31.16; Markkula A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-759; Martin AM, 2017, JAMA ONCOL, V3, P1069, DOI 10.1001/jamaoncol.2017.0001; Park S, 2015, J BREAST CANCER, V18, P160, DOI 10.4048/jbc.2015.18.2.160; Peng SH, 2013, MUTAGENESIS, V28, P25, DOI 10.1093/mutage/ges048; Ribelles N, 2014, CANCER TREAT REV, V40, P293, DOI 10.1016/j.ctrv.2013.09.010; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Ruzzo A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-357; Salgado R, 2003, INT J CANCER, V103, P642, DOI 10.1002/ijc.10833; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh A, 1997, J STEROID BIOCHEM, V61, P185; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Stewart BW, 2014, WILD CPE WORLD CANC; You YH, 2013, BREAST CANCER RES TR, V137, P893, DOI 10.1007/s10549-012-2401-1; Zhang GJ, 1999, ANTICANCER RES, V19, P1427	34	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181725	10.1371/journal.pone.0181725	http://dx.doi.org/10.1371/journal.pone.0181725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732081	gold, Green Submitted, Green Published			2022-12-26	WOS:000406643100058
J	Benitez, AD; Martins, FDC; Mareze, M; Santos, NJR; Ferreira, FP; Martins, CM; Garcia, JL; Mitsuka-Bregano, R; Freire, RL; Biondo, AW; Navarro, IT				Benitez, Aline do Nascimento; Cardoso Martins, Felippe Danyel; Mareze, Marcelle; Rodrigues Santos, Nelson Jesse; Ferreira, Fernanda Pinto; Martins, Camila Marinelli; Garcia, Joao Luis; Mitsuka-Bregano, Regina; Freire, Roberta Lemos; Biondo, Alexander Welker; Navarro, Italmar Teodorico			Spatial and simultaneous representative seroprevalence of anti-Toxoplasma gondii antibodies in owners and their domiciled dogs in a major city of southern Brazil	PLOS ONE			English	Article							RISK-FACTORS; PREGNANT-WOMEN; URBAN AREA; WATERBORNE TOXOPLASMOSIS; ONE HEALTH; PET DOGS; INFECTION; TRANSMISSION; PREVALENCE; STATE	Toxoplasmosis, caused by Toxoplasma gondii, has traditionally been considered an important water and foodborne protozoonosis with important public health considerations. Although felids play a well-established role as definitive hosts, canine epidemiological involvement in the parasite's life cycle remains questionable and controversial. The increasing closeness of the human-dog bond, particularly seen in urban settings, has been recognized as a historically unprecedented worldwide movement. Sharing daily lives in the same households, dogs may be exposed to similar associated risks of T. gondii infection as their owners. Thus, epidemiological assessment of the intra-domiciled environment, especially among socio-economically different human populations, may provide novel information regarding the actual role of dogs in animal and human toxoplasmosis. Despite spatial approaches being recently used for other water and foodborne diseases, no study has been conducted on the simultaneous spatial seroprevalence of both human and animal IgG antiT. gondii antibodies in urban areas of major cities. Accordingly, the aim of the present study was to assess the seroprevalence and associated variables of Toxoplasma infection in owners and their domiciled dogs in Londrina, southern Brazil. Human and canine seroprevalence rates and variables associated with seroprevalence were investigated through representative random sampling among 564 households, which included 597 owners and 729 dogs. Overall, statistically significant differences between the seroprevalence of human and dog anti-T. gondii antibodies were found by Immunofluorescence Antibody Testing in 248/597 (41.54%) owners and 119/729 (16.32%) dogs. Through multiple analysis, significant concomitant variables for seropositivity of household individuals (people and dogs) were determined, including public sewer service, yard cleaning frequency, and having a dirty yard. Although no statistically significant multiple logistic model was observed among owners, univariate analysis detected associations with monthly income, soil contact, and occupation. Among dogs, the absence of other dogs and the absence of a dirty yard were concomitant significantly protective associated factors. Age differences between seropositive and seronegative individuals was significant only for human beings, with the median age of negative individuals significantly higher than positive individuals. Although no spatial clusters were identified for humans or residences, a significant cluster was identified for dogs. In conclusion, characteristics of urban toxoplasmosis may include significantly higher owner seroprevalence than their owned dogs, with canine seroprevalence directly associated with having more dogs and a dirty backyard, and spatial differences in both human and dog exposures. Although not a good indicator for human foodborne diseases, dogs may be a reliable sentinel for environmental infection. Moreover, such a holistic approach may provide crucial information for more focused prevention and monitoring programs, particularly in households with multiple pets and trash-filled backyards.	[Benitez, Aline do Nascimento; Cardoso Martins, Felippe Danyel; Mareze, Marcelle; Rodrigues Santos, Nelson Jesse; Ferreira, Fernanda Pinto] Univ Estadual Londrina, Lab Zoonoses & Publ Hlth, Londrina, Parana, Brazil; [Martins, Camila Marinelli] Univ Sao Paulo, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, SP, Brazil; [Garcia, Joao Luis; Mitsuka-Bregano, Regina; Freire, Roberta Lemos; Navarro, Italmar Teodorico] Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil; [Biondo, Alexander Welker] Univ Fed Parana, Dept Vet Med, Curitiba, Parana, Brazil	Universidade Estadual de Londrina; Universidade de Sao Paulo; Universidade Estadual de Londrina; Universidade Federal do Parana	Navarro, IT (corresponding author), Univ Estadual Londrina, Dept Vet Prevent Med, Londrina, Parana, Brazil.	italmar@uel.br	Garcia, João Luis/X-4279-2019; BIONDO, ALEXANDER WELKER W/E-8823-2018; BIONDO, ALEXANDER WELKER/AAU-8955-2021; Luis, João/AAE-9252-2019; Martins, Felippe Danyel Cardoso/T-5710-2019; Benitez, Aline N/M-1677-2017; Bregano, Regina Mitsuka/AAX-3103-2020; Santos, Nelson JR/H-7989-2018; Garcia, Joao Luis/Y-8864-2019; Martins, felippe danyel cardoso/E-8522-2019	Garcia, João Luis/0000-0003-1826-7582; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; Benitez, Aline N/0000-0002-0770-9552; Santos, Nelson JR/0000-0003-4811-312X; Garcia, Joao Luis/0000-0002-5736-7511; Martins, felippe danyel cardoso/0000-0002-9162-1536	CAPES/CNPq	CAPES/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	CAPES/CNPq have provided only funding for Dr. Benitez costs, which included fellowship and travel grants for meeting presentations. No funding was granted for publication.	Afonso Eve, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P278, DOI 10.1016/j.ijppaw.2013.09.006; AndreAleixo M, 2015, SEMIN-CIENC AGRAR, V36, P1451, DOI 10.5433/1679-0359.2015v36n3p1451; Alvarado-Esquivel C, 2009, J PARASITOL, V95, P271, DOI 10.1645/GE-1829.1; Alvarado-Esquivel C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-13; Alvarado-Esquivel C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-235; Ayres M., 2003, BIOESTAT 3 0 APLICAC; Baddeley A, 2015, SPATIAL POINT PATTER, P799; Bahia-Oliveira LMG, 2003, EMERG INFECT DIS, V9, P55; Benitez AD, 2012, SEMIN-CIENC AGRAR, V33, P3201, DOI 10.5433/1679-0359.2012v33Supl2p3201; Cabezon O, 2010, PARASITOL RES, V107, P1505, DOI 10.1007/s00436-010-2015-7; CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117; Cano-Terriza D, 2016, PARASITOL INT, V65, P363, DOI 10.1016/j.parint.2016.05.001; Canon-Franco WA, 2004, VET RES COMMUN, V28, P113, DOI 10.1023/B:VERC.0000012114.71235.73; Casartelli-Alves L, 2015, GEOSPATIAL HEALTH, V10, P20, DOI 10.4081/gh.2015.311; CDC, 2006, PRINC EP PUBL HLTH P; Condoleo R, 2016, GEOSPATIAL HEALTH, V11, P206, DOI 10.4081/0.2016.432; Coryell W, 2016, ARCH SUICIDE RES, V20, P605, DOI 10.1080/13811118.2016.1158677; Dard C, 2016, TRENDS PARASITOL, V32, P492, DOI 10.1016/j.pt.2016.04.001; de B Bittencourt LHF, 2012, REV BRAS GINECOL OBS, V34, P63; de Barros LD, 2014, REV BRAS PARASITOL V, V23, P443, DOI [10.1590/S1984-29612014073, 10.1590/s1984-29612014073]; Dean AG, 1990, EPIINFO WORD PROCESS; Del Grande C, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010003; Duan G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-118; DUBEY JP, 1985, J AM VET MED ASSOC, V186, P969; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Engroff P, 2014, CIENC SAUDE COLETIVA, V19, P3385, DOI 10.1590/1413-81232014198.12402013; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Etheredge GD, 2004, REV PANAM SALUD PUBL, V16, P176, DOI 10.1590/S1020-49892004000900004; FAO OIE WHO UN System Influenza Coordination UNICEF World Bank Group, 2008, CONTR ON WORLD ON HL; Ferguson W, 2011, IRISH J MED SCI, V180, P807, DOI 10.1007/s11845-011-0723-3; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Dias RCF, 2011, REV INST MED TROP SP, V53, P185, DOI 10.1590/S0036-46652011000400002; Francisco Fabio de Moraes, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P167; Frank D, 2008, CAN VET J, V49, P1063; Frenkel JK, 1995, AM J TROP MED HYG, V53, P226; Guimaraes AM, 2009, REV BRAS PARASITOL V, V18, P49, DOI 10.4322/rbpv.018e1009; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Heidenreich NB, 2013, ASTA-ADV STAT ANAL, V97, P403, DOI 10.1007/s10182-013-0216-y; IBGE, 2014, SAL IMPR IBGE DIV ES; Jones J L, 2001, Infect Dis Obstet Gynecol, V9, P23, DOI 10.1155/S1064744901000059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M., 2020, SATSCAN SOFTWARE SPA; Lindsay DS, 1997, VET PARASITOL, V73, P27, DOI 10.1016/S0304-4017(97)00048-4; Magalhaes FJR, 2017, PARASITOL INT, V66, P43, DOI 10.1016/j.parint.2016.11.014; Mangot Ajish G, 2016, J Parasit Dis, V40, P1636, DOI 10.1007/s12639-015-0684-y; Meireles LR, 2004, TROP MED INT HEALTH, V9, P876, DOI 10.1111/j.1365-3156.2004.01280.x; Menezes JA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621854; NRC, 1991, AN SENT ENV HLTH HAZ; Paredes H, 2010, CAD SAUDE PUBLICA, V26, P1013, DOI 10.1590/S0102-311X2010000500023; Paul M, 2010, TRENDS PARASITOL, V26, P153, DOI 10.1016/j.pt.2010.01.008; Pereira KS, 2010, ADV FOOD NUTR RES, V60, P1, DOI 10.1016/S1043-4526(10)60001-0; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Raimundo JM, 2015, REV BRAS PARASITOL V, V24, P475, DOI 10.1590/S1984-29612015068; Rengifo-Herrera C, 2017, PARASITE, V24, DOI 10.1051/parasite/2017009; Rosso F, 2008, AM J TROP MED HYG, V78, P504, DOI 10.4269/ajtmh.2008.78.504; Ruffolo BB, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658028, 10.1590/S1678-9946201658028]; Lopes-Mori FMR, 2013, BRAZ J INFECT DIS, V17, P405, DOI 10.1016/j.bjid.2012.12.003; Samudio M, 2015, REV CHIL INFECTOL, V32, P658, DOI 10.4067/S0716-10182015000700007; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Sousa IC, 2016, VET PARASITOL, V223, P159, DOI 10.1016/j.vetpar.2016.04.041; Sroka S, 2010, AM J TROP MED HYG, V83, P528, DOI 10.4269/ajtmh.2010.10-0082; Sugden K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148435; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; VanWormer E, 2013, COMP IMMUNOL MICROB, V36, P217, DOI 10.1016/j.cimid.2012.10.006; Varandas N. P., 2001, Semina: Ciencias Agrarias (Londrina), V22, P105; Vieira FP, 2015, MEM I OSWALDO CRUZ, V110, P929, DOI 10.1590/0074-02760150262; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Wei HX, 2016, COMP PARASITOL, V83, P11, DOI 10.1654/1525-2647-83.1.11; WHO, 2010, CONTR LEISHM; Wilking H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22551; Woldehanna S, 2015, SOC SCI MED, V129, P87, DOI 10.1016/j.socscimed.2014.10.059; Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6; ZHOU XN, 2007, PARASITE VECTOR, V2, P10	74	19	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180906	10.1371/journal.pone.0180906	http://dx.doi.org/10.1371/journal.pone.0180906			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732033	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100014
J	Tan, WG; Zubkova, I; Kachko, A; Wells, F; Adler, H; Sutter, G; Major, ME				Tan, Wendy G.; Zubkova, Iryna; Kachko, Alla; Wells, Frances; Adler, Heiko; Sutter, Gerd; Major, Marian E.			Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens	PLOS ONE			English	Article							IMMUNE-RESPONSES; VIRAL CLEARANCE; INFECTION; HCV; PERSISTENCE; DIFFERENTIATION; RESTORATION; VACCINATION; CHIMPANZEES; EXPRESSION	T-cell based vaccines have been considered as attractive candidates for prevention of hepatitis C virus (HCV) infections. In this study we compared the magnitude and phenotypic characteristics of CD8+ T-cells induced by three commonly used viral vectors, Adenovirus-5 (Ad5), Vaccinia virus (VV) and Modified Vaccinia Ankara (MVA) expressing the HCV NS3/4A protein. C57/BL6 mice were primed with DNA expressing NS3/4A and boosted with each of the viral vectors in individual groups of mice. We then tracked the vaccine-induced CD8+ T-cell responses using pentamer binding and cytokine production analysis. Overall, our data indicate that the memory cells induced by Ad5 were inferior to those induced by VV or MVA. We found that Ad5 boosting resulted in rapid expansion and significantly higher frequencies of NS3-specific T-cells compared to VV and MVA boosting. However, the functional profiles, assessed through analysis of the memory cell marker CD127 and the antiapoptotic molecule Bcl-2 in the blood, spleen, and liver; and measurements of interferongamma, tumor necrosis factor-alpha, and interleukin-2 production indicated significantly lower frequencies of long-lived memory T-cells following Ad5 boosting compared to VV and MVA. This same set of analyses suggested that the memory cells induced following boosting with MVA were superior to those induced by both Ad5 and VV. This superiority of the MVA-induced CD8+ T-cells was confirmed following surrogate challenge of mice with a recombinant mouse herpes virus expressing the HCV NS3 protein. Higher levels of NS3-specific CD8+ T-cells displaying the functional markers CD69, Ki67 and Granzyme B were found in the spleens of mice boosted with MVA compared to VV and Ad5, both alone and in combination. These data suggest that MVA may be a more successful viral vector for induction of effective CD8+ T-cell responses against hepatitis C virus.	[Tan, Wendy G.; Zubkova, Iryna; Kachko, Alla; Wells, Frances; Major, Marian E.] US FDA, Lab Hepatitis Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Adler, Heiko] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Lung Repair & Regenerat, Comprehens Pneumol Ctr, Munich, Germany; [Adler, Heiko] German Ctr Lung Res DZL, Munich, Germany; [Sutter, Gerd] LMU Univ Munich, Inst Infect Dis & Zoonoses, Munich, Germany	US Food & Drug Administration (FDA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Major, ME (corresponding author), US FDA, Lab Hepatitis Viruses, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	marian.major@fda.hhs.gov		Sutter, Gerd/0000-0001-6143-082X; Major, Marian/0000-0003-0874-359X	Food and Drug Administration intramural funds [Z01 BK 04010-11 LHV]; Oak Ridge Institute for Science and Education (ORISE fellowship); FDA Commissioner's Fellowship	Food and Drug Administration intramural funds; Oak Ridge Institute for Science and Education (ORISE fellowship); FDA Commissioner's Fellowship	Financial support for this work was provided by the Food and Drug Administration intramural funds [Program Number Z01 BK 04010-11 LHV to M.E.M, the Oak Ridge Institute for Science and Education (ORISE fellowship) to AK, and FDA Commissioner's Fellowship to WT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Cox MA, 2011, TRENDS IMMUNOL, V32, P180, DOI 10.1016/j.it.2011.01.004; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Dunkle A, 2013, J IMMUNOL, V190, P940, DOI 10.4049/jimmunol.1103481; El-Gogo S, 2008, J GENE MED, V10, P177, DOI 10.1002/jgm.1144; El-Gogo S, 2007, VACCINE, V25, P3934, DOI 10.1016/j.vaccine.2007.02.054; Feinstone SM, 2012, CLIN INFECT DIS, V55, pS25, DOI 10.1093/cid/cis362; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Grakoui A, 2003, SCIENCE, V302, P659, DOI 10.1126/science.1088774; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; Lauer GM, 2004, GASTROENTEROLOGY, V127, P924, DOI 10.1053/j.gastro.2004.06.015; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Puig M, 2006, HEPATOLOGY, V44, P736, DOI 10.1002/hep.21319; Shiffman ML, 2014, CURR OPIN GASTROEN, V30, P217, DOI 10.1097/MOG.0000000000000062; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Spada E, 2004, GUT, V53, P1673, DOI 10.1136/gut.2003.037788; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001; Zubkova I, 2009, VACCINE, V27, P2594, DOI 10.1016/j.vaccine.2009.02.045; Zubkova I, 2014, HEPATOLOGY, V59, P803, DOI 10.1002/hep.26747; zur Wiesch JS, 2005, J IMMUNOL, V175, P3603, DOI 10.4049/jimmunol.175.6.3603	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181578	10.1371/journal.pone.0181578	http://dx.doi.org/10.1371/journal.pone.0181578			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732046	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100046
J	Adler, PH; Hamada, N; do Nascimento, JMC; Grillet, ME				Adler, Peter H.; Hamada, Neusa; Cavalcante do Nascimento, Jeane Marcelle; Grillet, Maria Eugenia			River-specific macrogenomic diversity in Simulium guianense s. l. (Diptera: Simuliidae), a complex of tropical American vectors associated with human onchocerciasis	PLOS ONE			English	Article							BLACK FLIES DIPTERA; POPULATION; BIODIVERSITY; IDENTIFICATION; EPIDEMIOLOGY; ECOREGIONS; VERECUNDUM; HABITAT; LARVAL; FOCUS	Simulium guianense Wise is a Latin American vector complex of black flies associated with transmission of the causal agent of human onchocerciasis (river blindness). An analysis of the chromosomal banding patterns of 607 larvae of S. guianense s. l. revealed a high level of variation involving 83 macrogenomic rearrangements across 25 populations in Brazil, French Guiana, and Venezuela. The 25 populations were assigned to 13 cytoforms (A1, A2, B1-B4, C, D, E1-E4, and F), some of which are probably valid species. Based on geographical proximity, a member of the B group of cytoforms probably represents the name-bearing type specimen of S. guianense and the primary vector in the last-remaining onchocerciasis foci in the Western Hemisphere. Cytoform B3 in Amapa A State is implicated as an anthropophilic simuliid in an area currently and historically free of onchocerciasis. Distributions of cytoforms are associated with geography, elevation, and drainage basin, and are largely congruent with ecoregions. Despite extraordinarily large larval populations of S. guianense s. l. in big rivers and consequent production of female flies for dispersal, the cytoforms maintain their chromosomal distinction within individual rivers, suggesting a high degree of fidelity to the specialized breeding habitats-rocky shoals-of the natal rivers.	[Adler, Peter H.] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA; [Hamada, Neusa; Cavalcante do Nascimento, Jeane Marcelle] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Curso Posgrad Entomol, Manaus, Amazonas, Brazil; [Grillet, Maria Eugenia] Univ Cent Venezuela, Inst Zool & Ecol Trop, Fac Ciencias, Lab Biol Vectores & Parasitos, Caracas, Venezuela	Clemson University; Institute Nacional de Pesquisas da Amazonia; University of Central Venezuela	Adler, PH (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	padler@clemson.edu	Grillet, Maria Eugenia/AAR-6116-2021; Nascimento, Jeane Marcelle/AAT-3193-2020; Hamada, Neusa/E-3383-2013	Nascimento, Jeane Marcelle/0000-0002-5428-7495; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475663/2012-8]; Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC)/Instituto Nacional de Pesquisas da Amazonia (INPA); Ministerio da Ciencia, Tecnologia, Inovacoes e Cornunicacoes (MCTIC)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Secretaria de Ciencia, Tecnologia e Inovacao do Amazonas/Fundacao de Amparo a Pesquisa do Estado do Amazonas (SECTI-AM/FAPEAM)-Edital [015/2014 PAPAC]; Council for Sciences and Humanities Development (CDCH-UCV) [PG 03-00-5739]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC)/Instituto Nacional de Pesquisas da Amazonia (INPA); Ministerio da Ciencia, Tecnologia, Inovacoes e Cornunicacoes (MCTIC)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Secretaria de Ciencia, Tecnologia e Inovacao do Amazonas/Fundacao de Amparo a Pesquisa do Estado do Amazonas (SECTI-AM/FAPEAM)-Edital; Council for Sciences and Humanities Development (CDCH-UCV)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) processo n. 475663/2012-8 to NH and JMCN (URL: www.cripg.br); Ministerio da Ciencia, Tecnologia, Inovacoes e Comunicacoes (MCTIC)/Instituto Nacional de Pesquisas da Amazonia (INPA) to NH (URL: http://portal.inpa.gov.br/); Ministerio da Ciencia, Tecnologia, Inovacoes e Cornunicacoes (MCTIC)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to NH (URL: www.cripq.br); Secretaria de Ciencia, Tecnologia e Inovacao do Amazonas/Fundacao de Amparo a Pesquisa do Estado do Amazonas (SECTI-AM/FAPEAM)-Edital 015/2014 PAPAC to NH (URL: http://www.fapeam.am.gov.br/); and Council for Sciences and Humanities Development (CDCH-UCV, PG 03-00-5739) to MEG (URL: http./Avww.ucv.ve/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Adler P. H., 2017, WORLD BLACKFLIES DIP; Adler P. H., 1988, BLACK FLIES ECOLOGY, P63; Adler PH, 2017, ACTA TROP, V173, P171, DOI 10.1016/j.actatropica.2017.06.017; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158272; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Adler PH, 2016, NOVA ACTA LEOPOLDINA, V411, P23; Adler PH, PLOS ONE, V673; Adler PH, 2017, INSECT BIODIVERSITY, V1, P713; Adler PH, 2004, BLACK FLIES SIMULIID; Amorim DS, 2012, BIOGEOGRAFIA NEOTROP; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P501; Arteaga LT, 1999, J MED ENTOMOL, V36, P133, DOI 10.1093/jmedent/36.2.133; Basanez MG, 2009, ADV PARASIT, V68, P263, DOI 10.1016/S0065-308X(08)00611-8; BASANEZ MG, 1988, ANN TROP MED PARASIT, V82, P597, DOI 10.1080/00034983.1988.11812296; Botto C., 2013, REF MODULE EARTH SYS; Botto C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1313-z; Charalambous M, 1996, MED VET ENTOMOL, V10, P111, DOI 10.1111/j.1365-2915.1996.tb00716.x; CONN J, 1989, CAN J ZOOL, V67, P1217, DOI 10.1139/z89-176; Coscaron S., 2007, AQUATIC BIODIVERSITY, V3; Crainey JL, 2014, ACTA TROP, V131, P47, DOI 10.1016/j.actatropica.2013.10.019; dos Santos-Neto CR, 2015, FLA ENTOMOL, V98, P446, DOI 10.1653/024.098.0209; FEOW, 2015, FRESHW EC WORLD; Goloboff PA, 2001, CLADISTICS, V17, pS26, DOI 10.1111/j.1096-0031.2001.tb00102.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Gomes Silvana Angelica Gama, 2002, Entomologia y Vectores, V9, P443; Grillet ME, 2001, J MED ENTOMOL, V38, P520, DOI 10.1603/0022-2585-38.4.520; Hamada N, 2010, ZOOTAXA, P22; Hamada Neusa, 2001, Entomotropica, V16, P29; Hernandez-Triana LM., 2011, THESIS; Hernandez-Triana LM, 2015, ZOOTAXA, V3936, P93, DOI 10.11646/zootaxa.3936.1.5; Hernandez-Triana LM, 2012, ZOOTAXA, P43; HIRAI H, 1994, GENOME, V37, P36, DOI 10.1139/g94-006; Mattos AA, 2007, THESIS; McCreadie JW, 2006, ECOGRAPHY, V29, P603, DOI 10.1111/j.0906-7590.2006.04541.x; McCreadie JW, 1998, OECOLOGIA, V114, P79, DOI 10.1007/s004420050423; MCCREADIE JW, 1993, CAN J ZOOL, V71, P358, DOI 10.1139/z93-050; Meredith S. E. O., 1988, BLACK FLIES ECOLOGY, P53; Ministe A rio do Meio Ambiente, 2006, CAD MEIO AMB; Negrel P, 2000, J HYDROL, V237, P212, DOI 10.1016/S0022-1694(00)00308-5; Nixon K.C., 2002, WINCLADA VERSION 1 0; Pomara LY, 2014, J BIOGEOGR, V41, P784, DOI 10.1111/jbi.12247; Post RJ, 2007, TROP MED INT HEALTH, V12, P1342, DOI 10.1111/j.1365-3156.2007.01921.x; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; Pramual P, 2011, GENOME, V54, P1, DOI 10.1139/G10-100; Prendini L, 2000, CLADISTICS, V16, P1, DOI 10.1111/j.1096-0031.2000.tb00348.x; PROCUNIER WS, 1986, PARASITOL TODAY, V2, P307, DOI 10.1016/0169-4758(86)90125-0; PROCUNIER WS, 1989, GENOME, V32, P559, DOI 10.1139/g89-483; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K, 1981, CAN J ZOOL, V59, P1857, DOI 10.1139/z81-255; ROTHFELS KH, 1979, ANNU REV ENTOMOL, V24, P507, DOI 10.1146/annurev.en.24.010179.002451; Shelley A.J., 1997, Bulletin of the Natural History Museum Entomology Series, V66, P1; Shelley AJ, 2001, MED VET ENTOMOL, V15, P28, DOI 10.1046/j.1365-2915.2001.00275.x; SHELLEY AJ, 2010, AQUATIC BIODIVERSITY, V6; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Villamizar N, 2011, B MALARIOL SALUD AMB, V51, P97; WHO (World Health Organization), 2017, ONCH	60	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181679	10.1371/journal.pone.0181679	http://dx.doi.org/10.1371/journal.pone.0181679			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727841	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500102
J	Jara-Samaniego, J; Perez-Murcia, MD; Bustamante, MA; Paredes, C; Perez-Espinosa, A; Gavilanes-Teran, I; Lopez, M; Marhuenda-Egea, FC; Brito, H; Moral, R				Jara-Samaniego, J.; Perez-Murcia, M. D.; Bustamante, M. A.; Paredes, C.; Perez-Espinosa, A.; Gavilanes-Teran, I.; Lopez, M.; Marhuenda-Egea, F. C.; Brito, H.; Moral, R.			Development of organic fertilizers from food market waste and urban gardening by composting in Ecuador	PLOS ONE			English	Article							DISTILLERY WASTES; GREEN WASTE; NITROGEN; CARBON; BIOTRANSFORMATION; EVOLUTION; MATTER; SOIL; AGROINDUSTRIAL; VERMICOMPOST	Currently, the management of urban waste streams in developing countries is not optimized yet, and in many cases these wastes are disposed untreated in open dumps. This fact causes serious environmental and health problems due to the presence of contaminants and pathogens. Frequently, the use of specific low-cost strategies reduces the total amount of wastes. These strategies are mainly associated to the identification, separate collection and composting of specific organic waste streams, such as vegetable and fruit refuses from food markets and urban gardening activities. Concretely, in the Chimborazo Region (Ecuador), more than 80% of municipal solid waste is dumped into environment due to the lack of an efficient waste management strategy. Therefore, the aim of this study was to develop a demonstration project at field scale in this region to evaluate the feasibility of implanting the composting technology not only for the management of the organic waste fluxes from food market and gardening activities to be scaled-up in other developing regions, but also to obtain an end-product with a commercial value as organic fertilizer. Three co-composting mixtures were prepared using market wastes mixed with pruning of trees and ornamental palms as bulking agents. Two piles were created using different proportions of market waste and prunings of trees and ornamental palms: pile 1 (50: 33: 17) with a C/N ratio 25; pile 2: (60: 30: 10) with C/N ratio 24 and pile 3 (75: 0: 25) with C/N ratio 33), prepared with market waste and prunings of ornamental palm. Throughout the process, the temperature of the mixtures was monitored and organic matter evolution was determined using thermogravimetric and chemical techniques. Additionally, physico-chemical, chemical and agronomic parameters were determined to evaluate compost quality. The results obtained indicated that all the piles showed a suitable development of the composting process, with a significant organic matter decomposition, reached in a shorter period of time in pile 3. At the end of the process, all the composts showed absence of phytotoxicity and suitable agronomic properties for their use as organic fertilizers. This reflects the viability of the proposed alternative to be scaled-up in developing areas, not only to manage and recycle urban waste fluxes, but also to obtain organic fertilizers, including added value in economic terms related to nutrient contents.	[Jara-Samaniego, J.; Brito, H.] Escuela Super Politecn Chimborazo, Fac Ciencias, Riobamba, Chimborazo, Ecuador; [Perez-Murcia, M. D.; Bustamante, M. A.; Paredes, C.; Perez-Espinosa, A.; Moral, R.] Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain; [Gavilanes-Teran, I.] Escuela Super Politecn Chimborazo, Fac Salud Publ, Riobamba, Chimborazo, Ecuador; [Lopez, M.] Univ Politecn Cataluna, Dept Agrifood Engn & Biotechnol, Castelldefels, Spain; [Marhuenda-Egea, F. C.] Alicante Univ, Dept Biochem & Agrochem, Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat Politecnica de Catalunya; Universitat d'Alacant	Bustamante, MA (corresponding author), Miguel Hernandez Univ, Dept Agrochem & Environm, Alicante, Spain.	marian.bustamante@umh.es	Bustamante, Maria Angeles/ABF-3793-2020; Marhuenda-Egea, Frutos C/B-3412-2018; murcia, perez MD/O-9753-2014; Gavilanes, Irene/G-1280-2018; Gavilanes Terán, Irene/AAE-4736-2022; Moral, Raul/C-7473-2009; López, Marga/AAU-5531-2020; Bustamante, Maria Angeles/H-9171-2013; Perez Espinosa, Aurelia/ABC-4951-2021; Paredes, Concepcion/C-9325-2012	Bustamante, Maria Angeles/0000-0001-9931-1711; Marhuenda-Egea, Frutos C/0000-0002-0402-9770; murcia, perez MD/0000-0003-0722-9599; Gavilanes, Irene/0000-0001-5576-2908; Gavilanes Terán, Irene/0000-0001-5576-2908; Moral, Raul/0000-0002-4881-480X; López, Marga/0000-0001-5913-6445; Bustamante, Maria Angeles/0000-0001-9931-1711; Perez Espinosa, Aurelia/0000-0003-2881-3073; Paredes, Concepcion/0000-0002-9735-5099; Marhuenda-Egea, Frutos/0000-0002-7457-1805	National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador; project of the Spanish Ministry of Economy and Competitiveness - EU through the Social Funds [AGL2013-41612-R]; Spanish Ministry of Economy and Competitiveness [AGL2013-41612-R]	National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador; project of the Spanish Ministry of Economy and Competitiveness - EU through the Social Funds; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by a PhD scholarship to JJS of the National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador and it was also developed in the framework of the project of the Spanish Ministry of Economy and Competitiveness co-funded by the EU through the Social Funds (ref. AGL2013-41612-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the National Secretary of Higher Education, Science, Technology and Innovation SENESCYT of Ecuador, since this work is a part of the doctoral research project on the issue of waste management in the province of Chimborazo-Ecuador, also developed in the framework of the project reference AGL2013-41612-R of the Spanish Ministry of Economy and Competitiveness. The authors also wish to thank the Polytechnic School of Chimborazo (Ecuador) and the Applied Research in Agrochemistry and Environment group (GIAAMA) of the Miguel Hernandez University (Spain), for their invaluable technical and scientific contribution.	Alburquerque JA, 2006, CHEMOSPHERE, V64, P470, DOI 10.1016/j.chemosphere.2005.10.055; Ali M, 2012, BIODEGRADATION, V23, P231, DOI 10.1007/s10532-011-9502-0; [Anonymous], THESIS; Bernache G., 1995, ECOLOGIA SOC GUADALA; Bernal MP, 2009, BIORESOURCE TECHNOL, V100, P5444, DOI 10.1016/j.biortech.2008.11.027; Bernal MP, 1996, BIOL FERT SOILS, V22, P141, DOI 10.1007/BF00384446; Boldrin A, 2010, WASTE MANAGE, V30, P551, DOI 10.1016/j.wasman.2009.11.031; Brewer LJ, 2003, COMPOST SCI UTIL, V11, P96; Brinton W.F, 2000, COMPOST QUALITY STAN; Buenrostro O, 1999, REV INT CONTAM AMBIE, V15, P27; Bustamante MA, 2008, CHEMOSPHERE, V72, P551, DOI 10.1016/j.chemosphere.2008.03.030; Bustamante MA, 2008, RESOUR CONSERV RECY, V52, P792, DOI 10.1016/j.resconrec.2007.11.005; Bustamante MA, 2007, BIORESOURCE TECHNOL, V98, P3269, DOI 10.1016/j.biortech.2006.07.013; Bustamante MA, 2010, BIORESOURCE TECHNOL, V101, P4068, DOI 10.1016/j.biortech.2010.01.085; Bustamante MA, 2009, BIORESOURCE TECHNOL, V100, P4766, DOI 10.1016/j.biortech.2009.04.033; Caceres R, 2015, BIORESOURCE TECHNOL, V179, P398, DOI 10.1016/j.biortech.2014.12.051; EC, 2014, JRC SCI POL REP; EC, OFFICIAL J EUROPEA L, V325, P28; El Fels L, 2014, INT BIODETER BIODEGR, V87, P128, DOI 10.1016/j.ibiod.2013.09.024; Epstein E., 1997, SCI COMPOSTING TECHN, P83; Farrell M, 2009, BIORESOURCE TECHNOL, V100, P4301, DOI 10.1016/j.biortech.2009.04.029; Gavilanes-Teran I, 2016, WASTE MANAGE, V48, P127, DOI 10.1016/j.wasman.2015.11.026; Gregorich EG, 2015, SOIL BIOL BIOCHEM, V91, P182, DOI 10.1016/j.soilbio.2015.08.032; Guendez R, 2005, FOOD CHEM, V89, P1, DOI 10.1016/j.foodchem.2004.02.010; Huerta-Pujol O, 2011, RESOUR CONSERV RECY, V55, P1095, DOI 10.1016/j.resconrec.2011.06.008; Iglesias-Jimenez E., 1992, AGR ECOSYST ENVIRON, V38, P331, DOI DOI 10.1016/0167-8809(92)90154-4; Jara-Samaniego J, 2017, J CLEAN PROD, V141, P1349, DOI 10.1016/j.jclepro.2016.09.178; Jara-Samaniego J, 2015, COMMUN SOIL SCI PLAN, V46, P157, DOI 10.1080/00103624.2014.988587; Gonzalez-Fernandez JJ, 2015, J ENVIRON MANAGE, V147, P132, DOI 10.1016/j.jenvman.2014.09.016; Jurado MM, 2014, J ENVIRON MANAGE, V133, P355, DOI 10.1016/j.jenvman.2013.12.020; Lim SL, 2016, J CLEAN PROD, V111, P262, DOI 10.1016/j.jclepro.2015.08.083; Lim SL, 2015, ECOL ENG, V84, P515, DOI 10.1016/j.ecoleng.2015.09.050; Lim SL, 2015, J SCI FOOD AGR, V95, P1143, DOI 10.1002/jsfa.6849; Lopez M, 2010, RESOUR CONSERV RECY, V54, P222, DOI 10.1016/j.resconrec.2009.08.003; Mathava K, 2010, WASTE MANAGE, V30, P602; Paredes C, 2000, BIOL FERT SOILS, V32, P222, DOI 10.1007/s003740000239; Paredes C, 2001, BIODEGRADATION, V12, P225, DOI 10.1023/A:1017374421565; RICHARDSON GM, 1995, HUM ECOL, V23, P455, DOI 10.1007/BF01190132; Smidt E, 2005, BIODEGRADATION, V16, P67, DOI 10.1007/s10531-004-0430-8; TAM NFY, 1994, RESOUR CONSERV RECY, V11, P261, DOI 10.1016/0921-3449(94)90094-9; Tchobanoglaus G, 1993, INTEGRATED SOLID WAS, P421; Torres-Climent A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138925; US Composting Council, 2001, FIELD GUID COMP US 2; USEPA, 1998, EPA530R97003; Varma VS, 2015, INT J ENVIRON SCI TE, V12, P2015, DOI 10.1007/s13762-014-0582-3; Varma V. Sudharsan, 2014, Environmental Engineering Research, V19, P67, DOI 10.4491/eer.2014.19.1.067; VIEL M, 1987, BIOL WASTE, V20, P167, DOI 10.1016/0269-7483(87)90152-2; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088279; Wu TY, 2014, CHEM ENGINEER TRANS, V39, P1579, DOI 10.3303/CET1439264; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078121; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059; ZUCCONI F, 1981, BIOCYCLE, V22, P54	52	26	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181621	10.1371/journal.pone.0181621	http://dx.doi.org/10.1371/journal.pone.0181621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727757	Green Published, gold			2022-12-26	WOS:000406634500094
J	Nakamura, T; Matsumine, A; Matsubara, T; Asanuma, K; Yada, Y; Hagi, T; Sudo, A				Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Yada, Yuki; Hagi, Tomohito; Sudo, Akihiro			Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CLINICOPATHOLOGICAL ANALYSIS; LYMPHOCYTE RATIO; MYXOFIBROSARCOMA; SURVIVAL; NEUTROPHIL; EMPHASIS; LEVEL; MRI	Objective The aim of this study was to determine whether the tumor infiltrative growth pattern on magnetic resonance imaging (MRI) was associated with blood inflammatory markers (C-reactive protein; CRP and Neutrophil-lymphocyte ratio; NLR) and survival in patients with high-grade soft-tissue sarcoma (STS). Methods The cohort for this retrospective study included 81 patients with a mean age of 63 years. The tumor depth was superficial or deep in 15 and 66 patients, respectively. The mean CRP and NLR were 1.31 mg/dL and 2.81, respectively. The assessment of a peripheral growth pattern which divided into three patterns on MRI was based on the largest midsection of the tumor. Results On MRI scans, diffuse-type, focal-type, and pushing-type growth patterns were observed in 18, 33, and 30 patients, respectively. Superficial high-grade STS were prone to show a focal-type pattern on MRI. There were no correlations between growth pattern type and clinicopathological factors such as age, sex, tumor size, and histological grade. However, the incidence of infiltrative growth was significantly higher in patients with elevated CRP (p = 0.0002). In multivariate analysis, growth pattern and CRP were independent prognostic factors for disease-specific survival, metastasis-free survival. Growth pattern was also related to local tumor control. Conclusions There were significant associations between the tumor growth pattern and CRP levels in patients with high-grade soft-tissue sarcoma. An infiltrative growth pattern and elevated CRP may be associated with inferior disease-specific and metastasis-free survival rates in these patients. Therefore, careful post-treatment follow-up should be conducted in such patients.	[Nakamura, Tomoki; Matsumine, Akihiko; Matsubara, Takao; Asanuma, Kunihiro; Yada, Yuki; Hagi, Tomohito; Sudo, Akihiro] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan	Mie University	Nakamura, T (corresponding author), Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie, Japan.	tomoki66@clin.medic.mie-u.ac.jp						CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fernebro Josefin, 2006, Sarcoma, V2006, P1, DOI 10.1155/SRCM/2006/21251; Huang HY, 2004, HUM PATHOL, V35, P612, DOI 10.1016/j.humpath.2004.01.016; Idowu OK, 2012, BIOMARKERS, V17, P539, DOI 10.3109/1354750X.2012.699554; Iwata S, 2014, J SURG ONCOL, V110, P707, DOI 10.1002/jso.23708; Kikuta K, 2015, SKELETAL RADIOL, V44, P55, DOI 10.1007/s00256-014-1992-5; Lefkowitz RA, 2013, SKELETAL RADIOL, V42, P809, DOI 10.1007/s00256-012-1563-6; Manoso MW, 2006, CLIN ORTHOP RELAT R, P89, DOI 10.1097/01.blo.0000229292.98850.14; Mentzel T, 1996, AM J SURG PATHOL, V20, P391, DOI 10.1097/00000478-199604000-00001; Nakamura T, 2015, BONE JOINT J, V97B, P847, DOI [10.1302/0301-620X.97B6.35098, 10.1302/0301-620X.97B.35098]; Nakamura T, 2015, ONCOL LETT, V10, P841, DOI 10.3892/ol.2015.3289; Nakamura T, 2013, J SURG ONCOL, V108, P481, DOI 10.1002/jso.23424; Nakamura T, 2013, EUR J CANCER, V49, P377, DOI 10.1016/j.ejca.2012.09.004; Nakamura T, 2012, CANCER-AM CANCER SOC, V118, P1055, DOI 10.1002/cncr.26353; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679, DOI 10.1200/JCO.1996.14.5.1679; Szkandera J, 2013, BRIT J CANCER, V109, P2316, DOI 10.1038/bjc.2013.595; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Yoo HJ, 2014, EUR RADIOL, V24, P1749, DOI 10.1007/s00330-014-3181-2	19	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181787	10.1371/journal.pone.0181787	http://dx.doi.org/10.1371/journal.pone.0181787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727824	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500110
J	Pannakal, ST; Jager, S; Duranton, A; Tewari, A; Saha, S; Radhakrishnan, A; Roy, N; Kuntz, JF; Fermas, S; James, D; Mellor, J; Misra, N; Breton, L				Pannakal, Steve Thomas; Jager, Sibylle; Duranton, Albert; Tewari, Amit; Saha, Subarna; Radhakrishnan, Aneesha; Roy, Nita; Kuntz, Jean Francois; Fermas, Soraya; James, Darryl; Mellor, Jane; Misra, Namita; Breton, Lionel			Longevity effect of a polysaccharide from Chlorophytum borivilianum on Caenorhabditis elegans and Saccharomyces cerevisiae	PLOS ONE			English	Article							IONIZATION MASS-SPECTROMETRY; CHRONOLOGICAL LIFE-SPAN; HUMAN SKIN; OXIDATIVE STRESS; CD44; AGE; SECRETION; GENETICS	The traditional Indian medicine, Ayurveda, provides insights and practical solutions towards a healthy life style. Rasayana is a branch of Ayurveda known for preserving and promoting health, enhancing the quality of life and delaying the aging process. In the traditional knowledge, the Rasayana herb, Chlorophytum borivilianum (C. borivilanum) is regarded as a general health promoting tonic that delays aging and increases lifespan, cognitive function and physical strength. Aging is a complex and multifactorial physiological phenomenon that manifests itself over a wide range of biological systems, tissues, and functions. Longevity is an obvious marker of physiological aging. Simple model systems such as the single-cell budding yeast Saccharomyces cerevisiae (S. cerevisiae) and the nematode, Caenorhabditis elegans (C. elegans) are widely used to study the aging process and longevity. Here, we show that a polysaccharide fraction obtained from C. borivilianum increases the lifespan of S. cerevisiae and C. elegans, using an automated screening platform (Chronoscreen TM). Chemical analysis of this extract revealed a low molecular weight polysaccharide of 1000 Da, predominantly comprising Glu1 -> 6Glu linkage. This polysaccharide showed significant dose-dependent extension of the median lifespan of S. cerevisiae by up to 41% and of the median lifespan of C. elegans by up to 10%. Taking cue from these results and the traditionally described benefits of Rasayanas on skin rejuvenation, we tested in vitro the polysaccharide for potential skin benefits. In a keratinocyte culture, we observed that this polysaccharide increased cell proliferation significantly, and induced synthesis of hyaluronic acid (HA), a well-known extracellular matrix component. Furthermore, when added to culture medium of human reconstructed epidermis, we observed an enhanced production of epidermal markers, e.g. CD44 and HA that are otherwise diminished in aged skin. Together, these results suggest that in addition to lifespan extension of S. cerevisiae and C. elegans, a polysaccharide from the Rasayana herb, C. borivilianum may have beneficial effects on skin aging parameters.	[Pannakal, Steve Thomas; Tewari, Amit; Saha, Subarna; Roy, Nita; James, Darryl; Misra, Namita] LOreal Res & Innovat, Bangalore, Karnataka, India; [Jager, Sibylle; Duranton, Albert; Kuntz, Jean Francois; Fermas, Soraya; Breton, Lionel] LOreal Res & Innovat, Aulnay Sous Bois, France; [Radhakrishnan, Aneesha] Inst Bioinformat, Int Tech Pk, Bangalore, Karnataka, India; [Mellor, Jane] Univ Oxford, Dept Biochem, Oxford, England; [Mellor, Jane] Sibelius Ltd, Oxford, England	L'Oreal Group; L'Oreal Group; University of Oxford	Pannakal, ST; Misra, N (corresponding author), LOreal Res & Innovat, Bangalore, Karnataka, India.	spannakal@rd.loreal.com; nmisra@rd.loreal.com		Mellor, Jane/0000-0002-5196-3734; Jager, Sibylle/0000-0001-8102-7149; Duranton, Albert/0000-0002-4057-7176				Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; Baaten Bas Jg, 2010, Commun Integr Biol, V3, P508, DOI 10.4161/cib.3.6.13495; Balasubramani SP, 2011, CHIN J INTEGR MED, V17, P88, DOI 10.1007/s11655-011-0659-5; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; BRENNER S, 1974, GENETICS, V77, P71; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Daubenmier JJ, 2007, ANN BEHAV MED; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELIAS PM, 1991, J CONTROL RELEASE, V15, P199, DOI 10.1016/0168-3659(91)90111-P; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; GARROZZO D, 1995, RAPID COMMUN MASS SP, V9, P937, DOI 10.1002/rcm.1290091014; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Guo LQ, 2007, FOOD CHEM, V100, P643, DOI 10.1016/j.foodchem.2005.09.087; Hsu AL, 2009, NEUROBIOL AGING, V30, P1498, DOI 10.1016/j.neurobiolaging.2007.12.007; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khanam Z, 2013, J ETHNOPHARMACOL, V150, P421, DOI 10.1016/j.jep.2013.08.064; Kim MS, 2005, INT J ONCOL, V27, P839; Kumar R, 2013, ANN NEUROSCI, V20, P13, DOI 10.5214/ans.0972.7531.200106; Larsen BS, 1996, J AM SOC MASS SPECTR, V7, P287, DOI 10.1016/1044-0305(95)00706-7; Laurent M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009346; Li WJ, 2012, J AGR FOOD CHEM, V60, P1413, DOI 10.1021/jf204748a; Lorencini M, 2014, AGEING RES REV, V15, P100, DOI 10.1016/j.arr.2014.03.002; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; Mechref Y, 2003, ANAL CHEM, V75, P4895, DOI 10.1021/ac0341968; Murakami S, 2005, NEUROBIOL AGING, V26, P899, DOI 10.1016/j.neurobiolaging.2004.08.007; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Oh JH, 2011, EXP DERMATOL, V20, P455, DOI 10.1111/j.1600-0625.2011.01258.x; Okamoto I, 2001, J CELL BIOL, V155, P755, DOI 10.1083/jcb.200108159; Olshansky SJ, 2007, ANN NY ACAD SCI, V1114, P11, DOI 10.1196/annals.1396.050; Papakonstantinou E, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.21923; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Priess J. R., 1997, C ELEGANS 2; Raja R, 2016, ONCOTARGET, V7, P61229, DOI 10.18632/oncotarget.11310; Rizzarelli P, 2006, RAPID COMMUN MASS SP, V20, P1683, DOI 10.1002/rcm.2483; Robert C, 2003, PATHOL BIOL, V51, P586, DOI 10.1016/j.patbio.2003.09.009; Ronkart SN, 2006, TALANTA, V70, P1006, DOI 10.1016/j.talanta.2006.02.024; Scherfer C, 2013, AGING-US, V5, P276, DOI 10.18632/aging.100549; Singh R, 2008, BIOGERONTOLOGY, V9, P369, DOI 10.1007/s10522-008-9185-z; Subramaniam V, 2007, EXP MOL PATHOL, V83, P341, DOI 10.1016/j.yexmp.2007.08.007; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067; THURINGER JM, 1959, J INVEST DERMATOL, V33, P35, DOI 10.1038/jid.1959.119; Udapa MH, 2004, COMPREHENSIVE KAAYAC; VARANI J, 1994, J CLIN INVEST, V94, P1747, DOI 10.1172/JCI117522; Varley H, 1980, PRACTICAL CLIN CHEM, VI, P491; WEST MD, 1994, ARCH DERMATOL, V130, P87, DOI 10.1001/archderm.130.1.87; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023525; Zhang YS, 2015, PHARMACOGN MAG, V11, P449, DOI [10.4103/0973-1296.1604471, 10.4103/0973-1296.160447]; 2006, ULTRAFLEX 3 USER MAN	59	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179813	10.1371/journal.pone.0179813	http://dx.doi.org/10.1371/journal.pone.0179813			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727758	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500010
J	Ando, S; Malivindi, R; Catalano, S; Rizza, P; Barone, I; Panza, S; Rovito, D; Emprou, C; Bornert, JM; Laverny, G; Metzger, D				Ando, S.; Malivindi, R.; Catalano, S.; Rizza, P.; Barone, I.; Panza, S.; Rovito, D.; Emprou, C.; Bornert, J-M; Laverny, G.; Metzger, D.			Conditional expression of Ki-Ras(G12V) in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ER alpha)-positive adenocarcinoma	ONCOGENE			English	Article							SITE-SPECIFIC RECOMBINATION; BREAST-CANCER; MOUSE MODEL; GENE-EXPRESSION; RAS ACTIVATION; TUMOR-GROWTH; K-RAS; MYC; INHIBITION; ONCOGENE	Appropriate 'in vivo' models are crucial for studying breast cancer biology and evaluating the efficacy of therapeutic agents. Thus we engineered a novel transgenic mouse line expressing the human Ki-Ras bearing an activating mutation (Ki-Ras(G12V)) selectively in the mammary epithelium after lactation. These mice develop invasive ductal adenocarcinomas with 100% incidence within 3-9 months after Ki-Ras(G12V) induction. Immunophenotyping revealed that the mammary tumors express luminal markers, are positive for estrogen and progesterone receptors, negative for HER2 and have a low proliferation index. Moreover, cell lines derived from such tumors are estrogen-responsive and, when transplanted into nude mice, form tumors that respond to the antiestrogen ICI 182780. In conclusion, the mammary tumors of these transgenic mice and the derived cell lines exhibit key features of the major form of human breast cancer, that is, luminal A subtype and thus have a high potential for breast cancer research and treatment.	[Ando, S.; Malivindi, R.; Catalano, S.; Rizza, P.; Barone, I.; Panza, S.; Rovito, D.] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Edificio Polifunz,Via P Bucci, I-87036 Arcavacata Di Renda, CS, Italy; [Ando, S.] Univ Calabria, Ctr Sanit, Arcavacata Di Renda, CS, Italy; [Rovito, D.; Emprou, C.; Bornert, J-M; Laverny, G.; Metzger, D.] Univ Strasbourg, Dept Funct Genom & Canc, U964, CNRS,INSERM,IGBMC,UMR 7104, F-67404 Illkirch Graffenstaden, France	University of Calabria; University of Calabria; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Ando, S (corresponding author), Univ Calabria, Dept Pharm Hlth & Nutr Sci, Edificio Polifunz,Via P Bucci, I-87036 Arcavacata Di Renda, CS, Italy.; Metzger, D (corresponding author), Univ Strasbourg, Dept Funct Genom & Canc, U964, CNRS,INSERM,IGBMC,UMR 7104, F-67404 Illkirch Graffenstaden, France.	sebastiano.ando@unical.it; metzger@igbmc.fr	Rovito, Daniela/AEN-0314-2022; Malivindi, Rocco/ABB-8562-2021; Emprou, Camille/F-3854-2019; Laverny, Gilles/G-5412-2017	Rovito, Daniela/0000-0001-5390-5477; Emprou, Camille/0000-0002-0185-3668; MALIVINDI, Rocco/0000-0002-8313-2492; Metzger, Daniel/0000-0002-5555-046X; Laverny, Gilles/0000-0002-2666-6877; CATALANO, Stefania/0000-0002-6352-9628; BARONE, Ines/0000-0002-9769-1615	PRIN [2015B7M39T]; Fondazione Italiana per la Ricerca sul Cancro (AIRC) [11595]; PROGRAMMA 'FUTURO IN RICERCA' [RBFR12FI27]; AIRC Fellowships [19552]; EMBO ASTF [182010]; European Social Fund operational programme of the Calabria region; Faculte de Medecine, Universite de Strasbourg; Centre National pour la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Strasbourg; French state funds through the Agence Nationale de la Recherche [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; MFAG [16899]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); PROGRAMMA 'FUTURO IN RICERCA'; AIRC Fellowships(Fondazione AIRC per la ricerca sul cancro); EMBO ASTF(European Molecular Biology Organization (EMBO)); European Social Fund operational programme of the Calabria region; Faculte de Medecine, Universite de Strasbourg; Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Strasbourg; French state funds through the Agence Nationale de la Recherche(French National Research Agency (ANR)); MFAG	We thank Dr Watson and Dr Whitelaw for BLG-Cre mice, Merck Research Laboratories for the MMTV-Ki-Ras<SUP>(G12V)</SUP> plasmid and Catherine Tomasetto and Fabien Alpy for helpful discussions. We also thank Neil E Hubbard and Judith Walls (Center for Comparative Medicine, University of California, Davis, CA, USA), the staff of the mouse and genetic engineering facilities from ICS and IGBMC and Elise Grelet for their excellent assistance. This work was supported by: PRIN2015 #2015B7M39T (to SA), Fondazione Italiana per la Ricerca sul Cancro (AIRC) grants: IG no. 11595 (to SA), MFAG no. 16899 (to IB), PROGRAMMA 'FUTURO IN RICERCA' Anno 2012 no. RBFR12FI27 (to IB), AIRC Fellowships for abroad no. 19552 (to DR), EMBO ASTF no. 182010 (to RM), European Social Fund operational programme of the Calabria region (to SP), Faculte de Medecine, Universite de Strasbourg (to CE) and by the Centre National pour la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the Universite de Strasbourg and French state funds through the Agence Nationale de la Recherche ANR-10-LABX-0030-INRT under the frame programme Investissements d'Avenir labelled ANR-10-IDEX-0002-02.	Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Barone I, 2012, ENDOCRINOLOGY, V153, P5157, DOI 10.1210/en.2012-1561; Barone I, 2009, CANCER RES, V69, P4724, DOI 10.1158/0008-5472.CAN-08-4194; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Catalano S, 2016, MINI-REV MED CHEM, V16, P691, DOI 10.2174/1389557516666160321113041; Catalano S, 2013, INT J CANCER, V132, P2237, DOI 10.1002/ijc.27915; Catalano S, 2009, MOL ENDOCRINOL, V23, P1634, DOI 10.1210/me.2009-0039; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen M, 2013, ONCOL LETT, V6, P118, DOI 10.3892/ol.2013.1324; Dabydeen SA, 2014, ENDOCR-RELAT CANCER, V21, pR195, DOI 10.1530/ERC-13-0512; DATI C, 1991, INT J CANCER, V47, P833, DOI 10.1002/ijc.2910470607; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Giordano C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21782; Giordano C, 2016, ONCOTARGET, V7, P1262, DOI 10.18632/oncotarget.6014; Grande F, 2016, FUTURE MED CHEM, V8, P93, DOI 10.4155/fmc.15.176; Green JE, 2000, ONCOGENE, V19, P1020, DOI 10.1038/sj.onc.1203280; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Habashy HO, 2012, HISTOPATHOLOGY, V60, P854, DOI 10.1111/j.1365-2559.2011.03912.x; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Imai T, 2000, GENESIS, V26, P147, DOI 10.1002/(SICI)1526-968X(200002)26:2<147::AID-GENE15>3.0.CO;2-3; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Malaney S, 2001, J MAMMARY GLAND BIOL, V6, P101, DOI 10.1023/A:1009572700317; Mauro L, 2007, CANCER RES, V67, P3412, DOI 10.1158/0008-5472.CAN-06-2890; McGlynn LM, 2013, EUR J CANCER, V49, P1176, DOI 10.1016/j.ejca.2012.11.020; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; O'Hagan Ronan C, 2011, Genes Cancer, V2, P335, DOI 10.1177/1947601911408080; Omer CA, 2000, CANCER RES, V60, P2680; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Reddy Haritha K D L, 2010, Genes Cancer, V1, P69, DOI 10.1177/1947601909358105; SANDGREN EP, 1995, CANCER RES, V55, P3915; Santen RJ, 2009, ENDOCR REV, V30, P343, DOI 10.1210/er.2008-0016; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Shen Q, 2005, MUTAT RES-FUND MOL M, V576, P93, DOI 10.1016/j.mrfmmm.2004.10.013; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920	51	11	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 16	2017	36	46					6420	6431		10.1038/onc.2017.252	http://dx.doi.org/10.1038/onc.2017.252			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM9WN	28745321	Green Submitted			2022-12-26	WOS:000415622900006
J	Guo, Y; Cui, J; Ji, Z; Cheng, C; Zhang, K; Zhang, C; Chu, M; Zhao, Q; Yu, Z; Zhang, Y; Fang, YX; Gao, WQ; Zhu, HH				Guo, Y.; Cui, J.; Ji, Z.; Cheng, C.; Zhang, K.; Zhang, C.; Chu, M.; Zhao, Q.; Yu, Z.; Zhang, Y.; Fang, Y-X; Gao, W-Q; Zhu, H. H.			miR-302/367/LATS2/YAP pathway is essential for prostate tumor- propagating cells and promotes the development of castration resistance	ONCOGENE			English	Article							HIPPO PATHWAY; ANDROGEN RECEPTOR; DOWN-REGULATION; CANCER; EXPRESSION; ANTIGEN; HYPERMETHYLATION; SUPPRESSION; REGULATORS; THERAPY	Clinical intervention for patients with advanced prostate cancer (PCa) remains challenging due to the inevitable recurrence of castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT). Cancer stem cells (CSCs) with serial tumor-propagating capacity are considered to be the driving force for PCa progression and recurrence. In this study, we report that the miR-302/367 cluster, a previously identified potent pluripotency regulator, is upregulated in prostate tumors. Specifically, the forced expression of the miR-302/367 cluster accelerates the in vitro and in vivo growth of PCa cells and their resistance to androgen ablation, whereas the knockdown of the miR-302/367 cluster using anti-sense RNA suppresses the incidence of formation, growth rate and endpoint weight of PCa cell tumors. Mechanistically, we find that LATS2, a key component of the tumor-suppressive Hippo signaling pathway, acts as a direct target of the miR-302/367 cluster in PCa cells. The downregulation of LATS2 by the miR-302/367 cluster reduces the phosphorylation and enhances the nuclear translocation of the YAP oncoprotein. Conversely, the restoration of LATS2 expression abrogates the tumor-promoting effects of forced miR-302/367 cluster expression. Collectively, the potent pluripotency regulator-triggered miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes castration resistance. Thus, targeting this signaling axis may represent a promising therapeutic strategy for CRPC.	[Guo, Y.; Cui, J.; Zhang, C.; Chu, M.; Fang, Y-X; Gao, W-Q; Zhu, H. H.] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ren Ji Med X Clin Stem Cell Res Ctr,State Key Lab, Shanghai, Peoples R China; [Ji, Z.; Cheng, C.; Zhang, K.; Gao, W-Q] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Ji, Z.; Cheng, C.; Zhang, K.; Gao, W-Q] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China; [Zhao, Q.; Yu, Z.; Zhang, Y.] Tongji Univ, Sch Med, Shanghai East Hosp, Res Ctr Translat Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Tongji University	Gao, WQ; Zhu, HH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Stem Cell Res Ctr, 160 Pujian Rd, Shanghai 200127, Peoples R China.	gao.weiqiang@sjtu.edu.cn; zhuhecrane@shsmu.edu.cn	Gao, Wei/GXH-0380-2022	ji, Zhongzhong/0000-0003-0562-2477; Chu, Mingliang/0000-0003-0559-8921	Chinese Ministry of Science and Technology [2017YFA0102900]; National Natural Science Foundation of China [81372189, 81630073]; Science and Technology Commission of Shanghai Municipality [16JC1405700]; KC Wong foundation; Shanghai Eastern Hospital Stem Cell Research Base Fund; State Key Laboratory of Oncogenes and Related Genes [90-16-03]; Shanghai Rising-Star Program [17QA1402100]; Shanghai Institutions of Higher Learning (The Program for Professor of Special Appointment (Young Eastern Scholar) [QD2015002]; School of Medicine at Shanghai Jiao Tong University (Excellent Youth Scholar Initiation Grant) [16XJ11003]; Ren Ji Hospital [RJZZ14-010]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); KC Wong foundation; Shanghai Eastern Hospital Stem Cell Research Base Fund; State Key Laboratory of Oncogenes and Related Genes; Shanghai Rising-Star Program; Shanghai Institutions of Higher Learning (The Program for Professor of Special Appointment (Young Eastern Scholar); School of Medicine at Shanghai Jiao Tong University (Excellent Youth Scholar Initiation Grant); Ren Ji Hospital	The study is supported by grants from the Chinese Ministry of Science and Technology (2017YFA0102900), the National Natural Science Foundation of China (81372189 and 81630073), the Science and Technology Commission of Shanghai Municipality (16JC1405700), the KC Wong foundation, and the Shanghai Eastern Hospital Stem Cell Research Base Fund to Wei-Qiang Gao, and Helen He Zhu received support from the State Key Laboratory of Oncogenes and Related Genes (90-16-03), Shanghai Rising-Star Program (17QA1402100), Shanghai Institutions of Higher Learning (The Program for Professor of Special Appointment (Young Eastern Scholar) QD2015002), School of Medicine at Shanghai Jiao Tong University (Excellent Youth Scholar Initiation Grant 16XJ11003) and Ren Ji Hospital (Seed Project RJZZ14-010).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Badcock G, 1999, CANCER RES, V59, P4715; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen EJ, 2015, CLIN CANCER RES, V21, P1273, DOI 10.1158/1078-0432.CCR-14-1220; Chen L, 2015, COMP BIOCHEM PHYS D, V16, P83, DOI 10.1016/j.cbd.2015.08.002; Chu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116197; Dai JL, 1996, STEROIDS, V61, P531; Domingo-Domenech J, 2012, CANCER CELL, V22, P373, DOI 10.1016/j.ccr.2012.07.016; Eisinger-Mathason TSK, 2015, P NATL ACAD SCI USA, V112, pE3402, DOI 10.1073/pnas.1420005112; Fang YX, 2010, MOL BIOTECHNOL, V45, P71, DOI 10.1007/s12033-010-9244-y; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; GERDES J, 1984, J IMMUNOL, V133, P1710; GROGAN TM, 1988, BLOOD, V71, P1157; Haraguchi T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp040; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hayashi H, 2015, CANCER RES, V75, P4985, DOI 10.1158/0008-5472.CAN-15-0291; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jiang Z, 2006, NEUROSCI RES, V56, P450, DOI 10.1016/j.neures.2006.09.006; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; Kim T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10186; Li WQ, 2011, CANCER RES, V71, P2162, DOI 10.1158/0008-5472.CAN-10-3268; Lu Y, 2014, CELL STEM CELL, V15, P92, DOI 10.1016/j.stem.2014.04.002; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Matsuyama H, 2011, BLOOD, V118, P6881, DOI 10.1182/blood-2011-05-354654; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Sebio A, 2015, CLIN CANCER RES, V21, P5002, DOI 10.1158/1078-0432.CCR-15-0411; Suzuki H, 1998, CANCER RES, V58, P204; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Torre LA, 2016, CA-CANCER J CLIN, V66, P182, DOI 10.3322/caac.21335; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang Y, 2016, GYNECOL ONCOL, V141, P592, DOI 10.1016/j.ygyno.2015.11.034; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang K, 2016, ONCOGENE, V35, P1271, DOI 10.1038/onc.2015.184; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao LY, 2016, SHOCK VIB, V2016, DOI 10.1155/2016/3891429; Zlotorynski Eytan, 2016, Nat Rev Cancer, V16, P481, DOI 10.1038/nrc.2016.78	48	49	51	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6336	6347		10.1038/onc.2017.240	http://dx.doi.org/10.1038/onc.2017.240			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28745315				2022-12-26	WOS:000414774800012
J	Al-Owais, MM; Hettiarachchi, NT; Kirton, HM; Hardy, ME; Boyle, JP; Scragg, JL; Steele, DS; Peers, C				Al-Owais, Moza M.; Hettiarachchi, Nishani T.; Kirton, Hannah M.; Hardy, Matthew E.; Boyle, John P.; Scragg, Jason L.; Steele, Derek S.; Peers, Chris			A key role for peroxynitrite-mediated inhibition of cardiac ERG (Kv11.1) K+ channels in carbon monoxide-induced proarrhythmic early afterdepolarizations	FASEB JOURNAL			English	Article						nitric oxide; arrhythmia; potassium channel	HERG POTASSIUM CHANNELS; LONG-QT SYNDROME; HEME OXYGENASE-1; I-KR; TRANSGENIC MICE; ARRHYTHMIA; RANOLAZINE; RATS; INFARCTION; EXPRESSION	Exposure to CO causes early afterdepolarization arrhythmias. Previous studies in rats have indicated that arrhythmias arose as a result of augmentation of the late Na+ current. The purpose of the present study was to examine the basis for CO-induced arrhythmias in guinea pig myocytes in which action potentials (APs) more closely resemble those of human myocytes. Whole-cell current- and voltage-clamp recordings were made from isolated guinea pig myocytes as well as from human embryonic kidney 293 (HEK293) cells that express wild-type or a C723S mutant form of ether-a-go-go-related gene (ERG; Kv11.1). We also monitored the formation of peroxynitrite (ONOO-) in HEK293 cells fluorimetrically. CO-applied as the CO-releasing molecule, CORM-2-prolonged the APs and induced early afterdepolarizations in guinea pig myocytes. In HEK293 cells, CO inhibited wild-type, but not C723S mutant, Kv11.1 K+ currents. Inhibition was prevented by an antioxidant, mitochondrial inhibitors, or inhibition of NO formation. CO also raised ONOO- levels, an effect that was reversed by the ONOO- scavenger, FeTPPS [5,10,15,20-tetrakis-(4-sulfonatophenyl)-porphyrinato-iron(III)], which also prevented the CO inhibition of Kv11.1 currents and abolished the effects of CO on Kv11.1 tail currents and APs in guinea pig myocytes. Our data suggest that CO induces arrhythmias in guinea pig cardiac myocytes via the ONOO--mediated inhibition of Kv11.1 K+ channels.	[Al-Owais, Moza M.; Hettiarachchi, Nishani T.; Boyle, John P.; Scragg, Jason L.; Peers, Chris] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Fac Med & Hlth, Div Cardiovasc & Diabet Res, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England; [Kirton, Hannah M.; Hardy, Matthew E.; Steele, Derek S.] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Peers, C (corresponding author), Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Fac Med & Hlth, Div Cardiovasc & Diabet Res, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Hardy, Matt/ABD-1397-2022	Hardy, Matt/0000-0002-3129-9549; Steele, Derek/0000-0002-1339-784X; Al-Owais, Moza/0000-0001-9122-7873; Kirton, Hannah Marie/0000-0001-5179-9770	British Heart Foundation [PG/13/61/30410]; British Heart Foundation [RG/16/6/32233] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by a grant from the British Heart Foundation (PG/13/61/30410; to C.P., J.L.S., and D.S.S.). The authors declare no conflicts of interest.	Andre L, 2010, AM J RESP CRIT CARE, V181, P587, DOI 10.1164/rccm.200905-0794OC; Balijepalli SY, 2012, CIRCULATION, V126, P2809, DOI 10.1161/CIRCULATIONAHA.112.118018; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Dallas ML, 2012, AM J RESP CRIT CARE, V186, P648, DOI 10.1164/rccm.201204-0688OC; Davie C, 2004, J CARDIOVASC ELECTR, V15, P1302, DOI 10.1046/j.1540-8167.2004.04099.x; Du CY, 2014, J MOL CELL CARDIOL, V74, P220, DOI 10.1016/j.yjmcc.2014.05.013; Gandini C, 2001, J TOXICOL-CLIN TOXIC, V39, P35, DOI 10.1081/CLT-100102878; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Lakkisto P, 2002, J MOL CELL CARDIOL, V34, P1357, DOI 10.1006/jmcc.2002.2094; Lee SY, 2004, J CARDIOVASC PHARM, V43, P706, DOI 10.1097/00005344-200405000-00014; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; Liang SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5676; MEREDITH T, 1988, BMJ-BRIT MED J, V296, P77, DOI 10.1136/bmj.296.6615.77; Misko TP, 1998, J BIOL CHEM, V273, P15646, DOI 10.1074/jbc.273.25.15646; Musameh MD, 2006, BRIT J PHARMACOL, V149, P1104, DOI 10.1038/sj.bjp.0706939; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Otterbein LE, 2016, CIRC RES, V118, P1940, DOI 10.1161/CIRCRESAHA.116.306588; Peers C, 2015, BRIT J PHARMACOL, V172, P1546, DOI 10.1111/bph.12760; Peers C, 2012, J MOL CELL CARDIOL, V52, P359, DOI 10.1016/j.yjmcc.2011.05.013; Rajamani S, 2008, J CARDIOVASC PHARM, V51, P581, DOI 10.1097/FJC.0b013e3181799690; Regan CP, 2005, J CARDIOVASC PHARM, V46, P68, DOI 10.1097/01.fjc.0000162774.86780.9d; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Taglialatela M, 1997, P NATL ACAD SCI USA, V94, P11698, DOI 10.1073/pnas.94.21.11698; Thomas D, 2004, CARDIOVASC RES, V64, P467, DOI 10.1016/j.cardiores.2004.07.023; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Varon J, 1999, J EMERG MED, V17, P87, DOI 10.1016/S0736-4679(98)00128-0; Von Burg R, 1999, J APPL TOXICOL, V19, P379; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Witchel HJ, 2007, EXPERT OPIN THER TAR, V11, P321, DOI 10.1517/14728222.11.3.321; Witchel HJ, 2011, CARDIOVASC THER, V29, P251, DOI 10.1111/j.1755-5922.2010.00154.x; Wu L, 2004, J PHARMACOL EXP THER, V310, P599, DOI 10.1124/jpet.104.066100; Wymore RS, 1997, CIRC RES, V80, P261, DOI 10.1161/01.RES.80.2.261; Yang WX, 2007, NEUROSCI LETT, V426, P128, DOI 10.1016/j.neulet.2007.09.007; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Yoshida T, 2001, CIRCULATION, V103, P1695, DOI 10.1161/01.CIR.103.12.1695	46	9	9	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4845	4854		10.1096/fj.201700259R	http://dx.doi.org/10.1096/fj.201700259R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28743763	Green Published			2022-12-26	WOS:000413398500016
J	Citterio, CE; Veluswanny, B; Morgan, SJ; Galton, VA; Banga, JP; Atkins, S; Morishita, Y; Neumann, S; Latif, R; Gershengorn, MC; Smith, TJ; Arvan, P				Citterio, Cintia E.; Veluswanny, Balaji; Morgan, Sarah J.; Galton, Valerie A.; Banga, J. Paul; Atkins, Stephen; Morishita, Yoshiaki; Neumann, Susanne; Latif, Rauf; Gershengorn, Marvin C.; Smith, Terry J.; Arvan, Peter			De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN CONTROLS; IODINATION SITES; GRAVES-DISEASE; THYROGLOBULIN; THYROXINE; IODINE; CELLS; MANAGEMENT; TERMINUS; BIOLOGY	The thyroid gland secretes primarily tetraiodothyronine (T-4), and some triiodothyronine (T-3). Under normal physiological circumstances, only one-fifth of circulating T-3 is directly released by the thyroid, but in states of hyperactivation of thyroid-stimulating hormone receptors (TSHRs), patients develop a syndrome of relative T-3 toxicosis. Thyroidal T-4 production results from iodination of thyroglobulin (TG) at residues Tyr(5) and Tyr(130), whereas thyroidal T-3 production may originate in several different ways. In this study, the data demonstrate that within the carboxyl-terminal portion of mouse TG, T-3 is formed de novo independently of deiodination from T-4. We found that upon iodination in vitro, de novo T-3 formation in TG was decreased in mice lacking TSHRs. Conversely, de novo T-3 that can be formed upon iodination of TG secreted from PCCL3 (rat thyrocyte) cells was augmented from cells previously exposed to increased TSH, a TSHR agonist, a cAMP analog, or a TSHR-stimulating antibody. We present data suggesting that TSH-stimulated TG phosphorylation contributes to enhanced de novo T-3 formation. These effects were reversed within a few days after removal of the hyperstimulating conditions. Indeed, direct exposure of PCCL3 cells to human serum from two patients with Graves' disease, but not control sera, led to secretion of TG with an increased intrinsic ability to form T-3 upon in vitro iodination. Furthermore, TG secreted from human thyrocyte cultures hyperstimulated with TSH also showed an increased intrinsic ability to form T-3. Our data support the hypothesis that TG processing in the secretory pathway of TSHR-hyperstimulated thyrocytes alters the structure of the iodination substrate in a way that enhances de novo T-3 formation, contributing to the relative T-3 toxicosis of Graves' disease.	[Citterio, Cintia E.; Veluswanny, Balaji; Morishita, Yoshiaki; Smith, Terry J.; Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Citterio, Cintia E.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Microbiol Inmunol & Biotecnol Catedra Genet, C1113AAD, Buenos Aires, DF, Argentina; [Citterio, Cintia E.] Univ Buenos Aires, Inst Inmunol Genet & Metab INIGEM, CONICET, C1120AAR, Buenos Aires, DF, Argentina; [Morgan, Sarah J.; Neumann, Susanne; Gershengorn, Marvin C.] NIDDK, NIH, LERB, Bethesda, MD 20892 USA; [Galton, Valerie A.] Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH 03756 USA; [Banga, J. Paul] Univ Duisburg Essen, Dept Mol Ophthalmol, D-45147 Essen, Germany; [Atkins, Stephen; Smith, Terry J.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Latif, Rauf] Icahn Sch Med Mt Sinai, Thyroid Res Unit, James J Peters Vet Affairs Med Ctr, New York, NY 10468 USA	University of Michigan System; University of Michigan; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Dartmouth College; University of Duisburg Essen; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai	Arvan, P (corresponding author), Brehm Tower,Rm 5112,1000 Wall St, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Morishita, Yoshiaki/AAX-6552-2021; Smith, Terry/ABG-1360-2020; Neumann, Susanne/GPK-6035-2022; latif, rauf/AAR-1634-2020; Latif, Rauf/ABH-4394-2020; Citterio, Cintia E./AAI-4888-2021; Morishita, Yoshiaki/GWQ-6726-2022	Morishita, Yoshiaki/0000-0003-4733-7981; Latif, Rauf/0000-0002-4226-3728; Citterio, Cintia E./0000-0002-3547-5458; Smith, Terry/0000-0002-6279-9685	National Institutes of Health [R01 DK40344]; NATIONAL EYE INSTITUTE [R01EY008976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI110557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK011006, R01DK040344, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK40344 (to P. A.).	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Bernal J, 2017, J ENDOCRINOL, V232, pR83, DOI 10.1530/JOE-16-0424; Bianco AC, 2005, THYROID, V15, P777, DOI 10.1089/thy.2005.15.777; BRAMHALL S, 1969, ANAL BIOCHEM, V31, P146, DOI 10.1016/0003-2697(69)90251-6; Burch HB, 2015, JAMA-J AM MED ASSOC, V314, P2544, DOI 10.1001/jama.2015.16535; Calza L, 2015, COMPR PHYSIOL, V5, P1405, DOI 10.1002/cphy.c140035; Cetrangolo GP, 2014, BIOCHEM BIOPH RES CO, V450, P488, DOI 10.1016/j.bbrc.2014.05.144; Chanoine J. P., 1993, J CLIN INVEST, V91, P2709; CONSIGLIO E, 1987, J BIOL CHEM, V262, P10304; Davis PJ, 2016, NAT REV ENDOCRINOL, V12, P111, DOI 10.1038/nrendo.2015.205; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; DESRUISSEAU S, 1994, ENDOCRINOLOGY, V134, P1676, DOI 10.1210/en.134.4.1676; Desruisseau S, 1996, MOL CELL ENDOCRINOL, V122, P223, DOI 10.1016/0303-7207(96)03880-4; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; DIJESO B, 1992, J BIOL CHEM, V267, P1938; Dunn JT, 2001, THYROID, V11, P407, DOI 10.1089/105072501300176363; DUNN JT, 1987, J BIOL CHEM, V262, P16948; FASSLER CA, 1988, J BIOL CHEM, V263, P17366; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gilbert JA, 2006, J IMMUNOL, V176, P5084, DOI 10.4049/jimmunol.176.8.5084; GROLLMAN EF, 1993, J BIOL CHEM, V268, P3604; HAEBERLI A, 1981, ENDOCRINOLOGY, V109, P523, DOI 10.1210/endo-109-2-523; Holzer G, 2016, J BIOL CHEM, V291, P16553, DOI 10.1074/jbc.M116.719047; IZUMI M, 1977, J CLIN INVEST, V59, P1105, DOI 10.1172/JCI108734; KASAGI K, 1987, ACTA ENDOCRINOL-COP, V115, P30, DOI 10.1530/acta.0.1150030; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kleinau Gunnar, 2014, Adv Pharmacol, V70, P81, DOI 10.1016/B978-0-12-417197-8.00003-1; Koibuchi Noriyuki, 2012, Nihon Rinsho, V70, P1844; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; LAMAS L, 1986, ENDOCRINOLOGY, V118, P2131, DOI 10.1210/endo-118-5-2131; LARSEN PR, 1975, J CLIN ENDOCR METAB, V41, P1098, DOI 10.1210/jcem-41-6-1098; Latif R, 2015, THYROID, V25, P51, DOI 10.1089/thy.2014.0119; LAURBERG P, 1984, METABOLISM, V33, P379, DOI 10.1016/0026-0495(84)90203-8; LEONARDI A, 1994, BIOCHEM BIOPH RES CO, V202, P38, DOI 10.1006/bbrc.1994.1890; Marians RC, 2002, P NATL ACAD SCI USA, V99, P15776, DOI 10.1073/pnas.242322099; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Morgan SJ, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00168; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Nlend MC, 1999, EUR J ENDOCRINOL, V141, P61, DOI 10.1530/eje.0.1410061; Palmero CY, 2013, MOL CELL ENDOCRINOL, V376, P12, DOI 10.1016/j.mce.2013.05.020; Prummel MF, 1998, THYROID, V8, P545, DOI 10.1089/thy.1998.8.545; SCHIMMEL M, 1977, ANN INTERN MED, V87, P760, DOI 10.7326/0003-4819-87-6-760; Sellitti DF, 2014, THYROID, V24, P625, DOI 10.1089/thy.2013.0344; Smith TJ, 2016, NEW ENGL J MED, V375, P1552, DOI 10.1056/NEJMra1510030; STERLING K, 1970, J AMER MED ASSOC, V213, P571, DOI 10.1001/jama.213.4.571; Suban D, 2012, BIOCHIMIE, V94, P719, DOI 10.1016/j.biochi.2011.10.018; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Targovnik HM, 2011, HORM RES PAEDIAT, V75, P311, DOI 10.1159/000324882; Taurog AM, 2000, WERNER INGBARS THYRO, P61; Woeber KA, 2006, THYROID, V16, P687, DOI 10.1089/thy.2006.16.687; Xavier ACW, 2016, ARCH ENDOCRIN METAB, V60, P66, DOI 10.1590/2359-3997000000103; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	54	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15434	15444		10.1074/jbc.M117.784447	http://dx.doi.org/10.1074/jbc.M117.784447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28743746	Green Published, hybrid			2022-12-26	WOS:000410809800023
J	Diao, LT; Chen, CC; Dennehey, B; Pal, S; Wang, PP; Shen, ZJ; Deem, A; Tyler, JK				Diao, Li-Ting; Chen, Chin-Chuan; Dennehey, Briana; Pal, Sangita; Wang, Pingping; Shen, Zie-Jie; Deem, Angela; Tyler, Jessica K.			Delineation of the role of chromatin assembly and the Rtt101(Mms1) E3 ubiquitin ligase in DNA damage checkpoint recovery in budding yeast	PLOS ONE			English	Article							DOUBLE-STRAND BREAK; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; MMS22L-TONSL COMPLEX; DISTINCT MECHANISMS; REPLICATION STRESS; SRS2 HELICASE; S-PHASE; REPAIR; RAD51	The DNA damage checkpoint is activated in response to DNA double-strand breaks (DSBs). We had previously shown that chromatin assembly mediated by the histone chaperone Asf1 triggers inactivation of the DNA damage checkpoint in yeast after DSB repair, also called checkpoint recovery. Here we show that chromatin assembly factor 1 (CAF-1) also contributes to chromatin reassembly after DSB repair, explaining its role in checkpoint recovery. Towards understanding how chromatin assembly promotes checkpoint recovery, we find persistent presence of the damage sensors Ddc1 and Ddc2 after DSB repair in asf1 mutants. The genes encoding the E3 ubiquitin ligase complex Rtt101(Mms1) are epistatic to ASF1 for survival following induction of a DSB, and Rtt101(Mms1) are required for checkpoint recovery after DSB repair but not for chromatin assembly. By contrast, the Mms22 substrate adaptor that is degraded by Rtt101(Mms1) is required for DSB repair per se. Deletion of MMS22 blocks loading of Rad51 at the DSB, while deletion of ASF1 or RTT101 leads to persistent Rad51 loading. We propose that checkpoint recovery is promoted by Rtt101(Mms1) mediated ubiquitylation of Mms22 in order to halt Mms22-dependent loading of Rad51 onto double-stranded DNA after DSB repair, in concert with the chromatin assembly-mediated displacement of Rad51 and checkpoint sensors from the site of repair.	[Diao, Li-Ting; Pal, Sangita; Wang, Pingping; Shen, Zie-Jie; Tyler, Jessica K.] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Chen, Chin-Chuan; Dennehey, Briana; Deem, Angela] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA; [Chen, Chin-Chuan] Chang Gung Univ, Grad Inst Nat Prod, Mol Genet Lab, Taoyuan, Taiwan	Cornell University; University of Texas System; UTMD Anderson Cancer Center; Chang Gung University	Tyler, JK (corresponding author), Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA.	jet2021@med.cornell.edu	Pal, Sangita/AAO-4415-2020; Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; Dennehey, Briana/0000-0002-9238-1079; Wang, Pingping/0000-0001-6203-5725; Tyler, Jessica/0000-0001-9765-1659; Pal, Sangita/0000-0002-4892-841X	National Institutes of Health RO1 grant [CA95641]; NIH RO1 grant from the National Cancer Institute [CA95641]; NATIONAL CANCER INSTITUTE [R01CA095641] Funding Source: NIH RePORTER	National Institutes of Health RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH RO1 grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institutes of Health RO1 grant CA95641 to JKT.; We are very grateful for the generous gift of yeast strains from Jim Haber, and to Achille Pellicioli, John Diffley and Marie-Claude Marsolier-Kergoat for antibodies. We thank Lauren Waldrop for help with strain construction. This work was supported by an NIH RO1 grant CA95641 from the National Cancer Institute to Jessica Tyler.	Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Ben-Aroya S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000852; Buser R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005843; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chi P, 2006, J BIOL CHEM, V281, P26268, DOI 10.1074/jbc.M602983200; Clemenson C, 2009, DNA REPAIR, V8, P1101, DOI 10.1016/j.dnarep.2009.04.008; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Duro E, 2008, DNA REPAIR, V7, P811, DOI 10.1016/j.dnarep.2008.01.007; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Guillemain G, 2007, MOL CELL BIOL, V27, P3378, DOI 10.1128/MCB.00863-06; Gurard-Levin ZA, 2014, ANNU REV BIOCHEM, V83, P487, DOI 10.1146/annurev-biochem-060713-035536; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Kats ES, 2006, P NATL ACAD SCI USA, V103, P3710, DOI 10.1073/pnas.0511102103; Kim JA, 2011, MOL CELL BIOL, V31, P507, DOI 10.1128/MCB.01168-10; Kim JA, 2009, P NATL ACAD SCI USA, V106, P1151, DOI 10.1073/pnas.0812578106; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lee SE, 2001, CURR BIOL, V11, P1053, DOI 10.1016/S0960-9822(01)00296-2; Leroy C, 2003, MOL CELL, P11; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Malkova A, 2005, MOL CELL BIOL, V25, P933, DOI 10.1128/MCB.25.3.933-944.2005; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Melo JA, 2001, GENE DEV, V15, P2809; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; O'Neill BM, 2007, P NATL ACAD SCI USA, V104, P9290, DOI 10.1073/pnas.0703252104; Piwko W, 2016, EMBO J, V35, P2584, DOI 10.15252/embj.201593132; Rabut G, 2011, MOL CELL, V43, P488, DOI 10.1016/j.molcel.2011.05.032; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Shah PP, 2010, MOL CELL, V39, P862, DOI 10.1016/j.molcel.2010.08.028; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Sugawara Neal, 2012, Methods Mol Biol, V920, P349, DOI 10.1007/978-1-61779-998-3_25; Toh GWL, 2010, DNA REPAIR, V9, P718, DOI 10.1016/j.dnarep.2010.02.013; Tsabar M, 2016, GENE DEV, V30, P1211, DOI 10.1101/gad.280685.116; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Yang JY, 2016, CELL REP, V14, P1128, DOI 10.1016/j.celrep.2015.12.096; Yeung M, 2011, DNA REPAIR, V10, P1213, DOI 10.1016/j.dnarep.2011.09.005; Zou L, 2001, Harvey Lect, V97, P1	61	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180556	10.1371/journal.pone.0180556	http://dx.doi.org/10.1371/journal.pone.0180556			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749957	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700011
J	Iglesias-Rodriguez, MD; Jones, BM; Blanco-Ameijeiras, S; Greaves, M; Huete-Ortega, M; Lebrato, M				Iglesias-Rodriguez, Maria Debora; Jones, Bethan M.; Blanco-Ameijeiras, Sonia; Greaves, Mervyn; Huete-Ortega, Maria; Lebrato, Mario			Physiological responses of coccolithophores to abrupt exposure of naturally low pH deep seawater	PLOS ONE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; NORTHWESTERN ARABIAN SEA; OCEAN ACIDIFICATION; PHYTOPLANKTON BLOOMS; CARBONATE CHEMISTRY; ELEVATED PCO(2); MONTEREY BAY; SR/CA RATIOS; FRESH-WATER; MARINE	Upwelling is the process by which deep, cold, relatively high-CO2, nutrient-rich seawater rises to the sunlit surface of the ocean. This seasonal process has fueled geoengineering initiatives to fertilize the surface ocean with deep seawater to enhance productivity and thus promote the drawdown of CO2. Coccolithophores, which inhabit many upwelling regions naturally 'fertilized' by deep seawater, have been investigated in the laboratory in the context of ocean acidification to determine the extent to which nutrients and CO2 impact their physiology, but few data exist in the field except from mesocosms. Here, we used the Porcupine Abyssal Plain (north Atlantic Ocean) Observatory to retrieve seawater from depths with elevated CO2 and nutrients, mimicking geoengineering approaches. We tested the effects of abrupt natural deep seawater fertilization on the physiology and biogeochemistry of two strains of Emiliania huxleyi of known physiology. None of the strains tested underwent cell divisions when incubated in waters obtained from < 1,000 m (pH = 7.99-8.08; CO2 = 373-485 p.p.m; 1.5-12 mu M nitrate). However, growth was promoted in both strains when cells were incubated in seawater from similar to 1,000 m (pH = 7.9; CO2 similar to 560 p.p.m.; 14-17 mu M nitrate) and similar to 4,800 m (pH = 7.9; CO2 similar to 600 p.p.m.; 21 mu M nitrate). Emiliania huxleyi strain CCMP 88E showed no differences in growth rate or in cellular content or production rates of particulate organic (POC) and inorganic (PIC) carbon and cellular particulate organic nitrogen (PON) between treatments using water from 1,000 m and 4,800 m. However, despite the N: P ratio of seawater being comparable in water from similar to 1,000 and similar to 4,800 m, the PON production rates were three times lower in one incubation using water from similar to 1,000 m compared to values observed in water from similar to 4,800 m. Thus, the POC: PON ratios were threefold higher in cells that were incubated in similar to 1,000 m seawater. The heavily calcified strain NZEH exhibited lower growth rates and PIC production rates when incubated in water from similar to 4,800 m compared to similar to 1,000 m, while cellular PIC, POC and PON were higher in water from similar to 4,800 m. Calcite Sr/Ca ratios increased with depth despite constant seawater Sr/Ca, indicating that upwelling changes coccolith geochemistry. Our study provides the first experimental and field trial of a geoengineering approach to test how deep seawater impacts coccolithophore physiological and biogeochemical properties. Given that coccolithophore growth was only stimulated using waters obtained from > 1,000 m, artificial upwelling using shallower waters may not be a suitable approach for promoting carbon sequestration for some locations and assemblages, and should therefore be investigated on a site-by-site basis.	[Iglesias-Rodriguez, Maria Debora] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Barbara, CA 56635 USA; [Iglesias-Rodriguez, Maria Debora] Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England; [Lebrato, Mario] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR USA; [Jones, Bethan M.] Univ Geneva, Environm & Aquat Sci, 66 Blvd Carl Vogt,CH, Geneva, Switzerland; [Blanco-Ameijeiras, Sonia; Huete-Ortega, Maria] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge, England; [Greaves, Mervyn; Huete-Ortega, Maria; Lebrato, Mario] Univ Sheffield, Dept Chem & Biol Engn, Mappin St, Sheffield, S Yorkshire, England; [Blanco-Ameijeiras, Sonia; Huete-Ortega, Maria] Univ Vigo, Dept Ecolog Biolog Anim, Vigo, Spain	University of California System; University of California Santa Barbara; NERC National Oceanography Centre; University of Southampton; Oregon State University; University of Geneva; University of Cambridge; University of Sheffield; Universidade de Vigo	Iglesias-Rodriguez, MD (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Barbara, CA 56635 USA.; Iglesias-Rodriguez, MD (corresponding author), Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England.	iglesias@lifesci.ucsb.edu	; Huete-Ortega, Maria/K-4530-2014	Blanco-Ameijeiras, Sonia/0000-0003-2698-1735; Greaves, Mervyn/0000-0001-8014-8627; Huete-Ortega, Maria/0000-0002-8746-5518	"European Project on Ocean Acidification" (EPOCA) from the European Community's Seventh Framework Programme (FP7) [211384]; European Community's Seventh Framework Programme (FP7) [211384]; Federal Ministry of Education and Research (BMBF) [03F0722A]	"European Project on Ocean Acidification" (EPOCA) from the European Community's Seventh Framework Programme (FP7); European Community's Seventh Framework Programme (FP7)(European Commission); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by "European Project on Ocean Acidification" (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211384.; We are grateful to the officers and crew of the R.R.S. James Clark Ross for their support at sea, to Professor Richard S. Lampitt for making space and facilities at R.R.S. James Clark Ross available, and Dr. Emilio Maranon for kindly allowing us to keep the E. huxleyi strains in his lab at the University of Vigo before starting the oceanographic cruise. This work is a contribution to the "European Project on Ocean Acidification" (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211384. This study was also financed by a grant from the Federal Ministry of Education and Research (BMBF) to ML under contract No. 03F0722A. We gratefully acknowledge the contribution made by our colleague, Professor Henry Elderfield FRS, who sadly passed away during the preparation of this manuscript.	Abrantes F, 1999, OCEANOL ACTA, V22, P67, DOI 10.1016/S0399-1784(99)80034-6; ANDERSON TR, 1992, J PLANKTON RES, V14, P1645, DOI 10.1093/plankt/14.12.1645; [Anonymous], 1954, BIOL APPL FREEZING D; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Aure J, 2007, MAR ECOL PROG SER, V352, P39, DOI 10.3354/meps07139; Ramos JBE, 2010, BIOGEOSCIENCES, V7, P177, DOI 10.5194/bg-7-177-2010; Bartholomew G. A., 1964, Symposia of the Society for Experimental Biology, V18, P7; Bauman SJ, 2014, OCEANOGRAPHY, V27, P17, DOI 10.5670/oceanog.2014.79; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Blanco-Ameijeiras S, 2012, GEOCHIM COSMOCHIM AC, V89, P226, DOI 10.1016/j.gca.2012.04.043; Blanco-Ameijeiras S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157697; BROCK JC, 1991, J GEOPHYS RES-OCEANS, V96, P20623, DOI 10.1029/91JC01711; BROCK JC, 1992, J GEOPHYS RES-OCEANS, V97, P733, DOI 10.1029/91JC02225; Brooks AN, 2011, WIRES SYST BIOL MED, V3, P544, DOI 10.1002/wsbm.136; Brzezinski MA, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007397; Buck KR, 2005, AQUAT MICROB ECOL, V40, P293, DOI 10.3354/ame040293; Charalampopoulou A, 2011, MAR ECOL PROG SER, V431, P25, DOI 10.3354/meps09140; Crawford DW, 1997, LIMNOL OCEANOGR, V42, P365, DOI 10.4319/lo.1997.42.2.0365; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; de Villiers S, 1999, EARTH PLANET SC LETT, V171, P623, DOI 10.1016/S0012-821X(99)00174-0; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Dutreuil S, 2009, BIOGEOSCIENCES, V6, P901, DOI 10.5194/bg-6-901-2009; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; FAGERBAKKE KM, 1994, SARSIA, V79, P349, DOI 10.1080/00364827.1994.10413566; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fan W, 2013, OCEAN ENG, V59, P47, DOI 10.1016/j.oceaneng.2012.11.014; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Findlay HS, 2011, LIMNOL OCEANOGR, V56, P1168, DOI 10.4319/lo.2011.56.3.1168; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Firme GF, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001824; Garcia VMT, 2008, DEEP-SEA RES PT I, V55, P1150, DOI 10.1016/j.dsr.2008.04.011; GIRAUDEAU J, 1995, CONT SHELF RES, V15, P1825, DOI 10.1016/0278-4343(94)00095-5; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hales B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002295; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hauri C, 2013, BIOGEOSCIENCES, V10, P193, DOI 10.5194/bg-10-193-2013; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Henderiks J, 2008, MAR MICROPALEONTOL, V67, P143, DOI 10.1016/j.marmicro.2008.01.005; HILTON J, 1986, HYDROBIOLOGIA, V141, P269, DOI 10.1007/BF00014221; Hlaili AS, 2006, J EXP MAR BIOL ECOL, V333, P79, DOI 10.1016/j.jembe.2005.12.049; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Hoppe CJM, 2012, BIOGEOSCIENCES, V9, P2401, DOI 10.5194/bg-9-2401-2012; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Hutchins DA, 2002, LIMNOL OCEANOGR, V47, P997, DOI 10.4319/lo.2002.47.4.0997; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Iglesias-Rodriguez MD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001454; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jones BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061868; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Kenyon KE, 2007, J OCEANOGR, V63, P327, DOI 10.1007/s10872-007-0031-8; KNAUER GA, 1973, LIMNOL OCEANOGR, V18, P597, DOI 10.4319/lo.1973.18.4.0597; Lampitt RS, 2008, PHILOS T R SOC A, V366, P3919, DOI 10.1098/rsta.2008.0139; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lannig G, 2010, MAR DRUGS, V8, P2318, DOI 10.3390/md8082318; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lovelock JE, 2007, NATURE, V449, P403, DOI 10.1038/449403a; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Martiny AC, 2013, GLOBAL BIOGEOCHEM CY, V27, P723, DOI 10.1002/gbc.20061; Maruyama S, 2011, DEEP-SEA RES PT I, V58, P567, DOI 10.1016/j.dsr.2011.02.012; Mawji E, 2015, MAR CHEM, V177, P1, DOI 10.1016/j.marchem.2015.04.005; McClimans TA, 2010, AQUACULT ENG, V42, P140, DOI 10.1016/j.aquaeng.2010.02.002; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Muller MN, 2014, BIOGEOSCIENCES, V11, P1065, DOI 10.5194/bg-11-1065-2014; Muller-Karger F, 2001, J GEOPHYS RES-OCEANS, V106, P4527, DOI 10.1029/1999JC000291; Oschlies A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041961; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; Poulton AJ, 2013, GLOBAL BIOGEOCHEM CY, V27, P1023, DOI 10.1002/2013GB004641; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; REYNOLDS CS, 1984, FRESHWATER BIOL, V14, P111, DOI 10.1111/j.1365-2427.1984.tb00027.x; Ridgwell A, 2005, MAR GEOL, V217, P339, DOI 10.1016/j.margeo.2004.10.036; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rixen T, 2000, DEEP-SEA RES PT II, V47, P2155, DOI 10.1016/S0967-0645(00)00020-5; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; Rouco M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00155; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Shepherd J, 2007, NATURE, V449, P781, DOI 10.1038/449781a; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stevenson EI, 2014, GEOCHIM COSMOCHIM AC, V128, P225, DOI 10.1016/j.gca.2013.11.043; Stoll HM, 2007, DEEP-SEA RES PT II, V54, P581, DOI 10.1016/j.dsr2.2007.01.003; Stoll HM, 2002, GEOCHIM COSMOCHIM AC, V66, P927, DOI 10.1016/S0016-7037(01)00836-5; Stoll HM, 2002, PHILOS T R SOC A, V360, P719, DOI 10.1098/rsta.2001.0966; TIMMERMANS KR, 1994, MAR BIOL, V121, P389, DOI 10.1007/BF00346749; van Geen A, 2000, DEEP-SEA RES PT II, V47, P975, DOI 10.1016/S0967-0645(99)00133-2; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; White A, 2010, J ATMOS OCEAN TECH, V27, P385, DOI 10.1175/2009JTECHO679.1; Winter Amos, 1994, P161; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Woods HA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P32, DOI 10.1086/319302; Yool A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004792	105	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181713	10.1371/journal.pone.0181713	http://dx.doi.org/10.1371/journal.pone.0181713			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750008	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000406575700077
J	Neher, T; Azizi, AH; Cheng, S				Neher, Torsten; Azizi, Amir Hossein; Cheng, Sen			From grid cells to place cells with realistic field sizes	PLOS ONE			English	Article							SPATIAL REPRESENTATION; ENTORHINAL CORTEX; PATH-INTEGRATION; LAYER III; RAT; DISTINCT; INPUT; CA3; TRANSFORMATION; HIPPOCAMPUS	While grid cells in the medial entorhinal cortex (MEC) of rodents have multiple, regularly arranged firing fields, place cells in the cornu ammonis (CA) regions of the hippocampus mostly have single spatial firing fields. Since there are extensive projections from MEC to the CA regions, many models have suggested that a feedforward network can transform grid cell firing into robust place cell firing. However, these models generate place fields that are consistently too small compared to those recorded in experiments. Here, we argue that it is implausible that grid cell activity alone can be transformed into place cells with robust place fields of realistic size in a feedforward network. We propose two solutions to this problem. Firstly, weakly spatially modulated cells, which are abundant throughout EC, provide input to downstream place cells along with grid cells. This simple model reproduces many place cell characteristics as well as results from lesion studies. Secondly, the recurrent connections between place cells in the CA3 network generate robust and realistic place fields. Both mechanisms could work in parallel in the hippocampal formation and this redundancy might account for the robustness of place cell responses to a range of disruptions of the hippocampal circuitry.	[Neher, Torsten; Azizi, Amir Hossein; Cheng, Sen] Ruhr Univ Bochum, Inst Neural Computat, Bochum, Germany; [Neher, Torsten; Cheng, Sen] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Neher, Torsten] Ruhr Univ Bochum, Dept Psychol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Cheng, S (corresponding author), Ruhr Univ Bochum, Inst Neural Computat, Bochum, Germany.; Cheng, S (corresponding author), Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany.	sen.cheng@rub.de	Cheng, Sen/A-5722-2009	Cheng, Sen/0000-0002-6719-8029	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, BMBF) as part of a German-US Collaboration in Computational Neuroscience [01GQ1506]; Stiftung Mercator; German Federal Ministry of Education and Research (BMBF) [01GQ1506]	German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, BMBF) as part of a German-US Collaboration in Computational Neuroscience(Federal Ministry of Education & Research (BMBF)); Stiftung Mercator; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung and Forschung, BMBF) as part of a German-US Collaboration in Computational Neuroscience (grant no. 01GQ1506) and a grant from the Stiftung Mercator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the German Federal Ministry of Education and Research (BMBF), grant 01GQ1506, and by the Stiftung Mercator.	Aghajan ZM, 2015, NAT NEUROSCI, V18, P121, DOI 10.1038/nn.3884; Appleby PA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001063; Azizi AH, 2013, FRONTIERS COMPUTATIO, V7, P1; Azizi AH, 2014, HIPPOCAMPUS, V24, P912, DOI 10.1002/hipo.22306; Azizi AH, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00161; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Barry C, 2012, P NATL ACAD SCI USA, V109, P17687, DOI 10.1073/pnas.1209918109; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Brandon MP, 2014, NEURON, V82, P789, DOI 10.1016/j.neuron.2014.04.013; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burak Y, 2009, PLOS COMPUT BIOL, V5; Burgess N, 1997, PHILOS T ROY SOC B, V352, P1535, DOI 10.1098/rstb.1997.0140; Bush D, 2014, TRENDS NEUROSCI, V37, P136, DOI 10.1016/j.tins.2013.12.003; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2011, NEUROSCIENCE, V197, P293, DOI 10.1016/j.neuroscience.2011.09.002; Cheng S, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00088; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; DAlbis T, 2015, NEURAL COMPUT, P1; de Almeida L, 2012, HIPPOCAMPUS, V22, P200, DOI 10.1002/hipo.20882; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Fiete IR, 2008, J NEUROSCI, V28, P6858, DOI 10.1523/JNEUROSCI.5684-07.2008; Franzius M, 2007, J COMPUT NEUROSCI, V22, P297, DOI 10.1007/s10827-006-0013-7; Franzius M, 2007, PLOS COMPUT BIOL, V3, P1605, DOI 10.1371/journal.pcbi.0030166; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Gilman Neyda V., 2015, Science & Technology Libraries, V34, P1, DOI 10.1080/0194262X.2014.1001544; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hales JB, 2014, CELL REP, V9, P893, DOI 10.1016/j.celrep.2014.10.009; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Honda Y, 2012, NEUROSCI RES, V74, P200, DOI 10.1016/j.neures.2012.10.005; Kali S, 2000, J NEUROSCI, V20, P7463; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Kubie JL, 2015, P NATL ACAD SCI USA, V112, P3860, DOI 10.1073/pnas.1503155112; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lu L, 2013, NAT NEUROSCI, V16, P1085, DOI 10.1038/nn.3462; Lyttle D, 2013, HIPPOCAMPUS, V23, P729, DOI 10.1002/hipo.22132; Mathis A, 2012, NEURAL COMPUT, V24, P2280, DOI 10.1162/NECO_a_00319; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Monasson R, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032803; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Moustafa AA, 2009, BRAIN RES, V1276, P180, DOI 10.1016/j.brainres.2009.04.020; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nakamura NH, 2013, J NEUROSCI, V33, P11506, DOI 10.1523/JNEUROSCI.4480-12.2013; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Neher T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004250; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Neunuebel JP, 2013, J NEUROSCI, V33, P9246, DOI 10.1523/JNEUROSCI.0946-13.2013; Neunuebel JP, 2012, J NEUROSCI, V32, P3848, DOI 10.1523/JNEUROSCI.6038-11.2012; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Ormond J, 2015, P NATL ACAD SCI USA, V112, P4116, DOI 10.1073/pnas.1421963112; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pyka M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00091; Pyka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085016; QUIRK GJ, 1990, J NEUROSCI, V10, P2008; Renno-Costa C, 2010, NEURON, V68, P1051, DOI 10.1016/j.neuron.2010.11.024; Rojas R, 1996, NEURAL NETWORKS SYST; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Rolls ET, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P51; Roudi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000012; Rowland DC, 2014, CURR OPIN NEUROBIOL, V24, P22, DOI 10.1016/j.conb.2013.08.012; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Savelli F, 2010, J NEUROPHYSIOL, V103, P3167, DOI 10.1152/jn.00932.2009; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Si B, 2009, COGN NEURODYNAMICS, V3, P177, DOI 10.1007/s11571-009-9079-z; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; TAUBE JS, 1990, J NEUROSCI, V10, P420; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; TREVES A, 1992, PSYCHOBIOLOGY, V20, P1; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Vazdarjanova A, 2004, J NEUROSCI, V24, P6489, DOI 10.1523/JNEUROSCI.0350-04.2004; Wang YX, 2015, NAT NEUROSCI, V18, P282, DOI 10.1038/nn.3904; Welinder PE, 2008, HIPPOCAMPUS, V18, P1283, DOI 10.1002/hipo.20519; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Yoganarasimha D, 2011, HIPPOCAMPUS, V21, P1363, DOI 10.1002/hipo.20839; Young BJ, 1997, J NEUROSCI, V17, P5183; Zhang S, 2014, FRONTIERS BEHAV NEUR, V222; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; ZHU XO, 1995, EUR J NEUROSCI, V7, P753, DOI 10.1111/j.1460-9568.1995.tb00679.x; ZHU XO, 1995, NEUROSCIENCE, V69, P821, DOI 10.1016/0306-4522(95)00320-I	105	8	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181618	10.1371/journal.pone.0181618	http://dx.doi.org/10.1371/journal.pone.0181618			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750005	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700066
J	Villoria, A; Garcia, V; Dosal, A; Moreno, L; Montserrat, A; Figuerola, A; Horta, D; Calvet, X; Ramirez-Lazaro, MJ				Villoria, Albert; Garcia, Victor; Dosal, Angelina; Moreno, Laura; Montserrat, Antonia; Figuerola, Ariadna; Horta, Diana; Calvet, Xavier; Ramirez-Lazaro, Maria Jose			Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors	PLOS ONE			English	Article							QUALITY-OF-LIFE; CROHNS-DISEASE; DEFICIENCIES; REMISSION; VITAMIN; ZINC	Background and Aim Fatigue is a common and bothersome symptom in inflammatory bowel disease (IBD) patients. The study was aimed to determine the relationship of biological and psychological factors with IBD-related fatigue. Methods Consecutive clinically inactive IBD outpatients receiving immunosuppressants or biological drugs were enrolled between January and December 2013. Patients completed a Fatigue score (FACIT-F), various psychological, quality of life (IBDQ-9), and IBD activity scores. Biological parameters were assessed, including levels of interleukins (IL-5, IL-8 and IL-12) and micronutrients. Results We prospectively recruited 202 patients (28% ulcerative colitis and 72% Crohn's disease) for the study. Fatigue measured by FACIT-F score was prevalent in the studied population (54%, 96/177) and higher than in the general population. In the univariate analysis no relation was found between IL levels or micronutrient deficiencies and fatigue. Fatigue was significantly related to female sex, Crohn's disease, joint disorders, body mass index (BMI), psychological tests, thiopurine use, and anti-TNF treatment. All these variables were included in the multivariate analysis. Female sex (OR: 4.8), high BMI (OR: 1.2) and higher depression rates (OR: 1.2) were predictors of increased fatigue. High IBDQ-9 score (OR: 0.82) was significantly related to lower degrees of fatigue. Conclusion Fatigue was prevalent in quiescent IBD patients with moderate-to-severe disease. It was associated with high levels of depression, low quality of life, and female sex. No association was found with the other biological and psychological factors evaluated.	[Villoria, Albert; Garcia, Victor; Dosal, Angelina; Moreno, Laura; Montserrat, Antonia; Figuerola, Ariadna; Horta, Diana; Calvet, Xavier; Ramirez-Lazaro, Maria Jose] Hosp Univ Parc Tauli, Serv Aparell Digestiu, Inst Invest & Innovacio Parc Tauli, Sabadell, Spain; [Villoria, Albert; Calvet, Xavier] Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain; [Villoria, Albert; Figuerola, Ariadna; Calvet, Xavier; Ramirez-Lazaro, Maria Jose] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [Villoria, Albert; Montserrat, Antonia; Figuerola, Ariadna; Calvet, Xavier; Ramirez-Lazaro, Maria Jose] Grp Recerca Consolidat SGR01500, Barcelona, Spain	Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Calvet, X (corresponding author), Hosp Univ Parc Tauli, Serv Aparell Digestiu, Inst Invest & Innovacio Parc Tauli, Sabadell, Spain.; Calvet, X (corresponding author), Inst Salud Carlos III, CIBERehd, Madrid, Spain.	xcalvet@tauli.cat	Calvet, Xavier/H-3288-2019	Calvet, Xavier/0000-0002-6278-9663; Calvet, Xavier/0000-0002-4413-4209; Ramirez Lazaro, Maria Jose/0000-0002-7044-6126; Ramirez-Lazaro, Maria Jose/0000-0003-0534-6070; Horta Sangenis, Diana/0000-0002-3675-1135	Fundacio Parc Tauli [2013043]	Fundacio Parc Tauli	The study was funded with the research grant 2013043 from Fundacio Parc Tauli.	Alcala MJ, 2004, INFLAMM BOWEL DIS, V10, P383, DOI 10.1097/00054725-200407000-00009; Alkhouri RH, 2013, J PEDIATR GASTR NUTR, V56, P89, DOI 10.1097/MPG.0b013e31826a105d; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bol Y, 2010, J PSYCHOSOM RES, V69, P43, DOI 10.1016/j.jpsychores.2009.11.011; Cella D, 2011, SUPPORT CARE CANCER, V19, P1441, DOI 10.1007/s00520-010-0971-1; Chiner E, 1999, Arch Bronconeumol, V35, P422; Cordova Alfredo, 1995, Magnesium Research, V8, P367; Czuber-Dochan W, 2013, ALIMENT PHARM THER, V37, P505, DOI 10.1111/apt.12205; De Haar C, 2012, GASTROENTEROLOGY, V142, pS8; DROSSMAN DA, 1989, DIGEST DIS SCI, V34, P1379, DOI 10.1007/BF01538073; Filippi J, 2006, INFLAMM BOWEL DIS, V12, P185, DOI 10.1097/01.MIB.0000206541.15963.c3; Graff LA, 2011, INFLAMM BOWEL DIS, V17, P1882, DOI 10.1002/ibd.21580; HARVEY RF, 1980, LANCET, V1, P514; Hwang C, 2012, INFLAMM BOWEL DIS, V18, P1961, DOI 10.1002/ibd.22906; Jelsness-Jorgensen LP, 2011, ALIMENT PHARM THER, V33, P106, DOI 10.1111/j.1365-2036.2010.04498.x; Jelsness-Jorgensen LP, 2011, INFLAMM BOWEL DIS, V17, P1564, DOI 10.1002/ibd.21530; Le Goaziou Marie-France, 2013, Presse Med, V42, pe106, DOI 10.1016/j.lpm.2012.09.021; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Mayoux-Benhamou M. A., 2006, Annales de Readaptation et de Medecine Physique, V49, P385, DOI 10.1016/j.annrmp.2006.04.012; Miwa K, 2010, HEART VESSELS, V25, P319, DOI 10.1007/s00380-009-1206-6; Romberg-Camps MJL, 2010, INFLAMM BOWEL DIS, V16, P2137, DOI 10.1002/ibd.21285; Simren M, 2008, ALIMENT PHARM THER, V28, P638, DOI 10.1111/j.1365-2036.2008.03770.x; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Tinsley A, 2011, ALIMENT PHARM THER, V34, P1328, DOI 10.1111/j.1365-2036.2011.04871.x; van Langenberg DR, 2010, ALIMENT PHARM THER, V32, P131, DOI 10.1111/j.1365-2036.2010.04347.x; Vogelaar L, 2013, EUR J GASTROEN HEPAT, V25, P246, DOI 10.1097/MEG.0b013e32835aba83; Wolfe F, 1996, J RHEUMATOL, V23, P1407	27	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181435	10.1371/journal.pone.0181435	http://dx.doi.org/10.1371/journal.pone.0181435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749985	gold, Green Submitted, Green Published			2022-12-26	WOS:000406575700045
J	Vivcharuk, V; Baardsnes, J; Deprez, C; Sulea, T; Jaramillo, M; Corbeil, CR; Mullick, A; Magoon, J; Marcil, A; Durocher, Y; O'Connor-McCourt, MD; Purisima, EO				Vivcharuk, Victor; Baardsnes, Jason; Deprez, Christophe; Sulea, Traian; Jaramillo, Maria; Corbeil, Christopher R.; Mullick, Alaka; Magoon, Joanne; Marcil, Anne; Durocher, Yves; O'Connor-McCourt, Maureen D.; Purisima, Enrico O.			Assisted Design of Antibody and Protein Therapeutics (ADAPT)	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; BINDING AFFINITIES; FORCE-FIELD; ANTIGEN; SIMULATION; COMPLEXES	Effective biologic therapeutics require binding affinities that are fine-tuned to their disease-related molecular target. The ADAPT (Assisted Design of Antibody and Protein Therapeutics) platform aids in the selection of mutants that improve/modulate the affinity of antibodies and other biologics. It uses a consensus z-score from three scoring functions and interleaves computational predictions with experimental validation, significantly enhancing the robustness of the design and selection of mutants. The platform was tested on three antibody Fab-antigen systems that spanned a wide range of initial binding affinities: bH1-VEGFA- (44 nM), bH1-HER2 (3.6 nM) and Herceptin-HER2 (0.058 nM). Novel triple mutants were obtained that exhibited 104-, 46- and 32-fold improvements in binding affinity for each system, respectively. Moreover, for all three antibody-antigen systems over 90% of all the intermediate single and double mutants that were designed and tested showed higher affinities than the parent sequence. The contributions of the individual mutants to the change in binding affinity appear to be roughly additive when combined to form double and triple mutants. The new interactions introduced by the affinity-enhancing mutants included long-range electrostatics as well as short-range nonpolar interactions. This diversity in the types of new interactions formed by the mutants was reflected in SPR kinetics that showed that the enhancements in affinities arose from increasing on-rates, decreasing off-rates or a combination of the two effects, depending on the mutation. ADAPT is a very focused search of sequence space and required only 20-30 mutants for each system to be made and tested to achieve the affinity enhancements mentioned above.	[Vivcharuk, Victor; Baardsnes, Jason; Deprez, Christophe; Sulea, Traian; Jaramillo, Maria; Corbeil, Christopher R.; Mullick, Alaka; Magoon, Joanne; Marcil, Anne; Durocher, Yves; O'Connor-McCourt, Maureen D.; Purisima, Enrico O.] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada; [Vivcharuk, Victor] Weill Cornell Med Coll, New York, NY USA; [O'Connor-McCourt, Maureen D.] Format Biol, Montreal, PQ, Canada	National Research Council Canada; Cornell University	Purisima, EO (corresponding author), Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada.	Enrico.Purisima@nrc-cnrc.gc.ca	Durocher, Yves/K-8709-2019	Corbeil, Christopher/0000-0001-7657-0286; Marcil, Anne/0000-0002-4111-1781	CQDM; National Research Council Canada	CQDM; National Research Council Canada	MO, YD and EOP were partially funded by an Explore grant from CQDM (http://cgdm.org). Additional funding was provided by the National Research Council Canada. There was no additional external funding received for this study.	Bhat S, 2007, BIOCONTROL SCI TECHN, V47, P122; Bostrom J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017887; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; Conchuir SO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130433; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Farady CJ, 2009, BIOORG MED CHEM LETT, V19, P3744, DOI 10.1016/j.bmcl.2009.05.005; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Little M, 2000, IMMUNOL TODAY, V21, P364, DOI 10.1016/S0167-5699(00)01668-6; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sastry GM, 2013, J CHEM INF MODEL, V53, P1531, DOI 10.1021/ci300463g; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sulea T, 2016, J CHEM INF MODEL, V56, P1292, DOI 10.1021/acs.jcim.6b00043; Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19	23	18	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181490	10.1371/journal.pone.0181490	http://dx.doi.org/10.1371/journal.pone.0181490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750054	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700049
J	Burri, O; Wolf, B; Seitz, A; Gonczy, P				Burri, Olivier; Wolf, Benita; Seitz, Arne; Goenczy, Pierre			TRACMIT: An effective pipeline for tracking and analyzing cells on micropatterns through mitosis	PLOS ONE			English	Article							SPINDLE ORIENTATION; IMAGE; MECHANISMS	The use of micropatterns has transformed investigations of dynamic biological processes by enabling the reproducible analysis of live cells using time-lapse fluorescence microscopy. With micropatterns, thousands of individual cells can be efficiently imaged in parallel, rendering the approach well suited for screening projects. Despite being powerful, such screens remain challenging in terms of data handling and analysis. Typically, only a fraction of micropatterns is occupied in a manner suitable to monitor a given phenotypic output. Moreover, the presence of dying or otherwise compromised cells complicates the analysis. Therefore, focusing strictly on relevant cells in such large time-lapse microscopy dataset poses interesting analysis challenges that are not readily met by existing software packages. This motivated us to develop an image analysis pipeline that handles all necessary image processing steps within one open-source platform to detect and analyze individual cells seeded on micropatterns through mitosis. We introduce a comprehensive image analysis pipeline running on Fiji termed TRACMIT (pipeline for TRACking and analyzing cells on micropatterns through MITosis). TRACMIT was developed to rapidly and accurately assess the orientation of the mitotic spindle during metaphase in time-lapse fluorescence microscopy of human cells expressing mCherry:: histone 2B and plated on L-shaped micropatterns. This solution enables one to perform the entire analysis from the raw data, avoiding the need to save intermediate images, thereby decreasing data volume and thus reducing the data that needs to be processed. We first select micropatterns containing a single cell and then identify anaphase figures in the time-lapse recording. Next, TRACMIT tracks back in time until metaphase, when the angle of the mitotic spindle with respect to the micropattern is assessed. We designed the pipeline to allow for manual validation of selected cells with a simple user interface, and to enable analysis of cells plated on micropatterns of different shapes. For ease of use, the entire pipeline is provided as a series of Fiji/ImageJ macros, grouped into an ActionBar. In conclusion, the open source TRACMIT pipeline enables high-throughput analysis of single mitotic cells on micropatterns, thus accurately and efficiently allowing automatic determination of spindle positioning from time-lapse recordings.	[Burri, Olivier; Seitz, Arne] Swiss Fed Inst Technol EPFL, Sch Life Sci, Bioimaging & Opt Platform BIOP, Lausanne, Switzerland; [Wolf, Benita; Goenczy, Pierre] Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Gonczy, P (corresponding author), Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland.	pierre.goenczy@epfl.ch	Wolf, Benita/AAX-4507-2020	Wolf, Benita/0000-0001-5673-4239; Seitz, Arne/0000-0002-5013-1557; Gonczy, Pierre/0000-0002-6305-6883	MEHTRICS project, European Union framework partner [FP7-HEALTH F5 2011-278758EU]; CYTOO; European Union FP7 program MEHTRICS; Deutsche Krebshilfe (Mildred-Scheel post-doctoral fellowship)	MEHTRICS project, European Union framework partner; CYTOO; European Union FP7 program MEHTRICS; Deutsche Krebshilfe (Mildred-Scheel post-doctoral fellowship)	Funded by MEHTRICS project, European Union framework partner (FP7-HEALTH F5 2011-278758EU) to P.G.; Mildred-Scheel (German Cancer Aid) postdoctoral fellowship to B. W.; We thank Sebastien Degot and Yoran Margaron at CYTOO for support with the design of customized L-shaped micropatterned 96-well plates, Erik Meijering for the FeatureJ Package containing the Laplacian implementation, Arnaud Echard for HeLa mCherry::histone 2B cells, as well as Alexandra Bezler, Simon Blanchoud, Romain Guiet and Petra Catalina Schwalie for critical comments on the manuscript. Supported in part by the European Union FP7 program MEHTRICS (to P.G.), as well as the Deutsche Krebshilfe (Mildred-Scheel post-doctoral fellowship, to B.W.).	Azioune A, 2011, LANGMUIR, V27, P7349, DOI 10.1021/la200970t; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kotak S, 2013, CURR OPIN CELL BIOL, V25, P741, DOI 10.1016/j.ceb.2013.07.008; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Matsumura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1634; Mutterer J., 2017, CUSTOM TOOLBARS MINI; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitter D, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-6; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schmitz MHA, 2009, METHODS MOL BIOL, V545, P113, DOI 10.1007/978-1-60327-993-2_7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheehan Moira J, 2013, Methods Mol Biol, V990, P79, DOI 10.1007/978-1-62703-333-6_8; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sonka M., 1999, THOMSON ENG, Vxxiv, P770; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307	19	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0179752	10.1371/journal.pone.0179752	http://dx.doi.org/10.1371/journal.pone.0179752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746386	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800007
J	Geerts, CJ; Mancini, R; Chen, N; Koopmans, FTW; Li, KW; Smit, AB; van Weering, JRT; Verhage, M; Groffen, AJA				Geerts, Cornelia J.; Mancini, Roberta; Chen, Ning; Koopmans, Frank T. W.; Li, Ka Wan; Smit, August B.; van Weering, Jan R. T.; Verhage, Matthijs; Groffen, Alexander J. A.			Tomosyn associates with secretory vesicles in neurons through its N-and C-terminal domains	PLOS ONE			English	Article							RECYCLING SYNAPTIC VESICLES; ADRENAL CHROMAFFIN CELLS; PRESYNAPTIC ACTIVE ZONES; SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; NEUROTROPHIC FACTOR; AXONAL-TRANSPORT; SYNAPTOTAGMIN-I; BINDING PROTEIN; RAB GTPASE	The secretory pathway in neurons requires efficient targeting of cargos and regulatory proteins to their release sites. Tomosyn contributes to synapse function by regulating synaptic vesicle (SV) and dense-core vesicle (DCV) secretion. While there is large support for the presynaptic accumulation of tomosyn in fixed preparations, alternative subcellular locations have been suggested. Here we studied the dynamic distribution of tomosyn-1 (Stxbp5) and tomosyn-2 (Stxbp5l) in mouse hippocampal neurons and observed a mixed diffuse and punctate localization pattern of both isoforms. Tomosyn-1 accumulations were present in axons and dendrites. As expected, tomosyn-1 was expressed in about 75% of the presynaptic terminals. Interestingly, also bidirectional moving tomosyn-1 and -2 puncta were observed. Despite the lack of a membrane anchor these puncta co-migrated with synapsin and neuropeptide Y, markers for respectively SVs and DCVs. Genetic blockade of two known tomosyn interactions with synaptotagmin-1 and its cognate SNAREs did not abolish its vesicular comigration, suggesting an interplay of protein interactions mediated by the WD40 and SNARE domains. We hypothesize that the vesicle-binding properties of tomosyns may control the delivery, pan-synaptic sharing and secretion of neuronal signaling molecules, exceeding its canonical role at the plasma membrane.	[Geerts, Cornelia J.; Mancini, Roberta; Koopmans, Frank T. W.; Verhage, Matthijs; Groffen, Alexander J. A.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Chen, Ning; Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Mol & Cellular Neurobiol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [van Weering, Jan R. T.; Verhage, Matthijs; Groffen, Alexander J. A.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Groffen, AJA (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Funct Genom, Neurosci Campus Amsterdam, Amsterdam, Netherlands.; Groffen, AJA (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	a.j.a.groffen@vu.nl	Koopmans, Frank/GPK-2561-2022; Groffen, A.J.A./C-1118-2009	Koopmans, Frank/0000-0002-4973-5732; Groffen, A.J.A./0000-0003-0046-4027; van Weering, Jan/0000-0001-5259-4945; li, ka wan/0000-0001-6983-5055; verhage, matthijs/0000-0002-6085-7503	Medical Systems Biology (CMSB2 project) [3.3.5]; EU [FP7 SYNSYS HEALTH-F2-2009-242167, FP7-PEOPLE-2013-607508]; Netherlands Organization for Health Research and Development (ZonMW project) [91111009, 91113022]; EU and the Erasmus Mundus ENC network	Medical Systems Biology (CMSB2 project); EU(European Commission); Netherlands Organization for Health Research and Development (ZonMW project); EU and the Erasmus Mundus ENC network	The research was supported by the Centre for Medical Systems Biology (CMSB2 project 3.3.5) to MV, the EU (FP7 SYNSYS HEALTH-F2-2009-242167 to AS, FP7-PEOPLE-2013-607508 and the Erasmus Mundus ENC network to AG) and the Netherlands Organization for Health Research and Development (ZonMW project 91111009 to the VU/Umc EM facility and 91113022 to AG).	Adachi N, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-42; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Barak B, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00149; Bittins CM, 2010, CELL MOL NEUROBIOL, V30, P369, DOI 10.1007/s10571-009-9459-2; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Bury LAD, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-24; Cazares VA, 2016, J NEUROSCI, V36, P11208, DOI 10.1523/JNEUROSCI.1297-16.2016; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Chen N, 2014, J PROTEOME RES, V13, P5695, DOI 10.1021/pr500697b; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; de Wit J, 2006, TRAFFIC, V7, P1060, DOI 10.1111/j.1600-0854.2006.00442.x; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Geerts CJ, 2015, BRAIN STRUCT FUNCT, V220, P1971, DOI 10.1007/s00429-014-0766-0; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Herzog E, 2011, J NEUROSCI, V31, P15544, DOI 10.1523/JNEUROSCI.2073-11.2011; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Kretzschmar S, 1996, NEUROSCI RES, V26, P141, DOI 10.1016/S0168-0102(96)01086-3; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; Matsuda N, 2009, J NEUROSCI, V29, P14185, DOI 10.1523/JNEUROSCI.1863-09.2009; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Mitchell SJ, 2004, J NEUROSCI, V24, P4884, DOI 10.1523/JNEUROSCI.0174-04.2004; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Parisotto D, 2012, J BIOL CHEM, V287, P31041, DOI 10.1074/jbc.M112.386805; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; Rossi G, 2011, MOL BIOL CELL, V22, P842, DOI 10.1091/mbc.E10-07-0570; Rossi G, 2015, J BIOL CHEM, V290, P612, DOI 10.1074/jbc.M114.595892; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Scales SJ, 2002, J BIOL CHEM, V277, P28271, DOI 10.1074/jbc.M204929200; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; Sytnyk V, 2004, J CELL SCI, V117, P381, DOI 10.1242/jcs.00956; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tao-Cheng JH, 2007, NEUROSCIENCE, V150, P575, DOI 10.1016/j.neuroscience.2007.09.031; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Trexler AJ, 2016, MOL BIOL CELL, V27, P2423, DOI 10.1091/mbc.E16-01-0057; van de Bospoort R., 2012, J CELL BIOL, V199, P883, DOI DOI 10.1083/JCB.201208024; Watson K, 2015, MOL BIOL CELL, V26, P3289, DOI 10.1091/mbc.E15-04-0228; Weber-Boyvat M, 2016, TRAFFIC, V17, P131, DOI 10.1111/tra.12349; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Wu Y, 2012, J CELL BIOL, V198, P323, DOI 10.1083/jcb.201106158; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4	69	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180912	10.1371/journal.pone.0180912	http://dx.doi.org/10.1371/journal.pone.0180912			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746398	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800021
J	Pietro-Souza, W; Mello, IS; Vendruscullo, SJ; da Silva, GF; da Cunha, CN; White, JF; Soares, MA				Pietro-Souza, William; Mello, Ivani Souza; Vendruscullo, Suzana Junges; da Silva, Gilvan Ferreira; da Cunha, Catia Nunes; White, James Francis; Soares, Marcos Antonio			Endophytic fungal communities of Polygonum acuminatum and Aeschynomene fluminensis are influenced by soil mercury contamination	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; HEAVY-METAL TOLERANCE; PLANT-GROWTH; PHRAGMITES-AUSTRALIS; TRICHODERMA-HARZIANUM; FUNCTIONAL ROLES; ROOT ENDOPHYTE; 1ST REPORT; DIVERSITY; CD	The endophytic fungal communities of Polygonum acuminatum and Aeschynomene fluminensis were examined with respect to soil mercury (Hg) contamination. Plants were collected in places with and without Hg+2 for isolation and identification of their endophytic root fungi. We evaluated frequency of colonization, number of isolates and richness, indices of diversity and similarity, functional traits (hydrolytic enzymes, siderophores, indoleacetic acid, antibiosis and metal tolerance) and growth promotion of Aeschynomene fluminensis inoculated with endophytic fungi on soil with mercury. The frequency of colonization, structure and community function, as well as the abundant distribution of taxa of endophytic fungi were influenced by mercury contamination, with higher endophytic fungi in hosts in soil with mercury. The presence or absence of mercury in the soil changes the profile of the functional characteristics of the endophytic fungal community. On the other hand, tolerance of lineages to multiple metals is not associated with contamination. A. fluminensis depends on its endophytic fungi, since plants free of endophytic fungi grew less than expected due to mercury toxicity. In contrast plants containing certain endophytic fungi showed good growth in soil containing mercury, even exceeding growth of plants cultivated in soil without mercury. The data obtained confirm the hypothesis that soil contamination by mercury alters community structure of root endophytic fungi in terms of composition, abundance and species richness. The inoculation of A. fluminensis with certain strains of stress tolerant endophytic fungi contribute to colonization and establishment of the host and may be used in processes that aim to improve phytoremediation of soils with toxic concentrations of mercury.	[Pietro-Souza, William; Mello, Ivani Souza; Soares, Marcos Antonio] Univ Fed Mato Grosso, Inst Biosci, Lab Biotechnol & Microbial Ecol, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil; [Pietro-Souza, William; Mello, Ivani Souza; Vendruscullo, Suzana Junges; da Cunha, Catia Nunes; Soares, Marcos Antonio] Univ Fed Mato Grosso, Inst Biosci, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil; [da Silva, Gilvan Ferreira] Embrapa Amazonia Ocidental, Manaus, Amazonas, Brazil; [White, James Francis] Rutgers State Univ, Dept Plant Biol, New Brunswick, NJ USA	Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Rutgers State University New Brunswick	Soares, MA (corresponding author), Univ Fed Mato Grosso, Inst Biosci, Lab Biotechnol & Microbial Ecol, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil.; Soares, MA (corresponding author), Univ Fed Mato Grosso, Inst Biosci, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil.	drmsoares@gmail.com	Soares, Marcos/Y-7844-2019; Soares, Marcos A/B-7683-2013	Soares, Marcos/0000-0002-8938-3188; Soares, Marcos A/0000-0002-8938-3188; White, James/0000-0002-6780-7066; Mello, Ivani/0000-0002-3355-0493; Vendruscolo, Suzana/0000-0002-2107-0046; Pietro-Souza, William/0000-0002-8244-163X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [47044/2014-1]; Marcos Antonio Soares, Ph.D; Mato Grosso Research Foundation [FAPEMAT.0583867/2016]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Marcos Antonio Soares, Ph.D; Mato Grosso Research Foundation	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Award Number: 447044/2014-1 | Recipient: Marcos Antonio Soares, Ph.D, and Mato Grosso Research Foundation Award Number: FAPEMAT.0583867/2016 | Recipient: Marcos Antonio Soares, Ph.D. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aziz FA, 2016, PHYTOTAXA, V267, P279, DOI 10.11646/phytotaxa.267.4.4; Abdel-Raheem A, 2002, FUNGAL DIVERS, V11, P1; Aguilar-Trigueros CA, 2014, TRENDS PLANT SCI, V19, P432, DOI 10.1016/j.tplants.2014.02.006; Aldrich-Wolfe L, 2007, ECOLOGY, V88, P559, DOI 10.1890/05-1177; Almoneafy AA, 2014, SYMBIOSIS, V63, P59, DOI 10.1007/s13199-014-0288-9; An HM, 2015, MICROBIOL RES, V176, P29, DOI 10.1016/j.micres.2015.03.013; Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Aznar A, 2015, J EXP BOT, V66, P3001, DOI 10.1093/jxb/erv155; Babu AG, 2014, J ENVIRON MANAGE, V132, P129, DOI 10.1016/j.jenvman.2013.10.009; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Bacon CW, 2016, SYMBIOSIS, V68, P87, DOI 10.1007/s13199-015-0350-2; Ban YH, 2015, ANN MICROBIOL, V65, P503, DOI 10.1007/s13213-014-0886-z; Bullock JM, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P186, DOI 10.1017/CBO9780511790508.005; Buyer JS, 2011, PLANT SOIL, V339, P401, DOI 10.1007/s11104-010-0592-y; Callil CT, 2001, WATER AIR SOIL POLL, V125, P319, DOI 10.1023/A:1005230716898; Callil CT, 2011, PANTANAL ECOLOGY BIO, P695; Castilhos Z, 2015, ENVIRON SCI POLLUT R, V22, P11255, DOI 10.1007/s11356-015-4340-y; Cea M, 2010, J HAZARD MATER, V181, P315, DOI 10.1016/j.jhazmat.2010.05.013; Ceccatto APS, 2016, ENVIRON GEOCHEM HLTH, V38, P713, DOI 10.1007/s10653-015-9754-4; da Cunha C Nunes, 2015, CLASSIFICACAO E DELI; Dash HR, 2012, INT BIODETER BIODEGR, V75, P207, DOI 10.1016/j.ibiod.2012.07.023; De Beeck MO, 2015, SOIL BIOL BIOCHEM, V86, P58, DOI 10.1016/j.soilbio.2015.03.007; Deng ZJ, 2014, ENVIRON SCI POLLUT R, V21, P2346, DOI 10.1007/s11356-013-2163-2; Deng ZJ, 2011, J HAZARD MATER, V185, P717, DOI 10.1016/j.jhazmat.2010.09.078; Sanchez-Fernandez RE, 2016, MICROB ECOL, V71, P347, DOI 10.1007/s00248-015-0679-3; Felczak A, 2014, PROCESS BIOCHEM, V49, P295, DOI 10.1016/j.procbio.2013.12.001; Findlay SEG, 2002, WETLANDS, V22, P616, DOI 10.1672/0277-5212(2002)022[0616:MGANRI]2.0.CO;2; Friesen ML, 2011, ANNU REV ECOL EVOL S, V42, P23, DOI 10.1146/annurev-ecolsys-102710-145039; Giauque H, 2016, FUNGAL ECOL, V20, P108, DOI 10.1016/j.funeco.2015.12.005; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Glynou K, 2015, ENVIRON MICROBIOL, P1; Gong JX, 2009, BIOTECHNOL ADV, V27, P996, DOI 10.1016/j.biotechadv.2009.05.016; Gontia-Mishra I, 2016, J PLANT GROWTH REGUL, V35, P1000, DOI 10.1007/s00344-016-9598-x; Hardoim PR, 2015, MICROBIOL MOL BIOL R, V79, P293, DOI 10.1128/MMBR.00050-14; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Hui N, 2011, FEMS MICROBIOL ECOL, V76, P121, DOI 10.1111/j.1574-6941.2010.01038.x; ICHIKAWA T, 1971, FOLIA MICROBIOL, V16, P218, DOI 10.1007/BF02884210; Carrim AJI, 2006, BRAZ ARCH BIOL TECHN, V49, P353, DOI 10.1590/S1516-89132006000400001; Jean-Philippe SR, 2011, ENVIRON POLLUT, V159, P2733, DOI 10.1016/j.envpol.2011.05.017; Junk WJ, 2014, AQUAT CONSERV, V24, P5, DOI 10.1002/aqc.2386; Karimzadeh L, 2012, CHEMOSPHERE, V88, P683, DOI 10.1016/j.chemosphere.2012.03.075; Khan AL, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-86; Khan AR, 2017, ENVIRON EXP BOT, V135, P126, DOI 10.1016/j.envexpbot.2016.03.005; Kim JO, 2013, KSCE J CIV ENG, V17, P1596, DOI 10.1007/s12205-013-0323-z; Kraus GF, 2004, MYCOLOGIA, V96, P1059, DOI 10.2307/3762089; Kuldau GA, 2000, BOOK SOIL P, P85; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumaresan V, 2002, FUNGAL DIVERS, V9, P81; Kurniati E, 2014, J ENVIRON SCI-CHINA, V26, P1223, DOI 10.1016/S1001-0742(13)60592-6; Kusari S, 2014, TRENDS BIOTECHNOL, V32, P297, DOI 10.1016/j.tibtech.2014.03.009; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lazaro WL, 2015, CHEMOSPHERE, V138, P25, DOI 10.1016/j.chemosphere.2015.05.007; Leady B. S., 2001, Wetlands Ecology and Management, V9, P349, DOI 10.1023/A:1011856517552; Lecomte C, 2016, BIOL CONTROL, V101, P17, DOI 10.1016/j.biocontrol.2016.06.004; Li HY, 2012, FUNGAL ECOL, V5, P309, DOI 10.1016/j.funeco.2011.06.002; Li X, 2016, J PLANT INTERACT, V11, P186, DOI 10.1080/17429145.2016.1266043; Likar M, 2013, PLANT SOIL, V370, P593, DOI 10.1007/s11104-013-1656-6; Lima AD, 2011, MOLECULES, V16, P2486, DOI 10.3390/molecules16032486; Ma Y, 2016, J ENVIRON MANAGE, V174, P14, DOI 10.1016/j.jenvman.2016.02.047; Milagres AMF, 1999, J MICROBIOL METH, V37, P1, DOI 10.1016/S0167-7012(99)00028-7; Milner MJ, 2014, PLANT ABIOTIC STRESS, 2ND EDITION, P179; Mohamed RM, 2012, J BASIC MICROB, V52, P53, DOI 10.1002/jobm.201100133; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; Oliveira L. J., 2004, Environmental Practice, V6, P121, DOI 10.1017/S1466046604000237; Osono T, 2009, MYCOSCIENCE, V50, P52, DOI 10.1007/s10267-008-0442-4; Petrini O., 1986, MICROBIOLOGY PHYLLOS, P175; Porras-Alfaro A, 2008, APPL ENVIRON MICROB, V74, P2805, DOI 10.1128/AEM.02769-07; Puglisi I, 2012, GENE, V506, P325, DOI 10.1016/j.gene.2012.06.091; Radhakrishnan R, 2015, ANN MICROBIOL, V65, P585, DOI 10.1007/s13213-014-0894-z; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Ramos-Garza J, 2016, ANN MICROBIOL, V66, P991, DOI 10.1007/s13213-015-1184-0; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Varanda CMR, 2016, FUNGAL BIOL-UK, V120, P1525, DOI 10.1016/j.funbio.2016.08.002; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Ruotsalainen AL, 2009, ENVIRON MONIT ASSESS, V148, P215, DOI 10.1007/s10661-007-0152-y; Saravanan VS, 2007, CHEMOSPHERE, V66, P1794, DOI 10.1016/j.chemosphere.2006.07.067; Schulz Barbara J. E., 2006, V9, P1; Shahabivand S, 2012, PLANT PHYSIOL BIOCH, V60, P53, DOI 10.1016/j.plaphy.2012.07.018; Shannon C.E., 1964, MATH THEORY COMMUNIC; Shen M, 2013, FUNGAL ECOL, V6, P539, DOI 10.1016/j.funeco.2013.08.001; Sheng XF, 2008, INT BIODETER BIODEGR, V62, P88, DOI 10.1016/j.ibiod.2007.12.003; Shentu XP, 2014, BRAZ J MICROBIOL, V45, P248, DOI 10.1590/S1517-83822014005000036; Shi YA, 2017, ENVIRON SCI POLLUT R, V24, P417, DOI 10.1007/s11356-016-7693-y; Silva C. F. da, 2015, African Journal of Microbiology Research, V9, P1907; Sim CSF, 2016, DESALIN WATER TREAT, V57, P6959, DOI 10.1080/19443994.2015.1013507; Soares MA, 2016, BIOL INVASIONS, V18, P2689, DOI 10.1007/s10530-016-1160-z; Soleimani M, 2010, CHEMOSPHERE, V81, P1084, DOI 10.1016/j.chemosphere.2010.09.034; Suryanarayanan TS, 2011, BIODIVERS CONSERV, V20, P913, DOI 10.1007/s10531-011-0004-5; Tanaka Kazuaki, 2005, Mycoscience, V46, P287, DOI 10.1007/s10267-005-0248-6; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tonin C, 2001, MYCORRHIZA, V10, P161, DOI 10.1007/s005720000072; Tsang CC, 2014, MED MYCOL, V52, P736, DOI 10.1093/mmy/myu043; Ullah A, 2015, ENVIRON EXP BOT, V117, P28, DOI 10.1016/j.envexpbot.2015.05.001; Unterseher M, 2013, BIODIVERS CONSERV, V22, P999, DOI 10.1007/s10531-013-0464-x; Van Ryckegem G, 2005, NOVA HEDWIGIA, V80, P173, DOI 10.1127/0029-5035/2005/0080-0173; Wang Y, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-1966-3; Wani ZA, 2015, APPL MICROBIOL BIOT, V99, P2955, DOI 10.1007/s00253-015-6487-3; Waqas M, 2014, BIOL FERT SOILS, V50, P1155, DOI 10.1007/s00374-014-0937-4; Weaver L, 2010, LETT APPL MICROBIOL, V50, P18, DOI 10.1111/j.1472-765X.2009.02753.x; Wezowicz K, 2014, SYMBIOSIS, V64, P139, DOI 10.1007/s13199-015-0312-8; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wood JL, 2016, SOIL BIOL BIOCHEM, V103, P131, DOI 10.1016/j.soilbio.2016.08.021; Xu JY, 2015, ENVIRON INT, V74, P42, DOI 10.1016/j.envint.2014.09.007; Xu RB, 2015, APPL SOIL ECOL, V93, P11, DOI 10.1016/j.apsoil.2015.03.013; Yamaji K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169089; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yousaf S, 2010, J HAZARD MATER, V184, P523, DOI 10.1016/j.jhazmat.2010.08.067; Zafar S, 2007, BIORESOURCE TECHNOL, V98, P2557, DOI 10.1016/j.biortech.2006.09.051; Zazzerini A, 2010, PLANT DIS, V94, P372, DOI 10.1094/PDIS-94-3-0372C; Zhan FD, 2011, WORLD J MICROB BIOT, V27, P2483, DOI 10.1007/s11274-011-0712-8; Zhao D, 2015, MICROBIOL RES, V170, P27, DOI 10.1016/j.micres.2014.09.005; Zheng YK, 2016, ANN MICROBIOL, V66, P529, DOI 10.1007/s13213-015-1153-7; Zhou Yong, 2014, Chinese Journal of Plant Ecology, V38, P54, DOI 10.3724/SP.J.1258.2014.00006; [No title captured]	118	22	24	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0182017	10.1371/journal.pone.0182017	http://dx.doi.org/10.1371/journal.pone.0182017			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742846	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000066
J	Yakovleva, A; Plieskatt, JL; Jensen, S; Humeida, R; Lang, J; Li, GZ; Bracci, P; Silver, S; Bethony, JM				Yakovleva, Anna; Plieskatt, Jordan L.; Jensen, Sarah; Humeida, Razan; Lang, Jonathan; Li, Guangzhao; Bracci, Paige; Silver, Sylvia; Bethony, Jeffrey Michael			Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue	PLOS ONE			English	Article							MICRORNA EXPRESSION; GENE-EXPRESSION; RNA; EXTRACTION; QUALITY; BLOCKS; DNA; VALIDATION; FIXATION; PCR	The demand for nucleic acid and protein derivatives from formalin-fixed paraffin-embedded (FFPE) tissue has greatly increased due to advances in extraction and purification methods, making these derivatives available for numerous genomic and proteomic platforms. Previously, DNA, RNA, microRNA (miRNA), or protein derived from FFPE tissue blocks were considered "unfit" for such platforms, as the process of tissue immobilization by FFPE resulted in cross-linked, fragmented, and chemically modified macromolecules. We conducted a systematic examination of nucleic acids and proteins co-extracted from 118 FFPE blocks sampled from the AIDS and Cancer Specimen Resource (ACSR) at The George Washington University after stratification by storage duration and the three most common tumor tissue types at the ACSR (adenocarcinoma, squamous cell carcinoma, and papillary carcinoma). DNA, RNA, miRNA, and protein could be co-extracted from 98% of the FFPE blocks sampled, with DNA and miRNA "fit" for diverse genomic purposes including sequencing. While RNA was the most labile of the FFPE derivatives, especially when assessed by RNA integrity number (RIN), it was still "fit" for genomic methods that use smaller sequence lengths, e.g., quantitative PCR. While more than half of the protein derivatives were fit for proteomic purposes, our analyses indicated a significant interaction effect on the absorbance values for proteins derived from FFPE, implying that storage duration may affect protein derivatives differently by tumor tissue type. The mean absorbance value for proteins derived from more recently stored FFPE was greater than protein derived from older FFPE, with the exception of adenocarcinoma tissue. Finally, the fitness of one type of derivative was weakly associated with the fitness of derivatives co-extracted from the same FFPE block. The current study used several novel quality assurance approaches and metrics to show that archival FFPE tissue blocks are a valuable resource for contemporary genomic and proteomic platforms.	[Yakovleva, Anna; Plieskatt, Jordan L.; Jensen, Sarah; Humeida, Razan; Lang, Jonathan; Li, Guangzhao; Silver, Sylvia; Bethony, Jeffrey Michael] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Plieskatt, Jordan L.; Humeida, Razan; Lang, Jonathan; Silver, Sylvia; Bethony, Jeffrey Michael] George Washington Univ, AIDS & Canc Specimen Resource ACSR, Washington, DC 20052 USA; [Bracci, Paige] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bracci, Paige] Univ Calif San Francisco, AIDS & Canc Specimen Resource ACSR, San Francisco, CA 94143 USA	George Washington University; George Washington University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bethony, JM (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.; Bethony, JM (corresponding author), George Washington Univ, AIDS & Canc Specimen Resource ACSR, Washington, DC 20052 USA.	jbethony@gwu.edu	Li, Guangzhao/AAW-3587-2021; li, guangzhao/CAG-8631-2022	Plieskatt, Jordan/0000-0002-2333-7234; Bethony, Jeffrey/0000-0002-7901-2113	National Cancer Institute (NCI) of the National Institutes of Health, USA [UM1CA81255]; NATIONAL CANCER INSTITUTE [UM1CA181255] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the award UM1CA81255 from the National Cancer Institute (NCI) of the National Institutes of Health, USA. The contents are solely the responsibility of the authors and do not represent the official views of the NCI (NIH).	Abrahamsen HN, 2003, J MOL DIAGN, V5, P34, DOI 10.1016/S1525-1578(10)60449-7; Betsou F, 2015, BIOPRESERV BIOBANK, V13, P69, DOI 10.1089/bio.2015.1321; Bing Z, 2012, VIRCHOWS ARCH, V461, P663, DOI 10.1007/s00428-012-1325-9; Boisen MK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2030-2; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Carter A, 2011, BIOPRESERV BIOBANK, V9, P157, DOI 10.1089/bio.2010.0031; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Dijkstra JR, 2012, J CELL MOL MED, V16, P683, DOI 10.1111/j.1582-4934.2011.01467.x; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kokkat TJ, 2013, BIOPRESERV BIOBANK, V11, P101, DOI 10.1089/bio.2012.0052; Kokkat TJ, 2013, CYTOJOURNAL, V10, DOI 10.4103/1742-6413.122299; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Lucena-Aguilar G, 2016, BIOPRESERV BIOBANK, V14, P264, DOI 10.1089/bio.2015.0064; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mizuno T, 1998, DIAGN MOL PATHOL, V7, P202, DOI 10.1097/00019606-199808000-00004; Plieskatt JL, 2014, J HEPATOL, V61, P850, DOI 10.1016/j.jhep.2014.05.035; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Senguven B, 2014, INT J MED SCI, V11, P494, DOI 10.7150/ijms.8842; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Turashvili G, 2012, EXP MOL PATHOL, V92, P33, DOI 10.1016/j.yexmp.2011.09.013; TYRRELL L, 1995, AM J DERMATOPATH, V17, P476, DOI 10.1097/00000372-199510000-00008; Vincek V, 2003, LAB INVEST, V83, P1427, DOI 10.1097/01.LAB.0000090154.55436.D1; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181756	10.1371/journal.pone.0181756	http://dx.doi.org/10.1371/journal.pone.0181756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742856	Green Submitted, gold, Green Published			2022-12-26	WOS:000406370000052
J	Saegusa, N; Sarukawa, S; Ohta, K; Takamatsu, K; Watanabe, M; Sugino, T; Nakagawa, M; Akiyama, Y; Kusuhara, M; Kishi, K; Inoue, K				Saegusa, Noriko; Sarukawa, Shunji; Ohta, Kunihiro; Takamatsu, Kensuke; Watanabe, Mitsuhiro; Sugino, Takashi; Nakagawa, Masahiro; Akiyama, Yasuto; Kusuhara, Masatoshi; Kishi, Kazuo; Inoue, Keita			Sutureless microvascular anastomosis assisted by an expandable shape-memory alloy stent	PLOS ONE			English	Article							VASCULAR ANASTOMOSIS; LESIONS; MODEL	Vascular anastomosis is the highlight of cardiovascular, transplant, and reconstructive surgery, which has long been performed by hand using a needle and suture. However, anastomotic thrombosis occurs in approximately 0.5-10% of cases, which can cause serious complications. To improve the surgical outcomes, attempts to develop devices for vascular anastomosis have been made, but they have had limitations in handling, cost, patency rate, and strength at the anastomotic site. Recently, indwelling metal stents have been greatly improved with precise laser metalwork through programming technology. In the present study, we designed a bare metal stent, Microstent, that was constructed by laser machining of a shape-memory alloy, NiTi. An end-to-end microvascular anastomosis was performed in SD rats by placing the Microstent at the anastomotic site and gluing the junction. The operation time for the anastomosis was significantly shortened using Microstent. Thrombus formation, patency rate, and blood vessel strength in the Microstent anastomosis were superior or comparable to hand-sewn anastomosis. The results demonstrated the safety and effectiveness, as well as the operability, of the new method, suggesting its great benefit for surgeons by simplifying the technique for microvascular anastomosis.	[Saegusa, Noriko; Nakagawa, Masahiro; Inoue, Keita] Shizuoka Canc Ctr, Div Plast & Reconstruct Surg, Shizuoka, Japan; [Saegusa, Noriko; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast Surg, Tokyo, Japan; [Sarukawa, Shunji; Inoue, Keita] Jichi Med Univ, Sch Med, Dept Plast & Reconstruct Surg, Shimotsuke, Tochigi, Japan; [Ohta, Kunihiro; Takamatsu, Kensuke] Tamachi Ind Co Ltd, Tokyo, Japan; [Watanabe, Mitsuhiro] Takumi Kogyo Co Ltd, Shizuoka, Japan; [Sugino, Takashi] Shizuoka Canc Ctr, Div Pathol, Shizuoka, Japan; [Akiyama, Yasuto; Kusuhara, Masatoshi] Shizuoka Canc Ctr, Res Inst, Shizuoka, Japan; [Inoue, Keita] Ave Cell Clin, Tokyo, Japan; [Inoue, Keita] Ave Cell Clin, Minato Ku, Tokyo, Japan	Shizuoka Cancer Center; Keio University; Jichi Medical University; Shizuoka Cancer Center; Shizuoka Cancer Center	Inoue, K (corresponding author), Shizuoka Canc Ctr, Div Plast & Reconstruct Surg, Shizuoka, Japan.; Inoue, K (corresponding author), Jichi Med Univ, Sch Med, Dept Plast & Reconstruct Surg, Shimotsuke, Tochigi, Japan.; Inoue, K (corresponding author), Ave Cell Clin, Tokyo, Japan.; Inoue, K (corresponding author), Ave Cell Clin, Minato Ku, Tokyo, Japan.	kinaue-tky@umin.ac.jp			Keio University; Kanto Bureau of Economy, Trade and Industry "Problem Solving Type Project for Development of Medical Devices [20140422-Kanto-7]; Strategic Support Project for Core Technologies [20150901-Kanto-93]; Grants-in-Aid for Scientific Research [17K07209] Funding Source: KAKEN	Keio University; Kanto Bureau of Economy, Trade and Industry "Problem Solving Type Project for Development of Medical Devices; Strategic Support Project for Core Technologies; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	N.S. was supported by a scholarship from Keio University. N.S., S.S., K.O., K.T., M.N., and K.I. were supported by the Kanto Bureau of Economy, Trade and Industry "Problem Solving Type Project for Development of Medical Devices, #20140422-Kanto-7" and "Strategic Support Project for Core Technologies (Support Industry Project), #20150901-Kanto-93". URL: http.//www.kanto.meti.goj.pi/data/english/index/html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors N.S., S.S., K.O., K.T., M.N., and K.I., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDROSOV PI, 1956, ARCH SURG-CHICAGO, V73, P902; Bauer F, 2015, J CRANIO MAXILL SURG, V43, P204, DOI 10.1016/j.jcms.2014.11.005; BLAKEMORE AH, 1945, JAMA-J AM MED ASSOC, V127, P685, DOI 10.1001/jama.1945.02860120001001; Carrel A., 1902, TECHNIQUE OPERATOIRE, V98, P859; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Finn AV, 2002, J VASC RES, V39, P414, DOI 10.1159/000064518; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; GOTTLOB R, 1968, J CARDIOVASC SURG, V9, P337; HARII K, 1973, PLAST RECONSTR SURG, V52, P541, DOI 10.1097/00006534-197311000-00012; HOLT G P, 1960, Surg Forum, V11, P242; KIRSCH WM, 1992, AM SURGEON, V58, P722; Kloppel M, 2007, J RECONSTR MICROSURG, V23, P45, DOI 10.1055/s-2006-958702; Komiyama H, 2015, WORLD J CARDIOL, V7, P776, DOI 10.4330/wjc.v7.i11.776; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; OSTRUP LT, 1986, ANN PLAS SURG, V17, P521; Solem JO, 2000, EUR J CARDIO-THORAC, V17, P312, DOI 10.1016/S1010-7940(99)00357-7; Stewart RB, 1996, LASER SURG MED, V19, P9, DOI 10.1002/(SICI)1096-9101(1996)19:1<9::AID-LSM2>3.0.CO;2-W; Zeebregts CJ, 2003, BRIT J SURG, V90, P261, DOI 10.1002/bjs.4063	18	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181520	10.1371/journal.pone.0181520	http://dx.doi.org/10.1371/journal.pone.0181520			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742116	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700049
J	Wang, K; Duan, SX; Wen, XP; Wang, WZ; Fang, SP; Qi, DY; Huan, X; Wang, LW; He, ZZ				Wang, Kai; Duan, Shaoxia; Wen, Xueping; Wang, Weizhong; Fang, Shangping; Qi, Dunyi; Huan, Xiang; Wang, Liwei; He, Zhenzhou			Angiotensin II system in the nucleus tractus solitarii contributes to autonomic dysreflexia in rats with spinal cord injury	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; SYMPATHETIC-NERVE ACTIVITY; AT(1) RECEPTORS; BAROREFLEX; PATHWAYS; BRAIN; STIMULATION; SENSITIVITY; MODULATION; EXPRESSION	Background Autonomic dysreflexia (AD) is a potentially life-threating complication after spinal cord injury (SCI), characterized by episodic hypertension induced by colon or bladder distension. The objective of this study was to determine the role of impaired baroreflex regulation by the nucleus tractus solitarii(NTS) in the occurrence of AD in a rat model. Methods T4 spinal cord transection animal model was used in this study, which included 40 Male rats Colorectal distension (CD) was performed to assess AD and compare the changes of BP, HR, and BRS, six weeks after operation. After that, SCI rats with successfully induced AD were selected. Losartan was microinjected into NTS in SCI rats, then 10, 30, 60 minutes later, CD was performed to calculate the changes of BP, HR, and BRS in order to explicit whether Ang II system was involved in the AD occurrence. Ang II was then Intra-cerebroventricular infused in sham operation rats with CD to mimic the activation of Ang II system in AD. Finally, the level of Ang II in NTS and colocalization of AT1R and NMDA receptor within the NTS neurons were also detected in SCI rats. Results Compared with sham operation, SCI significantly aggravated the elevation of blood pressure (BP) and impaired baroreflex sensitivity (BRS) induced by colorectal distension; both of which were significantly improved by microinjection of the angiotensin receptor type I (AT1R) antagonist losartan into the NTS. Level of angiotensin II (Ang II) in the NTS was significantly increased in the SCI rats than sham. Intracerebroventricular infusion of Ang II also mimicked changes in BP and BRS induced by colorectal distension. Blockade of baroreflex by sinoaortic denervation prevented beneficial effect of losartan on AD. Conclusion We concluded that the activation of Ang II system in NTS may impair blood pressure baroreflex, and contribute to AD after SCI.	[Wang, Kai; Huan, Xiang; Wang, Liwei] Cent Hosp Xuzhou, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China; [Duan, Shaoxia; He, Zhenzhou] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Anesthesiol, South Campus, Shanghai, Peoples R China; [Duan, Shaoxia; He, Zhenzhou] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, ICU, South Campus, Shanghai, Peoples R China; [Wen, Xueping] Ningxiang Peoples Hosp Hunan Prov, Dept Orthoped, Ningxiang, Hunan, Peoples R China; [Wang, Weizhong] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China; [Fang, Shangping] Second Mil Med Univ, Changzheng Hosp, Dept Anesthesiol, Shanghai, Peoples R China; [Qi, Dunyi] Xuzhou Med Univ, Affiliated Hosp, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Naval Medical University; Naval Medical University; Xuzhou Medical University	Wang, LW (corresponding author), Cent Hosp Xuzhou, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China.; He, ZZ (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Anesthesiol, South Campus, Shanghai, Peoples R China.; He, ZZ (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, ICU, South Campus, Shanghai, Peoples R China.	18952170255@163.com; sandyhzz@126.com						Al Dera H, 2012, AM J PHYSIOL-HEART C, V302, pH752, DOI 10.1152/ajpheart.00745.2011; Barker RN, 2009, SPINAL CORD, V47, P149, DOI 10.1038/sc.2008.82; Cameron AA, 2006, J NEUROSCI, V26, P2923, DOI 10.1523/JNEUROSCI.4390-05.2006; Chaves GZ, 2000, J HYPERTENS, V18, P1841, DOI 10.1097/00004872-200018120-00019; Ciampone S, 2011, J RENIN-ANGIO-ALDO S; Ciampone S, 2011, J RENIN-ANGIO-ALDO S, V12, P394, DOI 10.1177/1470320311408750; Claydon VE, 2006, J NEUROTRAUM, V23, P1713, DOI 10.1089/neu.2006.23.1713; Cloutier F, 2010, NEUROPEPTIDES, V44, P199, DOI 10.1016/j.npep.2009.12.012; Colachis S C 3rd, 1992, J Am Paraplegia Soc, V15, P171; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Furlan JC, 2003, J NEUROTRAUM, V20, P1351, DOI 10.1089/089771503322686148; Furlan JC, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E13; GEHLERT DR, 1991, NEUROSCIENCE, V44, P501, DOI 10.1016/0306-4522(91)90073-W; Gunduz H, 2012, CARDIOL J, V19, P215, DOI 10.5603/CJ.2012.0040; Hagen EM, 2010, J NEUROL NEUROSUR PS, V81, P368, DOI 10.1136/jnnp.2009.178798; Karlsson AK, 1999, SPINAL CORD, V37, P383, DOI 10.1038/sj.sc.3100867; Krassioukov AV, 2003, J NEUROTRAUM, V20, P707, DOI 10.1089/089771503767869944; Krassioukov AV, 2002, J NEUROTRAUM, V19, P1521, DOI 10.1089/089771502762300193; KRUM H, 1992, J HYPERTENS, V10, P245, DOI 10.1097/00004872-199203000-00007; Kvochina L, 2007, AM J PHYSIOL-REG I, V293, pR2295, DOI 10.1152/ajpregu.00365.2007; Lawrence AJ, 1996, PROG NEUROBIOL, V48, P21, DOI 10.1016/0301-0082(95)00034-8; Lee B Y, 1995, J Spinal Cord Med, V18, P75; Lujan HL, 2010, AM J PHYSIOL-REG I, V299, pR985, DOI 10.1152/ajpregu.00329.2010; Maiorov DN, 1997, AM J PHYSIOL-HEART C, V273, pH1266, DOI 10.1152/ajpheart.1997.273.3.H1266; Matsumura K, 1998, AM J PHYSIOL-REG I, V275, pR1611, DOI 10.1152/ajpregu.1998.275.5.R1611; Milligan J, 2012, CAN FAM PHYSICIAN, V58, P831; Nunes FC, 2011, J RENIN-ANGIO-ALDO S, V12, P440, DOI 10.1177/1470320310394891; Nunes FC, 2011, J RENIN-ANGIO-ALDO S; Pan B, 2007, AM J PHYSIOL-REG I, V293, pR178, DOI 10.1152/ajpregu.00044.2007; Paton JFR, 2008, J MOL MED, V86, P705, DOI 10.1007/s00109-008-0324-4; Phillips AA, 2012, J NEUROTRAUM, V29, P2431, DOI 10.1089/neu.2012.2507; SCHREIHOFER AM, 1994, AM J PHYSIOL, V266, pR1705, DOI 10.1152/ajpregu.1994.266.5.R1705; Shan ZY, 2013, HYPERTENSION, V61, P1328, DOI 10.1161/HYPERTENSIONAHA.111.00156; Teasell RW, 2000, ARCH PHYS MED REHAB, V81, P506, DOI 10.1053/mr.2000.3848; Wang WZ, 2007, AM J PHYSIOL-REG I, V292, pR1137, DOI 10.1152/ajpregu.00590.2006; Wehrwein Erica A, 2013, Handb Clin Neurol, V117, P89, DOI 10.1016/B978-0-444-53491-0.00008-0; Wu MY, 2007, BRAIN RES, V1156, P80, DOI 10.1016/j.brainres.2007.04.065; Yamakawa H, 2003, REGUL PEPTIDES, V111, P117, DOI 10.1016/S0167-0115(02)00264-1; Yao FR, 2008, AM J PHYSIOL-HEART C, V294, pH2712, DOI 10.1152/ajpheart.00729.2007; Yoshimura R, 2000, J CARD FAIL, V6, P66, DOI 10.1016/S1071-9164(00)00013-0	40	1	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181495	10.1371/journal.pone.0181495	http://dx.doi.org/10.1371/journal.pone.0181495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742157	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700047
J	Dave, E; Ozbek, U; Gupta, V; Genden, E; Miles, B; Teng, M; Posner, M; Misiukiewicz, K; Bakst, RL				Dave, Eesha; Ozbek, Umut; Gupta, Vishal; Genden, Eric; Miles, Brett; Teng, Marita; Posner, Marshall; Misiukiewicz, Krzysztof; Bakst, Richard L.			The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer	PLOS ONE			English	Article								Introduction Despite the human papillomavirus conferring a better prognosis in the primary treatment setting, the prognostic impact of viral status after treatment failure in oropharyngeal squamous cell carcinoma patients is poorly understood. Methods We retrospectively identified 33 oropharyngeal squamous cell carcinoma (OPC) patients with local and/or distant disease recurrence post-treatment, and looked at metastatic patterns, time to failure and survival patterns by HPV status. Results Median overall survival following local failure was not significantly different by HPV status (17 months for HPV+ vs. 14 months for HPV-, p = 0.23). However, following distant failures, HPV+ patients lived significantly longer than HPV- patients (median 42 months vs. 11 months, p = 0.004). HPV- patients were more likely to have locoregional failures as compared to HPV+ patients (p = 0.005), but the difference in distant failure between both groups was not significant (p = 0.09). HPV+ patients were more likely to develop metastases to sites other than the lung and bones. Conclusion HPV positivity predicts a favorable prognosis with the potential for long-term survival following distant, not locoregional, failures. These results have important implications for the aggressiveness of treatment and type of surveillance imaging performed.	[Dave, Eesha] Icahn Sch Med, Dept Med Educ, New York, NY USA; [Ozbek, Umut] Mt Sinai Hosp, Dept Populat Sci & Policy, New York, NY 10029 USA; [Gupta, Vishal; Bakst, Richard L.] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA; [Genden, Eric; Miles, Brett; Teng, Marita] Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA; [Posner, Marshall; Misiukiewicz, Krzysztof] Icahn Sch Med Mt Sinai, Dept Hematol Oncol, Tisch Canc Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Bakst, RL (corresponding author), Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA.	richard.bakst@mountsinai.org			NATIONAL CANCER INSTITUTE [P30CA196521] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA196521] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Argiris A, ANN ONCOLOGY OFFICIA; Dang RP, ANTICANCER RES; Fakhry C, J NATL CANC I; Goodman MT, EUROPEAN J CANC; Huang SH, 2013, ORAL ONCOL, V49, P79, DOI 10.1016/j.oraloncology.2012.07.015; Kano S, INT J CLIN ONCOLOGY, P817; Mouw KW, CLIN CANC RES OFFICI, P1117; NCCN Clinical Practice Guidelines in Oncology, 2013, NCCN CLIN PRACT GUID, P2; OSullivan B, RADIOTHERAPY ONCOLOG; Posner MR, ANN ONCOLOGY OFFICIA; Trosman SJ, JAMA OTOLARYNGOLOGY, P2168; Wang MB, OTOLARYNGOLOGY HEAD	13	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181108	10.1371/journal.pone.0181108	http://dx.doi.org/10.1371/journal.pone.0181108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732044	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100023
J	Feng, D; Wang, YW; Lu, TG; Zhang, ZG; Han, X				Feng, Dan; Wang, Yanwei; Lu, Tiegang; Zhang, Zhiguo; Han, Xiao			Proteomics analysis reveals a dynamic diurnal pattern of photosynthesis-related pathways in maize leaves	PLOS ONE			English	Article							KEY PATHWAYS; ACID; ARABIDOPSIS; DEHYDROGENASE; TRANSCRIPTOME; CARBOXYLASE; MECHANISM; DROUGHT; GROWTH	Plant leaves exhibit differentiated patterns of photosynthesis rates under diurnal light regulation. Maize leaves show a single-peak pattern without photoinhibition at midday when the light intensity is maximized. This mechanism contributes to highly efficient photosynthesis in maize leaves. To understand the molecular basis of this process, an isobaric tag for relative and absolute quantitation (iTRAQ)-based proteomics analysis was performed to reveal the dynamic pattern of proteins related to photosynthetic reactions. Steady, single-peak and double-peak protein expression patterns were discovered in maize leaves, and antenna proteins in these leaves displayed a steady pattern. In contrast, the photosystem, carbon fixation and citrate pathways were highly controlled by diurnal light intensity. Most enzymes in the limiting steps of these pathways were major sites of regulation. Thus, maize leaves optimize photosynthesis and carbon fixation outside of light harvesting to adapt to the changes in diurnal light intensity at the protein level.	[Feng, Dan; Wang, Yanwei; Lu, Tiegang; Zhang, Zhiguo; Han, Xiao] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhang, ZG; Han, X (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	lutiegang@caas.cn; hanxiao@caas.cn	han, xiao/CAI-6839-2022; han, xiao/CAG-0473-2022	han, xiao/0000-0002-4557-1304; 	National Key Basic Research Program of China [2015CB150103]; National Nature Science Foundation [31471166]; collaborative project of the Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences [CMS-XTCX2016002]; Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	National Key Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); collaborative project of the Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences; Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences	This work was support by National Key Basic Research Program of China (project number. 2015CB150103), National Nature Science Foundation (project number: 31471166), the collaborative project of the Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences (CMS-XTCX2016002) and Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences to TG Lu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD B, 1953, J BIOL CHEM, V204, P939; Bagard M, 2015, ENVIRON POLLUT, V206, P411, DOI 10.1016/j.envpol.2015.07.046; Belcher S, 2015, BBA-BIOENERGETICS, V1847, P1004, DOI 10.1016/j.bbabio.2015.02.014; BOWES G, 1971, BIOCHEM BIOPH RES CO, V45, P716, DOI 10.1016/0006-291X(71)90475-X; Cao PJ, 2012, RICE, V5, DOI 10.1186/1939-8433-5-17; Chan AyeNyein, 2015, American Journal of Plant Sciences, V6, P2209, DOI 10.4236/ajps.2015.613223; Chikov VI, 2016, RUSS J PLANT PHYSL+, V63, P620, DOI 10.1134/S1021443716050034; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Ding ZS, 2015, PHOTOSYNTHETICA, V53, P481, DOI 10.1007/s11099-015-0126-1; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Facella P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002798; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Fries M, 2003, BIOCHEMISTRY-US, V42, P6996, DOI 10.1021/bi027397z; Ghimire B, 2015, J MAIZE RES DEV, V1, P134, DOI 10.3126/jmrd.v1i1.14251; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; HATHAWAY JA, 1963, J BIOL CHEM, V238, P2875; Haydon MJ, 2013, NATURE, V502, P689, DOI 10.1038/nature12603; Ifuku K, 2014, PLANT PHYSIOL BIOCH, V81, P108, DOI 10.1016/j.plaphy.2014.01.001; Joriczyk M, 2011, PLOS ONE, V6, P366; KAUFMAN S, 1955, J BIOL CHEM, V216, P153; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; Knuesting J, 2015, PLANT PHYSIOL, V167, P1643, DOI 10.1104/pp.15.00049; Ludwig M, 2013, PHOTOSYNTH RES, V117, P147, DOI 10.1007/s11120-013-9853-y; MAZELIS M, 1957, PLANT PHYSIOL, V32, P591, DOI 10.1104/pp.32.6.591; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Murchie EH, 2009, NEW PHYTOL, V181, P532, DOI 10.1111/j.1469-8137.2008.02705.x; Neiff N, 2016, HIGH TEMPERATURES FL; OCHOA S, 1954, ADV ENZYMOL REL S BI, V15, P183; Ono K, 2015, PLANT PROD SCI, V6, P281; Perduns R, 2015, PLANT PHYSIOL, V168, P1378, DOI 10.1104/pp.15.00934; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Sachanowicz K, 2012, PURIFICATION PROPERT, P437; Samira M, 2015, AFRICAN CROP SCI J, V628, P1; Schoning JC, 2005, FEBS LETT, V579, P3246, DOI 10.1016/j.febslet.2005.03.028; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Sugiyama N, 2001, PLANT J, V26, P607, DOI 10.1046/j.1365-313x.2001.01063.x; Tang N, 2015, RES J BIOTECHNOL, V10, P89; Tovar-Mendez A, 2000, PLANT PHYSIOL, V123, P149, DOI 10.1104/pp.123.1.149; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; VANROOYEN JPG, 1994, J INHERIT METAB DIS, V17, P738, DOI 10.1007/BF00712017; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; WALKER DA, 1960, BIOCHEM J, V74, P216, DOI 10.1042/bj0740216; WISHNICK M, 1969, J BIOL CHEM, V244, P5761; Yakir E, 2007, FEBS J, V274, P335, DOI 10.1111/j.1742-4658.2006.05616.x; Yan Xiao-hong, 2013, Shengtaixue Zazhi, V32, P604; Zhang Y, 2015, JMATERCHEMA, V3; Zhao Wen-Sai, 2016, Chinese Journal of Plant Ecology, V40, P594, DOI 10.17521/cjpe.2015.0345; Zhu YN, 2012, J SHENYANG AGR U	50	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180670	10.1371/journal.pone.0180670	http://dx.doi.org/10.1371/journal.pone.0180670			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732011	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100009
J	Goos, C; Dejung, M; Janzen, CJ; Butter, F; Kramer, S				Goos, Carina; Dejung, Mario; Janzen, Christian J.; Butter, Falk; Kramer, Susanne			The nuclear proteome of Trypanosoma brucei	PLOS ONE			English	Article							BLOOD-STREAM FORM; LIFE-CYCLE STAGES; FUNCTIONAL-CHARACTERIZATION; IDENTIFICATION; REVEALS; COMPLEX; EXOSOME; ROLES; SILAC; INTERFACE	Trypanosoma brucei is a protozoan flagellate that is transmitted by tsetse flies into the mammalian bloodstream. The parasite has a huge impact on human health both directly by causing African sleeping sickness and indirectly, by infecting domestic cattle. The biology of trypanosomes involves some highly unusual, nuclear-localised processes. These include polycistronic transcription without classical promoters initiated from regions defined by histone variants, trans-splicing of all transcripts to the exon of a spliced leader RNA, transcription of some very abundant proteins by RNA polymerase I and antigenic variation, a switch in expression of the cell surface protein variants that allows the parasite to resist the immune system of its mammalian host. Here, we provide the nuclear proteome of procyclic Trypanosoma brucei, the stage that resides within the tsetse fly midgut. We have performed quantitative label-free mass spectrometry to score 764 significantly nuclear enriched proteins in comparison to whole cell lysates. A comparison with proteomes of several experimentally characterised nuclear and non-nuclear structures and pathways confirmed the high quality of the dataset: the proteome contains about 80% of all nuclear proteins and less than 2% false positives. Using motif enrichment, we found the amino acid sequence KRxR present in a large number of nuclear proteins. KRxR is a sub-motif of a classical eukaryotic monopartite nuclear localisation signal and could be responsible for nuclear localization of proteins in Kinetoplastida species. As a proof of principle, we have confirmed the nuclear localisation of six proteins with previously unknown localisation by expressing eYFP fusion proteins. While proteome data of several T. brucei organelles have been published, our nuclear proteome closes an important gap in knowledge to study trypanosome biology, in particular nuclearrelated processes.	[Goos, Carina; Janzen, Christian J.; Kramer, Susanne] Univ Wurzburg, Bioctr, Dept Cell & Dev Biol, Wurzburg, Germany; [Dejung, Mario; Butter, Falk] Inst Mol Biol, Ackermannweg 4, Mainz, Germany	University of Wurzburg; Institute of Molecular Biology (IMB)	Kramer, S (corresponding author), Univ Wurzburg, Bioctr, Dept Cell & Dev Biol, Wurzburg, Germany.; Butter, F (corresponding author), Inst Mol Biol, Ackermannweg 4, Mainz, Germany.	f.butter@imb.de; susanne.kramer@uni-wuerzburg.de		Butter, Falk/0000-0002-7197-7279	DFG [Kr4017/1-2]	DFG(German Research Foundation (DFG))	This work was supported by DFG, www.dfg.de Kr4017/1-2 (SK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bessat M, 2009, MOL MICROBIOL, V71, P1371, DOI 10.1111/j.1365-2958.2009.06611.x; Bluhm A, 2016, PROTEOMICS, V16, P427, DOI 10.1002/pmic.201500217; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Butter F, 2013, MOL CELL PROTEOMICS, V12, P172, DOI 10.1074/mcp.M112.019224; Cassola A, 2010, RNA BIOL, V7, P339, DOI 10.4161/rna.7.3.12087; Clayton C, 2010, ADV EXP MED BIOL, V702, P39, DOI 10.1007/978-1-4419-7841-7_4; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; D'Archivio S, 2016, J CELL BIOL, V36; Dean S, 2017, TRENDS PARASITOL, V33, P80, DOI 10.1016/j.pt.2016.10.009; Dean S, 2016, P NATL ACAD SCI USA, V113, pE5135, DOI 10.1073/pnas.1604258113; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; DeGrasse Jeffrey A., 2008, V463, P77, DOI 10.1007/978-1-59745-406-3_6; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; DuBois KN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001287; Estevez AM, 2003, J BIOL CHEM, V278, P34943, DOI 10.1074/jbc.M305333200; Estevez AM, 2001, EMBO J, V20, P3831, DOI 10.1093/emboj/20.14.3831; Fadda A, 2013, RNA, V19, P937, DOI 10.1261/rna.038430.113; Gassen A, 2012, NUCLEIC ACIDS RES, V40, P10302, DOI 10.1093/nar/gks801; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Guther MLS, 2014, J PROTEOME RES, V13, P2796, DOI 10.1021/pr401209w; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kramer S, 2016, MOL BIOCHEM PARASIT, V205, P1, DOI 10.1016/j.molbiopara.2016.02.009; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Liu Q, 2004, J BIOL CHEM, V279, P18210, DOI 10.1074/jbc.M400678200; Lueong S, 2016, MOL MICROBIOL, V100, P457, DOI 10.1111/mmi.13328; Marchetti MA, 2000, J CELL SCI, V113, P899; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Nett IRE, 2009, MOL CELL PROTEOMICS, V8, P1527, DOI 10.1074/mcp.M800556-MCP200; Obado SO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002365; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Preusser C, 2012, INT J MED MICROBIOL, V302, P221, DOI 10.1016/j.ijmm.2012.07.004; Rout MP, 2001, J BIOL CHEM, V276, P38261; Santos Junior dos A de CM, 2015, PLOS ONE, V10; Shimogawa MM, 2015, MOL CELL PROTEOMICS, V14, P1977, DOI 10.1074/mcp.M114.045146; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; Subota I, 2014, MOL CELLULAR PROTEOM; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Tkacz ID, 2008, MOL BIOCHEM PARASIT, V160, P22, DOI 10.1016/j.molbiopara.2008.03.003; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	51	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181884	10.1371/journal.pone.0181884	http://dx.doi.org/10.1371/journal.pone.0181884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727848	Green Submitted, gold, Green Published			2022-12-26	WOS:000406634500111
J	Jakovac, CC; Dutrieux, LP; Siti, L; Pena-Claros, M; Bongers, F				Jakovac, Catarina Conte; Dutrieux, Loic Paul; Siti, Latifah; Pena-Claros, Marielos; Bongers, Frans			Spatial and temporal dynamics of shifting cultivation in the middle-Amazonas river: Expansion and intensification	PLOS ONE			English	Article							FOREST-AGRICULTURE FRONTIERS; LAND-USE; SWIDDEN AGRICULTURE; DEFORESTATION; ACCESSIBILITY; RESOURCES; LANDSCAPE; DRIVERS; IMPACT; CARBON	Shifting cultivation is the main land-use system transforming landscapes in riverine Amazonia. Increased concentration of the human population around villages and increasing market integration during the last decades may be causing agricultural intensification. Studies have shown that agricultural intensification, i.e. higher number of swidden-fallow cycles and shorter fallow periods, reduces crop productivity of swiddens and the regrowth capacity of fallows, undermining the resilience of the shifting cultivation system as a whole. We investigated the temporal and spatial dynamics of shifting cultivation in Brazilian Amazonia to test the hypotheses that (i) agriculture has become more intensive over time, and (ii) patterns of land-use intensity are related to land accessibility and human population density. We applied a breakpoint-detection algorithm to Landsat time-series spanning three decades (1984-2015) and retrieved the temporal dynamics of shifting cultivation fields, which go through alternating phases of crop production (swidden) and secondary forest regrowth (fallow). We found that fallow-period length has decreased from 6.4 to 5.1 years on average, and that expansion over old-growth forest has slowed down over time. Shorter fallow periods and higher frequency of slash and burn cycles are practiced closer to residences and around larger villages. Our results indicate that shifting cultivation in riverine Amazonia has gone through a process of agricultural intensification in the past three decades. The resulting landscape is predominantly covered by young secondary forests (<= 12 yrs old), and 20% of it have gone through intensive use. Reversing this trend and avoiding the negative consequences of agricultural intensification requires land use planning that accounts for the constraints of land use in riverine areas.	[Jakovac, Catarina Conte] Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil; [Jakovac, Catarina Conte; Pena-Claros, Marielos; Bongers, Frans] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Dutrieux, Loic Paul; Siti, Latifah] Wageningen Univ & Res, Lab Geoinformat Sci & Remote Sensing, Wageningen, Netherlands	Institute Nacional de Pesquisas da Amazonia; Wageningen University & Research; Wageningen University & Research	Jakovac, CC (corresponding author), Inst Nacl de Pesquisas da Amazonia, Manaus, Amazonas, Brazil.; Jakovac, CC (corresponding author), Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands.	catacj@gmail.com	Jakovac, Catarina/P-7599-2018	Jakovac, Catarina/0000-0002-8130-852X; Dutrieux, Loic/0000-0002-5058-2526; Pena-Claros, Marielos/0000-0001-9134-6733	Wageningen University [11/00220]; NUFFIC [NFP 3246/11]; Comissao Nacional de Etica em Pesquisa-CONEP [20361713.7.0000.0006]; Direct For Biological Sciences [1147429] Funding Source: National Science Foundation	Wageningen University(European Commission); NUFFIC; Comissao Nacional de Etica em Pesquisa-CONEP; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was financially supported by Wageningen University (Sandwich grant 11/00220; NL; http.//www.wur.nl/en/Education-Programmes/PhD-Programme/Funding-your-PhD. htm) and by NUFFIC (NFP 3246/11; NL; https//www.epnuffic.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the farmers who authorized and contributed to this research. We also thank Luke Parry for contributing information on the location and size of villages of the study area, and Patrick Jansen for assistance with statistical analysis. This research is in accordance with the Brazilian regulation on ethics in research, under project number 20361713.7.0000.0006, approved by the Comissao Nacional de Etica em Pesquisa-CONEP and Comite de Etica em Pesquisa from the Instituto Nacional de Pesquisas da Amazonia (Br).	Adams C, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P1, DOI 10.1007/978-1-4020-9283-1; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P765, DOI 10.1111/j.1529-8817.2003.00756.x; Asner GP, 2001, INT J REMOTE SENS, V22, P3855, DOI 10.1080/01431160010006926; Barber CP, 2014, BIOL CONSERV, V177, P203, DOI 10.1016/j.biocon.2014.07.004; BOSERUP E., 1965, The conditions of agricultural growth. The economics of agrarian change under population pressure.; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Brondizio E, 2009, AMAZON PEASANT SOCIETIES IN A CHANGING ENVIRONMENT, P181, DOI 10.1007/978-1-4020-9283-1_9; Castella JC, 2005, APPL GEOGR, V25, P308, DOI 10.1016/j.apgeog.2005.07.003; Coomes OT, 2000, ECOL ECON, V32, P109, DOI 10.1016/S0921-8009(99)00066-X; Coppin P, 2004, INT J REMOTE SENS, V25, P1565, DOI 10.1080/0143116031000101675; Core-Team R-D, 2013, R LANG ENV STAT COMP; Dalle SP, 2006, ECOL SOC, V11; Dalle SP, 2011, ECOL APPL, V21, P1557, DOI 10.1890/10-0700.1; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Dutrieux LP, 2016, INT J APPL EARTH OBS, V47, P112, DOI 10.1016/j.jag.2015.11.018; Dutrieux LP, 2015, ISPRS J PHOTOGRAMM, V107, P112, DOI 10.1016/j.isprsjprs.2015.03.015; Eloy L, 2015, B LAT AM RES, V34, P1, DOI 10.1111/blar.12268; Emperaire L, 2015, B LAT AM RES, V34, P70, DOI 10.1111/blar.12176; Emperaire L, 2012, CAH AGRIC, V21, P25, DOI 10.1684/agr.2012.0537; ESRI, 2012, ARCGIS DESKT 10 1; Fox J, 2009, HUM ECOL, V37, P305, DOI 10.1007/s10745-009-9240-7; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; IBGE, 2013, PRODES; Jakovac CC, 2016, AGR ECOSYST ENVIRON, V218, P116, DOI 10.1016/j.agee.2015.11.013; Jakovac CC, 2015, J ECOL, V103, P67, DOI 10.1111/1365-2745.12298; Johnson CM, 2001, FOREST ECOL MANAG, V147, P245, DOI 10.1016/S0378-1127(00)00466-7; Kauffman JB, 2009, ECOL APPL, V19, P1211, DOI 10.1890/08-1696.1; Kawa NC, 2013, CURR ANTHROPOL, V54, P764, DOI 10.1086/673528; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Latifah SH, 2015, THESIS; Lawrence D, 1998, LANDSCAPE ECOL, V13, P135, DOI 10.1023/A:1007985915187; Lawrence D, 2007, P NATL ACAD SCI USA, V104, P20696, DOI 10.1073/pnas.0705005104; Li P, 2014, REMOTE SENS-BASEL, V6, P1654, DOI 10.3390/rs6021654; MORAN EF, 1993, HUM ECOL, V21, P1, DOI 10.1007/BF00890069; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Padoch C, 2008, ECOL SOC, V13; Parry L, 2010, POPUL ENVIRON, V32, P137, DOI 10.1007/s11111-010-0127-8; Parry L, 2010, CONSERV LETT, V3, P251, DOI 10.1111/j.1755-263X.2010.00106.x; Pereira H.S., 1994, REV U AMAZONAS CA, V3, P1; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Salonen M, 2012, APPL GEOGR, V32, P501, DOI 10.1016/j.apgeog.2011.06.017; Siren AH, 2007, HUM ECOL, V35, P669, DOI 10.1007/s10745-006-9089-y; Soler LD, 2009, APPL GEOGR, V29, P182, DOI 10.1016/j.apgeog.2008.09.005; Therneau T.M., 2000, MODELING SURVIVAL DA; Turner BL, 1996, P NATL ACAD SCI USA, V93, P14984, DOI 10.1073/pnas.93.25.14984; van Breugel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082433; van Vliet N, 2013, SOC NATUR RESOUR, V26, P1454, DOI 10.1080/08941920.2013.820813; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; Vance C, 2002, AGR ECON-BLACKWELL, V27, P317, DOI 10.1111/j.1574-0862.2002.tb00123.x; Vogt ND, 2015, SOC NAT RES, P1, DOI DOI 10.1080/08941920.2015.1014603; Vosti SA, 2002, AGR INTENSIFICATION; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zuur A, 2009, MIXED EFFECTS MODELS	54	43	43	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181092	10.1371/journal.pone.0181092	http://dx.doi.org/10.1371/journal.pone.0181092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727828	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500039
J	Xiao, SL; Li, YG; Wong, TW; Hui, DSC				Xiao, Shenglan; Li, Yuguo; Wong, Tze-Wai; Hui, David S. C.			Role of fomites in SARS transmission during the largest hospital outbreak in Hong Kong	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; SUPER-SPREADERS; AIR-FLOW; INFLUENZA; INFECTION; VIRUS; CONTAMINATION; PREVENTION; PATIENT	The epidemic of severe acute respiratory syndrome (SARS) had a significant effect on global society in the early 2000s and the potential of its resurgence exists. Studies on the modes of transmission of SARS are limited though a number of outbreak studies have revealed the possible airborne route. To develop more specific and effective control strategies, we conducted a detailed mechanism-based investigation that explored the role of fomite transmission in the well-known Ward 8A outbreak. We considered three hypothetical transmission routes, i.e., the long-range airborne, fomite and combined routes, in 1,744 scenarios with combinations of some important parameters. A multi-agent model was used to predict the infection risk distributions of the three hypothetical routes. Model selection was carried out for different scenarios to compare the distributions of infection risk with that of the reported attack rates and select the hypotheses with the best fitness. Our results reveal that under the assumed conditions, the SARS coronavirus was most possible to have spread via the combined long-range airborne and fomite routes, and that the fomite route played a non-negligible role in the transmission.	[Xiao, Shenglan; Li, Yuguo] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Wong, Tze-Wai] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Hui, David S. C.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Xiao, SL (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.	u3002980@hku.hk	Li, Yuguo/A-9469-2010; Shenglan, Xiao/M-9801-2019; Hui, David Shu-Cheong/O-2754-2015	Li, Yuguo/0000-0002-2281-4529; Shenglan, Xiao/0000-0002-6265-9199; Hui, David Shu-Cheong/0000-0003-4382-2445	Research Grants Council (RGC) General Research Fund (GRF) of the Hong Kong SAR Government [17205014]; Research Grants Council (RGC) Theme-based Research Scheme (TRS) of the Hong Kong SAR Government [T11-705/14-N]	Research Grants Council (RGC) General Research Fund (GRF) of the Hong Kong SAR Government; Research Grants Council (RGC) Theme-based Research Scheme (TRS) of the Hong Kong SAR Government	The study was supported by an Research Grants Council (RGC) General Research Fund (GRF) grant (No. 17205014) and an Research Grants Council (RGC) Theme-based Research Scheme (TRS) grant (No. T11-705/14-N) of the Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chen C, 2011, J R SOC INTERFACE, V8, P699, DOI 10.1098/rsif.2010.0486; Chen YC, 2004, EMERG INFECT DIS, V10, P782, DOI 10.3201/eid1005.030579; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016; DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005; Dowell SF, 2004, CLIN INFECT DIS, V39, P652, DOI 10.1086/422652; Draper NR, 1966, APPL REGRESSION ANAL, V3; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Gao X., 2011, THESIS; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gryphon Scientific, 2015, SUPPL INF DOS RESP P; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Legislative Council Select Committee, 2003, OUTBR PRINC WAL HOSP; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li Y, 2005, INDOOR AIR, V15, P96, DOI 10.1111/j.1600-0668.2004.00318.x; Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x; Li YG, 2000, BUILD ENVIRON, V35, P191, DOI 10.1016/S0360-1323(99)00011-6; McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06; Nicas M, 2009, RISK ANAL, V29, P1292, DOI 10.1111/j.1539-6924.2009.01253.x; Otter JA, 2016, J HOSP INFECT, V92, P235, DOI 10.1016/j.jhin.2015.08.027; Peckham R., 2016, HAS SARS GONE STRANG; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Samuel H., 2014, DAILY TELEGRAPH; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Shirato K, 2012, J GEN VIROL, V93, P1908, DOI 10.1099/vir.0.043117-0; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; WHO, 2004, SUMM PROB SARS CAS O; Wolff MH, 2005, BIRK ADV INFECT DIS, P201; Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013; Wong RSM, 2004, EMERG INFECT DIS, V10, P339, DOI 10.3201/eid1002.030645; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; World Health Organisation, CHIN LAT SARS OUTBR; World Health Organization, 2016, SIT UPD SARS; World Health Organization, 2003, AL VER PUBL HLTH MAN; World Health Organization, 2003, SEV AC RESP SYNDR SA; World Health Organization, SEV AC RESP SYNDR SA; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	45	65	68	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181558	10.1371/journal.pone.0181558	http://dx.doi.org/10.1371/journal.pone.0181558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727803	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500086
J	Bassi, R; Burgoyne, JR; DeNicola, GF; Rudyk, O; DeSantis, V; Charles, RL; Eaton, P; Marber, MS				Bassi, Rekha; Burgoyne, Joseph R.; DeNicola, Gian F.; Rudyk, Olena; DeSantis, Vittorio; Charles, Rebecca L.; Eaton, Philip; Marber, Michael S.			Redox-dependent dimerization of p38 alpha mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MAP KINASE; HYDROGEN-PEROXIDE; SIMULATED ISCHEMIA; OXIDATIVE STRESS; CELL-SURVIVAL; MURINE MODEL; FATTY-ACIDS; P38 MAPK; REPERFUSION	The kinase p38 alpha MAPK (p38 alpha) plays a pivotal role in many biological processes. p38 alpha is activated by canonical upstream kinases that phosphorylate the activation region. The purpose of our study was to determine whether such activation may depend on redox-sensing cysteines within p38 alpha. p38 alpha was activated and formed a disulfide-bound heterodimer with MAP2K3 (MKK3) in rat cardiomyocytes and isolated hearts exposed to H2O2. This disulfide heterodimer was sensitive to reduction by mercaptoethanol and was enhanced by the thioredoxin-reductase inhibitor auranofin. We predicted that Cys-119 or Cys-162 of p38 alpha, close to the known MKK3 docking domain, were relevant for these redox characteristics. The C119S mutation decreased whereas the C162S mutation increased the dimer formation, suggesting that these two Cys residues act as vicinal thiols, consistent with C119S/C162S being incapable of sensing H2O2. Similarly, disulfide heterodimer formation was abolished in H9C2 cells expressing both MKK3 and p38 alpha C119S/C162S and subjected to simulated ischemia and reperfusion. However, the p38 alpha C119S/C162S mutants did not exhibit appreciable alteration in activating dual phosphorylation. In contrast, the anti-inflammatory agent 10-nitro-oleic acid (NO2-OA), a component of the Mediterranean diet, reduced p38 alpha activation and covalently modified Cys-119/Cys-162, probably obstructing MKK3 access. Moreover, NO2-OA reduced the dephosphorylation of p38 alpha by hematopoietic tyrosine phosphatase (HePTP). Furthermore, steric obstruction of Cys-119/Cys-162 by NO2-OA pretreatment in Langendorff-perfused murine hearts prevented the p38-MKK3 disulfide dimer formation and attenuated H2O2-induced contractile dysfunction. Our findings suggest that cysteine residues within p38 alpha act as redox sensors that can dynamically regulate the association between p38 and MKK3.	[Bassi, Rekha; Burgoyne, Joseph R.; DeNicola, Gian F.; Rudyk, Olena; DeSantis, Vittorio; Charles, Rebecca L.; Eaton, Philip; Marber, Michael S.] Kings Coll London British Heart Fdn Ctr Excellenc, St Thomas Hosp, Dept Cardiol, Rayne Inst, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Marber, MS (corresponding author), KCL, Rayne Inst, Cardiovasc Div, St Thomas Hosp Campus, London SE1 7EH, England.	mike.marber@kcl.ac.uk	marber, michael/AAW-7916-2021; Rudyk, Olena/AAY-3789-2020; Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Charles, Rebecca/0000-0003-4115-6135; Rudyk, Olena/0000-0001-9422-9233; Burgoyne, Joseph/0000-0001-7325-7382; Marber, Michael/0000-0002-3463-7128	British Heart Foundation [SP/14/2/30922]; Medical Research Council [MR/J007501/1]; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; Department of Health via Clinical Research Facilities awards; King's College London; King's College Hospital NHS Foundation Trust; MRC [MR/P023150/1, G0600785, G0700320, G1000458, MR/K003232/1, MR/L009684/1, MR/J007501/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C503646/1] Funding Source: researchfish; British Heart Foundation [PG/17/44/33064, PG/10/98/28655, PG/13/13/30018, RG/12/12/29872, FS/11/45/28859, PG/15/26/31373, FS/14/57/31138, FS/14/29/30896, FS/14/1/30551] Funding Source: researchfish; Medical Research Council [MR/P023150/1, MR/L009684/1, MR/K003232/1, G0600785, G1000458, G0700320] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Department of Health via Clinical Research Facilities awards; King's College London(General Electric); King's College Hospital NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by British Heart Foundation Grant SP/14/2/30922 and Medical Research Council Grant MR/J007501/1. This work was also supported by the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre and Clinical Research Facilities awards to Guy and St. Thomas NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Akella R, 2010, STRUCTURE, V18, P1571, DOI 10.1016/j.str.2010.09.015; Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Bellahcene M, 2006, J AM COLL CARDIOL, V48, P545, DOI 10.1016/j.jacc.2006.02.072; Bukhtiyarova M, 2004, PROTEIN EXPRES PURIF, V37, P154, DOI 10.1016/j.pep.2004.05.017; Burgoyne JR, 2011, BIOCHEM SOC T, V39, P1260, DOI 10.1042/BST0391260; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Charles RL, 2014, P NATL ACAD SCI USA, V111, P8167, DOI 10.1073/pnas.1402965111; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; De Nicola GF, 2013, NAT STRUCT MOL BIOL, V20, P1182, DOI 10.1038/nsmb.2668; Diao YR, 2010, P NATL ACAD SCI USA, V107, P20974, DOI 10.1073/pnas.1007225107; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Engelbrecht A-M, 2004, BASIC RES CARDIOL, V99, P338, DOI 10.1007/s00395-004-0478-3; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Groeger AL, 2010, MOL INTERV, V10, P39, DOI 10.1124/mi.10.1.7; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Klinke A, 2014, AM J RESP CELL MOL, V51, P155, DOI 10.1165/rcmb.2013-0063OC; Liu HY, 2008, AM J PHYSIOL-RENAL, V295, pF942, DOI 10.1152/ajprenal.90236.2008; Longen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29808; Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; Matsumoto Y, 2000, MOL CELL BIOCHEM, V204, P97, DOI 10.1023/A:1007042611127; Meldrum DR, 1998, SURGERY, V124, P291, DOI 10.1067/msy.1998.90570; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Mockridge JW, 2000, BIOCHEM BIOPH RES CO, V270, P947, DOI 10.1006/bbrc.2000.2522; Patel SB, 2004, BBA-PROTEINS PROTEOM, V1696, P67, DOI 10.1016/j.bbapap.2003.09.009; Punn A, 2000, BIOCHEM J, V350, P891, DOI 10.1042/0264-6021:3500891; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Sanchez R, 2008, PROTEIN SCI, V17, P473, DOI 10.1110/ps.073252408; Saurin AT, 2000, FASEB J, V14, P2237, DOI 10.1096/fj.99-0671com; SHATTOCK MJ, 1982, PHARMACOLOGY, V24, P118, DOI 10.1159/000137585; Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Yamada T, 2012, FREE RADICAL BIO MED, V52, P1285, DOI 10.1016/j.freeradbiomed.2012.02.003; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zimmer KM, 1997, MOL CELL BIOCHEM, V176, P171, DOI 10.1023/A:1006812003834	40	19	19	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16161	16173		10.1074/jbc.M117.785410	http://dx.doi.org/10.1074/jbc.M117.785410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28739872	hybrid, Green Published			2022-12-26	WOS:000412109400016
J	Fuentes, EG; Hernandez-Suarez, E; Simon, O; Williams, T; Caballero, P				Gabriel Fuentes, Ernesto; Hernandez-Suarez, Estrella; Simon, Oihane; Williams, Trevor; Caballero, Primitivo			Chrysodeixis chalcites nucleopolyhedrovirus (ChchNPV): Natural occurrence and efficacy as a biological insecticide on young banana plants in greenhouse and open-field conditions on the Canary Islands	PLOS ONE			English	Article							EXIGUA MULTIPLE NUCLEOPOLYHEDROVIRUS; NUCLEAR POLYHEDROSIS-VIRUS; SPODOPTERA-EXIGUA; BEET ARMYWORM; HELICOVERPA-ARMIGERA; LEPIDOPTERA; POPULATIONS; NOCTUIDAE; BACULOVIRUSES; FORMULATIONS	Chrysodeixis chalcites, an important pest of banana crops on the Canary Islands, is usually controlled by chemical insecticides. The present study aimed to evaluate the efficacy of the most prevalent isolate of the Chrysodeixis chalcites nucleopolyhedrovirus (ChchNPV, Baculoviridae) as a biological insecticide. Overall the prevalence of ChchNPV infection in C. chalcites populations was 2.3% (103 infected larvae out of 4,438 sampled), but varied from 0-4.8% on Tenerife and was usually low (0-2%) on the other islands. On Tenerife, infected larvae were present at 11 out of 17 plantations sampled. The prevalence of infection in larvae on bananas grown under greenhouse structures was significantly higher (3%) than in open-field sites (1.4%). The ChchNPV-TF1 isolate was the most abundant and widespread of four genetic variants of the virus. Application of 1.0x10(9) viral occlusion bodies (OBs)/l of ChchNPV-TF1 significantly reduced C. chalcites foliar damage in young banana plants as did commonly used pesticides, both in greenhouse and open-field sites. The insecticidal efficacy of ChchNPV-TF1 was similar to that of indoxacarb and a Bacillus thuringiensis (Bt)-based insecticide in one year of trials and similar to Bt in the following year of trails in greenhouse and field crops. However, larvae collected at different time intervals following virus treatments and reared in the laboratory experienced 2-7 fold more mortality than insects from conventional insecticide treatments. This suggests that the acquisition of lethal dose occurred over an extended period (up to 7 days) compared to a brief peak in larvae on plants treated with conventional insecticides. These results should prove useful for the registration of a ChchNPV-based insecticide for integrated management of this pest in banana crops on the Canary Islands.	[Gabriel Fuentes, Ernesto; Hernandez-Suarez, Estrella] Inst Canario Invest Agr, Dept Protecc Vegetal, San Cristobal la Laguna, Tenerife, Spain; [Simon, Oihane; Caballero, Primitivo] CSIC Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Caballero, Primitivo] Univ Publ Navarra, Dept Agr Prod, Campus Arrosadia S-N, Navarra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Instituto de Ecologia - Mexico; Universidad Publica de Navarra	Caballero, P (corresponding author), CSIC Gobierno Navarra, Inst Agrobiotecnol, Navarra, Spain.; Caballero, P (corresponding author), Univ Publ Navarra, Dept Agr Prod, Campus Arrosadia S-N, Navarra, Spain.	pcm92@unavarra.es	Caballero, Primitivo/D-5063-2009; Williams, Trevor/ABG-3961-2020; Suárez, ESTRELLA Hernández/AAB-2466-2019; Williams, Trevor/F-1447-2011; Simon, Oihane/G-5703-2014	Caballero, Primitivo/0000-0003-0065-9625; Williams, Trevor/0000-0003-3414-3440; Hernandez Suarez, Estrella/0000-0002-4240-800X; Simon, Oihane/0000-0003-1239-1486	National Institute of the Agricultural Research from the Spanish Ministry of Economy, Industry and Competitiveness [RTA2010-00016-C02, RTA2013-00114-C02]; Spanish Ministry for Science and Technology [AGL2014-57752-C02-1R]	National Institute of the Agricultural Research from the Spanish Ministry of Economy, Industry and Competitiveness; Spanish Ministry for Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study received financial support from the National Institute of the Agricultural Research from the Spanish Ministry of Economy, Industry and Competitiveness project numbers RTA2010-00016-C02 and RTA2013-00114-C02 and from the Spanish Ministry for Science and Technology AGL2014-57752-C02-1R). E. G. F. received a student scholarship from National Institute of the Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrizubieta M, 2014, PEST MANAG SCI, V70, P967, DOI 10.1002/ps.3637; Barrera-Cubillos Gloria Patricia, 2017, Acta Agron., V66, P267, DOI 10.15446/acag.v66n2.54354; Belda J. E., 2000, Boletin de Sanidad Vegetal, Plagas, V26, P619; Bernal A, 2013, BIOL CONTROL, V67, P101, DOI 10.1016/j.biocontrol.2013.08.006; Biswas D., 2003, Entomon, V28, P179; Caballero P., 1992, Biocontrol Science and Technology, V2, P35, DOI 10.1080/09583159209355215; Caballero P, 2014, European Patent WO, Patent No. [2014161974 A1, 2014161974]; Cabello T, ACTIVIDAD ALIMENTACI; Carnero A, 2011, PHYTOMA ESP, V225, P21; Cherry AJ, 2000, CROP PROT, V19, P51, DOI 10.1016/S0261-2194(99)00089-7; Cory JS, 2009, J ANIM ECOL, V78, P646, DOI 10.1111/j.1365-2656.2008.01519.x; Cory JS, 2005, J INVERTEBR PATHOL, V89, P101, DOI 10.1016/j.jip.2005.03.008; Costa HS, 2002, J ECON ENTOMOL, V95, P113, DOI 10.1603/0022-0493-95.1.113; Dominguez E, 2012, CALIDAD SOSTENIBILID, P145; Eberle KE, 2012, INTEGRATED PEST MANAGEMENT, P281, DOI 10.1079/9781845938086.0281; Erlandson M, 2007, BIOL CONTROL, V41, P256, DOI 10.1016/j.biocontrol.2007.01.011; Erlandson Martin A., 2009, Virologica Sinica, V24, P458, DOI 10.1007/s12250-009-3052-1; Flint M.L., 1981, INTRO INTEGRATED PES; Gómez Valderrama Juliana Andrea, 2010, Rev. Fac. Nac. Agron. Medellín, V63, P5511; Graham RI, 2004, J INVERTEBR PATHOL, V87, P29, DOI 10.1016/j.jip.2004.06.002; Grzywacz D, 2008, CROP PROT, V27, P17, DOI 10.1016/j.cropro.2007.04.005; Gupta R. K., 2007, International Journal of Virology, V3, P45; HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157; Hodgson DJ, 2002, ECOL LETT, V5, P512, DOI 10.1046/j.1461-0248.2002.00338.x; Horowitz AR, 1998, PHYTOPARASITICA, V26, P231, DOI 10.1007/BF02981438; HUGHES PR, 1981, J INVERTEBR PATHOL, V37, P154, DOI 10.1016/0022-2011(81)90069-0; IGNOFFO CM, 1992, ENVIRON ENTOMOL, V21, P210, DOI 10.1093/ee/21.1.210; Knox C, 2015, BIOCONTROL SCI TECHN, V25, P1, DOI 10.1080/09583157.2014.949222; Kolodny-Hirsch DM, 1997, BIOCONTROL SCI TECHN, V7, P475, DOI 10.1080/09583159730550; Lasa R, 2007, BIOCONTROL SCI TECHN, V17, P221, DOI 10.1080/09583150701211335; Lasa R, 2007, BIOL CONTROL, V40, P89, DOI 10.1016/j.biocontrol.2006.06.015; MAPAMA, 2016, SUP PROD AN CULT AC; Moscardi F, 1999, ANNU REV ENTOMOL, V44, P257, DOI 10.1146/annurev.ento.44.1.257; Ordonez-Garcia Magali, 2015, Florida Entomologist, V98, P843; Pedigo LP., 1996, ENTOMOLOGY PEST MANA, V2nd ed; Perera S., 2007, CULTIVO ECOLOGICO PL, P77; ROBERTSON JL, 1995, J ECON ENTOMOL, V88, P1, DOI 10.1093/jee/88.1.1; ROBINSON JC, 2010, BANANAS AND PLANTAIN; RUBERSON JR, 1994, FLA ENTOMOL, V77, P440, DOI 10.2307/3495698; Sauco VG, 1998, ACTA HORTIC, P247, DOI 10.17660/ActaHortic.1998.490.25; Simon O, 2015, PEST MANAG SCI, V71, P1623, DOI 10.1002/ps.3969; Valicente FH, SOC ENTOMOL	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7								10.1371/journal.pone.0181384	http://dx.doi.org/10.1371/journal.pone.0181384			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750003	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700041
J	Kishimoto, M; Akashi, M; Tsuji, K; Kusumoto, J; Furudoi, S; Shibuya, Y; Inui, Y; Yakushijin, K; Kawamoto, S; Okamura, A; Matsuoka, H; Komori, T				Kishimoto, Megumi; Akashi, Masaya; Tsuji, Kazuyuki; Kusumoto, Junya; Furudoi, Shungo; Shibuya, Yasuyuki; Inui, Yumiko; Yakushijin, Kimikazu; Kawamoto, Shinichiro; Okamura, Atsuo; Matsuoka, Hiroshi; Komori, Takahide			Intensity and duration of neutropenia relates to the development of oral mucositis but not odontogenic infection during chemotherapy for hematological malignancy	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; PULMONARY INFECTION; DENTAL MANAGEMENT; D-INDEX; CARE; PROTOCOL; PREDICT; CANCER	Background D-index which combines the intensity and duration of neutropenia is reported as a tool for evaluating the dynamics of neutropenia. This study aimed to analyze the relationship between D-index and oral complications (i.e., oral mucositis [OM] and odontogenic infection [OI]) during chemotherapies for hematological malignancies. Methods A total of 421 chemotherapeutic courses in 104 patients were analyzed. Chemotherapeutic courses in patients who finished all of the prophylactic dental treatments were defined as "treatment Finish". Chemotherapeutic courses in patients who did not finish prophylactic dental treatments were defined as "treatment not-Finish". OM was evaluated according to the Common Terminology Criteria for Adverse Events, version 4.0. D-index was compared between chemotherapeutic courses with versus without oral complications. Results D-index was significantly higher in chemotherapeutic courses with grade 1 or 2 OM (p < 0.001) than courses without OM. In contrast, higher D-index did not relate to the development of OI (p = 0.18). The occurrence of OI (p < 0.001) but not OM (p = 0.56) during chemotherapy was significantly higher in chemotherapeutic courses without the completion of dental intervention. Conclusions Higher D-index relates to the development of OM. In contrast, OI occurs due to untreated odontogenic foci, and its occurrence does not relate to higher D-index.	[Kishimoto, Megumi; Akashi, Masaya; Tsuji, Kazuyuki; Kusumoto, Junya; Furudoi, Shungo; Komori, Takahide] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan; [Shibuya, Yasuyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Oral & Maxillofacial Surg, Nagoya, Aichi, Japan; [Inui, Yumiko; Yakushijin, Kimikazu; Kawamoto, Shinichiro; Matsuoka, Hiroshi] Kobe Univ, Grad Sch Med, Dept Med, Dept Med Oncol Hematol, Kobe, Hyogo, Japan; [Okamura, Atsuo] Kakogawa West City Hosp, Div Med Oncol Hematol, Kakogawa, Hyogo, Japan	Kobe University; Nagoya City University; Kobe University	Akashi, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan.	akashim@med.kobe-u.ac.jp	Akashi, Masaya/X-9847-2019; Kusumoto, Junya/AAR-4910-2021	Kusumoto, Junya/0000-0003-4289-1852				Akashi M, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-41; Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Elad S, 2008, ORAL ONCOL, V44, P37, DOI 10.1016/j.oraloncology.2006.12.006; Elad S, 2015, SUPPORT CARE CANCER, V23, P223, DOI 10.1007/s00520-014-2378-x; Epstein JB, 2014, SUPPORT CARE CANCER, V22, P1981, DOI 10.1007/s00520-014-2228-x; Epstein JB, 2009, ORAL SURG ORAL MED O, V107, P301, DOI 10.1016/j.tripleo.2008.12.006; Ishihara Y, 2016, HEMATOLOGY, V21, P19, DOI 10.1179/1607845415Y.0000000051; Kashiwazaki H, 2012, SUPPORT CARE CANCER, V20, P367, DOI 10.1007/s00520-011-1116-x; Kimura S, 2014, HEMATOLOGY, V19, P107, DOI 10.1179/1607845413Y.0000000103; Kubota K, 2015, SUPPORT CARE CANCER, V23, P3323, DOI 10.1007/s00520-015-2774-x; Leppla L, 2016, SUPPORT CARE CANCER, V24, P773, DOI 10.1007/s00520-015-2843-1; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Portugal RD, 2009, J CLIN ONCOL, V27, P3849, DOI 10.1200/JCO.2008.21.0856; Tomblyn M, 2009, BONE MARROW TRANSPL, V44, P453, DOI 10.1038/bmt.2009.254; Tsuji K, 2015, J DENT RES, V94, P289, DOI 10.1177/0022034514561768; Yamagata K, 2006, BONE MARROW TRANSPL, V38, P237, DOI 10.1038/sj.bmt.1705429	16	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182021	10.1371/journal.pone.0182021	http://dx.doi.org/10.1371/journal.pone.0182021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750016	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700115
J	Kuen, J; Darowski, D; Kluge, T; Majety, M				Kuen, Janina; Darowski, Diana; Kluge, Tobias; Majety, Meher			Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; T-CELL IMMUNITY; EXPRESSION; ACTIVATION; IMPACT; LYMPHOCYTES; RESISTANCE; CARCINOMA; SURVIVAL; MARKERS	Pancreatic cancer (PC) remains one of the most challenging solid tumors to treat with a high unmet medical need as patients poorly respond to standard-of-care-therapies. Prominent desmoplastic reaction involving cancer-associated fibroblasts (CAFs) and the immune cells in the tumor microenvironment (TME) and their cross-talk play a significant role in tumor immune escape and progression. To identify the key cellular mechanisms induce an immunosuppressive tumor microenvironment, we established 3D co-culture model with pancreatic cancer cells, CAFs and monocytes. Using this model, we analyzed the influence of tumor cells and fibroblasts on monocytes and their immune suppressive phenotype. Phenotypic characterization of the monocytes after 3D co-culture with tumor/fibroblast spheroids was performed by analyzing the expression of defined cell surface markers and soluble factors. Functionality of these monocytes and their ability to influence T cell phenotype and proliferation was investigated. 3D co-culture of monocytes with pancreatic cancer cells and fibroblasts induced the production of immunosuppressive cytokines which are known to promote polarization of M2 like macrophages and myeloid derived suppressive cells (MDSCs). These co-culture spheroid polarized monocyte derived macrophages (MDMs) were poorly differentiated and had an M2 phenotype. The immunosuppressive function of these co-culture spheroids polarized MDMs was demonstrated by their ability to inhibit CD4+ and CD8+ T cell activation and proliferation in vitro, which we could partially reverse by 3D co-culture spheroid treatment with therapeutic molecules that are able to re-activated spheroid polarized MDMs or block immune suppressive factors such as Arginase-I.	[Kuen, Janina; Darowski, Diana; Kluge, Tobias; Majety, Meher] Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev, Discovery Oncol, Penzberg, Germany; [Darowski, Diana] Roche Innovat Ctr Zurich, Roche Pharma Res & Early Dev, Discovery Oncol, Schlieren, Switzerland	Roche Holding	Majety, M (corresponding author), Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev, Discovery Oncol, Penzberg, Germany.	meher.majety@roche.com			Roche Diagnostics GmbH	Roche Diagnostics GmbH	This study was funded internally by Roche Diagnostics GmbH. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; BERD D, 1994, CANCER IMMUNOL IMMUN, V39, P141, DOI 10.1007/BF01533378; Berghoff AS, 2014, CLIN NEUROPATHOL, V33, P42, DOI 10.5414/NP300698; Chand S, 2016, INT J BIOL SCI, V12, P273, DOI 10.7150/ijbs.14951; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Delitto D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1820-x; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Evans A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00270; Foley K, 2016, CANCER LETT, V381, P244, DOI 10.1016/j.canlet.2015.12.020; Grugan KD, 2012, J IMMUNOL, V189, P5457, DOI 10.4049/jimmunol.1201889; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Imamura Y, 2015, CANCER RES, P75; Inman KS, 2014, WORLD J GASTROENTERO, V20, P11160, DOI 10.3748/wjg.v20.i32.11160; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Koeck S, 2016, IMMUNOBIOLOGY, V221, P604, DOI 10.1016/j.imbio.2015.12.010; Kunk PR, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0119-z; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; LaBarbera DV, 2012, EXPERT OPIN DRUG DIS, V7, P819, DOI 10.1517/17460441.2012.708334; Ladanyi A, 2004, CLIN CANCER RES, V10, P521, DOI 10.1158/1078-0432.CCR-1161-03; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Linde N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040058; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Majety M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127948; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mielgo A, 2013, BMB REP, V46, P131, DOI 10.5483/BMBRep.2013.46.3.036; MIESCHER S, 1986, J IMMUNOL, V136, P1899; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nam KH, 2015, JALA-J LAB AUTOM, V20, P201, DOI 10.1177/2211068214557813; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Paniccia A, 2015, CHINESE J CANCER RES, V27, P376, DOI 10.3978/j.issn.1000-9604.2015.05.01; Protti MP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00210; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Schmieder A, 2012, SEMIN CANCER BIOL, V22, P289, DOI 10.1016/j.semcancer.2012.02.002; Sharda DR, 2011, J IMMUNOL, V187, P2181, DOI 10.4049/jimmunol.1003460; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Williams CB, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2015.25; Winograd R, 2015, CANCER IMMUNOL RES, V3, P399, DOI 10.1158/2326-6066.CIR-14-0215; Yang ZH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00533; Yeon SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073345; Yuan A, 2008, ADV CLIN CHEM, V45, P199, DOI 10.1016/S0065-2423(07)00008-X; Zhu YW, 2014, CLIN CANCER RES, V20, P3, DOI 10.1158/1078-0432.CCR-13-2573	46	102	103	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182039	10.1371/journal.pone.0182039	http://dx.doi.org/10.1371/journal.pone.0182039			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750018	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700119
J	Tubiana, T; Boulard, Y; Bressanelli, S				Tubiana, Thibault; Boulard, Yves; Bressanelli, Stephane			Dynamics and asymmetry in the dimer of the norovirus major capsid protein	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RAY SOLUTION SCATTERING; VIRUS-LIKE PARTICLES; MOLECULAR-DYNAMICS; MACROMOLECULES; NOMENCLATURE; SIMULATION; RESTRAINTS; COMPLEXES; PROGRAMS	Noroviruses are the major cause of non-bacterial acute gastroenteritis in humans and livestock worldwide, despite being physically among the simplest animal viruses. The icosahedral capsid encasing the norovirus RNA genome is made of 90 dimers of a single ca 60-kDa polypeptide chain, VP1, arranged with T = 3 icosahedral symmetry. Here we study the conformational dynamics of this main building block of the norovirus capsid. We use molecular modeling and all-atom molecular dynamics simulations of the VP1 dimer for two genogroups with 50% sequence identity. We focus on the two points of flexibility in VP1 known from the crystal structure of the genogroup I (GI, human) capsid and from subsequent cryo-electron microscopy work on the GII capsid (also human). First, with a homology model of the GIII (bovine) VP1 dimer subjected to simulated annealing then classical molecular dynamics simulations, we show that the N-terminal arm conformation seen in the GI crystal structure is also favored in GIII VP1 but depends on the protonation state of critical residues. Second, simulations of the GI dimer show that the VP1 spike domain will not keep the position found in the GII electron microscopy work. Our main finding is a consistent propensity of the VP1 dimer to assume prominently asymmetric conformations. In order to probe this result, we obtain new SAXS data on GI VP1 dimers. These data are not interpretable as a population of symmetric dimers, but readily modeled by a highly asymmetric dimer. We go on to discuss possible implications of spontaneously asymmetric conformations in the successive steps of norovirus capsid assembly. Our work brings new lights on the surprising conformational range encoded in the norovirus major capsid protein.	[Tubiana, Thibault; Boulard, Yves; Bressanelli, Stephane] Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Boulard, Y; Bressanelli, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, CEA,I2BC, Gif Sur Yvette, France.	yves.boulard@cea.fr; stephane.bressanelli@i2bc.paris-saclay.fr	Tubiana, Thibault/AAI-4268-2021	Tubiana, Thibault/0000-0002-6490-4602; Bressanelli, Stephane/0000-0002-0921-6727	Region Ile-de-France	Region Ile-de-France(Region Ile-de-France)	This work was supported by a grant from Region Ile-de-France to S.B. including predoctoral funding for T.T. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Case DA, 2006, AMBER; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eswar N., 2001, CURRENT PROTOCOLS PR; Evrard G, 2011, J APPL CRYSTALLOGR, V44, P1264, DOI 10.1107/S0021889811035758; Glass PJ, 2000, J VIROL, V74, P6581, DOI 10.1128/JVI.74.14.6581-6591.2000; Green K., 2013, FIELDS VIROLOGY, V1, P583; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansman GS, 2012, J VIROL, V86, P3635, DOI 10.1128/JVI.06868-11; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katpally U, 2008, J VIROL, V82, P2079, DOI 10.1128/JVI.02200-07; Koromyslova AD, 2015, J VIROL, V89, P2718, DOI 10.1128/JVI.03176-14; Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tresset G, 2013, J AM CHEM SOC, V135, P15373, DOI 10.1021/ja403550f; Tresset G, 2013, ARCH BIOCHEM BIOPHYS, V537, P144, DOI 10.1016/j.abb.2013.07.003; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Tubiana T, BIOINFORMA OXF ENGL; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	46	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182056	10.1371/journal.pone.0182056	http://dx.doi.org/10.1371/journal.pone.0182056			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750021	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700125
J	Verdino, A; Vigliotta, G; Giordano, D; Caputo, I; Soriente, A; De Rosa, M; Marabotti, A				Verdino, Anna; Vigliotta, Giovanni; Giordano, Deborah; Caputo, Ivana; Soriente, Annunziata; De Rosa, Margherita; Marabotti, Anna			Synthesis and biological evaluation of the progenitor of a new class of cephalosporin analogues, with a particular focus on structure-based computational analysis	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STEREOSELECTIVITY; CHALLENGES; RING	We present the synthesis and biological evaluation of the prototype of a new class of cephalosporins, containing an additional isolated beta lactam ring with two phenyl substituents. This new compound is effective against Gram positive microorganisms, with a potency similar to that of ceftriaxone, a cephalosporin widely used in clinics and taken as a reference, and with no cytotoxicity against two different human cell lines, even at a concentration much higher than the minimal inhibitory concentration tested. Additionally, a deep computational analysis has been conducted with the aim of understanding the contribution of its moieties to the binding energy towards several penicillin-binding proteins from both Gram positive and Gram negative bacteria. All these results will help us developing derivatives of this compound with improved chemical and biological properties, such as a broader spectrum of action and/or an increased affinity towards their molecular targets.	[Verdino, Anna; Vigliotta, Giovanni; Giordano, Deborah; Caputo, Ivana; Soriente, Annunziata; De Rosa, Margherita; Marabotti, Anna] Univ Salerno, Dept Chem & Biol A Zambelli, Fisciano, SA, Italy; [Giordano, Deborah] Italian Natl Res Council, Inst Food Sci, Avellino, Italy; [Giordano, Deborah] Univ Foggia, PhD Sch Hlth Food Innovat & Management, Foggia, FG, Italy	University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Foggia	De Rosa, M; Marabotti, A (corresponding author), Univ Salerno, Dept Chem & Biol A Zambelli, Fisciano, SA, Italy.	maderosa@unisa.it; amarabotti@unisa.it	Vigliotta, Giovanni/GPF-7237-2022; Giordano, Deborah/ABG-2697-2021; vigliotta, giovanni/AAW-6401-2020; De Rosa, Margherita/N-5449-2016	vigliotta, giovanni/0000-0001-5132-0037; Marabotti, Anna/0000-0002-9510-5205; De Rosa, Margherita/0000-0001-7451-5523	University of Salerno [151138, 161582, 143020, 158155, 132575]	University of Salerno	This work has been made in the frame of the projects FARB-ORSA 151138 and 161582 (for A. V., D. G., I. C., A. M.), FARB-ORSA 143020 and 158155 (for G.V.), FARB-ORSA 132575 (for A. S. and M. D. R.), funded by University of Salerno (http://www.unisa.it). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bianco G, 2016, PROTEIN SCI, V25, P295, DOI 10.1002/pro.2733; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bouley R, 2015, J AM CHEM SOC, V137, P1738, DOI 10.1021/jacs.5b00056; Ciliao HL, 2015, EXP TOXICOL PATHOL, V67, P179, DOI 10.1016/j.etp.2014.11.008; Coates A, 2002, NAT REV DRUG DISCOV, V1, P895, DOI 10.1038/nrd940; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De Rosa M, 2015, MOLECULES, V20, P22044, DOI 10.3390/molecules201219828; De Rosa M, 2013, EUR J MED CHEM, V69, P779, DOI 10.1016/j.ejmech.2013.09.035; Demain AL, 2012, ANTIBIOTICS CONTAINI; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Grimaldi M, 2010, BIOORGAN MED CHEM, V18, P7985, DOI 10.1016/j.bmc.2010.09.033; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Jiao L, 2006, J AM CHEM SOC, V128, P6060, DOI 10.1021/ja056711k; Ketenes Staudinger H., 1907, LIEBIGS ANN CHEM, V356, P51; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; King AM, 2016, ACS CHEM BIOL, V11, P864, DOI 10.1021/acschembio.5b00944; King DT, 2016, PROTEIN SCI, V25, P787, DOI 10.1002/pro.2889; Kishida H, 2006, BIOCHEMISTRY-US, V45, P783, DOI 10.1021/bi051533t; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Mersch-Sundermann V, 2004, TOXICOLOGY, V198, P329, DOI 10.1016/j.tox.2004.02.009; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; National Committee for Clinical Laboratory Standards, 2001, METH DIL ANT SUSC TE; Navratna V, 2010, J BACTERIOL, V192, P134, DOI 10.1128/JB.00822-09; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Page MGP, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P79, DOI 10.1007/978-1-4614-1400-1_3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers JH, 2004, CLIN MICROBIOL INFEC, V10, P23, DOI 10.1111/j.1465-0691.2004.1007.x; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sauvage E, 2007, J MOL BIOL, V371, P528, DOI 10.1016/j.jmb.2007.05.071; Sauvage E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098042; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Smith JD, 2013, ANTIMICROB AGENTS CH, V57, P3137, DOI 10.1128/AAC.00505-13; Wang YK, 2006, J ORG CHEM, V71, P6983, DOI 10.1021/jo0611521; Wang YB, 2011, MED CHEM, V7, P534, DOI 10.2174/157340611797928271; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yoshida H, 2012, J MOL BIOL, V423, P351, DOI 10.1016/j.jmb.2012.07.012; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181563	10.1371/journal.pone.0181563	http://dx.doi.org/10.1371/journal.pone.0181563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749999	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700058
J	Zago, M; Sheridan, JA; Traboulsi, H; Hecht, E; Zhang, YL; Guerrina, N; Matthews, J; Nair, P; Eidelman, DH; Hamid, Q; Baglole, CJ				Zago, Michela; Sheridan, Jared A.; Traboulsi, Hussein; Hecht, Emelia; Zhang, Yelu; Guerrina, Necola; Matthews, Jason; Nair, Parameswaran; Eidelman, David H.; Hamid, Qutayba; Baglole, Carolyn J.			Low levels of the AhR in chronic obstructive pulmonary disease (COPD)-derived lung cells increases COX-2 protein by altering mRNA stability	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NF-KAPPA-B; CIGARETTE-SMOKE; GENE-EXPRESSION; MEMBER; RELB; CYCLOOXYGENASE-2; TRANSCRIPTION; INFLAMMATION; FIBROBLASTS	Heightened inflammation, including expression of COX-2, is associated with chronic obstructive pulmonary disease (COPD) pathogenesis. The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is reduced in COPD-derived lung fibroblasts. The AhR also suppresses COX-2 in response to cigarette smoke, the main risk factor for COPD, by destabilizing the Cox-2 transcript by mechanisms that may involve the regulation of microRNA (miRNA). Whether reduced AhR expression is responsible for heightened COX-2 in COPD is not known. Here, we investigated the expression of COX-2 as well as the expression of miR-146a, a miRNA known to regulate COX-2 levels, in primary lung fibroblasts derived from non-smokers (Normal) and smokers (At Risk) with and without COPD. To confirm the involvement of the AhR, AhR knock-down via siRNA in Normal lung fibroblasts and MLE-12 cells was employed as were A549-AhR(ko) cells. Basal expression of COX-2 protein was higher in COPD lung fibroblasts compared to Normal or Smoker fibroblasts but there was no difference in Cox-2 mRNA. Knockdown of AhR in lung structural cells increased COX-2 protein by stabilizing the Cox-2 transcript. There was less induction of miR-146a in COPD-derived lung fibroblasts but this was not due to the AhR. Instead, we found that RelB, an NF-.B protein, was required for transcriptional induction of both Cox-2 and miR-146a. Therefore, we conclude that the AhR controls COX-2 protein via mRNA stability by a mechanism independent of miR-146a. Low levels of the AhR may therefore contribute to the heightened inflammation common in COPD patients.	[Zago, Michela; Sheridan, Jared A.; Traboulsi, Hussein; Eidelman, David H.; Hamid, Qutayba; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Hecht, Emelia; Baglole, Carolyn J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Zhang, Yelu; Hamid, Qutayba; Baglole, Carolyn J.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Guerrina, Necola; Eidelman, David H.; Hamid, Qutayba; Baglole, Carolyn J.] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Matthews, Jason] Univ Oslo, Dept Nutr, Oslo, Norway; [Nair, Parameswaran] McMaster Univ, Dept Med, Hamilton, ON, Canada	McGill University; McGill University; McGill University; McGill University; University of Oslo; McMaster University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Dept Pathol, Montreal, PQ, Canada.	Carolyn.baglole@McGill.ca		Matthews, Jason/0000-0002-9815-8636	Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR); Fonds de recherche du Quebec-Sante (FRQ-S); Canada Research Chair in Airway Inflammometry	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec-Sante (FRQ-S); Canada Research Chair in Airway Inflammometry(Canada Research Chairs)	This work was supported by the Canada Foundation for Innovation (CFI) and the Canadian Institutes of Health Research (CIHR). CJB was supported by a salary award from the Fonds de recherche du Quebec-Sante (FRQ-S). Dr Nair is supported by a Canada Research Chair in Airway Inflammometry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Canada Foundation for Innovation (CFI) and the Canadian Institutes of Health Research (CIHR). CJB was supported by a salary award from the Fonds de recherche du Quebec-Sante (FRQ-S). Dr Nair is supported by a Canada Research Chair in Airway Inflammometry. Acquisition of human lung tissue was facilitated by Katherine Radford, Department of Pathology, the Division of Thoracic Surgery and the Department of Pathology of St Joseph's Healthcare Hamilton, ON.	Ahmed S, 2013, TOXICOL SCI; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; de Souza AR, 2014, TOXICOL SCI, V140, P204, DOI 10.1093/toxsci/kfu068; de Souza AR, 2011, J BIOL CHEM, V286, P43214, DOI 10.1074/jbc.M111.258764; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Hanieh H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0443-9; Hecht E, 2014, TOXICOL APPL PHARM; Hockley SL, 2007, CHEM RES TOXICOL, V20, P1797, DOI 10.1021/tx700252n; Hu WX, 2013, J BIOL CHEM, V288, P22972, DOI 10.1074/jbc.M113.475624; HYMAN RW, 1970, J MOL BIOL, V50, P421, DOI 10.1016/0022-2836(70)90202-0; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Labonte LE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149974; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; LO D, 1992, AM J PATHOL, V141, P1237; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; McMillan DH, 2011, AM J PATHOL, V179, P125, DOI 10.1016/j.ajpath.2011.03.030; Newton R, 1997, BIOCHEM BIOPH RES CO, V237, P28, DOI 10.1006/bbrc.1997.7064; Petkova DK, 1999, CLIN EXP ALLERGY, V29, P965; Roh GS, 2010, AM J PHYSIOL-LUNG C, V299, pL184, DOI 10.1152/ajplung.00303.2009; RUBEN SM, 1992, GENE DEV, V6, P745, DOI 10.1101/gad.6.5.745; Rumzhum NN, 2016, CLIN EXP ALLERGY, V46, P397, DOI 10.1111/cea.12697; Sarill M, 2015, FREE RADIC BIOL MED, p[S0891, 00521]; Sato T, 2010, AM J RESP CRIT CARE; Scheffler S, 2015, INT J ENV RES PUB HE, V12, P12466, DOI 10.3390/ijerph121012466; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020; Zago M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074953; Zhang S, 2012, MOL CANCER THER, V11, P108, DOI 10.1158/1535-7163.MCT-11-0548	44	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180881	10.1371/journal.pone.0180881	http://dx.doi.org/10.1371/journal.pone.0180881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749959	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700023
J	Aguilera, O; Silva, GOA; Lopes, RT; Machado, AS; dos Santos, TM; Marques, G; Bertucci, T; Aguiar, T; Carrillo-Briceno, J; Rodriguez, F; Jaramillo, C				Aguilera, Orange; Andrade Silva, Guilherme Oliveira; Lopes, Ricardo Tadeu; Machado, Alessandra Silveira; dos Santos, Thais Maria; Marques, Gabriela; Bertucci, Thayse; Aguiar, Thayanne; Carrillo-Briceno, Jorge; Rodriguez, Felix; Jaramillo, Carlos			Neogene Proto-Caribbean porcupinefishes (Diodontidae)	PLOS ONE			English	Article							MIOCENE GATUN FORMATION; MARINE PALEOENVIRONMENTS; GUAJIRA PENINSULA; SEA CATFISHES; LA GUAJIRA; TETRAODONTIFORMES; FOSSIL; FISHES; ACANTHOMORPHA; PHYLOGENY	Fossil Diodontidae in Tropical America consist mostly of isolated and fused beak-like jawbones, and tooth plate batteries. These durophagous fishes are powerful shell-crushing predators on shallow water invertebrate faunas from Neogene tropical carbonate bottom, rocky reefs and surrounding flats. We use an ontogenetic series of high-resolution micro CT of fossil and extant species to recognize external and internal morphologic characters of jaws and tooth plate batteries. We compare similar sizes of jaws and/or tooth-plates from both extant and extinct species. Here, we describe three new fossil species including dagger Chilomycterus exspectatus n. sp. and dagger Chilomycterus tyleri n. sp. from the late Miocene Gatun Formation in Panama, and dagger Diodon serratus n. sp. from the middle Miocene Socorro Formation in Venezuela. Fossil Diodontidae review included specimens from the Neogene Basins of the Proto-Caribbean (Brazil: Pirabas Formation; Colombia: Jimol Formation, Panama: Gatun and Tuira formations; Venezuela: Socorro and Cantaure formations). Diodon is present in both the Atlantic and Pacific oceans, whereas the distribution of Chilomycterus is highly asymmetrical with only one species in the Pacific. It seems that Diodon was as abundant in the Caribbean/Western Atlantic during the Miocene as it is there today. We analyze the paleogeographic distribution of the porcupinefishes group in Tropical America, after the complete exhumation of the Panamanian isthmus during the Pliocene.	[Aguilera, Orange; Andrade Silva, Guilherme Oliveira; Marques, Gabriela; Bertucci, Thayse; Aguiar, Thayanne] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Niteroi, RJ, Brazil; [Aguilera, Orange; Andrade Silva, Guilherme Oliveira; Marques, Gabriela; Bertucci, Thayse; Aguiar, Thayanne] Univ Fed Fluminense, Inst Biol, Programa Posgrad Biol Marinha & Ambientes Costeir, Niteroi, RJ, Brazil; [Lopes, Ricardo Tadeu; Machado, Alessandra Silveira; dos Santos, Thais Maria] Fed Univ Rio de Janeiro UFRJ, COPPE, Nucl Instrumentat Lab, Nucl Engn Program, Rio De Janeiro, Brazil; [Carrillo-Briceno, Jorge] Univ Zurich, Palaeontol Inst & Museum, Karl Schmid Str 4, Zurich, Switzerland; [Rodriguez, Felix; Jaramillo, Carlos] Smithsonian Trop Res Inst, Balboa, Panama	Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; University of Zurich; Smithsonian Institution; Smithsonian Tropical Research Institute	Silva, GOA (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Niteroi, RJ, Brazil.; Silva, GOA (corresponding author), Univ Fed Fluminense, Inst Biol, Programa Posgrad Biol Marinha & Ambientes Costeir, Niteroi, RJ, Brazil.	guilhermeoas@id.uff.br	Lopes, Ricardo T/O-8840-2014; Aguilera, Orangel/D-5055-2013	Lopes, Ricardo T/0000-0001-7250-824X; Oliveira Andrade da Silva, Guilherme/0000-0003-2625-1089; jaramillo, carlos/0000-0002-2616-5079; Rodriguez, Felix/0000-0002-6015-7945; Aguilera, Orangel/0000-0003-4418-8351	Colciencias [121566044585]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was funded by the Colciencias grant 121566044585, "Causas y consecuencias de la acidificacion de ecosistemas humedos tropicales". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For their assistance, support and photographs of collection specimens the authors wish to thank John Lundberg, Kyle Luckenbill, Mark Sabaj and Ned Gilmore from the Academy of Natural Sciences of Philadelphia; John Maisey, Lorraine Meeker, Melanie Stiassny and Rad-ford Arrindell from the American Museum of Natural History; Alice Schumacher and Ursula Gohlich from the Natural History Museum of Vienna; Mark McGrouther from the Australian Museum; Sandrine Grouard and Philippe Bearez from the Natural History Museum of Paris; Walter Etter from the Naturhistorisches Museum of Basel; Jesus Pajon from the Museo Nacional de Historia Natural de La Havana; Luciana Carvalho from the Museu Nacional da Universidade Federal do Rio de Janeiro; Flavia Alessandra Figueiredo from the Museu of Geology da Universidade Federal do Rio de Janeiro; Athila Bertoncini from the Universidade do Rio de Janeiro and Mariana Lopes from the Universidade Federal Fluminense. Acacio Tomas from the Instituto de Pesca de Sao Paulo; Cristiano Albuquerque from the Universidade Federal Rural do Semi-Arido in Brazil, and Ross Robertson from the Smithsonian Tropical Research Institute in Panama. To Rodolfo Sanchez, Julio Reyes and Dione Rodrigues de Aguilera for his collaboration in the field activities, and to the Alcadia del Municipio de Urumaco and the Instituto del Patrimonio Cultural de Venezuela (IPC) for the authorization for collecting and study the specimens. We thank Cassiano Monteiro-Neto and Aguinaldo Nepomuceno for access to UFF laboratorial facilities. Special thanks to Aaron O'Dea from the Smithsonian Tropical Research Institute for supporting this contribution under the scope of the Caribbean reef-fish baseline project, the Ministry of Economy and Finance, Department of Mineral Resources of Panama, and to Celideth De Leon for assisting with the fossil collection permits in Panama. Thanks to the Departamento Nacional de Producao Mineral (DNPM) authorities for permission to conduct the field trip in Brazil, and thanks to Colciencias grant 121566044585 "Causas y consecuencias de la acidificacion de ecosistemas humedos tropicales. Una Mirada climatica y geologica durante el Neogeno de Suramerica". Many thanks to James Tyler, Werner Schwarzhans, John Lundberg, Geerat J. Vermeij (Academic Editor of PLoS One) and to anonymous reviewers who has greatly improved the manuscript.; This contribution was part of the regular course of paleontology from the Marine Biology and Coastal Environment post-graduation at Universidade Federal Fluminense in Brazil.	Agassiz L, 1843, RECHERCHES POISSONS, VIII, P1; Aguilera O, 2004, J PALEONTOL, V78, P1202, DOI 10.1666/0022-3360(2004)078<1202:GGPSFT>2.0.CO;2; Aguilera O, 2001, J PALEONTOL, V75, P732, DOI 10.1666/0022-3360(2001)075<0732:AECUFA>2.0.CO;2; Aguilera O. A., 2016, PALAEO ICHTHYOLOGICA, V14, P7; Aguilera OA, 2010, PECES FOSILES CARIBE; Aguilera O, 2014, J S AM EARTH SCI, V56, P422, DOI 10.1016/j.jsames.2014.09.021; Aguilera Orangel, 1999, Bulletins of American Paleontology, V357, P251; Aguilera Orangel, 2013, Swiss Journal of Palaeontology, V132, P99, DOI 10.1007/s13358-013-0051-5; Aguilera O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076202; Aguilera Orangel, 2012, Swiss Journal of Palaeontology, V131, P265, DOI 10.1007/s13358-012-0043-x; Aguilera Orangel, 2010, P103; Aguilera Orangel A., 2010, P129; Aguilera Orangel Antonio, 2013, Swiss Journal of Palaeontology, V132, P45, DOI 10.1007/s13358-013-0052-4; Aguilera Socorro Orangel, 2012, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V7, P29; Aguilera Socorro Orangel Antonio, 2011, Swiss Journal of Palaeontology, V130, P217, DOI 10.1007/s13358-011-0020-9; Aguirre-Fernandez G, 2017, J MAMM EVOL, V24, P71, DOI 10.1007/s10914-016-9353-x; Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; [Anonymous], 1928, MEMOIRES SOC PALEONT, V48, P1; [Anonymous], [No title captured]; [Anonymous], 1995, AM ASS PETROLEUM GEO; Arcila D, 2015, MOL PHYLOGENET EVOL, V82, P131, DOI 10.1016/j.ympev.2014.10.011; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Betancur-R R., 2013, PLOS CURR; Blonnm DD, 2017, J BIO GEOGR; Blow W. H., 1969, P199; Bonaparte CL, 1835, NUOVI ANN SCI NAT 1, V4, P181; Brisout de Bameville C., 1846, REV ZOOLOGIQUE PARIS, P136; Brito A., 1990, Vieraea, V19, P271; Buchs DM, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002901; Butzin M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001901; Carrillo-Briceno JD, 2016, PALAEONTOL ELECTRON, V19, P1; Carrillo-Briceno JD, 2016, AMEGHINIANA, V53, P77, DOI 10.5710/AMGH.26.10.2015.2931; Carrillo-Briceno JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139230; CASIER E, 1958, MEMOIRES SUISSES PAL, V74, P1, DOI DOI 10.1111/J.1463-6395.2011.00502.X; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Coates AG, 2003, GEOL SOC AM BULL, V115, P271, DOI 10.1130/0016-7606(2003)115<0271:ENHOTC>2.0.CO;2; Coates AG, 2013, B MAR SCI, V89, P801, DOI 10.5343/bms.2012.1076; Collins JSH, 2009, SCRIPTA GEOL, V138, P56; Collins Laurel S., 1999, Bulletins of American Paleontology, V357, P81; Cuvier GL, 1818, MEMOIRES MUSEUM NATL, V4, P121; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Diaz de Gamero M.L., 1974, B INFORM ASOCIACION, V17, P41; Donovan Stephen K., 1994, Caribbean Journal of Science, V30, P164; Eschmeyer W. N., 2015, CATALOG FISHES GENER; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Fernandes J.M.G., 1988, ANAIS C BRASILEIRO G, V35, P2376; Fernandes JMG, 1984, ANAIS ACAD BRASILEIR, V1, P330; Fernandes JMG, 1990, AN 36 C BRAS GEOL; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; FROESE R., 2022, US; Gallo V, 2009, CRETACEOUS RES, V30, P599, DOI 10.1016/j.cretres.2008.12.001; Goes A.M., 1990, B MUS PARA EMILIO GO, V2, P3; Hambalek N., 1994, BOLET N SOC VENEZOLA, V191, P7; Hendy AJW, 2015, SWISS J PALAEONTOL, V134, P45, DOI 10.1007/s13358-015-0074-1; Hendy AJW, 2013, PALAIOS, V28, P210, DOI 10.2110/palo.2012.p12-024r; Hoorn C, 2017, GLO PLANET CHANGE; Howe E., 1907, REPORT GEOLOGY CANAL, P108; Huizar AR, 2000, B CTR INVESTIG BIOL, V34, P181; Hunter V.F, 1974, B INFORM ASOCIACION, V17, P143; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Iturralde-Vinent Manuel A., 1998, Revista de la Sociedad Mexicana de Paleontologia A.C., V8, P123; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; Jaramillo C., 2016, MOUNTAINS CLIMATE BI; Jaramillo C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601693; Jaramillo CA, 2011, PALYNOLOGY, V35, P46, DOI 10.1080/01916122.2010.515069; Jordan D.S., 1897, P ACAD NAT SCI PHILA, V49, P91; JUNG PETER, 1965, BULL AMER PALEONTOL, V49, P389; Korff WL, 2004, ZOOLOGY, V107, P335, DOI 10.1016/j.zool.2004.09.001; Landau B, 2009, B SOC GEOL FR, V180, P343, DOI 10.2113/gssgfbull.180.4.343; Leidy J., 1877, J ACAD NATURAL SCI P, V8, P209; Leigh EG, 2013, BIOL REV; Leis Jeffrey M., 2006, Memoirs of Museum Victoria, V63, P77; LEIS JM, 1978, FISH B-NOAA, V76, P535; Leriche M., 1942, MEM SOC GEOL FR, V45, P4; Linnaeus C, 1758, SYSTEMA NATURAE REGN, V1, P1; MacFadden BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170300; Machado AC, 2015, APPL RADIAT ISOTOPES, V96, P129, DOI 10.1016/j.apradiso.2014.10.027; Martin K., 1883, PALAEONTOLOGISCHE ER, P380; Mihaljevic M, 2010, PALAEONTOL ELECTRON, V13; Molnar P, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602320; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; Moreno F, 2015, SWISS J PALAEONTOL, V134, P5, DOI 10.1007/s13358-015-0071-4; Near TJ, 2013, P NATL ACAD SCI USA, V110, P12738, DOI 10.1073/pnas.1304661110; Nolf Dirk, 1998, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V68, P237; O'Dea A, 2007, P NATL ACAD SCI USA, V104, P5501, DOI 10.1073/pnas.0610947104; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Petri S., 1957, Boletim Univ Sao Paulo Fac Filos Cienc Let, V216, P1; Petuch E.J., 2004, CENOZOIC SEAS VIEW E; PETUCH EJ, 1982, PALAEOGEOGR PALAEOCL, V37, P277, DOI 10.1016/0031-0182(82)90041-4; PETUCH EJ, 1988, NEOGENE HIST TROPICA; Pimiento C, 2013, J PALEONTOL, V87, P755, DOI 10.1666/12-117; Pindell JL, 2009, GEOL SOC SPEC PUBL, V328, P1, DOI 10.1144/SP328.1; Purdy RW, 2001, SM C PALEOB, V90, P71; Purdy RW, 1996, J VERTEBR PALEONTOL, V16, P165, DOI 10.1080/02724634.1996.10011294; Quiroz L.I, 2010, URUMACO VENEZUELAN P, P153; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Regali M., 1974, B TEC PETROBRAS, V17, P177; Regan C.T., 1929, ENCY BRITANNICA, V9, P305; Renz O., 1960, B GEOLOGICO PUBLICAC, V3, P317; Rey O.T, 1996, REV FACULTAD INGENIE, V11, P35; Robertson D. R., 2015, SHOREFISHES TROPICAL; Robertson D. Ross, 2004, Pacific Science, V58, P507, DOI 10.1353/psc.2004.0041; Robertson DR, 2015, SHOREFISHES GRATER C; ROSEN D E, 1984, American Museum Novitates, P1; Rossetti D.F., 2004, NE OGENO AMAZO NIA O, P13; Rossetti DD, 2001, J S AM EARTH SCI, V14, P77; Rossetti DF, 2013, EARTH-SCI REV, V123, P87, DOI 10.1016/j.earscirev.2013.04.005; Santini F, 2004, INTEGR COMP BIOL, V44, P349, DOI 10.1093/icb/44.5.349; Santini F, 2003, ZOOL J LINN SOC-LOND, V139, P565, DOI 10.1111/j.1096-3642.2003.00088.x; Santini F, 2013, MOL PHYLOGENET EVOL, V69, P177, DOI 10.1016/j.ympev.2013.05.014; Santos MEC, 1958, EQUINOIDES MIOCENICO, V179, P7; SANTOS RS, 1960, MONOGRAFIA DIVISAO G, V16, P1; Schneider B, 2006, EARTH PLANET SC LETT, V246, P367, DOI 10.1016/j.epsl.2006.04.028; Schultz Ortwin, 2006, Joannea Geologie und Palaeontologie, V8, P25; Schwarzhans W, 2016, PALAEO ICHTHYOL, V14, P91; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P83; Schweitzer CE, 2006, ANN CARNEGIE MUS, V75, P111, DOI 10.2992/0097-4463(2006)75[111:OAMDTA]2.0.CO;2; Sepulchre P, 2014, PALEOCEANOGRAPHY, V29, P176, DOI 10.1002/2013PA002501; Shaw G., 1804, GEN ZOOLOGY SYSTEMAT, V5; Steph S, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001092; Tavora V.A., 1999, REV GEOL AM CENT, V22, P63, DOI [10.15517/rgac.v0i22.8587, DOI 10.15517/RGAC.V0I22.8587]; Terrey R., 1926, OCCAS PAP CALIF ACAD, V23, P1; Thomas D. J, 1970, Boln inf. Asoc. venezol. Geol. Min. Petrol., V13, P177; Todd JA, 2002, P ROY SOC B-BIOL SCI, V269, P571, DOI 10.1098/rspb.2001.1923; Toula F., 1909, JUNGTERTIARE FAUNA V, V58, P687; Tyler J. C., 2009, J ICHTHYOL+, V49, P703; Tyler James C., 2002, Studi e Ricerche sui Giacimenti Terziari di Bolca, V9, P47; Tyler JC, 1980, 434 NOAA NMFS, P12743; Van Erve A. W., 1987, AM ASS STRATIGR PALY, V19, P7; Vermeij Geerat J., 2015, Bishop Museum Bulletins in Zoology, V9, P169; VERMEIJ GJ, 1980, BIOL BULL, V158, P383, DOI 10.2307/1540864; Walbaum JJ, 1792, ICHTHYOLOGIAE 3, Vi-viii, P1; Winterbottom R., 1974, Smithsonian Contributions to Zoology, VNo. 155, P1; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8; WOODRING W P, 1974, Verhandlungen der Naturforschenden Gesellschaft in Basel, V84, P209; WOODRING WP, 1957, US GEOLOGICAL SURV A, V306, P1; Yamanoue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017410	137	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181670	10.1371/journal.pone.0181670	http://dx.doi.org/10.1371/journal.pone.0181670			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746370	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000406371800049
J	Geiger, A; Niessen, E; Bente, G; Vogeley, K				Geiger, Alexander; Niessen, Eva; Bente, Gary; Vogeley, Kai			Eyes versus hands: How perceived stimuli influence motor actions	PLOS ONE			English	Article							VISUAL-ATTENTION; SPATIAL ATTENTION; GAZE DIRECTION; SOCIAL GAZE; ARROW CUES; REFLEXIVE; PERCEPTION; LOOKING; FACILITATION; INDIVIDUALS	Many studies showed that biological (e.g., gaze-shifts or hand movements) and non-biological stimuli (e.g., arrows or moving points) redirect attention. Biological stimuli seem to be more suitable than non-biological to perform this task. However, the question remains if biological stimuli do have different influences on redirecting attention and if this property is dependent on how we react to those stimuli. In two separate experiments, participants interact either with a biological or a non-biological stimulus (experiment 1), or with two biological stimuli (gaze-shifts, hand movements)(experiment 2) to which they responded with two different actions (saccade, button press), either in a congruent or incongruent manner. Results from experiment 1 suggest that interacting with the biological stimulus lead to faster responses, compared to the non-biological stimulus, independent of the response type. Results from experiment 2 show longer reaction times when the depicted stimulus was not matching the response type (e.g., reacting with hand movements to a moving object or gaze-shift) compared to a matching condition, while especially the gaze-following condition (reacting with a gaze shift to a perceived gaze shift) led to the fastest responses. These results suggest that redirecting attention is not only dependent on the perceived stimulus but also on the way how those stimuli are responded to.	[Geiger, Alexander; Niessen, Eva; Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM 3, Julich, Germany; [Geiger, Alexander; Vogeley, Kai] Univ Hosp Cologne, Dept Psychiat, Brain Imaging Lab, Cologne, Germany; [Bente, Gary] Univ Cologne, Fac Human Sci, Dept Psychol, Cologne, Germany; [Bente, Gary] Michigan State Univ, Dept Commun, E Lansing, MI 48824 USA	Helmholtz Association; Research Center Julich; University of Cologne; University of Cologne; Michigan State University	Geiger, A (corresponding author), Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM 3, Julich, Germany.; Geiger, A (corresponding author), Univ Hosp Cologne, Dept Psychiat, Brain Imaging Lab, Cologne, Germany.	al.geiger@fz-juelich.de	Niessen, Eva/H-8529-2017; Vogeley, Kai/E-4860-2012	Niessen, Eva/0000-0002-2801-0986; Vogeley, Kai/0000-0002-5891-5831				BARONCOHEN S, 1992, J CHILD PSYCHOL PSYC, V33, P1141, DOI 10.1111/j.1469-7610.1992.tb00934.x; Butterworth G, 2000, BRIT J DEV PSYCHOL, V18, P25, DOI 10.1348/026151000165553; BUTTERWORTH G, 1980, INT J BEHAV DEV, V3, P253, DOI 10.1177/016502548000300303; Calder AJ, 2002, NEUROPSYCHOLOGIA, V40, P1129, DOI 10.1016/S0028-3932(02)00008-8; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Crostella F, 2009, EXP BRAIN RES, V197, P143, DOI 10.1007/s00221-009-1900-8; Deak GO, 2008, INFANT BEHAV DEV, V31, P34, DOI 10.1016/j.infbeh.2007.06.004; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Eimer M, 1997, BIOL PSYCHOL, V46, P67, DOI 10.1016/S0301-0511(97)05254-X; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Friesen CK, 2005, BRAIN COGNITION, V57, P66, DOI 10.1016/j.bandc.2004.08.025; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; GIBSON JJ, 1963, AM J PSYCHOL, V76, P386, DOI 10.2307/1419779; Gregory NJ, 2016, EXP BRAIN RES, V234, P1351, DOI 10.1007/s00221-016-4627-3; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hietanen JK, 1999, NEUROREPORT, V10, P3443, DOI 10.1097/00001756-199911080-00033; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Macrae CN, 2002, PSYCHOL SCI, V13, P460, DOI 10.1111/1467-9280.00481; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfeiffer UJ, 2013, NEUROSCI BIOBEHAV R, V37, P2516, DOI 10.1016/j.neubiorev.2013.07.017; Quadflieg S, 2004, PSYCHON B REV, V11, P826, DOI 10.3758/BF03196708; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Schilbach L, 2012, AUTISM, V16, P151, DOI 10.1177/1362361311409258; Schilbach L, 2011, SOC COGN AFFECT NEUR, V6, P393, DOI 10.1093/scan/nsq067; Stevens SA, 2008, PSYCHON B REV, V15, P1148, DOI 10.3758/PBR.15.6.1148; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2003, DEV PSYCHOL, V39, P906, DOI 10.1037/0012-1649.39.5.906; Wang Y, 2011, BIOL LETTERS, V7, P7, DOI 10.1098/rsbl.2010.0279; ZAJONC RB, 1965, SCIENCE, V149, P269, DOI 10.1126/science.149.3681.269	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180780	10.1371/journal.pone.0180780	http://dx.doi.org/10.1371/journal.pone.0180780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8EN	28746352	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800019
J	Wilson, CR; Davies, NW; Corkrey, R; Wilson, AJ; Mathews, AM; Westmore, GC				Wilson, Calum R.; Davies, Noel W.; Corkrey, Ross; Wilson, Annabel J.; Mathews, Alison M.; Westmore, Guy C.			Receiver Operating Characteristic curve analysis determines association of individual potato foliage volatiles with onion thrips preference, cultivar and plant age	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; WESTERN FLOWER THRIPS; GREEN PEACH APHID; FRANKLINIELLA-OCCIDENTALIS; BEHAVIORAL MANIPULATION; RESISTANCE; THYSANOPTERA; RESPONSES; HOST; INFECTION	Tomato spotted wilt virus (TSWV) causes sporadic but serious disease in Australian potato crops. TSWV is naturally spread to potato by thrips of which Thrips tabaci is the most important. Prior studies indicated possible non-preference of potato cultivars to T. tabaci. Select potato cultivars were assessed for non-preference to T. tabaci in paired and group choice trials. Cultivars 'Bismark', 'Tasman' and 'King Edward' were less preferred than 'Atlantic', 'Russet Burbank' and 'Shepody'. Green leaf volatiles were sampled using solid-phase microextraction from the headspace of potato cultivars of two ages that differed in T. tabaci preference. Analysis of headspace volatile data using Receiver Operating Characteristic curves identified individual volatiles associated with T. tabaci preference and non-preference, young and old plants and individual cultivars. These data could be used to inform breeding programs for selection of T. tabaci resistance to assist with TSWV management, and biological testing of novel thrips management compounds.	[Wilson, Calum R.; Corkrey, Ross; Wilson, Annabel J.; Mathews, Alison M.; Westmore, Guy C.] Univ Tasmania UTAS, New Town Res Labs, TIA, Newtown, Tas, Australia; [Davies, Noel W.] UTAS, Cent Sci Lab, Hobart, Tas, Australia; [Mathews, Alison M.] Dept Agr & Food, S Perth, WA, Australia; [Westmore, Guy C.] Dept Primary Ind Pk Water & Environm, Kings Meadows, Tas, Australia	University of Tasmania; University of Tasmania; Government of Western Australia; Department of Agriculture & Food - Western Australia	Wilson, CR (corresponding author), Univ Tasmania UTAS, New Town Res Labs, TIA, Newtown, Tas, Australia.	Calum.Wilson@utas.edu.au	Davies, Noel W/J-7714-2014	Davies, Noel W/0000-0002-9624-0935; Wilson, Calum/0000-0001-5434-3816	Australian Research Council [LP0667635]; McCain Foods Australia Pty Ltd; Australian Postgraduate Award from the University of Tasmania	Australian Research Council(Australian Research Council); McCain Foods Australia Pty Ltd; Australian Postgraduate Award from the University of Tasmania	The study was partially supported by a grant from the Australian Research Council (Linkage scheme, LP0667635) and McCain Foods Australia Pty Ltd. GCW was in receipt of an Australian Postgraduate Award from the University of Tasmania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JA, 2005, AM J POTATO RES, V82, P255, DOI 10.1007/BF02853592; Abtew A, 2015, INSECTS, V6, P608, DOI 10.3390/insects6030608; Agelopoulos NG, 1998, J CHEM ECOL, V24, P1161, DOI 10.1023/A:1022442818196; Agelopoulos NG, 2000, J CHEM ECOL, V26, P497, DOI 10.1023/A:1005473825335; Ali S, 2014, CROP PROT, V62, P79; Aramburu J, 2003, PLANT PATHOL, V52, P407, DOI 10.1046/j.1365-3059.2003.00829.x; AVE DA, 1987, ENTOMOL EXP APPL, V44, P131, DOI 10.1007/BF00367620; BECK SD, 1965, ANNU REV ENTOMOL, V10, P207, DOI 10.1146/annurev.en.10.010165.001231; Berlandier FA, 1997, ANN APPL BIOL, V131, P297, DOI 10.1111/j.1744-7348.1997.tb05158.x; Bockstaller C, 2009, SUSTAINABLE AGRICULTURE, P725, DOI 10.1007/978-90-481-2666-8_44; BROADBENT AB, 1990, CAN ENTOMOL, V122, P1111, DOI 10.4039/Ent1221111-11; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cristescu SM, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046009; CURTIS CE, 1979, ENVIRON ENTOMOL, V8, P330, DOI 10.1093/ee/8.2.330; de Bokx JA, 1987, VIRUSES POTATO SEED; deKogel WJ, 1997, ENTOMOL EXP APPL, V82, P283, DOI 10.1046/j.1570-7458.1997.00142.x; Dickens JC, 2000, J CHEM ECOL, V26, P1265, DOI 10.1023/A:1005492229377; DOEDERLEIN TA, 1993, J ECON ENTOMOL, V86, P1706, DOI 10.1093/jee/86.6.1706; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Foster SP, 1997, ANNU REV ENTOMOL, V42, P123, DOI 10.1146/annurev.ento.42.1.123; FRASER RSS, 1990, ANNU REV PHYTOPATHOL, V28, P179, DOI 10.1146/annurev.py.28.090190.001143; GAUM WG, 1994, B ENTOMOL RES, V84, P487, DOI 10.1017/S0007485300032715; Hern A, 2004, NATURWISSENSCHAFTEN, V91, P77, DOI 10.1007/s00114-003-0484-6; Herrin B, 2002, HORTSCIENCE, V37, P802, DOI 10.21273/HORTSCI.37.5.802; Jericho Jr C, 2005, THESIS; JONES AT, 1987, ANN APPL BIOL, V111, P745, DOI 10.1111/j.1744-7348.1987.tb02033.x; Karlsson MF, 2009, J AGR FOOD CHEM, V57, P5903, DOI 10.1021/jf803730h; Khalilov LM, 1999, CHEM NAT COMPD+, V35, P422, DOI 10.1007/BF02282508; Koschier EH, 2000, J CHEM ECOL, V26, P2643, DOI 10.1023/A:1026470122171; Koschier EH, 2002, CROP PROT, V21, P419, DOI 10.1016/S0261-2194(01)00124-7; Koschier EH, 2006, ADV PHYTOMED, V3, P221; Kumar S, 2013, ANAL CHEM, V85, P6121, DOI 10.1021/ac4010309; Laothawornkitkul J, 2010, CROP PROT, V29, P872, DOI 10.1016/j.cropro.2010.03.003; Latham LJ, 1997, AUST J AGR RES, V48, P359, DOI 10.1071/A96084; Maharijaya A, 2011, EUPHYTICA, V177, P401, DOI 10.1007/s10681-010-0277-x; Maris PC, 2003, PHYTOPATHOLOGY, V93, P96, DOI 10.1094/PHYTO.2003.93.1.96; Metcalf RL, 1992, PLANT KAIROMONES INS; NAULT L R, 1973, Environmental Entomology, V2, P101, DOI 10.1093/ee/2.1.101; NORRIS DO, 1951, AUST J AGR RES, V2, P221, DOI 10.1071/AR9510221; NOTTINGHAM SF, 1991, J CHEM ECOL, V17, P1231, DOI 10.1007/BF01402946; Nyalugwe EP, 2012, PLANT DIS, V96, P43, DOI 10.1094/PDIS-04-11-0305; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; Painter RH, 1951, INSECT RESISTANCE CR; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pickett JA, 2006, WAG UR FRON, V16, P161; Rajabaskar D, 2013, AM J POTATO RES, V90, P171, DOI 10.1007/s12230-012-9282-z; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roggero Piero, 2002, Plant Dis, V86, P950, DOI 10.1094/PDIS.2002.86.9.950; Romeo John T, 2009, J Chem Ecol, V35, P1383, DOI 10.1007/s10886-009-9733-2; Stokes M.E., 2012, CATEGORICAL DATA ANA; Szafranek B, 2005, J AGR FOOD CHEM, V53, P2817, DOI 10.1021/jf040437g; Szendrei Z, 2010, ENTOMOL EXP APPL, V134, P201, DOI 10.1111/j.1570-7458.2009.00954.x; Turechek WW, 2008, PHYTOPATHOLOGY, V98, P359, DOI 10.1094/PHYTO-98-3-0359; van de Wetering F, 1998, ENTOMOL EXP APPL, V88, P9, DOI 10.1046/j.1570-7458.1998.00340.x; van Tol RWHM, 2007, ENTOMOL EXP APPL, V122, P69, DOI 10.1111/j.1570-7458.2006.00489.x; VERMA S. K., 1966, Indian Journal of Entomology, V28, P396; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Webster B, 2010, ANIM BEHAV, V79, P451, DOI 10.1016/j.anbehav.2009.11.028; Weissbecker B, 2000, J CHEM ECOL, V26, P1433, DOI 10.1023/A:1005535708866; Werner BJ, 2009, ENVIRON ENTOMOL, V38, P1429, DOI 10.1603/022.038.0511; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; Westmore GC, 2012, THESIS; Wilson C.R., 2014, APPL PLANT VIROLOGY; WILSON CR, 1990, ANN APPL BIOL, V116, P103, DOI 10.1111/j.1744-7348.1990.tb06589.x; WILSON CR, 1993, AUST J AGR RES, V44, P1891, DOI 10.1071/AR9931891; Wilson CR, 2001, PLANT PATHOL, V50, P402, DOI 10.1046/j.1365-3059.2001.00562.x; WOHLERS P, 1983, ENTOMOL EXP APPL, V33, P79, DOI 10.1111/j.1570-7458.1983.tb03236.x; YUDIN LS, 1988, ENVIRON ENTOMOL, V17, P522, DOI 10.1093/ee/17.3.522	70	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181831	10.1371/journal.pone.0181831	http://dx.doi.org/10.1371/journal.pone.0181831			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746359	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000406371800063
J	Contreras-Trevino, HI; Reyna-Rosas, E; Leon-Rodriguez, R; Ruiz-Ordaz, BH; Dinkova, TD; Cevallos, AM; Padilla-Noriega, L				Contreras-Trevino, Hugo I.; Reyna-Rosas, Edgar; Leon-Rodriguez, Renato; Ruiz-Ordaz, Blanca H.; Dinkova, Tzvetanka D.; Cevallos, Ana M.; Padilla-Noriega, Luis			Species A rotavirus NSP3 acquires its translation inhibitory function prior to stable dimer formation	PLOS ONE			English	Article							PROTEIN NSP3; RNA-BINDING; EXPRESSION; EIF4G; REPLICATION; RECOGNITION; INITIATION	Species A rotavirus non-structural protein 3 (NSP3) is a translational regulator that inhibits or, under some conditions, enhances host cell translation. NSP3 binds to the translation initiation factor eIF4G1 and evicts poly-(A) binding protein (PABP) from eIF4G1, thus inhibiting translation of polyadenylated mRNAs, presumably by disrupting the effect of PABP bound to their 3'-ends. NSP3 has a long coiled-coil region involved in dimerization that includes a chaperone Hsp90-binding domain (HS90BD). We aimed to study the role in NSP3 dimerization of a segment of the coiled-coil region adjoining the HS90BD. We used a vaccinia virus system to express NSP3 with point mutations in conserved amino acids in the coiled-coil region and determined the effects of these mutations on translation by metabolic labeling of proteins as well as on accumulation of stable NSP3 dimers by non-dissociating Western blot, a method that separates stable NSP3 dimers from the monomer/ dimerization intermediate forms of the protein. Four of five mutations reduced the total yield of NSP3 and the formation of stable dimers (W170A, K171E, R173E and R187E:K191E), whereas one mutation had the opposite effects (Y192A). Treatment with the proteasome inhibitor MG132 revealed that stable NSP3 dimers and monomers/dimerization intermediates are susceptible to proteasome degradation. Surprisingly, mutants severely impaired in the formation of stable dimers were still able to inhibit host cell translation, suggesting that NSP3 dimerization intermediates are functional. Our results demonstrate that rotavirus NSP3 acquires its function prior to stable dimer formation and remain as a proteasome target throughout dimerization.	[Contreras-Trevino, Hugo I.; Reyna-Rosas, Edgar] Univ Nacl Autonoma Mexico, Programa Maestria & Doctorado Ciencias Bioquim, Mexico City, DF, Mexico; [Contreras-Trevino, Hugo I.; Reyna-Rosas, Edgar; Padilla-Noriega, Luis] Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City, DF, Mexico; [Contreras-Trevino, Hugo I.; Reyna-Rosas, Edgar; Leon-Rodriguez, Renato; Ruiz-Ordaz, Blanca H.; Cevallos, Ana M.; Padilla-Noriega, Luis] Univ Nacl Autonoma Mexico, Dept Biol Mol & Biotecnol, Inst Invest Biomed, Mexico City, DF, Mexico; [Dinkova, Tzvetanka D.] Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Quim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Padilla-Noriega, L (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Microbiol & Parasitol, Mexico City, DF, Mexico.; Padilla-Noriega, L (corresponding author), Univ Nacl Autonoma Mexico, Dept Biol Mol & Biotecnol, Inst Invest Biomed, Mexico City, DF, Mexico.	lpadilla@unam.mx	Dinkova, Tzvetanka/AAE-6073-2020; Dinkova, Tzvetanka/L-5678-2019; Cevallos, Ana Maria/B-7234-2018	Dinkova, Tzvetanka/0000-0001-7971-525X; Cevallos, Ana Maria/0000-0002-0753-7420; Padilla-Noriega, Luis/0000-0002-1121-144X	Consejo Nacional de Ciencia y Tecnologia [CB2011/168046, I0012/264230]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT); Direccion General de Asuntos del Personal Academic (DGAPA)	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Direccion General de Asuntos del Personal Academic (DGAPA)	This work was supported by two grants to LPN from the Consejo Nacional de Ciencia y Tecnologia (CB2011/168046 and I0012/264230), and one grant to LPN from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academic (DGAPA),	Black EP, 1996, J VIROL, V70, P47, DOI 10.1128/JVI.70.1.47-54.1996; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Dutta D, 2011, J BIOL CHEM, V286, P20065, DOI 10.1074/jbc.M111.231878; Elroy-Stein O, 2001, CURR PROTOC MOL  MAY; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Gratia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145998; Gratia M, 2015, J VIROL, V89, P8773, DOI 10.1128/JVI.01402-15; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Harb M, 2008, J VIROL, V82, P11283, DOI 10.1128/JVI.00872-08; Leppek K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt956; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Michel YM, 2000, J BIOL CHEM, V275, P32268, DOI 10.1074/jbc.M004304200; Padilla-Noriega L, 2002, VIROLOGY, V298, P1, DOI 10.1006/viro.2002.1477; Patton JT, 2007, ADV VIRUS RES, V69, P167, DOI 10.1016/S0065-3527(06)69004-0; Piron M, 1999, J VIROL, V73, P5411, DOI 10.1128/JVI.73.7.5411-5421.1999; Piron M, 1998, EMBO J, V17, P5811, DOI 10.1093/emboj/17.19.5811; Rubio RM, 2013, J VIROL, V87, P6336, DOI 10.1128/JVI.00361-13; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006; Vende P, 2000, J VIROL, V74, P7064, DOI 10.1128/JVI.74.15.7064-7071.2000; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773	23	3	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181871	10.1371/journal.pone.0181871	http://dx.doi.org/10.1371/journal.pone.0181871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738064	Green Submitted, Green Published, gold			2022-12-26	WOS:000406362700082
J	Haga, F; Maruko, R; Sato, C; Kataoka, K; Ito, Y; Terasaki, H				Haga, Fuminori; Maruko, Ruka; Sato, Chiaki; Kataoka, Keiko; Ito, Yasuki; Terasaki, Hiroko			Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study	PLOS ONE			English	Article							SUBFOVEAL CHOROIDAL THICKNESS; HUMAN EYES; VERTEPORFIN; CORTICOSTEROIDS; RETINOPATHY; RISK	Purpose To evaluate the long-term efficacy and factors involved in the recurrence and persistence of subretinal fluid (SRF) after half-dose photodynamic therapy (PDT) for chronic central serous chorioretinopathy (CSC). Methods In this retrospective observational case series, 79 eyes (73 patients) with chronic CSC were treated with half-dose PDT and followed up for at least 3 years. They were divided into successful (64 eyes) and unsuccessful (15 eyes) groups based on SRF absorption and disease recurrence after one PDT session. Age, best-corrected visual acuity (BCVA), central foveal thickness, neuroretinal thickness, height of SRF, subfoveal choroidal thickness, window defect area detected by fluorescein angiography, and PDT spot area were compared between the groups. Factors associated with PDT success and BCVA at 3 years were investigated. Results LogMAR BCVA improved from 0.21 +/- 0.24 to 0.08 +/- 0.16 (P<0.001) at 3 years after PDT. Compared with the unsuccessful group, the successful group had a significantly younger mean age (50.5 +/- 9.7 vs. 56.5 +/- 9.1 years, P = 0.032) and better baseline BCVA (0.18 +/- 0.23 vs. 0.32 +/- 0.25, P = 0.034). Other parameters were not significantly different. Multivariate analyses showed that unsuccessful PDT was significantly associated with lower baseline BCVA (P = 0.026) and older age (P = 0.029) and that BCVA at 3 years after PDT was positively associated with baseline BCVA (P<0.001). Conclusions Half-dose PDT has a long-term efficacy in chronic CSC. Relatively early PDT may improve anatomic and functional outcomes of chronic CSC.	[Haga, Fuminori; Maruko, Ruka; Sato, Chiaki; Kataoka, Keiko; Ito, Yasuki; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi, Japan	Nagoya University	Ito, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi, Japan.	yasu@med.nagoya-u.ac.jp	Maruko, Ruka/M-4929-2014; Ito, Yasuki/M-4876-2014; Kataoka, Keiko/B-2806-2016	Maruko, Ruka/0000-0003-0208-1011; Ito, Yasuki/0000-0001-9219-9261; Kataoka, Keiko/0000-0002-8795-6536	Japan Society for the Promotion of Science (JSPS, Tokyo, Japan) KAKENHI [16K11265, 15H04994]	Japan Society for the Promotion of Science (JSPS, Tokyo, Japan) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Japan Society for the Promotion of Science (JSPS, Tokyo, Japan) KAKENHI Grant Number (16K11265 (YI) and 15H04994(HT)). There was no additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT G, 1955, Br J Ophthalmol, V39, P605, DOI 10.1136/bjo.39.10.605; Carvalho-Recchia CA, 2002, OPHTHALMOLOGY, V109, P1834, DOI 10.1016/S0161-6420(02)01117-X; Chan WM, 2008, OPHTHALMOLOGY, V115, P1756, DOI 10.1016/j.ophtha.2008.04.014; Chan WM, 2008, RETINA-J RET VIT DIS, V28, P85, DOI 10.1097/IAE.0b013e318156777f; Chan WM, 2003, BRIT J OPHTHALMOL, V87, P1453, DOI 10.1136/bjo.87.12.1453; CHUMBLEY LC, 1974, AM J OPHTHALMOL, V77, P158, DOI 10.1016/0002-9394(74)90667-9; Colucciello M, 2006, RETINA-J RET VIT DIS, V26, P239, DOI 10.1097/00006982-200602000-00027; Fujita K, 2015, OPHTHALMOLOGY, V122, P555, DOI 10.1016/j.ophtha.2014.09.034; Gass JD, 1967, AM J OPHTHALMOL S, V63; GELBER GS, 1987, AM J PSYCHIAT, V144, P46; GILBERT CM, 1984, BRIT J OPHTHALMOL, V68, P815, DOI 10.1136/bjo.68.11.815; Haimovici R, 2004, OPHTHALMOLOGY, V111, P244, DOI 10.1016/j.ophtha.2003.09.024; Imamura Y, 2011, OPHTHALMOLOGY, V118, P700, DOI 10.1016/j.ophtha.2010.08.017; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Inoue R, 2010, AM J OPHTHALMOL, V149, P441, DOI 10.1016/j.ajo.2009.10.011; Karakus SH, 2013, EYE, V27, P612, DOI 10.1038/eye.2013.24; KLEIN ML, 1974, ARCH OPHTHALMOL-CHIC, V91, P247; Lai TYY, 2006, BRIT J OPHTHALMOL, V90, P869, DOI 10.1136/bjo.2006.090282; Lee PY, 2009, JPN J OPHTHALMOL, V53, P52, DOI 10.1007/s10384-008-0613-z; Lim JI, 2014, OPHTHALMOLOGY, V121, P1073, DOI 10.1016/j.ophtha.2013.11.040; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1921, DOI 10.1097/IAE.0b013e31822bf6b1; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Moon JW, 2009, GRAEF ARCH CLIN EXP, V247, P1315, DOI 10.1007/s00417-009-1104-8; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; PandaJonas S, 1996, AM J OPHTHALMOL, V121, P181, DOI 10.1016/S0002-9394(14)70583-5; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; Prunte C, 1996, AM J OPHTHALMOL, V121, P26; Pryds A, 2012, ACTA OPHTHALMOL, V90, P738, DOI 10.1111/j.1755-3768.2011.02157.x; Schlotzer-Schrehardt U, 2002, GRAEF ARCH CLIN EXP, V240, P748, DOI 10.1007/s00417-002-0517-4; Taban M, 2004, AM J OPHTHALMOL, V137, P1073, DOI 10.1016/j.ajo.2004.01.043; Thavikulwat AT, 2015, DOC OPHTHALMOL; Tsai DC, 2014, RETINA-J RET VIT DIS, V34, P1867, DOI 10.1097/IAE.0000000000000159; Tseng CC, 2015, BR J OPHTHALMOL; Uetani R, 2012, EYE, V26, P641, DOI 10.1038/eye.2012.66; Wang MSM, 2002, AM J OPHTHALMOL, V133, P787, DOI 10.1016/S0002-9394(02)01438-1; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048; Yannuzzi L A, 1986, Trans Am Ophthalmol Soc, V84, P799; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002	38	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181479	10.1371/journal.pone.0181479	http://dx.doi.org/10.1371/journal.pone.0181479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742138	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700046
J	Isaevska, E; Manasievska, M; Alessi, D; Mosso, ML; Magnani, C; Sacerdote, C; Pastore, G; Fagioli, F; Merletti, F; Maule, M				Isaevska, Elena; Manasievska, Milena; Alessi, Daniela; Mosso, Maria Luisa; Magnani, Corrado; Sacerdote, Carlotta; Pastore, Guido; Fagioli, Franca; Merletti, Franco; Maule, Milena			Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011	PLOS ONE			English	Article							CHILDHOOD-CANCER; EUROPEAN CHILDREN; INCREASING INCIDENCE; TIME TRENDS; SURVIVAL; TUMORS; PATTERNS; CLASSIFICATION; LEUKEMIAS; LYMPHOMAS	In the past, increases in childhood cancer incidence were reported in Europe and North America. The aim of this study is to show updated patterns of temporal behavior using data of the Childhood Cancer Registry of Piedmont (CCRP), a region with approximately 4.5 million inhabitants in North-West Italy. CCRP has been recording incident cases in children (0-14 years) since 1967 and in adolescents (15-19) since 2000. Time trends were estimated as annual percent change (APC) over the 1976-2011 period for children, and over 2000-2011 for both children and adolescents. CCRP registered 5020 incident cases from 1967 to 2011. Incidence rates were 157 per million person-years for children (1967-2011) and 282 for adolescents (2000-2011). From 1976-2011, increasing trends were observed in children for all neoplasms (APC 1.1, 95%CI: 0.8; 1.5) and for both embryonal and non-embryonal tumors: 1.1%, (0.5; 1.6) and 1.2%, (0.7; 1.6), respectively. Increases were observed in several tumor types, including leukemia, lymphoma, central nervous system tumors and neuroblastoma. In 2000-2011, incidence rates showed mostly non statistically significant variations and large variability. The observation of trends over a long period shows that the incidence of most tumors has increased, and this is only partially explained by diagnostic changes. Large rate variability hampers interpretation of trend patterns in short periods. Given that no satisfying explanation for the increases observed in the past was ever found, efforts must be made to understand and interpret this peculiar and still ununderstood pattern of childhood cancer incidence.	[Isaevska, Elena; Manasievska, Milena; Alessi, Daniela; Mosso, Maria Luisa; Sacerdote, Carlotta; Pastore, Guido; Merletti, Franco; Maule, Milena] Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Childhood Canc Registry Piedmont, Turin, Italy; [Magnani, Corrado] CPO Piemonte, Unit Med Stat & Canc Epidemiol, Dept Translat Med, Novara, Italy; [Magnani, Corrado] Univ Piemonte Orientale, Novara, Italy; [Fagioli, Franca] Regina Margherita Childrens Hosp, Pediat Oncohaematol Stem Cell Transplantat & Cell, Turin, Italy	University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Eastern Piedmont Amedeo Avogadro; A.O.U. Citta della Salute e della Scienza di Torino	Isaevska, E (corresponding author), Univ Turin, Dept Med Sci, Canc Epidemiol Unit, Childhood Canc Registry Piedmont, Turin, Italy.	isaevska.elena@gmail.com	Maule, Milena M/K-3858-2018; Fagioli, Franca/AAC-2181-2022	Maule, Milena M/0000-0003-2142-1288; Isaevska, Elena/0000-0002-1846-7990; Sacerdote, Carlotta/0000-0002-8008-5096	European Commission through the Erasmus Mundus for Western Balkans II programme [2011-2586/001-001-EMA2]; Master of Epidemiology (University of Turin)	European Commission through the Erasmus Mundus for Western Balkans II programme; Master of Epidemiology (University of Turin)	El and MMan received scholarships from the European Commission through the Erasmus Mundus for Western Balkans II programme, Grant Agreement 2011-2586/001-001-EMA2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Master of Epidemiology (University of Turin). Elena Isaevska and Milena Manasievska acknowledge two scholarships from the European Commission through the Erasmus Mundus for Western Balkans II programme (Grant Agreement 2011-2586/001-001-EMA2). We are extremely grateful to Benedetto Terracini for many useful discussions and revision of the manuscript and to Carlotta Buzzoni for her suggestions.	AIRTUM Working Group, 2008, Epidemiol Prev, V32, P5; AIRTUM Working Group, 2015, EPIDEMIOL PREV S2, V40, P1; [Anonymous], DAT INC SEER 9 REGS; Arora RS, 2009, NEURO-ONCOLOGY, V11, P403, DOI 10.1215/15228517-2008-097; Barnes L., 2005, PATHOLOGY GENETICS H, V9; Bosman FT, 2010, WHO CLASSIFICATION T, V3; Campbell RJ, 1998, HISTOLOGICAL TYPING; Clavel J, 2006, EUR J CANCER, V42, P2037, DOI 10.1016/j.ejca.2006.05.012; Dalmasso P, 2005, HAEMATOLOGICA, V90, P1197; DeLellis RA, 2004, PATHOLOGY GENETICS T, V8; Dreifaldt AC, 2004, EUR J CANCER, V40, P1351, DOI 10.1016/j.ejca.2004.02.003; Eble JN, 2004, PATHOLOGY GENETICS T, V7; Engholm G., 2016, NORDCAN CANC INCIDEN; Fritz A, 2000, INT CLASSIFICATION D, VThird; Gatta G, 2012, EUR J CANCER, V48, P1425, DOI 10.1016/j.ejca.2011.12.027; Howlader N., 2016, SEER CANC STAT REV; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Kroll ME, 2006, J NATL CANCER I, V98, P417, DOI 10.1093/jnci/djj095; Linet MS, 2016, INT J CANCER, V138, P1862, DOI 10.1002/ijc.29924; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MacCarthy A, 2006, EUR J CANCER, V42, P2092, DOI 10.1016/j.ejca.2006.06.003; Magnani C, 2003, INT J CANCER, V105, P552, DOI 10.1002/ijc.11112; McNally RJQ, 2001, LEUKEMIA, V15, P1612, DOI 10.1038/sj.leu.2402252; National Cancer Institute, 2015, JOINP REGR PROGR SUR; Pastore G, 2006, EUR J CANCER, V42, P2103, DOI 10.1016/j.ejca.2006.05.010; Peris-Bonet R, 2006, EUR J CANCER, V42, P2064, DOI 10.1016/j.ejca.2006.05.009; Smith MA, 1998, J NATL CANCER I, V90, P1269, DOI 10.1093/jnci/90.17.1269; Spix C, 2008, INT J CANCER, V122, P1859, DOI 10.1002/ijc.23281; Spix C, 2006, EUR J CANCER, V42, P2081, DOI 10.1016/j.ejca.2006.05.008; Steliarova-Foucher E, 2006, EUR J CANCER, V42, P1915, DOI 10.1016/j.ejca.2006.05.007; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; Stiller CA, 2006, EUR J CANCER, V42, P2006, DOI 10.1016/j.ejca.2006.06.002; Tavassoli F.A., 2003, PATHOLOGY GENETICS T, V4; Terracini B, 2013, EPIDEMIOL PREV, V37, P1; Travis W., 2004, PATHOLOGY GENETICS T, V10; Tulla M, 2015, PEDIATRICS, V136, pE623, DOI 10.1542/peds.2015-0224; WILLIS RA, 1950, B NEW YORK ACAD MED, V26, P440	39	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181805	10.1371/journal.pone.0181805	http://dx.doi.org/10.1371/journal.pone.0181805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742150	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700073
J	Modo, M; Crum, WR; Gerwig, M; Vernon, AC; Patel, P; Jackson, MJ; Rose, S; Jenner, P; Iravani, MM				Modo, Michel; Crum, William R.; Gerwig, Madeline; Vernon, Anthony C.; Patel, Priya; Jackson, Michael J.; Rose, Sarah; Jenner, Peter; Iravani, Mahmoud M.			Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease	PLOS ONE			English	Article							RAT MODEL; IN-VIVO; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; COGNITIVE IMPAIRMENT; CLINICAL-DIAGNOSIS; MARMOSET MODEL; RODENT MODEL; VOLUME LOSS; BRAIN	Parkinson's disease (PD) is the second most common neurodegenerative disorder producing a variety of motor and cognitive deficits with the causes remaining largely unknown. The gradual loss of the nigrostriatal pathway is currently considered the pivotal pathological event. To better understand the progression of PD and improve treatment management, defining the disease on a structural basis and expanding brain analysis to extra-nigral structures is indispensable. The anatomical complexity and the presence of neuromelanin, make the use of non-human primates an essential element in developing putative imaging biomarkers of PD. To this end, ex vivo T-2-weighted magnetic resonance images were acquired from control and 1-methyl-4 phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated marmosets. Volume measurements of the caudate, putamen, and substantia nigra indicated significant atrophy and cortical thinning. Tensor-based morphometry provided a more extensive and hypothesis free assessment of widespread changes caused by the toxin insult to the brain, especially highlighting regional cortical atrophy. The results highlight the importance of developing imaging biomarkers of PD in non-human primate models considering their distinct neuroanatomy. It is essential to further develop these biomarkers in vivo to provide non-invasive tools to detect pre-symptomatic PD and to monitor potential disease altering therapeutics.	[Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Modo, Michel] Univ Pittsburgh, Ctr Neural Basis Behav, Pittsburgh, PA 15260 USA; [Modo, Michel; Vernon, Anthony C.; Patel, Priya] Kings Coll London, Dept Basic & Clin Neurosci, London, England; [Crum, William R.] Kings Coll London, Dept Neuroimaging, London, England; [Gerwig, Madeline] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Vernon, Anthony C.] Kings Coll London, MRC Ctr Neurodev Disorders, London, England; [Jackson, Michael J.; Rose, Sarah; Jenner, Peter; Iravani, Mahmoud M.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Iravani, Mahmoud M.] Univ Hertfordshire, Dept Pharm Pharmacol & Postgrad Med, Hatfield, Herts, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; King's College London; University of London; King's College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; King's College London; University of London; King's College London; University of Hertfordshire	Modo, M (corresponding author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Univ Pittsburgh, Ctr Neural Basis Behav, Pittsburgh, PA 15260 USA.; Modo, M (corresponding author), Kings Coll London, Dept Basic & Clin Neurosci, London, England.	modomm@upmc.edu		Iravani, Mahmoud/0000-0002-4905-9682; ROSE, SARAH/0000-0003-4723-7665; Vernon, Anthony/0000-0001-7305-1069; Modo, Michel/0000-0003-4436-735X	Edmund J. Safra Foundation; MRC [MR/N026063/1] Funding Source: UKRI; Medical Research Council [MR/N026063/1] Funding Source: researchfish	Edmund J. Safra Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Edmund J. Safra Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the generous support of the Edmund J. Safra Foundation.	Algarni MA, 2016, EXPERT REV NEUROTHER, V16, P187, DOI 10.1586/14737175.2016.1135056; Bannon D, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0571-z; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Bukhatwa S, 2009, J NEUROCHEM, V109, P52, DOI 10.1111/j.1471-4159.2009.05956.x; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Cousins DA, 2013, BIOL PSYCHIAT, V73, P652, DOI 10.1016/j.biopsych.2012.09.029; Crum WR, 2013, J NEUROSCI METH, V218, P170, DOI 10.1016/j.jneumeth.2013.05.009; Crum WR, 2013, J NEUROSCI METH, V216, P62, DOI 10.1016/j.jneumeth.2013.03.015; Crum WR, 2005, PHYS MED BIOL, V50, P5153, DOI 10.1088/0031-9155/50/21/014; Delfino M, 2007, NEUROPSYCHOPHARMACOL, V32, P1911, DOI 10.1038/sj.npp.1301329; Delli Pizzi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056501; Dorph-Petersen KA, 2005, NEUROPSYCHOPHARMACOL, V30, P1649, DOI 10.1038/sj.npp.1300710; Eslamboli A, 2005, BRAIN RES BULL, V68, P140, DOI 10.1016/j.brainresbull.2005.08.005; Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1007/BF03206574; Finlay CJ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00095; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goldman JG, 2012, MOVEMENT DISORD, V27, P727, DOI 10.1002/mds.24938; Hamani C, 2003, ANN NY ACAD SCI, V991, P15; Harrison IF, 2015, BRIT J PHARMACOL, V172, P4200, DOI 10.1111/bph.13208; Hikishima K, 2015, NEUROSCIENCE, V300, P585, DOI 10.1016/j.neuroscience.2015.05.041; Hikishima K, 2015, RADIOLOGY, V275, P430, DOI 10.1148/radiol.14140601; Iravani MM, 2006, J NEUROCHEM, V96, P1315, DOI 10.1111/j.1471-4159.2005.03625.x; Iravani MM, 2005, EUR J NEUROSCI, V21, P841, DOI 10.1111/j.1460-9568.2005.03915.x; Jenner P, 2009, PARKINSONISM RELAT D, V15, P406, DOI [10.1016/j.parkreldis.2008.12.006, 10.1016/S1353-8020(09)70829-6]; Kim WS, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0073-2; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kondoh T, 2005, EXP NEUROL, V192, P194, DOI 10.1016/j.expneurol.2004.12.016; Lehericy S, 2017, MOVEMENT DISORD, V32, P510, DOI 10.1002/mds.26968; Lerch JP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00006; Mak E, 2014, AM J NEURORADIOL, V35, P2257, DOI 10.3174/ajnr.A4055; Mak E, 2015, PARKINSONISM RELAT D, V21, P862, DOI 10.1016/j.parkreldis.2015.05.013; MILETICH RS, 1994, ANN NEUROL, V35, P689, DOI 10.1002/ana.410350609; Okano H, 2015, NEUROSCI RES, V93, P3, DOI 10.1016/j.neures.2014.08.014; Pagonabarraga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054980; Palazzi X., 2008, MARMOSET BRAIN STERE; Pelled G, 2005, EUR J NEUROSCI, V21, P2227, DOI 10.1111/j.1460-9568.2005.04035.x; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Philippens IHCHM, 2010, DRUG DISCOV TODAY, V15, P985, DOI 10.1016/j.drudis.2010.08.009; Pienaar IS, 2015, BRAIN STRUCT FUNCT, V220, P479, DOI 10.1007/s00429-013-0669-5; Porras G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009308; Reimao S, 2016, EUR J NEUROL, V23, P368, DOI 10.1111/ene.12838; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Rizzo G, 2016, NEUROLOGY, V86, P566, DOI 10.1212/WNL.0000000000002350; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; Soria G, 2011, EUR J NEUROSCI, V33, P1551, DOI 10.1111/j.1460-9568.2011.07639.x; Sterling NW, 2016, J PARKINSON DIS, V6, P557, DOI 10.3233/JPD-160824; Stockwell KA, 2008, EXP NEUROL, V211, P172, DOI 10.1016/j.expneurol.2008.01.019; Tardif SD, 2003, COMPARATIVE MED, V53, P364; Tokuno H, 2009, NEUROSCI RES, V64, P128, DOI 10.1016/j.neures.2009.02.003; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Ulusoy A, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0198-y; Van Camp N, 2009, NMR BIOMED, V22, P697, DOI 10.1002/nbm.1381; van Vlieta SAM, 2008, BRAIN RES, V1189, P219, DOI 10.1016/j.brainres.2007.10.059; Vernon AC, 2012, MOVEMENT DISORD, V27, P166, DOI 10.1002/mds.24018; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Vernon AC, 2010, BRAIN RES REV, V65, P28, DOI 10.1016/j.brainresrev.2010.05.006; Vernon AC, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-1; Virel A, 2015, EUR J NEUROSCI, V42, P2761, DOI 10.1111/ejn.13044; Virel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112941; Westphal R, 2016, NEUROSCIENCE, V334, P166, DOI 10.1016/j.neuroscience.2016.07.046; Worker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114167; Worker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112638; Yun Jun-Won, 2015, Lab Anim Res, V31, P155, DOI 10.5625/lar.2015.31.4.155; Zhang ZM, 2006, NEUROIMAGE, V33, P636, DOI 10.1016/j.neuroimage.2006.07.004; Ziegler DA, 2013, JAMA NEUROL, V70, P241, DOI 10.1001/jamaneurol.2013.597	67	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180733	10.1371/journal.pone.0180733	http://dx.doi.org/10.1371/journal.pone.0180733			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738061	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700015
J	Hughes, MG; Tucker, WW; Reddy, S; Brier, ME; Koch, D; McClain, CJ; Jonsson, CB; Matoba, N; Chung, D				Hughes, Michael G.; Tucker, William W.; Reddy, Sreelatha; Brier, Michael E.; Koch, David; McClain, Craig J.; Jonsson, Colleen B.; Matoba, Nobuyuki; Chung, Donghoon			Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition	PLOS ONE			English	Article							B TYPE-I; VIRUS-INFECTION; TRANSMISSION; RECEPTOR; KINETICS; CD81	To better understand the dynamics of early hepatitis C virus (HCV) infection, we determined how rapidly non-cirrhotic HCV-uninfected liver allografts clear HCV from the circulation of cirrhotic HCV-infected patients at the time of transplantation but before administration of immunosuppression. Specifically, we characterized serum HCV kinetics during the first 90 min of reperfusion for 19 chronically HCV-infected patients transplanted with an HCV-uninfected liver by measuring serum viral load immediately prior to reperfusion (t = 0) and then every 15 min for a total of 90 min (t = 90). Immunosuppression was withheld until all samples were taken to better model primary infection. During this period, rates of viral clearance varied more than 20-fold with a median rate constant of 0.0357 1/min, range 0.0089 - 0.2169; half-life (minutes) median 19.4, range 3.2 - 77.8. The majority of viral clearance occurred within the first 60 min. The amount of blood transfused during this 90-min period (a potential confounding variable of this human liver transplant model of primary infection) accounted for 53% and 59% of k (r = 0.53, p = 0.05) and half-life (r = 0.59, p = 0.03) variability, respectively. No other clinical variables tested (age, allograft weight, and degree of reperfusion injury as assessed by peak postoperative ALT or AST) accounted for the remaining variability (p> 0.05). Conclusion: In a human liver transplant model of primary infection, HCV rapidly clears the bloodstream. With approximately 90% of clearance occurring in the first 90 minutes of reperfusion, studies of HCV entry inhibition could utilize rate of clearance during this early period as an outcome measure.	[Hughes, Michael G.; Tucker, William W.; Reddy, Sreelatha] Univ Louisville, Dept Surg, Louisville, KY 40292 USA; [Brier, Michael E.; McClain, Craig J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Koch, David] Med Univ South Carolina, Dept Med, Charleston, SC USA; [McClain, Craig J.; Matoba, Nobuyuki] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig J.] Robley Rex Louisville Veteran Affairs Med Ctr, Louisville, KY USA; [Jonsson, Colleen B.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Chung, Donghoon] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; Medical University of South Carolina; University of Louisville; University of Tennessee System; University of Tennessee Knoxville; University of Louisville	Hughes, MG (corresponding author), Univ Louisville, Dept Surg, Louisville, KY 40292 USA.	mike.hughes@louisville.edu	Jonsson, Colleen/GPC-4424-2022; Jonsson, Colleen/X-2360-2019; Brier, Michael/B-9805-2013	Jonsson, Colleen/0000-0002-2640-7672; Brier, Michael/0000-0002-5952-9561; Matoba, Nobuyuki/0000-0001-7231-3004	American Society of Transplant Surgeons; American Association for the Study of Liver Diseases; ASTS Roche Surgical Scientist Scholarship; ASTS Team Donate Life Junior Faculty Award; AASLD Career Development Award in Liver in Transplantation; NIH through an institutional KL2 at the Medical University of South Carolina; American Society of Transplant Surgeons Team Donate Life Junior Faculty Award; American Association for the Study of Liver Diseases Career Development Award in Liver Transplantation; National Institutes of Health [KL2 1KL2RR029880-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023681] Funding Source: NIH RePORTER	American Society of Transplant Surgeons; American Association for the Study of Liver Diseases; ASTS Roche Surgical Scientist Scholarship; ASTS Team Donate Life Junior Faculty Award; AASLD Career Development Award in Liver in Transplantation; NIH through an institutional KL2 at the Medical University of South Carolina; American Society of Transplant Surgeons Team Donate Life Junior Faculty Award; American Association for the Study of Liver Diseases Career Development Award in Liver Transplantation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The American Society of Transplant Surgeons and American Association for the Study of Liver Diseases have funded this work, as the ASTS Roche Surgical Scientist Scholarship (MGH), the ASTS Team Donate Life Junior Faculty Award (MGH) and the AASLD Career Development Award in Liver in Transplantation (MGH). Additionally, the NIH through an institutional KL2 at the Medical University of South Carolina (MGH) helped fund this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support was received from the following sources: American Society of Transplant Surgeons Team Donate Life Junior Faculty Award (MGH); American Association for the Study of Liver Diseases Career Development Award in Liver Transplantation (MGH); and National Institutes of Health KL2 1KL2RR029880-01 (MGH). We would like to extend a special thanks to Marion McClain and Margaret Abby for review and editing of the manuscript. Members of the University of Louisville Center for Predictive Medicine Virology Discussion Group also made significant contributions to the design and analysis of results.	ALTER MJ, 1994, NEW ENGL J MED, V330, P784, DOI 10.1056/NEJM199403173301111; Charlton M, 1998, HEPATOLOGY, V28, P823, DOI 10.1002/hep.510280333; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Eyre Nicholas S, 2009, Hepatology, V49, P1770, DOI 10.1002/hep.22935; Felmlee DJ, 2016, LANCET INFECT DIS, V16, P735, DOI 10.1016/S1473-3099(16)00120-1; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; GORDON SC, 1993, HEPATOLOGY, V18, P1338, DOI 10.1002/hep.1840180609; Graziadei IW, 2012, LIVER TRANSPLANT, V18, P671, DOI 10.1002/lt.23402; GRETCH DR, 1995, HEPATOLOGY, V22, P1; Hughes MG, 2005, AM J TRANSPLANT, V5, P2504, DOI 10.1111/j.1600-6143.2005.01060.x; Hughes MG, 2004, LIVER TRANSPLANT, V10, P208, DOI 10.1002/lt.20060; Hughes MG, 2009, LIVER TRANSPLANT, V15, P1395, DOI 10.1002/lt.21866; Liu RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066872; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Mensa L, 2011, HEPATOLOGY, V53, P1436, DOI 10.1002/hep.24110; OHTO H, 1994, NEW ENGL J MED, V330, P744, DOI 10.1056/NEJM199403173301103; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Rowe IA, 2016, LIVER TRANSPLANT, V22, P287, DOI 10.1002/lt.24349; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Uprichard SL, 2015, GUT, V64, P690, DOI 10.1136/gutjnl-2014-308396; Wiesmann F, 2015, MED MICROBIOL IMMUN, V204, P515, DOI 10.1007/s00430-014-0364-z; Xiao F, 2015, GUT, V64, P483, DOI 10.1136/gutjnl-2013-306155	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180719	10.1371/journal.pone.0180719	http://dx.doi.org/10.1371/journal.pone.0180719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732019	gold, Green Submitted, Green Published			2022-12-26	WOS:000406643100011
J	Shaw, GTW; Liu, AC; Weng, CY; Chou, CY; Wang, DY				Shaw, Grace Tzun-Wen; Liu, An-Chi; Weng, Chieh-Yin; Chou, Chu-Yang; Wang, Daryi			Inferring microbial interactions in thermophilic and mesophilic anaerobic digestion of hog waste	PLOS ONE			English	Article							NON-ACETICLASTIC METHANOGENESIS; INTESTINAL BACTERIAL COMMUNITY; ACETATE OXIDATION; BIOGAS; NETWORKS; DYNAMICS; PATHWAY; ECOLOGY; METHANE; DIVERSITY	Anaerobic digestion (AnD) is a microbiological process that converts organic waste materials into biogas. Because of its high methane content, biogas is a combustible energy source and serves as an important environmental technology commonly used in the management of animal waste generated on large animal farms. Much work has been done on hardware design and process engineering for the generation of biogas. However, little is known about the complexity of the microbiology in this process. In particular, how microbes interact in the digester and eventually breakdown and convert organic matter into biogas is still regarded as a "black box." We used 16S rRNA sequencing as a tool to study the microbial community in laboratory hog waste digesters under tightly controlled conditions, and systematically unraveled the distinct interaction networks of two microbial communities from mesophilic (MAnD) and thermophilic anaerobic digestion (TAnD). Under thermophilic conditions, the well-known association between hydrogen-producing bacteria, e.g., Ruminococcaceae and Prevotellaceae, and hydrotrophic methanogens, Methanomicrobiaceae, was reverse engineered by their interactive topological niches. The inferred interaction network provides a sketch enabling the determination of microbial interactive relationships that conventional strategy of finding differential taxa was hard to achieve. This research is still in its infancy, but it can help to depict the dynamics of microbial ecosystems and to lay the groundwork for understanding how microorganisms cohabit in the anaerobic digester.	[Shaw, Grace Tzun-Wen; Weng, Chieh-Yin; Wang, Daryi] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Liu, An-Chi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Liu, An-Chi; Chou, Chu-Yang] Natl Taiwan Univ, Dept Bioind Mechatron Engn, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wang, DY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	dywang@gate.sinica.edu.tw			Sustainability Science Research Project, Academia Sinica	Sustainability Science Research Project, Academia Sinica	This work was supported by Sustainability Science Research Project, Academia Sinica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; Angly FE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-11; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Borjesson P, 2008, TRENDS BIOTECHNOL, V26, P7, DOI 10.1016/j.tibtech.2007.09.007; Campanaro S, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0441-1; [承磊 Cheng Lei], 2016, [微生物学通报, Microbiology China], V43, P1143; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Deng Y, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-113; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Etchebehere C, 2016, APPL MICROBIOL BIOT, V100, P3371, DOI 10.1007/s00253-016-7325-y; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Fuentes S, 2014, ISME J, V8, P1621, DOI 10.1038/ismej.2014.13; Gao RuiFang, 2012, African Journal of Biotechnology, V11, P6494; Gause G. F., 1934, STRUGGLE EXISTENCE; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; Klocke M, 2007, SYST APPL MICROBIOL, V30, P139, DOI 10.1016/j.syapm.2006.03.007; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuever J., 2014, FAMILY SYNTROPHOBACT, P289, DOI DOI 10.1007/978-3-642-39044-9_268; Leclerc M, 2004, ENVIRON MICROBIOL, V6, P809, DOI 10.1111/j.1462-2920.2004.00616.x; Leven L, 2007, FEMS MICROBIOL ECOL, V59, P683, DOI 10.1111/j.1574-6941.2006.00263.x; Levy R, 2013, P NATL ACAD SCI USA, V110, P12804, DOI 10.1073/pnas.1300926110; Li YF, 2015, APPL MICROBIOL BIOT, V99, P969, DOI 10.1007/s00253-014-6036-5; Liu AC, 2015, J BIOTECHNOL, V194, P124, DOI 10.1016/j.jbiotec.2014.11.026; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McHugh S, 2004, FEMS MICROBIOL ECOL, V48, P369, DOI 10.1016/j.femsec.2004.02.012; McMahon KD, 2001, WATER RES, V35, P1817, DOI 10.1016/S0043-1354(00)00438-3; Moset V, 2015, MICROB BIOTECHNOL, V8, P787, DOI 10.1111/1751-7915.12271; Mounier J, 2008, APPL ENVIRON MICROB, V74, P172, DOI 10.1128/AEM.01338-07; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oren A., 2014, FAMILY METHANOMICROB, P231; PETERSEN SP, 1991, FEMS MICROBIOL ECOL, V86, P149, DOI 10.1111/j.1574-6968.1991.tb04804.x; Pihur V, 2008, BIOINFORMATICS, V24, P561, DOI 10.1093/bioinformatics/btm640; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Saengkerdsub S, 2007, LETT APPL MICROBIOL, V45, P629, DOI 10.1111/j.1472-765X.2007.02243.x; Sahlstrom L, 2003, BIORESOURCE TECHNOL, V87, P161, DOI 10.1016/S0960-8524(02)00168-2; Sasaki D, 2011, J BIOSCI BIOENG, V111, P41, DOI 10.1016/j.jbiosc.2010.08.011; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Shankar V, 2015, ISME J, V9, P1899, DOI 10.1038/ismej.2014.258; Shaw GTW, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1359-0; Shih JC, 2015, DEV ANAEROBIC DIGEST, P339; Sivagurunathan P, 2016, RSC ADV; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Tang YQ, 2011, APPL MICROBIOL BIOT, V91, P1447, DOI 10.1007/s00253-011-3479-9; Tour JM, 2010, NAT MATER, V9, P871, DOI 10.1038/nmat2887; Trosvik P, 2008, ISME J, V2, P707, DOI 10.1038/ismej.2008.36; Trosvik P, 2010, ISME J, V4, P151, DOI 10.1038/ismej.2009.96; Tuan NN, 2014, MICROBIOL RES, V169, P717, DOI 10.1016/j.micres.2014.02.003; Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Wold H., 1985, PARTIAL LEAST SQUARE, P581; WOOD HG, 1986, TRENDS BIOCHEM SCI, V11, P14, DOI 10.1016/0968-0004(86)90223-9; Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15; Xu ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093445; Yadvika, 2004, BIORESOURCE TECHNOL, V95, P1, DOI 10.1016/j.biortech.2004.02.010; Yang ZM, 2015, BIORESOURCE TECHNOL, V190, P132, DOI 10.1016/j.biortech.2015.04.057; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zhu CG, 2011, MICROBIOL RES, V166, P27, DOI 10.1016/j.micres.2010.01.004; ZINDER SH, 1984, ARCH MICROBIOL, V138, P263, DOI 10.1007/BF00402133	75	17	17	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181395	10.1371/journal.pone.0181395	http://dx.doi.org/10.1371/journal.pone.0181395			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732056	Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100034
J	Wang, J; Huo, BB; Liu, WT; Li, DL; Liao, L				Wang, Jun; Huo, Beibei; Liu, Wanting; Li, Daili; Liao, Ling			Abnormal meiosis in an intersectional allotriploid of Populus L. and segregation of ploidy levels in 2X x 3Xprogeny	PLOS ONE			English	Article							EMBRYO SAC DEVELOPMENT; GENETIC DIVERSITY; TRIPLOID POPULUS; MECHANISMS; ANEUPLOIDY; DOSAGE; EVOLUTION; BALANCE; MICROSPOROGENESIS; HYBRIDIZATION	Triploid plants are usually highly aborted owing to unbalanced meiotic chromosome segregation, but limited viable gametes can participate in the transition to different ploidy levels. In this study, numerous meiotic abnormalities were found with high frequency in an intersectional allotriploid poplar (Populus alba x P. berolinensis 'Yinzhong'), including univalents, precocious chromosome migration, lagging chromosomes, chromosome bridges, micronuclei, and precocious cytokinesis, indicating high genetic imbalance in this allotriploid. Some micronuclei trigger mini-spindle formation in metaphase II and participate in cytokinesis to form polyads with microcytes. Unbalanced chromosome segregation and chromosome elimination resulted in the formation of microspores with aneuploid chromosome sets. Fusion of sister nuclei occurs in microsporocytes with precocious cytokinesis, which could form second meiotic division restitution (SDR)-type gametes. However, SDR-type gametes likely contain incomplete chromosome sets due to unbalanced segregation of homologous chromosomes during the first meiotic division in triploids. Misorientation of spindles during the second meiotic division, such as fused and tripolar spindles with low frequency, could result in the formation of first meiotic division restitution (FDR)-type unreduced gametes, which most likely contain three complete chromosome sets. Although 'Yinzhong' yields 88.7% stainable pollen grains with wide diameter variation from 23.9 to 61.3 mu m, the pollen viability is poor (2.78% +/- 0.38). A cross of 'Yinzhong' pollen with a diploid female clone produced progeny with extensive segregation of ploidy levels, including 29 diploids, 18 triploids, 4 tetraploids, and 48 aneuploids, suggesting the formation of viable aneuploidy and unreduced pollen in 'Yinzhong'. Individuals with different chromosome compositions are potential to analyze chromosomal function and to integrate the chromosomal dosage variation into breeding programs of Populus.	[Wang, Jun; Huo, Beibei; Liu, Wanting] Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China; [Wang, Jun; Huo, Beibei; Liu, Wanting] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China; [Wang, Jun; Li, Daili] Beijing Forestry Univ, MOE, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Wang, Jun; Huo, Beibei; Liu, Wanting; Li, Daili; Liao, Ling] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Li, Daili] Beijing Huang Fa Nursery, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University; Beijing Forestry University; Beijing Forestry University	Wang, J (corresponding author), Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China.; Wang, J (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.; Wang, J (corresponding author), Beijing Forestry Univ, MOE, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.; Wang, J (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	wangjun@bjfu.edu.cn	Wang, Jun/Y-9104-2018	Wang, Jun/0000-0003-0679-1125	National Natural Science Foundation of China [31470662]; 12th National Key Technology RD Program [2015BAD09B02]; Program for New Century Excellent Talents in University [NCET-13-0672]; Beijing Nova program [Z141105001814007]; Beijing Municipal Education Commission [CEFF-PXM2017_014207_000043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th National Key Technology RD Program; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Nova program(Beijing Municipal Science & Technology Commission); Beijing Municipal Education Commission(Beijing Municipal Commission of Education)	This work was supported by the National Natural Science Foundation of China (31470662), the 12th National Key Technology R&D Program (2015BAD09B02), Program for New Century Excellent Talents in University (NCET-13-0672), the Beijing Nova program (Z141105001814007), and the program from the Beijing Municipal Education Commission (CEFF-PXM2017_014207_000043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister G., 1980, ALLG FORESTZ, V35, P697; BEDNARA J, 1986, PROTOPLASMA, V130, P145, DOI 10.1007/BF01276596; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; BRETAGNOLLE F, 1995, NEW PHYTOL, V129, P1, DOI 10.1111/j.1469-8137.1995.tb03005.x; Brown RC, 1996, SEX PLANT REPROD, V9, P145, DOI 10.1007/BF02221394; [陈成彬 Chen Chengban], 2004, [武汉植物学研究, Journal of Wuhan Botanical Research], V22, P565; Chester M, 2012, P NATL ACAD SCI USA, V109, P1176, DOI 10.1073/pnas.1112041109; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; De Storme N, 2013, NEW PHYTOL, V198, P670, DOI 10.1111/nph.12184; Del Bosco SF, 1999, HEREDITY, V83, P373, DOI 10.1038/sj.hdy.6885770; Dong CB, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0799-9; DWEIKAT IM, 1988, THEOR APPL GENET, V76, P555, DOI 10.1007/BF00260907; Einspahr D. W., 1984, Iowa State Journal of Research, V58, P401; EZURA H, 1994, PLANT CELL TISS ORG, V38, P61, DOI 10.1007/BF00034445; Farco GE, 2014, PLANT SYST EVOL, V300, P1843, DOI 10.1007/s00606-014-1011-2; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gale MD., 1987, WHEAT BREEDING ITS S, P173, DOI DOI 10.1007/978-94-009-3131-2_7; Henry IM, 2009, HEREDITY, V103, P458, DOI 10.1038/hdy.2009.81; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Henry IM, 2006, PLANT J, V48, P307, DOI 10.1111/j.1365-313X.2006.02871.x; Henry IM, 2015, PLANT CELL, V27, P2370, DOI 10.1105/tpc.15.00349; Henry IM, 2010, GENETICS, V186, P1231, DOI 10.1534/genetics.110.121079; [Hu Baoquan 胡宝全], 2012, [南开大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Nankaiensis], V45, P58; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Husband BC, 2004, BIOL J LINN SOC, V82, P537, DOI 10.1111/j.1095-8312.2004.00339.x; ISING G, 1966, HEREDITAS-GENETISK A, V56, P27; JACKSON RC, 1976, ANNU REV ECOL SYST, V7, P209, DOI 10.1146/annurev.es.07.110176.001233; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Johnsson H, 1940, HEREDITAS, V26, P321; Jorgensen MH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-346; Kang XiangYang, 2000, Journal of Beijing Forestry University, V22, P8; Kang XiangYang, 2002, Journal of Beijing Forestry University, V24, P67; Kohler C, 2010, TRENDS GENET, V26, P142, DOI 10.1016/j.tig.2009.12.006; Law CN., 1987, WHEAT BREEDING ITS S, P71, DOI [10.1007/978-94-009-3131-2_4, DOI 10.1007/978-94-009-3131-2_4]; Li DW, 2014, TREE GENET GENOMES, V10, P1451, DOI 10.1007/s11295-014-0773-6; Liehr T, 2006, CYTOGENET GENOME RES, V114, P240, DOI 10.1159/000094207; Lin HB, 1988, J BEIJING FORESTRY U, V10, P97; Liu YH, 1979, J NE FORESTRY I, V2, P1; LUPTON FGH, 1987, WHEAT BREEDING ITS S; Mashkina O. S., 1989, Lesovedenie, P19; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; NIJS TPMD, 1977, EUPHYTICA, V26, P585, DOI 10.1007/BF00021684; Ogilvie CM, 2005, J HISTOCHEM CYTOCHEM, V53, P285, DOI 10.1369/jhc.4B6409.2005; Osuji J. O., 1997, Tropicultura, V15, P37; Rae Anne M., 2007, V7, P1; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Rao JingYun, 2012, Acta Horticulturae Sinica, V39, P1447; Rauch A, 2004, J MED GENET, V41, P916, DOI 10.1136/jmg.2004.022855; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Schatlowski N, 2012, J EXP BOT, V63, P6059, DOI 10.1093/jxb/ers288; SEITZ F. W., 1954, Zeitschrift fur Forstgenetik und Forstpflanzenzuchtung, V3, P1; [史全良 Shi Quanliang], 2006, [分子植物育种, Molecular Plant Breeding], V4, P255; Stanton BJ, 2010, PLANT GENET GENOMICS, V8, P309, DOI 10.1007/978-1-4419-1541-2_14; Tel-Zur N, 2005, J HERED, V96, P124, DOI 10.1093/jhered/esi012; Tian J, 2015, EUPHYTICA, V206, P433, DOI 10.1007/s10681-015-1507-z; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Wang J, 2012, SILVAE GENET, V61, P85, DOI 10.1515/sg-2012-0011; Wang J, 2010, SILVAE GENET, V59, P40, DOI 10.1515/sg-2010-0005; Wang J, 2009, SILVAE GENET, V58, P220, DOI 10.1515/sg-2009-0028; Wang J, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0880-z; Wang J, 2013, SILVA FENN, V47, DOI 10.14214/sf.932; Wang J, 2012, ANN FOREST SCI, V69, P59, DOI 10.1007/s13595-011-0152-5; Wang J, 2010, TREE GENET GENOMES, V6, P281, DOI 10.1007/s11295-009-0248-3; Weisgerber H., 1980, ALLG, V26, P665; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Zhang Chun Hua, 2009, Horticulture Environment and Biotechnology, V50, P203; Zhang L., 2010, J NUCL AGR SCI, V24, P1158; Zhang S, 2004, SILVAE GENET, V53, P69, DOI 10.1515/sg-2004-0013; Zhang SG, 2005, ACTA PHYTOTAXON SIN, V43, P539, DOI 10.1360/aps040008; Zhang ZH, 2010, EUPHYTICA, V173, P151, DOI 10.1007/s10681-009-0051-0; Zhou L.J., 1992, PROTECT SCI TECHNOL, V1, P23; Zhu ZhiTi, 1998, Scientia Silvae Sinicae, V34, P22	74	13	15	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e018176 7	10.1371/journal.pone.0181767	http://dx.doi.org/10.1371/journal.pone.0181767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732039	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100061
J	Zhang, WL; Wang, WN; Chai, W; Luo, XM; Li, JN; Shi, J; Bi, LQ; Niu, LZ				Zhang, Wenlong; Wang, Wanning; Chai, Wei; Luo, Xiaomei; Li, Jiannan; Shi, Jian; Bi, Liqi; Niu, Lizhi			Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; CANCER PATIENTS; EARLY-STAGE; LIVER; CARCINOMA; HARMS	Background and aim Irreversible electroporation (IRE) was confirmed to control several solid tumors effectively in vivo. Our preclinical study aimed to assess the feasibility and safety of IRE in the breast of rabbit. Methods Thirty New Zealand white rabbits were randomly divided into 3 groups of 10 rabbits (control group, IRE group A, and B). Two mono-electrode needles were inserted into the breast tissue by percutaneous puncture. Electrocardiogram and vital signs were monitored before, during, and after ablation. Histopathology, immunohistochemistry, and transmission electron microscopy were examined at 0 hours, 12 hours, 24 hours, 4 days, 7 days, 14 days, and 28 days after ablation. Results All the rabbits survived the procedure with no significant adverse effects. Intra-operative ventricular arrhythmias occurred in 1 rabbit from IRE group B and was immediately relieved after ablation. Reversible subcutaneous hemorrhage was observed in 8 rabbits from IRE group A and 7 rabbits from IRE group B. No skin was burnt, however, pectoralis major muscle injuries were found in all rabbits. Histopathological and ultrastructural examination revealed the coexistence of cell necrosis and apoptosis. HE, TUNEL, and Masson staining revealed breast tissue injury and the recovery of damage by fibrous tissue and granulation tissue. Notably, the structures of mammary gland lobules and interstitial components of the breasts were well preserved. Conclusions Our study suggests that IRE destroys breast cancer while effectively preserving the skin, the structure of mammary gland lobules, and interstitial components. IRE may be a promising technique to locally control breast cancer and to maintain the esthetic of the breast.	[Zhang, Wenlong] Jilin Univ, China Japan Union Hosp, Dept Hematol & Oncol, Changchun, Jilin, Peoples R China; [Wang, Wanning] Jilin Univ, Hosp 1, Dept Nephrol, Changchun, Jilin, Peoples R China; [Chai, Wei] Jilin Univ, Hosp 1, Dept Gynecol & Obstet, Changchun, Jilin, Peoples R China; [Luo, Xiaomei] Jinan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China; [Li, Jiannan; Shi, Jian] Jilin Univ, Hosp 2, Dept Gen Surg, Changchun, Jilin, Peoples R China; [Bi, Liqi] Jilin Univ, China Japan Union Hosp, Dept Rheumatol & Immunol, Changchun, Jilin, Peoples R China; [Niu, Lizhi] Jinan Univ, Fuda Canc Hosp, Sch Med, Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China	Jilin University; Jilin University; Jilin University; Jinan University; Jilin University; Jilin University; Jinan University	Bi, LQ (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Rheumatol & Immunol, Changchun, Jilin, Peoples R China.; Niu, LZ (corresponding author), Jinan Univ, Fuda Canc Hosp, Sch Med, Guangzhou Fuda Canc Hosp, Guangzhou, Guangdong, Peoples R China.	liqibi2016@sina.com; fudaclab@163.com	li, jn/ABH-3120-2021	Li, Jiannan/0000-0001-9744-7666				Akinwande O, 2015, J ONCOL, V2015, DOI 10.1155/2015/680319; Angarita FA, 2015, EJSO-EUR J SURG ONC, V41, P625, DOI 10.1016/j.ejso.2015.01.028; Chen XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16233; Cheng RG, 2015, J VASC INTERV RADIOL, V26, P1184, DOI 10.1016/j.jvir.2015.05.014; Deodhar A, 2011, AM J ROENTGENOL, V196, pW330, DOI 10.2214/AJR.10.4490; Dunki-Jacobs EM, 2014, BRIT J SURG, V101, P1113, DOI 10.1002/bjs.9536; Garcia-Saenz JA, 2015, CLIN TRANSL ONCOL, V17, P939, DOI 10.1007/s12094-015-1427-3; Guo Y, 2010, CANCER RES, V70, P1555, DOI 10.1158/0008-5472.CAN-09-3067; Izzo F, 2001, CANCER, V92, P2036, DOI 10.1002/1097-0142(20011015)92:8<2036::AID-CNCR1542>3.0.CO;2-W; Kerlikowske K, 2016, JAMA INTERN MED, V176, P562, DOI 10.1001/jamainternmed.2016.0225; Klassen Anne F, 2009, BMC Womens Health, V9, P11, DOI 10.1186/1472-6874-9-11; Lee EW, 2012, J VASC INTERV RADIOL, V23, P833, DOI 10.1016/j.jvir.2012.02.017; Long G, 2014, TECHNOL CANCER RES T, V13, P561, DOI 10.7785/tcrtexpress.2013.600253; Manenti G, 2013, BREAST CARE, V8, P356, DOI 10.1159/000355707; Maor E, 2007, TECHNOL CANCER RES T, V6, P307, DOI 10.1177/153303460700600407; Martin RCG, 2013, ANN SURG ONCOL, V20, pS443, DOI 10.1245/s10434-012-2736-1; Memon Zahid Ali, 2015, Asian Pac J Cancer Prev, V16, P7485; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Neal RE, 2010, BREAST CANCER RES TR, V123, P295, DOI 10.1007/s10549-010-0803-5; Neal RE, 2009, ANN BIOMED ENG, V37, P2615, DOI 10.1007/s10439-009-9796-9; Niessen C, 2015, CLIN HEMORHEOL MICRO, V61, P135, DOI 10.3233/CH-151985; Noguchi M, 2012, EJSO-EUR J SURG ONC, V38, P1036, DOI 10.1016/j.ejso.2012.08.006; Ohtani S, 2011, BREAST, V20, P431, DOI 10.1016/j.breast.2011.04.007; Oura Shoji, 2007, Breast Cancer, V14, P48, DOI 10.2325/jbcs.14.48; Peek MCL, 2015, BRIT J SURG, V102, P873, DOI 10.1002/bjs.9793; Philips P, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.1; Sawyer DB, 2013, NEW ENGL J MED, V368, P1154, DOI 10.1056/NEJMcibr1214975; Schassburger KU, 2014, BREAST, V23, P152, DOI 10.1016/j.breast.2013.12.007; Scheffer HJ, 2014, EUR RADIOL, V24, P2467, DOI 10.1007/s00330-014-3259-x; Sherwell-Cabello S, 2015, CIR CIR, V83, P199, DOI 10.1016/j.circir.2015.05.015; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sierink JC, 2014, BREAST, V23, P793, DOI 10.1016/j.breast.2014.08.006; Song ZQ, 2014, INT J CLIN EXP MED, V7, P2386; Sugimoto K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0828-7; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Ting F, 2016, PROSTATE CANCER P D, V19, P46, DOI 10.1038/pcan.2015.47; van Gemert MJC, 2015, PROSTATE, V75, P332, DOI 10.1002/pros.22913; Wiksell H, 2010, BREAST, V19, P219, DOI 10.1016/j.breast.2010.01.016; Witherby S, 2016, SEMIN RADIAT ONCOL, V26, P59, DOI 10.1016/j.semradonc.2015.09.005; Zhang ZL, 2014, NANOMEDICINE-UK, V9, P1181, DOI [10.2217/nnm.13.72, 10.2217/NNM.13.72]; Zhao Z, 2010, EJSO-EUR J SURG ONC, V36, P1149, DOI 10.1016/j.ejso.2010.09.012; Zhou W, 2012, J CANCER RES THER, V8, P80, DOI 10.4103/0973-1482.95179	43	7	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181555	10.1371/journal.pone.0181555	http://dx.doi.org/10.1371/journal.pone.0181555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732031	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100043
J	Alicke, M; Boakye-Appiah, JK; Abdul-Jalil, I; Henze, A; van der Giet, M; Schulze, MB; Schweigert, FJ; Mockenhaupt, FP; Bedu-Addo, G; Danquah, I				Alicke, Marie; Boakye-Appiah, Justice K.; Abdul-Jalil, Inusah; Henze, Andrea; van der Giet, Markus; Schulze, Matthias B.; Schweigert, Florian J.; Mockenhaupt, Frank P.; Bedu-Addo, George; Danquah, Ina			eAdolescent health in rural Ghana: A crosssectional study on the co-occurrence of infectious diseases, malnutrition and cardiometabolic risk factors	PLOS ONE			English	Article							VITAMIN-A; ADOLESCENTS; OBESITY; PREVALENCE; CHILDREN; MALARIA; TRANSITION; OVERWEIGHT; HOUSEHOLD; BURDEN	In sub-Saharan Africa, infectious diseases and malnutrition constitute the main health problems in children, while adolescents and adults are increasingly facing cardio-metabolic conditions. Among adolescents as the largest population group in this region, we investigated the co-occurrence of infectious diseases, malnutrition and cardio-metabolic risk factors (CRFs), and evaluated demographic, socio-economic and medical risk factors for these entities. In a cross-sectional study among 188 adolescents in rural Ghana, malarial infection, common infectious diseases and Body Mass Index were assessed. We measured ferritin, C-reactive protein, retinol, fasting glucose and blood pressure. Socio-demographic data were documented. We analyzed the proportions (95% confidence interval, CI) and the cooccurrence of infectious diseases (malaria, other common diseases), malnutrition (underweight, stunting, iron deficiency, vitamin A deficiency [VAD]), and CRFs (overweight, obesity, impaired fasting glucose, hypertension). In logistic regression, odds ratios (OR) and 95% CIs were calculated for the associations with socio-demographic factors. In this Ghanaian population (age range, 14.4-15.5 years; males, 50%), the proportions were for infectious diseases 45% (95% CI: 38-52%), for malnutrition 50% (43-57%) and for CRFs 16% (11- 21%). Infectious diseases and malnutrition frequently co-existed (28%; 21-34%). Specifically, VAD increased the odds of non-malarial infectious diseases 3-fold (95% CI: 1.03, 10.19). Overlap of CRFs with infectious diseases (6%; 2-9%) or with malnutrition (7%; 3-11%) was also present. Male gender and low socio-economic status increased the odds of infectious diseases and malnutrition, respectively. Malarial infection, chronic malnutrition and VAD remain the predominant health problems among these Ghanaian adolescents. Investigating the relationships with evolving CRFs is warranted.	[Alicke, Marie; Mockenhaupt, Frank P.] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Boakye-Appiah, Justice K.; Abdul-Jalil, Inusah; Bedu-Addo, George] Kwame Nkrumah Univ Sci & Technol, Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Henze, Andrea; Schweigert, Florian J.] Univ Potsdam, Inst Nutr Sci, Dept Physiol & Pathophysiol Nutr, Potsdam, Germany; [van der Giet, Markus] Charite, Dept Nephrol 4, Berlin, Germany; [Schulze, Matthias B.; Danquah, Ina] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Danquah, Ina] Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Kwame Nkrumah University Science & Technology; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Danquah, I (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany.; Danquah, I (corresponding author), Charite, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	ina.danquah@dife.de	Mockenhaupt, Frank P/U-9824-2017; Schulze, Matthias B/AAH-6906-2021; Henze, Andrea/A-9176-2019	Mockenhaupt, Frank P/0000-0002-8117-5421; Schulze, Matthias B/0000-0002-0830-5277; Henze, Andrea/0000-0002-5708-2989; van der Giet, Markus/0000-0003-3590-5451				Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585; Afrifa-Anane E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1546-3; Agbre-Yace ML, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0261-7; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; [Anonymous], 2009, WHO GLOBAL DATABASE; Babio N, 2014, PUBLIC HEALTH NUTR, V17, P1403, DOI 10.1017/S1368980013001274; Danquah I, 2015, AM J CLIN NUTR, V102, P207, DOI 10.3945/ajcn.114.101345; Defo BK, 2014, GLOBAL HEALTH ACTION, V7, P17, DOI 10.3402/gha.v7.22443; Dop MC, 2012, FOOD NUTR BULL, V33, pS221, DOI 10.1177/15648265120333S211; Duah FD, 2013, SAGE OPEN, P1; Duda RB, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-44; Egbi G., 2012, AFRIC J FOOD AGR NUT, V12; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Ferreira ED, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0870-5; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Frank LK, 2013, TROP MED INT HEALTH, V18, P141, DOI 10.1111/tmi.12024; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Genuth S, 2003, DIABETES CARE, V26, P3160; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service Ghana Health Service ICF Macro, 2009, GHAN DEM HLTH SURV; Hervish A., 2012, STATUS REPORT ADOLES; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jones AD, 2016, J NUTR, V146, P1257, DOI 10.3945/jn.115.226654; Kurtis JD, 2001, INFECT IMMUN, V69, P123, DOI 10.1128/IAI.69.1.123-128.2001; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Manyanga T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-887; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Muthuri SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092846; Oluwayemi IO, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/417859; Oni T, 2015, INT HEALTH, V7, P390, DOI 10.1093/inthealth/ihv040; Organization WH, 2016, GLOBAL STATUS REPORT; Peltzer K, 2011, INT J ENV RES PUB HE, V8, P3859, DOI 10.3390/ijerph8103859; Peltzer K, 2011, INT J BEHAV MED, V17, P271, DOI 10.1007/s12529-009-9073-1; Rubio J M, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS199; Schweigert FJ, 2003, HUM REPROD, V18, P1259, DOI 10.1093/humrep/deg249; Senbanjo IO, 2011, J HEALTH POPUL NUTR, V29, P364, DOI 10.3329/jhpn.v29i4.8452; Sifft KC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1606-x; Smallman-Raynor M, 1999, HEALTH PLACE, V5, P209, DOI 10.1016/S1353-8292(99)00010-6; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; U.S. Department of Health and Human Services National Institute of Health National Heart Lung and Blood Institute, 2005, 4 US DEP HLTH HUM SE; World Health Organization, 2004, SER FERR CONC ASS IR; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180436	10.1371/journal.pone.0180436	http://dx.doi.org/10.1371/journal.pone.0180436			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727775	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000406634500021
J	He, LY; Yin, F; Zhong, ZQ; Ding, ZH				He, Lingyun; Yin, Fang; Zhong, Zhangqi; Ding, Zhihua			The impact of local government investment on the carbon emissions reduction effect: An empirical analysis of panel data from 30 provinces and municipalities in China	PLOS ONE			English	Article							ENERGY-CONSUMPTION; CO2 EMISSIONS; DIOXIDE EMISSIONS; ECONOMIC-GROWTH; TECHNOLOGICAL-INNOVATION; PRICES; SYSTEM; TRADE	Among studies of the factors that influence carbon emissions and related regulations, economic aggregates, industrial structures, energy structures, population levels, and energy prices have been extensively explored, whereas studies from the perspective of fiscal leverage, particularly of local government investment (LGI), are rare. Of the limited number of studies on the effect of LGI on carbon emissions, most focus on its direct effect. Few studies consider regulatory effects, and there is a lack of emphasis on local areas. Using a cointegration test, a panel data model and clustering analysis based on Chinese data between 2000 and 2013, this study measures the direct role of LGI in carbon dioxide (CO2) emissions reduction. First, overall, within the sample time period, a 1% increase in LGI inhibits carbon emissions by 0.8906% and 0.5851% through its influence on the industrial structure and energy efficiency, respectively, with the industrial structure path playing a greater role than the efficiency path. Second, carbon emissions to some extent exhibit inertia. The previous year's carbon emissions impact the following year's carbon emissions by 0.5375%. Thus, if a reduction in carbon emissions in the previous year has a positive effect, then the carbon emissions reduction effect generated by LGI in the following year will be magnified. Third, LGI can effectively reduce carbon emissions, but there are significant regional differences in its impact. For example, in some provinces, such as Sichuan and Anhui, economic growth has not been decoupled from carbon emissions. Fourth, the carbon emissions reduction effect in the 30 provinces and municipalities sampled in this study can be classified into five categories - strong, relatively strong, medium, relatively weak and weak - based on the degree of local governments' regulation of carbon emissions. The carbon emissions reduction effect of LGI is significant in the western and central regions of China but not in the eastern and northeast regions. This study helps overcome the limitations of previous studies on the regulatory effects of LGI on carbon emissions, and the constructed model may more closely reflect actual economic conditions. Moreover, the current study can benefit countries similar to China that aim to objectively identify the impacts of their LGI on carbon emissions, and such countries can use it as a reference in the formulation of investment policies based on their economic and industrial characteristics.	[He, Lingyun; Yin, Fang; Ding, Zhihua] China Univ Min & Technol, Sch Management, Xuzhou, Peoples R China; [Zhong, Zhangqi] Zhejiang Univ Finance & Econ, Sch Econ, Hangzhou, Zhejiang, Peoples R China	China University of Mining & Technology; Zhejiang University of Finance & Economics	Yin, F (corresponding author), China Univ Min & Technol, Sch Management, Xuzhou, Peoples R China.	yindf_11@126.com			National Natural Science Foundation of China [71203219]; key project of National Social Sciences Program Fund of China [15ZDB163]; Ministry of education of Humanities and Social Science project of China [16YJAZH015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of National Social Sciences Program Fund of China; Ministry of education of Humanities and Social Science project of China	The authors are grateful for the financial support provided by the National Natural Science Foundation of China under grant no. 71203219, the key project of National Social Sciences Program Fund of China under grant no. 15ZDB163, and the Ministry of education of Humanities and Social Science project of China under grant no. 16YJAZH015.	Adom PK, 2012, ENERGY, V47, P314, DOI 10.1016/j.energy.2012.09.025; Al-Mulali U, 2015, NAT HAZARDS, V79, P621, DOI 10.1007/s11069-015-1865-9; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Baek JH, 2009, J EAST ASIAN ECON IN, V13, P87, DOI 10.11644/KIEP.JEAI.2009.13.2.202; Ben Jebli M, 2016, ECOL INDIC, V60, P824, DOI 10.1016/j.ecolind.2015.08.031; Ben Jebli M, 2015, ENVIRON SCI POLLUT R, V22, P16022, DOI 10.1007/s11356-015-4792-0; Chen X.P., 2012, EMPIRICAL METHODS OR; Dogan E, 2016, ENVIRON SCI POLLUT R, P1; Dogan E, 2017, CURR ISSUES TOUR, V20, P1701, DOI 10.1080/13683500.2015.1119103; Dogan E, 2016, RENEW SUST ENERG REV, V60, P1074, DOI 10.1016/j.rser.2016.02.006; Dogan E, 2016, RENEW ENERG, V94, P429, DOI 10.1016/j.renene.2016.03.078; Dogan E, 2016, ENVIRON SCI POLLUT R, V23, P1203, DOI 10.1007/s11356-015-5323-8; Drezner JA, 1999, THESIS, P60; Du LM, 2012, CHINA ECON REV, V23, P371, DOI 10.1016/j.chieco.2012.02.004; Ertugrul HM, 2016, ECOL INDIC, V67, P543, DOI 10.1016/j.ecolind.2016.03.027; Fei Q, 2014, ENRGY PROCED, V61, P1142, DOI 10.1016/j.egypro.2014.11.1041; Framstad NC, 2013, RESOUR ENERGY ECON, V41, P1; Fu F, 2014, ENERG CONVERS MANAGE, V85, P573, DOI 10.1016/j.enconman.2014.05.046; Glomm G, 2008, J POLICY MODEL, V30, P19, DOI 10.1016/j.jpolmod.2007.09.001; [何凌云 He Lingyun], 2016, [资源科学, Resources Science], V38, P1383; Hubler M, 2012, ENERG POLICY, V50, P315, DOI 10.1016/j.enpol.2012.07.025; Jorgenson AndrewK., 2007, INT J COMP SOCIOL, V48, P29, DOI DOI 10.1177/0020715207072158; Kais S, 2016, RENEW SUST ENERG REV, V59, P1101, DOI 10.1016/j.rser.2016.01.054; Kaya Y., 1989, COMMUNICATION; Lee KH, 2015, INT J PROD ECON, V167, P1, DOI 10.1016/j.ijpe.2015.05.018; Lee S, 2016, RESOUR CONSERV RECY, V107, P220, DOI 10.1016/j.resconrec.2016.01.003; Li K, 2015, RENEW SUST ENERG REV, V42, P952, DOI 10.1016/j.rser.2014.10.083; Liu LC, 2007, ENERG POLICY, V35, P5892, DOI 10.1016/j.enpol.2007.07.010; Lu CY, 2010, ENERGY, V35, P4319, DOI 10.1016/j.energy.2009.04.007; Mahesh A, 2013, RENEW SUST ENERG REV, V26, P414, DOI 10.1016/j.rser.2013.05.069; Mao GZ, 2013, ENERGY STRATEG REV, V2, P199, DOI 10.1016/j.esr.2013.07.004; Martinsen D, 2007, ENERG POLICY, V35, P4504, DOI 10.1016/j.enpol.2007.03.003; Mi ZF, 2015, J CLEAN PROD, V103, P455, DOI 10.1016/j.jclepro.2014.06.011; Ministry of Finance of the People's Republic of China, 2001, CHIN FIN YB 2001 201; National Bureau of Statistics of People's Republic of China, 2001, CHIN STAT YB 2001 20; National Bureau of Statistics of People's Republic of China, 2002, CHIN EN STAT YB 2002; National Bureau of Statistics of People's Republic of China, 2013, CHIN EN STAT YB 2013; Peng Y., 2010, PUBLIC FINANCE RES, V12, P30; Peng Y., 2013, COMP EC SOCIAL SYSTE, V3, P92; Purohit I, 2007, INT J ENERGY SECT MA, V1, P141, DOI 10.1108/17506220710761564; Shafiei S, 2014, ENERG POLICY, V66, P547, DOI 10.1016/j.enpol.2013.10.064; Shen L, 2014, RES EC MANAGEMENT, V1, P56; Shi D., 2003, EC THEORY BUS MANAG, V8, P30, DOI 10.3969/j.issn.1000-596X.2003.08.006; Song ZJ, 2013, ENTERPRISE EC, V10, P171; Sun JW, 1998, ENERG ECON, V20, P85, DOI 10.1016/S0140-9883(97)00012-1; Wang J., 2014, EC MANAG, V36, P13; Wang K-I, 2012, MANAG REV, V24, P40; Wang SH, 2016, RESOURCES SCI, V36, P2500; Zhang D. J., 2016, TRANSPORT RES D-TR E, P1; Zhang HX, 2011, J INNER MONGOLIA FIN, V3, P22; Zhang LF, 2011, J ARID LAND RESOURCE, V5, P1; Zhang M, 2009, ECOLOGICAL EC, V68, P2111; Zhang N, 2016, ENERGY, V99, P10, DOI 10.1016/j.energy.2016.01.012; Zhang TT, 2012, STAT DECISION, V9, P161; Zhang WG, 2015, ECOLOGICAL EC, V31, P14; Zhang WG, 2010, CHINA IND EC, V8, P23; Zhao P., 2013, FINANCE EC, V18, P75; [郑蕾 Zheng Lei], 2015, [资源科学, Resources Science], V37, P2330; Zhou GL, 2012, EC PROBLEMS, V1, P24; Zhou J, 2012, SHANGHAI J EC, V1, P24; Zhou XY, 2013, ENERG POLICY, V57, P43, DOI 10.1016/j.enpol.2012.07.017	61	9	9	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180946	10.1371/journal.pone.0180946	http://dx.doi.org/10.1371/journal.pone.0180946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727783	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500032
J	Hull-Sanders, H; Pepper, E; Davis, K; Trotter, RT				Hull-Sanders, Helen; Pepper, Eugene; Davis, Kevin; Trotter, Robert Talbot, III			Description of an establishment event by the invasive Asian longhorned beetle (Anoplophora glabripennis) in a suburban landscape in the northeastern United States	PLOS ONE			English	Article							COLEOPTERA-CERAMBYCIDAE; MARK-RECAPTURE; DISPERSAL; ECOLOGY; INFESTATION; POPULATIONS; WELENSII; STANDS; DEHESA	The establishment of non-native species is commonly described as occurring in three phases: arrival, establishment, and dispersal. Both arrival and dispersal by the Asian longhorned beetle (Anoplophora glabripennis Motschulsky), a xylophagous Cerambycid native to China and the Korean peninsula, has been documented for multiple locations in both North America and Europe, however the transitional phase, establishment, is not well understood for this species due to the need to rapidly remove populations to prevent dispersal and assist eradication, and the evident variation in the behavior of populations. Here we describe the dynamics of an establishment event for the Asian longhorned beetle in a small, isolated population within the regulated quarantine zone near Worcester, Massachusetts, USA. These data were collected during an opportunity afforded by logistical limits on the Cooperative Asian Longhorned Beetle Eradication Program administered by state, federal, and local government partners. Seventy-one infested red maple (Acer rubrum) trees and 456 interspersed un-infested trees were surveyed in an isolated, recently established population within a similar to 0.29 ha stand in a suburban wetland conservation area in which nearly 90% of the trees were host species, and nearly 80% were Acer rubrum. Tree-ring analyses show that within this establishing population, Asian longhorned beetles initially infested one or two A. rubrum, before moving through the stand to infest additional A. rubrum based not on distance or direction, but on tree size, with infestation biased towards trees with larger trunk diameters. Survey data from the larger landscape suggest this population may have generated long-distance dispersers (similar to 1400 m), and that these dispersal events occurred before the originally infested host trees were fully exploited by the beetle. The distribution and intensity of damage documented in this population suggest dispersal here may have been spatially more rapid and diffuse than in other documented infestations. Dispersal at these larger spatial scales also implies that when beetles move beyond the closed canopy of the stand, the direction of dispersal may be linked to prevailing winds.	[Hull-Sanders, Helen] USDA, Ctr Plant Hlth Sci & Technol, Anim & Plant Hlth Inspect Serv, Plant Protect & Quarantine,Otis Lab, Washington, DC 20250 USA; [Pepper, Eugene; Davis, Kevin] USDA, Anim & Plant Hlth Inspect Serv, Asian Longhorned Beetle Cooperat Eradicat Program, 151 West Boylston Dr, Worcester, MA USA; [Trotter, Robert Talbot, III] US Forest Serv, USDA, Northern Res Stn, Hamden, CT USA; [Hull-Sanders, Helen] US EPA, USEPA Headquarters, William Jefferson Clintom Bldg,1200 Penn Ave NW, Washington, DC 20460 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Forest Service; United States Environmental Protection Agency	Hull-Sanders, H (corresponding author), USDA, Ctr Plant Hlth Sci & Technol, Anim & Plant Hlth Inspect Serv, Plant Protect & Quarantine,Otis Lab, Washington, DC 20250 USA.; Hull-Sanders, H (corresponding author), US EPA, USEPA Headquarters, William Jefferson Clintom Bldg,1200 Penn Ave NW, Washington, DC 20460 USA.	hhullsanders@gmail.com			USDA Animal Plant Health Inspection Service; USDA Forest Service; USDA PPQ-Otis Laboratory, Buzzards Bay, Massachusetts; USDA PPQ Asian Longhorned Beetle Eradication Program, Worcester, Massachusetts	USDA Animal Plant Health Inspection Service; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); USDA PPQ-Otis Laboratory, Buzzards Bay, Massachusetts; USDA PPQ Asian Longhorned Beetle Eradication Program, Worcester, Massachusetts	This work supported by the USDA Animal Plant Health Inspection Service and the USDA Forest Service. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the USDA PPQ-Otis Laboratory, Buzzards Bay, Massachusetts and USDA PPQ Asian Longhorned Beetle Eradication Program, Worcester, Massachusetts for all their cooperation and support on this project. We would also like to acknowledge the contributions of Christopher Perry, J. Chris Fagan, and David Mikus for their invaluable technical help in the field and processing of wood samples. Any reference to commercial software is made for the convenience of the reader, and does not constitute an endorsement of any software or company.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; [Anonymous], 2013, MATLAB STAT TOOLB RE; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Bancroft JS, 2005, ENTOMOL EXP APPL, V116, P83, DOI 10.1111/j.1570-7458.2005.00320.x; Bartell SM, 2004, RISK ANAL, V24, P833, DOI 10.1111/j.0272-4332.2004.00482.x; Dodds Kevin J., 2014, Insects, V5, P105, DOI 10.3390/insects5010105; Dodds KJ, 2011, CAN J FOREST RES, V41, P1729, DOI [10.1139/X11-097, 10.1139/x11-097]; Drag L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021345; Environmental Systems Research Institute (ESRI), 2006, ARCPAD VERS 10 SOFTW; ESRI, 2011, ARCGIS DESKT REL 10; Favaro R, 2015, ENTOMOL EXP APPL, V155, P95, DOI 10.1111/eea.12292; Fritts H. C., 1976, TREE RINGS CLIMATE; (GAO) Government Accountability Office, 2006, GAO06353 COMM RES HO; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Hsiao K. J., 1982, Crop Protection, V1, P359, DOI 10.1016/0261-2194(82)90011-4; Hu JF, 2009, AGR FOREST ENTOMOL, V11, P359, DOI 10.1111/j.1461-9563.2009.00443.x; Li Guo-hong, 2010, Forest Research, V23, P678; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Lingafelter S.W., 2002, REVISION GENUS ANOPL; Lopez-Pantoja G, 2008, CENT EUR J BIOL, V3, P431, DOI 10.2478/s11535-008-0044-3; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Parker BL, 2012, NAPR0512 USDA; Peng J., 1992, ICONOGRAPHY FOREST I; R Foundation for Statistical Computing V. Austria. . R Development Core Team, 2008, R LANG ENV STAT COMP; Sawyer A., 2009, EXPECTED DISPERSAL A; SHIBATA E, 1986, RES POPUL ECOL, V28, P253, DOI 10.1007/BF02515453; Smith Michael T., 2009, American Entomologist, V55, P21; Smith MT, 2004, ENVIRON ENTOMOL, V33, P435, DOI 10.1603/0046-225X-33.2.435; Smith MT, 2002, ENVIRON ENTOMOL, V31, P76, DOI 10.1603/0046-225X-31.1.76; Smith MT, 2001, ENVIRON ENTOMOL, V30, P1036, DOI 10.1603/0046-225X-30.6.1036; Straw NA, 2016, AGR FOREST ENTOMOL, V18, P280, DOI 10.1111/afe.12160; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Torres-Vila LM, 2013, ENTOMOL EXP APPL, V149, P273, DOI 10.1111/eea.12133; Trotter RT, 2015, BIOL INVASIONS, V17, P3359, DOI 10.1007/s10530-015-0961-9; Turgeon JJ, 2015, COLEOPTS BULL, V69, P674, DOI 10.1649/0010-065X-69.4.674; United States Army, 1956, 2126 FM US ARM DEP A; Wang B., 2005, GEN TECHNICAL REPORT, P89; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williams DW, 2004, ENVIRON ENTOMOL, V33, P540, DOI 10.1603/0046-225X-33.3.540; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wu Weiwen, 1998, Acta Entomologica Sinica, V41, P284; Xiao G.R., 1992, FOREST INSECTS CHINA, V2nd eds; Yan J., 1992, FOREST INSECTS CHINA, P455	44	11	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181655	10.1371/journal.pone.0181655	http://dx.doi.org/10.1371/journal.pone.0181655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727772	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500100
J	Singh, SP; Swanson, M				Singh, Shane P.; Swanson, Meili			How issue frames shape beliefs about the importance of climate change policy across ideological and partisan groups	PLOS ONE			English	Article							PUBLIC-OPINION; SUPPORT; MITIGATION; POLARIZATION; INFORMATION; ENVIRONMENT; COMPASSION; ATTITUDES; DISTANCE; LIMITS	We use an experiment to examine whether the way in which climate change is framed affects individuals' beliefs about its importance as a policy issue. We employ frames that emphasize national security, human rights, and environmental importance about the consequences of climate change. We find no evidence that issue frames have an overall effect on opinions about the importance of climate change policy. We do find some evidence that the effect of issue frames varies across ideological and partisan groups. Most notably, issue frames can lead Republicans and those on the political right to view climate change policy as less important. We conclude by discussing our findings relative to extant literature and considering the implications of our findings for those who seek to address the issue of climate change.	[Singh, Shane P.] Univ Georgia, Dept Int Affairs, Athens, GA 30602 USA; [Swanson, Meili] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA	University System of Georgia; University of Georgia; United States Department of Energy (DOE); Sandia National Laboratories	Singh, SP (corresponding author), Univ Georgia, Dept Int Affairs, Athens, GA 30602 USA.	singh@uga.edu		Singh, Shane/0000-0003-3263-5281				Aklin M, 2013, GLOBAL ENVIRON CHANG, V23, P1225, DOI 10.1016/j.gloenvcha.2013.03.007; Armitage CJ, 2000, PERS SOC PSYCHOL B, V26, P1421, DOI 10.1177/0146167200263009; Aschemann-Witzel J, 2015, FOOD QUAL PREFER, V42, P90, DOI 10.1016/j.foodqual.2015.01.008; Bechtel MM, 2015, POLIT SCI RES METH, V3, P683, DOI 10.1017/psrm.2014.39; Berinsky AJ, 2006, J POLIT, V68, P640, DOI 10.1111/j.1468-2508.2006.00451.x; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bernauer T, 2016, NAT CLIM CHANGE, V6, P680, DOI [10.1038/nclimate2948, 10.1038/NCLIMATE2948]; Bolsen T, 2014, PUBLIC OPIN QUART, V78, P1, DOI 10.1093/poq/nft044; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; De Mesquita BB, 2005, INT STUD QUART, V49, P439, DOI 10.1111/j.1468-2478.2005.00372.x; Druckman JN, 2001, J POLIT, V63, P1041, DOI 10.1111/0022-3816.00100; Gallup, CLIM CHANG NOT TOP W; Gauchat G., 2012, AM SOCIOL REV, V77, P167, DOI [10.1177/0003122412438225, DOI 10.1177/0003122412438225]; Gill J, 1999, POLIT RES QUART, V52, P647, DOI 10.1177/106591299905200309; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Gross K, 2004, POLIT PSYCHOL, V25, P1, DOI 10.1111/j.1467-9221.2004.00354.x; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hochschild J, 2015, BRIT J POLIT SCI, V45, P467, DOI 10.1017/S000712341400043X; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Huff C, 2015, RES POLITICS, V2, DOI 10.1177/2053168015604648; Jacoby WG, 2000, AM J POLIT SCI, V44, P750, DOI 10.2307/2669279; Kahan DM, 2015, ANN AM ACAD POLIT SS, V658, P192, DOI 10.1177/0002716214559002; Kamradt-Scott A, 2012, GLOB PUBLIC HEALTH, V7, pS95, DOI 10.1080/17441692.2012.725752; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; Keohane RO, 2015, PS-POLIT SCI POLIT, V48, P19, DOI 10.1017/S1049096514001541; Kolsto SD, 2006, INT J SCI EDUC, V28, P1689, DOI 10.1080/09500690600560878; KROSNICK JA, 1990, AM POLIT SCI REV, V84, P497, DOI 10.2307/1963531; Lahav G, 2012, POLIT BEHAV, V34, P477, DOI 10.1007/s11109-011-9171-z; Leiserowitz AA, 2005, RISK ANAL, V25, P1433, DOI 10.1111/j.1540-6261.2005.00690.x; Liberman N, 2007, J EXP SOC PSYCHOL, V43, P143, DOI 10.1016/j.jesp.2005.12.009; Lu H, 2016, J ENVIRON PSYCHOL, V45, P192, DOI 10.1016/j.jenvp.2016.01.007; Maibach EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-299; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Molden D. C., 2005, CAMBRIDGE HDB THINKI, P295, DOI DOI 10.13140/2.1.5188.6883; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; National Public Radio, NEARL 200 NAT AD CLI; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Nyhan B, 2010, POLIT BEHAV, V32, P303, DOI 10.1007/s11109-010-9112-2; Petrovic N, 2014, CLIMATIC CHANGE, V126, P245, DOI 10.1007/s10584-014-1192-2; Pfattheicher S, 2016, ENVIRON BEHAV, V48, P929, DOI 10.1177/0013916515574549; Rathzel N, 2009, GLOBAL ENVIRON CHANG, V19, P326, DOI 10.1016/j.gloenvcha.2009.05.001; Riffkin R., UNEMPLOYMENT RISES T; Schuldt JP, 2011, PUBLIC OPIN QUART, V75, P115, DOI 10.1093/poq/nfq073; Severson AW, 2015, SOC SCI QUART, V96, P1277, DOI 10.1111/ssqu.12159; Soroka StuartN., 2010, DEGREES DEMOCRACY PO; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; STIMSON JA, 1995, AM POLIT SCI REV, V89, P543, DOI 10.2307/2082973; Stokes B., 2013, AM FOREIGN POLICY PR; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; The White House, 2015, NAT SEC STRAT; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; United States Department of Defense, 2015, NAT SEC IMPL CLIM RE; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Warner K., 2011, EHR, V76, P789; Wiest SL, 2015, GLOBAL ENVIRON CHANG, V31, P187, DOI 10.1016/j.gloenvcha.2014.12.006; Yang FY, 2003, INT J SCI EDUC, V25, P221, DOI 10.1080/09500690210126739; Yarnal B., 2003, LOCAL ENVIRON, V8, P457, DOI [10.1080/13549830306668, DOI 10.1080/13549830306668]	58	15	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181401	10.1371/journal.pone.0181401	http://dx.doi.org/10.1371/journal.pone.0181401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727842	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500067
J	Takeuchi, H; Yu, HJ; Hao, HL; Takeuchi, M; Ito, A; Li, HL; Haltiwanger, RS				Takeuchi, Hideyuki; Yu, Hongjun; Hao, Huilin; Takeuchi, Megumi; Ito, Atsuko; Li, Huilin; Haltiwanger, Robert S.			O-Glycosylation modulates the stability of epidermal growth factor-like repeats and thereby regulates Notch trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; DOWLING-DEGOS DISEASE; LIGAND-BINDING REGION; PROTEIN O-FUCOSYL-TRANSFERASE-1; DROSOPHILA NOTCH; QUALITY-CONTROL; MODIFIES NOTCH; LINKED FUCOSE; MOUSE NOTCH1; EGF MODULES	Glycosylation in the endoplasmic reticulum (ER) is closely associated with protein folding and quality control. We recently described a non-canonical ER quality control mechanism for folding of thrombospondin type 1 repeats by protein O-fucosyl-transferase 2 (POFUT2). Epidermal growth factor-like (EGF) repeats are also small cysteine-rich protein motifs that can be O-glycosylated by several ER-localized enzymes, including protein O-glucosyltransferase 1 (POGLUT1) and POFUT1. Both POGLUT1 and POFUT1 modify the Notch receptor on multiple EGF repeats and are essential for full Notch function. The fact that POGLUT1 and POFUT1 can distinguish between folded and unfolded EGF repeats raised the possibility that they participate in a quality control pathway for folding of EGF repeats in proteins such as Notch. Here, we demonstrate that cell-surface expression of endogenous Notch1 in HEK293T cells is dependent on the presence of POGLUT1 and POFUT1 in an additive manner. In vitro unfolding assays reveal that addition of O-glucose or O-fucose stabilizes a single EGF repeat and that addition of both O-glucose and O-fucose enhances stability in an additive manner. Finally, we solved the crystal structure of a single EGF repeat covalently modified by a full O-glucose trisaccharide at 2.2 angstrom resolution. The structure reveals that the glycan fills up a surface groove of the EGF with multiple contacts with the protein, providing a chemical basis for the stabilizing effects of the glycans. Taken together, this work suggests that O-fucose and O-glucose glycans cooperatively stabilize individual EGF repeats through intramolecular interactions, thereby regulating Notch trafficking in cells.	[Takeuchi, Hideyuki; Hao, Huilin; Takeuchi, Megumi; Ito, Atsuko; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Yu, Hongjun; Li, Huilin] Van Andel Res Inst, CryoEM Struct Biol Lab, Grand Rapids, MI 49503 USA; [Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Takeuchi, Hideyuki] Nagoya Univ, Sch Med, Dept Mol Biochem, Nagoya, Aichi 4668550, Japan	University System of Georgia; University of Georgia; Van Andel Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nagoya University	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rhalti@uga.edu	Takeuchi, Hideyuki/AAZ-9210-2020	Yu, Hongjun/0000-0002-1483-2962; Li, Huilin/0000-0001-8085-8928	National Institutes of Health [GM061126, AG029979]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029979] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants GM061126 (to R.S.H.) and AG029979 (to H.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Adams JC, 2000, DEV DYNAM, V218, P280; Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berger RP, 2016, STEM CELLS, V34, P1742, DOI 10.1002/stem.2379; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Gordon WR, 2015, DEV CELL, V33, P729, DOI 10.1016/j.devcel.2015.05.004; Haltom AR, 2015, GLYCOBIOLOGY, V25, P1027, DOI 10.1093/glycob/cwv052; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Harvey BM, 2016, J BIOL CHEM, V291, P16348, DOI 10.1074/jbc.M116.732537; Hayakawa S, 2016, BIOCHEMISTRY-US, V55, P776, DOI 10.1021/acs.biochem.5b01284; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Lee TV, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006723; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Li M, 2013, AM J HUM GENET, V92, P895, DOI 10.1016/j.ajhg.2013.04.022; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Matsumoto K, 2016, J BIOL CHEM, V291, P13743, DOI 10.1074/jbc.M115.710483; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Rampal R, 2005, J BIOL CHEM, V280, P42454, DOI 10.1074/jbc.M509552200; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; RAO Z, 1995, CELL, V82, P131, DOI 10.1016/0092-8674(95)90059-4; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Servian-Morilla E, 2016, EMBO MOL MED, V8, P1289, DOI 10.15252/emmm.201505815; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Takeuchi H, 2011, P NATL ACAD SCI USA, V108, P16600, DOI 10.1073/pnas.1109696108; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yu HJ, 2016, NAT CHEM BIOL, V12, P735, DOI 10.1038/nchembio.2135	50	60	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15964	15973		10.1074/jbc.M117.800102	http://dx.doi.org/10.1074/jbc.M117.800102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28729422	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000411512200032
J	Sun, Y; Li, Y; Wu, YR; Xiong, L; Li, CW; Wang, CD; Li, DS; Lan, JC; Zhang, ZH; Jing, B; Gu, XB; Xie, Y; Lai, WM; Peng, XR; Yang, GY				Sun, Ying; Li, Yu; Wu, Yiran; Xiong, Lang; Li, Caiwu; Wang, Chengdong; Li, Desheng; Lan, Jingchao; Zhang, Zhihe; Jing, Bo; Gu, Xiaobing; Xie, Yue; Lai, Weimin; Peng, Xuerong; Yang, Guangyou			Fatty-binding protein and galectin of Baylisascaris schroederi: Prokaryotic expression and preliminary evaluation of serodiagnostic potential	PLOS ONE			English	Article							PANDA AILUROPODA-MELANOLEUCA; GIANT PANDA; MITOCHONDRIAL GENOMES; FASCIOLA-GIGANTICA; SEQUENCE-ANALYSIS; ASCARIS-SUUM; GENE; VACCINATION; INFECTIONS; EFFICACY	Baylisascaris schroederi is a common parasite of captive giant pandas. The diagnosis of this ascariasis is normally carried out by a sedimentation-floatation method or PCR to detect eggs in feces, but neither method is suitable for early diagnosis. Fatty acid-binding protein (FABP) and galectin (GAL) exist in various animals and participate in important biology of parasites. Because of their good immunogenicity, they are seen as potential antigens for the diagnosis of parasitic diseases. In this study, we cloned and expressed recombinant FABP and GAL from B. schroederi (rBs-FABP and rBs-GAL) and developed indirect enzymelinked immunosorbent assays (ELISAs) to evaluate their potential for diagnosing ascariasis in giant pandas. Immunolocalization showed that Bs-FABP and Bs-GAL were widely distributed in adult worms. The ELISA based on rBs-FABP showed sensitivity of 95.8% (23/24) and specificity of 100% (12/12), and that based on rBs-GAL had sensitivity of 91.7% (22/24) and specificity of 100% (12/12).	[Sun, Ying; Li, Yu; Wu, Yiran; Xiong, Lang; Jing, Bo; Gu, Xiaobing; Xie, Yue; Lai, Weimin; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Chengdu, Sichuan, Peoples R China; [Li, Caiwu; Wang, Chengdong; Li, Desheng] China Conservat & Res Ctr Giant Panda, Wolong, Peoples R China; [Lan, Jingchao; Zhang, Zhihe] Chengdu Res Base Giant Panda Breeding, Chengdu, Sichuan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Sci, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Chengdu, Sichuan, Peoples R China.	guangyou1963@aliyun.com			Chengdu Giant Panda Breeding Research Foundation [CPF2012-13]	Chengdu Giant Panda Breeding Research Foundation	This study was funded by the Chengdu Giant Panda Breeding Research Foundation (No. CPF2012-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CMOS, 2010, IMMUNOBIOLOGY, V215, P475, DOI 10.1016/j.imbio.2009.08.001; Alvite G, 2008, FEBS J, V275, P107, DOI 10.1111/j.1742-4658.2007.06179.x; Anuracpreeda P, 2016, PARASITOLOGY, V143, P1; Astorgues-Xerri L, 2014, CANCER TREAT REV, V40, P307, DOI 10.1016/j.ctrv.2013.07.007; Azzouz S, 2010, CHROMATOGRAPHIA, V71, P721, DOI 10.1365/s10337-010-1515-z; Bronson E, 2007, J ZOO WILDLIFE MED, V38, P363, DOI 10.1638/1042-7260(2007)038[0363:SRTACC]2.0.CO;2; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chen C, 2013, DEV COMP IMMUNOL, V39, P399, DOI 10.1016/j.dci.2012.10.008; Chunchob S, 2010, PARASITOLOGY, V137, P1805, DOI 10.1017/S003118201000079X; Franchini GR, 2015, PROSTAG LEUKOTR ESS, V93, P31, DOI 10.1016/j.plefa.2014.08.003; He GZ, 2012, DNA CELL BIOL, V31, P1174, DOI 10.1089/dna.2011.1395; He GZ, 2009, VACCINE, V27, P3007, DOI 10.1016/j.vaccine.2009.02.077; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Li De-sheng, 2014, Jingji Dongwu Xuebao, V18, P214; Litster A, 2012, VET MICROBIOL, V157, P86, DOI 10.1016/j.vetmic.2011.12.030; Liu LH, 2013, PARASITOL RES, V112, P933, DOI 10.1007/s00436-012-3210-5; Morchon R, 2014, VET PARASITOL, V203, P144, DOI 10.1016/j.vetpar.2014.02.005; Nambi PA, 2005, PARASITOL RES, V97, P129, DOI 10.1007/s00436-005-1397-4; Pelletier I, 2003, J BIOL CHEM, V278, P22223, DOI 10.1074/jbc.M302693200; Qin Q, 2010, VET MICROBIOL, V142, P199, DOI 10.1016/j.vetmic.2009.09.062; Sripa J, 2016, PARASITOL INT, V102, P757; Tan XM, 2007, MOL IMMUNOL, V44, P3061, DOI 10.1016/j.molimm.2006.12.017; Tang X. P., 2015, FOREST RESOURCES MAN, P11; Toscano MA, 2012, PARASITE IMMUNOL, V34, P383, DOI 10.1111/j.1365-3024.2012.01366.x; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vlaminck J, 2015, VET PARASITOL, V210, P151, DOI 10.1016/j.vetpar.2015.04.012; Vlaminck J, 2012, VET PARASITOL, V189, P267, DOI 10.1016/j.vetpar.2012.04.024; Wang N, 2013, PARASITOL INT, V62, P435, DOI 10.1016/j.parint.2013.05.004; Wang ZQ, 2016, GEN COMP ENDOCR, V229, P32, DOI 10.1016/j.ygcen.2016.02.016; Xie Y, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0606-3; Xie Y, 2011, GENE, V482, P59, DOI 10.1016/j.gene.2011.05.004; Young AR, 2002, GLYCOCONJUGATE J, V19, P601, DOI 10.1023/B:GLYC.0000014091.00844.0a; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zhang L, 2015, J WILDLIFE DIS, V47, P164; Zhang WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041995; Zhou X, 2013, J WILDLIFE DIS, V49, P1052, DOI 10.7589/2012-07-175	37	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							0182094	10.1371/journal.pone.0182094	http://dx.doi.org/10.1371/journal.pone.0182094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750056	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700134
J	Zhang, C; Rissman, RA				Zhang, Cheng; Rissman, Robert A.			Corticotropin-releasing factor receptor-1 modulates biomarkers of DNA oxidation in Alzheimer's disease mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA PRODUCTION; RNA OXIDATION; STRESS; DAMAGE; METHYLATION; PROTEIN; BRAIN	Increased production of hydroxyl radical is the main source of oxidative damage in mammalian DNA that accumulates in Alzheimer's disease (AD). Reactive oxygen species (ROS) react with both nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) to generate 8-hydroxy-2'-deoxyguanosine (8-OHdG), both of which can be measured in the urine. Knowledge of this pathway has positioned measurement of urine 8-OHdG as a reliable index of DNA oxidation and a potential biomarker target for tracking early cellular dysfunction in AD. Furthermore, epigenetic studies demonstrate decreased global DNA methylation levels (e.g. 5-methyl-2'-deoxycytidine, 5-mdC) in AD tissues. Moreover, stress hormones can activate neuronal oxidative stress which will stimulate the release of additional stress hormones and result in damages to hippocampal neurons in the AD brain. Our previous work suggests that treating AD transgenic mice the type-1 corticotropin-releasing factor receptor (CRFR1) antagonist, R121919, to reduce stress signaling, prevented onset of cognitive impairment, synaptic/dendritic loss and A beta plaque accumulation. Therefore, to investigate whether levels of DNA oxidation can be impacted by the same therapeutic approach, urine levels of hydrogen peroxide, 8-OHdG, 5-mdC and total antioxidant capacity (TAC) were analyzed using an AD Tg mouse model. We found that Tg animals had an 80% increase in hydrogen peroxide levels compared to wild type (Wt) counterparts, an effect that could be dramatically reversed by the chronic administration with R121919. A significant decrease of 8-OHdG levels was observed in Tg mice treated with CRFR1 antagonist. Collectively our data suggest that the beneficial effects of CRFR1 antagonism seen in Tg mice may be mechanistically linked to the modulation of oxidative stress pathways.	[Zhang, Cheng; Rissman, Robert A.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Rissman, Robert A.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Zhang, Cheng] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Miami	Rissman, RA (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.; Rissman, RA (corresponding author), Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA.	rrissman@ucsd.edu			National Institute on Aging [AG051848, AG0051839, AG005131, AG018440, AG000216]; National Institutes of Health [BX003040]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Robert A. Rissman received the following grants in support of this study: National Institute on Aging (AG051848); National Institutes of Health BX003040; National Institute on Aging (AG0051839); National Institute on Aging (AG005131); National Institute on Aging (AG018440); National Institute on Aging (AG000216).	Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Campbell SN, 2015, J ALZHEIMERS DIS, V45, P1175, DOI 10.3233/JAD-142844; Campbell SN, 2015, INCREASED TAU PHOSPH; Dong HX, 2009, J ALZHEIMERS DIS, V18, P459, DOI 10.3233/JAD-2009-1152; Donkena KV, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/302051; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Foy CJ, 1999, QJM-INT J MED, V92, P39, DOI 10.1093/qjmed/92.1.39; Guo X, 2011, NEUROSCIENCE, V194, P272, DOI 10.1016/j.neuroscience.2011.07.012; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kusano C, 2008, J CELL MOL BIOL, V7, P1; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Lovell MA, 2008, NEUROBIOL DIS, V29, P169, DOI 10.1016/j.nbd.2007.07.030; Lovell MA, 2007, J NEUROSCI RES, V85, P3036, DOI 10.1002/jnr.21346; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Mangialasche F, 2009, AGEING RES REV, V8, P285, DOI 10.1016/j.arr.2009.04.002; Nunomura A, 1999, ANN NY ACAD SCI, V893, P362, DOI 10.1111/j.1749-6632.1999.tb07855.x; Nunomura A, 1999, J NEUROSCI, V19, P1959; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P733, DOI 10.1037/a0012520; Pulido R, 2005, EUR J NEUROL, V12, P531, DOI 10.1111/j.1468-1331.2005.01000.x; RATH PC, 1989, FEBS LETT, V244, P193, DOI 10.1016/0014-5793(89)81191-3; Ray D, 2006, J GERONTOL A-BIOL, V61, P115, DOI 10.1093/gerona/61.2.115; Rissman RA, 2007, J NEUROSCI, V27, P6552, DOI 10.1523/JNEUROSCI.5173-06.2007; Rissman RA, 2012, P NATL ACAD SCI USA, V109, P6277, DOI 10.1073/pnas.1203140109; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Vitale G, 2013, NAT REV ENDOCRINOL, V9, P228, DOI 10.1038/nrendo.2013.29; Wang SY, 2012, LAB CHIP, V12, P3362, DOI 10.1039/c2lc40132k; Xiong HQ, 2011, NEUROSCI BULL, V27, P221, DOI 10.1007/s12264-011-1015-7; Zhang C, 2016, ALZHEIMERS DEMENT, V12, P527, DOI 10.1016/j.jalz.2015.09.007; Zhang C, 2015, J ALZHEIMERS DIS, V45, P639, DOI 10.3233/JAD-141722; Zhang C, 2015, J ALZHEIMERS DIS, V44, P375, DOI 10.3233/JAD-141890; Zhang C, 2013, ELECTROPHORESIS, V34, P2268, DOI 10.1002/elps.201300036; Zhang C, 2012, J ALZHEIMERS DIS, V30, P919, DOI 10.3233/JAD-2012-120028; Zhang C, 2012, J ALZHEIMERS DIS, V28, P655, DOI 10.3233/JAD-2011-111244; Zhang C, 2011, ANAL BIOANAL CHEM, V401, P2165, DOI 10.1007/s00216-011-5311-x	37	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181367	10.1371/journal.pone.0181367	http://dx.doi.org/10.1371/journal.pone.0181367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750017	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700039
J	Hajek, A; Bock, JO; Konig, HH				Hajek, Andre; Bock, Jens-Oliver; Koenig, Hans-Helmut			The role of personality in health care use: Results of a population-based longitudinal study in Germany	PLOS ONE			English	Article							MENTAL-HEALTH; SERVICE UTILIZATION; MEDICAL-CARE; LIFE-COURSE; MEAN-LEVEL; BIG 5; NEUROTICISM; EXTROVERSION; METAANALYSIS; TRAITS	Objective To determine the role of personality in health care use longitudinally. Methods Data were derived from the German Socio-Economic Panel (GSOEP), a nationally representative, longitudinal cohort study of German households starting in 1984. Concentrating on the role of personality, we used data from the years 2005, 2009 and 2013. Personality was measured by using the GSOEP Big Five Inventory (BFI-S). Number of physician visits in the last 3 months and hospital stays in the last year were used as measures of health care use. Results Adjusting for predisposing factors, enabling resources, and need factors, fixed effects regressions revealed that physician visits increased with increasing neuroticism, whereas extraversion, openness to experience, agreeableness and conscientiousness did not affect physician visits in a significant way. The effect of self-rated health on physician visits was significantly moderated by neuroticism. Moreover, fixed effects regressions revealed that the probability of hospitalization in the past year increased with increasing extraversion, whereas the other personality factors did not affect this outcome measure significantly. Conclusion Our findings suggest that changes in neuroticism are associated with changes in physician visits and that changes in extraversion are associated with the probability of hospitalization. Since recent studies have shown that treatments can modify personality traits, developing interventional strategies should take into account personality factors. For example, efforts to intervene in changing neuroticism might have beneficial effects for the healthcare system.	[Hajek, Andre; Bock, Jens-Oliver; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	a.hajek@uke.de	PAN, ZEQIANG/X-6341-2018; König, Hans-Helmut/P-1211-2018	König, Hans-Helmut/0000-0001-5711-6862; Hajek, Andre/0000-0002-6886-2745				ADAY LA, 1981, MED CARE, V19, P4, DOI 10.1097/00005650-198112001-00004; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x; Boyce CJ, 2015, J APPL PSYCHOL, V100, P991, DOI 10.1037/a0038647; Boyce CJ, 2013, SOC INDIC RES, V111, P287, DOI 10.1007/s11205-012-0006-z; Cameron C., 2005, MICROECONOMETRICS US, P1056; Chapman BP, 2009, AM J GERIAT PSYCHIAT, V17, P526, DOI 10.1097/JGP.0b013e3181a2fbb1; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; Costa P. T., 1992, PSYCHOL ASSESSMENT R; Costa PT Jr, 1985, AGING 2000 OUR HLTH, P75; Friedman B, 2013, MILBANK Q, V91, P491, DOI 10.1111/1468-0009.12024; Friedman HS, 2000, J PERS, V68, P1089, DOI 10.1111/1467-6494.00127; Fydrich T, MANUAL; Gohl D, 2012, GMS PSYCHOSOCIAL MED, V9; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Goodwin RD, 2002, SOC PSYCH PSYCH EPID, V37, P561, DOI 10.1007/s00127-002-0563-6; Greene W.H., 2012, ECONOMETRIC ANAL; Hahn E, 2012, J RES PERS, V46, P355, DOI 10.1016/j.jrp.2012.03.008; Hakulinen C, 2015, ADDICTION, V110, P1844, DOI 10.1111/add.13079; Hakulinen C, 2015, DRUG ALCOHOL DEPEN, V151, P110, DOI 10.1016/j.drugalcdep.2015.03.008; Heider D, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-71; Hopwood CJ, 2008, PERSONAL MENT HEALTH, V2, P207, DOI 10.1002/pmh.51; Issakidis C, 2002, SOC PSYCH PSYCH EPID, V37, P153, DOI 10.1007/s001270200009; Jackson JJ, 2012, PSYCHOL AGING, V27, P286, DOI 10.1037/a0025918; John O, 1991, BIG 5 INVENTORY VERS; JOHNSON RJ, 1993, J HEALTH SOC BEHAV, V34, P105, DOI 10.2307/2137238; Kandler C, 2015, J PERS SOC PSYCHOL, V109, P175, DOI 10.1037/pspp0000028; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Lajunen T, 2001, PERS INDIV DIFFER, V31, P1365, DOI 10.1016/S0191-8869(00)00230-0; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; Lipps O., 2009, ATTRITION HOUSEHOLDS; Marusic A, 2001, NORD J PSYCHIAT, V55, P157; Michie S, 2002, OCCUP ENVIRON MED, V59, P67, DOI 10.1136/oem.59.1.67; Mroczek DK, 2007, PSYCHOL SCI, V18, P371, DOI 10.1111/j.1467-9280.2007.01907.x; Nettle D, 2005, EVOL HUM BEHAV, V26, P363, DOI 10.1016/j.evolhumbehav.2004.12.004; Pandhi N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009738; Parslow RA, 2000, AUST NZ J PSYCHIAT, V34, P997, DOI 10.1080/000486700276; Paunonen SV, 2000, J PERS, V68, P821, DOI 10.1111/1467-6494.00117; Paunonen SV, 2003, EUR J PERSONALITY, V17, P413, DOI 10.1002/per.496; Ricketts TC, 2005, NURS OUTLOOK, V53, P274, DOI 10.1016/j.outlook.2005.06.007; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Roberts BW, 2005, REV GEN PSYCHOL, V9, P156, DOI 10.1037/1089-2680.9.2.156; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Schoeni RF, 2013, ANN AM ACAD POLIT SS, V645, P60, DOI 10.1177/0002716212456363; Schupp J., 2005, DIW RES NOTES, V4, P2005, DOI DOI 10.1016/J.JSIS.2005.07.003; Seidl H, 2016, J EVALUATION CLIN PR; Specht J, 2011, J PERS SOC PSYCHOL, V101, P862, DOI 10.1037/a0024950; Springer KW, 2011, J HEALTH SOC BEHAV, V52, P212, DOI 10.1177/0022146510393972; ten Have M, 2006, SOC PSYCH PSYCH EPID, V41, P285, DOI 10.1007/s00127-005-0028-9; ten Have M, 2005, SOC PSYCH PSYCH EPID, V40, P425, DOI 10.1007/s00127-005-0916-z; Unesco, 1997, INT STAT CLASS ED; VANHEMERT AM, 1993, INT J PSYCHIAT MED, V23, P295, DOI 10.2190/TC5N-AQ3R-9CFK-EC9G; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Wagner G.G., 2007, J APPL SOCIAL SCI ST, V127, P139, DOI DOI 10.2139/SSRN.1028709; WEISENBERG M, 1977, PSYCHOL BULL, V84, P1008, DOI 10.1037/0033-2909.84.5.1008; Williams PG, 2004, PERS INDIV DIFFER, V37, P83, DOI 10.1016/j.paid.2003.08.001; Wrzus C, 2016, PERS SOC PSYCHOL REV	60	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181716	10.1371/journal.pone.0181716	http://dx.doi.org/10.1371/journal.pone.0181716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8EN	28746388	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800052
J	Lee, K; Seo, PJ				Lee, Kyounghee; Seo, Pil Joon			Coordination of matrix attachment and ATP-dependent chromatin remodeling regulate auxin biosynthesis and Arabidopsis hypocotyl elongation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR HY5; DNA-BINDING PROTEIN; GENE-EXPRESSION; PHYTOCHROME B4-NUMBER-3; REGIONS MARS; PLANTS; GROWTH; LIGHT; SUPPRESSOR; THALIANA	Hypocotyl elongation is extensively controlled by hormone signaling networks. In particular, auxin metabolism and signaling play key roles in light-dependent hypocotyl growth. The nuclear matrix facilitates organization of DNA within the nucleus, and dynamic interactions between nuclear matrix and DNA are related to gene regulation. Conserved scaffold/matrix attachment regions (S/MARs) are anchored to the nuclear matrix by the AT-HOOK MOTIF CONTAINING NUCLEAR LOCALIZED (AHL) proteins in Arabidopsis. Here, we found that ESCAROLA (ESC)/AHL27 and SUPPRESSOR OF PHYTOCHROME B-4 #3 (SOB3)/AHL29 redundantly regulate auxin biosynthesis in the control of hypocotyl elongation. The light-inducible AHL proteins bind directly to an S/MAR region of the YUCCA 9 (YUC9) promoter and suppress its expression to inhibit hypocotyl growth in light-grown seedlings. In addition, they recruit the SWI2/SNF2-RELATED 1 (SWR1) complex and promote exchange of H2A with the histone variant H2A.Z at the YUC9 locus to further elaborately control auxin biosynthesis. Consistent with these results, the long hypocotyl phenotypes of light-grown genetic mutants of the AHLs and H2A.Z-exchanging components were suppressed by potent chemical inhibitors of auxin transport and YUC enzymes. These results suggest that the coordination of matrix attachment and chromatin modification underlies auxin biosynthesis in light-dependent hypocotyl growth.	[Lee, Kyounghee; Seo, Pil Joon] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea	Sungkyunkwan University (SKKU)	Seo, PJ (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	pjseo1@skku.edu	Seo, Pil Joon/AAR-9426-2020		Basic Science Research by the National Research Foundation of Korea [NRF-2016R1D1A1B03931139]; Global Research Network by the National Research Foundation of Korea [NRF-2014S1A2A2028392]; Next-Generation BioGreen 21 Program by the Rural Development Administration [PJ01119204]	Basic Science Research by the National Research Foundation of Korea(National Research Foundation of Korea); Global Research Network by the National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program by the Rural Development Administration	This work was supported by the Basic Science Research (NRF-2016R1D1A1B03931139) and Global Research Network (NRF-2014S1A2A2028392) programs provided by the National Research Foundation of Korea and by the Next-Generation BioGreen 21 Program (PJ01119204) provided by the Rural Development Administration.	Allen GC, 2000, PLANT MOL BIOL, V43, P361, DOI 10.1023/A:1006424621037; Arope S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079262; Bode J, 1996, CRIT REV EUKAR GENE, V6, P115, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.20; Challa KR, 2016, PLANT CELL, V28, P2117, DOI 10.1105/tpc.16.00360; Chemmannur SV, 2015, MUCOSAL IMMUNOL, V8, P1201, DOI 10.1038/mi.2015.11; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Farcot E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122231; Favero DS, 2017, PLANT J, V89, P1133, DOI 10.1111/tpj.13451; Favero DS, 2016, PLANT PHYSIOL, V171, P2701, DOI 10.1104/pp.16.00405; Fujimoto S, 2004, PLANT MOL BIOL, V56, P225, DOI 10.1007/s11103-004-3249-5; Galande S, 2007, CURR OPIN GENET DEV, V17, P408, DOI 10.1016/j.gde.2007.08.003; Halliday KJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001586; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Jing YJ, 2013, PLANT CELL, V25, P242, DOI 10.1105/tpc.112.105742; Kohwi-Shigematsu T, 2012, METHODS, V58, P243, DOI 10.1016/j.ymeth.2012.06.019; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Linnemann AK, 2009, HUM MOL GENET, V18, P645, DOI 10.1093/hmg/ddn394; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; March-Diaz R, 2007, PLANT PHYSIOL, V143, P893; March-Diaz R, 2009, MOL PLANT, V2, P565; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Michalowski SM, 1999, BIOCHEMISTRY-US, V38, P12795, DOI 10.1021/bi991142c; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Ng KH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000251; Nishimura T, 2014, PLANT J, V77, P352, DOI 10.1111/tpj.12399; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Platts AE, 2006, CELL MOL BIOL LETT, V11, P191, DOI 10.2478/s11658-006-0016-4; Rampalli S, 2005, MOL CELL BIOL, V25, P8415, DOI 10.1128/MCB.25.19.8415-8429.2005; Rosa M, 2013, PLANT CELL, V25, P1990, DOI 10.1105/tpc.112.104067; Rudd S, 2004, PLANT PHYSIOL, V135, P715, DOI 10.1104/pp.103.037861; Selinger CI, 2011, J THORAC ONCOL, V6, P1179, DOI 10.1097/JTO.0b013e31821b4ce0; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Stamm P, 2013, PLANT CELL REP, V32, P759, DOI 10.1007/s00299-013-1406-5; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Street IH, 2008, PLANT J, V54, P1, DOI 10.1111/j.1365-313X.2007.03393.x; Sun JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002594; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Tetko IV, 2006, PLOS COMPUT BIOL, V2, P136, DOI 10.1371/journal.pcbi.0020021; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Toto M, 2014, CHROMOSOMA, V123, P91, DOI 10.1007/s00412-013-0447-4; VONKRIES JP, 1991, CELL, V64, P123, DOI 10.1016/0092-8674(91)90214-J; Weijers D, 2016, ANNU REV PLANT BIOL, V67, P539, DOI 10.1146/annurev-arplant-043015-112122; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wu SH, 2014, ANNU REV PLANT BIOL, V65, P311, DOI 10.1146/annurev-arplant-050213-040337; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xu YF, 2013, CURR BIOL, V23, P345, DOI 10.1016/j.cub.2013.01.030; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yokota T, 2014, INT J HEMATOL, V100, P238, DOI 10.1007/s12185-014-1602-2; Yun J, 2012, J BIOL CHEM, V287, P15307, DOI 10.1074/jbc.M111.318477; Zhao JF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0266-7; Zhao JF, 2013, P NATL ACAD SCI USA, V110, pE4688, DOI 10.1073/pnas.1219277110; Zhao YD, 2002, GENE DEV, V16, P3100, DOI 10.1101/gad.1035402; Zheng ZY, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.25, 10.1038/nplants.2016.25]; Zhong SW, 2012, CURR BIOL, V22, P1530, DOI 10.1016/j.cub.2012.06.039	62	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181804	10.1371/journal.pone.0181804	http://dx.doi.org/10.1371/journal.pone.0181804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746399	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800062
J	Jun, JC; Jones, MB; Oswald, DM; Sim, ES; Jonnalagadda, AR; Kreisman, LSC; Cobb, BA				Jun, Janice C.; Jones, Mark B.; Oswald, Douglas M.; Sim, Edward S.; Jonnalagadda, Amruth R.; Kreisman, Lori S. C.; Cobb, Brian A.			T cell-intrinsic TLR2 stimulation promotes IL-10 expression and suppressive activity by CD45Rb(Hi) T cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ADOPTIVE TRANSFER; GAMMA-PRODUCTION; DENDRITIC CELLS; IN-VIVO; CD4(+); POLYSACCHARIDE; INDUCTION; RESPONSES; INNATE	While Toll-like receptors (TLRs) represent one of the best characterized innate immune pathways, evidence suggests that TLRs are not restricted to innate leukocytes and some epithelial cells, but are also expressed in T cells. Specifically, published evidence focusing on FoxP3 + regulatory T cells demonstrate that they express functional TLR2, which is already known among the TLR family for its association with immune suppression; however, little is known about the relationship between T cell-intrinsic TLR2 binding and cytokine production, T cell differentiation, or T cell receptor (TCR) stimulation. Here, we demonstrate that TCR and TLR2 co-stimulation provides a T cell-intrinsic signal which generates a dramatic, synergistic cytokine response dominated by IL-10. Importantly, the response was not seen in either CD4(+) CD25(+) or CD4(+) FoxP3(+) Tregs, yet resulted in the expansion of a suppressive CD4(+) CD25(+) CD62L(-) CD44(+) CD45Rb hi effector/memory T cell subset not typically associated with immune inhibition. This study reveals the striking ability of a prototypical innate immune receptor to trigger a potent and suppressive IL-10 response in effector/memory T cells, supporting the notion that TLR2 is a co-regulatory receptor on T cells.	[Jun, Janice C.; Jones, Mark B.; Oswald, Douglas M.; Sim, Edward S.; Jonnalagadda, Amruth R.; Kreisman, Lori S. C.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Jun, Janice C.] Case Western Reserve Univ, Sch Dent Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Cobb, BA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	brian.cobb@case.edu		Cobb, Brian/0000-0003-1055-2530	USA National Institutes of Health National Institute for General Medical Sciences [GM082916]; Hartwell Foundation; USA National Institutes of Health Institute for Allergy and Infectious Disease [F32A1114109]; Case Comprehensive Cancer Center [P30CA043703]; Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI089474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916] Funding Source: NIH RePORTER	USA National Institutes of Health National Institute for General Medical Sciences; Hartwell Foundation; USA National Institutes of Health Institute for Allergy and Infectious Disease; Case Comprehensive Cancer Center; Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the USA National Institutes of Health National Institute for General Medical Sciences (GM082916), the Hartwell Foundation to BAC, and a fellowship from the USA National Institutes of Health Institute for Allergy and Infectious Disease (F32A1114109) to MBJ, and a grant to the Case Comprehensive Cancer Center (P30CA043703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Clifford Harding for critical evaluation of our work and generous use of reagents, including TLR2 knockout mice. We also thank Dr. Jenny Johnson for technical assistance and helpful discussions. We also thank the support from the Cytometry & Imaging Microscopy Core Facility of the Case Comprehensive Cancer Center.	Asprodites N, 2008, FASEB J, V22, P3628, DOI 10.1096/fj.08-108274; Bacchetta R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00016; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Desreumaux P, 2012, GASTROENTEROLOGY, V143, P1207, DOI 10.1053/j.gastro.2012.07.116; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Edinger M, 2011, CURR OPIN IMMUNOL, V23, P679, DOI 10.1016/j.coi.2011.06.006; Gelman AE, 2004, J IMMUNOL, V172, P6065, DOI 10.4049/jimmunol.172.10.6065; Gonzalez-Navajas JM, 2010, J CLIN INVEST, V120, P570, DOI 10.1172/JCI40055; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jang S, 2004, J IMMUNOL, V173, P3392, DOI 10.4049/jimmunol.173.5.3392; Johnson JL, 2015, GLYCOBIOLOGY, V25, P368, DOI 10.1093/glycob/cwu117; Johnson JL, 2015, J BIOL CHEM, V290, P5007, DOI 10.1074/jbc.M114.621771; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kreisman LSC, 2011, J BIOL CHEM, V286, P8810, DOI 10.1074/jbc.M110.206011; Lapierre P, 2013, HEPATOLOGY, V57, P217, DOI 10.1002/hep.26023; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038; Matsuzaki J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14896; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Nawijn MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055307; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; Platzbecker U, 2008, LEUKEMIA, V22, P1438, DOI 10.1038/sj.leu.2405075; Protti MP, 2014, TISSUE ANTIGENS, V83, P237, DOI 10.1111/tan.12329; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sarkar D, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.30; Sing A, 2005, P NATL ACAD SCI USA, V102, P16049, DOI 10.1073/pnas.0504728102; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tanaka H, 2014, CLIN EXP IMMUNOL, V178, P253, DOI 10.1111/cei.12415; TOPALIAN SL, 1994, CURR OPIN IMMUNOL, V6, P741, DOI 10.1016/0952-7915(94)90078-7; Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001; Wang Q, 2006, J EXP MED, V203, P2853, DOI 10.1084/jem.20062008; Zanin-Zhorov A, 2006, J CLIN INVEST, V116, P2022, DOI 10.1172/JCI28423; Zhang Y, 2011, J IMMUNOL, V186, P1963, DOI 10.4049/jimmunol.1002320	49	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180688	10.1371/journal.pone.0180688	http://dx.doi.org/10.1371/journal.pone.0180688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742882	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000017
J	Rhodes, DCJ				Rhodes, Diana C. J.			Human Tamm-Horsfall protein, a renal specific protein, serves as a cofactor in complement 3b degradation	PLOS ONE			English	Article							FACTOR-I; FACTOR-H; BINDING-SITE; KIDNEY; GLYCOPROTEIN; C3B; GLYCOSYLATION; CARBOHYDRATE; LOCALIZATION; ACTIVATION	Tamm-Horsfall protein (THP) is an abundant urinary protein of renal origin. We hypothesize that THP can act as an inhibitor of complement since THP binds complement 1q (C1q) of the classical complement pathway, inhibits activation of this pathway, and is important in decreasing renal ischemia-reperfusion injury (a complement-mediated condition). In this study, we began to investigate whether THP interacted with the alternate complement pathway via complement factor H (CFH). THP was shown to bind CFH using ligand blots and in an ELISA (K-D of 1 x 10(-6) M). Next, the ability of THP to alter CFH's normal action as it functioned as a cofactor in complement factor I (CFI)-mediated complement 3b (C3b) degradation was investigated. Unexpectedly, control experiments in these in vitro assays suggested that THP, without added CFH, could act as a cofactor in CFI-mediated C3b degradation. This cofactor activity was present equally in THP isolated from 10 different individuals. While an ELISA demonstrated small amounts of CFH contaminating THP samples, these CFH amounts were insufficient to explain the degree of cofactor activity present in THP. An ELISA demonstrated that THP directly bound C3b (K-D similar to 5 x 10(-8) M), a prerequisite for a protein acting as a C3b degradation cofactor. The cofactor activity of THP likely resides in the protein portion of THP since partially deglycosylated THP still retained cofactor activity. In conclusion, THP appears to participate directly in complement inactivation by its ability to act as a cofactor for C3b degradation, thus adding support to the hypothesis that THP might act as an endogenous urinary tract inhibitor of complement.	[Rhodes, Diana C. J.] Pacific Northwest Univ Hlth Sci, Dept Anat, Yakima, WA 98901 USA		Rhodes, DCJ (corresponding author), Pacific Northwest Univ Hlth Sci, Dept Anat, Yakima, WA 98901 USA.	drhodes@pnwu.edu			Warner/Fermaturo and A.T. Still University Board of Trustees Research Funds; Pacific Northwest University Research Start-up Funds; PNWU Research Start-up Funds at Pacific Northwest University of Health Science in Yakima, WA	Warner/Fermaturo and A.T. Still University Board of Trustees Research Funds; Pacific Northwest University Research Start-up Funds; PNWU Research Start-up Funds at Pacific Northwest University of Health Science in Yakima, WA	This work was supported by the Warner/Fermaturo and A.T. Still University Board of Trustees Research Funds and the Pacific Northwest University Research Start-up Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author is grateful to James A. Rhodes for his insightful suggestions during these experiments and for his assistance with the data analysis. These experiments were partially funded through Warner/Fermaturo and ATSU Board of Trustees Research Funds (while the author was at A.T. Still University in Kirksville, MO) and through PNWU Research Start-up Funds (at Pacific Northwest University of Health Science in Yakima, WA).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bates JM, 2004, KIDNEY INT, V65, P791, DOI 10.1111/j.1523-1755.2004.00452.x; Bernet J, 2004, J VIROL, V78, P9446, DOI 10.1128/JVI.78.17.9446-9457.2004; Braun MC, 2006, AM J NEPHROL, V26, P127, DOI 10.1159/000092211; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; COYNE KE, 1992, J IMMUNOL, V149, P2906; DAVIS AE, 1982, BIOCHEMISTRY-US, V21, P5745, DOI 10.1021/bi00266a003; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; El-Achkar TM, 2008, AM J PHYSIOL-RENAL, V295, pF534, DOI 10.1152/ajprenal.00083.2008; El-Achkar TM, 2013, AM J PHYSIOL-RENAL, V304, pF1066, DOI 10.1152/ajprenal.00543.2012; Ghebremariam YT, 2010, J SURG RES, V159, P747, DOI 10.1016/j.jss.2009.04.049; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; HARDIG Y, 1995, BIOCHEM J, V308, P795; Hong CY, 2015, ASIAN PAC J ALLERGY, V33, P26, DOI 10.12932/AP0463.33.1.2015; HORTON JK, 1990, KIDNEY INT, V37, P717, DOI 10.1038/ki.1990.38; Huang ZQ, 1997, J CLIN INVEST, V99, P732, DOI 10.1172/JCI119218; HUNT JS, 1985, BIOCHEM J, V227, P957, DOI 10.1042/bj2270957; HUNT JS, 1978, IMMUNOLOGY, V35, P391; Koscielska-Kasprzak K, 2014, ARCH IMMUNOL THER EX, V62, P47, DOI 10.1007/s00005-013-0254-x; Liu MJ, 2016, J CELL MOL MED, V20, P1821, DOI 10.1111/jcmm.12872; Machii R, 2004, J CLIN LAB ANAL, V18, P231, DOI 10.1002/jcla.20028; Matafora V, 2014, BBA CLIN, V2, P79, DOI 10.1016/j.bbacli.2014.10.001; Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614; McCullough JW, 2013, SEMIN NEPHROL, V33, P543, DOI 10.1016/j.semnephrol.2013.08.005; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Micanovic R, 2015, J AM SOC NEPHROL, V26, P2172, DOI 10.1681/ASN.2014070664; Montero RM, 2016, SEMIN IMMUNOL, V28, P250, DOI 10.1016/j.smim.2016.04.007; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; RHODES DCJ, 1993, KIDNEY INT, V44, P1014, DOI 10.1038/ki.1993.343; Rhodes DCJ, 2000, IMMUNOL CELL BIOL, V78, P474, DOI 10.1111/j.1440-1711.2000.t01-3-.x; Rhodes DCJ, 2006, IMMUNOL CELL BIOL, V84, P357, DOI 10.1111/j.1440-1711.2006.01434.x; Rhodes DCJ, 2002, IMMUNOL CELL BIOL, V80, P558, DOI 10.1046/j.1440-1711.2002.01125.x; Ricklin D, 2016, NAT REV NEPHROL, V12, P383, DOI 10.1038/nrneph.2016.70; Romero MC, 2002, CLIN BIOCHEM, V35, P65, DOI 10.1016/S0009-9120(02)00274-6; ROSS GD, 1982, J IMMUNOL, V129, P2051; Rother RP, 1996, J BIOL CHEM, V271, P23842, DOI 10.1074/jbc.271.39.23842; Sahu A, 1998, J IMMUNOL, V160, P5596; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Sheen JH, 2015, CURR OPIN ORGAN TRAN, V20, P468, DOI 10.1097/MOT.0000000000000216; SHERBLOM AP, 1989, J IMMUNOL, V143, P939; SHERBLOM AP, 1988, J BIOL CHEM, V263, P5418; Sigdel TK, 2010, PROTEOM CLIN APPL, V4, P32, DOI 10.1002/prca.200900124; Song D, 1998, NEPHRON, V78, P15, DOI 10.1159/000044876; Tamano M, 2002, NEPHRON, V92, P705, DOI 10.1159/000064090; THOMAS DBL, 1993, AM J PATHOL, V142, P249; Trewick AL, 1999, UROL RES, V27, P250, DOI 10.1007/s002400050118; Tsiftsoglou SA, 2005, BIOCHEMISTRY-US, V44, P6239, DOI 10.1021/bi047680t; Tsiftsoglou SA, 2006, BBA-PROTEINS PROTEOM, V1764, P1757, DOI 10.1016/j.bbapap.2006.09.007; Van Rooijen JJM, 1998, EUR J BIOCHEM, V256, P471, DOI 10.1046/j.1432-1327.1998.2560471.x; Vieyra MB, 2010, KIDNEY INT, V77, P495, DOI 10.1038/ki.2009.491	51	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181857	10.1371/journal.pone.0181857	http://dx.doi.org/10.1371/journal.pone.0181857			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742158	gold, Green Submitted, Green Published			2022-12-26	WOS:000406362700079
J	Micewicz, ED; Kim, K; Iwamoto, KS; Ratikan, JA; Cheng, GH; Boxx, GM; Damoiseaux, RD; Whitelegge, JP; Ruchala, P; Nguyen, C; Purbey, P; Loos, J; Deng, G; Jung, ME; Sayre, JW; Norris, AJ; Schaue, D; McBride, WH				Micewicz, Ewa D.; Kim, Kwanghee; Iwamoto, Keisuke S.; Ratikan, Josephine A.; Cheng, Genhong; Boxx, Gayle M.; Damoiseaux, Robert D.; Whitelegge, Julian P.; Ruchala, Piotr; Nguyen, Christine; Purbey, Prabhat; Loos, Joseph; Deng, Gang; Jung, Michael E.; Sayre, James W.; Norris, Andrew J.; Schaue, Dorthe; McBride, William H.			4-(Nitrophenylsulfonyl) piperazines mitigate radiation damage to multiple tissues	PLOS ONE			English	Article							P53-DEPENDENT APOPTOSIS; MEDICAL COUNTERMEASURES; IONIZING-RADIATION; LOCAL IRRADIATION; SUPPRESSOR-CELLS; COX-2 INHIBITOR; PROTECTS MICE; GROWTH-FACTOR; LUNG-CANCER; STEM-CELLS	Our ability to use ionizing radiation as an energy source, as a therapeutic agent, and, unfortunately, as a weapon, has evolved tremendously over the past 120 years, yet our tool box to handle the consequences of accidental and unwanted radiation exposure remains very limited. We have identified a novel group of small molecule compounds with a 4-nitrophenylsulfonamide (NPS) backbone in common that dramatically decrease mortality from the hematopoietic acute radiation syndrome (hARS). The group emerged from an in vitro high throughput screen (HTS) for inhibitors of radiation-induced apoptosis. The lead compound also mitigates against death after local abdominal irradiation and after local thoracic irradiation (LTI) in models of subacute radiation pneumonitis and late radiation fibrosis. Mitigation of hARS is through activation of radiation-induced CD11b(+)Ly6G(+)Ly6C(+) immature myeloid cells. This is consistent with the notion that myeloerythroid-restricted progenitors protect against WBI-induced lethality and extends the possible involvement of the myeloid lineage in radiation effects. The lead compound was active if given to mice before or after WBI and had some anti-tumor action, suggesting that these compounds may find broader applications to cancer radiation therapy.	[Micewicz, Ewa D.; Kim, Kwanghee; Iwamoto, Keisuke S.; Ratikan, Josephine A.; Nguyen, Christine; Schaue, Dorthe; McBride, William H.] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA; [Cheng, Genhong; Boxx, Gayle M.; Purbey, Prabhat] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Damoiseaux, Robert D.] Univ Calif Los Angeles, Mol Screening Shared Resource, Los Angeles, CA USA; [Whitelegge, Julian P.; Ruchala, Piotr] Univ Calif Los Angeles, Pasarow Mass Spectrometry Lab, Los Angeles, CA USA; [Loos, Joseph; Deng, Gang; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Sayre, James W.] Univ Calif Los Angeles, Sch Publ Hlth Biostat & Radiol, Los Angeles, CA USA; [Norris, Andrew J.] BCN Biosci LLC, Pasadena, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schaue, D (corresponding author), Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA 90024 USA.	dschaue@mednet.ucla.edu	Damoiseaux, Robert/F-1086-2011; Damoiseaux, Robert/S-6712-2019	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; RUCHALA, PIOTR/0000-0002-5574-2779	NIH/NIAID [U19 A1067769]; UCLA Center for Medical Countermeasures Against Radiation; BCN Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCLA Center for Medical Countermeasures Against Radiation; BCN Biosciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH/NIAID Award U19 A1067769 (to Dr. William H. McBride), UCLA Center for Medical Countermeasures Against Radiation. We hereby declare that BCN Biosciences provided support in the form of salaries for author AJN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. E. Angelis for editorial assistance with the manuscript. This work was supported by NIH/NIAID Award U19 AI067769, UCLA Center for Medical Countermeasures Against Radiation.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Berredjem M., 2010, X-RAY STRUCT ANAL ON, V26, P13, DOI [https://doi.org/10.2116/xraystruct.26.13, DOI 10.2116/XRAYSTRUCT.26.13]; Bisht KS, 2003, INT J RADIAT BIOL, V79, P879, DOI 10.1080/09553000310001621400; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Bond FP, 1965, MAMMALIAN RAD LETHAL; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Casey-Sawicki K, 2014, HEALTH PHYS, V106, P704, DOI 10.1097/HP.0000000000000095; CRONKITE EP, 1955, ANN NY ACAD SCI, V59, P815, DOI 10.1111/j.1749-6632.1955.tb45985.x; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Frantz MC, 2013, ORG BIOMOL CHEM, V11, P4147, DOI 10.1039/c3ob40489g; Girvan RC, 2011, VACCINE, V29, P545, DOI 10.1016/j.vaccine.2010.10.040; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; Hochst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119662; Jablonska J, 2010, J CLIN INVEST, V120, P4163, DOI 10.1172/JCI37223C1; Katoch O, 2012, J ENVIRON PATHOL TOX, V31, P357, DOI 10.1615/JEnvironPatholToxicolOncol.2013005833; Kim J, 2005, CANCER RES, V65, P8242, DOI 10.1158/0008-5472.CAN-05-0942; Kim K, 2011, INT J RADIAT BIOL, V87, P839, DOI 10.3109/09553002.2011.560994; Kim K, 2009, CLIN CANCER RES, V15, P7238, DOI 10.1158/1078-0432.CCR-09-1964; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Kuipers GK, 2007, INT J RADIAT BIOL, V83, P677, DOI 10.1080/09553000701558985; Liu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04833; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; MCBRIDE WH, 1992, CANCER RES, V52, P3931; Medhora M, 2014, RADIAT RES, V182, P545, DOI 10.1667/RR13425.1; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Morita A, 2014, BIOCHEM BIOPH RES CO, V450, P1498, DOI 10.1016/j.bbrc.2014.07.037; Moulder JE, 2014, HEALTH PHYS, V107, P164, DOI 10.1097/HP.0000000000000082; Mukherjee D, 2014, J PATHOL, V232, P289, DOI 10.1002/path.4299; Mukherjee D, 2013, INT J RADIAT BIOL, V89, P139, DOI 10.3109/09553002.2013.741280; Nakorn TN, 2002, J CLIN INVEST, V109, P1579, DOI 10.1172/JCI200215272; Patil R, 2015, CHEM BIOL, V22, P206, DOI 10.1016/j.chembiol.2014.12.009; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Pyo H, 2001, CLIN CANCER RES, V7, P2998; Riehl TE, 2004, AM J PHYSIOL-GASTR L, V286, pG166, DOI 10.1152/ajpgi.00537.2002; Saha D, 2003, AM J CLIN ONCOL-CANC, V26, pS70, DOI 10.1097/01.COC.0000074161.92815.93; Saha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024072; Sekihara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078772; Shakhov AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033044; Shen ZH, 1997, J IMMUNOL, V158, P2723; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; Turinetto V, 2010, DNA REPAIR, V9, P1200, DOI 10.1016/j.dnarep.2010.09.003; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Wang XW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08566; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Xu JY, 2013, CANCER RES, V73, P2782, DOI 10.1158/0008-5472.CAN-12-3981; Yang WC, 2013, J MOL CELL BIOL, V5, P207, DOI 10.1093/jmcb/mjt009; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181577	10.1371/journal.pone.0181577	http://dx.doi.org/10.1371/journal.pone.0181577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732024	Green Published, gold			2022-12-26	WOS:000406643100045
J	Passos, LF; Garcia, G; Young, RJ				Passos, Luiza Figueiredo; Garcia, Gerardo; Young, Robert John			The tonic immobility test: Do wild and captive golden mantella frogs (Mantella aurantiaca) have the same response?	PLOS ONE			English	Article							BODY CONDITION INDEX; GENETIC ADAPTATION; CONSERVATION; STRESS; AMPHIBIANS; PREDATORS; HEALTH; POPULATIONS; MADAGASCAR; RADIATION	Adaptations to captivity that reduce fitness are one of many reasons, which explain the low success rate of reintroductions. One way of testing this hypothesis is to compare an important behavioural response in captive and wild members of the same species. Thanatosis, is an anti-predator strategy that reduces the risk of death from predation, which is a common behavioral response in frogs. The study subjects for this investigation were captive and wild populations of Mantella aurantiaca. Thanatosis reaction was measured using the Tonic Immobility (TI) test, a method that consists of placing a frog on its back, restraining it in this position for a short period of time and then releasing it and measuring how much time was spent feigning death. To understand the pattern of reaction time, morphometric data were also collected as body condition can affect the duration of thanatosis. The significantly different TI times found in this study, one captive population with shorter responses, were principally an effect of body condition rather than being a result of rearing environment. However, this does not mean that we can always dismiss the importance of rearing environment in terms of behavioural skills expressed.	[Passos, Luiza Figueiredo; Young, Robert John] Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England; [Passos, Luiza Figueiredo; Garcia, Gerardo] Chester Zoo, Cedar House, Chester, Cheshire, England		Young, RJ (corresponding author), Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England.	r.j.young@salford.ac.uk	Young, Robert/B-7356-2013	Young, Robert/0000-0002-8407-2348	CAPES postgraduate scholarship [6060-13-7]	CAPES postgraduate scholarship	LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Chester Zoo, Mitsinjo Association (Devin Edmonds), Madagasikara-Voakajy and Ambatovy for the chance to develop this project at their facilities and for logistical support. LFP was in receipt of a CAPES postgraduate scholarship Proc. 6060-13-7.	Alberts AC, 2007, APPL ANIM BEHAV SCI, V102, P380, DOI 10.1016/j.applanim.2006.05.037; Antwis RE, 2009, COMP BIOCHEM PHYS A, V154, P184, DOI 10.1016/j.cbpa.2009.06.008; Balmford A, 1996, CONSERV BIOL, V10, P719, DOI 10.1046/j.1523-1739.1996.10030719.x; Bartolomucci A, 2004, PSYCHONEUROENDOCRINO, V29, P899, DOI 10.1016/j.psyneuen.2003.08.003; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Broom D.M., 2019, STRESS ANIMAL WELFAR, V2nd ed., P99; Burghardt GM, 2013, APPL ANIM BEHAV SCI, V147, P286, DOI 10.1016/j.applanim.2013.04.013; CHROUSOS GP, 1997, GROWTH GENET HORM, V13, P1; DABROWSKA B, 1982, BEHAV PROCESS, V7, P179, DOI 10.1016/0376-6357(82)90026-2; Edmonds D, 2015, SALAMANDRA, V51, P315; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Fureix C, 2015, APPL ANIM BEHAV SCI, V171, P8, DOI 10.1016/j.applanim.2015.08.036; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; Gilligan DM, 2003, CONSERV GENET, V4, P189, DOI 10.1023/A:1023391905158; Griffin AS, 2000, CONSERV BIOL, V14, P1317, DOI 10.1046/j.1523-1739.2000.99326.x; Hing S, 2016, WILDLIFE RES, V43, P51, DOI 10.1071/WR15183; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; JOHNSON JA, 1975, AM MIDL NAT, V93, P139, DOI 10.2307/2424112; Johnson K., 2008, AMPHIBIAN ARK SPECIE; Jovanovic O, 2009, ZOOTAXA, P21, DOI 10.11646/zootaxa.2124.1.2; Konkle ATM, 2003, BRAIN RES, V992, P227, DOI 10.1016/j.brainres.2003.08.047; Kraaijeveld-Smit FJL, 2006, J APPL ECOL, V43, P360, DOI 10.1111/j.1365-2664.2006.01137.x; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Livingston S, 2014, ZOO BIOL, V33, P565, DOI 10.1002/zoo.21177; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Machado Leonardo L., 2007, South American Journal of Herpetology, V2, P136, DOI 10.2994/1808-9798(2007)2[136:DBOTLT]2.0.CO;2; Michaels CJ, 2015, J ANIM PHYSIOL AN N, V99, P391, DOI 10.1111/jpn.12203; Miyatake T, 2009, P R SOC B, V276, P2763, DOI 10.1098/rspb.2009.0558; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Narayan EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073564; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V165, P304, DOI 10.1016/j.cbpa.2013.03.033; NASH RF, 1970, PSYCHON SCI, V21, P155; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; R Studio Team, 2016, RSTUDIO INT DEV ENV; Randrianavelona R, 2010, AFR J HERPETOL, V59, P65, DOI 10.1080/04416651.2010.481761; Reading R.P., 2013, ZOO BIOL, V9999, P1; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schulte-Hostedde AI, 2015, EVOL APPL, V8, P413, DOI 10.1111/eva.12258; Schumann K, 2014, J APPL ANIM WELF SCI, V17, P111, DOI 10.1080/10888705.2014.884407; Suzuki K, 2013, BEHAV PROCESS, V100, P58, DOI 10.1016/j.beproc.2013.08.004; Tapley B, 2015, ZOO BIOL, V34, P46, DOI 10.1002/zoo.21170; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Toledo LF, 2010, J NAT HIST, V44, P1979, DOI 10.1080/00222931003624804; TSIGOS C, 1995, HDB STRESS MED, P61; Vences M., 2004, IUCN 2009 IUCN RED L, V1; Young R. J., 2003, ENV ENRICHMENT CAPTI, P150	47	8	8	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181972	10.1371/journal.pone.0181972	http://dx.doi.org/10.1371/journal.pone.0181972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732029	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000406643100073
J	Zhao, DD; Sun, B; Sun, SY; Fu, B; Liu, CT; Liu, DW; Chu, YF; Ma, YL; Bai, L; Wu, YG; Zhou, Y; Su, WH; Hou, A; Cai, LJ; Xu, F; Kong, W; Jiang, CL				Zhao, Dandan; Sun, Bo; Sun, Shiyang; Fu, Bin; Liu, Chuntian; Liu, Dawei; Chu, Yanfei; Ma, Youlei; Bai, Lu; Wu, Yongge; Zhou, Yan; Su, Weiheng; Hou, Ali; Cai, Linjun; Xu, Fei; Kong, Wei; Jiang, Chunlai			Characterization of human enterovirus71 virus-like particles used for vaccine antigens	PLOS ONE			English	Article							IMMUNE-RESPONSES; MOUTH-DISEASE; LINKED GLYCOSYLATION; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; LETHAL; HAND; FOOT; STABILITY; IMMUNOGENICITY	Human enterovirus 71 (EV71) is a major causative pathogen of hand, foot and mouth disease (HFMD) and has caused outbreaks with significant mortality among young children in the Asia-Pacific region in recent years. Towards developing a vaccine for this disease, we have expressed and purified EV71 virus-like particles (VLPs), which resemble the authentic virus in appearance, capsid structure and protein sequence, from insect cells (Sf9) using a multistep chromatography process. We demonstrated intracellular localization of the VLPs in host cells by in situ immunogold detection, electron microscopy and immunofluorescence. Characteristics of these EV71 VLPs were studied using a variety of immunological and physicochemical techniques, which aimed to reveal that the purified EV71 VLPs have good morphology and structure consistent with natural EV71 empty capsids. Results of the amino acid analysis, SDS-PAGE, Western blotting and high-performance liquid chromatography confirmed the high purity of the EV71 VLPs. However the sedimentation coefficient of the VLPs showed that they were smaller than that of secreted EV71 VLPs purified by discontinuous cesium chloride density gradients, they were similar to the empty capsids of natural EV71 virions reported previously. Combined with the previous study that EV71 VLPs purified by a multistep chromatography process were able to elicit strong humoral immune responses in mice, our results further supported the conclusion that our EV71 VLPs had well-preserved molecular and structural characteristics. The EV71 VLPs produced from the baculovirus expression system and purified by a multistep chromatography process displayed key structural and immunological features, which would contribute to their efficacy as a HFMD vaccine.	[Zhao, Dandan; Sun, Bo; Sun, Shiyang; Liu, Chuntian; Wu, Yongge; Zhou, Yan; Su, Weiheng; Hou, Ali; Cai, Linjun; Xu, Fei; Kong, Wei; Jiang, Chunlai] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin, Peoples R China; [Zhao, Dandan] Jilin Agr Univ, Sch Life Sci, Changchun, Jilin, Peoples R China; [Fu, Bin] Beijing Proteome Res Ctr, Beijing, Peoples R China; [Liu, Dawei; Chu, Yanfei; Ma, Youlei; Bai, Lu] Changchun BCHT Biotechnol Co, Changchun, Jilin, Peoples R China	Jilin University; Jilin Agricultural University	Kong, W; Jiang, CL (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin, Peoples R China.	weikong@jlu.edu.cn; jiangcl@jlu.edu.cn		Cai, Linjun/0000-0002-1095-1868	Jilin Province Science and Technology Development Program [20130204013YY, 20130521001JH, 20160209016YY]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX10001009-002]	Jilin Province Science and Technology Development Program; National Science and Technology Major Project of the Ministry of Science and Technology of China	This study was funded by Jilin Province Science and Technology Development Program (No.20130204013YY, No.20130521001JH, No.20160209016YY) and the National Science and Technology Major Project of the Ministry of Science and Technology of China (No.2012ZX10001009-002). The authors (D W and Y C and Y M) employed by a commercial company, Changchun BCHT Biotechnology Company, are responsible for preparation of the EV71 VLPs, and the author (L B) is responsible for Sf9 cell culture.	Arita M, 2007, J VIROL, V81, P9386, DOI 10.1128/JVI.02856-06; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chen SA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-536; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Chung YC, 2006, WORLD J GASTROENTERO, V12, P921, DOI 10.3748/wjg.v12.i6.921; Cifuente JO, 2013, J VIROL, V87, P7637, DOI 10.1128/JVI.03519-12; Costa AR, 2014, CRIT REV BIOTECHNOL, V34, P281, DOI 10.3109/07388551.2013.793649; Deschuyteneer M, 2010, HUM VACCINES, V6, P407, DOI 10.4161/hv.6.5.11023; Gong MQ, 2014, J VIROL, V88, P6444, DOI 10.1128/JVI.00200-14; Gotoh T, 2008, BIOCHEM ENG J, V40, P379, DOI 10.1016/j.bej.2008.01.008; Hossler P, 2012, ADV BIOCHEM ENG BIOT, V127, P187, DOI 10.1007/10_2011_113; Hyakumura M, 2015, J VIROL, V89, P11312, DOI 10.1128/JVI.01123-15; Kirk K, 2012, VACCINE, V30, P7105, DOI 10.1016/j.vaccine.2012.09.030; Ku ZQ, 2014, VACCINE, V32, P4296, DOI 10.1016/j.vaccine.2014.06.025; Kulakosky PC, 1998, GLYCOBIOLOGY, V8, P741, DOI 10.1093/glycob/8.7.741; Kunkel JP, 2000, BIOTECHNOL PROGR, V16, P462, DOI 10.1021/bp000026u; Lee J, 2003, BIOCHEM BIOPH RES CO, V303, P427, DOI 10.1016/S0006-291X(03)00351-6; Levy HC, 2010, J VIROL, V84, P4426, DOI 10.1128/JVI.02393-09; Li HY, 2013, VACCINE, V31, P3281, DOI 10.1016/j.vaccine.2013.05.019; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Lin SY, 2014, J BIOSCI BIOENG, V117, P366, DOI 10.1016/j.jbiosc.2013.08.015; Lin YL, 2012, VACCINE, V30, P1305, DOI 10.1016/j.vaccine.2011.12.081; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Lyu K, 2015, J VIROL, V89, P6196, DOI 10.1128/JVI.00422-15; Lyu K, 2015, J BIOL CHEM, V290, P3198, DOI 10.1074/jbc.M114.624536; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Rohrmann GF, 2013, BACULOVIRUS MOL BIOL, V3rd; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun SY, 2015, HUM VACC IMMUNOTHER, V11, P2406, DOI 10.1080/21645515.2015.1053675; Sun SY, 2014, HUM VACC IMMUNOTHER, V10, P2885, DOI 10.4161/hv.29823; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang XX, 2012, NAT STRUCT MOL BIOL, V19, P424, DOI 10.1038/nsmb.2255; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yin XG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-251; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhao D, 2015, J APPL MICROBIOL, V119, P1196, DOI 10.1111/jam.12922; Zhao QJ, 2012, NANOMED-NANOTECHNOL, V8, P1182, DOI 10.1016/j.nano.2012.01.007; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	44	8	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181182	10.1371/journal.pone.0181182	http://dx.doi.org/10.1371/journal.pone.0181182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732070	gold, Green Submitted, Green Published			2022-12-26	WOS:000406643100026
J	Bakshi, N; Sinha, CB; Ross, D; Khemani, K; Loewenstein, G; Krishnamurti, L				Bakshi, Nitya; Sinha, Cynthia B.; Ross, Diana; Khemani, Kirshma; Loewenstein, George; Krishnamurti, Lakshmanan			Proponent or collaborative: Physician perspectives and approaches to disease modifying therapies in sickle cell disease	PLOS ONE			English	Article							SHARED DECISION-MAKING; STROKE PREVENTION TRIAL; QUALITY-OF-LIFE; HEALTH-CARE; ANEMIA; TRANSPLANTATION; HYDROXYUREA; PATIENT; IMPACT; ATTITUDES	Sickle cell disease (SCD) is an inherited blood disorder that primarily affects African-American and other ethnic minority populations. There are three available disease-modifying therapies for sickle cell disease: hydroxyurea (HU), bone marrow transplantation (BMT), and chronic blood transfusion (CBT). Since these treatments vary in their therapeutic intent, efficacy in preventing progression of the disease, short and long-term adverse effects, costs and patient burden, the decision-making process regarding these therapies is complicated for both the patient and healthcare provider. While previous research has focused on the patient perspective of treatment-related decision making, there is a paucity of research investigating the physician perspective of treatment-related decision making. We conducted a qualitative study with physicians who were experts in the field of SCD. Interviews focused on physician perceptions of patient decisional needs as well as physicians' approach to decision making regarding disease-modifying therapies in SCD. Thirty-six physician interviews were analyzed, with a focus on their perspectives regarding available treatment options and on how they approach decision making with patients. We identified two narrative approaches. The Collaborative approach (CA) was characterized by emphasizing the need to discuss all possible treatment options to ensure that the patient and/or family was equipped to make an informed decision. The Proponent approach (PA) was characterized by strongly advocating a pre-determined treatment plan and providing patients/families with information, with the objective of convincing them to accept the treatment. An interplay of patient-related and disease-related factors, decision type and physician-related factors, as well as institutional frameworks, influenced physician perspectives on treatment options and decision making regarding these therapies. These findings point to the potential value of developing systems to foster patient engagement as a way of facilitating shared decision making.	[Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Childrens Hosp Pittsburgh, Div Pediat Hematol Oncol, Pittsburgh, PA 15213 USA; [Bakshi, Nitya; Ross, Diana; Krishnamurti, Lakshmanan] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Bakshi, Nitya; Krishnamurti, Lakshmanan] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders, Atlanta, GA 30329 USA; [Bakshi, Nitya; Sinha, Cynthia B.; Ross, Diana; Khemani, Kirshma; Krishnamurti, Lakshmanan] Emory Univ, Dept Pediat, Div Pediat Hematol Oncol BMT, Atlanta, GA 30322 USA; [Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Bakshi, Nitya; Krishnamurti, Lakshmanan] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30329 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Healthcare of Atlanta (CHOA); Emory University; Carnegie Mellon University; Children's Healthcare of Atlanta (CHOA)	Krishnamurti, L (corresponding author), Childrens Hosp Pittsburgh, Div Pediat Hematol Oncol, Pittsburgh, PA 15213 USA.; Krishnamurti, L (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.; Krishnamurti, L (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders, Atlanta, GA 30329 USA.; Krishnamurti, L (corresponding author), Emory Univ, Dept Pediat, Div Pediat Hematol Oncol BMT, Atlanta, GA 30322 USA.; Krishnamurti, L (corresponding author), Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30329 USA.	lkrishn@emory.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Krishnamurti, Lakshmanan/0000-0003-3242-0037	Patient Centered Outcomes Research Institute (PCORI)	Patient Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI)	This study was funded by the Patient Centered Outcomes Research Institute (PCORI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2000, J CHILD NEUROL, V15, P344, DOI 10.1177/088307380001500511; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Corbin JM, 2015, BASICS QUALITATIVE R, Vxviii; Crowe M, 2015, AUST NZ J PSYCHIAT, V49, P616, DOI 10.1177/0004867415582053; Drake RE, 2009, PSYCHIAT SERV, V60, P1007, DOI 10.1176/appi.ps.60.8.1007; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Foley KA, 2006, MED CARE, V44, P421, DOI 10.1097/01.mlr.0000208017.18278.1a; Haywood C, 2014, J GEN INTERN MED, V29, P1657, DOI 10.1007/s11606-014-2986-7; Haywood C, 2010, J GEN INTERN MED, V25, P543, DOI 10.1007/s11606-009-1247-7; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Kim SP, 2001, CANCER INVEST, V19, P684, DOI 10.1081/CNV-100106143; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Legare F, 2006, CAN FAM PHYSICIAN, V52, P476; Lipstein EA, 2015, MED DECIS MAKING, V35, P703, DOI 10.1177/0272989X15581805; Matlock DD, 2011, PACE, V34, P1634, DOI 10.1111/j.1540-8159.2011.03237.x; McCavit TL, 2012, PEDIATR REV, V33, P195, DOI 10.1542/pir.33-5-195; Miller ST, 2001, J PEDIATR-US, V139, P785, DOI 10.1067/mpd.2001.119593; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Muller-Engelmann M, 2011, PATIENT EDUC COUNS, V82, P240, DOI 10.1016/j.pec.2010.04.028; Panepinto JA, 2012, PEDIATR BLOOD CANCER, V59, P377, DOI 10.1002/pbc.24176; Panepinto J, 2009, QUAL LIFE RES, V18, P5, DOI 10.1007/s11136-008-9412-8; Peek ME, 2010, SOC SCI MED, V71, P13, DOI 10.1016/j.socscimed.2010.03.018; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Pollard S, 2015, PATIENT EDUC COUNS, V98, P1046, DOI 10.1016/j.pec.2015.05.004; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Walters MC, 2015, CURR OPIN HEMATOL, V22, P227, DOI 10.1097/MOH.0000000000000136; Walters MC, 2010, BIOL BLOOD MARROW TR, V16, P263, DOI 10.1016/j.bbmt.2009.10.005; Walters MC, 2004, PEDIATR TRANSPLANT, V8, P33, DOI 10.1111/j.1398-2265.2004.00188.x; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Wennberg J E, 1984, Health Manage Q, P6, DOI 10.1377/hlthaff.3.2.6	33	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e178413	10.1371/journal.pone.0178413	http://dx.doi.org/10.1371/journal.pone.0178413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727801	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500003
J	Haggblom, A; Santacatterina, M; Neogi, U; Gisslen, M; Hejdeman, B; Flamholc, L; Sonnerborg, A				Haggblom, Amanda; Santacatterina, Michele; Neogi, Ujjwal; Gisslen, Magnus; Hejdeman, Bo; Flamholc, Leo; Sonnerborg, Anders			Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients	PLOS ONE			English	Article							DRUG-RESISTANCE; VIRAL LOAD; VIROLOGICAL RESPONSE; DISEASE PROGRESSION; REGRESSION; MORTALITY; OUTCOMES; TYPE-1; WEB	Background Switch from first line antiretroviral therapy (ART) to second-line ART is common in clinical practice. However, there is limited knowledge of to which extent different reason for therapy switch are associated with differences in long-term consequences and sustainability of the second line ART. Material and methods Data from 869 patients with 14601 clinical visits between 1999-2014 were derived from the national cohort database. Reason for therapy switch and viral load (VL) levels at first-line ART failure were compared with regard to outcome of second line ART. Using the Laplace regression model we analyzed the median, 10th, 20th, 30th and 40th percentile of time to viral failure (VF). Results Most patients (n = 495; 57.0%) switched from first-line to second-line ART without VF. Patients switching due to detectable VL with (n = 124; 14.2%) or without drug resistance mutations (DRM) (n = 250; 28.8%) experienced VF to their second line regimen sooner (median time, years: 3.43 (95% CI 2.90-3.96) and 3.20 (95% 2.65-3.75), respectively) compared with those who switched without VF (4.53 years). Furthermore level of VL at first-line ART failure had a significant impact on failure of second-line ART starting after 2.5 years of second-line ART. Conclusions In the context of life-long therapy, a median time on second line ART of 4.53 years for these patients is short. To prolong time on second-line ART, further studies are needed on the reasons for therapy changes. Additionally patients with a high VL at first-line VF should be more frequently monitored the period after the therapy switch.	[Haggblom, Amanda; Sonnerborg, Anders] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Santacatterina, Michele] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Neogi, Ujjwal; Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Hejdeman, Bo] South Gen Hosp, Dept Infect Dis Venhalsan, Stockholm, Sweden; [Flamholc, Leo] Malmo Univ Hosp, Dept Infect Dis, Malmo, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Lund University; Skane University Hospital	Haggblom, A (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden.	Amanda.haggblom@ki.se	Neogi, Ujjwal/E-4274-2012; Santacatterina, Michele/AAL-5050-2020; Neogi, Ujjwal/ABF-1172-2021; Sönnerborg, Anders/W-2011-2019; Gisslen, Magnus/D-7454-2015	Santacatterina, Michele/0000-0003-0599-3876; Neogi, Ujjwal/0000-0002-0844-3338; Sönnerborg, Anders/0000-0001-8928-3374; Gisslen, Magnus/0000-0002-2357-1020	Physician Against AIDS Research Fund [FOa2013-0014]	Physician Against AIDS Research Fund	This work was supported by Physician Against AIDS Research Fund, Grant number: FOa2013-0014, http://www.aidsfond.se/ansokanomforskningsanslag-24944283.	Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059337; Bottai M, 2010, BIOMETRICAL J, V52, P487, DOI 10.1002/bimj.200900310; Charpentier C, 2004, J VIROL, V78, P4234, DOI 10.1128/JVI.78.8.4234-4247.2004; Cozzi-Lepri A, 2008, AIDS, V22, P2187, DOI 10.1097/QAD.0b013e328310e04f; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Kozal MJ, 2011, ANTIVIR THER, V16, P925, DOI 10.3851/IMP1851; Lepri AC, 2001, AIDS, V15, P47, DOI 10.1097/00002030-200101050-00008; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; Lohse N, 2007, ANTIVIR THER, V12, P909; Lucas GM, 2004, AIDS, V18, P1539, DOI 10.1097/01.aids.0000131339.68666.1a; Lucas GM, 2005, J ANTIMICROB CHEMOTH, V55, P413, DOI 10.1093/jac/dki042; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Napravnik S, 2013, AIDS RES HUM RETROV, V29, P574, DOI [10.1089/aid.2012.0210, 10.1089/AID.2012.0210]; Neogi U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099390; Ormaasen V, 2004, HIV MED, V5, P400, DOI 10.1111/j.1468-1293.2004.00244.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Ramadhani HO, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu079; ROBINS JM, 1995, J AM STAT ASSOC, V90, P122, DOI 10.2307/2291135; Santoro MM, 2013, ANTIVIR THER, V18, P867, DOI 10.3851/IMP2531; Taiwo B, EFFICACY NUCLOSIDE S; van Leth F, EFFECT BASELINE CD4; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; Zaccarelli M, 2005, AIDS, V19, P1081, DOI 10.1097/01.aids.0000174455.01369.ad	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180140	10.1371/journal.pone.0180140	http://dx.doi.org/10.1371/journal.pone.0180140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727795	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500014
J	Potocnik, N; Perse, M; Cerar, A; Injac, R; Finderle, Z				Potocnik, Nejka; Perse, Martina; Cerar, Anton; Injac, Rade; Finderle, Zarko			Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; INDUCED CARDIOTOXICITY; NERVOUS-SYSTEM; CARDIOVASCULAR VARIABILITY; MYOCARDIAL DAMAGE; FAILURE SECONDARY; VAGAL MODULATION; DOWN-REGULATION; RATS; C-60(OH)(24)	The very effective anticancer drug doxorubicin (DOX) is known to have cardiotoxic side effects, which could be accompanied by autonomic modulation. Autonomic disbalance might even be an initiating mechanism underlying DOX-induced cardiotoxicity and can be studied noninvasively by the analysis of heart rate variability (HRV). A number of strategies have been assessed to predict chemotherapy-induced cardiac dysfunction while HRV, a potential detecting tool, has not yet been tested. Thus, we aimed to determine the effect of DOX treatment on HRV in a rat model of colorectal cancer. While pretreatment with fullerenol (Frl) acts protectively on DOX-induced cardiotoxicity, we aimed to test the effect of Frl pretreatment on DOX-induced HRV alterations. After the induction of colorectal cancer, adult male Wistar rats were treated with saline (n = 7), DOX (1.5 mg/kg per week, n = 7) or DOX after pretreatment with Frl (25 mg/kg per week, n = 7) for three weeks (cumulative DOX dose 4.5 mg/kg). One week after treatment rats were anaesthetized, standard ECG was measured and HRV was analyzed in time and frequency domain. During autopsy the intestines and hearts were gathered for biochemical analysis and histopathological examination. DOX treatment significantly decreased parasympathetically mediated high-frequency component (p<0.05) and increased the low-frequency component of HRV (p<0.05), resulting in an increased LF/HF ratio (p<0.05) in cancerous rats. When pretreated with Frl, DOX-induced HRV alterations were prevented: the high-frequency component of HRV increased (p<0.01), the low-frequency decreased (p<0.01), LF/HF ratio decreased consequently (p<0.01) compared to DOX only treatment. In all DOX-treated animals, disbalance of oxidative status in heart tissue and early myocardial lesions were found and were significantly reduced in rats receiving Frl pretreatment. Autonomic modulation accompanied the development of DOX-induced cardiotoxicity in rat model of colorectal cancer and was prevented by Frl pretreatment. Our results demonstrated the positive prognostic power of HRV for the early detection of DOX-induced cardiotoxicity.	[Potocnik, Nejka; Finderle, Zarko] Univ Ljubljana, Fac Med, Inst Physiol, Ljubljana, Slovenia; [Perse, Martina; Cerar, Anton] Univ Ljubljana, Fac Med, Med Expt Ctr, Inst Pathol, Ljubljana, Slovenia; [Injac, Rade] Univ Ljubljana, Dept Pharmaceut Biol, Fac Pharm, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana	Potocnik, N (corresponding author), Univ Ljubljana, Fac Med, Inst Physiol, Ljubljana, Slovenia.	nejka.potocnik@mf.uni-lj.si	Perse, Martina/AAS-2898-2020		Slovenian Research Agency, Slovenia [P4-0127]	Slovenian Research Agency, Slovenia(Slovenian Research Agency - Slovenia)	This work was supported by a grant from the Slovenian Research Agency, Slovenia, Grant no. P4-0127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0198-3; Apaijai N, 2013, BRIT J PHARMACOL, V169, P1048, DOI 10.1111/bph.12176; Arab C, 2016, PSYCHONEUROENDOCRINO, V68, P57, DOI 10.1016/j.psyneuen.2016.02.018; Bertinchant JP, 2003, CLIN CHIM ACTA, V329, P39, DOI 10.1016/S0009-8981(03)00013-5; Bianucci E, 2012, BIOMETALS, V25, P23, DOI 10.1007/s10534-011-9480-z; BINKLEY PF, 1991, J AM COLL CARDIOL, V18, P464, DOI 10.1016/0735-1097(91)90602-6; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnevali L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00118; Carnevali L, 2014, PHYSIOL BEHAV, V128, P16, DOI 10.1016/j.physbeh.2014.01.033; CARRE F, 1994, EUR HEART J, V15, P58, DOI 10.1093/eurheartj/15.suppl_D.58; Cekici L, 2009, BRIT J CLIN PHARMACO, V67, P394, DOI 10.1111/j.1365-2125.2009.03377.x; CERUTTI C, 1991, AM J PHYSIOL, V261, pH1292, DOI 10.1152/ajpheart.1991.261.4.H1292; Chaswal M, 2011, CAN J PHYSIOL PHARM, V89, P865, DOI [10.1139/Y11-084, 10.1139/y11-084]; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Chen X, 2007, CARDIOVASC DRUG THER, V21, P367, DOI 10.1007/s10557-007-6052-0; Chung WB, 2016, KOREAN J INTERN MED, V31, P625, DOI 10.3904/kjim.2016.017; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; De Angelis K, 2012, AM J PHYSIOL-REG I, V302, pR950, DOI 10.1152/ajpregu.00450.2011; ECKBERG DL, 1971, NEW ENGL J MED, V285, P877, DOI 10.1056/NEJM197110142851602; Fadillioglu E, 2004, J APPL TOXICOL, V24, P47, DOI 10.1002/jat.945; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Hasan W, 2013, ORGANOGENESIS, V9, P176, DOI 10.4161/org.24892; Hellstrom HR, 2007, MED HYPOTHESES, V68, P415, DOI 10.1016/j.mehy.2006.05.031; HRUSHESKY WJM, 1991, CIRCULATION, V84, P697, DOI 10.1161/01.CIR.84.2.697; Injac Rade, 2013, Methods Mol Biol, V1028, P75, DOI 10.1007/978-1-62703-475-3_5; Injac R, 2009, PHARMACOL REP, V61, P335, DOI 10.1016/S1734-1140(09)70041-6; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052; Kang YJ, 1999, P SOC EXP BIOL MED, V222, P263, DOI 10.1046/j.1525-1373.1999.d01-143.x; Kazmi SZH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157557; Kelishomi RB, 2008, TOXICOLOGY, V243, P96, DOI 10.1016/j.tox.2007.09.026; Kenk M, 2010, J NUCL CARDIOL, V17, P254, DOI 10.1007/s12350-009-9190-x; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kur'yanova EV, 2014, B EXP BIOL MED+, V157, P311, DOI 10.1007/s10517-014-2553-6; Lara A, 2010, MOL CELL BIOL, V30, P1746, DOI 10.1128/MCB.00996-09; Lee MS, 2014, INT J CARDIOL, V176, P166, DOI 10.1016/j.ijcard.2014.07.012; Lichota A, 2016, MED PR, V67, P817, DOI 10.13075/mp.5893.00466; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Loncar-Turukalo T, 2015, PHYSIOL MEAS, V36, P727, DOI 10.1088/0967-3334/36/4/727; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MASKENS AP, 1976, CANCER RES, V36, P1585; Menna P, 2010, CHEM RES TOXICOL, V23, P6, DOI 10.1021/tx9003424; Merlet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064711; MINCHIN RF, 1988, CANCER, V61, P1320, DOI 10.1002/1097-0142(19880401)61:7<1320::AID-CNCR2820610708>3.0.CO;2-J; Molinaro M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/138148; Mong MC, 2013, J FOOD SCI, V78, pH1621, DOI 10.1111/1750-3841.12257; Ong DS, 2014, EXPERT REV CARDIOVAS, V12, P487, DOI 10.1586/14779072.2014.893824; PANINA G, 1995, AM HEART J, V129, P748, DOI 10.1016/0002-8703(95)90325-9; Papaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010; Parati G, 2006, J APPL PHYSIOL, V101, P676, DOI 10.1152/japplphysiol.00446.2006; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Pecoraro M, 2016, TOXICOL APPL PHARM, V293, P44, DOI 10.1016/j.taap.2016.01.006; Perse M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/473964; Ribeiro ALP, 2007, INT J CARDIOL, V117, P59, DOI 10.1016/j.ijcard.2006.04.053; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; PORTER TR, 1990, J CLIN INVEST, V85, P1362, DOI 10.1172/JCI114580; Ramirez-Villegas JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017060; Roca-Alonso L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.89; Rowan WH, 2007, CARDIOVASC TOXICOL, V7, P28, DOI 10.1007/s12012-007-0004-6; Schumann A, 2002, STAT MED, V21, P2225, DOI 10.1002/sim.979; Sebastian S, 2013, AM J PHYSIOL-REG I, V305, pR435, DOI 10.1152/ajpregu.00037.2013; Srdjenovic B, 2010, TOXICOL MECH METHOD, V20, P298, DOI 10.3109/15376516.2010.485622; Svorc P Jr, 2013, Prague Med Rep, V114, P72; Szabo BM, 1997, AM J CARDIOL, V79, P978, DOI 10.1016/S0002-9149(97)00026-X; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; TONG J, 1991, AM J PHYSIOL, V260, pH909, DOI 10.1152/ajpheart.1991.260.3.H909; Torres VM, 2010, PHARMACOL REP, V62, P707, DOI 10.1016/S1734-1140(10)70328-5; Ueno M, 2006, J PHARMACOL SCI, V101, P151, DOI 10.1254/jphs.FP0050980; Vapa I, 2012, EUR J DRUG METAB PH, V37, P301, DOI 10.1007/s13318-012-0092-y; VIQUERAT CE, 1985, AM J MED, V78, P455, DOI 10.1016/0002-9343(85)90338-9; Wallace KB, 1997, FUND APPL TOXICOL, V38, P23, DOI 10.1006/faat.1997.2320; Wang HB, 2016, CELL PHYSIOL BIOCHEM, V40, P1163, DOI 10.1159/000453170; Wulsin LR, 2015, J CLIN ENDOCR METAB, V100, P2443, DOI 10.1210/jc.2015-1748; Xu XL, 2006, AUTON NEUROSCI-BASIC, V130, P6, DOI 10.1016/j.autneu.2006.04.005; Yagmurca M, 2003, PHARMACOL RES, V48, P377, DOI 10.1016/S1043-6618(03)00185-3; Yu AF, 2016, HEART, V102, P425, DOI 10.1136/heartjnl-2015-307894; Zhao Y, 2014, FREE RADICAL BIO MED, V72, P55, DOI 10.1016/j.freeradbiomed.2014.03.001; Zila I, 2015, PHYSIOL RES, V64, pS669, DOI 10.33549/physiolres.933226	80	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181632	10.1371/journal.pone.0181632	http://dx.doi.org/10.1371/journal.pone.0181632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727839	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500098
J	Shen, YQ; Huang, GY; McCormick, BP; Song, T; Xu, XF				Shen, Youqing; Huang, Guoyuan; McCormick, Bryan P.; Song, Tao; Xu, Xiangfeng			Effects of high-intensity interval versus mild-intensity endurance training on metabolic phenotype and corticosterone response in rats fed a high-fat or control diet	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ANXIETY-LIKE BEHAVIORS; REDUCES LIVER FAT; INTERMITTENT EXERCISE; SKELETAL-MUSCLE; INDUCED OBESITY; LOW-VOLUME; STRESS; MODEL; HYPERINSULINEMIA	The aim of the present study was to compare the effects of high-intensity interval training (HI) to mild-intensity endurance training (ME), combined with a high-fat diet (HFD) or control diet (CD) on metabolic phenotype and corticosterone levels in rats. Fifty-three rats were randomized to 6 groups according to diet and training regimen as follows: CD and sedentary (CS, n = 11), CD and ME (CME, n = 8), CD and HI (CHI, n = 8), HFD and sedentary (HS, n = 10), HFD and ME (HME, n = 8), and HFD and HI (HHI, n = 8). All exercise groups were trained for 10 weeks and had matched running distances. Dietary intake, body composition, blood metabolites, and corticosterone levels were measured. Histological lipid droplets were observed in the livers. The HFD led to hyperglycemia, hyperlipidemia and higher body fat (all, P < 0.01, eta(2) > 0.06), as well as higher corticosterone levels (P < 0.01, eta(2) = 0.09) compared with the CD groups. Exercise training improved fat weight, glucose, and lipid profiles, and reduced corticosterone levels (P < 0.01, eta(2) = 0.123). Furthermore, body and fat weight, serum glucose and triglycerides, lipid content in the liver, and corticosterone levels (P < 0.05) were lower with HI training compared to ME training. Reductions in HFD-induced body weight gain, blood glucose and lipid profiles, and corticosterone levels, as well as improvements in QUICKI were better with HHI compared to HME. Correlation analyses revealed that corticosterone levels were significantly associated with phenotype variables (P < 0.01). Corticosterone level was inversely correlated with QUICKI (r = -0.38, P < 0.01). Altogether, these results indicate that HFD may elicit an exacerbated basal serum corticosterone level and thus producing a metabolic imbalance. Compared with ME training, HI training contributes to greater improvements in metabolic and corticosterone responses, leading to a greater reduction in susceptibility to HFD-induced disorders.	[Shen, Youqing] Hubei Univ Educ, Sch Phys Educ, Wuhan, Hubei, Peoples R China; [Huang, Guoyuan] Univ Southern Indiana, Pott Coll Sci Engn & Educ, Evansville, IN USA; [Shen, Youqing; McCormick, Bryan P.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA; [Song, Tao] Jianghan Univ, Sch Phys Educ, Wuhan, Hubei, Peoples R China; [Xu, Xiangfeng] Wuhan Sports Univ, Sch Phys Educ, Wuhan, Hubei, Peoples R China	Hubei University Education; Indiana University System; Indiana University Bloomington; Jianghan University; Wuhan Sports University	Xu, XF (corresponding author), Wuhan Sports Univ, Sch Phys Educ, Wuhan, Hubei, Peoples R China.	future0104@126.com			Department of Scientific Research, Hubei Province [B2016220]; China Scholarship Council [201508420205]; Wuhan Institutes of Biomedical Science and Jianghan University	Department of Scientific Research, Hubei Province; China Scholarship Council(China Scholarship Council); Wuhan Institutes of Biomedical Science and Jianghan University	This project was partly funded by a Grant (#B2016220) from the Department of Scientific Research, Hubei Province. We also thank the China Scholarship Council (201508420205) for funding Youqing Shen's academic scholarship at the Indiana University-Bloomington, which was a requirement for her research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These experiments were supported by Wuhan Institutes of Biomedical Science and Jianghan University. The authors thank Dr. Kai Yue and Qiu Pang for assisting with experimental trials. We are also grateful to Accdon for English language assistance during the revision of this manuscript. The authors have no conflicts to declare.	Alvarez C, 2016, INT J SPORTS MED, V37, P723, DOI 10.1055/s-0042-104935; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Auvinen HE, 2011, HORM METAB RES, V43, P899, DOI 10.1055/s-0031-1291305; Ayroldi E, 2014, FASEB J, V28, P5055, DOI 10.1096/fj.14-254755; Beaudry JL, 2015, J APPL PHYSIOL, V118, P1331, DOI 10.1152/japplphysiol.00467.2014; Beaudry JL, 2013, ENDOCRINOLOGY, V154, P3197, DOI 10.1210/en.2012-2114; BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278; Campeau S, 2010, J NEUROENDOCRINOL, V22, P872, DOI 10.1111/j.1365-2826.2010.02007.x; Cassidy S, 2016, DIABETOLOGIA, V59, P56, DOI 10.1007/s00125-015-3741-2; Duggan GE, 2011, J APPL PHYSIOL, V110, P1311, DOI 10.1152/japplphysiol.00701.2010; Dutheil S, 2016, NEUROPSYCHOPHARMACOL, V41, P1874, DOI 10.1038/npp.2015.357; Ebada ME, 2016, BEHAV BRAIN RES, V311, P228, DOI 10.1016/j.bbr.2016.05.051; Field BCT, 2014, BRIT MED BULL, V109, P73, DOI 10.1093/bmb/ldu001; Galitzky J, 2013, CELL METAB, V18, P3, DOI 10.1016/j.cmet.2013.06.008; Gergerlioglu HS, 2016, LIFE SCI, V148, P279, DOI 10.1016/j.lfs.2016.02.011; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Glastras SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162131; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Hallsworth K, 2015, CLIN SCI, V129, P1097, DOI 10.1042/CS20150308; Hare BD, 2014, NEUROPSYCHOPHARMACOL, V39, P1262, DOI 10.1038/npp.2013.329; Hicks JA, 2016, BEHAV BRAIN RES, V310, P1, DOI 10.1016/j.bbr.2016.04.051; Higgins JA, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-49; Jacks DE, 2002, J STRENGTH COND RES, V16, P286, DOI 10.1519/00124278-200205000-00018; Jankord R, 2008, APPL PHYSIOL NUTR ME, V33, P461, DOI 10.1139/H08-022; Jones AB, 2016, BEHAV BRAIN RES, V311, P279, DOI 10.1016/j.bbr.2016.05.058; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lee SH, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010401; Legendre A, 2006, AM J PHYSIOL-REG I, V291, pR1288, DOI 10.1152/ajpregu.00234.2006; Li CT, 2015, BEHAV BRAIN RES, V288, P39, DOI 10.1016/j.bbr.2015.04.007; Manolopoulos Konstantinos, 2015, Lancet, V385 Suppl 1, pS63, DOI 10.1016/S0140-6736(15)60378-6; Martins C, 2016, INT J SPORT NUTR EXE, V26, P197, DOI 10.1123/ijsnem.2015-0078; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Morris RT, 2008, J APPL PHYSIOL, V104, P708, DOI 10.1152/japplphysiol.01034.2007; Motta VF, 2016, J SPORT MED PHYS FIT, V56, P655; Muniyappa R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1023, DOI 10.1152/ajpendo.00397.2009; Patterson ZR, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00130; Pimenta M, 2015, LIFE SCI, V139, P75, DOI 10.1016/j.lfs.2015.08.004; Rose AJ, 2010, J STEROID BIOCHEM, V122, P10, DOI 10.1016/j.jsbmb.2010.02.010; Sene-Fiorese M, 2008, OBESITY, V16, P2217, DOI 10.1038/oby.2008.339; Shen YQ, 2015, OBESITY, V23, P1000, DOI 10.1002/oby.21056; Shin AC, 2010, INT J OBESITY, V34, P1218, DOI 10.1038/ijo.2010.34; Shpilberg Y, 2012, DIS MODEL MECH, V5, P671, DOI 10.1242/dmm.008912; Sivanathan S, 2015, BEHAV BRAIN RES, V286, P265, DOI 10.1016/j.bbr.2015.02.036; Smith-Ryan AE, 2016, J SPORT SCI, V34, P2038, DOI 10.1080/02640414.2016.1149609; Suzuki M, 2011, INT J SPORT NUTR EXE, V21, P222, DOI 10.1123/ijsnem.21.3.222; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Touati S, 2011, MED SCI SPORT EXER, V43, P398, DOI 10.1249/MSS.0b013e3181eeb12d; Vicennati V, 2009, OBESITY, V17, P1678, DOI 10.1038/oby.2009.76; Wang Deng, 2015, Zhong Yao Cai, V38, P1919	50	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181684	10.1371/journal.pone.0181684	http://dx.doi.org/10.1371/journal.pone.0181684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727846	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500103
J	Zhou, AT; Wang, K; Fan, LP; Tao, B				Zhou, Aitao; Wang, Kai; Fan, Lingpeng; Tao, Bo			Propagation characteristics of pulverized coal and gas two-phase flow during an outburst	PLOS ONE			English	Article							SHOCK-WAVES; MINE; STABILIZATION; TECHNOLOGY; DRAINAGE; MODEL; SEAM	Coal and gas outbursts are dynamic failures that can involve the ejection of thousands tons of pulverized coal, as well as considerable volumes of gas, into a limited working space within a short period. The two-phase flow of gas and pulverized coal that occurs during an outburst can lead to fatalities and destroy underground equipment. This article examines the interaction mechanism between pulverized coal and gas flow. Based on the role of gas expansion energy in the development stage of outbursts, a numerical simulation method is proposed for investigating the propagation characteristics of the two-phase flow. This simulation method was verified by a shock tube experiment involving pulverized coal and gas flow. The experimental and simulated results both demonstrate that the instantaneous ejection of pulverized coal and gas flow can form outburst shock waves. These are attenuated along the propagation direction, and the volume fraction of pulverized coal in the two-phase flow has significant influence on attenuation of the outburst shock wave. As a whole, pulverized coal flow has a negative impact on gas flow, which makes a great loss of large amounts of initial energy, blocking the propagation of gas flow. According to comparison of numerical results for different roadway types, the attenuation effect of T-type roadways is best. In the propagation of shock wave, reflection and diffraction of shock wave interact through the complex roadway types.	[Zhou, Aitao; Wang, Kai; Fan, Lingpeng; Tao, Bo] China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrown Energy & R, Beijing, Peoples R China; [Zhou, Aitao; Wang, Kai; Fan, Lingpeng; Tao, Bo] China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology	Wang, K (corresponding author), China Univ Min & Technol Beijing, Beijing Key Lab Precise Min Intergrown Energy & R, Beijing, Peoples R China.; Wang, K (corresponding author), China Univ Min & Technol Beijing, Sch Resource & Safety Engn, Beijing, Peoples R China.	kaiwang@cumtb.edu.cn			State Key Research Development Program of China [2016YFC0801402]; National Natural Science Foundation of China [51474219]	State Key Research Development Program of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the State Key Research Development Program of China (grant no. 2016YFC0801402), National Natural Science Foundation of China (grant no. 51474219). Thank you again for your consideration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FH, 2013, COMPUT GEOTECH, V54, P222, DOI 10.1016/j.compgeo.2013.07.013; [程五一 Cheng Wuyi], 2004, [煤炭学报, Journal of China Coal Society], V29, P57; Guo HJ, 2016, J NAT GAS SCI ENG, V33, P867, DOI 10.1016/j.jngse.2016.06.033; Jiang J.J., 2015, PLOS ONE, V10; Jiang JY, 2015, J NAT GAS SCI ENG, V24, P412, DOI 10.1016/j.jngse.2015.04.001; Otuonye F, 1994, GEOTECH GEOL ENG, V12, P15; Peng SJ, 2012, SAFETY SCI, V50, P816, DOI 10.1016/j.ssci.2011.08.027; Sobczyk J, 2014, FUEL, V115, P288, DOI 10.1016/j.fuel.2013.07.016; Tang J, 2016, J NAT GAS SCI ENG, V34, P412, DOI 10.1016/j.jngse.2016.07.010; Wang K, 2012, SAFETY SCI, V50, P835, DOI 10.1016/j.ssci.2011.08.024; Yang W, 2012, TUNN UNDERGR SP TECH, V31, P139, DOI 10.1016/j.tust.2012.04.015; Yuan L, 2016, J ROCK MECH GEOTECH, V8, P559, DOI 10.1016/j.jrmge.2016.01.005; Zhao W, 2017, POWDER TECHNOL, V305, P39, DOI 10.1016/j.powtec.2016.09.047; Zhou AT, 2017, J LOSS PREVENT PROC, V47, P104, DOI 10.1016/j.jlp.2017.02.014; Zhou A, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6564-2; Zhou AT, 2016, J NAT GAS SCI ENG, V35, P720, DOI 10.1016/j.jngse.2016.09.021; Zhou AT, 2015, INT J MIN SCI TECHNO, V25, P106, DOI 10.1016/j.ijmst.2014.12.009; Zhou AT, 2014, INT J MIN SCI TECHNO, V24, P23, DOI 10.1016/j.ijmst.2013.12.005; Zhou HX, 2014, J NAT GAS SCI ENG, V20, P357, DOI 10.1016/j.jngse.2014.07.023	19	7	7	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180672	10.1371/journal.pone.0180672	http://dx.doi.org/10.1371/journal.pone.0180672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727738	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500027
J	Garnett, S; Dutchak, KL; McDonough, RV; Dankort, D				Garnett, S.; Dutchak, K. L.; McDonough, R. V.; Dankort, D.			p53 loss does not permit escape from Braf(V600E)-induced senescence in a mouse model of lung cancer	ONCOGENE			English	Article							CELL-CYCLE ARREST; K-RAS ONCOGENE; SOMATIC MUTATIONS; SIGNALING PATHWAY; CDKN2A LOCUS; OPEN-LABEL; PTEN LOSS; IN-VIVO; BRAF; ACTIVATION	Lung cancer arises through the acquisition of a number of genetic lesions, with a preponderance of activating mutations in the canonical mitogen-activated protein kinase (MAPK) cascade (RTK-RAS-RAF-MEK). Braf(V600E) expression induces benign lung adenomas that fail to progress to adenocarcinoma because of oncogene-induced senescence (OIS). BrafV600E expression, coupled with simultaneous p53 ablation, permits bypass of senescence and progression to lung adenocarcinoma. However, spontaneous human tumors sustain mutations in a temporally separated manner. Here, we use a mouse lung cancer model where oncogene activation (Braf(V600E) expression) and tumor suppressor loss (p53 ablation) are independently controlled through the actions of Flp and Cre recombinase, respectively. We show that p53 loss before OIS is permissive for the transition from lung adenoma to adenocarcinoma. In contrast, p53 loss after senescence is established fails to enable escape from senescence and disease progression. This study demonstrates that Braf(V600E) induced senescence is irreversible in vivo and suggests that therapy-induced senescence would halt further tumor progression.	[Garnett, S.; Dutchak, K. L.; McDonough, R. V.; Dankort, D.] McGill Univ, Dept Biol, 1205 Ave Docteur Penfield,Stewart Bldg,N3-17, Montreal, PQ H3A 1B1, Canada; [Dankort, D.] Goodman Canc Res Ctr, Montreal, PQ, Canada	McGill University	Dankort, D (corresponding author), McGill Univ, Dept Biol, 1205 Ave Docteur Penfield,Stewart Bldg,N3-17, Montreal, PQ H3A 1B1, Canada.	david.dankort@mcgill.ca		Dankort, David/0000-0002-5862-6829	Canadian Institutes of Health Research (CIHR) [MOP-97925]; Canadian Cancer Society Research Initiative [704228]; Cancer Research Society [19087]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Initiative; Cancer Research Society	DD would like to thank Martin McMahon for his generosity and guidance, which enabled this work. We thank members of the Dankort lab for discussions, Eve Bigras for administrative assistance, Drs Siegfried Hekimi, Alain Nepveu and Peter M Siegel for critical comments. We thank the lab of Dr Hoang Trang for providing necessary reagents. These studies were supported by grants from the Canadian Institutes of Health Research (CIHR, MOP-97925), Canadian Cancer Society Research Initiative (no. 704228) and Cancer Research Society (no. 19087).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Ameyar-Zazoua M, 2005, ONCOGENE, V24, P2298, DOI 10.1038/sj.onc.1208424; Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; BENNETT WP, 1995, CANCER DETECT PREV, V19, P503; Bieging-Rolett KT, 2016, ONCOGENE, V35, P4414, DOI 10.1038/onc.2015.490; Bivona TG, 2016, NAT MED, V22, P472, DOI 10.1038/nm.4091; Chakradeo S, 2016, CURR DRUG TARGETS, V17, P460, DOI 10.2174/1389450116666150825113500; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Cisowski J, 2016, ONCOGENE, V35, P1328, DOI 10.1038/onc.2015.186; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Devarakonda S, 2015, LANCET ONCOL, V16, pE342, DOI 10.1016/S1470-2045(15)00077-7; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eroglu Z, 2016, THER ADV MED ONCOL, V8, P48, DOI 10.1177/1758834015616934; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Huillard E, 2012, P NATL ACAD SCI USA, V109, P8710, DOI 10.1073/pnas.1117255109; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Inoue K, 1999, P NATL ACAD SCI USA, V96, P3993, DOI 10.1073/pnas.96.7.3993; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim ES, 2016, ADV EXP MED BIOL, V893, P189, DOI 10.1007/978-3-319-24223-1_10; Kinno T, 2014, ANN ONCOL, V25, P138, DOI 10.1093/annonc/mdt495; Ko A, 2016, BMB REP, V49, P598, DOI 10.5483/BMBRep.2016.49.11.120; Kramer BW, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-24; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Larsson LG, 2011, SEMIN CANCER BIOL, V21, P367, DOI 10.1016/j.semcancer.2011.10.005; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Lemjabbar-Alaoui H, 2015, BBA-REV CANCER, V1856, P189, DOI 10.1016/j.bbcan.2015.08.002; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lipsyc M, 2015, J GASTROINTEST ONCOL, V6, P645, DOI 10.3978/j.issn.2078-6891.2015.045; Mallakin A, 2007, CANCER CELL, V12, P381, DOI 10.1016/j.ccr.2007.08.034; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Muzumdar MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12685; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Noguchi M, 2010, CANCER METAST REV, V29, P15, DOI 10.1007/s10555-010-9210-y; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Pencik J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8736; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Puzanov I, 2010, SEMIN CUTAN MED SURG, V29, P196, DOI 10.1016/j.sder.2010.06.005; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shai A, 2015, CANCER RES, V75, P3167, DOI 10.1158/0008-5472.CAN-14-3701; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tabor V, 2014, CANCER RES, V74, P4222, DOI 10.1158/0008-5472.CAN-13-3234; Trejo CL, 2013, CANCER RES, V73, P6448, DOI 10.1158/0008-5472.CAN-13-0681; Trejo CL, 2012, CANCER RES, V72, P3048, DOI 10.1158/0008-5472.CAN-11-3649; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Turski ML, 2016, MOL CANCER THER, V15, P533, DOI 10.1158/1535-7163.MCT-15-0643; Vicent S, 2004, BRIT J CANCER, V90, P1047, DOI 10.1038/sj.bjc.6601644; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Volanakis EJ, 2009, BLOOD, V114, P4451, DOI 10.1182/blood-2009-07-233346; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang JQ, 2012, CANCER RES, V72, P4765, DOI 10.1158/0008-5472.CAN-12-0820; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Welsh SJ, 2016, EUR J CANCER, V62, P76, DOI 10.1016/j.ejca.2016.04.005; Wistuba II, 2006, ANNU REV PATHOL-MECH, V1, P331, DOI 10.1146/annurev.pathol.1.110304.100103; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; Young NP, 2010, P NATL ACAD SCI USA, V107, P10184, DOI 10.1073/pnas.1004796107; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	86	7	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6325	6335		10.1038/onc.2017.235	http://dx.doi.org/10.1038/onc.2017.235			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28745322				2022-12-26	WOS:000414774800011
J	Kwon, D; Park, E; Kang, SJ				Kwon, Dohyeong; Park, Eunbyeol; Kang, Suk-Jo			Stimulator of IFN genes-mediated DNA-sensing pathway is suppressed by NLRP3 agonists and regulated by mitofusin 1 and TBC1D15, mitochondrial dynamics mediators	FASEB JOURNAL			English	Article						inflammasome; mitochondria fission; IFN-beta pathway	CYCLIC DI-GMP; CELLULAR ANTIVIRAL RESPONSE; INNATE IMMUNE-RESPONSE; INFLAMMASOME ACTIVATION; I INTERFERON; NALP3 INFLAMMASOME; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; INTERLEUKIN-1-BETA RELEASE; ADAPTIVE IMMUNITY; SIGNALING PROTEIN	The stimulator of IFN genes (STING)-mediated DNA-sensing pathway plays an important role in the innate immune response to pathogen infection, autoimmunity, and cancer; however, its regulatory mechanism has not been fully elucidated, and we do not yet know whether the STING pathway is counter-regulated by other innate immune pathways. Here, we show that the NLRP3-activating agonists, ATP and nigericin, prevent STING pathway activation in association with mitochondrial fragmentation; however, the suppression of the STING pathway and mitochondria fission were not dependent on NLRP3 or potassium efflux. Although nigericin-induced mitochondria fission was rescued by knockdown of either dynamin-related protein 1 or TBC1 domain family member 15 (TBC1D15), which are two distinct mitochondria fission regulators, only TBC1D15 restored the activity of the STING pathway, which indicates that inflammasome-activating signals curtail STING pathway activation via TBC1D15. Finally, we found that deficiency of mitofusin (MFN) 1, a mediator of mitochondrial fusion, inhibited STING pathway activation, which leads to a decrease in the induction of IFN-beta and its inducible gene, ISG56, in conjunction with diminished activation of the signaling molecules, TANK-binding kinase 1 and IFN regulatory factor 3, that are downstream of STING. These results highlight the crucial role of MFN1 in maintaining the competency of the STING pathway. Collectively, our findings reveal that mitochondrial dynamics regulators modulate the activation of the STING signaling pathway.	[Kwon, Dohyeong; Park, Eunbyeol; Kang, Suk-Jo] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kang, SJ (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.	suk-jo.kang@kaist.ac.kr			National Research Foundation of Korea [NRF-2017R1A2B4007817]	National Research Foundation of Korea(National Research Foundation of Korea)	The authors thank their laboratory colleagues and are grateful to Dr. D. C. Chan (Caltech, Pasadena, CA, USA) for helpful input, Dr. S. Yanagi (Tokyo University of Pharmacy and Life Science, Tokyo, Japan), Dr. H. K. Lee (Korea Advanced Institute of Science and Technology), Dr. J. W. Yu (Yonsei University, Seoul, South Korea), Dr. G. M. Barton (University of California, Berkeley), and Dr. M. J. Song (Korea University) for providing valuable reagents and mice. This work was supported by the National Research Foundation of Korea (NRF-2017R1A2B4007817). The authors declare no conflicts of interest.	Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Cavlar T, 2013, EMBO J, V32, P1440, DOI 10.1038/emboj.2013.86; Chin KH, 2013, ACTA CRYSTALLOGR D, V69, P352, DOI 10.1107/S0907444912047269; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gates LT, 2016, J IMMUNOL, V197, P923, DOI 10.4049/jimmunol.1502611; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lei CQ, 2013, J BIOL CHEM, V288, P12596, DOI 10.1074/jbc.M112.444794; Liu YL, 2016, J VIROL, V90, P9406, DOI 10.1128/JVI.00748-16; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Prinarakis E, 2008, EMBO J, V27, P865, DOI 10.1038/emboj.2008.28; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zevini A, 2017, TRENDS IMMUNOL, V38, P194, DOI 10.1016/j.it.2016.12.004; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	66	17	17	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4866	4878		10.1096/fj.201700328R	http://dx.doi.org/10.1096/fj.201700328R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28729291				2022-12-26	WOS:000413398500018
J	Bouillet, S; Genest, O; Mejean, V; Iobbi-Nivol, C				Bouillet, Sophie; Genest, Olivier; Mejean, Vincent; Iobbi-Nivol, Chantal			Protection of the general stress response sigma(S) factor by the CrsR regulator allows a rapid and efficient adaptation of Shewanella oneidensis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FACTOR SPOIIAB; COMPLEX; RSSB	To cope with environmental stresses, bacteria have evolved various strategies, including the general stress response (GSR). GSR is governed by an alternative transcriptional sigma factor named sigma(S) ( RpoS) that associates withRNApolymerase and controls the expression of numerous genes. Previously, we have reported that posttranslational regulation of sigma(S) in the aquatic bacterium Shewanella oneidensis involves the CrsR-CrsA partner- switching regulatory system, but the exact mechanism by which CrsR and CrsA control sigma(S) activity is not completely unveiled. Here, using a translational gene fusion, we show that CrsR sequesters and protects sigma(S) during the exponential growth phase and thus enables rapid gene activation by sigma(S) as soon as the cells enter early stationary phase. Wefurther demonstrate by an in vitro approach that this protection is mediated by the anti-sigma domain of CrsR. Structure-based alignments of CsrR orthologs and other anti-sigma factors identified a CsrR-specific region characteristic of a new family of anti-sigma factors. Wefound that CrsR is conserved in many aquatic proteobacteria, and most of the time it is associated with CrsA. In conclusion, our results suggest that CsrR-mediated protection of sigma(S) during exponential growth enables rapid adaptation of S. oneidensis to changing and stressful growth conditions, and this ability is probably widespread among aquatic proteobacteria.	[Bouillet, Sophie; Genest, Olivier; Mejean, Vincent; Iobbi-Nivol, Chantal] Aix Marseille Univ, CNRS, BIP UMR7281, F-13402 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Iobbi-Nivol, C (corresponding author), CNRS, BIP IMM, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	iobbi@imm.cnrs.fr	Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827; Mejean, Vincent/0000-0001-6533-5846	CNRS; Aix-Marseille Universite (AMU); Ministere de l'Enseignement Superieur et de la Recherche fellowship; AMU	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite (AMU); Ministere de l'Enseignement Superieur et de la Recherche fellowship; AMU	This work was supported in part by the CNRS and Aix-Marseille Universite (AMU). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Ministere de l'Enseignement Superieur et de la Recherche fellowship and AMU.	Baraquet C, 2009, MOL MICROBIOL, V73, P278, DOI 10.1111/j.1365-2958.2009.06770.x; Barembruch C, 2007, MOL MICROBIOL, V65, P76, DOI 10.1111/j.1365-2958.2007.05770.x; Battesti A, 2013, GENE DEV, V27, P2722, DOI 10.1101/gad.229617.113; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Becker G, 2000, MOL MICROBIOL, V35, P657, DOI 10.1046/j.1365-2958.2000.01736.x; Bhuwan M, 2012, J BIOL CHEM, V287, P1903, DOI 10.1074/jbc.M111.256586; Bordi C, 2003, J BACTERIOL, V185, P2042, DOI 10.1128/JB.185.6.2042-2045.2003; Bouillet S, 2016, J BIOL CHEM, V291, P26151, DOI 10.1074/jbc.M116.751933; Campbell EA, 2002, CELL, V108, P795, DOI 10.1016/S0092-8674(02)00662-1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fiebig A, 2015, ANNU REV GENET, V49, P603, DOI 10.1146/annurev-genet-112414-054813; Francez-Charlot A, 2015, TRENDS MICROBIOL, V23, P164, DOI 10.1016/j.tim.2014.12.006; Hengge R, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P251; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Herrou J, 2015, MBIO, V6, DOI 10.1128/mBio.00910-15; Houot L, 2012, MICROBIOL-SGM, V158, P1964, DOI 10.1099/mic.0.057059-0; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanehisa M., 2000, POST GENOME INFORM; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lemaire ON, 2016, RES MICROBIOL, V167, P630, DOI 10.1016/j.resmic.2016.05.004; Mao XM, 2014, FEBS LETT, V588, P608, DOI 10.1016/j.febslet.2013.12.029; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Morris AR, 2013, MOL MICROBIOL, V87, P509, DOI 10.1111/mmi.12109; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Vallenet D, 2017, NUCLEIC ACIDS RES, V45, pD517, DOI 10.1093/nar/gkw1101	32	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14921	14928		10.1074/jbc.M117.781443	http://dx.doi.org/10.1074/jbc.M117.781443			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729423	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000409902100017
J	Wan, ZH; Huang, ZH; Chen, LB				Wan, Zihao; Huang, Zhihao; Chen, Liaobin			Survival predictors associated with signet ring cell carcinoma of the esophagus (SRCCE): A population-based retrospective cohort study	PLOS ONE			English	Article							GASTRIC-CANCER; INTRAPERITONEAL CHEMOTHERAPY; PREOPERATIVE CHEMORADIATION; GASTROESOPHAGEAL JUNCTION; PERITONEAL CARCINOMATOSIS; ESOPHAGOGASTRIC JUNCTION; ENDOSCOPIC ULTRASOUND; POOR-PROGNOSIS; MARITAL-STATUS; SQUAMOUS-CELL	Purpose Signet ring cell carcinoma of the esophagus (SRCCE) is an uncommon tumor associated with significant morbidity and mortality. There is still no consensus regarding cut-off values for tumor size, age and optimal treatment for SRCCE. Thus, we elucidated the current survival outcomes of patients with SRCCE and analyzed factors associated with prognosis. Methods A retrospective cohort study based on the SEER (The Surveillance, Epidemiology, and End Results) program database was conducted. We identified 537 patients (461 men and 76 women) newly diagnosed with SRCCE between January 2004 and December 2014. A multi-variate Cox proportional hazards model was utilized to measure the mortality-associated risk factors in patients with SRCCE after adjusting for various variables. Results The 1-,2- and 5-year disease-specific mortalities (DSM) were 51.6%, 67.6%, and 78.4%, respectively, and the median survival time was 12.0 months. The factors correlated with mortality hazard were marital status (unmarried versus married, Hazard Ratio (HR) = 1.443), tumor size (>= 5 cm versus < 5 cm, HR = 1.444), tumor grade (high grade versus low grade, HR = 3.001), condition of primary tumor (T4 versus T1, HR = 2.178), regional lymph node metastasis (N1 versus N0, HR = 1.739), further metastasis (M1 versus M0, HR = 1.951) and chemotherapy (receiving chemotherapy versus no chemotherapy, HR = 0.464). Conclusions The contemporary 5-year DSM was 78.4%. Being unmarried, having a tumor size >= 5 cm, a high tumor grade, a score of T4 for tumor invasion of adjacent organs, a score of N1 for regional lymph node metastasis, a score of M1 for distant metastasis and no chemotherapy were independent predictors of high DSM.	[Wan, Zihao; Chen, Liaobin] Wuhan Univ, Dept Orthoped Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China; [Huang, Zhihao] Wuhan Univ, Dept Colorectal & Anal Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Chen, LB (corresponding author), Wuhan Univ, Dept Orthoped Surg, Zhongnan Hosp, Wuhan, Hubei, Peoples R China.	liaobin_chen@163.com						Agoston AT, 2015, AM J SURG PATHOL, V39, P1085, DOI 10.1097/PAS.0000000000000420; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; ANTONIOLI DA, 1982, CANCER, V50, P775, DOI 10.1002/1097-0142(19820815)50:4<775::AID-CNCR2820500425>3.0.CO;2-W; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Chen L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176637; Chirieac LR, 2005, CLIN CANCER RES, V11, P2229, DOI 10.1158/1078-0432.CCR-04-1840; Chiu CT, 2011, DIGEST DIS SCI, V56, P1749, DOI 10.1007/s10620-010-1487-8; Coia LR, 2000, J CLIN ONCOL, V18, P455, DOI 10.1200/JCO.2000.18.3.455; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Enlow JM, 2013, ANN THORAC SURG, V96, P1927, DOI 10.1016/j.athoracsur.2013.06.047; Gaur P, 2011, CANCER-AM CANCER SOC, V117, P63, DOI 10.1002/cncr.25373; Glehen O, 2010, ANN SURG ONCOL, V17, P2370, DOI 10.1245/s10434-010-1039-7; GuerreroMedrano J, 1997, CANCER, V80, P277, DOI 10.1002/(SICI)1097-0142(19970715)80:2<277::AID-CNCR16>3.0.CO;2-R; Heath EI, 2000, J CLIN ONCOL, V18, P868, DOI 10.1200/JCO.2000.18.4.868; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Humar B, 2009, CANCER RES, V69, P2050, DOI 10.1158/0008-5472.CAN-08-2457; Ilson DH, 1998, J CLIN ONCOL, V16, P1826, DOI 10.1200/JCO.1998.16.5.1826; JASS JR, 1990, CANCER, V66, P2162, DOI 10.1002/1097-0142(19901115)66:10<2162::AID-CNCR2820661020>3.0.CO;2-N; KAVANAGH B, 1992, INT J RADIAT ONCOL, V24, P633, DOI 10.1016/0360-3016(92)90708-P; Kawano A, 2014, GASTRIC CANCER, V17, P54, DOI 10.1007/s10120-013-0238-x; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; KIM H, 1978, AM J SURG PATHOL, V2, P119, DOI 10.1097/00000478-197806000-00001; Li C, 2007, ONCOLOGY-BASEL, V72, P64, DOI 10.1159/000111096; Liu K, 2017, PATHOLOGY ONCOLOGY R; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; MAEHARA Y, 1992, CANCER, V69, P1645, DOI 10.1002/1097-0142(19920401)69:7<1645::AID-CNCR2820690702>3.0.CO;2-X; Mariette C, 2004, ANN THORAC SURG, V78, P1177, DOI 10.1016/j.athoracsur.2004.02.068; Nafteux PR, 2014, ANN SURG, V260, P1023, DOI 10.1097/SLA.0000000000000689; National Cancer Institute, SURV EP END RES PROG; Natsugoe S, 2001, ANN SURG, V234, P613, DOI 10.1097/00000658-200111000-00005; Nipp RD, 2016, CANCER-AM CANCER SOC, V122, P2110, DOI 10.1002/cncr.30025; Oppedijk V, 2014, J CLIN ONCOL, V32, P385, DOI 10.1200/JCO.2013.51.2186; Osborne C, 2005, BREAST CANCER RES TR, V93, P41, DOI 10.1007/s10549-005-3702-4; Otsuji E, 1998, J SURG ONCOL, V67, P216, DOI 10.1002/(SICI)1096-9098(199804)67:4<216::AID-JSO2>3.0.CO;2-B; Park JM, 2008, J SURG ONCOL, V98, P520, DOI 10.1002/jso.21150; Piessen G, 2009, ANN SURG, V250, P878, DOI 10.1097/SLA.0b013e3181b21c7b; SHEIBANI K, 1988, AM J SURG PATHOL, V12, P28, DOI 10.1097/00000478-198801000-00004; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Song YQ, 2016, ONCOTARGET, V7, P21347, DOI 10.18632/oncotarget.7256; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tustumi F, 2016, ABCD-ARQ BRAS CIR DI, V29, P138, DOI 10.1590/0102-6720201600030003; Twine CP, 2010, DIS ESOPHAGUS, V23, P652, DOI 10.1111/j.1442-2050.2010.01072.x; Wang XD, 2016, ONCOTARGET, V7, P24880, DOI 10.18632/oncotarget.8467; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Wu PC, 2003, LANCET ONCOL, V4, P481, DOI 10.1016/S1470-2045(03)01167-7; Yang XJ, 2009, ANN SURG ONCOL, V16, P345, DOI 10.1245/s10434-008-0226-2; Yendamuri S, 2013, CANCER-AM CANCER SOC, V119, P3156, DOI 10.1002/cncr.28099	49	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181845	10.1371/journal.pone.0181845	http://dx.doi.org/10.1371/journal.pone.0181845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746362	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800064
J	Lee, KY; Yoo, BW; Ahn, SS; Bae, WH; Lee, H; Jung, SM; Lee, SW; Park, YB; Song, JJ				Lee, Kyoung Yong; Yoo, Byung-Woo; Ahn, Sung Soo; Bae, William Han; Lee, Hyukmin; Jung, Seung Min; Lee, Sang-Won; Park, Yong-Beom; Song, Jason Jungsik			Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; VIRAL-LOAD; ORGAN; TRANSPLANTATION; RECIPIENTS; KINETICS; VIRUS; LUPUS	Objective Cytomegaloviruses (CMV) can have a significant impact on the prognosis of immunocompromised patients. Unlike in the transplantation and AIDS fields, only a few studies on CMV infections have been published in the field of autoimmunity. In this study, we examined the clinical outcomes of CMV infections in patients with autoimmune diseases at a single tertiary medical institution. Methods A retrospective study was performed to identify the mortality risk factors associated with CMV infections in patients with autoimmune diseases. We reviewed the medical records of patients with autoimmune diseases who were diagnosed with CMV infections using real-time quantitative polymerase chain reaction between December 2005 and March 2016. Clinical and laboratory parameters as well as treatment outcomes were analyzed. Results Seventy-three CMV infected patients were separated into survivors and non-survivors. Non-survivors had significantly higher median CMV-DNA copy numbers than survivors (95,500 vs 6,700 copies/mL, p = 0.005) and demonstrated significantly more frequent incidents of CMV pneumonitis (69.2 vs 36.2%, p = 0.007). After adjusting for multiple confounding covariates, the log CMV-DNA copies/mL (hazard ratio, 1.48; 95% confidence interval, 1.14-1.92; p = 0.003) and the presence of concurrent infections (hazard ratio, 22.00; 95% confidence interval, 2.75-175.97, p = 0.004) were identified as independent mortality risk factors. Furthermore, patients with high CMV copy numbers (> 60,000 copies/mL) had higher in-hospital mortality than those with low CMV copy numbers (p < 0.05). Conclusions CMV-DNA copy numbers and concurrent infections are predictors of in-hospital mortality in CMV-infected patients with autoimmune diseases. Therefore, serial measurements of CMV-DNA copy numbers and close observation for signs of other infections are recommended for patients with autoimmune diseases who have concurrent CMV infection.	[Lee, Kyoung Yong; Yoo, Byung-Woo; Ahn, Sung Soo; Bae, William Han; Jung, Seung Min; Lee, Sang-Won; Park, Yong-Beom; Song, Jason Jungsik] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Lee, Hyukmin] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Song, Jason Jungsik] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Song, JJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea.; Song, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Seoul, South Korea.	JSKSONG@yuhs.ac	Ahn, Sung Soo/AAB-4945-2021	Ahn, Sung Soo/0000-0002-9002-9880; Jung, Seung Min/0000-0003-3465-2181; Lee, Hyukmin/0000-0002-8523-4126; Lee, Sang-Won/0000-0002-8038-3341; Song, Jason/0000-0003-0662-7704	Basic Science Research Program through the National Research Foundation of Korea [2015R1C1A1A01053140]; Ministry of Education, Science, and Technology	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Basic Science Research Program (2015R1C1A1A01053140) through the National Research Foundation of Korea, and funded by the Ministry of Education, Science, and Technology. There are no conflicts of interest to declare and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allice T, 2008, J VIROL METHODS, V148, P9, DOI 10.1016/j.jviromet.2007.10.006; Atabani SF, 2012, AM J TRANSPLANT, V12, P2457, DOI 10.1111/j.1600-6143.2012.04087.x; Barzilai O, 2007, ANN NY ACAD SCI, V1108, P567, DOI 10.1196/annals.1422.059; Borthakur G, 2007, CANCER-AM CANCER SOC, V110, P2478, DOI 10.1002/cncr.23031; Dodt KK, 1997, AIDS, V11, pF21, DOI 10.1097/00002030-199703110-00001; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Meijer E, 2003, CLIN MICROBIOL REV, V16, P647, DOI 10.1128/CMR.16.4.647-657.2003; O'Shea JJ, 2013, ANN RHEUM DIS, V72, P111, DOI 10.1136/annrheumdis-2012-202576; Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47; Razonable RR, 2013, AM J TRANSPLANT, V13, P93, DOI 10.1111/ajt.12103; Razonable RR, 2013, CLIN MICROBIOL REV, V26, P703, DOI 10.1128/CMR.00015-13; Razonable RR, 2008, WORLD J GASTROENTERO, V14, P4849, DOI 10.3748/wjg.14.4849; Ross S A, 2011, Infect Disord Drug Targets, V11, P466; Rozenblyum Evelyn V, 2013, Int J Clin Rheumtol, V8, P137; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Takizawa Y, 2008, RHEUMATOLOGY, V47, P1373, DOI 10.1093/rheumatology/ken231; Taylor GH, 2003, AM FAM PHYSICIAN, V67, P519; Tsai WP, 2012, RHEUMATOL INT, V32, P2901, DOI 10.1007/s00296-011-2131-4; VANSON WJ, 1989, TRANSPLANT INT, V2, P147; Zhang J, 2014, LUPUS, V23, P889, DOI 10.1177/0961203314532560	20	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181590	10.1371/journal.pone.0181590	http://dx.doi.org/10.1371/journal.pone.0181590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742877	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000040
J	Lim, VC; Ramli, R; Bhassu, S; Wilson, JJ				Lim, Voon-Ching; Ramli, Rosli; Bhassu, Subha; Wilson, John-James			A checklist of the bats of Peninsular Malaysia and progress towards a DNA barcode reference library	PLOS ONE			English	Article							ECHOLOCATION CALL FREQUENCY; CHIROPTERA VESPERTILIONIDAE; FRUIT BATS; MAMMALIA CHIROPTERA; HIPPOSIDEROS-POMONA; SOUTHEAST-ASIA; NOSED BATS; STATE-PARK; DIVERSITY; PHYLOGENY	Several published checklists of bat species have covered Peninsular Malaysia as part of a broader region and/or in combination with other mammal groups. Other researchers have produced comprehensive checklists for specific localities within the peninsula. To our knowledge, a comprehensive checklist of bats specifically for the entire geopolitical region of Peninsular Malaysia has never been published, yet knowing which species are present in Peninsular Malaysia and their distributions across the region are crucial in developing suitable conservation plans. Our literature search revealed that 110 bat species have been documented in Peninsular Malaysia; 105 species have precise locality records while five species lack recent and/or precise locality records. We retrieved 18 species from records dated before the year 2000 and seven species have only ever been recorded once. Our search of Barcode of Life Data-systems (BOLD) found that 86 (of the 110) species have public records of which 48 species have public DNA barcodes available from bats sampled in Peninsular Malaysia. Based on Neighbour-Joining tree analyses and the allocation of DNA barcodes to Barcode Index Number system (BINs) by BOLD, several DNA barcodes recorded under the same species name are likely to represent distinct taxa. We discuss these cases in detail and highlight the importance of further surveys to determine the occurences and resolve the taxonomy of particular bat species in Peninsular Malaysia, with implications for conservation priorities.	[Lim, Voon-Ching; Ramli, Rosli; Bhassu, Subha] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Wilson, John-James] China Agr Univ, Int Coll Beijing, Beijing, Peoples R China	Universiti Malaya; China Agricultural University	Lim, VC (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.; Wilson, JJ (corresponding author), China Agr Univ, Int Coll Beijing, Beijing, Peoples R China.	voonchinglim@gmail.com; wilso04@gmail.com	Ramli, Rosli/A-8498-2010; BHASSU, SUBHA/B-9843-2010; Wilson, John-James/C-4656-2012	Ramli, Rosli/0000-0003-0410-9604; BHASSU, SUBHA/0000-0001-8658-6900; Wilson, John-James/0000-0002-3583-3550; Lim, Voon Ching/0000-0002-2722-4771	University of Malaya Postgraduate Research Fund [PG060-2016A]	University of Malaya Postgraduate Research Fund(Universiti Malaya)	This project was supported by a grant under the University of Malaya Postgraduate Research Fund (PG060-2016A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by a grant under the University of Malaya Postgraduate Research Fund (PG060-2016A). We thank Dr. Charles M. Francis of the Canadian Wildlife Service and an anonymous reviewer for providing valuable advice and constructive comments which substantially improved this manuscript. We extend our gratitude to Department of Wildlife and National Parks, Malaysia (DWNP) for giving us the access to the specimens in the Institute of Biodiversity, Lanchang, Malaysia. We also thank Dr. Zubaid Akbar Mukhtar Ahmad of National University of Malaysia, Professor Stephen Rossiter of Queen Mary University of London and Shahfiz Azman of the Forest Research Institute Malaysia (FRIM) for directing us towards valuable literature. We are grateful to Prof. Emeritus Dr. Yong Hoi Sen, Lee Ping Shin, Sing Kong Wah and Brandon Mong Guo Jie of the University of Malaya for their valuable advice.	AMNH, 2012, WING PUNCH HAIR SAMP; Anan S, 1998, J WILDLIFE PARKS, V16, P104; Andersen K., 1912, Annals & Magazine of Natural History Series 8, V10; Andersen K, 1905, P ZOOL SOC LOND, V1905, P75; Andersen K., 1918, Annals & Magazine of Natural History Series 9, V2; ANDERSEN K, 1911, ANN MAG NAT HIST, V7, P641; ANDERSEN K., 1912, CATALOGUE CHIROPTERA, V2nd; Andersen K, 1905, ANN MAG NAT HIST, V16, P546; [Anonymous], 2008, THESIS; [Anonymous], J TROPICAL BIOL CONS; Appleton BR, 2004, MOL PHYLOGENET EVOL, V31, P431, DOI 10.1016/j.ympev.2003.08.017; Aziz SA, 2017, PEER J; Azlan J. Mohd., 2000, Malayan Nature Journal, V54, P69; Bates PJJ, 2007, ACTA CHIROPTEROL, V9, P13, DOI 10.3161/1733-5329(2007)9[13:ANSOHC]2.0.CO;2; Bates PJJ, 2005, ACTA CHIROPTEROL, V7, P205, DOI 10.3161/1733-5329(2005)7[205:AROTGM]2.0.CO;2; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blainville HMD, 1840, OSTEOGRAPHIE DESCRIP, VII; Blainville HMD, 1840, OSTEOGRAPHIE DESCRIP, VI; BLYTH E, 1853, J ASIATIC SOC BENGAL, V22, P408; BLYTH E, 1844, J ASIATIC SOC BENGAL, V13, P463; BLYTH E, 1848, J ASIATIC SOC BENGAL, V17, P247; Bonhote J. L., 1903, Fasciculi Malayenses Zoology, Vi, P1; Bonhote J. L., 1908, Journal of the Federated Malay States Museums Kuala Lumpur, V3; Boonsong L, 1977, MAMMALS THAILAND, P758; BUCHANNAN F, 1800, T LINN SOC LOND, V5, P261; Bumrungsri S, 2008, DATABASE IUCN RED LI, V2008; Campbell P, 2004, MOL PHYLOGENET EVOL, V33, P764, DOI 10.1016/j.ympev.2004.06.019; Campbell P, 2007, J MAMMAL, V88, P105, DOI 10.1644/06-MAMM-A-160R1.1; CANTOR T, 1846, J ASIATIC SOC BENGAL, V15, P171; Chasen F N, 1940, B RAFFLES MUSEUM; Christine LJ, 2013, J TROP FOR SCI, V25, P118; Corbet GB, 1992, MAMMALS INDO MALAYAN; Csorba G, 1997, J MAMMAL, V78, P342, DOI 10.2307/1382887; Csorba G, 1999, J ZOOL, V248, P361, DOI 10.1017/S0952836999007086; Csorba G., 1997, Malayan Nature Journal, V50, P197; Csorba G, 2014, DATABASE IUCN RED LI; Csorba G, 2016, DATABASE IUCN RED LI, V2016; Csorba G., 2003, HORSESHOE BATS WORLD; Csorba G, 2015, ZOOTAXA, V3980, P267, DOI 10.11646/zootaxa.3980.2.7; Csorba Gabor, 1998, Bulletin of the Natural History Museum Zoology Series, V64, P207; Cuvier F., 1824, DENTS MAMMIFERES; Davison GWH, 2007, P SEM WORKSH STAT BI, P3; Desmarest AG, 1820, ENCY METHODIQUE; DOBSON G. E, 1871, P ASIATIC SOC BENGAL, P105; DOBSON G. E., 1876, MONOGRAPH ASIATIC CH; DOBSON G. E, 1877, J ASIATIC SOC BENGAL, V46, P310; Dobson GE., 1873, P ASIATIC SOC BENGAL, P22; Dobson GE, 1873, P ASIATIC SOC BENGAL, P147; Dobson GE., 1876, ANN MAG NAT HIST, V18, P266; Dobson GE, 1880, ANN MAG NAT HIST, V6, P163; Dobson GE, 1875, P ZOOL SOC LOND, P470; Douangboubpha B, 2016, MAMMALIA, V80, P21, DOI 10.1515/mammalia-2014-0004; Douangboubpha B, 2010, ACTA CHIROPTEROL, V12, P415, DOI 10.3161/150811010X537990; Douangboubpha B, 2010, ACTA CHIROPTEROL, V12, P29, DOI 10.3161/150811010X504572; [DWNP Department of wildlife and national parks], 2010, RED LIST MAMM PEN MA; Ellerman J. R., 1966, CHECKLIST PALAEARCTI; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; European Commission, 2020, GUID GEOGR IND GIS S; Faure PA, 2009, J MAMMAL, V90, P1148, DOI 10.1644/08-MAMM-A-332.1; Francis CM, 2007, ACTA CHIROPTEROL, V9, P1, DOI 10.3161/1733-5329(2007)9[1:ANSOKC]2.0.CO;2; Francis CM, 2012, ACTA CHIROPTEROL, V14, P15, DOI 10.3161/150811012X654231; Francis Charles M., 1999, Senckenbergiana Biologica, V79, P255; Francis Charles M., 1997, Malayan Nature Journal, V50, P359; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Francis Charles M., 1995, Malayan Nature Journal, V48, P403; FRANCIS CM, 1990, J TROP ECOL, V6, P421, DOI 10.1017/S0266467400004818; Francis CM, 1998, MAMMALIA, V62, P241, DOI 10.1515/mamm.1998.62.2.241; FRANCIS CM, 1989, CAN J ZOOL, V67, P2878, DOI 10.1139/z89-408; FRANCIS CM, 1986, MAMMALIA, V50, P43, DOI 10.1515/mamm.1986.50.1.43; Francis CM, 2016, DATABASE IUCN RED LI, V2016; Gabor C, 2011, ZOOTAXA, P41, DOI 10.11646/zootaxa.2925.1.4; GEOFFROY E, 1810, ANN MUSEUM NATL HIST, V15, P86; Geoffroy E., 1810, ANN MUSEUM HIST NATU, V15, P157; Geoffroy (-Saint Hilaire) E, 1813, ANN MUSEUM NATL HIST, V20, P11; Gorfol T, 2013, ACTA ZOOL ACAD SCI H, V59, P41; Gould J., 1854, MAMMALS AUSTR, V3; Gray J.E., 1838, MAGAZINE ZOOLOGY BOT, V2, P483; GRAY J. E., 1842, ANN MAGAZINE NATURAL, V10, P255, DOI DOI 10.1080/03745484209445232; GRAY J.E, 1846, CATALOGUE SPECIMENS; Gray JE, 1843, LIST SPECIMENS MAMMA; Hardwicke T., 1825, T LINN SOC LOND, V14, P525; HELLER KG, 1984, Z ZOOL SYST EVOL, V22, P65; Heller KG, 1989, SENCKENBERG BIOL, V69, P243; HILL J E, 1972, Bulletin of the British Museum (Natural History) Zoology, V22, P173; Hill J.E., 1984, Bulletin of the British Museum (Natural History) Zoology, V47, P77; Hill J. E., 1965, Mammalia, V29, P524, DOI 10.1515/mamm.1965.29.4.524; HILL J E, 1985, Malayan Nature Journal, V39, P147; HILL J. E., 1962, PROC ZOOL SOC LONDON, V139, P119; Hill J.E., 1984, Bulletin of the British Museum (Natural History) Zoology, V47, P305; Hill J.E., 1983, Bulletin of the British Museum (Natural History) Zoology, V45, P103; Hill J E, 1963, B BR MUS ZOOL, P1; HILL J. E., 1964, FEDERATION MUSEUMS J, V8, P48; HILL J. E., 1987, B BRIT MUS NAT HIST, V72, P225; HILL JE, 1986, MAMMALIA, V50, P535, DOI 10.1515/mamm.1986.50.4.535; HILL JE, 1989, MAMMALIA, V53, P307; Hill JE, 1972, B BRIT MUS NAT HIST, V23, P21; Hodgson BH, 1835, J ASIATIC SOC BENGAL, V4, P699; Horsfield T., 1823, ZOOLOGICAL RES JAVA; HORSFIELD T, 1855, ANN MAGAZINE NATURAL, V16, P101, DOI DOI 10.1080/037454809495489; Huang JCC, 2014, ACTA CHIROPTEROL, V16, P413, DOI 10.3161/150811014X687369; Ith S, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-015-0109-8; IUCN, IUCN RED LIST THRET; Jayaraj JVK, 2016, DATABASE IUCN RED LI; Jayaraj Vijaya Kumaran, 2013, Check List, V9, P1439; Jayaraj Vijaya Kumaran, 2012, Journal of Threatened Taxa, V4, P2617; Jenkins P.D., 1981, Bulletin of the British Museum (Natural History) Zoology, V41, P279; Jentink FA, 1891, NOTES LEYDEN MUSEUM, V13, P202; Joann C. L., 2011, Malayan Nature Journal, V63, P569; Khan F A A, 2008, 281 TEX TU; Khan FAA, 2010, J MAMMAL, V91, P1058, DOI 10.1644/09-MAMM-A-361.1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingston T, 1999, J ZOOL, V249, P359, DOI 10.1017/S0952836999009917; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; KINGSTON T, 2006, BATS KRAU WILDLIFE R; Kitchener D. J., 1992, Records of the Western Australian Museum, V16, P1; Kloss CB, 1921, J FEDERATED MALAY ST, V10, P229; Kock D., 2000, Malayan Nature Journal, V54, P63; Koopman KF, 1994, HDB ZOOLOGY 60; Kruskop S. V., 2011, RUSSIAN J THERIOLOGY, V10, P37; KUHL H, 1819, ANN WETTERAUISCHEN G, V4, P185; Kuhl H., 1819, ANN WETTERAUISCHEN G, V4, P11; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumaran Jayaraj Vijaya, 2016, Songklanakarin Journal of Science and Technology, V38, P213; Kumaran JV, 2013, MAL NAT J, V64, P233; LEACH W. E, 1821, T LINN SOC LOND, V13, P69; Lim B. L., 1999, Malayan Nature Journal, V53, P217; Lim BL, 1999, RAFFLES B ZOOL, P101; Lim BL, 1999, J WILDLIFE PARKS, V17, P1; Lim LS, 2016, ZOOTAXA, V4170, P169, DOI 10.11646/zootaxa.4170.1.10; Lim LS, 2014, J TROP ECOL, V30, P111, DOI 10.1017/S0266467413000874; Linnaeus C., 1758, SYSTEMA NATURAE, V1, P1758; Maeda K., 1982, HONYURUIKAGAKU S1; Matveev Vitaliy A., 2005, Russian Journal of Theriology, V4, P43; Medway L., 1969, WILD MAMMALS MALAYA; Medway L, 1966, MALAYAN SCI, V2, P1; Miller G. S., 1898, Proceedings of the Academy Philadelphia, P316; Miller G.S., 1905, P BIOL SOC WASH, V18, P229; Mohd-Hanif RMD, 2015, J TROP FOR SCI, V27, P506; Morni MA, 2016, RAFFLES B ZOOL, V64, P242; Muller S., 1838, TIJDSCHRIFT NATUURLI, V1838-1839, P134; Murray SW, 2012, MOL PHYLOGENET EVOL, V62, P597, DOI 10.1016/j.ympev.2011.10.021; Norsham Y, 1999, J WILDLIFE PARKS, V17, P28; Nowak RM, 1994, WALKERS BATS WORLD; Page RDM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0334; Pallas PS., 1767, SPEICLEGIA ZOOLOGICA; Peters W., 1868, Monatsberichte Akad Wiss Berlin, P626; PETERS W, 1872, MONATSBERICHTE KONIG, P256; Peters W., 1866, NEUE ODER UNGENUGEND, P392; Peters W., 1866, P ZOOL SOC LOND, P426; Peters W, 1861, MONATSBERICHTE KONIG, V6, P706; Peters W. C. H., 1866, MONATSBERICHTE KONIG, V1866, P16; Ratnam L, 1989, J WILDLIFE PARKS, V8, P9; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ridwan Mohd A. R., 2012, Pertanika Journal of Tropical Agricultural Science, V35, P459; Robinson HC, 1911, J FEDERATED MALAY ST, V4, P241; Roslan A, 2016, J WILDLIFE IN PRESS, V31; SANBORN C. C, 1931, PUBLICATIONS FIELD M, V18, P7; Sanborn CC, 1939, NAT HIST ZOOL, V24, P37; Schreber J.C.D., 1775, ABBILDUNGEN NACH NAT, V1; Shafie NJ, 2011, TROP LIFE SCI RES, V22, P13; Shahfiz MA, P 2 TEM SCI EXP 2012; Shahfiz MA, 2008, P FOR DEP PEN MAL 3, P293; Shahfiz MA, 2009, P FOR DEP PEN MAL 1, P265; Shahfiz MA, 2008, P FOR DEP PEN MAL 3, P299; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Sing KW, 2013, RAFFLES B ZOOL, P211; Soisook P, 2013, ACTA CHIROPTEROL, V15, P271, DOI 10.3161/150811013X678928; Soisook P, 2008, ACTA CHIROPTEROL, V10, P221, DOI 10.3161/150811008X414818; Soltis PS, 2003, STAT SCI, V18, P256; Struebig MJ, 2016, MAMMALIA; Syaripuddin K, 2014, ECOTOXICOLOGY, V23, P1164, DOI 10.1007/s10646-014-1258-y; Tamrin NAM, 2010, P NAT BIOD SEM 2008, P27; Tate G. H. H., 1943, AMER MUS NOVITATES, V1219, P1; Tate GHH, 1941, B AM MUS NAT HIST, V48, P353; TATE GHH, 1947, MAMMALS E ASIA; Taylor EH., 1934, MONOGRAPH, V30; TEMMINCK C. J, 1834, TIJDSCHRIFT NATUURLI, V1, P1; Temminck C.J., 1853, ESQUISSES ZOOLOGIQUE; Temminck CJ, 1824, VUES GEN ORDRE CHEIR, P157; Temminck CJ, 1837, MONOGRAPHIES MAMMALO, V2; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Thomas O., 1923, Annals & Magazine of Natural History Series 9, V11, P250; Thomas O., 1916, Journal of the Bombay Natural History Society, V24; Thomas O., 1916, Journal of the Federated Malay States Museums, V7; Thomas O., 1898, Annals of Natural History, V(7), P243; Thomas O., 1898, Annals of Natural History, V(7), P360; Thomas O., 1894, Annals of Natural History, V(6), P460; Thomas O., 1913, Annals & Magazine of Natural History, V12; Thomas O., 1915, Annals & Magazine of Natural History, V15; Thomas O., 1923, P ZOOL SOC LOND, P178; Thomas O, 1902, ANN MAG NAT, V9, P271; Thomas O., 1904, ZOOL ANZ, V27, P722; Thomas O, 1890, ANN MAGAZINE NATURAL, V5, P235; Thomas O, 1909, P ZOOLOGICAL SOC LON, V79; THOMAS O, 1905, ANN MAG NAT HIST, V16, P572; THONGLONGYA K, 1973, Mammalia, V37, P587, DOI 10.1515/mamm.1973.37.4.587; THONGLONGYA K, 1974, Mammalia, V38, P285, DOI 10.1515/mamm.1974.38.2.285; Tian LX, 2004, FOLIA ZOOL, V53, P303; Tingga RCT, 2012, SAINS MALAYS, V41, P659; Tomes RF, 1858, P ZOOL SOC LOND, P536; Uber die Gattungen und Arten der Hufeisennasen, 1871, MONATSBERICHTE KONIG, P301; VALH M, 1797, SKRIFTER NATURHISTOR, V4, P121; VANCAKENBERGHE V, 1993, MAMMALIA, V57, P227, DOI 10.1515/mamm.1993.57.2.227; Vanitharani J, 2003, ACTA CHIROPTEROL, V5, P49, DOI 10.3161/001.005.0104; Volleth M, 2015, ACTA CHIROPTEROL, V17, P1, DOI 10.3161/15081109ACC2015.17.1.001; Waterhouse GR., 1845, P ZOOL SOC LOND, P3; Wiantoro S., 2012, Pertanika Journal of Tropical Agricultural Science, V35, P271; Wilson JJ, 2014, GENET MOL RES, V13, P920, DOI 10.4238/2014.February.19.2; Yatim SH, 1985, J WILDLIFE PARKS, V4, P65; Yatim SH, 1983, J WILDLIFE PARKS, V2, P119; Yeap C A, 2003, MAL NAT J, V56, P397; Yeap CA, 2002, MAL NAT J, V56, P195; Yoshiyuki Mizuko, 2005, Bulletin of the National Science Museum Series A (Zoology), V31, P29; Zhao LZ, 2015, J MAMMAL, V96, P1305, DOI 10.1093/jmammal/gyv139; ZUBAID A, 1988, MAMMALIA, V52, P134; ZUBAID A, 1993, MAMMALIA, V57, P201, DOI 10.1515/mamm.1993.57.2.201; Zubaid A., 1994, Malayan Nature Journal, V48, P37; ZUBAID A, 1988, Malayan Nature Journal, V42, P29; Zubaid A, 1988, SAINS MALAYS, V17, P367	220	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0179555	10.1371/journal.pone.0179555	http://dx.doi.org/10.1371/journal.pone.0179555			65	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742835	gold, Green Published, Green Submitted			2022-12-26	WOS:000406370000003
J	Lu, LM; Zeng, JC				Lu, Liming; Zeng, Jingchun			Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; SURVIVAL; MUTATIONS; EPIDEMIOLOGY; BIOMARKERS; CARCINOMA; PROTEIN	Genetic alterations in K-ras and p53 are thought to be critical in pancreatic cancer development and progression. However, K-ras and p53 expression in pancreatic adenocarcinoma have not been systematically examined in The Cancer Genome Atlas (TCGA) Data Portal. Information regarding K-ras and p53 alterations, mRNA expression data, and protein/protein phosphorylation abundance was retrieved from The Cancer Genome Atlas (TCGA) databases, and analyses were performed by the cBioPortal for Cancer Genomics. The mutual exclusivity analysis showed that events in K-ras and p53 were likely to co-occur in pancreatic adenocarcinoma (Log odds ratio = 1.599, P = 0.006). The graphical summary of the mutations showed that there were hotspots for protein activation. In the network analysis, no solid association between K-ras and p53 was observed in pancreatic adenocarcinoma. In the survival analysis, neither K-ras nor p53 were associated with both survival events. As in the data mining study in the TCGA databases, our study provides a new perspective to understand the genetic features of K-ras and p53 in pancreatic adenocarcinoma.	[Lu, Liming] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zeng, Jingchun] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Lu, LM (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China.	lulimingleon@126.com			Guangdong Natural Science Foundation [2016A030310290]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [YN2015QN20]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine	This research was supported by Guangdong Natural Science Foundation (project no. 2016A030310290) and The Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine (No. YN2015QN20). The funder had no further role in study design, data collection, analysis and interpretation of data, writing of the report or the decision to submit the paper for publication.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Biankin AV, 2001, CANCER RES, V61, P8830; BOSCHMAN CR, 1994, AM J PATHOL, V145, P1291; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Castells A, 1999, J CLIN ONCOL, V17, P578, DOI 10.1200/JCO.1999.17.2.578; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen R, 2015, LAB INVEST, V95, P43, DOI 10.1038/labinvest.2014.128; Conlin A, 2005, GUT, V54, P1283, DOI 10.1136/gut.2005.066514; Dong M, 2000, CANCER EPIDEM BIOMAR, V9, P279; Dong M, 2003, J SURG ONCOL, V82, P111, DOI 10.1002/jso.10186; Fang BL, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0028-4; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ines C, 2014, TUMOR BIOL, V35, P7163, DOI 10.1007/s13277-014-1874-4; Jeong J, 2005, YONSEI MED J, V46, P519, DOI 10.3349/ymj.2005.46.4.519; Kawesha A, 2000, INT J CANCER, V89, P469, DOI 10.1002/1097-0215(20001120)89:6<469::AID-IJC1>3.0.CO;2-L; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; NAKAMORI S, 1995, JPN J CANCER RES, V86, P174, DOI 10.1111/j.1349-7006.1995.tb03036.x; Notarnicola M, 2000, DIGEST LIVER DIS, V32, P131, DOI 10.1016/S1590-8658(00)80400-4; Ormanns S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-624; Qin R, 2015, BRIT J CANCER, V112, P514, DOI 10.1038/bjc.2014.659; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Salek C, 2009, ANTICANCER RES, V29, P1803; Sheng WW, 2014, HISTOPATHOLOGY, V64, P523, DOI 10.1111/his.12273; Shin SH, 2013, PANCREAS, V42, P216, DOI 10.1097/MPA.0b013e31825b6ab0; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singh N, 2015, CANCER INVEST, V33, P78, DOI 10.3109/07357907.2014.1001894; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; Talar-Wojnarowska R, 2006, HEPATO-GASTROENTEROL, V53, P608; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Yeo CJ, 1998, LANGENBECK ARCH SURG, V383, P129, DOI 10.1007/s004230050104; Yuan QY, 2015, MOL MED REP, V11, P277, DOI 10.3892/mmr.2014.2693; Zhao H, 2016, PANCREAS, V45, P204, DOI 10.1097/MPA.0000000000000453	33	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181532	10.1371/journal.pone.0181532	http://dx.doi.org/10.1371/journal.pone.0181532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742845	Green Submitted, Green Published, gold			2022-12-26	WOS:000406370000035
J	Niihata, K; Fukuma, S; Akizawa, T; Fukuhara, S				Niihata, Kakuya; Fukuma, Shingo; Akizawa, Tadao; Fukuhara, Shunichi			Association of coping strategies with mortality and health-related quality of life in hemodialysis patients: The Japan Dialysis Outcomes and Practice Patterns Study	PLOS ONE			English	Article							SHORT-FORM; SURVIVAL; STRESS; CANCER; DOPPS; HOSPITALIZATION; INDIVIDUALS; DEPRESSION; MANAGEMENT; PREDICTOR	Background Hemodialysis patients are exposed to disease-and treatment-related stresses, and use various coping strategies to deal with these stresses. Although some studies have reported the association of coping strategies with mortality or health-related quality of life (QOL) in some populations, the effect of coping strategies on clinical outcomes in hemodialysis patients remains unclear. We investigated the association in a longitudinal design among Japanese hemodialysis patients. Methods We examined Japanese hemodialysis patients who participated in the Dialysis Outcomes and Practice Patterns Study (DOPPS) IV, which was conducted between 2009 and 2012. The exposure variable was stress coping strategy, as assessed using subscales in Coping Strategies Inventory Short Form: problem-focused engagement, problem-focused disengagement, emotion-focused engagement, and emotion-focused disengagement. Hazard ratios were estimated using Cox proportional hazard model for all-cause mortality and mean differences for change in health-related QOL in 1 year were estimated using a regression model. Results Among 1,354 patients, only problem-focused engagement was significantly associated with longer survival; other subscales were not associated with all-cause mortality after adjustment for potential confounding factors. In terms of health-related QOL, the subscale of problem-focused engagement was also associated with improvement in physical functioning and mental health among 1,045 patients. Emotion-focused disengagement was associated with deterioration in mental health, but not with change in physical functioning. The other subscales were not associated with change in physical functioning or mental health. Conclusions Among hemodialysis patients, "problem-focused engagement" coping strategies were associated with longer survival and also with improvement in physical functioning and mental health. To achieve greater longevity and improve QOL in hemodialysis patients under ongoing stresses, problem-focused engagement should be encouraged.	[Niihata, Kakuya] Fukushima Med Univ, Div Clin Epidemiol, Fukushima, Japan; [Niihata, Kakuya; Fukuma, Shingo; Fukuhara, Shunichi] Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence CIR, Fukushima, Japan; [Fukuma, Shingo; Fukuhara, Shunichi] Kyoto Univ Med, Sch Publ Hlth, Dept Healthcare & Epidemiol, Kyoto, Japan; [Fukuma, Shingo] Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan; [Akizawa, Tadao] Showa Univ, Div Nephrol, Dept Med, Sch Med, Tokyo, Japan	Fukushima Medical University; Fukushima Medical University; Kyoto University; Showa University	Fukuma, S (corresponding author), Fukushima Med Univ, Ctr Innovat Res Communities & Clin Excellence CIR, Fukushima, Japan.; Fukuma, S (corresponding author), Kyoto Univ Med, Sch Publ Hlth, Dept Healthcare & Epidemiol, Kyoto, Japan.; Fukuma, S (corresponding author), Inst Hlth Outcomes & Proc Evaluat Res iHope Int, Kyoto, Japan.	fukumashingo.3m@kyoto-u.ac.jp		Fukuma, Shingo/0000-0002-8379-8761	Kyowa Hakko Kirin	Kyowa Hakko Kirin(Kyowa Kirin Ltd)	This study was supported by Kyowa Hakko Kirin. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison Clifton C, 2007, Int J Environ Res Public Health, V4, P289, DOI 10.3390/ijerph200704040004; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; BOLGER N, 1990, J PERS SOC PSYCHOL, V59, P525, DOI 10.1037/0022-3514.59.3.525; CHRISTENSEN AJ, 1995, J CONSULT CLIN PSYCH, V63, P454, DOI 10.1037//0022-006X.63.3.454; Cukor D, 2014, J AM SOC NEPHROL, V25, P196, DOI 10.1681/ASN.2012111134; Dehkordi Leila Mardanian, 2013, Iran J Nurs Midwifery Res, V18, P42; Gillanders S, 2008, AM J KIDNEY DIS, V51, P651, DOI 10.1053/j.ajkd.2007.12.023; Graven LJ, 2013, HEART LUNG, V42, P183, DOI 10.1016/j.hrtlng.2012.12.002; GREER S, 1991, PSYCHOL MED, V21, P43, DOI 10.1017/S003329170001463X; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Iioka Y, 2015, JPN J NURS SCI, V12, P1, DOI 10.1111/jjns.12036; Ko B, 2007, NEPHROL DIAL TRANSPL, V22, P2985, DOI 10.1093/ndt/gfm341; Krageloh CU, 2011, RELIGIONS, V2, P216, DOI 10.3390/rel2030216; Krageloh CU, 2012, J RELIG HEALTH, V51, P1137, DOI 10.1007/s10943-010-9416-x; Kvillemo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112733; MacDonald DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117701; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Messerli-Burgy N, 2015, BRIT J PSYCHIAT, V207, P256, DOI 10.1192/bjp.bp.114.154419; Monti PM, 1997, ADDICTION, V92, P1717, DOI 10.1111/j.1360-0443.1997.tb02892.x; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; Pisoni RL, 2004, AM J KIDNEY DIS, V44, pS7, DOI 10.1053/j.ajkd.2004.08.005; Reynolds P, 2000, AM J EPIDEMIOL, V152, P940, DOI 10.1093/aje/152.10.940; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; TOBIN DL, 1989, COGNITIVE THER RES, V13, P343, DOI 10.1007/BF01173478; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wolf EJ, 2009, HEALTH PSYCHOL, V28, P330, DOI 10.1037/a0013583; Yalcin BM, 2014, J AM BOARD FAM MED, V27, P645, DOI 10.3122/jabfm.2014.05.140083; Yeh SCJ, 2007, PSYCHOSOM MED, V69, P182, DOI 10.1097/PSY.0b013e318031cdcc; Young EW, 2000, KIDNEY INT, V57, pS74, DOI 10.1046/j.1523-1755.2000.07413.x	29	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180498	10.1371/journal.pone.0180498	http://dx.doi.org/10.1371/journal.pone.0180498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8DV	28742807	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000013
J	Han, S; Sung, KR; Park, J; Yoon, JY; Shin, JW				Han, Seungbong; Sung, Kyung Rim; Park, Jimin; Yoon, Joo Young; Shin, Joong Won			Sub-classification of myopic glaucomatous eyes according to optic disc and peripapillary features	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; NORMAL-TENSION GLAUCOMA; LAMINA-CRIBROSA; RISK-FACTORS; BEIJING EYE; POPULATION; PREVALENCE; MICROSTRUCTURE; ATROPHY	Purpose To investigate the sub-classification of myopic glaucomatous eyes by optic disc and peripapillary features. Methods Optic disc tilt and torsion were determined from retinal nerve fiber layer photographs. Based on the location of the Bruch's membrane (BM) opening within the beta-zone of the peripapillary atrophy (PPA) area, the widths of beta-zone PPA (PPA1W), PPA(+BM) (PPA2W), and PPA(-BM) (PPA3W) were measured with enhanced depth imaging spectral-domain optical coherence tomography. Cluster analysis that employed partitioning around medoids was performed with these parameters, the presence of inward rotation of BM ending axial length (AXL), and central corneal thickness. Results A total of 115 eyes (AXL >= 24 mm) were included. Two clusters produced maximum overall silhouette widths (average = 0.43). Visual field (VF) mean deviation was not different between cluster 1 (52 eyes; -4.02 +/- 3.01 dB) and cluster 2 (63 eyes; -5.21 +/- 5.62 dB; p = 0.174). In cluster 1 compared to cluster 2, optic disc tilt was significantly greater, PPA1W and PPA3W were longer, and AXL was longer (all p<0.001). The presence of an inward rotation of BM ending was more frequent in cluster 2 (p = 0.043). Forty-one eyes (78.8%) in cluster 1 had superior VF defects while 10 eyes (19.2%) had inferior defects, and only one eye (2%) had defects in both hemifields. Eyes in cluster 2 were more evenly distributed: 55.6% had superior defects, 34.9% had inferior defects, and 9.5% had defects in both hemifields (p = 0.023). Conclusions Myopic glaucomatous eyes characterized by optic disc and peripapillary configurations can be classified as two distinct types, and the most distinct difference between the two was degree of optic disc tilt and width of PPA. The location of VF defects were also significantly different between two clusters.	[Han, Seungbong] Gachon Univ, Dept Appl Stat, Seongnam Si, South Korea; [Sung, Kyung Rim; Shin, Joong Won] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Jimin; Yoon, Joo Young] Univ Ulsan, Coll Med, Seoul, South Korea	Gachon University; University of Ulsan; Asan Medical Center; University of Ulsan	Sung, KR (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Ophthalmol, Seoul, South Korea.	sungeye@gmail.com			Student Research Grant of University of Ulsan College of Medicine, Seoul, Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [NRF-2014R1A1A3A04051089]	Student Research Grant of University of Ulsan College of Medicine, Seoul, Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Student Research Grant (2016) of University of Ulsan College of Medicine, Seoul, Korea, and the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science, and Technology (no. NRF-2014R1A1A3A04051089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Chon B, 2013, INVEST OPHTH VIS SCI, V54, P6570, DOI 10.1167/iovs.13-12173; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Kim S, 2013, OPHTHALMOLOGY, V120, P1798, DOI 10.1016/j.ophtha.2013.02.015; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Kim YW, 2014, OPHTHALMOLOGY, V121, P1341, DOI 10.1016/j.ophtha.2014.01.008; Kwon J, 2017, BR J OPHTHALMOL; Lee JE, 2017, GRAEF ARCH CLIN EXP, V255, P591, DOI 10.1007/s00417-016-3542-4; Lee JE, 2015, INVEST OPHTH VIS SCI, V56, P6925, DOI 10.1167/iovs.15-17892; Liang YB, 2011, INVEST OPHTH VIS SCI, V52, P8250, DOI 10.1167/iovs.11-7472; Maechler M., CLUSTER ANAL BASICS; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P156, DOI 10.1167/iovs.13-12327; PHELPS CD, 1982, AM J OPHTHALMOL, V93, P622, DOI 10.1016/S0002-9394(14)77378-7; Reynolds A., 1992, J MATH MODEL ALGORIT, V5, P475, DOI DOI 10.1007/S10852-005-9022-1; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sung KR, 2011, INVEST OPHTH VIS SCI, V52, P737, DOI 10.1167/iovs.10-5351; Sung MS, 2016, OPHTHALMOLOGY; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Vongphanit J, 2002, AM J OPHTHALMOL, V133, P679, DOI 10.1016/S0002-9394(02)01339-9; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; WILSON MR, 1987, ARCH OPHTHALMOL-CHIC, V105, P1066; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Yamada H, 2016, OPHTHALMOLOGY, V123, P542, DOI 10.1016/j.ophtha.2015.10.061; Yun SC, 2015, GRAEF ARCH CLIN EXP, V253, P2247, DOI 10.1007/s00417-015-3131-y	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181841	10.1371/journal.pone.0181841	http://dx.doi.org/10.1371/journal.pone.0181841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742160	Green Submitted, gold, Green Published			2022-12-26	WOS:000406362700077
J	Pinho, CPS; Diniz, AD; de Arruda, IKG; Leite, APDL; Petribu, MDMV; Rodrigues, IG				Sabino Pinho, Claudia Porto; Diniz, Alcides da Silva; Grande de Arruda, Ilma Kruze; Dornelas Leao Leite, Ana Paula; Vasconcelos Petribu, Marina de Moraes; Rodrigues, Ise Galvao			Predictive models for estimating visceral fat: The contribution from anthropometric parameters	PLOS ONE			English	Article							ABDOMINAL-ADIPOSE-TISSUE; WAIST CIRCUMFERENCE; CARDIOMETABOLIC RISK; COMPUTED-TOMOGRAPHY; NECK CIRCUMFERENCE; OBESITY; ACCUMULATION; AREA; POPULATION; INDICATOR	Background Excessive adipose visceral tissue (AVT) represents an independent risk factor for cardiometabolic alterations. The search continues for a highly valid marker for estimating visceral adiposity that is a simple and low cost tool able to screen individuals who are highly at risk of being viscerally obese. The aim of this study was to develop a predictive model for estimating AVT volume using anthropometric parameters. Objective Excessive adipose visceral tissue (AVT) represents an independent risk factor for cardiometabolic alterations. The search continues for a highly valid marker for estimating visceral adiposity that is a simple and low cost tool able to screen individuals who are highly at risk of being viscerally obese. The aim of this study was to develop a predictive model for estimating AVT volume using anthropometric parameters. Methods A cross-sectional study involving overweight individuals whose AVT was evaluated (using computed tomography-CT), along with the following anthropometric parameters: body mass index (BMI), abdominal circumference (AC), waist-to-hip ratio (WHpR), waist-to-height ratio (WHtR), sagittal diameter (SD), conicity index (CI), neck circumference (NC), neck-to-thigh ratio (NTR), waist-to-thigh ratio (WTR), and body adiposity index (BAI). Results 109 individuals with an average age of 50.3 +/- 12.2 were evaluated. The predictive equation developed to estimate AVT in men was AVT = -1647.75 +2.43(AC) +594.74(WHpR) +883.40(CI) (R-2 adjusted: 64.1%). For women, the model chosen was: AVT = -634.73 +1.49(Age) +8.34(SD) + 2 91.51(CI) + 6.92(NC) (R-2 adjusted: 40.4%). The predictive ability of the equations developed in relation to AVT volume determined by CT was 66.9% and 46.2% for males and females, respectively (p < 0.001). Conclusions A quick and precise AVT estimate, especially for men, can be obtained using only AC, WHpR, and CI for men, and age, SD, CI, and NC for women. These equations can be used as a clinical and epidemiological tool for overweight individuals.	[Sabino Pinho, Claudia Porto; Dornelas Leao Leite, Ana Paula; Rodrigues, Ise Galvao] Pronto Socorro Univ Cardiol Pernambuco PROCAPE UP, Recife, PE, Brazil; [Sabino Pinho, Claudia Porto; Diniz, Alcides da Silva; Grande de Arruda, Ilma Kruze; Vasconcelos Petribu, Marina de Moraes] Univ Fed Pernambuco UFPE, Recife, PE, Brazil	Universidade Federal de Pernambuco	Pinho, CPS (corresponding author), Pronto Socorro Univ Cardiol Pernambuco PROCAPE UP, Recife, PE, Brazil.; Pinho, CPS (corresponding author), Univ Fed Pernambuco UFPE, Recife, PE, Brazil.	claudiasabinopinho@hotmail.com						Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ben-Noun Liubov Louba, 2006, Exp Clin Cardiol, V11, P14; Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brundavani V, 2006, EUR J CLIN NUTR, V60, P658, DOI 10.1038/sj.ejcn.1602366; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Cervi Adriane, 2005, Rev. Nutr., V18, P765, DOI 10.1590/S1415-52732005000600007; Chen CH, 2014, INTERNATIONAL CONFERENCE ON E-COMMERCE AND CONTEMPORARY ECONOMIC DEVELOPMENT (ECED 2014), P1, DOI 10.1155/2014/925370; Chuang YC, 2006, ANN EPIDEMIOL, V16, P321, DOI 10.1016/j.annepidem.2005.04.014; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Demura S, 2007, J SPORT SCI, V25, P823, DOI 10.1080/02640410600875010; Goel K, 2008, OBESITY, V16, P451, DOI 10.1038/oby.2007.55; Iribarren C, 2006, AM J EPIDEMIOL, V164, P1150, DOI 10.1093/aje/kwj341; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Vasques ACJ, 2010, REV NUTR, V23, P107, DOI 10.1590/S1415-52732010000100012; Kahn HS, 1996, J CLIN EPIDEMIOL, V49, P1017, DOI 10.1016/0895-4356(96)00113-8; Kim JA, 2006, J KOREAN MED SCI, V21, P1048, DOI 10.3346/jkms.2006.21.6.1048; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Liu Da-Feng, 2006, Sichuan Da Xue Xue Bao Yi Xue Ban, V37, P943; Lohman T. G., 1998, ANTROPOMETRIC STANDA; MEYERS R., 1990, CLASSICAL MODERN REG; Nagai M, 2008, J ATHEROSCLER THROMB, V15, P193, DOI 10.5551/jat.E566; Oliveira Carolina Cunha de, 2014, Rev. bras. cineantropom. desempenho hum., V16, P485, DOI 10.5007/1980-0037.2014v16n5p485; Onat A, 2004, INT J OBESITY, V28, P1018, DOI 10.1038/sj.ijo.0802695; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779; Ran Xingwu, 2003, Sichuan Da Xue Xue Bao Yi Xue Ban, V34, P519; Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929; Rockall AG, 2003, EUR J ENDOCRINOL, V149, P561, DOI 10.1530/eje.0.1490561; Roriz AKC, 2014, PLOS ONE, V9; Ross R, 2003, ACTA DIABETOL, V40, pS45, DOI 10.1007/s00592-003-0025-y; Sampaio LR, 2007, ARQ BRAS ENDOCRINOL, V51, P980, DOI 10.1590/S0004-27302007000600013; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; VALDEZ R, 1991, J CLIN EPIDEMIOL, V44, P955, DOI 10.1016/0895-4356(91)90059-I; *WHO, 1998, REP WHO CONS OB GEN; World Health Organisation (WHO), 2000, TECHNICAL REPORT SER; Yang L, 2010, CLIN ENDOCRINOL, V73, P197, DOI 10.1111/j.1365-2265.2009.03772.x; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	38	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0178958	10.1371/journal.pone.0178958	http://dx.doi.org/10.1371/journal.pone.0178958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742086	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700004
J	Filliat, G; Mirsaidi, A; Tiaden, AN; Kuhn, GA; Weber, FE; Oka, C; Richards, PJ				Filliat, Gladys; Mirsaidi, Ali; Tiaden, Andre N.; Kuhn, Gisela A.; Weber, Franz E.; Oka, Chio; Richards, Peter J.			Role of HTRA1 in bone formation and regeneration: In vitro and in vivo evaluation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SERINE-PROTEASE HTRA1; SMALL-VESSEL DISEASE; FRACTURE REPAIR; OSTEOGENIC DIFFERENTIATION; MACULAR DEGENERATION; UP-REGULATION; A1 HTRA1; MARROW; REQUIREMENT	The role of mammalian high temperature requirement protease A1 (HTRA1) in somatic stem cell differentiation and mineralized matrix formation remains controversial, having been demonstrated to impart either anti- or pro-osteogenic effects, depending on the in vitro cell model used. The aim of this study was therefore to further evaluate the role of HTRA1 in regulating the differentiation potential and lineage commitment of murine mesenchymal stem cells in vitro, and to assess its influence on bone structure and regeneration in vivo. Our results demonstrated that short hairpin RNA-mediated ablation of Htra1 in the murine mesenchymal cell line C3H10T1/2 increased the expression of several osteogenic gene markers, and significantly enhanced matrix mineralization in response to BMP-2 stimulation. These effects were concomitant with decreases in the expression of chondrogenic gene markers, and increases in adipogenic gene expression and lipid accrual. Despite the profound effects of loss-of-function of HTRA1 on this in vitro osteochondral model, these were not reproduced in vivo, where bone microarchitecture and regeneration in 16-week-old Htra1-knockout mice remained unaltered as compared to wild-type controls. By comparison, analysis of femurs from 52-week-old mice revealed that bone structure was better preserved in Htra1-knockout mice than age-matched wildtype controls. These findings therefore provide additional insights into the role played by HTRA1 in regulating mesenchymal stem cell differentiation, and offer opportunities for improving our understanding of how this multifunctional protease may act to influence bone quality.	[Filliat, Gladys; Mirsaidi, Ali; Tiaden, Andre N.; Richards, Peter J.] Univ Zurich, CABMM, Bone & Stem Cell Res Grp, Zurich, Switzerland; [Filliat, Gladys; Weber, Franz E.; Richards, Peter J.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Kuhn, Gisela A.] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Weber, Franz E.] Univ Zurich, Ctr Dent Med, Oral Biotechnol & Bioengn, Zurich, Switzerland; [Oka, Chio] Nara Inst Sci & Technol, Div Gene Funct Anim, Nara, Japan	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Nara Institute of Science & Technology	Richards, PJ (corresponding author), Univ Zurich, CABMM, Bone & Stem Cell Res Grp, Zurich, Switzerland.; Richards, PJ (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	peter.richards@cabmm.uzh.ch	Weber, Franz E./I-7831-2019	Weber, Franz E./0000-0003-1670-2296	Swiss National Science Foundation [31003A_156313]; Swiss Life; Foundation for Research in Science and Humanities at the University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Life; Foundation for Research in Science and Humanities at the University of Zurich	This study was supported by grants from the Swiss National Science Foundation (31003A_156313), Swiss Life, and the Foundation for Research in Science and Humanities at the University of Zurich.	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Altobelli E, 2015, ONCOL REP, V34, P555, DOI 10.3892/or.2015.4016; Beaufort N, 2014, P NATL ACAD SCI USA, V111, P16496, DOI 10.1073/pnas.1418087111; Beederman Maureen, 2013, J Biomed Sci Eng, V6, P32; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Egermann M, 2010, J ORTHOP RES, V28, P798, DOI 10.1002/jor.21041; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2; Ford JL, 2003, J ORTHOP RES, V21, P54, DOI 10.1016/S0736-0266(02)00087-6; Glanz S, 2016, STEM CELLS DEV, V25, P687, DOI 10.1089/scd.2015.0368; Glaza P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131142; Graham JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063884; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Grongroft I, 2009, J BIOMECH, V42, P2089, DOI 10.1016/j.jbiomech.2009.06.004; Hadfield KD, 2008, J BIOL CHEM, V283, P5928, DOI 10.1074/jbc.M709299200; Hadjiargyrou M, 2014, J BONE MINER RES, V29, P2307, DOI 10.1002/jbmr.2373; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; Hasan MZ, 2015, DEV BIOL, V397, P89, DOI 10.1016/j.ydbio.2014.10.015; Howie RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167805; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Kim GY, 2012, MOL CELL BIOL, V32, P4482, DOI 10.1128/MCB.00872-12; Kohler T, 2007, BONE, V41, P659, DOI 10.1016/j.bone.2007.05.018; Launay S, 2008, CELL DEATH DIFFER, V15, P1408, DOI 10.1038/cdd.2008.82; Lee MJ, 2013, J CELL MOL MED, V17, P1188, DOI 10.1111/jcmm.12098; Li R, 2015, J MOL HISTOL, V46, P137, DOI 10.1007/s10735-015-9612-9; Mendioroz M, 2010, NEUROLOGY, V75, P2033, DOI 10.1212/WNL.0b013e3181ff96ac; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Pei XT, 2015, GRAEF ARCH CLIN EXP, V253, P565, DOI 10.1007/s00417-014-2901-2; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; Scharrer E., 2015, THESIS; Schmidt N, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2425-8; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Shiga A, 2011, HUM MOL GENET, V20, P1800, DOI 10.1093/hmg/ddr063; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Supanji, 2013, EXP EYE RES, V112, P79, DOI 10.1016/j.exer.2013.04.013; Tennstaedt A, 2012, J BIOL CHEM, V287, P20931, DOI 10.1074/jbc.M111.316232; Teoh SSY, 2015, PLACENTA, V36, P990, DOI 10.1016/j.placenta.2015.07.001; Tiaden AN, 2016, STEM CELLS, V34, P1601, DOI 10.1002/stem.2297; Tiaden AN, 2012, STEM CELLS, V30, P2271, DOI 10.1002/stem.1190; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tiaden AN, 2013, AM J PATHOL, V182, P1482, DOI 10.1016/j.ajpath.2013.02.003; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Weber FE, 2002, INT J ORAL MAX SURG, V31, P60, DOI 10.1054/ijom.2001.0154; Wu XH, 2014, FEBS LETT, V588, P143, DOI 10.1016/j.febslet.2013.11.022; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zhang XY, 2004, J VIROL, V78, P1219, DOI 10.1128/JVI.78.3.1219-1229.2004	57	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181600	10.1371/journal.pone.0181600	http://dx.doi.org/10.1371/journal.pone.0181600			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732055	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000406643100048
J	Ozkan, M; Johnson, NW; Sehirli, US; Woodhall, GL; Stanford, IM				Ozkan, Mazhar; Johnson, Nicholas W.; Sehirli, Umit S.; Woodhall, Gavin L.; Stanford, Ian M.			Dopamine acting at D1-like, D2-like and alpha 1-adrenergic receptors differentially modulates theta and gamma oscillatory activity in primary motor cortex	PLOS ONE			English	Article							RAT PREFRONTAL CORTEX; HIPPOCAMPUS IN-VITRO; TRANSCRANIAL MAGNETIC STIMULATION; MEMBRANE-POTENTIAL OSCILLATIONS; LOCUS-CERULEUS ACTIVATION; FAST-SPIKING INTERNEURONS; DEEP-BRAIN-STIMULATION; PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; ADRENERGIC-RECEPTORS	The loss of dopamine (DA) in Parkinson's is accompanied by the emergence of exaggerated theta and beta frequency neuronal oscillatory activity in the primary motor cortex (M1) and basal ganglia. DA replacement therapy or deep brain stimulation reduces the power of these oscillations and this is coincident with an improvement in motor performance implying a causal relationship. Here we provide in vitro evidence for the differential modulation of theta and gamma activity in M1 by DA acting at receptors exhibiting conventional and nonconventional DA pharmacology. Recording local field potentials in deep layer V of rat M1, co- application of carbachol (CCh, 5 mu M) and kainic acid (KA, 150 nM) elicited simultaneous oscillations at a frequency of 6.49 +/- 0.18 Hz (theta, n = 84) and 34.97 +/- 0.39 Hz (gamma, n = 84). Bath application of DA resulted in a decrease in gamma power with no change in theta power. However, application of either the D1-like receptor agonist SKF38393 or the D2-like agonist quinpirole increased the power of both theta and gamma suggesting that the DA-mediated inhibition of oscillatory power is by action at other sites other than classical DA receptors. Application of amphetamine, which promotes endogenous amine neurotransmitter release, or the adrenergic alpha 1-selective agonist phenylephrine mimicked the action of DA and reduced gamma power, a result unaffected by prior co- application of D1 and D2 receptor antagonists SCH23390 and sulpiride. Finally, application of the alpha 1-adrenergic receptor antagonist prazosin blocked the action of DA on gamma power suggestive of interaction between alpha 1 and DA receptors. These results show that DA mediates complex actions acting at dopamine D1-like and D2-like receptors, a1 adrenergic receptors and possibly DA/alpha 1 heteromultimeric receptors to differentially modulate theta and gamma activity in M1.	[Ozkan, Mazhar; Johnson, Nicholas W.; Woodhall, Gavin L.; Stanford, Ian M.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Ozkan, Mazhar; Sehirli, Umit S.] Marmara Univ, Sch Med, Dept Anat, Istanbul, Turkey	Aston University; Marmara University	Stanford, IM (corresponding author), Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham, W Midlands, England.	I.M.Stanford@aston.ac.uk	OZKAN, Mazhar/A-6451-2012	OZKAN, Mazhar/0000-0002-8745-2493; Stanford, Ian M/0000-0002-5677-8538; SEHIRLI, UMIT SULEYMAN/0000-0001-6261-4567; woodhall, gavin/0000-0003-1281-9008; Johnson, Nicholas W./0000-0003-2898-9490	Scientific and Technological Research Council of Turkey (TUBITAK); Marmara University Scientific Research Committee [SAG-C-DRP-080415-0102]; Biotechnology and Biological Sciences Research Council [1220729] Funding Source: researchfish	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Marmara University Scientific Research Committee(Marmara University); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Mazhar Ozkan was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) and Marmara University Scientific Research Committee (SAG-C-DRP-080415-0102). Nicholas Johnson was a BBSRC CASE student (with Lily U.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERRIDGE CW, 1991, J NEUROSCI, V11, P3135; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; Bland BH, 2002, J NEUROPHYSIOL, V88, P3046, DOI 10.1152/jn.00315.2002; BLAND BH, 1988, BRAIN RES, V447, P364, DOI 10.1016/0006-8993(88)91141-9; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Brown RAM, 2005, J NEUROSCI, V25, P1985, DOI 10.1523/JNEUROSCI.4307-04.2005; Cilz NI, 2014, CEREB CORTEX, V24, P3195, DOI 10.1093/cercor/bht177; Cornil CA, 2002, J NEUROSCI, V22, P9320; DAWSON TM, 1986, J NEUROSCI, V6, P2352; DESCARRIES L, 1987, NEUROSCIENCE, V21, P807, DOI 10.1016/0306-4522(87)90038-8; DOZE VA, 1991, NEURON, V6, P889, DOI 10.1016/0896-6273(91)90229-S; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; GASPAR P, 1991, ANN NEUROL, V30, P365, DOI 10.1002/ana.410300308; GASPAR P, 1995, EUR J NEUROSCI, V7, P1050, DOI 10.1111/j.1460-9568.1995.tb01092.x; Gee S, 2012, J NEUROSCI, V32, P4959, DOI 10.1523/JNEUROSCI.5835-11.2012; Gonzalez S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001347; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Haggerty DC, 2013, NEUROSCIENCE, V253, P142, DOI 10.1016/j.neuroscience.2013.08.028; Hall SD, 2014, NEUROSCIENCE, V281, P68, DOI 10.1016/j.neuroscience.2014.09.037; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Harsing LG, 1997, NEUROSCIENCE, V77, P419, DOI 10.1016/S0306-4522(96)00475-7; HASTINGS TG, 1994, J NEUROCHEM, V63, P1126; Hastings TG, 1996, P NATL ACAD SCI USA, V93, P1956, DOI 10.1073/pnas.93.5.1956; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hosp JA, 2009, NEUROSCIENCE, V159, P692, DOI 10.1016/j.neuroscience.2008.12.056; Khedr EM, 2003, EUR J NEUROL, V10, P567, DOI 10.1046/j.1468-1331.2003.00649.x; KONOPACKI J, 1993, NEUROREPORT, V4, P963, DOI 10.1097/00001756-199307000-00032; Kuhn AA, 2006, EUR J NEUROSCI, V23, P1956, DOI 10.1111/j.1460-9568.2006.04717.x; Lacey MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085109; LEEDHAM JA, 1986, J AUTON PHARMACOL, V6, P39, DOI 10.1111/j.1474-8673.1986.tb00629.x; Lefaucheur JP, 2004, CLIN NEUROPHYSIOL, V115, P2530, DOI 10.1016/j.clinph.2004.05.025; LeMoine C, 1998, MOL BRAIN RES, V58, P231, DOI 10.1016/S0169-328X(98)00118-1; LEUNG LWS, 1991, BRAIN RES, V553, P261, DOI 10.1016/0006-8993(91)90834-I; Levy R, 2000, J NEUROSCI, V20, P7766; Li S, 2007, J NEUROPHYSIOL, V98, P3525, DOI 10.1152/jn.00808.2007; Lin Y, 2008, SYNAPSE, V62, P516, DOI 10.1002/syn.20517; MADISON DV, 1986, J PHYSIOL-LONDON, V372, P221, DOI 10.1113/jphysiol.1986.sp016006; MADISON DV, 1988, BRAIN RES, V442, P131, DOI 10.1016/0006-8993(88)91440-0; Mallet N, 2008, J NEUROSCI, V28, P14245, DOI 10.1523/JNEUROSCI.4199-08.2008; MANDEL RJ, 1994, BRAIN RES, V653, P57, DOI 10.1016/0006-8993(94)90372-7; Mitrano DA, 2014, NEUROSCIENCE, V258, P90, DOI 10.1016/j.neuroscience.2013.11.002; Muly EC, 1998, J NEUROSCI, V18, P10553; Pagni C A, 2003, J Neurosurg Sci, V47, P189; Pedarzani P, 1996, J PHARMACOL EXP THER, V8, P209; Pollok B, 2012, J PHYSIOL-LONDON, V590, P3203, DOI 10.1113/jphysiol.2012.231316; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Prokic EJ, 2015, NEUROPHARMACOLOGY, V95, P192, DOI 10.1016/j.neuropharm.2015.03.006; Raghanti MA, 2008, NEUROSCIENCE, V155, P203, DOI 10.1016/j.neuroscience.2008.05.008; RAITERI M, 1975, EUR J PHARMACOL, V34, P189, DOI 10.1016/0014-2999(75)90239-3; Rashid AJ, 2007, TRENDS PHARMACOL SCI, V28, P551, DOI 10.1016/j.tips.2007.10.001; Rebois RV, 2012, CELL SIGNAL, V24, P2051, DOI 10.1016/j.cellsig.2012.06.011; Ronnqvist KC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00132; Santana N, 2009, CEREB CORTEX, V19, P849, DOI 10.1093/cercor/bhn134; SCANZIANI M, 1993, J NEUROSCI, V13, P5393, DOI 10.1523/JNEUROSCI.13-12-05393.1993; SESACK SR, 1989, J PHARMACOL EXP THER, V248, P1323; Sesack SR, 1998, CEREB CORTEX, V8, P614, DOI 10.1093/cercor/8.7.614; Siebner HR, 2000, J NEUROL SCI, V178, P91, DOI 10.1016/S0022-510X(00)00370-1; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Traub RD, 2003, P NATL ACAD SCI USA, V100, P11047, DOI 10.1073/pnas.1934854100; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Vitrac C, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00013; Walling SG, 2011, HIPPOCAMPUS, V21, P1250, DOI 10.1002/hipo.20816; Weiss T, 2003, EUR J NEUROSCI, V18, P2573, DOI 10.1046/j.1460-9568.2003.02970.x; WHISHAW IQ, 1978, EXP NEUROL, V62, P748, DOI 10.1016/0014-4886(78)90282-0; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Whittington MA, 1997, J PHYSIOL-LONDON, V502, P591, DOI 10.1111/j.1469-7793.1997.591bj.x; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Wojtowicz AM, 2009, HIPPOCAMPUS, V19, P273, DOI 10.1002/hipo.20508; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021; Yang CR, 1996, J NEUROSCI, V16, P1922; Yang N, 2014, NEUROSCI LETT, V559, P61, DOI 10.1016/j.neulet.2013.11.037; Zhang WP, 2004, NEUROPHARMACOLOGY, V47, P438, DOI 10.1016/j.neuropharm.2004.04.017	84	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181633	10.1371/journal.pone.0181633	http://dx.doi.org/10.1371/journal.pone.0181633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732063	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000406643100051
J	Liu, PL; Liu, WL; Chang, JM; Chen, YH; Liu, YP; Kuo, HF; Hsieh, CC; Ding, YS; Chen, WW; Chong, IW				Liu, Po-Len; Liu, Wei-Lun; Chang, Jia-Ming; Chen, Yung-Hsiang; Liu, Yu-Peng; Kuo, Hsuan-Fu; Hsieh, Chong-Chao; Ding, Yu-Sian; Chen, Wei-Wei; Chong, Inn-Wen			MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1	PLOS ONE			English	Article							TUMOR-CELL INVASIVENESS; GROUP BOX PROTEIN-1; ACTIN CYTOSKELETON; GASTRIC-CANCER; EXPRESSION; PROGRESSION; MIR-200C; METASTASIS; RESISTANCE; ZEB2	MicroRNAs (miRs) play critical roles in cancer development, proliferation, epithelial-mesenchymal transition (EMT), invasion, and migration through regulating the expression of onco-genes and tumour suppressor genes. Previous studies have indicated that miR-200c acts as a tumour suppressor in various cancers by downregulating high-mobility group box 1 (HMGB1) and thereby suppressing EMT and metastasis. In addition, miR-200c was reported to be downregulated and correlated with poor outcomes in non-small cell lung cancer (NSCLC). However, its functional role in HMGB1 regulation in NSCLC is still unclear. This study aimed to clarify whether miR-200c acts as a tumour suppressor in NSCLC by downregulating HMGB1, which is associated with EMT, invasion, cytoskeleton rearrangement, and migration in vitro and in vivo. In order to demonstrate HMGB1 downregulation by miR-200c, the NSCLC cell line A549 was transfected with miR-200c mimic or inhibitor. The mimic significantly reduced HMGB1 expression and suppressed EMT, invasion, and migration, while the inhibitor generated the opposite effects. Additionally, using xenograft mouse models, we confirmed that HMGB1 overexpression increased tumour EMT. In summary, our results demonstrated that miR-200c could suppress EMT, invasion, and migration of NSCLC cells by downregulating HMGB1.	[Liu, Po-Len; Chong, Inn-Wen] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan; [Liu, Wei-Lun] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Liu, Wei-Lun] Fu Jen Catholic Univ, Coll Med, Sch Med, New Taipei, Taiwan; [Chang, Jia-Ming; Ding, Yu-Sian; Chen, Wei-Wei] Natl Res Project Biopharmaceut, Preclin Anim Pharmacol Testing Ctr, New Taipei, Taiwan; [Chang, Jia-Ming; Ding, Yu-Sian; Chen, Wei-Wei] Dev Ctr Biotechnol, Inst Drug Evaluat Platform, Dept Pharmacol, New Taipei, Taiwan; [Chen, Yung-Hsiang] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Chen, Yung-Hsiang] Asia Univ, Coll Med & Hlth Sci, Dept Psychol, Taichung, Taiwan; [Liu, Yu-Peng] Kaohsiung Med Univ, Dept Genome Med, Kaohsiung, Taiwan; [Kuo, Hsuan-Fu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsieh, Chong-Chao] Kaohsiung Med Univ Hosp, Dept Surg, Div Cardiovasc Surg, Kaohsiung, Taiwan; [Chong, Inn-Wen] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Chi Mei Hospital; Fu Jen Catholic University; China Medical University Taiwan; Asia University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chong, IW (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung, Taiwan.; Chong, IW (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.	chong@kmu.edu.tw	Chen, Yung-Hsiang/K-6766-2015; Chang, Jia-Ming/P-4010-2019; Kuo, Hsuan-Fu/GVS-2875-2022	Chen, Yung-Hsiang/0000-0002-8756-5113; 	Taiwan Ministry of Science and Technology [MOST 104-2314-6-037-087, MOST 104-2314-6-037-071-MY2, MOST 101-2314-B-037-065-MY2, MOST 102-2314-B-037-067, MOST 103-2314-6-037-051]; Chi Mei Medical Center, Liouying [CLEHR10423]; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation [103CM-KMU-08]; Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan	Taiwan Ministry of Science and Technology; Chi Mei Medical Center, Liouying; Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation; Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan	This study was supported in part by grants from the Taiwan Ministry of Science and Technology (MOST 104-2314-6-037-087, MOST 104-2314-6-037-071-MY2, MOST 101-2314-B-037-065-MY2, MOST 102-2314-B-037-067, and MOST 103-2314-6-037-051), the Chi Mei Medical Center, Liouying (CLEHR10423), and the Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation (103CM-KMU-08). The animal study was supported by grants from the Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the anonymous reviewers for their constructive helpful comments that contributed to improving the final version of the paper. We would also like to thank the Editor for his generous comments and support during the review process. The animal study was supported by grants from the Core Service Platform Project for Animal Pharmacology, National Research Program, Ministry of Science and Technology, Taiwan. We thank the Center for Research Resources and Development of Kaohsiung Medical University for confocal microscopy support.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Ananthula S, 2016, ONCOTARGET, V7, P20869, DOI 10.18632/oncotarget.8029; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Bryant JL, 2012, BRIT J CANCER, V106, P148, DOI 10.1038/bjc.2011.465; Chang BP, 2014, J HUAZHONG U SCI-MED, V34, P201, DOI 10.1007/s11596-014-1259-3; Chang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10979; Chen Y., 2016, SCI REP, P6; Chevalier SA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003917; Chung HW, 2015, INT J CANCER, V137, P1598, DOI 10.1002/ijc.29539; Feng AL, 2016, ONCOTARGET, V7, P20507, DOI 10.18632/oncotarget.7050; Feng B, 2012, BIOMED PHARMACOTHER, V66, P397, DOI 10.1016/j.biopha.2012.06.002; Gonzalez-Arriaga P, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-378; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Hashida S, 2015, CANCER SCI, V106, P1377, DOI 10.1111/cas.12749; He J, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0378-z; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Jiao AH, 2016, MOL MED REP, V13, P3349, DOI 10.3892/mmr.2016.4901; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Khurana S, 2011, CELL ADHES MIGR, V5, P409, DOI 10.4161/cam.5.5.17644; Kumar S, 2015, CURR DRUG TARGETS, V16, P1381, DOI 10.2174/1389450116666150325231419; Kuo HF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156059; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li Y, 2014, NEOPLASMA, V61, P579, DOI 10.4149/neo_2014_070; Liu PL, 2005, AM J PHYSIOL-LUNG C, V289, pL739, DOI 10.1152/ajplung.00099.2005; Liu PL, 2010, AM J RESP CELL MOL, V43, P530, DOI 10.1165/rcmb.2009-0269OC; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; Liu ZK, 2016, ONCOTARGET, V7, P36909, DOI 10.18632/oncotarget.9377; Lu Y., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/162517; Lynch J, 2010, AM J NEPHROL, V32, P590, DOI 10.1159/000320485; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mitselou A, 2016, ANTICANCER RES, V36, P2271; Mutlu M, 2016, J MOL MED, V94, P629, DOI 10.1007/s00109-016-1420-5; Osugi J, 2016, J CANCER RES THER, V12, P945, DOI 10.4103/0973-1482.176168; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perdigao-Henriques R, 2016, ONCOGENE, V35, P158, DOI 10.1038/onc.2015.69; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; SALGADO J, 1993, BIOCHIM BIOPHYS ACTA, V1145, P284, DOI 10.1016/0005-2736(93)90301-F; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Shan WL, 2016, GENE, V593, P265, DOI 10.1016/j.gene.2016.07.038; Sohun M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.05.36; Tsai JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144462; Wang XB, 2015, INT J MOL SCI, V16, P22527, DOI 10.3390/ijms160922527; Wu TY, 2016, ONCOTARGET, V7, P50417, DOI 10.18632/oncotarget.10413; Xu YF, 2015, WORLD J GASTROENTERO, V21, P3256, DOI 10.3748/wjg.v21.i11.3256; Zhang JY, 2016, MOL CLIN ONCOL, V4, P933, DOI 10.3892/mco.2016.842; Zhao HG, 2015, INT J CLIN EXP PATHO, V8, P15582; Zhou XL, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0428-3; Zhu LY, 2015, CANCER LETT, V357, P527, DOI 10.1016/j.canlet.2014.12.012	50	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180844	10.1371/journal.pone.0180844	http://dx.doi.org/10.1371/journal.pone.0180844			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727734	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500031
J	Postnikov, AV; Uvarov, IV; Lokhanin, MV; Svetovoy, VB				Postnikov, Alexander V.; Uvarov, Ilia V.; Lokhanin, Mikhail V.; Svetovoy, Vitaly B.			Electrically controlled cloud of bulk nanobubbles in water solutions	PLOS ONE			English	Article							HYDROGEN NANOBUBBLES; GENERATION; COMBUSTION; BUBBLES	Using different experimental techniques we visualize a cloud of gas in water that is produced electrochemically by the alternating polarity process. Liquid enriched with gas does not contain bubbles strongly scattering visible light but its refractive index changes significantly near the electrodes. The change of the refractive index is a collective effect of bulk nanobubbles with a diameter smaller than 200 nm. Any alternative explanation fails to explain the magnitude of the effect. Spatial structure of the cloud is investigated with the optical lever method. Its dynamics is visualised observing optical distortion of the electrode images or using differential interference contrast method. The cloud covers concentric electrodes, in a steady state it is roughly hemispherical with a size two times larger than the size of the electrode structure. When the electrical pulses are switched off the cloud disappears in less than one second. The total concentration of gases can reach very high value estimated as 3.5 x 10(20) cm(-3) that corresponds to an effective supersaturation of 500 and 150 for hydrogen and oxygen, respectively.	[Postnikov, Alexander V.; Uvarov, Ilia V.; Svetovoy, Vitaly B.] Russian Acad Sci, Inst Phys & Technol, Yaroslavl Branch, Yaroslavl, Russia; [Lokhanin, Mikhail V.] PG Demidov Yaroslavl State Univ, Dept Phys, Yaroslavl, Russia; [Svetovoy, Vitaly B.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands	Russian Academy of Sciences; Yaroslavl State University; University of Groningen	Svetovoy, VB (corresponding author), Russian Acad Sci, Inst Phys & Technol, Yaroslavl Branch, Yaroslavl, Russia.; Svetovoy, VB (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands.	v.b.svetovoy@rug.nl	Svetovoy, Vitaly/F-8654-2011; Uvarov, Ilia V/B-6394-2015; Institute, Zernike/W-7033-2019	Svetovoy, Vitaly/0000-0002-9649-5663; Uvarov, Ilia V/0000-0002-6882-0625; 	Russian Science Foundation [15-19-20003]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by Russian Science Foundation, grant 15-19-20003, VBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Alheshibri M, 2016, LANGMUIR, V32, P11086, DOI 10.1021/acs.langmuir.6b02489; ASPNES DE, 1982, THIN SOLID FILMS, V89, P249, DOI 10.1016/0040-6090(82)90590-9; Azevedo A, 2016, MINER ENG, V94, P29, DOI 10.1016/j.mineng.2016.05.001; Bunkin NF, 2012, J CHEM PHYS, V137; Kikuchi K, 2001, J ELECTROANAL CHEM, V506, P22, DOI 10.1016/S0022-0728(01)00517-4; Kikuchi K, 2007, J ELECTROANAL CHEM, V600, P303, DOI 10.1016/j.jelechem.2006.10.005; Kikuchi K, 2006, ELECTROCHIM ACTA, V52, P904, DOI 10.1016/j.electacta.2006.06.026; Kikuchi K, 2006, J COLLOID INTERF SCI, V298, P914, DOI 10.1016/j.jcis.2006.01.010; Kikuchi K, 2009, J COLLOID INTERF SCI, V329, P306, DOI 10.1016/j.jcis.2008.10.009; Li P, 2009, CHEMOSPHERE, V77, P1157, DOI 10.1016/j.chemosphere.2009.07.062; Liu GM, 2008, J PHYS CHEM C, V112, P16748, DOI 10.1021/jp805143c; Liu GM, 2009, ACS APPL MATER INTER, V1, P481, DOI 10.1021/am800150p; Lohse D, 2015, REV MOD PHYS, V87, P981, DOI 10.1103/RevModPhys.87.981; Mishchuk N, 2006, J COLLOID INTERF SCI, V301, P168, DOI 10.1016/j.jcis.2006.04.071; Modi KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103606; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Murphy D B, 2001, FUNDAMENTALS LIGHT M; Ohgaki K, 2010, CHEM ENG SCI, V65, P1296, DOI 10.1016/j.ces.2009.10.003; Pan G, 2016, LANGMUIR, V32, P11133, DOI 10.1021/acs.langmuir.6b01483; Postnikov AV, 2016, SCI REP-UK, V6, DOI 10.1038/srep39381; Postnikov AV, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4944780; Prokaznikov A, 2017, ENERGIES, V10, DOI 10.3390/en10020178; Seddon JRT, 2012, CHEMPHYSCHEM, V13, P2179, DOI 10.1002/cphc.201100900; Svetovoy V, 2016, ENERGIES, V9, DOI 10.3390/en9020094; Svetovoy VB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04296; Svetovoy VB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.035302; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Tasaki T, 2009, IND ENG CHEM RES, V48, P4237, DOI 10.1021/ie801279b; Thormaehlen I, 1985, J PHYS CHEM REF DATA, V14; Urrejola S, 2010, J CHEM ENG DATA, V55, P2924, DOI 10.1021/je9010129; Ushikubo FY, 2010, COLLOID SURFACE A, V361, P31, DOI 10.1016/j.colsurfa.2010.03.005; Van Gils S, 2004, SURF COAT TECH, V185, P303, DOI 10.1016/j.surfcoat.2004.01.021; Vogt H, 2005, ELECTROCHIM ACTA, V50, P2073, DOI 10.1016/j.electacta.2004.09.025; Wang YL, 2010, SOFT MATTER, V6, P29, DOI 10.1039/b917017k; Wang YL, 2009, LANGMUIR, V25, P9328, DOI 10.1021/la901186a; Wu ZH, 2008, J COLLOID INTERF SCI, V328, P10, DOI 10.1016/j.jcis.2008.08.064; Yurchenko SO, 2016, LANGMUIR, V32, P11245, DOI 10.1021/acs.langmuir.6b01644; Zhu J, 2016, LANGMUIR, V32, P11203, DOI 10.1021/acs.langmuir.6b01004	39	18	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181727	10.1371/journal.pone.0181727	http://dx.doi.org/10.1371/journal.pone.0181727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727812	Green Published, gold			2022-12-26	WOS:000406634500108
J	Takada, K; Okamoto, T; Tominaga, M; Teraishi, K; Akamine, T; Takamori, S; Katsura, M; Toyokawa, G; Shoji, F; Okamoto, M; Oda, Y; Hoshino, T; Maehara, Y				Takada, Kazuki; Okamoto, Tatsuro; Tominaga, Masaki; Teraishi, Koji; Akamine, Takaki; Takamori, Shinkichi; Katsura, Masakazu; Toyokawa, Gouji; Shoji, Fumihiro; Okamoto, Masaki; Oda, Yoshinao; Hoshino, Tomoaki; Maehara, Yoshihiko			Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression	PLOS ONE			English	Article							INTERLEUKIN-1 FAMILY; CANCER-IMMUNOTHERAPY; PROTEIN EXPRESSION; DOCETAXEL; CELLS; NIVOLUMAB; INSIGHTS	Interleukin (IL)-38, a novel member of the IL-1 cytokine family, is homologous to IL-1 receptor antagonist (IL-1Ra) and IL-36Ra, and has been reported to act as an antagonist. IL-38 expression is found in tonsil, placenta, and spleen, and recent studies suggest an association between IL-38 and autoimmune diseases. However, whether IL-38 plays a role in carcinogenesis or cancer growth is unclear. In the present study, we identified increases in IL-38 expression by immunohistochemistry in multiple types of cancer cells. In the examination of 417 surgically resected primary lung adenocarcinomas, Fisher's exact tests showed significant associations between high IL-38 expression and high tumor grades, an advanced T status, advanced N status, advanced stage, and the presence of pleural and vessel invasions. Survival analyses by the Kaplan-Meier method showed that patients with high expression of IL-38 had significantly shorter disease-free survival and shorter overall survival after surgery than patients with low expression of IL-38 (log-rank test: P = 0.0021 and P = 0.0035, respectively). Moreover, programmed cell death-ligand 1 (PD-L1)-positive cases showed higher expression of IL-38 than PD-L1-negative cases (Wilcoxon rank-sum test: P < 0.0001). In conclusion, IL-38 was expressed in tumor cells of various cancers, and IL-38 expression was associated with poor survival of lung adenocarcinoma patients. IL-38 may affect host immunity or the tumor microenvironment, and contribute to the progression of lung adenocarcinoma.	[Takada, Kazuki; Okamoto, Tatsuro; Teraishi, Koji; Akamine, Takaki; Takamori, Shinkichi; Katsura, Masakazu; Toyokawa, Gouji; Shoji, Fumihiro; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan; [Takada, Kazuki; Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Fukuoka, Japan; [Tominaga, Masaki; Okamoto, Masaki; Hoshino, Tomoaki] Kurume Univ, Div Respirol Neurol & Rheumatol, Dept Internal Med, Sch Med, Kurume, Fukuoka, Japan	Kyushu University; Kyushu University; Kurume University	Okamoto, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.	tatsuro@surg2.med.kyushu-u.ac.jp		Okamoto, Tatsuro/0000-0002-3568-1876; Katsura, Masakazu/0000-0001-8059-1768				Akdis M, 2016, J ALLERGY CLIN IMMUN; [Anonymous], [No title captured]; Barton BE, 1997, CLIN IMMUNOL IMMUNOP, V85, P16, DOI 10.1006/clin.1997.4420; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Boutet MA, 2015, CLIN EXPT IMMUNOLOGY; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; CHU M, 2016, MOLECULES, V21; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Hahn M, 2016, CURRENT OPINION RHEU; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Keermann M, 2015, J DERMATOL SCI; Kohno M, 2014, CLIN CANCER RES, V20, P3613, DOI 10.1158/1078-0432.CCR-13-2683; Lin HS, 2001, J BIOL CHEM, V276, P20597, DOI 10.1074/jbc.M010095200; Lv ZL, 2016, MOL MED REP, V13, P1404, DOI 10.3892/mmr.2015.4667; Palomo J, 2015, CYTOKINE; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Patel SP, 2015, MOL CANCER THER, V14, P847, DOI 10.1158/1535-7163.MCT-14-0983; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Reck M, 2016, NEW ENGLAND J MED; Rudloff I, 2015, ARTHRITIS RHEUMATOL, V67, P3219, DOI 10.1002/art.39328; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Solahaye-Kahnamouii S, 2014, IRAN J CANCER PREV, V7, P197; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Takada K, 2016, J THORAC ONCOL, V11, P1879, DOI 10.1016/j.jtho.2016.06.006; Takada K, 2016, ANTICANCER RES, V36, P3409; Takenaka Shin-Ichi, 2015, Biochem Biophys Rep, V4, P386, DOI 10.1016/j.bbrep.2015.10.015; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Toyokawa G, 2016, ANTICANCER RES, V36, P4329; Tsurutani N, 2016, J IMMUNOL, V196, P124, DOI 10.4049/jimmunol.1501217; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Wang M, 2016, CELL MOL BIOL, V62, P31, DOI 10.14715/cmb/2016.62.4.6; Weinstein AM, 2015, ADV CANCER RES, V128, P197, DOI 10.1016/bs.acr.2015.04.003; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yuan XL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/807976; Zhang L, 2014, INFLAMMATION, V37, P1213, DOI 10.1007/s10753-014-9848-7	42	28	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181598	10.1371/journal.pone.0181598	http://dx.doi.org/10.1371/journal.pone.0181598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727766	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500092
J	Zhang, C; Wang, DD; Yang, CH; Kong, N; Shi, Z; Zhao, P; Nan, YY; Nie, TK; Wang, RQ; Ma, HL; Chen, Q				Zhang, Chao; Wang, Dongdong; Yang, Chenghui; Kong, Nana; Shi, Zheng; Zhao, Peng; Nan, Yunyou; Nie, Tengkun; Wang, Ruoqiu; Ma, Haoli; Chen, Qin			Genome-wide identification of the potato WRKY transcription factor family	PLOS ONE			English	Article							EXPRESSION ANALYSIS; GENE FAMILY; STRESS-RESPONSE; DNA-BINDING; EVOLUTION; SUPERFAMILY; RESISTANCE; TOLERANCE; WHEAT; PATHWAY	WRKY transcription factors play pivotal roles in regulation of stress responses. This study identified 79 WRKY genes in potato (Solanum tuberosum). Based on multiple sequence alignment and phylogenetic relationships, WRKY genes were classified into three major groups. The majority of WRKY genes belonged to Group II (52 StWRKYs), Group III had 14 and Group I consisted of 13. The phylogenetic tree further classified Group II into five subgroups. All StWRKY genes except StWRKY79 were mapped on potato chromosomes, with eight tandem duplication gene pairs and seven segmental duplication gene pairs found from StWRKY family genes. The expression analysis of 22 StWRKYs showed their differential expression levels under various stress conditions. Cis-element prediction showed that a large number of elements related to drought, heat and salicylic acid were present in the promotor regions of StWRKY genes. The expression analysis indicated that seven StWRKYs seemed to respond to stress (heat, drought and salinity) and salicylic acid treatment. These genes are candidates for abiotic stress signaling for further research.	[Zhang, Chao; Wang, Dongdong; Yang, Chenghui; Kong, Nana; Shi, Zheng; Zhao, Peng; Nan, Yunyou; Nie, Tengkun; Wang, Ruoqiu; Ma, Haoli; Chen, Qin] Northwest A&F Univ, Dept Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Ma, HL; Chen, Q (corresponding author), Northwest A&F Univ, Dept Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	mahaoli@nwsuaf.edu.cn; chenpeter2289@nwsuaf.edu.cn			Northwest Agriculture and Forestry University [Z111021202]	Northwest Agriculture and Forestry University	This work was financially supported by the Research funding for special professor of Northwest Agriculture and Forestry University (grant Nos. Z111021202).; We thank the Northwest Agriculture Forestry University and State Key Laboratory of Crop Stress Biology for Arid Areas. This work was financially supported by the Research funding for special professor of Northwest Agriculture and Forestry University (grant Nos. Z111021202).	Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Diao WP, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01727, 10.3389/fpls.2016.00211]; Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7; Dou LL, 2014, MOL GENET GENOMICS, V289, P1103, DOI 10.1007/s00438-014-0872-y; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Evers D, 2012, PLANT MOL BIOL, V78, P503, DOI 10.1007/s11103-012-9879-0; Fan XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126148; Gallou A, 2012, FUNCT INTEGR GENOMIC, V12, P183, DOI 10.1007/s10142-011-0241-4; Goel R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00299; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6; Huang Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3123-2; Jiang YZ, 2014, J EXP BOT, V65, P6629, DOI 10.1093/jxb/eru381; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Kumar K, 2016, DNA RES, V23, P225, DOI 10.1093/dnares/dsw010; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23101; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Liu XF, 2016, PROTOPLASMA, V253, P1265, DOI 10.1007/s00709-015-0885-3; Ma HL, 2016, PLANT PHYSIOL BIOCH, V107, P164, DOI 10.1016/j.plaphy.2016.06.007; Ma JH, 2014, CYTOGENET GENOME RES, V144, P243, DOI 10.1159/000370172; Massa AN, PLANT GENOME; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Niu CF, 2012, PLANT CELL ENVIRON, V35, P1156, DOI 10.1111/j.1365-3040.2012.02480.x; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Pan LJ, 2014, MOL BIOL REP, V41, P1215, DOI 10.1007/s11033-013-2966-8; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Qiu YP, 2004, CHINESE SCI BULL, V49, P2159, DOI 10.1360/982004-183; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Sanchez-Rojo S, 2013, SALICYLIC ACID, P315; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Satapathy L, 2014, MOL GENET GENOMICS, V289, P1289, DOI 10.1007/s00438-014-0890-9; Shahzad Raheel, 2016, Plant Omics, V9, P149, DOI 10.21475/poj.160902.p7649x; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00534; Song Y, 2010, RICE SCI, V17, P60, DOI 10.1016/S1672-6308(08)60105-5; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587; Wang LN, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-103; Wang QS, 2011, GENETICA, V139, P973, DOI 10.1007/s10709-011-9599-4; Wang YY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0076-3; Wei W, 2016, PLANT PHYSIOL BIOCH, V105, P129, DOI 10.1016/j.plaphy.2016.04.014; Wen F, 2014, DNA RES, V21, P327, DOI 10.1093/dnares/dst060; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0; Yin GJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-148; Yogendra KN, 2015, J EXP BOT, V66, P7377, DOI 10.1093/jxb/erv434; Yogendra KN, 2016, PLANT SCI; Yu FF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-144; Yu YC, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2647-x; Zhang YZ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017023; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154312; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x; Zou Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148243	60	46	51	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181573	10.1371/journal.pone.0181573	http://dx.doi.org/10.1371/journal.pone.0181573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727761	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500089
J	Miranda, MZ; Bialik, JF; Speight, P; Dan, QH; Yeung, T; Szaszi, K; Pedersen, SF; Kapus, A				Miranda, Maria Zena; Bialik, Janne Folke; Speight, Pam; Dan, Qinghong; Yeung, Tony; Szaszi, Katalin; Pedersen, Stine F.; Kapus, Andras			TGF-beta 1 regulates the expression and transcriptional activity of TAZ protein via a Smad3-independent, myocardin-related transcription factor-mediated mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; YES-ASSOCIATED PROTEIN; SERUM RESPONSE FACTOR; BREAST-CANCER CELLS; TGF-BETA; MYOFIBROBLAST TRANSITION; STEM-CELLS; HIPPO PATHWAY; OSTEOGENIC DIFFERENTIATION	Hippo pathway transcriptional coactivators TAZ and YAP and the TGF-beta 1 (TGF beta) effector Smad3 regulate a common set of genes, can physically interact, and exhibit multilevel crosstalk regulating cell fate-determining and fibrogenic pathways. However, a key aspect of this cross-talk, TGF beta-mediated regulation of TAZ or YAP expression, remains uncharacterized. Here, we show that TGF beta induces robust TAZ but not YAP protein expression in both mesenchymal and epithelial cells. TAZ levels, and to a lesser extent YAP levels, also increased during experimental kidney fibrosis. Pharmacological or genetic inhibition of Smad3 did not prevent the TGF beta-induced TAZ up-regulation, indicating that this canonical pathway is dispensable. In contrast, inhibition of p38 MAPK, its downstream effector MK2 (e.g. by the clinically approved antifibrotic pirferidone), or Akt suppressed the TGF beta-inducedTAZexpression. Moreover, TGF beta elevated TAZmRNAin a p38-dependent manner. Myocardin-related transcription factor (MRTF) was a central mediator of this effect, as MRTF silencing/inhibition abolished the TGF beta-induced TAZ expression. MRTF overexpression drove the TAZ promoter in a CC(A/T-rich) 6GG (CArG) box-dependent manner and induced TAZ protein expression. TGF beta did not act by promoting nuclear MRTF translocation; instead, it triggered p38-and MK2-mediated, Nox4-promoted MRTF phosphorylation and activation. Functionally, higher TAZ levels increased TAZ/TEAD-dependent transcription and primed cells for enhancedTAZactivity upon a second stimulus (i. e. sphingosine 1-phosphate) that induced nuclear TAZ translocation. In conclusion, our results uncover an important aspect of the cross-talk between TGF beta and Hippo signaling, showing that TGF beta induces TAZ via a Smad3-independent, p38-and MRTF-mediated and yet MRTF translocation-independent mechanism.	[Miranda, Maria Zena; Bialik, Janne Folke; Speight, Pam; Dan, Qinghong; Yeung, Tony; Szaszi, Katalin; Kapus, Andras] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1T8N, Canada; [Szaszi, Katalin; Kapus, Andras] Univ Toronto, Dept Surg, Toronto, ON M5B 1T8N, Canada; [Miranda, Maria Zena; Kapus, Andras] Univ Toronto, Dept Biochem, Toronto, ON M5B 1T8N, Canada; [Bialik, Janne Folke; Pedersen, Stine F.] Univ Copenhagen, Dept Cell & Dev Biol, DK-2100 Copenhagen, Denmark	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Copenhagen	Kapus, A (corresponding author), Keenan Res Ctr Biomed Sci, Rm 621,209 Victoria St, Toronto, ON M5B 1T8, Canada.	kapusa@smh.ca	Pedersen, Stine Falsig/O-1133-2019	Pedersen, Stine Falsig/0000-0002-3044-7714; Yeung, Tony/0000-0002-1970-5751; Kapus, Andras/0000-0002-6610-9530	Canadian Institutes of Health Research (CIHR) [MOP-106625, MOP-130463]; Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN227-908-13, RGPIN 327407]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-106625 and MOP-130463 (to A. K.), the Kidney Foundation of Canada (to A. K. and K. S.), and Natural Sciences and Engineering Research Council of Canada (NSERC) Grants RGPIN227-908-13 (to A. K.) and RGPIN 327407 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdalla M, 2013, J BIOL CHEM, V288, P33483, DOI 10.1074/jbc.M113.504290; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Bertero T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18277; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Bian HJ, 2016, MOL METAB, V5, P970, DOI 10.1016/j.molmet.2016.08.012; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen JC, 2016, J AM SOC NEPHROL, V27, P1689, DOI 10.1681/ASN.2015040415; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Goettsch C, 2009, BIOCHEM BIOPH RES CO, V380, P355, DOI 10.1016/j.bbrc.2009.01.107; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hayashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10627; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Jorgenson AJ, 2017, AM J PHYSIOL-CELL PH, V312, pC277, DOI 10.1152/ajpcell.00205.2016; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee J, 2010, J BIOL CHEM, V285, P26618, DOI 10.1074/jbc.M109.073155; Lee M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153199; Liu CY, 2016, ONCOTARGET, V7, P13706, DOI 10.18632/oncotarget.7333; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2011, CELLS TISSUES ORGANS, V193, P41, DOI 10.1159/000320180; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Matsuzaki K, 2013, CYTOKINE GROWTH F R, V24, P385, DOI 10.1016/j.cytogfr.2013.06.002; Mauviel A, 2012, ONCOGENE, V31, P1743, DOI 10.1038/onc.2011.363; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mourey RJ, 2010, J PHARMACOL EXP THER, V333, P797, DOI 10.1124/jpet.110.166173; Moustakas A, 2014, BBA-GEN SUBJECTS, V1840, P2621, DOI 10.1016/j.bbagen.2014.02.004; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Onwuegbusi BA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000177; Panayiotou R, 2016, ELIFE, V5, DOI 10.7554/eLife.15460; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rogliani P, 2016, PULM PHARMACOL THER, V40, P95, DOI 10.1016/j.pupt.2016.07.009; Ronkina N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31219; Rozycki M, 2016, J BIOL CHEM, V291, P227, DOI 10.1074/jbc.M115.674606; Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015; Sebe A, 2008, FEBS LETT, V582, P291, DOI 10.1016/j.febslet.2007.12.021; Seo E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31931; Sousa AM, 2007, J CELL BIOCHEM, V100, P1581, DOI 10.1002/jcb.21154; Speight P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11642; Speight P, 2013, MOL BIOL CELL, V24, P3326, DOI 10.1091/mbc.E13-04-0220; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wu HT, 2013, CELL REP, V3, P1663, DOI 10.1016/j.celrep.2013.04.020; Xiang LS, 2014, ONCOTARGET, V5, P12509, DOI 10.18632/oncotarget.2997; Xie WB, 2013, CIRC RES, V113, pE76, DOI 10.1161/CIRCRESAHA.113.301921; Xue P, 2013, BIOCHEM BIOPH RES CO, V433, P226, DOI 10.1016/j.bbrc.2013.02.088; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yu OM, 2016, MOL CELL BIOL, V36, P39, DOI 10.1128/MCB.00772-15; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]	88	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14902	14920		10.1074/jbc.M117.780502	http://dx.doi.org/10.1074/jbc.M117.780502			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739802	Green Published, hybrid			2022-12-26	WOS:000409902100016
J	Yin, N; Lepp, A; Ji, YS; Mortensen, M; Hou, SW; Qi, XM; Myers, CR; Chen, G				Yin, Ning; Lepp, Adrienne; Ji, Yongsheng; Mortensen, Matthew; Hou, Songwang; Qi, Xiao-Mei; Myers, Charles R.; Chen, Guan			The K-Ras effector p38 gamma MAPK confers intrinsic resistance to tyrosine kinase inhibitors by stimulating EGFR transcription and EGFR dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; ESTROGEN-RECEPTOR ER; BREAST-CANCER; THERAPEUTIC TARGET; COLON-CANCER; TUMOR-SUPPRESSOR; STRESS-RESPONSE; P38-GAMMA MAPK; GROWTH; ACTIVATION	Mutations in K-Ras and epidermal growth factor receptor (EGFR) are mutually exclusive, but it is not known how K-Ras activation inactivates EGFR, leading to resistance of cancer cells to anti-EGFR therapy. Here, we report that the K-Ras effector p38 gamma MAPK confers intrinsic resistance to small molecular tyrosine kinase inhibitors (TKIs) by concurrently stimulating EGFR gene transcription and protein dephosphorylation. We found that p38 gamma increases EGFR transcription by c-Jun-mediated promoter binding and stimulates EGFR dephosphorylation via activation of protein-tyrosine phosphatase H1 (PTPH1). Silencing the p38 gamma/c-Jun/PTPH1 signaling network increased sensitivities to TKIs in K-Ras mutant cells in which EGFR knockdown inhibited growth. Similar results were obtained with the p38 gamma-specific pharmacological inhibitor pirfenidone. These results indicate that in K-Ras mutant cancers, EGFR activity is regulated by the p38 gamma/c-Jun/PTPH1 signaling network, whose disruption may be a novel strategy to restore the sensitivity to TKIs.	[Yin, Ning; Lepp, Adrienne; Ji, Yongsheng; Mortensen, Matthew; Hou, Songwang; Qi, Xiao-Mei; Myers, Charles R.; Chen, Guan] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Chen, Guan] Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI 53295 USA	Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.; Chen, G (corresponding author), Zablocki Vet Affairs Med Ctr, Res Serv, Milwaukee, WI 53295 USA.	gchen@mcw.edu	Ji, Yongsheng/AAB-7772-2020; Yin, Ning/AAA-7617-2020	Mortensen, Matthew/0000-0002-0629-6856	Department of Veterans Affairs Merit Review Grant [1I01BX002883]; Department of Defense Grant [BC141898]; Cancer Center of the Medical College of Wisconsin; Veterans Affairs [I01BX002883] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs); Department of Defense Grant(United States Department of Defense); Cancer Center of the Medical College of Wisconsin; Veterans Affairs(US Department of Veterans Affairs)	This study was supported by Department of Veterans Affairs Merit Review Grant 1I01BX002883, Department of Defense Grant BC141898, and the Cancer Center of the Medical College of Wisconsin (to G.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Ashktorab H, 2007, AM J GASTROENTEROL, V102, P2135, DOI 10.1111/j.1572-0241.2007.01400.x; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Dolloff NG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001384; Frank D, 2012, J GASTROINTEST ONCOL, V3, P90, DOI 10.3978/j.issn.2078-6891.2011.049; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Grana TM, 2003, CANCER RES, V63, P7807; Hou S., 2010, UCSD NAT MOL, P1038; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hou SW, 2012, J BIOL CHEM, V287, P27895, DOI 10.1074/jbc.M111.335794; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Logue JS, 2012, GENE DEV, V26, P641, DOI 10.1101/gad.186965.112; Ma S, 2015, ONCOTARGET, V6, P13320, DOI 10.18632/oncotarget.3645; Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2015, STEM CELLS, V33, P2738, DOI 10.1002/stem.2068; Qi XM, 2014, ONCOTARGET, V5, P4269, DOI 10.18632/oncotarget.2001; Qi XM, 2012, J BIOL CHEM, V287, P14681, DOI 10.1074/jbc.M112.349357; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Sabio G, 2010, J CELL SCI, V123, P2596, DOI 10.1242/jcs.066514; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Segovia-Mendoza M, 2015, AM J CANCER RES, V5, P2531; Shaib W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/j.issn.2078-6891.2013.029; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Suresh PS, 2014, MOL CANCER THER, V13, P230, DOI 10.1158/1535-7163.MCT-13-0610; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; van Houdt WJ, 2010, NEOPLASIA, V12, P443, DOI 10.1593/neo.92088; Wang F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-65; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yamaguchi H, 2014, ONCOGENE, V33, P1073, DOI 10.1038/onc.2013.74; Yin N, 2016, ONCOGENE, V35, P1039, DOI 10.1038/onc.2015.158; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412; Zhi HY, 2011, ONCOGENE, V30, P1706, DOI 10.1038/onc.2010.543; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	55	6	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					15070	15079		10.1074/jbc.M117.779488	http://dx.doi.org/10.1074/jbc.M117.779488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739874	Green Published, hybrid			2022-12-26	WOS:000409902100029
J	Malandraki, I; Beris, D; Isaioglou, I; Olmos, A; Varveri, C; Vassilakos, N				Malandraki, Ioanna; Beris, Despoina; Isaioglou, Ioannis; Olmos, Antonio; Varveri, Christina; Vassilakos, Nikon			Simultaneous detection of three pome fruit tree viruses by one-step multiplex quantitative RT-PCR	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; PITTING-VIRUS; APPLE-TREES; WOODY-PLANTS; GROOVING VIRUS; RNA EXTRACTION; PEAR; DIFFERENTIATION; ASSAY; VARIABILITY	A one-step multiplex real-time reverse transcription polymerase chain reaction (RT-qPCR) based on TaqMan probes was developed for the simultaneous detection of Apple mosaic virus (ApMV), Apple stem pitting virus (ASPV) and Apple stem grooving virus (ASGV) in total RNA of pome trees extracted with a CTAB method. The sensitivity of the method was established using in vitro synthesized viral transcripts serially diluted in RNA from healthy, virus-tested (negative) pome trees. The three viruses were simultaneously detected up to a 10(-4) dilution of total RNA from a naturally triple-infected apple tree prepared in total RNA of healthy apple tissue. The newly developed RT-qPCR assay was at least one hundred times more sensitive than conventional single RT-PCRs. The assay was validated with 36 field samples for which nine triple and 11 double infections were detected. All viruses were detected simultaneously in composite samples at least up to the ratio of 1: 150 triple-infected to healthy pear tissue, suggesting the assay has the capacity to examine rapidly a large number of samples in pome tree certification programs and surveys for virus presence.	[Malandraki, Ioanna; Beris, Despoina; Isaioglou, Ioannis; Varveri, Christina; Vassilakos, Nikon] Benaki Phytopathol Inst, Dept Phytopathol, Virol Lab, Athens, Greece; [Olmos, Antonio] IVIA, Plant Protect & Biotechnol Ctr, Valencia, Spain		Vassilakos, N (corresponding author), Benaki Phytopathol Inst, Dept Phytopathol, Virol Lab, Athens, Greece.	N.Vassilakos@bpi.gr	Olmos, Antonio/C-1570-2013	Olmos, Antonio/0000-0001-8406-7963; Isaioglou, Ioannis/0000-0002-0269-6887	Hellenic Greek Secretariat of Research and Technology Project [09SYN-22-638]; FP7-REGPOT-1 project BPI-PlantHeal [230010]; Hellenic GSRT Project [09SYN-22-638]; FP7-REGPOT-2008-1 project [BPI-PlantHeal 230010]	Hellenic Greek Secretariat of Research and Technology Project; FP7-REGPOT-1 project BPI-PlantHeal; Hellenic GSRT Project; FP7-REGPOT-2008-1 project	This work was supported by: 1. Hellenic Greek Secretariat of Research and Technology Project 09SYN-22-638; 2. FP7-REGPOT-2008-1 project BPI-PlantHeal 230010 (Partially). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank Dr. P. Gentit (CTIFL), Dr. T. Candresse (INRA), Dr. F. Faggioli (Centro di Ricerca per la Patologia Vegetale, ISPAVE, Italy) and Prof N. Katis (Aristotle University of Thessaloniki) for providing pathogen isolates, Fitotechniki Tissue Culture Laboratory Xylogiannis Bross (Greece) for providing healthy pear and apple plants and Ms. C. Panayotidi and O. Kektsidou for technical assistance. This work was supported by the Hellenic GSRT Project '09SYN-22-638' and partially by FP7-REGPOT-2008-1 project 'BPI-PlantHeal 230010'.	Boulila M, 2010, BIOCHEM GENET, V48, P357, DOI 10.1007/s10528-009-9317-4; Brakta A, 2013, PLANT DIS, V97, P1001, DOI 10.1094/PDIS-11-12-1082-PDN; Chen S, 2014, PLOS ONE, V9; DESVIGNES JC, 1999, VIRUS DISEASES FRUIT; EPPO, 2015, PQR EPPO DAT QUAR PE; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Guo L., 2006, ACTA PHYTOPATHOLOGIC, V1, P8; Hadidi A, 2011, EC IMPACT POME STONE; Hao L, 2016, J VIROL METHODS, V234, P16, DOI 10.1016/j.jviromet.2016.04.003; James D, 1999, J VIROL METHODS, V83, P1, DOI 10.1016/S0166-0934(99)00078-6; Klerks MM, 2001, PHYTOPATHOLOGY, V91, P1085, DOI 10.1094/PHYTO.2001.91.11.1085; Komorowska B, 2010, J VIROL METHODS, V168, P242, DOI 10.1016/j.jviromet.2010.04.024; Kumar S, 2014, INDIAN J MICROBIOL, V54, P203, DOI 10.1007/s12088-013-0431-y; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Lin LM, 2013, EUR J PLANT PATHOL, V137, P797, DOI 10.1007/s10658-013-0289-1; Lopez-Fabuel I, 2013, J VIROL METHODS, V188, P21, DOI 10.1016/j.jviromet.2012.11.034; Ma XF, 2016, CAN J PLANT PATHOL, V38, P218, DOI 10.1080/07060661.2016.1158741; MacKenzie DJ, 1997, PLANT DIS, V81, P222, DOI 10.1094/PDIS.1997.81.2.222; Magome H, 1997, PHYTOPATHOLOGY, V87, P389, DOI 10.1094/PHYTO.1997.87.4.389; Malandraki I, 2015, J VIROL METHODS, V213, P12, DOI 10.1016/j.jviromet.2014.11.010; Massart S, 2008, ACTA HORTIC, P107, DOI 10.17660/ActaHortic.2008.781.15; Massart S, 2011, APPLE STEM GROOVING; Mathioudakis MM, 2009, PLANT PATHOL, V58, P228, DOI 10.1111/j.1365-3059.2008.01952.x; Menzel W, 2002, J VIROL METHODS, V99, P81, DOI 10.1016/S0166-0934(01)00381-0; Nickel O, 2014, J PLANT PATHOL, V96, P207; Pallas V., 2009, V508, P193, DOI 10.1007/978-1-59745-062-1_16; Papayiannis LC, 2014, J VIROL METHODS, V196, P93, DOI 10.1016/j.jviromet.2013.11.001; Park Honglyeol, 2006, The Plant Pathology Journal, V22, P168; Petrzik K, 2002, ARCH VIROL, V147, P1275, DOI 10.1007/s00705-002-0819-1; Plese N, 1975, J PHYTOPATHOL, V82, P315; Posnette AF, 1989, LOSSES CAUSED VIRUS; Roussel S, 2005, DNA PROBES DETECTION, V35, P105; ROWHANI A, 1995, PHYTOPATHOLOGY, V85, P347, DOI 10.1094/Phyto-85-347; Shim H, 2004, MOL CELLS, V18, P192; Shipley G., 2006, INTRO REAL TIME PCR; Valasevich N, 2015, EUR J PLANT PATHOL, V141, P839, DOI 10.1007/s10658-014-0580-9; Winkowska L, 2016, PHYTOPATHOL MEDITERR, V55, P207, DOI 10.14601/Phytopathol_Mediterr-16825; Wu ZB, 2010, EUR J PLANT PATHOL, V128, P71, DOI 10.1007/s10658-010-9631-z; Yao BY, 2014, J VIROL METHODS, V196, P113, DOI 10.1016/j.jviromet.2013.11.005; Yokomi RK, 2010, PHYTOPATHOLOGY, V100, P319, DOI 10.1094/PHYTO-100-4-0319; Yoshikawa N, 2001, ACTA HORTIC, P285, DOI 10.17660/ActaHortic.2001.550.41	41	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0180877	10.1371/journal.pone.0180877	http://dx.doi.org/10.1371/journal.pone.0180877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749955	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700022
J	Wesseler, J; Smart, RD; Thomson, J; Zilberman, D				Wesseler, Justus; Smart, Richard D.; Thomson, Jennifer; Zilberman, David			Foregone benefits of important food crop improvements in Sub-Saharan Africa	PLOS ONE			English	Article							AGRICULTURAL BIOTECHNOLOGY; ECONOMIC-IMPACT; GOLDEN-RICE; INDIA	A number of new crops have been developed that address important traits of particular relevance for smallholder farmers in Africa. Scientists, policy makers, and other stakeholders have raised concerns that the approval process for these new crops causes delays that are often scientifically unjustified. This article develops a real option model for the optimal regulation of a risky technology that enhances economic welfare and reduces malnutrition. We consider gradual adoption of the technology and show that delaying approval reduces uncertainty about perceived risks of the technology. Optimal conditions for approval incorporate parameters of the stochastic processes governing the dynamics of risk. The model is applied to three cases of improved crops, which either are, or are expected to be, delayed by the regulatory process. The benefits and costs of the crops are presented in a partial equilibrium that considers changes in adoption over time and the foregone benefits caused by a delay in approval under irreversibility and uncertainty. We derive the equilibrium conditions where the net-benefits of the technology equal the costs that would justify a delay. The sooner information about the safety of the technology arrive, the lower the costs for justifying a delay need to be i.e. it pays more to delay. The costs of a delay can be substantial: e.g. a one year delay in approval of the pod-borer resistant cowpea in Nigeria will cost the country about 33 million USD to 46 million USD and between 100 and 3,000 lives.	[Wesseler, Justus] Wageningen Univ, Dept Social Sci, Wageningen, Netherlands; [Smart, Richard D.] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Freising Weihenstephan, Germany; [Thomson, Jennifer] Univ Cape Town, Dept Mol & Cell Biol, Rondebosch, South Africa; [Zilberman, David] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA	Wageningen University & Research; Technical University of Munich; University of Cape Town; University of California System; University of California Berkeley	Wesseler, J (corresponding author), Wageningen Univ, Dept Social Sci, Wageningen, Netherlands.	justus.wesseler@wur.nl	Wesseler, Justus/H-5347-2016	Wesseler, Justus/0000-0002-6009-8543				AATF, PODB RES COWP; AATF, MAR RES COWP; AATF. Maruca- Resistant Cowpea, 2012, MAR RES COWP PROGR R; Addae P., 2014, COMMUNICATION   0715; African Union, 2006, C AFRI CAN UN MIN AG; [Anonymous], 2016, SECRETARIAT CONVENTI; Bennett AB, 2013, ANNU REV ENV RESOUR, V38, P191; De Groote H, 2011, AFR J BIOTECHNOL, V10, P4741; Englberger Lois, 2003, Food and Nutrition Bulletin, V24, P303; Falck-Zepeda Jose, 2013, World Review of Science, Technology and Sustainable Development, V10, P203; Gbegbelegbe SD, 2015, AGR ECON-BLACKWELL, V46, P563, DOI 10.1111/agec.12182; Gomez C, 2004, COWPEA POSTHARVEST O; Gouse M., 2014, GENETICALLY MODIFIED, P25; Herring RJ, 2015, J PEASANT STUD, V42, P159, DOI 10.1080/03066150.2014.951835; KARI, 2007, 27 IRMA; KARI, 2003, 10 IRMA; KARl, 2005, 20 IRMA; Kumar Shinoi Parappurathu, 2011, AGR EC RES REV, V24, P1, DOI DOI 10.15294/JEJAK.V12I1.18430; Lodin J.B., 2014, NAT BIOTECHNOL, V36, P129; Magrini E, 2016, 1601 SSA GEORG AUG U; Mamiro P. S., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P4490; Nguema A, 2011, AFJARE, V6, P70; Paarlberg R., 2008, STARVED SCI BIOTECHN; Qaim M, 2016, PALGR STUD AGRICULT, P1, DOI 10.1057/9781137405722; Santaniello V, 2005, AGR ECON-BLACKWELL, V32, P189, DOI 10.1111/j.0169-5150.2004.00023.x; Shekar M., 2013, COSTS STUNTING; Smart RD, 2017, J AGR ECON, V68, P182, DOI 10.1111/1477-9552.12171; Smith LC, 2015, WORLD DEV, V68, P180, DOI 10.1016/j.worlddev.2014.11.014; Snipes K, 2012, KENYA BANS GENETICAL; Stein AJ, 2008, WORLD DEV, V36, P144, DOI 10.1016/j.worlddev.2007.02.013; Tosun J, 2016, 20 INT C INT CONS AP; UNICEF, 2013, ACH IMP GLOB PROGR; Wafula D., 2005, Journal of International Development, V17, P679, DOI 10.1002/jid.1231; Wesseler J., 2009, AgBioForum, V12, P8; Wesseler JHH., 2014, HDB AGR BIOTECHNOLOG, P793; Wesseler J, 2014, ENVIRON DEV ECON, V19, P724, DOI 10.1017/S1355770X1300065X; Wetherell S., 2013, RESULTS 2013 STATE F; World Food Programme, 2014, 2013 FACTS FIG PARTN	38	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181353	10.1371/journal.pone.0181353	http://dx.doi.org/10.1371/journal.pone.0181353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1CT	28749984	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700038
J	Altszyler, E; Berbeglia, F; Berbeglia, G; Van Hentenryck, P				Altszyler, Edgar; Berbeglia, Franco; Berbeglia, Gerardo; Van Hentenryck, Pascal			Transient dynamics in trial-offer markets with social influence: Trade-offs between appeal and quality	PLOS ONE			English	Article								We study a trial-offer market where consumers may purchase one of two competing products. Consumer preferences are affected by the products quality, their appeal, and their popularity. While the asymptotic convergence or stationary states of these, and related dynamical systems, has been vastly studied, the literature regarding the transitory dynamics remains surprisingly sparse. To fill this gap, we derive a system of Ordinary Differential Equations, which is solved exactly to gain insight into the roles played by product qualities and appeals in the market behavior. We observe a logarithmic tradeoff between quality and appeal for medium and long-term marketing strategies: The expected market shares remain constant if a decrease in quality is followed by an exponential increase in the product appeal. However, for short time horizons, the trade-off is linear. Finally, we study the variability of the dynamics through Monte Carlo simulations and discover that low appeals may result in high levels of variability. The model results suggest effective marketing strategies for short and long time horizons and emphasize the significance of advertising early in the market life to increase sales and predictability.	[Altszyler, Edgar] Univ Buenos Aires, Dept Comp, Buenos Aires, DF, Argentina; [Altszyler, Edgar] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Berbeglia, Franco] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; [Berbeglia, Gerardo] Univ Melbourne, Melbourne Business Sch, Carlton, Vic, Australia; [Van Hentenryck, Pascal] Univ Michigan, Ind & Operat Engn, Ann Arbor, MI 48109 USA	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Carnegie Mellon University; University of Melbourne; University of Michigan System; University of Michigan	Berbeglia, G (corresponding author), Univ Melbourne, Melbourne Business Sch, Carlton, Vic, Australia.	g.berbeglia@mbs.edu	Berbeglia, Gerardo/R-1656-2017	Berbeglia, Gerardo/0000-0003-0108-2936				Abeliuk A., 2016, P 25 INT JOINT C ART, P2458; Abeliuk A, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P745, DOI 10.1145/3038912.3052680; Abeliuk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121934; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ceyhan S, 2011, INTERNET MATH, V7, P107, DOI 10.1080/15427951.2011.579849; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Eggenberger F, 1923, Z ANGEW MATH MECH, V3, P279, DOI 10.1002/zamm.19230030407; Engstrom P., 2014, DEMAND EFFECTS CONSU; Hogg T, 2014, ARXIV14106744; Jiang B, 2016, P 2016 ACM SIGMETRIC, P299; Jiang B, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/11/P11022; Kempe D, 2008, INT WORKSH INT NETW, P585; Krumme C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033785; Kushner Harold, 2003, STOCHASTIC APPROXIMA, V35; Mahmoud H., 2008, POLYA URN MODELS; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Perc M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0378; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Strogatz S.H., 2014, NONLINEAR DYNAMICS C; Van Hentenryck P, 2016, 10 INT AAAI C WEB SO, P398; Viglia G, 2014, INT J HOSP MANAG, V42, P155, DOI 10.1016/j.ijhm.2014.07.001	21	2	2	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180040	10.1371/journal.pone.0180040	http://dx.doi.org/10.1371/journal.pone.0180040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746334	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800008
J	Armeanu, D; Andrei, JV; Lache, L; Panait, M				Armeanu, Daniel; Andrei, Jean Vasile; Lache, Leonard; Panait, Mirela			A multifactor approach to forecasting Romanian gross domestic product (GDP) in the short run	PLOS ONE			English	Article							DYNAMIC-FACTOR MODEL; NUMBER; ARBITRAGE	The purpose of this paper is to investigate the application of a generalized dynamic factor model (GDFM) based on dynamic principal components analysis to forecasting short-term economic growth in Romania. We have used a generalized principal components approach to estimate a dynamic model based on a dataset comprising 86 economic and non-economic variables that are linked to economic output. The model exploits the dynamic correlations between these variables and uses three common components that account for roughly 72% of the information contained in the original space. We show that it is possible to generate reliable forecasts of quarterly real gross domestic product (GDP) using just the common components while also assessing the contribution of the individual variables to the dynamics of real GDP. In order to assess the relative performance of the GDFM to standard models based on principal components analysis, we have also estimated two Stock-Watson (SW) models that were used to perform the same out-of-sample forecasts as the GDFM. The results indicate significantly better performance of the GDFM compared with the competing SW models, which empirically confirms our expectations that the GDFM produces more accurate forecasts when dealing with large datasets.	[Armeanu, Daniel; Lache, Leonard] Bucharest Univ Econ Studies, Dept Finance, Bucharest, Romania; [Andrei, Jean Vasile] Petr Gas Univ Ploiesti, Business Adm Dept, Ploiesti, Prahova, Romania; [Panait, Mirela] Petr Gas Univ Ploiesti, Cybernet Econ Informat Finance & Accounting Dept, Ploiesti, Prahova, Romania	Bucharest University of Economic Studies; Oil & Gas University of Ploiesti; Oil & Gas University of Ploiesti	Andrei, JV (corresponding author), Petr Gas Univ Ploiesti, Business Adm Dept, Ploiesti, Prahova, Romania.	andrei_jeanvasile@yahoo.com	Jean-Vasile, Andrei/A-5270-2011; Panait, Mirela/K-3300-2019; Armeanu, Dan/N-9365-2018	Jean-Vasile, Andrei/0000-0002-8332-6537; Panait, Mirela/0000-0002-5158-753X; 				Ajevskis V, 22008 WP LATV BANK; Anderson TW, 1984, INTRO MULTIVARIATE S; Andrei J, 2016, ENERGIES, V9, DOI 10.3390/en9110902; Artis MJ, 2005, J FORECASTING, V24, P279, DOI 10.1002/for.957; Bai J, 2003, ECONOMETRICA, V71, P135, DOI 10.1111/1468-0262.00392; Bai JS, 2002, ECONOMETRICA, V70, P191, DOI 10.1111/1468-0262.00273; Bai JS, 2007, J BUS ECON STAT, V25, P52, DOI 10.1198/073500106000000413; Barhoumi K, 2322009 DT BANQ FRAN; Bernanke BS, 2003, J MONETARY ECON, V50, P525, DOI 10.1016/S0304-3932(03)00024-2; Breitung J, 382005 DP DTSCH BUND; Brockwell P J, 2009, TIME SERIES THEORY M, V2; Catell RB, 1966, 11966 MULT BEH RES; CHAMBERLAIN G, 1983, ECONOMETRICA, V51, P1281, DOI 10.2307/1912275; CONNOR G, 1986, J FINANC ECON, V15, P373, DOI 10.1016/0304-405X(86)90027-9; CONNOR G, 1988, J FINANC ECON, V21, P255, DOI 10.1016/0304-405X(88)90062-1; Cuevas A, 2012, SERIES-J SPAN ECON, V3, P311, DOI 10.1007/s13209-011-0060-9; Doz C, 57242006 CEPR; Doz C, 60432007 CEPR; Dragoi MC, 2015, FARMACIA, V63, P593; ENGLE R, 1981, J AM STAT ASSOC, V76, P774, DOI 10.2307/2287567; European Commission, WINT 2007 EC FOR; Florea N.V., 2016, VALAHIAN J EC STUDIE, V7, P45; Forni M, 2000, REV ECON STAT, V82, P540, DOI 10.1162/003465300559037; Forni M, 2003, J MONETARY ECON, V50, P1243, DOI 10.1016/S0304-3932(03)00079-5; Forni M, 2001, ECON J, V111, pC62, DOI 10.1111/1468-0297.00620; Fuller WA, 1995, INTRO STAT TIME SERI, V2; Geweke J., 1977, LATENT VARIABLES SOC, P365; Giannone D, 2008, J MONETARY ECON, V55, P665, DOI 10.1016/j.jmoneco.2008.05.010; Kabundi A, 2008, J EC LIT, V2008; Liebermann J., 2012, 39452 MPRA; Marcellino M, 2012, SHORT TERM GDP FOREC; Masten A, 92008 IMAD WP; Ng S., 2005, UNDERSTANDING COMP F; Onatski A, 2010, REV ECON STAT, V92, P1004, DOI 10.1162/REST_a_00043; Popescu G, 2017, EC COMPUT EC CYBERN, V51; Porshakov A, 22015 WP BANK RUSS; Quah D, 771992 DP FED RES BA; Reinsel G., 1997, TIME SERIES ANAL; Rogleva P., DP862011 BULG NAT BA; Sargent Y, 551977 WP FED RES BA; Schneider M, 2004, 89 WP; Schumacher C., 242005 DP BUND; Stock JH, 2002, J AM STAT ASSOC, V97, P1167, DOI 10.1198/016214502388618960; Tanase A, NBR OCCASIONAL PAPER; Toth P., 2017, 77245 MPRA; Van Nieuwenhuyze C., 802006 WP	48	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181379	10.1371/journal.pone.0181379	http://dx.doi.org/10.1371/journal.pone.0181379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28742100	Green Published, Green Submitted, gold			2022-12-26	WOS:000406362700039
J	Janouskova, M; Krak, K; Vosatka, M; Puschel, D; Storchova, H				Janouskova, Martina; Krak, Karol; Vosatka, Miroslav; Puschel, David; Storchova, Helena			Inoculation effects on root-colonizing arbuscular mycorrhizal fungal communities spread beyond directly inoculated plants	PLOS ONE			English	Article							HIGH FUNCTIONAL DIVERSITY; GLOMUS-INTRARADICES; GENETIC-VARIABILITY; COLONIZATION; ESTABLISHMENT; POPULATION; FERTILIZATION; GLOMEROMYCOTA; METAANALYSIS; PERSISTENCE	Inoculation with arbuscular mycorrhizal fungi (AMF) may improve plant performance at disturbed sites, but inoculation may also suppress root colonization by native AMF and decrease the diversity of the root-colonizing AMF community. This has been shown for the roots of directly inoculated plants, but little is known about the stability of inoculation effects, and to which degree the inoculant and the inoculation-induced changes in AMF community composition spread into newly emerging seedlings that were not in direct contact with the introduced propagules. We addressed this topic in a greenhouse experiment based on the soil and native AMF community of a post-mining site. Plants were cultivated in compartmented pots with substrate containing the native AMF community, where AMF extraradical mycelium radiating from directly inoculated plants was allowed to inoculate neighboring plants. The abundances of the inoculated isolate and of native AMF taxa were monitored in the roots of the directly inoculated plants and the neighboring plants by quantitative real-time PCR. As expected, inoculation suppressed root colonization of the directly inoculated plants by other AMF taxa of the native AMF community and also by native genotypes of the same species as used for inoculation. In the neighboring plants, high abundance of the inoculant and the suppression of native AMF were maintained. Thus, we demonstrate that inoculation effects on native AMF propagate into plants that were not in direct contact with the introduced inoculum, and are therefore likely to persist at the site of inoculation.	[Janouskova, Martina; Krak, Karol; Vosatka, Miroslav; Puschel, David] Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic; [Storchova, Helena] Czech Acad Sci, Inst Expt Bot, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Janouskova, M (corresponding author), Czech Acad Sci, Inst Bot, Pruhonice, Czech Republic.	martina.janouskova@ibot.cas.cz	STORCHOVA, Helena/F-4723-2010; Püschel, David/G-3085-2014; Janouskova, Martina/H-1595-2014	STORCHOVA, Helena/0000-0001-6701-179X; Püschel, David/0000-0002-1949-3242; Vosatka, Miroslav/0000-0002-1378-3185; Janouskova, Martina/0000-0002-6041-8068; Krak, Karol/0000-0002-0340-2086	Ministry of Education, Youth and Sports of the Czech Republic [LH14285]; long-term research project of the Academy of Sciences of the Czech Republic [RVO 67985939]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); long-term research project of the Academy of Sciences of the Czech Republic	The study was supported by Ministry of Education, Youth and Sports of the Czech Republic (project No. LH14285) and by the long-term research project of the Academy of Sciences of the Czech Republic (RVO 67985939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; Avio L, 2009, CAN J MICROBIOL, V55, P242, DOI [10.1139/W08-129, 10.1139/w08-129]; Berruti A, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01559; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Borstler B, 2008, NEW PHYTOL, V180, P452, DOI 10.1111/j.1469-8137.2008.02574.x; Borstler B, 2010, MOL ECOL, V19, P1497, DOI 10.1111/j.1365-294X.2010.04590.x; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Ceccarelli N, 2010, PLANT SOIL, V335, P311, DOI 10.1007/s11104-010-0417-z; Chagnon PL, 2013, TRENDS PLANT SCI, V18, P484, DOI 10.1016/j.tplants.2013.05.001; Chen BD, 2007, SCI TOTAL ENVIRON, V379, P226, DOI 10.1016/j.scitotenv.2006.07.038; Clapp JP, 2001, NEW PHYTOL, V149, P539, DOI 10.1046/j.1469-8137.2001.00060.x; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; Croll D, 2008, NEW PHYTOL, V180, P564, DOI 10.1111/j.1469-8137.2008.02602.x; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; Farmer MJ, 2007, APPL SOIL ECOL, V35, P599, DOI 10.1016/j.apsoil.2006.09.012; Gavito ME, 1998, PLANT SOIL, V198, P185, DOI 10.1023/A:1004314406653; Giovannetti M, 2003, APPL ENVIRON MICROB, V69, P616, DOI 10.1128/AEM.69.1.616-624.2003; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; GRYNDLER M, 1992, NEW PHYTOL, V122, P455, DOI 10.1111/j.1469-8137.1992.tb00073.x; Gryndler M, 2008, BIORESOURCE TECHNOL, V99, P6391, DOI 10.1016/j.biortech.2007.11.059; Hoeksema JD, 2010, ECOL LETT, V13, P394, DOI 10.1111/j.1461-0248.2009.01430.x; Jakobsen I., 1995, P297; Janouskova M, 2013, APPL ENVIRON MICROB, V79, P6507, DOI 10.1128/AEM.02135-13; Ji BM, 2013, MOL ECOL, V22, P2573, DOI 10.1111/mec.12268; Jin HY, 2013, MYCORRHIZA, V23, P45, DOI 10.1007/s00572-012-0448-9; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Johnson NC, 1998, J APPL ECOL, V35, P86, DOI 10.1046/j.1365-2664.1998.00277.x; Kabir Z, 1997, PLANT SOIL, V192, P285, DOI 10.1023/A:1004205828485; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Koch AM, 2011, BIOL INVASIONS, V13, P1627, DOI 10.1007/s10530-010-9920-7; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; Kohl L, 2016, PLANT CELL ENVIRON, V39, P136, DOI 10.1111/pce.12600; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Krak K, 2012, APPL ENVIRON MICROB, V78, P3630, DOI 10.1128/AEM.00035-12; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Li HY, 2005, PLANT SOIL, V277, P221, DOI 10.1007/s11104-005-7082-7; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; Maherali H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036695; Maltz MR, 2015, RESTOR ECOL, V23, P625, DOI 10.1111/rec.12231; Mensah JA, 2015, MYCORRHIZA, V25, P533, DOI 10.1007/s00572-015-0631-x; Middleton EL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00152.1; milauer P., 2012, CANOCO REFE; Mummey DL, 2009, SOIL BIOL BIOCHEM, V41, P1173, DOI 10.1016/j.soilbio.2009.02.027; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; Oehl F, 2011, PEDOBIOLOGIA, V54, P321, DOI 10.1016/j.pedobi.2011.07.006; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; PEARSON JN, 1993, NEW PHYTOL, V123, P93, DOI 10.1111/j.1469-8137.1993.tb04534.x; Pellegrino E, 2012, NEW PHYTOL, V194, P810, DOI 10.1111/j.1469-8137.2012.04090.x; Peyret-Guzzon M, 2016, MYCORRHIZA, V26, P33, DOI 10.1007/s00572-015-0644-5; Pinior A, 1999, CAN J BOT, V77, P891, DOI 10.1139/cjb-77-6-891; Puschel D, 2008, PLANT SOIL, V302, P273, DOI 10.1007/s11104-007-9480-5; Raab PA, 2005, MYCOL RES, V109, P1315, DOI 10.1017/S0953756205003977; Robinson-Boyer L, 2009, FUNGAL ECOL, V2, P1, DOI 10.1016/j.funeco.2008.11.001; Roger A, 2013, ISME J, V7, P2137, DOI 10.1038/ismej.2013.112; Schwartz MW, 2006, ECOL LETT, V9, P501, DOI 10.1111/j.1461-0248.2006.00910.x; Sykorova Z, 2012, MYCORRHIZA, V22, P69, DOI 10.1007/s00572-011-0375-1; Symanczik S, 2015, MYCORRHIZA, V25, P639, DOI 10.1007/s00572-015-0638-3; Thonar C, 2014, MOL ECOL, V23, P733, DOI 10.1111/mec.12625; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Verbruggen E, 2013, NEW PHYTOL, V197, P1104, DOI 10.1111/j.1469-8137.2012.04348.x; Werner GDA, 2015, NEW PHYTOL, V205, P1515, DOI 10.1111/nph.13092; WILSON JM, 1984, NEW PHYTOL, V97, P427, DOI 10.1111/j.1469-8137.1984.tb03608.x	66	20	22	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181525	10.1371/journal.pone.0181525	http://dx.doi.org/10.1371/journal.pone.0181525			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738069	Green Submitted, gold, Green Published			2022-12-26	WOS:000406362700050
J	Ellison-Loschmann, L; Sporle, A; Corbin, M; Cheng, S; Harawira, P; Gray, M; Whaanga, T; Guilford, P; Koea, J; Pearce, N				Ellison-Loschmann, Lis; Sporle, Andrew; Corbin, Marine; Cheng, Soo; Harawira, Pauline; Gray, Michelle; Whaanga, Tracey; Guilford, Parry; Koea, Jonathan; Pearce, Neil			Risk of stomach cancer in Aotearoa/New Zealand: A M(a)over-barori population based case-control study	PLOS ONE			English	Article							GASTRIC-CANCER; HELICOBACTER-PYLORI; PASSIVE SMOKING; SOCIAL-CLASS; FOLLOW-UP; MORTALITY; COHORT; ADENOCARCINOMA; METAANALYSIS; INEQUALITIES	M (a) over bar ori, the indigenous people of New Zealand, experience disproportionate rates of stomach cancer, compared to non-Maori. The overall aim of the study was to better understand the reasons for the considerable excess of stomach cancer in M (a) over bar ori and to identify priorities for prevention. Maori stomach cancer cases from the New Zealand Cancer Registry between 1 February 2009 and 31 October 2013 and Maori controls, randomly selected from the New Zealand electoral roll were matched by 5-year age bands to cases. Logistic regression was used to estimate odd ratios (OR) and 95% confidence intervals (CI) between exposures and stomach cancer risk. Post-stratification weighting of controls was used to account for differential non-response by deprivation category. The study comprised 165 cases and 480 controls. Nearly half (47.9%) of cases were of the diffuse subtype. There were differences in the distribution of risk factors between cases and controls. Of interest were the strong relationships seen with increased stomach risk and having >2 people sharing a bedroom in childhood (OR 3.30, 95% CI 1.95-5.59), testing for H pylori (OR 12.17, 95% CI 6.15-24.08), being an ex-smoker (OR 2.26, 95% CI 1.44-3.54) and exposure to environmental tobacco smoke in adulthood (OR 3.29, 95% CI 1.94-5.59). Some results were attenuated following post-stratification weighting. This is the first national study of stomach cancer in any indigenous population and the first M (a) over bar ori-only population-based study of stomach cancer undertaken in New Zealand. We emphasize caution in interpreting the findings given the possibility of selection bias. Population-level strategies to reduce the incidence of stomach cancer in M (a) over bar ori include expanding measures to screen and treat those infected with H pylori and a continued policy focus on reducing tobacco consumption and uptake.	[Ellison-Loschmann, Lis; Corbin, Marine; Cheng, Soo; Gray, Michelle; Whaanga, Tracey] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Sporle, Andrew] Univ Auckland, Dept Stat, Auckland, New Zealand; [Harawira, Pauline] Kimihauora Hlth Ctr, Tauranga, New Zealand; [Guilford, Parry] Univ Otago, Ctr Translat Res, Dunedin, New Zealand; [Koea, Jonathan] Waitemata Dist Hlth Board, Auckland, New Zealand; [Pearce, Neil] London Sch Hyg & Trop Med, Dept Med Stat, London, England	Massey University; University of Auckland; University of Otago; University of London; London School of Hygiene & Tropical Medicine	Ellison-Loschmann, L (corresponding author), Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand.	l.ellison-loschmann@massey.ac.nz		Pearce, Neil/0000-0002-9938-7852; , Lis/0000-0002-9958-3570	Maori Committee of the Health Research Council of New Zealand [HRC 08/258]; Health Research Council of New Zealand	Maori Committee of the Health Research Council of New Zealand; Health Research Council of New Zealand(Health Research Council of New Zealand)	The study was funded by a project grant (HRC 08/258) from the Maori Committee of the Health Research Council of New Zealand. The Centre for Public Health Research is supported by a programme grant from the Health Research Council of New Zealand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, MAOR SMOK TOB US 201; [Anonymous], 2015, CANC NEW REG DEATHS; Arnold M, 2014, GUT, V63, P64, DOI 10.1136/gutjnl-2013-305033; Baker MG, 2013, INFECT DIS ATTRIBUTA; Ball J, 2016, NEW ZEAL MED J, V129, P93; Behrens G, 2014, EUR J EPIDEMIOL, V29, P151, DOI 10.1007/s10654-014-9895-2; Biggar M, 2011, NZ MED J, V124, P1; Blair V, GASTROENTEROLOGY; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Chen MJ, 2004, AM J GASTROENTEROL, V99, P1250, DOI 10.1111/j.1572-0241.2004.30872.x; DOCKERTY JD, 1991, INT J EPIDEMIOL, V20, P45, DOI 10.1093/ije/20.1.45; Duan L, 2009, BRIT J CANCER, V100, P1483, DOI 10.1038/sj.bjc.6605023; Fang XX, 2015, EUR J CANCER, V51, P2820, DOI 10.1016/j.ejca.2015.09.010; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Glover M, 2005, NEW ZEAL J PSYCHOL, V34, P13; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1994, SCHIST LIV FLUK HEL; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee YC, 2016, GUT LIVER, V10, P12, DOI 10.5009/gnl15091; McDonald A, HELICOBACTER, V20, P139; Ministry of Health, 2014, ANN UPD KEY RES 2013; Ministry of Health, 2004, PORTR HLTH KEY RES 2; Ministry of Health, 2016, EUR J CANCER CARE, V25, P214; Ministry of Social Development, 2016, SOC REP 2016 PUR OR; National HBP/ Upper GI Tumour Standards Working Group, 2013, STAND SERV PROV UPP; New Zealand Government, 2020, ED TRAIN ACT 2020; Nishino Y, 2001, CANCER CAUSE CONTROL, V12, P797, DOI 10.1023/A:1012273806199; Norat T, 2002, IARC Sci Publ, V156, P123; Pearce N, 1997, NEW ZEAL MED J, V110, P200; PEARCE NE, 1986, INT J EPIDEMIOL, V15, P456, DOI 10.1093/ije/15.4.456; Plummer M, 2015, INT J CANCER, V136, P487, DOI 10.1002/ijc.28999; Praud D, 2016, EUR J CANCER PREV; Ryan AM, 2006, EUR J CANCER, V42, P1151, DOI 10.1016/j.ejca.2005.12.024; Salmond C., 2007, NZDEP2006 INDEX DEPR; Sarfati D, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-821; Serafini M, 2002, GASTROENTEROLOGY, V123, P985, DOI 10.1053/gast.2002.35957; Signal V, 2015, GASTRIC CANCER, V18, P571, DOI 10.1007/s10120-014-0410-y; Siman JH, 2001, SCAND J GASTROENTERO, V36, P208, DOI 10.1080/003655201750065988; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Teng AM, 2016, GASTRIC CANC; Teng AM, 2017, INT J CANCER, V140, P1306, DOI 10.1002/ijc.30555; Teng AM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2781-4; Tseng CH, 2013, J CLIN GASTROENTEROL, V47, pE60, DOI 10.1097/MCG.0b013e31827245eb; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wiencke JK, 2002, ENVIRON HEALTH PERSP, V110, P555, DOI 10.1289/ehp.02110555; Wu SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-26	52	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181581	10.1371/journal.pone.0181581	http://dx.doi.org/10.1371/journal.pone.0181581			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732086	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000406643100047
J	Sliwicka, E; Cison, T; Kasprzak, Z; Nowak, A; Pilaczynska-Szczesniak, L				Sliwicka, Ewa; Cison, Tomasz; Kasprzak, Zbigniew; Nowak, Alicja; Pilaczynska-Szczesniak, Lucja			Serum irisin and myostatin levels after 2 weeks of high-altitude climbing	PLOS ONE			English	Article							BODY-COMPOSITION CHANGES; SKELETAL-MUSCLE ATROPHY; VITAMIN-D-RECEPTOR; OXIDATIVE STRESS; CYTOKINE RESPONSE; WEIGHT-LOSS; EXERCISE; HYPOXIA; HUMANS; DIFFERENTIATION	Exposure to high-altitude hypoxia causes physiological and metabolic adaptive changes by disturbing homeostasis. Hypoxia-related changes in skeletal muscle affect the closely interconnected energy and regeneration processes. The balance between protein synthesis and degradation in the skeletal muscle is regulated by several molecules such as myostatin, cytokines, vitamin D, and irisin. This study investigates changes in irisin and myostatin levels in male climbers after a 2-week high-altitude expedition, and their association with 25 (OH) D and indices of inflammatory processes. The study was performed in 8 men aged between 23 and 31 years, who participated in a 2-week climbing expedition in the Alps. The measurements of body composition and serum concentrations of irisin, myostatin, 25(OH) D, interleukin-6, myoglobin, high-sensitivity C-reactive protein, osteoprotegerin, and high-sensitivity soluble receptor activator of NF-kappa B ligand (sRANKL) were performed before and after expedition. A 2-week exposure to hypobaric hypoxia caused significant decrease in body mass, body mass index (BMI), free fat mass and irisin, 25-Hydroxyvitamin D levels. On the other hand, significant increase in the levels of myoglobin, high-sensitivity C-reactive protein, interleukin-6, and osteoprotegerin were noted. The observed correlations of irisin with 25(OH) D levels, as well as myostatin levels with inflammatory markers and the OPG/RANKL ratio indicate that these myokines may be involved in the energy-related processes and skeletal muscle regeneration in response to 2-week exposure to hypobaric hypoxia.	[Sliwicka, Ewa; Kasprzak, Zbigniew; Nowak, Alicja; Pilaczynska-Szczesniak, Lucja] Poznan Univ Phys Educ, Dept Hyg, Poznan, Poland; [Cison, Tomasz] State Higher Vocat Sch, Dept Biomed Sci, Nowy Sacz, Poland		Sliwicka, E (corresponding author), Poznan Univ Phys Educ, Dept Hyg, Poznan, Poland.	sliwicka@awf.poznan.pl	Kasprzak, Zbigniew/AAT-9016-2021; Śliwicka, Ewa/ABB-7085-2021	Pilaczynska-Szczesniak, Lucja/0000-0002-3683-9428; Sliwicka, Ewa/0000-0002-5475-3011				Bhat M, 2015, J STEROID BIOCHEM, V152, P171, DOI 10.1016/j.jsbmb.2015.05.012; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chaillou T, 2013, ACTA PHYSIOL, V209, P272, DOI 10.1111/apha.12110; Chang J. S., 2017, GERIATR GERONTOL INT; Chaudhary P, 2012, MOL CELL BIOCHEM, V364, P101, DOI 10.1007/s11010-011-1210-x; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Dufresne SS, 2015, AM J PATHOL, V185, P920, DOI 10.1016/j.ajpath.2015.01.006; Eleganczyk-Kot H, 2011, J HUM KINET, V27, P45; Feng X., 2013, DISCRETE DYN NAT SOC, V2013, P1, DOI DOI 10.1155/2013/160123; FULCO CS, 1992, J APPL PHYSIOL, V72, P2181, DOI 10.1152/jappl.1992.72.6.2181; Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159; Girgis CM, 2014, ENDOCRINOLOGY, V155, P347, DOI 10.1210/en.2013-1205; Hagobian TA, 2006, MED SCI SPORT EXER, V38, P276, DOI 10.1249/01.mss.0000188577.63910.51; Hamad N, 2006, EUR J GASTROEN HEPAT, V18, P5, DOI 10.1097/00042737-200601000-00002; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Himadri P, 2010, HIGH ALT MED BIOL, V11, P231, DOI 10.1089/ham.2009.1057; Hirose L, 2004, EXERC IMMUNOL REV, V10, P75; Hjorth M, 2015, ACTA PHYSL OXF; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; Horscroft JA, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-19; Howald H, 2003, EUR J APPL PHYSIOL, V90, P360, DOI 10.1007/s00421-003-0872-9; Huh JY, 2014, INT J OBESITY, V38, P1538, DOI 10.1038/ijo.2014.42; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Jacobs RA, 2013, EXP PHYSIOL, V98, P245, DOI 10.1113/expphysiol.2012.066092; Kanamaru F, 2004, IMMUNOL LETT, V94, P239, DOI 10.1016/j.imlet.2004.05.010; Kasprzak Z, 2015, HIGH ALT MED BIOL, V16, P230, DOI 10.1089/ham.2015.0008; Kermanac'h NS, 2002, EUR CYTOKINE NETW, V13, P144; Kirk S, 2000, J CELL PHYSIOL, V184, P356, DOI 10.1002/1097-4652(200009)184:3<356::AID-JCP10>3.0.CO;2-R; Lee MJ, 2015, ATHEROSCLEROSIS, V242, P476, DOI 10.1016/j.atherosclerosis.2015.08.002; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Magalhaes J, 1985, J APPL PHYSIOL, V99, P1247, DOI DOI 10.1152/JAPPLPHYSI01.01324.2004; Martin DS, 2010, EXP PHYSIOL, V95, P463, DOI 10.1113/expphysiol.2009.047589; Mazzeo RS, 2008, SPORTS MED, V38, P1, DOI 10.2165/00007256-200838010-00001; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Ostrowski K, 2000, EUR J APPL PHYSIOL, V83, P512, DOI 10.1007/s004210000312; Peake JM, 2005, MED SCI SPORT EXER, V37, P737, DOI 10.1249/01.MSS.0000161804.05399.3B; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Philippou A, 2009, CLIN CHEM LAB MED, V47, P777, DOI 10.1515/CCLM.2009.163; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Shimamura M, 2014, P NATL ACAD SCI USA, V111, P8191, DOI 10.1073/pnas.1400544111; SILLAU AH, 1977, PFLUG ARCH EUR J PHY, V370, P227, DOI 10.1007/BF00585531; Sinha A, 2013, J CLIN ENDOCR METAB, V98, pE509, DOI 10.1210/jc.2012-3592; Stratos I, 2013, AM J PATHOL, V182, P895, DOI 10.1016/j.ajpath.2012.11.006; Vaughan RA, 2015, J PHYSIOL BIOCHEM, V71, P679, DOI 10.1007/s13105-015-0433-9; Zaccagni L, 2014, HIGH ALT MED BIOL, V15, P176, DOI 10.1089/ham.2013.1133; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	50	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181259	10.1371/journal.pone.0181259	http://dx.doi.org/10.1371/journal.pone.0181259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732027	Green Submitted, Green Published, gold			2022-12-26	WOS:000406643100029
J	D'Souza, WN; Douangpanya, J; Mu, SR; Jaeckel, P; Zhang, M; Maxwell, JR; Rottman, JB; Labitzke, K; Willee, A; Beckmann, H; Wang, YC; Li, Y; Schwandner, R; Johnston, JA; Towne, JE; Hsu, HL				D'Souza, Warren N.; Douangpanya, Jason; Mu, Sharon; Jaeckel, Peter; Zhang, Ming; Maxwell, Joseph R.; Rottman, James B.; Labitzke, Katja; Willee, Angela; Beckmann, Holger; Wang, Yingcai; Li, Yang; Schwandner, Ralf; Johnston, James A.; Towne, Jennifer E.; Hsu, Hailing			Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROTEIN-COUPLED RECEPTOR; DEXTRAN SULFATE COLITIS; NF-KAPPA-B; METABOLITE BUTYRATE; MONONUCLEAR-CELLS; EPITHELIAL-CELLS; GUT INFLAMMATION; CROHNS-DISEASE; UP-REGULATION	Inflammatory bowel disease (IBD) is associated with a loss of intestinal barrier function and dysregulated immune responses. It has been shown that short chain fatty acids (SCFAs) are protective in IBD and that GPR43 mediates the protective effects of SCFAs. In this study, we investigated the effects of SCFAs in comparison to highly specific GPR43 agonists on human intestinal epithelial and immune cells. Our results confirm that SCFAs are enhancers of barrier function in intestinal epithelial cells. Additionally, SCFAs also displayed potent immunoregulatory properties based upon the ability to inhibit LPS-induced cytokine production in PBMC, and human T cell proliferation and cytokine production. Unexpectedly, and in contrast to the current belief, specific GPR43 agonists failed to exhibit similar barrier enhancing and anti-inflammatory properties. These findings demonstrate that SCFA possess broad protective functions in IBD and agonizing GPR43 alone is unlikely to be beneficial in patients.	[D'Souza, Warren N.; Mu, Sharon; Zhang, Ming; Willee, Angela; Johnston, James A.; Hsu, Hailing] Amgen Inc, Thousand Oaks, CA 91320 USA; [Douangpanya, Jason; Maxwell, Joseph R.; Towne, Jennifer E.] Amgen Inc, Seattle, WA USA; [Jaeckel, Peter; Labitzke, Katja; Beckmann, Holger; Schwandner, Ralf] Amgen Inc, Regensburg, Germany; [Rottman, James B.] Amgen Inc, Cambridge, MA USA; [Wang, Yingcai; Li, Yang] Amgen Inc, San Francisco, CA USA	Amgen; Amgen; Amgen; Amgen Research Munich GmbH; Amgen; Amgen	D'Souza, WN (corresponding author), Amgen Inc, Thousand Oaks, CA 91320 USA.	wdsouza@amgen.com			Amgen	Amgen(Amgen)	Amgen provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aoyama M, 2010, NUTRITION, V26, P653, DOI 10.1016/j.nut.2009.07.006; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Boismenu R, 2000, J LEUKOCYTE BIOL, V67, P267, DOI 10.1002/jlb.67.3.267; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Butzner JD, 1996, GUT, V38, P568, DOI 10.1136/gut.38.4.568; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448; EFTIMIADI C, 1987, J INFECTION, V14, P43, DOI 10.1016/S0163-4453(87)90808-5; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Mariadason JM, 1997, AM J PHYSIOL-GASTR L, V272, pG705, DOI 10.1152/ajpgi.1997.272.4.G705; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Masui R, 2013, INFLAMM BOWEL DIS, V19, P2848, DOI 10.1097/01.MIB.0000435444.14860.ea; Mishiro T, 2013, LAB INVEST, V93, P834, DOI 10.1038/labinvest.2013.70; Nancy S, 2002, DIGEST DIS SCI, V47, P921, DOI 10.1023/A:1014781109498; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Okamoto T, 2000, J GASTROENTEROL, V35, P341, DOI 10.1007/s005350050358; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Saemann MD, 2000, FASEB J, V14, P2380; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Schultsz C, 1999, GASTROENTEROLOGY, V117, P1089, DOI 10.1016/S0016-5085(99)70393-8; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Soldavini J, 2013, DIGEST DIS SCI, V58, P2756, DOI 10.1007/s10620-013-2744-4; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Venkatraman A, 2000, SCAND J GASTROENTERO, V35, P1053; Venkatraman A, 2003, AM J PHYSIOL-GASTR L, V285, pG177, DOI 10.1152/ajpgi.00307.2002; Vieira ELM, 2012, J NUTR BIOCHEM, V23, P430, DOI 10.1016/j.jnutbio.2011.01.007; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Wilson AJ, 1997, GASTROENTEROLOGY, V113, P487, DOI 10.1053/gast.1997.v113.pm9247468	50	69	74	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180190	10.1371/journal.pone.0180190	http://dx.doi.org/10.1371/journal.pone.0180190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727837	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500017
J	Sanchez, P; Everett, B; Salamonson, Y; Ajwani, S; Bhole, S; Bishop, J; Lintern, K; Nolan, S; Rajaratnam, R; Redfern, J; Sheehan, M; Skarligos, F; Spencer, L; Srinivas, R; George, A				Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Ajwani, Shilpi; Bhole, Sameer; Bishop, Joshua; Lintern, Karen; Nolan, Samantha; Rajaratnam, Rohan; Redfern, Julie; Sheehan, Maria; Skarligos, Fiona; Spencer, Lissa; Srinivas, Ravi; George, Ajesh			Oral health and cardiovascular care: Perceptions of people with cardiovascular disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PERIODONTAL-DISEASE; MYOCARDIAL-INFARCTION; CONSENSUS REPORT; PREGNANT-WOMEN; RISK; MIDWIVES; PROGRAM; METAANALYSIS	Main objective The aim of this study was to explore the perception of patients with cardiovascular disease towards oral health and the potential for cardiac care clinicians to promote oral health. Method A needs assessment was undertaken with twelve patients with cardiovascular disease attending cardiac rehabilitation between 2015 and 2016, in three metropolitan hospitals in Sydney, Australia. These patients participated in face-to-face semi-structured interviews. Data was analysed using thematic analysis. Results Results suggested that while oral health was considered relevant there was high prevalence of poor oral health among participants, especially those from socioeconomic disadvantaged background. Awareness regarding the importance of oral health care its impact on cardiovascular outcomes was poor among participants. Oral health issues were rarely discussed in the cardiac setting. Main barriers deterring participants from seeking oral health care included lack of awareness, high cost of dental care and difficulties in accessing the public dental service. Findings also revealed that participants were interested in receiving further information about oral health and suggested various mediums for information delivery. The concept of cardiac care clinicians, especially nurses providing education, assessment and referrals to ongoing dental care was well received by participants who felt the post-acute period was the most appropriate time to receive oral health care advice. The issues of oral health training for non-dental clinicians and how to address existing barriers were highlighted by participants. Relevance to clinical practice The lack of oral health education being provided to patients with cardiovascular disease offers an opportunity to improve care and potentially, outcomes. In view of the evidence linking poor oral health with cardiovascular disease, cardiac care clinicians, especially nurses, should be appropriately trained to promote oral health in their practice. Affordable and accessible dental care services for people with cardiovascular disease should be considered and offered by health services in Australia.	[Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Srinivas, Ravi; George, Ajesh] Western Sydney Univ, Sch Nursing & Midwifery, Sydney, NSW, Australia; [Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Lintern, Karen; Rajaratnam, Rohan; Sheehan, Maria; Srinivas, Ravi; George, Ajesh] South Western Sydney Local Hlth Dist, Sydney, NSW, Australia; [Sanchez, Paula; Srinivas, Ravi; George, Ajesh] Collaborat Oral Hlth Outcomes Res Translat & Eval, Liverpool, Australia; [Sanchez, Paula; Everett, Bronwyn; Salamonson, Yenna; Srinivas, Ravi; George, Ajesh] Ingham Inst Appl Med Res, Liverpool, Australia; [Everett, Bronwyn; Salamonson, Yenna] Ctr Appl Nursing Res, Liverpool, Australia; [Ajwani, Shilpi; Bhole, Sameer; Bishop, Joshua; Nolan, Samantha; Skarligos, Fiona; Spencer, Lissa] Sydney Local Hlth Dist, Sydney, NSW, Australia; [Ajwani, Shilpi; Bhole, Sameer] Sydney Dent Hosp, Oral Hlth Serv, Sydney, NSW, Australia; [Ajwani, Shilpi; Bhole, Sameer; George, Ajesh] Univ Sydney, Fac Dent, Sydney, NSW, Australia; [Rajaratnam, Rohan] Western Sydney Univ, Sch Med, Sydney, NSW, Australia; [Rajaratnam, Rohan] Univ New South Wales, Sydney, NSW, Australia; [Redfern, Julie] George Inst Global Hlth, Sydney, NSW, Australia; [Redfern, Julie] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; University of Sydney; Western Sydney University; University of New South Wales Sydney; George Institute for Global Health; University of Sydney; University of Sydney	Sanchez, P (corresponding author), Western Sydney Univ, Sch Nursing & Midwifery, Sydney, NSW, Australia.; Sanchez, P (corresponding author), South Western Sydney Local Hlth Dist, Sydney, NSW, Australia.; Sanchez, P (corresponding author), Collaborat Oral Hlth Outcomes Res Translat & Eval, Liverpool, Australia.; Sanchez, P (corresponding author), Ingham Inst Appl Med Res, Liverpool, Australia.	paula.sanchez@sswahs.nsw.gov.au	Salamonson, Yenna/AAX-4499-2020; Sanchez, Paula/ABG-8563-2021; Redfern, Julie/AAM-8617-2020; George, Ajesh/AAW-7813-2020; Everett, Bronwyn Lee/AAT-1308-2021	Redfern, Julie/0000-0001-8707-5563; George, Ajesh/0000-0002-6795-2546; Everett, Bronwyn/0000-0003-1733-7462; Rajaratnam, Rohan/0000-0002-7643-0221; Bhole, Sameer/0000-0002-3111-6335	Australian Postgraduate Award PhD scholarship through Western Sydney University; NHMRC Career Development Fellowship - National Heart Foundation Future Fellowship [1061793, G160523]	Australian Postgraduate Award PhD scholarship through Western Sydney University; NHMRC Career Development Fellowship - National Heart Foundation Future Fellowship	This study was supported by an Australian Postgraduate Award PhD scholarship through Western Sydney University. JR is funded by a NHMRC Career Development Fellowship (1061793) co-funded with a National Heart Foundation Future Fellowship (G160523).	American Heart Association, 2015, WHAT IS CARD DIS; Andersen R, 1995, REVISITING BEHAV MOD; [Anonymous], 2015, NAT REV IMMUNOL, DOI [DOI 10.1902/jop.2009.097001, DOI 10.1038/nri3785]; Australian Commission on Safety and Quality in Health Care, 2013, CONS HLTH SYST HLTH; Australian Dental Association, 2016, DENT PRACT SURV 2013; Australian Education Network, 2016, AUSTR U GUID; [Australian Government. Healthy Mouths Council CoAGCH], 2015, HLTH LIV AUSTR NAT O, P1; Australian Institute of Health and Welfare, 2016, COST DENT CAR; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Bartova J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/636893; Beukers NGFM, 2017, J EPIDEMIOL COMMUN H, V71, P37, DOI 10.1136/jech-2015-206745; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Bouchard P, 2010, EUR HEART J SUPPL, V12, pB13, DOI 10.1093/eurheartj/suq001; Bowyer V, 2011, BRIT DENT J, V211, DOI 10.1038/sj.bdj.2011.769; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Campbell PC, 2015, AWARENESS METHOD ORA; Caula AL, 2014, J CLIN PERIODONTOL, V41, P875, DOI 10.1111/jcpe.12290; Chalmers JM, 2005, SPEC CARE DENT, V25, P227, DOI 10.1111/j.1754-4505.2005.tb01654.x; CHOICE Australia, 2013, MOUTH DENT FEES; Chrisopoulos S, 2016, ORAL HLTH DENT CARE; Clemmens DA, 2008, MCN-AM J MATERN-CHIL, V33, P10, DOI 10.1097/01.NMC.0000305650.56000.e8; D'Aiuto F, 2013, J CLIN PERIODONTOL, V40, pS85, DOI [10.1902/jop.2013.134007, 10.1111/jcpe.12061]; Demmer RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077441; Dhadse Prasad, 2010, J Indian Soc Periodontol, V14, P148, DOI 10.4103/0972-124X.75908; Dolce MC, 2014, J PROF NURS, V30, P63, DOI 10.1016/j.profnurs.2013.06.002; Dorn JM, 2010, J PERIODONTOL, V81, P502, DOI 10.1902/jop.2009.090499; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Flores MF, 2014, J PERIODONTOL, V85, P545, DOI 10.1902/jop.2013.130255; Frenkel H, 2002, COMMUNITY DENT ORAL, V30, P91, DOI 10.1034/j.1600-0528.2002.300202.x; Furr LA, 2004, J ADV NURS, V48, P454, DOI 10.1111/j.1365-2648.2004.03228.x; Fusch PI, 2015, QUAL REP, V20, P1408; Genco R. J., 2010, PERIODONTAL DIS OVER; George A, 2013, 10 WORLD C PREV DENT; George A, 2016, WOMEN BIRTH, V29, P208, DOI 10.1016/j.wombi.2015.10.004; George A, 2015, HEALTH CARE WOMEN IN, V36, P1160, DOI 10.1080/07399332.2014.959170; George A, 2012, J CLIN NURS, V21, P1087, DOI 10.1111/j.1365-2702.2011.03870.x; George A, 2010, J CLIN NURS, V19, P3324, DOI 10.1111/j.1365-2702.2010.03426.x; Ghapanchi J, 2016, BR J MED MED RES, V11, P1; Gomes IS, 2011, J PERIODONTOL, V82, P969, DOI 10.1902/jop.2010.100511; Government of South Australia, 2011, STAT CARD CLIN NETW; Griffiths J, 2002, JDOH, V3, P30; Heart Foundation, 2014, DIR NSW ACT CARD HLT; Heilbrunn-Lang AY, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0536-x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Ioannidou E, 2006, J PERIODONTOL, V77, P1635, DOI 10.1902/jop.2006.050443; Johnson NA, 2010, AUST J ADV NURS, V27, P31; Joshy G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012386; Kandelman D, 2012, PERIODONTOL 2000, V60, P98, DOI 10.1111/j.1600-0757.2011.00427.x; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Khader YS, 2004, J PERIODONTOL, V75, P1046, DOI 10.1902/jop.2004.75.8.1046; Kinane D, 2008, J CLIN PERIODONTOL, V35, P333, DOI 10.1111/j.1600-051X.2008.01278.x; Kuramoto C, 2011, GERIATR GERONTOL INT, V11, P460, DOI 10.1111/j.1447-0594.2011.00709.x; Lam OLT, 2011, INT J CARDIOL, V151, P261, DOI 10.1016/j.ijcard.2010.11.014; Leng WD, 2015, INT J CARDIOL, V201, P469, DOI 10.1016/j.ijcard.2015.07.087; Li CJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009197.pub2; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Loos BG, 2016, ORAL INFECT GEN HLTH, P19; Maher L, 2012, HEALTH PROMOT J AUST, V23, P171, DOI 10.1071/HE12171; Montebugnoli L, 2002, J AM DENT ASSOC, V133, P468, DOI 10.14219/jada.archive.2002.0205; Moura Foz A, 2010, Minerva Stomatol, V59, P271; National Health Service England, 2014, IMPR DENT CAR OR HLT; Niwa H, 2000, ORAL SURG ORAL MED O, V89, P35, DOI 10.1016/S1079-2104(00)80011-6; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Petersen PE, 2009, COMMUNITY DENT ORAL, V37, P1, DOI 10.1111/j.1600-0528.2008.00448.x; QRS International Pty Ltd, 2015, NVIVO QUAL DAT AN SO; Rasouli-Ghahroudi AA, 2016, ARYA ATHEROSCLER, V12, P1; Sanchez P, 2017, J CARDIOVASC NURS, V32, pE10, DOI 10.1097/JCN.0000000000000388; Schwarz E, 2006, COMMUNITY DENT ORAL, V34, P225, DOI 10.1111/j.1600-0528.2006.00301.x; SLHD Sydney Cardiothoracic Surgeons, 2016, HEART VAL SURG BOOKL; Song M, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-65; Stevens J, 2007, JOGNN-J OBST GYN NEO, V36, P581, DOI [10.1111/j.1552-6909.2007.00189.x, 10.1111/J.1552-6909.2007.00189.x]; Teeuw WJ, 2014, J CLIN PERIODONTOL, V41, P70, DOI 10.1111/jcpe.12171; Teles R, 2011, ORAL DIS, V17, P450, DOI 10.1111/j.1601-0825.2010.01784.x; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Vieira CLZ, 2009, ORAL DIS, V15, P538, DOI 10.1111/j.1601-0825.2009.01589.x; Virdee P, 2006, BRIT DENT J, V201, P132, DOI 10.1038/sj.bdj.4813891; World Health Organization, 2016, INT STAT CLASS DIS R, V10th	78	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181189	10.1371/journal.pone.0181189	http://dx.doi.org/10.1371/journal.pone.0181189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727751	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500044
J	Carmon, KS; Gong, X; Yi, J; Wu, L; Thomas, A; Moore, CM; Masuho, I; Timson, DJ; Martemyanov, KA; Liu, QJY				Carmon, Kendra S.; Gong, Xing; Yi, Jing; Wu, Ling; Thomas, Anthony; Moore, Catherine M.; Masuho, Ikuo; Timson, David J.; Martemyanov, Kirill A.; Liu, Qingyun J.			LGR5 receptor promotes cell-cell adhesion in stem cells and colon cancer cells via the IQGAP1-Rac1 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; WNT RECEPTORS; E3 LIGASE; MEMBRANE; BINDING; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION; ENDOCYTOSIS; RECOGNITION	Leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5) is a bona fide marker of adult stem cells in several epithelial tissues, most notably in the intestinal crypts, and is highly up-regulated in many colorectal, hepatocellular, and ovarian cancers. LGR5 activation by R-spondin (RSPO) ligands potentiates Wnt/beta-catenin signaling in vitro; however, deletion of LGR5 in stem cells has little or no effect on Wnt/beta-catenin signaling or cell proliferation in vivo. Remarkably, modulation of LGR5 expression has a major impact on the actin cytoskeletal structure and cell adhesion in the absence of RSPO stimulation, but the molecular mechanism is unclear. Here, we show that LGR5 interacts with IQ motif-containing GTPase-activating protein 1 (IQGAP1), an effector of Rac1/CDC42 GTPases, in the regulation of actin cytoskeleton dynamics and cell-cell adhesion. Specifically, LGR5 decreased levels of IQGAP1 phosphorylation at Ser-1441/1443, leading to increased binding of Rac1 to IQGAP1 and thus higher levels of cortical F-actin and enhanced cell-cell adhesion. LGR5 ablation in colon cancer cells and crypt stem cells resulted in loss of cortical F-actin, reduced cell-cell adhesion, and disrupted localization of adhesion-associated proteins. No evidence of LGR5 coupling to any of the four major subtypes of heterotrimeric G proteins was found. These findings suggest that LGR5 primarily functions via the IQGAP1-Rac1 pathway to strengthen cell-cell adhesion in normal adult crypt stem cells and colon cancer cells.	[Carmon, Kendra S.; Gong, Xing; Yi, Jing; Wu, Ling; Thomas, Anthony; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA; [Carmon, Kendra S.; Gong, Xing; Yi, Jing; Wu, Ling; Thomas, Anthony; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Yi, Jing] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Moore, Catherine M.; Timson, David J.] Queens Univ Belfast, Med Biol Ctr, Sch Biol Sci, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Timson, David J.] Univ Brighton, Sch Pharm & Biomol Sci, Huxley Bldg,Lewes Rd, Brighton BN2 4GJ, E Sussex, England; [Moore, Catherine M.] St Georges Univ London, Div Clin Sci, Ctr Infect & Immun, Cranmer Terrace, London SW17 0RE, England	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Queens University Belfast; Scripps Research Institute; University of Brighton; St Georges University London	Liu, QJY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA.	Qingyun.liu@uth.tmc.edu	Moore, Catherine M/AAS-9688-2021	Moore, Catherine M/0000-0001-6678-6999; Carmon, Kendra/0000-0002-3244-6096; Timson, David/0000-0002-0985-8818	Cancer Prevention and Research Institute of Texas [RP100678]; National Institutes of Health [R01GM102485, MH105482]; Texas Emerging Technology Fund; Janice D. Gordon endowment for bowel cancer research; Biotechnology and Biological Sciences Research Council UK [BB/D000394/1]; Action Cancer, Northern Ireland, UK [PG2 2005]; BBSRC [BB/D000394/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/D000394/1] Funding Source: researchfish	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Emerging Technology Fund; Janice D. Gordon endowment for bowel cancer research; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Action Cancer, Northern Ireland, UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Prevention and Research Institute of Texas Grant RP100678, National Institutes of Health Grant R01GM102485, the Texas Emerging Technology Fund, and the Janice D. Gordon endowment for bowel cancer research (to Q.J.L.); Biotechnology and Biological Sciences Research Council UK Grant BB/D000394/1 and Action Cancer, Northern Ireland, UK Grant PG2 2005 (to D.J.T.); and National Institutes of Health Grant MH105482 (to K.A.M.). Q.J.L. is a co-founder of Wntrix. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BRAUTBOUCHER F, 1995, J IMMUNOL METHODS, V178, P41, DOI 10.1016/0022-1759(94)00239-S; Brieher WM, 2013, CURR OPIN CELL BIOL, V25, P39, DOI 10.1016/j.ceb.2012.10.010; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Carter RL, 2009, MOL PHARMACOL, V76, P1341, DOI 10.1124/mol.109.058578; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Elliott Sarah F, 2012, World J Biol Chem, V3, P53, DOI 10.4331/wjbc.v3.i3.53; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fukuma M, 2013, EXP CELL RES, V319, P113, DOI 10.1016/j.yexcr.2012.10.011; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Glatt S, 2008, INT J CANCER, V122, P2008, DOI 10.1002/ijc.23349; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Gong X, 2016, MOL CANCER THER, V15, P1580, DOI 10.1158/1535-7163.MCT-16-0114; Gong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037137; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Kwon MS, 2013, MOL CELLS, V36, P267, DOI 10.1007/s10059-013-0173-z; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; McDonald T, 1998, BIOCHEM BIOPH RES CO, V247, P266, DOI 10.1006/bbrc.1998.8774; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; PHILLIPS DR, 1980, J CELL BIOL, V86, P77, DOI 10.1083/jcb.86.1.77; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Snyder JC, 2017, J BIOL CHEM, V292, P7208, DOI 10.1074/jbc.M116.756635; Snyder JC, 2015, J CELL SCI, V128, P1230, DOI 10.1242/jcs.166322; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Zebisch M, 2015, PROG BIOPHYS MOL BIO, V118, P112, DOI 10.1016/j.pbiomolbio.2015.04.006; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	58	40	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14989	15001		10.1074/jbc.M117.786798	http://dx.doi.org/10.1074/jbc.M117.786798			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28739799	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000409902100022
J	Elissen, AMJ; Hertroijs, DFL; Schaper, NC; Bosma, H; Dagnelie, PC; Henry, RM; van der Kallen, CJ; Koster, A; Schram, MT; Stehouwer, CDA; Schouten, JSAG; Berendschot, TTJM; Ruwaard, D				Elissen, Arianne M. J.; Hertroijs, Dorijn F. L.; Schaper, Nicolaas C.; Bosma, Hans; Dagnelie, Pieter C.; Henry, Ronald M.; van der Kallen, Carla J.; Koster, Annemarie; Schram, Miranda T.; Stehouwer, Coen D. A.; Schouten, Johannes S. A. G.; Berendschot, Tos T. J. M.; Ruwaard, Dirk			Differences in biopsychosocial profiles of diabetes patients by level of glycaemic control and health-related quality of life: The Maastricht Study	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; CHRONIC CARE; MANAGEMENT; COMPLICATIONS; DETERMINANTS; LESSONS; PREDICT; UTILITY; PEOPLE; NUMBER	Aims Tailored, patient-centred innovations are needed in the care for persons with type 2 diabetes mellitus (T2DM), in particular those with insufficient glycaemic control. Therefore, this study sought to assess their biopsychosocial characteristics and explore whether distinct biopsychosocial profiles exist within this subpopulation, which differ in health-related quality of life (HRQoL). Methods Cross-sectional study based on data from The Maastricht Study, a population-based cohort study focused on the aetiology, pathophysiology, complications, and comorbidities of T2DM. We analysed associations and clustering of glycaemic control and HRQoL with 38 independent variables (i.e. biopsychosocial characteristics) in different subgroups and using descriptive analyses, latent class analysis (LCA), and logistic regressions. Results Included were 840 persons with T2DM, mostly men (68.6%) and with a mean age of 62.6 (+/- 7.7) years. Mean HbA1c was 7.1% (+/- 3.2%); 308 patients (36.7%) had insufficient glycaemic control (HbA1c>7.0% [53 mmol/mol]). Compared to those with sufficient control, these patients had a significantly worse-off status on multiple biopsychosocial factors, including self-efficacy, income, education and several health-related characteristics. Two 'latent classes' were identified in the insufficient glycaemic control subgroup: with low respectively high HRQoL. Of the two, the low HRQoL class comprised about one-fourth of patients and had a significantly worse biopsychosocial profile. Conclusions Insufficient glycaemic control, particularly in combination with low HRQoL, is associated with a generally worse biopsychosocial profile. Further research is needed into the complex and multidimensional causal pathways explored in this study, so as to increase our understanding of the heterogeneous care needs and preferences of persons with T2DM, and translate this knowledge into tailored care and support arrangements.	[Elissen, Arianne M. J.; Hertroijs, Dorijn F. L.; Ruwaard, Dirk] Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands; [Elissen, Arianne M. J.; Hertroijs, Dorijn F. L.; Schaper, Nicolaas C.; Bosma, Hans; Dagnelie, Pieter C.; Koster, Annemarie; Ruwaard, Dirk] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Schaper, Nicolaas C.; Henry, Ronald M.; van der Kallen, Carla J.; Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Schaper, Nicolaas C.; Dagnelie, Pieter C.; Henry, Ronald M.; van der Kallen, Carla J.; Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Bosma, Hans; Koster, Annemarie] Maastricht Univ, Dept Social Med, Maastricht, Netherlands; [Dagnelie, Pieter C.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Schram, Miranda T.] Maastricht Univ, Med Ctr, Heart & Vasc Ctr, Maastricht, Netherlands; [Schouten, Johannes S. A. G.; Berendschot, Tos T. J. M.] Maastricht Univ, Med Ctr, Univ Eye Clin Maastricht, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Elissen, AMJ (corresponding author), Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands.; Elissen, AMJ (corresponding author), Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands.	a.elissen@maastrichtuniversity.nl	Schaper, Nicolaas C/E-7112-2014; Koster, Annemarie/E-7438-2010; Berendschot, Tos TJM/M-8509-2016; Stehouwer, Coen/AAB-3435-2021; Bosma, Hans/A-6184-2013	Koster, Annemarie/0000-0003-1583-7391; Berendschot, Tos TJM/0000-0002-8101-939X; Stehouwer, Coen/0000-0001-8752-3223; van der Kallen, Carla/0000-0003-1468-8793; Ruwaard, Dirk/0000-0003-4887-8413; schaper, nicolaas/0000-0002-2128-8029	Novo Nordisk Farma B.V.; European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs [310.041]; Stichting De Weijerhorst (Maastricht, the Netherlands); Pearl String Initiative Diabetes (Amsterdam, the Netherlands); Cardiovascular Center (CVC, Maastricht, the Netherlands); Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands); School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands); School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)	Novo Nordisk Farma B.V.(Novo Nordisk); European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting De Weijerhorst (Maastricht, the Netherlands)(Netherlands Government); Pearl String Initiative Diabetes (Amsterdam, the Netherlands)(Netherlands Government); Cardiovascular Center (CVC, Maastricht, the Netherlands); Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands); School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands)(Netherlands Government); School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)(Netherlands Government)	This study was sponsored by Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands; no grant number assigned). The Maastricht Study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 310.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands), School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands), School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Banerji Mary Ann, 2013, Am Health Drug Benefits, V6, P382; Beckerle C. M., 2013, Diabetes Spectrum, V26, P172, DOI 10.2337/diaspect.26.3.172; Bosma H, 2006, SOCIAL INEQUALITIES, P153; Bosscher R. J., 1992, BEWEGEN HULPVERLENIN, V9, P225; Cebolla Garrofe B, 2014, EURO DIABETES INDEX; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; de Bakker DH, 2012, HEALTH AFFAIR, V31, P426, DOI 10.1377/hlthaff.2011.0912; Dogan H, 2016, J AM SOC HYPERTENS, V10, P81, DOI 10.1016/j.jash.2015.11.014; Elissen AMJ, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2208; Elissen AMJ, 2013, J EVAL CLIN PRACT, V19, P753, DOI 10.1111/j.1365-2753.2012.01817.x; Elissen AMJ, 2012, AM J MANAG CARE, V18, P619; Finch WH, 2011, STRUCT EQU MODELING, V18, P132, DOI 10.1080/10705511.2011.532732; Groffen DAI, 2012, EUR J PUBLIC HEALTH, V22, P587, DOI 10.1093/eurpub/ckr063; Health Council of the Netherlands, 2006, GUID HLTH DIET 2006; InEen. Transparent integrated care, 2016, REP 2015 CAR GROUPS; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Klabbers G, 2014, J BEHAV MED, V37, P357, DOI 10.1007/s10865-013-9493-x; Kleefstra N, 2016, J DIABETES, V8, P863, DOI 10.1111/1753-0407.12370; Kohnert KD, 2015, WORLD J DIABETES, V6, P17, DOI 10.4239/wjd.v6.i1.17; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lau C Y, 2004, J Postgrad Med, V50, P189; Lloyd A, 2001, Value Health, V4, P392, DOI 10.1046/j.1524-4733.2001.45029.x; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Luteijn F, 2000, HANDLEIDING BIJ NPV; Martens RJH, 2017, AM J KIDNEY DIS, V69, P179, DOI 10.1053/j.ajkd.2016.04.017; Mertens VC, 2012, EUR J PUBLIC HEALTH, V22, P666, DOI 10.1093/eurpub/ckr104; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; National Institute for Public Health and the Environment (RIVM), 2015, HLTH REL QUAL LIF DE; Netherlands Diabetes Federation (NDF). NDF Care Standard, 2015, NDF CAR STAND TRANSP; Nolte E, 2012, HEALTH ECON POLICY L, V7, P125, DOI 10.1017/S1744133111000338; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; OECD, 2012, QUAL REV OECD DAT HO; Oliva J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-812; Pandey R, 2015, TRAC-TREND ANAL CHEM, V64, P100, DOI 10.1016/j.trac.2014.09.005; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Porter ME, 2016, NEW ENGL J MED, V374, P504, DOI 10.1056/NEJMp1511701; Riddle MC, 2012, DIABETES CARE, V35, P2100, DOI 10.2337/dc12-0650; Rijken M., 2008, CARING PEOPLE CHRONI, P116; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549; Smith RC, 2002, J GEN INTERN MED, V17, P309, DOI 10.1046/j.1525-1497.2002.20210.x; Snoek F, 2006, PROBLEM AREAS DIABET; Spauwen PJJ, 2016, DIABETIC MED, V33, P1632, DOI 10.1111/dme.13105; StataCorp, 2015, STAT STAT SOFTW REL; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; Struijs JN, 2016, BUNDLED HLTH CARE PA; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Vermunt JK., 2004, SAGE ENCY SOCIAL SCI; Ware J.E., 1994, SF 36 PHYS MENTAL HL; WHO/Europe, 2006, PREVENTION CONTROL N	52	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0182053	10.1371/journal.pone.0182053	http://dx.doi.org/10.1371/journal.pone.0182053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1CT	28750026	gold, Green Published, Green Submitted			2022-12-26	WOS:000406575700123
J	Nova, IC; Derrington, IM; Craig, JM; Noakes, MT; Tickman, BI; Doering, K; Higinbotham, H; Laszlo, AH; Gundlach, JH				Nova, Ian C.; Derrington, Ian M.; Craig, Jonathan M.; Noakes, Matthew T.; Tickman, Benjamin I.; Doering, Kenji; Higinbotham, Hugh; Laszlo, Andrew H.; Gundlach, Jens H.			Investigating asymmetric salt profiles for nanopore DNA sequencing with biological porin MspA	PLOS ONE			English	Article							IONIC SELECTIVITY; TRANSLOCATION; NUCLEOTIDE; MOLECULES; CHANNEL	Nanopore DNA sequencing is a promising single-molecule analysis technology. This technique relies on a DNA motor enzyme to control movement of DNA precisely through a nanopore. Specific experimental buffer conditions are required based on the preferred operating conditions of the DNA motor enzyme. While many DNA motor enzymes typically operate in salt concentrations under 100 mM, salt concentration simultaneously affects signal and noise magnitude as well as DNA capture rate in nanopore sequencing, limiting standard experimental conditions to salt concentrations greater than similar to 100 mM in order to maintain adequate resolution and experimental throughput. We evaluated the signal contribution from ions on both sides of the membrane (cis and trans) by varying cis and trans [KCl] independently during phi29 DNA Polymerase-controlled translocation of DNA through the biological porin MspA. Our studies reveal that during DNA translocation, the negatively charged DNA increases cation selectivity through MspA with the majority of current produced by the flow of K+ ions from trans to cis. Varying trans [K+] has dramatic effects on the signal magnitude, whereas changing cis [Cl-] produces only small effects. Good signal-to-noise can be maintained with cis [Cl-] as small as 20 mM, if the concentration of KCl on the trans side is kept high. These results demonstrate the potential of using salt-sensitive motor enzymes (helicases, polymerases, recombinases) in nanopore systems and offer a guide for selecting buffer conditions in future experiments to simultaneously optimize signal, throughput, and enzyme activity.	[Nova, Ian C.; Derrington, Ian M.; Craig, Jonathan M.; Noakes, Matthew T.; Tickman, Benjamin I.; Doering, Kenji; Higinbotham, Hugh; Laszlo, Andrew H.; Gundlach, Jens H.] Univ Washington, Dept Phys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gundlach, JH (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	jens@phys.washington.edu	Noakes, Matthew/AAI-7657-2020	Craig, Jonathan M/0000-0003-4791-5112; Higinbotham, Hugh/0000-0002-9418-7958; Gundlach, Jens Horst/0000-0002-0773-8038	National Institute of Health, National Human Genome Research Institute [R01HG005115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005115] Funding Source: NIH RePORTER	National Institute of Health, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institute of Health, National Human Genome Research Institute (httbs://www.genome.gov/) grant R01HG005115. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz A, 2004, BIOPHYS J, V87, P943, DOI 10.1529/biophysj.104/043414; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Butler TZ, 2008, P NATL ACAD SCI USA, V105, P20647, DOI 10.1073/pnas.0807514106; Cherf GM, 2012, NAT BIOTECHNOL, V30, P344, DOI 10.1038/nbt.2147; CORONADO R, 1980, J GEN PHYSIOL, V76, P425, DOI 10.1085/jgp.76.4.425; Datta K, 2003, J BIOL CHEM, V278, P5694, DOI 10.1074/jbc.M208133200; David S, 2015, NANOTECHNOLOGY, V26; Derrington IM, 2015, NAT BIOTECHNOL, V33, P1073, DOI 10.1038/nbt.3357; Gopfrich K, 2013, LANGMUIR, V29, P355, DOI 10.1021/la3041506; He YH, 2016, ACS SENSORS, V1, P807, DOI 10.1021/acssensors.6b00176; He YH, 2013, BIOPHYS J, V105, P776, DOI 10.1016/j.bpj.2013.05.065; Jeon BJ, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4855075; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Laszlo AH, 2014, NAT BIOTECHNOL, V32, P829, DOI 10.1038/nbt.2950; Laszlo AH, 2013, P NATL ACAD SCI USA, V110, P18904, DOI 10.1073/pnas.1310240110; Manrao EA, 2012, NAT BIOTECHNOL, V30, P349, DOI 10.1038/nbt.2171; Manrao EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025723; Wanunu M, 2010, NAT NANOTECHNOL, V5, P160, DOI [10.1038/nnano.2009.379, 10.1038/NNANO.2009.379]	19	18	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181599	10.1371/journal.pone.0181599	http://dx.doi.org/10.1371/journal.pone.0181599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749972	Green Submitted, Green Published, gold			2022-12-26	WOS:000406575700061
J	Brandlistuen, RE; Ystrom, E; Hernandez-Diaz, S; Skurtvelt, S; Selmer, R; Handal, M; Nordeng, H				Brandlistuen, Ragnhild E.; Ystrom, Eivind; Hernandez-Diaz, Sonia; Skurtvelt, Svetlana; Selmer, Randi; Handal, Marte; Nordeng, Hedvig			Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study	PLOS ONE			English	Article							MONTE-CARLO-SIMULATION; EPIDEMIOLOGIC RESEARCH; BEHAVIOR CHECKLIST; COMPARISON DESIGNS; CAUSAL-DIAGRAMS; PREGNANT-WOMEN; LATE INFANCY; DIAZEPAM; POPULATION; BIAS	Background During pregnancy, many women experience sleep problems and anxiety that require treatment. The long-term safety for the child of maternal benzodiazepine (BZD) and z-hypnotic use during pregnancy remains controversial. Method We conducted a cohort and a sibling control study using data from the Norwegian Mother and Child Cohort Study. Data on use of BZD and z-hypnotics, internalizing and externalizing outcomes, and covariates were collected from mothers at gestational weeks 17 and 30 and when children were 0.5, 1.5, and 3 years of age. The total sample consisted of 71,996 children (19,297 siblings) at 1.5 years and 55,081 children (13,779 siblings) at 3 years. Shortterm use was defined as use in one pregnancy period only. Long-term use was defined as use in two or more pregnancy periods. Linear full cohort random-effect and sibling-matched fixed-effect regression models were used to compare internalizing and externalizing behavior in children prenatally exposed compared to those unexposed in the full cohort of pregnancies accounting for family clusters, as well as within sibling clusters comparing pregnancies with discordant exposures. Propensity score (PS) adjustment included variables on indication for use (sleep problems, symptoms of anxiety and depression) and other potential confounding factors. Results Long-term prenatal exposure to BZD or z-hypnotics was associated with increased internalizing behavior in crude cohort analyses and at age 1.5 years after PS adjustment in siblingmatched fixed-effect models [beta 0.60, 95% confidence interval 0.17-0.95]. Analyses on specific drug groups showed that prenatal exposure to BZD-anxiolytics was associated with increased internalizing problems at both 1.5 years [beta 0.25, 0.01-0.49] and 3 years [beta 0.26, 0.002-0.52] while exposure to z-hypnotics was not associated with any adverse outcomes after adjustment. Conclusion The findings suggest a moderate association between BZD-anxiolytic exposure and child internalizing problems that is not likely due to stable familial confounding factors.	[Brandlistuen, Ragnhild E.; Nordeng, Hedvig] Univ Oslo, Fac Math & Nat Sci, Pharmacoepidemiol & Drug Safety Res Grp, Sch Pharm,PharmaTox Strateg Res Initiat, Oslo, Norway; [Brandlistuen, Ragnhild E.; Ystrom, Eivind; Skurtvelt, Svetlana; Selmer, Randi; Handal, Marte; Nordeng, Hedvig] Norwegian Inst Publ Hlth, Oslo, Norway; [Ystrom, Eivind] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway; [Hernandez-Diaz, Sonia] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Brandlistuen, RE (corresponding author), Univ Oslo, Fac Math & Nat Sci, Pharmacoepidemiol & Drug Safety Res Grp, Sch Pharm,PharmaTox Strateg Res Initiat, Oslo, Norway.; Brandlistuen, RE (corresponding author), Norwegian Inst Publ Hlth, Oslo, Norway.	Ragnhild.Eek.Brandlistuen@fhi.no	Ystrom, Eivind/C-4094-2009	Ystrom, Eivind/0000-0003-4390-6171; Handal, Marte/0000-0003-1773-0184; Brandlistuen, Ragnhild/0000-0001-8054-0960; Skurtveit, Svetlana/0000-0001-7525-9701	Norwegian Ministry of Health; Norwegian Ministry of Education and Research; U.S. National Institutes of Health; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [U01 NS 047537-01, U01 NS 047537-06A1]; Norwegian Research Council [204493/H10]; European Research Council Starting Grant "DrugInPregnancy" [678033]	Norwegian Ministry of Health; Norwegian Ministry of Education and Research; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); European Research Council Starting Grant "DrugInPregnancy"	The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health, the Norwegian Ministry of Education and Research and the U.S. National Institutes of Health https//www.nih.gov/https://www.regjeringen.no/en/id4/, NIH/NIEHS [contract no N01-ES-75558], NIH/NINDS [grant no.1 U01 NS 047537-01 and grant no.2 U01 NS 047537-06A1]. This work was supported by the Norwegian Research Council [grant no. 204493/H10] to R.B. http://www. forskningsradet.no/en/Home page/1177315753906. This work was supported by the European Research Council Starting Grant "DrugInPregnancy" (Grant number 678033).	ACHENBAC.TM, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0093906; Brandlistuen RE, 2013, INT J EPIDEMIOL, V42, P1702, DOI 10.1093/ije/dyt183; Brandlistuen RE, 2015, INT J EPIDEMIOL; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; El Marroun H, 2014, EUR CHILD ADOLES PSY, V23, P973, DOI 10.1007/s00787-014-0558-3; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; GAI N, 1982, PSYCHOPHARMACOLOGY, V78, P225, DOI 10.1007/BF00428155; Gidai J, 2008, TOXICOL IND HEALTH, V24, P61, DOI 10.1177/0748233708089016; GILLBERG C, 1977, LANCET, V2, P244; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Gustavson K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-133; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; KELLOGG C, 1980, SCIENCE, V207, P205, DOI 10.1126/science.7350658; Kellogg C K, 1983, Monogr Neural Sci, V9, P119; KELLOGG CK, 1988, PROG BRAIN RES, V73, P207; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P863; Kordas K, 2015, INT J EPIDEMIOL, V44, P731, DOI 10.1093/ije/dyv132; LAEGREID L, 1992, NEUROPEDIATRICS, V23, P60, DOI 10.1055/s-2008-1071314; LAEGREID L, 1992, NEUROPEDIATRICS, V23, P18, DOI 10.1055/s-2008-1071305; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; MANDELLI M, 1975, CLIN PHARMACOL THER, V17, P564; MCELHATTON PR, 1994, REPROD TOXICOL, V8, P461, DOI 10.1016/0890-6238(94)90029-9; Mortensen JT, 2003, EUR J EPIDEMIOL, V18, P769, DOI 10.1023/A:1025306304635; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Novik TS, 1999, EUR CHILD ADOLES PSY, V8, P247, DOI 10.1007/s007870050098; Okun ML, 2015, AM J OBSTET GYNECOL, V212, P428, DOI 10.1016/j.ajog.2014.10.1106; Olney JW, 2002, ANN MED, V34, P109, DOI 10.1080/07853890252953509; Petty CR, 2008, J ANXIETY DISORD, V22, P532, DOI 10.1016/j.janxdis.2007.04.003; Raitasalo K, 2015, ADDICTION, V110, P636, DOI 10.1111/add.12808; REMENTERIA JL, 1977, J PEDIATR-US, V90, P123, DOI 10.1016/S0022-3476(77)80785-3; Riska BS, 2014, EUR J CLIN PHARMACOL, V70, P1367, DOI 10.1007/s00228-014-1744-4; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; SCHLUMPF M, 1989, NEUROTOXICOLOGY, V10, P501; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Sjolander A, 2016, EPIDEMIOLOGY, V27, P852, DOI 10.1097/EDE.0000000000000541; Skurtveit S., 2014, Norsk Epidemiologi, V24, P209; Skurtveit S, 2013, J CLIN EPIDEMIOL, V66, P964, DOI 10.1016/j.jclinepi.2013.02.011; STIKA L, 1990, PHARM WEEKBLAD, V12, P252; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; VIGGEDAL G, 1993, J CHILD PSYCHOL PSYC, V34, P295, DOI 10.1111/j.1469-7610.1993.tb00993.x; World Health Organization, 2012, CLASS AN THER CHEM C; Zachrisson HD, 2015, CHILD DEV, V86, P425, DOI 10.1111/cdev.12306	45	19	20	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181042	10.1371/journal.pone.0181042	http://dx.doi.org/10.1371/journal.pone.0181042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8EN	28746341	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000406371800024
J	Mantooth, K; Hadziabdic, D; Boggess, S; Windham, M; Miller, S; Cai, GH; Spatafora, J; Zhang, N; Staton, M; Ownley, B; Trigiano, R				Mantooth, Kristie; Hadziabdic, Denita; Boggess, Sarah; Windham, Mark; Miller, Stephen; Cai, Guohong; Spatafora, Joseph; Zhang, Ning; Staton, Meg; Ownley, Bonnie; Trigiano, Robert			Confirmation of independent introductions of an exotic plant pathogen of Cornus species, Discula destructiva, on the east and west coasts of North America	PLOS ONE			English	Article							DNA AMPLIFICATION FINGERPRINTS; DOUBLE-STRANDED-RNA; DOGWOOD ANTHRACNOSE; POPULATION-STRUCTURE; FLOWERING DOGWOOD; GENETIC-STRUCTURE; SEQUENCE SIGNATURES; NUMBER; BOTTLENECKS; PHYLOGENY	Cornus florida (flowering dogwood) and C. nuttallii (Pacific dogwood) are North American native tree species that belong to the big-bracted group of dogwoods. Cornus species are highly valued for their ornamental characteristics, and have fruits that contain high fat content for animals. Also, they are an important understory tree in natural forests. Dogwood anthracnose, caused by Discula destructiva, was observed in the late 1970s on the east and west coasts of the United States and by 1991 had quickly spread throughout most of the native ranges of C. florida and C. nuttalli. We investigated the genetic diversity and population structure of 93 D. destructiva isolates using 47 microsatellite loci developed from the sequenced genome of the type strain of D. destructiva. Clone-corrected data indicated low genetic diversity and the presence of four genetic clusters that corresponded to two major geographic areas, the eastern United States and the Pacific Northwest, and to the two collection time periods when the isolates were collected (pre- and post-1993). Linkage disequilibrium was present in five out of six subpopulations, suggesting that the fungus only reproduced asexually. Evidence of population bottlenecks was indicated across four identified genetic clusters, and was probably the result of the limited number of founding individuals on both coasts. These results support the hypothesis that D. destructiva is an exotic pathogen with independent introductions on the east and west coasts of North America. We also tested the cross-amplification of these microsatellite primers to other Discula species. Genomic DNA from 17 isolates of four other Discula species and two isolates of Juglanconis species (formerly Melanconis species) were amplified by 17 of 47 primer pairs. These primers may be useful for investigating the genetic diversity and population structure of these Discula species.	[Mantooth, Kristie; Hadziabdic, Denita; Boggess, Sarah; Windham, Mark; Staton, Meg; Ownley, Bonnie; Trigiano, Robert] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Miller, Stephen; Zhang, Ning] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ USA; [Miller, Stephen] APHIS PPQ, Linden, NJ USA; [Cai, Guohong] ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN USA; [Cai, Guohong] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Spatafora, Joseph] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Rutgers State University New Brunswick; United States Department of Agriculture (USDA); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University	Trigiano, R (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	rtrigian@utk.edu	Cai, Guohong/N-1274-2013; Zhang, Ning/K-3046-2012	Cai, Guohong/0000-0002-7700-6019; Zhang, Ning/0000-0002-2680-1354; Hadziabdic, Denita/0000-0003-1991-2563; Ownley, Bonnie/0000-0002-5294-3882; Staton, Margaret/0000-0003-2971-9353	United States Department of Agriculture [5864041637 RT]	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funded by United States Department of Agriculture Grant number 5864041637 RT.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Allen WC, 2016, TAXON, V65, P388, DOI 10.12705/652.19; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Anderson RL, 1994, DOGWOOD ANTHRACNOSE, P26; BORING LR, 1981, ECOLOGY, V62, P1244, DOI 10.2307/1937289; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; BRITTON KO, 1993, PLANT DIS, V77, P34, DOI 10.1094/PD-77-0034; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Byther RS, 1979, ORNAMENTALS NW NEWSL, V3, P20; Caetano-Anolles G, 2001, CURR GENET, V39, P346, DOI 10.1007/s002940100223; CaetanoAnolles G, 1996, BIOTECHNIQUES, V20, P1044; CaetanoAnolles G, 1996, FEMS MICROBIOL LETT, V145, P377; Call A, 2016, J SYST EVOL, V54, P136, DOI 10.1111/jse.12171; Castlebury LA, 2002, MYCOLOGIA, V94, P1017, DOI 10.2307/3761867; COLBY DM, 1995, ENVIRON ENTOMOL, V24, P1075, DOI 10.1093/ee/24.5.1075; Cornuet JM, 1996, GENETICS, V144, P2001; DAUGHTREY M L, 1988, Journal of Arboriculture, V14, P159; Daughtrey ML, 1996, PLANT DIS, V80, P349, DOI 10.1094/PD-80-0349; DAUGHTREY ML, 1994, ANNU REV PHYTOPATHOL, V32, P61, DOI 10.1146/annurev.py.32.090194.000425; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; EYDE RH, 1988, BOT REV, V54, P233, DOI 10.1007/BF02868985; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Franco RI, 2016, UPV SCIE SER ING CIV, P1; Goss EM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000583; Grunwald NJ, 2012, MOL ECOL, V21, P3896, DOI 10.1111/j.1365-294X.2012.05597.x; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; HAEMMERLI UA, 1992, MOL PLANT MICROBE IN, V5, P479, DOI 10.1094/MPMI-5-479; Hansen MA, 2009, FOLIAR DIS DOGWOOD; HIBBEN CR, 1988, PLANT DIS, V72, P199, DOI 10.1094/PD-72-0199; Holdenrieder O, 2007, ALIEN INVASIVE SPECI; HOLMES F W, 1989, Journal of Arboriculture, V15, P290; Kamvar ZN, 2015, PHYTOPATHOLOGY, V105, P982, DOI 10.1094/PHYTO-12-14-0350-FI; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Keir KR, 2011, AM J BOT, V98, P1327, DOI 10.3732/ajb.1000466; Li YH, 2006, CAN J PLANT PATHOL, V28, P71, DOI 10.1080/07060660609507272; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; MARUYAMA T, 1985, GENETICS, V111, P675; MATTMAN LH, 1958, APPL MICROBIOL, V6, P153, DOI 10.1128/AEM.6.2.153-154.1958; May KJ, 2004, MYCOL RES, V108, P471, DOI [10.1017/S0953756204009876, 10.1017/s0953756204009876]; MCELREATH SD, 1994, CURR MICROBIOL, V29, P57, DOI 10.1007/BF01570193; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; McRitchie J., 1994, FLORIDA DEP AGR CONS; Mielke M., 1986, PARK SCI, V6, P6; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Miller S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154030; Mitchell WA, 1988, EL889 US ARM WAT EXP; MOORE SS, 1991, GENOMICS, V10, P654, DOI 10.1016/0888-7543(91)90448-N; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pirone PP, 1980, NY TIMES, V24, P34; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Pritchard JK, 2000, GENETICS, V155, P945; RCore Team, 2020, R LANG ENV STAT COMP; REDLIN SC, 1991, MYCOLOGIA, V83, P633, DOI 10.2307/3760218; Rossman Amy Y., 2007, Mycoscience, V48, P135, DOI 10.1007/s10267-007-0347-7; Salogga D. S., 1983, Plant Disease, V67, P1290, DOI 10.1094/PD-67-1290; Samarasekera GDNG, 2012, MOL ECOL, V21, P2931, DOI 10.1111/j.1365-294X.2012.05587.x; SANTAMOUR FS, 1989, PLANT DIS, V73, P590, DOI 10.1094/PD-73-0590; Schoebel CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085368; Sherald JL, 1996, PLANT DIS, V80, P310, DOI 10.1094/PD-80-0310; Smetham GM, 2010, PLANT PATHOL, V59, P736, DOI 10.1111/j.1365-3059.2010.02302.x; Stinzing A., 2003, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V55, P1; Tantardini A., 2004, Informatore Fitopatologico, V54, P44; TRIGIANO RN, 1995, MYCOLOGIA, V87, P490, DOI 10.2307/3760766; Trigiano RN, 1991, P S NURSERY MENS ASS, V36, P209; Tsui CKM, 2012, MOL ECOL, V21, P71, DOI 10.1111/j.1365-294X.2011.05366.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; USDA National Agricultural Statistics Service, 2012, CENS AGR CENS HORT S; USDA-Forest Service, 1991, RES 1990 DOGW ANTHR; Vercauteren A, 2010, MOL ECOL, V19, P92, DOI 10.1111/j.1365-294X.2009.04443.x; Voglmayr H, 2017, PERSOONIA, V38, P136, DOI 10.3767/003158517X694768; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Woudenberg JHC, 2015, STUD MYCOL, P1, DOI 10.1016/j.simyco.2015.07.001; Yao JM, 1997, CURR MICROBIOL, V34, P67, DOI 10.1007/s002849900146; Zhang N, 2002, PHYTOPATHOLOGY, V92, P1276, DOI 10.1094/PHYTO.2002.92.12.1276; Zhang N, 2001, MYCOLOGIA, V93, P355, DOI 10.2307/3761657	85	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0180345	10.1371/journal.pone.0180345	http://dx.doi.org/10.1371/journal.pone.0180345			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746379	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800012
J	Boutevillain, L; Dupeyron, A; Rouch, C; Richard, E; Coudeyre, E				Boutevillain, Laura; Dupeyron, Arnaud; Rouch, Caroline; Richard, Emilie; Coudeyre, Emmanuel			Facilitators and barriers to physical activity in people with chronic low back pain: A qualitative study	PLOS ONE			English	Article							HOME EXERCISE; CLINICAL MANAGEMENT; SELF-MANAGEMENT; FOCUS GROUPS; BELIEFS; ADHERENCE; CARE; REHABILITATION; INTERVENTION; EXPERIENCES	Background For medical teams, one of the main objectives of rehabilitation for people with chronic low back pain is adherence to physical activity (PA). Objective The objective of this study was to identify PA barriers and facilitators in this population. Methods This qualitative study included 4 discussion groups and 16 semi-structured interviews conducted among people with non-specific chronic low back pain who were involved in a specific rehabilitation program or seen in primary care settings. Results Three main themes were identified: physical factors, psychological factors and socio-environmental factors. The main barrier to PA practice is pain. Psychological barriers were associated with the difficulty in integrating PA in the person's daily life. Environmental barriers were dominated by lack of time. Facilitators identified associated the supervised nature of the physical activity (supervision by professionals) and group practice, which improved people's adherence. Conclusion The results of this study will allow teams to target relevant educational objectives for these people and develop dedicated self-management programs.	[Boutevillain, Laura; Rouch, Caroline; Richard, Emilie; Coudeyre, Emmanuel] Ctr Hosp Univ, Serv Med Phys & Readaptat, Clermont Ferrand, France; [Boutevillain, Laura; Coudeyre, Emmanuel] Univ Clermont Auvergne, INRA, Clermont Ferrand, France; [Dupeyron, Arnaud] Ctr Hosp Univ Caremeau, Serv Med Phys & Readaptat, Fac Med Montpellier Nimes, Nimes, France; [Dupeyron, Arnaud] Univ Montpellier, Euromov, Montpellier, France	CHU Clermont Ferrand; INRAE; Universite Clermont Auvergne (UCA); Universite de Montpellier; CHU de Nimes; Universite de Montpellier	Dupeyron, A (corresponding author), Ctr Hosp Univ Caremeau, Serv Med Phys & Readaptat, Fac Med Montpellier Nimes, Nimes, France.; Dupeyron, A (corresponding author), Univ Montpellier, Euromov, Montpellier, France.	arnaud.dupeyron@umontpellier.fr		Dupeyron, Arnaud/0000-0001-5085-3739				Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Beinart NA, 2013, SPINE J, V13, P1940, DOI 10.1016/j.spinee.2013.08.027; Bronfort G, 2011, SPINE J, V11, P585, DOI 10.1016/j.spinee.2011.01.036; Bunzli S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008847; Bunzli S, 2013, CLIN J PAIN, V29, P907, DOI 10.1097/AJP.0b013e31827a6dd8; Byerly P N, 1994, J Athl Train, V29, P352; Chaory K, 2004, SPINE, V29, P908, DOI 10.1097/00007632-200404150-00018; Chou R, 2007, ANN INTERN MED, V147, P492, DOI 10.7326/0003-4819-147-7-200710020-00007; Coppack RJ, 2012, CLIN REHABIL, V26, P1032, DOI 10.1177/0269215512436613; Crowe M, 2010, J ADV NURS, V66, P1478, DOI 10.1111/j.1365-2648.2010.05316.x; Damsgard E, 2011, SCAND J CARING SCI, V25, P108, DOI 10.1111/j.1471-6712.2010.00798.x; Darlow B, 2012, EUR J PAIN, V16, P3, DOI 10.1016/j.ejpain.2011.06.006; Dima A, 2013, BRIT J GEN PRACT, V63, pE490, DOI 10.3399/bjgp13X669211; Dupeyron A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P319, DOI 10.1016/j.rehab.2011.06.001; Engers A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004057.pub3; Escolar-Reina P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-60; Figueiredo IT, 2016, ANN PHYS REHABIL MED, V59, P289, DOI 10.1016/j.rehab.2016.03.006; Friedrich M, 2005, SPINE, V30, P995, DOI 10.1097/01.brs.0000160844.71551.af; Glaser BG, 1968, DISCOVERY GROUNDED T; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Jordan JL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005956.pub2; Keefe FJ, 2012, PAIN, V153, P2163, DOI 10.1016/j.pain.2012.05.030; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Liddle SD, 2007, DISABIL REHABIL, V29, P1899, DOI 10.1080/09638280701189895; Maxwell J, 2008, HDB APPL SOCIAL RES; May S, 2010, NAT REV RHEUMATOL, V6, P199, DOI 10.1038/nrrheum.2010.26; Medina-Mirapeix F, 2009, J REHABIL MED, V41, P347, DOI 10.2340/16501977-0338; Miller JS, 2009, PHYSIOTHERAPY, V95, P29, DOI 10.1016/j.physio.2007.07.009; Palazzo C, 2016, ANN PHYS REHABIL MED, V59, P107, DOI 10.1016/j.rehab.2016.01.009; Prochaska J, 1994, THE TRANSTHEORETICAL; Rainville J, 2011, SPINE J, V11, P895, DOI 10.1016/j.spinee.2011.08.006; Sallis R, 2015, PHYSICIAN SPORTSMED, V43, P22, DOI 10.1080/00913847.2015.1001938; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; Schneiders AG, 1998, MAN THER, V3, P147, DOI [10.1016/S1356-689X(98)80005-2, DOI 10.1016/S1356-689X(98)80005-2]; Slade SC, 2014, CLIN J PAIN, V30, P995, DOI 10.1097/AJP.0000000000000044; Slade SC, 2009, AUST J PHYSIOTHER, V55, P115, DOI 10.1016/S0004-9514(09)70041-8; SLUIJS EM, 1993, PHYS THER, V73, P786, DOI 10.1093/ptj/73.11.786; Snelgrove S, 2013, CHRONIC ILLN, V9, P283, DOI 10.1177/1742395313476901; Symonds TL, 1996, OCCUP MED-OXFORD, V46, P25, DOI 10.1093/occmed/46.1.25; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002; Yvanes-Thomas M, 2002, JOINT BONE SPINE, V69, P397, DOI 10.1016/S1297-319X(02)00415-3	44	49	52	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0179826	10.1371/journal.pone.0179826	http://dx.doi.org/10.1371/journal.pone.0179826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742820	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000007
J	Doring, D; Nick, O; Bauer, A; Kuchenhoff, H; Erhard, MH				Doering, Dorothea; Nick, Ophelia; Bauer, Alexander; Kuechenhoff, Helmut; Erhard, Michael H.			How do rehomed laboratory beagles behave in everyday situations? Results from an observational test and a survey of new owners	PLOS ONE			English	Article							SEPARATION ANXIETY; RISK-FACTORS; DOG BITES; SOCIALIZATION; PERSONALITY; PREVALENCE; PREVENTION; CHILDREN; PROGRAM	When laboratory dogs are rehomed into private households, they experience an extreme change in their life situation. They leave their familiar, limited environment in the research facility and encounter a multitude of animate and inanimate stimuli in their new home. Although literature reports have described the experiences with rehoming as being mostly positive, scientific observations of the dogs in everyday situations have not been done. Hence, we conducted an observational test with 74 laboratory beagles 6 weeks after adoption in their new homes. This test included standardized tasks and elements; the dogs were observed during specific interactions with their new owners and during a walk. Furthermore, the owners of these 74 and of 71 additional dogs participated in standardized phone interviews 1 and 12 weeks after adoption, during which they answered questions about the dogs' behavior in everyday situations. In the observational test, the dogs behaved mostly friendly towards humans and dogs, were tolerant during manipulations by the owner and were relaxed during the walk, even in traffic. Eighty percent (of n = 71) of the dogs walked well behaved on the leash without pulling. According to the interviews, the majority of the dogs showed desired, friendly and relaxed behavior, and the survey results reflected the bonding between dog and owner. The analysis of a possible influence of various factors (age, sex, origin, etc.) using mixed regression models confirmed the results from two previous behavior tests and interviews. Specifically, dogs that had been bred in the research facility scored significantly better than dogs that the research facility had purchased from commercial laboratory dog breeders (p = 0.0113). The results of this study demonstrate a successful adaptation of the rehomed beagles to their new life situation.	[Doering, Dorothea; Nick, Ophelia; Erhard, Michael H.] Ludwig Maximilians Univ Munchen, Chair Anim Welf Ethol Anim Hyg & Husb, Fac Vet, Dept Vet Sci, Munich, Germany; [Bauer, Alexander; Kuechenhoff, Helmut] Ludwig Maximilians Univ Munchen, Stat Consulting Unit, StaBLab, Dept Stat, Munich, Germany	University of Munich; University of Munich	Doring, D (corresponding author), Ludwig Maximilians Univ Munchen, Chair Anim Welf Ethol Anim Hyg & Husb, Fac Vet, Dept Vet Sci, Munich, Germany.	d.doering@lmu.de		Doring, Dorothea/0000-0001-9533-2179; Kuchenhoff, Helmut/0000-0002-6372-2487; Erhard, Michael Helmut/0000-0002-2527-0424	Bayer AG	Bayer AG(Bayer AG)	ON received a doctoral stipend from Bayer AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We want to thank Dr. Stefan Auer, Dr. Klaus-Dieter Bremm and the caretakers from Bayer AG for the excellent support of our study. Furthermore, we thank the rehoming organizations "Tierheim Wermelskirchen" and "Laborbeaglehilfe" for the wonderful collaboration. Last but not least we thank Mr. Andre Klima of StaBLab Munich for statistical consulting and Ms. Nicole Zobel for her assistance.	Adams KM, 2004, LAB ANIMAL, V33, P32, DOI 10.1038/laban0104-32; Ake HJ, 1996, CONTEMP TOP LAB ANIM, V35, P51; [Anonymous], 2014, R LANG ENV STAT COMP; Bayne Kathryn, 2002, ILAR J, V43, P4; Bennett PC, 2007, APPL ANIM BEHAV SCI, V102, P65, DOI 10.1016/j.applanim.2006.03.009; Bennett SL, 2012, APPL ANIM BEHAV SCI, V141, P139, DOI 10.1016/j.applanim.2012.08.005; Blackwell E, 2006, VET REC, V158, P551, DOI 10.1136/vr.158.16.551; Blackwell EJ, 2013, APPL ANIM BEHAV SCI, V145, P15, DOI 10.1016/j.applanim.2012.12.004; Boxall J, 2004, ATLA-ALTERN LAB ANIM, V32, P81, DOI 10.1177/026119290403202s16; Carbone L, 2003, LAB ANIMAL, V32, P37, DOI 10.1038/laban1003-37; Carbone L., 1997, ANIMAL WELFARE INFOR, V7, P9; Chanvin A., 2012, SCI TECH ANIM LAB, V38, P51; Cornelissen JMR, 2010, VET J, V186, P292, DOI 10.1016/j.tvjl.2009.10.001; Diesel G, 2008, PREV VET MED, V84, P228, DOI 10.1016/j.prevetmed.2007.12.004; Diesel G, 2010, J APPL ANIM WELF SCI, V13, P15, DOI 10.1080/10888700903369255; DiGangi Brian A., 2006, Journal of Applied Animal Welfare Science, V9, P143, DOI 10.1207/s15327604jaws0902_4; Doring D, 2016, J VET BEHAV, V11, P18, DOI 10.1016/j.jveb.2015.10.004; Doring D, 2014, J VET BEHAV, V9, P295, DOI 10.1016/j.jveb.2014.08.007; Doring D, 2005, ALTEX-ALTERN TIEREXP, V22, P7; Doring D, 2016, ALTEX-ALTERN TIEREXP, V34, P133; Elliott R, 2010, APPL ANIM BEHAV SCI, V124, P121, DOI 10.1016/j.applanim.2010.02.006; Fahrmeir L, 2007, METODOLOSKI ZVEZKI; Fahrmeir L., 2013, REGRESSION, DOI DOI 10.1007/978-3-642-34333-9; Flannigan G, 2001, J AM VET MED ASSOC, V219, P460, DOI 10.2460/javma.2001.219.460; Fratkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054907; Gazzano A, 2008, J VET BEHAV, V3, P125, DOI 10.1016/j.jveb.2008.04.004; Goktas A., 2011, METODOLOSKI ZVEZKI, V8, P17, DOI DOI 10.5897/SRE11.1283; Martinez AG, 2011, J VET BEHAV, V6, P225, DOI 10.1016/j.jveb.2011.01.006; Herron ME, 2007, JAVMA-J AM VET MED A, V231, P558, DOI 10.2460/javma.231.4.558; Herron ME, 2014, J VET BEHAV, V9, P13, DOI 10.1016/j.jveb.2013.09.003; Hubrecht R. C., 2002, COMFORTABLE QUARTERS, pp56; Joint Working Group on Refinement, 2004, LAB ANIM S1, V38, P28; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kutsumi A, 2013, J VET MED SCI, V75, P141, DOI 10.1292/jvms.12-0008; LASA, 2004, LASA GUID REH LAB DO, P1; LORZ A, 1999, TIERSCHUTZGESETZ TIE; Love M, 2001, J AM VET MED ASSOC, V219, P446, DOI 10.2460/javma.2001.219.446; Marston LC, 2005, ANTHROZOOS, V18, P358, DOI 10.2752/089279305785593965; Martin P., 2007, MEASURING BEHAV; Nahlik J, 2010, ACTA VET BRNO, V79, P627, DOI 10.2754/avb201079040627; Parthasarathy V, 2006, J VET BEHAV, V1, P109, DOI 10.1016/j.jveb.2006.09.005; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Wells DL, 2000, APPL ANIM BEHAV SCI, V69, P55, DOI 10.1016/S0168-1591(00)00118-0; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wyrick B J, 1996, Contemp Top Lab Anim Sci, V35, P43	47	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181303	10.1371/journal.pone.0181303	http://dx.doi.org/10.1371/journal.pone.0181303			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742824	Green Submitted, gold, Green Published			2022-12-26	WOS:000406370000026
J	Bernitsas, E; Khan, O; Razmjou, S; Tselis, A; Bao, F; Caon, C; Millis, S; Seraji-Bozorgzad, N				Bernitsas, Evanthia; Khan, Omar; Razmjou, Sara; Tselis, Alexandros; Bao, Fen; Caon, Christina; Millis, Scott; Seraji-Bozorgzad, Navid			Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; OLIGOCLONAL IGG BANDS; NERVOUS-SYSTEM; CLASSIFICATION CRITERIA; NEUROLOGICAL DISEASES; CONSENSUS STATEMENT; CSF; UPDATE; NEUROSARCOIDOSIS; ELECTROPHORESIS	Background The diagnostic accuracy of cerebrospinal fluid oligoclonal bands (CSF-OCB) detected by isoelectric focusing (IEF) in patients with multiple sclerosis (MS) was evaluated in our study. Methods Three hundred and twenty-one patients with MS and other central nervous system (CNS) immune mediated disorders were assessed (CIMD). Cerebrospinal fluid and matched serum samples were examined for the presence of OCB by IEF-IB (isoelectric focusing with immunoblotting). Results Isolated oligoclonal bands (ISO-OCB) were the only predictor of MS diagnosis independent of age, gender and CSF-OCB. ISO-OCB >= 3.5 detected by IEF yielded a sensitivity of 98% and specificity of 87% in distinguishing MS from MS mimickers. Conclusions For the neurologist, a score of >= 4 ISO-OCB supports the diagnosis of MS. On the other hand, ISO-OCB <= 3 favors CIMD. Further studies with larger population samples are warranted to confirm these findings.	[Bernitsas, Evanthia; Khan, Omar; Razmjou, Sara; Tselis, Alexandros; Bao, Fen; Caon, Christina; Seraji-Bozorgzad, Navid] Wayne State Sch Med, Dept Neurol, Detroit, MI USA; [Millis, Scott] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA	Wayne State University; Wayne State University	Bernitsas, E (corresponding author), Wayne State Sch Med, Dept Neurol, Detroit, MI USA.	ebernits@med.wayne.edu	seraji-bozorgzad, navid/J-1684-2019; Seraji-Bozorgzad, Navid/AAH-2704-2019	Seraji-Bozorgzad, Navid/0000-0002-8215-6513; bernitsas, evanthia/0000-0001-9382-1008				ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; Axelsson M, 2013, J NEUROIMMUNOL, V264, P100, DOI 10.1016/j.jneuroim.2013.09.003; Bourahoui A, 2004, EUR J NEUROL, V11, P525, DOI 10.1111/j.1468-1331.2004.00822.x; Correale J, 2002, J NEUROL, V249, P375, DOI 10.1007/s004150200026; Csako Gyorgy, 2012, Methods Mol Biol, V869, P247, DOI 10.1007/978-1-61779-821-4_20; Dale RC, 2010, CURR OPIN PEDIATR, V22, P718, DOI 10.1097/MOP.0b013e3283402b71; Fortini AS, 2003, AM J CLIN PATHOL, V120, P672, DOI 10.1309/Y5VFF2UAW0RK5W63; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Gastaldi M, 2017, EXPERT REV MOL DIAGN, V17, P31, DOI 10.1080/14737159.2017.1262260; Haertle M, 2014, J NEUROL, V261, P554, DOI 10.1007/s00415-013-7234-2; Huss AM, 2016, J NEUROL, V263, P2499, DOI 10.1007/s00415-016-8302-1; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P297, DOI 10.1136/jnnp.2008.151977; Joseph FG, 2009, J NEUROL NEUROSUR PS, V80, P292, DOI 10.1136/jnnp.2008.150896; Kuhle J, 2015, MULT SCLER J, V21, P1013, DOI 10.1177/1352458514568827; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Lunding J, 2000, ACTA NEUROL SCAND, V102, P322, DOI 10.1034/j.1600-0404.2000.102005322.x; MCLEAN BN, 1995, J NEUROL NEUROSUR PS, V58, P548, DOI 10.1136/jnnp.58.5.548; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mygland A, 2007, ACTA NEUROL SCAND, V115, P122, DOI 10.1111/j.1600-0404.2006.00763.x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Powers WJ, 2015, NEUROL CLIN, V33, P515, DOI 10.1016/j.ncl.2014.12.004; Schneider M, 2007, LUPUS, V16, P418; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; THOMPSON EJ, 1983, J NEUROL NEUROSUR PS, V46, P547, DOI 10.1136/jnnp.46.6.547; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Tintore M, 2001, MULT SCLER, V7, P359, DOI 10.1191/135245801701567069; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WALSH MJ, 1986, J EXP MED, V163, P41, DOI 10.1084/jem.163.1.41; Wengert O, 2013, J NEUROL SCI, V335, P124, DOI 10.1016/j.jns.2013.09.008; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103	30	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181431	10.1371/journal.pone.0181431	http://dx.doi.org/10.1371/journal.pone.0181431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727770	gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500072
J	Fukumoto, R; Kawai, M; Minai, K; Ogawa, K; Yoshida, J; Inoue, Y; Morimoto, S; Tanaka, T; Nagoshi, T; Ogawa, T; Yoshimura, M				Fukumoto, Risa; Kawai, Makoto; Minai, Kosuke; Ogawa, Kazuo; Yoshida, Jun; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro			Conflicting relationship between agedependent disorders, valvular heart disease and coronary artery disease by covariance structure analysis: Possible contribution of natriuretic peptide	PLOS ONE			English	Article							MITRAL ANNULUS; FAILURE; CALCIFICATION; VALVE; BNP; ATHEROSCLEROSIS; PREDICTOR; SECRETION; CALCIUM; SYSTEM	Background It is conceivable that contemporary valvular heart disease (VHD) is affected largely by an age-dependent atherosclerotic process, which is similar to that observed in coronary artery disease (CAD). However, a comorbid condition of VHD and CAD has not been precisely examined. The first objective of this study was to examine a possible comorbid condition. Provided that there is no comorbidity, the second objective was to search for the possible reasons by using conventional risk factors and plasma B-type natriuretic peptide (BNP) because BNP has a potentiality to suppress atherosclerotic development. Methods The study population consisted of 3,457 patients consecutively admitted to our institution. The possible comorbid condition of VHD and CAD and the factors that influence the comorbidity were examined by covariance structure analysis and multivariate analysis. Results The distribution of the patients with VHD and those with CAD in the histograms showed that the incidence of VHD and the severity of CAD rose with seniority in appearance. The real statistical analysis was planned by covariance structure analysis. The current path model revealed that aging was associated with VHD and CAD severity (P < 0.001 for each); however, as a notable result, there was an inverse association regarding the comorbid condition between VHD and CAD ( Correlation coefficient [ beta]: -0.121, P < 0.001). As the second objective, to clarify the factors leading to this inverse association, the contribution of conventional risk factors, such as age, gender, hypertension, smoking, diabetes, obesity and dyslipidemia, to VHD and CAD were examined by multivariate analysis. However, these factors did not exert an opposing effect on VHD and CAD, and the inverse association defied explanation. Since different pathological mechanisms may contribute to the formation of VHD and CAD, a differentially proposed path model using plasma BNP revealed that an increase in plasma BNP being drawn by VHD suppressed the progression of CAD ( beta: -0.465, P < 0.001). Conclusions The incidence of VHD and CAD showed a significant conflicting relationship. This result supported the likely presence of unknown diverse mechanisms on top of the common cascade of atherosclerosis. Among them, the continuous elevation of plasma BNP due to VHD might be one of the explicable factors suppressing the progression of CAD.	[Fukumoto, Risa; Kawai, Makoto; Minai, Kosuke; Ogawa, Kazuo; Yoshida, Jun; Inoue, Yasunori; Morimoto, Satoshi; Tanaka, Toshikazu; Nagoshi, Tomohisa; Ogawa, Takayuki; Yoshimura, Michihiro] Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan	Jikei University	Kawai, M (corresponding author), Jikei Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo, Japan.	cadmk@jikei.ac.jp	Tanaka, Toshikazu D/K-5989-2018	Tanaka, Toshikazu D/0000-0002-0711-7880; Kawai, Makoto/0000-0002-0914-9376	Grants-in-Aid for Scientific Research [17K09531] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adler Y, 2001, ATHEROSCLEROSIS, V155, P1, DOI 10.1016/S0021-9150(00)00737-1; Allison MA, 2006, CIRCULATION, V113, P861, DOI 10.1161/CIRCULATIONAHA.105.552844; Barasch E, 2006, AM HEART J, V151, P39, DOI 10.1016/j.ahj.2005.03.052; Cilliers AM, 2006, BMJ-BRIT MED J, V333, P1153, DOI 10.1136/bmj.39031.420637.BE; Clerico A, 2012, CLIN CHIM ACTA, V414, P112, DOI 10.1016/j.cca.2012.07.017; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Conte L, 2007, J AM SOC ECHOCARDIOG, V20, P703, DOI 10.1016/j.echo.2006.11.018; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; Holtz JE, 2012, AM J CARDIOL, V109, P1092, DOI 10.1016/j.amjcard.2011.11.043; Inoue Y, 2016, METABOLISM, V65, P38, DOI 10.1016/j.metabol.2015.09.019; Ito S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176435; Kawai M, 2013, INTERNAL MED, V52, P171, DOI 10.2169/internalmedicine.52.8704; Kinoshita K, 2016, INT J CARDIOL, V215, P283, DOI 10.1016/j.ijcard.2016.04.111; Komukai K, 2008, CIRC J, V72, P1152, DOI 10.1253/circj.72.1152; KORN D, 1962, NEW ENGL J MED, V267, P900, DOI 10.1056/NEJM196211012671802; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Minai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108983; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; MUKOYAMA M, 1991, J CLIN INVEST, V87, P1402, DOI 10.1172/JCI115146; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; Ogawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173898; Omiand T, 2008, EXPERT REV MOL DIAGN, V8, P217, DOI 10.1586/14737159.8.2.217; Oremus M, 2008, CLIN BIOCHEM, V41, P260, DOI 10.1016/j.clinbiochem.2007.09.011; Pressman GS, 2011, INT J CARDIOL, V146, P202, DOI 10.1016/j.ijcard.2009.06.057; ROBERTS WC, 1983, AM J CARDIOL, V51, P1005, DOI 10.1016/S0002-9149(83)80181-7; Shumaker RE, 2016, BEGINNERS GUIDE STRU; Tanaka Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02707-y; Tsutsumi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177327; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Yoshida J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02247-5; YOSHIMURA M, 1993, CIRCULATION, V87, P464, DOI 10.1161/01.CIR.87.2.464; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	34	12	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181206	10.1371/journal.pone.0181206	http://dx.doi.org/10.1371/journal.pone.0181206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727835	Green Published, gold, Green Submitted			2022-12-26	WOS:000406634500047
J	Madi, MK; Karameh, FN				Madi, Mahmoud K.; Karameh, Fadi N.			Hybrid Cubature Kalman filtering for identifying nonlinear models from sampled recording: Estimation of neuronal dynamics	PLOS ONE			English	Article							LOCAL LINEARIZATION METHOD; EFFECTIVE CONNECTIVITY; POPULATION-DYNAMICS; CAUSAL-MODELS; STATE; RESPONSES; EEG; DISTRIBUTIONS; DISCHARGE; FMRI	Kalman filtering methods have long been regarded as efficient adaptive Bayesian techniques for estimating hidden states in models of linear dynamical systems under Gaussian uncertainty. Recent advents of the Cubature Kalman filter (CKF) have extended this efficient estimation property to nonlinear systems, and also to hybrid nonlinear problems where by the processes are continuous and the observations are discrete (continuous-discrete CD-CKF). Employing CKF techniques, therefore, carries high promise for modeling many biological phenomena where the underlying processes exhibit inherently nonlinear, continuous, and noisy dynamics and the associated measurements are uncertain and time-sampled. This paper investigates the performance of cubature filtering (CKF and CD-CKF) in two flagship problems arising in the field of neuroscience upon relating brain functionality to aggregate neurophysiological recordings: (i) estimation of the firing dynamics and the neural circuit model parameters from electric potentials (EP) observations, and (ii) estimation of the hemodynamic model parameters and the underlying neural drive from BOLD (fMRI) signals. First, in simulated neural circuit models, estimation accuracy was investigated under varying levels of observation noise (SNR), process noise structures, and observation sampling intervals (dt). When compared to the CKF, the CD-CKF consistently exhibited better accuracy for a given SNR, sharp accuracy increase with higher SNR, and persistent error reduction with smaller dt. Remarkably, CD-CKF accuracy shows only a mild deterioration for non-Gaussian process noise, specifically with Poisson noise, a commonly assumed form of background fluctuations in neuronal systems. Second, in simulated hemodynamic models, parametric estimates were consistently improved under CD-CKF. Critically, time-localization of the underlying neural drive, a determinant factor in fMRI-based functional connectivity studies, was significantly more accurate under CD-CKF. In conclusion, and with the CKF recently benchmarked against other advanced Bayesian techniques, the CD-CKF framework could provide significant gains in robustness and accuracy when estimating a variety of biological phenomena models where the underlying process dynamics unfold at time scales faster than those seen in collected measurements.	[Madi, Mahmoud K.; Karameh, Fadi N.] Amer Univ Beirut, Dept Elect & Comp Engn, Beirut, Lebanon	American University of Beirut	Madi, MK (corresponding author), Amer Univ Beirut, Dept Elect & Comp Engn, Beirut, Lebanon.	mkm08@mail.aub.edu			American University of Beirut; Faculty of Engineering of the American University of Beirut; Lebanese National Council for Scientific Research; Lebanese National Council for Scientific Research (LNCSR); AUB F. Jabre Grant	American University of Beirut; Faculty of Engineering of the American University of Beirut; Lebanese National Council for Scientific Research; Lebanese National Council for Scientific Research (LNCSR); AUB F. Jabre Grant	This study is financially supported by the Farouk Jabre internal grant at the American University of Beirut, Dean's office at the Faculty of Engineering of the American University of Beirut, and the Lebanese National Council for Scientific Research. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the Lebanese National Council for Scientific Research (LNCSR) and the AUB F. Jabre Grant.	Aarabi A, 2014, CLIN NEUROPHYSIOL, V125, P930, DOI 10.1016/j.clinph.2013.10.051; Arasaratnam I, 2010, IEEE T SIGNAL PROCES, V58, P4977, DOI 10.1109/TSP.2010.2056923; Arasaratnam I, 2009, IEEE T AUTOMAT CONTR, V54, P1254, DOI 10.1109/TAC.2009.2019800; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Baker SM, 2013, BIOINFORMATICS; Bavdekar VA, 2011, J PROCESS CONTR, V21, P585, DOI 10.1016/j.jprocont.2011.01.001; BERGER D, 1990, EXP BRAIN RES, V80, P129; Biscay R, 1996, ANN I STAT MATH, V48, P631, DOI 10.1007/BF00052324; Chen CC, 2008, NEUROIMAGE, V41, P1293, DOI 10.1016/j.neuroimage.2008.03.026; Chong M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026001; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; De Kock CP, 2007, J PHYSL, P581; Fellous JM, 2003, NEUROSCIENCE, P122; Freestone DR, 2011, NEUROIMAGE, V56, P1043, DOI 10.1016/j.neuroimage.2011.02.027; Freestone DR, 2014, FRONTIERS NEUROSCIEN, P8; Friston KJ, 2008, NEUROIMAGE, V41, P849, DOI 10.1016/j.neuroimage.2008.02.054; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galka A, 2004, NEUROIMAGE, V23, P435, DOI 10.1016/j.neuroimage.2004.02.022; Giraldo E, 2010, IEEE ENG MED BIO, P2914, DOI 10.1109/IEMBS.2010.5626281; Gorzelic P, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026016; Grant MM, 2014, HUM BRAIN MAPP, V35, P4815, DOI 10.1002/hbm.22514; Graupner M, 2013, J NEUROSCI, V33, P15075, DOI 10.1523/JNEUROSCI.0347-13.2013; Hamid L, 2013, IEEE ENG MED BIO, P4819, DOI 10.1109/EMBC.2013.6610626; Havlicek M, 2011, NEUROIMAGE, V56, P2109, DOI 10.1016/j.neuroimage.2011.03.005; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hu X, 2007, IEEE T BIO-MED ENG, V54, P597, DOI 10.1109/TBME.2006.890130; Hutcheson NL, 2015, HUM BRAIN MAPP, V36, P1442, DOI 10.1002/hbm.22714; Jimenez JC, 1999, J STAT PHYS, V94, P587, DOI 10.1023/A:1004504506041; Julier SJ, 1997, P SOC PHOTO-OPT INS, V3068, P182, DOI 10.1117/12.280797; Karameh F, 2014, BIOSIGNALS 2014; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Kloeden P.E., 1999, NUMERICAL SOLUTION S; Kostal L, 2006, BIOL CYBERN, V94, P157, DOI 10.1007/s00422-005-0036-6; Lankarany M, 2013, BMC NEUROSCI, V14, pO2; LEVINE MW, 1991, BIOL CYBERN, V65, P459, DOI 10.1007/BF00204659; Lillacci G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000696; Lopez-Cuevas A, 2015, NEUROIMAGE, V113, P374, DOI 10.1016/j.neuroimage.2015.02.059; Marreiros AC, 2008, NEUROIMAGE, V42, P147, DOI 10.1016/j.neuroimage.2008.04.239; Marreiros AC, 2009, NEUROIMAGE, V44, P701, DOI 10.1016/j.neuroimage.2008.10.008; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Min Zheng, 2010, Proceedings of the SICE 2010 - 49th Annual Conference of the Society of Instrument and Control Engineers of Japan, P2192; Moran RJ, 2011, NEUROIMAGE, V55, P1694, DOI 10.1016/j.neuroimage.2011.01.012; Nahas Z, 2014, NEUROPSYCHOPHARMACOL, V39, pS561; Ramos JI, 1999, APPL MATH COMPUT, V104, P109, DOI 10.1016/S0096-3003(98)10056-5; Riera JJ, 2004, NEUROIMAGE, V21, P547, DOI 10.1016/j.neuroimage.2003.09.052; Rudolph M, 2003, NEUROSCIENCE, V119, P855, DOI 10.1016/S0306-4522(03)00164-7; SCHIFF S, 2008, BMC NEUROSCI, V9, pO1; Schiff SJ, 2009, IEEE ENG MED BIO, P3318, DOI 10.1109/IEMBS.2009.5333752; Sedigh-Sarvestani M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002788; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith SM, 2014, BRIT J RADIOLOGY; Sommerlade L, 2014, FRONT NEUROENG, P161; Sorenson HW., 1985, KALMAN FILTERING THE; Stephan KE, 2008, NEUROIMAGE, V42, P649, DOI 10.1016/j.neuroimage.2008.04.262; Toppi J, 2012, IEEE ENG MED BIO, P6192, DOI 10.1109/EMBC.2012.6347408; Ullah G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000776; Ullah G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040901; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; van der Merwe R, 2001, INT CONF ACOUST SPEE, P3461, DOI 10.1109/ICASSP.2001.940586; Walters-Williams J., 2010, 2010 IEEE/ICME International Conference on Complex Medical Engineering. CME 2010, P45, DOI 10.1109/ICCME.2010.5558873; Wang JL, 2010, CHINESE J CHEM ENG, V18, P258, DOI 10.1016/S1004-9541(08)60351-1; Wei YN, 2011, IEEE DECIS CONTR P, P5844, DOI 10.1109/CDC.2011.6161358; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585	66	2	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181513	10.1371/journal.pone.0181513	http://dx.doi.org/10.1371/journal.pone.0181513			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727850	gold, Green Submitted, Green Published			2022-12-26	WOS:000406634500081
J	Siddiqui, SS; Springer, SA; Verhagen, A; Sundaramurthy, V; Alisson-Silva, F; Jiang, WP; Ghosh, P; Varki, A				Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Sundaramurthy, Venkatasubrannaniam; Alisson-Silva, Frederico; Jiang, Weiping; Ghosh, Pradipta; Varki, Ajit			The Alzheimer's disease-protective CD33 splice variant mediates adaptive loss of function via diversion to an intracellular pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; PHYLOGENETIC ANALYSIS; TARGETING SIGNAL-1; COMMON VARIANTS; RARE VARIANTS; 2 ISOFORMS; RECEPTOR; EXPRESSION; RISK; PEROXISOMES	The immunomodulatory receptor Siglec-3/CD33 influences risk for late-onset Alzheimer's disease (LOAD), an apparently human-specific post-reproductive disease. CD33 generates two splice variants: a full-length CD33M transcript produced primarily by the "LOAD-risk" allele and a shorter CD33m isoform lacking the sialic acid-binding domain produced primarily from the "LOAD-protective" allele. An SNP that modulates CD33 splicing to favor CD33m is associated with enhanced microglial activity. Individuals expressing more protective isoform accumulate less brain beta-amyloid and have a lower LOAD risk. How the CD33m isoform increases beta-amyloid clearance remains unknown. We report that the protection by the CD33m isoform may not be conferred by what it does but, rather, from what it cannot do. Analysis of blood neutrophils and monocytes and a microglial cell line revealed that unlike CD33M, the CD33m isoform does not localize to cell surfaces; instead, it accumulates in peroxisomes. Cell stimulation and activation did not mobilize CD33m to the surface. Thus, the CD33m isoform may neither interact directly with amyloid plaques nor engage in cell-surface signaling. Rather, production and localization of CD33m in peroxisomes is a way of diminishing the amount of CD33M and enhancing beta-amyloid clearance. We confirmed intracellular localization by generating a CD33m-specific monoclonal antibody. Of note, CD33 is the only Siglec with a peroxisome-targeting sequence, and this motif emerged by convergent evolution in toothed whales, the only other mammals with a prolonged post-reproductive lifespan. The CD33 allele that protects post-reproductive individuals from LOAD may have evolved by adaptive loss-of-function, an example of the less-is-more hypothesis.	[Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Sundaramurthy, Venkatasubrannaniam; Alisson-Silva, Frederico; Varki, Ajit] Univ Calif San Diego, CARTA, La Jolla, CA 92093 USA; [Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Sundaramurthy, Venkatasubrannaniam; Alisson-Silva, Frederico; Varki, Ajit] Univ Calif San Diego, GRTC, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Alisson-Silva, Frederico; Ghosh, Pradipta; Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Siddiqui, Shoib S.; Springer, Stevan A.; Verhagen, Andrea; Alisson-Silva, Frederico; Ghosh, Pradipta; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Jiang, Weiping] BioLegend Inc, San Diego, CA 92121 USA; [Sundaramurthy, Venkatasubrannaniam] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Alisson-Silva, Frederico] CAPES, Program Sci Borders Ciencias Sem Fronteiras, BR-70040031 Brasilia, DF, Brazil	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Varki, A (corresponding author), Univ Calif San Diego, GRTC, 9500 Gilman Dr, La Jolla, CA 92093 USA.	a1varki@ucsd.edu	da Silva, Frederico/AAY-4758-2021; da Silva, Frederico/X-7822-2018	da Silva, Frederico/0000-0001-6717-2518; da Silva, Frederico/0000-0001-6717-2518; Sundaramurthy, Venkatasubramaniam/0000-0002-9245-1604; Siddiqui, Shoib/0000-0002-7028-290X	National Institutes of Health [R01GM32373, P01HL107150, CA160911, DK099226]; Program Science Without Borders (Ciencias sem Fronteiras), CAPES, Brasilia, Brazil; NATIONAL CANCER INSTITUTE [R01CA160911, R01CA100768] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program Science Without Borders (Ciencias sem Fronteiras), CAPES, Brasilia, Brazil; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM32373 and P01HL107150 (to A.V.) and CA160911 and DK099226 (to P.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship from the Program Science Without Borders (Ciencias sem Fronteiras), CAPES, Brasilia 70040-031, Brazil.	AJIOKA RS, 1986, P NATL ACAD SCI USA, V83, P6445, DOI 10.1073/pnas.83.17.6445; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Brinkman-Vand der Linden ECM, 2003, MOL CELL BIOL, V23, P4199, DOI 10.1128/MCB.23.12.4199-4206.2003; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; CARP H, 1982, J EXP MED, V155, P264, DOI 10.1084/jem.155.1.264; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Crocker P R, 1998, Glycobiology, V8, pv; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Croft DP, 2015, TRENDS ECOL EVOL, V30, P407, DOI 10.1016/j.tree.2015.04.011; DEHOOP MJ, 1992, BIOCHEM J, V286, P657, DOI 10.1042/bj2860657; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Fanelli F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-8; Finch CE, 2015, NEUROBIOL AGING, V36, P553, DOI 10.1016/j.neurobiolaging.2014.10.025; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Grimsey NL, 2010, BIOCHEM PHARMACOL, V80, P1050, DOI 10.1016/j.bcp.2010.06.007; Hernandez-Caselles T, 2006, J LEUKOCYTE BIOL, V79, P46, DOI 10.1189/jlb.0205096; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; MARASCO WA, 1984, J BIOL CHEM, V259, P5430; Mohan KVK, 2003, BIOINFORMATICS, V19, P10, DOI 10.1093/bioinformatics/19.1.10; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; O'SHEA JJ, 1985, J IMMUNOL, V134, P2580; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Paul SP, 2000, BLOOD, V96, P483; Perez-Oliva AB, 2011, GLYCOBIOLOGY, V21, P757, DOI 10.1093/glycob/cwq220; Porcellotti S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/967203; Razi N, 1999, GLYCOBIOLOGY, V9, P1225, DOI 10.1093/glycob/9.11.1225; Rivas MA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12342; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rosen RF, 2008, J COMP NEUROL, V509, P259, DOI 10.1002/cne.21744; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Schwarz F, 2016, P NATL ACAD SCI USA, V113, P74, DOI 10.1073/pnas.1517951112; Schwarz F, 2015, ADV EXP MED BIOL, V842, P1, DOI 10.1007/978-3-319-11280-0_1; Siddiqui S, 2017, J BIOL CHEM, V292, P1029, DOI 10.1074/jbc.M116.738351; SIMMONS D, 1988, J IMMUNOL, V141, P2797; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Springer S. A., 2016, SEPARATING SPANDRELS, P309; Springer SA, 2016, P NATL ACAD SCI USA, V113, pE1591, DOI 10.1073/pnas.1601419113; Stitziel NO, 2014, NEW ENGL J MED, V371, P2072, DOI 10.1056/NEJMoa1405386; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terlecky Stanley R, 2012, World J Biol Chem, V3, P93, DOI 10.4331/wjbc.v3.i5.93; Trompier D, 2014, BIOCHIMIE, V98, P102, DOI 10.1016/j.biochi.2013.09.009; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Walke DG, 2015, NEUROBIOL AGING, V36, P571, DOI 10.1016/j.neurobiolaging.2014.09.023; Walter RB, 2008, J LEUKOCYTE BIOL, V83, P200, DOI 10.1189/jlb.0607388; WEIGEL PH, 1983, J BIOL CHEM, V258, P5095; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	67	41	41	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15312	15320		10.1074/jbc.M117.799346	http://dx.doi.org/10.1074/jbc.M117.799346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28747436	Green Published, hybrid			2022-12-26	WOS:000410809800013
J	Gyongyosi, N; Szoke, A; Ella, K; Kaldi, K				Gyongyosi, Norbert; Szoke, Anita; Ella, Krisztina; Kaldi, Krisztina			The small G protein RAS2 is involved in the metabolic compensation of the circadian clock in the circadian model Neurospora crassa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT SIGNAL-TRANSDUCTION; GATED CALCIUM-CHANNELS; SUPRACHIASMATIC NUCLEUS; SACCHAROMYCES-CEREVISIAE; FREQUENCY DETERMINES; TRANSCRIPTION FACTOR; REGULATED GENES; WHITE COLLAR-1; FEEDBACK LOOPS; KINASE	Accumulating evidence from both experimental and clinical investigations indicates a tight interaction between metabolism and circadian timekeeping; however, knowledge of the underlying mechanism is still incomplete. Metabolic compensation allows circadian oscillators to run with a constant speed at different substrate levels and, therefore, is a substantial criterion of a robust rhythm in a changing environment. Because previous data have suggested a central role of RAS2-mediated signaling in the adaptation of yeast to different nutritional environments, we examined the involvement of RAS2 in the metabolic regulation of the clock in the circadian model organism Neurospora crassa. We show that, in a ras2-deficient strain, the period is longer than in the control. Moreover, unlike in the WT, in Delta ras2, operation of the circadian clock was affected by glucose; compared with starvation conditions, the period was longer and the oscillation of expression of the frequency (frq) gene was dampened. In constant darkness, the delayed phosphorylation of the FRQ protein and the long-lasting accumulation of FRQ in the nucleus were in accordance with the longer period and the less robust rhythm in the mutant. Although glucose did not affect the subcellular distribution of FRQ in the WT, highly elevated FRQ levels were detected in the nucleus in Delta ras2. RAS2 interacted with the RAS-binding domain of the adenylate cyclase in vitro, and the cAMP analogue 8-bromo-cyclic AMP partially rescued the circadian phenotype in vivo. We therefore propose that RAS2 acts via a cAMP-dependent pathway and exerts significant metabolic control on the Neurospora circadian clock.	[Gyongyosi, Norbert; Szoke, Anita; Ella, Krisztina; Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary	Semmelweis University	Kaldi, K (corresponding author), Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary.	kaldi.krisztina@med.semmelweis-univ.hu	Káldi, Krisztina/X-4080-2019; Ella, Krisztina/N-8552-2017	Ella, Krisztina/0000-0003-4961-5615; Kaldi, Krisztina/0000-0002-5724-0182; Szoke, Andrei/0000-0003-2973-7981	EMBO-HHMI; National Research, Development and Innovation Office, NKFIH [K115953]	EMBO-HHMI(Howard Hughes Medical InstituteEuropean Molecular Biology Organization (EMBO)); National Research, Development and Innovation Office, NKFIH	This work was supported by an EMBO-HHMI startup grant (to K. K.) and the National Research, Development and Innovation Office, NKFIH (K115953). The authors declare that they have no conflicts of interest with the contents of this article.	Adhvaryu K, 2016, J BIOL RHYTHM, V31, P258, DOI 10.1177/0748730416639717; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; BOS JL, 1989, CANCER RES, V49, P4682; Bouchard-Cannon P, 2012, CHRONOBIOL INT, V29, P965, DOI 10.3109/07420528.2012.707264; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cha J, 2013, EMBO REP, V14, P923, DOI 10.1038/embor.2013.131; Chen CH, 2010, P NATL ACAD SCI USA, V107, P16715, DOI 10.1073/pnas.1011190107; Cheng HYM, 2006, J NEUROSCI, V26, P12984, DOI 10.1523/JNEUROSCI.4253-06.2006; Cheng HYM, 2006, SEMIN CELL DEV BIOL, V17, P345, DOI 10.1016/j.semcdb.2006.03.006; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; Dettmann A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004762; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Emerson JM, 2015, P NATL ACAD SCI USA, V112, P15707, DOI 10.1073/pnas.1521918112; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gai KX, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006732; Gerstner JR, 2006, NEUROSCIENCE, V139, P1435, DOI 10.1016/j.neuroscience.2006.01.020; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; Gyongyosi N, 2014, ANTIOXID REDOX SIGN, V20, P3007, DOI 10.1089/ars.2013.5558; Gyongyosi N, 2013, FREE RADICAL BIO MED, V58, P134, DOI 10.1016/j.freeradbiomed.2012.12.016; Hayashi Y, 2001, FEBS LETT, V491, P71, DOI 10.1016/S0014-5793(01)02153-6; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Huang CCY, 2012, J CELL BIOCHEM, V113, P911, DOI 10.1002/jcb.23419; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Hurley JM, 2016, FUNGAL GENET BIOL, V90, P39, DOI 10.1016/j.fgb.2015.10.002; Johnson C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004183; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Kanauchi A, 1997, MOL GEN GENET, V254, P427, DOI 10.1007/s004380050435; KATAOKA T, 1985, CELL, V40, P19, DOI 10.1016/0092-8674(85)90304-6; Ko GYP, 2004, J NEUROSCI, V24, P1296, DOI 10.1523/JNEUROSCI.3560-03.2004; Ko ML, 2008, INVEST OPHTH VIS SCI, V49, P1615, DOI 10.1167/iovs.07-1189; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Koletar MM, 2011, CHRONOBIOL INT, V28, P553, DOI 10.3109/07420528.2011.592235; Kozma-Bognar L, 2008, CHEMBIOCHEM, V9, P2565, DOI 10.1002/cbic.200800385; Larrondo LF, 2015, SCIENCE, V347, DOI 10.1126/science.1257277; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lee N, 2002, EUKARYOT CELL, V1, P954, DOI 10.1128/EC.1.6.954-966.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Linden H, 1997, EMBO J, V16, P98, DOI 10.1093/emboj/16.1.98; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Margolin BS, 1997, FUNGAL GENET NEWSLET, V44, P34, DOI [10.4148/1941-4765.1281, DOI 10.1128/EC.00244-07]; Mehra A, 2009, CELL, V137, P749, DOI 10.1016/j.cell.2009.03.019; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Pandey A, 2004, EUKARYOT CELL, V3, P348, DOI 10.1128/EC.3.2.348-358.2004; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Querfurth C, 2011, MOL CELL, V43, P713, DOI 10.1016/j.molcel.2011.06.033; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Relogio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004338; Sancar G, 2012, GENE DEV, V26, P2435, DOI 10.1101/gad.199547.112; Sancar G, 2011, MOL CELL, V44, P687, DOI 10.1016/j.molcel.2011.10.019; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Serchov T, 2016, MOL NEUROBIOL, V53, P1843, DOI 10.1007/s12035-015-9135-0; Shi M, 2013, ACTA BIOCH BIOPH SIN, V45, P61, DOI 10.1093/abbs/gms110; Shimizu K, 2003, J BIOL CHEM, V278, P14920, DOI 10.1074/jbc.M213214200; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; Tsuchiya Y, 2013, P JPN ACAD B-PHYS, V89, P59, DOI 10.2183/pjab.89.59; Weber F, 2006, J NEUROCHEM, V98, P248, DOI 10.1111/j.1471-4159.2006.03865.x; Weeks G, 2003, CELL SIGNAL, V15, P901, DOI 10.1016/S0898-6568(03)00073-1; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097	80	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 8	2017	292	36					14929	14939		10.1074/jbc.M117.804922	http://dx.doi.org/10.1074/jbc.M117.804922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG2FL	28729421	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000409902100018
J	Russelli, G; Pizzillo, P; Iannolo, G; Barbera, F; Tuzzolino, F; Liotta, R; Traina, M; Vizzini, G; Gridelli, B; Badami, E; Conaldi, PG				Russelli, Giovanna; Pizzillo, Paola; Iannolo, Gioacchin; Barbera, Floriana; Tuzzolino, Fabio; Liotta, Rosa; Traina, Mario; Vizzini, Giovanni; Gridelli, Bruno; Badami, Ester; Conaldi, Pier Giulio			HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; BLOOD MONONUCLEAR-CELLS; LOW-DENSITY; FREQUENT COMPARTMENTALIZATION; ENTEROENDOCRINE CELLS; GASTRIC-MUCOSA; CORE PROTEIN; LOCALIZATION; INTERFERON; ASSOCIATION	Purpose Hepatitis C virus (HCV) predominantly infects hepatocytes, although it is known that receptors for viral entry are distributed on a wide array of target cells. Chronic HCV infection is indeed characterized by multiple non-liver manifestations, suggesting a more complex HCV tropism extended to extrahepatic tissues and remains to be fully elucidated. In this study, we investigated the gastrointestinal mucosa (GIM) as a potential extrahepatic viral replication site and its contribution to HCV recurrence. Methods We analyzed GIM biopsies from a cohort of 76 patients, 11 of which were HCV-negative and 65 HCV-positive. Of these, 54 biopsies were from liver-transplanted patients. In 29 cases, we were able to investigate gastrointestinal biopsies from the same patient before and after transplant. To evaluate the presence of HCV, we looked for viral antigens and genome RNA, whilst to assess viral replicative activity, we searched for the replicative intermediate minus-strand RNA. We studied the genetic diversity and the phylogenetic relationship of HCV quasispecies from plasma, liver and gastrointestinal mucosa of HCV-liver-transplanted patients in order to assess HCV compartmentalization and possible contribution of gastrointestinal variants to liver re-infection after transplantation. Results Here we show that HCV infects and replicates in the cells of the GIM and that the favorite hosts were mostly enteroendocrine cells. Interestingly, we observed compartmentalization of the HCV quasispecies present in the gastrointestinal mucosa compared to other tissues of the same patient. Moreover, the phylogenetic analysis revealed a high similarity between HCV variants detected in gastrointestinal mucosa and those present in the re-infected graft. Conclusions Our results demonstrated that the gastrointestinal mucosa might be considered as an extrahepatic reservoir of HCV and that could contribute to viral recurrence. Moreover, the finding that HCV infects and replicates in neuroendocrine cells opens new perspectives on the role of these cells in the natural history of HCV infection.	[Russelli, Giovanna; Iannolo, Gioacchin] IRCCS ISMETT, Dept Lab Med & Adv Biotechnol, Palermo, Italy; [Russelli, Giovanna] Univ Vita Salute San Raffaele, Milan, Italy; [Barbera, Floriana] IRCCS ISMETT, Res Off, Palermo, Italy; [Tuzzolino, Fabio] IRCCS ISMETT, Dept Diagnost & Therapeut Serv, Pathol Serv, Palermo, Italy; [Liotta, Rosa] IRCCS ISMETT, Dept Diagnost & Therapeut Serv, Endoscopy Serv, Palermo, Italy; [Vizzini, Giovanni] IRCCS ISMETT, Dept Treatment Study Abdominal Dis & Abdominal Tr, Palermo, Italy; [Barbera, Floriana] Fondazione Ri MED, Palermo, Italy	IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); Vita-Salute San Raffaele University; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT); IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Russelli, G (corresponding author), IRCCS ISMETT, Dept Lab Med & Adv Biotechnol, Palermo, Italy.; Russelli, G (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	grusselli@ismett.edu	traina, mario/A-1309-2012; Conaldi, Pier Giulio/AAC-1573-2019; Iannolo, Gioacchin/AAC-2375-2022; Tuzzolino, Fabio Ph.D./F-2233-2019; Barbera, Floriana/AAB-9557-2020	Tuzzolino, Fabio Ph.D./0000-0003-2058-2135; Badami, Ester/0000-0002-0154-6270; Traina, Mario/0000-0001-5041-0858; Vizzini, Giovanni/0000-0002-3273-1719; iannolo, gioacchin/0000-0002-7710-4735; Conaldi, Pier Giulio/0000-0003-1994-8005	Banco di Sicilia Foundation; RiMED Foundation; IRCCS - ISMETT	Banco di Sicilia Foundation; RiMED Foundation; IRCCS - ISMETT	G.R. and F.B. were funded by a grant from Banco di Sicilia Foundation (http://fondazionesicilia.it/it/). This study was also funded by RiMED Foundation (http://www.fondazionerimed.eu/Content/home.aspx) and by IRCCS - ISMETT (http://www.ismettedu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AMR, 1999, J VIROL, V73, P9213, DOI 10.1128/JVI.73.11.9213-9221.1999; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Arumugaswami V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000182; Bare P, 2005, J GEN VIROL, V86, P1717, DOI 10.1099/vir.0.80882-0; Bare P, 2009, WORLD J HEPATOL, V1, P67, DOI 10.4254/wjh.v1.i1.67; Bassendine M, 1999, 11 INT C VIR SIDN AU, P227; Biggins SW, LIVER TRANSPL, V18, P1471; Blackard JT, 2012, J MED VIROL, V84, P242, DOI 10.1002/jmv.22269; Bridge SH, 2011, GUT, V60, P680, DOI 10.1136/gut.2010.222133; Cacoub P, 2016, THER ADV INFECT DIS, V3, P3, DOI 10.1177/2049936115585942; CARMICHAEL J, 1988, EUR J CANCER CLIN ON, V24, P1219, DOI 10.1016/0277-5379(88)90131-9; Catanese MT, 2013, P NATL ACAD SCI USA, V110, P9505, DOI 10.1073/pnas.1307527110; Caussin-Schwemling C, 2001, J MED VIROL, V65, P14, DOI 10.1002/jmv.1095; Chen TC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005116; Cheung Dae Young, 2005, Korean J Gastroenterol, V45, P294; Ciesek S, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2011.01548.x; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; De Vita S, 2000, HEPATOLOGY, V31, P182, DOI 10.1002/hep.510310127; Deforges S, 2004, J GEN VIROL, V85, P2515, DOI 10.1099/vir.0.80071-0; Demetris AJ, 2009, LIVER TRANSPLANT, V15, pS35, DOI 10.1002/lt.21890; Dhanasekaran R, 2014, WORLD J GASTROENTERO, V20, P3391, DOI 10.3748/wjg.v20.i13.3391; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Ducoulombier D, 2004, HEPATOLOGY, V39, P817, DOI 10.1002/hep.20087; Elmasry S, 2016, GASTROENTEROLOGY; European Association for the Study of the Liver, 2016, J HEPATOL; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Goutagny N, 2003, J INFECT DIS, V187, P1951, DOI 10.1086/375350; Grebely J, J VIRAL HEPAT, V17, P896; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Haruna Y, 2001, HEPATOLOGY, V33, P977, DOI 10.1053/jhep.2001.23435; Hiasa Y, 2006, J VIROL METHODS, V132, P195, DOI 10.1016/j.jviromet.2005.10.014; Horner SM, 2014, J MOL BIOL, V426, P1198, DOI 10.1016/j.jmb.2013.10.032; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Hughes MG, 2005, AM J TRANSPLANT, V5, P2504, DOI 10.1111/j.1600-6143.2005.01060.x; Hughes MG, 2004, LIVER TRANSPLANT, V10, P208, DOI 10.1002/lt.20060; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jackowiak P, 2014, INFECT GENET EVOL, V21, P67, DOI 10.1016/j.meegid.2013.10.021; Januszkiewicz-Lewandowska D, 2007, JPN J INFECT DIS, V60, P29; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067982; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Lee C, 2013, BIOMOL THER, V21, P97, DOI 10.4062/biomolther.2013.007; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; Maasoumy B, BEST PRACTICE RES, V26, P401; Mee CJ, 2008, J VIROL, V82, P461, DOI 10.1128/JVI.01894-07; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Miglioresi L, 2003, HEPATOLOGY, V38, P775, DOI 10.1053/jhep.2003.50322; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Moran Gordon W, 2008, Therap Adv Gastroenterol, V1, P51, DOI 10.1177/1756283X08093943; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; NEI M, 1986, MOL BIOL EVOL, V3, P418; PARK JG, 1987, CANCER RES, V47, P5875; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pfaender S, 2015, APPL ENVIRON MICROB, V81, P1616, DOI 10.1128/AEM.03580-14; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Plauzolles A, 2013, SCI WORLD J, DOI 10.1155/2013/673240; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Ramirez S, 2009, AM J TRANSPLANT, V9, P1591, DOI 10.1111/j.1600-6143.2009.02666.x; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Sansonno D, 2006, CLIN EXP IMMUNOL, V143, P288, DOI 10.1111/j.1365-2249.2005.02987.x; Sansonno D, 2004, J VIRAL HEPATITIS, V11, P27, DOI 10.1046/j.1365-2893.2003.00474.x; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Scholtes C, 2012, HEPATOLOGY, V56, P39, DOI 10.1002/hep.25628; Schramm F, 2008, J INFECT DIS, V198, P1656, DOI 10.1086/592986; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tursi A, 2002, AM J GASTROENTEROL, V97, P1802; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WATANABE S, 1993, INTERNAL MED, V32, P523, DOI 10.2169/internalmedicine.32.523; Wyles DL, J INFECT DIS S1, V207, pS33; Yan FM, 2000, WORLD J GASTROENTERO, V6, P805, DOI 10.3748/wjg.v6.i6.805; Zehender G, 2005, J VIROL, V79, P9145, DOI 10.1128/JVI.79.14.9145-9156.2005; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824	87	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181683	10.1371/journal.pone.0181683	http://dx.doi.org/10.1371/journal.pone.0181683			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28750044	Green Published, gold, Green Submitted			2022-12-26	WOS:000406575700071
J	O'Boyle, N; Sutherland, E; Berry, CC; Davies, RL				O'Boyle, Nicky; Sutherland, Erin; Berry, Catherine C.; Davies, Robert L.			Temporal dynamics of ovine airway epithelial cell differentiation at an air-liquid interface	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; IN-VITRO MODEL; BIGHORN SHEEP; PSEUDOMONAS-AERUGINOSA; MYCOPLASMA-OVIPNEUMONIAE; CYSTIC-FIBROSIS; MUCOCILIARY DIFFERENTIATION; MANNHEIMIA-HAEMOLYTICA; INFLAMMATORY RESPONSE; BARRIER FUNCTION	The respiratory tract and lungs are subject to diverse pathologies with wide-ranging implications for both human and animal welfare. The development and detailed characterization of cell culture models for studying such forms of disease is of critical importance. In recent years the use of air-liquid interface (ALI)-cultured airway epithelial cells has increased markedly, as this method of culture results in the formation of a highly representative, organotypic in vitro model system. In this study we have expanded on previous knowledge of differentiated ovine tracheal epithelial cells by analysing the progression of differentiation over an extensive time course at an ALI. We observed a pseudo-stratified epithelium with ciliation and a concurrent increase in cell layer thickness from 9 days post-ALI with ciliation approaching a maximum level at day 24. A similar pattern was observed with respect to mucus production with intensely stained PAS-positive cells appearing at day 12. Ultrastructural analysis by SEM confirmed the presence of both ciliated cells and mucus globules on the epithelial surface within this time-frame. Trans-epithelial electrical resistance (TEER) peaked at 1049 ohm x cm(2) as the cell layer became confluent, followed by a subsequent reduction as differentiation proceeded and stabilization at similar to 200 ohm x cm(2). Importantly, little deterioration or de-differentiation was observed over the 45 day time-course indicating that the model is suitable for long-term experiments.	[O'Boyle, Nicky; Sutherland, Erin; Davies, Robert L.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Berry, Catherine C.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Glasgow	Davies, RL (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	robert.davies@glasgow.ac.uk	Berry, Catherine/AAE-4493-2021; O'Boyle, Nicky/GLU-1241-2022	O'Boyle, Nicky/0000-0002-8669-7237	Biotechnology and Biological Sciences Research Council [BB/L010534/1]; MSD Animal Health; BBSRC [BB/L010534/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MSD Animal Health(Merck & CompanyIntervet International B.V.); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (grant reference: BB/L010534/1; URL: http://www.bbsrc.ac.uk) and by MSD Animal Health (URL: http://www.msd-animal-health.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-26; Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; ANDREWS PM, 1974, AM J ANAT, V139, P399, DOI 10.1002/aja.1001390308; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bateman AC, 2013, INFLUENZA OTHER RESP, V7, P139, DOI 10.1111/j.1750-2659.2012.00371.x; Berge ACB, 2006, JAVMA-J AM VET MED A, V229, P1279, DOI 10.2460/javma.229.8.1279; Besser TE, 2008, J CLIN MICROBIOL, V46, P423, DOI 10.1128/JCM.01931-07; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen P, 2013, AM J PATHOL, V183, P1405, DOI 10.1016/j.ajpath.2013.07.007; Chinnapaiyan S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01052; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Cobb LM, 2004, J IMMUNOL, V173, P5659, DOI 10.4049/jimmunol.173.9.5659; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Dassanayake RP, 2013, VET MICROBIOL, V162, P166, DOI 10.1016/j.vetmic.2012.08.029; Dassanayake RP, 2010, VET MICROBIOL, V145, P354, DOI 10.1016/j.vetmic.2010.04.011; Diamond G, 2000, IMMUNOL REV, V173, P27, DOI 10.1034/j.1600-065X.2000.917304.x; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Ehrhardt C, 2002, CELL TISSUE RES, V308, P391, DOI 10.1007/s00441-002-0548-5; Fliegauf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059925; Ganesan S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24997; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Gazdar AF, 2010, LUNG CANCER, V68, P309, DOI 10.1016/j.lungcan.2009.12.005; Gershwin LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142479; Ghio AJ, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-25; Goris K, 2009, J VIROL, V83, P1962, DOI 10.1128/JVI.01271-08; Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Grubbs ST, 2001, J VET DIAGN INVEST, V13, P128, DOI 10.1177/104063870101300206; Haig S-J, 2011, BIOSCI HORIZ; Hartwig SM, 2016, VIROLOGY, V498, P128, DOI 10.1016/j.virol.2016.08.020; Horvath G, 2007, AM J RESP CELL MOL, V36, P53, DOI 10.1165/rcmb.2006-0230OC; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Jino J, 2013, FRONT MED-PRC, V7, P486, DOI 10.1007/s11684-013-0287-x; KAARTINEN L, 1993, IN VITRO CELL DEV-AN, V29A, P481, DOI 10.1007/BF02639383; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kirchhoff J, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-20; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lawrence PK, 2010, J WILDLIFE DIS, V46, P706, DOI 10.7589/0090-3558-46.3.706; Li YN, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0842-0; Loneragan GH, 2001, J AM VET MED ASSOC, V219, P1122, DOI 10.2460/javma.2001.219.1122; Malik Z, 2015, INT FORUM ALLERGY RH, V5, P551, DOI 10.1002/alr.21517; Mao H, 2009, CRYOBIOLOGY, V59, P250, DOI 10.1016/j.cryobiol.2009.07.012; Mathis C, 2013, AM J PHYSIOL-LUNG C, V304, pL489, DOI 10.1152/ajplung.00181.2012; Mukasa-Mugerwa E, 2000, SMALL RUMINANT RES, V37, P1, DOI 10.1016/S0921-4488(99)00152-2; Nomura K, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-21; OBERDORSTER G, 1994, ENVIRON HEALTH PERSP, V102, P173, DOI 10.2307/3432080; Office of National Statistics DfEFRA, 2016, TOT INC FARM UK 2 ES; OSTROWSKI LE, 1995, EXP LUNG RES, V21, P957, DOI 10.3109/01902149509031773; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Persson BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102368; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Prince OA, 2014, INFECT IMMUN, V82, P579, DOI 10.1128/IAI.01036-13; Prytherch Z, 2011, MACROMOL BIOSCI, V11, P1467, DOI 10.1002/mabi.201100181; Rach J, 2014, J APPL TOXICOL, V34, P506, DOI 10.1002/jat.2899; Radi ZA, 2004, J VET MED A, V51, P167, DOI 10.1111/j.1439-0442.2004.00620.x; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Reid L, 2005, AM J RESP CRIT CARE, V172, P136, DOI 10.1164/rccm.200502-203WS; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rogers DF, 2003, INT J BIOCHEM CELL B, V35, P1, DOI 10.1016/S1357-2725(02)00083-3; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Scharfman A, 1996, INFECT IMMUN, V64, P5417, DOI 10.1128/IAI.64.12.5417-5420.1996; Schwab U, 2014, INFECT IMMUN, V82, P4729, DOI 10.1128/IAI.01876-14; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Stewart C.E., 2012, J ALLERGY, V2012; Tachibana K, 2006, GLYCOBIOLOGY, V16, P46, DOI 10.1093/glycob/cwj038; Thiebes AL, 2015, BIORESEARCH OPEN ACC, V4, P278, DOI 10.1089/biores.2015.0015; Thomas A, 2003, MICROB PATHOGENESIS, V34, P141, DOI 10.1016/S0882-4010(03)00003-2; TRIGO FJ, 1984, AM J VET RES, V45, P1671; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Ward ACS, 2006, CAN J VET RES, V70, P34; WHITCUTT MJ, 1988, IN VITRO CELL DEV B, V24, P420; Wiszniewski L, 2006, AM J RESP CELL MOL, V34, P39, DOI 10.1165/rcmb.2005-0161OC; Xue D, 2015, VET IMMUNOL IMMUNOP, V163, P57, DOI 10.1016/j.vetimm.2014.11.008; Young TF, 2000, VET MICROBIOL, V71, P269, DOI 10.1016/S0378-1135(99)00176-5	85	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181583	10.1371/journal.pone.0181583	http://dx.doi.org/10.1371/journal.pone.0181583			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746416	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800043
J	Rashpa, R; Vazquez-Pianzola, P; Colombo, M; Hernandez, G; Beuchle, D; Berger, F; Peischl, S; Bruggmann, R; Suter, B				Rashpa, Ravish; Vazquez-Pianzola, Paula; Colombo, Martino; Hernandez, Greco; Beuchle, Dirk; Berger, Fabienne; Peischl, Stephan; Bruggmann, Remy; Suter, Beat			Cbp80 is needed for the expression of piRNA components and piRNAs	PLOS ONE			English	Article							WIDE RNAI SCREEN; DROSOPHILA; BIOGENESIS; GENOME; PIWI; PHOSPHORYLATION; SUPPRESSES; GERMLINE; PATHWAY; PROTEIN	Cap binding protein 80 (Cbp80) is the larger subunit of the nuclear cap-binding complex (nCBC), which is known to play important roles in nuclear mRNA processing, export, stability and quality control events. Reducing Cbp80 mRNA levels in the female germline revealed that Cbp80 is also involved in defending the germline against transposable elements. Combining such knockdown experiments with large scale sequencing of small RNAs further showed that Cbp80 is involved in the initial biogenesis of piRNAs as well as in the secondary biogenesis pathway, the ping-pong amplification cycle. We further found that Cbp80 knockdown not only led to the upregulation of transposons, but also to delocalization of Piwi, Aub and Ago3, key factors in the pi RNA biosynthesis pathway. Furthermore, compared to controls, levels of Piwi and Aub were also reduced upon knock down of Cbp80. On the other hand, with the same treatment we could not detect significant changes in levels or subcellular distribution (nuage localization) of piRNA precursor transcripts. This shows that Cbp80 plays an important role in the production and localization of the protein components of the pi RNA pathway and it seems to be less important for the production and export of the pi RNA precursor transcripts.	[Rashpa, Ravish; Vazquez-Pianzola, Paula; Beuchle, Dirk; Berger, Fabienne; Suter, Beat] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Colombo, Martino; Peischl, Stephan; Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Colombo, Martino; Peischl, Stephan; Bruggmann, Remy] Univ Bern, Swiss Inst Bioinformat, Bern, Switzerland; [Colombo, Martino] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Hernandez, Greco] Natl Inst Canc, Div Basic Res, Tlalpan, Mexico; [Rashpa, Ravish] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland	University of Bern; University of Bern; Swiss Institute of Bioinformatics; University of Bern; University of Bern; University of Geneva	Vazquez-Pianzola, P; Suter, B (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	paula.vazquez@izb.unibe.ch; Beat.Suter@izb.unibe.ch	Peischl, Stephan/AAT-3078-2020	Peischl, Stephan/0000-0002-0474-6104; Rashpa, Ravish/0000-0001-7144-0829; Bruggmann, Remy/0000-0001-5629-6363; Colombo, Martino/0000-0001-5433-2623	Swiss National Science foundation [1003A_153280]; Canton of Bern / University of Bern; NOMIS Foundation	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Bern / University of Bern; NOMIS Foundation	This work was supported by the Swiss National Science foundation (grant 1003A_153280 to B.S.; www.snf.ch), by the Canton of Bern / University of Bern, by an equal opportunity grant form the Phil.-nat. Fakultat (http://www.philnat. unibe.ch) to P.V.-P.; M.C. was supported by a NOMIS Foundation (nomisfoundation.ch) grant to Marc-David Ruepp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cagney G, 2000, METHOD ENZYMOL, V328, P3, DOI 10.1016/S0076-6879(00)28386-9; Cao JW, 2016, MOL MED REP, V13, P2829, DOI 10.3892/mmr.2016.4842; Chen YCA, 2016, MOL CELL, V63, P97, DOI 10.1016/j.molcel.2016.05.010; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; Czech B, 2013, MOL CELL, V50, P749, DOI 10.1016/j.molcel.2013.04.007; Dufourt J, 2014, NUCLEIC ACIDS RES, V42, P2512, DOI 10.1093/nar/gkt1184; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Gurskiy D, 2012, NUCLEIC ACIDS RES, V40, P10689, DOI 10.1093/nar/gks857; Haase AD, 2010, GENE DEV, V24, P2499, DOI 10.1101/gad.1968110; Handler D, 2013, MOL CELL, V50, P762, DOI 10.1016/j.molcel.2013.04.031; Heerssen H, 2008, CURR BIOL, V18, P401, DOI 10.1016/j.cub.2008.02.055; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Koch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004552; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Muerdter F, 2013, MOL CELL, V50, P736, DOI 10.1016/j.molcel.2013.04.006; Nag R., 2016, MMS19 XPD MODULATORS; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Olivieri D, 2012, MOL CELL, V47, P954, DOI 10.1016/j.molcel.2012.07.021; Olivieri D, 2010, EMBO J, V29, P3301, DOI 10.1038/emboj.2010.212; Preall JB, 2012, RNA, V18, P1446, DOI 10.1261/rna.034405.112; Qu XH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0666-y; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2010, GENE DEV, V24, P2493, DOI 10.1101/gad.1989510; Sato K, 2015, MOL CELL, V59, P553, DOI 10.1016/j.molcel.2015.06.024; SCHUPBACH T, 1989, GENETICS, V121, P101; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; SPITZER JJ, 1982, REV ECON STAT, V64, P307, DOI 10.2307/1924310; Staller MV, 2013, GENETICS, V193, P51, DOI 10.1534/genetics.112.144915; STUURMAN N, 1995, J CELL SCI, V108, P3137; SUTER B, 1991, CELL, V67, P917, DOI 10.1016/0092-8674(91)90365-6; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Vazquez-Pianzola P, 2014, DEVELOPMENT, V141, P1915, DOI 10.1242/dev.099432; Vazquez-Pianzola P, 2011, DEV BIOL, V357, P404, DOI 10.1016/j.ydbio.2011.07.009; Wang XY, 2014, INT J ONCOL, V45, P2385, DOI 10.3892/ijo.2014.2673; Zhang Z, 2014, CELL, V157, P1353, DOI 10.1016/j.cell.2014.04.030	48	1	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181743	10.1371/journal.pone.0181743	http://dx.doi.org/10.1371/journal.pone.0181743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746365	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800057
J	Tang, L; Zhang, JJ; Cheng, PL				Tang, Liang; Zhang, Jinjie; Cheng, Pengle			Homogenized modeling methodology for 18650 lithium-ion battery module under large deformation	PLOS ONE			English	Article							REPRESENTATIVE VOLUME ELEMENTS; HYBRID ELECTRIC VEHICLES; MECHANICAL INTEGRITY; SHORT-CIRCUIT; BOUNDARY-CONDITIONS; STRAIN-RATE; UNIT CELLS; CHARGE; COMPOSITES; SIMULATION	Effective lithium-ion battery module modeling has become a bottleneck for full-size electric vehicle crash safety numerical simulation. Modeling every single cell in detail would be costly. However, computational accuracy could be lost if the module is modeled by using a simple bulk material or rigid body. To solve this critical engineering problem, a general method to establish a computational homogenized model for the cylindrical battery module is proposed. A single battery cell model is developed and validated through radial compression and bending experiments. To analyze the homogenized mechanical properties of the module, a representative unit cell (RUC) is extracted with the periodic boundary condition applied on it. An elastic-plastic constitutive model is established to describe the computational homogenized model for the module. Two typical packing modes, i.e., cubic dense packing and hexagonal packing for the homogenized equivalent battery module (EBM) model, are targeted for validation compression tests, as well as the models with detailed single cell description. Further, the homogenized EBM model is confirmed to agree reasonably well with the detailed battery module (DBM) model for different packing modes with a length scale of up to 15 x 15 cells and 12% deformation where the short circuit takes place. The suggested homogenized model for battery module makes way for battery module and pack safety evaluation for full-size electric vehicle crashworthiness analysis.	[Tang, Liang; Zhang, Jinjie; Cheng, Pengle] Beijing Forestry Univ, Sch Engn, Beijing, Peoples R China	Beijing Forestry University	Tang, L (corresponding author), Beijing Forestry Univ, Sch Engn, Beijing, Peoples R China.	tang-l04@mails.tsinghua.edu.cn	Cheng, Pengle/GPS-7502-2022		National Science Foundation of China [51605032]; National Science Foundation of Beijing [3174052]; Fundamental Research Funds for the Central Universities [2017ZY31]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Beijing; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is financially supported by the National Science Foundation of China under Grants No. 51605032, the National Science Foundation of Beijing under Grant No. 3174052 and the Fundamental Research Funds for the Central Universities No. 2017ZY31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is financially supported by the National Science Foundation of China under Grants No. 51605032, the National Science Foundation of Beijing under Grant No. 3174052 and the Fundamental Research Funds for the Central Universities No. 2017ZY31.	Ali MY, 2015, J POWER SOURCES, V273, P448, DOI 10.1016/j.jpowsour.2014.09.072; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Dai HF, 2015, INT J ELEC POWER, V67, P627, DOI 10.1016/j.ijepes.2014.12.053; Greve L, 2012, J POWER SOURCES, V214, P377, DOI 10.1016/j.jpowsour.2012.04.055; Hu XS, 2017, MECH SYST SIGNAL PR, V87, P4, DOI 10.1016/j.ymssp.2016.03.004; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Hu XS, 2016, IEEE T IND ELECTRON, V63, P2645, DOI 10.1109/TIE.2015.2461523; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; Kang B, 2009, NATURE, V458, P190, DOI 10.1038/nature07853; Kukreja J, 2016, EXTREME MECH LETT, V9, P371, DOI 10.1016/j.eml.2016.05.004; Lai WJ, 2014, J POWER SOURCES, V248, P789, DOI 10.1016/j.jpowsour.2013.09.128; Lars H, 2011, LITHIUM ION BATTERIE, P11; Li S, 2001, COMPOS PART A-APPL S, V32, P815, DOI 10.1016/S1359-835X(00)00182-2; Li SG, 1999, P ROY SOC A-MATH PHY, V455, P815, DOI 10.1098/rspa.1999.0336; Li SG, 2008, COMPOS SCI TECHNOL, V68, P1962, DOI 10.1016/j.compscitech.2007.03.035; Sahraei E., 2010, SAE TECHNICAL PAPERS; Sahraei E, 2012, J POWER SOURCES, V220, P360, DOI 10.1016/j.jpowsour.2012.07.057; Sahraei E, 2012, J POWER SOURCES, V201, P307, DOI 10.1016/j.jpowsour.2011.10.094; Song MK, 2013, NANO LETT, V13, P5891, DOI 10.1021/nl402793z; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Vikstrom H, 2013, APPL ENERG, V110, P252, DOI 10.1016/j.apenergy.2013.04.005; Wang DW, 2013, ENERGY, V59, P402, DOI 10.1016/j.energy.2013.07.035; Wang Z, 2013, MATH PROBL ENG, V69, P831; Wierzbicki T, 2013, J POWER SOURCES, V241, P467, DOI 10.1016/j.jpowsour.2013.04.135; Xia ZH, 2003, INT J SOLIDS STRUCT, V40, P1907, DOI 10.1016/S0020-7683(03)00024-6; Xu JS, 2016, SCI REP-UK, V6, DOI [10.1038/srep21829, 10.1038/srep27524]; Xu J, 2017, RSC ADV, V7, P14360, DOI 10.1039/c6ra27892b; Xu J, 2016, APPL ENERG, V172, P180, DOI 10.1016/j.apenergy.2016.03.108; Xu J, 2016, MATER DESIGN, V95, P319, DOI 10.1016/j.matdes.2016.01.082; Xu J, 2015, ENG FAIL ANAL, V53, P97, DOI 10.1016/j.engfailanal.2015.03.025; Zheng LF, 2016, APPL ENERG, V180, P424, DOI 10.1016/j.apenergy.2016.08.016; Zhou Y, 2015, MITIG ADAPT STRAT GL, V20, P777, DOI 10.1007/s11027-014-9611-2; Zou CF, 2016, J POWER SOURCES, V335, P121, DOI 10.1016/j.jpowsour.2016.10.040; Zou CF, 2016, IEEE T CONTR SYST T, V24, P1594, DOI 10.1109/TCST.2015.2502899	35	8	8	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181882	10.1371/journal.pone.0181882	http://dx.doi.org/10.1371/journal.pone.0181882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746390	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800067
J	Kato, T; Kubo, A; Nagayama, T; Kume, S; Tanaka, C; Nakayama, Y; Iida, K; Iida, H				Kato, Takafumi; Kubo, Aya; Nagayama, Tatsuya; Kume, Shinichiro; Tanaka, Chikara; Nakayama, Yoshitaka; Iida, Kazuko; Iida, Hidetoshi			Genetic analysis of the regulation of the voltage-gated calcium channel homolog Cch1 by the gamma subunit homolog Ecm7 and cortical ER protein Scs2 in yeast	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; COMPONENT MID1; BINDING-SITE; CA2+; PHOSPHORYLATION; INFLUX; STARGAZIN; PSD-95	The yeast Cch1/Mid1 Ca2+ channel is equivalent to animal voltage-gated Ca2+ channels and activated in cells incubated in low Ca2+ medium. We herein investigated the third subunit, Ecm7, under the same cell culture conditions. The deletion of ECM7 slightly lowered Ca2+ influx activity in the CNB1(+) background, in which calcineurin potentially dephosphorylates Cch1, but markedly lowered this activity in the cnb1 Delta background. The deletion of the C-terminal cytoplasmic region of Ecm7 also reduced Ca2+ influx activity. We identified a novel Cch1-interacting protein, Scs2, which is known as a cortical endoplasmic reticulum membrane protein. The deletion of SCS2 did not affect Ca2+ influx activity when calcineurin was inhibited by FK506, but enhanced this activity by 35% when the enzyme was not inhibited. However, this enhancement was canceled by the deletion of ECM7. These results suggest that Cch1/Mid1 is regulated differentially by Ecm7 and Scs2 in a manner that is dependent on the phosphorylation status of Cch1.	[Kato, Takafumi; Kubo, Aya; Nagayama, Tatsuya; Kume, Shinichiro; Tanaka, Chikara; Nakayama, Yoshitaka; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, Nukui Kita Machi, Koganei, Tokyo, Japan; [Iida, Kazuko] Tokyo Metropolitan Inst Med Sci Kamikitazawa, Lab Biomembrane, Setagaya Ku, Tokyo, Japan; [Kato, Takafumi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Kubo, Aya] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan; [Kume, Shinichiro] Natl Inst Physiol Sci, Dept Mol & Cellular Physiol, Div Biophys & Neurobiol, Okazaki, Aichi, Japan; [Nakayama, Yoshitaka] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia	Tokyo Gakugei University; University of Tokyo; University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Victor Chang Cardiac Research Institute	Iida, H (corresponding author), Tokyo Gakugei Univ, Dept Biol, Nukui Kita Machi, Koganei, Tokyo, Japan.	iida@u-gakugei.ac.jp	Nakayama, Yoshitaka/J-4973-2014; Iida, Hidetoshi/AAO-5506-2020; Nakayama, Yoshitaka/AAT-9699-2020	Nakayama, Yoshitaka/0000-0001-6797-5556; Nakayama, Yoshitaka/0000-0001-6797-5556; Kato, Takafumi/0000-0002-2285-1098; iida, Hidetoshi/0000-0002-3986-2615	Japan Society for the Promotion of Science (JSPS) [26291026]; Grants-in-Aid for Scientific Research [26291026] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research B No. 26291026 (to H.I.) from the Japan Society for the Promotion of Science (JSPS). Y.N. is a JSPS Fellow (No. 10J02008).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chao JT, 2014, CELL, V158, P620, DOI 10.1016/j.cell.2014.06.033; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Courchesne WE, 2011, ARCH MICROBIOL, V193, P323, DOI 10.1007/s00203-010-0673-6; Dunn B, 2002, SHORT PROTOCOLS MOL; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Gathrie C, 1991, METHODS ENZYMOL, V194; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huang JT, 2017, CURR OPIN PHARMACOL, V32, P1, DOI 10.1016/j.coph.2016.10.001; IIDA H, 1990, J BIOL CHEM, V265, P13391; IIDA H, 1985, NATURE, V315, P688, DOI 10.1038/315688a0; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Iida K, 2007, J BIOL CHEM, V282, P25659, DOI 10.1074/jbc.M703757200; Iyer Kavitha, 2005, Sci STKE, V2005, ppl3, DOI 10.1126/stke.2752005pl3; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Muller EM, 2001, GENETICS, V159, P1527; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Tada T, 2003, J BIOL CHEM, V278, P9647, DOI 10.1074/jbc.M206993200; Teng J, 2013, MICROBIOL-SGM, V159, P970, DOI 10.1099/mic.0.064030-0; Tokes-Fuzesi M, 2002, MOL MICROBIOL, V44, P1299, DOI 10.1046/j.1365-2958.2002.02956.x; Viladevall L, 2004, J BIOL CHEM, V279, P43614, DOI 10.1074/jbc.M403606200; Yoshimura H, 2004, EXP CELL RES, V293, P185, DOI 10.1016/j.yexcr.2003.09.020	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181436	10.1371/journal.pone.0181436	http://dx.doi.org/10.1371/journal.pone.0181436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742147	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700042
J	Albayrak, T; Sencan, I; Akca, O; Koc, EM; Aksoy, H; Unsal, S; Bulbul, I; Bahadir, A; Kasim, I; Kahveci, R; Ozkara, A				Albayrak, Turgay; Sencan, Irfan; Akca, Omer; Koc, Esra Meltem; Aksoy, Hilal; Unsal, Selim; Bulbul, Iskender; Bahadir, Adem; Kasim, Ismail; Kahveci, Rabia; Ozkara, Ademo			The ideas about advanced life support and affecting factors at the end-stage of life in a hospital in Turkey	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PATIENT SATISFACTION; DEATH ANXIETY; WITHDRAWAL; ADULTS	Background The participation of the people in health decisions may be structured in various levels. One of these is participation in decisions for the treatment. "Advanced directives" is one of the examples for the participation in decisions for the treatment. Aim We wanted to determine the decisions on advanced life support at the end-stage of life in case of a life-threatening illness for the people themselves and their first degree relatives and the factors effecting these decisions. Design and setting The cross-sectional study was conducted with volunteers among patients and patient relatives who applied to all polyclinics of the Ankara Numune Training and Research Hospital except the emergency, oncology and psychiatry polyclinics between 15.12.2012 and 15.03.2013. Method A questionnaire, the Hospital Anxiety Depression (HAD) scale, and Templer's Death Anxiety Scale (TDA) were applied to all individuals. SPSS for Win. Ver. 17.0 and MS-Excel 2010 Starter software bundles were used for all statistical analysis and calculations. Results The participants want both themselves and their first degree relatives included in end-stage decision-making process. Therefore, the patients and their families should be informed adequately during decision making process and quality communication must be provided. Conclusion Participants who have given their end-stage decisions previously want to be treated according to these decisions. This desire can just be possible by advanced directives. When moral and material loads of end-stage process are taken into consideration, countries, in which advanced directives are practiced, should be examined well and participants' desire should be evaluated in terms of practicability.	[Albayrak, Turgay] Yenimahalle Cigdemtepe Family Hlth Ctr, Ankara, Turkey; [Sencan, Irfan; Kasim, Ismail; Kahveci, Rabia] Ankara Numune Training & Res Hosp, Dept Family Med, Ankara, Turkey; [Akca, Omer] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey; [Koc, Esra Meltem] Izmir Katip Celebi Univ, Dept Family Med, Fac Med, Izmir, Turkey; [Aksoy, Hilal] Pamukkale Pelitlibag Family Hlth Ctr, Denizli, Turkey; [Unsal, Selim] Sefkat 2 Family Hlth Ctr, Ankara, Turkey; [Bulbul, Iskender] Guzelyurt State Hosp, Aksaray, Turkey; [Bahadir, Adem] Kalkandere 1 Family Hlth Ctr, Rize, Turkey; [Ozkara, Ademo] Corum Hitit Univ, Dept Family Med, Fac Med, Corum, Turkey	Ankara Numune Training & Research Hospital; Kayseri Training & Research Hospital; Izmir Katip Celebi University; Hitit University	Koc, EM (corresponding author), Izmir Katip Celebi Univ, Dept Family Med, Fac Med, Izmir, Turkey.	meltemnuzumlali@yahoo.com	Akça, Ömer Faruk/H-9626-2019; Koç, Esra Meltem/AAB-7724-2021; Şencan, İrfan/AAG-5653-2019	Şencan, İrfan/0000-0003-2008-8700; Kasim, Ismail/0000-0003-0762-5823				Abdel-Khalek AM, 2005, DEATH STUD, V29, P157, DOI 10.1080/07481180590906174; Aday RH, 1985, J DEATH DYING, V15, P67; Akca FK, 2008, CLIN PSYCHIATR, P11; [Anonymous], 1992, NEWSLETTER, V11, P4; Aydemir O, 1997, T RK PSIKIYATR DERG, V8, P280; Buckley TA, 2004, CRIT CARE MED, V32, P415, DOI 10.1097/01.CCM.0000110675.34569.A9; Carr D, 2013, J GERONTOL B-PSYCHOL, V68, P586, DOI 10.1093/geronb/gbt034; CARRHILL RA, 1992, J PUBLIC HEALTH MED, V14, P236; CONTE HR, 1982, J PERS SOC PSYCHOL, V43, P775, DOI 10.1037/0022-3514.43.4.775; Curtis JR, 2010, LANCET, V376, P1347, DOI 10.1016/S0140-6736(10)60143-2; Ellentuck AB, 1992, NATIONS BUS, V80, P79; Erdogdu M, 2007, J INONU U MEDICAL FA, V14, P171; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Kahveci R., 2007, TURKIYE KLIN J MED E, V15, P90; Kalaoglu Z, 2010, THESIS; Karan MA, 2012, KLIN GELISIM DERGISI; Kastenbaum R., 2007, DEATH ANXIETY; Kastenbaum R., 2007, ENCY STRESS, VSecond, P717; KELLER JW, 1984, J PSYCHOL, V116, P137, DOI 10.1080/00223980.1984.9923628; Mani RK, 2009, INTENS CARE MED, V35, P1713, DOI 10.1007/s00134-009-1561-x; Mc Whinney IR, 2012, CLIN METHOD, P140; Ortin G Diestre, 2013, REV ESP GERIATR GERO, p[48, 228]; Ozer A., 2007, J MED RES, V5, P140; PARK DC, 1994, SOUTH MED J, V87, P971, DOI 10.1097/00007611-199410000-00002; POLLAK JM, 1979, OMEGA-J DEATH DYING, V10, P97, DOI 10.2190/4KG5-HBH0-NNME-DM58; Senol C., 1989, THESIS; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stewart M, 1995, PATIENT CTR MED TRAN; Sypher B, 2002, AM FAM PHYSICIAN, V65, P2443; TURKEY Guven T., 2008, COUNTRY REPORTS ADV; WILLIAMS B, 1994, SOC SCI MED, V38, P509, DOI 10.1016/0277-9536(94)90247-X; Yazigi A, 2005, INTENS CARE MED, V31, P562, DOI 10.1007/s00134-005-2578-4; YILDIZ M., 1998, THESIS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181456	10.1371/journal.pone.0181456	http://dx.doi.org/10.1371/journal.pone.0181456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC2BU	28732071	Green Published, gold, Green Submitted			2022-12-26	WOS:000406643100036
J	Ngala, RA; Fondjo, LA; Gmagna, P; Ghartey, FN; Awe, MA				Amadu Ngala, Robert; Ahenkorah Fondjo, Linda; Gmagna, Peter; Naku Ghartey, Frank; Akilla Awe, Martin			Placental peptides metabolism and maternal factors as predictors of risk of gestational diabetes in pregnant women. A case-control study	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; MELLITUS; GROWTH; SECRETION; ETHNICITY; LACTOGEN; OBESITY; WEIGHT	Background Gestational diabetes is a risk factor for perinatal complications; include shoulder dystocia, birth injuries such as bone fractures and nerve palsies. It is associated with later development of type 2 diabetes, the risk of macrosomia and other long-term health effects of infants born to diabetic mothers. The study assesses placental peptides and maternal factors as potential predictors of gestational diabetes among pregnant women. Material and methods A total of 200 pregnant women were recruited for the study, 150 pregnant women without pre gestational diabetes including 50 women with low risk factors of diabetes as controls and 50 other pregnant women with pregestational diabetes as control. Fasting blood glucose and the lipid profile were determined by enzymatic methods using Envoy (R) 500 reagents (Vital Diagnostics, USA). Glycated haemoglobin was assessed using the Cation Exchange resin method. Leptin and the Human Placenta Lactogen were assayed using the Sand wich-ELISA technique. Beta chorionic gonadotrophin, insulin, progesterone and estradiol were determined using chemilumiscence imunoassay technique on MAGLUMI 600 analyzer. Anthropometry, including BMI and blood pressure were also measured. Results Fasting plasma glucose (FBG), insulin, insulin resistance, glycated haemoglobin and Human Placenta Lactogen(HPL) were significantly (p<0.0001) increased in the pregestational diabetic women whereas progesterone and estradiol were significantly decreased. In the second trimester however, there was no significant difference (p>0.05) in estradiol, insulin, insulin resistance and HPL between the pregnant women who developed gestational diabetes and those who did not. Leptin, progesterone and FBG were significantly increased in those who developed GDM. The risk of developing gestational diabetes increased with overweight (OR = 1.76, P = 0.370) and family history of diabetes (OR = 2.18, P = 0.282). Conclusion Leptin, progesterone, estradiol estimated in this study were increased in the gestational diabetes mellitus women and fairly predicted gestational diabetes in the non-diabetics pregnant women. Obesity, aging and family history of diabetes were strongly predictive of gestational diabetes.	[Amadu Ngala, Robert; Ahenkorah Fondjo, Linda; Gmagna, Peter; Akilla Awe, Martin] KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Naku Ghartey, Frank] Univ Cape Coast, Dept Chem Pathol, Cape Coast, Ghana	Kwame Nkrumah University Science & Technology; University of Cape Coast	Ngala, RA (corresponding author), KNUST, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	rngala2000@yahoo.com		Ngala, Robert/0000-0001-6915-5914	Ghana Education Trust Fund through the Kwame Nkrumah University of Science and Technology, Kumasi	Ghana Education Trust Fund through the Kwame Nkrumah University of Science and Technology, Kumasi	Peter Gmagna was supported by the Ghana Education Trust Fund through the Kwame Nkrumah University of Science and Technology, Kumasi- The fund was to enable Peter was to enable complete his MPhil programme. The fund was not exclusively for research and publication. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2000, DIABETES CARE, V23, pS77; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Barbour LA, 2007, DIABETES CARE, V30, pS112, DOI 10.2337/dc07-s202; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; BERKOWITZ GS, 1992, AM J EPIDEMIOL, V135, P965, DOI 10.1093/oxfordjournals.aje.a116408; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; BRELJE TC, 1993, ENDOCRINOLOGY, V132, P879, DOI 10.1210/en.132.2.879; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; COUSTAN DR, 1993, AM J OBSTET GYNECOL, V168, P1139, DOI 10.1016/0002-9378(93)90358-P; D'Anna R, 2004, ACTA OBSTET GYN SCAN, V83, P155, DOI 10.1111/j.0001-6349.2004.00291.x; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Freinkel N, 1985, Diabetes, V34 Suppl 2, P1; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; GREEN JR, 1990, AM J OBSTET GYNECOL, V163, P86, DOI 10.1016/S0002-9378(11)90675-9; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Hauguel-de Mouzon S, 2006, AM J OBSTET GYNECOL, V194, P1537, DOI 10.1016/j.ajog.2005.06.064; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Kuhl C, 1998, DIABETES CARE, V21, pB19; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Mamabolo RL, 2007, DIABETIC MED, V24, P233, DOI 10.1111/j.1464-5491.2006.02073.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; OSullivan J., 1989, CARBOHYD METABOL, P287; Petitt D J, 1985, Diabetes, V34 Suppl 2, P119; Qiu CF, 2004, OBSTET GYNECOL, V103, P519, DOI 10.1097/01.AOG.0000113621.53602.7a; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Ramiya VK, 2000, NAT MED, V6, P278; Rizzo TA, 1997, CHILD DEV, V68, P26, DOI 10.2307/1131922; Rodrigues S, 1999, AM J CLIN NUTR, V70, P1083; RYAN EA, 1985, DIABETES, V34, P380, DOI 10.2337/diabetes.34.4.380; Sacks David B, 2011, Diabetes Care, V34, pe61, DOI 10.2337/dc11-9998; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Wolf M, 2003, DIABETES CARE, V26, P819, DOI 10.2337/diacare.26.3.819	39	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0181613	10.1371/journal.pone.0181613	http://dx.doi.org/10.1371/journal.pone.0181613			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732072	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100049
J	Kho, DT; Johnson, R; Robilliard, L; du Mez, E; McIntosh, J; O'Carroll, SJ; Angel, CE; Graham, ES				Kho, Dan Ting; Johnson, Rebecca; Robilliard, Laverne; du Mez, Elyce; McIntosh, Julie; O'Carroll, Simon J.; Angel, Catherine E.; Graham, E. Scott			ECIS technology reveals that monocytes isolated by CD14(+ve) selection mediate greater loss of BBB integrity than untouched monocytes, which occurs to a greater extent with IL-1 beta activated endothelium in comparison to TNF alpha	PLOS ONE			English	Article							REAL-TIME; CELLS; CYTOKINE; EXPRESSION; INHIBITION; MECHANISMS; MIGRATION	Background We have previously shown that TNF alpha and IL-1 beta differentially regulate the inflammatory phenotype of human brain endothelial cells (hCMVECs). In this regard, IL-1 beta treatment was considerably more potent than TNFa at increasing expression of inflammatory chemokines and leukocyte adhesion molecules. We therefore hypothesised that interaction of the hCMVECs with human monocytes would also be dependent on the activation status of the endothelium. Therefore, the primary aim of this study was to assess whether brain endothelial cells activated by IL-1 beta or TNF alpha differed in their interaction with monocytes. Methods Monocyte interaction was measured using the real time, label-free impedance based ECIS technology, to evaluate endothelial barrier integrity during monocyte attachment and transendothelial migration. Results ECIS technology revealed that there was a greater loss of barrier integrity with IL-1 beta activation and this loss lasted for longer. This was expected and consistent with our hypothesis. However, more striking and concerning was the observation that the method of monocyte enrichment greatly influenced the extent of endothelial barrier compromise. Importantly, we observed that positively isolated monocytes (CD14(+ve)) caused greater reduction in barrier resistance, than the negatively selected monocytes (untouched). Analysis of the isolated monocyte populations revealed that the CD14(+ve) isolation consistently yields highly pure monocytes (>92%), whereas the untouched isolation was much more variable, yielding similar to 70% enrichment on average. These two enrichment methods were compared as it was thought that the presence of non-classical CD16(hi) monocytes in the untouched enrichment may mediate greater compromise than the classical CD14(hi) monocytes. This however, was not the case and these observations raise a number of important considerations pertaining to the enrichment strategy, which are essential for generating reliable and consistent data. Conclusions We conclude that IL-1 beta and TNF alpha differentially influence monocyte interaction with brain endothelial cells and moreover, the enrichment method also influences the monocyte response as revealed using ECIS technology.	[Kho, Dan Ting; Johnson, Rebecca; Robilliard, Laverne; O'Carroll, Simon J.; Graham, E. Scott] Univ Auckland, Sch Med Sci, Ctr Brain Res, Fac Med & Hlth Sci, Auckland, New Zealand; [Kho, Dan Ting; Johnson, Rebecca; Robilliard, Laverne; Graham, E. Scott] Univ Auckland, Sch Med Sci, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland, New Zealand; [du Mez, Elyce; McIntosh, Julie; Angel, Catherine E.] Univ Auckland, Sch Biol Sci, Fac Sci, Auckalnd, New Zealand; [O'Carroll, Simon J.] Univ Auckland, Sch Med Sci, Dept Anat & Med Imaging, Fac Med & Hlth Sci, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Graham, ES (corresponding author), Univ Auckland, Sch Med Sci, Ctr Brain Res, Fac Med & Hlth Sci, Auckland, New Zealand.; Graham, ES (corresponding author), Univ Auckland, Sch Med Sci, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland, New Zealand.	s.graham@auckland.ac.nz		Robilliard, Laverne/0000-0002-2717-5826; Kho, Dan/0000-0001-7193-2954; Angel, Catherine/0000-0003-1737-8539; Johnson, Rebecca. H./0000-0001-9473-2621	Health Research Council of New Zealand; Faculty Research Development fund, University of Auckland; New Zealand Lottery Health grant; New Zealand Lottery Health Board; Health Research Council; University of Auckland Faculty Research Development Fund	Health Research Council of New Zealand(Health Research Council of New Zealand); Faculty Research Development fund, University of Auckland; New Zealand Lottery Health grant; New Zealand Lottery Health Board; Health Research Council; University of Auckland Faculty Research Development Fund	Research Funding was obtained by ESG, and CEA from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). ESG and SJO received funding from the Faculty Research Development fund, University of Auckland. ECIS technology was purchased with funding from the New Zealand Lottery Health grant to SJO and ESG. The funders had no role in any aspect in the experimental design, decision to publish or content of this manuscript.; The author would like to thank all of the volunteers who donated blood for this study. We also wish to acknowledge the funding from the New Zealand Lottery Health Board who provided the grant to purchase the Accuri C6 flow cytometer and the ECIS technology. This research was conducted with funding from the Health Research Council (ESG) and University of Auckland Faculty Research Development Fund (ESG).	Barreiro O, 2009, REV ESP CARDIOL, V62, P552, DOI 10.1016/S0300-8932(09)71035-8; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Colgan OC, 2008, BRAIN RES, V1193, P84, DOI 10.1016/j.brainres.2007.11.072; Correale J, 2009, NEUROCHEM RES, V34, P2067, DOI 10.1007/s11064-009-0081-y; Elkord E, 2005, IMMUNOLOGY, V114, P204, DOI 10.1111/j.1365-2567.2004.02076.x; Fox ED, 2013, CRIT CARE, V17, DOI 10.1186/cc13049; Griffin JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157483; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Keil JM, 2013, INVEST OPHTH VIS SCI, V54, P4007, DOI 10.1167/iovs.13-11980; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Lee ES, 2012, J SURG RES, V177, P373, DOI 10.1016/j.jss.2012.06.021; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; O'Carroll SJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0346-0; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Reijerkerk A, 2012, J NEUROCHEM, V121, P730, DOI 10.1111/j.1471-4159.2011.07393.x; Rom S, 2013, AM J PATHOL, V183, P1548, DOI 10.1016/j.ajpath.2013.07.033; Rom S, 2012, AM J PATHOL, V181, P1414, DOI 10.1016/j.ajpath.2012.06.018; Stolwijk JA, 2014, PFLUGERS ARCH EUROPE; Szulcek R, 2014, JOVE-J VIS EXP, DOI 10.3791/51300; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Weksler B, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-16; Zhou L, 2012, CLIN VACCINE IMMUNOL, V19, P1065, DOI 10.1128/CVI.05715-11; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	27	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180267	10.1371/journal.pone.0180267	http://dx.doi.org/10.1371/journal.pone.0180267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732059	Green Submitted, gold, Green Published			2022-12-26	WOS:000406643100004
J	Alotaibi, NM; Ibrahim, GM; Wang, J; Guha, D; Mamdani, M; Schweizer, TA; Macdonald, RL				Alotaibi, Naif M.; Ibrahim, George M.; Wang, Justin; Guha, Daipayan; Mamdani, Muhammad; Schweizer, Tom A.; Macdonald, R. Loch			Neurosurgeon academic impact is associated with clinical outcomes after clipping of ruptured intracranial aneurysms	PLOS ONE			English	Article							VEHICLE-CONTROLLED TRIAL; HOSPITAL TEACHING STATUS; DOSE TIRILAZAD MESYLATE; SUBARACHNOID HEMORRHAGE; SURGEON-VOLUME; DOUBLE-BLIND; EXPERIENCE; PERFORMANCE; AUSTRALIA; MORTALITY	Background Surgeon-dependent factors such as experience and volume are associated with patient outcomes. However, it is unknown whether a surgeon's research productivity could be related to outcomes. The main aim of this study is to investigate the association between the surgeon's academic productivity and clinical outcomes following neurosurgical clipping of ruptured aneurysms. Methods We performed a post-hoc analysis of 3567 patients who underwent clipping of ruptured intracranial aneurysms in the randomized trials of tirilazad mesylate from 1990 to 1997. These trials included 162 centers and 156 surgeons from 21 countries. Primary and secondary outcomes were: Glasgow outcome scale score and mortality, respectively. Total publications, H-index, and graduate degrees were used as academic indicators for each surgeon. The association between outcomes and academic factors were assessed using a hierarchical logistic regression analysis, adjusting for patient covariates. Results Academic profiles were available for 147 surgeons, treating a total of 3307 patients. Most surgeons were from the USA (62, 42%), Canada (18, 12%), and Germany (15, 10%). On univariate analysis, the H-index correlated with better functional outcomes and lower mortality rates. In the multivariate model, patients under the care of surgeons with higher H-indices demonstrated improved neurological outcomes (p = 0.01) compared to surgeons with lower H-indices, without any significant difference in mortality. None of the other academic indicators were significantly associated with outcomes. Conclusion Although prognostication following surgery for ruptured intracranial aneurysms primarily depends on clinical and radiological factors, the academic impact of the operating neurosurgeon may explain some heterogeneity in surgical outcomes.	[Alotaibi, Naif M.; Ibrahim, George M.; Wang, Justin; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Alotaibi, Naif M.; Guha, Daipayan; Schweizer, Tom A.; Macdonald, R. Loch] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Alotaibi, Naif M.] King Fahad Med City, Dept Neurosurg, Natl Neurosci Inst, Riyadh, Saudi Arabia; [Mamdani, Muhammad] Inst Clin Evaluat Sci, Li Ka Shing Ctr Healthcare Analyt Res & Training, Toronto, ON, Canada; [Schweizer, Tom A.; Macdonald, R. Loch] St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst,Div Neurosurg, Toronto, ON, Canada	University of Toronto; University of Toronto; King Fahad Medical City; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Macdonald, RL (corresponding author), Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada.; Macdonald, RL (corresponding author), Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada.; Macdonald, RL (corresponding author), St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst,Div Neurosurg, Toronto, ON, Canada.	MacdonaldLo@smh.ca	Guha, Daipayan/AAV-1008-2021	Guha, Daipayan/0000-0002-2052-4819; Alotaibi, Naif/0000-0002-8227-347X				Almatar A, 2016, CUAJ-CAN UROL ASSOC, V10, P45, DOI 10.5489/cuaj.3214; Attenello FJ, 2016, J NEUROINTERV SURG, V8, P373, DOI 10.1136/neurintsurg-2014-011642; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; Barocas DA, 2010, UROL ONCOL-SEMIN ORI, V28, P243, DOI 10.1016/j.urolonc.2009.03.001; Basques BA, 2016, SPINE; Bennett WO, 2012, PUBLIC HEALTH, V126, pS40, DOI 10.1016/j.puhe.2012.05.021; Berman MF, 2003, STROKE, V34, P2200, DOI 10.1161/01.STR.0000086528.32334.06; Bilimoria KY, 2009, ANN SURG ONCOL, V16, P1799, DOI 10.1245/s10434-009-0467-8; Boudourakis LD, 2009, ANN SURG, V250, P159, DOI 10.1097/SLA.0b013e3181a77cb3; Ch'ng SL, 2015, HEART LUNG CIRC, V24, P583, DOI 10.1016/j.hlc.2014.11.014; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Cowan JA, 2002, J AM COLL SURGEONS, V195, P814, DOI 10.1016/S1072-7515(02)01345-5; DRAKE CG, 1988, J NEUROSURG, V68, P985; Duclos A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8041; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Gooden KM, 2008, MED CARE, V46, P1170, DOI 10.1097/MLR.0b013e31817d696d; Guha DPA, 2014, J NEUROSURG, V121, P1039, DOI 10.3171/2014.7.JNS132141; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HALEY EC, 1995, J NEUROSURG, V82, P786, DOI 10.3171/jns.1995.82.5.0786; Helbok R, 2013, J NEUROL NEUROSUR PS, V84, P266, DOI 10.1136/jnnp-2012-302804; Hyder O, 2013, J GASTROINTEST SURG, V17, P2114, DOI 10.1007/s11605-013-2349-4; Ibrahim GM, 2013, J NEUROSURG, V119, P347, DOI 10.3171/2013.3.JNS122097; Jaja BN, 2013, STROKE; Kassell NF, 1996, J NEUROSURG, V84, P221, DOI 10.3171/jns.1996.84.2.0221; Kawashima H, 2015, SCIENTOMETRICS, V103, P1061, DOI 10.1007/s11192-015-1580-z; Kim Hyun Su, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P67, DOI 10.7461/jcen.2013.15.2.67; Lai PMR, 2014, WORLD NEUROSURG, V82, P380, DOI 10.1016/j.wneu.2013.07.015; Lanzino G, 1999, J NEUROSURG, V90, P1011, DOI 10.3171/jns.1999.90.6.1011; Lanzino G, 1999, J NEUROSURG, V90, P1018, DOI 10.3171/jns.1999.90.6.1018; Lau RL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-250; Lee J, 2009, J NEUROSURG, V111, P387, DOI 10.3171/2008.10.JNS08978; Lipsman N, 2009, J NEUROSURG, V111, P67, DOI 10.3171/2008.10.JNS08184; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; McAteer JP, 2013, JAMA PEDIATR, V167, P468, DOI 10.1001/jamapediatrics.2013.25; McDonald RJ, 2012, J NEUROSURG, V116, P157, DOI 10.3171/2011.8.JNS11324; Meguid RA, 2008, ANN THORAC SURG, V85, P1015, DOI 10.1016/j.athoracsur.2007.09.046; Meguid RA, 2009, J VASC SURG, V50, P243, DOI 10.1016/j.jvs.2009.01.046; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Pacella SJ, 2006, PLAST RECONSTR SURG, V117, P1296, DOI 10.1097/01.prs.0000204962.85336.51; Patel VM, 2011, J ROY SOC MED, V104, P251, DOI 10.1258/jrsm.2011.110005; Paulsen T, 2006, INT J GYNECOL CANCER, V16, P11, DOI 10.1111/j.1525-1438.2006.00319.x; Peltoniemi P, 2011, ANN SURG ONCOL, V18, P1684, DOI 10.1245/s10434-010-1514-1; Pons J, 2010, J HEALTH SERV RES PO, V15, P204, DOI 10.1258/jhsrp.2010.009125; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Seaburg LA, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0543-2; Tchetchik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129259; Vermeulen MJ, 2007, STROKE, V38, P1216, DOI 10.1161/01.STR.0000259661.05525.9a; Wilt TJ, 2008, J UROLOGY, V180, P820, DOI 10.1016/j.juro.2008.05.010; Yaghoubian A, 2010, AM J SURG, V200, P810, DOI 10.1016/j.amjsurg.2010.07.028	50	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181521	10.1371/journal.pone.0181521	http://dx.doi.org/10.1371/journal.pone.0181521			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727832	Green Submitted, Green Published, gold			2022-12-26	WOS:000406634500082
J	Gonzalez-Santiago, O; Claudio, PCMS; Cantu-Cardenas, LG; Favela-Hernandez, JMJ				Gonzalez-Santiago, Omar; Morales-San Claudio, Pilar C.; Cantu-Cardenas, Lucia G.; Favela-Hernandez, Juan M. J.			Unintentional and self-poisoning mortalities in Mexico, 2000-2012	PLOS ONE			English	Article							UNITED-STATES; SUICIDE; HOSPITALIZATIONS; SEX	Introduction Poisoning remains a major worldwide public health problem. Mortality varies by country, region and ethnicity. The objective of this study is to analyze recent trends in poisoning mortality in the Mexican population. Methods Data regarding mortality induced by poisoning was obtained from a publicly available national database maintained by the National Institute of Statistics and Geography. Results During the period from 2000 to 2012, average mortality rates for unintentional and self-poisoning were 1.09 and 0.41 per 100000 population, respectively. The highest mortality rate for unintentional poisoning was in older individuals of both genders while the highest mortality for self-poisoning was in older men and young women. Additional studies are needed in Mexico, especially those that analyze risk factors in older individuals and young women.	[Gonzalez-Santiago, Omar; Morales-San Claudio, Pilar C.; Cantu-Cardenas, Lucia G.; Favela-Hernandez, Juan M. J.] Univ Autonoma Nuevo Leon, Sch Chem Sci, Postgrad Div, San Nicolas De Los Garza, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Gonzalez-Santiago, O (corresponding author), Univ Autonoma Nuevo Leon, Sch Chem Sci, Postgrad Div, San Nicolas De Los Garza, Nuevo Leon, Mexico.	omargs28@yahoo.com	González-Santiago, Omar/H-3898-2019	González-Santiago, Omar/0000-0003-1841-1783; Favela-Hernandez, Juan Manuel J/0000-0002-1547-7771				Ahmad OB, 2001, 31 WHO; Andrew E, 2008, CLIN TOXICOL, V46, P310, DOI 10.1080/15563650701378712; [Anonymous], 2017, SUIC DAT MENT HLTH; [Anonymous], POIS PREV MAN INT PR; Belanger F, 2008, POISONING RELATED DE; Bohnert ASB, 2010, PUBLIC HEALTH REP, V125, P542, DOI 10.1177/003335491012500409; Center for Disease Control and Prevention, SUIC DUE ALC DRUG OV; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P233; Chien WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-703; Coben JH, 2010, AM J PREV MED, V38, P517, DOI 10.1016/j.amepre.2010.01.022; Courtin E, 2017, HEALTH SOC CARE COMM, V25, P799, DOI 10.1111/hsc.12311; Davalos J, 2010, INJ PREV S1, V16, pA1; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Hawton K, 2000, BRIT J PSYCHIAT, V177, P484, DOI 10.1192/bjp.177.6.484; Instituto Nacional de Estadistica y Geografia (INEGI), EST MORT; Olguin HJ, 2011, J POPUL THER CLIN PH, V18, pE156; Muazzam S, 2012, WEST J EMERG MED, V13, P230, DOI 10.5811/westjem.2012.3.11762; Peiris-John R, 2014, INTERN MED J, V44, P273, DOI 10.1111/imj.12364; Pruss-Ustun A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-9; Rockett IRH, 2016, JAMA PSYCHIAT, V73, P1072, DOI 10.1001/jamapsychiatry.2016.1870; Rockett IRH, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302244; Rogers JJ, 2007, CLIN TOXICOL, V45, P705, DOI 10.1080/15563650701517491; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; ROMIEU I, 1994, ENVIRON HEALTH PERSP, V102, P384, DOI 10.2307/3431627; Valtorta N, 2012, J ROY SOC MED, V105, P518, DOI 10.1258/jrsm.2012.120128	25	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0181708	10.1371/journal.pone.0181708	http://dx.doi.org/10.1371/journal.pone.0181708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727851	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000406634500107
J	Keating, J; Affleck-Brodie, C; Wiegand, R; Morcom, AM				Keating, Jessica; Affleck-Brodie, Caitlin; Wiegand, Ronny; Morcom, Alexa M.			Aging, working memory capacity and the proactive control of recollection: An event-related potential study	PLOS ONE			English	Article							LATE POSTERIOR NEGATIVITY; COGNITIVE CONTROL; INDIVIDUAL-DIFFERENCES; EPISODIC RETRIEVAL; OLDER-ADULTS; BRAIN ACTIVITY; ERP; AGE; CONTEXT; FAMILIARITY	The present study investigated the role of working memory capacity (WMC) in the control of recollection in young and older adults. We used electroencephalographic event-related potentials (ERPs) to examine the effects of age and of individual differences in WMC on the ability to prioritize recollection according to current goals. Targets in a recognition exclusion task were words encoded using two alternative decisions. The left parietal ERP old/new effect was used as an electrophysiological index of recollection, and the selectivity of recollection measured in terms of the difference in its magnitude according to whether recognized items were targets or non-targets. Young adults with higher WMC showed greater recollection selectivity than those with lower WMC, while older adults showed nonselective recollection which did not vary with WMC. The data suggest that aging impairs the ability to engage cognitive control effectively to prioritize what will be recollected.	[Keating, Jessica; Affleck-Brodie, Caitlin; Wiegand, Ronny; Morcom, Alexa M.] Univ Edinburgh, Sch Psychol Philosophy & Language Sci, Edinburgh, Midlothian, Scotland; [Morcom, Alexa M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Morcom, AM (corresponding author), Univ Edinburgh, Sch Psychol Philosophy & Language Sci, Edinburgh, Midlothian, Scotland.; Morcom, AM (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	alexa.morcom@ed.ac.uk		Morcom, Alexa/0000-0003-4654-5308; Keating, Jessica/0000-0002-0224-854X	UK Medical Research Council [MR/K026992/1]; UK cross-council Lifelong Health and Wellbeing Initiative [MR/K026992/1]; Medical Research Council [MR/K026992/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK cross-council Lifelong Health and Wellbeing Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Alexa M. Morcom is a member of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the UK cross-council Lifelong Health and Wellbeing Initiative, UK Medical Research Council Grant number MR/K026992/1 (https://www.mrc.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alexa M. Morcom is a member of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the UK cross-council Lifelong Health and Wellbeing Initiative, Grant number MR/K026992/1.	Abdulrahman H, 2014, NEUROIMAGE; Angel L, 2010, BRAIN RES, V1335, P41, DOI 10.1016/j.brainres.2010.03.040; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Bergstrom ZM, 2013, NEUROIMAGE, V68, P141, DOI 10.1016/j.neuroimage.2012.11.030; Braver T. S., 2008, HDB AGING COGNITION, V3rd, P311, DOI DOI 10.4324/9780203837665.CH7; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Braver TS, 2001, J EXP PSYCHOL GEN, V130, P746, DOI 10.1037//0096-3445.130.4.746; Bridger EK, 2012, NEUROIMAGE, V63, P1334, DOI 10.1016/j.neuroimage.2012.07.047; Bridger EK, 2012, J COGNITIVE NEUROSCI, V24, P1476, DOI 10.1162/jocn_a_00152; Bugg JM, 2014, PSYCHOL AGING, V29, P115, DOI 10.1037/a0035270; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; de Chastelaine M, 2007, J COGNITIVE NEUROSCI, V19, P1286, DOI 10.1162/jocn.2007.19.8.1286; Delis DC, 2001, DELIS KAPLAN EXECUTI; Dew ITZ, 2012, CEREB CORTEX, V22, P2542, DOI 10.1093/cercor/bhr334; Duarte A, 2006, J COGNITIVE NEUROSCI, V18, P33, DOI 10.1162/089892906775249988; Duverne S, 2008, EFFECTS AGE NEURAL C, P1; Dywan J, 1998, BRAIN COGNITION, V36, P390, DOI 10.1006/brcg.1997.0979; Dzulkifli MA, 2006, NEUROPSYCHOLOGIA, V44, P1120, DOI 10.1016/j.neuropsychologia.2005.10.021; Dzulkifli MA, 2005, NEUROPSYCHOLOGIA, V43, P1152, DOI 10.1016/j.neuropsychologia.2004.11.019; Elward RL, 2010, BRAIN RES, V1342, P55, DOI 10.1016/j.brainres.2010.04.040; Elward RL, 2013, CORTEX, V49, P1452, DOI 10.1016/j.cortex.2012.07.003; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Evans LH, 2010, BRAIN RES, V1324, P43, DOI 10.1016/j.brainres.2010.02.010; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Friedman D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00111; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Herron JE, 2007, PSYCHOPHYSIOLOGY, V44, P233, DOI 10.1111/j.1469-8986.2006.00489.x; Herron JE, 2003, PSYCHON B REV, V10, P703, DOI 10.3758/BF03196535; Hofer SM, 2001, GERONTOLOGY, V47, P341, DOI 10.1159/000052825; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Johansson M, 2003, BIOL PSYCHOL, V64, P91, DOI 10.1016/S0301-0511(03)00104-2; Johnson MK, 1997, NEUROREPORT, V8, P1317, DOI 10.1097/00001756-199703240-00051; Koen JD, 2014, NEUROPSYCHOL REV, V24, P332, DOI 10.1007/s11065-014-9266-5; Kopp B, 2014, BRAIN COGNITION, V85, P209, DOI 10.1016/j.bandc.2013.12.008; Kucera H., 1967, COMPUTATIONAL ANAL P; Li J, 2004, COGN AFFECT BEHAV NE, V4, P279, DOI 10.3758/CABN.4.3.279; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Makeig S, 1996, ADV NEUR IN, V8, P145; Mark RE, 1998, BRAIN, V121, P861, DOI 10.1093/brain/121.5.861; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Mecklinger A, 2016, NEUROSCI BIOBEHAV R, V68, P621, DOI 10.1016/j.neubiorev.2016.06.024; Morcom AM, 2016, CURR DIR PSYCHOL SCI, V25, P143, DOI 10.1177/0963721416645536; Morcom AM, 2004, NEUROPSYCHOLOGIA, V42, P1525, DOI 10.1016/j.neuropsychologia.2004.03.009; Morcom AM, 2003, BRAIN, V126, P213, DOI 10.1093/brain/awg020; Morcom AM, 2015, J COGN NEUROSCI, V27; Nuwer M R, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P11; Old SR, 2008, PSYCHOL AGING, V23, P104, DOI 10.1037/0882-7974.23.1.104; Paxton JL, 2006, PSYCHOL AGING, V21, P499, DOI 10.1037/0882-7974.21.3.499; Paxton JL, 2008, COGNITIVE CONTROL GO; Redick TS, 2014, ACTA PSYCHOL, V145, P1, DOI 10.1016/j.actpsy.2013.10.010; Redick TS, 2011, Q J EXP PSYCHOL, V64, P1048, DOI 10.1080/17470218.2011.577226; RUGG MD, 1995, NEUROPSYCHOLOGIA, V33, P471, DOI 10.1016/0028-3932(94)00132-9; Rugg MD, 2005, COGNITIVE NEUROSCIEN, P132; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; Sprondel V, 2012, DEVELOPMENTAL SCI, V15, P330, DOI 10.1111/j.1467-7687.2011.01130.x; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2007, J EXP PSYCHOL LEARN, V33, P1020, DOI 10.1037/0278-7393.33.6.1020; Unsworth N, 2016, PSYCHOL LEARN MOTIV, V65, P1, DOI 10.1016/bs.plm.2016.03.001; Unsworth N, 2012, MEMORY, V20, P167, DOI 10.1080/09658211.2011.651087; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Voss JL, 2011, PSYCHOPHYSIOLOGY, V48, P532, DOI 10.1111/j.1469-8986.2010.01085.x; Wechsler D., 2009, TEST PREMORBID FUNCT; Wechsler D., 2012, WAIS 4 KASIKIRJA; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wilson M., MRC PSYCHOLINGUISTIC; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	77	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e0180367	10.1371/journal.pone.0180367	http://dx.doi.org/10.1371/journal.pone.0180367			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC1YQ	28727792	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500020
J	Barska, K; Kwiatkowska, W; Knysz, B; Arczynska, K; Karczewski, M; Witkiewicz, W				Barska, Katarzyna; Kwiatkowska, Wieslawa; Knysz, Brygida; Arczynska, Katarzyna; Karczewski, Maciej; Witkiewicz, Wojciech			The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV	PLOS ONE			English	Article							FACTOR PATHWAY INHIBITOR; INTIMA-MEDIA THICKNESS; BLOOD-COAGULATION; EXTRINSIC PATHWAY; UP-REGULATION; RISK-FACTORS; P-SELECTIN; IN-VIVO; INFECTION; EXPRESSION	Introduction HIV infection is associated with an increased risk of cardiovascular disease in connection with atherosclerosis and thromboembolic complications. The pathogenesis of atherosclerosis is still unclear in this group of patients. Studies on pathogenesis of atherosclerosis in the general population emphasize the role of the extrinsic pathway of blood coagulation, particularly the tissue factor (TF) and tissue factor pathway inhibitor ( TFPI). The effect of persistent activation of the immune system on enhanced expression of TF on the surface of monocytes in subjects infected with HIV is known to be correlated with the level of HIV RNA in blood serum. Study aim The aim of this study was to evaluate the concentration of TF and its inhibitor TFPI in blood plasma, the impact of traditional and non-traditional cardiovascular risk factors on their concentration and the impact of both markers of haemostasis on the severity of subclinical atherosclerosis as assessed by the intima-media measurement of the carotid artery in HIV infected patients. Materials The study included 121 HIV-infected people with known clinical, immunological and virological status. The control group consisted of 42 healthy individuals, selected in terms of age and sex. Results and conclusions Higher concentrations of TF occurred in HIV-infected patients with a low current plasma HIV RNA level, nadir CD4+ T-cell count and longer duration of cumulative antiretroviral treatment. In multivariate analysis, it was the length of cumulative NRTI treatment that impacted on the concentration of TF. The determinants of cardiovascular disease (CVD) risk factors and inflammatory markers did not show any effect on the concentrations of TF. The TFPI level in HIV-infected patients was significantly higher than in the control group and was negatively correlated with the current level of HIV RNA and nadir CD4+ T-cell count, being higher in patients subjected to antiretroviral treatment. It was shown that the higher the cardiovascular risk and the higher the levels of total cholesterol, low-density lipoprotein cholesterol (LDL) and non-high-density lipoprotein cholesterol (non-HDL), the higher the concentrations of TFPI observed. The levels of TF and TFPI were positively correlated with carotid intima media thickness (cIMT); in the multivariate analysis, TF, non-HDL cholesterol and lifetime smoking (pack-years) independently affected the growth of cIMT. A similar effect on cIMT was demonstrated by TFPI.	[Barska, Katarzyna; Kwiatkowska, Wieslawa; Knysz, Brygida; Arczynska, Katarzyna; Karczewski, Maciej; Witkiewicz, Wojciech] Reg Specialist Hosp, Res & Dev Ctr Wroclaw, Wrovasc Integrated Cardiovasc Ctr, Wroclaw, Poland; [Barska, Katarzyna; Kwiatkowska, Wieslawa; Witkiewicz, Wojciech] Reg Specialist Hosp, Dept Angiol, Res & Dev Ctr Wroclaw, Wroclaw, Poland; [Knysz, Brygida] Wroclaw Med Univ, Dept Infect Dis, Wroclaw, Poland	Wroclaw Medical University	Barska, K (corresponding author), Reg Specialist Hosp, Res & Dev Ctr Wroclaw, Wrovasc Integrated Cardiovasc Ctr, Wroclaw, Poland.; Barska, K (corresponding author), Reg Specialist Hosp, Dept Angiol, Res & Dev Ctr Wroclaw, Wroclaw, Poland.	barska.kat@gmail.com		Knysz, Brygida/0000-0003-2605-1079	European Regional Development Fund within Innovative Economy Operational Program; European Funds	European Regional Development Fund within Innovative Economy Operational Program; European Funds	This publication is part of Project "Wrovasc - Integrated Cardiovascular Centre," cofinanced by the European Regional Development Fund within Innovative Economy Operational Program 2007-2013, realized in Regional Specialist Hospital, Research and Development Center in Wroclaw. This work is also supported by "European Funds-for the development of innovative economy." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication is part of Project "Wrovasc-Integrated Cardiovascular Centre", co-financed by the European Regional Development Fund, within Innovative Economy Operational Program, 2007-2013 realized in Regional Specialist Hospital, Research and Development Center	Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Chou J, 2004, BLOOD, V104, P3190, DOI 10.1182/blood-2004-03-0935; de Larranaga GF, 2003, THROMB RES, V110, P93, DOI 10.1016/S0049-3848(03)00291-3; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Falati S, 2003, J EXP MED, V197, P1585, DOI 10.1084/jem.20021868; Falciani M, 1998, THROMB HAEMOSTASIS, V79, P495; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Funderburg NT, 2010, BLOOD, V115, P161, DOI 10.1182/blood-2009-03-210179; HANSEN JB, 1994, ARTERIOSCLER THROMB, V14, P223, DOI 10.1161/01.ATV.14.2.223; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Jacobson MC, 2004, CLIN INFECT DIS, V39, P1214, DOI 10.1086/424664; Kotschy M, 2010, KARDIOL POL, V68, P1158; Kwiatkowska W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113857; Kwiatkowska W, 2011, POSTEP HIG MED DOSW, V65, P770, DOI 10.5604/17322693.967075; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Manner IW, 2013, J CLIN HYPERTENS, V15, P101, DOI 10.1111/jch.12029; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Morel O, 2006, ARTERIOSCL THROM VAS, V26, P2594, DOI 10.1161/01.ATV.0000246775.14471.26; Nakagomi A, 2011, J ATHEROSCLER THROMB, V18, P475, DOI 10.5551/jat.6874; Saito M, 1996, Rinsho Ketsueki, V37, P794; Sakkinen PA, 1998, THROMB HAEMOSTASIS, V80, P134, DOI 10.1055/s-0037-1615152; SANDSET PM, 1991, BLOOD COAGUL FIBRIN, V2, P425, DOI 10.1097/00001721-199106000-00004; Sardo MA, 2008, CLIN CHEM, V54, P814, DOI 10.1373/clinchem.2007.095547; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Third Report of the Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), EV TREATM HIGH BLOOD; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; Yau JW, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0124-z	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181533	10.1371/journal.pone.0181533	http://dx.doi.org/10.1371/journal.pone.0181533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749986	Green Submitted, gold, Green Published			2022-12-26	WOS:000406575700053
J	Jorgensen, MK; Bugge, TV; Larsen, P; Nielsen, PH; Christensen, ML				Jorgensen, Mads Koustrup; Bugge, Thomas Vistisen; Larsen, Poul; Nielsen, Per Halkjaer; Christensen, Morten Lykkegaard			Membrane filtration device for studying compression of fouling layers in membrane bioreactors	PLOS ONE			English	Article							SLUDGE CHARACTERISTICS; FILTERABILITY; PERFORMANCE; PROPENSITY; MBRS	A filtration devise was developed to assess compressibility of fouling layers in membrane bioreactors. The system consists of a flat sheet membrane with air scouring operated at constant transmembrane pressure to assess the influence of pressure on resistance of fouling layers. By fitting a mathematical model, three model parameters were obtained; a back transport parameter describing the kinetics of fouling layer formation, a specific fouling layer resistance, and a compressibility parameter. This stands out from other on-site filterability tests as model parameters to simulate filtration performance are obtained together with a characterization of compressibility. Tests on membrane bioreactor sludge showed high reproducibility. The methodology's ability to assess compressibility was tested by filtrations of sludges from membrane bioreactors and conventional activated sludge wastewater treatment plants from three different sites. These proved that membrane bioreactor sludge showed higher compressibility than conventional activated sludge. In addition, detailed information on the underlying mechanisms of the difference in fouling propensity were obtained, as conventional activated sludge showed slower fouling formation, lower specific resistance and lower compressibility of fouling layers, which is explained by a higher degree of flocculation.	[Jorgensen, Mads Koustrup; Nielsen, Per Halkjaer; Christensen, Morten Lykkegaard] Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, Aalborg, Denmark; [Bugge, Thomas Vistisen] Grundfos Singapore Pte Ltd, 25 Jalan Tukang, Singapore, Singapore; [Larsen, Poul] Dansk Miljoradgivning AS, Fanogade 17, Jerslev, Denmark	Aalborg University	Jorgensen, MK (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, Aalborg, Denmark.	mkj@bio.aau.dk	Christensen, Morten/T-6726-2018; Nielsen, Per Halkjær/T-6796-2018	Christensen, Morten/0000-0002-7671-817X; Nielsen, Per Halkjær/0000-0002-6402-1877; Jorgensen, Mads Koustrup/0000-0002-4733-0395	Innovation Fund Denmark; EcoDesign MBR Centre	Innovation Fund Denmark; EcoDesign MBR Centre	The funding body of this study, Innovation Fund Denmark. "The funder provided support in the form of salaries for authors MKJ, TVB, PJ, PHN, MLC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; Author T.V. Bugge (TVB) is employed by Grundfos Singapore Pte, ltd., and his employer did not have an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded through the EcoDesign MBR Centre funded by the Innovation Fund Denmark. The authors would like to thank Lisbeth Wybrandt, Marta Nierychlo, Kim Morkholt, and the staff at Aalborg Vest WWTP for technical assistance.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Bugge TV, 2012, WATER RES, V46, P4330, DOI 10.1016/j.watres.2012.06.015; Christensen ML, 2016, J MEMBRANE SCI, V504, P176, DOI 10.1016/j.memsci.2016.01.006; Christensen ML, 2009, J MEMBRANE SCI, V333, P94, DOI 10.1016/j.memsci.2009.02.007; de la Torre T, 2010, WATER SCI TECHNOL, V61, P2809, DOI 10.2166/wst.2010.084; Drews A, 2009, DESALINATION, V236, P224, DOI 10.1016/j.desal.2007.10.071; Evenblij H, 2005, DESALINATION, V178, P115, DOI 10.1016/j.desal.2005.02.005; Huyskens C, 2008, J MEMBRANE SCI, V323, P185, DOI 10.1016/j.memsci.2008.06.021; Huyskens C, 2011, SEP PURIF TECHNOL, V81, P208, DOI 10.1016/j.seppur.2011.07.031; Iversen V, 2009, J MEMBRANE SCI, V345, P21, DOI 10.1016/j.memsci.2009.08.014; Jorgensen MK, 2012, J MEMBRANE SCI, V409, P335, DOI 10.1016/j.memsci.2012.04.002; Lousada-Ferreira M, 2010, DESALINATION, V250, P618, DOI 10.1016/j.desal.2009.09.036; Lousada-Ferreira M, 2014, MEMBRANES-BASEL, V4, P227, DOI 10.3390/membranes4020227; Masse A, 2006, WATER RES, V40, P2405, DOI 10.1016/j.watres.2006.04.015; McCarthy AA, 1998, BIOTECHNOL PROGR, V14, P279, DOI 10.1021/bp980006g; Meng FG, 2012, ENVIRON ENG SCI, V29, P139, DOI 10.1089/ees.2010.0420; Merlo R. P., 2004, P WATER ENV FEDERATI, V2004, P625; Metzger U, 2007, J MEMBRANE SCI, V301, P180, DOI 10.1016/j.memsci.2007.06.016; Naessens W, 2012, BIORESOURCE TECHNOL, V122, P95, DOI 10.1016/j.biortech.2012.05.070; Ng HY, 2005, WATER ENVIRON RES, V77, P187, DOI 10.2175/106143005X41753; Poorasgari E, 2014, WATER SCI TECHNOL, V69, P1641, DOI 10.2166/wst.2014.068; Sui Y, 2012, J MEMBRANE SCI, V413, P38, DOI 10.1016/j.memsci.2012.03.055; Tiller F.M., 1980, J CHINESE I CHEM ENG, V11, P61; Van den Broeck R, 2011, J MEMBRANE SCI, V378, P330, DOI 10.1016/j.memsci.2011.05.010; Wisniewski C, 1998, COLLOID SURFACE A, V138, P403, DOI 10.1016/S0927-7757(96)03898-8	25	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2017	12	7							e0181652	10.1371/journal.pone.0181652	http://dx.doi.org/10.1371/journal.pone.0181652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1CT	28749990	Green Published, Green Submitted, gold			2022-12-26	WOS:000406575700068
J	Andresen, C; Niklasson, M; Eklof, SC; Wallner, B; Lundstrom, P				Andresen, Cecilia; Niklasson, Markus; Eklof, Sofie Cassman; Wallner, Bjorn; Lundstrom, Patrik			Biophysical characterization of the calmodulin-like domain of Plasmodium falciparum calcium dependent protein kinase 3	PLOS ONE			English	Article							DISPERSION NMR-SPECTROSCOPY; NUCLEAR-MAGNETIC-RESONANCE; EF-HAND PROTEINS; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; RELAXATION RATES; MALARIA PARASITE; BINDING; STATES; PREDICTION	Calcium dependent protein kinases are unique to plants and certain parasites and comprise an N-terminal segment and a kinase domain that is regulated by a C-terminal calcium binding domain. Since the proteins are not found in man they are potential drug targets. We have characterized the calcium binding lobes of the regulatory domain of calcium dependent protein kinase 3 from the malaria parasite Plasmodium falciparum. Despite being structurally similar, the two lobes differ in several other regards. While the monomeric N-terminal lobe changes its structure in response to calcium binding and shows global dynamics on the sub-millisecond time-scale both in its apo and calcium bound states, the C-terminal lobe could not be prepared calcium-free and forms dimers in solution. If our results can be generalized to the full-length protein, they suggest that the C-terminal lobe is calcium bound even at basal levels and that activation is caused by the structural reorganization associated with binding of a single calcium ion to the N-terminal lobe.	[Andresen, Cecilia; Niklasson, Markus; Eklof, Sofie Cassman; Lundstrom, Patrik] Linkoping Univ, Dept Phys Chem & Biol, Div Chem, Linkoping, Sweden; [Wallner, Bjorn] Linkoping Univ, Dept Phys Chem & Biol, Div Bioinformat, Linkoping, Sweden	Linkoping University; Linkoping University	Lundstrom, P (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Div Chem, Linkoping, Sweden.	patlu@ifm.liu.se		Lundstrom, Patrik/0000-0002-4874-5381	Vetenskapsradet [Dnr. 2012-5136, Dnr. 2012-5270]; Swedish e-science	Vetenskapsradet(Swedish Research Council); Swedish e-science	This work was supported by Vetenskapsradet, Grant numbers: Dnr. 2012-5136 and Dnr. 2012-5270, URL: http//www.vr.se; Swedish e-science, Grant number: N/A, URL: http://www.e-science.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Hui R, 2015, TRENDS PHARMACOL SCI, V36, P452, DOI 10.1016/j.tips.2015.04.011; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Korzhnev DM, 2002, J AM CHEM SOC, V124, P10743, DOI 10.1021/ja0204776; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li JL, 2000, BBA-GENE STRUCT EXPR, V1491, P341, DOI 10.1016/S0167-4781(00)00032-4; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lundstrom P, 2008, J BIOMOL NMR, V42, P35, DOI 10.1007/s10858-008-9260-4; Lundstrom P, 2005, J BIOMOL NMR, V32, P163, DOI 10.1007/s10858-005-5027-3; MacQueen J., 1967, SOME METHODS CLASSIF, P281; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MEIBOOM S, 1961, J CHEM PHYS, V34, P375, DOI 10.1063/1.1700960; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; Nagamune Kisaburo, 2008, V47, P70; Niklasson M, 2015, PROTEIN SCI, V24, P2055, DOI 10.1002/pro.2809; Niklasson M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004022; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Weljie AM, 2004, BIOCHEMISTRY-US, V43, P15131, DOI 10.1021/bi048751r; Weljie AM, 2003, J BIOL CHEM, V278, P43764, DOI 10.1074/jbc.M306799200; Wernimont AK, 2011, PROTEINS, V79, P803, DOI 10.1002/prot.22919; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; WHO, 2013, WORLD MALARIA REPORT 2013, P1	44	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181721	10.1371/journal.pone.0181721	http://dx.doi.org/10.1371/journal.pone.0181721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746405	Green Published, Green Submitted, gold			2022-12-26	WOS:000406371800053
J	Gianoglio, S; Moglia, A; Acquadro, A; Comino, C; Portis, E				Gianoglio, Silvia; Moglia, Andrea; Acquadro, Alberto; Comino, Cinzia; Portis, Ezio			The genome-wide identification and transcriptional levels of DNA methyltransferases and demethylases in globe artichoke	PLOS ONE			English	Article							TOMATO FRUIT-DEVELOPMENT; WHOLE-GENOME; METHYLATION; GENE; EVOLUTION; STRESS; ARABIDOPSIS; DIVERSIFICATION; BIOSYNTHESIS; CYNAROPICRIN	Changes to the cytosine methylation status of DNA, driven by the activity of C5 methyltransferases (C5-MTases) and demethylases, exert an important influence over development, transposon movement, gene expression and imprinting. Three groups of C5-MTase enzymes have been identified in plants, namely MET (methyltransferase 1), CMT (chromomethyltransferases) and DRM (domains rearranged methyltransferases). Here the repertoire of genes encoding C5-MTase and demethylase by the globe artichoke (Cynara cardunculus var. scolymus) is described, based on sequence homology, a phylogenetic analysis and a characterization of their functional domains. A total of ten genes encoding C5-MTase (one MET, five CMTs and four DRMs) and five demethylases was identified. An analysis of their predicted product's protein structure suggested an extensive level of conservation has been retained by the C5-MTases. Transcriptional profiling based on quantitative real time PCR revealed a number of differences between the genes encoding maintenance and de novo methyltransferases, sometimes in a tissue-or development-dependent manner, which implied a degree of functional specialization.	[Gianoglio, Silvia; Moglia, Andrea; Acquadro, Alberto; Comino, Cinzia; Portis, Ezio] Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, Italy	University of Turin	Comino, C (corresponding author), Univ Torino, Dept Agr Forest & Food Sci, Grugliasco, Italy.	cinzia.comino@unito.it		PORTIS, Ezio/0000-0002-1548-6096; ACQUADRO, Alberto/0000-0002-5322-9701; MOGLIA, Andrea/0000-0001-7431-844X; COMINO, CINZIA/0000-0002-1503-505X				Alonso C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00004; Ashapkin VV, 2016, BIOCHEMISTRY-MOSCOW+, V81, P141, DOI 10.1134/S0006297916020085; Barker MS, 2008, MOL BIOL EVOL, V25, P2445, DOI 10.1093/molbev/msn187; Baurens FC, 2004, TREE PHYSIOL, V24, P401, DOI 10.1093/treephys/24.4.401; Berger F, 2009, TRENDS PLANT SCI, V14, P550, DOI 10.1016/j.tplants.2009.08.003; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Candaele J, 2014, PLANT PHYSIOL, V164, P1350, DOI 10.1104/pp.113.233312; Cao DY, 2014, GENE, V550, P230, DOI 10.1016/j.gene.2014.08.034; Chang LL, 2009, PLANT CELL REP, V28, P1373, DOI 10.1007/s00299-009-0737-8; DNA methyltransferase Homolog, 2006, SCIENCE, V311, P395; Eljounaidi K, 2015, PLANT SCI, V239, P128, DOI 10.1016/j.plantsci.2015.07.020; Eljounaidi K, 2014, PLANT SCI, V223, P59, DOI 10.1016/j.plantsci.2014.03.007; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Foti S, 1999, IND CROP PROD, V10, P219, DOI 10.1016/S0926-6690(99)00026-6; Garg R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088947; Gehring M, 2006, BIOCHIM BIOPHYS ACTA, V1769, p276 ; Goll MG, METHYLATION OF TRNA; Hofberger JA, 2013, GENOME BIOL EVOL, V5, P2155, DOI 10.1093/gbe/evt162; Ierna A, 2010, BIOMASS BIOENERG, V34, P754, DOI 10.1016/j.biombioe.2010.01.018; Ponferrada-Marin MI, 2009, NUCLEIC ACIDS RES, V37, P4264, DOI 10.1093/nar/gkp390; Jackson S, 2010, CURR OPIN PLANT BIOL, V13, P153, DOI 10.1016/j.pbi.2009.11.004; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Jurkowski TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028104; Kankel MW, 2003, GENETICS, V163, P1109; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Kim MY, 2014, TRENDS PLANT SCI, V19, P320, DOI 10.1016/j.tplants.2014.01.014; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lei L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-51; Liu RE, 2015, P NATL ACAD SCI USA, V112, P10804, DOI 10.1073/pnas.1503362112; Menin B, 2012, PLANT SCI, V190, P1, DOI 10.1016/j.plantsci.2012.03.006; Michalak M, 2015, ANN BOT-LONDON, V116, P369, DOI 10.1093/aob/mcv104; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Moglia A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01424; Moglia A, 2009, PLANT CELL REP, V28, P963, DOI 10.1007/s00299-009-0695-1; Mok YG, 2010, P NATL ACAD SCI USA, V107, P19225, DOI 10.1073/pnas.1014348107; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Pavlopoulou A, 2007, GENOMICS, V90, P530, DOI 10.1016/j.ygeno.2007.06.011; Portis E, 2014, MOL BREEDING, V34, P615, DOI 10.1007/s11032-014-0061-z; Portis Ezio, 2012, BMC Res Notes, V5, P252, DOI 10.1186/1756-0500-5-252; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaglione D, 2016, SCI REPORTS, V6; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Teyssier E, 2008, PLANTA, V228, P391, DOI 10.1007/s00425-008-0743-z; Thiagarajan D, 2011, EPIGENETICS-US, V6, P103, DOI 10.4161/epi.6.1.13418; Thomas M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-922; Xu JD, 2015, PLANT MOL BIOL REP, V33, P1, DOI 10.1007/s11105-014-0732-2; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; Zhong XH, 2015, P NATL ACAD SCI USA, V112, P911, DOI 10.1073/pnas.1423603112	54	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181669	10.1371/journal.pone.0181669	http://dx.doi.org/10.1371/journal.pone.0181669			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746368	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800048
J	Wang, JH; Su, K; Guo, YS; Xing, HY; Zhao, YH; Liu, ZD; Li, K; Guo, XW				Wang, Jiahui; Su, Kai; Guo, Yinshan; Xing, Huiyang; Zhao, Yuhui; Liu, Zhendong; Li, Kun; Guo, Xiuwu			Construction of a high-density genetic map for grape using specific length amplified fragment (SLAF) sequencing	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; SCALE MARKER DEVELOPMENT; QUANTITATIVE TRAIT LOCI; LINKAGE MAP; SNP DISCOVERY; IDENTIFICATION; DNA; FRAMEWORK; 2B-RAD; SSR	Genetic maps are important tools in plant genomics and breeding. We report a large-scale discovery of single nucleotide polymorphisms (SNPs) using the specific length amplified fragment sequencing (SLAF-seq) technique for the construction of high-density genetic maps for two elite wine grape cultivars, 'Chardonnay' and ` Beibinghong', and their 130 F1 plants. A total of 372.53 M paired-end reads were obtained after preprocessing. The average sequencing depth was 33.81 for 'Chardonnay' (the female parent), 48.20 for 'Beibinghong' (the male parent), and 12.66 for the F1 offspring. We detected 202,349 high-quality SLAFs of which 144,972 were polymorphic; 10,042 SNPs were used to construct a genetic map that spanned 1,969.95 cM, with an average genetic distance of 0.23 cM between adjacent markers. This genetic map contains the largest molecular marker number of the grape maps so far reported. We thus demonstrate that SLAF-seq is a promising strategy for the construction of high-density genetic maps; the map that we report here is a good potential resource for QTL mapping of genes linked to major economic and agronomic traits, mapbased cloning, and marker-assisted selection of grape.	[Wang, Jiahui; Su, Kai; Guo, Yinshan; Xing, Huiyang; Zhao, Yuhui; Liu, Zhendong; Li, Kun; Guo, Xiuwu] Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University	Guo, YS; Guo, XW (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang, Liaoning, Peoples R China.	guoyinshan77@126.corn; guoxw1959@163.com			National Natural Science Foundation of China [31372021, 31572085]; China Agriculture Research System [CRAS-30-yz-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (Grant No. 31372021, 31572085), and the China Agriculture Research System (CRAS-30-yz-6).	Bai ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32608; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; DaCosta JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106713; Dalbo MA, 2000, GENOME, V43, P333, DOI 10.1139/gen-43-2-333; Davik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137746; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Des Marais DL, 2016, PLANT SCI, V251, P2, DOI 10.1016/j.plantsci.2016.03.010; Dohadwala MM, 2009, J NUTR, V139, p1788S, DOI 10.3945/jn.109.107474; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu BD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28679; Gardner KM, 2014, G3-GENES GENOM GENET, V4, P1681, DOI 10.1534/g3.114.011023; Guo YS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00393; Guo Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-956; Hanania U, 2004, PLANT MOL BIOL REP, V22, P173, DOI 10.1007/BF02772724; Houel C, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0588-0; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen J, 2001, THEOR APPL GENET, V102, P1113, DOI 10.1007/s001220000489; Jiang B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2220-y; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Liu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083052; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24070; Liu ZD, 2013, PAK J BOT, V45, P191; Liu ZW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2781-4; LODHI MA, 1995, GENOME, V38, P786, DOI 10.1139/g95-100; Moreira FM, 2011, TREE GENET GENOMES, V7, P153, DOI 10.1007/s11295-010-0322-x; Pap D, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0855-8; Pezzuto JM, 2009, J NUTR, V139, p1783S, DOI 10.3945/jn.109.107458; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Riaz S, 2004, THEOR APPL GENET, V108, P864, DOI 10.1007/s00122-003-1488-5; Scaglione D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-3; Shang JL, 2016, SCI HORTIC-AMSTERDAM, V203, P38, DOI 10.1016/j.scienta.2016.03.007; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Song R, 2008, SINO OVERSEAS GRAPEV, V4, P19; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141261; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang S, 2012, NAT METHODS, V9, P808, DOI [10.1038/nmeth.2023, 10.1038/NMETH.2023]; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Wu CD, 2009, J NUTR, V139, p1818S, DOI 10.3945/jn.109.107854; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15612; Zhang C, 2014, PLANT CELL REP, V33, P111, DOI 10.1007/s00299-013-1516-0; Zhang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157777; Zhang J, 2015, DNA RES, V22, P183, DOI 10.1093/dnares/dsv003; Zhang Q, 2015, DNA RES, V22, P367, DOI 10.1093/dnares/dsv019; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhou XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-351	64	13	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e018172	10.1371/journal.pone.0181728	http://dx.doi.org/10.1371/journal.pone.0181728			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746364	Green Published, gold, Green Submitted			2022-12-26	WOS:000406371800055
J	Zhou, YJ; Yu, J; Wu, YZ; Tian, L; Han, Z; Wang, J; Chi, FL				Zhou, Yu-Juan; Yu, Jing; Wu, Yong-Zhen; Tian, Liang; Han, Zhao; Wang, Jing; Chi, Fang-Lu			The potential dysfunction of otolith organs in patients after mumps infection	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; INNER-EAR; VESTIBULAR DYSFUNCTION; COMPLICATIONS; VACCINATION; OUTBREAK; VIRUS	Objective To investigate the relationship between mumps and the extent of hearing impairment and otolith organ damage. Methods A total of 27 patients with unilateral hearing impairment following mumps were enrolled. The degrees of hearing loss and otolith organ damage were confirmed by audiometric and vestibular evoked myogenic potential [VEMP] tests. All the results were compared and analyzed using Stata 13.0 software for Windows. Results The VEMP thresholds of the affected ears were significantly higher than those of the unaffected ears in both tests (cervical VEMP [cVEMP] test and ocular VEMP [oVEMP] test; p = 0.000 and 0.001, respectively). The mean cVEMP and oVEMP threshold values of the affected ears with hearing impairment for <= 10 years were significantly lower than those of affected ears with hearing impairment for >10 years [p = 0.009 and 0.004, respectively]. Conclusions Deafness resulting from mumps is usually profound and permanent, which indicates severe damage to the cochlea due to the disease. The functions of otolith organs in the vestibular system are also impaired. Over time, the function of the otolith organs or their neural pathway may suffer secondary damage.	[Zhou, Yu-Juan; Yu, Jing; Wu, Yong-Zhen; Tian, Liang; Han, Zhao; Wang, Jing; Chi, Fang-Lu] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai, Peoples R China; [Zhou, Yu-Juan; Yu, Jing; Wu, Yong-Zhen; Tian, Liang; Han, Zhao; Wang, Jing; Chi, Fang-Lu] Shanghai Auditory Med Ctr, Shanghai, Peoples R China; [Zhou, Yu-Juan; Yu, Jing; Wu, Yong-Zhen; Tian, Liang; Han, Zhao; Wang, Jing; Chi, Fang-Lu] Minist Hlth, Key Lab Hearing Sci, Shanghai, Peoples R China	Fudan University	Wang, J; Chi, FL (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai, Peoples R China.; Wang, J; Chi, FL (corresponding author), Shanghai Auditory Med Ctr, Shanghai, Peoples R China.; Wang, J; Chi, FL (corresponding author), Minist Hlth, Key Lab Hearing Sci, Shanghai, Peoples R China.	jingwang615@126.com; chifanglu@126.com			National Nature Science Foundation of China [81200739]; Major State Basic Research Development Program of China (973 Program) [2011CB504500, 2011CB504506]; Innovation Project of Shanghai Municipal Science and Technology Commission [11411952300]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Innovation Project of Shanghai Municipal Science and Technology Commission	This work was supported by the National Nature Science Foundation of China (Grant: 81200739 to JW; http://www.nsfc.gov.cn/), the Major State Basic Research Development Program of China (973 Program) (Grants: 2011CB504500 and 2011CB504506 to FC; htpp://www.most.gov.cn/), and the Innovation Project of Shanghai Municipal Science and Technology Commission (Grant: 11411952300 to FC; http://www.stcsmgov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dayan GH, 2008, NEW ENGL J MED, V358, P1580, DOI 10.1056/NEJMoa0706589; Dittrich S, 2011, VACCINE, V29, P9271, DOI 10.1016/j.vaccine.2011.09.072; El-Badry MM, 2015, J LARYNGOL OTOL, V129, P337, DOI 10.1017/S0022215115000511; Fanoy EB, 2014, PEDIATR INFECT DIS J, V33, P889, DOI 10.1097/INF.0000000000000320; Fei FangRong, 2011, Disease Surveillance, V26, P691; Fukuda S, 2001, AURIS NASUS LARYNX, V28, pS3, DOI 10.1016/S0385-8146(01)00081-5; Hashimoto H, 2009, PEDIATR INFECT DIS J, V28, P173, DOI 10.1097/INF.0b013e31818a8ca8; Hatchette TF, 2009, J CLIN VIROL, V46, P381, DOI 10.1016/j.jcv.2009.09.024; Kanra G, 2002, PEDIATR INFECT DIS J, V21, P1167, DOI 10.1097/00006454-200212000-00018; Kausas Aidas, 2002, Medicina (Kaunas), V38, P1179; Niu XR, 2016, ACTA OTO-LARYNGOL, V136, P225, DOI 10.3109/00016489.2015.1110750; Orlikova H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2958-4; Park SH, 2015, INFECT CHEMOTHER, V47, P1, DOI 10.3947/ic.2015.47.1.1; Pyykko I, 2008, ORL-J OTO-RHIN-LARYN, V70, P32, DOI 10.1159/000111046; Rubin SA, 2011, VACCINE, V29, P2850, DOI 10.1016/j.vaccine.2011.02.005; Sabbe M, 2016, HUM VACC IMMUNOTHER, P1; SMITH GA, 1976, ARCH OTOLARYNGOL, V102, P108; Tsubota M, 2008, ACTA OTO-LARYNGOL, V128, P644, DOI 10.1080/00016480701646305; Walther LE, 2013, OTOL NEUROTOL, V34, P1084, DOI 10.1097/MAO.0b013e318280da47; Wang Yi, 2003, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V17, P602; Xu XD, 2016, HEARING RES, V331, P41, DOI 10.1016/j.heares.2015.10.006; Zamir CS, 2015, HUM VACC IMMUNOTHER, V11, P1413, DOI 10.1080/21645515.2015.1021522	22	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2017	12	7							e0181907	10.1371/journal.pone.0181907	http://dx.doi.org/10.1371/journal.pone.0181907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8EN	28746415	gold, Green Published, Green Submitted			2022-12-26	WOS:000406371800068
J	Abatangelo, V; Bacci, NP; Boncompain, CA; Amadio, AA; Carrasco, S; Suarez, CA; Morbidoni, HR				Abatangelo, Virginia; Peressutti Bacci, Natalia; Boncompain, Carina A.; Amadio, Ariel A.; Carrasco, Soledad; Suarez, Cristian A.; Morbidoni, Hector R.			Broad-range lytic bacteriophages that kill Staphylococcus aureus local field strains	PLOS ONE			English	Article							MYOVIRIDAE BACTERIOPHAGE; GENOMIC ANALYSIS; DAIRY-COWS; PHAGE-K; SEQUENCE; GENE; PROTEIN; TWORT; INFECTIONS; RESISTANCE	Staphylococcus aureus is a very successful opportunistic pathogen capable of causing a variety of diseases ranging from mild skin infections to life-threatening sepsis, meningitis and pneumonia. Its ability to display numerous virulence mechanisms matches its skill to display resistance to several antibiotics, including beta-lactams, underscoring the fact that new anti-S. aureus drugs are urgently required. In this scenario, the utilization of lytic bacteriophages that kill bacteria in a genus -or even species-specific way, has become an attractive field of study. In this report, we describe the isolation, characterization and sequencing of phages capable of killing S. aureus including methicillin resistant (MRSA) and multi-drug resistant S. aureus local strains from environmental, animal and human origin. Genome sequencing and bio-informatics analysis showed the absence of genes encoding virulence factors, toxins or antibiotic resistance determinants. Of note, there was a high similarity between our set of phages to others described in the literature such as phage K. Considering that reported phages were obtained in different continents, it seems plausible that there is a commonality of genetic features that are needed for optimum, broad host range antistaphylococcal activity of these related phages. Importantly, the high activity and broad host range of one of our phages underscores its promising value to control the presence of S. aureus in fomites, industry and hospital environments and eventually on animal and human skin. The development of a cocktail of the reported lytic phages active against S. aureus- currently under way-is thus, a sensible strategy against this pathogen.	[Abatangelo, Virginia; Peressutti Bacci, Natalia; Boncompain, Carina A.; Suarez, Cristian A.; Morbidoni, Hector R.] Univ Nacl Rosario, Lab Microbiol Mol, Fac Ciencias Med, Rosario, Santa Fe, Argentina; [Amadio, Ariel A.] INTA, EEA Rafaela, Rafaela, Santa Fe, Argentina; [Carrasco, Soledad] Univ Nacl Rosario, Bioinformat Program, Rosario, Santa Fe, Argentina	National University of Rosario; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Rosario	Suarez, CA; Morbidoni, HR (corresponding author), Univ Nacl Rosario, Lab Microbiol Mol, Fac Ciencias Med, Rosario, Santa Fe, Argentina.	suarez@inv.rosario-conicet.gov.ar; morbiatny@yahoo.com		Amadio, Ariel Fernando/0000-0002-1147-4485	PICT START UP [1406]; ANPCyT-MinCyT (Agencia Nacional para la Promocion de Ciencia y Tecnologia; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina)	PICT START UP; ANPCyT-MinCyT (Agencia Nacional para la Promocion de Ciencia y Tecnologia; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina)	This work was supported by PICT START UP 1406; http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt.r We thank Dr. G. Leotta (Universidad Nacional de La Plata, Argentina) and Dr. Juan P. Scapini (Idymic, Rosario, Argentina) for their generous gift of S. aureus strains. V. A, N. P B and C. A. B. are fellows of CONICET (Consejo de Investigaciones Cientificas y Tecnologicas, Argentina), C. A. S. and A. A. are Career Investigators of CONICET. H. R. M. is Principal Investigator of CIUNR (Consejo de Investigaciones de la Universidad Nacional de Rosario, Argentina). This project was funded by a grant (PICT-START UP 1406) from ANPCyT-MinCyT (Agencia Nacional para la Promocion de Ciencia y Tecnologia; Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina).	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Alves DR, 2014, APPL ENVIRON MICROB, V80, P6694, DOI 10.1128/AEM.01789-14; Appelbaum PC, 2004, CLIN LAB MED, V24, P381, DOI 10.1016/j.cll.2004.03.004; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bassetti M, 2017, CURR OPIN INFECT DIS; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boncompain CA, 2017, REV ARGENT MICROBIOL; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chang HH, 2015, MICROBIOL MOL BIOL R, V79, P101, DOI 10.1128/MMBR.00039-14; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Silveira ACDO, 2014, DIAGN MICR INFEC DIS, V79, P401, DOI 10.1016/j.diagmicrobio.2014.04.008; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Demos M, 2012, BRIT J DERMATOL, V167, P725, DOI 10.1111/j.1365-2133.2012.11151.x; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fraser JS, 2007, CURR OPIN MICROBIOL, V10, P382, DOI 10.1016/j.mib.2007.05.018; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Gu JM, 2012, J VIROL, V86, P8914, DOI 10.1128/JVI.01313-12; Habann M, 2014, MOL MICROBIOL, V92, P84, DOI 10.1111/mmi.12539; Han JE, 2013, RES VET SCI, V95, P758, DOI 10.1016/j.rvsc.2013.06.001; Herpers BL, 2015, FUTURE MICROBIOL, V10, P309, DOI [10.2217/FMB.14.142, 10.2217/fmb.14.142]; Hsieh SE, 2016, VIRUS GENES, V52, P107, DOI 10.1007/s11262-015-1276-8; Humphreys H, 2012, SURG-J R COLL SURG E, V10, P357, DOI 10.1016/j.surge.2012.05.003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacobs-Sera D, 2012, VIROLOGY, V434, P187, DOI 10.1016/j.virol.2012.09.026; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x; Kelly David, 2011, Bioeng Bugs, V2, P31, DOI 10.4161/bbug.2.1.13657; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Krupovic M, 2016, ARCH VIROL, V161, P1095, DOI 10.1007/s00705-015-2728-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Landthaler M, 2002, NUCLEIC ACIDS RES, V30, P1935, DOI 10.1093/nar/30.9.1935; Landthaler M, 1999, P NATL ACAD SCI USA, V96, P7005, DOI 10.1073/pnas.96.12.7005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li LP, 2014, MOL BIOL REP, V41, P5829, DOI 10.1007/s11033-014-3457-2; Lobocka M, 2012, ADV VIRUS RES, V83, P143, DOI 10.1016/B978-0-12-394438-2.00005-0; Louie L, 2002, J CLIN MICROBIOL, V40, P2786, DOI 10.1128/JCM.40.8.2786-2790.2002; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Magana M, 2015, CURR PHARM DESIGN, V21, P2058, DOI 10.2174/1381612821666150310101851; Mathur M D, 2003, J Assoc Physicians India, V51, P593; McCarthy AJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00006; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Monaco M, 2016, CURR TOP MICROBIOL I; Montero-Diez C, 2013, J BACTERIOL, V195, P3621, DOI 10.1128/JB.00499-13; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; NEWBOULD FH, 1974, CAN J COMP MED, V38, P411; Novacek J, 2016, P NATL ACAD SCI USA, V113, P9351, DOI 10.1073/pnas.1605883113; O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P482, DOI 10.1111/j.1472-765X.2005.01781.x; O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004; Otter JA, 2010, CLIN MICROBIOL INFEC, V16, P68, DOI 10.1111/j.1469-0691.2009.02925.x; Payne DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0086; Pintado V, 2002, EUR J CLIN MICROBIOL, V21, P864, DOI 10.1007/s10096-002-0814-1; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P6369, DOI 10.1128/AEM.01236-12; Sanz-Gaitero M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-133; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takeuchi I, 2016, APPL ENVIRON MICROB, V82, P5763, DOI 10.1128/AEM.01385-16; Treangen T.J., 2014, GENOME ANNOUNC, V2; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Vandersteegen K, 2013, J VIROL, V87, P3237, DOI 10.1128/JVI.02763-12; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z; Zhang LL, 2015, VIRUS GENES, V50, P111, DOI 10.1007/s11262-014-1130-4; Zorzet A, 2014, UPSALA J MED SCI, V119, P170, DOI 10.3109/03009734.2014.897277	71	25	30	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181671	10.1371/journal.pone.0181671	http://dx.doi.org/10.1371/journal.pone.0181671			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742812	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000045
J	Bonaventura, P; Lamboux, A; Albarede, F; Miossec, P				Bonaventura, Paola; Lamboux, Aline; Albarede, Francis; Miossec, Pierre			Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; HEAVY-METALS; EXPRESSION; METALLOTHIONEIN; IL-17; TRANSPORTER; MECHANISMS; RESISTANCE	Objectives Zinc (Zn) has major effects on immune system activation while Cadmium (Cd) has anti-inflammatory and anti-proliferative effects in several chronic inflammatory contexts. The aim of this work was to investigate by which mechanisms Zn could compete with Cd and eventually counteract its deleterious effects. Rheumatoid arthritis (RA) synoviocytes exposed to cytokines were used as a model of chronic inflammation; osteoarthritis (OA) synoviocytes were used as control. Methods Cell/medium fractionation constants were analyzed for different metals by inductively-coupled-plasma mass-spectrometry by comparison to the 70 Zn spike. Interleukin-17 (IL-17) and tumor necrosis factor-alpha (TNF-alpha) were used to mimic inflammation. Gene expression of ZIP-8 importer, metallothioneins-1 (MT-1s) and the ratio between metalloprotease-3 and the tissue inhibitor of metalloproteinases (MMP-3)/TIMP-1) were evaluated after pre-exposure to cytokines and Cd, with or without the addition of exogenous Zn (0.9 ppm). Cell viability was measured by neutral red assay and IL-6 production by ELISA. Results Synoviocytes selectively absorbed and retained Cd in comparison to Zn. Metal import increased with IL-17/TNF-alpha exposure, through the enhanced ZIP-8 expression. Zn did not modify ZIP-8 expression, while Cd reduced it (p<0.05). Zn induced a reduction of Cd-induced MT-1s expression, in particular of MT-1X (3-fold), and subsequently the final intracellular content of Cd. By reducing Cd accumulation in cells, Zn reversed Cd anti-proliferative and anti-inflammatory effects but preserved the low MMP-3/TIMP-1 ratio induced by Cd, which was enhanced by inflammatory conditions. Conclusion Zinc counteracts the deleterious effect of Cd by reducing its import and accumulation in the cell, without the reactivation of destructive pathways such as MMPs.	[Bonaventura, Paola; Miossec, Pierre] Univ Lyon, Dept Immunol & Rheumatol, Immunogen & Inflammat Res Unit, Edouard Herriot Hosp,EA 4130, Lyon, France; [Lamboux, Aline; Albarede, Francis] Ecole Normale Super Lyon, Geol Lab, Dept Earth Sci, Lyon, France; [Lamboux, Aline; Albarede, Francis] CNRS, Lyon, France	CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Miossec, P (corresponding author), Univ Lyon, Dept Immunol & Rheumatol, Immunogen & Inflammat Res Unit, Edouard Herriot Hosp,EA 4130, Lyon, France.	pierre.miossec@univ-lyon1.fr	Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428; Miossec, Pierre/0000-0002-3280-6346	7th Framework program of the EU [289903]; IHU prometteur OPERA; Cluster 1 region Rhone-Alpes; Institut Universitaire de France	7th Framework program of the EU; IHU prometteur OPERA; Cluster 1 region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Institut Universitaire de France	This project and PB have received funding from the 7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-2011-ITN, under the Marie Skfodowska-Curie grant agreement No 289903. This work has been supported in part by grants from the IHU prometteur OPERA and the 'Cluster 1 region Rhone-Alpes.' PM is a senior member of and supported by the 'Institut Universitaire de France.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 2008, MOL PHARMACOL, V74, P823, DOI 10.1124/mol.108.046862; Aimola P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033647; Babula P, 2012, METALLOMICS, V4, P739, DOI 10.1039/c2mt20081c; Blanco FJ, 2017, ARTHRITIS RHEUMATOL, V69, P1144, DOI 10.1002/art.40070; Bonaventura P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02611-5; Bonaventura P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147146; Ebaid H, 2014, CENT EUR J IMMUNOL, V39, P441, DOI 10.5114/ceji.2014.47726; Freisinger E, 2013, METAL IONS LIFE SCI, V11, P339, DOI 10.1007/978-94-007-5179-8_11; Gunther V, 2012, BBA-MOL CELL RES, V1823, P1416, DOI 10.1016/j.bbamcr.2012.01.005; Hot A, 2012, ANN RHEUM DIS, V71, P768, DOI 10.1136/annrheumdis-2011-200468; Hwang SY, 2004, ARTHRITIS RES THER, V6, pR120, DOI 10.1186/ar1038; Iranzo O, 2004, INORG CHEM, V43, P1743, DOI 10.1021/ic035120x; Ishiguro N, 2001, ARTHRITIS RHEUM, V44, P2503, DOI 10.1002/1529-0131(200111)44:11<2503::AID-ART430>3.0.CO;2-P; Jacquillet G, 2006, AM J PHYSIOL-RENAL, V290, pF127, DOI 10.1152/ajprenal.00366.2004; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Krezel A, 2007, J AM CHEM SOC, V129, P10911; Lafuente A, 2004, BIOMETALS, V17, P451, DOI 10.1023/B:BIOM.0000029441.20037.72; LAWRENCE DA, 1981, TOXICOL APPL PHARM, V57, P439, DOI 10.1016/0041-008X(81)90241-6; Liu MJ, 2013, CELL REP, V3, P386, DOI 10.1016/j.celrep.2013.01.009; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Mohammadi-Bardbori A, 2014, CHEM-BIOL INTERACT, V224, P183, DOI 10.1016/j.cbi.2014.10.034; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Parenti A, 2016, BRIT J PHARMACOL, V173, P953, DOI 10.1111/bph.13392; Partsch G, 1998, ANN RHEUM DIS, V57, P691, DOI 10.1136/ard.57.11.691; Pinter TBJ, 2015, BIOCHEMISTRY-US, V54, P5006, DOI 10.1021/acs.biochem.5b00452; PRASAD AS, 1995, NUTRITION, V11, P93; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sahmoun AE, 2005, CANCER INVEST, V23, P256, DOI 10.1081/CNV-200055968; Sakulsak N, 2012, INT J MORPHOL, V30, P1007, DOI 10.4067/S0717-95022012000300039; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Taki M, 2013, METAL IONS LIFE SCI, V11, P99, DOI 10.1007/978-94-007-5179-8_5; Tan Y, 2012, TOXICOL APPL PHARM, V265, P175, DOI 10.1016/j.taap.2012.10.003; Tang L, 2014, METALLOMICS, V6, P1313, DOI 10.1039/c4mt00080c; Telfer JF, 2002, ANN RHEUM DIS, V61, P741, DOI 10.1136/ard.61.8.741; Thevenod F, 2013, METAL IONS LIFE SCI, V11, P415, DOI 10.1007/978-94-007-5179-8_14; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179; WAALKES MP, 1984, TOXICOL LETT, V20, P33, DOI 10.1016/0378-4274(84)90179-6; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Won Y, 2016, ANN RHEUM DIS, V75, P2045, DOI 10.1136/annrheumdis-2015-208406	42	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180879	10.1371/journal.pone.0180879	http://dx.doi.org/10.1371/journal.pone.0180879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742830	Green Submitted, gold, Green Published			2022-12-26	WOS:000406370000018
J	Jara, M; Berge, M; Caljon, G; de Muylder, G; Cuypers, B; Castillo, D; Maes, I; Orozco, MD; Vanaerschot, M; Dujardin, JC; Arevalo, J				Jara, Marlene; Berge, Maya; Caljon, Guy; de Muylder, Geraldine; Cuypers, Bart; Castillo, Denis; Maes, Ilse; Orozco, Maria del Carmen; Vanaerschot, Manu; Dujardin, Jean-Claude; Arevalo, Jorge			Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE-EXPRESSION; MESOCRICETUS-AURATUS; PARASITE LOAD; DONOVANI; DNA; QUANTIFICATION; CHOLESTEROL; PERSISTENCE; ERGOSTEROL	It was recently hypothesized that Leishmania amastigotes could constitute a semi-quiescent stage characterized by low replication and reduced metabolic activity. This concept developed with Leishmania (Leishmania) mexicana and Leishmania (Leishmania) major models might explain numerous clinical and sub-clinical features of Leishmania (Viannia) braziliensis infections, like reactivation of the disease, non-response to chemotherapy or asymptomatic infections. We compared here in vitro the proliferative capability of L. (V.) braziliensis amastigotes and promastigotes, assessed the expression of key molecular parameters and performed metabolomic analysis. We found that contrary to the highly proliferative promastigotes, amastigotes (axenic and intracellular) do not show evidence of extensive proliferation. In parallel, amastigotes showed a significant decrease of (i) the kDNA mini-circle abundance, (ii) the intracellular ATP level, (iii) the ribosomal components: rRNA subunits 18S and 28S alpha and ribosomal proteins RPS15 and RPL19, (iv) total RNA and protein levels. An untargeted metabolomic study identified clear differences between the different life stages: in comparison to logarithmic promastigotes, axenic amastigotes showed (a) a strong decrease of 14 essential and non-essential amino acids and eight metabolites involved in polyamine synthesis, (b) extensive changes in the phospholipids composition and (c) increased levels of several endogenous and exogenous sterols. Altogether, our results show that L. (V.) braziliensis amastigotes can show a phenotype with negligible rate of proliferation, a lower capacity of biosynthesis, a reduced bio-energetic level and a strongly altered metabolism. Our results pave the way for further exploration of quiescence among amastigotes of this species.	[Jara, Marlene; Orozco, Maria del Carmen; Arevalo, Jorge] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Jara, Marlene; Berge, Maya; Caljon, Guy; de Muylder, Geraldine; Cuypers, Bart; Maes, Ilse; Vanaerschot, Manu; Dujardin, Jean-Claude] Inst Trop Med Antwerp, Mol Parasitol Unit, Antwerp, Belgium; [Cuypers, Bart; Dujardin, Jean-Claude] Univ Antwerp, Antwerp, Belgium; [Castillo, Denis; Arevalo, Jorge] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Fac Ciencias & Filosofia, Lima, Peru; [Caljon, Guy] Univ Antwerp, Lab Microbiol Parasitol & Hyg, Antwerp, Belgium; [Vanaerschot, Manu] Columbia Univ, Dept Microbiol, Coll Phys & Surg, Fidock Lab, New York, NY 10032 USA	Universidad Peruana Cayetano Heredia; Institute of Tropical Medicine (ITM); University of Antwerp; Universidad Peruana Cayetano Heredia; Columbia University	Arevalo, J (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Dujardin, JC (corresponding author), Inst Trop Med Antwerp, Mol Parasitol Unit, Antwerp, Belgium.; Dujardin, JC (corresponding author), Univ Antwerp, Antwerp, Belgium.; Arevalo, J (corresponding author), Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Fac Ciencias & Filosofia, Lima, Peru.	jcdujardin@itg.be; Jorge.arevalo@upch.pe	Vanaerschot, Manu/B-6812-2013; Dujardin, Jean-Claude/AAO-1783-2021; Caljon, Guy/E-1310-2017; Cuypers, Bart/B-4853-2014; Berg, Maya A.H./C-2026-2019	Vanaerschot, Manu/0000-0002-9141-2347; Caljon, Guy/0000-0002-4870-3202; Cuypers, Bart/0000-0002-7198-1470; Berg, Maya A.H./0000-0002-2139-3777; Jara, Marlene/0000-0002-9739-3589; Arevalo, Jorge/0000-0003-3837-2849	Belgian Directorate General for Development Cooperation-DGDC [1.13]; Baillet Latour Foundation; Research Foundation Flanders [12Q8115N, 1101614N]	Belgian Directorate General for Development Cooperation-DGDC; Baillet Latour Foundation; Research Foundation Flanders(FWO)	This work was financially supported by the Belgian Directorate General for Development Cooperation-DGDC within the context of the framework agreement 3.III., project 1.13. MB was supported by the Baillet Latour Foundation; GdM and BC were supported by the Research Foundation Flanders (Grants 12Q8115N and 1101614N, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaui V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001021; Alves-Ferreira EVC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004018; Araujo-Santos JM, 2003, BIOCHEM BIOPH RES CO, V306, P250, DOI 10.1016/S0006-291X(03)00947-1; Bari Arfan Ul, 2012, Dermatol Online J, V18, P4; Berg M, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301002; Berg M, 2013, MOL MICROBIOL, V90, P428, DOI 10.1111/mmi.12374; BERMAN JD, 1986, MOL BIOCHEM PARASIT, V20, P85, DOI 10.1016/0166-6851(86)90145-3; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Castilho TM, 2008, AM J TROP MED HYG, V78, P122, DOI 10.4269/ajtmh.2008.78.122; Cloutier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035085; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Czub J, 2006, BIOPHYS J, V90, P2368, DOI 10.1529/biophysj.105.072801; Decuypere S, 2008, PARASITOLOGY, V135, P183, DOI 10.1017/S0031182007003782; Delgado FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067590; Farine L, 2013, BBA-MOL CELL BIOL L, V1831, P533, DOI 10.1016/j.bbalip.2012.09.008; Gomes-Silva A, 2013, PARASITOLOGY, V140, P771, DOI 10.1017/S0031182012002156; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Hartley MA, 2014, TRENDS PARASITOL, V30, P412, DOI 10.1016/j.pt.2014.05.006; Imamura H, 2016, ELIFE, V5, DOI 10.7554/eLife.12613; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; JAFFE CL, 1989, INFECT IMMUN, V57, P3770, DOI 10.1128/IAI.57.12.3770-3777.1989; Jara M, 2016, AM J TROP MED HYG, V94, P107, DOI 10.4269/ajtmh.15-0514; Jara M, 2013, J CLIN MICROBIOL, V51, P1826, DOI 10.1128/JCM.00208-13; Jensen RE, 2012, ANNU REV MICROBIOL, V66, P473, DOI 10.1146/annurev-micro-092611-150057; Kloehn J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004683; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Liendo A, 1999, MOL BIOCHEM PARASIT, V104, P81, DOI 10.1016/S0166-6851(99)00129-2; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; Mandell MA, 2017, P NATL ACAD SCI USA, V114, pE801, DOI 10.1073/pnas.1619265114; Mary C, 2006, AM J TROP MED HYG, V75, P858, DOI 10.4269/ajtmh.2006.75.858; Mathur R, 2015, FASEB J, V29, P4201, DOI 10.1096/fj.15-272757; McCall LI, 2014, TRENDS PARASITOL, V30, P342, DOI 10.1016/j.pt.2014.05.001; Mendonca MG, 2004, J INFECT DIS, V189, P1018, DOI 10.1086/382135; Miller-Fleming L, 2015, J MOL BIOL, V2015; Mondal S, 2014, J BIOENERG BIOMEMBR, V46, P395, DOI 10.1007/s10863-014-9569-5; Moreira D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001469; Nasereddin A, 2010, ACTA TROP, V113, P72, DOI 10.1016/j.actatropica.2009.09.009; PAN AA, 1986, EXP PARASITOL, V62, P254, DOI 10.1016/0014-4894(86)90030-5; Pencer J, 2005, BBA-BIOMEMBRANES, V1720, P84, DOI 10.1016/j.bbamem.2005.10.017; Ribeiro-Romao RP, 2014, INFECT IMMUN, V82, P5203, DOI 10.1128/IAI.02083-14; Rittershaus ESC, 2013, CELL HOST MICROBE, V13, P643, DOI 10.1016/j.chom.2013.05.012; Rodriguez NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019000; Rosales-Chilama M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004273; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; SARAVIA NG, 1990, LANCET, V336, P398, DOI 10.1016/0140-6736(90)91945-7; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Schubach A, 1998, J INFECT DIS, V178, P911, DOI 10.1086/515355; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Singh N, 1999, ACTA TROP, V73, P313, DOI 10.1016/S0001-706X(99)00036-4; Sudarshan M, 2014, DIAGN MICR INFEC DIS, V80, P40, DOI 10.1016/j.diagmicrobio.2014.01.031; t'Kindt R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000904; Xu W, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004427; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004	59	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0180532	10.1371/journal.pone.0180532	http://dx.doi.org/10.1371/journal.pone.0180532			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742826	Green Published, Green Submitted, gold			2022-12-26	WOS:000406370000014
J	Vanco, J; Travnicek, Z; Hosek, J; Suchy, P				Vanco, Jan; Travnicek, Zdenek; Hosek, Jan; Suchy, Pavel, Jr.			In vitro and in vivo anti-inflammatory active copper(II)-lawsone complexes	PLOS ONE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; LAWSONIA-INERMIS L.; COPPER-COMPLEXES; OXIDATIVE STRESS; 2-HYDROXY-1,4-NAPHTHOQUINONE; HENNA; MYELOPEROXIDASE; BENOXAPROFEN; RATS	We report in vitro and in vivo anti-inflammatory activities of a series of copper(II)-lawsone complexes of the general composition [Cu(Law)(2)(LN)x(H2O)((2-x))]center dot yH(2)O; where HLaw = 2-hydroxy-1,4-naphthoquinone, x = 1 when LN = pyridine (1) and 2-aminopyridine (3) and x = 2 when LN = imidazole (2), 3-aminopyridine (4), 4-aminopyridine (5), 3-hydroxypyridine (6), and 3,5-dimethylpyrazole (7). The compounds were thoroughly characterized by physical techniques, including single crystal X-ray analysis of complex 2. Some of the complexes showed the ability to suppress significantly the activation of nuclear factor kB (NF-kB) both by lipopolysaccharide (LPS) and TNF-alpha (complexes 3-7 at 100 nM level) in the similar manner as the reference drug prednisone (at 1 mu M level). On the other hand, all the complexes 1-7 decreased significantly the levels of the secreted TNF-alpha after the LPS activation of THP-1 cells, thus showing the anti-inflammatory potential via both NF-kB moderation and by other mechanisms, such as influence on TNF-alpha transcription and/or translation and/or secretion. In addition, a strong intracellular pro-oxidative effect of all the complexes has been found at 100 nM dose in vitro. The ability to suppress the inflammatory response, caused by the subcutaneous application of lambda-carrageenan, has been determined by in vivo testing in hind-paw edema model on rats. The most active complexes 1-3 (applied in a dose corresponding to 40 mu mol Cu/kg), diminished the formation of edema simalarly as the reference drug indomethacine (applied in 10 mg/kg dose). The overall effect of the complexes, dominantly 1-3, shows similarity to anti-inflammatory drug benoxaprofen, known to induce intracellular pro-oxidative effects.	[Vanco, Jan; Travnicek, Zdenek; Hosek, Jan] Palacky Univ Olomouc, Dept Inorgan Chem, Fac Sci, 17 Listopadu 12, Olomouc, Czech Republic; [Vanco, Jan; Travnicek, Zdenek; Hosek, Jan] Palacky Univ Olomouc, Reg Ctr Adv Technol & Mat, Fac Sci, 17 Listopadu 12, Olomouc, Czech Republic; [Suchy, Pavel, Jr.] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Palackeho Tr 1946-1, Brno, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University of Veterinary Sciences Brno	Travnicek, Z (corresponding author), Palacky Univ Olomouc, Dept Inorgan Chem, Fac Sci, 17 Listopadu 12, Olomouc, Czech Republic.; Travnicek, Z (corresponding author), Palacky Univ Olomouc, Reg Ctr Adv Technol & Mat, Fac Sci, 17 Listopadu 12, Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Vanco, Jan/H-2705-2013; Hosek, Jan/B-6274-2009	Vanco, Jan/0000-0003-3351-1192; Hosek, Jan/0000-0003-0975-1671; Travnicek, Zdenek/0000-0002-5890-7874; Suchy, Pavel/0000-0002-6277-2749	Faculty of Science, Palacky University in Olomouc; Ministry of Education, Youth and Sports [L01305]	Faculty of Science, Palacky University in Olomouc; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	The authors acknowledge the financial support from institutional sources of the Faculty of Science, Palacky University in Olomouc (http://www.prf.upol.cz/) and from the Ministry of Education, Youth and Sports, httm://www.msmt.cz/?lang=2, a grant no. L01305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BH, 1995, PHARMACOLOGY, V51, P356, DOI 10.1159/000139347; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Babula P, 2012, INT J ELECTROCHEM SC, V7, P7349; Biradar S, 2013, INDIAN J EXP BIOL, V51, P256; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brandelli Adriano, 2004, Rev. Bras. Cienc. Farm., V40, P247, DOI 10.1590/S1516-93322004000200014; Bruker, 2015, APEX3; Casanova I, 2013, NEW J CHEM, V37, P2303, DOI 10.1039/c3nj00227f; Chang HZ, 2011, ALTERNAT MED; Duncan C, 2012, METALLOMICS, V4, P127, DOI 10.1039/c2mt00174h; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; Galati G, 2002, CHEM-BIOL INTERACT, V142, P25, DOI 10.1016/S0009-2797(02)00052-2; Garber JC, 2011, GUIDE CARE USE LAB A; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hawley RC, 2005, US Patent, Patent No. [US 6.846.828 B2, 6846828]; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kobayashi K, 2011, MED CHEM, V7, P37, DOI 10.2174/157340611794072742; Lever A. B. P., 1984, INORGANIC ELECT SPEC; LUKEY PT, 1988, BRIT J PHARMACOL, V93, P289, DOI 10.1111/j.1476-5381.1988.tb11433.x; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Marzin D, 2004, MUTAT RES-GEN TOX EN, V560, P41, DOI 10.1016/j.mrgentox.2004.02.004; McKallip RJ, 2010, TOXICOL APPL PHARM, V247, P41, DOI 10.1016/j.taap.2010.05.013; Medici S, 2015, COORDIN CHEM REV, V284, P329, DOI 10.1016/j.ccr.2014.08.002; Miyamoto G, 1997, CHEM RES TOXICOL, V10, P414, DOI 10.1021/tx960190k; Morgan MJ, CROSSTALK REACTIVE O; Oramas-Royo S, 2013, BIOORGAN MED CHEM, V21, P2471, DOI 10.1016/j.bmc.2013.03.002; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pouchert C., 1981, ALDRICH LIB INFRARED; Pradhan R, 2012, CURR DRUG TARGETS, V13, P1777, DOI 10.2174/138945012804545588; Salunke-Gawali S, 2004, INDIAN J CHEM A, V43, P2563; Salunke-Gawali S, 2004, POLYHEDRON, V23, P2541, DOI 10.1016/j.poly.2004.08.022; Semwal RB, 2014, J ETHNOPHARMACOL, V155, P80, DOI 10.1016/j.jep.2014.05.042; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Singh DK, 2015, IND CROP PROD, V65, P269, DOI 10.1016/j.indcrop.2014.11.025; SINGH S, 1982, CURR SCI INDIA, V51, P470; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Tabrizi L, 2017, J BIOMOL ST IN PRESS; Tabrizi L, 2016, BIOMETALS, V29, P981, DOI 10.1007/s10534-016-9970-0; Uetrecht JP, 1995, BIOCHEM SOC SYMP, P163, DOI 10.1042/bss0610163; Valle-Bourrouet G, 2010, ELECTROCHIM ACTA, V55, P9042, DOI 10.1016/j.electacta.2010.08.006; Vanco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109901; VANRENSBURG AJ, 1991, AGENTS ACTIONS, V33, P292; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zelova H, 2013, INFLAMM RES, V62, P641, DOI 10.1007/s00011-013-0633-0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2017	12	7							e0181822	10.1371/journal.pone.0181822	http://dx.doi.org/10.1371/journal.pone.0181822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8DV	28742852	Green Published, gold, Green Submitted			2022-12-26	WOS:000406370000056
J	Hung, TH; Liang, CM; Hsu, CN; Tai, WC; Tsai, KL; Ku, MK; Wang, JW; Tseng, KL; Yuan, LT; Nguang, SH; Yang, SC; Wu, CK; Hsu, PI; Wu, DC; Chuah, SK				Hung, Tsung-Hsing; Liang, Chih-Ming; Hsu, Chien-Ning; Tai, Wei-Chen; Tsai, Kai-Lung; Ku, Ming-Kun; Wang, Jiunn-Wei; Tseng, Kuo-Lun; Yuan, Lan-Ting; Nguang, Seng-Howe; Yang, Shih-Cheng; Wu, Cheng-Kun; Hsu, Pin-I; Wu, Deng-Chyang; Chuah, Seng-Kee			Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; SPONTANEOUS BACTERIAL PERITONITIS; EPIDEMIOLOGY; MORTALITY; POPULATION; FIBROSIS; ALCOHOL; DISEASE; CANCER	Hepatic encephalopathy, ascites, and variceal bleeding are the three major complications of cirrhosis. It is well known that cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC). However, little is known about whether the severity of liver cirrhosis has an effect on the incidence of HCC. This population-based cohort study aimed to explore the association between complicated cirrhosis and HCC, and identify the risk factors of HCC in patients with complicated cirrhosis. Data of the years 1997-2011 were extracted from the National Health Insurance Research Database of Taiwan. A total of 2568 patients with complicated cirrhosis without HCC at baseline were enrolled. After propensity score matching, another 2568 patients with non-complicated cirrhosis were included. Hazards Cox regression analysis by using a competing risk regression model to control for possible confounding factors was utilized to estimate the association of the complications of liver cirrhosis with the risk of HCC. We observed by using competing risk analysis that the adjusted hazard ratio (HR) for developing HCC during the follow-up period after the initial hospitalization was higher among the patients with baseline complicated cirrhosis than in those with uncomplicated cirrhosis (HR, 1.23; 95% confidence interval, CI, 1.10-1.37, p<0.001). Additionally, older patients (HR, 1.01; 95% CI, 1.01-1.02, p<0.001), males (HR, 0.84; 95% CI, 0.74-0.96, p = 0.009), and patients with alcohol-related cirrhosis (HR, 1.93; 95% CI, 1.65-2.26, p<0.001) had a statistically significant difference in the incidence of HCC. In conclusion, complicated liver cirrhosis is associated with a higher risk of HCC in Taiwan compared with cirrhosis without complications.	[Hung, Tsung-Hsing] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Div Gastroenterol, Chiayi, Taiwan; [Hung, Tsung-Hsing] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Liang, Chih-Ming; Tai, Wei-Chen; Yang, Shih-Cheng; Wu, Cheng-Kun; Chuah, Seng-Kee] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Hsu, Chien-Ning] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Tai, Wei-Chen; Chuah, Seng-Kee] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Tsai, Kai-Lung] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Kaohsiung, Taiwan; [Ku, Ming-Kun] FooYin Univ Hosp, Div Gastroenterol, Pingtung, Taiwan; [Wang, Jiunn-Wei; Tseng, Kuo-Lun; Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Wang, Jiunn-Wei; Tseng, Kuo-Lun; Wu, Deng-Chyang] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Yuan, Lan-Ting] Yuan Gen Hosp, Div Gastroenterol, Kaohsiung, Taiwan; [Nguang, Seng-Howe] Pin Tung Christian Hosp, Div Gastroenterol, Pingtung, Taiwan; [Hsu, Pin-I] Natl Yang Ming Univ, Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University	Chuah, SK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Chuah, SK (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Wu, DC (corresponding author), Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan.; Wu, DC (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan.	dechwu@yahoo.com; Chuahsk@seecl.net.tw	Hsu, Chien-Ning/GLS-4014-2022	Hsu, Chien-Ning/0000-0001-7470-528X; Wang, Jiunn-Wei/0000-0003-2534-438X	Kaohsiung Medical University Aim for the Top Universities Grant [KMU-TP105G00, KMU-TP105G01]; Kaohsiung Medical University Hospital [KMUH105-5R02]; Kaohsiung Municipal Ta-Tung Hospital [KMTTH-105-019]	Kaohsiung Medical University Aim for the Top Universities Grant; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital	This study was supported partially by grants from Kaohsiung Medical University "Aim for the Top Universities Grant, (grant No. KMU-TP105G00, KMU-TP105G01), Kaohsiung Medical University Hospital (KMUH105-5R02) and Kaohsiung Municipal Ta-Tung Hospital (KMTTH-105-019). The funders had no role in study design, data collection nd analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2016, ONCOLOGY-BASEL, V91, P341, DOI 10.1159/000450551; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; BATEY RG, 1992, MED J AUSTRALIA, V156, P413, DOI 10.5694/j.1326-5377.1992.tb139846.x; Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056; Cabibbo G, 2010, EUR REV MED PHARMACO, V14, P352; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; FATTOVICH G, 1995, HEPATOLOGY, V21, P77; Huang YT, 2011, J CLIN ONCOL, V29, P3643, DOI 10.1200/JCO.2011.36.2335; Hung TH, 2013, EPIDEMIOL INFECT, V141, P2671, DOI 10.1017/S0950268813000186; Hung TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162987; Hung TH, 2016, GUT LIVER, V10, P803, DOI 10.5009/gnl13468; Hung TH, 2012, CLIN GASTROENTEROL H, V10, P677, DOI 10.1016/j.cgh.2012.02.026; International Agency for Research on Cancer (IARC), 1998, ALCOHOL DRINKING, V44, P207; Kalra M, 2008, WORLD J GASTROENTERO, V14, P5945, DOI 10.3748/wjg.14.5945; Kew MC, 2013, ANN HEPATOL, V12, P173, DOI 10.1016/S1665-2681(19)31354-7; Kim JH, 2016, J CLIN GASTROENTEROL, V50, P882, DOI 10.1097/MCG.0000000000000574; Kim MN, 2015, HEPATOLOGY, V61, P1851, DOI 10.1002/hep.27735; Liang CM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004795; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Ruggieri A, 2010, INT J CANCER, V127, P499, DOI 10.1002/ijc.25298; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Stickel F, 2015, ADV EXP MED BIOL, V815, P113, DOI 10.1007/978-3-319-09614-8_7; Turati F, 2014, ANN ONCOL, V25, P1526, DOI 10.1093/annonc/mdu020; Walker M, 2016, ALIMENT PHARM THER, V43, P621, DOI 10.1111/apt.13505; Wang JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164824	28	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181858	10.1371/journal.pone.0181858	http://dx.doi.org/10.1371/journal.pone.0181858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742130	Green Submitted, gold, Green Published			2022-12-26	WOS:000406362700080
J	Lai, CC; Ho, CH; Chen, CM; Chiang, SR; Chao, CM; Liu, WL; Lin, YC; Wang, JJ; Cheng, KC				Lai, Chih-Cheng; Ho, Chung-Han; Chen, Chin-Ming; Chiang, Shyh-Ren; Chao, Chien-Ming; Liu, Wei-Lun; Lin, Yu-Chieh; Wang, Jhi-Joung; Cheng, Kuo-Chen			Long-term risk of dementia after acute respiratory failure requiring intensive care unit admission	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; CRITICAL ILLNESS; EPIDEMIOLOGY; IMPAIRMENT; SURVIVORS; OUTCOMES; DISEASE	This retrospective, population-based cohort study aims to investigate the long-term risk of newly diagnosed dementia in patients discharged for acute respiratory failure that required mechanical ventilation (MV) and intensive care unit (ICU) admission. From the Taiwan National Health Insurance Research Database, first-time ICU patients using MV between June 1, 1998, and December 31, 2012, were enrolled, and they were followed-up until the earliest onset of one of our two endpoints: a new diagnosis of dementia (primary endpoint), or the end of the study. A total of 18,033 patients were enrolled and thirteen hundred eighty-seven patients had been newly diagnosed with dementia (mean onset: 3.2 years post-discharge). Patients >= 85 years old had the highest risk (multivariate analysis). Males had a lower risk than did females in both models (HR: 0.81, 95% CI: 0.72-0.9 in model 1; HR: 0.80, 95% CI: 0.72-0.89 in model 2). ICU stays > 5 days, hospital stays > 14 days, and more ICU readmissions were associated with a higher risk of developing dementia. In conclusion, the long-term risks of a subsequent diagnosis of dementia for acute respiratory failure with MV patients who survive to discharge increase with age and are higher in women than in men. Additionally, the longer the ICU or hospital stay is, and the more ICU readmissions a patient has, are both significantly associated with developing dementia.	[Lai, Chih-Cheng; Chao, Chien-Ming; Liu, Wei-Lun] Chi Mei Med Ctr, Dept Intens Care Med, Liouying, Taiwan; [Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Chen, Chin-Ming] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chen, Chin-Ming; Chiang, Shyh-Ren] Chia Nan Univ Pharm Sci, Tainan, Taiwan; [Chiang, Shyh-Ren; Cheng, Kuo-Chen] Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Yu-Chieh] Chi Mei Med Ctr, Dept Family Med, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Cheng, Kuo-Chen] Chung Hwa Univ Med Technol, Dept Safety Hlth & Environm Engn, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chi Mei Hospital; Chung Hua University	Cheng, KC (corresponding author), Mei Med Ctr, Dept Internal Med, Tainan, Taiwan.; Cheng, KC (corresponding author), Chung Hwa Univ Med Technol, Dept Safety Hlth & Environm Engn, Tainan, Taiwan.	kcg.cheng@gmail.com		Ho, Chung-Han/0000-0001-5925-8477				Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Carson Shannon S, 2006, J Intensive Care Med, V21, P173, DOI 10.1177/0885066605282784; Chen TB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175475; Collett D, 1994, MODELLING SURVIVAL D; Debette S, 2013, REV NEUROL-FRANCE, V169, P757, DOI 10.1016/j.neurol.2013.07.022; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Elias MF, 2013, CONTRIB NEPHROL, V179, P42, DOI 10.1159/000346722; Fan YC, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0236-z; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guerra C, 2015, ANESTHESIOLOGY, V123, P1105, DOI 10.1097/ALN.0000000000000821; Guerra C, 2012, CRIT CARE, V16, DOI 10.1186/cc11901; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Iwashyna TJ, 2010, ANN INTERN MED, V153, P204, DOI 10.7326/0003-4819-153-3-201008030-00013; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jones C, 2006, INTENS CARE MED, V32, P923, DOI 10.1007/s00134-006-0112-y; Kovacic JC, 2012, MT SINAI J MED, V79, P664, DOI 10.1002/msj.21347; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Sahathevan R, 2012, INT J STROKE, V7, P61, DOI 10.1111/j.1747-4949.2011.00731.x; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Tsai HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171671; Vagelatos NT, 2013, EPIDEMIOL REV, V35, P152, DOI 10.1093/epirev/mxs012; Wong CS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002549	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0180914	10.1371/journal.pone.0180914	http://dx.doi.org/10.1371/journal.pone.0180914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742105	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700021
J	Leiser, S; Deruaz-Luyetl, A; N'Goran, AA; Pasquier, J; Streit, S; Neuner-Jehle, S; Zeller, A; Haller, DM; Herzig, L; Bodenmann, P				Leiser, Silja; Deruaz-Luyetl, Anouk; N'Goran, A. Alexandra; Pasquier, Jerome; Streit, Sven; Neuner-Jehle, Stefan; Zeller, Andreas; Haller, Dagmar M.; Herzig, Lilli; Bodenmann, Patrick			Determinants associated with deprivation in multimorbid patients in primary care-A cross-sectional study in Switzerland	PLOS ONE			English	Article							OF-THE-LITERATURE; SOCIOECONOMIC-STATUS; HEART-FAILURE; CHRONIC PAIN; HEALTH-CARE; RISK; EPIDEMIOLOGY; PREVALENCE; EDUCATION	Background Deprivation usually encompasses material, social, and health components. It has been shown to be associated with greater risks of developing chronic health conditions and of worse outcome in multimorbidity. The DipCare questionnaire, an instrument developed and validated in Switzerland for use in primary care, identifies patients subject to potentially higher levels of deprivation. Objectives To identifying determinants of the material, social, and health profiles associated with deprivation in a sample of multimorbid, primary care patients, and thus set priorities in screening for deprivation in this population. Design Secondary analysis from a nationwide cross-sectional study in Switzerland. Participants A random sample of 886 adult patients suffering from at least three chronic health conditions. Main measures The outcomes of interest were the patients' levels of deprivation as measured using the DipCare questionnaire. Classification And Regression Tree analysis identified the independent variables that separated the examined population into groups with increasing deprivation scores. Finally, a sensitivity analysis (multivariate regression) confirmed the robustness of our results. Key results Being aged under 64 years old was associated with higher overall, material, and health deprivation; being aged over 77 years old was associated with higher social deprivation. Other variables associated with deprivation were the level of education, marital status, and the presence of depression or chronic pain. Conclusion Specific profiles, such as being younger, were associated with higher levels of overall, material, and health deprivation in multimorbid patients. In contrast, patients over 77 years old reported higher levels of social deprivation. Furthermore, chronic pain and depression added to the score for health deprivation. It is important that GPs consider the possibility of deprivation in these multimorbid patients and are able to identify it, both in order to encourage treatment adherence and limit any forgoing of care for financial reasons.	[Leiser, Silja; Deruaz-Luyetl, Anouk; N'Goran, A. Alexandra; Herzig, Lilli] Univ Lausanne, Inst Family Med, Lausanne, Switzerland; [Pasquier, Jerome] Univ Lausanne, Inst Prevent & Social Med, Lausanne, Switzerland; [Streit, Sven] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Neuner-Jehle, Stefan] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Zeller, Andreas] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland; [Haller, Dagmar M.] Univ Geneva, Primary Care Unit, Fac Med, Geneva, Switzerland; [Bodenmann, Patrick] Lausanne Univ Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Bern; University of Zurich; University of Basel; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Leiser, S (corresponding author), Univ Lausanne, Inst Family Med, Lausanne, Switzerland.	silja.eiser@gmail.com	Neuner-Jehle, Stefan/W-3094-2019; Streit, Sven/I-3788-2019; Haller, Dagmar M./AAA-5078-2021	Streit, Sven/0000-0002-3813-4616; Bodenmann, Patrick/0000-0002-1058-1035; Neuner-Jehle, Stefan/0000-0002-6260-8148; Haller, Dagmar/0000-0003-1781-3318	Swiss University; Swiss university family medicine institute (Basel) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Bern) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Geneva) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Zurich) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Lausanne) under Swiss Academy of Family Medicine (SAFMED)	Swiss University; Swiss university family medicine institute (Basel) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Bern) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Geneva) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Zurich) under Swiss Academy of Family Medicine (SAFMED); Swiss university family medicine institute (Lausanne) under Swiss Academy of Family Medicine (SAFMED)	The Swiss University Conference granted funding to reinforce teaching and research in primary care in Switzerland. Within this framework of financial support, the five Swiss university family medicine institutes (Basel, Bern, Geneva, Zurich, and Lausanne) collaborated under the denomination of the Swiss Academy of Family Medicine (SAFMED). The Swiss University Conference had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAG, 2016, FAKT PRAM, P242; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bloch G, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-62; Blyth FM, 2003, PAIN, V103, P41, DOI 10.1016/S0304-3959(02)00380-9; Bodenmann P, 2014, PLOS ONE; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Briesacher BA, 2007, J GEN INTERN MED, V22, P864, DOI 10.1007/s11606-007-0180-x; Chaturvedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094048; Deruaz-luyet A, 2015, MULTIMORBIDITY PRIMA; Egan M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-239; Guessous I, 2012, HIGH PREVALENCE FORG; Guggisberg M, 2014, FSO NEWS; Hardee JT, 2005, J GEN INTERN MED, V20, P666, DOI 10.1111/j.1525-1497.2005.0125.x; Hawkins NM, 2012, EUR J HEART FAIL, V14, P138, DOI 10.1093/eurjhf/hfr168; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Lewis R.J., 2000, ANN M SOC AC EM MED, V14; Linn BS, 1968, J AM GERIATR SOC; Macleod U, 2004, EUR J; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Marmot M, 1999, ANN NY ACAD SCI, V896, P16, DOI 10.1111/j.1749-6632.1999.tb08102.x; Marmot M., 2013, REV SOCIAL DETERMINA; N'Goran AA, 2016, FAM PRACT, V33, P439, DOI 10.1093/fampra/cmw030; Rathore SS, 2006, AM HEART J, V152, P371, DOI 10.1016/j.ahj.2005.12.002; Rose G., 1992, STRATEG PREV MED; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Salisbury C, 2011, BR J GEN PR; Salmond C, 2006, SOC SCI MED; Sass C, COMP SCORE INDIVIDUE; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Therneau TM., 2015, INTRO RECURSIVE PART; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Van den Akker M, 1998, J CLIN; van den Akker M, 1996, EUR J; Vaucher P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000692; World Health Organization, 2013, NUTR PHYS ACT OB NET, V2013, P5	37	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181534	10.1371/journal.pone.0181534	http://dx.doi.org/10.1371/journal.pone.0181534			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB8BB	28738070	Green Published, gold, Green Submitted			2022-12-26	WOS:000406362700051
J	McElroy, JA; Kruse, RL; Guthrie, J; Gangnon, RE; Robertson, JD				McElroy, Jane A.; Kruse, Robin L.; Guthrie, James; Gangnon, Ronald E.; Robertson, J. David			Cadmium exposure and endometrial cancer risk: A large midwestern US population-based case-control study	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; IOWA WOMENS HEALTH; DIETARY-CADMIUM; URINARY CADMIUM; PROSPECTIVE COHORT; IRON STATUS; IN-VIVO; ESTROGEN; METAANALYSIS; CREATININE	Estrogen-mimicking chemicals, such as cadmium, may be associated with increased susceptibility to hormone-dependent cancers, though supporting data are sparse, particularly for endometrial cancer. The Health and Environmental Exposure Research (HEER) study worked with the Arkansas Central Cancer Registry, Iowa Cancer Registry and Missouri Cancer Registry to obtain names of women diagnosed with endometrial cancer who were willing to be contacted for participation in our case control study. Voter registration lists from Iowa and Missouri were used to randomly select similarly aged women as represented in the case population. Participants were interviewed by telephone to obtain information on known or suspected endometrial risk factors. Urine kits were sent to participants for home collection and returned for analysis. Our case-control study consisted of 631 incident cases of endometrial cancer diagnosed from January 2010 to October 2012 and 879 age-matched population-based controls, ages 18-81 years (mean age 65 years). We quantified cadmium amounts in urine and standardized these values through creatinine adjustment. Using data from all survey completers, we developed a multivariable model for endometrial cancer. Creatinine-adjusted cadmium concentration was added to this model. Odds ratio (OR) and 95% confidence intervals (CIs) for endometrial cancer were calculated. After multivariable adjustment, higher creatinine-adjusted cadmium exposure was associated with a statistically significant increase of endometrial cancer risk (OR: 1.22; 95% CI: 1.03-1.44). Our results provide evidence that cadmium may increase the risk of endometrial cancer, possibly through estrogenic effects.	[McElroy, Jane A.; Kruse, Robin L.] Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65211 USA; [McElroy, Jane A.; Guthrie, James; Robertson, J. David] Univ Missouri, Res Reactor Ctr, Columbia, MO 65211 USA; [Gangnon, Ronald E.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI USA; [Gangnon, Ronald E.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia	McElroy, JA (corresponding author), Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65211 USA.; McElroy, JA (corresponding author), Univ Missouri, Res Reactor Ctr, Columbia, MO 65211 USA.	mcelroyja@missouri.edu		Gangnon, Ronald/0000-0003-2587-6714; McElroy, Jane/0000-0001-7518-747X	American Cancer Society [RSG-10-197-01-CNE]; National Science Foundation [BCS-0922374]; National Program of Cancer Registries, Centersfor Disease Control and Prevention (CDC); Missouri Cancer Registry and Research Center,cooperative agreement between the CDC; Missouri Department of Health and Senior Services (DHSS) [5NU58DP003924-04]; Surveillance Contract between DHSS; University of Missouri. State Health Registry of Iowa, Iowa Cancer Registry,Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261201000032C]	American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); National Program of Cancer Registries, Centersfor Disease Control and Prevention (CDC); Missouri Cancer Registry and Research Center,cooperative agreement between the CDC; Missouri Department of Health and Senior Services (DHSS); Surveillance Contract between DHSS; University of Missouri. State Health Registry of Iowa, Iowa Cancer Registry,Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services	This work was supported by the American Cancer Society (RSG-10-197-01-CNE; www.acs.org) and the National Science Foundation (BCS-0922374). TheArkansas Central Cancer Registry is fully funded by a grant from the National Program of Cancer Registries, Centersfor Disease Control and Prevention (CDC). Missouri Cancer Registry and Research Center is supported in part by a cooperative agreement between the CDC and the Missouri Department of Health and Senior Services (DHSS) (5NU58DP003924-04) and a Surveillance Contract between DHSS and the University of Missouri. State Health Registry of Iowa, Iowa Cancer Registry is funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under contract no. HHSN261201000032C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2014, ENVIRON HEALTH PERSP, V122, P594, DOI 10.1289/ehp.1307054; Adams SV, 2014, J EXPO SCI ENV EPID, V24, P163, DOI 10.1038/jes.2013.55; Adams SV, 2012, OCCUP ENVIRON MED, V69, P153, DOI 10.1136/oemed-2011-100111; Akesson A, 2002, AM J PUBLIC HEALTH, V92, P284, DOI 10.2105/AJPH.92.2.284; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Ali I, 2010, ENVIRON HEALTH PERSP, V118, P1389, DOI 10.1289/ehp.1001967; American Cancer Society, 2017, KEY STAT END CANC; [Anonymous], 2017, LIF SCI TRAC EL EP; [Anonymous], 2015, PENN MED PROGR LGBT; [Anonymous], 2017, CAR US NALG LABW; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Cabrera C, 1998, Rev Environ Contam Toxicol, V154, P55; Centers for Disease Control and Prevention, 2013, NHANES ENV CHEM DAT; CHANEY RL, 1999, DEV PLANT SOIL SCI C, P219; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Davies J L, 1981, Obstet Gynecol Surv, V36, P107, DOI 10.1097/00006254-198103000-00001; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Elinder C-G, 1985, CADMIUM HLTH TOXICOL, P81; Eriksen KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100815; Friberg L., 1985, CADMIUM HLTH TOXICOL, VII; Furberg AS, 2003, INT J CANCER, V104, P669, DOI 10.1002/ijc.10974; Ganmaa D, 2012, INT J CANCER, V130, P2664, DOI 10.1002/ijc.26265; Garcia-Esquinas E, 2014, ENVIRON HEALTH PERSP, V122, P363, DOI 10.1289/ehp.1306587; Green GA, 2001, CLIN J SPORT MED, V11, P254, DOI 10.1097/00042752-200110000-00008; Haswell-Elkins M, 2007, J EXPO SCI ENV EPID, V17, P298, DOI 10.1038/sj.jes.7500547; Jarrett JM, 2008, J ANAL ATOM SPECTROM, V23, P962, DOI 10.1039/b801927d; JAWAID M, 1983, TALANTA, V30, P509, DOI 10.1016/0039-9140(83)80119-2; Johnson MD, 2003, NAT MED, V9, P1081, DOI 10.1038/nm902; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Key TJ, 2002, LANCET, V360, P861, DOI 10.1016/S0140-6736(02)09958-0; Klaassen C D, 1981, Fundam Appl Toxicol, V1, P353, DOI 10.1016/S0272-0590(81)80003-6; Little RJ, 2003, STAT MED, V22, P1589, DOI 10.1002/sim.1513; Lobo RA., 2000, MENOPAUSE BIOL PATHO; Mason HJ, 1998, OCCUP ENVIRON MED, V55, P132, DOI 10.1136/oem.55.2.132; McElroy JA, 2007, SCI TOTAL ENVIRON, V382, P214, DOI 10.1016/j.scitotenv.2007.04.015; McElroy JA, 2006, JNCI-J NATL CANCER I, V98, P869, DOI 10.1093/jnci/djj233; McPherson CP, 1996, AM J EPIDEMIOL, V143, P1195, DOI 10.1093/oxfordjournals.aje.a008707; Moore SC, 2010, BRIT J CANCER, V103, P933, DOI 10.1038/sj.bjc.6605902; Olson JE, 2002, CANCER-AM CANCER SOC, V94, P1612, DOI 10.1002/cncr.10370; Olsson IM, 2002, ENVIRON HEALTH PERSP, V110, P1185, DOI 10.1289/ehp.021101185; Piltonen TT, 2016, BEST PRACT RES CL OB, V37, P66, DOI 10.1016/j.bpobgyn.2016.03.008; Quraishi SM, 2016, J EXPO SCI ENV EPID, V26, P303, DOI 10.1038/jes.2015.40; RYAN JA, 1982, ENVIRON RES, V28, P251, DOI 10.1016/0013-9351(82)90128-1; Satarug S, 2003, TOXICOL LETT, V137, P65, DOI 10.1016/S0378-4274(02)00381-8; Sawada N, 2012, EPIDEMIOLOGY, V23, P368, DOI 10.1097/EDE.0b013e31824d063c; Setiawan VW, 2008, INT J CANCER, V122, P634, DOI 10.1002/ijc.23072; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; Sturgeon SR, 2012, CANCER CAUSE CONTROL, V23, P547, DOI 10.1007/s10552-012-9912-2; Suwazono Y, 2005, BIOMARKERS, V10, P117, DOI 10.1080/13547500500159001; Tokmak A, 2014, ASIAN PAC J CANCER P, V15, P7011, DOI 10.7314/APJCP.2014.15.17.7011; Vacchi-Suzzi C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138784; Vahter M, 2007, ENVIRON RES, V104, P85, DOI 10.1016/j.envres.2006.08.003; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; Weiderpass E, 1999, CANCER CAUSE CONTROL, V10, P277, DOI 10.1023/A:1008945721786; Win AK, 2015, OBSTET GYNECOL, V125, P89, DOI 10.1097/AOG.0000000000000563; Yang HP, 2013, AM J EPIDEMIOL, V177, P142, DOI 10.1093/aje/kws200; Zhou B, 2008, AM J MED, V121, P501, DOI 10.1016/j.amjmed.2008.01.044	58	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0179360	10.1371/journal.pone.0179360	http://dx.doi.org/10.1371/journal.pone.0179360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28742092	Green Submitted, gold, Green Published			2022-12-26	WOS:000406362700006
J	Keith, RA; Mitchell-Olds, T				Keith, Rose A.; Mitchell-Olds, Thomas			Testing the optimal defense hypothesis in nature: Variation for glucosinolate profiles within plants	PLOS ONE			English	Article							CHEMICAL DIVERSITY; PATTERNS; HERBIVORY; BOECHERA; DIFFERENTIATION; POLYMORPHISM; ALLOCATION; SELECTION; FITNESS; COSTS	Plants employ highly variable chemical defenses against a broad community of herbivores, which vary in their susceptibilities to specific compounds. Variation in chemical defenses within the plant has been found in many species; the ecological and evolutionary influences on this variation, however, are less well-understood. One central theory describing the allocation of defenses in the plant is the Optimal Defense Hypothesis (ODH), which predicts that defenses will be concentrated in tissues that are of high fitness value to the plant. Although the ODH has been repeatedly supported within vegetative tissues, few studies have compared vegetative and reproductive tissues, and the results have not been conclusive. We quantified variation in glucosinolate profile and tissue value between vegetative and reproductive tissues in Boechera stricta, a close relative of Arabidopsis. B. stricta manufactures glucosinolates, a set of defensive compounds that vary genetically and are straightforward to quantify. Genetic diversity in glucosinolate profile has been previously demonstrated to be important to both herbivory and fitness in B. stricta; however, the importance of glucosinolate variation among tissues has not. Here, we investigate whether allocation of glucosinolates within the plant is consistent with the ODH. We used both clipping experiments on endogenous plants and ambient herbivory in a large-scale transplant experiment at three sites to quantify fitness effects of loss of rosette leaves, cauline leaves, and flowers and fruits. We measured glucosinolate concentration in leaves and fruits in the transplant experiment, and asked whether more valuable tissues were more defended. We also investigated within-plant variation in other aspects of the glucosinolate profile. Our results indicated that damage to fruits had a significantly larger effect on overall fitness than damage to leaves, and that fruits had much higher concentrations of glucosinolates, supporting the ODH. This is, to the best of our knowledge, the first study to explicitly compare both tissue value and chemical defense concentrations between vegetative and reproductive tissues under natural conditions.	[Keith, Rose A.; Mitchell-Olds, Thomas] Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA; [Keith, Rose A.; Mitchell-Olds, Thomas] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University; Duke University	Mitchell-Olds, T (corresponding author), Duke Univ, Univ Program Genet & Genom, Durham, NC 27708 USA.; Mitchell-Olds, T (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	tmo1@duke.edu	; Mitchell-Olds, Thomas/K-8121-2012	Keith, Rose/0000-0003-1129-1969; Mitchell-Olds, Thomas/0000-0003-3439-9921	National Science Foundation [1406805]; National Institute of Health [R01GM086496]; NSF [1406805]; NIH [R01GM086496]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007754, R01GM086496] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by: National Science Foundation grant 1406805 to RK, https://www.nsf.gov; National Institute of Health grant R01GM086496 to TMO, https://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Catherine Rushworth, Margaret Wagner, Kathryn Ghattas, Lauren Carley, and Chris Finn for assistance with plant care, field work, data collection, and HPLC analyses. This research was supported by NSF grant 1406805 to RK, and NIH grant R01GM086496 to TMO.	Alves MN, 2007, J CHEM ECOL, V33, P297, DOI 10.1007/s10886-006-9214-9; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bidart-Bouzat MG, 2008, J CHEM ECOL, V34, P1026, DOI 10.1007/s10886-008-9498-z; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Brunelle A, 2005, QUATERNARY SCI REV, V24, P2281, DOI 10.1016/j.quascirev.2004.11.010; Cazetta E, 2008, OECOLOGIA, V155, P277, DOI 10.1007/s00442-007-0917-6; Clarke DB, 2010, ANAL METHODS-UK, V2, P310, DOI 10.1039/b9ay00280d; Clauss MJ, 2006, J CHEM ECOL, V32, P2351, DOI 10.1007/s10886-006-9150-8; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Godschalx AL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0719-2; Gols R, 2008, ECOLOGY, V89, P1616, DOI 10.1890/07-0873.1; Heath JJ, 2014, NEW PHYTOL, V202, P1357, DOI 10.1111/nph.12755; HERRERA CM, 1982, AM NAT, V120, P218, DOI 10.1086/283984; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Jorgensen ME, 2015, TRENDS PLANT SCI, V20, P508, DOI 10.1016/j.tplants.2015.04.006; Lankau RA, 2008, AM NAT, V171, P150, DOI 10.1086/524959; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; Lee CR, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0119; Lee CR, 2013, MOL ECOL, V22, P2204, DOI 10.1111/mec.12250; Lee CR, 2011, MOL ECOL, V20, P4631, DOI 10.1111/j.1365-294X.2011.05310.x; Manzaneda AJ, 2010, NEW PHYTOL, V188, P464, DOI 10.1111/j.1469-8137.2010.03385.x; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; McKey D, 1979, HERBIVORES THEIR INT, P55; Moyes CL, 2000, J CHEM ECOL, V26, P2625, DOI 10.1023/A:1005549115751; Muller R, 2010, J CHEM ECOL, V36, P905, DOI 10.1007/s10886-010-9825-z; NELSON CJ, 1981, J CHEM ECOL, V7, P981, DOI 10.1007/BF00987622; Newton EL, 2009, OECOLOGIA, V160, P63, DOI 10.1007/s00442-009-1281-5; Poelman EH, 2009, ECOLOGY, V90, P1863, DOI 10.1890/08-0977.1; Prasad KVSK, 2012, SCIENCE, V337, P1081, DOI 10.1126/science.1221636; REICHMAN OJ, 1991, ECOLOGY, V72, P116, DOI 10.2307/1938907; Rhoades DF, 1979, HERBIVORES THEIR INT, P1; Rushworth CA, 2011, MOL ECOL, V20, P4843, DOI 10.1111/j.1365-294X.2011.05340.x; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Traw MB, 2008, ECOLOGY, V89, P763, DOI 10.1890/07-0729.1; Whitehead SR, 2013, J CHEM ECOL, V39, P1373, DOI 10.1007/s10886-013-0362-4; Wise MJ, 2008, EVOL ECOL, V22, P19, DOI 10.1007/s10682-007-9156-x; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	42	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2017	12	7							e0180971	10.1371/journal.pone.0180971	http://dx.doi.org/10.1371/journal.pone.0180971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC2BU	28732049	gold, Green Published, Green Submitted			2022-12-26	WOS:000406643100019
J	Andre-Garnier, E; Besse, B; Rodallec, A; Ribeyrol, O; Ferre, V; Luco, C; Le Guen, L; Bourgeois, N; Gournay, J; Billaud, E; Raffi, F; Coste-Burel, M; Imbert-Marcille, BM				Andre-Garnier, Elisabeth; Besse, Bernard; Rodallec, Audrey; Ribeyrol, Olivier; Ferre, Virginie; Luco, Caroline; Le Guen, Laura; Bourgeois, Nathalie; Gournay, Jerome; Billaud, Eric; Raffi, Francois; Coste-Burel, Marianne; Imbert-Marcille, Berthe-Marie			An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains	PLOS ONE			English	Article							ANTIVIRAL DRUGS; VIRUS; HCV; SOFOSBUVIR; INFECTION; VELPATASVIR; VARIANTS; THERAPY; NS3	The objective was to develop a method of HCV genome sequencing that allowed simultaneous genotyping and NS5A inhibitor resistance profiling. In order to validate the use of a unique RT-PCR for genotypes 1-5, 142 plasma samples from patients infected with HCV were analysed. The NS4B-NS5A partial region was successfully amplified and sequenced in all samples. In parallel, partial NS3 sequences were analyzed obtained for genotyping. Phylogenetic analysis showed concordance of genotypes and subtypes with a bootstrap >95% for each type cluster. NS5A resistance mutations were analyzed using the Geno2-pheno [hcv] v0.92 tool and compared to the list of known Resistant Associated Substitutions recently published. In conclusion, this tool allows determination of HCV genotypes, subtypes and identification of NS5A resistance mutations. This single method can be used to detect pre-existing resistance mutations in NS5A before treatment and to check the emergence of resistant viruses while undergoing treatment in major HCV genotypes (G1-5) in the EU and the US	[Andre-Garnier, Elisabeth; Besse, Bernard; Rodallec, Audrey; Ribeyrol, Olivier; Ferre, Virginie; Luco, Caroline; Le Guen, Laura; Coste-Burel, Marianne; Imbert-Marcille, Berthe-Marie] CHU Nantes, Serv Virol, Nantes, France; [Andre-Garnier, Elisabeth; Imbert-Marcille, Berthe-Marie] Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR1064, Nantes, France; [Bourgeois, Nathalie] CHU Nantes, Plateforme Sequencage, Nantes, France; [Gournay, Jerome] CHU Nantes, Serv Hepatogastroenterol, Nantes, France; [Billaud, Eric; Raffi, Francois] CHU Nantes, Serv Malad Infect & Trop, Nantes, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Andre-Garnier, E (corresponding author), CHU Nantes, Serv Virol, Nantes, France.; Andre-Garnier, E (corresponding author), Univ Nantes, INSERM, Ctr Rech Transplantat & Immunol, UMR1064, Nantes, France.	elisabeth.andre@chu-nantes.fr						Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Andre-Garnier E, 2016, ANTIVIR THER; Besse B, 2012, J VIROL METHODS, V185, P94, DOI 10.1016/j.jviromet.2012.06.011; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Dvory-Sobol H, 2015, J HEPATOL, V62, pS221, DOI 10.1016/S0168-8278(15)30073-8; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Fourati S, 2015, VIRUSES-BASEL, V7, P6346, DOI 10.3390/v7122941; Jacobson IM, 2015, HEPATOLOGY, V62, p1393A; Jesudian Arun B, 2012, Gastroenterol Hepatol (N Y), V8, P91; Kalaghatgi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155869; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Larrat S, 2015, J CLIN MICROBIOL, V53, P2195, DOI 10.1128/JCM.03633-14; Lole KS, 2003, J CLIN MICROBIOL, V41, P5240, DOI 10.1128/JCM.41.11.5240-5244.2003; Mansoor S, 2016, INFECT GENET EVOL, V44, P61, DOI 10.1016/j.meegid.2016.06.031; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2016, GASTROENTEROLOGY, V151, P70, DOI 10.1053/j.gastro.2016.04.003; Pawlotsky JM, 2014, SEMIN LIVER DIS, V34, P7, DOI 10.1055/s-0034-1371178; Pawlotsky JM, 2013, CURR TOP MICROBIOL, V369, P321, DOI 10.1007/978-3-642-27340-7_13; Poordad F, 2011, AM J MANAG CARE, V17, pS123; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2017	12	7							e179562	10.1371/journal.pone.0179562	http://dx.doi.org/10.1371/journal.pone.0179562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1YQ	28727784	Green Published, Green Submitted, gold			2022-12-26	WOS:000406634500006
J	Tashiro, M; Iwata, A; Yamauchi, M; Shimizu, K; Okada, A; Ishiguro, N; Inoshima, Y				Tashiro, Manami; Iwata, Ami; Yamauchi, Marika; Shimizu, Kaori; Okada, Ayaka; Ishiguro, Naotaka; Inoshima, Yasuo			The N-terminal region of serum amyloid A3 protein activates NF-kappa B and up-regulates MUC2 mucin mRNA expression in mouse colonic epithelial cells	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; GENE-EXPRESSION; IN-VITRO; BACTERIA; ALPHA; MICE; DEXAMETHASONE; MICROBIOTA; CYTOKINES; PATHWAY	Serum amyloid A (SAA) is the major acute-phase protein and a precursor of amyloid A (AA) in AA amyloidosis in humans and animals. SAA isoforms have been identified in a wide variety of animals, such as SAA1, SAA2, SAA3, and SAA4 in mouse. Although the biological functions of SAA isoforms are not completely understood, recent studies have suggested that SAA3 plays a role in host defense. Expression of SAA3 is increased on the mouse colon surface in the presence of microbiota in vivo, and it increases mRNA expression of mucin 2 (MUC2) in murine colonic epithelial cells in vitro, which constitutes a protective mucus barrier in the intestinal tract. In this study, to identify responsible regions in SAA3 for MUC2 expression, recombinant murine SAA1 (rSAA1), rSAA3, and rSAA1/3, a chimera protein constructed with mature SAA1 (amino acids 1-36) and SAA3 (amino acids 37-103), and vice versa for rSAA3/1, were added to murine colonic epithelial CMT-93 cells, and the mRNA expressions of MUC2 and cytokines were measured. Inhibition assays with NF-kappa B inhibitor or TLR4/MD2 inhibitor were also performed. Up-regulation of MUC2 mRNA expression was strongly stimulated by rSAA3 and rSAA3/1, but not by rSAA1 or rSAA1/3. Moreover, NF-kappa B and TLR4/MD2 inhibitors suppressed the increase of MUC2 mRNA expression. These results suggest that the major responsible region for MUC2 expression exists in amino acids 1-36 of SAA3, and that up-regulations of MUC2 expression by SAA3 and SAA3/1 are involved with activation of NF-kappa B via the TLR4/MD2 complex.	[Tashiro, Manami; Iwata, Ami; Yamauchi, Marika; Shimizu, Kaori; Okada, Ayaka; Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, Fac Appl Biol Sci, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan; [Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan; [Inoshima, Yasuo] Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan	Gifu University; Gifu University	Inoshima, Y (corresponding author), Gifu Univ, Fac Appl Biol Sci, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan.	inoshima@gifu-u.ac.jp		Moriyama, Masafumi/0000-0003-2911-2244	Research Center for Zoonosis Control, Hokkaido University; Ministry of Education, Culture, Sports, Science and Technology, Japan; Ito Foundation, Japan;  [25292171];  [16H05027]	Research Center for Zoonosis Control, Hokkaido University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ito Foundation, Japan; ; 	This study was partly supported by a Grant-in-Aid for Scientific Research (No. 25292171 and 16H05027) and the Grant for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Ito Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by Grant-in-Aid for Scientific Research (No. 25292171 and 16H05027) and the Grant for Joint Research Program of the Research Center for Zoonosis Control, Hokkaido University, from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Ito Foundation, Japan.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bottero Virginie, 2003, Mol Diagn, V7, P187, DOI 10.2165/00066982-200307030-00008; Cadera EJ, 2009, J EXP MED, V206, P1803, DOI 10.1084/jem.20082815; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; DEBEER MC, 1995, J LIPID RES, V36, P526; Deguchi A, 2013, J IMMUNOL, V191, P1856, DOI 10.4049/jimmunol.1201996; Dilly AK, 2015, TRANSL RES, V166, P344, DOI 10.1016/j.trsl.2015.03.004; Eckhardt ERM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-133; Enss ML, 2000, INFLAMM RES, V49, P162, DOI 10.1007/s000110050576; Fasshauer M, 2004, J ENDOCRINOL, V183, P561, DOI 10.1677/joe.1.05699; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x; Kasahara DI, 2014, AM J PHYSIOL-LUNG C, V306, pL508, DOI 10.1152/ajplung.00235.2013; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Mack DR, 2003, PEDIATR RES, V53, P137, DOI 10.1203/01.PDR.0000041517.15440.F3; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Mejias-Luque R, 2008, BBA-MOL CELL RES, V1783, P1728, DOI 10.1016/j.bbamcr.2008.05.020; Obici L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13580; Rahman A, 2011, CLIN EXP IMMUNOL, V163, P123, DOI 10.1111/j.1365-2249.2010.04282.x; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shigemura H, 2014, J VET MED SCI, V76, P985, DOI 10.1292/jvms.14-0007; SHIMIZU H, 1994, GENE, V149, P305; Son DS, 2004, ENDOCRINOLOGY, V145, P2245, DOI 10.1210/en.2003-1261; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	30	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2017	12	7							e0181796	10.1371/journal.pone.0181796	http://dx.doi.org/10.1371/journal.pone.0181796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8BB	28738073	gold, Green Published, Green Submitted			2022-12-26	WOS:000406362700072
